{
    "pages": [
        {
            "index": 0,
            "markdown": "![img-0.jpeg](img-0.jpeg)\n\n# 2. Posterior mid-calf communicating veins \n\nlocated posteriorly $5+12 \\mathrm{~cm}$ above os calcis joining lesser saphenous vein to peroneal veins\n3. Soleal + gastrocnemius points joining short saphenous vein to soleal / gastrocnemius veins\n\n## PHASICITY\n\n[ phasis, Greek = speech]\n$=$ description of fluctuating / undulating cyclic (phasic) flow events ( $=$ velocity changes of acceleration, deceleration, direction) in a vessel audible by Doppler / graphically depicted as a Doppler waveform\nCause: pressure gradients generated by cardiac $\\pm$ respiratory activity and exerted on the \"column\" of blood within the interrogated vessel segment\nOrigin: audible Doppler sounds created by changes in flow acceleration\nAntegrade flow may be either toward or away from the transducer, depending on the spatial relationship of the transducer to the vessel. Therefore, antegrade flow may be displayed above or below the baseline.\nAmbiguous terminology:\n\n1. Flow direction: above / below baseline (favored)\n2. Points of inflection $=$ modulation of pitch (original)\n\n## PULSATILITY\n\n$=$ assessment of vascular resistance (increased resistance reduces diastolic flow)\n$\\diamond$ Can be assessed in vessels too small / tortuous to be imaged (Doppler angle unnecessary)!\n$\\diamond$ Index should be calculated for each of several cardiac cycles ( 5 heartbeats adequate) an average value taken\n\n$$\n\\mathrm{S}=\\mathrm{A}=\\text { maximal systolic shift }\n$$",
            "images": [
                {
                    "id": "img-0.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 189,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 838,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 1,
            "markdown": "$$\n\\mathrm{D}=\\mathrm{B}=\\text { end-diastolic frequency shift }\n$$\n\n1. Full pulsatility index of Gosling (PIF) $=1 / \\mathrm{A} 0_{2} \\mathrm{SAi}_{2}$\n2. Simplified pulsatility index $(\\mathrm{PI})=(\\mathrm{S}-\\mathrm{D}) /$ mean\n3. Resistance index $(\\mathrm{RI})=$ Pourcelot index $=(\\mathrm{S}-\\mathrm{D}) / \\mathrm{S}$ or $1-(\\mathrm{D} / \\mathrm{S})$\n4. Stuart index $=\\mathrm{A} / \\mathrm{B}$ ratio $=\\mathrm{S} / \\mathrm{D}$ ratio\n5. $\\mathrm{B} / \\mathrm{A}$ ratio $=\\mathrm{B}(100 \\%) / \\mathrm{A}$\n\n# High-Resistance Arteries \n\n1. External carotid arteries\n2. Extremity arteries\n3. Fasting mesenteric arteries\n\n## Low-Resistance Arteries\n\n1. Internal carotid arteries\n2. Hepatic arteries\n3. Renal arteries\n4. Testicular arteries\n\n## HEMOGLOBIN\n\ncomposed of 4 globular protein subunits + porphyrin ring holding an $\\mathrm{Fe} 2+$ ion in fetus: HbF\nin adult: $\\mathrm{Hb} \\mathrm{A}, \\mathrm{Hb} \\mathrm{A} 2, \\mathrm{Hb} \\mathrm{F}$\nVariants: $\\mathrm{Hb} \\mathrm{H}(\\beta 4)$.\n$\\mathrm{Hb} \\mathrm{S}(\\alpha 2 \\beta \\mathrm{~S} 2)$\n$\\mathrm{HbC}(\\alpha 2 \\beta \\mathrm{C} 2)$\nHb SA\nHb SC\n![img-1.jpeg](img-1.jpeg)",
            "images": [
                {
                    "id": "img-1.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 1339,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1755,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 2,
            "markdown": "![img-2.jpeg](img-2.jpeg)",
            "images": [
                {
                    "id": "img-2.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 191,
                    "bottom_right_x": 1339,
                    "bottom_right_y": 994,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 3,
            "markdown": "![img-3.jpeg](img-3.jpeg)",
            "images": [
                {
                    "id": "img-3.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 191,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1614,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 4,
            "markdown": "![img-4.jpeg](img-4.jpeg)\n\n# Hb A (96-98\\%) \n\n$=$ in Adult composed of 4 subunits of polypeptides $\\mathrm{Hb} \\alpha 1, \\mathrm{Hb} \\alpha 2, \\mathrm{Hb} \\beta, \\mathrm{Hb} \\beta$\nGenes \\& Locus:\nHBA1 on chromosome 16p13.3\nHBA2 on chromosome 16p13.3\nHBB on chromosome 11 p 15.5\ntetramer $\\alpha 2 \\beta 2$ composed of\n\n- 2 a globin chains (141 amino acids)\n- 2 ß globin chains (146 amino acids)\n\n\n## $\\mathrm{Hb} \\mathrm{A}_{2}(1.5-3.5 \\%)$\n\ntetramer $\\alpha 2 \\delta 2$ composed of\n\n- 2 a globin chains\n- 2 ö globin chains",
            "images": [
                {
                    "id": "img-4.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 187,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1379,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 5,
            "markdown": "# Hb F \n\nin Fetus + in F-cells of the adult\ntetramer $\\alpha 2 \\gamma 2$ composed of\n\n- $2 \\alpha$ globin chains\n- $2 \\gamma$ globin chains\n- greater affinity to oxygen than Hb A\n\n\n## CONTENTS OF FEMORAL TRIANGLE\n\nmnemonic: NAVEL (from lateral to medial)\nNerve\nArtery\nVein\nEmpty space\nLymphatics\n![img-5.jpeg](img-5.jpeg)",
            "images": [
                {
                    "id": "img-5.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 792,
                    "bottom_right_x": 1507,
                    "bottom_right_y": 1152,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 6,
            "markdown": "# CARDIOVASCULAR DISORDERS \n\n## ABERRANT LEFT PULMONARY ARTERY\n\n$=$ LEFT PULMONARY ARTERY SLING = ANOMALOUS ORIGIN OF LEFT PULMONARY ARTERY\nEmbryology: failure of development / obliteration of left $6^{\\text {th }}$ aortic arch (= vascular pedicle for left lung); left lung parenchyma maintains a connection with right lung leading to development of a collateral branch of the right pulmonary artery to supply the left lung\nSite: left PA passes above right mainstem bronchus + between trachea and esophagus on its way to left lung (= sling around proximal right main bronchus + distal trachea)\nAge at presentation: neonate to adulthood\nClassification:\n(1) Normal bronchial pattern\n(2) Malformation of bronchotracheal tree\n\nAssociated with:\n(a) \"napkin-ring trachea\" = absent pars membranacea (50\\%)\n(b) stenosis of long tracheal segment\n(c) PDA (most common), ASD, persistent left SVC\n\n- stridor (most common), wheezing, apneic spells, cyanosis\n- respiratory infection, feeding problems\n$\\sqrt{ }$ deviation of trachea to left\n$\\sqrt{ }$ \"inverted-T\" appearance of mainstem bronchi $=$ horizontal course $\\leftarrow$ lower origin of right mainstem bronchus\n$\\sqrt{ }$ anterior bowing of right mainstem bronchus\n$\\sqrt{ }$ \"carrot-shaped trachea\" = narrowing of tracheal diameter in caudad direction resulting in functional tracheal stenosis\n$\\sqrt{ }$ obstructive emphysema / atelectasis of RUL + LUL\n$\\sqrt{ }$ low left hilum\n$\\sqrt{ }$ separation of trachea + esophagus at hilum by soft-tissue mass\n$\\sqrt{ }$ anterior indentation on esophagram",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 7,
            "markdown": "![img-6.jpeg](img-6.jpeg)\n\n# AMYLOIDOSIS \n\n$=$ extracellular deposits of insoluble fibrillar protein (most commonly amyloid $\\mathrm{AL}=$ light chain) in myocardial interstitium\nIncidence: AL amyloidosis (50\\%); AA amyloidosis (2\\%);\nisolated myocardial amyloid deposition (in $25 \\%$ of autopsied patients $>85$ years of age)\nPath: commonly involvement of all 4 chambers\n\n- asymptomatic / fatigue, weakness\n- angina, CHF (diastolic dysfunction $\\square$ restrictive cardiomyopathy), arrhythmia\n\nCXR:\n$\\checkmark$ normal / generalized cardiomegaly\n$\\checkmark$ pulmonary congestion\n$\\checkmark$ pulmonary deposits of amyloid\nNUC:\n$\\checkmark$ striking uptake of ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-pyrophosphate greater than bone ( $50-90 \\%$ )\nECHO:\n$\\checkmark$ granular sparkling appearance of myocardium\n$\\checkmark$ LV wall thickening\n$\\checkmark$ decreased LV systolic + diastolic function\nMR:\n$\\checkmark$ diffuse decrease in SI on T1WI\n$\\checkmark$ diffuse pattern of ventricular myocardial hypertrophy\n$\\checkmark$ increase in thickness of interatrial septum + right atrial free wall $>6 \\mathrm{~mm}$ (SPECIFIC)\n[DDx: ischemic heart disease thins myocardium]",
            "images": [
                {
                    "id": "img-6.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 189,
                    "bottom_right_x": 1319,
                    "bottom_right_y": 976,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 8,
            "markdown": "CEMR:\n$\\sqrt{ }$ predominant late enhancement of entire subendocardial circumference (HIGHLY SPECIFIC + SENSITIVE)\n$D x$ : endomyocardial Bx with potential for severe complications\n\n# ANOMALOUS (INNOMINATE) BRACHIOCEPHALIC ARTERY COMPRESSION SYNDROME \n\n$=$ origin of R innominate (brachiocephalic) artery to the left of trachea coursing to the right\n$\\sqrt{ }$ anterior tracheal compression\n\n- ablation of right radial pulse by rigid endoscopic pressure\n$\\sqrt{ }$ posterior tracheal displacement\n$\\sqrt{ }$ focal collapse of trachea at fluoroscopy\n$\\sqrt{ }$ pulsatile indentation of anterior tracheal wall by innominate artery on MR\n$R x$ : surgical attachment of innominate artery to manubrium\n\n\n## ANOMALOUS LEFT CORONARY ARTERY\n\n$=$ A NOMALOUS ORIGIN OF L EFT C ORONARY A RTERY FROM P ULMONARY A RTERY SYNDROME = ALCAPA $=$ BLAND-WHITE-GARLAND SYNDROME\nPrevalence: $1 \\div 300,000$ live births; $0.25-0.50 \\%$ of congenital heart defects\n$\\diamond$ One of the most common causes of myocardial ischemia + infarction in children!\nAge: infancy / early childhood; adulthood (rare)\nIn 5\\% associated with: ASD, VSD, aortic coarctation\nLocation: LCA arises from left inferolateral aspect of main pulmonary artery just beyond pulmonary valve\nHemodynamics:\npostnatal fall in pulmonary arterial pressure $\\rightarrow$ perfusion of LCA drops (= \"coronary steal\")\n$\\rightarrow$ L-to-R shunt ( $=$ collateral circulation from RCA with flow reversal in LCA)\n> adequate collateral circulation $=$ lifesaving\n> inadequate collateral circulation $=$ myocardial infarction\n$>$ large collateral circulation $=$ volume overload of heart\n\n- ECG: anterolateral infarction\n$\\sqrt{ }$ LCA arising from the main pulmonary artery (HALLMARK) along its left inferolateral aspect just beyond pulmonic valve\n$\\sqrt{ }$ coronary steal into PA\n$\\sqrt{ }$ left ventricular wall motion abnormalities, mostly global hypokinesis\nRx: (1) Ligation of LCA at its origin from pulmonary trunk\n(2) Ligation of LCA + graft of left subclavian artery to LCA\n(3) Creation of an AP window + baffle from AP window to ostium of LCA\n\nDDx: endocardial fibroelastosis; dilated cardiomyopathy; viral cardiomyopathy (NO shocklike symptoms)\nA. INFANT TYPE\n\n- symptomatic about 8 weeks after birth:\n- failure to thrive, profuse sweating, dyspnea, pallor\n- atypical chest pain while eating / crying\n$\\sqrt{ }$ massive cardiomegaly during newborn period:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 9,
            "markdown": "$\\checkmark$ dilatation of $\\mathrm{LV} \\leftarrow$ chronic myocardial ischemia\n$\\checkmark$ enlargement of LA\n$\\checkmark$ congestive heart failure\n$\\checkmark$ mitral insufficiency $\\leftarrow$ myocardial infarction\n$\\checkmark$ normal pulmonary vascularity / redistribution\nPrognosis: if untreated death within $1^{\\text {st }}$ year (in up to $90 \\%$ )\nB. ADULT TYPE (rare)\n$=$ sufficient right-to-left coronary artery collaterals\n\n- asymptomatic, continuous murmur (if collaterals large)\n- ischemic cardiomyopathy, malignant dysrhythmia\n$\\checkmark$ massively enlarged and tortuous collateral circulation from RCA to LCA $\\leftarrow$ increased flow:\n$\\checkmark$ abundant intercoronary collaterals on epicardial surface\n$\\checkmark$ development of dilated bronchial artery collaterals\n$C x$ : chronic left ventricular subendocardial ischemia $\\rightarrow$ malignant ventricular dysrhythmia\nPrognosis: sudden cardiac death (in 80-90\\%)\n\n\n# ANOMALOUS PULMONARY VENOUS RETURN \n\n$=$ complete / partial failure of developing lung to connect with primitive common pulmonary vein retaining connections to primitive splanchnic system of cardinal veins (L-to-R shunt)\n\n## Total Anomalous Pulmonary Venous Return\n\n$=\\mathrm{TAPVR}=$ entire pulmonary venous return directed to $\\mathrm{RA}=$ admixture lesion because of the combination of cyanosis + increased pulmonary vascularity (L-to-R and R-to-L shunt) = absent connection of pulmonary veins with LA\nEmbryology: persistence of primitive splanchnic pulmonary veins connecting to fetal cardinal systemic veins + failure of primitive common pulmonary vein to develop from posterior LA wall\n$\\diamond$ Usually isolated defect!\nMay be associated with:\nasplenia; ASD / patent foramen ovale (necessary for survival); bronchopulmonary sequestration; pulmonary arteriovenous malformation; cystic adenomatoid malformation Types: according to termination of anomalous pulmonary veins\n\n| I | supracardiac level | $55 \\%$ |\n| :-- | :-- | :-- |\n| II | cardiac level | $30 \\%$ |\n| III | infracardiac / infradiaphragmatic level | $13 \\%$ |\n| IV | termination at $\\geq 2$ levels (= mixed type) | $2 \\%$ |\n\nPrevalence: $2 \\%$ of CHD\nAge: symptomatic in $1^{\\text {st }}$ year of life\n\n- cyanosis and congestive heart failure typically develop in the early neonatal period\n\nHemodynamics:\nobstruction along the pulmonary venous pathway",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 10,
            "markdown": "| RA | $\\leftrightarrow$ | RV | $\\leftrightarrow$ | Main PA | $\\leftrightarrow$ |\n| :-- | :-- | :-- | :-- | :-- | :-- |\n| Pulm vessels $\\uparrow$ |  |  |  |  |  |\n| LA | $\\leftrightarrow$ | LV | $\\leftrightarrow$ | Ao | $\\leftrightarrow$ |\n\nMR:\n$\\sqrt{ }$ \"retroatrial\" sign = presence of veins posterior to LA\n$\\checkmark$ small LA without pulmonary venous connections\n$\\checkmark$ patent foramen ovale / ASD\n![img-7.jpeg](img-7.jpeg)\n$\\checkmark$ anomalous vein with variable location\nIn most potentially clinically unstable neonates with TAPVR, complete anatomic delineation of the defect is possible with echocardiography alone!\nOverall prognosis: $75 \\%$ mortality rate within 1 year of birth if untreated\n\n# Supradiaphragmatic TAPVR (85\\%) \n\nHemodynamics:\n> functional L-to-R shunt from pulmonary veins to RA\n> increased pulmonary blood flow (= overcirculation)\n> obligatory R-to-L shunt via usually patent foramen ovale / ASD $\\rightarrow$ restores oxygenated blood to left side\n> normal systemic venous pressure with increased flow through widened SVC",
            "images": [
                {
                    "id": "img-7.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 528,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1441,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 11,
            "markdown": "> after birth CHF secondary to\n(a) mixture of systemic + pulmonary venous blood in RA\n(b) volume overload of RV\n\nAge: presentation $<1$ years of age\nIn 30\\% associated with: other cardiac lesions, asplenia\n\n- cyanosis, neck veins undistended (shunt level distally)\n- R ventricular heave (= increased contact of enlarged RV with sternum)\n- systolic ejection murmur (large shunt volume)\n$\\sqrt{ }$ overall heart size notably normal:\n$\\sqrt{ }$ slightly enlarged RV (= volume overload with time)\n$\\sqrt{ }$ normal / enlarged RA\n$\\sqrt{ }$ normal LA (= ASD acts as escape valve)\n$\\sqrt{ }$ increased pulmonary blood flow (= overcirculation)\n\n\n# Supracardiac TAPVR (55\\%) \n\n$=$ drainage of pulmonary veins into a horizontally oriented confluence posterior to LA $\\rightarrow$ ascending vertical vein posterior to left atrial appendage + usually anterior to left pulmonary a. $\\rightarrow$ left brachiocephalic (innominate) vein / right or left persistent SVC / azygos vein\n$\\sqrt{ }$ \"figure of 8\" / \"snowman\" configuration of cardiac silhouette:\n$\\sqrt{ }$ \"head of snowman\" = dilated vertical vein on left + innominate vein on top + SVC on right\n$\\sqrt{ }$ \"body of snowman\" = heart with enlarged RA\n$\\sqrt{ }$ pretracheal density on lateral film (= left vertical vein)\n$=4$ anomalous pulmonary veins converge behind LA forming a common vertical vein, which passes anterior to left PA + left main bronchus to join\n(a) innominate vein (most commonly)\n(b) left brachiocephalic vein\n(c) right SVC\n(d) azygos vein\n$\\sqrt{ }$ extrinsic venous obstruction if vertical vein courses between left PA anteriorly + left main bronchus posteriorly ( $10 \\%$ )\n\n\n## CARDIACTAPVR (30\\%)\n\n$=$ drainage of pulmonary veins into coronary sinus ( $80 \\%$ ) / RA / SVC / (often obstructed) azygos vein\nECHO:\n$\\sqrt{ }$ \"whale's tail\" appearance $\\leftarrow$ dilated pulmonary veins and coronary sinus\n\n## Sub-/ Infradiaphragmatic / Infracardiac TAPVR (13\\%)\n\n$=$ drainage of pulmonary veins into vertically oriented confluence posterior to $\\mathrm{LA} \\rightarrow$ portal vein / ductus venosus / IVC / hepatic veins / left gastric vein; R-to-L shunt through ASD\nAge: presentation in neonatal period with severe CHF\n\n- intense cyanosis + respiratory distress\n\nHemodynamics: constriction of descending pulmonary vein by diaphragm en route through",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 12,
            "markdown": "esophageal hiatus $\\rightarrow$ (in $>90 \\%$ ) pulmonary venous hypertension +RV pressure overload\nAssociated with: asplenia syndrome ( $80 \\%$ ), polysplenia\n$\\sqrt{ }$ pulmonary veins join to form a common vertical descending vein (\"inverted fir tree\") posterior to LA:\n$\\sqrt{ }$ vertical vein lies anterior to esophagus + descends through esophageal hiatus\n$\\checkmark$ low anterior indentation on barium-filled esophagus\n$\\checkmark$ connects (most commonly) to portal vein at confluence of splenic v. + superior mesenteric v.\n$\\checkmark$ unique appearance of pulmonary edema + pulmonary venous congestion with normalsized heart (DDx: hyaline membrane disease)\n$\\checkmark$ thymic atrophy + depression of diaphragm\n$C x$ : obstruction of pulmonary venous return in $>90 \\%$\nPrognosis: death within a few days of life\n\n# Mixed Type of TAPVR (2\\%) \n\n$=$ with various connections to R side of heart ( $6 \\%$ ) at $\\geq 2$ levels, most commonly (a) vertical vein drains into left innominate (brachiocephalic) vein (b) anomalous vein(s) from right lung drain into RA / coronary sinus\n\n## Partial Anomalous Pulmonary Venous Return\n\n$=$ PAPVR $=\\geq 1$ pulmonary veins drain into systemic venous system / RA rather than LA (= L-to-R shunt)\nEmbryology: early atresia / malposition of central pulmonary v.\nPrevalence: $0.3-0.7 \\%$ of patients with CHD\nAge: presentation later in life than TAPVR\nN.B.: venous return almost never obstructed!\n\nMay be associated with: may occur in isolation\n(1) Atrial septal defect $(25 \\%)$\n(a) RUL pulmonary vein ( $66 \\%$ ) enters SVC, RA, azygos vein, coronary sinus, IVC\n\nAge: more common in children\n$\\diamond$ in $90 \\%$ of patients with sinus venosus type ASD\n$\\diamond 50 \\%$ of patients with PAPVR have a high sinus venosus type ASD near orifice of SVC\n$\\checkmark$ RUL vein courses in a horizontal direction\n(b) LUL pulmonary vein ( $33 \\%$ ) enters brachiocephalic vein / coronary sinus Age: more common in adults as incidental finding\nFrequently associated with: ostium secundum type ASD (10-15\\%)\n$\\checkmark$ vertical mediastinal density lateral to aortic knob extending upward and medially with smooth curvilinear border (DDx: persistent left SVC)\n(2) Hypogenetic lung as a component of congenital pulmonary venolobar / scimitar syndrome\n\n- acyanotic and often asymptomatic\n- ASD symptomatology (if $\\geq 50 \\%$ of pulmonary venous flow)\n$\\checkmark$ radiographic findings similar to ASD",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 13,
            "markdown": "$\\sqrt{ }$ anomalous course of draining vein\n$\\sqrt{ }$ enlargement of draining site: SVC, IVC, azygos vein\nCECT:\n$\\sqrt{ }$ nodular / tubular opacity (= anomalous vein), which opacifies in phase with pulmonary vein\nPrognosis: near normal life expectancy\n\n# Scimitar Syndrome \n\n$=$ HYPOGENETIC LUNG SYNDROME $=$ CONGENITAL PULMONARY VENOLOBAR SYNDROME\n[ scimitar $=$ Persian or Turkish sword with curved blade]\n$=$ lower part / all of the hypogenetic lung is drained by an anomalous vein $\\rightarrow$ L-to-R shunt\nHemodynamics: insignificant L-to-R shunt\nComponents: systemic supply + drainage of RLL\n(1) Anomalous arterial supply of right lower lobe from abdominal aorta = systemic arterialization of the lung without sequestration (= pseudosequestration)\n(2) Scimitar vein\n(3) Hyopoplasia of right lung with dextroposition of heart:\n(4) $\\rightarrow$ Hypo- / aplasia of right pulmonary artery\n\nAssociated with: CHD (47-90\\%, most commonly ASD), extralobar sequestration, horseshoe lung, pulmonary AVM, bronchogenic cyst, accessory diaphragm\n$\\diamond$ High incidence of sinus venosus ASD with right upper lobe PAPVR\n\n- asymptomatic (for shunt of $<50 \\%$ of pulmonary flow) / pulmonary to systemic blood flow $(\\mathrm{Qp}+\\mathrm{Qs}) \\geq 1.5 \\div 1$\n- acyanotic (until pulmonary arterial HTN occurs)\n- heart murmur, fatigue, dyspnea\n\nLocation: almost exclusively on right side (1 case on left)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 14,
            "markdown": "![img-8.jpeg](img-8.jpeg)\n\n# Cast \n\nCXR:\n$\\sqrt{ }$ tubular structure paralleling the right heart border in an outward curved configuration of a Turkish sword increasing in diameter as the vein descends (PA view)\nSite: middle of right lung to cardiophrenic angle\n$\\sqrt{ }$ hypoplastic ipsilateral lung\n$\\sqrt{ }$ small ipsilateral pulmonary hilum $\\leftarrow$ hypoplasia / aplasia of pulmonary artery\n$\\sqrt{ }$ shift of heart + mediastinum into right chest\n$\\sqrt{ }$ hyperinflated and hyperlucent contralateral lung\nMR/CT:\nThe amount of L-to-R shunting is quantifiable by MR with cine phase-contrast flow analysis of the aorta and main pulmonary artery to estimate the $\\mathrm{Qp} / \\mathrm{Qs}$ ratio!\n$\\sqrt{ }$ systemic arterialization of right lung (without sequestration) $\\leftarrow$ anomalous artery from abdominal aorta / visceral artery\n$\\sqrt{ }$ scimitar vein drains any / all lobes of right lung and connects to:\n> infradiaphragmatic IVC (33\\%)\n> suprahepatic IVC (22\\%)\n> hepatic veins\n> portal vein ( $11 \\%$ )\n> azygos vein\n> coronary sinus\n> right atrium ( $22 \\%$ )\n> left atrium = \"meandering pulmonary vein\"\n$\\diamond$ Drainage into suprahepatic portion of IVC / right atrium may be a clue for",
            "images": [
                {
                    "id": "img-8.jpeg",
                    "top_left_x": 357,
                    "top_left_y": 187,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 996,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 15,
            "markdown": "interruption of intrahepatic portion of IVC!\nPrognosis: normal / near-normal life span\n$R x$ : anomalous vein / veins anastomosed to LA + repair of ASD\n\n# Sinus Venosus Defect \n\n$=$ SINUS VENOSUS-TYPE ATRIAL SEPTAL DEFECT\n$=$ unroofing of right pulmonary veins into SVC / IVC\nN.B.: sinus venosus atrial septal defect is a misnomer since the true atrial septum is not involved\nTypes:\n\n1. Sinus venosus defect of the SVC type\n$=$ unroofing of the right upper pulmonary vein (RUPV) into SVC = defect of the superior inlet portion of extraseptal atrial wall separating SVC-right atrial junction from posterosuperior aspect of LA = drainage of RUPV into SVC\nLocation: superior to fossa ovalis near entrance of superior vena cava (SVC straddles ASD)\n2. Sinus venosus defect of the IVC type\n$=$ unroofing of the right lower pulmonary vein (RLPV) into IVC\nvariable: involvement of the right middle pulmonary vein (RMPV) can occur with either type\nFunction: R-to-L shunt similar to large ASD\n\n- symptoms of right ventricular volume overload:\n![img-9.jpeg](img-9.jpeg)\n- fatigue, dyspnea, arrhythmia, heart murmur\n\nAssociated with:\npartial anomalous pulmonary venous return in $90 \\%$ (RUL pulmonary veins connect to SVC / right atrium), Holt-Oram syndrome, Ellis-van Creveld syndrome\n\n## AORTIC ANEURYSM\n\nAn aneurysm is defined as a vessel segment with a diameter of $>150 \\%$ of the diameter of a normal adjacent segment + involving $<50 \\%$ of the total vessel length!\n\n## Cause:\n\n1. Aortic dissection (53\\%)",
            "images": [
                {
                    "id": "img-9.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 1097,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1511,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 16,
            "markdown": "2. Atherosclerosis (29-80\\%): descending aorta; usually multiple\n3. Traumatic ( $15-20 \\%$ ): descending aorta; $\\leftarrow$ transection\n4. Congenital ( $2 \\%$ ): aortic sinus, post coarctation, ductus diverticulum\n5. Syphilis $(4 \\%)$ : ascending aorta + arch\n6. Mycotic infection = bacterial dissection; anywhere\n7. Cystic media necrosis (Marfan / Ehlers-Danlos syndrome, annuloaortic ectasia): ascending aorta\n8. Aortitis = inflammation of media + adventitia: Takayasu arteritis, giant cell arteritis, relapsing polychondritis, rheumatic fever, rheumatoid arthritis, ankylosing spondylitis, Reiter syndrome, psoriasis, ulcerative colitis, systemic lupus erythematosus, scleroderma, Behçet disease, ulcerative colitis, radiation\n9. Increased pressure: systemic hypertension, aortic valve stenosis\n10. Abnormal volume load: severe aortic regurgitation\n\nPathophysiology:\nintimal injury of aortic wall $\\rightarrow$ lipid-laden macrophage + lymphocyte infiltration $\\rightarrow$ inflammatory cells secrete cytokines $\\rightarrow$ activation of multiple proteolytic cascades $\\rightarrow$ degradation of collagen + elastin within tunica media $\\rightarrow$ weakening + dilatation of aortic wall\nLocation: abdominal aorta (31\\%), ascending aorta (22\\%), arch (12\\%), descending thoracic aorta ( $8 \\%$ ), thoracoabdominal ( $3 \\%$ )\n\n# True AneURYsm \n\n$=$ permanent dilatation of all 3 layers (intima + media + adventitia) of weakened but intact wall\n\n## Fusiform Aneurysm (80\\%)\n\n[ fusus, Latin = spindle (tapered at each end)]\n$=$ longitudinal measurement $>$ transverse diameter\nCause: atherosclerotic degeneration\n$\\sqrt{ }$ circumferential involvement of wall over longer arterial segment\n$\\sqrt{ }$ NO definable neck",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 17,
            "markdown": "![img-10.jpeg](img-10.jpeg)\n$\\sqrt{ }$ NO relation to proximal stenosis\n\n# Saccular Aneurysm (20\\%) \n\n[saccus, Latin = sack, pouch]\n$=$ transverse diameter $>$ longitudinal measurement\nCause: penetrating ulcer / inflammation / infection\n$\\sqrt{ }$ berry-like outpouching of portion of wall\n$\\checkmark$ frequently distal to area of proximal stenosis\n$\\checkmark$ often multisegmental\n$C x$ : prone to thrombosis and rupture\n\n## False Aneurysm = Pseudoaneurysm\n\n$=$ loss of wall integrity with transition from 3-layered wall to an outwardly single/double layer\nCause: trauma, penetrating atherosclerotic ulcer, infection (= \"mycotic\" aneurysm)\nPathophysiology: escaped blood contained by adventitia / perivascular connective tissue + organized blood\nHisto: disruption of the external elastic membrane\n$\\checkmark$ saccular dilatation with a narrow neck\n\n## Arterial Ectasia\n\n$=$ diffuse dilatation\nType I diffuse dilatation of $2-3$ vessels\nType II ectasia of 1 vessel + aneurysm in another\nType III solitary ectatic vessel\n\n## Abdominal Aortic Aneurysm (AAA)\n\n$=$ focal widening $>3 \\mathrm{~cm}$ (ultrasound literature); twice the size of normal aorta $/>4 \\mathrm{~cm}$ [Bergan, Ann Surg 1984]\nNormal size of abdominal aorta $>50$ years of age:",
            "images": [
                {
                    "id": "img-10.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 803,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 18,
            "markdown": "$14-21[12-19]$ mm in men [women]\nPrevalence: $1.4-8.2 \\%$ in unselected population; in $6 \\%>80$ years of age; in $6-20 \\%$ of patients with signs of atherosclerotic disease; $\\mathrm{M}>\\mathrm{F}$; Whites $\\div$ Blacks $=3 \\div 1$\nCause: structural defect; ? genetic ( 10 -fold $\\uparrow$ in risk as $1^{\\text {st }}$ - degree relative of patient with AAA); copper deficiency\nRisk factors: male sex, age $>75$ years, white race, prior vascular disease, hypertension, cigarette smoking, family history, hypercholesterolemia\nAge: $\\quad>60$ years; $\\mathrm{M} \\div \\mathrm{F}=5-9 \\div 1$\nAssociated with:\n(a) visceral + renal artery aneurysm (2\\%)\n(b) isolated iliac + femoral artery aneurysm (16\\%):\ncommon iliac ( $89 \\%$ ), internal iliac ( $10 \\%$ ), external iliac ( $1 \\%$ )\n(c) stenosis / occlusion of celiac trunk / SMA (22\\%)\n(d) stenosis of renal artery ( $22-30 \\%$ )\n(e) occlusion of inferior mesenteric artery ( $80 \\%$ )\n(f) occlusion of lumbar arteries ( $78 \\%$ )\n\nGrowth rate of aneurysm of 3-6 cm in diameter:\n0.39 cm annually\n\n- asymptomatic (30\\%), abdominal mass (26\\%) / pain (37\\%)\n\nᄋ Imaging should provide information about:\n(a) anatomic considerations of aneurysm:\n» size\n» proximal extent, which determines the site of clamping of the aorta (eg, origin of renal arteries)\n» course of the left renal vein (retroaortic?)\n(b) aneurysm growth rate\n(c) findings of aneurysm instability\n\nLocation: infrarenal (91-95\\%) with extension into iliac arteries (66-70\\%)\n$\\diamond$ The infrarenal abdominal aorta has a lower concentration of elastin + vasa vasorum making it vulnerable to aneurysm formation!\nPlain film:\n$\\sqrt{ }$ mural calcification (75-86\\%)\nUS:\n$\\sqrt{ }>98 \\%$ accuracy in size measurement\nNCCT:\n$\\sqrt{ }$ perianeurysmal fibrosis $(10 \\%) \\rightarrow \\pm$ ureteral obstruction\nCECT:\n(a) ruptured aneurysm\n$\\sqrt{ }$ anterior displacement of kidney\n$\\sqrt{ }$ extravasation of contrast material\n$\\sqrt{ }$ fluid collection / hematoma within posterior pararenal + perirenal spaces\n$\\sqrt{ }$ free intraperitoneal fluid\n$\\sqrt{ }$ perirenal \"cobwebs\"\n(b) contained leak\n$\\sqrt{ }$ laminated mural calcification",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 19,
            "markdown": "$\\sqrt{ }$ periaortic mass of mixed / soft-tissue density\n$\\sqrt{ }$ lateral \"draping\" of aneurysm around vertebral body\n$\\sqrt{ }$ indistinct aortic wall (unreliable)\n$\\sqrt{ }$ focal discontinuity of calcifications (unreliable)\nA patchy discontinuous intimal calcification is common in stable and unstable aneurysms.\nAngio (AP + LAT filming):\n$\\sqrt{ }$ focally widened aortic lumen $>3 \\mathrm{~cm}$\n$\\sqrt{ }$ apparent normal size of lumen $\\leftarrow$ mural thrombus ( $11 \\%$ )\n$\\sqrt{ }$ mural clot ( $80 \\%$ )\n$\\sqrt{ }$ slow antegrade flow of contrast medium\n$C x$ :\n(1) Aortic rupture ( $25 \\%$ )\n(2) Peripheral embolization\n(3) Infection\n(4) Spontaneous occlusion of aorta\n\nPrognosis: $17 \\%$-year survival without surgery, $50-60 \\%$-year survival with surgery\nRx: (1) Excision of aneurysm + aortic interposition graft ( $4-5 \\%$ surgical mortality for nonruptured, $30-80 \\%$ for ruptured aneurysm)\n(2) Endovascular aneurysm repair ( $70 \\%$ ) with post-repair complications of graft migration $>5 \\mathrm{~mm}$, graft kinking / fracture, persistent endoleak\nPostoperative $C x$ :\n(1) Left colonic ischemia ( $1.6 \\%$ ) with $10 \\%$ mortality\n(2) Renal failure ( $14 \\%$ )\n(3) $0-8 \\%$ mortality rate for elective surgery\n\n# Acute Aortic Aneurysm Rupture \n\n$\\diamond$ Leading cause of death ( 4,500 annually) in USA in $1.3 \\%$ of men $>65$ years\nRisk factors: female sex $(\\mathrm{M}+\\mathrm{F}=1 \\div 4)$, larger baseline aneurysm diameter, hypertension, continued tobacco use, low 1-second forced expiratory volume, history of cardiac / renal transplant\nRisk for aneurysm rupture:\ndirectly related to aneurysm size + rate of enlargement\nIncreased risk of aneurysm rupture: size $>6 \\mathrm{~cm}$\n\n| Aneurysm Size vs. Likelihood of Rupture |  |  |  |\n| :--: | :--: | :--: | :--: |\n| $<4 \\mathrm{~cm}$ | $10 \\%$ | $5-7 \\mathrm{~cm}$ | $25 \\%$ |\n| $4-5 \\mathrm{~cm}$ | $23 \\%$ | $7-10 \\mathrm{~cm}$ | $46 \\%$ |\n|  |  | $>10 \\mathrm{~cm}$ | $60 \\%$ |\n\n> growth $>5 \\mathrm{~mm} / 6$ months\nThe most accurate + reproducible bidimensional aneurysm measurements are those that are orthogonal to a center line through the aorta.\n\n- pain + tenderness\n$\\diamond$ The exact moment of rupture is unpredictable\n- sudden severe abdominal pain $\\pm$ radiating into back",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 20,
            "markdown": "- faintness, syncope, hypotension\n\nSite:\n(1) into retroperitoneum: commonly on left\n(2) into GI tract: massive GI hemorrhage\n(3) into IVC: rapid cardiac decompensation\n\nCT:\n$\\sqrt{ }$ high-attenuation crescent within mural thrombus = acute contained rupture / impending rupture\n$\\sqrt{ }$ retroperitoneal hematoma $\\pm$ extension into perirenal space / pararenal space / psoas muscle / peritoneum\nCECT:\n$\\sqrt{ }$ active extravasation into thrombosed portion\nPrognosis: 64-94\\% die before reaching hospital\n$R x$ : most vascular surgeons electively repair a typical fusiform abdominal aortic aneurysm if $>5.4 \\mathrm{~cm}$\n\n# Chronic Contained Aortic Aneurysm Rupture \n\n$=$ aortic wall no longer fully intact with hemorrhage enclosed by a thrombus and/or retroperitoneal soft tissues\n\n- hemodynamically stable\n- $\\pm$ previous episode of abdominal pain\n\nAngio:\n$\\checkmark$ absent parenchymal stain $=$ avascular halo\n$\\checkmark$ displacement + stretching of aortic branches\nCT:\n$\\checkmark$ loss of periaortic fat planes:\n$\\checkmark$ commonly posterolateral focal area of soft-tissue attenuation intimately associated with aorta\n$\\checkmark$ \"draped aorta\" sign = posterior aortic wall not identifiable as distinct from adjacent structures / closely apposed to adjacent vertebral body contour\n$\\checkmark$ new saccular outpouching (= focal breach) of aneurysm wall in the region that appears draped on AXIAL view\n$\\checkmark$ anterior vertebral body scalloping $\\leftarrow$ chronic repetitive aortic pulsations and pressure\nN.B.: contained rupture is unrelated to aneurysm size\n\n## Impending Aortic Aneurysm Rupture\n\nA focal discontinuity of a circumferential calcified intimal plaque and outward displacement may indicate a contained rupture at NECT. A contained rupture is definite if the finding is new.\n$\\sqrt{ }$ increasing size of aneurysm\nLaplace law:\nT (circumferential wall tension) $=\\mathrm{P}$ (transmural pressure) $\\cdot \\mathrm{r}$ (vessel radius)\n$\\sqrt{ }$ thinning of thrombus = decreasing thrombus volume with progressive enlargement of flow lumen $\\leftarrow$ lysis of thrombus (thrombus protects against rupture)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 21,
            "markdown": "$\\sqrt{ }$ focal discontinuity in circumferential wall calcifications $\\leftarrow$ focal plaque erosion $=$ unstable aneurysm\n$\\sqrt{ }$ \"crescent\" sign = periluminal curvilinear area of hyperattenuation in aneurysm wall / thrombus (= acute intramural hematoma) is $93 \\%$ specific:\n$\\checkmark$ attenuation higher than intraluminal blood on NECT\n$\\checkmark$ attenuation higher than psoas muscle on CECT\n$\\sqrt{ } \\pm$ perianeurysmal fat stranding\nWith bolus tracking a large aneurysm may not fully opacify, which can result in suboptimal enhancement of the aortic branches.\nExtravasation indicative of active hemorrhage may not be apparent in a large rupturing aneurysm during the early arterial phase but rather during the late arterial / venous phase after the aneurysm has filled with contrast.\nIndication for surgical repair:\n$\\sqrt{ }$ diameter of $>5-6-7 \\mathrm{~cm}$\n$\\sqrt{ }$ enlargement rate of $\\geq 10 \\mathrm{~mm}$ annually\n\n# Atherosclerotic Aneurysm of Abdominal Aorta \n\n$\\diamond$ There is no consensus regarding the definition of an atherosclerotic AAA!\nFrequency: most common cause of aortic aneurysms; leading cause of thoracic aortic aneurysm\nHisto: diseased intima with secondary degeneration + fibrous replacement of media $\\rightarrow$ ultimately wall of aneurysm composed of acellular + avascular connective tissue\nPathophysiology:\nprogressive weakening of media $\\rightarrow$ vessel dilatation + increased tension of vessel wall (law of Laplace $=$ tensile stress varies with product of blood pressure and radius of vessel); compromise of mural vascular nutrition (vasa vasorum) $\\rightarrow$ further degeneration + progressive dilatation\nAge: elderly; $\\mathrm{M}>\\mathrm{F}$\n\n- asymptomatic (most)\n- chest pain; symptoms related to compression of adjacent structures (dysphagia, hoarseness, lobar atelectasis, pneumonia, parenchymal hemorrhage, superior vena cava syndrome)\nLocation: distal abdominal aorta ( $66 \\%$ ) > iliac a. $>$ popliteal a. $>$ common femoral a. $>$ aortic + descending thoracic aorta $>$ carotid a. $>$ ascending aorta\nSite:\n(1) Infrarenal aorta (associated with thoracic aneurysm in 29\\%)\n(2) Descending thoracic aorta distal to left subclavian artery\n(3) Thoracoabdominal aorta\n$\\sqrt{ }$ fusiform ( $80 \\%$ ), saccular ( $20 \\%$ )\n$\\sqrt{ }$ frequently contain calcified thrombus with irregular inner contour\n$C x$ : rupture (cause of death in 50\\%): usually unrestrained + fatal in thoracic location\n\n\n## Degenerative Aneurysm\n\n$=$ medial degeneration\nMost common cause of aneurysm in ascending aorta",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 22,
            "markdown": "Cause:\n(1) Genetically transmitted metabolic disorder: Marfan syndrome, Ehlers-Danlos syndrome\n(2) Acquired: result of repetitive aortic injury + repair associated with aging\n\n# Idiopathic Inflammatory Aortic Aneurysm \n\n$=$ defined as triad of\n(1) thickened wall of aneurysm\n(2) extensive perianeurysmal + retroperitoneal fibrosis\n(3) dense adhesions of adjacent abdominal organs\n\nCause: slow leakage from aneurysm related to periaortic retroperitoneal fibrosis and autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus, giant cell arteritis)\nFrequency: $5-25 \\%$ of all AAAs; rare in ascending aorta + aortic arch\nMean age: $62-68$ years; $\\mathrm{M}+\\mathrm{F}=6 \\div 1$ to $30 \\div 1$\n\n- abdominal / back pain; weight loss + anorexia (20-41\\%)\n- elevated ESR (40-88\\%), fever\n- tender pulsatile abdominal mass (15-30\\%)\n\nComorbidities: arterial hypertension (34-69\\%), arterial occlusive disease (10-47\\%), diabetes mellitus (3-13\\%), coronary artery disease (33-55\\%)\nSize: usually small at presentation because of early symptomatology\nCECT ( $83 \\%$ sensitive, $99 \\%$ specific):\n$\\sqrt{ }$ rind of homogeneous soft-tissue density surrounding aorta anteriorly + laterally sparing posterior wall\n$\\sqrt{ }$ delayed contrast enhancement of soft-tissue component (DDx from hematoma)\nMR:\n$\\sqrt{ }$ periaortic inflammation and adventitial fibrosis\n$\\sqrt{ }$ turbulent intraluminal flow\nUS:\n$\\sqrt{ }$ sonolucent halo around aorta\nPET:\n$\\sqrt{ }$ grading extent of inflammation\nCx: (1) Entrapment of ureters (10-21\\%) + hydronephrosis\n(2) Aortic-sigmoid colon fistula + bleeding\n(3) Secondary bacterial infection (eg, Salmonella)\n(4) Enlargement + rupture irrespective of size (lower rate than in noninflammatory aneurysm)\nPrognosis: $23 \\%$ mortality during surgical repair\n\n## Leaking Aortic Aneurysm\n\n- acute chest pain\n\nAt risk for rupture: symptomatic $>$ asymptomatic aneurysm; mycotic aneurysm; thoracic aortic aneurysm $>6 \\mathrm{~cm}$\nMR:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 23,
            "markdown": "$\\sqrt{ }$ irregular aneurysm wall\n$\\sqrt{ }$ extra-aortic blood\n$\\sqrt{ }$ pleural effusion containing high SI on T1WI (methemoglobin)\n$\\sqrt{ }$ admixture of lower-intensity blood products + fat in mediastinum\n$C x$ : rupture into left pleural space (descending thoracic aorta); rupture into pericardium/mediastinum (ascending thoracic aorta)\n\n# Mycotic (Infected) Aneurysm \n\n[mycotic $=$ misnomer used by Osler in 1885 describing a mushroom-shaped aneurysm associated with endocarditis]\n$=$ false (majority) / true aneurysm that is prone to rupture\nFrequency: $\\quad 0.7-2.6 \\%$ of all aortic aneurysms\nAge: $\\quad>5^{\\text {th }}$ decade; $\\mathrm{M}>\\mathrm{F}$\nLocation: (a) aorta: suprarenal ( $70 \\%$ ) > infrarenal $>$ descending thoracic $>$ thoracoabdominal $>$ juxtarenal $>$ ascending aorta near sinus of Valsalva (b) other arteries: abdominal visceral artery $>$ intracranial artery $>$ lower / upper extremity a.\n\nA mycotic aneurysm of the aortic root and sinus of Valsalva may be associated with infectious endocarditis, uni- / bicuspid aortic valve, and infected prosthetic aortic valve!\nA. PRIMARY MYCOTIC ANEURYSM (rare) unassociated with any demonstrable intravascular inflammatory process\nB. SECONDARY MYCOTIC ANEURYSM\n$=$ aneurysm due to nonsyphilitic infection\nPredisposing factors:\n(1) Atherosclerosis\n(2) Aortic trauma $\\leftarrow$ accidents, aortic valve surgery, arterial graft, coronary artery bypass surgery, intravascular catheter, arterial catheterization, joint prosthesis\nRisk factors:\n(1) IV drug abuse\n(2) Sepsis\n(3) Bacterial endocarditis ( $12 \\%$ )\n(4) Immunocompromise (malignancy, alcoholism, corticosteroid therapy, chemotherapy, autoimmune disease, diabetes)\nMechanism:\n(a) hematogenous:\n> septicemia with abscess formation via vasa vasorum\n> septicemia with abscess formation via vessel lumen\n(b) direct extension from adjacent infection: osteomyelitis of sternum or spine, renal or psoas abscess $\\rightarrow$ weakening + destruction part of the aortic wall\n(c) traumatic / iatrogenic: intima laceration (trauma, atherosclerosis, coarctation)\n\nOrganism: S. aureus (53\\%) > E. coli > Salmonella (33-50\\%) > nonhemolytic Streptococcus $>$ Listeria $>$ Haemophilus, Pneumococcus, Gonococcus, Mycobacterium (contiguous spread from spine / lymph nodes)\nHisto: loss of intima + destruction of internal elastic lamella; varying degrees of destruction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 24,
            "markdown": "of muscularis of media + adventitia\n\n- frequently insidious $\\rightarrow$ late-stage septic shock\n- persistent fever, leukocytosis $\\leftarrow$ bacteremia (positive blood culture in only $53 \\%$ ); NO acute chest pain\nSize: $\\quad 1-11 \\mathrm{~cm}$\n$\\sqrt{ }$ CHARACTERISTIC saccular formation ( $>90 \\%$ ) with lobular contour arising eccentrically from aortic wall\n$\\checkmark$ rapid enlargement (faster expansion rate compared with atherosclerotic aneurysm as short as 7 days)\n$\\checkmark$ interrupted ring of aortic wall calcification\n$\\checkmark$ periaortic fat stranding / fluid / gas collection\n$\\checkmark$ adjacent vertebral / sternal osteomyelitis (rare)\n$\\checkmark$ periaortic / psoas abscess\n$\\checkmark$ adjacent reactive lymph node enlargement\nCx: (1) Life-threatening rupture + hemorrhage (50-75\\%)\n(2) Uncontrolled sepsis if untreated\n$R x:$ prompt surgery\nPrognosis: $67 \\%$ overall mortality\n\n\n# Syphilitic Aneurysm \n\n$=$ sexually transmitted chronic systemic infection caused by spirochete Treponema pallidum\n$=$ tertiary stage of syphilis consisting of neurosyphilis, gumma, cardiovascular involvement\nSpectrum:\n\n1. Uncomplicated syphilitic aortitis\n2. Syphilitic aortic aneurysm (mostly saccular)\n3. Syphilitic aortic valvulitis (aortic regurgitation)\n4. Syphilitic coronary ostial stenosis\nN.B.: dissection (uncommon) $\\leftarrow$ scarring of media\n\nFrequency: $12 \\%$ of patients with untreated syphilis\nOnset: 5-30 years after initial spirochete infection\nHisto: chronic inflammation of vasa vasorum $\\rightarrow$ obstruction of vasa vasorum $\\rightarrow$ nutritional impairment of aortic media $\\rightarrow$ focal destruction of aortic media with loss of elastic + smooth muscle fibers replaced by scar\n\n- positive venereal disease research laboratory (VDRL) test\n- positive microhemagglutination assay - Treponema pallidum (MHA-TP) test\n\nLocation: ascending aorta ( $36-60 \\%$ ), aortic arch ( $34 \\%$ ), proximal descending aorta ( $25 \\%$ ), distal descending aorta ( $5 \\%$ ), aortic sinuses ( $<1 \\%$ )\n$\\checkmark$ asymmetric enlargement of aortic sinuses (DDx to annuloaortic ectasia with symmetric enlargement)\n$\\checkmark$ saccular ( $75 \\%$ ) / fusiform ( $25 \\%$ ) aneurysm\n$\\sqrt{ }$ TYPICAL pencil-thin dystrophic aortic wall calcification (up to $40 \\%$ ) most severe in ascending aorta, frequently obscured by thick coarse irregular calcifications of secondary atherosclerosis\n$\\checkmark$ early sternal erosion affecting mainly right side of manubrium + medial end of right",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 25,
            "markdown": "clavicle\n$\\sqrt{ }$ narrowing of coronary ostia (subintimal scarring)\nPrognosis: death $\\leftarrow$ aortic rupture in $40 \\%$; death $\\leftarrow$ myocardial infarction within 6-8 months of onset of symptoms if untreated\n$R x:$ penicillin\n\n# Thoracic Aortic Aneurysm \n\nMost common vascular cause of mediastinal mass!\n$\\diamond 10 \\%$ of mediastinal masses are of vascular origin!\nDefinitions:\ndiameter of $4-5 \\mathrm{~cm}=$ aortic ectasia\ndiameter of $>5 \\mathrm{~cm}=$ aortic aneurysm\nFrequency: $25 \\%$ of all aneurysms\nCause: atherosclerosis (29\\%), aortic dissection (53\\%), aortitis (8\\%), cystic medial necrosis (6\\%), syphilis (4\\%)\n$\\diamond$ Bicuspid aortic valve $=$ independent risk factor!\nAssociated with: hypertension, coronary artery disease, abdominal aneurysm (30\\%)\nMean age: 65 years; $\\mathrm{M} \\div \\mathrm{F}=3 \\div 1$\n\n- substernal / back / shoulder pain (26\\%)\n- SVC syndrome $\\leftarrow$ venous compression)\n- dysphagia $\\leftarrow$ esophageal compression)\n- stridor, dyspnea $\\leftarrow$ tracheobronchial compression)\n- hoarseness $\\leftarrow$ recurrent laryngeal nerve compression)\n\nLocation: $\\quad$ arch $>$ descending aorta\n$\\sqrt{ }$ mediastinal mass with proximity to aorta\n$\\sqrt{ }$ wide tortuous aorta:\n$\\sqrt{ }$ annual growth rate of $0.07-0.42 \\mathrm{~cm}$\n$\\sqrt{ }$ curvilinear peripheral calcifications ( $75 \\%$ )\n$\\sqrt{ }$ circumferential / crescentic mural thrombus\nN.B.: Angio may show normal caliber $\\leftarrow$ mural thrombus!\n$C x$ :\n(1) Rupture into mediastinum, pericardium, either pleural cavity, airway, esophagus\n\nMedian size at rupture-dissection:\n5.9 cm for ascending aorta,\n7.2 cm for descending aorta\n$\\sqrt{ }$ high-attenuation fluid\n(2) Aortobronchopulmonary fistula\n$\\sqrt{ }$ consolidation of lung adjacent to aneurysm\n$\\diamond$ Most aneurysms rupture when $>10 \\mathrm{~cm}$ in size\nPrognosis: 1-year survival 57\\%; 3-year survival 26\\%; 5-year survival 19\\% ( $60 \\%$ die from ruptured aneurysm, $40 \\%$ die from other causes)\n$R x$ : operative repair should be considered\nfor ascending aorta at $>5.5 \\mathrm{~cm}$\nfor descending aorta at $>6.5 \\mathrm{~cm}$\nfor Marfan syndrome $>5.0 \\mathrm{~cm}$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 26,
            "markdown": "at annual growth rate $>1.0 \\mathrm{~cm}$\nSurgical mortality: $9 \\%$ for elective $+22 \\%$ for emergent surgery\n\n# Annuloaortic Ectasia \n\n$=$ dilated sinuses of Valsalva with effacement of sinotubular junction\nCause: Marfan syndrome, idiopathic (30\\%), homocystinuria, Ehlers-Danlos syndrome, osteogenesis imperfecta\n$\\sqrt{ }$ pear-shaped aorta\n\n## Valsalva Sinus Aneurysm\n\n$=$ aneurysm originating from a coronary sinus above aortic annulus\nPrevalence: in $0.09 \\%$ of autopsies; in $0.15 \\%-3.50 \\%$ of heart surgeries\nTypes:\n(a) congenital: localized weakness of elastic lamina at junction of aortic media and annulus fibrosus in Marfan and Ehlers-Danlos syndrome\n(b) acquired: infectious disease (bacterial endocarditis, syphilis, tuberculosis); degenerative (atherosclerosis, cystic medial necrosis); deceleration injury; aortic valve replacement\nAssociated with: supracristal VSD (30\\%-60\\% of patients), aortic insufficiency (20\\%$30 \\%$ ), bicuspid aortic valve ( $10 \\%$ ), coronary anomalies\nAge: 35.4 (range, 4 days -96 ) years; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 1$ to $4 \\div 1$; Eastern/Asian+Western countries $=5 \\div 1$\n\n- asymptomatic $(14 \\%)$\n- cardiac murmur (57\\%), dyspnea (56\\%), chest pain\n- insidiously progressive heart failure $\\leftarrow$ volume overload\n\nLocation: (a) right coronary sinus $(72 \\%)$\n(b) noncoronary sinus $(22 \\%$\n(c) coronary sinus $(6 \\%)$\n\nECHO: diagnostic in $90 \\%$\nImaging criteria for a Valsalva sinus aneurysm include\n(1) origin above aortic annulus\n(2) saccular shape\n(3) normal dimensions of adjacent aortic root and ascending aorta!\n\nCx :\n(a) rupture $(66 \\%)$ :\n\n1. Aortic regurgitation (in $30-50 \\%$ )\n2. Aortocardiac shunt with RV (56\\%), RA (30\\%), RVOT (9\\%), LV (2\\%), interventricular septum ( $2 \\%$ ), LA ( $1 \\%$ ), extracardiac space (rare)\n(b) mass effect:\n3. Aortic regurgitation\n4. Impaired function of tricuspid / mitral valve\n5. Occluded / partially obstructed RVOT\n6. Dissection into interventricular septum\n7. Compression / occlusion of a coronary artery $\\rightarrow$ myocardial ischemia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 27,
            "markdown": "Surgery is indicated for asymptomatic patients without another underlying cardiovascular condition or disease, when aortic root measures $\\geq 5.5 \\mathrm{~cm}$\n$D D x$ : prolapsing aortic cusp (below annulus)\n\n# Traumatic Aortic Pseudoaneurysm \n\n$=$ CHRONIC AORTIC PSEUDOANEURYSM\n$\\diamond 2^{\\text {nd }}$ most common form of thoracic aortic aneurysm\n$\\diamond$ Most common type occurring in young patients\nFrequency: $2.5 \\%$ of patients who survive initial trauma of acute aortic transection\n$\\sqrt{ }$ usually calcified\n$\\sqrt{ }$ may contain thrombus\nCx: (1) Progressive enlargement\n(2) Rupture (even years after insult)\n\n## Complications of Endovascular Stent-Graft Repair\n\n1. Endoleak (2-45\\%)\n$=$ leakage into the aneurysm outside stent-graft\n![img-11.jpeg](img-11.jpeg)\n\nType 1 = incomplete fixation of stent-graft to aortic wall at the proximal / distal attachment site\nType $2=$ retrograde flow via parent artery (eg, lumbar / inferior mesenteric artery) in up to $24 \\%$\n$\\diamond$ High rate of spontaneous resolution if aneurysmal sac size remains stable\nType $3=$ endograft defect with disruption of either metallic support / fabric\nType $4=$ porous graft (uncommon)",
            "images": [
                {
                    "id": "img-11.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 924,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1672,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 28,
            "markdown": "Type $5=$ endotension $=$ aneurysm expansion $>5 \\mathrm{~mm}$ without demonstrable endoleak ( $\\leftarrow$ nonvisualized endoleak, ultrafiltration of blood across graft membrane, thrombus as ineffective barrier)\n2. Graft kinking\n\nCause: diminishing diameter of aneurysm after stent-graft implantation also decreases length of aneurysm\nAssociated with: distal migration of stent-graft\n3. Graft infection\n$\\sqrt{ }$ interval development of perigraft soft-tissue attenuation / air\n$R x:$ antibiotics + total excision of infected graft\n4. Graft thrombosis ( $3-19 \\%$ )\n$=$ intraluminal circular / semicircular thrombus\nPrognosis: spontaneous shrinkage, development of complete thrombosis\n5. Graft occlusion\n6. Shower embolism ( $4-17 \\%$ )\n\nCause: mural thrombus dispersed by delivery system\nPrognosis: perioperative death\n7. Colon necrosis\n\nCause: occlusion of inferior mesenteric a. by stent-graft\n8. Aortic dissection\n\nCause: retrograde injury by delivery system\n\n# AORTIC DISSECTION \n\n= spontaneous longitudinal separation of aortic intima and adventitia by circulating blood having gained access to and splitting the media of the aortic wall\n$\\diamond$ Most common ACUTE EMERGENCY condition of the aorta!\nIncidence: $3 \\div 1,000$ (more common than all ruptures of thoracic + abdominal aorta combined); $1 \\div 205$ autopsies; 2,000 cases annually in USA\nPeak age: 60 years (range $13-87$ years); $\\mathrm{M} \\div \\mathrm{F}=3 \\div 1$\nPredisposed: cystic medial necrosis / disease of aortic wall\n$\\diamond$ Starts in fusiform aneurysms in $28 \\%$\n$\\diamond$ Does not occur in aneurysms $<5 \\mathrm{~cm}$ in diameter\n\n1. Hypertension ( $60-90 \\%$ )\n2. Marfan syndrome ( $5-16 \\%$ )\n3. Ehlers-Danlos syndrome\n4. Turner syndrome\n5. Noonan syndrome\n6. Polycystic kidney disease\n7. Osteogenesis imperfecta\n8. Valvular aortic stenosis\n9. Coarctation\n10. Bicuspid aortic valve\n11. S/P prosthetic valve / other cardiovascular procedure\n12. Blunt trauma (rare)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 29,
            "markdown": "13. Inflammatory collagen vascular disease\n14. Relapsing polychondritis\n15. Aortitis (eg, Takayasu disease, SLE)\n16. Behçet disease\n17. Patient on corticosteroids\n18. Cocaine abuse\n19. Family history of dissection\n20. Personal history of aortic aneurysm (2-12\\%)\n21. Atherosclerosis of aorta ( $24-42 \\%$ )\n22. Pregnancy\n$\\diamond$ In women $50 \\%$ of dissections occur during pregnancy!\nN.B.: NOT syphilis\n\nPath: destruction of media leads to formation of a false channel:\n(1) Transverse tear in weakened intima (95-97\\%)\n$\\diamond$ The diagnosis relies primarily on visualization of an intimal flap + blood flow within a false lumen\n(2) Primary hemorrhage into aortic wall without intimal tear (3-5-13\\%) = atypical noncommunicating aortic dissection\n\n# Pathogenesis: \n\nintimal tear results from combination of the following factors:\n(a) media degeneration decreases cohesiveness of aortic wall\n(b) persistent motion $\\leftarrow$ beating heart stresses aortic wall",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 30,
            "markdown": "![img-12.jpeg](img-12.jpeg)",
            "images": [
                {
                    "id": "img-12.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1322,
                    "bottom_right_y": 1399,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 31,
            "markdown": "![img-13.jpeg](img-13.jpeg)\n(c) hypertension accentuates hydrodynamic forces\n\nThe classic intimal flap is seen in $\\sim 70 \\%$ of aortic dissections.\nPathophysiology:\nluminal pressures:\nintimal tear allows blood to enter media ( $=$ false lumen) with pressure in false lumen $\\geq$ pressure in true lumen $\\rightarrow$ collapse of true lumen + expansion of false lumen $\\rightarrow$ possible compression + obstruction of true lumen;\ndegree of dilatation of false lumen depends on\n(a) blood pressure\n(b) depth of medial dissection plane,\n(c) percentage of involved wall circumference;\n\nflow direction in false lumen: antegrade / retrograde\neffect on branch vessel:\n(a) static obstruction = intimal flap enters branch-vessel origin without reentry point\n(b) dynamic obstruction = intimal flap prolapses into / covers branch vessel like a curtain fate of false lumen:\nmay remain patent / thrombose / recommunicate with true lumen through fenestrations / rupture into potential spaces (pericardial, pleural, peritoneal)\nDefinition of acute versus chronic dissection:\n(a) acute aortic dissection $=$ symptoms present for $<14$ days\n(b) chronic aortic dissection $=$ symptoms present for $\\geq 14$ days\n\n- sharp tearing intractable anterior / posterior chest pain (75-95\\%) radiating to jaw, neck, low back (DDx: myocardial infarction)",
            "images": [
                {
                    "id": "img-13.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 187,
                    "bottom_right_x": 1339,
                    "bottom_right_y": 1031,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 32,
            "markdown": "- murmur $\\pm$ bruit $(65 \\%)$ from aortic regurgitation\n- malperfusion symptoms:\n- asymmetric peripheral pulses + blood pressures (59\\%)\n- absent femoral pulses ( $25 \\%$ ), reappearing after reentry\n- pulse deficit: in up to $50 \\%$ of type A dissection, in $16 \\%$ of type B dissection; persistent oliguria, anuria\n- neurologic deficits (5-25\\%): hemiplegia, paraparesis $\\leftarrow$ compromise of anterior spinal artery of Adamkiewicz\n- hemodynamic shock ( $25 \\%$ )\n- congestive heart failure (rare) $\\leftarrow$ acute aortic insufficiency:\n- diastolic murmur ( $40-50 \\%$ )\n- recurrent arrhythmias / right bundle branch block\n- signs of pericardial tamponade: clouded sensorium, extreme restlessness, dyspnea, distended neck veins\nTypes:\nDeBakey Classification:\nType I $(29-34 \\%)=$ ascending aorta + portion distal to arch\nType II $(12-21 \\%)=$ ascending aorta only\nType III $(50 \\%)=$ descending aorta only\nsubtype III A = up to diaphragm\nsubtype III B = below diaphragm\nStanford Classification: based on need for surgical therapy\nType A $(60-70 \\%)=$ ascending aorta $\\pm$ arch in first 4 cm\nType B $(30-40 \\%)=$ descending aorta only\nmnemonic: A affects ascending aorta and arch; B begins beyond brachiocephalic vessels; I $=$ II + III\nFlow velocities (average):\n- $13.4 \\mathrm{~cm} /$ second in true lumen\n- $3.1 \\mathrm{~cm} /$ second in false lumen\n- retrograde flow more common in false lumen\n\nLocation of dissection flap (following helical flow pattern):\non right anterolateral wall of ascending aorta just distal to aortic valve ( $65 \\%$ )\n$>$ on posterosuperior wall of transverse aortic arch ( $10 \\%$ )\n$>$ on left posterolateral wall of upper descending aorta distal to left subclavian artery (20\\%)\n$>$ more distal aorta ( $5 \\%$ ) usually terminating in left iliac artery ( $80 \\%$ ) / right iliac artery\n$(10 \\%)$ [involvement of left renal artery in $50 \\%$ ]\n$\\diamond$ An exit / distal tear / reentry occurs in $10 \\%$ !\nImaging characteristics of true lumen:\n$\\checkmark$ usually smaller and oval / semiround\n$\\checkmark$ in continuity with undissected portion of aorta\n$\\checkmark$ higher concentration of contrast\n$\\checkmark$ ribbonlike\nImaging characteristics of false lumen:\n$\\sqrt{ }$ SPECIFIC \"cobweb\" sign = slender linear areas of low attenuation $\\leftarrow$ residual ribbons of",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 33,
            "markdown": "media\n$\\sqrt{ }$ \"beak\" sign at cross-sectional imaging = wedge of hematoma creating space for propagation of false lumen\n$\\sqrt{ }$ rewinding around true lumen on axial plane\n$\\sqrt{ }$ may become thrombosed\nAtypical configurations of intimal flap:\n$\\sqrt{ }$ circumferential intimal flap $\\leftarrow$ dissection of entire intima\n$\\sqrt{ }$ filiform intimal flap creating an extremely narrow true lumen $\\pm$ ischemic complications\n$\\sqrt{ }$ mural calcification of false lumen (in chronic dissection)\n$\\sqrt{ }$ three-channel aorta (= \"Mercedes-Benz\" sign) $\\leftarrow$ two false channels $\\leftarrow$ secondary dissection of one channel\n$\\diamond$ Multibarreled aortic dissections ( $9 \\%$ of all aortic dissections) have a significantly poorer survival!\n$\\sqrt{ }$ intimointimal intussusception $\\rightarrow$ \"windsock\" appearance\nSecondary signs of aortic dissection:\n$\\sqrt{ }$ internal displacement of intimal calcification\n$\\sqrt{ }$ delayed enhancement of false lumen\n$\\sqrt{ }$ widening of aorta and mediastinum\n$\\sqrt{ }$ pleural / pericardial hematoma\nCXR (best assessment by comparison with serial films):\n$\\sqrt{ }$ normal CXR in $10-25-40 \\%$\n$\\sqrt{ }$ \"calcification\" sign = inward displacement of atherosclerotic plaque by $>4-10 \\mathrm{~mm}$ from outer aortic contour $(7 \\%)$\nN.B.: can only be applied to contour of descending aorta due to projection; may be misleading in presence of periaortic soft-tissue mass / hematoma\n$\\sqrt{ }$ disparity in size between ascending + descending aorta\n$\\sqrt{ }$ irregular wavy contour / indistinct outline of aorta\n$\\sqrt{ }$ widening of superior mediastinum to $>8 \\mathrm{~cm} \\leftarrow$ hemorrhage / enlarging false channel (40$80 \\%)$\n$\\sqrt{ }$ cardiac enlargement $\\leftarrow$ LV hypertrophy / hemopericardium\n$\\sqrt{ }$ left pleural effusion $(27 \\%)$\n$\\sqrt{ }$ atelectasis of lower lobe\n$\\sqrt{ }$ rightward displacement of trachea / endotracheal tube\nECHO:\n(a) transesophageal echocardiography (TEE): $95-100 \\%$ sensitive $+77-97 \\%$ specific $\\diamond$ Ultrasound can be performed at bedside!\nFalse-positive (33\\%): reverberation artifacts from calcified aortic wall\n(b) transthoracic US: $59-85 \\%$ sensitive $+63-96 \\%$ specific for type A dissection; poorer for type B\n(c) intravascular US (in conjunction with aortography) to differentiate true from false lumen\n$\\sqrt{ }$ intimal flap (seen in more than one view)\n$\\sqrt{ }$ pericardial fluid\n$\\sqrt{ }$ aortic insufficiency\nFalse-positives: reverberation echoes from aneurysmal ascending aorta / calcified atheromatous plaque, postoperative periaortic hematoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 34,
            "markdown": "Angio ( $86-88 \\%$ sensitive, $75-94 \\%$ specific):\n$\\diamond$ Largely replaced by noninvasive cross-sectional imaging techniques\nSuperior to any other technique in demonstrating\n> entry + reentry points (in $50 \\%$ )\n> branch vessel involvement + coronary arteries\n$>$ aortic insufficiency\n$\\sqrt{ }$ visualization of intimal / medial flap $(75-79 \\%)=$ linear radiolucency within opacified aorta\n$\\sqrt{ }$ \"double barrel aorta\" $(87 \\%)=$ opacification of two aortic lumens\n$\\checkmark$ abnormal catheter position outside anticipated aortic course\n$\\checkmark$ compression of true lumen by false channel ( $72-85 \\%$ )\n$\\checkmark$ aortic valvular regurgitation $(30 \\%)$\n$\\checkmark$ increase in aortic wall thickness $>6-10 \\mathrm{~mm}$\n$\\checkmark$ obstruction of aortic branches: left renal artery ( $25-30 \\%$ )\n$\\checkmark$ ulcerlike projections caused by truncated branches\n$\\checkmark$ slower blood flow in false lumen\nFalse-negative: complete thrombosis / very slow blood flow of false channel (10\\%), intimal flap not tangential to x-ray beam\nFalse-positive: thickening of aortic wall due to aneurysm, aortitis, adjacent neoplasm / hemorrhage\nNECT:\n$\\checkmark$ high attenuation within aortic wall $2^{\\circ}$ to:\n(a) high-attenuation of false lumen (slow flow / thrombosis)\n(b) presence of intramural hematoma\n$\\checkmark$ intimal flap separating two aortic channels (may be seen without contrast in anemic patients)\nCECT ( $87-100 \\%$ sensitive, $87-100 \\%$ specific):\nwithin 4 hours (if patient responds rapidly to medical Rx ); detection as accurate as angio with single-level dynamic scanning (cardiac gating desirable to avoid overdiagnosis)\n$\\checkmark$ intimal flap separating two aortic channels\n$\\checkmark$ crescentic high-attenuation clot within false lumen\n$\\checkmark$ internally displaced intimal calcification (DDx: calcification of thrombus on luminal surface or within)\n$\\checkmark$ entry tear $=$ most proximal split / discontinuity in intimal flap\nFalse-negative: inadequate contrast opacification, thrombosed lumen misinterpreted as aortic aneurysm with mural thrombus\nFalse-positive: perivenous streaks $\\leftarrow$ beam hardening + motion, cardiac / aortic motion artifacts; opacified normal sinus of Valsalva; normal pericardial recess mistaken for thrombus; mural thrombus in a fusiform aortic aneurysm; periaortic fibrosis; anemia with apparent high attenuation of aortic wall\nMR ( $95-100 \\%$ sensitive, $90-100 \\%$ specific):\nAdvantage: large field of view in any plane; contrast material NOT necessary\nDisadvantage: longer imaging time; difficulty monitoring acutely ill patients; image degradation from motion (uncooperative patient, atrial fibrillation)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 35,
            "markdown": "SE images:\n$\\sqrt{ }$ intimal flap of medium intensity outlined by signal voids of rapidly flowing blood in true + false lumen\n$\\sqrt{ }$ intimal flap more difficult to detect in the presence of slow flow / thrombus $\\leftarrow$ false lumen has intermediate intensity instead of flow void\n$\\sqrt{ }$ \"cobwebs\" ( $25 \\%$ ) traversing the corners of the false lumen = bands of medial elastic lamellae spanning the junction of the dissecting septum with outer wall of false lumen\nGRE images:\n$\\sqrt{ }$ lower-intensity intimal flap between high-intensity channels of flowing blood\n$\\sqrt{ }$ intermediate signal from thrombosed lumen\n$\\sqrt{ }$ aortic valve insufficiency = conical area of signal loss from aortic valve into LV during systole $\\leftarrow$ intravoxel dephasing caused by turbulence\n$C x$ :\n(1) Retrograde dissection (in Stanford type A)\n(a) aortic insufficiency\n(b) occlusion of coronary artery ( $8 \\%$ )\n(c) internal rupture into RV, LA, vena cava, pulmonary artery producing a large L-to-R shunt\n(2) Occlusion / transient obstruction of major aortic branches (in up to 27\\%)\n(a) static obstruction\n$\\sqrt{ }$ flap enters branch-vessel origin\n(b) dynamic obstruction = flap spares branch-vessel origin but covers it like a curtain\n$\\sqrt{ }$ collapsed true lumen outlined by a C-shaped flap envelope which is concave toward false lumen (= ischemic configuration)\n(3) External rupture of aorta into mediastinum, pleural cavity / pericardial sac (75\\%), right ventricle, left atrium, vena cava, pulmonary artery: $70 \\%$ mortality ( $=$ most common cause of death within 24 hours)\nNECT: $\\sqrt{ }$ hyperattenuating mediastinal / pericardial / pleural fluid collection\nCECT: $\\sqrt{ }$ extravasation of vascular contrast material\n(4) Development of aneurysm ( $15 \\%$ ) of the true / false lumen\n$\\diamond$ Organs may receive their blood supply through either the true or false lumen or both!\n$R x$ :\n(1) Reducing peak systolic pressure to $120-70 \\mathrm{mmHg}$ (adequate ONLY for type III = B, which rarely progresses proximally):\n$C x$ : death from rupture of aortic aneurysm in $46 \\%$ of hypertensive $+17 \\%$ of normotensive patients\nSurvival rate: $40-70 \\%$ with medical / surgical management\n(2) Immediate surgical graft reinforcement of aortic wall (Type I, II = A) preventing rupture + extension into aortic root $\\rightarrow$ progressive aortic valve insufficiency\nNonsurgical survival rate: $<10 \\%$\nPostsurgical mortality: $10-35 \\%$\n$C x$ : myocardial infarction, stroke, respiratory insufficiency, pulmonary embolism, aortic rupture, pseudoaneurysm, graft infection\nPrognosis without Rx:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 36,
            "markdown": "immediate death (3\\%); death within: 1 day ( $20-30 \\%$ ), 1 week ( $50-62 \\%$ ), 3 weeks ( $60 \\%$ ), 1 month ( $75 \\%$ ), 3 months ( $80 \\%$ ), 1 year ( $80-95 \\%$ )\nPrognosis with Rx:\n$5-10 \\%$ mortality rate following timely surgery;\n$40 \\% 10$-year survival rate after leaving hospital\nDeath from thoracic aortic dissection may occur $\\leftarrow$ acute aortic regurgitation; $\\leftarrow$ major aortic branch obstruction; $\\leftarrow$ pericardial tamponade; $\\leftarrow$ aortic rupture into pericardium / left pleural cavity / mediastinum.\n$D D x$ : penetrating ulcer of thoracic aorta ( $=$ atherosclerotic lesion of mid-descending aorta with ulceration extending through intima into aortic media)\n\n# AORTIC HYPOPLASIA \n\nPrevalence: $5-10 \\%$ of congenital cardiac lesions\nCause: fibrous ridge deformity of aortic media + intima protruding into aortic lumen $\\rightarrow$ prominent posterior infolding of aortic lumen that may extend laterally $\\rightarrow$ eccentric narrowing of aortic lumen\nGenetics: usually sporadic; increased frequency among patients with Turner syndrome (13$15 \\%)$\n\n- CHF in neonatal period (in $50 \\%$ ) $=2^{\\text {nd }}$ most common cause of heart failure in newborns Definition:\n(a) external diameter of proximal arch segment $<60 \\%$\n(b) external diameter of distal arch segment $<50 \\%$\n(c) external diameter of isthmic segment $<40 \\%$ compared to external diameter of ascending aorta\n$\\sqrt{ }$ patent ductus arteriosus\nHemodynamics:\nfetus : no significant change because only $10 \\%$ of cardiac output flows through aortic isthmus neonate : determined by how rapidly the ductus closes; without concurrent VSD overload of LV leads to CHF in $2^{\\text {nd }} / 3^{\\text {rd }}$ week of life\nPrognosis: $11 \\%$ mortality prior to 6 months of age\nRx: ages 3-5 years are ideal time for operation (late enough to avoid restenosis + early enough before irreversible hypertension occurs); surgical correction past 1 year of age decreases operative mortality drastically Risk of surgery: $3-11 \\%$ perioperative mortality\nProcedures:\n\n1. Resection + end-to-end anastomosis\n2. Patch angioplasty\n3. Subclavian artery used as flap (Waldhausen procedure)\n\n## Postsurgical Cx:\n\n1. Residual coarctation (in 32\\%)\n2. Subsequent obstruction (rare)\n3. Mesenteric arteritis: $2-3$ days after surgery $\\leftarrow$ paradoxical hypertension from increased plasma renin\n\n- abdominal pain, loss of bowel control",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 37,
            "markdown": "4. Chronic persistent hypertension\n\nDDx: Normal (gradual tapering of distal aortic arch + isthmus during first 3 months of life)\n\n# Tubular Aortic Hypoplasia \n\n$=$ combination of abnormally small diameter + increased length ( $>5 \\mathrm{~mm}$ in infants) between aortic arch segments\n\n## AORTIC PROSTHETIC GRAFT INFECTION\n\nFrequency: 1.3-6\\% of prosthetic graft procedures\nClassification:\n(1) PERIGRAFT INFECTION (2-6\\%)\n\n- groin swelling, heat, tenderness, pulsatile mass, draining sinus tract; fever, chills, leukocytosis\n(2) AORTOENTERIC FISTULA ( $0.6-2 \\%)$\n- acute / chronic GI bleeding (may be occult), sepsis\n- may be temporally remote (up to 10 years):\nmedian time of 3 years to manifestation ( $70 \\%$ occur $>1^{\\text {st }}$ year)\n- intracavitary signs: malaise, back pain, fever, elevated sedimentation rate, hydronephrosis, ischemia from clotted graft\nNormal postoperative course:\n$\\sqrt{ }$ ring of fat attenuation in early postoperative period $<5 \\mathrm{~mm}$ between aneurysm wall and graft\n$\\diamond$ Complete resolution of hematoma by 3 months\n$\\diamond$ Disappearance of ectopic gas complete by $4-7$ weeks\nCT ( $94 \\%$ sensitive, $85 \\%$ specific, $91 \\%$ accurate):\n$\\checkmark$ perigraft fluid\n$\\checkmark$ perigraft soft-tissue attenuation with indistinctness of graft margins\n$\\checkmark$ ectopic gas $\\leftarrow$ fistulous communication with bowel / gas-producing organism\n$\\checkmark$ pseudoaneurysm ( $25 \\%$ )\n$\\checkmark$ focal bowel wall thickening $\\rightarrow$ indicates fistula\n$\\checkmark>5 \\mathrm{~mm}$ soft tissue between graft + surrounding wrap (beyond $7^{\\text {th }}$ postoperative week)\n$\\checkmark$ focal discontinuity of calcified aneurysmal wrap\nFalse positives:\nperigraft hematoma in early postoperative period, pseudoaneurysm (in 15-20\\%)\nNUC:\n$\\sqrt{ }$ uptake of ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-hexametazine labeled leukocytes (drawbacks: not performed quickly, hepatobiliary excretion)\nPrognosis: $17-75 \\%$ mortality; $30-50 \\%$ morbidity\n$D x$ : positive culture from needle aspirate (incubation period must be up to 14 days as organisms may be slow-growing)\n\n\n## AORTIC REGURGITATION / INSUFFICIENCY\n\n## Cause:\n\nA. PRIMARY DISEASE OF ASCENDING AORTA distorting aortic root (more common)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 38,
            "markdown": "(a) dilatation of aortic annulus\n\n1. Idiopathic dilatation (most common cause)\n2. Atherosclerosis $\\leftarrow$ systemic hypertension\n3. Aortic aneurysm\n4. Rheumatoid arthritis and variants:\n> Ankylosing spondylitis (5-10\\%)\n> Reiter disease\n> Psoriatic arthritis\n5. Familial connective tissue disease:\nmnemonic: HOME\n> Homocystinuria\n> Osteogenesis imperfecta\n> Marfan syndrome (most common cause $<40$ years of age)\n> Ehlers-Danlos syndrome\n6. Relapsing polychondritis\n7. Seronegative spondyloarthropathy: eg, Behçet\n8. Syphilitic aortitis\n(b) laceration of aorta\n\n| Classification of Aortic Regurgitation in Adults |  |  |  |\n| :--: | :--: | :--: | :--: |\n| Classification | Regurgitant Volume (mL/beat) | Regurgitant Fraction (\\%) | Valve Orifice Area (cm2) |\n| Mild | $<30$ | $<30$ | $<0.10$ |\n| Moderate | $30-59$ | $30-49$ | $0.10-0.29$ |\n| Severe | $\\geq 60$ | $\\geq 50$ | $>0.30$ |\n\n1. Deceleration trauma $\\rightarrow$ aortic dissection\n2. Prosthetic valve: mechanical break, thrombosis, paravalvular leak\nB. INTRINSIC AORTIC VALVE DISEASE impairing leaflet function (less common)\n3. Congenital bicuspid valve\nN.B.: Most common cause in developed nations\n4. Rheumatic endocarditis\nN.B.: Most common cause in developing world\n5. Bacterial endocarditis (perforation / prolapse of cusp)\n6. Rupture of congenitally fenestrated cusp\n7. Myxomatous valve associated with cystic medial necrosis\n8. Atherosclerotic degeneration\n$\\diamond$ Severely calcified aortic valves are often regurgitant\n9. Connective tissue disorder: Marfan syndrome\n10. Ergot toxicity, anorectic drugs\n11. Systemic inflammation: lupus erythematosus, Crohn disease, Takayasu arteritis, giant cell arteritis\n12. Aortic valve prolapse\n\nPathogenesis: LV volume overload $\\rightarrow$ progressive enlargement of diastolic + systolic LV dimensions $\\rightarrow$ increase in myocardial fiber length + increase in stroke volume;",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 39,
            "markdown": "decompensation occurs if critical limit of fiber length is reached\n\n- \"water-hammer pulse\" = twin-peaked pulse\n- systolic ejection murmur + high-pitched diastolic murmur\n- Austin Flint murmur $=$ soft mid-diastolic or presystolic bruit\n$\\sqrt{ }$ LV enlargement (cardiothoracic ratio $>0.55$ ) + initially normal pulmonary vascularity (DDx: congestive cardiomyopathy, pericardial effusion):\n$\\sqrt{ }$ LV wall may appear thin even with ventricular hypertrophy\n$\\checkmark$ normal aorta (in intrinsic valve disease)\n$\\checkmark$ dilatation of aorta (in systemic disease):\n$\\checkmark \\pm$ calcification of ascending aorta (in aortic wall disease)\n$\\checkmark \\pm$ enlarged aortic arch + tortuous descending aorta\n$\\checkmark$ increased pulsations along entire aorta\nECHO:\n$\\checkmark$ aortic root dilatation\n$\\sqrt{ }$ CHARACTERISTIC high frequency flutter of aML (occasionally pML) during first $2 / 3$ of diastole\n$\\checkmark$ high frequency diastolic flutter of IVS (uncommon)\n$\\checkmark$ diastolic flutter of aortic valve (SPECIFIC, but rare)\n$\\checkmark$ premature aortic valve opening (high diastolic LV pressure)\n$\\checkmark$ decreased MV opening (aML pushed posteriorly by regurgitant aortic jet)\n$\\checkmark$ premature closure of mitral valve (high diastolic LV pressure produces MV closure before beginning of systole in severe acute aortic insufficiency)\n$\\sqrt{ }$ LV dilatation + large amplitude of LV wall motion (volume overload, increased ejection fraction):\n\n| End-systolic LV diameter | Action |\n| :--: | :--: |\n| $<50 \\mathrm{~mm}$ | yearly follow-up |\n| $50-54 \\mathrm{~mm}$ | 4- to 6-month follow-up |\n| $>55 \\mathrm{~mm}$ | valve replacement |\n\nDoppler:\n$\\sqrt{ }$ decrease of slope of peak diastolic to end-diastolic velocity $>3 \\mathrm{~m} / \\mathrm{sec} 2$ in severe aortic regurgitation\n$\\sqrt{ }$ area of regurgitant flow visible by color Doppler\n$\\sqrt{ }$ ratio of width of regurgitant beam to width of aortic root is good predictor of severity (on color Doppler)\n\n# AORTIC RUPTURE \n\n$=$ blood leakage through aortic wall\n\n1. Spontaneous rupture of aortic aneurysm\n\nPathogenesis: small clefts occur at a fragile site within inner thrombus gradually expanding to outer layer of thrombus with gradual seepage of flowing blood into mural thrombus + aneurysmal wall\nCT:\n$\\sqrt{ }$ high-attenuation \"crescent\" sign ( $71 \\%$ )\n2. Spontaneous rupture of descending thoracic aorta",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 40,
            "markdown": "Predisposed: hypertension and atherosclerosis, NO preformed aneurysm!\nPathogenesis: pressure atrophy of media $\\leftarrow$ overlying intimal atheromatous plaque causing localized ballooning of aortic wall prior to perforation\n3. Traumatic rupture / transection of thoracic aorta\n\nCause: blunt trauma to thoracic aorta\n\n# AORTIC STENOSIS \n\nAortic valve area decreased to $<0.8 \\mathrm{~cm}^{2}=0.4 \\mathrm{~cm}^{2} / \\mathrm{m}^{2}$ BSA (normal $2.5-4.0 \\mathrm{~cm}^{2}$ )\nA. ACQUIRED AORTIC STENOSIS\n\n1. Rheumatic valvulitis: from postinflammatory fusion (almost invariably associated with mitral valve disease)\nN.B.: Most common cause worldwide\n2. Fibrocalcific senile aortic stenosis (degenerative)\nN.B.: Most common cause in developed countries\n3. Takayasu aortitis\n4. Radiation aortitis\n5. Aortic dissection\n6. Infected aortic aneurysm with abscess\n7. Pseudoaneurysm from laceration\n8. Atherosclerosis (rare)\n9. Syphilitic aortitis (rare)\nB. CONGENITAL AORTIC STENOSIS (most common)\n$=$ most frequent CHD associated with IUGR\nLocation:\n10. Subvalvular AS $(15-30 \\%)$\n11. Valvular AS $(60-70 \\%)$\n12. Supravalvular AS (rare)\n\nCause:\n\n1. Bicuspid aortic valve $\\rightarrow$ predisposed to early stenosis\n2. Williams syndrome\n3. Neurofibromatosis\n4. Rubella\n5. Mucopolysaccharidosis\n6. Hypoplastic left heart syndrome\n\n## Pathogenesis:\n\ngradual decrease in valve area $\\rightarrow \\uparrow$ gradient across valve $\\rightarrow \\uparrow$ LV afterload $\\mathrm{LV} \\rightarrow$ hypertrophy and diminished LV compliance; $\\uparrow$ muscle mass may outstrip coronary blood supply (subendocardial myocardial ischemia with angina $\\rightarrow$ fibrosis); LV decompensation with impaired contractility + compliance $\\rightarrow$ LV dilatation + pulmonary venous congestion\n\nAortic stenosis increases afterload on $\\mathrm{LV} \\rightarrow$ compensatory LV hypertrophy, which initially minimizes wall stress and maintains cardiac output!\n\n- asymptomatic for many years (until valve area $1 \\mathrm{~cm}^{2}$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 41,
            "markdown": "| Severity of Aortic Stenosis in Adults |  |  |  |\n| :--: | :--: | :--: | :--: |\n| Classification | Aortic Jet velocity (m/sec) | Mean Pressure <br> Gradient (mmHg) | Valve Orifice Area $\\left(\\mathrm{cm}^{2}\\right)$ |\n| Normal | $\\leq 2.0$ | $<5$ | $3.0-4.0$ |\n| Mild | $<3.0$ | $<25$ | $>1.5$ |\n| Moderate | $3.0-4.0$ | $25-40$ | $1.0-1.5$ |\n| Severe | $>4.0$ | $>40$ | $<1.0$ |\n\n- angina, dyspnea, syncope, heart failure, systolic murmur\n- diminished aortic component of $2^{\\text {nd }}$ heart sound\n- sudden death in severe stenosis ( $20 \\%$ ) after exercise (diminished flow in coronary arteries causes ventricular dysrhythmias + fibrillation); carotid pulsus parvus et tardus\n$\\sqrt{ }$ poststenotic dilatation of ascending aorta (in $90 \\%$ of acquired, in $70 \\%$ of congenital AS)\n$\\sqrt{ }$ normal-sized / enlarged LV (small LV chamber with thick walls)\n@ in adults $>30$ years\n$\\sqrt{ }$ calcification of aortic valve (best seen on RAO); indicates gradient $>50 \\mathrm{mmHg}$ :\n$\\sqrt{ }$ severe aortic calcifications = \"porcelain aorta\" $\\rightarrow$ technically difficult / impossible valve replacement\n$\\sqrt{ }$ ectasia / aneurysmal dilatation of ascending aorta ( NO correlation with severity of stenosis)\n$\\sqrt{ }$ calcification of mitral annulus\n$\\sqrt{ }$ \"left ventricular configuration\" = concavity along mid left lateral heart border + increased convexity along lower left lateral heart border\n@ in children / young adults\n$\\sqrt{ }$ prominent ascending aorta\n$\\sqrt{ }$ left ventricular heart configuration\n@ in infancy:\n$\\sqrt{ }$ left ventricular stress syndrome\nCT:\n$\\sqrt{ }$ thickening + calcification of cusps\n$\\sqrt{ }$ reduction of aortic valve area\nECHO:\n$\\sqrt{ }$ thickened + calcified aortic valve with multiple dense cusp echoes throughout cardiac cycle (right $>$ noncoronary $>$ left coronary cusp)\n$\\sqrt{ }$ decreased separation of leaflets in systole with $\\downarrow$ opening orifice: $13-14 \\mathrm{~mm}=$ mild AS; $8-$ $12 \\mathrm{~mm}=$ moderate AS; $<8 \\mathrm{~mm}=$ severe AS\n$\\sqrt{ } \\pm$ doming in systole\n$\\sqrt{ }$ dilated aortic root\n$\\sqrt{ }$ increased thickness of LV wall $\\leftarrow$ concentric LV hypertrophy\n$\\sqrt{ }$ hyperdynamic contraction of LV (in compensated state)\n$\\sqrt{ }$ decreased mitral EF slope $\\leftarrow$ reduced LV compliance\n$\\sqrt{ }$ LA enlargement\n$\\sqrt{ }$ increased aortic valve gradient (Doppler)\n$\\sqrt{ }$ decreased aortic valve area (unreliable)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 42,
            "markdown": "$D D x$ : calcification of aortic annulus in elderly / calcified coronary artery ostium (thickened cusp echoes only in diastole)\nPrognosis: depends on symptomatology (angina, syncope, CHF $\\rightarrow 2-3$ years average survival w/o surgery)\n$C x$ : aortic valve replacement (for symptomatic patient with substantial ventricular dysfunction)\n\n# Subvalvular Aortic Stenosis \n\n$=$ SUBAORTIC STENOSIS\nA. ANATOMIC / FIXED SUBAORTIC STENOSIS\n\nAssociated with: cardiac defects in $50 \\%$ (usually VSD)\nType I : thin $1-2-\\mathrm{mm}$ membranous diaphragmatic stenosis, usually located within 2 cm or less of valve annulus\nType II : thick collarlike stenosis\nType III : irregular fibromuscular stenosis\nType IV : \"tunnel subaortic stenosis\" = fixed tunnel-like narrowing of LVOT = excessive thickening of only upper ventricular septum with normal mitral valve motion\nB. FUNCTIONAL / DYNAMIC SUBAORTIC STENOSIS\n\n1. Asymmetric septal hypertrophy (ASH)\n2. Idiopathic hypertrophic subaortic stenosis (IHSS)\n3. Hypertrophic obstructive cardiomyopathy (HOCM) may occur in infants of diabetic mothers\n$\\sqrt{ }$ no dilatation of ascending aorta\n$\\checkmark$ asymmetrically thicker ventricular septum than free wall of LV (95\\%)\n$\\checkmark$ normal / small left + right ventricular cavities (95\\%)\n$\\checkmark$ lucent subaortic filling defect in systole\n$\\checkmark$ focal convexity of left upper-mid cardiac margin = anterior aspect of ventricular septum (rare)\nECHO:\n$\\checkmark$ coarse systolic flutter of valve cusps\n$\\checkmark$ opening of leaflets followed by rapid inward move in mid systole, leaflets may remain in partially closed position through latter portion of systole (to appose borders of the flow jet)\n$\\checkmark$ systolic anterior motion of mitral valve\n$C x$ : mitral regurgitation $\\leftarrow$ abnormal position of anterolateral papillary muscle preventing complete closure of MV in systole\n\n## Valvular Aortic Stenosis\n\n$=$ fusion of commissures between cusps\nDegree: mild: $>0.7 \\mathrm{~cm}^{2}$; moderate: $0.5-0.7 \\mathrm{~cm}^{2}$; severe: $<0.5 \\mathrm{~cm}^{2}$\nCongenital types:\n(1) Bicuspid / unicuspid (in 95\\%): in $0.7-2.0 \\%$ of population; $\\mathrm{M}>\\mathrm{F}$; commonly associated with aortic coarctation\n$\\diamond$ Valve degenerates a decade earlier compared with tricuspid configuration!\n$\\diamond$ Aortic ectasia $\\leftarrow$ marfanoid-type wall weakness + eccentric poststenotic jet\n(2) Tricuspid (5\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 43,
            "markdown": "(3) Dysplastic thickened aortic cusps\n@ IN INFANT with critical aortic stenosis:\n\n- intractable CHF in first days / weeks of life with severe dyspnea; may simulate neonatal sepsis\nAssociated with: L-to-R shunts (ASD, VSD)\n$\\sqrt{ }$ marked cardiomegaly $\\leftarrow$ thickened wall of LV\n$\\checkmark$ pulmonary venous hypertension\n$\\checkmark$ decreased ejection fraction\n$\\checkmark$ doming of thickened valve cusps\n$\\checkmark$ dilated ascending aorta\nRx: emergency surgical dilatation\n@ IN CHILD:\n- asymptomatic until late in life\n$\\checkmark$ normal pulmonary vascularity\n$\\checkmark$ LV configuration with normal size of heart\n$\\checkmark$ large posterior noncoronary cusp, smaller fused right + left cusps\n$\\checkmark$ doming of thickened valve cusps\n$\\checkmark$ eccentric jet of contrast\n\n| DDx of Valvular Aortic Stenoses |  |  |  |\n| :--: | :--: | :--: | :--: |\n|  | Congenital | Rheumatic | Degenerative |\n| Clinically apparent | $<30$ years | $30-60$ years | $>65$ years |\n| Valve calcifications |  |  |  |\n| $1^{\\text {st }}$ appearance | 25 years | 47 years | 54 years |\n| $\\mathrm{Ca}^{2+}$ pattern | nodular / <br> bicuspid | nodular | nodular / <br> tricuspid |\n| on CXR | $>90 \\%$ <br> $(40-65 \\mathrm{y})$ | $<10 \\%$ | $>90 \\%$ <br> $(>65 \\mathrm{y})$ |\n| Aortic ectasia | ascending Ao | ascending Ao | entire Ao |\n\n$\\sqrt{ }$ poststenotic dilatation of ascending aorta\n@ IN ADULT\n$\\checkmark$ valvular calcifications (in $60 \\%$ of $>24$ years of age)\nECHO:\n$\\checkmark$ increase in echoes from thickened deformed leaflets (maximal during diastole)\n$\\checkmark$ decrease in leaflet separation\n\n# Supravalvular Aortic Stenosis \n\n$=$ focal / diffuse narrowing of aorta starting at sinotubular junction + often involving entire ascending aorta ( $15 \\%$ )\nTypes:\n(a) localized hourglass narrowing just above aortic sinuses\n(b) discrete fibrous membrane above sinuses of Valsalva\n(c) diffuse tubular hypoplasia of ascending aorta + branching arteries\n\nGenetics: (rare) sporadic form/autosomal inherited: mutation of elastin gene on",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 44,
            "markdown": "chromosome 7q11.23\nPath: reduction + disorganization of elastin fibers within aortic media accompanied by hypertrophied smooth muscle cells and increased collagen content $\\rightarrow$ reduced elasticity + increased shear stress\nAssociated with:\nperipheral PS\n> valvular AS (in 50\\%): commonly bicuspid aortic valve\n> discrete subvalvular aortic stenosis (in 16\\%)\n> Williams-Beuren syndrome\n> Marfan syndrome\n> infantile hypercalcemia syndrome\n$\\sqrt{ }$ small ascending thoracic aorta\n$\\sqrt{ }$ dilatation + tortuosity of coronary arteries (may undergo early atherosclerotic degeneration $2^{\\circ}$ to high pressure)\nECHO:\n$\\sqrt{ }$ narrowing of supravalvular aortic area (normal root diameter: $20-37 \\mathrm{~mm}$ )\n$\\sqrt{ }$ normal movement of cusps\n$\\sqrt{ }$ left ventricular myocardial hypertrophy\n$\\sqrt{ }$ bicuspid aortic valve\n\n# AORTOENTERIC FISTULA \n\n$=$ life-threatening condition\nMortality: approaches $100 \\%$ without prompt surgery\n\n## Primary Aortoenteric Fistula (rare)\n\n= complication of atherosclerotic aortic aneurysms WITHOUT previous aortic surgery / trauma\nIncidence: $0.007 \\div 1,000,000$ annually\nPredisposed: syphilis, TB, mycotic infection, collagen vascular disease\n$\\sqrt{ }$ ectopic gas adjacent to / within aorta (KEY FINDING)\n$\\sqrt{ }$ obliteration of fat plane between aorta and bowel\n$\\sqrt{ }$ $\\pm$ hematoma in retroperitoneum / bowel wall or lumen\nSecondary Aortoenteric Fistula (more frequent)\n$=$ complication of aortic reconstructive surgery / stent graft\nIncidence: $0.6 \\%-2.0 \\%$ annually\nTime interval since surgery: 2 weeks to 10 years\nCause: complication of advanced perigraft infection\n\n- GI bleeding ( $80 \\%$ ) preceded by \"herald bleeds\"\n- abdominal pain ( $30 \\%$ ), back pain ( $15 \\%$ ), sepsis ( $44 \\%$ )\n- groin mass ( $12 \\%$ ), abdominal pulsatile mass ( $6 \\%$ )\n\nLocation: horizontal + ascending duodenum ( $80 \\%$ )\n$\\sqrt{ }$ loss of fat plane between aorta and adjacent bowel, pseudoaneurysm, disruption of aortic wall:\n$\\sqrt{ }$ tethering / puckering of bowel wall toward aorta\n$\\sqrt{ }$ perigraft soft-tissue edema, fluid / hematoma:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 45,
            "markdown": "N.B.: resolution within 2-3 months after surgery\n$\\checkmark$ hyperattenuating fluid collection / mass acute $=$ hematoma / partially thrombosed pseudoaneurysm\nStrongly suggestive CT findings:\n$\\checkmark$ ectopic gas\nN.B.: may be normal immediately after surgery\n\nCave: abnormal 3-4 weeks after surgery = sign of perigraft infection / fistulization\n$\\checkmark$ focal bowel wall thickening (challenging if involved bowel loop not distended)\n$\\checkmark$ breach of the aortic wall\n$\\checkmark$ extravasation of contrast material into bowel lumen (extremely rare but most SPECIFIC)\n$\\checkmark$ leakage of enteric contrast into periaortic space (rare)\nCT features of perigraft infection should raise concern about the possibility of a secondary aortoenteric fistula.\nAngio: usually no vascular abnormality\n$D D x$ : (1) Perigraft infection without fistulization\n(2) Retroperitoneal fibrosis\n(3) Infected (mycotic) aortic aneurysm\n(4) Infectious aortitis\n\n# Aortoesophageal Fistula \n\n$=$ rare life-threatening subtype of intramural hematoma\nFrequency: $3.5 \\%$ of all deaths $\\leftarrow$ upper esophageal bleeding\nCause:\n(a) aortic condition ( $75 \\%$ ): ruptured aneurysm, ruptured atheromatous plaque, penetrating ulcer, prosthetic grafting / reconstructive surgery\n(b) esophageal condition: foreign body ingestion, malignancy, corrosive esophagitis CT:\n$\\checkmark$ enhancing subepithelial esophageal mass with fistulous tract between aorta + esophagus\n\n## AORTOPULMONIC WINDOW\n\n$=$ AORTOPULMONARY WINDOW\n$=$ large round / oval communication between left wall of ascending aorta + right wall of pulmonary trunk / right pulmonary artery\nAortopulmonic window has well-defined separate aortic and pulmonary valve apparatuses unlike in truncus arteriosus!\nPrevalence: $0.1 \\%$ of all CHD\nCause: defect in septation process with incomplete fusion / malformation of right / left conotruncal rings\n\n- clinically resembles PDA with frequent CHF\n\nMori classification:\nType $=$ proximal communication near semilunar valves ( $70-96 \\%$ )\nI",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 46,
            "markdown": "Type $=$ distal communication near pulmonary bifurcation at level of right pulmonary artery\nII $(14-25 \\%)$; associated with type A of interrupted aortic arch\nType $=$ total absence of aortopulmonary septum (5\\%)\nIII\nAssociated with: other congenital cardiac anomalies (in up to 44\\%)\nCXR:\n$\\sqrt{ }$ shunt vascularity\n$\\sqrt{ }$ cardiomegaly $\\leftarrow \\mathrm{LA}+\\mathrm{LV}$ enlarged\n$\\sqrt{ }$ diminutive aortic knob\n$\\sqrt{ }$ prominent pulmonary trunk $\\leftarrow$ arterial pHTN\nAngio (left ventriculogram / aortogram in AP / LAO projection):\n$\\sqrt{ }$ defect several mm above aortic valve\n$\\sqrt{ }$ pulmonary valve identified (DDx to truncus arteriosus)\n$R x$ : surgery (pulmonary artery flap, pericardial patch); nonsurgical (Amplatzer device implantation)\n\n# ARTERIOSCLEROSIS OBLITERANS \n\n$=$ ASO $=$ HARDENING OF THE ARTERIES\nPrevalence: $2.7 \\%$ (in $1.0 \\%$ of $<60$ years of age, in $3.4 \\%$ of $\\geq 65$ years of age); 2.4 million people in USA; in $197812 \\%$ of autopsies had ASO as leading cause of death (excluding MI)\nEtiology: unknown\nContributing factors: aging, diabetes (16-44\\%), hypertension, atherosclerosis\nEffect of hyperlipidemia:\n(a) high-density lipoproteins (HDL) have a protective effect: carry $25 \\%$ of blood cholesterol\n(b) low-density lipoproteins (LDL): carry $60 \\%$ of cholesterol\n\nHisto: deposition of lipids, blood products, carbohydrates, begins as disruption of intimal surface; fatty streaks (as early as childhood); fibrous plaques (as early as $3^{\\text {rd }}$ decade); thrombosis, ulceration, calcification, aneurysm\nAge: $50-70$ years; $\\mathrm{M}>\\mathrm{F}$ (after menopause)\nClinical classification:\n(1) Intermittent claudication = ischemic symptoms with exercise: in calf, thigh, hip, buttock\n(2) Ischemic symptoms at rest (indicative of multisegment dz )\n\n- cramping / burning / aching pain; cold extremity; paresthesia\n- trophic changes: hair loss, thickened nails\n- ulcer, gangrene; decreased / absent pulses\n\nLocation: medium + large arteries; frequently at bifurcations; most frequently affected sites are:\n> superficial femoral artery within adductor canal (diabetics + nondiabetics)\n> aortoiliac segment (nondiabetics)\n> tibioperoneal trunk (diabetics)\nPrognosis:\nASO accelerated by diabetes ( $34 \\%$ will require amputation), hypertension, lipoprotein abnormalities, heart disease ( $=\\downarrow$ cardiac output $\\rightarrow$ polycythemia $\\rightarrow \\uparrow$ blood viscosity), chronic addiction to tobacco ( $11.4 \\%$ will require amputation), intermittent claudication (5-",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 47,
            "markdown": "$7 \\%$ require amputation if nondiabetic $=1-2 \\%$ annually), ischemic ulcer / rest pain ( $19.6 \\%$ require amputation)\n\n# ATRIAL SEPTAL DEFECT \n\n$\\diamond$ Most common congenital cardiac defect after bicuspid aortic valve!\nFrequency: $8-10-14 \\%$ of all CHD; $\\mathrm{M}+\\mathrm{F}=1 \\div 3$\nAge: presentation frequently $>$ age 40 secondary to benign course\n(a) mildly symptomatic ( $60 \\%$ ): dyspnea, fatigue, palpitations\n(b) severely symptomatic ( $30 \\%$ ): cyanosis, heart failure\n\n## Hemodynamics:\n\nno hemodynamic perturbance in fetus; after birth physiologic $\\uparrow$ in LA pressure + greater compliance of RA and RV create L-to-R shunt (shunt volume $\\sim 3-4$ times that of systemic blood flow); volume overload of RV is well tolerated in childhood, $\\rightarrow$ leads to RV dilatation, right heart failure; diastolic pressure differences in atria determine direction of shunt; pulmonary pressure remains normal for decades; after 40 years of age onset of pulmonary hypertension $\\rightarrow$ increased R-to-L shunting (Eisenmenger syndrome); pulmonary hypertension in young adulthood $(6 \\%)$\n\n| RA | $\\uparrow$ | RV | $\\uparrow$ | Main PA | $\\uparrow$ |\n| :-- | :-- | :-- | :-- | :-- | :-- |\n| Pulm. vessels | $\\uparrow$ |  |  |  |  |\n| LA | $\\leftrightarrow$ | LV | $\\leftrightarrow$ | Ao | $\\downarrow / \\leftrightarrow$ |\n\n- repeated respiratory infections; feeding difficulties\n- atrial arrhythmias: atrial flutter + atrial fibrillation increases with age; thromboembolism\n- asymptomatic; occasionally discovered by routine CXR\n- fixed splitting of second heart sound with accentuation of pulmonary component (ejection murmur grade II/VI) heard at $2^{\\text {nd }}$ left intercostal space along PA\n- ECG: right axis deviation + some right bundle branch block\n- exertional dyspnea after development of pulmonary arterial hypertension (= Eisenmenger syndrome)\n- cyanosis may occur (shunt reversal to R-to-L shunt), typically during $3^{\\text {rd }}-4^{\\text {th }}$ decade\n- right heart failure in patients $>40$ years; right ventricular heave\n\nTypes of ASD: ostium secundum $>$ ostium primum $>$ sinus venosus $>$ unroofed coronary sinus CXR:\n$\\checkmark$ normal (if shunt $<2 \\mathrm{x}$ systemic blood flow)\n$\\checkmark$ overcirculation $=$ increase in pulmonary blood flow (if pulmonary-to-systemic blood flow $\\geq 2 \\div 1$ )\n$\\checkmark$ cardiomegaly:\n$\\checkmark$ heart small compared with pulmonary vascularity $=$ closing shunt\n$\\checkmark$ heart large compared with pulmonary vascularity $=$ intercurrent myocardial / aortic disease\n$\\checkmark$ loss of visualization of SVC $\\leftarrow$ clockwise rotation of heart $\\leftarrow$ RV hypertrophy\n$\\checkmark$ small appearing aorta with normal aortic knob\n$\\checkmark$ normal size of LA after shunt reversal $\\leftarrow$ immediate decompression into RA (in\nEisenmenger syndrome):",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 48,
            "markdown": "$\\sqrt{ }$ enlargement of $\\mathrm{PA}+$ central pulmonary arteries\n$\\sqrt{ }$ RV enlargement\n$\\sqrt{ }$ \"hilar dance\" = increased pulsations of central pulmonary arteries (DDx: other L-to-R shunts)\nECHO:\n$\\sqrt{ }$ paradoxical interventricular septal motion $\\leftarrow \\mathrm{RV}$ volume overload\n$\\sqrt{ }$ direct visualization of ASD (= lack of echoes of atrial septum) in subcostal view\n$\\sqrt{ }$ diastolic blood flow from interatrial septum crossing RA + tricuspid valve directly observed by color Doppler\nMR:\n$\\sqrt{ }$ discrete area of interruption of the normal intermediate-intensity interatrial septum CAVE: normal thinning of fossa ovalis can cause drop-out of atrial signal\n$\\sqrt{ }$ area of signal loss from atrial septum into RA $\\leftarrow$ turbulent jet on GRE\n$\\sqrt{ }$ ratio of stroke volumes in aorta to PA (measurement of flow volume on cine phase-contrast images)\n![img-14.jpeg](img-14.jpeg)\n\nAngio:\n$\\sqrt{ }$ RA fills with contrast shortly after LA is opacified (on levophase of pulmonary angio in AP or LAO projection)\n$\\sqrt{ }$ injection into RUL pulmonary vein to visualize exact size + location of ASD (LAO $45^{\\circ}+$ C-C $45^{\\circ}$ )\nPrognosis:\n(1) Mortality: $0.6 \\%$ in $1^{\\text {st }}$ decade; $0.7 \\%$ in $2^{\\text {nd }}$ decade; $2.7 \\%$ in $3^{\\text {rd }}$ decade; $4.5 \\%$ in $4^{\\text {th }}$ decade; $5.4 \\%$ in $5^{\\text {th }}$ decade; $7.5 \\%$ in $6^{\\text {th }}$ decade; median age of death is 37 years\n(2) Spontaneous closure: $22 \\%$ in infants $<1$ year; $33 \\%$ between ages 1 and 2 years; $3 \\%$ in children $>4$ years\nCx: (1) Tricuspid insufficiency $\\leftarrow$ dilatation of AV ring\n(2) Mitral valve prolapse",
            "images": [
                {
                    "id": "img-14.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 825,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1436,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 49,
            "markdown": "(3) Atrial fibrillation (in $20 \\% 1^{\\text {st }}$ presenting symptom in patients $>$ age 40 )\n\nRx: (if vascular changes still reversible $=$ resistance of pulmonary-to-systemic system $\\leq 0.7$ )\n\n1. Surgical patch closure\n2. Rashkind foam + stainless steel prosthesis\n\nIndication for surgery ( $1 \\%$ surgical mortality):\n\n1. RA and RV enlargement $\\pm$ symptoms\n2. Paradoxical emboli\n3. Pulmonary-to-systemic flow ratio $>1.5$\n\n# Beneficial ASD \n\n$=$ secundum type ASD serves essential compensatory function in:\n\n1. Tricuspid atresia\n\nRA blood reaches pulmonary vessels via ASD + PDA; improvement through Rashkind procedure\n2. TAPVR\nsignificant shunt volume only available through ASD (VSD / PDA much less reliable)\n3. Hypoplastic left heart\nsystemic circulation maintained via RV with oxygenated blood from LA through ASD into RA\n\n## Ostium Secundum Defect\n\n$=$ persistent opening at site of foramen ovale\nCause: exaggerated resorptive process of septum primum $\\rightarrow$ absence / fenestration of foramen ovale flap (Chiari network)\nLocation: in the center of the atrial chamber at fossa ovalis\nSize: large defect of $1-3 \\mathrm{~cm}$ in diameter\nMay be associated with:\nprolapsing mitral valve ( $20-30 \\%$ ), pulmonary valve stenosis, tricuspid atresia, TAPVR, hypoplastic left heart, interrupted aortic arch",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 50,
            "markdown": "![img-15.jpeg](img-15.jpeg)\n$\\sqrt{ }$ large direct communication between atria\nPrognosis: often spontaneous closure by 2 years of age if diameter $<6 \\mathrm{~mm}$ and if discovered in neonate\n$D D x$ : patent foramen ovale (interatrial connection of variable width + length)\n\n# Ostium Primum Defect \n\n$=$ defect of atrioventricular endocardial cushion\nLocation: lower end of septum inferior to fossa ovalis (at outlet portion of atrial septum) adjacent to atrioventricular valves\nAlmost always associated with:\nDown syndrome, cleft mitral valve, common atrioventricular canal complex, anterior fascicular block\n$\\checkmark$ cardiomegaly + pulmonary vascular congestion\nECHO:\n$\\checkmark$ direct visualization of abnormality\n$\\checkmark$ measurement of flow and shunt size\n$\\checkmark$ evaluation for valvular regurgitation\n$\\checkmark$ both AV valves at same level (tricuspid valve usually more apically located than mitral valve)\n$\\checkmark$ enlargement $\\mathrm{RA}+\\mathrm{RV}+\\mathrm{PA} \\leftarrow$ secondary pulmonary arterial hypertension\n\n## Unroofed Coronary Sinus\n\n$=$ CORONARY SINUS DEFECT\nCause: lack of septation between left atrium and coronary sinus $\\rightarrow$ left-to-right shunt",
            "images": [
                {
                    "id": "img-15.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 187,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 990,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 51,
            "markdown": "Spectrum: multiple fenestrations in coronary sinus to complete atresia of thebesian valve $\\sqrt{ }$ normal coronary sinus typically absent (unroofed)\n$\\sqrt{ }$ dilated coronary sinus\n$\\sqrt{ }$ connection between coronary sinus and left atrium\n$\\sqrt{ }$ persistent SVC drains directly into LA\n\n# Malposition of Septum Primum \n\n$=$ anomalous drainage of right pulmonary vein into RA ( $=$ to right of leftward deviated septum primum)\nPathophysiology: lack of left heart filling $\\rightarrow$ left heart hypoplasia\nAssociated with: heterotaxy, polysplenia, complex CHDs\n\n## Lutembacher Syndrome\n\n$=\\mathrm{ASD}+$ mitral stenosis\n\n## AZYGOS CONTINUATION OF IVC\n\n$=$ INTERRUPTED IVC WITH AZYGOS / HEMIAZYGOS CONTINUATION = ABSENCE OF THE HEPATIC SEGMENT OF THE IVC WITH AZYGOS CONTINUATION\nPrevalence: $0.6 \\%$\nEtiology: formation failure of right subcardinal-hepatic venous anastomosis $\\rightarrow$ atrophy of right subcardinal vein $\\rightarrow$ shunting of blood from supracardinal-subcardinal anastomosis to cranial portion of supracardinal vein (= retrocrural azygos vein)\nMay be associated with:\npolysplenia syndrome (common), asplenia syndrome (rare), indeterminate situs (= situs ambiguus), persistent left SVC, dextrocardia, transposed abdominal viscera, duplicated IVC, retroaortic left renal vein, congenital pulmonary venolobar syndrome\n$\\checkmark$ absence of hepatic $\\pm$ infrahepatic IVC:\n$\\checkmark$ drainage of hepatic veins into RA via supra- / posthepatic segment of IVC (N.B.: IVC shadow present on LAT CXR!)\n$\\checkmark$ drainage of iliac + renal veins via azygos / hemiazygos vein:\n$\\checkmark$ right renal artery crosses anterior to \"IVC\" on US\n$\\checkmark$ both gonadal veins drain into ipsilateral renal vein (since postcardinal-subcardinal anastomosis does not contribute to formation of IVC)\nCXR:\n$\\checkmark$ enlargement of azygos arch to $>7 \\mathrm{~mm}$\n$\\checkmark$ widening of right paraspinal stripe contiguous with azygos arch (= enlarged paraspinal + retrocrural azygos veins)\n$\\checkmark$ widening of left paraspinal stripe (= enlarged hemiazygos v.)\nCT / MR:\n$\\checkmark$ intensely enhancing well-defined tubular structure behind diaphragmatic crura paralleling aorta\n$D D x$ : right-sided paratracheal mass with retrocrural adenopathy\n\n## BACTERIAL ENDOCARDITIS",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 52,
            "markdown": "Incidence: $1.7-6.2 \\div 100,000$ annually in developed countries\nPredisposed:\n\n1. Native valve disease:\n(a) bicuspid aortic valve:\nresponsible for $50 \\%$ of aortic valvular bacterial endocarditis\n(b) rheumatic valve disease\n(c) mitral valve prolapse with mitral regurgitation\n2. Prosthetic valve:\n$4 \\%$ incidence of bacterial endocarditis; mitral valve $>$ aortic valve\n$\\sqrt{ }$ exaggerated valve motion (= disintegration of suture line + regurgitation)\n3. Most CHD (VSD, TOF) except ostium secundum ASD\n4. Previous endocarditis\n5. Intravenous drug use:\nendocarditis of tricuspid valve $\\rightarrow$ multiple septic pulmonary emboli\n6. Central venous catheter\n7. Other sources of infection: poor dentition, long-term hemodialysis, diabetes mellitus, HIV infection\nMajor criteria:\n8. Oscillating valvular mass\n9. Abscess\n10. Dehiscent prosthetic valve\n\nMinor criteria:\n\n1. Pseudoaneurysm\n2. Septic infarction\n\n# Valve Vegetations \n\nManifestations:\n(1) Embolic phenomena\n(2) Valvular regurgitation\n\nCT:\n$\\sqrt{ }$ peripheral cavitary (septic) lung nodules $\\rightarrow$ assess for right-sided valvular vegetations\nECHO:\n$\\checkmark$ usually discrete focal echodensities with sharp edges; may show fuzzy / shaggy nonuniform thickening of cusps (vegetations) in systole + diastole\n$\\checkmark$ may appear as shaggy echoes that prolapse when the valve is closed (DDx to mitral valve prolapse)\nECG-gated CT ( $97 \\%$ sensitive, $88 \\%$ specific):\n$\\checkmark$ routinely depicts vegetations $>1 \\mathrm{~cm}$ in diameter\n$\\checkmark$ depicts perivalvular abscess + pseudoaneurysm\n$\\checkmark$ septic + peripheral emboli\nCx: bundle-branch block, fistulation, refractory sepsis\n(a) left: peripheral embolism, stroke, brain abscess\n(b) right: septic pulmonary embolism, infarction\n\n## BEHÇET DISEASE",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 53,
            "markdown": "[Hulusi Behçet (1889-1948), dermatologist in Istanbul, Turkey]\n$=$ rare multisystemic chronic relapsing inflammatory vasculitis of variable-sized vessels in multiple organs of unknown origin\nCountries: worldwide, most common in eastern Mediterranean countries, eastern rim of Asia; highest prevalence in Turkey with $80-370 \\div 100,000$\nHisto: nonspecific necrotizing vasculitis with deposition of immune complexes in walls of small blood vessels\nAssociated with: human leukocyte antigen HLA-B51; genetic mutations including factor V Leiden $\\rightarrow$ hyper-coagulability; triggered by microbial antigens\nAge at onset: $3^{\\text {rd }}$ decade; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 1$\nTRIAD of\n\n1. Orogenital ulcers\n2. Ocular inflammatory disease\n3. Cutaneous lesions\n\nDiagnostic criteria:\n(1) Recurrent oral ulcers $=$ aphthous stomatitis ( $95-100 \\%$ )\nplus 2 major criteria\n(2) Recurrent genital ulcers ( $65-90 \\%$ ): ulcers on penis + scrotum / vulva + vagina\n(3) Ocular inflammation ( $35-70 \\%$ ): anterior + posterior uveitis, relapsing iridocyclitis, hypopyon, choroiditis, papillitis, retinal vasculitis\n(4) Skin lesion $(40-50 \\%)$ :\n> erythema nodosum, pseudofolliculitis, papulopustular lesions, acneiform nodules\n> positive pathergy test ( $10-50 \\%$ ): pustule formation $24-48$ hours after skin prick\nMajor criteria: buccal + genital ulceration, ocular inflammation, skin lesions\nMinor criteria: thrombophlebitis, GI + CNS lesions, arthritis, family history\n@ Joints\n\n- arthritis $(30-80 \\%)$\n$\\sqrt{ }$ mild nondestructive arthritis\n$R x$ : systemic corticosteroids for disease exacerbation\n$D D x$ : Reiter syndrome, Stevens-Johnson syndrome, SLE, ulcerative colitis, ankylosing spondylitis\n\n\n# Gastrointestinal Behçet Disease (5-42-60\\%) \n\nPath: lymphocytic vasculitis of venules of bowel wall $\\rightarrow$ chronic inflammation + intestinal ulceration\n\n- abdominal pain + diarrhea ( $50 \\%$ )\n@ Esophagus (rarely involved)\n$\\sqrt{ }$ single / multiple erosions / ulcerations\n$\\sqrt{ }$ diffuse esophagitis, esophageal stenosis\n$\\sqrt{ }$ mucosal dissection, intramural hematoma\n$\\sqrt{ }$ downhill esophageal varices $\\leftarrow$ thrombotic occlusion of SVC $\\rightarrow$ fibrosing mediastinitis $\\rightarrow$ mediastinal collateral vessels draining into esophageal, coronary, hepatic veins + IVC\n- hematemesis, SVC syndrome\n@ Small bowel",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 54,
            "markdown": "Location: terminal ileum (most common), often together with proximal cecum\n$\\sqrt{ }$ geographic large collar-button-shaped deep ulcer\n$\\checkmark$ aneurysmal dilatation of terminal ileum\n$\\checkmark$ cecal mass\nCx: perforation, fistula, hemorrhage\n@ Large intestine\nLocation: ascending colon (most common)\n$\\checkmark$ multiple discrete punched-out ulcers throughout colon mimicking Crohn disease\n\n# Neurologic Behçet Disease (5-21-50\\%) \n\n$=$ develops $>10$ years after onset of Behçet disease\nPath: inflammatory cellular infiltrate around peripheral small venules + arterioles $\\leftarrow-$ demyelination + edema\n@ Parenchymal Neurobehçet ( $80 \\%$ )\nLocation: brainstem (cerebral peduncles, pons) $>$ thalamus $>$ basal ganglia $>$ centrum semiovale $>$ peri-ventricular region, spinal cord, cranial nerve\n$\\checkmark$ isolated / confluent irregular T2 hyperintense foci of circular / linear / crescent shape that are iso- or hypointense relative to brain parenchyma on T1WI\n$D D x$ : multiple sclerosis (smaller + less extensive lesions), brainstem infarction, dilated perivenular spaces\n$\\checkmark$ atypically space-occupying lesion masquerading as unilateral brain tumor\n$D D x$ : lymphoma, other malignant tumor, abscess\n$\\checkmark$ leptomeningeal enhancement $\\leftarrow$ cranial nerve palsy /meningoencephalitis\nCx: small / (occasionally) large infarction\n@ Nonparenchymal Neurobehçet (20\\%)\n$\\checkmark$ cerebrovascular disorders:\n$\\checkmark$ dural sinus thrombosis ( $5-25 \\%$ ) $\\rightarrow$ raised intracranial pressure\n$\\checkmark$ multiple arterial aneurysm\n$\\checkmark$ arterial dissection / occlusion (rare)\n$\\checkmark$ aseptic meningitis $(0.05-8.00 \\%)$\nCardiac Behçet Disease (1-16\\%)\n$=$ develops within 10 years after onset of Behçet disease\n$\\checkmark$ endocarditis, myocarditis, pericarditis\n$\\checkmark$ endomyocardial fibrosis\n$\\checkmark$ coronary artery disease, myocardial infarction\n$\\checkmark$ intracardiac thrombosis\n$\\checkmark$ aneurysm of sinus of Valsalva, periaortic pseudoaneurysm\n$\\checkmark$ valve dysfunction, conduction system disturbances\n\n## Vascular Behçet Disease (5-30-45\\%)\n\n@ Veins (25\\%): migratory thrombophlebitis\n$\\checkmark$ subcutaneous / superficial venous thrombophlebitis\n$\\checkmark$ mediastinal widening $\\leftarrow$ edema $\\leftarrow$ thrombosis of SVC\n$\\checkmark$ thrombosis of IVC, veins in upper extremities",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 55,
            "markdown": "$\\sqrt{ }$ deep vein thrombosis in lower extremities\n$\\sqrt{ }$ Budd-Chiari syndrome (3\\%)\n$\\sqrt{ }$ portal vein thrombosis (9\\%)\n@ Systemic arteries (3\\%)\n$\\sqrt{ }$ saccular arterial aneurysm formation ( $1 / 3$ )\nHisto: perivascular inflammatory cell infiltration $\\rightarrow$ occlusion of vasa vasorum $\\rightarrow$ transmural necrosis of wall $\\rightarrow$ severe destruction of elastic fibers in media $\\rightarrow$ perforation of vessel wall\nLocation: ascending thoracic aorta $>$ aortic arch $>$ abdominal aorta $>$ pulmonary $>$ femoral $>$ coronary $>$ subclavian $>$ popliteal arteries\n$\\sqrt{ }$ arterial occlusion/ pulseless disease ( $3 / 4$ )\n@ Pulmonary artery\n$\\sqrt{ }$ increased perihilar radiopacity $\\leftarrow$ pulmonary artery aneurysm\nLocation: artery to RLL $>$ RPA $>$ LPA\n$\\diamond$ Most common cause of pulmonary artery aneurysm!\n$\\sqrt{ }$ in situ pulmonary artery thrombosis\n$\\sqrt{ }$ pulmonary artery thromboembolism $\\leftarrow \\mathrm{DVT} \\leftarrow$ hypercoagulable state\n\n# Thoracic Behçet Disease (1-8\\%) \n\n@ Lung\n$\\sqrt{ }$ multiple subpleural wedge-shaped / ill-defined increased opacities $\\leftarrow$ areas of pulmonary infarction $\\leftarrow$ hemorrhage / parenchymal necrosis\n$\\sqrt{ }$ ill-defined ground-glass opacities with consolidation $=$ hemorrhage $\\leftarrow$ ruptured pulmonary artery aneurysm\n$\\sqrt{ }$ pleural effusion\n\n## BICUSPID AORTIC VALVE\n\n$=$ single fused commissure at birth resulting in 2 separate cusps of unequal size (usually fused $L$ +R coronary cusps)\nSievers classification: based on\n(a) number of raphes\n(b) position of cusps and raphes\n\nPrevalence: $1-2 \\%$ in general population\n$\\diamond$ Most common congenital cardiac anomaly!\nGenetics: autosomal dominant with incomplete penetrance\nHisto: cystic medial degeneration; $\\uparrow$ levels of matrix metalloproteinases; $\\downarrow$ levels of fibrillin-1 in aortic wall\n\nBicuspid aortic valve patients have an aortopathy similar to Marfan syndrome with an increased propensity for aortic dilatation, aneurysm, dissection, and rupture!\nAssociated with: dilatation of aortic root $(50 \\%)+$ ascending aorta + transverse arch aortic; CoA\nCx: stenosis, regurgitation, endocarditis, aneurysmal dilatation of ascending aorta, aortic dissection\nRecommendation: monitoring of aortic size with echocardiography / CT / MRI",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 56,
            "markdown": "# BUERGER DISEASE \n\n$=$ THROMBANGIITIS OBLITERANS\n[Leo Buerger (1879-1943), Austrian-American pathologist, surgeon and urologist at Mount Sinai Hospital, Beth David Hospital, Bronx Hospital, and Wyckoff Heights Hospital, Brooklyn, New York]\n$=$ idiopathic recurrent segmental obliterative vasculitis of small + medium-sized peripheral arteries + veins (panangiitis)\nFrequency: $<1 \\%$ of all chronic vascular diseases; more common in Israel, Orient, India\nEtiology: unknown\nHisto:\n(a) acute stage: multiple microabscesses within fresh / organizing thrombus; all layers of vessel wall inflamed but intact; internal elastic lamina may be damaged; multinucleated giant cells within microabscesses (PATHOGNOMONIC)\n(b) subacute stage: thrombus organization with little residual inflammation\n(c) chronic stage: lumen filled with organized recanalized thrombus, fibrosis of adventitia binds together artery, vein, and nerve\nAssociated with: cigarette smoking ( $95 \\%$ )\n\n- instep claudication $\\pm$ distal ulceration (symptoms abate on cessation of smoking + return on its resumption)\n- Raynaud phenomenon (33\\%)\n\nLocation: legs ( $80 \\%$ ), arms ( $10-20 \\%$ )\nSite: starts in palmar + plantar vessels with proximal progression\n$\\sqrt{ }$ superficial + deep migratory thrombophlebitis ( $20-33 \\%$ )\n$\\checkmark$ arterial occlusions, tapered narrowing of arteries\n$\\checkmark$ abundant corkscrew-shaped collaterals\n$\\checkmark$ direct collateral following the path of the original artery (Martorell sign) in $80 \\%$\n$\\checkmark$ skip lesions = multiple segments involved with portions of arterial wall remaining unaffected\n$\\checkmark$ absence of generalized arteriosclerosis / arterial calcifications ( $90 \\%$ )\n\n## CARDIAC ARREST\n\n$=$ sudden cessation of cardiac pump function\nCT:\n$\\checkmark$ layering of static blood within heart + great vessels\n$\\checkmark$ hematocrit effect $\\leftarrow$ sedimentation of RBCs\n$\\checkmark$ good depiction of cardiac anatomy $\\leftarrow$ NO cardiac motion\nCECT:\n$\\checkmark$ contrast pooling in dependent portion of venous system (right atrium, hepatic veins)\n$\\checkmark$ no contrast in pulmonary artery + left heart structures\n$R x:$ prompt cardiopulmonary resuscitation\n\n## CARDIAC FIBROMA\n\n$=$ FIBROMATOSIS $=$ FIBROUS HAMARTOMA $=$ FIBROELASTIC HAMARTOMA\n$=$ congenital neoplasm / hamartoma of the heart\nPrevalence: 100 cases reported; $2^{\\text {nd }}$ most common benign cardiac neoplasm of childhood (after",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 57,
            "markdown": "rhabdomyoma)\nMean age: 13 (range, $0-56$ ) years; $33 \\%$ in children $<1$ year of age / in utero; $15 \\%$ in adolescents + adults\nIncreased prevalence in: Gorlin (basal cell nevus) syndrome\n\n- heart failure, cardiac murmur ( $1 / 2$ ), ventricular arrhythmia\n- NO embolism; asymptomatic ( $1 / 2$ )\n\nPath: $2-10-\\mathrm{cm}$ large single round bulging well-circumscribed tumor within ventricular myocardium; foci of calcification / ossification ( $50 \\%$ )\nHisto: collection of fibroblasts interspersed among large amounts of collagen; numerous elastic fibers ( $>50 \\%$ ); NO foci of cystic change / hemorrhage / necrosis\nLocation: ventricular septum $>$ left ventricular free wall\n$\\sqrt{ }$ cardiomegaly\n$\\sqrt{ }$ focal cardiac bulge $\\leftarrow$ tumor in free ventricular wall\n$\\sqrt{ }$ may be pedunculated\n$\\sqrt{ }$ centrally cystic degeneration (rare)\n$\\sqrt{ } \\pm$ pericardial effusion\nECHO:\n$\\sqrt{ }$ noncontractile echogenic heterogeneous solid mass:\n$\\sqrt{ }$ mean diameter $>5 \\mathrm{~cm}$; may obliterate cardiac chamber\n$\\sqrt{ }$ multifocal dystrophic central tumor calcifications\n$\\sqrt{ }$ affected myocardium hypokinetic\n$D D x$ : focal hypertrophic cardiomyopathy, hypertrophy of ventricular septum\nCT:\n$\\sqrt{ }$ homogeneous mural mass of soft-issue attenuation\n$\\sqrt{ }$ sharply marginated / infiltrative\n$\\sqrt{ }$ calcifications $(25 \\%)$\n$\\sqrt{ }$ variable enhancement\nMR:\n$\\sqrt{ }$ iso- / hypointense homogeneous discrete mural mass / myocardial thickening on T1WI\n$\\sqrt{ }$ homogeneously hypointense on T2WI\n$\\sqrt{ }$ no / little hetero- or homogeneous enhancement\nPrognosis:\n(1) Sudden death $\\leftarrow$ arrhythmia $\\leftarrow$ invasion / compression of cardiac conduction system\n$\\diamond 2^{\\text {nd }}$ most common primary cardiac tumor associated with sudden death (after endodermal heterotopia of AV node)\n(2) May remain stable in size for years\n\nFibromas often are single lesions that do not regress, unlike rhabdomyomas!\n$C x$ : fetal hydrops $\\leftarrow$ obstruction, pericardial effusion, fetal arrhythmia, fetal death\n$R x$ : surgical excision / partial resection\n$D D x$ in infants: rhabdomyoma (multiple masses)\n$D D x$ in children: rhabdomyosarcoma (no calcification, cystic or necrotic tumor, invasion of pulmonary veins or pericardial space)\n\n# CARDIAC HEMANGIOMA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 58,
            "markdown": "$=$ rare benign vascular tumor of the heart\nPrevalence: $5-10 \\%$ of benign cardiac tumors\nAssociation: Kasabach-Merritt syndrome (multiple systemic hemangiomas, recurrent thrombocytopenia, consumptive coagulopathy)\nPath: predominantly intramural spongy mass / well-circumscribed endocardial-based soft mass growing into pericardial space; may contain fat\nHisto: capillary (= small capillary-like vessels); cavernous (= multiple thin-walled dilated vessels); arteriovenous ( $=$ thick-walled dysplastic arteries + veins + capillaries)\n\n- asymptomatic; dyspnea on exertion, chest pain, right-sided CHF\n- arrhythmia, syncope, pericarditis, sudden death\n\nLocation: any chamber\n$\\checkmark$ mass-occupying lesion impinging upon cardiac cavities\n$\\checkmark \\pm$ pericardial effusion\nUS:\n$\\checkmark$ hyperechoic mass\nCT:\n$\\checkmark$ heterogeneous intensely enhancing mass\nMR:\n$\\checkmark$ heterogeneously iso- / hypointense on T1WI\n$\\checkmark$ hyperintense / occasionally hypointense on T2WI\n$\\checkmark$ inhomogeneous hyperintense enhancement pattern\nAngio:\n$\\checkmark$ vascular blush in capillary + arteriovenous type\n$\\checkmark$ no enhancement for cavernous type\nPrognosis: spontaneous regression possible\nRx: surgical resection (for symptomatic lesion)\n\n# CARDIAC INJURY \n\nFrequency: $25 \\%$ of traumatic deaths related to heart injury\n$\\diamond$ Congestive heart failure, pulmonary edema, cardiogenic shock, new cardiac murmur, pericardial friction should prompt evaluation for cardiac injury!\nIn blunt trauma, a triad of hyperdense pericardial effusion + distention of IVC and renal vv. + hypodense periportal fluid suggests cardiac tamponade!\n\n## Blunt Cardiac Injury\n\n$=$ most common type of cardiac injury after blunt thoracic trauma, but difficult to diagnose\nCause: MVC, fall, explosion, work-related accident, recreational activity, CPR\nLocation: RV (35\\%), LV (25\\%), RA atrium (33\\%), LA (14\\%), aorta (14\\%)\nAssociated with: rib fracture ( $83 \\%$ ), pneumothorax (39\\%), hemothorax (31\\%), lung contusion ( $13 \\%$ ), fracture of clavicle ( $13 \\%$ ), sternum ( $10 \\%$ )\n\n## Myocardial Concussion\n\n$=$ mildest form of cardiac injury without proved myocardial cell damage / morphologic injury $=$ myocardial stunning",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 59,
            "markdown": "- NO chemical abnormalities; NO elevated enzymes\n- $\\pm$ arrhythmia\n\nECHO:\n$\\checkmark$ segmental wall motion abnormalities\n\n# Myocardial Contusion \n\nFrequency: $10-75 \\%$\nSite: anterior surface of heart ( $\\mathrm{RV}>\\mathrm{LV}$ )\n\n- precordial pain and dyspnea with varying ECG changes\n- elevated cardiac enzymes:\n> creatine kinase ( $>90 \\%$ sensitive, $<6 \\%$ specific)\n> serum cardiac troponin ( $>90 \\%$ sensitive + specific): level proportional to extent of myocardial damage\n$\\checkmark$ distinct boundary between normal + contused tissue\n$\\checkmark$ patchy necrosis + hemorrhage $\\rightarrow$ eventually heal to form patchy and irregular fibrosis\nECHO:\n$\\checkmark$ increased myocardial echogenicity\n$\\checkmark$ focal systolic hypokinesis\nNUC: not found to be helpful\n$C x$ : arrhythmia, low cardiac output, ventricular septal defect, ventricular rupture, valvular dysfunction\n$\\diamond$ Extensive myocardial contusion + hemopericardium may be present without external signs of thoracic trauma\n\n\n## Myocardial Rupture\n\nFrequency: 0.3-1.1\\% (in ER), 36-65\\% (in autopsy)\nSite: right side of heart\n\n- refractory hypotension + tachycardia\n$\\checkmark$ pericardial effusion $\\rightarrow$ tamponade $\\rightarrow$ cardiac arrest\n$\\checkmark$ myocardial disruption:\n$\\checkmark$ traumatic VSD typically occurs in the apical interventricular septum $\\leftarrow$ anteroposterior cardiac compression between sternum and thoracic spine.\n$\\checkmark$ extravasation of IV contrast into pericardial space\nPrognosis: 33\\% surgical mortality, excellent long-term prognosis in survivors\n\n\n## Pericardial Injury / Rupture\n\nLocation of tear: longitudinal path along phrenic nerve\n$\\checkmark$ pericardial effusion\n$\\checkmark$ pneumopericardium $\\leftarrow$ pericardial tear (in $0.3-0.5 \\%$ )\n$\\checkmark$ delayed traumatic diaphragmatic hernia\n$\\checkmark$ focal pericardial dimpling + discontinuity\n$\\checkmark$ lung interposition between aorta + pulmonary artery / heart + diaphragm / RA + RVOT\n$C x$ : partial / complete trans-defect cardiac herniation\n\n## CARDIAC HERNIATION\n\nN.B.: life-threatening condition (33-47\\% survival rate)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 60,
            "markdown": "Prevalence: in $64 \\%$ of pericardial ruptures\n$\\sqrt{ }$ contour abnormality of heart $=$ deformed ventricular silhouette\n$\\checkmark$ cardiac displacement into either hemithoracic cavity\n$\\checkmark$ pericardial sac \"empty\" = delineated by air / filled with loops of gas-containing bowel\n$C x$ : strangulation of cardiac structures $\\leftarrow$ constrictive pericardial defect\n\n# CARDIAC LUXATION \n\n$=$ cardiac herniation and volvulus\nFrequency: in $28 \\%$ of pericardial ruptures\n\n- change in electrical axis of heart\n$\\checkmark$ cardiac displacement:\n$\\checkmark$ leftward deviation of the myocardial septum\n$\\checkmark$ torsion along IVC + great vessels $=$ strangulation of entire heart\n$\\checkmark$ entrapment of LA + LV\n$\\checkmark$ cardiac herniation through pericardial defect\n$\\checkmark$ pneumopericardium, esp. if associated with pneumothorax\n$C x$ : SVC obstruction, right heart strain\nMortality rate: up to $67 \\%$\n\n\n## Coronary Artery Injury\n\nFrequency: $<2 \\%$ of blunt chest trauma\nSite: LAD $>$ RCA $>>$ left circumflex artery\nPath: intimal tear $\\rightarrow$ dissection $\\rightarrow$ thrombosis\n\n- hypotension, ventricular arrhythmias\n- acute myocardial infarction + ST-segment elevation\n$R x$ : percutaneous transluminal angioplasty + stenting\n$C x$ : rapid tamponade\n\n\n## Traumatic Valvular Dysfunction\n\nSite: aortic $>$ mitral $>$ tricuspid valve\nPathophysiology:\n(1) direct blunt cardiac trauma $\\rightarrow$ abrupt increase in intracardiac chamber pressure against closed valve $\\rightarrow$ maximal transvalvular gradient\n(2) sudden rise in intraabdominal pressure $\\rightarrow$ waterhammer effect to $\\mathrm{L}>\\mathrm{R}$ heart\n$\\checkmark$ pulmonary edema $\\leftarrow$ new onset heart failure\n@ Aortic valve\n$\\checkmark$ tear / avulsion from annulus of aortic valve cusp (esp. noncoronary cusp)\n@ Mitral valve\nSite: rupture of papillary muscle $>$ chordae tendineae $>$ tear of leaflet\n@ Tricuspid valve (rare)\nSite: rupture of chordae tendineae $>$ tear of anterior papillary muscle $>$ tear of leaflet\n\n## Penetrating Cardiac Injury\n\nCause: stabbing (knives), gunshot (handgun)\nLocation: RV (62\\%), LV (38\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 61,
            "markdown": "In penetrating chest trauma, CT is useful for depicting hemopericardium ( $100 \\%$ sensitive, $>96 \\%$ specific), pneumopericardium, intrapericardial hernia, and cardiac compression by a mediastinal hematoma.\nMortality: prehospital ( $94 \\%$ ), in-hospital ( $50 \\%$ ), gunshot ( $81-90 \\%$ ), stabbing ( $16-67 \\%$ ) Cause of death: hemorrhagic shock ( $78 \\%$ ), cardiac tamponade ( $22 \\%$ )\n\n# CARDIAC LIPOMA \n\n$=$ very rare benign neoplasm; $2^{\\text {nd }}$ most common cardiac tumor\nPrevalence: 60 reported cases\nAge: wide range; typically in adults\nPath: encapsulated spherical / elliptical solitary mass, often very large (up to $4,800 \\mathrm{~g}$ ) by the time they come to clinical attention; multiple lipomas in CHD, tuberous sclerosis\nHisto: mature adipocytes surrounded by capsule\nAssociated with: tuberous sclerosis (with multiple lipomas)\n\n- mostly asymptomatic\n- dyspnea (in intracavitary lipoma $\\leftarrow$ blood flow obstruction, in pericardial lipoma $\\leftarrow$ displacement of lung)\n- arrhythmia $\\leftarrow$ involvement of conduction system\n- right heart failure $\\leftarrow$ direct obstruction of tricuspid valve / vena cava with large lipoma\n\nLocation: broad-based from\n(a) epicardial surface growing into pericardial space\n(b) endocardial surface growing into cardiac chamber\n(c) interatrial septum (atrioventricular grooves)\n$\\checkmark$ cardiomegaly, globular-shaped heart\n$\\checkmark$ echogenic / hypoechoic broad-based nonmobile mass\n$\\checkmark$ round mass with smooth contour\nCT:\n$\\checkmark$ homogeneous mass of $\\leq-50 \\mathrm{HU}$ in cardiac chamber / pericardial space\nMR:\n$\\checkmark$ mass similar to adjacent subcutaneous / mediastinal fat:\n$\\checkmark$ homogeneously hyperintense on T1WI\n$\\checkmark$ intermediate to high signal intensity on T2WI\n$\\checkmark \\pm$ few thin septations\n$\\checkmark$ uniform drop in signal intensity with fat saturation\n$\\sqrt{ }$ NO contrast enhancement\nPET:\n$\\sqrt{ }$ NO FDG activity\n$R x$ : surgical resection\n\n## CARDIAC PARAGANGLIOMA\n\n$=$ extremely rare, usually benign sporadic neoplasm arising from intrinsic cardiac sympathetic paraganglial (chromaffin) cells\nPrevalence: $<50$ cases\nMean age: 40 (range, 18-85) years",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 62,
            "markdown": "- catecholamine-producing tumor (in the majority):\n- headache, arterial hypertension, palpitations, flushing\n- elevated levels of urinary norepinephrine, vanillylmandelic acid, total metanephrine, plasma norepinephrine, epinephrine\nAssociated with:\n(a) additional paragangliomas (in 20\\%) in carotid body, adrenal gland, bladder, paraaortic\n(b) metastases to bone (in 5\\%)\n\nPath: $2-14 \\mathrm{~cm}$ large encapsulated / poorly circumscribed and infiltrative highly vascular mass; necrotic in $60 \\%$\nHisto: monomorphic tumor composed of nests of paraganglial cells (= \"Zellballen\") surrounded by sustentacular cells\nLocation: posterior wall of left atrium > roof of left atrium > atrial cavity > interatrial septum > ventricle\nSite : epicardial surface of the base of the heart with tendency to involve coronary arteries CXR:\n$\\checkmark$ middle mediastinal mass splaying carina simulating left atrial enlargement (for typically located tumor)\nECHO:\n$\\checkmark$ large echogenic left atrial mass\n$\\checkmark$ compression of SVC, encasement of coronary arteries\n$D D x$ : myxoma (broad base of attachment, softer)\nNUC ( ${ }^{131}$ I- or ${ }^{123}$ I-MIBG):\n$\\checkmark$ for total body imaging with a sensitivity of $90 \\%$\nNECT:\n$\\checkmark$ circumscribed / ill-defined heterogeneous mass:\n$\\checkmark$ hypoattenuating\n$\\checkmark$ isoattenuating to cardiac structures (may be missed)\n$\\checkmark \\pm$ tumor calcifications\n$\\checkmark \\pm$ extracardiac extension\nCECT:\nCave: Premedicate patient with alpha- and beta-blockers as contrast material can trigger a hypertensive crisis!\n$\\checkmark$ markedly enhancing mass adherent to / involving left atrium / anterior to aortic root\n$\\checkmark$ central area of low attenuation (in $50 \\%$ ) from necrosis\nMR:\n$\\checkmark$ mass iso- / hypointense to myocardium on T1WI\n$\\checkmark$ very hyperintense mass on T2WI\n$\\checkmark$ intense often heterogeneous enhancement\n\n# CARDIAC SARCOMA \n\n$\\diamond$ Most common primary malignant tumor of the heart!\nMean age: 41 years; extremely rare in infants + children\n(a) right-sided heart inflow obstruction (tumor in right atrium)\n\n1. Angiosarcoma ( $37-80 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 63,
            "markdown": "(b) mitral valve obstruction (tumor in left atrium)\n2. Undifferentiated sarcoma ( $24-37 \\%$ )\n3. Malignant fibrous histiocytoma (11-24\\%)\n4. Leiomyosarcoma ( $1-9 \\%$ ): predilection for left atrium; tends to invade pulmonary veins + mitral valve\nAge: 5-10 years earlier than other sarcomas\n5. Primary cardiac osteogenic sarcoma (3-9\\%)\n\nDDx: myxoma (at fossa ovalis)\n\n- dyspnea, pericardial tamponade, arrhythmia, syncope, peripheral edema, sudden death\n- embolic phenomena, chest pain, pneumonia, fever\n$\\sqrt{ }$ contrast enhancement, areas of hemorrhage, central necrosis\nCXR:\n$\\checkmark$ cardiomegaly, RA enlargement\n$\\checkmark$ CHF\n$\\checkmark$ pleural effusion, pericardial effusion\n$\\checkmark$ focal cardiac mass\n$\\checkmark$ pulmonary consolidation\nPET:\n$\\checkmark$ difficult identification of sarcoma if myocardial FDG activity is high\nMetastatic to: lung, lymph nodes, bone, liver, brain, bowel, spleen, adrenal gland, pleura, diaphragm, kidney, thyroid, skin\nPrognosis: mean survival of 3 month to 1 year\n$D x$ : invasion of adjacent cardiac chambers + pericardium (DDx: benign mass)\nClue for subtypes:\n$\\checkmark$ macroscopic fat favors liposarcoma\n$\\checkmark$ calcifications favor fibrosarcoma\n$\\checkmark$ right atrial location favors angiosarcoma\n\n\n# Angiosarcoma (37-80\\%) \n\nFrequency: most common cardiac malignancy of adulthood\nAge: typically in middle-aged men\nPath: frequently hemorrhagic + necrotic mass, often adherent to pericardium $\\rightarrow$ pericardial effusion\nHisto: mesenchymal cells characterized by ill-defined vascular spaces lined by atypical endothelial cells\n\n- chest pain, right heart failure, supraventricular arrhythmia\n- fever, weight loss; pericardial tamponade $=$ bloody fluid on pericardiocentesis (rarely with malignant cells)\nSpread to: right ventricle, lung, vena cava, liver (in 66-89\\% at presentation)\nLocation: right atrial free wall + involvement of pericardium ( $80 \\%$ )\n(a) well-defined large mass protruding into a cardiac chamber\n$\\checkmark$ usually originating from RA with sparing of atrial septum\n$\\checkmark$ areas of central necrosis communicating with cardiac chamber\n$\\checkmark$ disruption of fat planes, pericardial thickening / nodularity\n$\\checkmark$ low-attenuation mass on CT",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 64,
            "markdown": "$\\checkmark$ heterogeneous contrast enhancement\n$\\checkmark$ heterogeneous MR signal:\n$\\checkmark$ \"cauliflower appearance\" = local nodular predominantly hyperintense areas interspersed within areas of intermediate SI on T2WI\n$\\checkmark$ central areas of necrosis\n(b) diffusely infiltrative mass extending along epicardial surface\n$\\checkmark$ obliterated pericardial space (hemorrhage + necrotic tumor debris)\n$\\checkmark$ \"sunray appearance\" = linear contrast enhancement along vascular lakes on MR\nPrognosis: poor ( $\\leftarrow$ late patient presentation); median survival of 6 months\n\n# Leiomyosarcoma of Heart (1-9\\%) \n\nLocation: predilection for left atrium; multiple (in 30\\%); tends to invade pulmonary veins + mitral valve\nAge: $\\quad 5-10$ years earlier than other sarcomas\n\n- dyspnea, $\\mathrm{CHF} \\leftarrow$ mitral valve obstruction\n$\\checkmark$ iso- to hypointense on T1WI + hyperintense on T2WI\n$\\checkmark$ marked contrast enhancement\n\n\n## Primary Osteogenic Sarcoma of Heart (3-9\\%)\n\n$=$ OSTEOSARCOMA OF HEART = CARDIAC OSTEOSARCOMA\nFrequency: rare; 3-9\\% of primary cardiac sarcomas\nHisto: osteo- / chondro- / fibroblastic differentiation\nLocation: left atrium sparing fossa ovalis\n$\\checkmark$ broad base of attachment with invasive behavior\n$\\checkmark$ dense calcifications (frequent) on CT\n$\\checkmark$ heterogeneously hypointense on T1WI\n$\\checkmark$ hyperintense on T2WI\n$D D x$ : metastatic osteosarcoma, myxoma\n\n## Rhabdomyosarcoma of Heart\n\nFrequency: most common primary cardiac malignancy of childhood\nHisto: embryonal type (in children + adults); pleomorphic type (in adults)\nLocation: no specific chamber with tendency to involve valves; multiple sites\n\n- CHF (common)\n\nMR:\n$\\checkmark$ isointense to myocardium on T1WI\n$\\checkmark$ central areas of low SI $\\leftarrow$ tumor necrosis\n$\\checkmark$ homogeneous enhancement\n\n## Undifferentiated Sarcoma (24-37\\%)\n\n$=$ PLEOMORPHIC SARCOMA $=$ ROUND CELL SARCOMA $=$ SPINDLE CELL SARCOMA\nFrequency: $2^{\\text {nd }}$ most common cardiac malignancy\nAge: 45 years (range, neonates to elderly)\n\n- pulmonary congestion\n\nLocation: left atrium",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 65,
            "markdown": "$\\sqrt{ }$ large irregular hypodense intracavitary mass\n$\\sqrt{ }$ polypoid mass isointense to myocardium\n$\\sqrt{ }$ thickening / irregularity of myocardium $\\leftarrow$ tumor infiltration\n$\\sqrt{ }$ tendency to involve valves\n$\\sqrt{ }$ hemorrhagic mass replacing the pericardium (similar to angiosarcoma)\n\n# CARDIAC TAMPONADE \n\n$=$ PERICARDIAL TAMPONADE\n$\\diamond$ Cardiac tamponade is a clinical diagnosis!\n$=$ significant compression of heart by fluid / blood / pus / gas / tissue (= benign or malignant neoplasia) contained within pericardial sac $\\rightarrow$ impaired diastolic filling of ventricles\nIn blunt trauma, the triad of hyperdense pericardial effusion + distention of IVC and renal veins + hypodense periportal fluid suggests cardiac tamponade!\n\n## Hemodynamics:\n\nincremental $\\uparrow$ in intrapericardial volume exceeds limit of pericardial stretch $\\rightarrow \\uparrow$ intrapericardial pressure $\\rightarrow$ compression of heart $\\rightarrow \\uparrow$ diastolic filling pressures $+\\downarrow$ volumes of cardiac chambers $\\rightarrow$ severe hemodynamic impairment $(=\\downarrow$ stroke volume $) \\rightarrow$ reduced cardiac output $\\rightarrow \\downarrow$ arterial blood pressure $+\\downarrow$ coronary blood flow\nIntrapericardial pressure: normally equals intrapleural pressure; pathologically equals cardiac chamber pressure\n$\\diamond$ With rapid fluid accumulation as little as 200 mL of fluid can cause cardiac tamponade!\n$D x$ : clinical suspicion confirmed by echocardiography\nRate of accumulation versus pericardial volume:\n(a) rapid / acute: $100-200 \\mathrm{~mL}$\n(b) slow / gradual: up to $1,000-1,500 \\mathrm{~mL}$\n\n- Beck triad:\n- muffled \"distant\" heart sounds\n- jugular venous distention $\\leftarrow \\uparrow$ central venous pressure\n- falling blood pressure / hypotension\n- compensatory mechanisms:\n- tachycardia, increased contractility\n- vasoconstriction: cool legs, arms, ears, nose, peripheral cyanosis\n- pulsus paradoxus = exaggerated drop in systolic arterial pressure $>10 \\mathrm{mmHg}$ during inspiration ( $\\leftarrow \\uparrow$ in right heart filling during inspiration at the expense of left heart filling)\n$D D x$ : massive pulmonary thromboembolism, obstructive lung disease, profound hemorrhagic shock / other forms of severe hypotension\n- shortness of breath\n- ECG: reduced voltage, ST elevation, PR depression, nonspecific T-wave abnormalities\n\nCXR:\n$\\checkmark$ normal lung fields + normal pulmonary vascularity\n$\\checkmark$ rapid enlargement of heart size (requires $>200 \\mathrm{~mL}$ of pericardial effusion):\n$\\checkmark$ global cardiomegaly with \"water bottle\" cardiac silhouette\n$\\checkmark$ mediastinal widening",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 66,
            "markdown": "$\\sqrt{ }$ hilar mass\n$\\sqrt{ } \\pm$ epicardial \"fat pad\" sign:\n$\\sqrt{ }$ curvilinear fat density displaced posteriorly from sternum by pericardial effusion on LAT view\n$\\sqrt{ } \\pm$ tension pneumopericardium:\n$\\sqrt{ }$ \"small heart\" sign = substantial decrease in size of cardiac silhouette\nECHO (imaging method of choice):\n$\\sqrt{ }$ cardiac chamber compression:\n$\\sqrt{ }$ RV collapse during early diastole $\\leftarrow$ pericardial pressure exceeds RV pressure ( $38-48 \\%$ sensitive, $84-100 \\%$ specific)\n$\\sqrt{ }$ inward movement of RA wall during late diastole + early systole lasting for $>30 \\%$ of cardiac cycle ( $55-60 \\%$ sensitive, $50-68 \\%$ specific)\n$\\sqrt{ }$ highly specific collapse of LA during late diastole (late sign in $25 \\%$ )\n$\\sqrt{ }$ exaggerated respiratory variation in mitral + tricuspid inflow $\\leftarrow$ increased ventricular coupling\n$\\sqrt{ }$ distended inferior vena cava (IVC plethora) $\\rightarrow$ NO decrease in diameter of proximal IVC by $>50 \\%$ after deep inspiration / sniff\n$\\sqrt{ }$ Doppler flow velocity paradoxus = exaggerated paradoxical increase of right versus decrease of left transvalvular inflow velocities during early diastole\n$\\sqrt{ }$ compression of intrapericardial pulmonary trunk + thoracic IVC $\\rightarrow$ indentation of RA at level of IVC junction anteriorly\n$\\sqrt{ }$ paradoxical motion of the interventricular septum $\\rightarrow$ during inspiration sharply toward left, during expiration to right\n$\\sqrt{ }$ swinging motion of heart inside pericardial sac\nLimitations of ECHO:\n\n1. High rate of false-positive findings $\\leftarrow$ adjacent pathologic conditions simulating pericardial effusions: pleural effusion, lower lobe atelectasis, pericardial + intracardiac mass, other mediastinal lesions\n2. Difficulty in identifying blood clot within pericardium\n3. Differentiation of small fluid collections from pericardial thickening\n4. Differentiation of fluid in the anterior and posterior spaces around the heart from epicardial fat\n5. Identification of loculations in complex pericardial collections\n\nCT:\n$\\sqrt{ }$ various attenuation values:\n$\\sqrt{ }$ fat (chylopericardium)\n$\\sqrt{ }$ simple serous fluid (underlying heart failure, renal failure, nonhemorrhagic carcinomatous involvement)\n$\\sqrt{ }$ greater than water (hemopericardium, malignancy, purulent exudates, myxedematous effusion associated with hypothyroidism)\n$\\sqrt{ }$ signs of pericardial thickening:\n$\\sqrt{ }$ presence of nodular areas\n$\\sqrt{ }$ typically anterior location\n$\\sqrt{ }$ lack of change at decubitus positioning",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 67,
            "markdown": "$\\checkmark$ pericardial contrast enhancement\n$\\checkmark$ extrapericardial venous changes:\n$\\checkmark$ SVC enlargement: SVC diameter $\\geq$ adjacent thoracic aorta\n$\\checkmark$ IVC enlargement: diameter $>$ twice that of adjacent aorta\n$\\checkmark$ distension of hepatic + renal veins\n$\\checkmark$ reflux of contrast medium into azygos vein + IVC\n$\\checkmark$ periportal lymphedema\n$\\checkmark$ hepatomegaly\n$\\checkmark$ intrapericardial venous changes:\n$\\checkmark$ compression of coronary sinus\n$\\checkmark$ compression of pulmonary trunk\n$\\checkmark$ compression of short intrathoracic segment of IVC (extrapericardial posteriorly, but covered by pericardium anteriorly)\n$\\checkmark$ \"flattened heart\" sign $\\leftarrow$ pericardial fluid / tissue ( $\\uparrow$ intrapericardial pressure $\\rightarrow$ transient reversal of transmural left ventricular pressure during diastole):\n$\\checkmark$ flattening of anterior heart surface with $\\downarrow$ in AP diameter\n$\\checkmark$ straightening of the right cardiac contour\n$\\checkmark$ inversion of wall with concave deformity of RA / RV\n$\\checkmark \\mathrm{RV}+\\mathrm{LV}$ of equal size $\\leftarrow$ equalization of ventricular pressures\n$\\checkmark$ angulation / bowing / inversion of interventricular septum\nMR:\n$\\diamond$ Limited role due to emergent life-threatening disease!\n$\\checkmark$ detection of pericardial effusions as small as 30 mL\n$\\checkmark$ swinging heart and paradoxical septal bounce (cine MR)\nDoppler-US:\n$\\checkmark$ distension of IVC + hepatic veins with diastolic flow reversal (= hepatopetal flow)\n$\\checkmark$ episodes of high-velocity hepatopetal flow separated by long intervals of minimal flow\n$R x$ : needle pericardiocentesis ( $95 \\%$ success with anterior effusion $>10 \\mathrm{~mm}$ ) / surgical pericardial drainage (intrapericardial bleeding, purulent effusion, clotted hemopericardium)\n$D D x$ : effusive-constrictive pericarditis\n\n# Malignant Pericardial Disease \n\n$\\checkmark$ mass arising from / contiguous with pericardium\n$\\checkmark$ obliteration of normal tissue planes between paracardiac mass and heart / pericardium\n$\\checkmark$ compression + narrowing of cardiac chambers by pericardial effusion / mass\n$\\checkmark$ hyperattenuating pericardial effusion $\\leftarrow$ hemorrhage / debris with fluid usually $>20 \\mathrm{HU}$\n$\\checkmark$ irregular enhancing nodular pericardial thickening\n$\\checkmark$ signs of right-sided heart failure\n$\\checkmark$ often evidence of primary malignancy of breast / lung\n$R x$ : emergent pericardiocentesis $\\pm$ drain placement\n\n## CARDIAC THROMBUS\n\nA thrombus is the most common cause of a cardiac mass!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 68,
            "markdown": "Cardiac thrombi in children are more commonly associated with indwelling central venous catheters, less likely with congenital heart disease or dilated cardiomyopathy.\nA. Left atrial thrombus\n\nAssociated with: mitral valve disease\n\n- atrial fibrillation\n\nSite: atrial appendage\n$\\sqrt{ }$ atrial dilatation\n$\\sqrt{ }$ irregular / lobulated border\n$\\sqrt{ }$ microcavitations\n$\\sqrt{ }$ laminated appearance\nB. Right atrial thrombus\n\nCause: underlying coagulation disorders / atrial arrhythmias / central venous catheters / pacemaker leads / mechanical tricuspid valve\nIncidence: $4-7 \\%$ with suspected pulmonary embolism\n$\\sqrt{ }$ hyperechoic mass (DDx: crista terminalis, myxoma)\n$\\sqrt{ }$ absence of mobility\n$\\sqrt{ }$ multiple lesions favor thrombus\nPrognosis: $80-100 \\%$ mortality in untreated patients\n$\\diamond$ Large right atrial mobile thrombi are life-threatening!\n$R x$ : anticoagulation, thrombectomy, thrombolysis, surgical resection\n$D D x$ : cardiac myxoma\nC. Left ventricular thrombus\n\nSite: region of ventricular dyskinesia / aneurysm $\\leftarrow$ prior myocardial infarction\n$\\checkmark$ usually NO enhancement:\n$\\checkmark$ peripheral enhancement $\\leftarrow$ neovascularization in chronic thrombus\n$\\checkmark$ homogeneous attenuation on CT\n$\\checkmark$ heterogeneous signal on SE MR images\n$\\checkmark$ low-signal intensity on GRE MR images\n$D D x$ : myxoma (heterogeneous texture on CT)\n\n# CARDIOMYOPATHY \n\n$=$ mechanical / electrical dysfunction of myocardium exhibiting inappropriate ventricular hypertrophy + dilatation\nPrevalence: $1 \\div 5439$ in USA\nCause:\nA. PRIMARY / INTRINSIC CARDIOMYOPATHY\n(a) genetic\n\n1. Hypertrophic cardiomyopathy\n2. Arrhythmogenic RV dysplasia\n3. Noncompaction cardiomyopathy\n4. Glycogen storage disease\n5. Conduction defects\n6. Mitochondrial myopathy\n7. Ion channel disorders",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 69,
            "markdown": "(b) acquired\n\n1. Inflammatory (myocarditis)\n2. Stress provoked\n3. Peripartum\n4. Tachycardia induced\n5. Infants of diabetic mothers\n(c) mixed\n6. Dilated cardiomyopathy\n7. Restrictive cardiomyopathy\nB. SECONDARY CARDIOMYOPATHY (majority of cases)\n$=$ characterized by multiorgan involvement\n(a) infiltrative: amyloidosis, Gaucher disease, Hurler disease, Hunter disease\n(b) storage: hemochromatosis, Fabry disease, glycogen-storage disease type II, NiemannPick disease\n(c) toxicity: drugs, heavy metals, chemical agents\n(d) endomyocardial: endomyocardial fibrosis, hypereosinophilic syndrome (Löffler endocarditis)\n(e) inflammatory: sarcoidosis\n(f) endocrine: diabetes mellitus, hyperparathyroidism, hyper- / hypothyroidism, pheochromocytoma, acromegaly\n(g) neurologic: Friedreich ataxia, Duchenne-Becker muscular dystrophy, myotonic dystrophy, neurofibromatosis, tuberous sclerosis\n(h) autoimmune: SLE, dermatomyositis, rheumatoid arthritis, scleroderma, polyarteritis nodosa\n(i) electrolyte imbalance: deficiencies of potassium, phosphate, magnesium; anorexia nervosa; laxative abuse\n(j) cancer therapy: anthracyclines (doxorubicin), cyclophosphamide, radiation\n\n# Dilated and Ischemic Cardiomyopathy \n\n$=$ CONGESTIVE CARDIOMYOPATHY\nEtiology:\n\n1. Idiopathic\n2. Myocarditis: viruses, bacteria\n3. Alcoholism\n4. Pregnancy / post partum\n5. Endocardial fibroelastosis $=$ thickened endocardium + reduced contractility\n6. Infants of diabetic mothers\n7. Inborn error of metabolism: glycogenosis, mucolipidosis, mucopolysaccharidosis\n8. Coronary artery disease: myocardial infarction, anomalous origin of L coronary artery, coronary calcinosis\n9. Muscular dystrophies\n\n- tendency for CHF when $\\mathrm{EF}<40 \\%$\n$\\sqrt{ }$ global 4-chamber enlargement\n$\\sqrt{ }$ poor ventricular contractility (= reduced EF)\n$\\sqrt{ }$ LA enlargement without enlargement of LA appendage",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 70,
            "markdown": "$\\sqrt{ }$ bilateral atrioventricular valve insufficiency\nECHO:\n$\\sqrt{ }$ enlarged LV with global hypokinesis\n$\\sqrt{ }$ IVS + LVPW of equal thickness with $\\downarrow$ motion amplitude\n$\\sqrt{ }$ low-profile / \"miniaturized\" mitral valve\n$\\sqrt{ }$ mildly enlarged LA $\\leftarrow$ elevated end-diastolic LV pressure\n$\\sqrt{ }$ enlarged hypokinetic right ventricle\n\n# Dilated Cardiomyopathy \n\n$=$ dilatation + impaired contraction of LV or LV + RV\nPrevalence: $36 \\div 100,000$ in USA\nCause:\n\n1. Idiopathic $(50 \\%)$\n(a) familial (20-35\\%): autosomal dominant / recessive, maternal, X chromosomelinked trait\n2. Injury: coronary artery disease, systemic disease, nutritional deficiency, excessive consumption of alcohol, anthracyclines, catecholamines\n3. Infection: viral, bacterial, fungal, rickettsial\n4. Neuromuscular syndromes: Duchenne muscular dystrophy, Friedreich ataxia\n\nHisto: patchy loss of myocytes with progressive replacement by interstitial fibrosis + eccentric hypertrophy of adjacent uninvolved cells\nHemodynamics: $\\uparrow$ diastolic volume, $\\uparrow$ systolic volumes, $\\downarrow$ ejection fraction\n\n- congestive heart failure, progressive dyspnea, orthopnea\n$\\diamond 3^{\\text {rd }}$ most common cause of heart failure after ischemia + valvular disease\n$\\diamond$ Most common cause of heart failure in the young\n- arrhythmias, thromboembolism\n$\\sqrt{ }$ biventricular dilatation\n$\\sqrt{ }$ global ventricular hypokinesia\n$\\sqrt{ }$ myocardial wall thinning ( $=$ diastolic wall thickness $<5.5 . \\mathrm{mm}$ )\n$\\sqrt{ }$ increase in myocardial mass\n$\\sqrt{ }$ mitral / tricuspid regurgitation, atrial enlargement\n$\\sqrt{ }$ intracardiac thrombus\nRisk factor of sudden death: LV ejection fraction $<35 \\%$\nRx: ICD placement (for LV ejection fraction of $\\leq 35 \\%$ )\n$D D x:$ CAD, myocarditis, cardiac sarcoidosis\n\n\n## Hypertrophic Cardiomyopathy (10\\%)\n\n$=$ genetic disorder of cardiac muscle characterized by hypertrophy of LV in the absence of cardiac / systemic disease with subsequently decreasing size of LV cavity\nPhenotypes (variable penetrance + expression):\n\n1. Asymmetric (septal) HCM $60-70 \\%$\n2. Apical HCM $2-25 \\%$\n3. Symmetric (concentric) HCM in up to $42 \\%$\n4. Midventricular HCM\n5. Masslike HCM",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 71,
            "markdown": "Prevalence: $2 \\div 1,000$ (one of the most common genetic disorders)\nEtiology: mutation in one of sarcomeric genes with autosomal dominant transmission (> $60 \\%$ ); sporadic form\nHisto: myocyte disarray + interstitial fibrosis; dysplasia of small intramural coronary arterioles $\\leftarrow$ increased pressure from adjacent hypertrophic myocytes\nAge: $\\quad 3^{\\text {rd }}-5^{\\text {th }}$ decade; occasionally infants + elderly\n\n- asymptomatic, fatigue, systolic murmur\n- dyspnea on exertion $(75 \\%) \\leftarrow$ impaired diastolic function $\\leftarrow$ impaired LV filling + preserved systolic function:\n- elevated LV diastolic pressure\n- angina $(66 \\%) \\leftarrow$ LV outflow obstruction + decreased flow through intramural coronary arteries\n- syncope $\\leftarrow$ arrhythmia / decreased cardiac output during exercise because of LV outflow obstruction\n- high voltage + inverted T waves at ECG\n- sudden cardiac death in children ( $5 \\%$ risk annually)\n\nRisk factors of sudden cardiac death:\n(1) Family history of sudden cardiac death\n(2) Unexplained syncope\n(3) Nonsustained ventricular tachycardia $=$ greater than 3 beats at $\\geq 120 \\mathrm{bpm}$\n(4) Hypotensive / blunted blood pressure response to exercise $=$ rise of systolic pressure $<20 \\mathrm{mmHg}$\nRisk factors identified on cardiac imaging:\n(1) LV wall thickness of $\\geq 30 \\mathrm{~mm}$\n(2) LVOT obstruction with gradient of $\\geq 30 \\mathrm{mmHg}$ at rest or $\\geq 50 \\mathrm{mmHg}$ with provocation\n(3) LV dilatation with depressed ejection fraction\n(4) Fibrosis\n(5) Perfusion defect\n(6) Reduced functional reserve flow\n\nRole of imaging:\n(1) Establish diagnosis\n(2) Monitor gene carriers without phenotypic hypertrophic cardiomyopathy for development of the disease\n(3) Screen family members of affected individuals\n(4) Help stratify risk for sudden cardiac death\n(5) Evaluate for complications",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 72,
            "markdown": "![img-16.jpeg](img-16.jpeg)\n\nThere is a linear relationship between maximal myocardial thickness + risk for sudden cardiac death: maximal myocardial thickness of $>30 \\mathrm{~mm} \\rightarrow$ indication for ICD placement!\n\n# Location: \n\n, asymmetric septal hypertrophy = ratio of septal to inferolateral wall thickness of $\\geq 1.3$\n, apical / midventricular hypertrophy\n, focal masslike hypertrophy\n, right ventricular hypertrophy\n$\\sqrt{ }$ LV wall hypertrophy $>15 \\mathrm{~mm}$ at end-diastole; often asymmetric / segmental / discontinuous\n$\\sqrt{ }$ NO dilatation of LV cavity $\\rightarrow$ decreasing in size\n$\\sqrt{ }$ normal heart size\n$\\sqrt{ }$ diastolic dysfunction:\n$\\sqrt{ }$ reduced LV compliance with relatively preserved systolic function and normal LV ejection fraction\n$\\sqrt{ }$ LA enlargement $\\leftarrow$ mitral insufficiency $\\leftarrow$ abnormal mitral valve apparatus (in 30\\%) / diastolic dysfunction\n$\\sqrt{ }$ prominent left midheart border (septal hypertrophy)\n$\\sqrt{ } \\pm$ mild pulmonary venous hypertension\nMR:\nCardiac MR imaging is a powerful imaging modality for differentiating HCM from other cardiomyopathies!\n$\\sqrt{ }$ marked thickening of LV wall + small LV cavity\n$\\sqrt{ }$ myocardial crypts at base of LV\n$\\sqrt{ }$ average end-diastolic thickness of septal + posterolateral wall $=23.5 \\mathrm{~mm}+11.4 \\mathrm{~mm}$; ratio 2.1\n$\\sqrt{ }$ increased LV mass (estimated by cine MR)\n$\\sqrt{ }$ large + prolonged signal void from site of obstruction toward aortic valve within normally high-intensity flowing blood $\\leftarrow$ turbulent flow during systole\n$\\sqrt{ }$ substantially elevated ejection fraction\n$\\sqrt{ }$ prolonged systolic contact of the anterior mitral valve leaflet with septum $\\leftarrow$ elongation of anterior MV leaflet\n$\\sqrt{ }$ systolic flow void from mitral valve into left atrium $\\leftarrow$ mitral valve regurgitation (on cine MR)\n$\\sqrt{ }$ impairment of LV relaxation (= abnormal LV stiffness) $\\rightarrow$ poor early diastolic filling\nCEMR:\n$\\sqrt{ }$ delayed hyperenhancement of hypertrophic myocardium (in $80 \\%$ ), on average $10 \\%$ of",
            "images": [
                {
                    "id": "img-16.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 187,
                    "bottom_right_x": 1502,
                    "bottom_right_y": 514,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 73,
            "markdown": "overall LV myocardial volume\nECHO (modality of choice):\n$\\sqrt{ }$ IVS $\\geq 15 \\mathrm{~mm}$ thick; posterolateral wall $>11 \\mathrm{~mm}$ thick; IVS+LVPW thickness $>1.3 \\div 1$\n$\\sqrt{ }$ systolic anterior motion of mitral valve (SAM) $\\rightarrow$ narrowed LVOT during systole\n$\\sqrt{ }$ dynamic LVOT obstruction $\\leftarrow$ hypertrophy of basal septum + SAM:\n$\\sqrt{ }$ increased LVOT gradient with late systolic peaking on Doppler\n$\\sqrt{ }$ midsystolic closure of aortic valve\n$\\sqrt{ }$ hyperdynamic ventricular contraction $\\rightarrow$ high LV ejection fraction\n$\\sqrt{ }$ impaired myocardial relaxation\n$D x: \\quad$ LV wall thickness $\\geq 15 \\mathrm{~mm}$ at end-diastole (without explanation); $12-14 \\mathrm{~mm}=$ borderline values of mild dz\nPrognosis: 1-6\\% annual mortality rate (sudden death in young patients); progressive LV dilatation, atrial arrhythmia, intractable CHF\nHypertrophic cardiomyopathy is the most common cause of sudden cardiac death in young adults and athletes!\n$R x$ : beta-blockers, calcium antagonists, myomectomy of hypertrophied septum, septal alcohol ablation, cardiac transplantation, ICD (effective prevention of cardiac death)\n$D D x$ : athlete's heart\n\n# Apical Hypertrophic Cardiomyopathy \n\n$=$ myocardial wall thickening confined to apical portion of LV with sparing of septum Age: middle-aged men\n\n- usually clinically benign (no obstruction to LV flow), rarely associated with sudden cardiac death\n- frequently complicated by hypertension\n- giant (negative) inverted T-wave\n$D x$ : (1) Absolute apical wall thickness $>15 \\mathrm{~mm}$ (typically most evident in anteroseptal myocardium) or\n(2) Thickness ${ }_{\\text {apical wall }}+$ Thickness $_{\\text {basal LV wall }}=1.3-1.5$\n$\\sqrt{ }$ spade-like deformity of LV cavity at end-diastole (best seen on vertical long axis view)\nSpecific Cx: apical infarction resulting in aneurysm formation (= burned-out apex)\nAt risk for: thrombus formation, thromboembolism\nPrediction of adverse outcome:\n$\\sqrt{ }$ significant amount of delayed enhancement ( $>5 \\%$ )\n\n\n## Arrhythmogenic Right Ventricular Cardiomyopathy\n\n$=$ ARRHYTHMOGENIC RV DYSPLASIA\n$=$ heritable genetic progressive replacement of RV myocardium by fibrofatty tissue\n\n- palpitations, fatigue, heart failure syncope, chest pain\n- sustained monomorphic ventricular tachycardia with left bundle-branch block during exercise\n- sudden cardiac death with physical exertion (rare)\n\nPrevalence: $1 \\div 1,000-1 \\div 5,000$; increase during $15-20$ years of age; familial in up to $50 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 74,
            "markdown": "Age: adolescence to middle-aged; $\\mathrm{M} \\div \\mathrm{F}=3 \\div 1$\nLocation: triangle of dysplasia $=$ between RV outflow tract + RV apex + diaphragmatic aspect of RV beneath posterior leaflet of tricuspid valve\nSite: progression from epicardium to endocardium\nPath: segmental / diffuse transmural loss of ( $\\mathrm{RV} \\gg>\\mathrm{LV}>$ interventricular septum) myocardium with replacement by fibrofatty tissue; saccular aneurysm in triangle of dysplasia (in up to $50 \\%$ )\n$\\sqrt{ }$ almost imperceptibly thin free wall of RV\n$\\sqrt{ }$ dilatation of RV (body + RVOT)\n$\\sqrt{ }$ regional RV akinesia / dyskinesia / dyssynchrony\nECHO:\n$\\sqrt{ }$ RVOT $\\geq 29 \\mathrm{~mm}$ on parasternal long axis view\n$\\sqrt{ }$ RVOT $\\geq 32 \\mathrm{~mm}$ on parasternal short axis view\n$\\sqrt{ }$ reduction of RV ejection fraction to $\\leq 45 \\%$\n$\\sqrt{ }$ increased RV end-diastolic volume index\nCT:\n$\\sqrt{ }$ myocardial fat in RV trabeculae + moderator band (difficult DDx: abundant epicardial fat)\n$\\sqrt{ }$ conspicuous trabeculae\n$\\sqrt{ }$ scalloped / bulging appearance of RV free wall\nFunctional and structural assessment of the RV is more reliable than fibrofatty changes!\nMR:\n$\\sqrt{ }$ fatty infiltration of RV / (rarely) epicardial LV free wall\n$\\sqrt{ }$ aneurysm formation of RV\n$\\sqrt{ }$ ratio of RV end-diastolic volume to body surface area $\\geq 100(90) \\mathrm{mL} / \\mathrm{m} 2$ for male (female) on parasternal long axis view\n$\\sqrt{ }$ reduction of RV ejection fraction to $\\leq 45 \\%$\n$\\sqrt{ }$ \"accordion\" sign = corrugated pattern to RV wall $\\leftarrow$ RV akinesia / dyskinesia / dyssynchronous contraction\n\nA diagnosis of ARVC requires these RV findings: dilatation, wall motion abnormalities, scalloped / bulging free wall, and myocardial fat in free wall, trabeculae, moderator band, interventricular septum!\n$R x$ : avoidance of strenuous exercise, $\\beta$ blocker, ICD placement, antiarrhythmic Rx, catheter ablation\n$D D x$ : (1) Physiologic myocardial fat (normal myocardial thickness + size of RV)\n(2) Healed MI (coronary artery territory, subendocardial location)\n(3) Cardiac sarcoidosis (left / biventricular enlargement)\n(4) Unrecognized shunt lesion: ASD, PAPVR\n(5) Pectus excavatum (restricted motion of basolateral + inferolateral RV wall, narrowing of RV base with relative enlargement of RV apex + RVOT)\n\n# Asymmetric Septal Hypertrophy (ASH) \n\n$=$ IDIOPATHIC HYPERTROPHIC SUBAORTIC STENOSIS (IHSS) = SUBAORTIC STENOSIS",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 75,
            "markdown": "Asymmetric septal hypertrophy is the most common morphologic variant of HCM (60-70\\%). The ventricular septum is disproportionately enlarged, most commonly involving the anteroseptal myocardium. Septal hypertrophy can be limited to subaortic / midventricular / apical regions.\n$\\diamond$ Most common + clinically significant form!\n$D x$ : The normal thickness of the LV is $\\leq 11 \\mathrm{~mm}$ measured during diastole.\n(1) Septal thickness $\\geq 15 \\mathrm{~mm}$ (typically most evident in anteroseptal myocardium) or\n(2) Thickness ${ }_{\\text {septum }}+$ Thickness inferior LV wall $>1.5$ at midventricular level\n\n# Clinical distinction: \n\n1. Hypertrophic obstructive cardiomyopathy\n$=$ gradient between LV outflow tract + aorta at rest and/or with provocation\nCause: systolic anterior motion of MV leaflets + midsystolic contact of MV leaflets with IVS\n$\\sqrt{ }$ peak systolic pressure gradient at rest $\\geq 50 \\mathrm{mmHg}$\n2. Nonobstructive cardiomyopathy\n$=$ no systolic obstruction of LV outflow tract\nHemodynamics:\n> LV hypertrophy $\\rightarrow$ subaortic stenosis $\\rightarrow$ abnormal diastolic function $\\rightarrow$ myocardial ischemia\n> rapid blood flow through narrow outflow tract $\\rightarrow$ anterior leaflet of mitral valve displaced anteriorly toward septum during systole (Venturi effect)\n> concomitant mitral regurgitation $\\leftarrow$ displaced MV leaflets with incomplete leaflet apposition\n\n- mitral regurgitation\n$\\sqrt{ }$ basal / upper part of LV septum disproportionately thickened\n$\\sqrt{ }$ anterolateral wall of LV often also abnormally thick\nCEMR:\n$\\checkmark$ midwall patchy or punctate midwall hyperenhancement in thickened myocardium in a noncoronary distribution\n$R x$ : septal myomectomy / alcohol ablation\n\n\n## MidVENTRICULAR CARDIOMYOPATHY\n\n$=$ rare variant of asymmetric HCM\n\n- ventricular arrhythmia, myocardial necrosis\n- systemic embolism\n$\\checkmark$ hypertrophy of middle $1 / 3$ of LV wall\n$\\checkmark$ apposition of midventricular wall $\\rightarrow$ obstruction\nMay be associated with: apical aneurysm $\\leftarrow$ increased systolic pressure in apex\n\n\n## Symmetric / Concentric Hypertrophic Cardiomyopathy\n\n$=$ HYPERTENSIVE HYPERTROPHIC CARDIOMYOPATHY\n$=$ concentric LV hypertrophy with a small cavity WITHOUT evidence of secondary causes\n\n- commonly in older women\n(a) midventricular\n(b) diffuse",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 76,
            "markdown": "(c) apical\n$\\sqrt{ }$ marked concentric LV hypertrophy\n$\\sqrt{ }$ small LV cavity\n$D D x$ : Concentric LV hypertrophy\n\n# Masslike Hypertrophic Cardiomyopathy \n\n$=$ focal segmental hypertrophic cardiomyopathy\n$\\sqrt{ }$ parallels homogeneous SI + perfusion of normal myocardium\n$D D x$ : neoplasm\n\n## Noncompaction Cardiomyopathy\n\n$=$ sponge myocardium\n$=$ rare congenital myocardial disorder caused by intrauterine arrest of endomyocardial\ncompaction $\\rightarrow$ persistence of embryonic myocardium\nPrevalence: in $0.05 \\%$ of adult echocardiograms\nPath: noncompacted subendocardial myocardium comprises numerous prominent trabeculations; deep intertrabecular recesses extend into compacted myocardial layer\n\n- asymptomatic; supraventricular / ventricular arrhythmia\n- congestive heart failure, embolic event, sudden cardiac death\n\nLocation: primarily LV + concomitant RV involvement (41\\%)\nSite: from apex along lateral + inferior wall to mid portion of left ventricle\nMR:\n$\\sqrt{ }$ overall increased myocardial thickness:\n$\\sqrt{ } 2$-layers of thin compacted subepicardial layer (C) + thick noncompacted subendocardial layer (NC)\n$\\sqrt{ } \\mathrm{NC} \\div \\mathrm{C}$ ratio of $>2.3$ in end-diastole (on 2D Steady State Free Precession imaging)\nECHO:\n$\\sqrt{ }$ maximal end-systolic $\\mathrm{NC} \\div \\mathrm{C}$ ratio of $>2$ (short-axis view)\n\n## Restrictive Cardiomyopathy\n\n$=$ intrinsic myocardial disease that impairs the myocardial ability to relax normally + impairs ventricular filling\nEtiology: (a) idiopathic: endomyocardial fibroelastosis, drugs, anthracyclines, carcinoid (b) infiltrative disease: amyloidosis, sarcoidosis, hemochromatosis, Fabry disease, glycogen storage disease, Löffler's hypereosinophilic endocarditis, Gaucher disease\nHemodynamics: reduced myocardial compliance $\\rightarrow \\uparrow$ ventricular pressure with small increases in volume $\\rightarrow \\downarrow$ diastolic ventricular filling $\\rightarrow$ diastolic heart failure with preservation of systolic function\n\n- increasing dyspnea + exercise intolerance\n- palpitations, syncopal attacks, conduction disturbances\n$\\sqrt{ }$ varying degrees of pulmonary venous hypertension\n$\\sqrt{ }$ dilatation of RA + IVC reflecting high RV filling pressure (DDx: constrictive pericarditis)\n$\\sqrt{ } \\pm$ LA enlargement\nECHO:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 77,
            "markdown": "$\\sqrt{ }$ reduced early + late diastolic annular velocities\nDiagnostic key imaging features:\n$\\sqrt{ }$ left ventricular hypertrophy\n$\\sqrt{ }$ delayed enhancement of myocardium at MRI\n$\\sqrt{ }$ normal pericardium\nPrognosis: 70\\% 5-year mortality rate after initial manifestation of symptoms\n$D D x$ : constrictive pericarditis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 78,
            "markdown": "# CHRONIC VENOUS STASIS DISEASE \n\n$=$ CHRONIC VENOUS INSUFFICIENCY\n$=$ insufficiency / incompetence of venous valves in deep venous system of lower extremity Cause:\n(a) postphlebitic valvular incompetence: short thickened valves $\\leftarrow$ scar formation $\\leftarrow$ destruction of valve apparatus\n(b) primary valvular incompetence: shallow elongated redundant valve cusps prevent effective closure\nAssociated with: incompetent venous valves in calf $\\leftarrow$ pressure dilatation from stasis in deep venous system leading to superficial vein varicosities\n\n- edema (= fluid exudation from increased capillary pressure), induration; aching pain\n- ulceration $\\leftarrow$ minor trauma + decreased diffusion of oxygen $\\leftarrow$ fibrin deposits around capillaries\n- skin hyperpigmentation (= breakdown products of exudated RBCs)\n$\\sqrt{ }$ venous reflux on descending venography with Valsalva:\n(a) $82 \\%$ in deep venous system alone\n(b) $2 \\%$ in saphenous vein alone\n(c) $16 \\%$ in both\nbilateral in $75 \\%$\nGrade:\n$1=$ minimal incompetence $=$ to level of upper thigh\n$2=$ mild incompetence $\\quad=$ to level of lower thigh\n$3=$ moderate incompetence $=$ to level of knee\n$4=$ severe incompetence $\\quad=$ to level of calf veins\n\n\n## CHURG-STRAUSS SYNDROME\n\n$=$ ALLERGIC ANGITIS AND GRANULOMATOSIS = EOSINOPHILIC GRANULOMATOSIS WITH POLYANGITIS\n$=$ rare multisystemic disorder with necrotizing vasculitis of small vessels associated with extravascular eosinophilic granulomas occurring exclusively in patients with asthma + peripheral eosinophilia $=$ variant of polyarteritis nodosa\nEtiology: ? hypersensitivity response to an inhaled agent\nIncidence: $1-7 \\div 1,000,000$ annually\nMean age: 28 (range, 20-40) years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$\nClinical phases (CLASSIC TRIAD):\n(1) Prodromal: asthma, allergic rhinitis, sinus pain, headaches\n(2) Eosinophilic: peripheral blood ( $>30 \\%$ ) and tissue hypereosinophilia with Löffler syndrome (almost in $100 \\%$ )\n(3) Systemic small-vessel granulomatous vasculitis: usually developing within 3 years of onset of asthma\nPath: (1) Necrotizing vasculitis\n(2) Eosinophilic tissue infiltration",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 79,
            "markdown": "(a) eosinophilic pneumonia\n(b) eosinophilic gastroenteritis\n(3) Extravascular \"allergic\" granulomas / eosinophilic abscesses\n\nDiagnostic criteria of American College of Rheumatology (at least 4 must be present):\n(1) Asthma (in older patient)\n(2) Eosinophilia $>10 \\%$ of WBC differential count\n(3) Polyneuropathy\n(4) Migratory / transient pulmonary opacities\n(5) Paranasal sinus abnormalities\n(6) Extravascular eosinophils at biopsy\n\n- fever, malaise, gastrointestinal symptoms, arthralgias\n- p-ANCA (perinuclear antineutrophil cytoplasmic autoantibodies) in 40-70\\%\n- elevated rheumatoid factor in $52 \\%$\n$\\checkmark$ vascular aneurysms + thrombosis\n@ Lung (most frequent): intraalveolar hemorrhage\n$\\checkmark$ normal CXR (25\\%)\n$\\checkmark$ often transient peripheral widespread nonsegmental air-space opacities without zonal predominance\n$\\checkmark$ diffuse miliary nodules:\n$\\checkmark$ nodules may coalesce up to 2 cm (rare)\n$\\checkmark$ cavitation is atypical (and suggests infection)\n$\\checkmark$ eosinophilic pleural effusions (29\\%)\nHRCT:\n$\\checkmark$ subpleural consolidation / ground-glass attenuation in a lobular distribution (59\\%)\n$\\checkmark$ bilateral centrilobular nodules\n$\\checkmark$ diffuse interstitial reticular / reticulonodular opacities\n$\\checkmark$ interlobular septal thickening\n$\\checkmark$ bronchial wall thickening\n$\\checkmark$ uni- / bilateral pleural (30\\%)\nless common:\n$\\checkmark$ hyperinflation\n$\\checkmark$ mediastinal / hilar lymphadenopathy\n$\\checkmark$ pericardial effusion\n@ Skin ( $2^{\\text {nd }}$ most frequent): palpable purpura, macular / papular erythematous rash, subcutaneous nodules\n@ GI tract (20\\%): ulceration, hemorrhage, perforation\n- diarrhea, bleeding, obstruction\n$\\checkmark$ mesenteric vasculitis (= polyarteritis nodosa)\n$\\checkmark$ eosinophilic gastroenteritis (= bowel wall infiltration by eosinophils)\n@ Heart (up to 47\\%): coronary vasculitis with myocardial infarction, myocarditis, acute pericarditis with pericardial tamponade (accounting for $50 \\%$ of deaths)\n$\\diamond$ Higher frequency of cardiac involvement than in Wegener granulomatosis\n@ CNS (commonly involved)\n- diffuse peripheral neuritis, mononeuritis multiplex\n- cranial nerve palsy (frequent): ischemic optic neuropathy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 80,
            "markdown": "- confusion, seizures, coma (in severe cases)\n$\\sqrt{ }$ micro- or macrohemorrhages of cerebral ischemia\n@ Kidney:\n- renal artery-induced hypertension, hematuria\n$\\sqrt{ }$ focal segmental glomerulonephritis\n$\\diamond$ Less frequent + less severe renal disease compared with Wegener granulomatosis + microscopic polyangiitis\n@ Muscles \\& joints: myalgia, joint pain\nPrognosis: 85\\% 5-year survival; death from intraabdominal /cardiac complications, cerebral hemorrhage, renal failure, status asthmaticus\nRx: corticosteroids, cyclophosphamide\n$D D x$ : (1) Chronic eosinophilic pneumonia (no granulomatous arteritis, no extrapulmonary lesions, homogeneous peripheral airspace consolidation)\n(2) Wegener granulomatosis (solitary / multiple nodules with cavitation)\n(3) Hypereosinophilic syndrome\n\n\n# COARCTATION OF AORTA \n\n$=\\mathrm{CoA}=$ JUXTADUCTAL COARCTATION\n$=$ short aortic narrowing at level of ligamentum arteriosum\nFormer Classification:\n(a) adult / postductal / localized type of aortic coarctation\n(b) infantile / preductal / diffuse type of aortic coarctation\n\nPrevalence: $7 \\%$ of congenital heart disease; $\\mathrm{M}+\\mathrm{F}=1.5 \\div 1$; rare in Blacks\nCause: hemodynamic hypothesis (= abnormal preductal flow); ductal hypothesis (= ectopic ductal tissue extending into aorta)\n$\\diamond$ Usually solitary lesion (in $82 \\%$ )!\nMay be associated with:\n\n1. Bicuspid aortic valve ( $22-42 \\%$ ), which may result in calcific aortic valve stenosis (after 25 years of age) + bacterial endocarditis\n2. Intracardiac malformations:\n> PDA (33\\%), VSD (15\\%), ASD, TGV\n> aortic stenosis / insufficiency\n> ostium primum defect\n> truncus arteriosus, double-outlet right ventricle\n> Shone complex = LVOT obstruction + parachute mitral valve\n> aortic hypoplasia: isolated isthmic hypoplasia, isolated aortic arch hypoplasia, isthmic + aortic arch hypoplasia\n3. Noncardiac malformations (13-15\\%): Turner syndrome\n4. Intracranial berry aneurysms ( $10 \\%$ )\n5. Mycotic aneurysm distal to CoA\n\nPath: juxta- / periductal narrowing $\\pm$ extension into aortic arch and isthmus\nHisto: cystic medial necrosis (common), intimal thickening with fragmentation of elastin and increased collagen deposition $\\rightarrow$ gradually thickening of media and $\\downarrow$ luminal diameter",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 81,
            "markdown": "![img-17.jpeg](img-17.jpeg)\n\nLocalized Coarctation\nCoarctation of the Aorta\n\nLocation: most frequent in juxtaductal portion of arch\n\n- systemic arterial hypertension in upper extremities\n- incidental finding late in life with differential pressures between upper + lower extremities\n- systolic murmur; ductus usually closed\n$\\sqrt{ }$ shelflike lesion at any point along the aortic arch\n$\\checkmark$ poststenotic aortic dilatation\n$\\checkmark$ juxtaductal aortic narrowing\n$\\checkmark$ collateral circulation via subclavian artery and its branches:\n>thoracoacromial trunk > thyrocervical trunk\n> anterior spinal artery > descending scapular artery\n> lateral thoracic artery > transverse cervical artery\n> internal mammary artery\n$\\rightarrow$ draining into external iliac + intercostal arteries\n$C x$ : wall changes predispose to infective endarteritis, intimal dissection, aortic aneurysm\nPrognosis: $75 \\%$ mortality by 46 years of age\nCause of death: CHF (26\\%), aortic rupture (21\\%), complications of endocarditis (18\\%), intracranial hemorrhage ( $12 \\%$ )\n$R x$ : prosthetic overlay, tube graft, aortoplasty, percutaneous balloon angioplasty $\\pm$ stent placement\n$D D x$ : pseudocoarctation\n\n\n# Symptomatic CoA \n\n$\\diamond$ Second most common cause of CHF in neonate (after hypoplastic left heart)\nOnset:\n(a) toward the end of $1^{\\text {st }}$ week of life in \"critical stenosis\"\n(b) more commonly presents in older child\n\n- lower extremity cyanosis (in tubular hypoplasia)\n- left ventricular failure (usually toward end of $1^{\\text {st }}$ week of life)\n\nCXR:\n$\\checkmark$ generalized cardiomegaly\n$\\checkmark$ increased pulmonary vascularity (L-to-R shunt through PDA / VSD)\n$\\checkmark$ pulmonary venous hypertension / edema",
            "images": [
                {
                    "id": "img-17.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 782,
                    "bottom_right_y": 600,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 82,
            "markdown": "$\\sqrt{ }$ \"figure-of-3\" sign hidden by thymus\n\n# Asymptomatic CoA \n\n- headaches $\\leftarrow$ hypertension; claudication $\\leftarrow$ hypoperfusion\n$\\checkmark$ \"figure-of-3\" sign (in 50-66\\% of adults)\n$=$ indentation of left lateral margin of aortic arch in the region of aortic-pulmonic window resembling the number 3 on frontal CXR view:\n$\\checkmark$ dilatation of left subclavian artery + prestenotic aorta\n$\\checkmark$ indentation at site of aortic stenosis\n$\\checkmark$ dilatation of poststenotic aorta\n$\\checkmark$ \"reverse figure-of-3\" sign = indentation of esophageal contour during barium esophagram on LAO view\n$\\checkmark$ elevated left ventricular apex $\\leftarrow$ LV hypertrophy\n$\\checkmark$ collateral vessels bypassing coarctation:\n$\\checkmark$ dilatation of brachiocephalic vessels + aorta proximal to stenosis\n$\\checkmark$ obscuration of superior margin of aortic arch\n@ superior epigastric arteries\n@ internal mammary arteries\n$\\checkmark$ scalloped contouring of soft-tissues posterior to sternum (= dilated tortuous internal mammary arteries) on LAT CXR (in 28\\%)\n@ intercostal arteries\n$\\checkmark$ inferior rib notching (in $75 \\%$; mostly in adults over age 20 ; unusual before age 6 )\nLocation: ribs 3-8 (most pronounced in $3^{\\mathrm{rd}}+4^{\\text {th }}$ ribs, less pronounced in lower ribs); $1^{\\text {st }}+2^{\\text {nd }}$ rib do not participate because they have arteries originating from the costocervical trunk\nSite: central + lateral thirds of posterior ribs\n(a) bilateral\n(b) unilateral on left side: left aortic arch with aberrant right subclavian artery below CoA\n(c) unilateral on right side: right aortic arch and anomalous left subclavian artery below CoA\n\n\n## CONGENITAL ABSENCE OF PULMONARY VALVE\n\n$=$ massive regurgitation between pulmonary artery and RV\nIn 90\\% associated with: VSD, tetralogy of Fallot (50\\%)\n\n- cyanosis (not in immediate newborn period)\n- repeated episodes of respiratory distress; continuous murmur\n- ECG: right ventricular hypertrophy\n$\\checkmark$ prominent main, right, and left pulmonary artery\n$\\checkmark$ RV dilatation (increased stroke volume)\n$\\checkmark$ partial obstruction of right / left mainstem bronchus $\\leftarrow$ compression by vessel\n$\\checkmark$ right-sided aorta ( $33 \\%$ )\n\n\n## CONGESTIVE HEART FAILURE",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 83,
            "markdown": "# Congestive Left Heart Failure \n\n$=$ increase in circulating blood volume with diminishing cardiac function $\\rightarrow$ elevation of microvascular pressure of lung\nFrequency: most common cause of interstitial + airspace edema of lungs\nCause:\n(a) back pressure from LV: long-standing systemic hypertension, aortic valve disease, coronary artery disease, cardiomyopathy, myocardial infarction\n(b) obstruction proximal to LV: mitral valve disease, LA myxoma, cor triatriatum\n\nHisto:\n(1) Interstitial phase: fluid in loose connective tissue around conducting airways and vessels + engorgement of lymphatics\n(2) Alveolar phase: increase in alveolar wall thickness\n(3) Alveolar airspace phase: alveoli filled with fluid with loss of alveolar volume; pulmonary fibrosis upon organization of intraalveolar fibrin (if chronic)\n\n- LA pressure / pulmonary venous pressure $>12 \\mathrm{mmHg}$ (measured by wedging a pulmonary artery catheter $[$ PAWP])\n$\\sqrt{ }$ enlarged heart:\n$\\sqrt{ }$ enlargement of LA (mitral stenosis)\n$\\sqrt{ }$ enlargement of LA + LV (mitral regurgitation)\n$\\sqrt{ }$ enlargement of LV (aortic valve disease)\n\n1. Flow inversion = cephalization of pulmonary vessels\n\nCause: chronic elevation of LA pressure (as in left heart failure / mitral valve disease)\nPathophysiology:\nlong-standing $\\uparrow$ of LA pressure $\\rightarrow \\uparrow$ in atriovenous reflux; initially $\\uparrow$ LA pressure is met with an $\\uparrow$ tonus of LA wall (= absence of atrial enlargement in acute left heart failure); $\\rightarrow$ eventually LA enlarges $\\rightarrow$ inciting a protective atrial-pulmonary-vascular reflex vasospasm $\\rightarrow$ narrowing of lower lobe vessels and $\\downarrow$ atriovenous reflux\n\n- pulmonary artery wedge pressure $13-17 \\mathrm{mmHg}$\n$\\sqrt{ }$ basal oligemia (= arterial + venous constriction)\n$\\sqrt{ }$ hyperemia of upper lobes:\n$\\sqrt{ }$ vessel diameter equal to / greater than comparable lower zone vessels\n$\\sqrt{ }$ upper zone arteries wider than accompanying bronchus\n$\\sqrt{ }$ vessel diameter in $1^{\\text {st }}$ anterior intercostal space $>3 \\mathrm{~mm}$\nN.B.: flow inversion is never seen in pulmonary edema of renal failure / overhydration/ low oncotic pressure\n\n2. Interstitial pulmonary edema (invariably precedes alveolar edema) = engorgement of interstitium\n\n- NO abnormal physical finding\n- hypoxemia (ventilation-perfusion inequality)\n- pulmonary artery wedge pressure $>17 \\mathrm{mmHg}$\n$\\sqrt{ }$ perihilar haze $=$ loss of sharp definition of vascular markings in large perihilar interstitium\n$\\sqrt{ }$ thickening of interlobular septa (Kerley lines)\n$\\sqrt{ }$ peribronchial cuffing $=$ poorly defined increased bronchial wall thickness",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 84,
            "markdown": "$\\sqrt{ }$ thickening of interlobar fissures $\\leftarrow$ fluid accumulation in subpleural connective tissue layer\n$\\sqrt{ }$ usually right pleural effusion (if PAWP $>20 \\mathrm{mmHg}$ )\n3. Alveolar pulmonary edema $=$ airspace edema\n\nCause: acute LA pressure elevation $\\rightarrow$ volume of capillary filtration exceeds that of lymphatic drainage\n\n- severe dyspnea / orthopnea; tachypnea + cyanosis\n- dry cough / copious frothy sputum\n- hypoxemia $\\leftarrow$ vascular shunting\n$\\sqrt{ }$ pulmonary venous pressure $>20 \\mathrm{mmHg}$\n$\\sqrt{ }$ poorly defined patchy acinar opacities\n$\\sqrt{ }$ coalescence of acinar consolidation, particularly in medial $1 / 3$ of lung\n$\\sqrt{ }$ air bronchograms\n$\\sqrt{ }$ butterfly / bat-wing distribution of consolidation (= consolidated hilum + uninvolved lung cortex)\n$\\sqrt{ }$ always coexists with interstitial pulmonary edema\n\n4. Generalized oligemia\n\nCause: aortic valvular disease\n\n# Congestive Right Heart Failure \n\n- pitting edema of lower extremities\n$\\sqrt{ }$ abnormal hepatic vein Doppler spectrum:\n$\\sqrt{ }$ abnormally tall $a$ wave (increased right atrial pressure + volume toward end-diastole)\n$\\sqrt{ }$ abnormally tall $v$ wave (increased right atrial pressure + volume toward end systole) of hepatic vein waveform\n$\\sqrt{ }$ normal relationship between $S$ and $D$ waves\n![img-18.jpeg](img-18.jpeg)\n\nExtrathoracic Manifestations of CHF\n@ Hepatobiliary\n$\\sqrt{ }$ GB wall edema\n$\\sqrt{ }$ periportal edema\n$\\sqrt{ }$ enlarged IVC\n\n## CORONARY ARTERY FISTULA",
            "images": [
                {
                    "id": "img-18.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 1254,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1683,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 85,
            "markdown": "$=$ direct precapillary connection between branch of coronary a. + lumen of heart chamber / systemic or pulmonary circulation\nPrevalence: $0.05-0.25 \\%$ of coronary angiographies; $0.002 \\%$ of general population\nCause: congenital (most), posttraumatic, iatrogenic\nHemodynamics: L-to-R shunt; pulmonary+systemic blood flow $=<1.5 \\div 1$ (usually)\nInvolved coronary artery:\nRCA (in 50-60\\%), LCA (in 40-42\\%), both (in $<5 \\%$ )\nDrain into:\nRV (in 41-45\\%), RA (in 26\\%), pulmonary artery (in 15-17\\%), coronary sinus (7\\%), SVC\n\n- asymptomatic (commonly LCA, small fistula)\n- audible continuous heart murmur\n$\\sqrt{ }$ may have normal CXR (in small shunts)\n$\\sqrt{ }$ cardiomegaly + shunt vascularity (in large shunts)\nAngio:\n$\\sqrt{ }$ dilated tortuous coronary artery with anomalous connection\n$\\sqrt{ }$ single (most) / multiple communications / network of fine vessels\n$C x$ : myocardial ischemia / sudden cardiac death (in large shunt), CHF, endocarditis, arrhythmia, rupture, embolization\n$R x$ : observation, surgical ligation, transcatheter embolization\n\n\n# COR TRIATRIATUM \n\n$=$ rare congenital anomaly in which a fibromuscular septum with a single stenotic / fenestrated / large opening separates the embryologic common pulmonary vein from the LA:\n(1) proximal / accessory chamber lies posteriorly receiving pulmonary veins (= primitive common pulmonary vein)\n(2) distal / true atrial chamber lies anteriorly connected to left atrial appendage + emptying into LV through mitral valve\nEmbryology: failure of common pulmonary vein to incorporate normally into left atrium $\\rightarrow$ persistence of primitive splanchnic connections\nAssociated with: ASD, PDA, anomalous pulmonary venous drainage, left SVC, VSD, tetralogy of Fallot, atrioventricular canal\n\n- symptoms of pulmonary venous obstruction clinically similar to mitral valve stenosis:\n- pulmonary hypertension, heart failure with pulmonary edema\n- dyspnea, hemoptysis, failure to thrive\n- frequent pulmonary infections\n$\\sqrt{ }$ pulmonary venous distention + interstitial edema + dilatation of pulmonary trunk + pulmonary arteries (in severe obstruction)\n$\\sqrt{ }$ enlarged RA + RV\n$\\sqrt{ }$ mild enlargement of LA\nAngio:\n$\\sqrt{ }$ dividing membrane on levophase of pulmonary arteriogram\nMR:\n$\\sqrt{ }$ accessory chamber (representing the common pulmonary vein) communicates with LA through a stenosed opening",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 86,
            "markdown": "$\\sqrt{ }$ accessory chamber lies always above level of LA appendage\nPrognosis (if untreated):\nusually fatal within first 2 years of life; $50 \\%$ 2-year survival; $20 \\% 20$-year survival\nFlow gradient across stenosis +RV pressures are the most important pieces of information to assess the degree of pulmonary venous obstruction!\n$R x$ : surgical excision of obstructing membrane\n\n# DEEP VEIN THROMBOSIS (DVT) \n\nIncidence: $\\sim 600,000$ new cases annually in USA; $1 \\div 100$ patients with DVT dies ( $=15 \\%$ of inhospital deaths); 6-7 million stasis skin changes; in $0.5 \\%$ cause of skin ulcers\nPathogenetic factors:\n\n1. Hypercoagulability\n2. Decreased blood flow / stasis\n3. Intimal injury\n4. Decreased fibrinolytic potential of veins\n5. Platelet aggregation\n\nRisk factors:\n\n1. Surgery, esp. on legs / pelvis: orthopedic ( $45-50 \\%$ ) especially total hip replacement $>$ $50 \\%$ ), gynecologic ( $7-35 \\%$ ), neurosurgery ( $18-20 \\%$ ), urologic ( $15-35 \\%$ ), general surgery $(20-25 \\%)$\n2. Severe trauma\n3. Prolonged immobilization: hemiplegic extremity, paraplegia + quadriplegia, casting / orthopedic appliances\n4. Malignancy (risk factor 2.5 ) = Trousseau phenomenon\n5. Obesity (risk factor 1.5 )\n6. Diabetes\n7. Pregnancy (risk factor 5.5 ) with peak at 36 weeks and for $8-12$ weeks post partum\n\nCause: progesterone-induced venodilation, pelvic venous compression by gravid uterus\n8. Medication: birth control pills, estrogen replacement, tamoxifen (risk factor 3.2)\n9. Decreased cardiac function: congestive heart failure, myocardial infarction ( $20-50 \\%$; risk factor 3.5 )\n10. Inflammatory bowel disease\n11. Age $>40$ years (risk factor 2.2 )\n12. Varicose veins\n13. Previous DVT (risk factor 2.5 )\n14. Patients with blood group $\\mathrm{A}>$ blood group 0\n15. Polycythemia\n16. Smoking\n\n## Pathologic terminology:\n\n\"organized thrombus\" = transition to a vascularized lesion of connective tissue adherent to vessel wall\n\"recanalized thrombus\" = vascular channel network within an organized clot reducing it to septations of collagen and elastic fibers often lined by endothelium",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 87,
            "markdown": "# Location: \n\n1. Dorsal veins of calf ( $\\pm$ ascending thrombosis)\n2. Iliofemoral veins ( $\\pm$ descending thrombosis)\n3. Peripheral + iliofemoral veins simultaneously\n4. rare: internal iliac, ovarian, ascending lumbar veins\n\nSide: $\\quad \\mathrm{L} \\div \\mathrm{R}=7 \\div 3 \\leftarrow$ compression of left common iliac vein by left common iliac artery (arterial pulsations lead to chronic endothelial injury with formation of intraluminal spur (in $22 \\%$ of autopsies + in $90 \\%$ of patients with DVT)\n\n- Local symptoms $\\leftarrow$ obstruction / phlebitis usually only when (a) thrombus occlusive, (b) clot extends into popliteal / more proximal vein ( $14-78 \\%$ sensitivity, $4-21 \\%$ specificity):\n- warmth, swelling (measurement of circumference)\n- deep crampy pain in affected extremity: worse in erect position, improved while walking\n- tenderness along course of affected vein\n- Homans sign = calf pain with dorsal flexion of foot\n- Payr sign = pain upon compression of sole of foot\n$\\diamond 2 / 3$ of deep vein thromboses are clinically silent:\n$\\diamond$ DVT diagnosed ante mortem in $<30 \\%$\n$\\diamond$ Only $10-33 \\%$ of patients with fatal PE are symptomatic for DVT\n$\\diamond$ Clinically suspected DVT accurate in only $26-45 \\%$ :\n$\\diamond$ DVT symptomatology due to other causes in $15-35 \\%$\n$\\diamond$ Negative bilateral venograms in $30 \\%$ of patients with angiographically detected pulmonary emboli (big bang theory = clot embolizes in toto to the lung leaving no residual in vein)\nVenography ( $89 \\%$ sensitive, $97 \\%$ specific, $11 \\%$ FN, $5 \\%$ FP):\n$\\diamond$ venography aborted / nondiagnostic in $5 \\%$\nRisk: postvenography phlebitis ( $1-2 \\%$ ), contrast reaction, contrast material-induced skin slough, nephropathy\n$\\checkmark$ intraluminal filling defect constant on all images\n$\\checkmark$ nonfilling of calf veins\n$\\checkmark$ inadequate filling of common femoral vein and external + common iliac veins\nB-Mode US ( $88-100 \\%$ sensitive, $92-100 \\%$ specific, $>90 \\%$ accurate for DVT in thigh and popliteal veins):\nA. ACUTE DEEP VEIN THROMBOSIS\n$\\sqrt{ }$ NO complete luminal collapse with venous compression (DDx: deformity + scarring from prior DVT; technical difficulties in adductor canal + distal deep femoral vein)\n$\\checkmark$ visualization of clot within vein (DDx: slow flowing blood; machine noise):\n$\\checkmark$ homogeneous poorly echogenic / anechoic substance within venous lumen\n$\\checkmark$ smooth border of thrombus\n$\\sqrt{ }<75 \\%$ increase in diameter of common femoral vein during Valsalva\n$\\checkmark$ venous diameter at least twice that of adjacent artery suggests thrombus $<10$ days old\nB. SUBACUTE / CHRONIC DEEP VEIN THROMBOSIS\n$\\checkmark$ echogenic material within venous lumen\n$\\checkmark$ irregular surface of thrombus\n$\\checkmark$ incomplete compressibility of vein",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 88,
            "markdown": "# Doppler US: \n\n$\\sqrt{ }$ absence of spontaneity (= any waveform recording): NOT RELIABLE in peripheral veins\n$\\sqrt{ }$ continuous venous signal $=$ absence of phasicity ( $=$ no cyclic variation in flow velocity with respiration, ie, $\\downarrow$ in expiration and $\\uparrow$ in inspiration) is SUSPICIOUS for proximal obstruction\n$\\sqrt{ }$ attenuation / absence of augmentation (= no increase in flow velocity with distal compression) indicates venous occlusion / compression in intervening venous segments\n$\\checkmark$ pulsatile venous flow is a sign of congestive heart failure / pericardial effusion / cardiac tamponade / pulmonary embolism with pulmonary hypertension\nNEMR:\nN.B.: limited by flow signal artifacts\n$\\sqrt{ }$ high SI / absence of low SI flow within vein on true FISP sequence\n$\\sqrt{ }$ low-signal-intensity filling defect in a high-signal-intensity patent vein on true FISP sequence\n$\\checkmark$ absence of normal low-signal-intensity flow void in a patent vessel on T2WI\n$\\checkmark$ variable signal intensity on T1WI depending on age of luminal blood products\nVenous Occlusion Plethysmography:\n$=$ temporary obstruction of venous outflow by pneumatic cuff around mid-thigh inflated above venous pressure $\\rightarrow$ progressive increase in blood volume in lower leg; upon release of cuff $\\rightarrow$ limb quickly returns to resting volume with prompt venous runoff; limb blood volume changes are measured by impedance plethysmography in which a weak alternating current is passed through the leg; the electrical resistance varies inversely with blood volume; current strength is held constant so that voltage changes directly reflect blood volume changes\n> 87-95-100\\% sensitive, 92-100\\% specific for above-knee DVT\n$>17-33 \\%$ sensitive for below-knee DVT\n$\\sqrt{ } \\downarrow$ initial rise in venous capacitance (= venous volume)\n$\\sqrt{ }$ delay in venous outflow (= \"fall\" of curve) measured at 3 sec\nFalse positives (6\\%): severe cardiopulmonary disease, pelvic mass, reduced arterial inflow\nFalse negatives: calf vein thrombosis, small thrombus\n125I-Labeled Fibrinogen:\n$>90 \\%$ sensitive for calf vein thrombus\n$>60-80 \\%$ sensitive for femoral vein thrombus\n> insensitive for thrombus in upper thigh / pelvis\nRisk: results not available for several days, possible virus transmission\nFalse positives: hematoma, inflammation, wound, old small thrombus isolated in common femoral / iliac v.\nCx:\n(1) Pulmonary embolism ( $50 \\%$ ): in $90 \\%$ from lower extremity / pelvis; in $60 \\%$ with proximal \"free-floating\" / \"widow-maker\" thrombus; occurs usually between 2nd to 4th (7th) day of thrombosis\nSource of pulmonary emboli: multiple sites ( $1 / 3$ ), cryptogenic in $50 \\%$;",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 89,
            "markdown": "(a) lower extremity ( $46 \\%$ )\n(b) inferior vena cava ( $19 \\%$ )\n(c) pelvic veins ( $16 \\%$ )\n(d) mural heart thrombus ( $4.5 \\%$ )\n(e) upper extremity ( $2 \\%$ )\n\nLikelihood of pulmonary embolism:\n$77 \\%$ for iliac veins, $35-67 \\%$ for femoropopliteal vein, $0-46 \\%$ for calf veins\n(2) Postphlebitic syndrome in $20 \\%$ of cases with DVT $\\leftarrow$ valvular incompetence $\\leftarrow$ recanalization to a smaller lumen with focal wall changes\n(3) Phlegmasia [ phlegma, Greek = inflammation; dolens, Latin = painful] = blanching of skin (phlegmasia alba dolens) / blue leg (phlegmasia cerulea dolens) $\\rightarrow$ severely impaired venous drainage $\\rightarrow$ acute limb ischemia $\\rightarrow$ gangrene\nPrognosis: tibial / peroneal venous thrombi resolve spontaneously in $40 \\%$, stabilize in $40 \\%$, propagate into popliteal vein in $20 \\%$\nProphylaxis: intermittent compression of legs, heparin, warfarin\n$R x$ :\n(1) Heparin IV\n(2) Systemic anticoagulation (warfarin) for $\\geq 3$ months decreases risk of recurrent DVT in initial 3 months from $50 \\%$ to $3 \\%+$ fatal pulmonary embolism from $30 \\%$ to $8 \\%$; necessity for anticoagulation in DVT of calf veins is CONTROVERSIAL\n(3) Caval filter ( $10-15 \\%$ ) in patients with contraindication / complication from anticoagulation or progression of DVT / PE despite adequate anticoagulation\n$D D x$ : pseudothrombophlebitis ( $=$ signs + symptoms of DVT produced by popliteal cyst / traumatic hematoma)\n![img-19.jpeg](img-19.jpeg)",
            "images": [
                {
                    "id": "img-19.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 1188,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1973,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 90,
            "markdown": "# DOUBLE AORTIC ARCH \n\n$\\diamond$ Most common + serious type of a complete vascular ring; usually isolated condition\nEmbryology: failure of regression of both right + left embryonic $4^{\\text {th }}$ arches, joined to form dorsal aorta\nTypes:\n\n1. Dominant right (posterior) arch ( $75 \\%$ )\n2. Dominant left (anterior) arch ( $20 \\%$ )\n3. Symmetric arches of same size (5\\%)\n\nThe less dominant arch is atretic in $1 / 3$ !\nFrequency: $55 \\%$ of all vascular rings\nAge: usually detected in infancy\n\n- usually asymptomatic; stridor, dyspnea, recurrent pneumonia\n- dysphagia (less common than respiratory symptoms, more common after starting baby on solids)\nLocation: descending aorta in $75 \\%$ on left, in $25 \\%$ on right side; smaller arch anterior in $80 \\%$; right arch larger + more cephalad than left in $80 \\%$\n$\\sqrt{ }$ two separate arches arise from single ascending aorta\n$\\sqrt{ }$ each arch joins to form a common descending aorta\n$\\checkmark$ trachea in midline:\n$\\sqrt{ }$ impressions may be present on both sides of trachea: usually $\\mathrm{R}>\\mathrm{L}$ (in older children)\n$\\checkmark$ trachea narrowed and displaced posteriorly with small anterior impression\nEsophagram:\n$\\sqrt{ }$ broad horizontal posterior indentation at the level of $3^{\\text {rd }} / 4^{\\text {th }}$ thoracic vertebra $\\leftarrow$ right arch crossing obliquely to join left\n$\\checkmark$ bilateral esophageal indentations with a reversed S-shaped configuration (= right indentation higher than left)\nCT:\n$\\sqrt{ }$ \"four-artery\" sign = each arch gives rise to 2 dorsal subclavian +2 ventral carotid arteries evenly spaced around trachea on section cephalad to aortic arch\n$D D x$ : right arch with aberrant left subclavian artery (when dominant arch on right indistinguishable by esophagram)\n\n\n## DOUBLE-OUTLET RIGHT VENTRICLE\n\n$=$ DORV $=$ TAUSSIG-BING HEART\n$=$ most of the aorta + pulmonary artery arise from the $\\mathrm{RV} \\leftarrow$ maldevelopment of conotruncus\nPrevalence: $127 \\div 1,000,000$ live births\nHemodynamics:\nsimilar to: VSD, tetralogy of Fallot, transposition of great arteries, single ventricle, atrioventricular atresia\nfetus: NO CHF in utero (in absence of other obstructing anomalies)\nneonate: ventricular work overload $\\rightarrow$ CHF\nAssociated with: VSD (100\\%), pulmonary stenosis / atresia (75\\%), mitral stenosis / atresia, PDA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 91,
            "markdown": "$\\diamond$ location of VSD affects physiologic function and classification relative to semilunar valves into subaortic ( $50 \\%$ ), subpulmonic ( $30 \\%$ ), uncommitted, doubly committed\n$\\sqrt{ }$ NO continuity between mitral valve + adjacent semilunar valve (PATHOGNOMONIC)\n$\\sqrt{ }$ aorta posterior / parallel / anterior to pulmonary artery:\n$\\sqrt{ }$ aorta and pulmonary artery side by side with aorta in D-malposition on the right (most frequent)\n$\\sqrt{ }$ aorta overriding the interventricular septum with predominant connection to RV\n$\\sqrt{ }$ normal / hypoplastic / absent LV\n\n# DUCTUS ARTERIOSUS ANEURYSM \n\n$=$ fusiform aneurysm of ductus arteriosus, usually patent toward aorta + completely / incompletely occluded toward pulmonary a.\nPrevalence: $<100$ cases\nClassification:\n(a) according to age: infantile, childhood, adult type\n(b) according to cause: congenital, infectious, traumatic\n\nPathogenesis: ? delay in closure, ? myxoid degeneration of ductus wall, ? abnormal elastic fibers\nAge: most $<2$ months of age\n\n- dyspnea, tachypnea, hoarseness\n$\\sqrt{ }$ pulmonary artery displaced anteromedially\n$\\sqrt{ }$ distal aortic arch displaced laterally\nCXR:\n$\\sqrt{ }$ left upper mediastinal mass in aorticopulmonary window\n$\\sqrt{ }$ tracheal displacement to right + anteriorly / posteriorly\n$\\sqrt{ }$ consolidation of adjacent lung (compression, fibrosis, hemorrhage)\nCT:\n$\\sqrt{ }$ contrast-enhancing mass in classic location\nECHO:\n$\\sqrt{ }$ cystic mass with pulsatile flow\n$C x$ : rupture, dissection, infection, thromboembolic disease, phrenic nerve compression\nPrognosis: usually fatal (without prompt surgery)\n\n\n## EBSTEIN ANOMALY\n\n[Wilhelm Ebstein (1836-1912), internist in Breslau, Germany]\n$\\diamond$ Most common cause of congenital tricuspid regurgitation.\n=atrialization of RV (HALLMARK) = apical / downward displacement of septal + posterior leaflets of dysplastic tricuspid valve into inflow portion of RV\n\nRV is divided into:\n(a) a large superior atrialized inflow portion with thin ventricular wall (incorporating part of the RV into the RA), and\n(b) a small inferior functional chamber with shortened chordae tendineae\n\nValve morphology:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 92,
            "markdown": "inappropriately low attachment of posterior $\\pm$ septal malformed defective tricuspid valve leaflets; only anterior leaflet attaches normally to tricuspid annulus, but may be dysplastic / sail-like\nEtiology: oral lithium therapy during pregnancy (10\\%)\n$\\diamond 0.5-0.7 \\%$ of all CHD!\nHemodynamics:\ntricuspid valve insufficiency $\\rightarrow$ tricuspid regurgitation (\"ping-pong\" volume) + severely dilated RA; RA dilatation stretches interatrial septum $\\rightarrow$ incompetence of foramen ovale (R-to-L shunt) in $75 \\%$\n![img-20.jpeg](img-20.jpeg)\n\nAssociated with: ostium-secundum-type ASD / patent foramen ovale (R-to-L shunt), VSD, PDA, pulmonary atresia\n\n- symptoms and prognosis depend on amount of tricuspid regurgitation, right ventricular function, and cyanosis:\n- $\\pm$ cyanosis in neonatal period (depending on degree of R-to-L shunt): may improve / disappear postnatally with decrease in pulmonary arterial pressure\n- CHF in utero / in neonate (in 50\\%)\n- systolic murmur (tricuspid insufficiency)\n- Wolff-Parkinson-White syndrome (10\\%) = paroxysmal supraventricular tachycardia / right bundle branch block (responsible for sudden death)\nCause: conduction system develops during formation of tricuspid valve adjacent to it",
            "images": [
                {
                    "id": "img-20.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 580,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1489,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 93,
            "markdown": "Ebstein anomaly is the ONLY cyanotic CHD in which aorta and pulmonary trunk are hypoplastic (= smaller than normal)!\n$\\sqrt{ }$ \"box-shaped / funnel-like\" cardiomegaly:\n$\\sqrt{ }$ extreme RA enlargement $\\leftarrow$ insufficient tricuspid valve forming a common right ventriculoatrial chamber\n$\\sqrt{ }$ dilated right ventricular outflow tract\n$\\sqrt{ }$ IVC + azygos dilatation $\\leftarrow$ tricuspid regurgitation\n$\\sqrt{ }$ normal LA\n$\\sqrt{ }$ calcification of tricuspid valve may occur\n$\\sqrt{ }$ distance of septal leaflet to anterior mitral valve leaflet:\n$\\sqrt{ }>15 \\mathrm{~mm}$ in child $<14$ years of age\n$\\sqrt{ }>20 \\mathrm{~mm}$ in adult\n$\\sqrt{ }>0.8 \\mathrm{~mm} / \\mathrm{cm}^{2}$ of body surface area $=$ DIAGNOSTIC\nMR:\n$\\sqrt{ }$ marked right atrial enlargement\n$\\sqrt{ }$ small right ventricle $\\pm$ dilatation of RV infundibulum\nECHO:\n$\\sqrt{ }$ large \"sail-like\" tricuspid valve structure within dilated right heart\n$\\sqrt{ }$ tricuspid regurgitation identified by Doppler ultrasound\nPrognosis: sudden death $\\leftarrow$ fatal atrial arrhythmia; $50 \\%$ infant mortality; $13 \\%$ operative mortality\nSurvival rate: $70 \\%$ at 2 years, $50 \\%$ at 13 years; survival into adulthood if valve functions normally\nRx: 1. Digitalis + diuretics\n2. Tricuspid valve prosthesis\n\n# EISENMENGER COMPLEX \n\n$=$ EISENMENGER DEFECT\n$=$ (1) high VSD $\\pm$ overriding aorta with hypoplastic crista supraventricularis\n(2) RV hypertrophy\nand as consequence of increased pulmonary blood flow:\n(3) $\\rightarrow$ dilatation of pulmonary artery + branches\n(4) $\\rightarrow$ intimal thickening + sclerosis of small pulmonary arteries + arterioles\n\n- cyanosis appears in $2^{\\text {nd }}+3^{\\text {rd }}$ decade with shunt reversal\n\n\n## EISENMENGER SYNDROME\n\n$=$ EISENMENGER REACTION\n$=$ development of high pulmonary vascular resistance after many years of L-to-R shunt (ASD, PDA, VSD) $\\rightarrow \\uparrow$ pulmonary blood flow $\\rightarrow$ bidirectional (= balanced) shunt and ultimately $\\rightarrow$ shunt reversal (R-to-L shunt)\nEtiology:\npulmonary microscopic vessels undergo reactive muscular hypertrophy, endothelial thickening, in situ thrombosis, tortuosity + obliteration; once initiated, pulmonary hypertension accelerates vascular reaction $\\rightarrow$ increasing pulmonary hypertension in a vicious cycle",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 94,
            "markdown": "with RV failure + death\nPath: adaptive anastomotic pathways connect plexiform lesions of pulmonary arterial vessels to bronchial arteries supplying terminal bronchioles + vasa vasorum of pulmonary arteries\nPathologic classification of severity (Heath \\& Edwards):\nGrade I $=$ medial hypertrophy of muscular pulmonary arteries and arterioles\n\n- potentially reversible\n\nGrade II $=$ grade I + intimal proliferation in small muscular arteries and arterioles\n\n- potentially reversible\n\nGrade III $=$ grade II + intimal laminar fibrosis + progressive vessel obliteration\n\n- borderline for reversibility\n\nGrade IV $=$ occlusion of vessels with progressive aneurysmal dilatation of small arteries nearby\n\n- irreversible\n\nGrade V $=$ tortuous \"glomeruloid\" channels within proliferation of endothelial cells (= plexiform + angiomatoid lesions)\n\n- irreversible\n\nGrade VI $=$ thrombosis + necrotizing arteritis\n\n- irreversible\n\n\n# CXR: \n\n$\\sqrt{ }$ pronounced dilatation of central pulmonary arteries (pulmonary trunk, main pulmonary a., intermediate branches)\n$\\checkmark$ pruning of peripheral pulmonary arteries\n$\\checkmark$ enlargement of RV +RA (proportionate to volume overload)\n$\\sqrt{ } \\mathrm{LA}+\\mathrm{LV}$ return to normal size (with decrease of L-to-R shunt $\\leftarrow$ markedly elevated pulmonary vascular resistance)\n$\\checkmark$ normal pulmonary veins (unless superimposed cardiac volume overload):\n$\\checkmark$ pulmonary veins NOT distended $\\leftarrow$ NO increase in pulmonary blood flow)\n$\\sqrt{ }$ NO redistribution of pulmonary veins (normal venous pressure)\nCT:\n$\\sqrt{ }$ massive aneurysmal dilatation of pulmonary trunk\n$\\sqrt{ }$ linear calcification + thrombus in central pulmonary arteries\n$\\sqrt{ }$ atheromatous calcification of pulmonary arteries\n$\\sqrt{ }$ mural calcification / aneurysmal dilatation of ductus arteriosus (in case of patent ductus arteriosus)\n$D x:$ measurement of pulmonary artery pressure + flow via catheter\n$R x$ : heart-lung transplant\n\n## ENDOCARDIAL CUSHION DEFECT\n\n$=\\mathrm{ECD}=$ ATRIOVENTRICULAR SEPTAL DEFECT\n$=$ PERSISTENT OSTIUM ATRIOVENTRICULARE COMMUNE\n$=$ PERSISTENT COMMON ATRIOVENTRICULAR CANAL\n$=$ persistence of primitive atrioventricular canal + anomalies of AV valves $\\leftarrow$ interruption of normal development of endocardial tissues",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 95,
            "markdown": "Frequency: $4 \\%$ of all cases of CHD\nEndocardial cushion $=$ forms lower portion of atrial septum, upper portion of interventricular septum + septal leaflets of MV and TV\nCause: deficiency of conus + sinus portions of interventricular septum $\\rightarrow$ narrowing of left ventricular outflow tract\nA. INCOMPLETE / PARTIAL ECD\n$=$ (1) Ostium primum ASD\n(2) Separate tricuspid + mitral valves with cleft in anterior mitral valve leaflet / trileaflet\n(3) Accessory short chordae tendineae arising from anterior MV leaflet insert directly into crest of deficient ventricular septum\n$\\sqrt{ }$ left atrioventricular valve usually has 3 leaflets with a wide cleft between anterior + septal leaflet\n$\\sqrt{ }$ \"gooseneck\" deformity on LV angiography = concavity of IVS below MV + elongation and narrowing of LVOT $\\leftarrow$ downward attachment of anterior MV leaflet close to interventricular septum by accessory chordae tendineae\n$\\sqrt{ }$ communication between LA-RA or LV-RA, occasionally LV-RV\n$\\sqrt{ }$ right atrioventricular valve usually normal\nB. TRANSITIONAL / INTERMEDIATE ATRIOVENTRICULAR CANAL (uncommon)\n$=$ (1) Ostium primum ASD\n(2) High membranous VSD\n(3) Wide clefts in septal leaflets of both AV valves\n(4) Bridging tissue between anterior + posterior common leaflet of both AV valves\nC. COMPLETE ECD = AV COMMUNIS = COMMON AV CANAL\n$=$ (1) Ostium primum ASD above\n(2) Posterior inlet membranous VSD below\n(3) One AV valve common to RV + LV with 5-6 leaflets\n(a) anterior common \"bridging\" leaflet\n(b) two lateral leaflets\n(c) posterior common \"bridging\" leaflet\n\nType $1=$ chordae tendineae of anterior bridging leaflet attached to both sides of ventricular septum\nType $2=$ chordae tendineae of anterior leaflet attached medially to anomalous papillary muscle within RV, but unattached to septum\nType $3=$ free-floating anterior leaflet with chordae attachments to septum; only type becoming symptomatic in infancy!\nAssociated with:\n(1) Down syndrome:\nin $25 \\%$ of trisomy 21 an ECD is present;\nin $45 \\%$ of ECD trisomy 21 is present\n(2) Asplenia, polysplenia\n$\\sqrt{ }$ common atrioventricular orifice\n$\\sqrt{ }$ oval septal defect consisting of a low ASD + high VSD\n$\\sqrt{ }$ atrial septum secundum usually spared (\"common atrium\" if absent)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 96,
            "markdown": "$\\sqrt{ }$ frequently associated with mesocardia / dextrocardia\nHemodynamics:\nfetus: atrioventricular valves frequently incompetent leading to regurgitation + CHF\nneonate: L-to-R shunt after decrease of pulmonary vascular resistance resulting in pulmonary hypertension\n\n- incomplete right bundle branch block (distortion of conduction tissue); left-anterior hemiblock\nCXR:\n$\\diamond$ Radiographic findings similar to ASD, but more marked\n$\\checkmark$ increased pulmonary vascularity (= shunt vascularity)\n$\\checkmark$ redistribution of pulmonary blood flow (mitral regurgitation)\n$\\checkmark$ enlarged pulmonary artery\n$\\checkmark$ diminutive aorta $\\leftarrow$ L-to-R shunt\n$\\checkmark$ cardiac enlargement out of proportion to pulmonary vascularity $\\leftarrow$ L-to-R shunt + mitral insufficiency\n$\\checkmark$ enlarged RV + LV\n$\\checkmark$ enlarged RA $\\leftarrow$ LV blood shunted to RA\n$\\checkmark$ normal-sized LA $\\leftarrow$ ASD\nECHO:\n$\\checkmark$ visualization of ASD + VSD + valve + site of insertion of chordae tendineae\n$\\checkmark$ paradoxical anterior septal motion $\\leftarrow$ ASD\n$\\checkmark$ atrioventricular insufficiency + shunts identified by Doppler ultrasound\nAngio:\nAP projection:\n$\\checkmark$ \"gooseneck deformity\" (in diastole) $\\leftarrow$ deficiency of conus and sinus portion of interventricular septum below mitral valve with narrowing of LVOT\n$\\checkmark$ cleft in anterior leaflet of mitral valve (in systole)\n$\\checkmark$ mitral regurgitation\nHepatoclavicular projection in $45^{\\circ} \\mathrm{LAO}+\\mathrm{C}-\\mathrm{C} 45^{\\circ}$ (= 4-chamber view):\n$\\checkmark$ best view to demonstrate LV-RA shunt\n$\\checkmark$ best view to demonstrate VSD (inflow tract + posterior portion of interventricular septum in profile)\nLAT projection:\n$\\checkmark$ irregular appearance of superior segment of anterior mitral valve leaflet over LVOT\nPrognosis: $54 \\%$ survival rate at 6 months, $35 \\%$ at 12 months, $15 \\%$ at 24 months, $4 \\%$ at 5 years; $91 \\%$ long-term survival with primary intracardiac repair, $4-17 \\%$ operative mortality\n\n\n# ENDOCARDIAL FIBROELASTOSIS \n\n$=$ diffuse endocardial thickening of $\\mathrm{LV}+\\mathrm{LA} \\leftarrow$ deposition of collagen + elastic tissue Etiology:\n(1) ? Viral infection\n(2) Secondary endocardial fibroelastosis\n$=$ subendocardial ischemia in critical LVOT obstruction: aortic stenosis, coarctation, hypoplastic left heart syndrome",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 97,
            "markdown": "- sudden onset of CHF during first 6 months of life\n$\\sqrt{ }$ mitral insufficiency:\n(a) involvement of valve leaflets\n(b) shortening + thickening of chordae tendineae\n(c) distortion + fixation of papillary muscles\n$\\sqrt{ }$ enlarged LV (= dilatation of hypertrophied LV) $\\leftarrow$ mitral regurgitation\n$\\sqrt{ }$ restricted LV motion\n$\\sqrt{ }$ enlarged LA\n$\\sqrt{ }$ pulmonary venous congestion + pulmonary edema\n$\\sqrt{ }$ LLL atelectasis $\\leftarrow$ compression of left lower lobe bronchus by enlarged LA\nPrognosis: mortality almost $100 \\%$ by 2 years of age\n\n\n# Carcinoid Heart Disease \n\nEtiology: secretion of 5-hydroxytryptamine by tumor cells metastatic to liver $\\rightarrow$ deposition of fibrous tissue on endocardial surfaces of right heart\nPrevalence: in up to $60 \\%$ of patients with carcinoid syndrome\nLocation: both tricuspid and pulmonary valve leaflets + corresponding subvalvular apparatus\n$\\sqrt{ }$ thickening of valve leaflets and cusps $\\rightarrow$ eventually retracted + shortened + immobile\n$\\sqrt{ }$ thickening + fusion of chordae\n$C x$ : valvular regurgitation, valvular stenosis\n\n## EOSINOPHILIC HEART DISEASE\n\n$=$ manifestation of hypereosinophilic syndrome\nCause: active damage of endomyocardium by toxic cationic proteins released after degranulation of infiltrated eosinophils\nPathophysiology: Fibrous tissue deposition within endocardium + adjacent myocardium along inflow tracts and apices of one / both ventricles $\\rightarrow$ rigidity of ventricular walls, papillary muscles, atrioventricular valves\nPhases:\n(1) Acute necrosis\n\n- palpitations, dyspnea, fever, malaise\n(2) Mural thrombosis\n- infarction $\\leftarrow$ thromboembolism\n- DVT $\\leftarrow$ hypercoagulable state\n(3) Fibrosis\n- right / left ventricular dysfunction, valvular incompetence, thromboembolic episodes, organ dysfunction\nMR:\n$\\sqrt{ }$ ventricular wall thickening\n$\\sqrt{ }$ regional wall motion abnormalities\n$\\sqrt{ }$ extensive myocardial hyperintensity on T2WI\nCEMR (10-min delay):\n$\\sqrt{ }$ CHARACTERISTIC 3-layered appearance of ventricular wall:\n$\\sqrt{ }$ outer normal nulled (black) myocardium",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 98,
            "markdown": "$\\checkmark$ adjacent enhancing hyperintense subendocardium $\\leftarrow$ fibrosis\n$\\checkmark$ innermost nonenhancing mural thrombus\n$\\sqrt{ }$ pericardial effusion with variable degree of pericardial enhancement $\\leftarrow$ pericarditis (rare)\n$\\mathrm{ECHO} / \\mathrm{CT}$ :\n$\\checkmark$ endocardial thickening, cardiac mural thrombus\n$\\checkmark$ restrictive ventricular diastolic (filling) dysfunction $\\leftarrow$ reduced size, atrial enlargement, atrioventricular valve incompetence\n$\\checkmark$ nonenhancing intracardiac mural thrombus\n$\\checkmark$ fibrotic endocardial thickening\n\n# FIBROMUSCULAR DYSPLASIA \n\n$=$ nonatherosclerotic noninflammatory angiopathy of unknown pathogenesis caused by proliferation of muscular + fibrous elements in middle- and small-caliber arteries\nPrevalence: $0.6-1.1 \\% ;<1 \\%$ of cerebral angiographies\nAge: children + young adults $<30-40$ years; $2 / 3>50$ years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 3$ to $1 \\div 4$\n\n- hypertension, progressive renal insufficiency, neurologic deficits\n- decreased peripheral pulses, bruit, asymmetric limb pressures\n\nLocation:\n@ Craniovertebral arteries ( $25-30 \\%$ ):\ncervical + intracranial ICA ( $85 \\%$ ), extracranial carotid artery ( $30 \\%$ ), vertebral artery ( $7-$ $10 \\%$ ); both anterior + posterior circulations ( $8 \\%$ ); bilateral ( $60-65 \\%$ )\nSite: adjacent to C1-C2\nAssociated with: brain ischemia (up to 50\\%), intracranial aneurysms (up to 30\\%), intracranial tumors ( $30 \\%$ ), bruits, trauma\n@ Abdominal aorta:\nrenal artery ( $60-75 \\%$ ), other aortic branches (in $1-2 \\%$ : celiac a., hepatic a., splenic a., mesenteric a., iliac artery)\n$\\diamond$ Simultaneous involvement of renal / muscular arteries in 3\\%\n\n1. Intimal Fibroplasia (1-2\\%)\n$=$ INTIMAL HYPERPLASIA\n\n- progressive\n\nPath: circumferential / eccentric fibrous tissue between intima + internal elastic lamina\nAge: children + young adults; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$\nSite: main renal artery + major segmental branches; often bilateral\n$\\checkmark$ focal narrow annular radiolucent band\n$\\checkmark$ smooth tubular stenosis\n$\\checkmark$ poststenotic fusiform dilatation\nCx: spontaneous dissection\n$D D x$ : atherosclerosis, Takayasu arteritis\n2. Medial Fibroplasia ( $60-85 \\%$ )\n$=$ fibromuscular hyperplasia $=$ medial fibroplasia with microaneurysms\nAge: 20-50 years; typically affects women; common cause of renal artery stenosis in children\nPath: multiple fibromuscular ridges + severe mural thinning with loss of smooth muscle",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 99,
            "markdown": "+ internal elastic lamina\nSite: mid + distal renal artery + branches; bilateral in $50 \\%$\n$\\sqrt{ }$ \"string-of-beads\" sign = alternating areas of weblike stenoses + aneurysms (which exceed the normal diameter of the artery)\n$\\sqrt{ }$ single tubular focal stenosis\n$C x:$ dissection\n\n3. Perimedial Fibroplasia (rare)\n$=$ SUBADVENTITIAL FIBROPLASIA\nAge: young females\nPath: fibroplasia of outer $1 / 2$ of media replacing external elastic lamina\nSite: distal (mostly right) main renal artery\n$\\sqrt{ }$ long irregular stenosis\n$\\sqrt{ }$ beading $=\\mathrm{NO}$ aneurysm formation (diameter of beads not wider than normal diameter of artery)\n4. Medial Hyperplasia $(5-15 \\%)$\n$=$ FIBROMUSCULAR HYPERPLASIA\nPath: smooth muscle + fibrous tissue hyperplasia within arterial media\nSite: main renal artery and branches\n$\\sqrt{ }$ long smooth concentric tubular narrowing\n$D D x$ : Takayasu arteritis, sclerosing arteritis, vessel spasm, arterial hypoplasia\n5. Adventitial Fibroplasia $(<1 \\%)$\n$=$ SUBADVENTITIAL/PERIADVENTITIAL HYPERPLASIA\nPath: adventitial + periarterial proliferation in fibrofatty tissue\nSite: main renal artery, large branches\n$\\sqrt{ }$ long segmental stenosis\nadded to original 5 types:\n6. Medial Dissection $(5-10 \\%)$\n\nPath: new channel in outer $1 / 5$ of media within external elastic lamina\nSite: main renal artery + branches\n$\\sqrt{ }$ false channel, aneurysm\n7. Atypical Fibromuscular Dysplasia\n( $=$ ? variant of intimal fibroplasia)\n$\\sqrt{ }$ web $=$ smooth / corrugated mass involving only one wall of vessel + projecting into lumen\n$D D x$ : atherosclerotic disease, posttraumatic aneurysm\n\n# VARIANT: Segmental mediolytic arteriopathy \n\n$=$ rare noninflammatory disease of small + medium arteries\nHisto: focal segmental disruption of medial smooth muscle cells with mediolysis\n$\\sqrt{ }$ string-of-beads appearance\n$\\sqrt{ }$ irregular stenoses + aneurysms\n$C x$ : dissection (in 3\\%), macroaneurysm formation, intramural hemorrhage, subarachnoid hemorrhage\nPrognosis: tends to remain stable / minimal progression of lesions in $20 \\%$ causing decline in renal function",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 100,
            "markdown": "Rx: (1) Resection of diseased segment with end-to-end anastomosis\n(2) Replacement by autogenous vein graft, excision + repair by patch angioplasty\n(3) Transluminal balloon angioplasty ( $90 \\%$ success rate with very low restenosis rate)\n\n# FLAIL MITRAL VALVE \n\n## Cause:\n\n(1) Ruptured chordae tendineae in rheumatic heart disease, ischemic heart disease, bacterial endocarditis\n(2) Ruptured head of papillary muscle in acute myocardial infarction, chest trauma\n\nLocation: chordae to leaflet from posteromedial papillary muscle (single vessel blood supply)\n$\\checkmark$ deep holosystolic posterior movement of leaflet\n$\\checkmark$ random anarchic motion pattern of flail parts in diastole\n$\\checkmark$ excessively large amplitude of opening of aML\n\n## HENOCH-SCHÖNLEIN PURPURA\n\n[Eduard Heinrich Henoch (1820-1910, pediatrician in Berlin and director of the first children's hospital in Germany]\n[Johann Lukas Schönlein (1793-1864), German physician in Bamberg, the cradle of German hospital medicine, and at the University of Würzburg, where he introduced bedside teaching]\n$=1$ G A VASCULITIS\n$=$ most common systemic allergic hypersensitivity-related acute small-vessel vasculitis in children\nIncidence: $20 \\div 100,000$ annually; mostly occurring in winter\nPrecipitated by: bacterial (b-hemolytic Streptococcus) / viral infection (URI in 50\\%), allergies, insect sting, drugs (eg, penicillin, sulfonamides, aspirin), certain foods\nCause: deposition of IgA-dominant immune complexes in vessel walls (venules, capillaries, arterioles)\nPeak age: 7 (range, 3-15) years + adults $>20$ years (in up to $30 \\%$ ); $\\mathrm{M} \\div \\mathrm{F}=1.5 \\div 1.0$\n$\\diamond$ Most common vasculitis $4-7$ years of age\nPath: acute leukocytoclastic small-vessel vasculitis with IgA deposits at dermoepidermoid junction and renal mesangium\n\n- often begins as an upper respiratory tract infection\n- 3-4 weeks mean duration of symptoms; at least 1 recurrence ( $1 / 3$ )\n@ Skin disease\n- nonthrombocytopenic petechial / maculopapular skin rash\n- palpable purpura concentrated in dependent / pressure-bearing regions of lower extremities + buttocks + extensor surfaces of arms ( $95-100 \\%$ )\n@ Joint disease (60-84\\%)\n- arthralgias / arthritis of large joints\n@ GI tract involvement (57-65-76\\%)\n- may precede skin rash / within 1 week of onset of rash\n- colicky abdominal pain $\\pm$ diarrhea, nausea, vomiting\n- GI bleeding $\\pm$ melena",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 101,
            "markdown": "$\\sqrt{ }$ multifocal short-segment ( $<15 \\mathrm{~cm}$ ) small bowel wall thickening of $7-12 \\mathrm{~mm}$ ( $\\leftarrow-$ intramural hemorrhage + edema) with skipped areas (DDx from other types of vasculitis)\n$\\sqrt{ }$ \"comb\" sign = hypervascular engorged vasa recta\n$\\sqrt{ }$ intestinal dilatation\n$\\sqrt{ } \\pm$ bowel ulceration\n$\\sqrt{ }$ mesenteric fat stranding + adenopathy of $<1.5 \\mathrm{~cm}$\n@ Renal disease (20-100\\%)\n\n- microscopic hematuria + proteinuria in $50 \\%$\n- nephrotic syndrome in $10 \\%$\n- proliferative glomerulonephritis with IgA deposits demonstrated by immunofluorescence (in up to $1 / 3$ )\n$\\sqrt{ }$ normal / bilaterally enlarged kidneys\n$\\sqrt{ }$ increased echogenicity of renal cortex\n$\\sqrt{ } \\pm$ intramural hematoma of urinary bladder / ureter\n@ Scrotal disease (15-37\\%)\n$\\sqrt{ }$ mostly bilateral scrotal wall thickening\n$\\sqrt{ }$ epididymal enlargement, reactive hydrocele\n$\\sqrt{ } \\pm$ orchitis\n@ CNS (rare)\n$\\sqrt{ }$ hypertensive / uremic encephalopathy\n$\\sqrt{ }$ focal ischemic / hemorrhagic lesions\nCx: (1) Bowel infarct / perforation / irreducible ileocecal intussusception (1-3-5\\%)\n(2) Renal insufficiency ( $10-20 \\%$ ), end-stage renal disease (5\\%)\n\nDx: 4 diagnostic criteria:\n(1) Age $<20$ years at onset\n(2) Palpable purpura\n(3) Gastrointestinal bleeding\n(4) Biopsy evidence of granulocytes around small arteriolar + venular walls (skin biopsy)\n$R x$ : supportive; high doses of corticosteroids and azathioprine; IV immunoglobulin therapy\n$\\diamond$ Radiologic diagnosis avoids unnecessary surgery!\nPrognosis: self-limiting without requiring treatment in $37 \\%$ of adults $+60 \\%$ of children\nMortality: $60 \\%$ during $1^{\\text {st }}$ year of life\n$D D x$ : SLE (multiple segments of symmetric bowel thickening in jejunum + ileum, bowel dilatation, increased attenuation of mesentery, ascites); Yersinia enterocolitis (terminal ileum involved); Crohn disease (erythema nodosum + pyoderma gangrenosum)\n\n# HEMANGIOMA \n\n= true neoplasm with vascular channels lined by proliferating endothelial cells\n\n## Infantile Hemangioma\n\n$=$ CAPILLARY HEMANGIOMA\nPrevalence: $2-3 \\%$ in all children; higher in prematurity\n$\\diamond$ Most common vascular tumor of infancy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 102,
            "markdown": "Age: normally not visible at birth; manifest during first few weeks after birth; often evident by 3 months of age; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 3$ to $1 \\div 5$\nHisto:\n(a) proliferating phase $=$ hyperplastic proliferating endothelial cells forming syncytial masses with $\\uparrow$ metabolic turnover and $\\uparrow$ number of mast cell\n\n- strawberry-like pulsatile warm mass\n- in first few weeks of life\n- rapid growth with subsequent regression\n(b) involuting phase $=$ thinning of endothelial lining with progressive perivascular deposition of fibrofatty tissue\n- slow constant regression into grayish dark red mass\n- regression completed by age $7-10$ years\n\nLocation: face and neck ( $60 \\%$ ), trunk ( $25 \\%$ ), extremity ( $15 \\%$ )\n\n- subcutaneous strawberry-like bluish-red mass with bruit, pulsatility and warmth\n- rapid growth during first few months (= proliferating phase)\n\nMR:\n$\\checkmark$ well-defined lobulated mass with high SI on T2WI\n$\\checkmark$ intermediate SI on T1WI\n$\\checkmark$ flow voids within high-flow feeding arteries and draining veins on SE images\n$\\checkmark$ high signal intensity on GRE images\n$\\checkmark$ NO perilesional edema\n$\\checkmark$ early intense uniform enhancement without AV shunting\n$\\checkmark$ heterogeneous lesion with foci of increased SI intensity on T1WI (= fatty replacement) + less avid enhancement during involuting phase\n$R s$ : usually none; needed when symptomatic / in region with possible secondary loss of function or lifetime aesthetic impairment: propranolol / embolization / surgery\n\n# Congenital Hemangioma \n\nAge: present at birth (fully grown); $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$\n(a) rapidly involuting congenital hemangioma\n\n- complete regression during first 2 years of life\n(b) noninvoluting congenital hemangioma\n- growth proportional to that of child without regression\n\nMR:\n$\\checkmark$ similar to infantile hemangioma\n\n## HETEROTAXY SYNDROME\n\n[ hetero, Greek = different; taxis, Greek = arrangement]\n$=$ CARDIOSPLENIC SYNDROMES\n$=$ situs ambiguus with a spectrum of various congenital truncal abnormalities + frequently cardiac malformations from asplenia to polysplenia\nEmbryology:\nprimary defect in lateralization with disruption of complete separation of cardiac chambers during $20-30$ days of gestation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 103,
            "markdown": "Inheritance: multifactorial (autosomal dominant, autosomal recessive, X-linked recessive) Individualized approach of classification:\ndescribes all critical structures by analyzing\n(a) position of atria\n(b) position of venous drainage below diaphragm relative to midline\n(c) position of aorta relative to midline\n(d) position of the stomach + presence of malrotation\n(e) position of liver + gallbladder\n(f) position of cardiac apex\n(g) presence, appearance, and number of spleens\n(h) presence of bi- / trilobed lungs\n\n# Asplenia Syndrome \n\n$=$ BILATERAL RIGHT-SIDEDNESS $=$ RIGHT ISOMERISM\n$=$ IVEMARK SYNDROME\nPrevalence: $1 \\div 1,750-1 \\div 40,000$ livebirths; $\\mathrm{M}>\\mathrm{F}$\nAssociated with:\n(a) CHD (in 50\\%):\n\nTAPVR (almost 100\\%), endocardial cushion defect (85\\%), single ventricle (51\\%), TGA (58\\%), pulmonary stenosis / atresia (70\\%), dextrocardia (42\\%), mesocardia, VSD, ASD, absent coronary sinus, common atrium, common hepatic vein\n(b) GI anomalies:\n\nPartial / total situs inversus, annular pancreas, agenesis of gallbladder, ectopic liver, esophageal varices, duplication + hypoplasia of stomach, Hirschsprüng disease, hindgut duplication, imperforate anus\n(c) GU anomalies ( $15 \\%$ ):\n\nHorseshoe kidney, double collecting system, hydroureter, cystic kidney, fused / horseshoe adrenal, absent left adrenal, bilobed urinary bladder, bicornuate uterus\n(d) Cleft lip / palate, scoliosis, single umbilical artery, lumbar myelomeningocele\n\n- cyanosis in neonatal period / infancy (if severe cyanotic CHD)\n- severe respiratory distress; Howell-Jolly bodies $=$ RBC inclusions in patients with absent spleen\n@ Lung\n$\\sqrt{ }$ right bronchial isomerism:\n$\\sqrt{ }$ bilateral trilobed lungs $=$ bilateral minor fissures (SPECIFIC)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 104,
            "markdown": "| Heterotaxy Syndromes |  |  |\n| :--: | :--: | :--: |\n|  | Asplenia $=$ bilateral rightsidedness | Polysplenia $=$ bilateral leftsidedness |\n| Clinical |  |  |\n| Presenting age | newborn / infant | infant / adult |\n| Sex predominance | male | female |\n| Cyanosis | severe | usually absent |\n| Heart disease | severe | moderate / none (5-10\\%) |\n| Howell-Jolly / Heinz bodies | present | absent |\n| Spleen scan | no spleen | multiple small spleens |\n| Characteristic ECG | none | abnormal P-wave vector |\n| Prognosis | poor | good |\n| Mortality | high | low |\n| Plain radiograph |  |  |\n| Lung vascularity | decreased | normal / increased |\n| Aortic arch | right / left | right / left |\n| Cardiac apex | right / left / midline | right / left |\n| Bronchi | bilateral eparterial | bilateral hyparterial |\n| Minor fissure | possibly bilateral | none / normal |\n| Stomach | midline / right / left | right / left |\n| Liver | symmetrical / R / L | in various positions |\n| Malrotation of bowel | yes (microgastrina) | yes |\n| Cardiography |  |  |\n| Coronary sinus | usually absent | sometimes absent |\n| Atrial septum | common atrium (100\\%) | ASD (84\\%) |\n| AV valve | atresia / common valve | normal / abnormal MV |\n| Single ventricle | $44 \\%$ | infrequent |\n| IVS | VSD | VSD common |\n| Great vessels | d- / l-transposition (72\\%) | normal relationship |\n| Pulmonary stenosis | the rule | frequent |\n| Pulmonary veins | TAPVR | PAPVR (42\\%) <br> TAPVR (6\\%) |\n| Single coronary a. | $19 \\%$ |  |\n| SVC | bilateral (53\\%) | bilateral (33\\%) |\n| IVC-aorta relationship | same side of spine | normal |\n| IVC | normal | interrupted (84\\%) / normal |\n| Azygos vein | inapparent | continuation R / L |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 105,
            "markdown": "$\\sqrt{ }$ bilateral eparterial bronchi (MR / tomogram):\n$\\checkmark$ main bronchus passes superior to ipsilateral main pulmonary artery\n$\\checkmark$ pulmonary arteries inferior to bronchi (on PA view) + projecting anterior to trachea (on LAT view)\n$\\checkmark$ diminished pulmonary vascularity / pulmonary venous hypertension (TAPVR below diaphragm)\n@ Heart \\& great vessels\n$\\checkmark$ bilateral systemic / right morphologic atria with broad-based appendages\n$\\checkmark$ ipsilaterality of abdominal aorta + IVC\n= juxtaposed \"piggybacked\" IVC (aorta usually posterior) (MOST RELIABLE INDICATOR)\n$\\checkmark$ bilateral SVC\n@ Abdomen\n$\\checkmark$ asplenia $=$ absent spleen (risk of sepsis)\n$\\checkmark$ midline liver = centrally located \"bridging\" liver = hepatic symmetry\n$\\checkmark$ variably located stomach (on right / left side / in central position) and small (microgastria)\n$\\checkmark$ cardiac apex discordant from stomach + liver\nPrognosis: up to $90 \\%$ mortality by end of $1^{\\text {st }}$ year of life\n\n# Polysplenia Syndrome \n\n$=$ BILATERAL LEFT-SIDEDNESS $=$ LEFT ISOMERISM\nAge: presentation in infancy / adulthood; $\\mathrm{M}<\\mathrm{F}$\nAssociated with:\n(a) $\\mathrm{CHD}(>50 \\%)$ :\n\nAPVR (70\\%), dextrocardia (37\\%), ASD (37\\%), ECD (43-65\\%), pulmonic valvular stenosis ( $23 \\%$ ), TGA (13-17\\%), DORV (13-20\\%)\n\n- no / mild CHD in most patients\n(b) GI abnormalities:\nesophageal atresia, tracheoesophageal fistula, gastric duplication, preduodenal portal vein, duodenal webs + atresia, short bowel, mobile cecum, malrotation, semiannular pancreas, biliary atresia, absent GB\n(c) GU anomalies ( $15 \\%$ ):\nrenal agenesis, renal cysts, ovarian cysts\n(d) Vertebral anomalies, common celiac trunk-SMA\n- $\\mathrm{CHF} \\leftarrow \\mathrm{L}$-to-R shunt; heart murmur, occasional cyanosis\n- leftward / superiorly directed P-wave vector\n- heart block $\\leftarrow$ endocardial cushion defect\n- extrahepatic biliary obstruction\n$\\checkmark$ absence of IVC (on LAT CXR)\n$\\checkmark$ large azygos vein (on AP CXR) may mimic aortic arch\n@ Lung\n$\\checkmark$ left bronchial isomerism:\n$\\checkmark$ bilateral morphologic left lungs with 2 lobes (55-68\\%), normal (18\\%), bilateral Rsided lungs ( $7 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 106,
            "markdown": "$\\sqrt{ }$ bilateral hyparterial bronchi = main bronchus passes inferior to ipsilateral main pulmonary artery:\n$\\sqrt{ }$ arteries projecting superior to bronchi (on PA view) + posterior to tracheobronchial tree (on LAT view)\n$\\sqrt{ }$ normal / increased pulmonary vascularity\n$\\sqrt{ }$ absence of middle lobe fissure\n@ Heart \\& great vessels\n$\\sqrt{ }$ bilateral pulmonary / left morphologic atrium with pointed tubular narrow-based appendages\n$\\sqrt{ }$ cardiac apex on right / in midline\n$\\sqrt{ }$ bilateral SVC $(50 \\%)$\n$\\sqrt{ }$ interruption of hepatic segment of IVC with azygos / hemiazygos continuation in 65$70 \\%$ (MOST CONSISTENT FINDING)\n@ Abdominal heterotaxy $(56 \\%)$\n$\\sqrt{ }$ polysplenia $=$ presence of $\\geq 2$ spleens (usually two major + indefinite number of splenules) located on both sides of the mesogastrium (esp. greater curvature of stomach)\n$\\sqrt{ }$ midline centrally located liver $=$ hepatic symmetry\n$\\sqrt{ }$ absence of gallbladder $(50 \\%)$\n$\\sqrt{ }$ variably located stomach $\\rightarrow$ always on same side of spleen(s)\n$\\sqrt{ }$ malrotation of bowel $(80 \\%)$\n$\\sqrt{ }$ preduodenal portal vein\nOB-US:\n$\\sqrt{ }$ absence of intrahepatic IVC\n$\\sqrt{ }$ aorta anterior to spine in midline\n$\\sqrt{ }$ \"double vessel\" sign $=2$ vessels of similar size in paraspinous location posterior to heart $=$ aorta + azygos vein on left / right side of spine\nPrognosis: $50 \\%$ mortality by 4 months; $75 \\%$ mortality by 5 years; $90 \\%$ mortality by midadolescence\n\n# HYPOPLASTIC LEFT HEART SYNDROME \n\n$=$ SHONE SYNDROME $=$ AORTIC ATRESIA\n$=$ underdevelopment of left side of heart characterized by\n(a) hypoplastic / atretic aortic valve\n$\\sqrt{ }$ subvalvar aortic stenosis\n(b) hypoplastic / atretic mitral valve\n$\\sqrt{ }$ parachute mitral valve $=$ all chordae tendineae arise from single fused papillary muscle $\\sqrt{ }$ supravalvar mitral ring\n(c) hypoplastic $\\mathrm{LV} \\leftarrow$ endocardial fibroelastosis\n(d) hypoplastic ascending aorta\n$\\sqrt{ }$ aortic coarctation\n(e) normally related great vessels\n\nPrevalence: $0.2 \\div 1,000$ live births; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 1$\n$\\diamond 4^{\\text {th }}$ most common cardiac malformation manifesting in $1^{\\text {st }}$ year of life (after VSD, TGV,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 107,
            "markdown": "tetralogy of Fallot)\n$\\diamond$ Most common cause of CHF in neonate\n$\\diamond$ Responsible for $25 \\%$ of all cardiac deaths in $1^{\\text {st }}$ week of life\nHemodynamics:\npulmonary venous blood in LA faces an atretic / stenotic MV (= pulmonary venous outflow obstruction) $\\rightarrow$ flow diverted to RA through herniated foramen ovale / ASD (L-to-R shunt); RV supplies (a) pulmonary artery, (b) ductus arteriosus, (c) descending aorta (antegrade flow), (d) aortic arch + ascending aorta + coronary circulation (retrograde flow) $\\rightarrow$ RV work overload + CHF\nAssociated malformations:\ncoarctation of aorta, PDA, patent foramen ovale, dilated pulmonary artery, VSD, dilated RA, enlarged RV, double-outlet right ventricle, endocardial fibroelastosis\n\n- severe $\\mathrm{CHF} \\leftarrow \\mathrm{RV}$ volume + pressure overload:\n- characteristically presents within first few hours of life\n- ashen gray color / dusky complexion $\\leftarrow$ systemic underperfusion $\\leftarrow$ inadequate atrial L-to-R shunt\n- myocardial ischemia $\\leftarrow$ decreased perfusion of aorta [= \"common coronary artery\"] + coronary arteries):\n- cardiogenic shock, metabolic acidosis (when ductus arteriosus closes)\n\nCXR:\n$\\checkmark$ hypoplastic / normal / enlarged cardiac silhouette:\n$\\checkmark$ prominent right atrial border\n$\\checkmark \\pm$ absence of left ventricular silhouette\n$\\checkmark \\pm$ thymic atrophy\n$\\checkmark$ interstitial + alveolar pulmonary edema $\\leftarrow$ pulmonary venous hypertension with severely restrictive interatrial communication in $80 \\%$\n$\\checkmark$ normal pulmonary vasculature (with wide nonrestrictive interatrial communication in 20\\%)\nOB-US (may be missed $<22$ weeks GA):\n$\\checkmark$ small left ventricular cavity (apex of LV and RV should be at same level)\n$\\checkmark$ hypoplastic ascending aorta\n$\\checkmark$ aortic coarctation (in $80 \\%$ )\n$\\checkmark$ diastolic flow reversal in narrow ascending aorta is DIAGNOSTIC\nECHO:\n$\\checkmark$ normal / enlarged LA\n$\\checkmark$ slitlike / small / normal LV\n$\\checkmark$ enlarged RA\n$\\checkmark$ herniation + prolapse of foramen ovale flap into RA\n$\\checkmark$ hypoplastic ascending aorta ( $<5 \\mathrm{~mm}=$ aortic atresia $)$\n$\\checkmark$ absent / grossly distorted mitral valve echoes\nAngio:\n$\\checkmark$ retrograde flow in ascending aorta + aortic arch + coronary arteries via PDA\n$\\checkmark$ stringlike ascending aorta $<6 \\mathrm{~mm}$ in diameter\n$\\checkmark$ massive enlargement of RV + RVOT\nPrognosis: almost $100 \\%$ fatal by 6 weeks",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 108,
            "markdown": "Time of diagnosis: $32 \\%$ pre-, $65 \\% 1-4$ days postnatally\nRx: (1) Prostaglandin E1 $\\rightarrow$ patency of ductus arteriosus\n(2) Hypoventilation (increase in $\\mathrm{CO}_{2}$ maintains high pulmonary vascular resistance)\n(3) Nitroprusside IV (decreases systemic vascular resistance)\n(4) Norwood procedure $=$ palliative attempt\n(5) Cardiac transplant\n\n# HYPOPLASTIC RIGHT VENTRICLE \n\n$=$ PULMONARY ATRESIA WITH INTACT VENTRICULAR SEPTUM\n$=$ underdeveloped right ventricle $\\leftarrow$ pulmonary atresia in the presence of an intact interventricular septum\nType I $=$ small RV $\\leftarrow$ competent tricuspid valve (more common)\nType II $=$ normal / large RV $\\leftarrow$ incompetent tricuspid valve\nHemodynamics:\nfetus: L-to-R atrial shunt through foramen ovale; retrograde flow through ductus arteriosus into pulmonary vascular bed\nneonate: closure of ductus $\\rightarrow$ cyanosis, acidosis, death\n$\\sqrt{ }$ small right ventricular cavity (apex of RV + LV should be at same level)\n$\\checkmark$ atresia of pulmonary valve\n$\\checkmark$ hypoplastic proximal pulmonary artery\n$\\checkmark$ secundum atrial septal defect (frequently associated)\nRx: prostaglandin E1 infusion + valvotomy + systemic-pulmonary artery shunt\n\n## IDIOPATHIC DILATATION OF PULMONARY TRUNK\n\n$=$ CONGENITAL ANEURYSM OF PULMONARY ARTERY\nAge: adolescence; $\\mathrm{M}<\\mathrm{F}$\n\n- asymptomatic; systolic ejection murmur (in most cases)\n$\\checkmark$ dilated main pulmonary artery causes a round bulge at the mediastinal border simulating a mass\n$\\checkmark$ normal peripheral pulmonary vascularity\n$\\checkmark$ normal pulmonary arterial pulsations\n$\\checkmark$ NO lateralization of pulmonary flow\nDx per exclusion:\n\n1. Absence of shunts, CHD, acquired disease\n2. Normal RV pressure\n3. No significant pressure gradient across pulmonic valve\n\nPrognosis: nonprogressive\nDDx: (1) Marfan syndrome\n(2) Takayasu arteritis\n\n## INFECTIOUS AORTITIS\n\n$=$ inflammation of aorta caused by bacterium / virus / fungus",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 109,
            "markdown": "The aorta is normally very resistant to infection. However, an abnormal aortic wall as occurs with atherosclerotic disease, preexisting aneurysm, cystic medial necrosis, diabetes, vascular malformation, medical devices, or surgery, makes it susceptible to infection!\n\n# Organism: \n\n1. Bacterial: Staphylococcus $>$ Streptococcus $>$ Salmonella, Clostridium septicum (exceedingly rare, but strongly associated with GI / hematologic malignancy)\n2. Luetic $=$ syphilis\n3. Mycobacterial $=$ Mycobacterium tuberculosis\n4. Viral: eg, HIV infection / AIDS\n$\\sqrt{ }$ thickening of aortic wall + intramural gas (KEY FEATURE)\nN.B.: aorta may appear normal on imaging\n$R x$ : empiric antibiotic therapy against S . aureus and gram-negative rods\n$D D x$ : infected aortic aneurysm (dilated aorta prone to rupture)\n\n## Syphilitic Aortitis\n\n$=$ LUETIC AORTITIS\nPrevalence: in $10-15 \\%$ of untreated patients (accounts for death in $1 / 3$ )\nPath: periaortitis (via lymphatics), mesaortitis (via vasa vasorum) = primarily disease of media leading to secondary injury of intima, which predisposes the intima to premature calcific atherosclerosis\nAge: $\\quad 40-65$ years\nSite: ascending aorta ( $36 \\%$ ), aortic arch ( $24 \\%$ ), descending aorta ( $5 \\%$ ), sinus of Valsalva ( $1 \\%$ ), pulmonary artery\n$\\sqrt{ }$ thick aortic wall $\\leftarrow$ fibrous + inflammatory tissue\n$\\sqrt{ }$ saccular ( $75 \\%$ ) / fusiform ( $25 \\%$ ) dilatation of ascending aorta:\n$\\sqrt{ }$ small saccular aneurysm often protrudes from fusiform aneurysm\n$\\sqrt{ }$ fine pencil-like calcifications of intima ( $15-20 \\%$ ) in ascending aorta, late in disease\nCx: (1) Stenosis of coronary ostia $\\leftarrow$ intimal thickening\n(2) Aortic regurgitation (syphilitic valvulitis), rare\n$D D x$ : Degenerative calcification of ascending aorta (older population, no aneurysm, no aortic regurgitation)\n\n## INTERRUPTION OF AORTIC ARCH\n\n$=\\mathrm{IAA}=$ rare congenital anomaly with complete luminal and anatomic discontinuity between ascending + descending aorta\nPrevalence: $1 \\%$ of CHD\n$\\diamond$ Common cause of death in neonatal period after physiologic closure of PDA (410 days)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 110,
            "markdown": "![img-21.jpeg](img-21.jpeg)\n\nTrilogy: (1) Luminal discontinuity between ascending + descending thoracic aorta (2) VSD (in $90 \\%$ )\n(3) PDA (pulmonary blood supplies lower part of body) in nearly $100 \\%$\n\nCause: ? altered hemodynamics through $4^{\\text {th }}$ aortic arch / teratogenic exposure\nGenetics: chromosome 22q11.2 deletion (50\\%), DiGeorge syndrome (= hypocalcemia and Tcell defects $\\leftarrow$ thymic hypoplasia in $42 \\%$ )\nForms: (a) Simple IAA\n(b) Complex IAA (in $1 / 3$ ) associated with:\n\n1. Bicuspid aortic valve\n2. Muscular subaortic stenosis\n3. Truncus arteriosus\n4. Aortopulmonary window\n5. ASD\n6. Transposition of great arteries\n7. Double-outlet right ventricle\n8. Functional single ventricle\n9. Complete anomalous pulmonary venous return\n\n- presents with CHF\n\nLocation:\nType A: distal to left subclavian artery (13-42\\%)\nType B: between left CCA and subclavian artery (53-84\\%)\nType C: between innominate and left CCA (3-4\\%)\n$\\sqrt{ }$ dilatation of right atrium + ventricle\n$\\sqrt{ }$ dilatation of pulmonary artery\n$\\sqrt{ }$ ascending aorta much smaller than pulmonary artery\n$\\sqrt{ }$ arch formed by pulmonary artery + ductus arteriosus gives the appearance of a low aortic arch\n$\\sqrt{ }$ aortic knob absent",
            "images": [
                {
                    "id": "img-21.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 838,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 111,
            "markdown": "$\\sqrt{ }$ trachea in midline\n$\\sqrt{ }$ NO esophageal impression\n$\\sqrt{ }$ retrosternal clear space increased (small size of ascending aorta)\n$\\sqrt{ }$ increased pulmonary vascularity $\\leftarrow$ L-to-R shunt\n$\\sqrt{ }$ aberrant right subclavian artery arising from right side of proximal descending thoracic aorta\n$C x$ : hypoperfusion with acute renal failure + metabolic acidosis\nPrognosis: $59-70 \\%$ overall survival rate by 16 years of age\n$R x$ : prostaglandin E1 in neonatal period (to keep the ductus arteriosus open); cardiac surgery during $1^{\\text {st }}$ year of life (with $15-20 \\%$ mortality)\n\n# INTERRUPTION OF PULMONARY ARTERY \n\n$=$ pulmonary trunk continues only as one large artery to one lung while systemic aortic collaterals supply the other side\nCause: abnormal development of $6^{\\text {th }}$ aortic arch in utero\nAssociated with: CHD (particularly if interruption on left side):\n\n1. Tetralogy of Fallot\n2. Scimitar syndrome $=$ congenital pulmonary venolobar syndrome\n3. PDA, VSD\n4. Pulmonary hypertension\n\nCollateral supply:\n\n1. Arteries arising from arch + ascending aorta\n2. Bronchial vessels\n3. Intercostal vessels\n4. Branches from subclavian artery (internal mammary artery)\n\nLocation: usually opposite from aortic arch; $\\mathrm{R}>\\mathrm{L}$ pulmonary artery\nCXR:\n$\\sqrt{ }$ hypoplastic ipsilateral lung\n$\\sqrt{ }$ lung opacity similar to normal lung / slightly increased\n$\\sqrt{ }$ volume loss of affected hemithorax:\n$\\sqrt{ }$ small ipsilateral chest\n$\\sqrt{ }$ mediastinal shift toward involved lung\n$\\sqrt{ }$ ipsilateral shift of anterior junction line\n$\\sqrt{ } \\pm$ elevation of ipsilateral hemidiaphragm\n$\\sqrt{ }$ ipsilateral narrowed intercostal spaces\n$\\sqrt{ }$ absent / diminutive appearance of pulmonary hilum with \"comma-shaped\" small distorted hilar shadow\n$\\sqrt{ }$ occasionally rib notching\n$\\sqrt{ }$ hyperexpanded + hyperlucent contralateral lung with herniation into smaller hemithorax\n$\\sqrt{ }$ asymmetry of pulmonary vascularity\n$\\sqrt{ }$ normal respiratory motion (normal aeration of hypoplastic lung)\nCECT:\n$\\sqrt{ }$ affected pulmonary artery completely absent / terminates within 1 cm of its origin\n$\\sqrt{ }$ reconstitution of more peripheral pulmonary arteries $\\leftarrow$ collateral vessels\n$\\sqrt{ }$ multiple linear opacities perpendicular to pleural surface (= transpleural systemic",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 112,
            "markdown": "collateral vessels)\n$\\sqrt{ }$ serrated pleural thickening (= enlarged intercostal + transpleural arteries)\nNUC:\n$\\sqrt{ }$ absent perfusion with normal aeration\nAngio:\n$\\checkmark$ absent pulmonary artery\n$C x$ : recurrent pulmonary infection, hemorrhage, hemoptysis ( $10 \\%$ ), mild exertional dyspnea, pulmonary hypertension (19-25\\%)\n$R x$ : Surgical anastomosis between proximal + distal pulmonary artery (to prevent progressive pulmonary hypertension with dyspnea, cyanosis, hemoptysis, death)\n$D D x$ : (1) Hemitruncus\n(2) Swyer-James syndrome (ipsilateral air trapping, reduced ventilation + perfusion)\n(3) Chronic thromboembolic occlusion\n(4) Takayasu arteritis\n(5) Mediastinal fibrosis\n(6) Hypogenetic lung syndrome (abnormal bronchial branching pattern)\n\n# INTRAMURAL AORTIC HEMATOMA (3-13\\%) \n\n$=$ ATYPICAL AORTIC DISSECTION $=$ IMH\n$=$ aortic dissection without demonstrable intimal flap / penetrating aortic ulcer\nCause: rupture of vasa vasorum; in $94 \\%$ spontaneous; in $6 \\%$ traumatic (? early stage of limited dissection or thrombosis of false lumen)\nPathophysiology:\nrupture of vasa vasorum $\\rightarrow$ hemorrhage into aortic media $\\rightarrow$ intramural blood clot $\\rightarrow$\nweakening of aortic wall; no detectable flow within the \"false channel\"\nMedian age: 68 years\nRisk: hypertension (53\\%)\n\n- signs + symptoms + classification identical to classic aortic dissection:\n- chest pain / back pain or both (in $80 \\%$ )\n$\\diamond$ IMH detected in $5-20 \\%$ of patients presenting with signs of classic aortic dissection\nStanford classification: in $57 \\%$ type A; in $43 \\%$ type B\nMay be associated with: pericardial / pleural effusion, mediastinal hematoma\n$\\sqrt{ }$ NO intimal tear / flap at initial imaging\n$\\sqrt{ }$ NO penetrating atherosclerotic ulcer\nNECT (necessary):",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 113,
            "markdown": "![img-22.jpeg](img-22.jpeg)\n$\\sqrt{ }$ DIAGNOSTIC eccentric cuff / crescent of aortic wall $>7 \\mathrm{~mm}$ thick with a density of 60-70 HU:\n$\\checkmark$ attenuation identical to intraluminal blood after 1 week\n$\\checkmark$ decreased thickness within a few weeks\n$\\checkmark$ complete resolution within 1 year\n$\\checkmark$ displacement of intimal calcifications maintaining a semicircular / circular curvilinear configuration\nCECT:\n$\\checkmark$ nonenhancing mural region of low attenuation with smooth border maintaining a constant circumferential relationship with aortic wall\n$\\checkmark$ predictors of outcome:\n(a) maximal aortic diameter,\n(b) maximal axial thickness of hematoma,\n(c) minimum + maximum transverse aortic diameter at level of maximal thickness of intramural hematoma\nMR:\n$\\diamond$ Review source images!\n$\\checkmark$ crescent-shaped eccentric wall thickening\n$\\checkmark$ T2 white blood imaging:\n$\\checkmark$ hyperintense signal ( $<7$ days of age)\n$\\checkmark$ intermediate signal intensity ( $\\geq 7$ days)\n$\\checkmark$ subacute / chronic hematoma on T1 black blood imaging:\n$\\checkmark$ subacute isointense ( $=$ oxyhemoglobin)\n$\\checkmark$ hyperintense hematoma ( $=$ methemoglobin)\nAortography: not useful!\nCx: (1) Ulcerlike projection with progression to open dissection\n(2) Saccular or fusiform aneurysmal dilatation\n(3) Rupture\n\nRx: (1) Emergency surgical repair for type A hematoma (probably represents early stage",
            "images": [
                {
                    "id": "img-22.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 776,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 114,
            "markdown": "with development of classic aortic dissection)\n(2) Observation for type B hematoma (may heal completely)\n\nMortality: $21 \\%$ (similar to classic aortic dissection)\n$D D x$ :\n(1) Acutely thrombosed false lumen of dissection (opacification of true + false lumina; intimal flap; multilayered pattern of increasing attenuation; linear configuration of intimal calcifications; tendency to spiral longitudinally around aorta)\n(2) Aortitis (segmental mural thickening of aorta + branch vessels interspersed with normal segments)\n(3) Acute aortic hematoma of fusiform aortic aneurysm with hyperattenuating crescent ( $=$ sign of impending rupture)\n(4) Atheromatous mural thrombus (irregular intraluminal surface in segment of dilated aorta, abdominal location, multiple sites)\n(5) Penetrating atherosclerotic ulcer (small focal contrast-enhanced outpouching of intima + adjacent subintimal hematoma, located in abdominal / descending thoracic aorta, associated with extensive atherosclerosis)\n(6) Intramural blood pool\n$=$ intramural contrast-medium filled pool\n$\\sqrt{ }$ tiny intimal orifice $\\pm$ connection with intercostal / lumbar artery\nPrognosis: good\n(7) Focal periaortic soft-tissue mass (circumferential involvement with irregular external border)\n(a) Idiopathic retroperitoneal fibrosis\n(b) Periaortic lymphoma\n(8) Aortic motion artifact simulating type A IMH\n\n# ISCHEMIC HEART DISEASE \n\n$=$ CORONARY ARTERY DISEASE (CAD)\nIncidence: 1.5 million annually; leading cause of death in industrial nations\nPrognosis: $28.7 \\div 1,000$ men annually; $3.1 \\div 1,000$ deaths annually\n\n## - Acute Coronary Syndrome\n\n(a) transmural myocardial infarction\n(b) subendocardial myocardial infarction\n(c) unstable angina\n\n| Likelihood of <br> Myocardial Ischemia | Preferred Imaging Modality |\n| :--: | :-- |\n| high | Catheter angiography |\n| moderate | ECG-gated SPECT |\n| low | Coronary CT angiography |\n\nCXR:\n$\\sqrt{ }$ often normal\n$\\sqrt{ }$ coronary artery calcification\n$\\sqrt{ }$ pulmonary venous hypertension following acute infarction ( $40 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 115,
            "markdown": "# $\\sqrt{ }$ LV aneurysm \n\n## A. NONINVASIVE TESTING\n\n1. Noninvasive testing is of marginal benefit when disease prevalence is $<0.2 />0.7$\n2. Concordant ${ }^{201}$ Thallium and stress ECG are greater predictors of disease probability than either one used alone and/or when discordant\n3. Sequential ${ }^{201}$ Thallium and stress ECG are most useful to establish the diagnosis of CAD when pretest prevalence is intermediate + test results are concordant\nB. INVASIVE TESTING\n4. Nonstress Myocardial Perfusion Study ( ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-Sestamibi) administered during acute chest pain: $99 \\%$ NPV, $92 \\%$ sensitive for early diagnosis\n\n| Coronary CTA / Triple CTA |  |  |\n| :--: | :--: | :--: |\n| Risk category | CT Interpretation | Clinical Guideline |\n| High | Coronary calcium score $>400$ |  |\n|  | $>70 \\%$ stenosis in any vessel | Admission |\n|  | $>50 \\%$ stenosis in left main |  |\n| Medium | Coronary calcium score | Cardiology <br> consultation |\n|  | $100-400$ |  |\n|  | $30-70 \\%$ stenosis in any vessel | Follow-up with <br> cardiology |\n| Low | Coronary calcium score $<100$ | Follow-up with <br>  <br> regular MD |\n| Negative | Normal scan |  |\n| Results are negative / in low risk category in 75\\%! |  |  |\n\nPitfalls: breast attenuation, diaphragmatic attenuation (repeat study in prone position)\n2. ECHO ( $90 \\%$ sensitive, $53-78 \\%$ specific for infarction)\n$\\sqrt{ }$ region of dilatation with disturbance of wall motion:\n(1) Akinesis $=$ no wall motion\n(2) Hypokinesis $=$ reduced wall motion\n(3) Dyskinesis $=$ paradoxical systolic expansion\n(4) Asynchrony $=$ disturbed temporal sequence of contraction\n3. Coronary angiography: 1.2 million procedures annually\n4. Coronary CTA\n5. Cardiac PET/CT\n\n## Imaging of Coronary Artery Disease\n\n(1) DIRECTLY with myocardial perfusion imaging providing a pictorial representation of the relative perfusion of viable myocardial tissue using exercise + rest physiology images\n(a) ${ }^{201} \\mathrm{Tl}$ chloride SPECT imaging ( $92 \\%$ sensitive, $68 \\%$ specific)\n(b) ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-sestamibi / tetrofosmin SPECT imaging ( $89 \\%$ sensitive, $90 \\%$ specific)\n(c) PET\n(2) INDIRECTLY with imaging of ventricular function,\ni.e., evaluation of wall motion + ejection fraction\n(a) multigated acquisition studies (MUGA)\n) ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-labeled RBCs",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 116,
            "markdown": "$>99 \\mathrm{~m} T \\mathrm{Tc}$-human serum albumin\n(b) first-pass radionuclide angiography\n> sodium pertechnetate\n> diethylenetriamine pentaacetic acid (DTPA)\n> sulfur colloid\n> ${ }^{195 \\mathrm{~m}} \\mathrm{Au}$ (gold)\n> ${ }^{191 \\mathrm{~m}} \\mathrm{Ir}$ (iridium)\n(3) SIMULTANEOUS assessment of myocardial perfusion + ventricular function\n$=$ first-pass radionuclide angiography + gated SPECT perfusion imaging\nInterpretation:\nA. NORMAL MYOCARDIUM\n$\\sqrt{ }$ homogeneous perfusion\n$\\sqrt{ }$ similar appearance at rest + with exercise\nB. ISCHEMIC VIABLE MYOCARDIUM\n$\\sqrt{ }$ normal perfusion at rest\n$\\sqrt{ }$ relative hypoperfusion with exercise (= reversible defect)\n$D D x$ :\n(1) Reversible septal defect in left bundle branch block\n(2) Differing soft-tissue attenuation artifact\nC. MYOCARDIAL INFARCTION\n$\\sqrt{ }$ reduced muscle mass\n$\\sqrt{ }$ absent / reduced uptake at rest + with exercise (= fixed defect)\n$D D x$ : (1) \"Hibernating myocardium\" = chronic myocardial hypoperfusion producing abnormal regional ventricular function\n(2) Soft-tissue attenuation artifacts\n$\\sqrt{ }$ marked variability in LV tracer uptake of inferior wall (diaphragmatic attenuation) + anterior wall (breast attenuation)\n(3) Infiltrative disorders\n\nDDx of a mild fixed defect:\n\n1. Scar\n2. Hibernating myocardium\n3. Attenuation artifact\n\n# Myocardial Viability Assessment \n\n1. Perfusion",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 117,
            "markdown": "![img-23.jpeg](img-23.jpeg)\n» ${ }^{201} \\mathrm{Tl}$ rest injection with redistribution images preferable to sestamibi\n$\\sqrt{ }$ uptake $>50 \\%$ of maximum\n2. Metabolic activity\n» FDG may provide best assessment (normal myocardium uses fatty acids as chief metabolic substrate, but can switch to glucose metabolism)\n$\\sqrt{ }$ enhanced glucose uptake by ischemic but viable myocardium\n\n# Analysis of Perfusion Defect \n\nReport must address: location, size, severity, reversibility of a perfusion defect\n(1) TYPE OF PERFUSION ABNORMALITY\n$\\checkmark$ fixed defect\n$=$ myocardial scar / severe myocardial ischemia\n$\\checkmark$ reversible defect\n$=$ perfusion abnormality on poststress images normalizes on resting images\n$\\checkmark$ partially reversible defect\n$=20-30 \\%$ improvement in regional activity\n(2) LOCATION OF PERFUSION ABNORMALITY described with regard to\n(a) LV wall\n$\\rightarrow$ anterior, septal, inferior, lateral, apical\n$\\diamond$ Avoid \"posterior\" as it has been variably assigned to the lateral wall (LCX) or basal inferior wall (RCA)\n(b) expected coronary vascular territory involvement\n(3) DEGREE OF REVERSIBILITY OF PERFUSION DEFECT\n$\\checkmark$ cross-hatching of perfusion defect on stress image-based polar map\n$\\checkmark$ improvement by $\\geq 2$ points in SSS / absolute SSS of 0 or 1 on rest images\n$\\diamond$ If an area of infarcted myocardium with a fixed defect has perfusion of greater than $50 \\%$ of the database norm, it is considered to be at least partially viable\n(4) SIZE / EXTENT OF PERFUSION DEFECT",
            "images": [
                {
                    "id": "img-23.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 191,
                    "bottom_right_x": 1339,
                    "bottom_right_y": 756,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 118,
            "markdown": "| Size of Myocardial Perfusion Defect |  |\n| :--: | :--: |\n| Description | Size of Total LV Volume |\n| small | $5-10 \\%$ |\n| medium | $15-20 \\%$ |\n| large | $20-40 \\%$ |\n| extensive | $>40 \\%$ |\n\n(5) SEVERITY OF PERFUSION DEFECT\n\" Qualitative\n\n- mild $=10 \\%$ reduction of peak tracer activity, of unknown clinical significance\n- moderate\n- severe\n\" Semiquantitative Segmental Scoring for more accurate + more consistent reporting\n- Summed rest score (SRS)\n- Summed stress score (SSS\n\n| Semiquantitative Segmental Scoring |  |  |  |\n| :--: | :--: | :--: | :--: |\n| Score | Reduction in Perfusion | Decrease from Norm |  |\n| 0 | normal / no difference | 0\\% |  |\n| 1 | equivocal / mild | $<40 \\%$ |  |\n| 2 | moderate | $40-60 \\%$ |  |\n| 3 | severe | $>60 \\%$ |  |\n| 4 | absent perfusion | no activity |  |\n\n\n| Myocardial Perfusion SPECT <br> for Detection and Management of CAD |  |  |  |\n| :--: | :--: | :--: | :--: |\n|  | Normal | Mildly <br> Abnormal | Moderately <br> Severely <br> Abnormal |\n| Summed Stress Score | $<4$ | $4-8$ | $>8$ |\n| Likelihood of Coronary <br> Artery Disease | low | high | high |\n| Risk of Myocardial <br> Infarction | low | intermediate | intermediate |\n| Risk of Cardiac Death | low | low | intermediate |\n\n\n| Risk for Future Hard Cardiac Events |  |\n| :--: | :--: |\n| Risk | Summed Stress Score |\n| Normal | $0-3$ |\n| Low risk | $4-7$ |\n| Intermediate risk | $8-12$ |\n| High risk | $>12$ |\n\n- Summed difference score (SDS) = SRS - SSS\n$=$ measure of reversibility ( $\\geq 2$-grade improvement represents substantial ischemia)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 119,
            "markdown": "(a) no / mild ischemia $=$ SDS $\\leq 4$\n(b) determines risk for future hard cardiac even\n\n# QUANTITATIVE ANALYSIS \n\n$=$ using a reference profile ( $=$ database normalized to specific gender, radiopharmaceutical, and population) perfusion data is displayed as a polar map / bull's-eye projection / circumferential profile serving as a \"second observer\"\n$\\sqrt{ }$ blackout map (most popular) = perfusion values below a threshold (usually of 2.5 SD below mean) displayed in black\n$\\sqrt{ }$ cross-hatched areas = area above threshold value but with abnormal perfusion during stress indicating reversible defect\n\n## Common Artifacts in Myocardial Perfusion Imaging\n\n1. Patient motion artifact\n$\\diamond$ Motion $\\geq 2$ pixels is unacceptable!\n(a) superior $\\rightarrow$ inferior\n(b) laterally\n(c) \"upward creep\" $\\leftarrow$ increase of respiratory excursion after strenuous exercise\n$\\sqrt{ }$ heart in different locations on adjacent SPECT projection images\n$\\sqrt{ }$ \"apical flame / hurricane\" sign = artifactual perfusion defect in apical septum + mild offset of septal aspect of LV relative to lateral aspect + tail of activity extending superiorly from distal LV on short-axis views resembling depiction of a hurricane on weather maps\nRemedy: (1) repeat imaging without delay / reinjection $\\rightarrow 99 \\mathrm{mTc}$-labeled radiotracers remains relatively fixed for as long as 2 hours\n(2) use of motion correction software $\\rightarrow$ eliminates misregistration due to slight / moderate motion\n2. Misregistration artifact\n$=$ patient motion between sequential acquisition of low-dose CT data obtained for attenuation correction and SPECT image\nRemedy: use of coregistration software for precise superimposition of CT + SPECT\n3. Left bundle branch block artifact\n\nEffect: decrease in septal blood flow at higher heart rate $\\leftarrow$ asynchronous septal contraction $\\leftarrow$ perturbed activation sequence + incomplete relaxation of septum during diastole\n$\\sqrt{ }$ apparent septal defect typically sparing apex and anterior wall (often more pronounced during stress induced by exercise / dobutamine instead of vasodilators that have a limited effect on heart rate)\n$\\sqrt{ }$ asynchronous / hypokinetic / paradoxical septal wall motion with preserved septal wall thickness\n4. Normal prominent apical thinning\n$\\sqrt{ }$ apparent perfusion defect with matching stress and rest perfusion pattern\n$\\diamond$ Best seen on vertical and horizontal long-axis images + polar map display\n$\\sqrt{ }$ normal wall motion + normal wall thickness\n5. Lung activity increased $\\leftarrow$ severe left ventricular dysfunction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 120,
            "markdown": "6. RV uptake usually RV intensity $50 \\%$ of peak LV intensity; $\\uparrow$ in\n(a) RV hypertrophy $\\leftarrow$ pulmonary HTN\n(b) globally reduced LV uptake\n7. Extracardiac activity\n> skin / clothing contamination\n> intense subdiaphragmatic activity from liver / GI tract $\\leftarrow$ hepatobiliary excretion of 99 mTc -labeled radiotracers\nEffect: (1) Scatter radiation $\\rightarrow$ apparent increased perfusion in inferior myocardial wall masking true perfusion defect\n(2) Normalized to highest count activity apparent LV activity relatively low $\\rightarrow$ simulating extensive perfusion defect\n$\\sqrt{ }$ ramp artifact\n$=$ band of pixels with negative counts around hot objects during SPECT reconstruction\nRemedy: (1) Repeat acquisition after delay $\\rightarrow$ clearance of radiotracer superimposed on heart\n(2) Repeat imaging in prone position\n(3) Combination of vasodilator administration with low-level exercise protocol $\\rightarrow$ reduction of splanchnic blood flow may prevent subdiaphragmatic activity\n(4) Patient drinks water to clear stomach\n> neoplastic lesion lung, breast, sarcoma, lymphoma, thymoma, parathyroid tumor, thyroid abnormality, kidney tumor, liver tumor\n8. Attenuation (in up to $40 \\%$ of all studies)\n> overlapping breast tissue (women)\n> diaphragm (men) $\\rightarrow$ affects inferior myocardial wall\nEffect: artifactual activity decrease in anterior myocardial wall $\\pm$ septal and lateral walls\nClue: (1) Apparent perfusion defect present on stress-rest set of images (without change in position)\n(2) Normal LV wall motion and wall thickness\n(3) Noncoronary distribution of abnormality\n(4) Large dense breasts at cinematic review of raw images\n\nRemedy: (1) Attenuation correction method: like low-dose breath-hold CT on hybrid SPECT/CT\n(2) Repeat imaging in prone position\n\n# KAPOSIFORM HEMANGIOENDOTHELIOMA \n\n$=$ vascular neoplasm of borderline malignancy + intermediate aggressiveness\nAssociated with: Kasabach-Merritt syndrome\nLocation: extremity, trunk, head and neck\nSpread: to regional lymph nodes (rare)\nMR:\n$\\sqrt{ }$ ill-defined margins with involvement of multiple tissue planes + destructive changes",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 121,
            "markdown": "$\\sqrt{ }$ small feeding + draining vessels\n$\\sqrt{ }$ hemosiderin deposits\n$D D x$ : infantile hemangioma\n\n# KAWASAKI DISEASE \n\n$=$ MUCOCUTANEOUS LYMPH NODE SYNDROME\n$=$ acute febrile generalized multisystem vasculitis of unknown cause involving medium-sized (large + small) arteries with a HALLMARK predilection for coronary arteries\n$\\diamond$ Leading cause of acquired pediatric heart disease in developed countries; $2^{\\text {nd }}$ most common pediatric vasculitis\nIncidence: $20.8 \\div 100,000$ annually in children $<5$ years of age; highest in Asian countries (Japan, Korea)\nCause: unknown; probable activation of immune system by an infectious trigger in a genetically susceptible host\nHisto: necrotizing panvasculitis\nAge: $<5$ years of age (in $85 \\%$ ); peak age of $2-3$ years;\n$\\mathrm{M} \\div \\mathrm{F}=1.6 \\div 1.0$\nAssociated with: polyarthritis (30-50\\%), aseptic meningitis (25\\%), hepatitis (5-10\\%), pneumonitis $(5-10 \\%)$\nSeasonal variation: peaks in winter\nClinical phases:\n(1) Acute phase (lasts 11 days): fever, nonexudative bulbar conjunctivitis, erythema of lips + oral mucosa, rash; $\\pm$ pericarditis, myocarditis, abdominal pain, ascites, GB hydrops\n(2) Subacute phase (lasts 2 weeks): resolution of fever, coronary artery aneurysms may develop; highest risk of sudden cardiac death\n(3) Convalescent phase: $4-8$ weeks after onset\n\n- abrupt onset of high fever $>5$ days\n- mucosal reddening: injected fissured lips, injected pharynx, strawberry tongue in $99 \\%$\n- maculopapular rash on extensor surfaces ( $99 \\%$ )\n- bilateral nonpurulent conjunctivitis ( $96 \\%$ )\n- erythema of palms + soles with desquamation ( $88 \\%$ )\n@ Cardiovascular system ( $1 / 2$ )\n\n1. Coronary artery abnormality ( $15-25 \\%$ )\n$\\diamond$ Perform cardiac ECHO at diagnosis, at 2 weeks, and at 6-8 weeks after onset of illness!\n$\\sqrt{ }$ mild coronary artery dilatation (in up to $50 \\%$ )\n$\\sqrt{ }$ coronary artery aneurysm: LCA $\\left(2^{2} / 7\\right.$ ), RCA $\\left(1 / 5\\right)$; proximal segment in $70 \\%$; as early as 3 days after onset of illness; $48 \\%$ regress, $37 \\%$ diminish in size\nRisk factors: male sex, extremes of age, prolonged fever, delay in diagnosis, persistent fever after treatment\n$\\sqrt{ }$ coronary artery stenosis $(39 \\%) \\leftarrow$ thrombus formation in aneurysm with intimal thickening\n$\\sqrt{ }$ coronary artery occlusion $(8 \\%)$ in aneurysms $>9 \\mathrm{~mm}$\n2. Myocarditis ( $25 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 122,
            "markdown": "3. Pericarditis\n4. Valvulitis\n5. Atrioventricular conduction disturbance\n\nCoronary artery involvement is the most characteristic manifestation of Kawasaki disease. Other medium-sized muscular arteries may also be involved.\n@ CNS\n$\\sqrt{ }$ subdural effusion\n$\\sqrt{ }$ cerebral infarction, atrophy\n$\\sqrt{ }$ lesion with reversible T2 hyperintensity in splenium of corpus callosum + subcortically\n$\\sqrt{ }$ posterior reversible encephalopathy syndrome\n@ Neck\n\n- firm nonfluctuant cervical lymphadenopathy ( $82 \\%$ ), unresponsive to antibiotics\n$\\sqrt{ }$ typically unilaterally enlarged nonsuppurative lymph nodes\n@ Abdomen\n$\\sqrt{ }$ intestinal pseudoobstruction\n$\\sqrt{ }$ focal colitis\n$\\sqrt{ }$ bowel infarction $\\rightarrow$ ischemic stricture\n$\\sqrt{ }$ transient gallbladder hydrops ( $15 \\%$ )\nPrognosis: $0.4-3.0 \\%$ mortality (from myocardial infarction / myocarditis with congestive heart failure / rupture of coronary artery aneurysm)\n$R x:$ aspirin $(100 \\mathrm{mg} / \\mathrm{kg}$ per day $)+$ gamma globulin\n$D D x$ : infantile polyarteritis\n\n\n# LEFT AORTIC ARCH WITH ABERRANT RIGHT SUBCLAVIAN ARTERY \n\n$=$ right subclavian artery arises as $4^{\\text {th }}$ branch from proximal descending aorta $=$ arteria lusoria\nPrevalence: $0.4-2.3 \\%$ of population; in $37 \\%$ of Down syndrome children with CHD;\n$\\diamond$ Most common congenital aortic arch anomaly!\nAssociated with: (1) Absent recurrent pharyngeal nerve (2) CHD in 10-15\\%\n\n- asymptomatic / dysphagia lusoria (rare)\n[lusoria = lusus naturae, Latin = freak / mutant / monster of nature]\nCourse: (a) behind esophagus ( $80 \\%$ )\n(b) between esophagus + trachea ( $15 \\%$ )\n(c) anterior to trachea (5\\%)\n$\\sqrt{ }$ soft-tissue opacity crossing the esophagus obliquely upward toward the right shoulder (PATHOGNOMONIC)\n$\\sqrt{ }$ masslike opacity in right paratracheal region\n$\\sqrt{ }$ rounded opacity arising from superior aortic margin posterior to trachea + esophagus on LAT CXR\n$\\sqrt{ }$ dilated origin of aberrant right subclavian artery (in up to $60 \\%$ ) = diverticulum of Kommerell $=$ remnant of embryonic right arch\n$\\sqrt{ }$ unilateral L-sided rib notching (if aberrant right subclavian artery arises distal to",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 123,
            "markdown": "# LIPOMATOUS HYPERTROPHY OF INTERATRIAL SEPTUM \n\n$=$ LHIAS $=$ excessive deposition of brown fat in interatrial septum\nPrevalence: $3 \\% ; \\uparrow$ with older age\nAssociated with: obesity, pulmonary emphysema\n$D x$ : thickening of interatrial septum $>2 \\mathrm{~cm}$ (transverse diameter)\nHisto: unencapsulated infiltration of adipocytes (brown fat) between atrial muscle cells, NOT true neoplasm\nBrown fat: increased vascularity + high density of mitochondria $\\rightarrow$ generation of heat\n\n- commonly asymptomatic, more commonly female\n\nSite: at level of fossa ovalis BUT with sparing of fossa ovalis\n$\\sqrt{ }$ fatty mass of dumbbell shape $\\leftarrow$ sparing of fossa ovalis\n$\\sqrt{ }$ no contrast enhancement\n$\\sqrt{ }$ increase in mediastinal and epicardial fat\n$\\sqrt{ } \\pm$ focally increased FDG activity $=$ mean SUV of 1.84 (range, $0.48-3.48$ ) $\\leftarrow$ metabolically active brown fat\n$D D x$ : potential imaging pitfall suggesting infectious/inflammatory / neoplastic lesion\n$C x$ : supraventricular arrhythmias, vena caval obstruction\n\n## LEIOMYOSARCOMA OF IVC\n\n$=$ rare slow growing neoplasm; $<300$ patients in literature\n$\\diamond$ Most common primary tumor of the IVC\n$\\diamond 2^{\\text {nd }}$ most frequent retroperitoneal neoplasm in adults\nAge: $5^{\\text {th }}-6^{\\text {th }}$ decade; $\\mathrm{M}+\\mathrm{F}=1 \\div 2$ to $1 \\div 3$\nGrowth patterns: extraluminal (62\\%), intraluminal (5\\%), combined extra- and intraluminal $(33 \\%)$\nHisto: atypical interlaced pattern with sweeping bundles of spindle-shaped cells with elongated / occasionally truncated blunt-ended nuclei\n\n- most common:\n- exhaustion, abdominal pain, weight loss\n- abdominal mass / swelling, nausea, vomiting\n- late stage:\n- abdominal distention, changes in defecation habits\n- shortness of breath $\\leftarrow$ decreased cardiac return\n- leg edema, back / radicular pain, frequent urination\n- elevated liver functions, jaundice\n\nLocation:\n(a) upper IVC = hepatic vein to right atrium (24\\%) $\\rightarrow$ Budd-Chiari syndrome from sudden / gradual occlusion of hepatic veins / IVC / both\n(b) middle IVC = hepatic to renal veins $(42 \\%) \\rightarrow$ nephrotic syndrome\n(c) lower IVC = infrarenal area $(34 \\%) \\rightarrow$ lower extremity edema\n(d) entire length of IVC $(10-17 \\%)$\n\nSpread to: liver, lung, lymph nodes, brain, peritoneum; skin, soft tissue, bone, kidney, omentum",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 124,
            "markdown": "(less common)\n$\\diamond$ Distant seeding in $40 \\%$ at presentation!\n$\\checkmark$ lobulated well-defined heterogeneous tumor exhibiting signs of hemorrhage\n$\\checkmark$ rarely necrotic predominantly cystic mass\n$\\checkmark$ venous dilatation + total / near-complete vessel obstruction\n$\\checkmark$ calcification unusual\n$\\checkmark$ collateral pathways bypassing IVC: hemiazygos, azygos\n$\\checkmark$ tumor extension from IVC into right atrium / pulmonary artery\nUS:\n$\\checkmark$ blood flow in IVC / hepatic veins may be absent / reversed / turbulent (depending on degree of obstruction)\n$\\checkmark$ tumor vascularity (DDx from bland thrombus)\nCT:\n$\\checkmark$ irregular contrast enhancement of tumor\n$\\checkmark$ mass of intermediate attenuation mass\nPrognosis: local recurrence (40-77\\%)\n$D D x$ : retroperitoneal tumor compressing / invading IVC; bland thrombus\n$D D x$ of tumor extension into right atrium:\nrenal cell carcinoma, hepatocellular carcinoma\n\n# LYMPHATIC DYSPLASIA \n\n## Primary Lymphatic Dysplasia\n\n- uni- / bilateral swelling of lower / upper extremities\n> resembles other angiodysplastic syndromes:\n\n1. Klippel-Trénaunay-Servelle syndrome\n$=$ venous + lymphatic abnormalities\n2. Klippel-Trénaunay-Weber syndrome\n$=$ venous + lymphatic + arterial disturbances\n3. Milroy disease\n$=$ inherited autosomal disorder with high penetrance characterized by lymphedema of one / both lower /upper extremities, face, other body parts\n\n## Secondary Lymphatic Dysplasia\n\n$=$ obstruction of lymph flow from an acquired cause\nCause:\n\n1. Treatment of cancer: obliteration of lymph nodes by excision or irradiation\n$\\diamond$ Lymphedema may appear months to years after treatment $\\leftarrow$ gradual deterioration in intrinsic contractile force of lymphatic wall / valve incompetence\n2. Filariasis\n$=$ nematode (Wuchereria bancrofti, Brugia malayi) resides within peripheral lymphatic vessels + nodes + obstructs lymph flow\n\n- elephantine / pachydermatous extremities / genitalia\n- chyluria, hydrocele, chylous reflux (chylometrorrhagia, chylous vesicles), genital edema, massive breast engorgement",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 125,
            "markdown": "3. Long-standing venous disease / following venous stripping\n4. Lymphatic obstruction by cancer, Kaposi sarcoma\n5. Lymphatic inflammation: topical use of Cantharone ${ }^{\\circledR}$ (for eradication of plantar warts); injection treatment of varicosities\n6. Minor trauma to soft tissue / bone\n7. Sedentary condition: eg, confinement to wheelchair\n8. Morbid obesity\n9. Lymphedema tarda\n$=$ congenital lymphedema with delayed manifestation secondary to superimposed secondary cause\n\n# LYMPHEDEMA \n\n## Primary Lymphedema\n\n- no history of cancer chemotherapy, nodal extirpation / irradiation, severe trauma\n\nAge: birth to $>25$ years\nCause: primary / acquired lymphatic disorder\n$\\sqrt{ }$ complete absence / delay of radiotracer transport\n$\\sqrt{ }$ absence / paucity of lymphatic collectors (truncal flow)\n$\\sqrt{ }$ intense dermal dispersion / backflow\n\n- chylous skin vesicles; external leakage of milky lymph\n$\\sqrt{ }$ lymphatic dysplasia may involve viscera\nPitfall: subcutaneous injection leads to factitious failure of radiotracer movement\n\n\n## Congenital Lymphedema\n\nAge: birth to 5 years\n\n## Lymphedema Precox\n\nAge: puberty to 25 years\n(a) congenital\n$\\sqrt{ }$ lack of lymph collectors, dermal diffusion, delayed transport\n(b) acquired\n$\\sqrt{ }$ intact collectors, rapid regional transport, delayed dermal diffusion\n\n## Secondary Lymphedema\n\n$\\sqrt{ }$ prominent lymphatic trunks:\n$\\sqrt{ }$ long-standing lymphatic obstruction leads to \"die-back\" (obliteration) of lymphatics $\\leftarrow$ intraluminal coagulum-gel deposition / reactive inflammation\n$\\sqrt{ }$ dermal diffusion (backflow) of variable intensity\n$\\sqrt{ }$ delayed radiotracer transport\n$\\sqrt{ }$ faintly visualized regional lymph nodes\n\n## LYMPHOMA OF HEART\n\nPET:\n$\\sqrt{ }$ difficult to differentiate from normal myocardial uptake",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 126,
            "markdown": "$D D x$ : (1) Metastasis: lung cancer, malignant melanoma\n(2) Cardiac angiosarcoma (involving large areas of heart, more aggressive with penetration of valves + great vessels, central necrosis, prominent enhancement)\n\n# Secondary Cardiac Lymphoma \n\nPrevalence: in $16-28 \\%$ on autopsy for NHL; pericardial involvement more frequent than for primary; more common in immunocompromised patients\nSecondary cardiac involvement by lymphoma, either through direct extension or via hematogenous spread, is more common than primary cardiac lymphoma.\n\n## Primary Cardiac Lymphoma\n\n$=$ lymphoma that involves only heart $\\pm$ pericardium at time of diagnosis (extremely rare)\nMean age: 60 (range, 13-90) years\nPredisposed: immunocompromised patients, esp. AIDS\nPath: multiple firm nodules; contiguous invasion of pericardium\nHisto: typically NHL: well-differentiated B-cell lymphoma, follicular center cell lymphoma, diffuse large cell lymphoma, undifferentiated Burkitt-like lymphoma\nThe most common symptoms of cardiac lymphoma are dyspnea, congestive heart failure, pericardial effusion, hemopericardium, arrhythmias and nonspecific EKG abnormalities (AV block).\n\n- chest pain; unresponsive rapidly progressive heart failure\n- cardiac tamponade, SVC syndrome\n\nLocation: $\\mathrm{RA}>\\mathrm{RV}>\\mathrm{LV}>\\mathrm{LA}>$ atrial septum $>$ ventricular septum; $>1$ chamber ( $75 \\%$ )\nWhen infiltration beyond the myocardium occurs, the right atrium is most commonly involved, with subsequent venous extension leading to SVC / IVC thrombosis.\nA curious feature of cardiac lymphoma:\n$\\sqrt{ }$ tendency of tumor to extend along epicardial surfaces $\\rightarrow$ primarily encasing adjacent structures like coronary arteries and aortic root!\n$\\sqrt{ }$ massive pericardial effusion\nCXR:\n$\\sqrt{ }$ cardiomegaly\n$\\sqrt{ }$ signs of CHF\n$\\sqrt{ }$ massive pericardial effusion\nECHO:\n$\\sqrt{ }$ hypoechoic myocardial masses in RA / RV",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 127,
            "markdown": "![img-24.jpeg](img-24.jpeg)\n$\\sqrt{ }$ pericardial effusion\nCT:\n$\\sqrt{ }$ hypo- / isoattenuating masses relative to myocardium\n$\\sqrt{ }$ heterogeneous enhancement of masses\nMR:\n$\\sqrt{ }$ poorly marginated heterogeneous lesions of iso- to hypointensity relative to myocardium on T1WI\n$\\sqrt{ }$ heterogeneously hyperintense to myocardium on T2WI\n$\\sqrt{ }$ heterogeneous enhancement with gadolinium with areas of low enhancement in center of lesion\nDx: positive cytology in pericardial fluid (in 67\\%); exploratory thoracotomy with biopsy of cardiac tissue\nPrognosis: invariably very poor\n\n# Primary Effusion Lymphoma \n\n$=$ PEL = BODY CAVITY LYMPHOMA\nPrevalence: $4 \\%$ of all HIV-associated NHL\nAssociated with: concomitant diagnosis of Kaposi sarcoma\nHisto: unique subgroup of B-cell lymphoma with features of both high-grade anaplastic and B-cell immunoblastic lymphoma\nCXR: $\\quad \\sqrt{ }$ cardiomegaly\nCT: $\\quad \\sqrt{ }$ massive pericardial effusion\n\n## MALPOSITION OF SEPTUM PRIMUM\n\n$=$ anomalous drainage of normally connected pulmonary veins $\\leftarrow$ leftward deviation / curvature of septum primum\nAssociated with: complex congenital heart defects, heterotaxy, polysplenia\n$\\sqrt{ }$ leftward curvature of atrial septum\n$\\sqrt{ }$ anomalous drainage of right upper pulmonary vein into RA\nVariations: $\\pm$ right lower pulmonary vein $\\pm$ left pulmonary veins (in extreme degrees of",
            "images": [
                {
                    "id": "img-24.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 734,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 128,
            "markdown": "malposition)\n$\\sqrt{ } \\pm$ left heart hypoplasia $\\leftarrow$ lack of left heart filling\n$R x$ : resection + repositioning of atrial septum in a more normal position\n\n# MAY-THURNER SYNDROME \n\n$=$ ILIAC VEIN COMPRESSION SYNDROME = ILEOCAVAL COMPRESSION SYNDROME = COCKETT SYNDROME\n[Robert May (1912-1984), surgeon in Innsbruck, Austria]\n[Josef Thurner (1927-????), pathologist in Salzburg, Austria]\n$=$ obstruction of left common iliac vein caused by crossing of right common iliac artery\nPathophysiology:\n(a) extrinsic : physical entrapment with compression of left common iliac vein (CIV) by right common iliac artery against underlying vertebral body $\\rightarrow$ chronic venous stagnation $\\rightarrow$ chronic left lower extremity swelling $\\pm$ thrombosis of left iliac vein + femoral vein\n(b) intrinsic: chronic repetitive pulsatile force of the right common iliac artery $\\rightarrow$ intimal hypertrophy $\\rightarrow$ formation of endovascular spur ( $=$ intravenous web / band) in left CIV Path: spurlike projection in proximal left CIV in $22 \\%$ (autopsy), in 49-62\\% of left iliofemoral thrombosis\nRisk factors: surgery, injury, pregnancy, oral contraceptive use\nIncidence: $0.2 \\%$ annually in patients evaluated for venous thrombosis of left lower extremity\nAge: $2^{\\text {nd }}-4^{\\text {th }}$ decade; $\\mathrm{M}<\\mathrm{F}$\n\n- persistent left lower extremity swelling without obvious cause\n- exertional pain\n- varicose veins, venous eczema, hyperpigmentation\n$\\sqrt{ }$ compression of left common iliac vein on CT / venography\n$\\sqrt{ }$ tortuous pelvic venous collaterals joining contralateral veins\nPrognosis: $60 \\%$ of individuals with May-Thurner syndrome develop postthrombotic syndrome at some time during their lives\n$C x$ : deep vein thrombosis ( $\\mathrm{L} \\div \\mathrm{R}=5 \\div 1$ ), chronic venous stasis ulcer; pulmonary embolism; phlegmasia cerulea dolens\nRx: (1) Endovascular stent after catheter-directed thrombolysis ( $95 \\%$ success rate)\n(2) Surgery: vein-patch angioplasty, relocation of right common iliac artery behind vein / IVC, contralateral saphenous vein bypass graft to ipsilateral common femoral vein with creation of a temporary AV fistula (Palma crossover)\n\n\n## MEDIAN ARCUATE LIGAMENT COMPRESSION\n\n$=$ MALS $=$ CELIAC AXIS COMPRESSION SYNDROME $=$ DUNBAR SYNDROME\n$=$ dynamic compression of celiac artery ( $\\pm$ superior mesenteric artery) by median arcuate ligament $\\rightarrow$ relieved by caudal movement of celiac artery with inspiration\nCause: abnormally cephalad origin of celiac artery / abnormally low median arcuate ligament Median arcuate ligament:\narchlike fibrous band connecting diaphragmatic crura on both sides of aortic hiatus passing\n(a) usually superior to celiac axis at L1\n(b) low anteriorly over celiac axis (in $10-24 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 129,
            "markdown": "Age: $\\quad 30-84$ years; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 3$; especially young thin women\nIncidence: $50-60 \\%$ stenosis in $5-12 \\%$ of healthy adults during inspiration / in $16 \\%$ during expiration\n\n- often postprandial epigastric pain, weight loss\n- abdominal bruit with expiration\n$\\diamond$ Isolated compression of celiac axis during expiration may not be clinically significant!\nCTA, DSA, MRA:\n$\\checkmark$ focal narrowing in proximal celiac axis (more prominent in expiration $\\rightarrow$ superior movement of aorta + celiac artery\n$\\diamond$ Narrowing observed during inspiration $\\rightarrow$ likely clinically significant!\n$\\checkmark$ superior indentation of proximal celiac a. creating a CHARACTERISTIC \"hooked\" appearance (SAG plane!)\n$\\checkmark$ direct visualization of median arcuate ligament\n$\\checkmark$ poststenotic dilatation of celiac a.\n$\\checkmark$ collateral filling via SMA + pancreaticoduodenal arcades\n$\\checkmark$ absence of atherosclerotic changes in adjacent aorta and proximal celiac segment\nUS:\n$\\checkmark$ peak systolic velocity in celiac artery $\\geq 250 \\mathrm{~cm} / \\mathrm{s}(70-99 \\%$ stenosis $)$ or in SMA $\\geq 275$ $\\mathrm{cm} / \\mathrm{s}(70-99 \\%$ stenosis $)$\n$\\checkmark$ normalization of elevated velocity during deep inspiration / standing upright position\n$D x$ : lateral aortography / reformatted MDCT\n$R x$ : surgical division of median arcuate lig. ( $50 \\%$ long-term cure) $\\pm$ celiac artery stenting (does not always relieve symptoms)\n$D D x$ : fixed celiac stenosis (atherosclerosis, vasculitis)\n\n\n# MICROSCOPIC POLYANGIITIS \n\n$=$ MICROSCOPIC POLYARTERITIS = HYPERSENSITIVITY VASCULITIS = LEUKOCYTOCLASTIC VASCULITIS\n$=$ pauci-immune necrotizing small-vessel angiitis without granulomatous inflammation\nPath: necrotizing arteritis identical to polyarteritis nodosa but in vessels smaller than arteries (= arterioles, venules and capillaries)\nTrigger: drugs (eg, penicillin), microorganisms, heterologous proteins, tumor antigens\n\n- hemoptysis, hematuria, proteinuria\n- abdominal pain, GI bleeding, muscle pain + weakness\n- ANCA (antineutrophil cytoplasmic autoantibodies) in $>80 \\%$\n- negative serologic tests for hepatitis B\n\nLocation: skin, mucous membranes, lung, brain, heart, GI tract, kidney, muscle\n$\\diamond$ Most common cause of pulmonary-renal syndrome!\n@ Kidney\n$\\checkmark$ glomerulonephritis ( $90 \\%$ )\n@ Lung\n$\\checkmark$ pulmonary infiltrates $\\leftarrow$ capillaritis\n@ CNS (involved in 37-72\\%)\n$\\checkmark$ mononeuritis multiplex",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 130,
            "markdown": "$\\sqrt{ }$ cerebral hemorrhage, nonhemorrhagic cerebral infarction\n$\\sqrt{ }$ pachymeningitis\n$\\sqrt{ }$ variable degrees of small-vessel disease involving white and gray matter\n$R x:$ removal of offending agent\n\n# MITRAL REGURGITATION \n\n$=$ MITRALINSUFFICIENCY\n$=$ most common manifestation of mitral valve dysfunction of any component (mitral valve annulus, leaflets, chordae tendineae, papillary muscle)\nHemodynamics:\nduring LV systole $\\rightarrow$ backward flow of blood from LV into LA $\\rightarrow \\uparrow$ volume of blood under elevated pressure $\\rightarrow$ dilatation of LA; $\\uparrow$ increase in LV diastolic volume with little increase in LV diastolic pressure ( $=$ increase in preload without increase in afterload $=\\uparrow$ ejection fraction $+\\uparrow$ LV stroke volume)\nQuantification of Severity of Mitral Regurgitation:\n\n| Degree | Regurgitant Volume | Regurgitant Fraction |\n| :-- | :--: | :--: |\n| Mild | $\\left[\\mathrm{mL} / \\mathrm{beat}\\right]$ | $\\left[\\mathrm{Vol}_{\\text {regurg }} / \\mathrm{Vol}_{\\text {stroke }}\\right]$ |\n| Moderate | $<30$ | $<30 \\%$ |\n| Severe | $30-59$ | $30-49 \\%$ |\n\nThe severity of mitral regurgitation can be quantified with CT / MRI by calculating the regurgitant volume and regurgitant fraction!\nECHO:\n$\\sqrt{ }$ left ventricular volume overload:\n$\\sqrt{ }$ normal-sized / enlarged LV\n$\\sqrt{ }$ increased septal + posterior wall motion\n$\\sqrt{ }$ increased EF slope\n$\\sqrt{ }$ early closure of aortic valve (LV stroke volume partially lost to LA)\n$\\sqrt{ }$ left atrial enlargement (in chronic MV insufficiency)\n$\\sqrt{ }$ bulging of interatrial septum to the right during systole\n$R x:$ surgical valve repair / replacement (if LV ejection fraction $<60 \\% / \\mathrm{LV}$ end-systolic diameter $>40 \\mathrm{~mm}$ )\n\n## Acute Mitral Regurgitation\n\n## Cause:\n\n1. Spontaneous rupture of chordae tendineae\n2. Myocardial infarction $\\rightarrow$ rupture / dysfunction of papillary muscle (posteromedial $>$ anterolateral papillary muscle)\n3. Bacterial ( $=$ infectious) endocarditis with rupture of chordae tendineae / leaflet perforation\n4. Periprosthetic valve leak\n\n- markedly elevated LA pressure\n$\\sqrt{ }$ pulmonary venous hypertension with engorged pulmonary vessels and cephalization (less",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 131,
            "markdown": "than with mitral stenosis)\n$\\sqrt{ }$ symmetric interstitial / alveolar pulmonary edema:\n$\\sqrt{ }$ asymmetric right upper lobe edema $(9 \\%) \\leftarrow$ preferential flow of regurgitant jet into pulmonary vein of RUL (PATHOGNOMONIC)\n$\\sqrt{ }$ limited cardiac enlargement\n\n# Chronic Mitral Regurgitation \n\n## Cause:\n\n1. Rheumatic heart disease $\\leftarrow$ acute rheumatic fever\n(a) isolated: frequently seen in children\n(b) uncommon in adults (mostly combined with stenosis)\n2. Mitral valve prolapse syndrome\n3. Atrial myxoma\n4. Coronary artery disease $=$ ischemic cardiomyopathy $\\rightarrow$ regional wall motion abnormality, LV / annular dilatation $\\rightarrow$ functional mitral regurgitation\n5. Idiopathic hypertrophic subaortic stenosis (IHSS)\n6. Myxomatous degeneration of mitral valve: eg, Marfan syndrome, SLE\n7. Mitral annulus calcification\n8. Dilated / hypertrophic obstructive / amyloid cardiomyopathy $\\rightarrow$ severe dilatation of LV $\\rightarrow$ dilatation of mitral ring\n9. Congenital heart disease: short / abnormally inserted chordae tendineae; persistent ostium primum ASD with cleft mitral valve; corrected transposition with Ebstein-like anomaly\n$\\checkmark$ massively dilated left atrium:\n$\\checkmark$ posterior LA wall calcification (McCallum patch)\n$\\checkmark$ enlarged LA appendage (with history of previous rheumatic heart disease)\n$\\checkmark$ elevation of left mainstem bronchus\n$\\checkmark$ enlarged pulmonary arteries $\\leftarrow$ venous hypertension\n$\\checkmark$ marked LV enlargement (cardiothoracic ratio $>0.55$ )\n$\\checkmark$ left heart failure\n$\\checkmark$ mitral annular calcification (frequent)\n\n## MITRAL STENOSIS\n\n$=$ characterized by fusion of edges of anterior + posterior leaflets along commissure\nCause: rheumatic heart disease (5-15 years after initial episode of rheumatic fever); carcinoid syndrome; eosinophilic endocarditis; rheumatoid arthritis; SLE; mass obstructing LV inflow (tumor, atrial myxoma, thrombus); congenital (parachute MV, double-orifice MV)\n\nMitral stenosis caused by rheumatic disease may have distinctive morphologic features unlike those of mitral stenosis produced by other causes!\n$\\mathrm{M} \\div \\mathrm{F}=1 \\div 8$\nHemodynamics:\nincreasing transvalvular pressure gradient (with mitral valve area of $<2.5 \\mathrm{~cm}^{2}$ ) $\\rightarrow$ rise in LA + pulmonary vascular pressure throughout systole and into diastole $\\rightarrow$ compensatory dilation of LA + pulmonary venous hypertension; development of medial hypertrophy + intimal",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 132,
            "markdown": "sclerosis in pulmonary arterioles $\\rightarrow$ postcapillary pulmonary arterial hypertension; RV hypertrophy; tricuspid regurgitation; RV dilatation; right heart failure\nMay be associated with: ASD = Lutembacher syndrome (in 0.6\\%) causing L-to-R shunt\n\n- history of rheumatic fever (in 50\\%)\n- dyspnea on exertion, orthopnea, paroxysmal nocturnal dyspnea $\\leftarrow$ pulmonary hypertension; atrial fibrillation\n- systemic embolization from thrombosis of atrial appendage\n\nStages (according to degree of pulmonary venous hypertension):\nStage 1 : loss of hilar angle, redistribution\nStage 2 : interstitial edema\nStage 3 : alveolar edema\nStage 4 : hemosiderin deposits + ossification\nQuantification of Severity of Mitral Stenosis:\n\n| Degree | Valve Area in <br> Diastole $\\left[\\mathrm{cm}^{2}\\right]$ | Mean Diastolic Gradient <br> $[\\mathrm{mmHg}]$ |\n| :-- | :--: | :--: |\n| Normal | $4.0-6.0$ | 0 |\n| Mild | $1.6-3.9$ | $<5$ |\n| Moderate | $1.0-1.5$ | $5-10$ |\n| Severe | $<1.0$ | $>10$ |\n\nQuantifiable parameters of severity of mitral stenosis are planimetric valve area + mean diastolic gradient across the valve on velocity-encoded phase-contrast cine images!\n@: Left heart\n$\\sqrt{ }$ enlarged $\\mathrm{LA} \\pm$ wall calcification:\n$\\sqrt{ }$ \"double density\" seen through right upper cardiac border (AP view)\n$\\sqrt{ }$ bulge of superior posterior cardiac border below carina (lateral view)\n$\\sqrt{ }$ splaying of mainstem bronchi\n$\\sqrt{ }$ esophagus displaced toward right + posteriorly\n$\\sqrt{ }$ dilated left atrial appendage (not present with retracting clot), in $90 \\%$ associated with rheumatic heart disease\n$\\diamond$ Dilatation of left atrial appendage + calcification = rheumatic heart disease!\n$\\sqrt{ }$ calcification of valve leaflets in $60 \\%$ of severe mitral stenosis, usually $>50$ years of age (DDx: calcification of mitral annulus, calcified chronic LA thrombus)\n$\\sqrt{ }$ normal / undersized $\\mathrm{LV} \\leftarrow \\mathrm{LV}$ hypertrophy\n$\\sqrt{ }$ small aorta $\\leftarrow$ decrease of forward cardiac output\n@: Right heart\n$\\sqrt{ }$ prominent pulmonary artery segment $\\leftarrow$ precapillary pulmonary hypertension\n$\\sqrt{ }$ RV hypertrophy\n$\\sqrt{ }$ dilatation of RV $\\leftarrow$ tricuspid insufficiency / pulmonary hypertension\n$\\sqrt{ }$ increase in cardiothoracic ratio\n$\\sqrt{ }$ diminution of retrosternal clear space\n$\\sqrt{ }$ IVC pushed backward (lateral view)\n@: Lung\n$\\sqrt{ }$ pulmonary arterial enlargement $\\leftarrow$ pulmonary hypertension",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 133,
            "markdown": "$\\sqrt{ }$ pulmonary vascular cephalization $=$ redistribution of pulmonary blood flow to upper lobes ( $=$ postcapillary pressure $16-19 \\mathrm{mmHg}$ ):\n$\\sqrt{ }$ diameter of pulmonary artery $>$ corresponding bronchus\n$\\sqrt{ }$ diameter of upper lobe vessels $>$ lower lobe vessels\n$\\sqrt{ }$ interstitial pulmonary edema ( $=$ postcapillary pressure $20-25 \\mathrm{mmHg}$ )\n$D D x$ : interstitial fibrosis / deposition of hemosiderin-laden macrophages (= \"brown induration\") of chronic mitral valve stenosis\n$\\sqrt{ }$ alveolar edema ( $=$ postcapillary pressure $25-30 \\mathrm{mmHg}$ )\n![img-25.jpeg](img-25.jpeg)\n\nD $x$ : diffuse alveolar hemorrhage $=$ diffuse confluent acinar / ground-glass areas of increased opacity sparing the lung periphery (= \"window frame\" effect)\n$\\sqrt{ }$ pulmonary hemosiderosis:\n$\\sqrt{ } 1-3 \\mathrm{~mm}$ ill-defined nodules\n$\\sqrt{ }$ fine / coarse reticular areas of increased opacity with bias for middle and lower lungs\n$\\sqrt{ }$ pulmonary ossification $(3-13 \\%)=$ densely calcified $1-3-5 \\mathrm{~mm}$ nodules ( $\\pm$ trabeculae) mainly in middle and lower lungs\nECHO:\n$\\sqrt{ }$ thickening of leaflets toward free edge (fibrosis, calcification)\n$\\sqrt{ }$ flattening of EF slope $=$ MV remains open throughout diastole $\\leftarrow$ persistently high LA pressure (crude index of severity of MV stenosis)\n$\\sqrt{ }$ diastolic anterior tracking of pML in $80 \\% \\leftarrow$ diastolic anterior pull by larger + more mobile aML\n$\\sqrt{ }$ diastolic doming of MV leaflets\n$\\sqrt{ }$ commissure fusion $=$ increased echodensity + decreased leaflet motion at level of commissure\n$\\sqrt{ }$ area reduction of MV orifice: (see under Quantification) (reproducible to within $0.3 \\mathrm{~cm}^{2}$ )\n$\\sqrt{ }$ shortening + fibrosis of chordae tendineae\n$\\sqrt{ }$ abnormal septal motion = early diastolic dip of IVS due to rapid filling of RV (in severe MV stenosis)\n$\\sqrt{ }$ slowed LV filling pattern of small LV",
            "images": [
                {
                    "id": "img-25.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 550,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1097,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 134,
            "markdown": "$\\sqrt{ }$ dilatation of LA ( $>5 \\mathrm{~cm}$ increases risk of atrial fibrillation + left atrial thrombus)\n$\\sqrt{ }$ DE opening amplitude reduced to $<20 \\mathrm{~mm}$ indicating loss of valve pliability (DDx: low cardiac output state)\n$\\sqrt{ }$ absent A-wave common (atrial fibrillation)\n$\\sqrt{ }$ increase in valve gradient + pressure halftime on Doppler\n\n# Rheumatic Mitral Stenosis \n\n$\\sqrt{ }$ \"fish-mouth\" appearance of thickened valve with commissural fusion on short-axis images\n$\\sqrt{ }$ \"hockey-stick\" appearance of bowed thickened fibrotic anterior leaflet during diastole on 2- / 4-chamber images\nRx: (1) Commissurotomy / balloon valvuloplasty if valves pliable + calcium absent + MV regurgitation absent\n(2) Valve replacement for symptomatic patients with severely stenotic valves\n\nDDx: (1) Pseudomitral stenosis in decreased LV compliance (decreased EF slope, normal leaflet thickness + motion)\n(2) Rheumatic mitral insufficiency (indistinguishable findings + evidence of LV volume overload)\n(3) LA myxoma (mass behind $\\mathrm{MV}+$ in LA)\n(4) Low cardiac output (apparent small valve orifice)\n\n## Lutembacher Syndrome\n\n$=$ rheumatic mitral valve stenosis + ASD\n\n## MITRAL VALVE PROLAPSE\n\n$=\\mathrm{MVP}=$ systolic bowing of mitral leaflet $\\geq 2 \\mathrm{~mm}$ beyond annular plane into atrium\n$\\diamond$ Most common cause of nonischemic mitral regurgitation\nAt increased risk for: ventricular arrhythmia, sudden death\nPrevalence: $2-6 \\%$ of general population; $5-20 \\%$ of young women; ? autosomal dominant inheritance\nAge: commonly 14-30 years\nTerminology:\n(1) billowing leaflet $=$ bowing of leaflet body\n(2) flail leaflet $=$ prolapse of free leaflet edge\n\n## Classification:\n\n(1) MVP syndrome $=$ systolic click + mid- to late-systolic murmur and classic echocardiographic criteria\nAge: young woman\n\n- benign clinical course\n(2) Myxomatous mitral valve disease $=$ thickened redundant valve leaflets (most common cause of MVP and mitral valve surgery)\n$=$ \"Floppy mitral valve\" = elongation of cusps + chordae tendineae $\\rightarrow$ redundant valve tissue $\\rightarrow$ prolapse into LA during systole\nAge: older man\n- higher risk for complications, frequently needing repair",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 135,
            "markdown": "Path: myxomatous proliferation of middle layer of MV leaflets, surface fibrosis of MV leaflets, thinning of chordae tendineae, myxomatous annulus\nAssociated with: Barlow syndrome = straight back syndrome\n(3) Secondary MVP:\n\nAssociated with:\n(a) Connective tissue disease: Marfan syndrome (MVP in 91\\%), Ehlers-Danlos syndrome (in 6\\%)\n(b) CHD: ASD (MVP in 10\\%), coarctation of aorta (MVP in 2\\%)\n(c) Skeletal abnormalities: scoliosis, straightening of thoracic spine, narrow anteroposterior chest dimension, pectus excavatum deformity of sternum\n(d) ischemia / infarction with papillary muscle dysfunction / rupture or rupture of chordae tendineae, rheumatic mitral insufficiency, infective endocarditis, hypertrophic cardiomyopathy, primary pulmonary hypertension, tricuspid valve prolapse, ADPKD\n![img-26.jpeg](img-26.jpeg)\n\nTo decrease mortality preoperative detection of coexisting coarctation of the aorta is important in patients with mitral regurgitation!\n\n- arrhythmia, palpitation, chest pain, light-headedness, syncope\n- responsible for midsystolic click + late systolic murmur (when associated with mitral regurgitation)\nLocation: middle scallop of posterior leaflet (P2 segment)\n$\\sqrt{ }$ LA NOT enlarged (unless associated with significant mitral regurgitation)\nECHO:\n$\\checkmark$ interruption of CD line with bulge toward left atrium:\n$\\checkmark$ abrupt midsystolic posterior buckling of both leaflets (classic pattern)",
            "images": [
                {
                    "id": "img-26.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 787,
                    "bottom_right_x": 1322,
                    "bottom_right_y": 1504,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 136,
            "markdown": "$\\sqrt{ }$ \"hammocklike\" pansystolic posterior bowing of both leaflets\n$\\sqrt{ }$ multiple scallops on mitral valve leaflets (short-axis parasternal view)\n$\\sqrt{ }$ valve leaflets may appear $>5 \\mathrm{~mm}$ thick (myxomatous degeneration + valve redundancy)\n$\\sqrt{ } \\pm$ flail leaflet $=$ eversion of mitral leaflet tip into atrium during systole $(\\leftarrow$ rupture of chordae tendineae)\n$\\sqrt{ }$ mitral valve leaflets passing $>2 \\mathrm{~mm}$ posterior to plane of mitral annulus (apical 4-chamber view)\n$\\sqrt{ }$ hyperactive atrioventricular groove\n$\\sqrt{ }$ mitral annulus may be dilated $>4.7 \\mathrm{~cm}^{2}$\nCT / MR:\n$\\sqrt{ }$ leaflet thickness $>5 \\mathrm{~mm}+$ flail leaflet\n2- and 3-chamber views are preferred when assessing mitral valve prolapse!\n$D D x$ : (1) Pericardial effusion (systolic posterior displacement of MV leaflets + entire heart)\n(2) Bacterial endocarditis (mimicked by locally thickened + redundant leaflets)\n\n# MYOCARDIAL INFARCTION \n\n$=\\mathrm{MI}=$ myocardial cell death $\\leftarrow$ prolonged ischemia overwhelming cellular repair mechanisms\nCause: luminal thrombosis (frequent) superimposed on coronary atherosclerosis, coronary spasm, embolism, > arteritis, dissection, congenital abnormalities, hypercoagulable states, cocaine\n\n## Pathophysiology:\n\n$\\downarrow$ perfusion $\\rightarrow \\downarrow$ tissue oxygenation $\\rightarrow \\downarrow$ phosphocreatine $\\rightarrow$ repolarization abnormalities $\\rightarrow$ diastolic dysfunction $\\rightarrow$ systolic dysfunction $\\rightarrow \\downarrow$ adenosine triphosphate $\\rightarrow$ edema $\\rightarrow$ tissue necrosis\nTime of dysfunction: loss of contractility (at 60 sec ): loss of viability (at $20-40 \\mathrm{~min}$ )\nWavefront phenomenon:\nmyocardial ischemia $\\rightarrow$ zone of subendocardial infarction $\\rightarrow$ extension to midmyocardial zone $\\rightarrow$ transmural infarction (from subendocardial to subepicardial layers)\nSize of infarct: microscopic $<10 \\%$ of myocardium moderate $10-30 \\%$ of myocardium large $>30 \\%$ of myocardium\nIncidence: 1,500,000 annually in USA resulting in 500,000 deaths ( $50 \\%$ occur in asymptomatic individuals)\nPeak age: $40-65$ years; more severe + lethal in women\n\n- ST-segment elevation MI (STEMI)\n- atrioventricular block (common with inferior wall infarction as AV nodal branch originates from RCA); complete heart block has worse prognosis because it indicates a large area of infarction\nCXR:\n$\\sqrt{ }$ normal-sized heart ( $84-95 \\%$ ) in acute phase, if previously normal\n$\\sqrt{ }$ cardiomegaly: high incidence of congestive heart failure with anterior wall infarction, multiple myocardial infarctions, double- and triple-vessel CAD, LV aneurysm\nCECT:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 137,
            "markdown": "$\\sqrt{ }$ perfusion defect within $60-90 \\mathrm{sec}$ after bolus injection\n$\\sqrt{ }$ delayed enhancement of infarcted tissue peaking at $10-15 \\mathrm{~min}(\\leftarrow$ accumulation of iodine in ischemic cells), size of enhanced area correlates well with size of infarct\nMR:\n$\\sqrt{ }$ no change / mildly decreased SI of myocardium on T1WI (= edema of myocardium)\n$\\sqrt{ }$ high-intensity focus + wall thickening in region of acute infarction on T2WI $\\leftarrow$ myocardial edema\n$\\sqrt{ }$ LV wall thinning + decreased SI on T2WI (in remote infarction)\n$\\sqrt{ }$ increased intracavitary signal $\\leftarrow$ slow flow caused by stasis of blood adjacent to infarcted myocardium\n$\\sqrt{ }$ regional wall-motion abnormalities on cine images\n$\\sqrt{ }$ pericardial effusion ( $25 \\%$ ), possibly hemorrhagic\nCEMR:\n$\\sqrt{ }$ hyperenhancement $=$ pooling of gadolinium within region of infarction on delayed images $20-30 \\mathrm{~min}$ post injection:\n$\\sqrt{ }$ higher volume of distribution $\\leftarrow$ increased extracellular space $\\leftarrow$ myocyte death with membrane disintegration / cell rupture\n$\\sqrt{ }$ increased intracellular entry of gadolinium\n$\\sqrt{ }$ slow wash-in and washout $\\leftarrow$ capillary plugging\n$\\sqrt{ }$ highlighting of infarcted tissue with contrast using magnetic susceptibility to selectively suppress signals from normal myocardium\nDelayed-enhancement imaging is the most important technique + most accurate method for diagnosing MI or nonischemic cardiomyopathies, quantifying scar, assessing viability, and evaluating thrombus!\nCx: myocardium is prone to rupture during $3^{\\text {rd }}-14^{\\text {th }}$ day post infarction\nPrognosis: $90-95 \\%$ survival for hospital admissions\n\n# Left Ventricular Failure (60-70\\%) \n\n- \"cardiac shock\" = systolic pressure $<90 \\mathrm{mmHg}$\n$\\diamond$ Signs of pulmonary venous hypertension are a good predictor of mortality ( $>30 \\%$ if present, $<10 \\%$ if absent)\n$\\sqrt{ }$ progressive enlargement of heart\n$\\sqrt{ }$ haziness + indistinctness of pulmonary arteries\n$\\sqrt{ } \\uparrow$ size of right descending pulmonary artery $>17 \\mathrm{~mm}$\n$\\sqrt{ }$ pleural effusion\n$\\sqrt{ }$ septal lines\n$\\sqrt{ }$ perihilar $\\pm$ peripheral parenchymal clouding\n$\\sqrt{ }$ alveolar pulmonary edema\nMortality: $30-50 \\%$ with mild LV failure; $44 \\%$ with pulmonary edema; $80-100 \\%$ with cardiogenic shock; $8 \\%$ in absence of LV failure\n\nVentricular Aneurysm (in 12-15\\% of survivors of MI)\n= saccular protrusion of LV wall of mechanically weak necrotic / scarred fibrotic wall\nLocation: anterior + apical walls ( $70-85 \\%$ )\n$\\sqrt{ }$ wide-mouthed protrusion with thrombus (in 50\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 138,
            "markdown": "$\\sqrt{ }$ calcification of wall and thrombus\n$\\sqrt{ }$ akinetic / dyskinetic wall section during systole\n$\\sqrt{ }$ delayed hyperenhancement $\\leftarrow$ scarring\nCx: heart failure, ventricular arrhythmia, thromboembolism\nMyocardial Rupture (in 3-20\\% of infarcts)\nAt increased risk: first MI, female, $\\geq 60$ years, multivessel disease, transmural MI involving $20 \\%$ of wall, poor collateral supply, absence of ventricular hypertrophy, delayed initiation of thrombolytics\nPath: myocardial rupture contained by parietal pericardium + thrombus + scar tissue $=$ pseudoaneurysm (mouth smaller than actual size of aneurysmal segment) $\\rightarrow$ high risk of expansion + rupture $(30-45 \\%)$\n\n- occurs usually on $3^{\\text {rd }}-5^{\\text {th }}$ day post MI\n\nLocation: free wall $>$ septum; $\\mathrm{LV}>\\mathrm{RV}$, commonly at apex\n$\\sqrt{ }$ enlargement of heart (slow leakage of blood into pericardium)\nCEMR (delayed-enhancement MRI):\n$\\sqrt{ }$ loss of continuity of myocardium with irregular margins\n$\\sqrt{ }$ pericardial enhancement\n$\\sqrt{ }$ dyskinetic section during systole + diastole\nPrognosis: cause of death in $13 \\%$ of all infarctions; mortality almost $100 \\%$\n$D D x$ : true aneurysm (mouth larger than size of aneurysmal segment; dyskinetic wall section during systole only)\n\n# Rupture of Papillary Muscle (1\\%) \n\nCause: infarction of posteromedial papillary muscle in inferior MI (common) / anterolateral papillary muscle in anterolateral MI (uncommon)\n\n- sudden onset of massive mitral insufficiency\n- unresponsive to medical management\n$\\sqrt{ }$ abrupt onset of severe persistent pulmonary edema\n$\\sqrt{ }$ asymmetric PVH in right upper lobe\n$\\sqrt{ }$ minimal LV enlargement / normal-sized heart\n$\\sqrt{ }$ NO dilatation of $\\mathrm{LA} \\leftarrow$ immediate decompression into pulmonary veins\nPrognosis: $70 \\%(80-90 \\%)$ mortality within 24 hours ( 2 weeks)\n\n\n## Rupture of Interventricular Septum (0.5-2\\%)\n\n$=$ VENTRICULAR SEPTAL RUPTURE\n\n- occurs usually within 2-21 days with rapid onset of L-to-R shunt\n- Swan-Ganz catheterization: increase in oxygen content of RV, capillary wedge pressure may be within normal limits\nLocation: typically at apex\n$\\sqrt{ }$ right-sided cardiac enlargement\n$\\sqrt{ }$ engorgement of pulmonary vasculature:\n$\\sqrt{ }$ asymmetric PVH of right upper lobe\n$\\sqrt{ }$ NO pulmonary edema (DDx to ruptured papillary muscle)\nPrognosis: $24 \\%$ mortality within 24 hours; $87 \\%$ mortality ( $>90 \\%$ ) within 2 months (1 year)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 139,
            "markdown": "Rx: emergency surgery (VSD patch repair + coronary artery bypass grafting)\n\n# Dressler Syndrome (3-4\\%) \n\n$=$ POSTMYOCARDIAL INFARCTION SYNDROME = LATE PERICARDITIS\nEtiology: autoimmune reaction to myocardial infarction\nOnset: 2-3 weeks (range 1 week-several months) following infarction\n\n- relapses occur as late as 2 years after initial episode\n- pleuritic chest pain, fever\n$\\checkmark$ thickening of pericardium\n$\\checkmark$ pericardial effusion\n$\\checkmark$ pleural effusion\n$\\checkmark$ pneumonitis\n\n\n## Right Ventricular Infarction\n\n$\\diamond$ RV involved in $33 \\%$ of left inferior myocardial infarction\n$\\checkmark$ decreased RV ejection fraction\n$\\checkmark$ accumulation of ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-pyrophosphate\nPrognosis: in $50 \\%$ RV ejection fraction returns to normal within 10 days\nCx: (1) Cardiogenic shock (unusual)\n(2) Elevation of RA pressure\n(3) Decrease of pulmonary artery pressure",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 140,
            "markdown": "# MYOCARDITIS \n\n$=$ acute / chronic inflammation of the myocardium\nCause:\n\n1. Infection: viral (Coxsackie B, other enteroviruses, herpesvirus, adenovirus, parvovirus B19, Epstein-Barr virus); bacterial (diphtheria, Streptococcus); parasitic (Trypanosoma cruzi)\n2. Autoimmune process\n3. Cardiotoxic drugs: anthracyclines, trastuzumab, catecholamines, chemotherapy\n4. Hypersensitivity reaction\n5. Myocardial infarction / mechanical injury / radiation Rx\n\nHisto: lymphocytic infiltration associated with myocyte injury in the absence of ischemia\n\n- usually asymptomatic; acute chest pain\n- atrial / ventricular arrhythmias\n- rapid recent onset of heart failure\n- cardiogenic shock, sudden cardiac death ( $12 \\%$ )\n- CK-MB (creatine kinase - myocardial b fraction specific for heart muscle) with high specificity but limited sensitivity\n- troponin I more often elevated than CK-MB\n\nSequela: dilated cardiomyopathy (in up to 10\\%)\nEchocardiography (low sensitivity):\n$\\sqrt{ }$ normal heart function or global / regional LV hypokinesis\nMR:\n$\\sqrt{ }$ patchy diffuse / nodular hyperenhancement in nonvascular distribution up to 4 weeks after infection $\\leftarrow$ inflammation and cell necrosis\nLocation: inferior and inferolateral myocardial segments\nSite: subepicardial / midmyocardial\n$\\sqrt{ }$ increased T2 signal\n$\\sqrt{ }$ wall motion abnormalities in affected regions\nBenefit: biopsy guidance to areas of higher pathologic yield\nPET/CT:\n$\\sqrt{ }$ increased metabolic activity in myocardium $\\leftarrow$ microvascular + myocyte damage + changes in fatty-acid metabolism\n$D x$ : endomyocardial biopsy\n\n## MYXOMA\n\n$=$ most common benign primary cardiac tumor (true neoplasm) in adults; $40-50 \\%$ of all cardiac tumors\nMean age: 50 (range, 11-82) years; $90 \\%$ of patients are between ages 30 and 60 years; $\\mathrm{M}+\\mathrm{F}=$ $1 \\div 1.7$ to $1 \\div 4$\nEtiology: ? overgrowth of trapped embryologic rest\nClassification: sporadic type (most frequent); familial type (mean age of 24 years); complex type $=$ Carney syndrome\nPath: (a) papillary / villous pedunculated friable gelatinous tumor",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 141,
            "markdown": "(b) round / ovoid lobular smooth sessile tumor (25\\%) with firm surface\n$\\diamond$ No infiltration of underlying tissues!\nHisto: composed of myxoma cells (= ovoid nucleus with large / inconspicuous nucleoli + abundant eosinophilic cytoplasm) forming rings / syncytia / cords; hypocellular amorphous acid mucopolysaccharide matrix in areas without fibrosis; hemorrhage and hemosiderin; fibrosis, calcifications (56\\%); covered by a mono-layer of endothelial cells (= endocardial tumor)\nMean size: 5.7 (range, $0.6-12.0) \\mathrm{cm}$\n\n- short history + rapid progression; dyspnea, chest pain\n- constitutional symptoms ( $30 \\%$ ):\n- fever, malaise, weight loss, myalgia, arthralgia, lethargy\n- leukocytosis, anemia, elevated ESR, petechiae\n- hypergammaglobulinemia\n\nCause: ? autoimmune phenomenon\n\n- positional symptoms (ie, change with position) due to hemodynamic obstruction:\n- arrhythmia (20\\%), heart murmur\n- congestive heart failure (valve obstruction); syncope\n- embolization ( $30-40 \\%$ ) to CNS, coronary artery, aorta, kidney, spleen, extremities, pulmonary artery $\\leftarrow$ tumor fragments / accumulated thrombus\nLocation: LA (75-80\\%); RA (10-20\\%); ventricle (5\\%); biatrial $\\leftarrow$ growth through fossa ovalis Site: attached to interatrial septum by small stalk adjacent to or in fossa ovalis (75\\%) / to wall of cardiac chambers / to valve surfaces; may protrude into ventricle causing partial obstruction of atrioventricular valve\n$\\checkmark$ small myxomas produce no CXR findings\n$\\checkmark$ cardiomegaly\n$\\checkmark$ atrial obstruction (mimicking valvular stenosis)\n$\\checkmark$ persistent defect in atrium / diastolic defect in ventricle\nA. LEFT ATRIAL MYXOMA ( $75-80 \\%$ ) with obstruction of mitral valve:\n$\\checkmark$ pulmonary venous hypertension:\n$\\checkmark$ pulmonary vascular redistribution\n$\\checkmark$ interstitial pulmonary edema\n$\\checkmark$ enlargement of LA\n$\\checkmark$ NO enlargement of atrial appendage\n$\\checkmark$ ossific lung nodules\nCx: systemic emboli (27\\%) in 50\\% to CNS (= stroke / \"mycotic\" aneurysm) $\\leftarrow$ thrombotic nature of mass\nB. RIGHT ATRIAL MYXOMA (10-20\\%) with obstruction of tricuspid valve:\n- peripheral edema, hepatic congestion, ascites $\\leftarrow$ potential obstruction of systemic venous return\n$\\checkmark$ tumor calcification: $\\mathrm{R}>\\mathrm{L}$\n$\\checkmark$ enlargement of RA\n$\\checkmark$ prominent SVC, IVC, azygos vein\n$\\checkmark$ decreased pulmonary vascularity\n$\\checkmark$ pleural effusion (occasionally)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 142,
            "markdown": "Cx: pulmonary emboli $\\leftarrow$ thrombotic nature of mass\nECHO: (2D-ECHO is study of choice)\n$\\sqrt{ }$ tumor attached by narrow stalk $\\rightarrow$ transvalvular prolapse (DDx to thrombus)\n$\\checkmark$ tumor mobility:\n$\\checkmark$ prolapse across AV valve during diastole\n$\\checkmark$ tumor distensibility\n$\\checkmark$ hyperechoic spherical mass:\n$\\checkmark$ internal hypoechoic areas (= hemorrhage, necrosis)\n$\\checkmark$ speckled echogenic foci (= calcifications)\n$\\checkmark$ frondlike surface projections\nDoppler:\n$\\checkmark$ valvular regurgitation\nM-mode findings of only historical interest:\n$\\checkmark$ dense echoes appearing posterior to aML soon after onset of diastole\n$\\checkmark$ pML obscured\n$\\checkmark$ tumor echoes can be traced into LA\n$\\checkmark$ dilated LA\n$\\checkmark$ reduced E-F slope\nCT:\n$\\checkmark$ well-defined spherical / ovoid intraluminal filling defect\n$\\checkmark$ lobular / smooth surface contour\n$\\checkmark$ tumor attenuation lower than unopacified blood $\\leftarrow$ gelatinous component\n$\\checkmark$ heterogeneous texture $\\leftarrow$ hemorrhage, necrosis, cyst formation, fibrosis, calcification ( $16 \\%$ ), ossification\nMR:\n$\\checkmark$ heterogeneous signal intensity:\n$\\checkmark$ iso- / hypointense on T1WI relative to myocardium\n$\\checkmark$ hyperintense areas on T1WI $\\leftarrow$ older hemorrhage\n$\\checkmark$ (nearly always) markedly hyperintense on T2WI $\\leftarrow$ myxomatous tissue\n$\\checkmark$ areas of decreased SI $\\leftarrow$ calcifications, hemosiderin deposits, fibrous tissue\n$\\checkmark$ heterogeneous contrast enhancement:\n$\\checkmark$ increased SI $\\leftarrow$ vascularity and inflammation\n$\\checkmark$ decreased SI $\\leftarrow$ necrotic areas\n$\\checkmark$ CHARACTERISTIC mobility $\\pm$ prolapse through AV valve (best seen on 4-chamber horizontal long-axis cine MRI) $\\leftarrow$ suspended by narrow stalk\nPET:\n$\\checkmark$ very low-grade / no significant FDG activity\n$R x$ : urgent surgical excision $\\pm$ valvuloplasty / valve replacement\nCx: malignant transformation (exceedingly rare)\nPrognosis: 5-14\\% recurrence rate (multifocal myxomas); isolated cases of metastatic disease\n$D D x$ : (1) Thrombus (more likely in posterior location in LA and LV, NO contrast enhancement, NO transvalvular prolapse)\n(2) Papillary fibroelastoma (also arises from narrow stalk, much smaller, different SI characteristics)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 143,
            "markdown": "(3) Other cardiac tumors: sarcoma, malignant mesenchymoma, metastasis\n\n# Carney Complex \n\n$=$ CARNEY SYNDROME $=$ COMPLEX MYOMA\n[J. Aidan Carney (-), pathologist at Mayo Clinic, Rochester, Minnesota]\n$=$ autosomal-dominant inherited syndromic disorder\nPrevalence: 7\\% of all myxomas; 150 patients identified since 1985 worldwide\nAge: younger than patients with sporadic myxoma\n\n- endocrine overactivity:\n- Cushing syndrome; sexual precocity; acromegaly\n(a) Cardiac myxomas: multifocal ( $66 \\%$ ), outside left atrium, recurring at an increased rate after resection\n(b) Hyperpigmented skin lesions: lentigines, ephelides, blue nevi\n(c) Extracardiac tumors:\n\n1. Pituitary adenoma\n2. Myxoid fibroadenoma of the breast\n3. Psammomatous melanotic schwannoma\n4. Testicular tumor: large-cell calcifying Sertoli cell tumor\n5. Primary pigmented nodular adrenocortical hyperplasia\nN.B.: not related to Carney triad (pulmonary hamartomas, extraadrenal paragangliomas, gastric leiomyosarcoma)\n\n## NUTCRACKER PHENOMENON\n\n$=$ RENAL VEIN ENTRAPMENT SYNDROME\n$=$ entrapment of left renal vein (LRV) between SMA and aorta (= anterior nutcracker) / between aorta and underlying vertebral body in retroaortic LRV (posterior nutcracker)\nAnterior nutcracker syndrome may occur simultaneously with SMA syndrome. Both are associated with a thin / asthenic body habitus, rapid weight loss, and loss of retroperitoneal fat.\nPrevalence: rare (unknown);\n$\\diamond$ Insignificant anatomic compression is present in $72 \\%$ of the general population!\nNormal anatomy:\nSMA arises from aorta at L1-2 forming an aortomesenteric angle (AMA) of $28-65^{\\circ}$; duodenum is cushioned by retroperitoneal fat in mesenteric root maintaining an aortomesenteric space / diameter (AMD) of $10-34 \\mathrm{~mm}$\nPathophysiology:\nsqueezed left renal vein $\\rightarrow$ increased venous pressure $\\rightarrow$ intra- and extrarenal hypertensive valveless venous collaterals\n(a) $\\rightarrow$ increased capillary pressure $\\rightarrow$ hematuria\n(b) $\\rightarrow$ reflux into left gonadal vein\n» female: ovarian vein $\\rightarrow$ congestion in ovarian and parametrial venous plexus $=$ pelvic congestion syndrome (vulvar + pelvic + thigh varices, postcoital ache, pelvic pain, dysmenorrhea, dyspareunia)\n» male: testicular vein $\\rightarrow$ left-sided varicocele\nPathogenesis: steep angulation of SMA relative to aorta can predispose to nutcracker",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 144,
            "markdown": "syndrome $\\rightarrow$ simultaneous SMA syndrome\nAge: $3^{\\text {rd }}-4^{\\text {th }}$ decade; $\\mathrm{M}<\\mathrm{F}$\n\n- intermittent asymptomatic mild microhematuria\n- severe gross hematuria $\\rightarrow$ passage of ureteral blood clots $\\rightarrow$ left flank pain\n- mild to severe orthostatic proteinuria\n$\\sqrt{ }$ compression of left renal vein + prestenotic dilatation\n$\\sqrt{ }$ reflux into dilated adrenal + gonadal veins\n$\\sqrt{ }$ hilar + periureteric + perirenal + pelvic venous collaterals\n$\\sqrt{ }$ decreased aortomesenteric space (AMD) of 3 mm\n$\\sqrt{ }$ decreased aortomesenteric angle (AMA) of $<16^{\\circ}$\nUS:\n$\\sqrt{ }$ venous flow velocity of $>100 \\mathrm{~cm} / \\mathrm{s}(78 \\%$ sensitive, $100 \\%$ specific)\n$\\sqrt{ }$ peak systolic velocity ratio of $>4.7$ at point of renal vein compression compared to hilar renal vein ( $100 \\%$ sensitive, $90 \\%$ specific)\nIVP:\n$\\sqrt{ }$ indentations / scalloping of renal pelvis / ureter $\\leftarrow$ enlarged retroperitoneal varices\nRetrograde venography:\n$\\sqrt{ }$ renal venous-caval pressure gradient $>3 \\mathrm{mmHg}$ (less than 1 mmHg in healthy subjects)\nRx: (1) Expectant: hyperalimentation in thin patient $<18$ years\n(2) Surgery (in severe cases): renal vein transposition, venous stent placement, left nephrectomy, renal autotransplantation to iliac fossa\n\n\n# PAPILLARY FIBROELASTOMA \n\n$=$ FIBROELASTIC PAPILLOMA $=$ PAPILLOMA / MYXOMA / FIBROMA OF VALVES $=$ GIANT LAMBL EXCRESCENCE\n$=$ MYXOFIBROMA $=$ HYALINE FIBROMA\n$=$ rare benign excrescence predominantly affecting surface of cardiac valves\nPrevalence: $25 \\%$ of all cardiac valvular tumors (most common valvular tumor); $10 \\%$ of all primary cardiac tumors ( $2^{\\text {nd }}$ most common primary benign cardiac neoplasm after myxoma + similar to lipoma)\nPeak age: $7^{\\text {th }}$ and $8^{\\text {th }}$ decade; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$\nCause: ? reactive process, ? hamartoma\nPath: gelatinous mass with \"sea anemone\" appearance $\\leftarrow$ multiple delicate branching papillary fronds attached to endocardium by short thin pedicle\nHisto: avascular papilloma = avascular connective tissue composed of fibrous core + lined by a single layer of endothelium; scattered smooth muscle cells within papillary projections\n\n- mostly asymptomatic (incidental finding at autopsy, surgery, echocardiography, cardiac catheterization)\n- chest pain, dyspnea, embolic events (TIA / stroke from thrombi collecting on tumor)\n- No valvular dysfunction $\\leftarrow$ away from free edge of valve\n\nLocation: cardiac valves $(>90 \\%)$ : aortic $(29 \\%)>$ mitral $(25 \\%)>$ tricuspid $(17 \\%)>$ pulmonary valve $(13 \\%)$\nSite: NOT at free edge of valve\n(a) AV valve: nonvalvular endocardial surface of atrium (frequently) / ventricle (16\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 145,
            "markdown": "(b) semilunar valve: nonvalvular endocardial surface of aorta\n\nSize: usually $<1.0-1.5 \\mathrm{~cm}$ in diameter (may be as large as 5 cm )\nECHO:\n$\\sqrt{ }$ homogeneous mobile pedunculated mass:\n$\\sqrt{ }$ elongated strandlike projection / well-defined head\n$\\sqrt{ }$ CHARACTERISTIC stippled edge with a \"shimmer / vibration\" at interface between tumor and surrounding blood (DDx: amorphous thrombus)\n$\\sqrt{ }$ flutters / prolapses with cardiac motion\n$\\sqrt{ }$ turbulent blood flow\nCT:\n$\\sqrt{ }$ slightly hypoattenuating mass\nMR: difficult to visualize on static fast SE images\n$\\sqrt{ }$ intermediate SI / hypointense compared to myocardium\n$\\sqrt{ }$ mobile mass (on cine gradient-echo images)\n$R x$ : surgical excision $\\pm$ leaflet repair / valve replacement\n$D D x$ : vegetation (destruction of valvular leaflets, valvular incompetence, fever, murmur, embolic events, small vessel vasculitis); thrombus; myxoma (slightly larger)\n\n# PATENT DUCTUS ARTERIOSUS \n\n$=\\mathrm{PDA}=$ persistence of left $6^{\\text {th }}$ aortic arch permeable $\\geq 3$ months after birth $=\\mathrm{L}$-to-R shunt\nPrevalence: 9 (range, 5-10)\\% of all CHD; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 2$; in $1 \\div 2,000$ full-term infants, higher in prematurity\nCause: failure of immature ductus arteriosus to close $\\leftarrow$ persistent postnatal hypoxia + failure of ductus contraction\nAssociated with:\nprematurity, birth asphyxia, high-altitude birth, maternal rubella syndrome, VSD, coarctation, trisomy $18+21,4$ p syndrome, single gene mutation (Carpenter syndrome, Holt-Oram syndrome), X-linked mutations (incontinentia pigmenti)\nMorphologic types (useful to select closure device):\nA. (conical): $\\sqrt{ }$ ampulla at aortic end (most common type)\nB. (window): $\\sqrt{ }$ ductus narrows at aortic end\nC. (tubular): $\\sqrt{ }$ NO narrowing / constrictions\nD. (complex): $\\sqrt{ }$ ductus with multiple constrictions\nE. (elongated): $\\sqrt{ }$ bizarre configuration; constriction away from pulmonary artery end\n\nHemodynamics of PDA:\nincreased volume of blood flows from aorta $\\rightarrow$ through PDA $\\rightarrow$ pulmonary artery $\\rightarrow$ lungs $\\rightarrow$ left side of heart\n![img-27.jpeg](img-27.jpeg)\n\n- mostly asymptomatic; continuous murmur\n- congestive heart failure (rare), usually by 3 months of age if L-to-R shunt large",
            "images": [
                {
                    "id": "img-27.jpeg",
                    "top_left_x": 499,
                    "top_left_y": 1718,
                    "bottom_right_x": 1201,
                    "bottom_right_y": 1892,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 146,
            "markdown": "- bounding peripheral pulses $\\leftarrow$ intraaortic pressure runoff through PDA\n\nCXR (mimics VSD):\n$\\sqrt{ }$ enlarged pulmonary artery segment\n$\\sqrt{ }$ increase of pulmonary vasculature; less flow directed to LUL\n$\\sqrt{ } \\uparrow$ ascending aorta + aortic arch (thymus may obscure this)\n$\\sqrt{ }$ LA + LV enlargement\n$\\sqrt{ }$ enlarged RV (only with pulmonary hypertension)\n$\\sqrt{ }$ prominent ductus infundibulum (diverticulum)\n$=$ prominence between aortic knob + pulmonary a. segment\n$\\sqrt{ }$ obscured aortopulmonary window\n$\\sqrt{ }$ \"railroad track\" = calcified ductus arteriosus\nECHO:\n$\\sqrt{ }$ LA+Ao ratio $\\geq 1.2 \\div 1$ (signalizes significant L-to-R shunt)\nAngio:\n$\\sqrt{ }$ catheter course from RA to RV, main pulmonary artery, PDA, descending aorta\n$\\sqrt{ }$ communication from aorta (distal to left subclavian artery) $\\rightarrow$ left pulmonary artery (on AP / LAT / LAO aortogram)\n\n# PDA in Premature Infant \n\npremature infant not subject to medial muscular hypertrophy of small pulmonary artery branches (which occurs in normal infants subsequent to progressive hypoxia in 3rd trimester)\n\n- CHF\n\nCause:\n(a) pulmonary artery pressure remains low without opposing any L-to-R shunts (PDA / VSD)\n(b) ductus arteriosus remains open $\\leftarrow$ hypoxia in RDS\n$\\sqrt{ }$ recurrence of alveolar airspace filling after resolution of RDS\n$\\sqrt{ }$ granular pattern of hyaline membrane disease becomes more opaque\n$\\sqrt{ }$ enlargement of heart (masked by positive pressure ventilation)\n$R x$ :\n(a) Medical therapy:\n(1) Supportive oxygen, diuretics, digitalis\n(2) Avoid fluid overload (NOT to increase shunt volume)\n(3) Antiprostaglandins = indomethacin opposes prostaglandins, which are potent duct dilators\n(b) Surgical ligation\n\n## Beneficial PDA\n\n$=$ compensatory effect of PDA (= decreasing shunt volume) in:\n\n1. Tetralogy of Fallot\ncyanosis usually occurs during closure of duct shortly after birth\n2. Eisenmenger pulmonary hypertension\n\nPDA acts as escape valve shunting blood to descending aorta\n3. Interrupted aortic arch\nsupply of lower extremity via PDA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 147,
            "markdown": "# Nonbeneficial PDA \n\nin L-to-R shunts (VSD, aortopulmonic window) a PDA increases shunt volume\n\n## PENETRATING AORTIC ULCER\n\n$=$ PENETRATING ATHEROSCLEROTIC ULCER OF THE AORTA\n$=\\mathrm{PAU}=$ atherosclerotic ulcer that penetrates deep through intima and internal elastic lamina into media rendering the aortic wall unstable $\\leftarrow$ complication of aortic atherosclerosis\nPrevalence: uncommon\nCause: new intimal disruption\nAge: elderly with hypertension, hyperlipidemia and severe atherosclerosis; $\\mathrm{M} \\div \\mathrm{F}=4 \\div 1$\n\n- often asymptomatic\n- chest pain that may radiate to back (29\\%) without pulse difference, aortic regurgitation, CNS symptoms\n- occasional distal ischemia $\\leftarrow$ embolic event\n\nLocation: middle / distal $1 / 3$ of descending thoracic aorta ( $70 \\%$ ); abdominal aorta ( $30 \\%$ )\n$\\sqrt{ }$ localized contrast-medium filled pouch widely communicating with true lumen\n$\\checkmark$ extensive atherosclerotic disease + ectasia\n$\\checkmark$ lack of compression of the aortic lumen\n$\\checkmark$ intramural hematoma (thoracic $>>$ abdominal aorta)\n$\\sqrt{ }$ NO intimal flap\nCECT:\n$\\checkmark$ focally ulcerated plaque\n$\\checkmark$ adjacent subintimal hematoma (DDx from intraluminal thrombus / atherosclerotic plaque not possible):\n$\\checkmark$ inward displacement of calcified intima (common)\n$\\checkmark$ thickening / enhancement of adjacent aortic wall\nMR (valuable for patients in renal failure):\n$\\checkmark$ focal excavation of aortic wall\n$\\checkmark$ subacute hematoma in aortic wall of high SI on T1WI + T2WI (methemoglobin) either localized or mimicking type 3 dissection\nAngio:\n$\\checkmark$ ulcerated atherosclerotic plaque\n$\\checkmark$ aortic wall thickening\nCx:\n(1) Ulcer expansion\n(2) Aortic dissection $(7 \\%) \\leftarrow$ intramural hemorrhage:\n(a) localized / extensive\n(b) communicating \"double-barreled\" / thrombosed\n(3) Saccular / fusiform aortic aneurysm ( $30 \\%$ ) $\\leftarrow$ stretching of aortic wall\n(4) Aortic rupture ( $40 \\%$ )\n\nPrognosis: poor and negatively modified by diameter of abdominal aorta, bidimensional size of ulcer, severity of intimal calcification\nRx: (1) Antihypertensive medication, analgesics\n(2) Excision of ulcer + aortic interposition graft (for recurrent symptoms /",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 148,
            "markdown": "pseudoaneurysm formation)\n$D D x$ : (1) Aortic dissection (intimal flap, patent false lumen)\n(2) Atheroma / chronic intramural thrombus (low SI on T1WI + T2WI)\n(3) Intramural blood pool\n\n# PERICARDIAL CYST \n\nEtiology:\n(a) defect in embryogenesis of celomic cavities\n(b) sequelae of pericarditis\n\nFrequency: $1 \\div 100000 ; 13-17 \\%$ of all mediastinal cysts\n$\\diamond$ Most common congenital cystic mediastinal lesion\nHisto: benign unilocular lesion composed of connective tissue + lined by single layer of mesothelial cells\nAge: $30-40$ years; $\\mathrm{M} \\div \\mathrm{F}=3 \\div 2$\n\n- asymptomatic $(50 \\%)$\n- chest pain (severe if torsed), dyspnea, cough (in $<1 / 3$ )\n\nLocation: $90 \\%$ of pericardial cysts contact diaphragm $\\pm$ extension into major fissure; $\\mathrm{R} \\div \\mathrm{L}=$ $3 \\div 1$ to $3 \\div 2$\n(a) right cardiophrenic angle $(65 \\%)$\n(b) left cardiophrenic angle $(25 \\%)$\n(c) mediastinum $(10 \\%)$\n\nCT:\n$\\sqrt{ }$ well-defined nonenhancing homogeneous lesion of water attenuation values ( $20-40 \\mathrm{HU}$ )\n$\\sqrt{ }$ no internal septa / nodules\n$\\sqrt{ } \\pm$ proteinaceous fluid of intermediate attenuation\n$\\sqrt{ } \\pm$ hemorrhagic content of increased attenuation\n$\\sqrt{ }$ encapsulated round / ovoid triangular mass usually $3-8 \\mathrm{~cm}$ (range, $1-28 \\mathrm{~cm}$ ) in diameter:\n$\\sqrt{ }$ change in location $=$ pedunculated migrating cyst\n$\\sqrt{ }$ change in shape with change in location $\\leftarrow$ compressible\nMRI:\n$\\sqrt{ }$ intermediate to low signal intensity on T1WI\n$\\sqrt{ }$ high signal intensity on T2WI\n$\\sqrt{ }$ proteinaceous cyst:\n$\\sqrt{ }$ high SI on T1WI\n$\\sqrt{ }$ intermediate to low signal intensity on T2WI\n$\\sqrt{ }$ no restricted diffusion on DWI + high signal on ADC map\n$\\sqrt{ }$ hemorrhagic cyst:\n$\\sqrt{ }$ high SI on T1WI\n$\\sqrt{ }$ susceptibility on GRE\n$R x$ : surgical resection / percutaneous drainage if\n(a) individual symptomatic (b) complication present\n(c) diagnosis uncertain (d) pathology needed\n$D D x$ : congenital cyst (thymic, bronchogenic, neurenteric, duplication cyst); cystic tumor",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 149,
            "markdown": "# Pericardial Diverticulum \n\n$=$ focal outpouching of pericardial sac\n$\\sqrt{ }$ direct communication with pericardial cavity\n$\\sqrt{ }$ change in size + shape with respiration / body position\n\n## PERICARDIAL DEFECT\n\n$=$ CONGENITAL ABSENCE OF PERICARDIUM\n$=$ failure of pericardial development $\\leftarrow$ premature atrophy of left duct of Cuvier (cardinal vein), which fails to nourish the left pleuropericardial membrane during embryogenesis\nFrequency: $1 \\div 13,000 ; \\mathrm{M} \\div \\mathrm{F}=3 \\div 1$\nMean age at detection: 21 years (range, newborn to 81 years)\nLocation:\nA. PARTIAL ABSENCE $(91 \\%)$\n(a) complete absence on left side $35 \\%$\n(b) foraminal defect on left side $35 \\%$\n(c) diaphragmatic pericardial aplasia $17 \\%$\n(d) foraminal defect on right side $4 \\%$\nB. TOTAL BILATERAL ABSENCE $(9 \\%)$\n\nIn $30 \\%$ associated with:\n(1) Bronchogenic cyst (30\\%)\n(2) VSD, PDA, mitral stenosis\n(3) Diaphragmatic hernia, sequestration\n\n- mostly asymptomatic\n- symptoms $\\leftarrow$ entrapment / incarceration of cardiac structures:\n- palpitations, tachycardia, dyspnea, dizziness, syncope\n- positional discomfort while lying on left side\n- nonspecific intermittent chest pain: lack of pericardial cushioning, torsion of great vessels, tension on pleuro-pericardial adhesions, pressure on coronary arteries by rim of pericardial defect\n- ECG: right axis deviation, right bundle branch block\n$\\checkmark$ variations in size:\n> small foraminal defect $=$ no abnormality\n> large defect $\\quad=$ herniation of cardiac structures / lung\n> complete absence $=$ levoposition of heart\n$\\sqrt{ }$ absence of left pericardial fat-pad\n$\\sqrt{ }$ levoposition of heart + aortic knob with lack of visualization of right heart border while trachea remains at midline\n$\\checkmark$ prominence / focal bulge in the area of RVOT, main pulmonary artery, left atrial appendage\n$\\checkmark$ sharp margination + elongation of left heart border\n$\\checkmark$ insinuation of lung between heart + left hemidiaphragm\n$\\checkmark$ insinuation of lung between aortic knob + pulmonary artery\n$\\checkmark$ increased distance between heart + sternum $\\leftarrow$ absence of sternopericardial ligament (crosstable lateral projection)\n$\\checkmark$ pneumopericardium following pneumothorax",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 150,
            "markdown": "$\\sqrt{ }$ NO tracheal deviation\n$\\mathrm{CT}+\\mathrm{MR}$ :\n$\\sqrt{ }$ excessive levorotation + displacement of heart\n$\\sqrt{ }$ cardiac indentation at location of defect\n$\\diamond$ Direct visualization of left pericardium NOT possible!\n$C x:$ cardiac strangulation\n$R x:$ foraminal defect requires surgery because of\n(a) herniation + strangulation of left atrial appendage $\\rightarrow$ infarction of appendage\n(b) herniation of LA / LV\n(c) compression of left coronary artery especially during exercise $\\rightarrow$ cardiac ischemia\n(1) Closure of defect with pleural flap\n(2) Resection of pericardium\n\n# PERICARDIAL MESOTHELIOMA \n\n$=$ PRIMARY MALIGNANT PERICARDIAL MESOTHELIOMA\n$=$ malignant primary neoplasm arising from mesothelial cells of the pericardium\nPrevalence: $0.0022 \\%$ at autopsy; $<1 \\%$ of all mesotheliomas; $50 \\%$ of all primary pericardial tumors\n$\\diamond$ Most common primary malignancy of pericardium!\nMean age: 46 (range, $2-78$ ) years; $\\mathrm{M}+\\mathrm{F}=2+1$\nPath: multiple coalescing pericardial masses with obliteration of pericardial space; myocardial invasion is rare\nHisto: epithelial $>$ biphasic (mixed) $>$ fibrous (spindle cell); biphasic tumor composed of epithelial areas forming tubulopapillary structures (resembling carcinoma) and spindled areas (resembling sarcoma)\n\n- chest pain, cough, dyspnea, palpitations\n- signs of constrictive pericarditis, cardiac tamponade\n- conduction abnormalities $\\leftarrow$ myocardial infiltration\n\nCXR:\n$\\sqrt{ }$ cardiac enlargement with irregular contour\n$\\sqrt{ }$ diffuse mediastinal enlargement\nCT / MR:\n$\\sqrt{ }$ irregular diffuse pericardial thickening / cardiac encasement by soft-tissue masses\n$\\sqrt{ } \\pm$ invasion of adjacent vascular + anatomic structures\n$\\sqrt{ }$ pericardial effusion\n$\\sqrt{ }$ heterogeneous enhancement with involvement of parietal + visceral layers of pericardium PET:\n$\\sqrt{ }$ hypermetabolic activity\n$D x:$ pericardiocentesis $\\rightarrow$ hemorrhagic fluid, malignant cells (in only 20\\%)\n$R x:$ palliative surgery + radiation therapy\nPrognosis: 6 weeks - 15 months survival, regardless of therapy\n\n## PERICARDIAL TERATOMA\n\n$=$ benign germ cell neoplasm",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 151,
            "markdown": "Age: infants + children\nHisto: derivatives of all 3 germ cell layers (neuroglia, cartilage, skeletal muscle, liver, intestine, pancreas, glandular tissue)\nLocation: within pericardial sac connected to a great vessel via a pedicle; intramyocardial (rare)\n\n- respiratory distress, cyanosis $\\leftarrow$ pericardial tamponade + compression of SVC, RA, aortic root, PA\nCXR:\n$\\checkmark$ enlarged cardiomediastinal silhouette\n$\\checkmark$ formed calcified teeth\nUS:\n$\\checkmark$ intrapericardial heterogeneous complex multilocular cystic mass:\n$\\checkmark$ intrinsic echogenic foci (= calcifications)\n$\\checkmark$ pericardial effusion\n$\\checkmark$ fetal hydrops (ascites, pleural effusion, subcutaneous edema, polyhydramnios)\nMR:\n$\\checkmark$ large mass of heterogeneous signal intensity\n$R x$ : emergent pericardiocentesis (life-threatening lesion); urgent surgical excision\nPrognosis: good\n\n\n# PERICARDITIS \n\nEtiology:\nA. IDIOPATHIC ( $85 \\%, 2^{\\text {nd }}$ most common cause today)\nB. NONIDIOPATHIC ( $15 \\%$ )\n(a) infectious / inflammatory\n\n1. Virus (Coxsackie B, influenza)\n2. Bacterium\n3. Tuberculosis (formerly most common etiology)\n$\\diamond$ TB is major cause in developing countries + in HIV-immunocompromised patients\n4. Fungus / parasite\n5. Connective tissue disease: rheumatoid arthritis, lupus erythematosus\n(b) traumatic\n6. Cardiac surgery (most frequent today)\n7. Radiotherapy to mediastinum: breast cancer, mediastinal tumor\n8. Percutaneous coronary intervention, pacemaker insertion, catheter ablation\n9. Acute myocardial infarction\n> Epistenocardiac pericarditis\n$=$ inflammation in close temporal relationship to acute transmural infarction\nFrequency: $10 \\%$ of patients with acute MI\nCause: pericardial spread of infarct-related inflammation\n> Dressler syndrome\n(c) autoimmune disorder (5\\%)\n(d) uremia $=$ chronic renal failure",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 152,
            "markdown": "(e) neoplastic $(5 \\%)=$ tumor invasion by carcinoma of breast / lung, lymphoma / leukemia, sarcoma, mesothelioma\n\n# Constrictive Pericarditis \n\n$=$ PERICARDIALCONSTRICTION\n$=$ fibrous thickening of pericardium interfering with filling of ventricular chambers via restriction of heart motion\nAge: $\\quad 30-50$ years; $\\mathrm{M} \\div \\mathrm{F}=3 \\div 1$\nEtiology: infection, trauma, radiation, postoperative status\nHemodynamics of decreased compliance of pericardium:\n(a) dissociation between intracardiac + intrathoracic pressure $\\rightarrow$ isolates heart from normal respiratory changes\n(b) increased ventricular coupling\n(c) increased cardiac filling pressures with equalization of atrial + ventricular pressures\n\n- dyspnea + weakness, peripheral edema, neck vein distension\n- abdominal enlargement (ascites + hepatomegaly)\n- pericardial knock sound = loud early-diastolic sound\n- Kussmaul sign = failure of venous pressure to fall (= elevation of jugular venous pressure) with inspiration\n- prominent X and Y descent on venous pressure curve\n$\\diamond$ Other causes of right heart failure must be excluded first, ie, pulmonary hypertension, severe tricuspid insufficiency, myocardial infarction\nDiagnostic key imaging features):\n$\\checkmark$ pericardial thickening + enhancement + calcifications\n$\\checkmark$ biatrial enlargement + tubular ventricles\n@ Pericardium\nLocation: most pronounced over RV + anterior AV groove + posterior surface of LV\n$\\checkmark$ irregular thickening of pericardium\n$\\checkmark$ linear / plaquelike pericardial calcifications ( $27 \\%$ ) as a nonspecific response to chronic inflammation\n@ Heart\n$\\checkmark$ flattened tubular shape of cardiac cavities\n$\\checkmark$ uni- / bilateral atrial enlargement\n$\\checkmark$ small atria; occasionally compensatory dilatation of nonconstricted portions, eg, LA enlargement $(20 \\%)$\n$\\checkmark$ normal / small-sized heart (enlargement only due to preexisting disease)\n$\\checkmark$ straightening of heart borders:\n$\\checkmark$ straight / concave on right side\n$\\checkmark$ squared on left side\n$\\checkmark$ pericardial tenting\n$\\checkmark$ increase in ejection fraction (small EDV)\n@ Veins ( $\\uparrow$ cardiac filling pressure)\n$\\checkmark$ dilatation of SVC (77\\%), IVC, azygos vein (69\\%), hepatic veins\n@ Lung \\& abdomen",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 153,
            "markdown": "$\\checkmark$ normal pulmonary vascularity / pulmonary venous hypertension (43\\%)\n$\\checkmark$ pleural effusion ( $34 \\%$ bilateral, $26 \\%$ right PE)\n$\\checkmark$ ascites\nCT:\n$\\checkmark$ pericardial thickening to $4 \\mathrm{~mm} \\pm 1 \\mathrm{~mm}$ in reversible constrictive pericarditis\n$\\checkmark$ thinning of pericardium to $2 \\mathrm{~mm} \\pm 1 \\mathrm{~mm}$ in end-stage irreversible chronic fibrosing pericarditis\n$\\checkmark$ reflux of contrast into coronary sinus\n$\\checkmark$ flattening of RV with narrow tubular configuration\n$\\checkmark$ sigmoid-shaped curvature of interventricular septum toward left\nMR:\n$\\checkmark$ pericardial thickening $\\geq 4 \\mathrm{~mm}$ (suggestive) and $>5-6 \\mathrm{~mm}$ (highly specific)\n$\\diamond$ Maximal pericardial thickness in constrictive pericarditis has a wide range of 1-17 mm !\n$\\diamond$ Up to $20 \\%$ of patients have normal thickness of $\\leq 2 \\mathrm{~mm}$\n$\\diamond$ Degree of pericardial thickening is only weakly related to degree of cardiac constriction!\n$\\checkmark$ pericardium of intermediate SI similar to myocardium sandwiched between high-signal epicardial and mediastinal fat (on T1WI); most easily identified anterior to RV $>\\mathrm{RA}>$ free wall of LV\n$\\checkmark$ often small LV + tubular appearing RV\n$\\checkmark$ dilatation of RA + IVC reflecting high RV filling pressure (DDx: restrictive cardiomyopathy)\n$\\checkmark$ flattened / sigmoid-shaped septum\n$\\checkmark$ NO pericardial enhancement in end stage of disease\nPhase-contrast MRI:\n$\\checkmark$ tricuspid valve inflow: $\\uparrow$ early filling $+\\downarrow /$ absent late filling\n$\\checkmark$ IVC: $\\downarrow /$ absent forward or reversed systolic flow; $\\uparrow$ early diastolic flow; late reversed diastolic flow\n$\\checkmark$ RV filling $\\uparrow$ on inspiration + LV filling $\\uparrow$ on expiration\n$\\checkmark$ \"septal bounce\" = flattening / inversion of septum during early diastolic ventricular filling $\\leftarrow$ increased ventricular coupling:\n$\\checkmark$ most pronounced at onset of inspiration\n$\\checkmark$ right-sided septal shift at onset of expiration\nECHO (nonspecific features):\n$\\checkmark$ thickening of pericardium (not reliably demonstrated unless pericardial fluid present)\n$\\checkmark$ immobile pericardium\n$\\checkmark$ rapid early filling of LV\n$\\checkmark$ rapid early filling motion followed by flat posterior wall motion during diastasis period ( $=$ period between early rapid filling and atrial contraction)\n$\\checkmark$ premature opening of pulmonic valve\n$C x$ : protein-losing enteropathy $\\leftarrow$ increased pressure in IVC + portal vein\n$R x$ : antiinflammatory drugs; pericardiectomy = surgical stripping of pericardium\n$D D x$ : (a) restrictive physiology:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 154,
            "markdown": "1. Cardiac tamponade\n2. Restrictive cardiomyopathy: eg, amyloid\n(b) nonrestrictive physiology:\n3. S/P recent cardiac surgery\n4. Organized intrapericardial hematoma\n\n# Epipericarditis \n\n$=$ EPIPERICARDIAL FAT NECROSIS\n$=$ uncommon benign condition of unknown cause that manifests with acute pleuritic chest pain and no prodrome\n\n- focal chest pain varying with changes in patient's position\n- normal levels of troponin\n\nCT:\n$\\sqrt{ }$ focally increased attenuation within epipericardial fat\nPET/CT:\n$\\sqrt{ }$ low-grade FDG uptake\n$R x$ : antiinflammatory medication\nPrognosis: symptoms and image findings resolve over time\n\n## Inflammatory Pericarditis\n\nPrevalence: $1 \\%$ of autopsies\nClinical course: acute / subacute / recurrent / chronic\n$\\sqrt{ }$ pericardial thickening + enhancement + fluid\n$\\sqrt{ }$ mild to moderate increase / NO increase in FDG uptake\n\n## Acute Pericarditis\n\nCause: mnemonic: MUSIC\nMyocardial infarction (acute)\nUremia\nSurgery (cardiac)\nInfection\nCancer\nHisto: inflamed pericardial layers composed of highly vascularized granulation tissue with fibrin deposition\n\n- typical often severe chest pain\n- pericardial friction rub ( $\\leftarrow$ pericarditis sicca)\n- elevated serologic markers of inflammation (eg, C-reactive protein); widespread ST elevation\nCT:\n$\\sqrt{ }$ thickening of pericardial layers\n$\\sqrt{ }$ diffuse enhancement of pericardium\n$\\sqrt{ }$ pericardial effusion $\\pm$ loculations\nMR:\n$\\sqrt{ }$ edema on STIR\n$\\sqrt{ }$ enhancement of pericardium $\\pm$ surrounding fat $\\pm$ myocardium",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 155,
            "markdown": "Cx: (1) Progression to chronic sclerosing pericarditis ( $<0.5 \\%$ for viral pericarditis, relatively frequent for purulent + tuberculous pericarditis)\n(2) Myocarditis = atypical ECG changes, transient regional / global wall motion abnormalities, increase in cardiac enzymes\nRx: NSAID\n\n# Chronic Pericarditis \n\nHisto: fibroblasts + collagen deposition\nSubtypes: (1) Chronic sclerosing pericarditis\n(2) Chronic fibrosing pericarditis\n$\\sqrt{ }$ irregularly thickened pericardial layers\n$\\sqrt{ }$ loculated pericardial effusion\nCx: stiff pericardium $\\rightarrow$ constrictive pericarditis\n\n## PERSISTENT DUCTUS VENOSUS (rare)\n\n$=$ portosystemic shunt $\\leftarrow$ failure of ductus closure during the $1^{\\text {st }}$ week of life (usually immediately after birth in full-term neonate)\nAnatomy: ductus arises from posterior aspect of left PV (opposite umbilical vein opening) and drains into HV\nAssociated with: prematurity, CHD\n\n## PERSISTENT FETAL CIRCULATION\n\n$=$ PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN\n$=$ delay in transition from intra- to extrauterine pulmonary circulation\nCause: primary disorder related to birth asphyxia; concurrent parenchymal lung disease (meconium aspiration, pneumonia, pulmonary hemorrhage, hyaline membrane disease, pulmonary hypoplasia); concurrent cardiovascular disease; hypoxic myocardial injury; hyperviscosity syndromes)\n\n- labile pO2\n$\\sqrt{ }$ structurally normal heart\n\n\n## POLYARTERITIS NODOSA\n\n$=$ PERIARTERITIS NODOSA $=$ PAN\n$=$ systemic necrotizing inflammation of medium-sized + small muscular arteries WITHOUT glomerulonephritis or vasculitis in arterioles, capillaries, venules\nFrequency: $4-9 \\div 1,000,000$ annually(rare); $70 \\div 1,000,000$ annually in patients with hepatitis B\nEtiology: ? deposition of immune complexes\nMean age: 55 (range, 8-81) years; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 13 \\%$ of childhood vasculitides in USA\nPath: focal panmural necrotizing vasculitis with nodules along the vessel walls; mucoid degeneration + fibrinoid necrosis begins within media; multiple small aneurysms of small + medium-sized arteries; absence of vasculitis in vessels other than arteries (DDx: necrotizing angiitis, mycotic aneurysm)\nHisto: polymorphonuclear cell infiltrate in all layers of arterial wall + perivascular tissue (acute phase), mononuclear cell infiltrate, intimal proliferation, thrombosis, perivascular",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 156,
            "markdown": "inflammation (chronic stage)\nAssociated with: hepatitis B + HIV antigenemia\n\n- low-grade fever, malaise, abdominal pain, weight loss\n- myalgia (over weeks), arthralgia, hypertension\n- elevated ESR, thrombocytosis, anemia\n- positive for hepatitis B surface antigen (up to 30\\%)\n- positive perinuclear ANCA titers; mononeuritis multiplex\n\nLocation: all organs may be involved, kidney ( $70-90 \\%$ ), heart ( $65 \\%$ ), liver ( $50-60 \\%$ ), spleen $(45 \\%)$, pancreas ( $25-35 \\%$ ), GI tract, CNS (cerebrovascular accident, seizure), skin\n@ Kidney (involved in 70-80-90\\%)\n\n- painless hematuria, nephrotic syndrome (proteinuria)\n- acute / chronic renal failure\n$\\checkmark$ irregular nephrogram\n$\\checkmark$ radiolucent cortical areas\n$\\checkmark$ prolonged washout of contrast material\n$\\checkmark$ multiple small intrarenal microaneurysms (at bifurcation of interlobar / arcuate arteries)\n$\\checkmark$ aneurysms may disappear (thrombosis) or appear in new locations\n$\\checkmark$ arterial narrowing + thrombosis (chronic / healing stage)\n$\\checkmark$ multiple small cortical infarcts\nCECT:\n$\\checkmark$ lobulated renal contour + irregular thinning $\\leftarrow$ prior cortical infarcts\n$\\checkmark$ multiple hypoattenuating bands (arterial occlusion)\nCx: intrarenal / subcapsular / perinephric hemorrhage $\\leftarrow$ rupture of aneurysm\n@ Chest (involved in 70\\%)\n- CHF, myocardial infarction\n$\\checkmark$ cardiac enlargement / pericardial effusion (14\\%)\n$\\checkmark$ pleural effusion (14\\%)\n$\\checkmark$ pulmonary venous engorgement ( $21 \\%$ )\n$\\checkmark$ massive pulmonary edema (4\\%)\n$\\checkmark$ linear densities / platelike atelectasis (10\\%)\n$\\checkmark$ wedge-shaped / round peripheral infiltrates of nonsegmental distribution (14\\%) simulating thromboembolic disease with infarction\n$\\checkmark$ cavitation may occur\n$\\checkmark$ interstitial pneumonitis in lower lung fields\n@ Liver (involved in 50-66\\%)\n$\\checkmark$ prolonged washout of contrast material $\\leftarrow$ increase in peripheral hepatic arterial resistance + hepatic infarcts\n@ GI tract (involved in 50-70\\%)\nLocation: small intestine $>$ mesentery $>$ colon\n- abdominal pain, nausea, vomiting (66\\%)\n$\\checkmark$ ulcer formation, GI bleeding (6\\%)\n$\\checkmark$ bowel perforation (5\\%), intestinal infarction (1.4\\%)\n$\\checkmark$ pneumatosis intestinalis $\\pm$ portal venous gas\n@ Skeletal muscle (involved in 39\\%)\n- myalgia, arthralgia (50\\%), limb claudication",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 157,
            "markdown": "$\\sqrt{ }$ aneurysms of lumbar + intercostal arteries (19\\%)\n$\\sqrt{ }$ lower extremity ischemia ( $16 \\%$ )\n@ Skin (involved in 20\\%)\n\n- palpable purpura, infection, ischemic ulcer\n- tender subcutaneous nodules ( $15 \\%$ )\n- peripheral neuropathy ( $=$ mononeuritis multiplex)\n@ CNS (involved in 10\\%)\n$\\sqrt{ }$ sulci of high-signal-intensity on FLAIR image\n$\\sqrt{ }$ leptomeningeal enhancement on T1WI\nAngiography ( $61-89 \\%$ sensitive, $90 \\%$ specific, $55 \\%$ PPV, $98 \\%$ NPV, $80 \\%$ true-positive rate):\n$\\sqrt{ }$ multiple ( $>10$ ) aneurysms of small + medium-sized arteries typically at branching points as a result of pannecrosis of the internal elastic lamina in $50-60 \\%$ (HALLMARK):\n$\\sqrt{ } 1-5 \\mathrm{~mm}$ saccular aneurysms in $60-75 \\%$\n$\\sqrt{ }$ fusiform aneurysms / arterial ectasia\n$\\diamond$ Aneurysms are found in $12-94 \\%$ of polyarteritis nodosa\n$\\sqrt{ }$ luminal irregularities (in up to $90 \\%$ )\n$\\sqrt{ }$ stenoses of arteries\n$\\sqrt{ }$ arterial occlusions + organ infarcts ( $98 \\%$ )\n$D D x$ : rheumatoid vasculitis, drug abuse, systemic lupus erythematosus, Churg-Strauss syndrome\n$D x$ : angiography, tissue biopsy\n$C x$ : renin-mediated hypertension, renal failure, hemorrhage $\\leftarrow$ aneurysm rupture ( $9 \\%$ ), organ infarction $\\leftarrow$ vessel thrombosis: gangrene of fingers / toes\nPrognosis: clinical course lasts several months to $>1$ year; relapse in $40 \\%$ with median interval of 33 months; $13 \\%$-year survival rate if untreated\n$R x$ : immunosuppression with corticosteroids + cyclophosphamide (increases 5-year survival rate to $48-90 \\%$ )\n\n\n# Polyarteritis Nodosa of Childhood \n\nFrequency: 3\\% of childhood vasculitides in USA\nMean age: 9 years\n\n- history of recent URI\n\nMay be associated with: familial Mediterranean fever\nTypes:\n(1) Systemic polyarteritis nodosa (57\\%)\n$=$ malaise, fever, weight loss, myalgia, abdominal pain, arthralgia\nOrgans: skin, MSK, kidney, GI, heart, CNS, lung\n\n- livido reticularis, subcutaneous nodules\n- peripheral gangrene\n$C x$ : visceral hemorrhage $\\leftarrow$ ruptured aneurysm, bowel infarction\n(2) Cutaneous polyarteritis nodosa ( $30 \\%$ )\n$=$ benign course\nInvolved organs: skin, MSK WITHOUT internal organs\n(3) Hepatitis B-associated polyarteritis nodosa ( $<5 \\%$ ) more typical for adults\n\nDx: CLASSIC angiographic findings of aneurysm, stenosis, occlusion of medium-sized to",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 158,
            "markdown": "small muscular arteries $\\leftarrow$ necrotizing vasculitis\nLocation: predominantly renal + mesenteric + hepatic arteries\nRenal DSA (digital subtraction angiography):\n$\\sqrt{ }$ aneurysms in small to medium-sized renal arteries ( $40 \\%$ )\n$\\sqrt{ }$ segmental narrowing\n$\\sqrt{ }$ variations in arterial caliber\n$\\sqrt{ }$ pruning of peripheral vascular tree\nMortality rate: $1-4 \\%$\n\n# POPLITEAL ARTERY ENTRAPMENT SYNDROME \n\n$=$ vascular compression syndrome of popliteal artery (PopA)\nPrevalence: $0.165 \\%$ of young males entering military service\nPrevalence: 35 cases in American surgical literature; bilateral in 22-67\\%\nNormal anatomy: PopA courses between the two heads of gastrocnemius muscle = lateral to medial head of gastrocnemius muscle (medGastroc)\nAberrant anatomy:\n(1) medial course of PopA around medGastroc\n(2) lateral insertion of medGastroc on distal femur\n(3) accessory slip of gastrocnemius m. ( $30 \\%$; most common)\n(4) hypertrophy / accessory slip of gastrocnemius muscle\n(4) fibrous band of popliteus muscle\n\nPathophysiology:\nflow unimpeded when muscle relaxed; increased arterial angulation with muscle contraction (early); progressive intimal hyperplasia (\"atheroma\" = misnomer) $\\leftarrow$ microtrauma in area of repeated arterial compression; ultimately occlusion / thrombosis within aneurysm (late)\nAge peaks: 17 and 47 years; $<35$ years in $68 \\% ; \\mathrm{M}+\\mathrm{F}=9 \\div 1$ to $15 \\div 1$\n\n- unilateral claudication + exercise-induced leg pain ( $90 \\%$ ):\n- slowly progressive, esp. during periods of prolonged standing\n- acute ischemia of leg with permanent occlusion of popliteal a. (late)\n\nPulse volume recording (PVR with $40 \\%$ false-positive results):\n$\\sqrt{ }$ posterior tibial pulse obliterated during active plantar flexion against resistance / dorsiflexion of foot\n$\\diamond 50 \\%$ of general population has some narrowing of PopA!\n$\\sqrt{ }$ ankle-arm index reduced during active muscle contraction\n$\\sqrt{ }$ Doppler waveforms of posterior tibial artery diminished during muscle contractions\nAngio (biplanar views with hyperextended knee):\n$\\sqrt{ }$ medial deviation of artery ( $29 \\%$ ), popliteal stenosis ( $11 \\%$ ), poststenotic dilatation ( $8 \\%$ )\n$D x:$\n$\\sqrt{ }$ arteriography with typical medial deviation of popliteal artery before + after gastrocnemius contraction\n$\\sqrt{ }$ popliteal artery thrombosis / occlusion\n$C x$ : popliteal artery aneurysm\n$D D x$ : cystic adventitial disease of popliteal artery, arterial embolism, premature arteriosclerosis, popliteal aneurysm with thrombosis, popliteal artery trauma, popliteal",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 159,
            "markdown": "artery thrombosis, Buerger disease, spinal cord stenosis (= neurogenic claudication)\n\n# POSTRHEUMATIC HEART DISEASE \n\nCause: infection by group A streptococcus $\\rightarrow$ acute rheumatic fever (= systemic inflammatory infection) involving heart, joints, skin, SQ tissue\nPath: pancarditis with vegetations forming predominantly on mitral + aortic valve $\\rightarrow$ scarring of chronic inflammation $\\rightarrow$ valvular deformity\n\n- manifestation after latency of $20-25$ years\n\nLocation: mitral valve $>$ aortic valve\n$C x$ : valvular malfunction (stenosis / insufficiency) $\\rightarrow$ volume overload of proximal cardiac chamber $\\rightarrow$ ventricular damage + remodeling\n\n## PRIMARY PULMONARY HYPERTENSION\n\n$=$ PLEXOGENIC PULMONARY ARTERIOPATHY $=$ ppHTN\n$=$ idiopathic precapillary cause of pulmonary hypertension (pHTN)\nDiagnosis per exclusion:\nNO identifiable cause; clinically unexplained progressive pulmonary arterial hypertension without evidence for thromboembolic disease / pulmonary venoocclusive disease\nAt risk: portal hypertension (with / without liver disease); autoimmune disorders (Raynaud disease, collagen vascular disease); pregnancy; HIV infection; aminorex fumarate (appetite suppressant) ingestion\nHisto: plexogenic arteriopathy (HALLMARK) = intimal cell proliferation with focal disruption of internal elastic lamina and media by glomeruloid small vascular channels that ramify into alveolar septal capillaries ( $75 \\%$ ); acute + organizing intraluminal thrombi ( $50 \\%$ )\nAge: $3^{\\text {rd }}$ decade (range, $20-45$ years); $\\mathrm{M}+\\mathrm{F}=1 \\div 3$\n\n- gradual onset of progressive dyspnea on exertion ( $60 \\%$ )\n- easy fatigability, syncope, angina, hyperventilation, hemoptysis\n- Raynaud phenomenon, symptoms of cor pulmonale\n$\\sqrt{ }$ right ventricular enlargement $\\leftarrow$ hypertrophy + dilatation\n$\\sqrt{ }$ dilatation of central pulmonary arteries\nCXR:\n$\\checkmark$ prominent central pulmonary arteries:\n$\\checkmark$ enlarged pulmonary trunk\n$\\checkmark$ right descending pulmonary artery $>25 \\mathrm{~mm}$ wide\n$\\checkmark$ pulmonary vascularity:\n$\\checkmark$ oligemia + rapidly tapering vessels\n$\\checkmark$ overcirculation + vascular distension\nCT:\n$\\checkmark$ enlargement of central pulmonary arteries:\n$\\checkmark$ diameter of main pulmonary artery $>29 \\mathrm{~mm}$ ( $87 \\%$ sensitive, $89 \\%$ specific) measured at scan plane of bifurcation at right angle to its long axis just lateral to ascending aorta\n$\\checkmark$ segmental artery-to-bronchus ratio $>1 \\div 1$\n$\\checkmark$ pulmonary artery-to-aorta ratio (rPA) $>1$\n$\\checkmark$ abrupt decrease in caliber of segmental + subsegmental arteries (at outer to medial $1 / 3$ of",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 160,
            "markdown": "lung mantle)\n$\\sqrt{ }$ small tortuous peripheral vessels $=$ plexogenic arteriopathy\n$\\sqrt{ }$ absence of detectable intraluminal thrombi\nin severe cases:\n$\\sqrt{ }$ wall-adherent apposition thrombus in central pulmonary aa.\n$\\sqrt{ }$ pericardial effusion (worse prognosis)\n$\\sqrt{ }$ focal perivascular groundglass opacities in peripheral / perihilar distribution\nHRCT:\n$\\sqrt{ }$ patchy mosaic pattern of lung attenuation $\\leftarrow$ regional variations in lung perfusion (rare):\n$\\sqrt{ }$ hyperdense areas containing large caliber vessels\n$\\sqrt{ }$ hypodense areas containing small caliber vessels\nMR:\n$\\sqrt{ }$ reversal of interventricular septal curvature\n$\\sqrt{ }$ direct linear correlation between mean pulmonary artery pressure (PAP) and ratio of main pulmonary artery caliber to descending aorta (MPA/AO)\n$\\sqrt{ }$ abnormal intravascular signal in $92 \\%$ on gated T1WI $\\leftarrow$ slow arterial flow $\\leftarrow \\uparrow$ pulmonary vascular resistance\nNUC:\n$\\sqrt{ }$ normal / low-probability V/Q scans\nAngio:\n$\\sqrt{ }$ symmetrically enlarged central arteries\n$\\sqrt{ }$ diffuse pattern of abruptly tapering + pruned subsegmental vessels\n$\\sqrt{ }$ filamentous / \"corkscrew\" peripheral arteries\n$\\sqrt{ }$ subpleural collaterals (occasionally)\n$\\sqrt{ }$ bronchial artery dilatation is uncommon ( $14 \\%$ ) in primary pHTN for unknown reasons and is useful for differentiation from chronic thromboembolic disease.\nPrognosis: death in 2-5 years; 34\\% 5-year survival\n$R x$ : vasodilators, calcium channel blockers, diuretics, anticoagulants; lung / heart-lung transplantation\n\n# PSEUDOCOARCTATION \n\n$=$ AORTIC KINKING\n$=$ elongated redundant thoracic aorta with acute kink / anterior buckling just distal to origin of left subclavian artery at ligamentum arteriosum\n$=$ variant of coarctation without a pressure gradient\nAge: 12-64 years\nAssociated with: hypertension, bicuspid aortic valve, PDA, VSD, aortic / subaortic stenosis, single ventricle, ASD, anomalies of aortic arch branches\n\n- asymptomatic; ejection murmur\n- NO pressure gradient across the buckled segment\n\nCXR:\n$\\sqrt{ }$ anteromedial deviation of aorta\n$\\sqrt{ }$ \"chimney-shaped\" high aortic arch (in children)\n$\\sqrt{ }$ rounded / oval soft-tissue mass in left paratracheal region + superior to presumed normally",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 161,
            "markdown": "positioned aortic arch $\\leftarrow$ elongation of ascending aorta + aortic arch (in adults)\n$\\sqrt{ }$ anterior displacement of esophagus\n$\\sqrt{ }$ NO rib notching / dilatation of brachiocephalic arteries / LV enlargement / poststenotic dilatation\nCT/MR:\n$\\sqrt{ }$ shelflike lesion at any point along the aortic arch\n$\\checkmark$ poststenotic aortic dilatation\nAngio:\n$\\checkmark$ high position of aortic arch\n$\\sqrt{ }$ \"figure 3\" sign = notch in descending aorta at attachment of short ligamentum arteriosum\n$D D x$ : true coarctation, aneurysm, mediastinal mass\n\n# PULMONARY ARTERY PSEUDOANEURYSM \n\n$=$ tear / disruption of layers of vessel wall with extravasation of blood contained by adventitia / clot / compressed surrounding tissue\nPrevalence: rare\nCause:\nA. TRAUMA\n\n1. Improper placement of Swan-Ganz catheter\n2. Penetrating / blunt (rare) trauma\nB. INFECTION:\n3. Mycotic aneurysm $\\leftarrow$ endovascular seeding from endocarditis / direct extension from necrotizing pneumonia\n4. Mycobacterial aneurysm (= Rasmussen aneurysm)\n5. Syphilitic aneurysm\nC. VASCULAR ABNORMALITY: cystic medial necrosis, Behçet disease, Marfan syndrome, Takayasu disease\nD. OTHER: septic emboli, neoplasm\n\nAssociated with: patent ductus arteriosus\n\n- hemoptysis $\\leftarrow$ leakage of blood into bronchial tree\n\nCXR:\n$\\checkmark$ stable / increasing focal lung mass\nCT:\n$\\checkmark$ enhancing round lung mass isointense to central pulmonary a.\n$C x: \\quad 100 \\%$ mortality with rupture\n\n## PULMONARY ATRESIA\n\n$=$ CONGENITAL ABSENCE OF PULMONARY ARTERY\n$=$ atretic pulmonary valve with underdeveloped pulmonary artery distally\nMay be associated with: hypogenetic lung\nCXR:\n$\\checkmark$ small hemithorax of normal radiodensity\n$\\checkmark$ mediastinal shift to affected side\n$\\checkmark$ elevation of ipsilateral diaphragm",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 162,
            "markdown": "$\\sqrt{ }$ reticular network of vessels on affected side $\\leftarrow$ systemic collateral circulation from bronchial arteries\n$\\sqrt{ }$ rib notching from prominence of intercostal arteries $\\leftarrow$ large transpleural collateral vessels OB-US:\n$\\sqrt{ }$ small / enlarged / normal right ventricle\n$\\sqrt{ }$ progressive atrial enlargement $\\leftarrow$ tricuspid regurgitation\n$\\sqrt{ }$ flow reversal in ductus arteriosus + main pulmonary artery (most reliable)\n\n# Proximal Interruption of Pulmonary Artery \n\n$=$ AGENESIS OF PULMONARY ARTERY\n$=$ atresia of mediastinal portion of right / left pulmonary artery (usually opposite the side of the aortic arch) with distal pulmonic circulation supplied by aortopulmonary collaterals / bronchial arteries\n\n- recurrent infections, dyspnea, pulmonary hypertension\n- hemoptysis ( $10 \\%$ ) $\\leftarrow$ ruptured systemic collateral vessels\n(a) Interrupted left pulmonary artery\n\nAssociated with: right aortic arch + severe CHD (including tetralogy of Fallot)\n(b) Interrupted right pulmonary artery (more common), generally as isolated finding CT:\n$\\sqrt{ }$ complete absence of mediastinal portion of affected pulmonary artery\n$\\sqrt{ }$ short pulmonary a. terminating within 1 cm of its origin\n$\\sqrt{ }$ hypoplastic ipsilateral lung + hyperinflated contralateral lung rotating across midline\n$\\sqrt{ }$ abundant systemic collaterals to affected lung $\\leftarrow$ dilated bronchial arteries, subclavian artery, intercostal arteries\n$\\sqrt{ }$ linear peripheral lung opacities $=$ transpleural vascular collaterals\n\n## Pulmonary Atresia with Ventricular Septal Defect\n\n$=$ part of spectrum of tetralogy of Fallot (TOF)\n\n## Pulmonary Atresia with Intact Interventricular Septum\n\nAssociated with: ASD $\\rightarrow$ R-to-L shunt\nType I : NO remaining RV, NO tricuspid regurgitation\n$\\sqrt{ }$ moderately $\\uparrow$ RA (depending on size of ASD)\nType II : normal RV with tricuspid regurgitation\n$\\sqrt{ }$ massive enlargement of RA\n$\\sqrt{ }$ cardiomegaly $\\leftarrow$ increase in size of $\\mathrm{LV}+\\mathrm{RA}$\n$\\sqrt{ }$ concave / small pulmonary artery segment\n$\\sqrt{ }$ diminished pulmonary vascularity\n$R x$ : prolonged infusion of prostaglandin E, stent placement into ductus, modified BlalockTaussig shunt, atrial septotomy, transpulmonary valvotomy\n\n## PULMONIC INSUFFICIENCY / REGURGITATION\n\n## Pathophysiology:\n\nforward blood flow may be maintained $\\leftarrow$ contraction of RA + pumping of systemic venous return from left heart",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 163,
            "markdown": "Cause:\n(a) normal (in 30\\%) if trivial / mild\n(b) bi- and quadricuspid valve\n(c) dilatation of valve: pulmonary hypertension, Marfan syndrome, syphilis\n(d) damage of cusps: carcinoid heart disease, rheumatic heart disease, infectious endocarditis\n(e) after surgical / percutaneous treatment for pulmonary stenosis and repair of TOF\n\nCT:\n$\\sqrt{ }$ inadequate apposition of cusp at end-diastole\n$\\sqrt{ }$ dilatation of pulmonic ring + pulmonary artery\n$\\sqrt{ }$ RV dilatation + hypertrophy\nMR / ECHO:\n$\\sqrt{ } \\pm$ late diastolic forward flow in pulmonary trunk with each atrial contraction $\\rightarrow$ regurgitant flow usually $<50 \\%$\nMeasurement of pulmonary regurgitant fraction:\n$\\sqrt{ }$ accurately quantified with through-plane (true transverse with $<15^{\\circ}$ angulation) velocity mapping\n= Volume $_{\\text {regurgitant }} \\times 100 /$ Volume $_{\\text {forward }}[\\%]$\n$\\diamond$ A regurgitant fraction of $\\geq 40 \\%$ is considered severe!\n\n# PULMONIC (PULMONARY) STENOSIS \n\nFrequency: pulmonary artery stenosis without VSD in 8\\% of all CHD\nEmbryology: infundibulum formed from proximal portion of bulbis cordis; pulmonary valves develop in $6^{\\text {th }}-9^{\\text {th }}$ week from outgrowth of 3 tubercles\n\n- mostly asymptomatic; cyanosis / heart failure\n- loud systolic ejection murmur\n$\\sqrt{ }$ systolic doming of pulmonary valve (= incomplete opening)\n$\\sqrt{ }$ normal / diminished / increased pulmonary vascularity (depending on presence + nature of associated malformations)\n$\\sqrt{ }$ enlarged pulmonary trunk + left pulmonary artery (= poststenotic dilatation)\n$\\sqrt{ }$ prominent left pulmonary artery + normal right pulmonary a.\n$\\sqrt{ }$ hypertrophy of RV with reduced size of RV chamber:\n$\\sqrt{ }$ elevation of cardiac apex\n$\\sqrt{ }$ increased convexity of anterior cardiac border on LAO\n$\\sqrt{ }$ diminution of retrosternal clear space\n$\\sqrt{ }$ cor pulmonale\n$\\sqrt{ }$ mild enlargement of LA (reason unknown)\n$\\sqrt{ }$ calcification of pulmonary valves in older adults (rare)\nPrognosis: death at mean age of 21 years if untreated\nShape of pulmonary stenosis:\n(1) Dome-shaped valve ( $40-60 \\%$ ) with normal leaflets\n(2) Dysplastic thickened immobile cusps ( $20-30 \\%$ )\n(3) Supravalvular narrowing with deep bottle-shaped sinuses + hourglass deformity (16\\%)\n(4) Bicuspid ( $0.1 \\%$ ) / quadricuspid ( $0.2 \\%$ ) pulmonary valve\n(5) Dome-shaped valve with dysplastic leaflets",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 164,
            "markdown": "# Subvalvular Pulmonic Stenosis \n\nA. INFUNDIBULAR PULMONIC STENOSIS typically in tetralogy of Fallot\nB. SUBINFUNDIBULAR PULMONIC STENOSIS\n$=$ hypertrophied anomalous muscle bundles crossing portions of RV\nAssociated with: VSD (73-85\\%)\n(a) low type: courses diagonally from low anterior septal side to crista posteriorly\n(b) high type: horizontal defect across RV below infundibulum\n$\\sqrt{ }$ late-peaking jet\n$\\sqrt{ }$ no dilatation of PA because of dissipation of RV force through elongated area of obstruction\n\n## Valvular Pulmonic Stenosis / Pulmonary Valve Stenosis\n\n## Cause:\n\n(a) congenital $(95 \\%)$ :\n> isolated (most often)\n> associated with other congenital anomalies:\n» tetralogy of Fallot (bicuspid pulmonary valve)\n» Noonan syndrome (dysplastic pulmonary valve)\n» LEOPARD syndrome (= lentigines, electrocardiographic anomalies, ocular hypertelorism, pulmonary stenosis, abnormalities of genitalia, retardation of growth, deafness)\n(b) acquired: metastatic carcinoid, rheumatic fever, infective endocarditis, prosthetic valve, RVOT conduit\n\n1. CLASSIC / TYPICAL PULMONIC VALVE STENOSIS (95\\%)\n$=$ commissural fusion of pulmonary cusps $\\rightarrow$ funnel shape with small circular orifice\nAge of presentation: childhood\n\n- pulmonic click\n- ECG: hypertrophy of RV\n$\\sqrt{ }$ dome-shaped valve:\n$\\sqrt{ }$ mobile valve with $2-4$ raphes\n$\\sqrt{ }$ incomplete separation of valve cusps\n$\\sqrt{ }$ jet of contrast through small central orifice\n$\\sqrt{ }$ dilated main + left pulmonary artery\n$R x$ : balloon valvuloplasty (for peak instantaneous gradient above 50 mmHg )\n\n2. DYSPLASTIC PULMONIC VALVE STENOSIS (5\\%)\n$=$ thickened redundant immobile distorted cusps $\\leftarrow$ myxomatous tissue\n\n- No click\n$\\sqrt{ }$ cauliflower-like thickening at free margin of leaflets\n$\\sqrt{ }$ NO poststenotic dilatation\n$R x$ : surgical resection of redundant valve tissue\nHemodynamics: obstruction of RV systolic ejection with pressure burden on RV\n\n| RA | $\\leftrightarrow /$ | RV | $\\uparrow$ | Main PA | $\\uparrow$ |\n| :-- | :-- | :-- | :-- | :-- | :-- |\n| Pulm. vessels | $\\leftrightarrow$ |  |  | LPA | $\\uparrow$ |\n| LA | $\\leftrightarrow$ | LV | $\\leftrightarrow$ | Ao | $\\leftrightarrow$ |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 165,
            "markdown": "CXR:\n$\\checkmark$ normal pulmonary vascularity\n$\\checkmark$ normal-sized heart\n$\\checkmark$ enlargement of main + left pulmonary artery\nCT:\n$\\checkmark$ poststenotic enlargement of main + left PA\n$\\checkmark$ normal size of right PA (not exposed to turbulent jet from stenotic valve due to $90^{\\circ}$ angle from main PA)\n$\\checkmark$ RV hypertrophy\n$\\checkmark$ bowing of interventricular septum to the left\n$\\checkmark$ decreased mobility of pliable + thin valve leaflets\nAngio:\n$\\checkmark$ increase in trabecular pattern of RV\n$\\checkmark$ hypertrophied crista supraventricularis (lateral projection)\n\n# Supravalvular Pulmonic Stenosis \n\n$60 \\%$ of all pulmonic valve stenoses\nSite of narrowing: sinutubular junction, pulmonary trunk, pulmonary bifurcation, one / both main pulmonary arteries, lobar pulmonary artery, segmental pulmonary artery\nShape of narrowing:\n(a) localized with poststenotic dilatation\n(b) long tubular hypoplasia\n\nMay be associated with:\n(1) Valvular pulmonic stenosis, supravalvular aortic stenosis, VSD, PDA, systemic arterial stenoses\n(2) Familial peripheral pulmonic stenoses + supravalvular aortic stenosis\n(3) Williams-Beuren syndrome: autosomal dominant multisystem disorder with supravalvular AS (in 71\\%), MV prolapse, PS, peculiar facies\n(4) Ehlers-Danlos syndrome\n(5) Postrubella syndrome: peripheral pulmonic stenoses, valvular pulmonic stenosis, PDA, low birth weight, deafness, cataract, mental retardation\n(6) Tetralogy of Fallot / critical valvular pulmonic stenosis\n\n## Peripheral Pulmonary Artery Stenosis\n\nFrequency: 5\\% of all pulmonary artery stenoses with an intact ventricular septum\n\n## RAYNAUD SYNDROME\n\n$=$ episodic digital ischemia in response to cold / emotional stimuli\nPathogenesis:\n(1) Increase in vasoconstrictor tone\n(2) Low blood pressure\n(3) Slight increase in blood viscosity\n(4) Immunologic factors ( $4-81 \\%$ )\n(5) Cold provocation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 166,
            "markdown": "- exaggerated response of digit to cold / emotional stress:\n- numbness + loss of tactile perception\n- demarcated pallor / cyanosis\n- hyperemic throbbing during rewarming\n- sclerodactyly; small painful ulcers at tip of digit\n\n\n# Raynaud Disease \n\n$=$ PRIMARY VASOSPASM $=$ SPASTIC FORM OF RAYNAUD SYNDROME\n$=$ exaggerated cold-induced constriction of smooth muscle cells in otherwise normal artery\nCause: ? acquired adrenoreceptor hypersensitivity\nMay be associated with: reflex sympathetic dystrophy, early stages of autoimmune disorders\nAge: most common in young women\n\n- usually affects all fingers of both hands equally\n$\\checkmark$ normal segmental arm + digit pressures at room temperature\n$\\checkmark$ peaked digit volume pulse $=$ rapid rise in systole, anacrotic notch just before the peak, dicrotic notch high on the downslope\nPPG:\n$\\checkmark$ flat-line tracing at low temperatures $\\left(10^{\\circ}-22^{\\circ} \\mathrm{C}\\right)$ with sudden reappearance of normal waveform at $24-26^{\\circ} \\mathrm{C}=$ \"threshold phenomenon\"\n\n\n## Raynaud Phenomenon\n\n$=$ SECONDARY VASOSPASM WITH OBSTRUCTION\n$=$ OBSTRUCTIVE FORM OF RAYNAUD SYNDROME\n$=$ digital artery occlusion $\\leftarrow$ stenotic process in normally constricting artery / associated with an abnormally high blood viscosity\nCause:\n\n1. Atherosclerosis (most frequent)\n(a) embolization from an upstream lesion\n(b) occlusion of major arteries supplying arm\n2. Arterial trauma\n3. End stage of many autoimmune disorders:\neg, scleroderma, rheumatoid arthritis, systemic lupus erythematosus\n4. Takayasu disease\n5. Buerger disease\n6. Drug intoxication: ergot, methysergide)\n7. Dysproteinemia\n8. Primary pulmonary hypertension\n9. Myxedema\n\n- normal vasoconstrictive response to cold\n$\\checkmark$ reduced segmental arm + digit pressures at room temperature\nPPG ( $76 \\%$ sensitivity, $92 \\%$ specificity):\n$\\checkmark$ flat-line / barely detectable tracing at low temperature with gradual increase of amplitude upon rewarming\nHand magnification angiography:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 167,
            "markdown": "1. Baseline angiogram with ambient temperature\n2. Stress angiogram immediately following immersion of hand in ice water for 20 seconds\n\n# RECREATIONAL DRUG ABUSE \n\n$=$ INTRAVENOUS DRUG ABUSE\nIncidence: $35,000,000>12$ years of age admit to cocaine use at least once in their lifetime; $6,000,000$ in a year, $2,300,000$ in a month; $8,000,000$ have used \"crack\"\n$\\diamond$ Cocaine is the most commonly used illicit drug + most frequent cause of drugrelated deaths\n\n## Drugs:\n\nnasal insufflation of cocaine, smoking of alkaloidal cocaine (\"freebase\", \"crack\"), amphetamines, amphetamine derivatives (3,4-methylenedioxymethamphetamine [MDMA] = \"ecstacy\"), opiates, cannabis, inhaled volatile agents (amyl and butyl nitrites = \"poppers\"), industrial solvents (toluene)\nComplications secondary to:\n(a) physical / mechanical effects of method of administration (eg, injection technique + choice of injection site [eg, \"groin hit\" into femoral vein; \"pocket shot\" into jugular, subclavian, brachiocephalic vein])\n(b) chemical / pharmacologic effects of drug or combination of drugs (eg, heroin + cocaine / Talwin ${ }^{\\circledR}$ )\n(c) effects of adulterants / filler agents (eg, heroin is mixed [\"cut\"] with quinine, baking soda, sawdust)\n(d) microbiologic sequelae (septic preparation)\n(e) social + behavioral consequences\n\n## Cardiovascular Complications of Drug Abuse\n\nA. Cardiac complications\n\n1. Acute myocardial ischemia + infarction\n\nCause: intense coronary vasoconstriction, platelet activation (cocaine)\nDrug: amphetamines, cocaine\n2. Arrhythmia\n3. Dilated cardiomyopathy (often reversible)\n\nCause: chronic drug abuse\n4. Endocarditis (esp. of tricuspid valve)\n\nCause: bacteremia (most commonly S. aureus) with nonsterile IV administration\nB. Arterial complications\n\n1. Aortic dissection\n\nCause: systemic hypertension + positive inotropic + chronotropic cardiac effects of cocaine\n2. Arterial occlusion\n(a) at injection site $\\leftarrow$ intimal damage, thrombosis, spasm\n(b) distal to injection site $\\leftarrow$ embolization, spasm\n3. Pseudoaneurysm\n4. Mycotic aneurysm",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 168,
            "markdown": "5. Arteriovenous fistula\n6. Embolization of infectious agent / foreign body / air through inadvertent arterial injection (\"hit the pink\")\nC. Venous complications\n7. Deep vein thrombosis (DVT) (after superficial veins have been exhausted) \"groin hit\" into femoral vein; \"pocket shot\" into jugular, subclavian vein, brachiocephalic vein\n8. Septic thrombophlebitis\n9. Intravenous migration of needle to heart / lungs\n\n# Respiratory Complications of Drug Abuse \n\n1. Bronchitis, epiglottitis, sinusitis\n\nDrug: nasal insufflation of cocaine hydrochloride, smoking of alkaloidal cocaine (freebase, crack)\n2. Nasal septal perforation = \"cocaine nose\"\n\nCause: ischemic necrosis from chronic cocaine use\n3. Pneumonia\n\nCause: aspiration during altered consciousness, anesthetic effect of cocaine on pharynx\n4. Pulmonary edema\n\nDrug: opiate overdose, IV use of cocaine hydrochloride, smoking of crack cocaine, amphetamine, MDMA\nCause: cardiogenic, neurogenic pulmonary edema $\\leftarrow$ CNS effects of drug, direct toxic effect on alveolar-capillary membrane, immune response activation\n5. Pulmonary hemorrhage\n\nDrug: crack cocaine\n6. Bland / septic pulmonary embolism\n\nCause: DVT, septic thrombophlebitis, tricuspid valve endocarditis\n7. Pulmonary granulomatosis\n\nDrug: insoluble filler agents in oral medications abused intravenously like talc (magnesium silicate), starch, cellulose\n8. Emphysema\n\nDrug: marijuana, IV abuse of methylphenidate (Ritalin)\n9 Hemo- / pyo- / pneumothorax\nCause: attempted subclavian / jugular vein puncture (\"pocket shot\"), rupture of drugrelated bulla, rupture of peripheral pulmonary abscess, inhalational maneuvers during crack / cannabis use\n\n## Neurologic Complications of Drug Abuse\n\n1. Intracranial hemorrhage\n\nCause: sympathomimetic effect of $\\rightarrow$ systemic vasoconstriction $\\rightarrow$ increased cardiac output $\\rightarrow$ severe acute hypertension\nN.B.: in $50 \\%$ underlying vascular lesion\n\nDrug: esp. alkaloidal form of cocaine, amphetamine\n2. Ischemic stroke\n\nCause: vasoconstrictive effects; platelet activation of cocaine; vasculitis in amphetamine",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 169,
            "markdown": "+ cocaine; embolic events in endocarditis / injection of particulate material Drug: cocaine, MDMA, heroin\n3. Posterior reversible encephalopathy syndrome (PRES)\n\nDrug: cocaine, amphetamine\n4. Diffuse cerebral edema\n\nCause: anoxic brain injury after drug-induced cardiac arrest, severe respiratory depression in opiate overdose, fulminant multiorgan failure in drug overdose\n5. Toxic leukoencephalopathy\n\nDrug: inhalation of heroin vapor (pyrolysate) heated on tinfoil (\"chasing the dragon\"); inhalant abuse of industrial solvent toluene\n6. Cerebral atrophy (esp. frontal lobes)\n\nCause: chronic drug abuse\n7. CNS infection\n\nCause: left-sided endocarditis\n\n# Soft-tissue Complications of Drug Abuse \n\n1. Cellulitis from subcutaneous injection (\"skin popping\") after exhausting all venous access\n2. Pyomyositis\n3. Necrotizing fasciitis\n4. Abscess: esp. iliopsoas\n5. Hematoma\n6. Foreign bodies\n7. Lymphadenopathy\n\n## Skeletal Complications of Drug Abuse\n\n1. Osteomyelitis\n(a) direct contamination: eg, pubic bone (\"groin hit\") / clavicle (\"pocket shot\")\n(b) hematogenous: spine most commonly affected\n2. Septic arthritis: sacroiliac, sternoclavicular, symphysis pubis, acromioclavicular, hip, knee, wrist\n3. Diskitis\n\nCx: 1. Spinal epidural abscess in $5-18 \\% \\leftarrow$ vertebral osteomyelitis\n2. Cord compression $\\leftarrow$ collapsed vertebral body\n\n## Visceral Complications of Drug Abuse\n\nA. Gastrointestinal complications\n\n1. Severe colonic ileus resulting in chronic constipation + fecal impaction $\\leftarrow$ opiates\n$C x$ : stercoral colitis $\\leftarrow$ pressure necrosis; perforation of rectum / sigmoid colon\n2. Mesenteric ischemia / infarction (cocaine, amphetamines)\n3. Colonic pseudoobstruction\n4. Necrotizing enterocolitis\n5. Liver abscess\nB. Genitourinary complications\n6. Acute renal toxicity\n7. Rhabdomyolysis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 170,
            "markdown": "3. Renal infarction\n4. Focal / segmental glomerulosclerosis $\\leftarrow$ heroin abuse\n5. Distal tubular renal acidosis $\\leftarrow$ toluene abuse\n6. Amyloidosis\nC. Acquired viral infection\n\nCause: sharing of contaminated needles\n\n1. HIV (in 5-10\\%)\n2. Hepatitis B + C (20-59\\%)\n\n# RHABDOMYOMA OF HEART \n\n$=$ benign myocardial hamartoma\nPrevalence: most common cardiac tumor in infancy + childhood (up to 90\\%)\nAge: usually discovered $<1$ year of age\nPath: well-circumscribed intramural lobulated nodule / multiple $<1 \\mathrm{~mm}$ nodules ( $=$ rhabdomyomatosis)\nHisto: \"spider cells\" = enlarged vacuolated cells with high glycogen content + central nucleus surrounded by clear cytoplasm and radial extensions\nAssociated with: congenital heart disease\nWith cardiac rhabdomyomas tuberous sclerosis is found in $60-80 \\%$. With tuberous sclerosis $>50 \\%$ have rhabdomyomas!\n\n- asymptomatic (incidental detection at prenatal US)\n- murmur, arrhythmia\n- heart failure $\\leftarrow$ obstruction of left ventricular outflow tract / reduction of enddiastolic volume / decreased contractility\n- supraventricular tachycardia $\\leftarrow$ accessory conductive pathways within tumor\n\nPresentation: cardiac rhabdomyomas may precede skin lesions (hypopigmented \"ash-leaf\" macules) and neuroradiologic findings (subependymal nodules, cortical tubers) by months or years!\nLocation: multifocal (in up to $90 \\%$ ); ventricular wall with intramural growth + tendency to involve interventricular septum; atrial wall (rare)\nAverage size: $3-4 \\mathrm{~cm}$; up to 10 cm in diameter\nUS (good for small intramural lesions):\n$\\checkmark$ fetal nonimmune hydrops\n$\\checkmark$ solid echogenic sessile mass $\\pm$ intracavitary component bulging into ventricular outflow tract / atrioventricular valve\n$\\checkmark$ diffuse myocardial thickening (with multiple small lesions)\nMR (complimentary to US):\n$\\checkmark$ tumor iso- to marginally hyperintense on T1WI\n$\\checkmark$ hyperintense to myocardium on T2WI\n$\\checkmark$ hypointense to myocardium after contrast enhancement\nPrognosis: may regress spontaneously in patients $<4$ years old\n$R x$ : surgical excision for life-threatening symptoms\n$D D x$ : fibroma (solitary centrally calcified + cystic tumor, in ventricular myocardium, associated with Gorlin syndrome); teratoma (single intrapericardial multicystic mass);",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 171,
            "markdown": "hemangioma (arise from right atrium, pericardial effusion, skin hemangiomas)\n\n# RIGHT AORTIC ARCH (RAA) \n\nPrevalence: $1-2 \\%$\nEmbryology: persistence of right aortic arch and right descending aorta + regression of left aortic arch\nCourse: to right of trachea + esophagus, over right mainstem bronchus; crosses lower thoracic spine; passes through left hemidiaphragm\nIncidence of right aortic arch in CHD:\n\n1. Truncus arteriosus $35 \\%$\n2. Pulmonary atresia $25 \\%$\n3. Tetralogy of Fallot $25 \\%$\n4. Tricuspid atresia $15 \\%$\n5. DORV $12 \\%$\n6. TGV $8 \\%$\n7. Large VSD $2 \\%$\n\nRare anomalies:\n\n1. Corrected transposition\n2. Pseudotruncus\n3. Asplenia\n4. Pink tetralogy\n\n## RAA with Aberrant Left Subclavian Artery\n\n$=$ RAA with ALSA + left ligamentum arteriosum\nEmbryology: interruption of embryonic left arch between left CCA + left subclavian artery\n$\\diamond$ Most common type of right aortic arch anomaly\nPrevalence: $1 \\div 2,500 ; 35-72 \\%$ of right aortic arch anomalies\n$\\diamond 2^{\\text {nd }}$ most common cause of vascular rings ( $12-25 \\%$ ) after double aortic arch\nAssociated with: congenital heart disease in 5-12\\%:\n\n1. Tetralogy of Fallot $(2 / 3=8 \\%)$\n2. $\\mathrm{ASD} \\pm \\mathrm{VSD}(1 / 4=3 \\%)$\n3. Coarctation $(1 / 12=1 \\%)$\n\n- usually asymptomatic (loose ring around trachea + esophagus)\n- may be symptomatic in infancy / early childhood:\n- wheezing + stridor provoked by bronchitis + tracheal edema\n- dysphagia ( $50 \\%$ of children and adults)\n- may be symptomatic in adulthood provoked by torsion of aorta\n$\\sqrt{ }$ left common carotid artery is first branch of ascending aorta\n$\\sqrt{ }$ left subclavian artery arises from descending aorta via the remnant of the left dorsal aortic root (= lusorian artery)\n$\\sqrt{ }$ bulbous configuration of origin of LSA (= remnant of embryonic left arch) = retroesophageal aortic diverticulum = diverticulum of Kommerell (N.B.: originally described as diverticular outpouching at origin of right subclavian artery with left aortic arch):",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 172,
            "markdown": "[Burckhard Friedrich Kommerell (1901-1990), chief of radiology at the Charité University Clinic in Berlin and radiologist in Heidelberg, Germany]\n$\\sqrt{ }$ small rounded density left lateral to trachea\n$\\sqrt{ }$ impression on left side of esophagus simulating a double aortic arch (by aortic diverticulum or ductus / ligamentum arteriosum)\n$\\checkmark$ vascular ring (= left ductus extends from aortic diverticulum to left pulmonary artery):\n$\\checkmark$ impression on tracheal air shadow (by right aortic arch)\n![img-28.jpeg](img-28.jpeg)\n$\\sqrt{ }$ right esophageal indentation (by right aortic arch)\n$\\sqrt{ }$ masslike density silhouetting top of aortic arch just posterior to trachea on LAT CXR $\\leftarrow$ aberrant left subclavian artery\n$\\sqrt{ }$ broad posterior impression on esophagus $\\leftarrow$ left subclavian artery / aortic diverticulum\n$\\checkmark$ small anterior impression on trachea $\\leftarrow$ left common carotid artery\n$\\checkmark$ descending aorta on right side\nCT:\n$\\sqrt{ }$ \"four artery\" sign $=2$ dorsal subclavian arteries and 2 ventral carotid arteries evenly spaced around trachea\n\n# Right Aortic Arch with Mirror-image Branching \n\n$\\diamond 2^{\\text {nd }}$ most common aortic arch anomaly: $24-60 \\%$\n$=$ interruption of embryonic left arch between left subclavian artery and descending aorta; retroesophageal left ductus arteriosus / lig. arteriosum\n\n## Interruption of Left Aortic Arch Distal to Ductus Arteriosus = Type 1 (common)\n\nAssociated with: cyanotic CHD in $98 \\%$ :",
            "images": [
                {
                    "id": "img-28.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 501,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1287,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 173,
            "markdown": "1. Tetralogy of Fallot (87\\%)\n2. Multiple defects $(7.5 \\%)$\n3. Truncus arteriosus $(2-6 \\%)$\n4. Transposition $(1-10 \\%)$\n5. Tricuspid atresia $(5 \\%)$\n6. $\\mathrm{ASD} \\pm \\mathrm{VSD}(0.5 \\%)$\n$\\diamond 25 \\%$ (37\\%) of patients with tetralogy of Fallot (truncus arteriosus) have a right aortic arch!\n$\\sqrt{ }$ NO vascular ring, NO retroesophageal component\n$\\sqrt{ }$ NO structure posterior to trachea\n$\\sqrt{ }$ R arch impression on tracheal air shadow\n$\\sqrt{ }$ NORMAL barium swallow\nInterruption of Left Aortic Arch Proximal to Ductus Arteriosus = Type 2 (rare)\n$=$ true vascular ring (if duct persists); rarely associated with CHD\n\n# RAA with Isolated Left Subclavian Artery \n\n$\\diamond 3^{\\text {rd }}$ most common right aortic arch anomaly: $2 \\%$\n$=$ interruption of embryonic left arch between\n(a) left CCA and left subclavian artery and\n(b) left ductus and descending aorta\nresulting in a connection of left subclavian artery with left pulmonary artery\nAssociated with: tetralogy of Fallot\n$\\sqrt{ }$ left common carotid artery arises as the first branch\n$\\sqrt{ }$ left subclavian artery attaches to left pulmonary artery through PDA\n$\\sqrt{ }$ NO vascular ring, NO retroesophageal component\n\n- congenital subclavian steal syndrome\n\n\n## RAA with Aberrant Left Brachiocephalic Artery\n\nSimilar in appearance to R aortic arch + aberrant L subclavian artery\n\n## SINGLE VENTRICLE\n\n$=$ UNIVENTRICULAR HEART = DOUBLE INLET SINGLE VENTRICLE\n$=$ failure of development of interventricular septum $\\pm$ absence of one atrioventricular valve (mitral / tricuspid atresia) $\\pm$ aortic / pulmonic stenosis\nAssociated with: TGV or DORV\n\n- conduction defect $\\leftarrow$ aberrant anatomy of conduction system\n$\\sqrt{ } 2$ atrioventricular valves connected to a main ventricular chamber\n$\\sqrt{ }$ the single ventricle may be a LV ( $85 \\%$ ) / RV / undetermined\n$\\sqrt{ }$ a second rudimentary ventricular chamber may be present, which is located anteriorly (in left univentricle) / posteriorly (in right univentricle):\n$\\sqrt{ }$ rudimentary chamber $\\pm$ connection to one great artery\n$\\sqrt{ }$ may be associated with tricuspid / mitral atresia\n\n\n## SPLENIC ARTERY ANEURYSM",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 174,
            "markdown": "$=$ most frequent of visceral artery aneurysms\nEtiology: medial degeneration with superimposed atherosclerosis, congenital, mycotic, pancreatitis, trauma, portal hypertension (in $7-10 \\% \\leftarrow$ high flow rate)\nPredisposed: women with $\\geq 2$ pregnancies ( $88 \\%$ )\nMay be associated with: fibromuscular disease (in 20\\%)\n$\\mathrm{M} \\div \\mathrm{F}=1 \\div 2$\n\n- usually asymptomatic / pain, GI bleeding\n\nLocation: intra- / extrasplenic\n$\\sqrt{ }$ calcified wall of aneurysm $\\left({ }^{2} / \\cdot\\right)$\nCx: rupture of aneurysm ( $6-9 \\%$, higher during pregnancy) especially if $>1.5 \\mathrm{~cm}$ in diameter\nMortality: up to $76 \\%$\n$D D x$ : renal artery aneurysm, tortuous splenic artery\n\n# SUBCLAVIAN STEAL SYNDROME \n\n$=$ stenosis / obstruction of subclavian artery near its origin with flow reversal in ipsilateral vertebral artery at the expense of the cerebral circulation\nFrequency: $2.5 \\%$ of all extracranial arterial occlusions\nEtiology:\n(a) congenital: interruption of aortic arch, preductal infantile coarctation, hypoplasia of left aortic arch, hypoplasia / atresia / stenosis of an anomalous left subclavian artery with right aortic arch, coarctation with aberrant subclavian artery arising distal to the coarctation\n(b) acquired: atherosclerosis ( $94 \\%$ ), dissecting aneurysm, chest trauma, embolism, tumor thrombosis, inflammatory arteritis (Takayasu, syphilitic), ligation of subclavian artery in Blalock-Taussig shunt, complication of coarctation repair, radiation fibrosis\nAverage age: 59-61 years; $\\mathrm{M} \\div \\mathrm{F}=3 \\div 1$; Whites $\\div$ Blacks $=8 \\div 2$\nAssociated with: additional lesions of extracranial arteries in $81 \\%$\n\n- lower systolic blood pressure by $>20-40 \\mathrm{mmHg}$ on affected side\n- delayed weak / absent pulse in ipsilateral extremity\n- signs of vertebrobasilar insufficiency ( $40 \\%$ ):\n- syncopal episodes initiated by exercising the ischemic arm\n- headaches, nausea, vertigo, ataxia\n- mono-, hemi-, para-, quadriparesis, paralysis\n- diplopia, dysphagia, dysarthria, paresthesias around mouth\n- uni- / bilateral homonymous hemianopia\n- signs of brachial insufficiency ( $3-10 \\%$ ):\n- intermittent / constant pain in affected arm precipitated by increased activity of that arm\n- paresthesia, weakness, coolness, numbness, burning in fingers + hand; fingertip necrosis\n\nLocation: $\\mathrm{L} \\div \\mathrm{R}=3 \\div 1$\nColor Doppler:\n$\\sqrt{ }$ reversal of vertebral artery flow $\\rightarrow$ augmented by arm exercise / reactive hyperemia (= blood pressure cuff inflated above systolic pressure for 5 min )\nAngio:\n$\\checkmark$ subclavian stenosis / occlusion (aortic arch injection)\n$\\checkmark$ reversal of vertebral artery flow (selective injection of contralateral subclavian / vertebral",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 175,
            "markdown": "artery)\nCAVE: \"false steal\" = transient retrograde flow in contralateral vertebral artery caused by high-pressure injection\n$R x$ : bypass surgery, PTA (good long-term results)\n\n# Partial Subclavian Steal Syndrome \n\n$=$ retrograde flow in systole + antegrade flow in diastole\n\n## Occult Subclavian Steal Syndrome\n\n$=$ reverse flow seen only after provocative maneuvers, ie, ipsilateral arm exercise of $5 \\mathrm{~min} /$\n5 min inflation of sphygmomanometer $>$ systolic blood pressure levels\n\n## SUPERIOR MESENTERIC ARTERY SYNDROME\n\n$=$ ARTERIOMESENTERIC DUODENAL COMPRESSION SYNDROME = WILKIE SYNDROME = CHRONIC DUODENALILEUS = BODY CAST SYNDROME\n$=$ rare cause of duodenal obstruction $\\leftarrow$ compression of $3^{\\text {rd }}$ portion of duodenum between SMA and aorta; probably representing a functional reflex dilatation\nNormal anatomy: see \"nutcracker phenomenon\"\nCause: congenital, weight loss, visceroptosis $\\leftarrow$ loss of abdominal muscle tone (as in pregnancy), asthenic build, exaggerated lumbar lordosis, prolonged bed rest in supine position\nPathophysiology:\n(1) rapid severe weight loss $\\leftarrow$ cachexia (AIDS, malabsorption, cancer); catabolic condition (burns, major surgery); eating disorder (anorexia nervosa); drug abuse; post bariatric surgery $\\rightarrow$ loss of retroperitoneal fat $\\rightarrow$ decrease in angle (AMA) + space (AMD) $\\rightarrow$ duodenal compression\n(2) Post scoliosis surgery $\\rightarrow$ lengthening of spine $\\rightarrow$ increased tension on mesentery $\\rightarrow$ decreased AMA and AMD\n(3) Applied external abdominal pressure (body / hip spica cast)\n(4) Anatomic variant: insertional variation of ligament of Treitz / low origin of SMA $\\rightarrow$ more cranial disposition of duodenum $\\rightarrow$ acute AMA\nFrequency: $0.1-0.3 \\%$ of barium studies\nAge: $10-39$ years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 2$\n\n- postprandial epigastric pain and fullness relieved by lying prone / in left lateral decubitus position\n- nausea, repetitive vomiting, weight loss, anorexia\n- severe esophagitis + gastritis $\\leftarrow$ stasis / chronic obstruction\n\nAngio / sagittal MR / reformatted CT (test of choice):\n$\\sqrt{ }$ narrowing of angle between SMA + aorta to $6-22^{\\circ}$ (AMA)\n$\\sqrt{ }$ reduced distance between SMA + aorta to $2-8 \\mathrm{~mm}$ (AMD)\nUpper GI:\n$\\sqrt{ }$ megaduodenum $=$ pronounced dilatation of $1^{\\text {st }}+2^{\\text {nd }}$ portion of duodenum + frequently dilated stomach (best seen in supine position)\n$\\sqrt{ }$ vertical linear compression defect in transverse portion of duodenum overlying spine\n$\\sqrt{ }$ abrupt change in caliber distal to compression defect",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 176,
            "markdown": "$\\sqrt{ }$ antiperistaltic waves proximal to obstruction\n$\\sqrt{ }$ delayed gastroduodenal emptying\n$\\sqrt{ }$ relief of obstruction by postural change into prone knee-elbow position\nRx: (1) conservative: fluid + electrolyte resuscitation, nasojejunal feeding, small liquid meals, prone / left lateral decubitus patient position, restoration of retroperitoneal fat through hyperalimentation)\n(2) surgery: duodenojejunostomy, gastrojejunostomy, Strong procedure (= lysis of ligament of Treitz with derotation of bowel)\n\n# SUPERIOR VENA CAVA SYNDROME \n\n$=$ obstruction of SVC with development of collateral pathways\nEtiology:\nA. MALIGNANT LESION (78-97\\%)\n\n1. Bronchogenic carcinoma ( $50-80 \\%$ )\n2. Lymphoma ( $2-20 \\%$ )\n3. Metastatic mediastinal nodes ( $\\leftarrow$ commonly breast ca.)\n4. Mediastinal germ cell tumor\n5. Malignant thymoma\nB. BENIGN LESION\n6. Granulomatous mediastinitis: usually histoplasmosis, sarcoidosis, TB\n7. Substernal goiter\n8. Ascending aortic aneurysm\n9. Pacer wires / central venous catheter ( $23 \\%$ )\n10. Constrictive pericarditis\n\n## Collateral routes:\n\n1. Esophageal venous plexus = \"downhill varices\" (predominantly upper $2 / 3$ of esophagus)\n2. Azygos + hemiazygos veins\n3. Accessory hemiazygos + superior intercostal veins = \"aortic nipple\" (visualization in normal population in $5 \\%$ )\n4. Lateral thoracic veins + umbilical vein\n5. Vertebral veins\n\n- head and neck edema ( $70 \\%$ ), headache, dizziness, syncope\n- cutaneous enlarged venous collaterals, proptosis, tearing\n- with benign etiology: slower onset + progression, both sexes at 25-40 years of age\n- with malignancy: rapid progression within weeks, mostly males at 40-60 years of age\n- dyspnea, cyanosis, chest pain, hematemesis ( $11 \\%$ )\n$\\checkmark$ superior mediastinal widening ( $64 \\%$ )\n$\\checkmark$ encasement / compression / occlusion of SVC\n$\\checkmark$ dilated cervical + superficial thoracic veins ( $80 \\%$ )\n$\\checkmark$ SVC thrombus\nNUC:\n$\\checkmark$ increased tracer uptake in quadrate lobe + posterior aspect of medial segment of left lobe\n$\\leftarrow$ umbilical pathway toward liver when injected in upper extremity",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 177,
            "markdown": "# TAKAYASU ARTERITIS \n\n$=$ PULSELESS DISEASE $=$ AORTITIS SYNDROME\n$=$ AORTOARTERITIS $=$ IDIOPATHIC MEDIAL AORTOPATHY $=$ AORTIC ARCH SYNDROME $=$ MARTORELL SYNDROME\n$=$ idiopathic chronic relapsing necrotizing obliterative segmental large-vessel panarteritis affecting mainly elastic arteries (aorta $>$ main aortic branches $>$ pulmonary arteries) limited to persons usually $<50$ years of age\n$\\diamond$ The only form of aortitis that produces stenosis / occlusion of the aorta!\nEtiology: probably cell-mediated autoimmune process\nPrevalence: $1 \\div 1,000,000 ; 2.2 \\%$ (at autopsy)\nIncidence: $2.6 \\div 1,000,000$ annually (USA)\nGeography: common in Asia, Mediterranean basin, South Africa, Latin America; rare in Europe + North America\nAge: 12-66 years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 8$; especially in Asians\n$\\diamond$ Primary large-vessel vasculitis in children and adults!\n$\\diamond 3^{\\text {rd }}$ most common form of childhood vasculitis!\nHisto: (a) Acute stage: granulomatous infiltrative process focused on elastic fibers of media of arterial wall consisting of multinucleated giant cells, lymphocytes, histiocytes, plasma cells; perivascular cuffing of vasa vasorum\n(b) Fibrotic stage (weeks to years): progressive fibrosis of vessel wall resulting in constriction from intimal proliferation / thrombotic occlusion / aneurysm formation ( $\\leftarrow$ extensive destruction of elastic fibers in media); $\\rightarrow$ ultimately fibrosis of intima + adventitia\n$\\diamond$ Morphologically indistinguishable from temporal arteritis!\nClinical stages: often overlapping $\\leftarrow$ relapsing course\n» prepulseless / systemic / early phase\nDuration: few months - 1 year\n\n- nonspecific systemic signs + symptoms: fever, night sweats, weakness, weight loss, myalgia, arthralgia\n$\\diamond$ Mean interval of 8 years between onset of symptoms + Dx\n» vascular inflammatory phase\n» pulseless / occlusive / late phase\n- signs + symptoms of ischemia of limb (arm claudication, pulse deficit, bruits, discrepant blood pressures)\n- renovascular hypertension, abdominal angina\n- visual symptoms\n- neurologic symptoms: transient ischemic attack, stroke, hypertensive encephalopathy\n- erythrocyte sedimentation rate (ESR) $>20 \\mathrm{~mm} /$ hour in $80 \\%$\n\nThe diagnosis of Takayasu arteritis is based on clinical information, laboratory evaluation, and diagnostic imaging, because a large-vessel biopsy cannot be performed.\nNumano classification: involvement usually bilateral\nType I : branches of aortic arch = brachiocephalic trunk + carotid arteries + subclavian arteries",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 178,
            "markdown": "Type II : combination of type I + III\nIIa : ascending aorta / aortic arch $\\pm$ branches\nIIb : descending thoracic aorta $\\pm$ ascending aorta / aortic arch with its branches\nType : entire descending aorta $\\pm$ renal arteries\nIII\nType : abdominal aorta $\\pm$ renal arteries\nIV\nType V : entire aorta with branches\n$\\mathrm{C} / \\mathrm{P}(+)=$ involvement of coronary / pulmonary arteries\nCommonly involved: left subclavian artery ( $<50 \\%$ ), left common carotid artery ( $20 \\%$ ), brachiocephalic trunk, renal arteries, celiac trunk, superior mesenteric a., pulmonary a.\nInfrequently involved: axillary, brachial, vertebral, iliac arteries (usually bilaterally), coronary arteries\nAngiography / DSA:\n$\\diamond$ Difficult catheterization / risk of ischemic complications $\\leftarrow$ increase in coagulation!\n$\\checkmark$ arterial wall thickening + contrast enhancement\n$\\checkmark$ full-thickness calcification (= chronic disease)\n$\\checkmark$ mural thrombi\nDx: involvement of $>2$ medium-sized branch vessels\nCXR:\n$\\checkmark$ widened supracardiac shadow $>3.0 \\mathrm{~cm}$\n$\\checkmark$ wavy / scalloped appearance of lateral margin of descending aorta\n$\\checkmark$ aortic calcifications ( $15 \\%$ ) commonly in aortic arch + descending aorta\n$\\checkmark$ focal decrease of pulmonary vascularity\nNECT:\n$\\checkmark$ high-attenuation arterial walls of variable thickness\n$\\checkmark$ calcifications in aorta + its branches\nCT angiography ( $95 \\%$ sensitive, $100 \\%$ specific):\n$\\checkmark$ concentric thickening of vessel wall $>3 \\mathrm{~mm}$ :\n$\\checkmark$ \"double ring\" appearance = poorly enhanced internal ring (= swollen intima) + enhancing outer ring (= inflamed media and adventitia)\n$\\checkmark$ mural thrombus, stenosis, occlusion\n$\\checkmark$ vessel ectasia, aneurysm, ulcer\n$\\checkmark$ typically linear wall calcifications after $>5$ years (usually sparing ascending aorta)\nMR:\n> acute / active inflammatory phase:\n$\\checkmark$ thickened enhancing arterial wall (on fat-suppressed T1)\n$\\checkmark$ mural edema of arterial wall (STIR) = measure of disease activity\n$\\checkmark$ bright T2 signal around inflamed vessel\n$\\checkmark$ mural thrombus, multilevel stenosis\n$\\checkmark$ thickening of aortic valve cusps\n$\\checkmark$ pericardial effusion\n$>$ late phase:\n$\\checkmark$ dilatation of ascending aorta",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 179,
            "markdown": "$\\checkmark$ segmental dilatation with stenotic regions of CCA + subclavian artery\n$\\checkmark$ complete occlusion of supra-aortic arteries at their origin, + multiple collaterals\n» luminal changes: multifocal stenoses, fusiform vascular dilatation, mural thrombi, collateral vessel formation\nUS:\n$\\checkmark$ \"macaroni sign\" long segment of smooth homogeneous concentric wall thickening\n$\\checkmark$ increased intimal-medial thickness $=$ reliable marker for disease activity\n@ Aorta (common involvement)\nLocation: abdominal aorta $>$ descending thoracic $>$ arch\n$\\checkmark$ long + diffuse / short + segmental irregular stenosis / occlusion of major branches of aorta near their origins\n$\\checkmark$ stenotic lesions of descending thoracic $>$ abdominal aorta\n$\\checkmark$ frequent skipped lesions\n$\\checkmark$ abundant collateralization (late phase)\n$\\checkmark$ aneurysmal dilatation of ascending aorta + arch (= diffusely dilated lumen with irregular contours) $\\rightarrow$ aortic insufficiency\n$\\checkmark$ fusiform / saccular aortic aneurysms ( $10-15 \\%$ ) (common in descending thoracic + abdominal aorta)\n$C x:$ rapid aneurysm expansion $\\rightarrow$ aortic rupture ( $33 \\%$ )\n@ Brachiocephalic arteries\n$\\checkmark$ multisegmented dilatation of carotid artery producing segmental septa\n$\\checkmark$ diffuse homogeneous circumferential thickening of vessel wall in proximal common carotid artery\n$\\checkmark$ increase in flow velocity + turbulence\n$\\checkmark$ distal CCA, ICA, ECA spared with dampened waveforms\n@ Pulmonary arteries ( $50-80 \\%$ )\nLocation: segmental + subsegmental (common); lobar + main pulmonary arteries (uncommon)\n$\\diamond$ often late manifestation of disease\n$\\checkmark$ dilatation of pulmonary trunk (19\\%)\n$\\checkmark$ nodular thrombi (3\\%)\n$\\checkmark$ \"pruned tree\" appearance / flame-shaped stenosis of pulmonary arteries (66\\%)\n$\\checkmark$ unilateral occlusion / aneurysm of pulmonary artery\n$\\checkmark$ systemic-pulmonary artery shunts\nCT angio:\n$\\checkmark$ wall thickening with enhancement (acute)\n$\\checkmark$ luminal + mural calcium deposition (chronic)\n$\\checkmark$ pulmonary artery stenosis / occlusion (chronic)\n@ Coronary arteries (in up to 20\\%)\n$C x: \\quad$ (1) Cerebrovascular accidents ( $10-20 \\%$ )\n(2) Heart failure $\\leftarrow$ aortic regurgitation\n\nDDx: atherosclerosis; temporal arteritis (CCA not involved); fibromuscular dysplasia (in ICA not CCA); idiopathic carotid dissection (ICA); syphilitic aortitis (calcification of ascending aorta)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 180,
            "markdown": "Rx: high-dose glucocorticoids, angioplasty after decline of active inflammation\n\n# TEMPORAL ARTERITIS \n\n$=$ CRANIAL / GRANULOMATOUS ARTERITIS\n$=$ POLYMYALGIA RHEUMATICA $=$ GIANT CELL ARTERITIS (poor choice because Takayasu disease is also a giant cell arteritis)\n$=$ systemic chronic granulomatous vasculitis\nGiant cell arteritis is a chronic vasculitis that affects large and medium-sized vessels, usually involving the superficial cranial arteries. It is closely related to polymyalgia rheumatica.\nIncidence: $20 \\div 100,000$ annually;\n$\\diamond$ Most common form of aortitis in North America!\nAge: usually limited to persons $>50$ years of age\nHisto: closely related to polymyalgia rheumatica\n(a) acute stage: granulomatous infiltrative process focused on elastic fibers of arterial wall (internal elastic lamina) consisting of multinucleated giant cells, lymphocytes, histiocytes, plasma cells\n(b) fibrotic stage (weeks to years): progressive fibrosis of vessel wall resulting in constriction from intimal proliferation / thrombotic occlusion / aneurysm formation\n$\\diamond$ Morphologically indistinguishable from Takayasu arteritis!\nAge peak: $65-75$ years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 3$\n> prodromal phase of flulike illness of 1-3 weeks:\n\n- malaise, low-grade fever, weight loss, myalgia\n- unilateral headache ( $50-90 \\%$ ), facial pain\n> chronic stage:\n- jaw claudication (while chewing + talking)\n- neuroophthalmic manifestations: visual impairment / diplopia / blindness; palpable tender temporal artery\n- polymyalgia rheumatica $(50 \\%)=$ intense myalgia of shoulder + hip girdles\n- erythrocyte sedimentation rate (ESR) of $40-140 \\mathrm{~mm} /$ hour (HALLMARK)\n\n\n## Location:\n\nany artery of the body; mainly medium-sized branches of aortic arch ( $10 \\%$ ), external carotid artery branches (particularly superficial temporal / occipital artery); vertebral artery; coronary arteries; mesenteric arteries; extracranial arteries below neck ( $9 \\%$ ): subclavian $>$ axillary $>$ brachial $>$ profunda femoris $>$ forearm $>$ calf",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 181,
            "markdown": "![img-29.jpeg](img-29.jpeg)\n\nNote: intracranial ICA + intracranial vertebral artery are not involved as internal elastic lamina ceases to exist 5 mm distal to entry point through dura mater\nDistribution: commonly bilateral + symmetric\n$\\sqrt{ }$ long smooth stenotic arterial segments with skip areas\n$\\sqrt{ }$ smooth tapered occlusions with abundance of collateral supply\n$\\sqrt{ }$ absence of atherosclerotic changes\nCT angiography:\n$\\sqrt{ }$ luminal changes: stenosis, occlusion, dilatation\n$\\sqrt{ }$ mural thrombus, aneurysm formation, mural calcifications\nMR angiography:\n$\\sqrt{ }$ edema of arterial wall (STIR) = measure of disease activity\n$\\sqrt{ }$ smooth tapering proximal + distal to lesion\nUS:\n$\\sqrt{ }$ \"halo\" sign = diffusely thickened hypoechoic arterial wall\n$\\sqrt{ } \\pm$ turbulent flow + stenosis of affected vessel\nPET ( $56 \\%$ sensitive, $98 \\%$ specific):\n$\\sqrt{ }$ abnormal uptake in aortic arch + large thoracic arteries\n@ Aorta\n$\\sqrt{ }$ anuloaortic ectasia + ascending aortic aneurysm that may extend into aortic arch (late",
            "images": [
                {
                    "id": "img-29.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 189,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1203,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 182,
            "markdown": "complication)\n$\\sqrt{ }$ aortic valve insufficiency, acute dissection\n$\\sqrt{ }$ abdominal aortic aneurysm\nCx: stroke in vertebrobasilar territory (rare)\n$D x$ : biopsy of palpable temporal artery\nPrognosis: disease may be self-limiting (1-2 years); 10\\% mortality within 2-3 years\n\n# TETRALOGY OF FALLOT \n\n[Etienne-Louis Arthur Fallot (1850-1911), physician of forensic medicine and hygiene in Marseille, France]\n$=$ underdevelopment of pulmonary infundibulum $\\leftarrow$ unequal partitioning of conotruncus $=$ anterior malalignment of conal septum\nFrequency: $8-11 \\%$ of all CHD; most common cyanotic CHD\nPrevalence: $3.3 \\div 100,000$ live births\nTETRAD:\n\n1. Large VSD immediately below aortic valve\n2. Right ventricular hypertrophy (in long-standing untreated disease) $\\leftarrow$ elevated RV systolic pressure\n3. Overriding aorta straddling VSD and receiving blood from both ventricles\n4. Obstruction of right ventricular outflow tract: usually of pulmonary infundibulum, occasionally pulmonic valve atresia\nmnemonic: Don't DROP the baby\nDefect: VSD\nRight ventricular hypertrophy\nOverriding aorta\nPulmonary stenosis\nEmbryology:\nabnormal spiraling caudad growth of truncoconal ridges in $3^{\\text {rd }}-4^{\\text {th }}$ week causes unequal partitioning of the conotruncus into a small underdeveloped anteromedial pulmonary infundibulum + large posterolateral LV outflow tract\nHemodynamics:\nfetus: pulmonary blood flow supplied by retrograde flow through ductus arteriosus with absence of RV hypertrophy / IUGR\nneonate: R-to-L shunt bypassing pulmonary circulation with decrease in systemic oxygen saturation (cyanosis); pressure overload + hypertrophy of RV $\\leftarrow$ pulmonicinfundibular stenosis\n\n| RA | $\\leftrightarrow / \\uparrow$ | RV | $\\uparrow$ | Main PA | $\\downarrow$ |\n| :-- | :-- | :-- | :-- | :-- | :-- |\n| Pulm. vessels | $\\downarrow$ |  |  | LPA | $\\uparrow$ |\n| LA | $\\leftrightarrow$ | LV | $\\leftrightarrow$ | Ao | $\\uparrow$ |\n\nSystemic pulmonary supply:\nvia major aortopulmonary (systemic-pulmonary) collaterals\nAssociated with:\n\n1. Bicuspid pulmonic valve $(40 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 183,
            "markdown": "2. Stenosis of left pulmonary artery ( $40 \\%$ )\n3. Right aortic arch ( $25 \\%$ ) with mirror-image branching\n4. Tracheoesophageal fistula\n5. Down syndrome\n6. Forked ribs, scoliosis\n7. Anomalies of coronary arteries in $10 \\%$ (single RCA / LAD from RCA)\n\n- cyanosis by 3-4 months of age (concealed at birth by PDA)\n- dyspnea on exertion, clubbing of fingers and toes\n- \"squatting position\" when fatigued $\\rightarrow \\uparrow$ pulmonary blood flow\n- \"episodic spells\" = loss of consciousness\n- polycythemia, lowered pO 2 values, systolic murmur in pulmonic area\n\nCXR:\n$\\sqrt{ }$ coeur en sabot (boot-shaped heart)\n[ sabot, French = wooden shoe / clog]\n$=$ uplifting of cardiac apex due to (1) right ventricular hypertrophy + (2) small / absent main pulmonary artery (in $65 \\%$ ) accentuated by large lung volume + small thymus + lordotic projection\n$\\checkmark$ pronounced concavity in region of pulmonary artery trunk $\\leftarrow$ small / absent PA\n$\\checkmark$ marked reduction in caliber + number of pulmonary arteries $\\leftarrow$ reduced blood flow to lungs:\n$\\checkmark$ asymmetric pulmonary vascularity\n$\\checkmark$ reticular pattern with horizontal course usually in periphery (= prominent collateral circulation of bronchial vessels + pleuropulmonary connections)\n$\\checkmark$ enlarged aorta\n$\\checkmark$ right-sided aortic arch in $25 \\%$\nOB-US:\n$\\checkmark$ dilated aorta overriding the interventricular septum\n$\\checkmark$ usually perimembranous VSD\n$\\checkmark$ mildly stenotic RV outflow tract\n$\\sqrt{ }$ NO RV hypertrophy in midtrimester\nECHO:\n$\\checkmark$ discontinuity between anterior aortic wall + interventricular septum (= overriding of the aorta)\n$\\checkmark$ small left atrium\n$\\checkmark$ RV hypertrophy with small right ventricular outflow tract\n$\\checkmark$ widening of the aorta\n$\\checkmark$ thickening of right ventricular wall + interventricular septum\nPrognosis: spontaneous survival without surgical correction in 50\\% (10\\%) up to age 7 (21) years\n$R x$ : surgery in early childhood\n(a) palliative\n\n1. Blalock-Taussig shunt $=$ end-to-side anastomosis of subclavian to pulmonary artery opposite aortic arch [64\\% (55\\%) survival rate at 15 (20) years]\n2. Pott operation on left = anastomosis of left PA with descending aorta",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 184,
            "markdown": "3. Waterston-Cooley procedure $=$ anastomosis between ascending aorta + right pulmonary artery\n4. Central shunt $=$ Rastelli procedure $=$ tubular synthetic graft between ascending aorta + pulmonary artery\n(b) corrective open cardiac surgery $=$ VSD-closure + reconstruction of RV outflow tract by excision of obstructing tissue ( $82 \\%$ survival rate at 15 years)\nOperative mortality: $3-10 \\%$\n\n# Pink Tetralogy \n\n$=$ infundibular hypertrophy $\\rightarrow$ minimal RVOT obstruction + VSD (3\\%) with predominantly L-to-R-shunt $\\rightarrow$ no cyanosis\n\n## Pentalogy of Fallot\n\n$=$ tetralogy + ASD\n\n## Trilogy of Fallot (infantile presentation)\n\n(1) Severe pulmonic valvular stenosis\n(2) Hypertrophy of RV\n(3) ASD with R-to-L shunt (increased pressure in RA forces foramen ovale open)\n\n## THORACIC OUTLET SYNDROME\n\n$=$ neurovascular syndrome caused by compression of subclavian vessels + brachial plexus between chest and arm\nPrevalence: $0.3-8.0 \\%$\nAge: $20-40$ years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 3$ to $1 \\div 4$\nThoracic outlet: above $1^{\\text {st }}$ rib and behind clavicle\n(a) interscalene triangle $=$ most medial space\n$\\diamond$ In $50 \\%$ responsible for neurologic compression!\nBorders: anterior scalene muscle (anteriorly), middle scalene muscle (posteriorly), medial surface of $1^{\\text {st }}$ rib (inferiorly)\nContent: subclavian artery, 3 divisions of brachial plexus\n(b) costoclavicular space\n$\\diamond$ Most frequent site of vascular compression!\n$\\diamond$ In $50 \\%$ responsible for neurologic compression!\nBorders: middle $1 / 3$ of clavicle (superiorly), subclavius muscle (anteriorly), $1^{\\text {st }}$ rib + middle scalene muscle (posteriorly)\nContent: subclavian vein\n(c) retropectoralis minor / subcoracoid space\n$\\diamond$ Rare site of compression!\nBorders: pectoralis minor muscle (anteriorly), subscapularis muscle (posteriorly + superiorly), anterior chest wall (posteriorly + inferiorly)\nContent: axillary vessels, 3 cords of brachial plexus\nArm abduction: $\\rightarrow$ narrowing of thoracic inlet in costoclavicular + retropectoralis minor spaces\nCause:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 185,
            "markdown": "# A. CONGENITAL / ANATOMIC \n\n1. Cervical rib ( $<1 \\%$ of general population)\n2. Scalene muscle anomaly\n(a) hypertrophy of anterior scalene muscle = scalenus anticus syndrome (most common)\n(b) common origin of anterior + middle scalene mm.\n(c) passage of brachial plexus through substance of anterior scalene muscle\n(d) supernumerary scalenus minimus muscle (rare) extending from transverse process of $7^{\\text {th }}$ cervical vertebra to $1^{\\text {st }}$ rib with insertion between brachial plexus + subclavian artery\n3. Anomalous $1^{\\text {st }}$ rib = unusually straight course with narrowing of costoclavicular space\n4. Elongated transverse process of C7\n5. Congenital fibromuscular bands\nB. ACQUIRED / POSTTRAUMATIC\n6. Fracture of clavicle / $1^{\\text {st }}$ rib (34\\%) with nonanatomic alignment / exuberant callus\n7. Posttraumatic fibrosis of scalene muscles\n8. Slender body habitus\n$=$ long neck, sagging / drooping shoulders $\\leftarrow$ backpacking\n9. Muscular body habitus\n$=$ arterial compression in pectoralis minor tunnel affecting weight lifter, swimmer, tennis player\n10. Supraclavicular tumor (lipoma, neurogenic tumor) / lymphadenopathy\n\n## Neurogenic Thoracic Outlet Syndrome (95\\%)\n\n- pain in forearm + hand that increases upon elevation and abduction of arm (sustained reaching overhead)\n- paresthesias of hand + fingers $(\\mathrm{C} 8+\\mathrm{T} 1)$ in ulnar nerve distribution with numbness, \"pins and needles\" in $95 \\%$\n- arm pain in radial nerve distribution (C5-C7 roots) and pain in neck, ear, upper chest, upper back\n- numbness, weakness, thenar wasting\n$R x$ : physical therapy; NSAID; muscle relaxants\n\n\n## Venous Thoracic Outlet Syndrome (4\\%)\n\n- arm swelling, distention of superficial veins, cyanosis, pain\n\n\n## Paget-von Schrötter Syndrome\n\n[Leopold von Schrötter (1837-1908), director of the world's first laryngological clinic at Vienna General Hospital and head of the department of internal medicine]\n$=$ EFFORT THROMBOSIS\n$=$ primary thrombosis of subclavian vein at costoclavicular junction (= subtype of thoracic outlet syndrome)\nIncidence: $1-2 \\div 100,000$ annually\nCause: repetitive / vigorous activity\n$R x$ : catheter-mediated thrombolysis (initially) + surgical decompression of",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 186,
            "markdown": "# Acterial Thoracic Outlet Syndrome (1\\%) \n\n- decreased skin temperature, discoloration of hand\n- intermittent claudication of fingers (from ischemia)\n- hyperabduction maneuver with obliteration of radial pulse (34\\%)\n- Raynaud phenomenon ( $40 \\%$ ): episodic constriction of small vessels\n- supraclavicular bruit ( $15-30 \\%$ )\n- Roos test = repeated clenching of fist with abducted + externally rotated arms\n- Adson test = palpation of radial pulse with patient sitting upright, hands on thigh, neck hyperextended, head turned toward affected side\n- Wright test = diminution of pulse during hyperabduction of arms\n\nBidirectional Doppler:\n\n1. Adson maneuver (for scalenus anticus muscle)\n$=$ hold deep inspiration while neck is fully extended + head turned toward ipsilateral and opposite side\n2. Costoclavicular maneuver (compression between clavicle $+1^{\\text {st }}$ rib) = exaggerated military position with shoulders drawn back and downward\n3. Hyperabduction maneuver (compression by humeral head / pectoralis minor muscle) $=$ extremity monitored through range of $180^{\\circ}$ abduction\n$\\sqrt{ }$ complete cessation of flow in one position\nPhotoplethysmography:\n4. Photo pulse transducer secured to palmar surface of one fingertip of each hand\n5. Arterial pulsations recorded with arm in\n(a) neutral position\n(b) extended $90^{\\circ}$ to side\n(c) $180^{\\circ}$ over the head\n(d) in \"military\" position with arms at $90^{\\circ}+$ shoulders pressed back\n$\\sqrt{ }$ complete disappearance of pulse in one position\nAngio:\n$\\sqrt{ }$ abnormal course of distal subclavian artery\n$\\sqrt{ }$ focal stenosis / occlusion\n$\\sqrt{ }$ poststenotic dilatation of distal subclavian artery\n$\\sqrt{ }$ aneurysm\n$\\sqrt{ }$ stress test: bandlike / concentric constriction\n$\\sqrt{ }$ mural thrombus $\\pm$ distal embolization\n$\\sqrt{ }$ venous thrombosis / obstruction\nPositional CTA (with adducted + then hyperabducted arms):\n$\\sqrt{ }$ vascular compression\n$\\sqrt{ }$ collateral arterial circulation\nMR:\n$\\sqrt{ }$ denervation-related fatty atrophy of muscles\n$\\sqrt{ }$ effacement of fat planes around compressed plexus\n$\\sqrt{ }$ abnormal intramuscular course of brachial plexus components\n$R x$ : thrombolytic therapy + concomitant anticoagulation (in acute thrombosis); NOT",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 187,
            "markdown": "endoluminal stent; surgery\n$D D x$ : Cervical disk disease, radiculopathy, spinal cord tumor, trauma to brachial plexus, arthritis, carpal tunnel syndrome, Pancoast tumor, peripheral arterial occlusive disease, aneurysm, causalgia, thromboembolism, Raynaud disease, vasculitis\n\n# TRANSPOSITION OF GREAT ARTERIES \n\n## Complete Transposition of Great Arteries\n\n$=$ TGA $=$ D-TRANSPOSITION\n$=$ great vessels originate from inappropriate ventricle:\n(1) Aorta originates from morphologic RV with an infundibulum\n(2) Pulmonary artery originates from morphologic LV\n(3) Normal position of atria + ventricles\n\nEmbryology: failure of the aorticopulmonary septum (= truncoconal ridges) to follow a spiral course\nFrequency: $5-7 \\%$ of all CHD\nIn $10 \\%$ associated with: a syndrome / extracardiac malformation; in $90 \\%$ isolated VARIATIONS:\n\n1. Complete TGA + intact interventricular septum\n![img-30.jpeg](img-30.jpeg)",
            "images": [
                {
                    "id": "img-30.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 983,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1940,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 188,
            "markdown": "2. Complete TGA + VSD: CHF due to VSD\n3. Complete TGA + VSD + PS: PS prevents CHF = longest survival\n\nHemodynamics:\nfetus : no hemodynamic compromise with normal birth weight\nneonate : mixing of the 2 independent circulations necessary to sustain life\nAdmixture of blood from both circulations via:\n(1) PDA (carries aortic blood into pulmonary artery)\n\nPrognosis: worst when PDA closes $\\rightarrow$ increase in volume of pulmonary blood flow\n(2) ASD / patent foramen ovale (allows saturated blood to enter RA from LA)\n(3) VSD (in $50 \\%$ )\n\n| RA | $\\uparrow$ | RV | $\\uparrow$ | Main PA | $\\leftrightarrow$ |\n| :-- | :-- | :-- | :-- | :-- | :-- |\n| Pulm. vessels | $\\uparrow$ |  |  |  |  |\n| LA | $\\leftrightarrow$ | LV | $\\leftrightarrow$ | Ao | $\\leftrightarrow$ |\n\nAssociated with: diabetic mothers\n\n- cyanosis: most common cause for cyanosis in neonate; $2^{\\text {nd }}$ most common cause of cyanosis after tetralogy of Fallot\n- symptomatic 1-2 weeks following birth\n\nCXR:\n$\\checkmark$ \"egg-on-a-string\" appearance of heart (on frontal CXR):\n$\\checkmark$ abnormal convexity of RA border (= \"egg\")\n$\\checkmark$ narrow superior mediastinum (= \"string\" = MOST CONSISTENT SIGN):\n$\\checkmark$ PA situated to the right of its normal location\n$\\checkmark$ PA obscured by aorta\n$\\checkmark$ stress-induced thymic atrophy\n$\\checkmark$ hyperaeration\n$\\checkmark$ cardiac enlargement beginning 2 weeks after birth (= \"egg on its side\") following closure of PDA:\n$\\checkmark$ enlargement of right heart\n$\\checkmark$ enlargement of LA (with VSD)\n$\\checkmark$ absent pulmonary trunk $(99 \\%)=$ PA located posteriorly in midline\n$\\checkmark$ increased pulmonary blood flow (if not associated with PS) $\\rightarrow$ enlargement of LA\n$\\checkmark$ midline aorta ( $30 \\%$ ) / ascending aorta with convexity to the right\n$\\checkmark$ right aortic arch in $3 \\%$ (difficult assessment due to midline position + small size)\nOB-US:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 189,
            "markdown": "![img-31.jpeg](img-31.jpeg)\n$\\sqrt{ }$ great arteries arise from ventricles in a parallel fashion\n$\\sqrt{ }$ aorta anterior + to right of pulmonary artery (in $60 \\%$; rarely side by side)\nPrognosis: overall $70 \\%$ survival rate at 1 week, $50 \\%$ at 1 month, $11 \\%$ at 1 year by natural history\n$R x$ :\n(1) Prostaglandin E1 administration to maintain ductal patency\n(2) Rashkind procedure $=$ balloon septostomy to create ASD\n(3) Blalock-Hanlon procedure $=$ surgical creation of ASD\n(4) Mustard operation (corrective) $=$ removal of atrial septum + creation of intraatrial baffle directing the pulmonary venous return to $\\mathrm{RV}+$ systemic venous return to $\\mathrm{LV} ; 79 \\%$ 1-year survival rate; $64-89 \\% 5$-year survival\n\n# Corrected Transposition of Great Arteries \n\n$=$ CONGENITALLY CORRECTED TRANSPOSITION $=$ L-TRANSPOSITION $=$ VENTRICULAR INVERSION\n$=$ anomalous looping of the bulboventricular loop ( $=$ primordial ventricles) associated with lack of spiral rotation of conotruncal septum characterized by\n(1) Transposition of great arteries ( $=$ aorta anterior + to right of PA)\n(2) Inversion of ventricles (LV on right side, RV on left side):\n(a) RA connected to morphologic LV\n(b) LA connected to morphologic RV\n(3) AV valves + coronary arteries follow their corresponding ventricles\n\nHemodynamics: functionally corrected abnormality\nAssociated with:\n(1) Usually perimembranous VSD (in $>50 \\%$ )\n(2) Pulmonic stenosis (in 50\\%)",
            "images": [
                {
                    "id": "img-31.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 187,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 965,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 190,
            "markdown": "(3) Anomaly of left (= tricuspid) atrioventricular valves (Ebstein-like) $\\rightarrow$ insufficiency\n(4) Dextrocardia (high incidence)\n\n- NO cyanosis, atrioventricular block (malalignment of atrial + ventricular septa)\n\nCXR:\n$\\sqrt{ }$ abnormal convexity / straightening in upper portion of left heart border (ascending aorta arising from inverted RV)\n$\\sqrt{ }$ inapparent aortic knob + descending aorta (overlying spine)\n$\\sqrt{ }$ inapparent pulmonary trunk (rightward posterior position) = PREMIER SIGN\n$\\sqrt{ }$ humped contour of lower left heart border with elevation above diaphragm (anatomic RV)\n$\\sqrt{ }$ apical notch (= septal notch)\n$\\sqrt{ }$ increased pulmonary blood flow (if shunt present)\n$\\sqrt{ }$ pulmonary venous hypertension (if left-sided AV valve incompetent)\n$\\sqrt{ }$ LA enlargement\nMR:\n$\\sqrt{ }$ posterior cardiac chamber has moderator band + muscular infundibulum (morphologic RV)\nAngio:\n$\\sqrt{ }$ original LV on right side: smooth-walled, cylinder- / cone-shaped with high recess emptying into aorta ( $=$ venous ventricle)\n$\\sqrt{ }$ original RV on left side: bulbous, triangular shape, trabeculated chamber with infundibular outflow tract into pulmonary trunk (= arterial ventricle)\nOB-US:\n$\\sqrt{ }$ great arteries arise from ventricles in a parallel fashion\n$\\sqrt{ }$ aortic valve separated from tricuspid valve by a complete infundibulum\n$\\sqrt{ }$ fibrous continuity between pulmonic valve + mitral valve\nPrognosis: (unfavorable $\\leftarrow$ additional cardiac defects); $40 \\%$ (30\\%) 1-year (10-year) survival rate\n\n# TRAUMATIC AORTIC INJURY \n\n$=$ AORTIC LACERATION = BLUNT TRAUMA TO THORACIC AORTA\n$=$ laceration that disrupts the physical integrity of $>1$ structural layer of the aorta\nIncidence: $>100,000$ people in USA annually\nCause: rapid deceleration (high-speed MVA $>48 \\mathrm{~km} /$ hour with unrestrained driver or ejected passenger, fall from height $>3 \\mathrm{~m}$ ) / crushing chest injury\nPathomechanism: horizontal / vertical deceleration with shear between fixed arch and mobile descending aorta, hydrostatic force, osseous pinch between spine and sternum\nExtent of laceration:\n\n1. Incomplete rupture ( $15 \\%$ )\n$\\diamond$ Aorta goes on to rupture completely within 24 hours in $50 \\%$ of patients!\n) INTIMA\n(a) intimal hemorrhage without tear\n(b) transverse laceration of intima with hemorrhage ( $=$ intimal tear $/$ flap $=$ traumatic",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 191,
            "markdown": "# aortic dissection) \n\nMinimal aortic injury $(10 \\%)=$ intimal flap of $<10 \\mathrm{~mm}$ without significant periaortic hematoma\n> MEDIA\ntear into media with subadventitial hematoma (40-60\\%)\n$>$ ADVENTITIA\n(a) periaortic hemorrhage ( $\\pm$ aortic injury)\n(b) traumatic pseudoaneurysm $=$ laceration of intima + media + adventitia with locally contained periadventitial hematoma\n2. Complete rupture $(85 \\%)=$ transmural extension of laceration $=$ aortic transection $=$ traumatic aortic rupture\n\n- exsanguination before patient reaches a hospital\n\nLength of tear: circumferential tear (in majority)\nSite: at aortic attachment\n(1) Aortic isthmus (88-95\\%): brachiocephalic arteries + ligamentum arteriosum fix aorta in this region\nSite: within 2 cm of origin of left subclavian artery\n(2) Aortic arch with avulsion of brachiocephalic trunk (4.5\\%)\n(3) Aortic root immediately above aortic valve (5-9\\%)\n\nCx: aortic valve rupture, coronary artery laceration, hemopericardium + cardiac tamponade; NO mediastinal hematoma\n(4) Aortic hiatus in diaphragm (1-3\\%)\n$\\diamond$ Most often posteriorly (in noncircumferential tear)\n\n## Acute Thoracic Aortic Injury\n\nPrevalence: 10-16-20\\% of all fatalities in high-speed deceleration accidents\n\n- severe chest pain: precordial (ascending aorta), neck-jaw (aortic arch), interscapular (descending thoracic aorta)\n- anterior chest wall contusion, dyspnea, dysphagia\n- blood pressure changes:\n- unexplained hypotension\n- scapulothoracic syndrome $=$ decreased / absent upper extremity pulses\n- acute coarctation syndrome $=$ decreased / absent lower extremity + normal upper extremity pulses with upper extremity hypertension + systolic murmur in $2^{\\text {nd }}$ left parasternal interspace\nCXR (53-100\\% sensitive, $1-60 \\%$ specific, $4-20 \\%$ PPV):\n$\\diamond$ A normal anteroposterior upright CXR virtually excludes acute thoracic aortic injury (96$98 \\% \\mathrm{NPV}$ )!\nN.B.: There are no plain CXR findings of aortic injury (since aortic integrity is maintained by intact adventitia)! The sources of mediastinal hematoma are frequently the azygos, hemiazygos, internal thoracic, paraspinal and intercostal vessels!\n$\\diamond$ Aortic injury is the cause of mediastinal hematoma in only $12.5 \\%$ !\n$\\sqrt{ }$ normal admission CXR in 28\\% (radiographic signs may not develop until 6-36 hours): supine CXR is very INACCURATE for mediastinal widening",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 192,
            "markdown": "Most specific and valuable signs:\n$\\sqrt{ }$ deviation of nasogastric / endotracheal tube to the right of T3-T4 spinous process $(12-100 \\%$ sensitive, $80-95 \\%$ specific)\n$\\checkmark$ depression of left mainstem bronchus anteroinferiorly $>40^{\\circ}$ below the horizontal + toward right (in 53\\%)\n$\\checkmark$ indistinct / blurred aortic contour at arch / descending aorta (53-100\\% sensitive, 21$55 \\%$ specific)\n$\\checkmark$ mediastinal widening $>8 \\mathrm{~cm}$ at level of origin of left subclavian artery (present in 75$92 \\% ; 90-95 \\%$ sensitive, $5-10 \\%$ specific):\n$\\checkmark$ mediastinal width to chest width $>0.25$\n$\\checkmark$ obscuration of aortopulmonary window ( $40-100 \\%$ sensitive, $56-83 \\%$ specific)\n$\\checkmark$ widened left paraspinal \"stripe\" $>5 \\mathrm{~mm}(12-83 \\%$ sensitive, $89-97 \\%$ specific)\n$\\checkmark$ thickening of right paratracheal stripe $>4-5 \\mathrm{~mm} \\leftarrow$ hematoma between pleura + trachea\n$\\checkmark$ left / right \"apical pleural cap\" sign in $37 \\%$\n$\\leftarrow$ extrapleural hematoma along brachiocephalic vessels\n$\\checkmark$ tracheal compression + displacement toward right ( $61 \\%$ )\n$\\checkmark$ rapidly accumulating commonly left-sided hemothorax without evident rib fracture $\\leftarrow$ break in mediastinal pleura\n$\\checkmark$ fractures of $1^{\\text {st }}+2^{\\text {nd }}$ rib ( $17 \\%$ )\nmnemonic: BAD MEAT\nBronchus depression (left main)\nAortic silhouette shaggy\nDeath in $80-90 \\%$\nMediastinal widening\nEnteric (nasogastric) tube displacement\nApical cap\nTracheal shift\nNECT screening ( $90-100 \\%$ sensitive, $19-45 \\%$ specific, $0-50 \\%$ PPV, $94-100 \\%$ NPV):\n$\\checkmark$ mediastinal fluid often of high density\n$\\checkmark$ obliteration of aorta-fat interface with increased attenuation $\\leftarrow$ mediastinal / periaortic hematoma\nSource of blood: small veins, vasa vasorum of aortic wall\n$\\diamond$ A negative CT examination for mediastinal hemorrhage has an almost $100 \\%$ NPV for aortic injury!\nFalse positive:\nresidual thymic tissue, periaortic atelectasis, pericardial recess, patient motion, streak artifacts, volume averaging of pulmonary artery, pleural effusion adjacent to descending aorta, sternal + spinal fracture\nCECT ( $100 \\%$ sensitive, $92-99 \\%$ specific, $0-39 \\%$ FP, $0.7 \\%$ FN):\nMultidetector CT: 100 mL at $4 \\mathrm{~mL} / \\mathrm{sec}$ with bolus tracking; $1-2 \\mathrm{~mm}$ collimation for 3D reconstruction with $50 \\%$ overlap\nDisadvantages: CT delays surgery\nAdvantages: unsuspected injuries are discovered (pulmonary contusion, pneumothorax, pericardial effusion, rib fracture)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 193,
            "markdown": "$\\sqrt{ }$ intraluminal low-density filling defect:\n$\\sqrt{ }$ linear $=$ intimal flap\n$\\sqrt{ }$ polypoid $=$ clot\n$\\sqrt{ }$ contour deformity of outer aortic wall $=$ pseudoaneurysm\n$\\sqrt{ }$ contour deformity of inner aortic wall:\n$\\sqrt{ }$ intramural hematoma\n$\\sqrt{ }$ pseudocoarctation $=$ abrupt tapering of the diameter of descending aorta compared with ascending aorta\n$\\sqrt{ }$ extravasation of contrast material (extremely rare)\nFalse positive:\npulsation artifact (aortic valve leaflets, wall of ascending aorta, cardiac motion), streak artifact $\\leftarrow$ high-density contrast in brachiocephalic vein, volume averaging, prominent periaortic bronchial / mediastinal vessels, atherosclerotic pseudoaneurysm, small ductus diverticulum\nTransesophageal echocardiography:\n(in $2-15 \\%$ technically unsuccessful, $57-63 \\%$ sensitive, $84-91 \\%$ specific):\n$\\sqrt{ }$ intimal flap\n$\\sqrt{ }$ intraluminal thick stripes\n$\\sqrt{ }$ pseudoaneurysm\n$\\sqrt{ }$ aortic occlusion $(=$ pseudocoarctation $)$\n$\\sqrt{ }$ fusiform aneurysm\n$\\sqrt{ }$ aortic wall hematoma\nAdvantage: portable, relatively fast\nDisadvantage: operator dependent with false negatives for ascending aorta + aortic arch Aortography ( $92 \\%$ sensitive, $98-100 \\%$ specific):\n\nTechnique: LAO + RAO projection; high-flow pigtail catheter; 50 mL at $35 \\mathrm{~mL} / \\mathrm{sec}$\nMorbidity: $1.7 \\%$ (iatrogenic extension of flap, entry of guidewire into pseudoaneurysm)\nDelay: 147 minutes between admission and angio\nTrue positive: in $17-20 \\%$ of mediastinal hematomas angio demonstrates acute traumatic aortic injury!\nFalse negative: small transverse intimal tears may be missed!\n$\\sqrt{ }$ resistance in advancing guide wire\n$\\sqrt{ }$ intimal irregularity, linear defect, filling defect $=$ intimal flap $=$ posttraumatic dissection $(5-10 \\%)$\n$\\sqrt{ }$ intramural injury:\n$\\sqrt{ }$ thickening of aortic wall\n$\\sqrt{ }$ posttraumatic coarctation\n$\\sqrt{ }$ transmural laceration:\n$\\sqrt{ }$ contained extravasation $=$ traumatic false aneurysm\n$\\sqrt{ }$ free extravasation $=$ aortic rupture\n$D D x$ : ductus diverticulum (in $10 \\%$ of normals), aortic spindle, infundibula of brachiocephalic arterial branches; volume averaging with left brachiocephalic vein / left superior intercostal vein / right bronchial arteries (vs. intimal flap); artifact from physiologic streaming / mixing of contrast material; athero-sclerotic aortic ulceration; atheromatous plaque; syphilitic aortic aneurysm",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 194,
            "markdown": "Recommendations for work-up:\n(1) Normal well-defined mediastinal + aortic contours on CXR: no further imaging\n(2) Stable patient:\nangio CT of chest + CT of head, abdomen, pelvis\n(3) Unstable patient + unequivocally abnormal CXR / strong clinical evidence of aortic injury: angio CT / emergency surgery\n$R x$ : (1) Antihypertensive medication\n(2) Stent graft for high-risk patients\n(3) Surgical repair : $20-54 \\%$ mortality, $5-10 \\%$ morbidity $\\leftarrow$ paraplegia\n\nPrognosis:\n(1) $80-90 \\%$ fatal at scene of accident\n$\\diamond$ Mortality rises rapidly within first 24 hours\n(2) $10-20 \\%$ reach hospital\n$\\leftarrow$ formation of periaortic hematoma + false aneurysm contained by adventitia $\\pm$ surrounding connective tissue\n(a) without intervention: $30 \\%(40-50 \\%)$ dead within 6 (24) hours; $90 \\%$ dead within 4 months; chronic false aneurysm may develop in $2-5 \\%$ at isthmus / descending aorta\n(b) with surgical repair: $60-70 \\%$ survive; surgical mortality rate of $9-44 \\%$ varies with degree of hemodynamic instability + severity of associated injuries + magnitude of aortic laceration\n$C x$ : postoperative paraplegia ( $9 \\%$ ) $\\leftarrow$ aortic cross clamping $>30$ minutes\n(3) Chronic pseudoaneurysm (1\\%): potentially unstable\n\n# Chronic Posttraumatic Aortic Pseudoaneurysm \n\n$=$ aneurysm that exists for $>3$ months\nRisk: amount of wall fibroplasia following rupture usually not sufficient to prevent subsequent rupture until at least 3 months after initial traumatic episode\nPrevalence: $2-5 \\%$ of patients surviving aortic transection $>24-48$ hours\n\n- symptom-free period of months to years (in $11 \\%>10$ years)\n- delayed clinical symptoms: $42 \\%$ (85\\%) within 5 (20) years consisting of chest pain, back pain, dyspnea, cough, hoarseness, dysphagia, systolic murmur\nLocation: descending aorta at level of lig. arteriosum filling the aorticopulmonary window (most commonly)\n$\\sqrt{ }$ well-defined rounded mass in left paramediastinal region\n$\\sqrt{ } \\pm$ inferior displacement of left mainstem bronchus\n$C x$ : CHF, partial obstruction of aortic lumen, bacterial endocarditis, aortoesophageal fistula, aortic dissection, obstruction of tracheobronchial tree, systemic emboli\nPrognosis: enlargement + eventual rupture;\n10 -year survival rate: $85 \\%$ with surgical repair, $66 \\%$ without surgical repair\n\n\n## TRICUSPID ATRESIA\n\n$2^{\\text {nd }}$ most common cause of pronounced neonatal cyanosis (after transposition) characterized by\n(1) Absent tricuspid valve\n(2) ASD",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 195,
            "markdown": "(3) Small VSD (in most patients)\n\nFrequency: $1.5 \\%$ of all CHD\nEmbryology: imbalanced tissue proliferation + resorption results in absence of valvular tissue\n\n1. TRICUSPID ATRESIA WITHOUT TRANSPOSITION ( $80 \\%$ )\n(a) without PS, (b) with PS, (c) with pulmonary atresia\n2. TRICUSPID ATRESIA WITH TRANSPOSITION\n(a) without PS, (b) with PS [most favorable combination], (c) with pulmonary atresia\n$\\diamond$ Usually small VSD + PS ( $75 \\%$ ) restrict pulmonary blood flow\nHemodynamics:\nabsent tricuspid valve forces blood from an enlarged RA through an ASD into LA (R-to-L shunt); pulmonary blood flow limited by pulmonary valvular stenosis\n![img-32.jpeg](img-32.jpeg)\n\n- progressive cyanosis from birth on, increasing with crying = OUTSTANDING FEATURE (inverse relationship between degree of cyanosis + volume of pulmonary blood flow)",
            "images": [
                {
                    "id": "img-32.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 664,
                    "bottom_right_x": 1339,
                    "bottom_right_y": 1887,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 196,
            "markdown": "- pansystolic murmur (VSD)\n- ECG: left-axis deviation\n\nCXR (typical cardiac contour):\n$\\sqrt{ }$ heart size ranges from normal to moderately enlarged (depending on volume of pulmonary blood flow and size of RA)\n$\\sqrt{ }$ left rounded contour $=$ enlargement + hypertrophy of LV\n$\\sqrt{ }$ right rounded contour $=$ enlarged RA\n$\\sqrt{ }$ flat / concave pulmonary segment\n$\\sqrt{ }$ normal / decreased pulmonary vascularity\n$\\sqrt{ }$ typical flattening of right heart border with transposition (in 15\\%)\nPrognosis: may survive well into early adulthood\n$R x$ :\n(1) Blalock-Taussig procedure (if pulmonary blood flow decreased in infancy)\n(2) Glenn procedure $=$ shunt between IVC + right PA (if total correction not anticipated)\n(3) Fontan procedure $=$ external conduit from RA to pulmonary trunk + closure of ASD (if pulmonary vascular disease has not developed)\n\n# TRICUSPID REGURGITATION / INSUFFICIENCY \n\n## Cause:\n\nRV dilatation is the most common cause of tricuspid regurgitation, with dilatation of the tricuspid annulus causing improper coaptation of the valve leaflets.\nA. SECONDARY $=$ dilatation of RV + annulus $\\leftarrow$ elevated pulmonary artery pressure\n\n1. Left heart failure\n2. Pulmonary vascular disease\n3. Chronic lung disease $\\leftarrow$ pulmonary hypertension\n4. Carcinoid syndrome\n$\\diamond$ Mild / trace of tricuspid regurgitation is normal!\nB. PRIMARY = lesion of intrinsic valve apparatus (chordae tendineae / leaflets / annulus / papillary muscles)\n5. Rheumatic heart disease\n6. Bacterial endocarditis\n7. Tricuspid valve prolapse\n8. Papillary muscle dysfunction: myocardial infarction, trauma, (metastatic) carcinoid heart syndrome\n9. Connective tissue disorder: Marfan syndrome\n10. Congenital heart disease: Ebstein anomaly, atrioventricular cushion defect\n11. Pacemaker leads\n12. Radiation therapy, certain drug-based treatments\n\n- exhaustion and fatigue\n- symptoms of right heart failure: peripheral edema, ascites\n$\\sqrt{ }$ normal / reduced pulmonary vascularity\n$\\sqrt{ }$ cardiomegaly $\\leftarrow \\mathrm{RA}+\\mathrm{RV}$ hypertrophy and enlargement\n$\\sqrt{ }$ distension of IVC $>$ SVC\nDoppler ECHO:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 197,
            "markdown": "$\\sqrt{ }$ systolic reversal of hepatic vein flow with normal sinus rhythm\n$\\sqrt{ }$ dilatation of RA\n$\\sqrt{ }$ flattening / leftward bowing of interventricular septum during diastole\n$\\sqrt{ }$ vena contracta ( $=$ smallest stream diameter) width $>0.7 \\mathrm{~cm}$\n$\\sqrt{ }$ color flow jet area $>10 \\mathrm{~cm}^{2}$\n$\\sqrt{ }$ proximal isovelocity surface area radius $>0.9 \\mathrm{~cm}$\n$\\sqrt{ }$ decreased $S$ wave $=S$ wave no longer as deep as the $D$ wave, gradually rising with degree of regurgitation\n$\\sqrt{ }$ one large $a-S-v$ complex in severe incompetence\nCT:\n$\\sqrt{ }$ RV displaced to the left\n$\\sqrt{ }$ interventricular septum bowed to the left\n$\\sqrt{ }$ hepatic venous congestion\n$\\sqrt{ }$ emphysema, pulmonary hypertension, left heart disease\nPrognosis: if untreated $\\rightarrow$ RV dysfunction, congestive hepatopathy, cardiac cirrhosis\n\n# TRICUSPID STENOSIS \n\n$=$ thickening + fusion of tricuspid valve apparatus\nCause:\n\n1. (Nearly always) rheumatic heart disease:\n$\\sqrt{ }$ often accompanied by mitral + aortic valve disease\n$\\sqrt{ }$ NO valve calcifications\n2. Infectious endocarditis: IV drug users\n3. Congenital abnormalities\n4. Fabry disease\n5. Whipple disease\n6. Metastatic carcinoid syndrome\n7. Pacemaker-related complications\n\n- fatigue, dyspnea, congestion, right heart failure with elevated jugular pressure, hepatomegaly, ascites\n- arrhythmias $\\leftarrow$ severe right atrial enlargement\n\nCXR:\n$\\sqrt{ }$ RA enlargement + dilatation of both venae cavae\n$\\sqrt{ }$ normal pulmonary arteries\nECHO (findings of hemodynamic significance):\n$\\sqrt{ }$ mean transvalvular pressure gradient of $>5 \\mathrm{mmHg}$ (clinically most relevant)\n$\\sqrt{ }$ inflow time-velocity integral $>60 \\mathrm{~cm}$\n$\\sqrt{ }$ pressure half-time $>190 \\mathrm{msec}$\n$\\sqrt{ }$ valve area by continuity equation of $<1 \\mathrm{~cm}^{2}$\nCT:\n$\\sqrt{ }$ thickened tricuspid valve leaflets: shortening of chordae tendineae + fusion of edges of leaflets\n$\\sqrt{ }$ narrowed valve annulus\n$\\sqrt{ }$ RA dilatation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 198,
            "markdown": "$\\sqrt{ }$ enlargement of superior + inferior venae cavae\n$\\sqrt{ }$ hepatic venous congestion\n$C x$ : often coexisting tricuspid regurgitation exacerbating RA enlargement $\\rightarrow$ increasing risk for arrhythmia\n\n# TROUSSEAU SYNDROME \n\n$=$ PARANEOPLASTIC THROMBOEMBOLISM\nPrevalence: $1-11 \\%$; higher in terminally ill cancer patients\nTumors: mucin-secreting adenocarcinoma of GI tract and pancreas (most common), lung, breast, ovary, prostate\nPathogenesis: (?)\n(a) tumors activate coagulation + depress anticoagulant function\n(b) cancer cells cause injury to endothelial lining, activate platelets + coagulation\n\nType of lesion: (1) Venous thrombosis\n(2) Arterial thromboembolism\n(3) Nonbacterial thrombotic endocarditis\n$\\diamond$ Patients with thromboembolism have an increased incidence of occult malignancy!\nPrevalent criteria:\n> absence of apparent cause for thromboembolism\n$>$ age $>50$ years\n> multiple sites of venous thrombosis\n> simultaneous venous + arterial thromboembolism\n> resistance to oral anticoagulant therapy\n> associated other paraneoplastic syndromes\n> regression of thromboembolism with successful treatment of cancer\n\n- disorders of consciousness $\\leftarrow$ cerebral emboli\n- muscular pain + weakness $\\leftarrow$ emboli to skeletal muscle\n- decompensated disseminated intravascular coagulation\n$\\checkmark$ deep vein thrombosis\n$\\checkmark$ pulmonary embolism\n$\\checkmark$ nonbacterial thrombotic endocarditis (echocardiography)\nRx: (1) Heparin (more successful than warfarin)\n(2) Greenfield filter",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 199,
            "markdown": "![img-33.jpeg](img-33.jpeg)\n\n# TRUNCUS ARTERIOSUS \n\n$=$ PERSISTENT TRUNCUS ARTERIOSUS $=$ SINGLE OUTLET OF THE HEART $=$ COMMON ARTERIAL TRUNK\n$=$ septation failure of the conotruncus characterized by\n(1) Single great artery arising from the heart (larger than the aorta at a comparable age)\n(2) Giving rise to coronary, pulmonary, and systemic arteries\n(3) Overriding the ventricular septum\n(4) Large VSD\n\nPrevalence: $1 \\%$ of CHD detected in fetus; $94 \\div 1,000,000$ live births\nCollett \\& Edwards classification:\nType I $\\quad(50 \\%)=$ both pulmonary arteries arise from a short pulmonary trunk distal to truncal valve\nType II $(25 \\%)=$ separate origin of both pulmonary arteries from posterior aspect of truncus\nType III $(10 \\%)=$ separate origin of both pulmonary arteries at lateral aspect of truncus\nType IV $\\quad=$ pseudotruncus\nSubtype $\\quad=$ infundibular VSD present\nA\nSubtype $\\quad=$ VSD absent",
            "images": [
                {
                    "id": "img-33.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 189,
                    "bottom_right_x": 1322,
                    "bottom_right_y": 1181,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 200,
            "markdown": "B\nAssociated with:\n(1) Right aortic arch (in 35\\%)\n$\\diamond$ Right aortic arch + cyanosis + shunt vascularity $=$ TRUNCUS\n(2) Genetic abnormality: chromosome 22q11 deletion, DiGeorge syndrome\n(3) Interrupted aortic arch / coarctation (11-14\\%)\n(4) Forked ribs\n\nHemodynamics:\nadmixture lesion (R-to-L and L-to-R shunt across VSD) with volume of pulmonary blood\nflow inversely related to degree of pulmonary vascular resistance\nfetus : CHF only with incompetent valve $\\leftarrow$ massive regurgitation from truncus to ventricles neonate : L-to-R shunt after decrease in pulmonary resistance (massive diversion of flow to pulmonary district) $\\rightarrow$ CHF (ventricular overload) / pulmonary hypertension with time\n\n| RA | $\\leftrightarrow$ | RV | $\\uparrow$ | Trunk | $\\uparrow$ |\n| :-- | :-- | :-- | :-- | :-- | :-- |\n| Pulm. vessels | $\\uparrow$ |  |  |  |  |\n| LA | $\\leftrightarrow$ | LV | $\\uparrow$ |  |  |\n\n- moderate cyanosis (degree inversely related to volume of pulmonary blood flow), apparent with crying\n- severe CHF within first days / months of life (in large R-to-L shunt); wide pulse pressure\n- systolic murmur (similar to VSD)\n- early diastolic murmur (with truncal insufficiency)\n\nCXR:\n$\\checkmark$ cardiomegaly:\n$\\checkmark$ increased volume of both ventricles\n$\\checkmark$ enlarged LA $(50 \\%) \\leftarrow$ increased pulmonary blood flow\n$\\checkmark$ wide mediastinum $\\leftarrow$ large \"aortic shadow\" = truncus arteriosus\n$\\checkmark$ \"waterfall / hilar comma\" sign = elevated right hilum (30\\%); elevated left hilum (10\\%)\n$\\checkmark$ concave pulmonary segment $(50 \\%)=$ type I has left convex pulmonary segment\n$\\checkmark$ markedly $\\uparrow$ pulmonary blood flow, may be asymmetric\nECHO:\n$\\checkmark$ single arterial vessel overriding the interventricular septum (DDx: tetralogy of Fallot)\n$\\checkmark$ frequently dysplastic single semilunar valve with 3-6 leaflets (most commonly tricommissural $=3$ leaflets)\n$\\checkmark$ truncal valve may be stenotic\n$\\checkmark$ truncal valve insufficiency with age (in 25\\%)\n$D x:$ (often stenotic / insufficient) truncal valve with $2-5$ cusps + atretic pulmonary valve + flow direction\nPrognosis: $40 \\%$ (20\\%) 6-month (1-year) survival rate\nRx: Rastelli procedure ( $30 \\%$ no longer operable at 4 years of age) $=$ (a) artificial valve placed high in RVOT and attached via a Dacron graft to main pulmonary artery (b) closure of VSD ( $5 \\%$ mortality rate)\n$D D x:$ aortopulmonary window (2 separate valves)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 201,
            "markdown": "# Hemitruncus \n\n$=$ rare acyanotic anomaly characterized by\n(a) one pulmonary artery (commonly right PA) arises from truncus\n(b) one pulmonary artery arises from RV / supplied by systemic collaterals\n\nAssociated with: PDA (80\\%), VSD, tetralogy (usually isolated to left PA)\n\n## Pseudotruncus Arteriosus\n\n$=$ TRUNCUS TYPE IV\n$=$ severe form of tetralogy of Fallot with atresia of the pulmonary trunk; entire pulmonary circulation through bronchial collateral arteries (NOT a form of truncus arteriosus in its true sense); characterized by\n(1) Pulmonary atresia\n(2) VSD with R-to-L shunt\n(3) RV hypertrophy\n\nAssociated with: right aortic arch in $50 \\%$\n\n- cyanosis\n$\\checkmark$ concavity in area of pulmonary segment\n$\\checkmark$ commalike abnormal appearance of pulmonary artery\n$\\checkmark$ absent normal right + left pulmonary artery (lateral chest film)\n$\\checkmark$ esophageal indentation posteriorly $\\leftarrow$ large systemic collaterals\n$\\checkmark$ prominent hilar + intrapulmonary vessels (= systemic collaterals)\n$\\checkmark$ \"coeur en sabot\" $=$ RV enlargement\n$\\checkmark$ prominent ascending aorta with hyperpulsations\n\n\n## VASCULAR MALFORMATION\n\n## Arteriovenous Malformation\n\n$=$ nidus composed of multiple dysplastic vascular channels connecting feeding arteries with draining veins in the absence of a normal capillary bed\nAge: present at birth in the early quiescent stage; not usually evident until childhood / adulthood\nGrowth: proportionate increase in size with child growth\nExacerbation: hormonal changes (puberty, pregnancy) / thrombosis, infection, trauma\n\n- red pulsatile warm mass with thrill\n- high-output congestive heart failure\n\nMR:\n$\\sqrt{ }$ NO well-defined mass\n$\\sqrt{ }$ large serpentine flow voids on SE images / high-signal-intensity foci on GRE images $=$ enlarged feeding arteries + draining veins\n$\\sqrt{ }$ decreased marrow signal intensity on T1WI $\\leftarrow$ intraosseous extension of lesion\n$\\checkmark$ areas of high signal intensity on T1WI $\\leftarrow$ hemorrhage, intravascular thrombosis, flowrelated enhancement\nCEMR:\n$\\sqrt{ }$ contrast material rise time of $5-10$ seconds\n$\\sqrt{ }$ early venous filling",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 202,
            "markdown": "Cx: bone overgrowth, arterial steal phenomenon, cutaneous ischemia\n\n# Congenital Arteriovenous Fistula \n\n$=$ single vascular channel between an artery and a vein\nCause: arrested vascular embryonic development\nLocation: extremity, neck, face\nMR:\n$\\sqrt{ }$ large signal voids on SE images or high-signal-intensity foci on GRE images without a well-defined mass $\\leftarrow$ arterial + venous components\n$D D x$ : chronic secondary AVF (with time enlarging supplying arteries + draining veins $\\leftarrow$ strong flow)\n\n## Capillary Malformation\n\n$=$ area of congenital ectasia of thin-walled small-caliber vessels of the skin (dermis / mucous membrane)\nAge: present at birth in $0.3 \\%$ of children\nAssociated with:\n(1) Sturge-Weber syndrome\n(2) Klippel-Trénaunay syndrome\n(3) Parkes Weber syndrome\n\n- cutaneous lesion of red discoloration\n\nLocation: predominantly in head \\& neck\nMR (MRI not usually required $\\leftarrow$ clinical diagnosis):\n$\\sqrt{ }$ subtle skin thickening $\\pm$ occasional increased subcutaneous thickness\n\n## Lymphatic Malformation\n\nPrevalence: $2^{\\text {nd }}$ most common type of vascular malformation after venous malformation\nCause: sequestered lymphatic sacs that fail to communicate with peripheral draining channels\nAge: discovered in first 2 years of life\nPath: infiltrative lesion permeating fat planes + involving multiple tissues consisting of chyle-filled cysts lined with endothelium\nCommonly associated with: other vascular malformations\n\n- smooth noncompressible soft-tissue mass with rubbery consistency:\nA. MACROCYSTIC lymphatic malformation $=$ cysts of variable size $>2 \\mathrm{~mm}$ in diameter\n- smooth translucent multiple masses beneath normal skin\n$\\sqrt{ }$ rim + septal enhancement without central filling of cystic structures\nB. MICROCYSTIC lymphatic malformation $=$ cysts of $<2 \\mathrm{~mm}$ in size on background of solid matrix\n- permeation of skin\n- diffuse soft-tissue thickening + surrounding lymphedema\n$\\sqrt{ }$ NO significant enhancement\n$\\sqrt{ }$ occasionally diffuse enhancement $\\leftarrow$ septal enhancement of small nonperceptible cysts / venous component in mixed venous-lymphatic malformation\nLocation: neck ( $70-80 \\%$ ); axillary region ( $20 \\%$ ); extremities (rare)\nSite: posterior cervical triangle",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 203,
            "markdown": "MR:\n$\\sqrt{ }$ lobulated septated mass with intermediate to decreased SI on T1WI + increased signal intensity on T2WI + STIR\n$\\sqrt{ }$ internal fluid-fluid levels (common)\n\n# Venous Malformation \n\n$=$ simple slow-flow malformation + abnormal venous network\n$=$ \"cavernous hemangioma\" (misnomer)\nPath: lesion may permeate across tissue planes and invade multiple adjacent tissues; connection to adjacent physiologic veins via narrow tributaries\nHisto: small + large dysplastic postcapillary thin-walled vascular channels with sparse smooth muscle and variable amounts of hamartomatous stroma, thrombi, phleboliths\nAge: childhood / early adulthood (present at birth)\n\n- skin level: faint blue soft compressible nonpulsatile mass\n- enlarging with Valsalva maneuver + in dependent position\n- decreasing with elevation of extremity + local compression\n- deep level: pain, impaired mobility, skeletal deformity\n\nLocation: head \\& neck (40\\%), extremities (40\\%), trunk (20\\%)\nAssociated with:\n(1) Blue rubber bleb nevus syndrome\n(2) Proteus syndrome\n(3) Maffucci syndrome\n$\\sqrt{ }$ absence of enlarged feeding vessels / arteriovenous shunting\n$\\sqrt{ }$ lack of arterial + early venous enhancement\n$\\sqrt{ }$ slow gradual filling with contrast material (contrast material rise time of about 90 seconds)\n\n+ CHARACTERISTIC nodular enhancement of tortuous vessels during delayed venous phase\nMR:\n$\\sqrt{ }$ septated lesion of intermediate to decreased SI on T1WI:\n$\\sqrt{ }$ heterogeneous SI on T1 $\\leftarrow$ thrombosis / hemorrhage\n$\\sqrt{ }$ increased signal intensity on T2WI and STIR\n$\\sqrt{ }$ occasionally internal fluid-fluid levels $\\leftarrow$ hemorrhage / high protein content\n$\\sqrt{ }$ small low-signal-intensity foci on all pulse sequences $\\leftarrow$ phleboliths\n$D x$ : low-flow malformation based on absence of flow voids on SE images\n$R x$ : sclerotherapy after lack of evident connection between malformation and deep venous system\n\n\n## VENTRICULAR ANEURYSM\n\nA. CONGENITAL LEFT VENTRICULAR ANEURYSM\nrare, young Black adult\n(1) Submitral type:\n$\\sqrt{ }$ bulge at left middle / upper cardiac border\n(2) Subaortic type:\n$\\sqrt{ }$ small + not visualized\n$\\sqrt{ }$ heart greatly enlarged (from aortic insufficiency)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 204,
            "markdown": "# B. ACQUIRED LEFT VENTRICULAR ANEURYSM \n\n$=$ complication of myocardial infarction, Chagas disease\n\n- may be asymptomatic + well tolerated for years\n- occasionally associated with persistent heart failure, arrhythmia, peripheral embolization\n\n\n## True Ventricular Aneurysm\n\n$=$ circumscribed noncontractile outpouching of ventricular cavity with broad mouth + localized dyskinesis\nCause: sequelae of transmural myocardial infarction\nLocation:\n(a) left anterior + anteroapical: readily detected (anterior + LAO views)\n(b) inferior + inferoposterior: less readily detected (steep LAO + LPO views)\n\nDetection rate: $50 \\%$ by fluoroscopy; $96 \\%$ by radionuclide ventriculography; frequently not visible on CXR\n$\\sqrt{ }$ localized bulge of heart contour = \"squared-off\" appearance of mid left lateral margin of heart border\n$\\checkmark$ localized paradoxical expansion during systole (CHARACTERISTIC)\n$\\checkmark$ rim of calcium in fibrotic wall (chronic), rare\n$\\checkmark$ akinetic / severely hypokinetic segment\n$\\checkmark$ left ventriculography in LAO, RAO is diagnostic\n$\\checkmark$ wide communication with heart chamber (NO neck)\n$C x:$ wall thrombus with embolization\nPrognosis: rarely ruptures\n\n## Pseudoaneurysm of Ventricle\n\n$=$ FALSE ANEURYSM\n$=$ left ventricular rupture contained by fused layers of visceral + parietal pericardium / extracardiac tissue\n(a) cardiac rupture with localized hematoma contained by adherent pericardium; typically in the presence of pericarditis\n(b) subacute rupture with gradual / episodic bleeding\n\nEtiology: trauma, myocardial infarction\nLocation: typically at posterolateral / diaphragmatic wall of LV\n$\\checkmark$ left retrocardiac double density\n$\\checkmark$ diameter of mouth smaller than the largest diameter of the globular aneurysm\n$\\checkmark$ delayed filling\n$C x$ : high risk of delayed rupture (infrequent in true aneurysms)\n\n## VENTRICULAR SEPTAL DEFECT\n\nMost common CHD (25-30\\%):\n(a) isolated in $20 \\%$\n(b) with other cardiac anomalies in $5 \\%$ (PDA, CoA)\n$\\diamond$ Acyanotic L-to-R shunt + right aortic arch (in 2-5\\%) = VSD\nEmbryology:\nsingle ventricular chamber divides into two by fusion of membranous portion of ventricular",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 205,
            "markdown": "septum + endocardial cushions + bulbis cordis (= proximal part of truncus arteriosus) between $4^{\\text {th }}-8^{\\text {th }}$ week\n\n1. MEMBRANOUS $=$ PERIMEMBRANOUS VSD $(75-80 \\%)$\n\nLocation: posterior + inferior to crista supraventricularis near commissure between right and posterior (= noncoronary) aortic valve cusps\nMay be associated with:\nsmall aneurysms of membranous septum commonly leading to decrease in size of membranous VSD (their presence does not necessarily predict eventual complete closure)\n2. SUPRACRISTAL = CONAL VSD $(5-8 \\%)$\n$\\diamond$ Crista supraventricularis $=$ inverted U-shaped muscular ridge posterior + inferior to pulmonary valve\n(a) RV view $=$ VSD just beneath pulmonary valve with valve forming part of superior margin of defect\n(b) LV view $=$ VSD just below commissure between R + L aortic valve cusps\n$C x$ : right aortic valve cusp may herniate into VSD $\\rightarrow$ aortic insufficiency\n3. MUSCULAR VSD $(5-10 \\%)$\n\nMay consist of multiple VSDs; bordered entirely by myocardium\nLocation: (a) inlet portion\n(b) trabecular portion\n(c) infundibular / outlet portion\n4. ATRIOVENTRICULAR CANAL TYPE\n$=$ ENDOCARDIAL CUSHION TYPE $=$ POSTERIOR VSD $(5-10 \\%)$\nLocation: adjacent to septal + anterior leaflet of mitral valve; rare as isolated defect\nHemodynamics:\nsmall bidirectional shunt during fetal life (similar pressures in RV + LV); after birth pulmonary arterial pressure $\\downarrow$ and systemic arterial pressure $\\uparrow$ with development of L-to-R shunt\nClassification:\n\"Maladie de Roger\"\n$=$ small restrictive VSD with defect $<1 \\mathrm{~cm}$; little / no hemodynamic significance with normal pulmonary artery pressure, normal pulmonary vascular resistance\n\n- asymptomatic\n- holosystolic heart murmur at $4^{\\text {th }}$ left rib interspace\n$\\sqrt{ }$ normal plain film\nPrognosis: spontaneous closure\n\n\n# Moderate Shunt \n\nVSD defect $<75 \\%$ of aortic diameter $(1-1.5 \\mathrm{~cm})$; systolic LV pressure $>$ systolic RV pressure; intermediate pulmonary artery pressure; normal pulmonary vascular resistance\n\n| Heart size | $\\uparrow$ | Main PA | $\\leftrightarrow$ to $\\uparrow$ |\n| :-- | :-- | :-- | :-- |\n| Pulm. vessels | $\\leftrightarrow$ to $\\uparrow$ | LA | $\\uparrow$ |\n\n- respiratory infections, mild dyspnea\n$\\sqrt{ }$ slight prominence of pulmonary vessels ( $45 \\%$ shunt)\n$\\sqrt{ }$ slight enlargement of LA\nPrognosis: spontaneous closure in large percentage",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 206,
            "markdown": "# Nonrestrictive Large Shunt \n\nVSD defect $>75 \\%$ of aortic diameter; systolic LV pressure $=$ systolic RV pressure (pulmonary vascular disease + hypertension increases RV pressure); pulmonary artery pressure approaching systemic levels; slightly increased pulmonary vascular resistance; pulmonary blood flow 2-4 times systemic flow\n\n| Heart size | $\\uparrow$ | Main PA | $\\uparrow$ |\n| :-- | :-- | :-- | :-- |\n| Pulm. vessels | $\\uparrow$ | LA | $\\uparrow$ |\n\n- bouts of respiratory infections\n- feeding problems, failure to thrive\n- CHF soon after birth $\\leftarrow \\mathrm{RV}$ overload\n$\\sqrt{ }$ prominent pulmonary segment + vessels (= shunt vascularity)\n$\\sqrt{ }$ calcification of pulmonary arteries\n= PATHOGNOMONIC for pulmonary arterial hypertension\n$\\sqrt{ }$ enlargement of LA + LV\n$\\sqrt{ }$ normal / small thoracic aorta\n\n\n## Eisenmenger syndrome\n\nlarge VSD eventually leads to shunt reversal (R-to-L shunt) $\\leftarrow$ irreversible increase in pulmonary vascular resistance ( $=$ intima + medial hyperplasia) when pulmonary vascular resistance $>0.75$ of systemic vascular resistance\n\n| RA | $\\uparrow$ | RV $\\uparrow$ | Main PA $\\uparrow$ |\n| :-- | :-- | :-- | :-- |\n| Pulm. vessels | $\\downarrow / \\uparrow$ |  |  |\n| LA | $\\uparrow$ to $\\leftrightarrow$ | LV $\\uparrow$ to $\\leftrightarrow$ | Ao $\\uparrow$ to $\\leftrightarrow$ |\n\nFrequency: $10 \\%$ of large VSDs by 2 years of age\n\n- cyanotic, but less symptomatic; CHF rare\n$\\sqrt{ }$ eventual decrease of pulmonary vessel caliber\n$\\sqrt{ }$ eventual decrease in size of LA + LV\nNATURAL HISTORY OF VSD causing reduction in pulmonary blood flow:\n\n1. Spontaneous closure\nin $40 \\%$ within first 2 years of life; $60 \\%$ by 5 years ( $65 \\%$ with muscular VSD, $25 \\%$ with membranous VSD); with small (large) VSD in $50 \\%(10 \\%)$\n2. RVOT obstruction infundibular hypertrophy in $3 \\%=$ pink tetrad\n3. Prolapse of right aortic valve cusp\n$=$ aortic valve insufficiency\nCXR (with increase in size of VSD):\n$\\sqrt{ }$ variable appearance $\\leftarrow$ variations in defect size\n$\\sqrt{ }$ enlargement of LA\n$\\sqrt{ }$ enlargement of pulmonary artery segment\n$\\sqrt{ }$ enlargement of LV\n$\\sqrt{ }$ RV hypertrophy\n$\\sqrt{ }$ increase in pulmonary blood flow (if $>45 \\%$ of pulmonary blood flow from systemic circulation)\n$\\sqrt{ }$ Eisenmenger reaction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 207,
            "markdown": "ECHO:\n$\\sqrt{ }$ prolapse of aortic valve cusp (in supracristal VSD)\n$\\sqrt{ }$ deformity of aortic cusp (in membranous VSD)\n$\\sqrt{ }$ lack of echoes in region of interventricular septum with sharp edges (DDx: artifactual dropout with sound beam parallel to septum); muscular VSD difficult to see\n$\\sqrt{ }$ LA enlargement\nAngio:\nProjections:\n(a) LAO $60^{\\circ} \\mathrm{C}-\\mathrm{C} 20^{\\circ}$ for membranous + anterior muscular VSD\n(b) LAO $45^{\\circ} \\mathrm{C}-\\mathrm{C} 45^{\\circ}$ (hepatoclavicular) for posterior endocardial cushion + posterior muscular VSD\n(c) RAO for supracristal VSD + assessment of RVOT\n$\\sqrt{ }$ RVOT / pulmonary valve fill without filling of RV chamber (in supracristal VSD)\n$R x$ :\n(a) large VSD + left heart failure at 3 months of age: aim is to delay closure until child is 18 months of age; pulmonary-to-systemic blood flow $>2 \\div 1$ requires surgery before pulmonary hypertension becomes manifest\n\n1. Digitalis + diuretics\n2. Pulmonary artery banding\n3. Patching of VSD: surgical approach through RA / through RV for supracristal VSD\n(b) small VSDs without increase in pulmonary arterial pressure are followed\n\n# WEGENER GRANULOMATOSIS \n\n[Friedrich Wegener (1907-1990), German pathologist in Berlin, Breslau and Lübeck describes rhinogenic granulomatosis in 1936]\n$=$ GRANULOMATOSIS WITH POLYANGIITIS\n$=$ ANCA-positive systemic vasculitis that affects small arteries characterized by systemic necrotizing granulomatous destructive angiitis\nIncidence: $3 \\div 100,000$ annually in USA\nPath: peribronchial necrotizing granulomas + vasculitis not intimately related to arteries with little / NO deposition of immunoglobulins / complement components (pauci-immune)\nMean age of onset: $40-50$ years (range of all ages); $\\mathrm{M}+\\mathrm{F}=2 \\div 1$; majority in Whites ( $90 \\%$ )\nMean age in childhood: 14 (range 4-17) years; $\\mathrm{M}<\\mathrm{F}$\nCLASSIC TRIAD:\n(1) Upper airway granulomatous inflammation\n$\\diamond$ The most common presenting symptoms (in up to $67 \\%$ ): rhinitis, sinusitis, otitis media, nasal mucosa ulcer, bone deformity, subglottic stenosis\n(2) Lower respiratory tract involvement\n(3) Necrotizing glomerulonephritis\n\n- circulating antineutrophil cytoplasmic antibodies (cANCA) directed against proteinase $3+$ myeloperoxidase (found in neutrophils) in up to $90 \\%$\n- rarely eosinophilia (DDx: Churg-Strauss syndrome)\n- constitutional symptoms: fever, malaise, weight loss\n\nLocation: upper respiratory tract + sinuses in $>90 \\%$; kidneys in $85 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 208,
            "markdown": "$\\diamond$ Prone to venous thrombosis in lower extremities $\\leftarrow$ antiphospholipid antibodies\n@ Pulmonary disease ( $94 \\%$ )\n\n- intractable cough (occasionally with hemoptysis)\n- chest pain, dyspnea\n- anemia, decrease in serum iron + ferritin levels (in diffuse alveolar hemorrhage)\n\nPath: vasculitis of medium-sized and small pulmonary arteries + veins + capillaries, geographic necrosis, granulomatous inflammation\n$\\sqrt{ }$ bilateral interstitial reticulonodular opacities, most prominent at lung bases (earliest stage)\n$\\checkmark$ randomly distributed irregular masses / nodules of varying sizes ( 5 mm to 10 cm ), especially in lower lung fields ( $69 \\%$ ) usually sparing apices:\n$\\checkmark$ usually $<10$ masses, solitary in up to $25 \\%$\n$\\checkmark$ cavitation of $>2-\\mathrm{cm}$ nodules with thick wall + irregular shaggy inner lining ( $25-50 \\%$ )\n$\\checkmark$ bilateral multifocal patchy air-space opacities (in up to $50 \\%$ ):\n$\\checkmark$ acute airspace pneumonia\n$\\checkmark$ intraalveolar pulmonary hemorrhage\n$\\checkmark$ smooth / nodular thickening of subglottic / tracheal / bronchial wall producing stenosis with oligemia + emphysema + lobar / segmental atelectasis ( $60 \\%$ )\n$\\checkmark$ uni- / bilateral pleural effusion (usually exudative) in 10-20\\%\n$\\checkmark$ focal pleural thickening $=$ acute / chronic fibrinous pleuritis\n$\\checkmark$ reactive hilar / mediastinal lymphadenopathy (unusual)\n$\\checkmark$ interstitial pulmonary edema $\\pm$ cardiomegaly (from renal / cardiac involvement)\nCT:\n$\\checkmark$ nodules in peribronchovascular distribution:\n$\\checkmark$ central cavitation in nodules $>2 \\mathrm{~cm}$ in diameter\n$\\checkmark$ feeding vessels entering nodules ( $=$ angiocentric distribution)\n$\\checkmark$ pleura-based wedge-shaped lesions (= infarcts)\n$\\checkmark$ ground-glass opacity and consolidation (= pulmonary hemorrhage / infection) in up to $50 \\%$ :\n$\\checkmark$ in a bilateral perihilar + peribronchovascular distribution\n$\\checkmark$ waxing and waning\n$\\checkmark$ air bronchogram in dense consolidation\n$\\checkmark$ CT \"halo\" sign (= rim of ground-glass attenuation surrounding a pulmonary lesion) due to adjacent parenchymal hemorrhage (in up to $15 \\%$ )\n$\\checkmark$ CT \"atoll\" / \"reverse halo\" sign = central ground-glass opacity surrounded by a rim of opacified lung $\\leftarrow$ organizing pneumonia reaction in periphery of focal hemorrhage\n$\\checkmark$ radiating linear scarring, spiculation + pleural tags of nodules and masses (prominent feature!)\nCx: (1) Dangerous airway stenosis ( $15 \\%$ of adults, $50 \\%$ of children)\n(2) Massive life-threatening pulmonary hemorrhage\n(3) Spontaneous pneumothorax (rare)\n@ Tracheobronchial stenosis (16-23\\%)\n\n- stridor $\\leftarrow$ tracheal inflammation + sclerosis\n\nLocation: subglottic portion of trachea (most often)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 209,
            "markdown": "$\\sqrt{ }$ uni- / multifocal / segmental subglottic / tracheobronchial stenosis:\n$\\sqrt{ } 2-4 \\mathrm{~cm}$ long segment\n$\\sqrt{ }$ smooth / nodular circumferential wall thickening of posterior membrane of trachea\n$\\sqrt{ } \\pm$ intra- and extraluminal soft-tissue masses\n@ Renal disease ( $85 \\%$ ) focal glomerulonephritis in $20-40 \\%$ at presentation, as disease progresses in $80-90 \\%$\nHisto: focal necrosis, crescent formation, paucity/ absence of immunoglobulin deposits\n\n- may present as overt acute renal failure\n$\\sqrt{ }$ large echogenic kidneys (early)\n$\\sqrt{ }$ small shrunken echogenic kidney (late in renal failure)\n@ Paranasal sinuses ( $91 \\%$ )\nLocation: maxillary antra most frequently\n- sinus pain, purulent sinus drainage, rhinorrhea\n$\\sqrt{ }$ thickening of mucous membranes of paranasal sinuses\n$\\sqrt{ }$ gradual reduction in sinus volume\n$\\sqrt{ }$ residual lumen filled with material of ground-glass opacity\n$\\sqrt{ }$ periantral soft-tissue infiltration\n$\\sqrt{ }$ bone thickening + sclerosis of sinus walls $\\leftarrow$ chronic obstruction + inflammation\n$C x$ : invasion of orbital fat + extraocular muscles + optic nerve $\\pm$ local bone destruction\n@ Nasopharynx ( $64 \\%$ )\n- chronic nasal obstruction (may be misdiagnosed as chronic sinusitis)\n- epistaxis from nasal mucosal ulceration\n- necrosis of nasal septum, saddle nose deformity\n$\\sqrt{ }$ partial / complete erosion of nasal septum\n$\\sqrt{ }$ truncated + shortened turbinates\n$\\sqrt{ }$ progressive destruction of turbinates + lateral nasal wall (DDx: relapsing polychondritis)\n$\\sqrt{ }$ destruction of hard palate with sinonasal-oral fistulas\n$\\sqrt{ }$ granulomatous masses filling nasal cavity\n@ CNS (involved late in $22-35 \\%$ )\n- central / peripheral neuritis\n$\\sqrt{ }$ cerebral lesions $\\leftarrow$ intracranial extension of granulomas located in nasal cavity + paranasal sinuses\n$\\sqrt{ }$ necrotizing cerebral vasculitis (nearly always with active sinusitis / otitis / lung disease)\n$\\sqrt{ }$ leptomeningeal enhancement\n$\\sqrt{ }$ nonspecific isolated enhancing intracranial / spinal lesions\n@ Other organ involvement:\n(a) Joints (67\\%): migratory polyarthropathy\n(b) Ear ( $61 \\%$ ): otitis media\n(c) Eye (58\\%): ocular inflammation, proptosis\n(d) Skin + muscle (45\\%): inflammatory nodular skin lesions, cutaneous purpura\n(e) Heart + pericardium (12-28\\%):\ncoronary vasculitis (rare), pancarditis, valvular lesions\n$C x$ : acute pericarditis ( $6 \\%$ ), dilated congestive cardiomyopathy, acute valvular insufficiency with pulmonary edema, cardiac arrest $\\leftarrow$ ventricular arrhythmia, myocardial infarction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 210,
            "markdown": "(f) Splenic disease\n(g) GI tract $(10 \\%)$ :\n\n- abdominal pain, diarrhea, blood loss\n$\\checkmark$ ischemia, inflammation, ulceration, perforation\nCx: (1) Hypertension\n(2) Uremia\n(3) Facial nerve paralysis\n\nDx: (1) Lung / renal biopsy\n(2) c-ANCA: $96 \\%$ sensitive for generalized disease, $99 \\%$ specific\n\nPrognosis: death within 2 years from renal ( $83 \\%$ ) / respiratory failure; $90-95 \\%$ mean 5-year survival under Rx\nRx: corticosteroids, cytotoxic drugs (cyclophosphamide), renal transplantation; 75-93\\% remission with therapy\n$D D x$ : Churg-Strauss (asthma, $47 \\%$ cardiac involvement, less severe renal + sinus disease, p ANCA); Goodpasture syndrome; SLE; mixed connective tissue disease; microscopic polyangiitis\n\n# Limited Wegener Granulomatosis \n\n$=$ Wegener granulomatosis largely confined to lung without renal / upper airway involvement\nDx: c-ANCA ( $96 \\%$ sensitive, $99 \\%$ specific)\n$\\mathrm{M}<\\mathrm{F}$\nPrognosis: more favorable than classical Wegener's\n\n## Midline Granuloma\n\n$=$ mutilating granulomatous + neoplastic lesions limited to nose + paranasal sinuses with very poor prognosis; considered a variant of Wegener granulomatosis without the typical granulomatous + cellular components",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 211,
            "markdown": "# LIVER, BILE DUCTS, PANCREAS AND SPLEEN \n\n## DIFFERENTIAL DIAGNOSIS OF HEPATIC, BILIARY, PANCREATIC AND SPLENIC DISORDERS\n\n## RIGHT UPPER QUADRANT PAIN\n\nA. BILE DUCTS\n\n1. Biliary colic / bile duct obstruction\n2. Acute cholecystitis / cholangitis\nB. LIVER\n3. Acute hepatitis:\n(a) alcoholic, viral, drug-related, toxic\n(b) steatohepatitis\n4. Hepatic abscess\n5. Hepatic tumor: metastases, hepatocellular carcinoma, hemangioma, focal nodular hyperplasia, hepatic adenoma\n6. Hemorrhagic cyst\n7. Hepatic congestion: acute hepatic congestion, Budd-Chiari syndrome\n8. Perihepatitis $=$ Fitz-Hugh-Curtis syndrome\nC. PANCREAS\n9. Acute pancreatitis\nD. INTESTINES\n10. Acute appendicitis\n11. Peripyloric ulcer\n12. Small bowel obstruction\n13. Irritable bowel\n14. Colitis / ileitis\n15. Intestinal tumor\nE. LUNG\n16. Pneumonia\n17. Pulmonary infarction\nF. KIDNEY\n18. Acute pyelonephritis\n19. Ureteral calculus\n20. Renal / perirenal abscess\n21. Renal infarction\n22. Renal tumor\nG. OTHERS\n23. Costochondritis\n24. Herpes zoster",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 212,
            "markdown": "# LIVER \n\n## Diffuse Liver Disease\n\nA. Infectious\n\n1. Hepatitis\n2. Candidiasis\n3. Sarcoidosis\nB. Reparative\n4. Cirrhosis\nC. Infiltrative\n5. Iron deposition: hemochromatosis\n6. Fat deposition: fatty liver\n7. Glycogen storage disease\n8. Wilson disease\nD. Vascular\n9. Intrahepatic shunts\n10. Budd-Chiari syndrome\n11. Right-sided CHF\n12. Portal vein thrombosis\n13. Venoocclusive disease\nE. BILIARY\n14. Caroli disease\n15. Cholangitis: primary sclerosing cholangitis\n\n## Diffuse Hepatic Enlargement = Hepatomegaly\n\nA. METABOLIC\n\n1. Fatty infiltration\n2. Amyloid\n3. Wilson disease\n4. Gaucher disease\n5. Von Gierke disease\n6. Niemann-Pick disease\n7. Weber-Christian disease\n8. Galactosemia\nB. MALIGNANCY\n9. Lymphoma\n10. Diffuse metastases\n11. Diffuse HCC\n12. Angiosarcoma\nC. INFLAMMATION / INFECTION\n13. Hepatitis\n14. Mononucleosis\n15. Miliary TB, histoplasmosis\n16. Malaria\n17. Syphilis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 213,
            "markdown": "6. Leptospirosis\n7. Chronic granulomatous disease of childhood\n8. Sarcoidosis\nD. VASCULAR\n9. Passive congestion\nE. OTHERS\n10. Early cirrhosis\n11. Polycystic liver disease\n\n# Hepatosplenomegaly \n\n1. Disorders associated with extramedullary hematopoiesis + hemolytic anemia\n2. Metabolic storage disease\n3. Viral infection\n4. Sarcoidosis\n5. Leukemia, lymphoma, myeloproliferative disease\n\n## Hepatic Gas\n\nHepatic gas may be indicative of serious acute disease or simply an incidental finding of no clinical significance. Knowledge of the clinical history and clues on images may allow to determine its clinical relevance.\nA. NONIATROGENIC\n\n1. Liver abscess\n2. Mesenteric infarction, necrotizing enterocolitis, colitis $\\rightarrow$ portal venous gas\n3. Hepatic artery thrombosis in liver transplant\n4. Inflammatory bowel disease\n5. Abdominal trauma\n6. Emphysematous cholecystitis, ascending cholangitis\nB. IATROGENIC\n\nHepatic gas is to be expected after therapeutic interventions like surgery, embolization, or tumor ablation.\n\n1. Biliary gas: sphincterotomy / choledochojejunostomy\n2. Colonoscopy, barium enema examination\n3. Liver biopsy\n4. Hepatic artery embolization: chemoembolization, brachytherapy, posttraumatic embolization\n5. Percutaneous tumor ablation\n6. Migration of hepatic venous gas: femoral venous / spinal / epidural catheter or lumbar puncture\n7. Oxidized cellulose sponge (SURGICEL ${ }^{\\circledR}$ )\n\nHepatic venous gas may be seen after placement of a femoral central venous catheter and aggressive fluid resuscitation.\n\n## Increased Liver Attenuation\n\n$=$ abnormal deposits of substances with high atomic numbers",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 214,
            "markdown": "$\\sqrt{ }$ normal liver density on NECT: 55-65 HU\nA. IRON\n$\\sqrt{ }$ density of iron-laden liver on NECT: $>72-80 \\mathrm{HU}$\n(a) diffuse iron deposition\n> hepatocyte deposition\n\n1. Genetic hemochromatosis\n2. Erythropoietic hemochromatosis: intravascular hemolysis, paroxysmal nocturnal hemoglobulinuria\n3. Bantu siderosis\n4. Cirrhosis\n> recticuloendothelial deposition\n5. Transfusional iron overload\n(b) focal iron accumulation\n6. Hemorrhagic metastases: choriocarcinoma, melanoma\n7. Hepatic adenoma\n8. Siderotic regenerative nodules of cirrhosis\n9. Focal hemochromatosis\nB. COPPER\n\nWilson disease\nC. IODINE\n\nAmiodarone (= antiarrhythmic drug with $37 \\%$ iodine by weight)\n$\\sqrt{ } 95-145 \\mathrm{HU}$ (range of normal for liver $30-70 \\mathrm{HU}$ )\nD. GOLD\n\nColloidal form of gold for therapy of rheumatoid arthritis\nE. THOROTRAST\n\nAlpha-emitter with atomic number of 90\nF. THALLIUM\n\nAccidental / suicidal ingestion of rodenticides (lethal dose is $0.2-1.0$ gram)\nG. ACUTE MASSIVE PROTEIN DEPOSITS\nH. GLYCOGEN STORAGE DISEASE\nmnemonic: GG CHAT\nGold therapy\nGlycogen storage disease\nCyclophosphamide\nHemochromatosis / hemosiderosis\nAmiodarone\nThorotrast\n\n# Generalized Increase in Liver Echogenicity \n\n1. Fatty liver\n2. Steatohepatitis\n3. Cirrhosis (fibrosis + fatty liver)\n4. Chronic hepatitis\n5. Vacuolar degeneration",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 215,
            "markdown": "# Marked Decrease in Hepatic T2 Signal Intensity \n\n$=$ paramagnetic effect of intracellular iron deposition (ferritin, hemosiderin)\n$\\diamond$ Signal intensity of pancreas does not help distinguish between primary + secondary hemochromatosis!\n\n1. Primary / hereditary hemochromatosis (dietary iron)\n2. Secondary hemochromatosis\n$\\sqrt{ }$ bone marrow of low SI (DDx: myelofibrosis)\n3. Transfusional siderosis (RES)\n$\\checkmark$ bone marrow of low signal intensity\n$\\checkmark$ decreased T2 signal in spleen\n4. Intravenous administration of ultrasmall superparamagnetic iron oxide\n\n## PERIHEPATIC SPACE\n\n## Perihepatic Fat Attenuation\n\n1. Spontaneous rupture of cystic ovarian teratoma\n2. Lipoma / liposarcoma\n3. Pseudolipoma\n$=$ detached degenerating epiploic appendage lodged between diaphragm and superior aspect of liver\n4. Juxtacaval fat\n$=$ medial to IVC near hepatic venous confluence\nPrevalence: $0.5 \\%$ of CTs in adults\n5. Omental infarction\n6. Intrahepatic omental packing\n\n## Perihepatitis\n\n$=$ inflammation of peritoneal capsule of liver\n$\\checkmark$ hepatic capsular enhancement\nA. Infection\n\n1. Fitz-Hugh-Curtis syndrome\n2. Perforated cholecystitis\n3. Perforated hepatic abscess\n4. Tuberculous peritonitis\nB. Inflammation\n5. SLE\n6. Radiation therapy\nC. Tumor $=$ peritoneal carcinomatosis\nD. Pseudoperihepatitis\n$=$ low liver density simulates capsular enhancement\n7. Fatty liver\n\n## LIVER MASS\n\n$\\diamond$ Hepatic masses account only for 5-6\\% of all intraabdominal masses in children!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 216,
            "markdown": "# Primary Benign Liver Tumor \n\nA. EPITHELIAL TUMORS\n(a) hepatocellular\n\n1. Hepatic adenoma\n2. Focal nodular hyperplasia\n3. Nodules in cirrhosis: regenerative nodule, dysplastic nodule\n4. Nodular regenerative hyperplasia\n(b) cholangiocellular\n5. Hepatic cyst\n6. Bile duct hamartoma\n7. Peribiliary cyst\n8. Biliary cystadenoma\n9. Caroli disease\n10. Biliary papillomatosis\nB. MESENCHYMAL TUMORS\n(a) tumor of adipose tissue\n11. Hepatic lipoma\n12. Hepatic myelolipoma\n13. Hepatic angiomyolipoma\n(b) tumor of muscle tissue\n14. Leiomyoma\n(c) tumor of blood vessels\n15. Infantile hemangioendothelioma\n16. Hemangioma\n17. Peliosis hepatis\n(d) tumor of neural crest\n18. Hepatic paraganglioma\n(e) mesothelial tumor\n19. Benign mesothelioma\nC. MIXED TISSUE TUMOR\n20. Mesenchymal hamartoma\n21. Hepatoblastoma\n22. Benign teratoma\nD. MISCELLANEOUS\n23. Adrenal rest tumor\n24. Pancreatic rest\nE. PSEUDOLESION\n25. Focal fatty infiltration\n26. Focal fat sparing\n27. Confluent hepatic fibrosis\n\n## Pediatric Benign Liver Mass\n\n1. Infantile hemangioendothelioma\n2. Mesenchymal hamartoma\n\n## infrequent:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 217,
            "markdown": "3. Focal nodular hyperplasia\n4. Hepatocellular adenoma\n5. Nodular regenerative hyperplasia\n\n# Primary Malignant Liver Tumor \n\n$\\diamond$ Hepatic malignancies are the most common GI malignancy in children, but account for $<$ $2 \\%$ of all pediatric malignancies!\nA. EPITHELIAL TUMOR\n(a) hepatocellular\n\n1. Hepatoblastoma (7\\%)\n2. Hepatocellular carcinoma ( $75 \\%$ )\n(b) cholangiocellular ( $6 \\%$ )\n3. Cholangiocarcinoma\n4. Biliary cystadenocarcinoma\nB. MESENCHYMAL TUMOR\n(a) tumor of blood vessels\n5. Angiosarcoma\n6. Epithelioid hemangioendothelioma\n7. Kaposi sarcoma\n(b) other tumor\n8. Embryonal sarcoma\n9. Fibrosarcoma\nC. TUMOR OF MUSCLE TISSUE\n10. Leiomyosarcoma\n11. Embryonal rhabdomyosarcoma of the biliary tree\nD. MISCELLANEOUS\n12. Carcinosarcoma\n13. Teratoma\n14. Yolk sac tumor\n15. Carcinoid\n16. Squamous carcinoma\n17. Primary lymphoma\n\n## Pediatric Malignant Liver Mass\n\nA. PRIMARY\n\n1. Hepatoblastoma\n2. Hepatocellular carcinoma\n3. Fibrolamellar carcinoma\n4. Undifferentiated (embryonal) sarcoma\n5. Epithelioid hemangioendothelioma\n6. Embryonal rhabdomyosarcoma\nB. SECONDARY (metastasis)\n$\\diamond$ Most common neoplasm involving liver\nOrigin: neuroblastoma, Wilms tumor, lymphoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 218,
            "markdown": "# Solitary Liver Lesion \n\nA. Benign tumor\n\n1. Cavernous hemangioma\n2. Adenoma\n3. Focal nodular hyperplasia\n4. Mesenchymal hamartoma\nB. Infection\n5. Pyogenic abscess\n6. Echinococcal cyst\n7. Inflammatory pseudotumor\nC. Trauma\n8. Hematoma\n9. Traumatic cyst\nD. Malignant tumor\n10. Primary tumor\n11. Metastasis\nE. Other\n12. Fatty change\n13. Simple cyst\n\n## Solitary Cystic Lesion\n\n$\\sqrt{ }$ well-defined lesion with predominant near-water attenuation ( $0-30 \\mathrm{HU}$ ) / signal intensity exhibiting negligible enhancement at dynamic imaging\n$\\sqrt{ }$ variability of cystic component accounts for differences in attenuation / signal intensity:\n(a) liquids: serous, mucinous, bilious, hemorrhagic, proteinaceous, or mixed fluids\n(b) intratumoral necrosis\n(c) tissue with a high water content\n$\\sqrt{ }$ septa may contain a range of tissues including epithelium, fibrotic tissue, stroma, neoplastic tissue, inflammatory cells.\n\n1. Biliary cystadenoma / biliary carcinoma\n2. Cystic degeneration of hepatocellular carcinoma\n3. Bacterial / parasitic abscess\n4. Metastatic disease\n5. Posttraumatic resolving hematoma\n\n| Typical MR Characteristics of Benign Liver Tumors |  |  |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: | :--: | :--: |\n| Lesion | T1WI | T2WI | Contrast Enhancement |  |  |  |\n|  | (relative to normal liver parenchyma) |  | Arterial Phase | Portal Venous Phase isointense |  | Delayed Phase |\n| Adenoma | hyper- to isointense | slightly hyperintense | hyperintense |  |  |  |\n| FNH | iso- to hypointense | hyper- to isointense (hyperintense central scar) | hyperintense <br> (hypointense central scar) | hyper- to isointense |  | isointense (hyper- to isointense central scar) |\n| Regenerative nodule | variable | hypointense | no enhancement |  | variable |  |\n| Dysplastic nodule | variable | variable - may have hyperintense foci | slight / no enhancement |  | variable |  |\n| Hepatic cyst | hypointense | hyperintense | no enhancement |  |  |  |\n| Hemangioma | hypointense | hyperintense | peripheral nodular enhancement | increasing peripheral enhancement |  | hyperintense |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 219,
            "markdown": "# Multilocular Cystic Hepatic Lesions \n\nA. CONGENITAL\n\n1. Polycystic liver disease\nB. NEOPLASTIC\n2. Biliary cystadenoma / carcinoma\n3. Hepatocellular carcinoma\n4. Cystic metastasis: neuroendocrine tumor, melanoma, GIST, mucinous colorectal / mucinous ovarian carcinoma; treated metastasis\n5. Inflammatory myofibroblastic tumor\n6. Mesenchymal hamartoma\nC. INFECTIOUS\n7. Pyogenic abscess\n8. Amebic abscess\n9. Echinococcal cyst\nD. TRAUMATIC\n10. Intraparenchymal hematoma\n11. Biloma\n\n## Attenuation of Cystic Hepatic Lesions\n\n1. Simple hepatic cyst $\\sim 10-10 \\mathrm{HU}$\n2. Hematoma (acute) $40-60 \\mathrm{HU}$\n3. Clotted blood $45-70 \\mathrm{HU}$\n4. Biloma $0-15 \\mathrm{HU}$\n5. Pyogenic abscess $0-45 \\mathrm{HU}$\n6. Hydatid mother cyst $3-30 \\mathrm{HU}$\n7. Hydatid daughter cyst lower than mother cyst\n8. Amebic abscess $10-20 \\mathrm{HU}$\n$\\diamond$ Density measurements in general are of little help due to variability of cyst content and change over time!\n\n## Solitary Echogenic Liver Mass\n\nmnemonic: Hyperechoic Focal Masses Affecting the Liver\nHematoma, Hepatoma, Hemangioma, Hemochromatosis, Hepatoblastoma\nFatty infiltration, Focal nodular hyperplasia, Fibrosis\nMetastasis\nAdenoma\nLipoma\n\n## Solid Liver Lesion with Cystic Degeneration\n\n1. Hepatocellular carcinoma / adenoma\n2. Fibrolamellar carcinoma\n3. Intrahepatic cholangiocarcinoma\n4. Angiosarcoma\n5. Epithelioid hemangioendothelioma\n6. Lymphoma\n7. Metastatic disease",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 220,
            "markdown": "# Liver Mass Surrounded by Echogenic Rim \n\n1. Metastasis: esp., cystic pancreatic endocrine tumor\n2. Adenoma\n3. Hemangioma\n\n## Multiple Liver Lesions\n\nA. BENIGN TUMOR\n\n1. Cavernous hemangioma\n2. Adenoma\n3. Regenerating hepatic nodules\n4. Biliary microhamartomas\nB. INFECTION\n5. Multiple abscesses / microabscesses\n6. Mycobacterial + fungal infection\n7. Inflammatory pseudotumors\nC. CONGENITAL\n8. Polycystic disease\n9. Caroli disease\nD. MALIGNANCY\n10. Metastases (most common malignant liver tumor)\n11. Multifocal hepatoma\n12. Lymphoma\nE. OTHER\n13. Sarcoidosis\n14. Simple cysts\n15. Langerhans cell histiocytosis (echogenic nodules)\n16. Multifocal fat deposition\n\n## Bull's-eye Lesions of Liver\n\n1. Candidiasis (in immunocompromised)\n2. Metastases\n3. Lymphoma, leukemia\n4. Sarcoidosis\n5. Septic emboli\n6. Other opportunistic infections\n7. Kaposi sarcoma\n\n## Miliary Hepatosplenic Lesions\n\n1. Tuberculosis\n2. Metastases\n3. Fungal infections\n4. Sarcoidosis\n5. Lymphoma\n\nFat- / Lipid containing Liver Mass\n\n1. Lipoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 221,
            "markdown": "2. Angiolipoma\n3. Angiomyolipoma: eg, tuberous sclerosis\n4. Hepatocellular carcinoma\n5. Hepatocellular adenoma\n6. Liposarcoma metastasis\n7. Malignant teratoma metastasis (+ calcifications)\n8. Focal fatty change\n9. Focal nodular hyperplasia (rare)\n10. Regenerative \\& dysplastic nodules\n11. Fat packing\n\n# Cystic Liver Lesion \n\nA. NONNEOPLASTIC\n\n1. Congenital hepatic cyst\n2. Hematoma\n3. Echinococcal cyst\n4. Liver abscess\n5. Fibropolycystic liver disease\n6. Intrahepatic pseudocyst\n7. Biloma\nB. NEOPLASTIC\n8. Mesenchymal hamartoma\n9. Undifferentiated (embryonal) sarcoma\n10. Malignant mesenchymoma\n11. Biliary cystadenoma / cystadenocarcinoma\n$\\diamond<5 \\%$ of intrahepatic cysts are of biliary origin!\n12. Lymphangioma\n13. Necrotic ischemic neoplasm: HCC, giant cavernous hemangioma\n14. Cystic metastasis: ovarian / gastric carcinoma\n\n## Fibropolycystic Liver Disease\n\n$=$ unique group of entities with derangement of embryonic biliary ductal plate development surrounding portal vein\n$\\diamond$ Coexistence of hepatic + renal anomalies\nA. SMALL INTERLOBULAR BILE DUCTS\n\n1. Congenital hepatic fibrosis\n2. Biliary hamartomas\n\nAssociated with: autosomal recessive (juvenile) polycystic kidney disease\nB. MEDIUM-SIZED BILE DUCTS\n\n1. Autosomal dominant polycystic disease\n\nAssociated with: autosomal dominant (adult) polycystic kidney disease\nC. LARGE INTRAHEPATIC BILE DUCTS\n\n1. Caroli disease\nD. LARGE EXTRAHEPATIC BILE DUCTS\n2. Choledochal cyst",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 222,
            "markdown": "# Liver Mass with Capsule \n\n1. Hepatocellular carcinoma\n2. Hepatocellular adenoma\n3. Focal nodular hyperplasia (thin incomplete capsule)\n\n## Liver Mass with Capsular Retraction\n\n1. Cholangiocarcinoma\n2. Fibrolamellar carcinoma\n3. Epithelioid hemangioendothelioma\n4. Confluent hepatic fibrosis\nor any hepatic malignancy\n\n## Disease of Hepatic Capsular \\& Subcapsular Region\n\nA. INFECTION / INFLAMMATION\n\n1. Perihepatitis\n2. Parasites: fascioliasis, paragonimiasis, sparganosis\n$\\rightarrow$ penetration of intestinal wall $\\rightarrow$ migration through peritoneal cavity $\\rightarrow$ perforation of liver capsule with initially subcapsular infestation\nB. METASTATIC DISEASE\n(a) seeded metastasis: ovarian cancer\n(b) invasion via perihepatic ligaments: cancer of stomach, duodenum, pancreas, colon, anterior abdominal wall\n(c) direct invasion from adjacent organ: cancer of stomach, gallbladder, adrenal gland, kidney\nC. PSEUDOLESION OF ALTERED HEMODYNAMICS\n3. Third inflow\n4. Arterioportal shunt\n5. Compression of liver\n6. Portal vein obstruction\n7. Hepatic vein / IVC obstruction\n8. Hepatic infarction\n9. Intrahepatic vascular shunt: superior vein of Sappey, umbilical + paraumbilical veins, right posterior portal vein, venovenous surface collaterals\nD. OTHERS\n10. Focal fat sparing / focal fat infiltration\n11. Confluent hepatic fibrosis\n\n## Hyperintense Liver Mass on T1WI\n\n$\\diamond$ Usually due to lipid, hemorrhage or melanin!\n\n1. Hepatocellular adenoma\n2. Hepatocellular carcinoma\n3. Regenerative \\& dysplastic nodule\n4. Melanoma\n5. Hemorrhage (methemoglobin), hemorrhagic tumor\n6. Focal fat deposit, lipoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 223,
            "markdown": "7. Cyst with high protein content\n8. Thrombosed hemangioma (rare)\n9. Paramagnetic contrast agents + iodized oil\n\n# Hypointense Liver Lesion on T2WI \n\nA. ABSOLUTE\n> blood degradation products\n» acute intracellular deoxyhemoglobin\n» subacute intracellular methemoglobin\n» chronic intracellular iron ferritin / hemosiderin\n\n1. Hepatocellular adenoma $\\leftarrow$ internal bleeding\n2. Hepatocellular carcinoma $\\leftarrow$ internal bleeding\n3. Metastasis\n4. Focal nodular hyperplasia $\\leftarrow$ intratumoral hemolysis\n5. Nodular regenerative hyperplasia\n6. Peliosis hepatis $\\leftarrow$ hemorrhage in large vascular spaces\n7. Hematoma\n> iron (intracellular paramagnetic Fe3+)\n8. Siderotic nodule\n9. Dysplastic nodule\n10. HCC\n> copper (= divalent paramagnetic copper)\n11. Wilson disease\n12. HCC\n13. Focal nodular hyperplasia\n> macromolecules $\\leftarrow$ restricted motion of water bound to protein\n» smooth muscle\n14. Leiomyoma\n15. Angiomyolipoma\n» fibrosis\n16. Fibrolamellar HCC\n17. Intrahepatic cholangiocarcinoma\n18. HCC\n19. Metastasis of adenocarcinoma\n20. Focal nodular hyperplasia\n21. HCA\n» mucin (= desiccated mucinous secretions)\n22. Metastasis\n» fibrinogen (intracytoplasmic inclusions = fibrinogen in dilated rough endoplasmic reticulum)\n23. HCC\n» keratin\n24. Metastasis\n» melanin $\\leftarrow$ presumably related to higher melanin levels or to old hemorrhage\n25. Malignant melanoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 224,
            "markdown": "2. Metastasis\n> necrosis (coagulative $=$ dehydrated necrosis)\n3. Metastasis\n4. Solitary necrotic nodule\n5. HCC\n6. HCA\n> calcium\n7. Granuloma\n8. Healed inactive hydatid cyst\n9. Fibrolamellar HCC\n10. Metastasis: mucinous cancer of colon, stomach, breast, ovary / osteo- and chondrosarcoma\n11. HCA\n12. Teratoma\nB. RELATIVE\n> fat (= macroscopic intratumoral fat)\n13. Hepatocellular adenoma\n14. Hepatocellular carcinoma\n15. Lipoma\n16. Angiomyolipoma\n17. Focal nodular hyperplasia\n\n# Liver Mass on Diffusion-Weighted Imaging \n\n$=$ quantification of water diffusion + microcapillary blood perfusion $\\leftarrow$ based on incoherent intravoxel motion\nA. Tissue with restricted diffusion $(\\downarrow \\mathrm{ADC})$\n\n1. Tumor: usually lower ADC for malignant lesion\n2. Cytotoxic edema\n3. Abscess\nB. Tissue with less restricted diffusion ( $\\uparrow \\mathrm{ADC}$ )\n= tissue of low cellularity / with disrupted cell membranes\n4. Cyst\n5. Hemangioma\n6. Treated nonviable / necrotic tumor\n\n## Uptake of Superparamagnetic Iron Oxide Particles\n\nAction: preferential entrapment by Kupffer cells\n\n1. Focal nodular hyperplasia\n2. Well-differentiated HCC\n3. Dysplastic nodule\n4. Hepatic adenoma\n\n## Enhancement Characteristics of Liver Mass\n\n## Hypovascular Liver Lesion",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 225,
            "markdown": "$=$ less dense than adjacent liver parenchyma during arterial + portal venous phase\n\n# Hypo- / Nonenhancing benign Liver Lesion \n\n1. \"To small to characterize\" implies unreliable density measurement\n> small metastasis = low probability\n> microabscesses = clinically obvious\n> biliary hamartoma = usually multiple\n2. Hepatic cyst\n3. Caroli disease\n4. ADPKD\n5. Abscess\n6. Hydatid cyst\n7. Biliary cystadenoma\n8. Regenerating / dysplastic nodule\n9. Lipoma\n10. Bile duct hamartoma\n11. Sarcoidosis\n12. Histoplasmosis\n\n## Hypoenhancing Malignant Liver Lesion\n\n1. Metastasis to liver\n2. Lymphoma\n3. Cholangiocarcinoma\n\n## Low-density Hepatic Mass with Enhancement\n\n1. Hepatocellular carcinoma\n2. Hypervascular metastases\n$=$ lesions that may be obscured after contrast injection: pheochromocytoma, carcinoid, melanoma\n3. Cavernous hemangioma\n4. Focal nodular hyperplasia with central fibrous scar\n5. Hepatic adenoma\n\n## Ring-enhancing Targetlike Liver Mass\n\n1. Metastasis\n2. Abscess\n3. Cholangiocarcinoma\n4. Treated HCC\n5. Epithelioid hemangioendothelioma\n6. Confluent hepatic fibrosis\n7. Giant atypical cavernous hemangioma\n\n## RIM ENHANCEMENT\n\n1. Biliary cystadenoma / adenocarcinoma\n2. Hematoma (some)\n$\\sqrt{ }$ bright on T1WI $\\leftarrow$ subacute hematoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 226,
            "markdown": "$\\sqrt{ }$ dark on T2WI $\\leftarrow$ hemosiderin of chronic hematoma\n\n# Hypervascular Liver Mass \n\n$\\sqrt{ }$ detected during hepatic arterial + portal venous phase\nA. BENIGN\n\n1. Focal nodular hyperplasia\n2. Hepatocellular adenoma\n3. Hemangioma (Type 1)\nB. MALIGNANT\n(a) Primary malignant liver tumor\n4. Hepatocellular carcinoma\n5. Hemangioendothelioma\n6. Angiosarcoma\n(b) Hypervascular liver metastases\n\n## Hypervascular Mass in Normal Liver\n\n1. Small hemangioma (Type 1)\n2. Focal nodular hyperplasia\n3. Hepatocellular adenoma\n4. Metastasis\n\n## Hypervascular Mass in Chronic Liver Disease\n\n1. Hepatocellular carcinoma\n2. Nodular regenerative hyperplasia\n3. Mimickers:\n\nAVM, FNH, hemangioma, dysplastic nodule, transient hepatic intensity difference\n\n## Hypervascular Mass with Central Scar\n\n1. Focal nodular hyperplasia\n2. Giant cavernous hemangioma\n3. Fibrolamellar carcinoma of liver\n4. Well-differentiated hepatocellular carcinoma\n5. Hypervascular metastasis\n6. Intrahepatic cholangiocarcinoma\n\n## Nodule-within-nodule Enhancement\n\n1. Focus of early HCC within dysplastic nodule\n$\\checkmark$ moderately high SI on T2WI within nodule of generally low SI\n$\\checkmark$ marked arterial enhancement on T1WI\n\n## Peripheral Washout Sign\n\n1. Metastasis: carcinoid, breast, colon, stomach\n$\\checkmark$ hypointense peripheral rim relative to center (best seen 10 minutes after contrast administration)\n\n## Delayed Phase-enhancing Lesion\n\n1. Hemangioma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 227,
            "markdown": "2. Intrahepatic cholangiocarcinoma\n3. Peliosis hepatis\n\n# Hepatic Calcification \n\nA. INFECTION (most common cause)\n\n1. Granulomatous disease: tuberculosis (48\\%), histoplasmosis, brucellosis, coccidioidomycosis\n$\\checkmark$ calcium involves entire lesion\n2. Echinococcal cyst (in $10-20 \\%$ )\n$\\checkmark$ curvilinear / ring calcification\n3. CMV, toxoplasmosis, Pneumocystis carinii\n4. Chronic granulomatous disease of childhood\n5. Old pyogenic / amebic abscess\n6. Schistosomiasis\n$\\checkmark$ turtleback / tortoise shell calcifications\n7. Cysticercosis, filariasis, paragonimiasis, Armillifer infection, dracunculiasis\n8. Syphilitic gumma\nB. VASCULAR\n9. Hepatic artery aneurysm\n10. Portal vein thrombosis\n11. Hematoma\nC. BILIARY\n12. Hepatolithiasis = intrahepatic calculi\n13. Recurrent pyogenic cholangitis\n14. Ascariasis\n15. Clonorchiasis\nD. BENIGN TUMORS\n16. Congenital cyst\n17. Cavernous hemangioma\n$\\checkmark$ large coarse centrally located calcification (in 10-20\\%)\n18. Hepatocellular adenoma\n19. Capsule of regenerating nodules\n20. Infantile hemangioendothelioma\nE. PRIMARY MALIGNANT TUMOR\n21. Fibrolamellar carcinoma (calcified in $15-25 \\%$ )\n22. Hepatocellular carcinoma\n23. Hepatoblastoma ( $10-20 \\%$ )\n24. Intrahepatic cholangiocarcinoma (in 18\\%)\n$\\checkmark$ calcification accompanied by desmoplastic reaction\n25. Epithelioid hemangioendothelioma\n26. Cystadenocarcinoma\nF. METASTATIC TUMOR\n27. Mucin-producing neoplasm: carcinoma of colon, breast, stomach\n28. Ovarian carcinoma (psammomatous bodies)\n29. Melanoma, thyroid carcinoma, pleural mesothelioma, chondro- and osteosarcoma,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 228,
            "markdown": "carcinoid, leiomyosarcoma, neuroblastoma\nmnemonic: 4H TAG MAP\nHepatoma\nHemochromatosis\nHemangioma\nHydatid disease\nThorotrast\nAbscess\nGranulomas (healed)\nMetastases\nAbsent mnemonic\nPorcelain gallbladder\n\n# Spontaneous Hepatic Hemorrhage \n\nA. RUPTURE OF PRIMARY HYPERVASCULAR NEOPLASM\n\n1. Hepatocellular carcinoma ( $86 \\%$ )\n2. Hepatocellular adenoma ( $6 \\%$ )\n3. Hepatic hemangioma (3\\%)\n4. Hepatic metastasis: lung, RCC, melanoma (1\\%)\n5. Focal nodular hyperplasia\n6. Amyloidosis\n7. Peliosis hepatis\n8. Angiomyolipoma\n(b) COAGULATION DISORDER\n9. Cirrhosis (4\\%)\n(c) SYNDROMIC HEMOLYSIS\n10. HELLP syndrome\n\n## Colloid Shift\n\n$=$ increased uptake of injected colloid by bone marrow\nA. HEPATIC DYSFUNCTION\n\n1. Cirrhosis\n2. Hepatitis\n3. Chronic passive congestion\nB. AUGMENTED PERFUSION of spleen + bone marrow\n4. Hematopoietic disorders\n5. Long-term corticosteroid therapy\n\n## Focal Hot Liver Lesion\n\n1. IVC / SVC obstruction\n$\\sqrt{ }$ increased perfusion of quadrate lobe located at posterior aspect of medial segment left hepatic lobe (collateral pathway via umbilical vein)\n2. Budd-Chiari syndrome\n$\\sqrt{ }$ \"increased\" perfusion of caudate lobe $\\leftarrow$ actually decrease of activity elsewhere in liver",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 229,
            "markdown": "3. FNH (varying amount of Kupffer cells)\n$\\sqrt{ }$ hot (DIAGNOSTIC) / cold / isoactive with surrounding parenchyma\n4. Regenerating nodules of cirrhosis\n\n# Focal Liver Defects \n\nA. NEOPLASTIC\n(a) primary liver tumor: hepatoma, hemangioma, hepatic adenoma, FNH\n(b) metastases: $85 \\%$ sensitive, $75-80 \\%$ specific for lesion $>1-2 \\mathrm{~cm}$\nB. INFECTIOUS DISEASE / ABSCESS\nC. BENIGN CYST\nD. TRAUMA (= hematoma)\nE. PSEUDOTUMOR = normal variant\nmnemonic: L-CHAIM\nLymphoma\nCyst\nHematoma\nAbscess\nInfarct\nMetastasis\n\n## Mottled Hepatic Uptake\n\n1. Cirrhosis\n2. Acute hepatitis\n3. Lymphoma\n4. Amyloidosis\n5. Granulomatous disease: sarcoidosis, fungal, viral, parasitic\n6. Chemo- / radiation therapy\n\n## PORTA HEPATIS\n\n## Spectrum of Disease of Porta Hepatis\n\nA. VASCULAR\n\n1. Main portal vein (MPV): thrombosis, stenosis, aneurysm, gas\n2. Common hepatic artery (CHA): thrombosis, stenosis, aneurysm\nB. BILE DUCTS\n3. Cholangiocarcinoma\n4. Intrabiliary metastasis\n\nOrigin: lung, breast, gallbladder, colon, testis, prostate, pancreas, melanoma, lymphoma\n3. Benign biliary stricture\n4. Choledochal cyst\nC. LYMPH NODES\n\n1. Benign reactive lymph nodes\n2. Noninfectious inflammatory disease\n3. Infectious disease",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 230,
            "markdown": "4. Metastasis\n5. Lymphoma\n6. Posttransplant proliferative disease\nD. NERVES\n7. Schwannoma $=$ neurilemmoma\n8. Neurofibroma\n9. Neurofibrosarcoma\nE. CONNECTIVE TISSUE\n10. Rhabdomyosarcoma\n11. Granulocytic sarcoma\nF. MISCELLANEOUS\n12. Periportal edema\n13. Porta hepatis fluid collection see below\n14. Periportal fat deposition\n\n# Low-density Mass in Porta Hepatis \n\n1. Choledochal cyst\n2. Hepatic cyst\n3. Pancreatic pseudocyst\n4. Enteric duplication\n5. Hepatic artery aneurysm\n6. Biloma\n7. Embryonal rhabdomyosarcoma of biliary tree\n\n## Porta Hepatis Fluid Collection\n\nCause: orthotopic liver transplantation, trauma, cholecystectomy, other biliary injury\n\n1. Biloma\n2. Hematoma\n3. Abscess\n4. Seroma\n\n## Enlarged Lymph Nodes of Porta Hepatis\n\nLocation: along anterior and posterior to portal vein + hepatoduodenal ligament\nNormal size: $<6 \\mathrm{~mm}$\nA. LIVER DISEASE\n\n1. Hepatitis B and C\n2. Cirrhosis\nB. INFECTION / INFLAMMATION\n3. Tuberculosis\n4. Autoimmune diseases\n5. Sarcoidosis\nC. MALIGNANCY\n6. Metastasis: esophagus, stomach, pancreas, gallbladder, liver, biliary tree, breast, lung, kidney\n$\\checkmark$ may be associated with hepatic metastasis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 231,
            "markdown": "$\\checkmark$ compression / thrombosis of portal vein\n2. Lymphoma\n\n# Defects in Porta Hepatis on Liver Scintigram \n\n1. Normal variant $\\leftarrow$ thinning of hepatic tissue overlying portal veins + gallbladder\n2. Biliary causes: dilatation of bile ducts, gallbladder hydrops\n3. Enlarged portal lymph nodes\n4. Metastases\n5. Hepatic cyst\n6. Hepatic parenchymal disease (= pseudotumor)\n7. Hepatic compression by adjacent extrinsic mass\n8. Postsurgical changes following cholecystectomy\n\n## LIVER CIRCULATION\n\n## Liver perfusion\n\nDual blood supply: normally hepatic artery $25 \\%+$ portal vein $75 \\%$\n$P V \\downarrow$ and $H A \\uparrow$ : cirrhosis \\& portal hypertension, portal vein thrombosis (bland, malignant), PV compression (adenopathy in porta hepatis)\n$P V \\uparrow$ and $H A \\downarrow$ : postprandial state, HA stenosis (orthotopic liver transplant) / thrombosis, HA encasement (pancreatic cancer)\n\n## Global Heterogeneous Hepatic Enhancement\n\n1. Passive hepatic congestion\n2. Budd-Chiari Syndrome\n3. Hereditary hemorrhagic telangiectasia\n4. Peliosis hepatis\n\n## Transient Hepatic Parenchymal Enhancement\n\n$=$ HYPERPERFUSION ABNORMALITIES OF LIVER\n$=$ TRANSIENT HEPATIC ATTENUATION DIFFERENCE (THAD LESION) = TRANSIENT HEPATIC INTENSITY DIFFERENCE (THID)\n$=$ attenuation difference of liver appearing during dynamic bolus-enhanced CT\n$\\checkmark$ patchy area of transient high attenuation during early arterial phase\n$\\checkmark$ fading with return to normal during portal venous phase\n$\\checkmark$ peripheral location, triangular shape, straight margins\n$\\checkmark$ presence of normal vessels coursing through lesion\nCause: imbalance between hepatic arterial + portal venous supply $\\leftarrow$ decreased portal blood flow, formation of intrahepatic arterioportal shunts, increased aberrant drainage through hepatic veins\nA. LOBAR / SEGMENTAL\n\n1. Portal vein obstruction: portal vein thrombosis, tumor invasion, surgical ligation\n2. Cirrhosis with arterioportal shunt\n3. Hypervascular gallbladder disease\nB. SUBSEGMENTAL",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 232,
            "markdown": "1. Obstruction of peripheral portal branches\n2. Percutaneous needle biopsy + drainage procedure / ethanol ablation\n3. Acute cholecystitis + cholangitis\nC. SUBCAPSULAR\n(a) due to peripheral parenchymal compression\n4. Rib compression\n5. Perihepatic peritoneal implants\n6. Pseudomyxoma peritonei\n7. Perihepatic fluid collections\n(b) idiopathic (unexplained)\nD. PSEUDOLESION\n$=$ systemic venous blood flow draining into hepatic sinusoids $=$ third hepatic inflow\n8. Accessory cystic vein of gallbladder fossa\n9. Aberrant right gastric vein\n10. Capsular veins\n11. Parabiliary venous system\n12. Epigastric-paraumbilical venous system\nE. RETICULAR-MOSAIC PATTERN\n13. Cirrhosis\n14. Hereditary hemorrhagic telangiectasia\n15. Hepatic vein obstruction\n\n# Arterioportal Shunt \n\n$=$ organic / functional communication between high-pressure hepatic arterial branch + lowpressure portal venous system at level of trunk / sinusoids / peribiliary venules\n$\\checkmark$ small nodular peripheral nonspherical focus isoattenuating with aorta during arterial phase $\\rightarrow$ isoattenuating to liver during portal phase\n$\\checkmark$ for peripheral arterioportal shunt transient wedge-shaped subsegmental area of enhancement during arterial phase $\\rightarrow$ normal parenchymal attenuation during portal venous phase\nPathophysiology:\n(a) shunted contrast material enhances a focal area of liver parenchyma before adjacent parenchyma is enhanced via the usual splanchnic route\n(b) large shunt may cause arterialized hepatofugal flow in portal vein detectable by Doppler ultrasound\nCause:\nA. CONGENITAL\n\n1. Hereditary hemorrhagic telangiectasia\nB. ACQUIRED\n2. Cirrhosis\n$\\checkmark$ normal SI on T1WI + T2WI\n$\\checkmark$ pseudolesion $=$ small peripheral subcapsular wedge-shaped area of transient homogeneous enhancement during arterial phase of CECT\n$\\checkmark$ pseudolesion remains stable / resolves spontaneously over time\n3. Primary hepatic neoplasm: HCC (63\\%), hemangioma, cholangiocarcinoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 233,
            "markdown": "$\\sqrt{ }$ abnormal SI on T1WI + T2WI with growth on follow-up\n$\\sqrt{ }$ transient wedge-shaped area of increased attenuation / intensity on arterial phase\nCECT / CEMR = Transient Hepatic Parenchymal Enhancement\n$\\sqrt{ }$ enhancement of portal vein branch $\\pm$ main portal vein from periphery without enhancement of splenic vein / superior mesenteric vein\n3. Secondary hepatic neoplasm: metastasis\n4. Hepatic trauma: blunt abdominal trauma, iatrogenic trauma (biopsy, percutaneous abscess drainage, transhepatic biliary drainage, ethanol injection)\n5. Rupture of hepatic artery pseudoaneurysm into portal vein\n\nSmall arterioportal shunts $2^{\\circ}$ to cirrhosis either remain stable or resolve spontaneously, whereas those $2^{\\circ}$ to HCC generally demonstrate growth at follow-up.\nRoute of fistulous communication:\n\n1. Macroscopic fistula\n2. Transsinusoidal $=$ between microscopic interlobular arteriole + portal venule\n3. Transvasal $=$ via tumor thrombus\n4. Transtumoral = via draining vein from a hypervascular tumor\n5. Transplexal / peribiliary = via capillary network surrounding bile ducts\n$D D x$ : HCC (hypoattenuated during portal venous and parenchymal phase; growth after repeat imaging in 6 months)\n\n# HEPATIC ARTERY \n\n## Hepatic Artery Enlargement\n\nA high RI is not specific for liver disease; therefore, it is less meaningful as an isolated finding than is a low RI.\n\n1. Cirrhosis $\\rightarrow$ compensatory response to decreased portal venous flow\n2. Intrahepatic arteriovenous shunting\n(a) vascular neoplasm\n(b) hepatic artery-portal vein fistula\n\nCause: biopsy, trauma\n$\\sqrt{ }$ turbulent high-velocity low-resistance flow\n$\\sqrt{ }$ soft-tissue bruit (= random assignment of color in perivascular soft tissue due to tissue vibration)\n$\\sqrt{ }$ arterialized frequently retrograde flow in portal vein\n3. Hereditary hemorrhagic telangiectasia\n$\\sqrt{ }$ large tortuous feeding arteries with high velocity + aliased flow\n$\\sqrt{ }$ multiple dilated vessels (representing AVMs)\n$\\sqrt{ }$ large draining veins\n$\\sqrt{ }$ areas of fatty change + fibrosis\n4. Chronic active hepatitis\n\n## Elevated Hepatic Artery Resistance (RI > 0.7)\n\nA. PHYSIOLOGIC\n\n1. Postprandial state",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 234,
            "markdown": "2. Advanced age of patient\nB. PATHOLOGIC\n3. Chronic hepatocellular disease\n4. Hepatic venous congestion\n(a) acute: generalized peripheral vasoconstriction\n(b) chronic: cardiac cirrhosis\n5. Transplant rejection\n\nAn RI that is too high may be the result of a postprandial state, advanced patient age, or diffuse distal microvascular disease with a wide variety of causes including chronic liver disease due to cirrhosis or chronic hepatitis.\n\n# Decreased Hepatic Artery Resistance (RI < 0.55) \n\nA. PROXIMAL ARTERIAL NARROWING\n\n1. Transplant stenosis\n2. Atherosclerotic disease\n3. Arcuate ligament syndrome\nB. DISTAL VASCULAR SHUNT\n4. Cirrhosis with portal hypertension\n5. Posttraumatic / iatrogenic\n6. Hereditary hemorrhagic telangiectasia\n\nAn RI that is too low may be the result of\nproximal stenosis or\ndistal vascular shunting (arteriovenous / arterioportal fistulas) as seen in severe cirrhosis;\ntrauma (including iatrogenic injury); or\nOsler-Weber-Rendu syndrome.\n\n## Hepatic Artery Aneurysm\n\n$=2^{\\text {nd }}$ most common type of splanchnic aneurysm $=$ up to $20 \\%$ of visceral aneurysms\nCause:\n\n1. Atherosclerosis\n2. Fibromuscular dysplasia\n3. Collagen vascular disease\n4. Trauma: penetrating, blunt, iatrogenic (liver transplant)\n5. Mycotic aneurysm\n6. Tumor-related aneurysm\n7. Vasculitis (multiple aneurysms): polyarteritis nodosa\n\n- abdominal pain (55\\%), gastrointestinal hemorrhage (46\\%)\n\nSite: common hepatic artery (in up to 63\\%)\n$C x$ : aneurysm rupture $\\rightarrow$ hemobilia / hemoperitoneum (20-35\\% mortality rate)\n$R x$ : endovascular stenting ( $89 \\%$ success rate)\n\n## HEPATIC VEINS\n\n## Dampening of Hepatic Vein Doppler Waveform",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 235,
            "markdown": "$=$ dampened oscillations of hepatic veins resembling portal vein flow $\\leftarrow$ \"shielding\" of hepatic veins from activity of right atrium = decreased phasicity\n$=$ \"portalization\" of hepatic vein flow pattern\n$\\sqrt{ }$ drop of $a$ wave of hepatic venous waveform below baseline\nA. INCREASED LIVER TISSUE STIFFNESS\n\n1. Liver cirrhosis\n2. Various parenchymal abnormalities of liver: fatty liver, diffuse metastatic liver disease\nB. INTRINSIC / EXTRINSIC VENOUS OBSTRUCTION\n3. Budd-Chiari syndrome intrahepatic / suprahepatic obstruction\n4. Hepatic venoocclusive disease\n5. Inferior vena cava obstruction\n6. Extrinsic compression of hepatic veins\n7. Right-sided CHF\n![img-34.jpeg](img-34.jpeg)\n\n# Irregular Flow Pattern in Hepatic Veins \n\n1. Arrhythmia\n2. Turbulent blood flow\n3. Technical / patient factors: sedated patient, mechanical ventilation, SOB\n\n## Pulsatile Hepatic Doppler\n\n$=D$ wave greater than $S$ wave\n\n1. Tricuspid regurgitation\n2. Right heart failure\n\n## PORTAL VEIN",
            "images": [
                {
                    "id": "img-34.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 741,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1500,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 236,
            "markdown": "# Abnormal Portal Venous Flow \n\n## Pulsatile Portal Vein\n\n$=$ waveform pulsatility with $>2 / 3$ change from peak velocity to minimum velocity\nPathophysiology: transmission of abnormal pressure to sinusoids via hepatic veins / arteries\nA. INCREASED VENOUS PRESSURE IN SINUSOIDS (sinusoids connect portal vein with hepatic arteries and hepatic veins)\n$\\sqrt{ }$ dilated hepatic veins\n\n1. Tricuspid regurgitation\n$\\sqrt{ }$ decreased $S$ wave in hepatic venous Doppler\n2. Right-sided CHF without tricuspid regurgitation\n$\\sqrt{ }$ tall $a$ and $v$ waves in hepatic venous Doppler\nB. ARTERIOVENOUS SHUNT\n3. Arteriovenous shunt in severe cirrhosis\n$\\checkmark$ compressed hepatic veins\n4. Hepatic artery-portal vein fistula\n5. Portal-to-hepatic vein fistula\n6. Hereditary hemorrhagic telangiectasia (rare) $\\rightarrow$ arteriovenous fistulas\n\n## Slow Portal Venous Flow\n\nPathophysiology: back pressure limits forward velocity\nCause:\nPortal hypertension: peak velocity $<16 \\mathrm{~cm} / \\mathrm{sec}$\n(a) prehepatic: portal vein thrombosis\n(b) intrahepatic: cirrhosis from any cause\n(c) posthepatic: right-sided heart failure, tricuspid regurgitation, Budd-Chiari syndrome\n\n## Hepatofugal (Retrograde) Portal Venous Flow\n\n$=$ waveform below the baseline\nPathophysiology: back pressure exceeds forward pressure with flow subsequently reversing direction\nCause: severe portal hypertension from any cause\n\n## Absent / Aphasic Portal Venous Flow\n\nA. STAGNANT PORTAL VENOUS FLOW\n\n1. Severe portal hypertension with neither hepatopetal nor hepatofugal flow $\\rightarrow$ at risk for portal vein thrombosis\nB. OCCLUSION OF PORTAL VEIN\n$\\sqrt{ }$ cavernous transformation $=$ development of collateral vessels in / around occluded portal vein\n2. Bland portal vein thrombus\n3. Malignant invasion of portal vein (= tumor thrombus)\n$\\sqrt{ }$ \"thread \\& streak\" sign = color signal with arterial (pulsatile) waveform within thrombus",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 237,
            "markdown": "# Periportal Hypoattenuating Halo \n\n$=$ accumulation of lymph around the portal tract\n\n1. Edema: CHF, acute hepatitis, hepatic venoocclusive disease\n2. Infiltration: lymphoma, extramedullary hematopoiesis\n3. Lymphatic dilatation $\\leftarrow$ obstruction in porta hepatis by enlarged nodes / mass / in liver transplant\n4. Hemorrhage (asymmetric involvement)\n5. Fat accumulation\n\n## Periportal Lymphedema\n\n$=$ ill-defined hypodensity at porta hepatis / hypodensity parallel to portal vein\n\n1. Acute hepatitis\n2. Cirrhosis\n3. Hepatic venoocclusive disease\n4. Liver / bone marrow transplant\n5. Overhydration\n6. Blunt abdominal trauma $\\pm$ liver injuries\n7. Chronic congestive heart failure\n8. Cardiac tamponade\n9. Malignancy: hepatic / retroperitoneal\n\n## Portosystemic Shunt\n\nA. EXTRAHEPATIC PORTOSYSTEMIC SHUNT\n(a) congenital (rare)\n(b) acquired (most common)\n\nCause: portal venous hypertension\nB. INTRAHEPATIC PORTOSYSTEMIC SHUNT (rare)\nC. ARTERIOPORTAL SHUNT\nD. PERSISTENT DUCTUS VENOSUS\n\n## Portal Venous Stenosis\n\n## Cause:\n\n1. Tumor encasement: locally recurrent periampullary cancers $=$ pancreatic carcinoma, hepatocellular carcinoma, cholangiocarcinoma, metastasis\n2. Inflammation: acute pancreatitis\n3. Surgical complication: liver transplantation ( $1 \\%$ ), partial hepatectomy, pancreaticoduodenectomy\n4. Radiation therapy\n$\\checkmark$ focal segment of vessel narrowing $\\pm$ poststenotic dilatation\n$\\checkmark$ inhomogeneous peripheral subcapsular increase in arterial inflow during hepatic arterial phase\n$\\checkmark$ secondary portal hypertension $\\rightarrow$ increased number and size of collaterals US:\n$\\checkmark$ focal color aliasing\n$\\checkmark$ accelerated flow across stenosis $=4$-fold velocity gradient",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 238,
            "markdown": "$\\sqrt{ }$ spectral broadening of waveform (= poststenotic turbulence)\n$C x$ : portal venous hypertension with massive intractable ascites + recurrent variceal bleeding\n$R x$ : balloon angioplasty, stent placement\n\n# Portal Venous Gas \n\n$\\diamond$ Should be considered a life-threatening event and sign of bowel infarction + gangrene until proved otherwise!\n\n## Etiology:\n\nA. INTESTINAL NECROSIS (in $74 \\%$ of adults)\n\n1. Bowel infarction $\\leftarrow$ arterial and venous occlusions (vascular accidents, SMA syndrome)\n2. Ulcerative colitis\n3. Necrotizing enterocolitis associated with mesenteric arterial thrombosis\n4. Perforated gastric ulcer\nB. GI OBSTRUCTION\n5. Small bowel obstruction: eg, duodenal atresia\n6. Imperforate anus\n7. Esophageal atresia\nC. MISCELLANEOUS\n8. Hemorrhagic pancreatitis\n9. Sigmoid diverticulitis\n10. Intraabdominal abscess\n11. Pneumonia\n12. Iatrogenic injection of air during endoscopy / BE\n13. Dead fetus\n14. Diabetes\n15. Diarrhea\nmnemonic: BE NICE\nBE (air embolism during double contrast barium enema)\nNecrotizing enterocolitis\nInfarction (mesenteric)\nCatheterization of umbilical vein\nErythroblastosis fetalis\n\n## Pathogenesis:\n\n1. Intestinal wall alteration permitting passage of intraluminal air into intestinal venules:\n(a) ulceration of gastric, duodenal, bowel wall\n(b) sloughing of epithelial lining\n(c) enhanced mucosal permeability\neg, intestinal ischemia with bowel necrosis (most common); perforated gastric carcinoma / ulcer; inflammatory bowel disease (Crohn disease, ulcerative colitis); ingestion of a caustic substance\nPrognosis: $75-90 \\%$ mortality rate within 1 week of Dx\n2. Bowel distension with elevated intraluminal pressure causes minimal mucosal",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 239,
            "markdown": "disruption + permits passage of intraluminal air into veins:\n(a) iatrogenic dilatation of hollow viscus: gastrostomy, sclerotherapy, ERCP, colonoscopy, barium enema)\n(b) spontaneous paralytic ileus, mechanical obstruction, acute gastric dilatation\n(c) blunt trauma $(<1 \\%)$ with acute pressure changes\n(d) barotrauma\n\nPrognosis: surgery often not indicated\n3. Intraabdominal sepsis\n(a) ? gas from septicemia in branches of mesenteric veins / portal vein (= pylephlebitis)\n(b) ? increased intraluminal fermentation of carbohydrates $\\leftarrow$ bacterial overgrowth\n(c) ? mesocolic abscess $\\rightarrow$ inframesocolic perforation dissecting between peritoneal leaflets, eg, diverticulitis, intra- or retroperitoneal abscess / gangrene, TB, inflammatory bowel disease, necrotizing pancreatitis\n4. Idiopathic ( $15 \\%$ )\neg, organ transplantation (liver [18%], kidney, bone marrow), pulmonary disease (chronic obstructive pulmonary disease, bronchopneumonia, asthma), drugs (steroids, cytostatics), seizure\nComposition of colonic gas:\nmethane, carbon dioxide, oxygen, nitrogen, hydrogen\nLocation: predominantly in left lobe = nondependent position when patient supine\nPlain film:\n$\\diamond$ Substantial amount necessary for detection\n$\\sqrt{ }$ branching linear gas densities:\n$\\sqrt{ }$ in periphery of liver extending to within 2 cm of liver capsule\n$\\sqrt{ }$ predominantly within more anteriorly located left lobe of liver\n$\\sqrt{ }$ pneumatosis of intestinal wall\nCT:\n$\\diamond$ Small amount of gas detectable\n$\\sqrt{ }$ tubular branching areas of decreased attenuation (similar to air) in periphery 2 cm deep to liver capsule\n$\\sqrt{ }$ gas in superior / inferior mesenteric veins\n$\\sqrt{ }$ gas in small mesenteric veins at mesenteric border of bowel\nMR:\n$\\sqrt{ }$ susceptibility artifacts in portal vein\nUS:\n$\\diamond$ Small amount of gas detectable\n$\\sqrt{ }$ intensely hyperechoic foci (= reverberation artifacts) within lumen of portal vein + intrahepatic portal radicles\nDoppler:\n$\\sqrt{ }$ sharp high-amplitude bidirectional spikes (overloading of Doppler receiver from strong reflection of gas bubble in bloodstream) superimposed on normal portal vein spectrum Mortality rate: $29-43 \\%$ for mesenteric ischemia with portal vein gas\nRx: (1) Surgery for mesenteric ischemia, diverticulitis, bowel obstruction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 240,
            "markdown": "(2) Conservative management in trauma, colonoscopy, idiopathic causes\n\nDDx: pneumobilia (located centrally within bile ducts close to liver hilum + within left lobe of liver)\n\n# Portal Vein Calcification \n\nLocation: portal vein $>$ splenic vein $>$ superior mesenteric vein $>$ inferior mesenteric vein\nAssociated with: portal venous hypertension, congenital abnormalities, umbilical vein catheterization\n\n- asymptomatic\n\nCx: biliary obstruction (if densely calcified)\n\n## GALLBLADDER\n\n## Nonvisualization of Gallbladder on US\n\n1. Status post cholecystectomy\n2. Obscured by costal margin\n3. Anomalous position (intrahepatic, subphrenic)\n4. Gallbladder carcinoma replacing gallbladder\n5. Perforation of gallbladder\n6. Congenital absence\n7. Contracted gallbladder\n(a) nonfasting status without stones\n(b) in fasting status with stones\n$\\checkmark$ wall-echo-shadow (WES triad) interfaces\n\n## Acoustic Shadowing in Gallbladder Fossa\n\n1. WES (wall-echo-shadow) triad\n2. Gas in duodenum / colon obscuring gallbladder\n3. Porcelain gallbladder\n4. Emphysematous cholecystitis\n5. Cholecystoenteric fistula\n6. Status post ERCP with retrograde air injection\n\n## Hyperattenuating Bile\n\n1. Hemorrhagic cholecystitis\n2. Hemobilia\n3. Prior contrast administration\n(a) vicarious excretion of IV iodinated contrast agent\n(b) retained contrast agent from cholangiography\n(c) cholecystopaque\n4. Milk of calcium bile\n5. Biliary sludge, purulent bile\n6. Aneurysm / pseudoaneurysm with active extravasation into biliary system\n7. Malignancy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 241,
            "markdown": "# Displaced Gallbladder \n\nA. NORMAL IMPRESSION\nby duodenum / colon (positional change)\nB. HEPATIC MASS\nhepatoma, hemangioma, regenerating nodule, metastases, intrahepatic cyst, polycystic\nliver, hydatid disease, hepar lobatum (tertiary syphilis), granuloma, abscess\nC. EXTRAHEPATIC MASS\n\n1. Retroperitoneal tumor (renal, adrenal)\n2. Polycystic kidney\n3. Lymphoma\n4. Lymph node metastasis to porta hepatis\n5. Pancreatic pseudocyst\n\n## Alteration in Gallbladder Size\n\n## Enlarged Gallbladder\n\n$=$ CHOLECYSTOMEGALY $=$ HYDROPS OF GALLBLADDER\nSize:\n(a) infants $<1$ year: $\\quad>3 \\mathrm{~cm}$ in length\n(b) children: $\\quad>7 \\mathrm{~cm}$ in length\n(c) adults: $\\quad>10 \\times 4 \\mathrm{~cm}(\\mathrm{Lx} \\mathrm{W})$\nA. OBSTRUCTION\n\n1. Cystic duct obstruction ( $40 \\%$ )\n(a) hydrops: chronic cystic duct obstruction + distension with clear sterile mucus (white bile)\n(b) empyema: acute / chronic obstruction with superinfection of bile\n2. Cholelithiasis causing obstruction (37\\%)\n3. Cholecystitis with cholelithiasis ( $11 \\%$ )\n4. Courvoisier phe nomenon ( $10 \\%$ )\n$\\leftarrow$ neoplastic process in pancreas / duodenal papilla / ampulla of Vater / common bile duct\n5. Pancreatitis\n6. Infection: leptospirosis, ascariasis, typhoid fever, scarlet fever, familial Mediterranean fever\nB. UNOBSTRUCTED (mostly neuropathic)\n7. S/P vagotomy\n8. Diabetes mellitus\n9. Alcoholism\n10. Appendicitis (in children)\n11. Narcotic analgesia\n12. WDHA syndrome\n13. Hyperalimentation\n14. Acromegaly\n15. Kawasaki syndrome\n16. Anticholinergics",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 242,
            "markdown": "11. Bedridden patient with prolonged illness\n12. AIDS (in 18\\%)\n13. Dehydration\n14. Prolonged fasting\n15. Total parenteral nutrition\n16. Sepsis\nC. NORMAL( $2 \\%)$\n\n# Small Gallbladder \n\n1. Chronic cholecystitis\n2. Cystic fibrosis: in $25 \\%$ of patients\n3. Congenital hypoplasia / multiseptated gallbladder\n4. Postprandial\n5. Intrahepatic cholestasis: viral, drug-related\n\n## Gallbladder Wall Thickening\n\n## Diffuse Gallbladder Wall Thickening\n\n$=$ anterior wall of gallbladder $>3 \\mathrm{~mm}$\nA. INTRINSIC\n(a) infection\n\n1. Acute cholecystitis\n2. Chronic cholecystitis ( $10-25 \\%$ )\n3. Xanthogranulomatous cholecystitis\n4. Gallbladder perforation\n5. Sepsis\n6. Brucellosis\n(b) inflammation\n7. AIDS cholangiopathy (average of 9 mm in up to $55 \\%$ )\n8. Sclerosing cholangitis\n9. Eosinophilic cholecystitis\n(c) tumor infiltration\n10. Gallbladder carcinoma (in $41 \\%$ diffuse)\n11. Leukemic infiltration (AML)\n12. Multiple myeloma\n(d) others\n13. Hyperplastic cholecystosis (in $91 \\%$ diffuse)\n14. Gallbladder varices\nB. EXTRINSIC\n(a) liver disease\n15. Hepatitis (in $80 \\%$ )\n16. Cirrhosis\n17. Hepatic venous obstruction\n18. Fitz-Hugh-Curtis syndrome\n(b) fluid overload",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 243,
            "markdown": "1. Hypoalbuminemia\n2. Renal failure\n3. Right heart failure\n4. Systemic venous hypertension\n5. Ascites\n6. Lymphatic obstruction (by portal nodes)\n(c) others\n7. Graft-versus-host disease\n8. Pancreatitis\n(d) drugs\n9. Chemoinfusion of hepatic artery (ischemia)\n10. Treatment with interleukin\nC. PHYSIOLOGIC\n$=$ contracted gallbladder after eating\n\n# Focal Gallbladder Wall Thickening \n\nA. METABOLIC\n\n1. Metachromatic sulfatides\n2. Hyperplastic cholecystoses\nB. BENIGN TUMOR\n3. Adenoma: glandular elements $(0.2 \\%)$\n4. Papilloma: fingerlike projections $(0.2 \\%)$\n5. Villous hyperplasia\n6. Fibroadenoma\n7. Cystadenoma: ? premalignant\n8. Neurinoma, hemangioma\n9. Carcinoid tumor\nC. MALIGNANT TUMOR\n10. Carcinoma of gallbladder: adenocarcinoma / squamous cell carcinoma (in $59 \\%$ focal)\n11. Leiomyosarcoma\n12. Metastases: from malignant melanoma ( $15 \\%$ ), lung, kidney, esophagus, breast, carcinoid, Kaposi sarcoma, lymphoma, leukemia\nD. INFLAMMATION / INFECTION\n13. Inflammatory polyp: in chronic cholecystitis\n14. Parasitic granuloma: Ascaris lumbricoides, Paragonimus westermani, Clonorchis, filariasis, Schistosoma, Fasciola\n15. Intramural epithelial cyst / mucinous retention cyst\n16. Xanthogranulomatous cholecystitis (in $9 \\%$ focal)\nE. WALL-ADHERENT GALLSTONE $=$ embedded stone\nF. HETEROTOPIC MUCOSA\n17. Ectopic pancreatic tissue\n18. Ectopic gastric glands\n19. Ectopic intestinal glands\n20. Ectopic hepatic tissue",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 244,
            "markdown": "5. Ectopic prostatic tissue\n\n# Filling Defects of Gallbladder \n\n## Fixed Filling Defects of Gallbladder\n\nmnemonic: PANTS\nPolyp\nAdenomyomatosis\nNeurinoma\nTumor, primary / secondary\nStone, wall-adherent\n\n## Gallbladder Polyp\n\n$=$ sessile projection of GB wall into GB lumen\nPrevalence: 3-7\\% by ultrasound, 2-12\\% of cholecystectomy specimens\nA. PSEUDOTUMOR\n\n1. Cholesterol polyp (63-74\\%): on average 8 polyps\n2. Adenomyoma (7\\%)\n3. Inflammatory polyp (4\\%)\n4. Others: heterotopic gastric glands\nB. TUMOROUS POLYP (85\\%)\n(a) benign $(85 \\%)$\n5. Adenoma ( $84 \\%$ )\n6. Fibroma, leiomyoma, lipoma, neurofibroma, neuroendocrine tumor (1\\%)\n(b) malignant $(15 \\%)$\n7. Adenocarcinoma (4\\%)\n8. Squamous cell carcinoma, carcinosarcoma, small cell carcinoma, lymphoma\n9. Metastasis: melanoma ( $60 \\%$ ), RCC\n$\\diamond 94 \\%$ of benign lesions are $<10 \\mathrm{~mm} ; 88 \\%$ of malignant lesions are $>10 \\mathrm{~mm}$\n$\\diamond$ Any polyp $>10 \\mathrm{~mm}$ should be operated on\n) in a symptomatic patient\n) in a patient $>50$ years of age\n) with coexisting gallstones\nor followed every 3-6 months for 1 year\n$D D x$ : (1) Adherent gallstone\n(2) Adherent tumefactive sludge\n\n## Mobile Intraluminal Mass in Gallbladder\n\n1. Tumefactive sludge\n2. Blood clot\n3. Nonshadowing stone\n\n## Comet-tail Artifact in Liver and Gallbladder\n\nA. LIVER\n\n1. Foreign metallic body: eg, surgical clip\n2. Intrahepatic calcification",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 245,
            "markdown": "3. Pneumobilia\n4. Multiple bile duct hamartoma $=$ von Meyenburg complex\nB. GALLBLADDER\n5. Rokitansky-Aschoff sinus\n6. Intramural stone\n7. Cholesterolosis of gallbladder\n\n# Echogenic Fat in Hepatoduodenal Ligament \n\n$=$ sign of pericholecystic inflammation\n\n1. Cholecystitis\n2. Perforated duodenal ulcer\n3. Pancreatitis\n4. Diverticulitis\n\n## False-positive DISIDA Scan\n\nmnemonic: F2C2 PAL\nFood (meal within last 4 hours $=$ GB empty)\nFasting / total parenteral nutrition (GB full)\nCystic duct cholangiocarcinoma\nChronic cholecystitis\nPancreatitis, acute\nAlcoholism (= alcohol-toxic hepatitis)\nLiver dysfunction (hepatitis)\n\n## False-negative DISIDA Scan\n\nmnemonic: ADA\nAcalculous cholecystitis\nDuodenal diverticulum simulating GB\nAccessory cystic duct\n\n## Rim Sign\n\n$=$ curvilinear pericholecystic rim of increased hepatic tracer activity adjacent to a photopenic gallbladder fossa\nCause: local hyperemia with increased perfusion + injury of hepatocytes with impaired excretion of radiotracer\n\n1. Acute cholecystitis ( $34-61 \\%$ sensitive)\n2. Complicated acute cholecystitis\n$\\checkmark$ nonvisualization of GB @ 1 hour ( $94-100 \\%$ PPV, $95-100 \\%$ specific)\n3. Chronic cholecystitis\n\n## BILE DUCTS\n\n## Hemobilia\n\n1. Iatrogenic trauma: liver biopsy, transhepatic cholangiography / percutaneous transhepatic biliary drainage ( $4-18 \\%$ ) / portography, sphincterotomy, endoscopic biliary stent",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 246,
            "markdown": "placement, radiofrequency ablation\n2. Blunt / penetrating trauma\n3. Rupture of hepatic artery aneurysm / pseudoaneurysm\n4. Anticoagulation\n\n# Gas in Biliary Tree $=$ Pneumobilia \n\nmnemonic: I GET UP\nIncompetent sphincter of Oddi (after sphincterotomy / passage of a gallstone)\nGallstone ileus\nEmphysematous cholecystitis (actually in gallbladder)\nTrauma\nUlcer (duodenal ulcer perforating into CBD)\nPostoperative (eg, cholecystoenterostomy)\n$\\sqrt{ }$ gas outlines choledochus $\\pm$ gallbladder\n$\\sqrt{ }$ peripheral branches of bile ducts not filled\nPneumobilia is a common finding with patent biliary stents. It may not be present when the stent is occluded $\\leftarrow$ no communication with the duodenum.\n\n## Obstructive Jaundice in Adult\n\nEtiology:\nA. BENIGN DISEASE (76\\%)\n\n1. Traumatic / postoperative stricture (44\\%): cholecystectomy (incidence of 0.2 $0.7 \\%$ ), liver transplantation\n2. Calculi $(21 \\%)$\n3. Chronic pancreatitis $(8 \\%)$\n4. Sclerosing cholangitis ( $1 \\%$ ): primary sclerosing cholangitis, IgG4-related sclerosing disease\n5. Recurrent pyogenic cholangitis\n6. Parasitic disease: eg, ascariasis\n7. Liver cysts\n8. Aortic aneurysm\n9. Papillary stenosis\nB. MALIGNANCY (24\\%)\n10. Pancreatic carcinoma (18\\%)\n11. Ampullary / duodenal carcinoma (8\\%)\n12. Cholangiocarcinoma (3\\%)\n13. Metastatic disease ( $2 \\%$ ): stomach, pancreas, lung, breast, colon, lymphoma\n\nLevel and cause of obstruction:\nA. INTRAPANCREATIC\n\n1. Choledocholithiasis\n$\\diamond$ Most common cause of biliary obstruction (in $15 \\%$ of patients with cholelithiasis)!\n2. Chronic pancreatitis\n3. Pancreatic carcinoma\nB. SUPRAPANCREATIC (5\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 247,
            "markdown": "$=$ between pancreas + porta hepatis\n\n1. Cholangiocarcinoma\n2. Metastatic adenopathy\nC. PORTA HEPATIS (5\\%)\n3. Klatskin tumor\n4. Spread from adjacent tumor (GB, liver)\n5. Surgical stricture\nD. INTRAHEPATIC\n6. Cystadenoma, cystadenocarcinoma\n7. Mirizzi syndrome\n8. Caroli disease\n9. Cholangitis: recurrent pyogenic cholangitis, sclerosing cholangitis, AIDS cholangitis\nIncidence of infected bile in bile duct obstruction:\n(a) in $64 \\%$ with incomplete / partial obstruction\n(b) in 10 with complete obstruction\n$\\diamond$ Infection twice as high with biliary calculi than with malignant obstruction!\nOrganism: E. coli (21\\%), Klebsiella (21\\%), enterococci (18\\%), Proteus (15\\%)\nTest sensitivity for common bile duct obstruction:\n10. Intravenous cholangiography\ndepends on level of bilirubin: $<1(2) \\mathrm{mg} / \\mathrm{dL}$ in $92 \\% ;<2 \\mathrm{mg} / \\mathrm{dL}$ in $82 \\% ;<3 \\mathrm{mg} / \\mathrm{dL}(>$\n4) in $40 \\%(<10 \\%)$\n\nFalse-negative rate: $45 \\%$\nCx: adverse reactions in $4-10 \\%$\n2. US\n$88-90 \\%$ sensitivity for dilatation of CBD\n$\\diamond$ In $27-95 \\%$ US gives correct level of obstruction\n$\\diamond$ In $23-81 \\%$ US gives correct cause of obstruction\n$\\sqrt{ }$ CBD $>4-6 \\mathrm{~mm} / 10 \\%$ of patient's age in years in mm\n$\\sqrt{ }$ increase in CBD size after fatty meal\n$\\sqrt{ }$ \"Swiss cheese\" sign = abundance of fluid-filled structures on liver sections $\\leftarrow$ dilated intrahepatic bile ducts\n$\\sqrt{ }$ intrahepatic bile duct $>2 \\mathrm{~mm} />40 \\%$ of adjacent portal vein branch\n$\\sqrt{ }$ intrahepatic \"double channel\" / \"shotgun\" sign = two parallel tubular structures composed of portal vein + dilated intrahepatic bile duct\nFalse-negative (= obstruction without dilatation):\nno dilatation in acute early obstruction (in $70 \\%$ ), sclerosing cholangitis, intermittent obstruction from choledocholithiasis\nFalse-positive (= dilatation without obstruction):\npost decompression of prior obstruction, dilated hepatic artery in cirrhosis / portal hypertension / hepatic neoplasm, in patients after cholecystectomy\n3. CT\n$100 \\%$ visualization in tumorous obstruction\n$60 \\%$ visualization in nontumorous obstruction\n4. CEMR cholangiopancreatography",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 248,
            "markdown": "$=1^{\\text {st }}$ imaging method of choice $\\rightarrow$ most comprehensive evaluation of biliary stricture\nCaveat: pseudostricture secondary to\n(a) MRI technique / postprocessing\n(b) incomplete volume acquisition\n(c) blooming artifact $\\leftarrow$ cholecystectomy clips\n(d) pulsation artifact from hepatic and gastroduodenal arteries\n5. MRCP provides information about the biliary tree that cannot be obtained with more invasive methods:\n(a) delineates biliary-enteric anastomosis\n(b) detects complications: anastomotic biliary stricture, intraductal stones, biliary dilatation\n6. NUC\n$\\sqrt{ }$ delayed / nonvisualization of biliary system ( $93 \\%$ specific)\n$\\sqrt{ }$ vicarious excretion of tracer through kidneys\n$D D x$ : Hepatocellular dysfunction (delayed clearance of cardiac blood pool)\n\n# Hyperbilirubinemia in Infants \n\n$=$ UNCONJUGATED HYPERBILIRUBINEMIA\nA. PHYSIOLOGIC\n\nFrequency: in $60 \\%$ of full-term infants, in $80 \\%$ of preterm infants\nCourse: increase by day $2-3$, peak by day $5-7$ (up to $12 \\mathrm{mg} / \\mathrm{dL}$ in full-term babies, up to $14 \\mathrm{mg} / \\mathrm{dL}$ in premature infants)\n$\\diamond$ Breast-fed babies may have an elevated bilirubin level until the end of $2^{\\text {nd }}$ week of life!\nB. NONPHYSIOLOGIC\n\n- onset of jaundice within first 24 hours\n- persistent / new-onset jaundice in infants 2 weeks of age\n- rise of serum bilirubin $>5 \\mathrm{mg} / \\mathrm{dL}$ per 24 hours\n- direct bilirubin level $>1 \\mathrm{mg} / \\mathrm{dL}$\n\n\n## Neonatal Obstructive Jaundice\n\n$=$ severe persistent jaundice in a child beyond 3-4 weeks of age\nCause:\nA. INFECTION\n(a) bacterial: E. coli, Listeria monocytogenes\n(b) viral: TORCH, coxsackie virus, ECHO virus, adenovirus\nB. METABOLIC\n(a) inherited: alpha-1 antitrypsin deficiency, cystic fibrosis, galactosemia, hereditary tyrosinemia\n(b) acquired: inspissated bile syndrome = \"bile plug\" syndrome (= cholestasis $\\leftarrow$ erythroblastosis); cholestasis $\\leftarrow$ total parenteral nutrition; choledocholithiasis\nC. BILIARY TRACT ABNORMALITIES\n(a) extrahepatic: biliary obstruction / hypoplasia / atresia, choledochal cyst, spontaneous perforation of bile duct\n(b) intrahepatic: ductular hypoplasia / atresia\nD. IDIOPATHIC NEONATAL HEPATITIS\n$\\diamond$ The 3 most common causes of jaundice in neonates are hepatitis, biliary atresia, and",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 249,
            "markdown": "choledochal cyst!\nmnemonic: CAN\nCholedochal cyst\nAtresia\nNeonatal hepatitis\nNUC-imaging regimen:\n(1) Premedication with phenobarbital ( $5 \\mathrm{mg} / \\mathrm{kg} / \\mathrm{d}$ ) over 5 days to induce hepatic microsomal enzymes $\\rightarrow$ enhancing uptake and excretion of certain compounds $\\rightarrow$ increase of bile flow\n(2) IDA scintigraphy ( $50 \\mu \\mathrm{Ci} / \\mathrm{kg}$; minimum of 1 mCi )\n(3) Imaging at 5 -min intervals for $1 \\mathrm{hr}+$ at $2,4,6,8,24$ hours\n\n# Jaundice in Older Children \n\nA. DISEASE OF HEPATOCYTES\n(a) infection / inflammaton\n\n1. Acute hepatitis: infection, toxic agents, drugs\n2. Chronic hepatitis\n(b) metabolic\n3. Wilson disease\n4. Cystic fibrosis\n5. Glycogen storage disease\n6. Tyrosinemia\n7. Alpha-1 antitrypsin deficiency\nB. OBSTRUCTION\n(a) malignant neoplasm\n8. Hepatoblastoma\n9. Hepatocellular carcinoma\n10. Sarcomas: angiosarcoma, lymphosarcoma, rhabdomyosarcoma of bile ducts, undifferentiated embryonal sarcoma\n11. Metastatic disease: neuroblastoma, Wilms tumor, leukemia/lymphoma\n(b) benign neoplasm\n12. Infantile hemangioendothelioma\n13. Mesenchymal hamartoma\n(c) benign stricture: congenital choledochal cyst\n(d) cholelithiasis / choledocholithiasis (uncommon)\n\n## Large Nonobstructed CBD\n\n1. Passage of stone (return to normal after days to weeks)\n2. Common bile duct surgery (return to normal in 30-50 days)\n3. Postcholecystectomy dilatation (in up to $16 \\%$ )\n4. Intestinal hypomotility\n5. Normal variant (aging)\n\nFatty-meal sonography (to differentiate from obstruction with $74 \\%$ sensitivity, $100 \\%$ specificity)\nMethod: peroral Lipomul ${ }^{\\circledR}(1.5 \\mathrm{~mL} / \\mathrm{kg})$ followed by 100 mL of water [cholecystokinin",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 250,
            "markdown": "causes contraction of gallbladder, relaxation of sphincter of Oddi, increase in bile secretion], CBD measured before and $45 / 60 \\mathrm{~min}$ after stimulation\n$\\sqrt{ }$ little change / decrease in size $=$ normal response\n$\\sqrt{ }$ increase in size $>2 \\mathrm{~mm}=$ partial obstruction\n\n# Filling Defect in Bile Ducts \n\nA. ARTIFACT\n\n1. Pseudocalculus\n(a) contracted sphincter of Boyden + Oddi with smooth arcuate contour\n(b) bridge of tissue between cystic duct + CHD\n(c) underfilling of cystic duct during ERCP\n(d) admixture defect at cystic duct junction\n2. Air bubble: confirmed by positional changes\n3. Blood clot: spheroid configuration, spontaneous resolution with time\nB. BILIARY CALCULI\nC. MIRIZZI SYNDROME\nD. NEOPLASM\n(a) malignant\n4. Cholangiocarcinoma: irregular stricture, intraluminal polypoid mass\n5. Metastatic tumor: colon, gallbladder, lung, breast, testis, prostate, pancreas, melanoma, lymphoma\n6. Others: ampullary carcinoma, hepatoma, hamartoma, carcinoid, embryonal rhabdomyosarcoma of biliary tree\n(b) benign\n7. Papilloma: most common benign neoplasm\n\nHisto: vascular connective tissue covered by single layer of columnar epithelium\n2. Adenoma\n\nHisto: epithelial glandular tissue surrounded by fibrous tissue\n3. Fibroma, lipoma, neuroma\n4. Granular cell myoblastoma (= Schwann-cell-derived biliary tumor) in young black woman\nE. PARASITES\n\n1. Ascaris lumbricoides\n2. Clonorchis sinensis\n3. Fasciola hepatica\n4. Schistosoma japonicum\n5. Hydatid cyst\n\n## Echogenic Material in Bile Ducts\n\n1. Calculi\n2. Gas\n3. Blood\n4. Tumor\n5. Parasites",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 251,
            "markdown": "# Bile Duct Narrowing / Stricture \n\n$=$ fixed focal narrowing of bile duct\nA stenosis caused by a malignant lesion usually manifests as an irregular stricture with shouldered margins, whereas a benign stenosis tends to have smooth borders with gradually tapered margins.\nA. BENIGN STRICTURE (44\\%)\n\nCause: injury $\\rightarrow$ inflammatory response $\\rightarrow$ fibrosis\n$\\sqrt{ }$ often short-segment involvement (not diagnostic!)\n$\\sqrt{ }$ often smooth concentric narrowing (not diagnostic!)\n(a) trauma\n\n1. Postoperative stricture $(95-99 \\%)$ :\n> open cholecystectomy $(0.2-0.7 \\%)$\n> laparoscopic cholecystectomy $(1.2 \\%)$\n> cadaveric liver transplant (5-15\\%)\n> living donor liver transplant (28-32\\%)\n2. Blunt / penetrating trauma\n3. Hepatic artery embolization\n(b) inflammation\n4. Sclerosing cholangitis:\n> primary sclerosing cholangitis\n> IgG4-related sclerosing disease\n5. Eosinophilic portal cholangiopathy\n6. Chronic pancreatitis\n$\\diamond 10 \\%$ of all benign biliary strictures\n7. Acute pancreatitis (less common)\n8. Pancreatic pseudocyst\n9. Perforated duodenal ulcer\n10. Erosion by biliary calculus\n11. Mirizzi syndrome\n12. Radiation therapy\n(c) infection\n13. Acute bacterial cholangitis\n14. Recurrent pyogenic cholangitis\n15. Chemotherapy-induced cholangitis\n16. AIDS-related cholangitis\n17. Abscess\n(d) congenital\n18. Choledochal cyst\nB. MALIGNANT STRICTURE\n19. Pancreatic adenocarcinoma\n20. Ampullary cancer\n21. Cholangiocarcinoma\n22. Compression by enlarged lymph node\n23. Metastasis\n\nA narrowed segment with the following MRI features is more likely to be malignant:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 252,
            "markdown": "$\\checkmark$ hyperenhancement relative to liver during portal venous phase\n$\\checkmark$ length of $>12 \\mathrm{~mm}$\n$\\checkmark$ wall thickness $>3 \\mathrm{~mm}$\n$\\checkmark$ indistinct outer margin\n$\\checkmark$ luminal irregularity and asymmetry\n\n# Cause of Biliary Stricture by Location \n\n@ distal CBD\n\n| Malignant vs. Benign CBD Stricture |  |  |\n| :--: | :--: | :--: |\n| Criteria | Malignant | Benign |\n| Borders | irregular | smooth |\n| Luminal margin | shouldered | tapered |\n| Stricture length (mm) | $18 \\pm 7$ | $9 \\pm 7$ |\n| Duct diameter proximally (mm) | $22 \\pm 5$ | $18 \\pm 5$ |\n| Duct wall thickness $>1.5 \\mathrm{~mm}$ | $80 \\%$ | $15 \\%$ |\n| Enhancement, arterial phase | $85 \\%$ | $10 \\%$ |\n| Enhancement, portal phase | $95 \\%$ | $15 \\%$ |\n| Progression of stricture | rapid | gradual |\n| Bilirubin $>8.4 \\mathrm{mg} / \\mathrm{dL}$ | $+$ | - |\n| CA $19-9>100 \\mathrm{U} / \\mathrm{L}$ | $+$ | - |\n\n1. IgG4-related sclerosing cholangitis\n@ junction of cystic duct + CHD\n2. Cholecystectomy\n3. Mirizzi syndrome\n@ confluence of left + right hepatic ducts\n4. Cholecystectomy\n5. IgG4-related sclerosing cholangitis\n@ intrapancreatic portion of CBD\n6. Chronic pancreatitis\n@ intra- and extrahepatic bile ducts\n7. Primary sclerosing cholangitis\n8. IgG4-related sclerosing cholangitis\n9. Recurrent pyogenic cholangitis\n10. AIDS cholangiopathy\n\n## Multifocal Intrahepatic Bile Duct Strictures\n\n1. Primary sclerosing cholangitis\n2. Ascending cholangitis $\\leftarrow$ stricture / stone / bile duct anomaly\n3. Oriental cholangiohepatitis\n4. AIDS-related cholangitis\n5. Ischemia\n(a) floxuridine treatment\n(b) hepatic arterial thrombosis (in liver transplant)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 253,
            "markdown": "6. NEOPLASM\n(a) cholangiocarcinoma\n(b) metastases: GI tract, lymphoma, breast, lung\n7. Previous bile surgery\n8. Congenital biliary anomalies\n\n# Congenital Biliary Cysts \n\n(Todani classification)\nI. Choledochal cyst (77-87\\%)\n\nIa diffuse cystic dilatation of entire extrahepatic duct\nIb focal segmental dilatation of extrahepatic duct\nIc fusiform cystic dilatation of only CBD\nCause: anomalous pancreaticobiliary union\nII. Diverticulum of extrahepatic ducts (1.2-3\\%)\noriginating from extrahepatic bile duct (CBD / CHD)\n$\\sqrt{ }$ neck of diverticulum open / closed\nIII. Choledochocele (1.4-6\\%)\nIV. Multiple segmental bile duct cysts\n\nIVa multiple intra- and extrahepatic biliary cysts + saccular dilatation of CBD (19\\%)\nIVb multiple extrahepatic biliary cysts + normal intrahepatic bile ducts (rare)\nV. Caroli disease $=$ intrahepatic biliary cysts\n\n## Papillary Stenosis\n\n$=$ blockage of bile / pancreatic fluid flow at sphincter of Oddi WITHOUT an ampullary mass / inflammatory lesion\nEtiology:\nA. PRIMARY PAPILLARY STENOSIS (10\\%)\n\n1. Congenital malformation of papilla\n2. Sequelae of acute / chronic inflammation\n3. Adenomyosis\nB. SECONDARY PAPILLARY STENOSIS ( $90 \\%$ )\n4. Sphincter of Oddi dysfunction\n\nPrevalence: $1.5 \\%$ (most common cause)\nAssociated with: pancreas divisum, history of pancreatitis\n2. Mechanical trauma of stone passage $\\rightarrow$ papillitis\n> choledocholithiasis in $64 \\%$\n> cholecystolithiasis in $26 \\%$\n3. Reflex spasm = papillary dyskinesia\n4. Scar from previous surgical manipulation\n5. Periampullary neoplasm",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 254,
            "markdown": "![img-35.jpeg](img-35.jpeg)\n$\\checkmark$ prestenotic dilatation of CBD\n$\\checkmark$ increase in pancreatic duct diameter ( $83 \\%$ )\n$\\checkmark$ long smooth narrowing / beak $\\leftarrow$ fibrotic stenosis\n$\\checkmark$ prolonged bile-to-bowel transit time $>45$ minutes on Tc-IDA scintigraphy\n$\\checkmark$ papillary size $<12.3 \\mathrm{~mm}=$ the only independently reliable variable for differentiating benign from malignant causes\nN.B.: for suspected ampullary stenosis employ secretin stimulation test with imaging 4-10 min post injection\n\n# Bulging Papilla \n\n1. Papillitis: $\\leftarrow$ acute pancreatitis, acute cholangitis, passage of biliary stone, periampullary diverticulum, parasite, infection\n2. Intraductal papillary mucinous neoplasm\n3. Ampullary neoplasm\n4. Periampullary neoplasm\n5. Autoimmune pancreatitis\n6. Choledochocele\n\nSigns of malignant ampullary obstruction:\n$\\checkmark$ identification of an ampullary mass\n$\\checkmark$ papillary bulging\n$\\checkmark$ irregular asymmetric luminal narrowing of distal CBD\n$\\checkmark$ diffuse upstream intra- + extrahepatic biliary dilatation\nSigns of a benign obstruction:\n$\\checkmark$ smooth symmetric luminal narrowing of CBD\n$\\checkmark$ central biliary dilatation without an ampullary mass or papillary bulging\n\n## Ampullary and Periampullary Lesions\n\nA. NEOPLASM\n(a) related to ampulla\n\n1. Ampullary cancer (4\\%)\n2. Ampullary adenoma\n3. Periampullary lipoma\n(b) related to pancreas",
            "images": [
                {
                    "id": "img-35.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 189,
                    "bottom_right_x": 1496,
                    "bottom_right_y": 679,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 255,
            "markdown": "1. Pancreatic adenocarcinoma ( $85 \\%$ )\n2. Pancreatic neuroendocrine tumor\n3. Intraductal papillary mucinous neoplasm\n(c) related to bile duct\n4. Cholangiocarcinoma distal CBD (6\\%)\n(d) related to duodenal wall\n5. Duodenal adenocarcinoma\n6. Duodenal adenoma\n7. Duodenal carcinoid\n8. GIST\nB. NONNEOPLASTIC LESION\n(a) related to hepatopancreatic duct\n9. Papillary stenosis\n10. Choledocholithiasis\n11. Pancreas divisum\n12. Santorinicele\n13. Choledochocele\n(b) related to pancreas\n14. Groove pancreatitis\n15. Autoimmune pancreatitis\n16. Pancreaticoduodenal artery pseudoaneurysm\n(c) related to duodenum\n17. Brunner gland hyperplasia and hamartoma\n18. Duodenitis\n19. Duodenal Crohn disease\n20. Duodenal diverticula\n21. Duodenal perforation and transection\n\n# Periampullary Tumor \n\n$=$ tumor arising within 2 cm of major duodenal papilla including carcinoma of ampulla of Vater, distal CBD, head + uncinate process of pancreas, periampullary portion of duodenum\n\n## Double-Duct Sign\n\n$=$ dilatation of common bile duct + pancreatic duct\nA. Malignant\n\n1. Ampullary tumor (most common)\n2. Pancreatic ductal adenocarcinoma\n3. Distal CBD cholangiocarcinoma\n4. Duodenal carcinoma\n5. Lymphoma\nB. BENIGN\n6. Stone impacted in ampulla of Vater\n7. Papillary / ampullary stenosis\n8. Chronic pancreatitis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 256,
            "markdown": "# PANCREAS \n\n## Congenital Pancreatic Anomalies\n\nA. Fusion Anomaly\n\n1. Pancreas divisum\n2. Agenesis of dorsal pancreas\nB. Migration Anomaly\n3. Annular pancreas\n4. Ectopic pancreas\nC. Duplication Anomaly\n(a) variations in number\n(b) variations in form\nD. Genetics\n5. Von Hippel-Lindau disease\nE. Underdevelopment\n6. Pancreatic Agenesis (extremely rare)\n\nCause: mutation of developmental protein IPF1\nAssociated with: gallbladder aplasia, polysplenia, fetal growth retardation\n\n- incompatible with life\n\n2. Pancreatic hypoplasia / partial agenesis\n$=$ absence of ventral / dorsal anlage\n(a) agenesis of dorsal pancreas\n(b) agenesis of ventral pancreas\n(c) isolated hypoplasia of uncinate process\n\n## Paraduodenal Pancreatitis\n\n1. Groove pancreatitis\n2. Cystic dystrophy of duodenal wall\n3. Paraduodenal wall cysts\n\nLocation: in + around minor papilla\nCommon features:\n$\\sqrt{ }$ dilated ducts and cysts in duodenal wall\n$\\sqrt{ }$ Brunner gland hyperplasia\n$\\sqrt{ }$ hamartomatous pancreatic tissue in pancreaticoduodenal groove\n\n## Pancreatic Calcifications\n\n1. CHRONIC PANCREATITIS\n\nNumerous irregular stippled calcifications of varying size; predominantly intraductal\n(a) Alcoholic pancreatitis (in $20-50 \\%$ ):\n$\\sqrt{ }$ small speckled intraductal calculi limited to head / tail in $25 \\%$\n(b) Biliary pancreatitis (in 2\\%)\n(c) Hereditary pancreatitis (in $35-60 \\%$ ):\n$\\sqrt{ }$ round calcifications throughout gland\n(d) Idiopathic pancreatitis\n(e) Pancreatic pseudocyst",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 257,
            "markdown": "(f) Juvenile tropical pancreatitis\n$\\checkmark$ discrete dense up to 5 cm large calculi\n2. NEOPLASM\n(a) Microcystic adenoma (in 33\\%):\n$\\checkmark$ \"sunburst\" appearance of calcifications\n(b) Macrocystic cystadenoma In 15\\%):\n$\\checkmark$ amorphous peripheral calcifications\n(c) Adenocarcinoma (in 2\\%): with \"sunburst\" pattern\n(d) Cavernous lymphangioma / hemangioma:\n$\\checkmark$ multiple phleboliths\n(e) Metastases from colon cancer\n3. INTRAPARENCHYMAL HEMORRHAGE\n(a) Old hematoma / abscess / infarction\n(b) Rupture of intrapancreatic aneurysm\n4. HYPERPARATHYROIDISM (in 20\\%):\n$\\diamond 50 \\%$ of patients develop chronic pancreatitis + concomitant nephrocalcinosis\n$\\diamond$ Indistinguishable from alcoholic pancreatitis\n5. CYSTIC FIBROSIS\n\nFine granular calcifications imply advanced pancreatic fibrosis\n6. HEMOCHROMATOSIS\n\n# Chronic Calcifying Pancreatitis \n\n1. Alcoholism ( $70-80 \\%$ ) in developed countries\n2. Juvenile tropical pancreatitis\n3. Hereditary pancreatitis\n4. Inborn errors of metabolism\n5. Hyperlipidemia\n6. Hypercalcemia\n\n## Atrophy and Fatty Replacement of Pancreas\n\n1. Main pancreatic duct obstruction\n2. Cystic fibrosis\n$\\diamond$ Most common cause in childhood!\n3. Shwachman-Diamond syndrome\n4. Johanson-Blizzard syndrome ( $=$ pancreatic insufficiency, nasal alar hypoplasia, absence of permanent teeth, short stature, congenital deafness)\n5. Hemochromatosis\n6. Viral infection\n7. Severe malnutrition\n8. Cushing syndrome, steroid therapy, obesity, elderly\n9. Diabetes mellitus\n\nDDx of total fatty replacement of pancreas:\npancreatic agenesis $\\rightarrow$ absence of ductal system\n\n## Uneven Pancreatic Lipomatosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 258,
            "markdown": "$\\sqrt{ }$ commonly focal sparing of peribiliary region\n1 sparing of uncinate process + peribiliary region\n1a replacement of head $35 \\%$\n1b replacement of head, neck, body $36 \\%$\n2 sparing of peribiliary region only\n2a replacement of head + uncinate process $12 \\%$\n2 b total replacement of pancreas $18 \\%$\n\n# Diffusely Enlarged Pancreas \n\n1. Malignant lymphoma\n2. Plasmacytoma\n3. Metastases\n4. Diffuse infiltrative pancreatic carcinoma\n5. Autoimmune pancreatitis\n\n## Pancreatic Neoplasm\n\nOrigin: > in $99 \\%$ exocrine ductal epithelium\n> in $1.0 \\%$ acinar portion of pancreatic glands\n> in $0.1 \\%$ malignant ampullary tumor with better prognosis\nA. EXOCRINE NEOPLASM\n(a) Ductal cell origin\n\n1. Ductal adenocarcinoma ( $90 \\%$ )\n2. Ductectatic mucinous tumor\n$=$ mucin-hypersecreting carcinoma\n3. Cystic neoplasm ( $10-15 \\%$ )\n> serous microcystic neoplasm\n> mucinous macrocystic neoplasm\n> cystic PET\n4. Solid pseudopapillary tumor (rare)\n5. Von Hippel-Lindau disease\n(b) Acinar cell origin\n6. Acinar cell carcinoma ( $1 \\%$ )\n7. Adenoma\n(c) Indeterminate origin\n8. Pancreatoblastoma\n9. Dermoid cyst ( $<27$ years of age, $8-12 \\mathrm{~cm}$ in size)\n10. Giant cell tumor\nB. PANCREATIC ENDOCRINE TUMOR (PET in 5\\%)\n(a) Nonfunctioning (nonsyndromic) PET\n(b) Functioning (syndromic) PET\n11. Insulinoma ( $\\beta$ cells)\n12. Glucagonoma\n13. Gastrinoma ( $\\delta$ cells)\n14. Somatostatinoma\n15. VIPoma (WDHA syndrome)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 259,
            "markdown": "6. \"PPoma\" = pancreatic polypeptide\n7. Carcinoid\nC. NONEPITHELIAL ORIGIN\n(a) Primary tumor\n8. Primary lymphoma $<1 \\%$ of pancreatic neoplasms\n9. Primitive neuroectodermal tumor (in children, part of Ewing sarcoma family of tumors)\n10. Rhabdomyosarcoma\n(b) Solid mesenchymal tumor (1\\%)\n\nBenign primary nonepithelial neoplasms of the pancreas are a rare group of usually sharply marginated solid and cystic tumors.\n\n1. Schwannoma\n2. Neurofibroma\n3. Ganglioneuroma\n4. Desmoid tumor\n5. Leiomyoma\n6. Lipoma\n7. Perivascular epithelioid cell tumor: clear cell \"sugar tumor\", angiomyolipoma, lymphangiomyomatosis, clear cell tumor\n(c) Cystic nonepithelial neoplasm\n8. Mature cystic teratoma\n9. Lymphangioma\n(d) Metastases to pancreas\n\n# Pediatric Pancreatic Tumors \n\n1. Pancreatoblastoma\n2. Solid-pseudopapillary tumor\n3. Islet cell tumor\n4. Nesidioblastosis\n5. Acinar cell carcinoma\n6. Burkitt lymphoma\n7. Lymphangioma\n8. Primitive neuroectodermal tumor (PNET)\n9. Neuroblastoma (secondary involvement)\n\n## Hypervascular Pancreatic Tumors\n\nA. PRIMARY\nislet cell tumor, microcystic adenoma, solid-pseudopapillary tumor of pancreas\nB. METASTASES from\nangiosarcoma, leiomyosarcoma, melanoma, carcinoid, RCC, adrenal carcinoma, thyroid carcinoma\n\n## Pancreatic Pseudotumor\n\n1. Intrapancreatic accessory spleen",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 260,
            "markdown": "Location: pancreatic tail\n2. Pancreatic lobulation\n\nPrevalence: $34 \\%$ of general population\nLocation: posterior (19\\%), anterior (10\\%), horizontal (5\\%)\n3. Tuber omentale $=$ focal prominence of anterior pancreatic surface to left of SMA\n4. Pancreas bifidum = fish tail pancreas = bifid pancreatic tail\n$\\sqrt{ }$ pancreatic tail does not reach splenic hilum\n\n# Pancreatic Cyst \n\nWith clearer depiction of septa, cyst contents and pancreatic ductal system, MRI can often achieve a more specific diagnosis.\nIncidence: $2.6 \\%$ of consecutive CT scans, $13.5 \\%$ at MRI\nA. INFLAMMATORY / INFECTIOUS\n(a) pseudocyst $(85 \\%)$ :\n(b) acquired cyst:\n\n1. Retention cyst (= exudate within bursa omentalis from acute pancreatitis)\n2. Parasitic cyst: Echinococcus multilocularis, amebiasis\n3. Pancreatic abscess\n4. Lymphoepithelial cyst: cysts are lined by squamous epithelium and surrounded by dense lymphoid tissue\n5. Mucinous non-neoplastic unilocular cyst\nB. CONGENITAL (rare)\n(a) solitary true pancreatic cyst\n(b) systemic disease / syndromes with multiple true cysts\n\nAssociated with: cystic disease of liver / other organs\n\n1. Autosomal dominant polycystic kidney disease (ADPKD); autoptic liver (pancreatic) cysts in $90 \\%(9 \\%)$\n$\\checkmark$ nearly always associated with renal cysts\n2. Von Hippel-Lindau disease pancreatic cysts in $72 \\%(25 \\%)$ at autopsy (CT)\n$\\checkmark$ renal involvement in all cases\n3. Beckwith-Wiedemann syndrome\n4. Meckel-Gruber syndrome\n5. Cystic fibrosis\nC. CYSTIC NEOPLASM\n\nFrequency: $<10 \\%$ of all pancreatic neoplasms\n(a) common cystic pancreatic neoplasms (5-15\\%)\n\n1. Intraductal papillary mucinous tumor (36\\%)\n2. Serous cystadenoma ( $20 \\%$ )\n3. Pseudocyst (14\\%)\n4. Cystadenocarcinoma (7\\%)\n5. Mucinous cystic neoplasm\n(b) rare cystic pancreatic neoplasms\n6. Solid pseudopapillary tumor",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 261,
            "markdown": "2. Acinar cell cystadenocarcinoma\n3. Retroperitoneal lymphangioma\n4. Retroperitoneal hemangioma\n5. Cystic neuroendocrine tumor\n(c) solid pancreatic neoplasms with cystic degeneration\n6. Pancreatic ductal adenocarcinoma\n7. Cystic pancreatic endocrine tumor (rare)\n8. Cystic metastasis ( $3-12 \\%$ at autopsy)\n\nRCC, melanoma, lung tumors, breast carcinoma, hepatocellular carcinoma, ovarian carcinoma\n4. Cystic teratoma\n5. Pancreatic sarcoma (extremely rare)\n\nFeatures of malignancy:\n$\\sqrt{ }>10 \\mathrm{~mm}$ main pancreatic duct dilatation\n$\\sqrt{ }>10 \\mathrm{~mm}$ large mural node\n$\\sqrt{ }>3 \\mathrm{~cm}$ large cyst\n$\\sqrt{ }>2.5$ SUV positivity on FDG\n$\\sqrt{ }$ irregular / septate features\n$\\sqrt{ }$ calcification\nImaging performance for malignant cystic lesion:\nFDG-PET: $56 \\%$ sensitive, $83 \\%$ specific\nCT: $81 \\%$ sensitive, $100 \\%$ specific\nPET/CT: $94 \\%$ sensitive, $100 \\%$ specific\nMRCP can image the pancreatic duct after Whipple procedure, distal pancreatectomy, and central pancreatectomy with pancreaticojejunostomy.\n\n# Unilocular Pancreatic Cyst \n\n$\\diamond$ A cyst $<3 \\mathrm{~cm}$ is almost always benign ( $97 \\% \\mathrm{PPV}$ ) + may be followed at 6-month intervals for 3 years!\n\n1. Pseudocyst\n\n- history of pancreatitis\n\n2. Intraductal papillary mucinous neoplasm (IPMN)\n$\\sqrt{ }$ narrow neck at cyst-duct junction\n3. Benign unclassified cyst\n4. Unilocular serous cystadenoma\n5. Lymphoepithelial cyst\n\n## Multiple Unilocular Pancreatic Cysts\n\n1. Pseudocysts\n2. Von Hippel-Lindau disease\n3. Intraductal papillary mucinous neoplasm (rarely)\n\n## Pancreatic Cyst with Solid Component\n\n$\\diamond$ All tumors are either malignant or have a high malignant potential!\n> true cystic neoplasm",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 262,
            "markdown": "1. Mucinous cystic neoplasm\n2. Intraductal papillary mucinous neoplasm (IPMN)\n> cystically degenerated neoplasm\n3. Pancreatic endocrine tumor\n4. Solid pseudopapillary tumor\n5. Pancreatic adenocarcinoma\n6. Metastasis\n\n# Macrocystic Lesion of Pancreas \n\n$=$ multilocular cyst, each compartment $>2 \\mathrm{~cm}$ in size\n\n1. Mucinous cystic neoplasm\n$\\sqrt{ }$ in body + tail of pancreas\n$\\sqrt{ }$ peripheral eggshell calcification\n2. Intraductal papillary mucinous neoplasm: side-branch / mixed\n$\\sqrt{ }$ septated cyst communicating with main duct\n3. Nonfunctioning neuroendocrine tumor\n4. Congenital lymphangioma\n\n## Microcystic Lesion of Pancreas\n\n$=$ pancreatic lesion with $>6$ cysts each $<2 \\mathrm{~cm}$ in size\n\n1. Serous cystadenoma\n$\\sqrt{ }$ fibrous central scar $\\pm$ stellate pattern $(30 \\%)$\n$\\sqrt{ }$ growth rate of $4 \\mathrm{~mm} /$ year at follow-up\n\n## Mucin-Containing Cyst of Pancreas\n\n1. Mucinous nonneoplastic cysts\n$=$ nonneoplastic mucinous differentiation of epithelial lining without soft-tissue component\n2. Mucinous cystadenoma\n3. Mucinous cystadenocarcinoma\n4. Intraductal papillary mucinous neoplasm\n\n## Hyperamylasemia\n\nA. PANCREATIC\n\n1. Acute / chronic pancreatitis\n2. Pancreatic trauma\n3. Pancreatic carcinoma\nB. GASTROINTESTINAL\n4. Perforated peptic ulcer\n5. Intestinal obstruction\n6. Peritonitis\n7. Acute appendicitis\n8. Afferent loop syndrome\n9. Mesenteric ischemia / infarction\n10. Portal vein thrombosis\nC. TRAUMA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 263,
            "markdown": "1. Burns\n2. Cerebral trauma\n3. Postoperative\nD. OBSTETRICAL\n4. Pregnancy\n5. Ruptured ectopic pregnancy\nE. RENAL\n6. Transplantation\n7. Renal insufficiency\nF. METABOLIC\n8. Diabetic ketoacidosis\n9. Drugs\nG. PNEUMONIA\nH. SALIVARY GLAND LESION\n10. Facial trauma\n11. Mumps\n\n# SPLEEN \n\n## Nonvisualization of Spleen\n\n1. Asplenia syndrome\n2. Polysplenia syndrome\n3. Traumatic fragmentation of spleen\n4. Wandering spleen\n\n## Small Spleen\n\n1. Infarction\n2. Celiac disease\n3. Congenital / hereditary hypoplasia of spleen\n$\\diamond$ Associated with recurrent bacterial infections!\n4. Fanconi anemia\n5. Irradiation\n6. Partial splenectomy\n7. Polysplenia syndrome\n8. Atrophy\n\n## Splenomegaly\n\n$\\sqrt{ }$ inferior tip of spleen extends below tip of right lobe of liver\n$\\sqrt{ }$ AP diameter of spleen $>2 / 3$ of abdominal diameter\nA. CONGESTIVE SPLENOMEGALY heart failure, portal hypertension, cirrhosis, cystic fibrosis, portal / splenic vein thrombosis, acute splenic sequestration crisis of sickle cell anemia\nB. NEOPLASM leukemia, lymphoma, lymphoproliferative disease, Langerhans cell histiocytosis, metastases, primary neoplasm\nC. STORAGE DISEASE Gaucher disease, Niemann-Pick disease, mucopolysaccharidoses,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 264,
            "markdown": "gargoylism, amyloidosis, diabetes mellitus, hemochromatosis\nD. INFECTION\n(a) bacterial: TB, subacute bacterial endocarditis, typhoid fever, syphilis, brucellosis\n(b) viral: hepatitis, infectious mononucleosis\n(c) protozoal: echinococcosis, malaria, kala azar, American leishmaniasis\n(d) fungal: histoplasmosis\nE. HEMOLYTIC ANEMIA hemoglobinopathy, hereditary spherocytosis, primary neutropenia, thrombotic thrombocytopenic purpura, extracorporeal membrane oxygenation ( $\\leftarrow \\mathrm{RBC}$ damage)\nF. EXTRAMEDULLARY HEMATOPOIESIS osteopetrosis, myelofibrosis\nG. COLLAGEN VASCULAR DISEASE SLE, rheumatoid arthritis, Felty syndrome\nH. SPLENIC TRAUMA\nI. OTHERS\n\n1. Sarcoidosis\n$\\checkmark$ splenomegaly in up to $60 \\%$\n$\\checkmark$ inhomogeneous enhancement after bolus injection (multiple $2-3-\\mathrm{cm}$ hypodense nodular lesions)\n$\\checkmark$ necrotic mass with focal calcifications\n2. Hemodialysis\n3. Autoimmune lymphoproliferative syndrome\n\n# Solid Splenic Lesion \n\nA. MALIGNANT TUMOR\n\n1. Lymphoma (Hodgkin disease, non-Hodgkin lymphoma, primary splenic lymphoma)\n$\\diamond$ Splenomegaly in non-Hodgkin lymphoma indicates involvement in most patients\n$\\diamond 30 \\%$ of patients with splenomegaly have NO involvement from non-Hodgkin lymphoma\n$\\diamond 30 \\%$ of patients with lymphoma of any kind have splenic involvement without splenomegaly\n$\\checkmark$ homogeneous splenomegaly (from diffuse infiltration)\n$\\checkmark$ miliary nodules\n$\\checkmark$ large $2-10-\\mathrm{cm}$ nodules $(10-25 \\%)$\n$\\checkmark$ nodes in splenic hilum ( $50 \\%$ ) in NHL; uncommon in Hodgkin disease\n2. Metastasis ( $7 \\%$ ) melanoma ( $6-34 \\%$ ), breast carcinoma ( $12-21 \\%$ ), bronchogenic carcinoma ( $9-18 \\%$ ), colon carcinoma ( $4 \\%$ ), renal cell carcinoma ( $3 \\%$ ), ovary ( $8 \\%$ ), prostate ( $6 \\%$ ), stomach ( $7 \\%$ ), pancreas, endometrial cancer\n3. Angiosarcoma\n4. Malignant fibrous histiocytoma, leiomyo-, fibrosarcoma\n5. Langerhans cell histiocytosis\n$\\checkmark$ splenomegaly\n$\\checkmark$ multiple hypoechoic nodules (less often)\nB. BENIGN TUMOR\n6. Hamartoma $=$ splenoma\n7. Hemangioma\n8. Hematopoietic",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 265,
            "markdown": "4. Sarcoidosis\n5. Gaucher disease (islands of RES cells laden with glucosylceramide)\n6. Inflammatory pseudotumor\n7. Lymphangioma\nC. SPLENIC INFARCTION\n\n# Cystic Splenic Lesion \n\nA. CONGENITAL\n\n1. Epidermoid cyst $=$ true cyst $=$ congenital cyst\nB. VASCULAR\n2. Splenic laceration / fracture\n3. Hematoma\n4. False cyst $=$ posttraumatic cyst $=$ nonpancreatic pseudocyst of the spleen\n$\\diamond 80 \\%$ of all splenic cysts are pseudocysts (= secondary cysts)\nCause: cystic end stage of trauma, infection, infarction\n$\\checkmark$ internal echoes from debris\n$\\checkmark$ calcifications within cyst wall may resemble eggshell\n$\\checkmark$ smaller size than true cyst\n5. Cystic degeneration of infarct\n(a) occlusion of splenic a. / branches (hemolytic anemia, endocarditis, SLE, arteritides, pancreatic cancer)\n(b) venous thrombosis of splenic sinusoids (massive splenomegaly)\n6. Peliosis\nC. INFECTION / INFLAMMATION\n7. Pyogenic abscess\n\nPrevalence: $0.1-0.7 \\%$\nCause: hematogenous spread in sepsis ( $75 \\%$ ), penetrating trauma ( $15 \\%$ ), infarction $(10 \\%)$\nPredisposed: endocarditis, drug abuse, penetrating trauma, neoplasm, sickle cell disease\n\n- fever, chills, LUQ pain (in $<50 \\%$ )\n$\\checkmark$ irregular borders without capsule\n$\\checkmark$ gas bubbles within abscess\n$\\checkmark$ rim enhancement\n$R x: \\quad 76 \\%$ success rate for percutaneous drain\n\n2. Microabscesses\n\nOrganism: fungus (especially Candida, Aspergillus, Cryptococcus)\nPrevalence: $26 \\%$ of splenic abscesses\nPredisposed: immunocompromised patient\n$\\checkmark$ hepatosplenomegaly\n$\\checkmark$ multiple round hypoechoic / hypoattenuating \"target\" lesions of $5-10 \\mathrm{~mm}$ often associated with hepatic + renal involvement\n$\\checkmark$ \"wheel-in-wheel\" appearance when central hyperechoic portion becomes necrotic + hypoechoic\n3. Granulomatous infection",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 266,
            "markdown": "(a) Mycobacterium tuberculosis: miliary TB\n$\\checkmark$ mild splenomegaly (uncommon)\n(b) M. avium-intracellulare\n$\\checkmark$ marked splenomegaly (in 20\\%)\n4. Pneumocystis carinii infection\n$\\checkmark$ splenomegaly + multiple hypoattenuating foci\n5. Parasitic cyst (Echinococcus)\n\nPrevalence: in $<2 \\%$ of patients with hydatid disease\nCause: systemic dissemination, intraperitoneal spread of ruptured liver cyst\n$\\checkmark$ solitary cyst $\\pm$ subjacent daughter cysts\n$\\checkmark$ hydatid sand $\\pm$ infolded membranes\n$\\checkmark \\pm$ linear calcification\n6. Intrasplenic pancreatic pseudocyst\n\nPrevalence: in $1-5 \\%$ of patients with pancreatitis\nD. CYSTIC NEOPLASM\n\n1. Cavernous hemangioma\n$\\checkmark$ Most common primary neoplasm of the spleen!\n$\\checkmark$ hyperdense lesion\n2. Lymphoma (most common malignant neoplasm!)\n$\\checkmark$ splenomegaly\n$\\checkmark$ multiple small / large masses\n3. Lymphangioma / lymphangiomatosis\n$\\checkmark$ multiple septated subcapsular cystic lesions\n4. Necrotic metastasis:\nmalignant melanoma (in $50 \\%$ ), breast, lung, ovarian, pancreatic, endometrial, colonic, prostatic, carcinoma; chondrosarcoma\n$\\checkmark$ In $7 \\%$ of patients with widespread metastasis!\nE. TRUE CYST (with epithelial lining)\n5. Congenital cyst $=$ epidermoid cyst\n6. Parasitic cyst\nF. FALSE CYST $=$ PSEUDOCYST (lacking epithelial lining)\n7. Traumatic cyst\n8. Postinfarct cyst\n\n# Solitary Splenic Lesion \n\nmnemonic: L'CHAIM\nLymphoma\nCyst\nHematoma, Hemangioma, Hamartoma\nAbscess\nInfarct\nMetastasis\n\n## Multiple Splenic Nodules and Masses\n\n1. Lymphoma, leukemia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 267,
            "markdown": "2. Metastases\n3. Inflammatory lesions\n4. Benign tumors\n5. Splenic cysts\n6. Splenic infarcts\n7. Gaucher cells\n\n# Increased Splenic Density \n\n1. Sickle cell anemia (in 5\\% of sicklers)\n2. Hemochromatosis\n3. Thorotrast exposure\n4. Lymphangiography\n\n## Splenic Calcifications\n\nA. DISSEMINATED\n\n1. Phlebolith: visceral angiomatosis\n2. Granuloma (most common): histoplasmosis, TB, brucellosis\nB. CAPSULAR \\& PARENCHYMAL\n3. Pyogenic / tuberculous abscess\n4. Pneumocystis carinii infection\n5. Infarction (multiple)\n6. Hematoma\nC. VASCULAR\n7. Splenic artery calcification\n8. Splenic artery aneurysm\n9. Splenic infarct\n10. Autosplenectomy\nD. CALCIFIED CYST WALL\n11. Congenital cyst\n12. Posttraumatic cyst\n13. Echinococcal cyst\n14. Cystic dermoid\n15. Epidermoid\nmnemonic: HITCH\nHistoplasmosis (most common)\nInfarct (sickle cell disease)\nTuberculosis\nCyst (Echinococcus)\nHematoma\n\n## Iron Accumulation in Spleen\n\nA. DIFFUSE\n\n1. Multiple blood transfusions\n2. Sickle cell anemia\nB. FOCAL",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 268,
            "markdown": "1. Gamma-Gandy bodies\n2. Angiosarcoma\n\n# Hyperechoic Splenic Spots \n\n1. Granulomas: miliary tuberculosis, histoplasmosis\n2. Phleboliths\n3. Lymphoma / leukemia\n4. Myelofibrosis\n5. Gamma-Gandy nodules (in portal hypertension)\n\n## Spontaneous Splenic Rupture\n\n1. Posttraumatic delayed rupture\n2. Splenomegaly\n3. Hemangioma\n4. Epidermoid cyst\n5. Peliosis\n6. Previous splenic infarction\n\n## Hyposplenism\n\n$=$ no uptake of ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-sulfur colloid\nA. ANATOMIC ABSENCE OF SPLEEN\n\n1. Congenital asplenia $=$ Ivemark syndrome\n2. Splenectomy\nB. FUNCTIONAL ASPLENIA\n$=$ marked decrease in splenic phagocytic function despite presence of splenic tissue within the body\n3. Circulatory disturbances: occlusion of splenic artery / vein, hemoglobinopathies (sickle cell disease, hemoglobin-SC disease, thalassemia), polycythemia vera, idiopathic thrombocytopenic purpura\n4. Altered RES activity: thorotrast, irradiation, combined splenic irradiation + chemotherapy, replacement of RES by tumor / infiltrate, splenic anoxia (cyanotic congenital heart disease), sprue\n5. Autoimmune disease\n$C x$ : children at risk for pneumococcal pneumonia (liver partially takes over immune response later in life)\nC. FUNCTIONAL ASPLENIA + SPLENIC ATROPHY ulcerative colitis, Crohn disease, celiac disease, tropical sprue, dermatitis herpetiformis, thyrotoxicosis, idiopathic thrombocytopenic purpura, thorotrast\nD. FUNCTIONAL ASPLENIA + NORMAL / LARGE SPLEEN sarcoidosis, amyloidosis, sickle cell anemia (if not infarcted), after bone marrow transplantation\n\n- RBC (acanthocytes, siderocytes)\n- lymphocytosis, monocytosis\n- Howell-Jolly bodies (intraerythrocytic inclusions)\n- thrombocytosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 269,
            "markdown": "$\\sqrt{ }$ spleen not visualized on ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-sulfur colloid\n$\\sqrt{ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-heat-damaged RBCs / ${ }^{111}$ In-labeled platelets may demonstrate splenic tissue if ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-sulfur colloid does not\nCx: increased risk of infection (pneumococcus, meningococcus, influenza)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 270,
            "markdown": "# ANATOMY OF LIVER, BILE DUCTS, PANCREAS AND SPLEEN \n\n![img-36.jpeg](img-36.jpeg)",
            "images": [
                {
                    "id": "img-36.jpeg",
                    "top_left_x": 190,
                    "top_left_y": 393,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1548,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 271,
            "markdown": "![img-37.jpeg](img-37.jpeg)\n\n# LIVER \n\n## Functional Segmental Liver Anatomy\n\nbased on distribution of 3 major hepatic veins:\n(a) middle hepatic vein\ndivides liver into right and left lobe;\nalso separated by main portal vein scissura\n(Rex-Cantlie line $=$ extrapolated line from posthepatic IVC to long axis of gallbladder demarcating on liver surface anteriorly the right and left parts of liver)\n(b) left hepatic vein\ndivides left lobe into medial + lateral sectors\n(c) right hepatic vein",
            "images": [
                {
                    "id": "img-37.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 191,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1467,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 272,
            "markdown": "divides right lobe into anterior + posterior sectors\nEach of the four sections is further divided:\nby an imaginary transverse line drawn through the right + left portal vein into anterior + posterior segments; the segments are numbered counterclockwise from IVC\n\n# Portal Vein Anatomy (Akgul Classification) \n\nType A Normal anatomy: bifurcation of MPV and RPV (79-86\\%)\n$\\diamond$ Posterior branch of RPV as $1^{\\text {st }}$ portal vein branch $(13 \\%)=$ most common variant N.B.: unintended devascularization of hepatic segments V + VIII during left trisegment-ectomy (resection of segments II, III, IV) / harvest of left lobe for liver transplantation if unrecognized\nType B Trifurcation of MPV (9-15\\%)\nType C Right anterior portal vein from LPV (1-4\\%)\nType D LPV from right anterior portal vein ( $0.3-1.2 \\%)$\nType E Right anterior portal vein from MPV (1-3\\%)\n\n## Maximum Cross-sectional Diameter of Portal Vein\n\n(a) child $<10$ years of age: 8.5 mm\n(b) $10-20$ years of age: 10.0 mm\n(c) adult: 13.0 mm",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 273,
            "markdown": "![img-38.jpeg](img-38.jpeg)\n\nIntrahepatic Portal Vein Branches (in 65\\% of individuals) (umbilical portion of L portal v. = segment between ligg. venosum + teres)\nR $\\quad=$ right portal vein\nRA $\\quad=$ right anterior segment\nRAI $=$ right anterior inferior (V)\nRAS $=$ right anterior superior (VIII)\n$\\mathrm{RP} \\quad=$ right posterior segment\nRPI $=$ right posterior inferior (VI)\nRPS $=$ right posterior superior (VII)\nC $\\quad=$ caudate lobe (I)\n$\\mathrm{L} \\quad=$ left portal vein\nLMI $=$ left median inferior (IVb)\nLMS $=$ left median superior (IVa)\nLLI $=$ left lateral inferior (III)\nLLS $=$ left lateral superior (II)",
            "images": [
                {
                    "id": "img-38.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1332,
                    "bottom_right_y": 1047,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 274,
            "markdown": "![img-39.jpeg](img-39.jpeg)\n\n# Embryology of Portal Vein \n\nTime: $4^{\\text {th }}-12^{\\text {th }}$ week of GA\n> paired vitelline veins around duodenum $\\rightarrow$ form 3 major side-to-side anastomoses (cranioventral + caudoventral + dorsal) $\\rightarrow$ pierce septum transversum (primitive liver) $\\rightarrow$ broken up into sinusoids $\\rightarrow$ drain into sinus venosus (of primitive heart)\n> selective involution of caudal part of right vitelline vein + cranial part of left vitelline vein:\n» regression of caudoventral anastomosis\n» dorsal anastomosis $\\rightarrow$ main portal vein\n» cranioventral anastomosis $\\rightarrow$ left portal vein\n» caudal right vitelline vein $\\rightarrow$ superior mesenteric vein\n» caudal left vitelline vein $\\rightarrow$ splenic vein\n\n## Major Anatomic Variants of Portal Vein (rare)\n\n1. Duplication of portal vein\n2. Congenital portosystemic shunt\n3. Congenital absence of portal vein\n4. Absent branching of portal vein\n5. Preduodenal portal vein\n\n## Hepatic Artery Anatomy (Michels classification)\n\nType $1(55-60 \\%)$ :\n> celiac trunk trifurcates into common hepatic artery (CHA) + left gastric artery (LGA) + splenic artery (SpA)\n> CHA divides into",
            "images": [
                {
                    "id": "img-39.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 187,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 974,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 275,
            "markdown": "Location: CHA courses to right along superior ridge of pancreas branching at lower end of epiploic foramen\n(a) proper hepatic artery (PHA)\n\nLocation: PHA courses right + upward along anterior border of epiploic foramen\n(b) gastroduodenal artery (GDA)\n> right hepatic artery (RHA) + left hepatic artery (LHA) arise from PHA\n> middle hepatic a. (supplying caudate lobe) arises from:\n(a) LHA / RHA\n(b) PHA (in $10 \\%$ )\n\nType $2(4-10 \\%)$ :\n> CHA divides into RHA + GDA\n> LHA replaced to LGA\n> middle hepatic artery from RHA\nType $3(8-11 \\%)$ :\n> CHA divides into GDA + LHA\n> RHA replaced to SMA\n> middle hepatic artery from LHA\nType $4(2-4 \\%)$ :\n> CHA divides into middle hepatic artery + GDA\n> RHA + LHA are both replaced\nType $5(9-16 \\%)$ :\n> accessory L hepatic a. arises from LGA\nType $6(1-7 \\%)$ :\n> accessory R hepatic artery arises from SMA\nType $7(1 \\%)$ :\n> accessory R + L hepatic arteries\nType $8(2-3 \\%)$ :\n> combinations of accessory + replaced hepatic arteries\nType $9(1-3 \\%)$ :\n> hepatic trunk replaced to SMA\nType $10(0.5 \\%)$ :\n> hepatic trunk replaced to LGA\nThe presence of a portal branch without corresponding artery indicates a replaced or accessory vascular anatomy or transhepatic hepatofugal collateral vessels.\n\n# Aberrant Hepatic Artery \n\n$=$ hepatic artery coursing between IVC + portal vein\n\n1. Replaced right hepatic artery $(50 \\%)$\n2. Right hepatic artery with early bifurcation of common hepatic artery into right + left hepatic arteries $(20 \\%)$\n3. Accessory right hepatic artery $(15 \\%)$\n4. Replacement of entire hepatic trunk to SMA (15\\%)\n\n## Left Hepatic Artery\n\n$=$ usually arises from proper hepatic artery (PHA)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 276,
            "markdown": "Location: from hepatic hilum to umbilical portion of left portal vein (usually to its right) coursing up- and leftward\nAccessory LHAs: from LGA / celiac trunk / aorta\nDivision (arteriographic description):\nafter forming an arch overriding the portal vein\n> A2 branches: course to left corner of liver, usually superior to A3\n> A3 branches: course ventral + caudal along left side of umbilical portion of PV and then toward left\n\n# Right Hepatic Artery \n\n$=$ usually arises from PHA / SMA when replaced\nAccessory RHAs: from SMA / celiac trunk / aorta\nDivision (arteriographic description):\n$>$ anterior branch: straight right + upward course\n> posterior branch: proximally meandering course\nA6: inferolateral course to lower corner of liver\nA7: compact complex meandering course superiorly (on frontal projection)\nThe RHA forms anterior and posterior branches characterized by a straight right upward course and by a meandering proximal portion, respectively.\n\n## Caudate Lobe\n\n$=$ located behind liver hilum + wrapping around IVC, supplied by multiple small branches from LHA + RHA\nVariations (arteriographic description):\n$>$ RHA + LHA (53\\%)\n$>$ RHA only $(35 \\%)$\nLocation: courses posteromedially mainly supplying the lateral (= paracaval portion and papillary process) of S1\n> LHA only ( $12 \\%$ )\nLocation: courses posteriorly mainly supplying medial portion (= caudate process, Spiegel lobe) of S1",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 277,
            "markdown": "![img-40.jpeg](img-40.jpeg)\n\nHepatic Vein Drainage Pattern of Right Hepatic Lobe (Nakamura Classification)\nType 1 Large right hepatic vein (RHV) drains extensive area of right lateral sector + part of right paramedian sector; small short hepatic vein drains small area of right lateral sector (occasionally absent) (39-57\\%)\nType 2 Right hepatic vein of medium size; one thick short hepatic vein of 5-10 mm in diameter ( $=$ middle / inferior hepatic vein) drains right lateral sector concomitantly directly into IVC (29-37\\%)\nType 3 Right lobe drainage allocated to a short RHV that drains superior part of right lateral sector and large middle hepatic vein (MHV) + inferior right hepatic vein that drains inferior part of right lateral sector ( $15-24 \\%$ )\n\nIt is important to identify any variation in the middle hepatic vein because the hepatectomy plane in living donors is about 1 cm to the right of the middle hepatic vein along the gallbladder fossa.\n\n# Third Inflow to Liver \n\n$=$ aberrant veins supplying small areas of liver tissue + communicating with intrahepatic portal vein branches\nEffect: focal decrease of portal vein perfusion resulting in areas of fat-sparing / fat accumulation\n\n1. Cholecystic veins\n> directly entering liver segments $4+5$\n> veins joining the parabiliary veins via triangle of Calot\n2. Parabiliary venous system\n$=$ venous network within hepatoduodenal ligament anterior to main portal vein",
            "images": [
                {
                    "id": "img-40.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 187,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1029,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 278,
            "markdown": "Tributaries:\n> cholecystic vein through triangle of Calot\n[Jean-François Calot (1861-1944), French surgeon]\n> pancreaticoduodenal vein\n> right gastric / pyloric vein\n$\\sqrt{ }$ pseudolesion at dorsal aspect of segment 4\n3. Epigastric-paraumbilical venous system\n$=$ small veins around falciform ligament draining anterior part of abdominal wall directly into liver\nSubgroups:\n(a) superior vein of Sappey\n[Marie Philibert Constant Sappey (1810-1896), professor of anatomy and president of the Académie Nationale de Médecine, Paris, France]\n> drains upper portion of falciform ligament + medial part of diaphragm\n> enters peripheral left portal vein branches\n> communicates with superior epigastric + internal thoracic veins\n(b) inferior vein of Sappey\n> drains lower portion of falciform ligament\n> enters peripheral left portal vein branches\n> communicates with branches of inferior epigastric vein around the umbilicus\n(c) vein of Burow\n> terminates in middle part of collapsed umbilical v.\n> communicates with branches of inferior epigastric vein around the umbilicus\n(d) intercalary veins\n> interconnect vein of Burow + inferior vein of Sappey\n\n# Normal Hemodynamic Parameters of Liver \n\nPortal vein velocity: $>11$ (range, 16-40) $\\mathrm{cm} / \\mathrm{sec}$\nPortal vein cross-section: $0.99 \\pm 0.28 \\mathrm{~cm}^{2}$\nCongestion index: $0.070 \\pm 0.09 \\mathrm{~cm} \\cdot \\mathrm{sec}$\n(= cross-sectional area of portal vein divided by average velocity)\nHepatic artery resistive index: $0.60-0.64 \\pm 0.06$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 279,
            "markdown": "![img-41.jpeg](img-41.jpeg)\n\nTime-correlated electrocardiographic (ECG), central venous pressure (CVP) and hepatic venous (HV) waveform\n$S$ wave $=$ trough correlates with peak negative pressure created by downward motion of AV annulus toward cardiac apex during midsystole $=$ ventricular Systole\nv wave $=$ transitional peak between systole + diastole correlates with return of tricuspid valve toward cardiac apex; caused by RA overfilling against a closed tricuspid valve; occurs in $<50 \\%$ of patient\n$D$ wave $=$ trough correlates with rapid early diastolic RV filling caused by opening of the tricuspid valve + blood flow from RA into RV during ventricular Diastole; equal to / smaller than $S$ wave\n$a$ wave $=$ retrograde $a$ wave at end-diastole caused by contraction of $\\mathrm{RA}=$ atrial systole; in $66 \\%$ of patients\n\n# Hepatic Fissures \n\n1. Fissure for ligamentum teres $=$ umbilical fissure\n$=$ invagination of ligamentum teres $=$ embryologic remnant of obliterated umbilical vein connecting placental venous blood with left portal vein\n, located at dorsal free margin of falciform ligament\n, runs into liver with visceral peritoneum\n, divides left hepatic lobe into medial + lateral segments (divides subsegment 3 from 4)",
            "images": [
                {
                    "id": "img-41.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 191,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 961,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 280,
            "markdown": "# 2. Fissure for ligamentum venosum \n\n$=$ invagination of obliterated ductus venosus\n$=$ embryologic connection of left portal vein with left hepatic vein\n> separates caudate lobe from left lobe of liver\n> lesser omentum within fissure separates the greater sac anteriorly from lesser sac posteriorly\n3. Fissure for gallbladder (GB)\n$=$ shallow peritoneal invagination containing the GB\n> divides right from left lobe of liver\n\n## 4. Transverse fissure\n\n$=$ invagination of hepatic pedicle into liver\n> contains horizontal portion of left + right portal veins\n5. Accessory fissures\n(a) Right inferior accessory fissure $=$ from gallbladder fossa $/$ just inferior to it $\\rightarrow$ to lateroinferior margin of liver\n(b) Others (rare)\n![img-42.jpeg](img-42.jpeg)\n\n## Size of Liver\n\nA. YOUNG INFANT\nright hepatic lobe should not extend $>1 \\mathrm{~cm}$ below right costal margin\nB. CHILD\nright hepatic lobe should not extend below right costal margin\nC. ADULT\n(a) midclavicular line (vertical / craniocaudad axis):\n\n$$\n\\begin{aligned}\n& <13 \\mathrm{~cm} \\quad=\\text { normal } \\\\\n& 13.0-15.5 \\mathrm{~cm}=\\text { indeterminate (in } 25 \\%)\n\\end{aligned}\n$$",
            "images": [
                {
                    "id": "img-42.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 860,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1564,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 281,
            "markdown": "$$\n>15.5 \\mathrm{~cm} \\quad=\\text { hepatomegaly }(87 \\% \\text { accuracy })\n$$\n\n(b) preaortic line $<10 \\mathrm{~cm}$\n(c) prerenal line $<14 \\mathrm{~cm}$\n\n# Liver Capsule \n\n$=2$ adherent layers:\n(a) thick, fibrous inner layer $=$ Glisson capsule\n(b) outer serous layer derived from peritoneum excluding\n> bare area near diaphragm\n> porta hepatis\n> gallbladder attachment\n\n## Liver Echogenicity \\& Attenuation\n\nUS: pancreatic $>$ splenic $\\geq$ hepatic $>$ renal echogenicity\nCT: $\\quad 50-65 \\mathrm{HU}$ (precontrast)\nCECT: early arterial phase ( 20 sec ), late arterial phase ( $30-40 \\mathrm{sec}$ ), portal venous phase $(60-70 \\mathrm{sec})$; maximal enhancement at $45-60 \\mathrm{sec}$\n\n## Enzymatic Liver Tests\n\nA. Alkaline phosphatase (AP)\n\nFormation: bone, liver, intestine, placenta\nHigh increase:\ncholestasis with extrahepatic biliary obstruction (confirmed by rise in $\\gamma \\mathrm{GT}$ ), drugs, granulomatous disease (sarcoidosis), primary biliary cirrhosis, primary + secondary malignancy of liver\nMild increase: all forms of liver disease, heart failure\nB. Gamma-glutamyl transpeptidase ( $\\gamma \\mathrm{GT}$ )\nvery sensitive in almost all forms of liver disease\nUtility: confirms hepatic source of elevated AP, may indicate significant alcohol use\nC. Transaminases\n\nHigh increase: viral / toxin-induced acute hepatitis\n(a) aspartate aminotransferase (AST; formerly serum glutamic oxaloacetic transaminase [SGOT])\nFormation: liver, muscle, kidney, pancreas, RBCs\n(b) alanine aminotransferase (ALT; formerly serum glutamic pyruvic transaminase [SGPT])\nFormation: primarily in liver\n\n- rather specific elevation in liver disease\nD. Bilirubin\nhelps differentiate between various causes of jaundice\n(a) unconjugated / indirect bilirubin = insoluble in water\n\nFormation: breakdown of senescent RBCs\nMetabolism: tightly bound to albumin in vessels, actively taken up by liver, cannot be excreted by kidneys\n(b) conjugated / direct bilirubin = water-soluble",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 282,
            "markdown": "Formation: conjugation in liver cells\nMetabolism: excretion into bile; NOT reabsorbed by intestinal mucosa; excreted in feces\nElevation:\n> $\\uparrow$ production: hemolytic anemia, resorption of hematoma, multiple transfusions\n$>\\downarrow$ hepatic uptake: drugs, sepsis\n> $\\downarrow$ conjugation: Gilbert syndrome, neonatal jaundice, hepatitis, cirrhosis, sepsis\n$>\\downarrow$ excretion into bile: hepatitis, cirrhosis, drug-induced cholestasis, sepsis, extrahepatic biliary obstruction\nE. Lactic dehydrogenase (LDH)\nnonspecific and therefore not helpful\nhigh increase: primary or metastatic liver involvement\nF. Alpha-fetoprotein (AFP)\n$>400 \\mathrm{ng} / \\mathrm{mL}$ strongly suggests that a focal mass represents a hepatocellular carcinoma\n\n# PORTA HEPATIS \n\n$=$ LIVER HILUM\n$=$ deep short transverse fissure that passes across left posterior aspect of undersurface of right lobe of liver separating caudate lobe from quadrate lobe\nContents:\n(a) portal triad:\n\n1. Main portal vein (MPV)\n2. Proper hepatic artery: left anterior to MPV\n3. Common hepatic duct: right anterior to MPV\n(b) nerves: left vagal trunk + sympathetic hepatic plexus\n(c) lymphatics\n\nWithin the porta hepatis, the common bile duct and proper hepatic artery typically are located anterior to the portal vein, with the common bile duct to the right and the proper hepatic artery to the left.\nEnveloped by:\n(a) hepatoduodenal ligament\n(b) lesser omentum\n(c) loose areolar tissue\n(d) fibrous capsule of Glisson\n\n## GALLBLADDER\n\n## Size \\& Capacity \\& Wall Thickness\n\nPhysiologic distension: optimal after 8-12 hours of fasting\nGB function: concentration of bile through absorption of $90 \\%$ of water\nWall layers: (a) mucosa\n(b) lamina propria\n(c) muscularis propria\n(d) serosa",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 283,
            "markdown": "N.B.: The GB has no muscularis mucosa / submucosa\n\n# Length: \n\n(a) infant $<1$ year old: $1.5-3.0 \\mathrm{~cm}$\n(b) older child: $3-7 \\mathrm{~cm}$\n(c) adult: $7-10 \\mathrm{~cm}$\n\nWall thickness: $2-3 \\mathrm{~mm}$\nWidth: $2.0-3.5 \\mathrm{~cm}$\nCapacity: $30-50 \\mathrm{~mL}$\nBile volume: $250-1,000 \\mathrm{~mL} / \\mathrm{d}$ secreted by hepatocytes\n\n## Gallbladder Function\n\n$=$ evaluation of volume and ejection fraction following ingestion of a fatty meal / infusion of cholecystokinin\nMethods:\n\n1. HIDA scintigraphy\n2. MR cholangiography with mangafodipir trisodium $=\\mathrm{MnDPDP}=$ manganese (II) DPDP [ $\\mathrm{N}, \\mathrm{N}^{\\prime}$-dipyridoxylethylenediamine- $\\mathrm{N}, \\mathrm{N}^{\\prime}$-diacetate $5,5^{\\prime}$-bis(phosphate)]\nDose: $0.5 \\mathrm{~mL} / \\mathrm{kg}$ of MnDPDP up to $35-50 \\mathrm{~mL}$\n» slow IV injection for 1-2 minutes\n» followed by a $10-\\mathrm{mL}$ saline flush\n» scanned $15-30$ minutes after injection\n3. MR cholangiography with gadolinium BenzylOxyPropionicTetraAcetate (Gd-BOPTA) $=$ MultiHance ${ }^{\\circledR}$ )\nDose: $0.05 \\mathrm{mmol}(0.1 \\mathrm{~mL}) / \\mathrm{kg}$ up to 15 mL\n» IV injection with power injector at $2 \\mathrm{~mL} / \\mathrm{sec}$\n» followed by a $20-\\mathrm{mL}$ saline flush\n» T1WI at 30-60 minutes after injection to obtain gadolinium-enhanced MR cholangiopancreatograms\n\n## Gallbladder Ejection Fraction (GBEF)\n\n$\\mathrm{GBEF}=\\left[\\mathrm{GB}_{\\text {initial }}-\\mathrm{GB}_{\\text {post }}\\right] \\div \\mathrm{GB}_{\\text {initial }}$\nIndication:\n(1) $\\uparrow$ sensitivity of study for acute (acalculous) cholecystitis\n(2) in patients with abdominal pain and no cholelithiasis\n(3) to establish that gallstones are the primary cause of abdominal pain\n\nTechnique:\n\n1. Discontinue opioids for $>24$ hours\n2. Select ROI over GB\n3. Administer Sincalide 1 hour post HIDA in a dose of $0.02 \\mu \\mathrm{~g} / \\mathrm{kg}$ body weight IV over 30 minutes (with infusion pump)\n4. Image acquisition for 20 more minutes post infusion to detect paradoxical filling of gallbladder in sphincter of Oddi dysfunction\nNormal result: $>30 \\%$ GBEF\n\n## Low Gallbladder Ejection Fraction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 284,
            "markdown": "Cause: CCK-induced cystic duct spasm in chronic calculous / acalculous cholecystitis, gallbladder dyskinesia, opioid intake\nReproducibility: a low GBEF does not recover (if opioid intake is ruled out) and further deteriorates over time\nFrequency: $1 / 3$ of all cholecystectomies are performed for chronic acalculous cholecystitis\n$R x$ : cholecystectomy with pain relief in $89 \\%$\nDifferentiation of abdominal pain:\n(a) biliary pain $=$ low GBEF $\\pm$ gallstones\n\nPathophysiology of biliary pain:\nCCK-induced cystic duct spasm $\\rightarrow$ reduction in\nGBEF $\\rightarrow$ bile stasis $\\rightarrow$ stretching of GB wall against impedance to bile flow $\\rightarrow$ biliary pain\n(b) nonbiliary pain = normal GBEF + gallstones\n\nCause of nonbiliary pain (?):\nCCK-induced rapid bile transit $\\leftarrow$ increased peristalsis in small intestine + colon; others\n\n# Congenital Gallbladder Anomalies \n\n## Agenesis of Gallbladder\n\nPrevalence: $0.04-0.07 \\%$ (autopsy)\nAssociated with:\ncommon: rectovaginal fistula, imperforate anus, hypoplasia of scapula + radius, intracardiac shunt\nrare: absence of corpus callosum, microcephaly, atresia of external auditory canal, tricuspid atresia, tracheoesophageal fistula, dextroposition of pancreas + esophagus, absent spleen, high position of cecum, polycystic kidney\n\n## Hypoplastic Gallbladder\n\n(a) congenital\n(b) associated with cystic fibrosis\n\n## Septations of Gallbladder\n\nA. LONGITUDINAL SEPTA\n\n1. Bilobed gallbladder $=$ duplication of gallbladder\n$=$ two separate lumina + two cystic ducts\nPrevalence: $1 \\div 3,000$ to $1 \\div 12,000$\n2. Bifid gallbladder $=$ double gallbladder\n$=$ two separate lumina with one cystic duct\n3. Triple gallbladder (extremely rare)\nB. TRANSVERSE SEPTA OF GALLBLADDER\n4. Isolated transverse septum\n5. Phrygian cap ( $2-6 \\%$ of population)\n$=$ kinking / folding of fundus $\\pm$ septum\n6. Multiseptated gallbladder (rare)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 285,
            "markdown": "$=$ multiple cystlike compartments connected by small pores\n$C x:$ stasis + stone formation\nC. GALLBLADDER DIVERTICULUM\n$=$ persistence of cystohepatic duct\n\n# Gallbladder Ectopia \n\nmost frequent locations:\n(1) beneath the left lobe of the liver $>$\n(2) intrahepatic $>$\n(3) retrohepatic\nrare locations:\n![img-43.jpeg](img-43.jpeg)\n(4) within falciform ligament, (5) within interlobar fissure, (6) suprahepatic (lodged between superior surface of right hepatic lobe + anterior chest wall), (7) within anterior abdominal wall, (8) transverse mesocolon, (9) retrorenal, (10) near posterior spine + IVC, (11) intrathoracic GB ( $\\leftarrow$ inversion of liver)\nAssociated with: eventration of diaphragm\n\n## \"FLOATING GB\"\n\n$=$ gallbladder with loose peritoneal reflections, may herniate through foramen of Winslow into lesser sac\n\n## BILE DUCTS\n\n## Embryology of Bile Ducts\n\nDuctal plate: hepatocyte cells form double-layer sleeve around central portal vein at 4",
            "images": [
                {
                    "id": "img-43.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 651,
                    "bottom_right_x": 1322,
                    "bottom_right_y": 1408,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 286,
            "markdown": "weeks GA $\\rightarrow$ remodelling over next few weeks $\\rightarrow$ into several normally connected bile ducts adjacent to portal tracts from hilum to periphery\nGenetics: PKHD1 (polycystic kidney hepatic disease 1) gene codes for fibrocystin/polyductin protein that acts on primary cilia lining bile ducts\nPathology: mutation of PKHD1 gene $\\rightarrow$ abnormal cilia $\\rightarrow$ abnormal ductal plate formation $\\rightarrow$ dilated abnormally branching irregular channels increased in number; intervening connective tissue over time becomes fibrotic\n\n# Normal Size of Bile Ducts \n\n@ CBD at point of maximum diameter $=$ free edge of gastrohepatic ligament (point of least constraint):\n(a) adolescents \\& adults\n$\\leq 5 \\mathrm{~mm}=$ normal; $6-7 \\mathrm{~mm}=$ equivocal;\n$\\geq 8 \\mathrm{~mm}=$ dilated\n$\\diamond$ In patient $>60$ years of age add $1 \\mathrm{~mm} /$ decade $=$ presbyductectasia (eg, $60=6 \\mathrm{~mm}$, $70=7 \\mathrm{~mm})$\n$\\diamond$ Following cholecystectomy up to 8 mm\n(b) neonates: $<1 \\mathrm{~mm}$\n(c) infants up to 1 year of age: $<2 \\mathrm{~mm}$\n(d) older children: $<4 \\mathrm{~mm}$\n@ CHD at porta hepatis + CBD in head of pancreas: 5 mm\n@ right intrahepatic bile duct just proximal to CHD: $2-3 \\mathrm{~mm} /<40 \\%$ of diameter of\naccompanying portal vein\n\n- Right Hepatic Duct (RHD): $\\leftarrow$ segments V-VIII\n> Right Posterior Duct (RPD $\\leftarrow$ segments VI \\& VII\n> Right Anterior Duct (RAD) $\\leftarrow$ segments V \\& VIII\n- Left Hepatic Duct (LHD): $\\leftarrow$ segments II-IV\n@ Cystic duct\nValves of Heister = normal mucosal folds\nDiameter: 1.8 mm\nAverage length: $1-2 \\mathrm{~cm}$\n$\\sqrt{ }$ distal cystic duct posterior to CBD (in 95\\%), anterior to CBD (in 5\\%)\n\n\n## Bile Duct Anatomy (Couinaud Classification)\n\n[Claude Couinaud (1922-2008), French surgeon and anatomist]\n$=$ intrahepatic biliary system runs parallel to portal venous supply of liver\n(1) Right hepatic duct (RHD) drains segments V-VIII of right hepatic lobe with 2 major branches:\n(a) right posterior duct (RPD) drains posterior segments VI + VII\n$\\checkmark$ almost horizontal course\n(b) right anterior duct (RAD) drains anterior segments V + VIII\n$\\checkmark$ more vertical course\n(2) Left hepatic duct (LHD) drains segments II-IV of left hepatic lobe\n\n## Variants of Bile Duct Confluence",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 287,
            "markdown": "N.B.: important for donor of right hepatic lobe transplant\n$\\diamond$ RPD has the most frequent anomalous insertions!\n$\\diamond$ Bile duct from caudate lobe joins origin of LHD / RHD\nType A Normal R posterior duct drains into R hepatic duct, which joins L hepatic duct to form CHD $54-61 \\%$\nType B \"triple confluence\" = trifurcation of RAD + RPD + LHD 11-16\\%\nType C RAD / RPD joins CHD separately 15-23\\%\nType D RPD empties into L hepatic duct 13-19\\%\nType ? RAD / RPD joins LHD separately 4-8\\%\nType E absence of defined upper biliary confluence with all sectorial ducts joining separately $3-4 \\%$\nType F RPD may join neck of GB / may be entered by cystic duct $1 \\%$\n\n# Bile Duct Aberrations \n\nPrevalence: $2.4 \\%$ of autopsies; 13-18.5\\% of operative cholangiograms\nSignificance: aberrant ducts near cystic duct / gallbladder have the greatest risk of iatrogenic injury at cholecystectomy\n$C x$ : (1) postoperative bile leak if severed\n(2) segmental biliary obstruction if ligated\n\n## A. ABERRANT HEPATIC DUCT\n\n= direct drainage of RPD into the CHD (CBD, cystic duct, gallbladder): on right side (5\\%) / on left side (1\\%)\n) RHD joins extrahepatic bile duct at / near cystic duct insertion (4-5\\%)\n> cysticohepatic duct $(1-2 \\%)=$ anomalous RHD inserts into cystic duct\n) anomalous LHD: not susceptible to injury and therefore of no clinical significance\nB. CYSTIC DUCT ENTERING RHD\nC. DUCTS OF LUSCHKA\n![img-44.jpeg](img-44.jpeg)",
            "images": [
                {
                    "id": "img-44.jpeg",
                    "top_left_x": 357,
                    "top_left_y": 1320,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1927,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 288,
            "markdown": "![img-45.jpeg](img-45.jpeg)\n[Hubert von Luschka (1820-1875), extraordinary ordinarius and director of the anatomical institute in Tübingen, Germany]\n$=$ SUBVESICAL / ACCESSORY BILE DUCTS\n$=$ small ducts from liver bed draining directly into GB\nIncidence: $2 \\%$\nOrigin: right hepatic lobe; R/ L ductal system\nCourse: along gallbladder fossa\nDrain: variably into gallbladder, intra- / extrahepatic bile ducts\nSignificance: may be injured during surgical dissection / cauterization $\\rightarrow$ bile leak\nD. DUPLICATION OF CYSTIC DUCT / CBD\n$\\pm$ duplication of gallbladder\nE. CONGENITAL TRACHEOBILIARY FISTULA\n$=$ fistulous communication between carina and LHD\n\n- infants with respiratory distress\n- productive cough with bilious sputum\n$\\sqrt{ }$ pneumobilia\n\n\n# Variants of Cystic Duct Insertion \n\nN.B.: important prior to laparoscopic cholecystectomy\n\nPrevalence: variations occur in $18-23 \\%$\n(a) craniocaudad insertion into extrahepatic bile duct\n> proximal $1 / 3=$ common hepatic duct high in porta hepatis\n> middle $1 / 3$ of extrahepatic bile duct $75 \\%$\n> distal $1 / 3$ of extrahepatic bile duct $10 \\%$\n$\\sqrt{ }$ cystic duct parallels extrahepatic bile duct (implies common fibrous sheath)",
            "images": [
                {
                    "id": "img-45.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 187,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 855,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 289,
            "markdown": "![img-46.jpeg](img-46.jpeg)\n$C x:$ during cholecystectomy\n(1) common hepatic duct stricture\n(2) inadvertent ligation / transection of extrahepatic bile duct\n(3) long cystic duct remnant\n(b) mediolateral insertion into common hepatic duct\n> left (medial) $10-17 \\%$\n> right lateral\n> anterior / posterior spiral\n> parallel course for $>2 \\mathrm{~cm} 1.5-25 \\%$\n» low lateral (with common sheath)\n» low medial (at / near ampulla of Vater)\n(c) insertion into intrahepatic bile duct\n> right hepatic duct $(0.3 \\%)$\n> left hepatic duct (rare)\n(d) absence of cystic duct\n$\\checkmark$ gallbladder drains directly into common bile duct\n\n# Hepatobiliary Triangle \n\n$=$ TRIANGLE OF CALOT\n$=$ anatomic space bordered by CHD medially, cystic duct inferiorly, and cystic artery superiorly\n\n## PANCREAS\n\n## Pancreatic Anatomy\n\nLocation: anterior pararenal space of retroperitoneum; crossing anterior to aorta, IVC, left kidney, renal veins, right renal artery\n\n## Parts:\n\n1. Head: within curvature (C-loop) of duodenum, to right of SMV\n\nRelationship to CBD: partially covered by pancreas posteriorly (53\\%), totally covered $(30 \\%)$, not at all covered $(17 \\%)$\nPosterior surface: separated from IVC by retroperitoneal fat",
            "images": [
                {
                    "id": "img-46.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 187,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 587,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 290,
            "markdown": "![img-47.jpeg](img-47.jpeg)\n\n# Age-dependent Pancreatic Diameters \n\n(on TRV image)\n$\\mathrm{H}=$ head $=10-22 \\mathrm{~mm} ; \\quad 24 \\pm 3.6 \\mathrm{~mm}$ (in $6^{\\text {th }}$ decade)\n$\\mathrm{B}=$ body $=4-10 \\mathrm{~mm} ; \\quad 16 \\pm 2.0 \\mathrm{~mm}$ (in $6^{\\text {th }}$ decade)\n$\\mathrm{T}=$ tail $=8-22 \\mathrm{~mm} ; \\quad 15 \\pm 1.9 \\mathrm{~mm}$ (in $6^{\\text {th }}$ decade)\n\n## Connection:\n\n> to liver + lesser gastric curvature via hepatoduodenal + gastrohepatic ligaments (= derivative of ventral mesogastrium)\n> to splenic hilum + greater gastric curvature via splenorenal + gastrosplenic ligaments ( $=$ derivative of dorsal mesogastrium)\n2. Uncinate process: triangular leftward prolongation of caudal part of head with straight / concave anteromedial border curving behind SMA and SMV; variably drained by dorsal and ventral ducts\n3. Neck: constricted portion of pancreas that lies anterior to SMA + SMV = beginning of portal vein\n4. Body: behind lesser sac + stomach\n5. Tail: begins about $1 / 2$ of distance between neck + tip of tail (located in splenorenal ligament)\nWeight: $90-100 \\mathrm{~g}$\nLength: $15-20 \\mathrm{~cm}$\nWidth: $1.0-1.5 \\mathrm{~cm}$\nSize: gradual decrease with age; pancreatic head \\& neck make up $60-70 \\%$ of the pancreatic parenchyma\nBlood supply: branches from celiac trunk and SMA\n\n## Physiology of Pancreas\n\nPancreatic islet cells = endocrine cells clustered in islets of Langerhans; 1-2\\% of total mass of pancreas receiving $10-15 \\%$ of pancreatic blood flow; innervated by parasympathetic + sympathetic neurons modulating secretion of insulin + glucagon\nFunction: secretion of\n> insulin production in $\\beta$-cells (B cells); most abundant in center of islet\n> glucagon in $\\alpha$-cells (A cells)\n> somatostatin in $\\delta$-cells (D cells)\n> VIP in $\\delta 1$-cells (D1 cells)\n> serotonin in enterochromaffin cells\n> pancreatic polypeptide in PP cells $\\rightarrow$ stimulate secretion of gastric and intestinal",
            "images": [
                {
                    "id": "img-47.jpeg",
                    "top_left_x": 498,
                    "top_left_y": 191,
                    "bottom_right_x": 1285,
                    "bottom_right_y": 508,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 291,
            "markdown": "enzymes + inhibit intestinal motility) in islets + scattered throughout exocrine pancreas\n\n# Pancreatic Development \n\nduring the $4^{\\text {th }}-5^{\\text {th }}$ week of gestation 2 endodermal diverticula form in the foregut near its junction with the yolk sac ( $=$ endodermal lining of duodenum)\nA. DORSAL ANLAGE ( $=$ single dorsal bud)\n\nOrigin: derives from dorsal wall of duodenum in dorsal mesoduodenum (mesogastrium) and is later displaced to the left\n> forms cranial portion of head + isthmus + body + tail of pancreas\n\n- prone to atrophy (poor in polypeptides)\n$\\sqrt{ }$ drains to minor papilla through accessory duct of Santorini\n![img-48.jpeg](img-48.jpeg)\nB. VENTRAL ANLAGE ( $=2$ ventral buds)\n\nOrigin: arises from ventral wall of duodenum $\\leftarrow$ hepatic diverticulum (below primordial liver bud)\n(a) left ventral bud regresses completely\n(b) right ventral bud rotates $180^{\\circ}$ clockwise posteriorly (viewed from top) and inferiorly (simultaneously with rotation of foregut); comes to lie to left and caudad of duodenum where it fuses with dorsal bud at $7^{\\text {th }}$ week EGA\n> forms caudal portion of pancreatic head + pancreatic neck + uncinate process + CBD\n\n- not prone to atrophy (rich in polypeptides)\n$\\sqrt{ }$ ventral duct drains with CBD through ampulla of Vater + becomes the major drainage pathway for the entire pancreas after fusion with dorsal duct\n\n\n## Peritoneal Investment of Pancreas\n\n$\\diamond$ NO distinct capsule\n$\\sqrt{ }$ appearance of fat clefts between glandular tissues at $\\mathrm{CT} \\rightarrow$ surround areolar tissue + dip into pancreas\n> during foregut rotation dorsal mesoduodenum + dorsal mesogastrium fuse with parietal layer of peritoneum\n$\\rightarrow$ forms posterior wall of lesser sac\n> dorsal mesogastrium pouches out\n$\\rightarrow$ forms omentum\n> posterior leaf of mesogastric outpouching fuses with mesentery of midgut",
            "images": [
                {
                    "id": "img-48.jpeg",
                    "top_left_x": 188,
                    "top_left_y": 653,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1084,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 292,
            "markdown": "$\\rightarrow$ forms transverse mesocolon over pancreas\n> most distal portion of pancreatic tail remains within dorsal mesogastrium $\\rightarrow$ splenorenal ligament carrying splenic artery and vein\n![img-49.jpeg](img-49.jpeg)\n\n# Main Pancreatic Duct of Wirsüng \n\nmnemonic: \"upside down M(ain) reads W(irsüng)\"\n[Johann Wirsüng (1589-1643), German physician in Padua, Italy]\n$=$ term broadly used for duct traversing the entire length of pancreas ( $=$ combination of MPD + duct of Wirsüng)\n$=$ in restricted sense portion of ventral duct between dorsal-ventral fusion point and major papilla\n> distal portion of dorsal duct connects with ventral duct\n> proximal portion of dorsal duct may disappear\nOrigin: dorsal anlage (duct) $\\rightarrow$ drains tail, body, and anterior portion of pancreatic head\nWidth: 3.5 mm in head, 2.5 mm in body, 1.5 mm in tail (gradual tapering)\nLength: $9.5-25 \\mathrm{~cm}$\n$\\sqrt{ }$ receives $20-35$ tributaries / side branches that enter at right angles\n$\\sqrt{ }$ usually drains through major papilla\n$\\sqrt{ }$ unites with CBD within sphincteric segment (sphincter of Oddi) in $80-90 \\%$\n$\\sqrt{ }$ focal saccular dilatation of terminal part of (ventral) MPD = wirsüngocele (incidental finding)\n$\\diamond$ Major drainage route for $91 \\%$ of individuals",
            "images": [
                {
                    "id": "img-49.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 343,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1097,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 293,
            "markdown": "![img-50.jpeg](img-50.jpeg)\n\n# Accessory Pancreatic Duct of Santorini \n\n[Giovanni Santorini (1681-1737), anatomist in Venice, Italy]\n$=$ proximal segment of dorsal duct distal to dorsal-ventral fusion point, which has not atrophied\n$\\diamond$ Present in $44 \\%$ of individuals\n$\\sqrt{ }$ drains anterosuperior portion of head into minor papilla\n\n## Downstream Variants of Pancreatic Ducts\n\n$\\sqrt{ }$ physiologic narrowing of duct caliber at \"knee\" of MPD = site of fusion of dorsal and ventral ducts\n(1) Bifid duct system $60 \\%$\n(2) Rudimentary duct of Santorini $30 \\%$\n$\\sqrt{ }$ branch of MPD after loss of communication with minor papilla\n(3) Dominant duct of Santorini $1 \\%$\n(4) Ansa pancreatica rare\n$\\sqrt{ }$ duct of Santorini forms sigmoid curve as it courses toward duct of Wirsüng\n(5) Duplication anomaly of MPD common",
            "images": [
                {
                    "id": "img-50.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 187,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1295,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 294,
            "markdown": "(6) Duplication anomaly of dorsal anlage / ventral anlage (rare)\n\n# Ampulla of Vater \n\n$=$ slightly dilated conduit that results from the union of common bile duct + duct of\nWirsüng\n$\\diamond$ Actual dilatation of common channel is unusual\nLocation: major duodenal papilla in medial wall of $2^{\\text {nd }} / 3^{\\text {rd }}$ portion of duodenum below surface of papilla of Vater\n(a) common channel $(74 \\%)$ :\n» 2-10 (mean 5) mm short common channel (55-85\\%) with a diameter of 3-5 mm\n$\\checkmark$ V-type configuration\n» $8-15 \\mathrm{~mm}$ long common channel\n$\\checkmark$ Y-type configuration\n(b) separate openings ( $19 \\%$ )\n» 1 orifice in papilla with 2 separate openings for each duct (= double-barrel configuration in $19-38 \\%$ )\n(c) interposed septum ( $7 \\%$ )\n» 2 orifices in papilla draining each duct separately\n\n## SPHINCTER OF ODDI\n\n[Ruggero Oddi (1864-1913), physiologist in Genoa, Italy]\n$=$ SPHINCTER OF HEPATICOPANCREATIC AMPULLA\n$=3$ separate smooth muscles interspersed with glandular tissue encircling ampulla of Vater\n(a) choledochal sphincter (Boyden) = encircles distal CBD\n(b) pancreatic duct sphincter (in $33 \\%$ separate)\n(c) ampullary sphincter\n\nLength: $10-15 \\mathrm{~mm}$\nFunction: regulates flow of bile + pancreatic juices into duodenum\n\n## Major Duodenal Papilla\n\n$=$ PAPILLAOF VATER\n$=$ conic / cylindric protuberance at medial aspect of duodenum\nLocation: middle $1 / 3$ of descending duodenum ( $75 \\%$ ), horizontal portion of duodenum $(25 \\%)$\n$\\diamond$ Drainage of common bile duct in $100 \\%$\n$\\diamond$ Drainage of main pancreatic duct of Wirsüng in $90 \\%$\n$\\checkmark$ oval protruding structure $<5-10 \\mathrm{~mm}$ in diameter (seen on thin-section CT in 20\\%)\n$\\checkmark \\pm$ targetlike enhancement similar to that of adjacent duodenal mucosa\n\n## Minor Duodenal Papilla (present in 60\\%)\n\nLocation: 2 cm anterosuperior from major duodenal papilla\n$\\diamond$ Drainage of accessory pancreatic duct of Santorini\n$\\diamond$ Drainage of main pancreatic duct in $10 \\%$\n\n## Pancreaticobiliary Junction Variants",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 295,
            "markdown": "A. Angle between $\\mathrm{CBD}+$ pancreatic duct:\n(a) usually acute at $5^{\\circ}-30^{\\circ}$\n(b) occasionally abnormal at up to $90^{\\circ}$\nB. Anomalous pancreaticobiliary junction\n![img-51.jpeg](img-51.jpeg)\n![img-52.jpeg](img-52.jpeg)\n$=$ anomalous high junction outside duodenal wall beyond influence of sphincter of Boyden $(1.5-3.2 \\%)$\n(a) pancreatic duct inserting into $\\mathrm{CBD}>15 \\mathrm{~mm}$ from entrance into duodenum\n> pancreaticobiliary reflux $\\rightarrow$ choledochal web / cyst $\\rightarrow$ gallbladder carcinoma\n> biliopancreatic reflux $\\rightarrow$ pancreatitis\n(b) CBD inserting into pancreatic duct\n\n# Relationship of CBD to Pancreatic Head",
            "images": [
                {
                    "id": "img-51.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 380,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1062,
                    "image_base64": null
                },
                {
                    "id": "img-52.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 1078,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1663,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 296,
            "markdown": "1. CBD covered posteriorly by pancreatic tissue:\n(a) partially covered $51.5 \\%$\n(b) totally covered $30.0 \\%$\n(c) not covered at all $16.5 \\%$\n2. CBD courses lateral to pancreatic head (occasionally)\n\n# SPLEEN \n\n## Size of Spleen\n\nin adults: 12 cm length, $7-8 \\mathrm{~cm}$ anteroposterior diameter, $3-4 \\mathrm{~cm}$ thick; normal upper limit for splenic length correlates with height of individual (for men: $183 \\mathrm{~cm}=14.0$ $\\mathrm{cm}, 193 \\mathrm{~cm}=14.8 \\mathrm{~cm}, 203 \\mathrm{~cm}=15.0 \\mathrm{~cm}, 213 \\mathrm{~cm}=16.3 \\mathrm{~cm}$\nfor women; $173 \\mathrm{~cm}=12.6 \\mathrm{~cm}, 183 \\mathrm{~cm}=13.2 \\mathrm{~cm} ; 188 \\mathrm{~cm}=13.4 \\mathrm{~cm}, 198 \\mathrm{~cm}=$ 14.0 cm )\nin children: logarithmic increase in length with increasing age; formula for length $=5.7+$ 0.31 x age (in years) cm\nin infants ( $0-3$ months of age): $<6.0 \\mathrm{~cm}$ in length\nSonographic index: $0.524 \\times \\mathrm{W} \\times \\mathrm{T} \\times(\\mathrm{ML}+\\mathrm{CCL}) / 2$ normal range: $107-314 / 480 \\mathrm{~cm}^{3}$\n![img-53.jpeg](img-53.jpeg)\n\nW\n$=$ width defined as greatest overall dimension from anterior to posterior on TRV image analog to CT\nT $\\quad=$ thickness as shortest distance between hilum and outer convex margin on same TRV image analog to CT",
            "images": [
                {
                    "id": "img-53.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 943,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1779,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 297,
            "markdown": "ML $\\quad=$ maximum length from most medial to most lateral margin on LON/COR image\nCCL $\\quad=$ craniocaudal length from superior to inferior margin on same LON/COR image\n\n# Weight of Spleen \n\nat birth: 15 g\nin adults: 150 (range, 100-265) g\nEstimated weight $=$ splenic index $=\\mathrm{L} \\times \\mathrm{W} \\times \\mathrm{T} \\times 0.55$\n\n## Embryology of Spleen\n\nspleen arises from mesenchymal cells between layers of dorsal mesogastrium during $5^{\\text {th }}$ week GA\n> splenic primordium differentiates $\\rightarrow$ forms capsule, connective tissue framework, splenic parenchyma\n> major site of hematopoiesis until 28 weeks GA; retains capacity for extramedullary hematopoiesis well into adult life\n$\\sqrt{ }$ spleen recognizable by $12^{\\text {th }}$ week GA $\\leftarrow$ as fusion of mesenchymal aggregates occurs\n$\\sqrt{ }$ splenic clefts / notches / lobules may persist\n$\\sqrt{ }$ accessory spleen (in up to $30 \\%$ by autopsy)\n\n## Histology of Spleen\n\n(a) RED PULP = numerous vascular sinuses\n(b) WHITE PULP = lymphoid follicles + cells of RES\n\nDevelopment: ratio of white to red pulp increases with age + progressive antigenic stimulation\n\n## Imaging Characteristics of Spleen\n\nA. CT ATTENUATION\n(a) without enhancement:\n$40-60 \\mathrm{HU}(=5-10 \\mathrm{HU}$ less than liver $)$\n(b) with enhancement: normal heterogeneous enhancement during first minute after bolus injection $\\leftarrow$ different blood flow rates through the cords of the red + white pulp\n$\\sqrt{ }$ arciform (alternating bands of high + low attenuation) / focal / diffuse heterogeneity\n$\\sqrt{ }$ heterogeneity resolved in portal venous phase\nB. MR SIGNAL INTENSITY directly related to ratio of white to red pulp\n(a) neonate $<8$ months of age:\n$\\sqrt{ }$ T1WI- and T2WI-intensity: spleen $<$ liver $\\leftarrow$ predominance of red pulp\n$D D x$ : hemochromatosis\n(b) adult + older child:\n$\\sqrt{ }$ T2WI-intensity: spleen $>$ liver\n$\\sqrt{ }$ T1WI-intensity: liver $>$ spleen $>$ muscle\n\n## IRON METABOLISM\n\nTotal body iron: 5 g",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 298,
            "markdown": "(a) functional iron: 4 g\n\nLocation: hemoglobin of RBCs, myoglobin of muscle, various enzymes (cytochromes)\n(b) stored iron: 1 g\n\nLocation: hepatocytes, reticuloendothelial cells of liver (Kupffer cells) + spleen + bone marrow\nAbsorption: $1-2 \\mathrm{mg} / \\mathrm{d}$ via gut mucosa ( $10 \\%$ of total amount ingested)\nRecycling: through reuse of iron from senescent erythrocytes\nLoss: $1-2 \\mathrm{mg} / \\mathrm{d}$ via epithelial desquamation, menstruation, other forms of blood loss\nExcretion: none\nTransport: bound to transferrin intravascularly\nDeposition: stored as ferritin\n(a) transferrin-transfer to:\nhepatocytes, RBC precursors in erythron, parenchymal tissues (eg, muscle)\n(b) phagocytosis by:\nreticuloendothelial cells phagocytize senescent erythrocytes (= extravascular hemolysis);\nRBC iron stored as ferritin / released and bound to transferrin\n$\\diamond$ RES cells are incapable of storing excess iron!\nExcess iron: leads to toxicity because it can catalyze the conversion of unstable hydrogen peroxide $\\left(\\mathrm{H}_{2} \\mathrm{O}_{2}\\right)$ into free radicals hydroxyl $(\\mathrm{HO}-)$ and superoxide $\\mathrm{O}_{2}-$ ) that cause damage to cell membranes, proteins, and DNA\nMedullary erythropoiesis: requires about $20 \\mathrm{mg} / \\mathrm{d}$ of iron",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 299,
            "markdown": "# DISORDERS OF LIVER, BILIARY TRACT, PANCREAS AND SPLEEN \n\n## ACCESSORY SPLEEN\n\n$=$ failure of coalescence of several small mesodermal buds in the dorsal mesogastrium that comprise the spleen\nPrevalence: $10-30 \\%$ of population; multiple (up to 6) in $10 \\%$\n\n- Undergoes hypertrophy after splenectomy and is responsible for recurrence of hematologic disorders (idiopathic thrombocytopenic purpura, hereditary spherocytosis, acquired autoimmune hemolytic anemia, hypersplenism)\n\n\n## Location:\n\n(a) near splenic hilum along the course of splenic vessels (most common)\n(b) within layers of omentum (gastrosplenic ligament, other suspensory ligaments of spleen)\n(c) anywhere in abdomen (eg, intrapancreatic, pelvis)\n(d) attached to left ovary / testis $=$ splenogonadal fusion $\\leftarrow$ close relationship between developing spleen + mesonephros + left gonadal anlage)\nNUC ( ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-sulfur colloid scan / spleen-specific ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-denatured RBCs):\n$\\sqrt{ }$ usually $<1 \\mathrm{~cm}$ in diameter\n$\\sqrt{ }<10 \\%$ identified when normal spleen present\n$C x$ : disease recurrence $\\leftarrow$ hypertrophy of accessory spleen after splenectomy for hypersplenism\n\n## AMPULLARY TUMOR\n\n$=$ benign / malignant tumors arising from glandular epithelium of ampulla of Vater\nHisto: (a) dysplastic epithelium in glandular / villous structures of tubular / villous adenoma\n(b) carcinoma in situ\n(c) invasive carcinoma often with desmoplastic reaction\n\nAge: $6^{\\text {th }}-7^{\\text {th }}$ decade; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 1$\nPath: average diameter of $<3 \\mathrm{~cm}$\n\n- malaise, epigastric pain, weight loss\n- intestinal bleeding (tumor ulceration)\n- intermittent painless jaundice (ductal obstruction), pruritus\n- gray \"aluminum / silver-colored\" stools (3\\%)\n- chills, fever, RUQ pain (ascending cholangitis) in up to $20 \\%$\n- endoscopy: tumor extending through orifice ( $63 \\%$ ), prominent papilla / submucosal mass $(25 \\%)$, not visualized $(9 \\%)$\n$\\sqrt{ }$ tumor often inapparent $\\leftarrow$ small size (more readily visualized with well-distended duodenum) UGI:\n$\\sqrt{ }$ indentation of duodenal lumen at papilla of Vater with filling defect $>1.5 \\mathrm{~cm}$\n$\\sqrt{ }$ surface irregularity + deep barium-filled crevices in villous tumor\nBiliary imaging:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 300,
            "markdown": "$\\sqrt{ }$ dilatation of most distal segment of common bile duct\n$\\sqrt{ }$ stenosis $\\leftarrow$ circumferential tumor growth around ampulla / desmoplastic reaction\n$\\sqrt{ }$ irregular predominantly polypoid filling defect\n$\\sqrt{ } \\pm$ pancreatic dilatation = \"double-duct\" sign (may be absent if tumor small / accessory pancreatic duct decompresses pancreatic system / main pancreatic duct drains into minor papilla)\n$D D x$ :\n\n1. Periampullary duodenal adenoma / adenocarcinoma (usually larger lesion with significant intraduodenal extension)\n2. Choledochocele (cystic lesion filling with biliary contrast)\n3. Brunner gland tumor, pancreatic rest (\"myoepithelial hamartoma\"), leiomyoma, carcinoid (often production of somatostatin)\n4. Duodenitis, pancreatitis\n5. Stone impaction in ampulla\n\n# Ampullary Cancer \n\n$=$ AMPULLARY ADENOCARCINOMA\n$=$ rare malignancy arising in ampullary complex distal to confluence of the pancreatic duct and CBD\nIncidence: $0.70 \\div 100,000$ men, $0.45 \\div 100,000$ women\nTNM staging:\nT1 : tumor confined to ampulla\nT2 : tumor extending into duodenal wall\nT3 : invasion of pancreas $<2 \\mathrm{~cm}$ deep\nT4 : invasion of pancreas $>2 \\mathrm{~cm}$ deep\nInternational Union Against Cancer Staging:\nI $\\quad=$ tumor confined to ampulla\nII $\\quad=$ tumor extension into duodenal wall / pancreas\nIII $\\quad=$ regional lymph node involvement (Lnn stations around head + body of pancreas, anterior + posterior pancreaticoduodenal, pyloric, common bile duct, proximal mesenteric nodes)\nIV $\\quad=$ invasion of pancreas $>2 \\mathrm{~cm}$ deep\n\n- obstructive symptoms early in disease process\n\nCT:\n$\\sqrt{ }$ discrete nodular mass with irregular filling defect at distal margin of pancreaticobiliary junction $(62 \\%)$ :\n$\\sqrt{ }$ lobulated / infiltrating borders\n$\\sqrt{ }$ hypoattenuating mass of $\\sim 40 \\mathrm{HU}$\n$\\sqrt{ }$ enhancement on arterial + portal venous phase\nMR:\n$\\sqrt{ }$ small nodular mass:\n$\\sqrt{ }$ isointense relative to adjacent duodenal wall on T1WI\n$\\sqrt{ }$ variable signal intensity on T2WI",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 301,
            "markdown": "$\\checkmark$ hypointense relative to surrounding duodenum at arterial phase imaging\n$\\checkmark$ delayed contrast enhancement\n$\\checkmark$ irregular ductal wall thickening\n$\\checkmark$ bulging of duodenal papilla\n$\\checkmark$ intraductal polypoid mass\n$\\checkmark$ improved detection of ampullary carcinoma with DWI\nMRCP:\n$\\checkmark$ filling defect / focal stricture at distal end of dilated CBD\n$\\checkmark$ \"double-duct\" sign = dilatation of biliary + pancreatic ducts (in 52\\%):\n$\\checkmark$ marked abrupt dilatation of distal CBD / pancreatic duct\n$\\checkmark$ NO signs of pancreatitis / pancreatic mass / stone\n$\\checkmark$ NO \"double-duct\" sign if separate duodenal openings for biliary and pancreatic ducts\nEndoscopic US (most sensitive technique):\n$87 \\%$ staging accuracy\n$D x$ : papillotomy + deep biopsy (for duct dilatation WITHOUT visible mass)\n$R x$ : Whipple procedure (= pancreaticoduodenectomy)\nPrognosis: $28-70 \\%$ 5-year survival for ampullary carcinomas (depending on stage)\n\n# Ampullary Adenoma \n\n$=$ uncommon premalignant lesion\nPrevalence: $0.04-0.12 \\%$ (at autopsy)\nAssociated with: familial adenomatous polyposis syndromes (eg, familial polyposis coli, Gardner syndrome) [100-200-fold risk], colon ca.\n$\\checkmark$ soft-tissue mass $>1 \\mathrm{~cm}$ with irregular margin of ampulla\n$\\checkmark$ extrahepatic biliary duct + pancreatic duct dilatation\n$C x$ : malignant transformation into adenocarcinoma\n\n## ANGIOSTRONGYLOSIS\n\n$=$ infection by nematode Angiostrongylus costaricensis\nCountries: Central America, South America (sporadic cases)\nInfection: ingestion of contaminated food\nCycle: parasite transmitted from snail to rat; ingestion of contaminated food by humans (= incidental host) $\\rightarrow$ migration through lymphatic system $\\rightarrow$ mesenteric veins + portal vein $\\rightarrow$ liver\nHisto: tissue eosinophilia, edema of intestinal wall, granulomas with eggs, larvae within blood vessels\n\n- abdominal pain, anorexia, eosinophilia, fever\n\nLocation: terminal ileum, appendix, cecum\nThe adult worm resides inside mesenteric artery branches evoking an inflammatory response. Tissue samples show marked eosinophilic vasculitis.\n$\\checkmark$ nonspecific imaging findings:\n$\\checkmark$ bowel wall edema, occasionally, perforation\n$D x$ : histopathologic findings",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 302,
            "markdown": "# ANNULAR PANCREAS \n\n$=$ rare; $2^{\\text {nd }}$ most common congenital anomaly\nCause: failed / incomplete rotation of portion of ventral anlage $\\rightarrow$ part of ventral pancreas passes posterior to descending duodenum $\\rightarrow$ partial / complete encirclement of $2^{\\text {nd }}$ part of duodenum\nTheory: (1) Adhesion of right anlage to duodenal wall (Lecco)\n(2) Persistence of left ventral anlage (Baldwin)\n(3) Tip of left ventral anlage adheres to duodenum\n\nTypes: (a) extramural = ventral pancreatic duct encircles duodenum and joins MPD\n(b) intramural = pancreatic tissue intermingled with muscle fibers inside duodenal wall; small ducts drain directly into duodenum\nPrevalence: $5-15 \\div 100,000$ (autoptic); $1 \\div 250$ (ERCP)\nAge at discovery: during childhood $(52 \\%)+4^{\\text {th }}-5^{\\text {th }}$ decade of adulthood $(48 \\%)=$ bimodal distribution\nAssociated with: other congenital anomalies (in 75\\%) like esophageal atresia, tracheoesophageal fistula, duodenal atresia / stenosis, duodenal diaphragm, imperforate anus, malrotation, Down syndrome (in child); pancreas divisum + bile duct carcinoma (in adult)\nLocation: $2^{\\text {nd }}$ portion of duodenum ( $85 \\%$ );\n$1^{\\text {st }} / 3^{\\text {rd }}$ portion of duodenum $(15 \\%)$\n\n- mostly asymptomatic with incidental discovery\n- neonate : persistent vomiting $\\leftarrow$ \"gastric outlet\" obstruction (in 10\\%)\n- adult : nausea, vomiting ( $60 \\%$ ), abdominal pain ( $70 \\%$ ), jaundice ( $50 \\%$ ), hematemesis ( $10 \\%$ ); symptoms of peptic ulcer disease ( $25 \\%$ ) / acute pancreatitis ( $13 \\%$ )\n$\\sqrt{ }$ \"double bubble\" = dilated duodenal bulb (= smaller distal bubble) + distended stomach (= larger proximal bubble)\n$\\checkmark$ proximal duodenal dilatation\nOB-US: $\\sqrt{\\text { polyhydramnios }}$\n![img-54.jpeg](img-54.jpeg)\n\nUGI:\n$\\checkmark$ eccentric narrowing with lateral notching + medial retraction of $2^{\\text {nd }}$ part of duodenum\n$\\checkmark$ concentric ringlike narrowing of mid-descending duodenum between major and minor papilla",
            "images": [
                {
                    "id": "img-54.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 1379,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1788,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 303,
            "markdown": "$\\sqrt{ }$ reverse peristalsis, pyloric incompetency\nCT:\n$\\sqrt{ }$ enlargement of pancreatic head\n$\\sqrt{ }$ pancreatic tissue encircling descending duodenum\nERCP (most specific) / MR pancreatography (MRCP):\n$\\sqrt{ }$ normally located main duct in pancreatic body + tail\n$\\sqrt{ }$ small aberrant duct encircles duodenum ( $=$ originates anterior to + passes posterior to duodenum) communicating with:\n> main duct of Wirsüng (in 85\\%)\n> accessory duct of Santorini\n> intrapancreatic common bile duct\n$C x$ : in adults increased incidence of\n(1) Periampullary peptic ulcers\n(2) Pancreatitis ( $15-20 \\%$ ): usually confined to pancreatic head and annulus\n(3) Duodenal obstruction ( $10 \\%$ )\n\nRx: gastrojejunostomy / duodenojejunostomy\n\n# AGENESIS OF DORSAL PANCREAS \n\nVariation: complete (extremely rare) / partial\nMay be associated with: heterotaxia (abnormal situs, polysplenia), intestinal malrotation\n\n- nonspecific abdominal pain $\\leftarrow$ ? pancreatitis\n- diabetes (in many)\n$\\sqrt{ }$ short round pancreatic head adjacent to duodenum\n$\\sqrt{ }$ absence of pancreatic neck, body, tail, duct of Santorini, minor duodenal papilla\n$D D x$ : pancreatic carcinoma with upstream pancreatic atrophy\n\n\n## ASCARIASIS\n\nOrganism: nematode (roundworm) Ascaris lumbricoides, $15-50 \\mathrm{~cm}$ long $+3-6 \\mathrm{~mm}$ thick adult worm; life span of 1 year\n$\\diamond 3^{\\text {rd }}$ most common helminthic infection (after hookworm + trichuriasis)\nEndemic: in tropical + subtropical areas\n(a) in parts of Africa (along Gulf Coast, Nigeria), Southeast Asia, China, South America: $90 \\%$\n(b) in USA: $12 \\%$ in blacks, $1 \\%$ in whites; endemic in Appalachian range + Ozark Mountains\nPrevalence: most common cosmopolitan parasitic infection ( $25 \\%$ of world population infected); 1 billion humans harbor the roundworm [ cosmos, Greek = world; polites, Greek = citizen]\nInfection: fecal-oral route\nCycle:\ncontaminated water / soil / vegetable $\\rightarrow$ ingestion of eggs; eggs hatch (= release larvae) in duodenum $\\rightarrow$ larvae penetrate intestinal wall + migrate into mesenteric lymphatics and venules; $\\rightarrow$ carried to lungs via right heart + pulmonary artery; $\\rightarrow$ mature in pulmonary capillary bed to $2-3 \\mathrm{~mm}$ length $\\rightarrow$ burrow into alveoli $\\rightarrow$ ascend in bronchial tree; through",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 304,
            "markdown": "swallowing again reach small intestine $\\rightarrow$ mature in jejunum into adult worms within 2.5 months (worms may migrate and settle in biliary + pancreatic ducts) $\\rightarrow$ production of 200,000 eggs daily leave body by fecal route\nAge: children $1-10$ years of age\n\n- pulmonary + intestinal symptoms:\n- fever, cough, expectoration (hematemesis / pneumonitis)\n- appendicitis\n- biliary symptoms:\n- jaundice (if bile ducts infested); abnormal liver function tests\n- biliary colic $\\leftarrow$ Ascaris secretions induce spasm of sphincter of Oddi\n- eosinophilia:\n- hypereosinophilia only present during acute stage of larval migration; Löffler syndrome = pulmonary eosinophilia\nPancreatic / biliary manifestations occur when the adult worm migrates from small bowel into the main pancreatic duct / biliary tree. Related complications are biliary colic, gallstone formation, cholecystitis, liver abscess, and pancreatitis.\nLocation: jejunum > ileum ( $99 \\%$ ), duodenum, stomach, CBD, pancreatic duct\nBarium study:\n$\\checkmark 15-35 \\mathrm{~cm}$ long elongated tubular filling defects\n$\\checkmark$ whirled appearance, occasionally in coiled clusters (\"bolus of worms\")\n$\\checkmark \\pm$ barium-opacification of enteric canal within nematode\nCT:\n$\\checkmark$ worms are hyperattenuating relative to bile\nMR:\n$\\checkmark$ worms exhibit low signal intensity on T2WI\n$\\checkmark$ fluid-filled GI tract of worms hyperintense on T2WI\nCXR:\n$\\checkmark$ migratory patchy alveolar infiltrates that characteristically clear within 10 days\n$\\checkmark$ lobar consolidation + alveolar hemorrhage\nCx: (1) Intestinal obstruction $\\leftarrow$ massive infestation\n(2) Bowel perforation\n(3) Intermittent biliary obstruction with acute cholangitis, cholecystitis, pancreatitis\n(4) Recurrent pyogenic cholangitis\n(5) Liver abscess (rare)\n(6) Granulomatous stricture of extrahepatic bile ducts (rare)\n\nDx: fecal examination (eggs in stool), larvae in sputum\nRx: mebendazole\n\n# Ascaris-induced Pancreatitis \n\n= occasional migration of worm through ampulla of Vater into pancreaticobiliary tree via abnormally open ampullary orifice $\\leftarrow$ preexisting biliary tract disease / endoscopic sphincterotomy\n$\\diamond$ Most common parasitic cause of pancreatitis!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 305,
            "markdown": "Mean age: $35-42$ years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 3$\nUS:\n$\\sqrt{ }$ biliary / pancreatic ductal dilatation\n$\\sqrt{ }$ pancreatic + peripancreatic inflammation\n$\\sqrt{ }$ echogenic tubular structure without acoustic shadowing within bile / pancreatic duct with $2-4-\\mathrm{mm}$ wide central sonolucent line ( $=$ worm's digestive tract)\n$\\sqrt{ }$ worm may slowly move at real-time imaging\n$C x$ : biliary colic, cholangitis, acute cholecystitis, hepatic abscess, acute pancreatitis, septicemia\n\n# AUTOSOMAL DOMINANT POLYCYSTIC DISEASE \n\n$=$ POLYCYSTIC LIVER DISEASE\n$=$ part of spectrum of fibropolycystic liver disease\nEtiology: biliary ductal plate malformation at the level of the small intrahepatic bile ducts with progressive dilation of the abnormal noncommunicating bile ducts of biliary hamartomas\n$\\mathrm{M} \\div \\mathrm{F}=1 \\div 2$\nAssociated with: polycystic kidney disease (in 50\\%)\n\n- upper abdominal pain + distension from hepatomegaly\n$\\sqrt{ }$ enlarged diffusely cystic liver: cysts of $1 \\mathrm{~mm}-12 \\mathrm{~cm}$ in diameter\n$\\sqrt{ }$ calcifications of cyst wall $\\leftarrow$ hemorrhage / infection\n$\\sqrt{ } \\pm$ diffuse dilatation of intra- and extrahepatic bile ducts\n$C x$ : infection, compression, bleeding, rupture of cysts\n\n\n## BANTI SYNDROME\n\n$=$ NONCIRRHOTIC IDIOPATHIC PORTAL HYPERTENSION = NONCIRRHOTIC PORTAL FIBROSIS = HEPATOPORTAL SCLEROSIS\n$=$ syndrome characterized by\n(1) Splenomegaly\n(2) Hypersplenism\n(3) Portal hypertension\n\nEtiology: increased portal vascular resistance possibly $\\leftarrow$ portal fibrosis + obliterative venopathy of intrahepatic portal branches\nHisto: slight portal fibrosis, dilatation of sinusoids, intimal thickening with eccentric sclerosis of peripheral portal vein walls\nAge: middle-aged women; rare in America + Europe; common in India + Japan\n\n- elevated portal vein pressure (without cirrhosis, parasites, venous occlusion)\n- normal liver function tests, cytopenia ( $\\leftarrow$ hypersplenism)\n- normal / slightly elevated hepatic venous wedge pressure\n$\\sqrt{ }$ esophageal varices\n$\\sqrt{ }$ patent hepatic veins\n$\\sqrt{ }$ patent extrahepatic portal vein + multiple collaterals\nPrognosis: 90\\% 5-year survival; 55\\% 30-year survival",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 306,
            "markdown": "# BILE LEAK \n\nPosttraumatic bile leaks / biliary tract injuries related to recent surgery are easily overlooked due to\n(a) nonspecific imaging findings, especially in the setting of multiorgan injury\n(b) even less specific clinical findings\n(c) difficulties to discern from other postoperative fluid collections.\n\n## Cause:\n\n1. Post orthotopic liver transplantation\n2. Pancreaticoduodenectomy\n3. Hepatic or biliary surgery\n4. Cholecystectomy ( $2 \\%$ ): laparoscopic $>$ open\n5. Radiofrequency ablation, percutaneous biliary drainage\n6. Transcatheter arterial chemoembolization\n\nPrevalence: 7\\% after laparoscopic cholecystectomy\nTime of onset: during $1^{\\text {st }}$ postoperative week\n\n- asymptomatic subclinical bile leak (7\\%)\n- abdominal pain, fever, nausea, vomiting\n\nLocation: cystic duct stump / ducts of Luschka (= subvesical / accessory biliary ducts)\nCholescintigraphy:\n$\\sqrt{ }$ DIAGNOSTIC but with poor anatomic definition and spatial resolution necessitating a secondary diagnostic evaluation (especially ERCP)\nMRCP with hepatobiliary contrast medium:\nAgents: gadoxetate disodium (Eovist ${ }^{\\circledR}$ ) with $50 \\%$ liver excretion 20 minutes after administration; gadobenate dimeglumine (MultiHance ${ }^{\\circledR}$ ) with $5 \\%$ liver excretion $60-$ 120 minutes after administration\n$\\checkmark$ dynamic biliary imaging during hepatobiliary phase with improved characterization of biliary anatomy\nERCP:\n$\\checkmark$ depicts peripheral sites of leakage that may not be filled with retrograde injection\nCx: (1) Biloma= encapsulated extrabiliary bile collection\n(2) Bile peritonitis (days to weeks after initial trauma)\n\nPrognosis: high morbidity + mortality rates if undiagnosed\nRx: endoscopic / surgical management\n\n## BILIARY CYSTADENOCARCINOMA\n\n$=$ BILE DUCT CYSTADENOCARCINOMA\n$=$ rare malignant multilocular cystic tumor originating from biliary cystadenoma\nHisto: (a) with ovarian stroma (good prognosis), in females only\n(b) without ovarian stroma (poor prognosis)\n\n- hemorrhagic internal fluid\n$\\checkmark$ nodularity with septations are suggestive of malignancy\n$\\checkmark$ coarse calcifications\n$D D x:$ NO image differentiation from biliary cystadenoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 307,
            "markdown": "# BILIARY CYSTADENOMA \n\n$=$ BILE DUCT CYSTADENOMA\n$=$ very rare benign multilocular cystic tumor originating in bile ducts as premalignant form of biliary cystadenocarcinoma; probably deriving from ectopic nests of primitive biliary tissue Frequency: $4.6 \\%$ of all intrahepatic cysts of bile duct origin\nAge: $>30$ years ( $82 \\%$ ), peak incidence in $5^{\\text {th }}$ decade; $\\mathrm{M}+\\mathrm{F}=1 \\div 4$; predominantly in Caucasians\nPath: multilocular cystic tumor containing proteinaceous fluid with well-defined thick capsule\nHisto: single layer of cuboidal / tall columnar mucin-secreting biliary-type epithelium with papillary projections, subepithelial stroma resembling that of the ovary\n$\\diamond$ Similar to mucinous cystic tumors of pancreas + ovary\nLocation: intrahepatic+extrahepatic bile ducts $=85 \\div 15$; right lobe ( $48 \\%$ ); left lobe ( $20-35 \\%$ ); both lobes ( $15-30 \\%$ ); gallbladder (rare)\n\n- chronic abdominal pain\n- dyspepsia, anorexia, nausea + vomiting, jaundice\n- abdominal swelling with palpable mass ( $90 \\%$ )\n\nSize: $1.5-35 \\mathrm{~cm}$ (reportedly up to 11 liters of liquid content)\n$\\sqrt{ }$ well-defined cystic mass containing clear / cloudy, serous / mucinous / gelatinous, purulent / hemorrhagic / bilious fluid with hemosiderin / cholesterol / necrosis\n$\\checkmark$ thick fibrous capsule\n$\\checkmark$ papillary excrescences + mural nodules\n$\\checkmark$ septations between cysts\nUS:\n$\\checkmark$ ovoid multiloculated anechoic mass with highly echogenic septations / papillary growths\n$\\checkmark$ may contain fluid-fluid levels\nCT:\n$\\checkmark$ multiloculated mass of near water density\n$\\checkmark$ contrast enhancement in wall + internal septa\nMR:\n$\\checkmark$ locules with variable SI on T1WI + T2WI depending on their protein content\nAngio:\n$\\checkmark$ avascular mass with small clusters of peripheral abnormal vessels\n$\\checkmark$ stretching + displacement of vessels\n$\\checkmark$ thin subtle blush of neovascularity in septa + wall\nCx: (1) Malignant transformation into cystadenocarcinoma (indicated by invasion of capsule)\n(2) Rupture into peritoneum / retroperitoneum\n\nRx: surgical resection (recurrence common)\nDDx: biliary cystadenocarcinoma, liver abscess, echinococcal cyst, cystic mesenchymal hamartoma (children + young adults), undifferentiated sarcoma (children + young adults), necrotic hepatic metastasis, cystic primary hepatocellular carcinoma\n\n## BILIARY-ENTERIC FISTULA\n\nFrequency: $5 \\%$ at cholecystectomy; $0.5 \\%$ at autopsy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 308,
            "markdown": "Etiology: cholelithiasis ( $90 \\%$ ), acute / chronic cholecystitis, biliary tract carcinoma, regional invasive neoplasm, diverticulitis, inflammatory bowel disease, peptic ulcer disease, echinococcal cyst, trauma, congenital communication\nCommunication with:\nduodenum ( $70 \\%$ ), colon ( $26 \\%$ ), stomach ( $4 \\%$ ), jejunum, ileum, hepatic artery, portal vein (caused death of Ignatius de Loyola), bronchial tree, pericardium, renal pelvis, ureter, urinary bladder, vagina, ovary\nA. CHOLECYSTODUODENAL FISTULA (51-80\\%)\n\n1. Perforated gallstone ( $90 \\%$ ): associated with gallstone ileus in $20 \\%$\n2. Perforated duodenal ulcer ( $10 \\%$ )\n3. Surgical anastomosis\n4. Gallbladder carcinoma\nB. CHOLECYSTOCOLIC FISTULA (13-21\\%)\nC. CHOLEDOCHODUODENAL FISTULA (13-19\\%)\ndue to perforated duodenal ulcer disease\nD. MULTIPLE FISTULAE (7\\%)\n$\\sqrt{ }$ pneumobilia $=$ branching tubular radiolucencies, more prominent centrally within the liver\n$\\sqrt{ }$ barium filling of biliary tree\n$\\sqrt{ }$ shrunken gallbladder mimicking pseudodiverticulum of duodenal bulb\n$\\sqrt{ }$ multiple hyperechoic foci with dirty shadowing\n$D D x$ : patulous sphincter of Oddi, ascending cholangitis, surgery (choledochoduodenostomy, cholecystojejunostomy, sphincterotomy)\n\n# BUDD-CHIARI SYNDROME \n\n$=$ syndrome of global / segmental hepatic venous outflow obstruction at level of hepatic veins / IVC\nCause:\nA. IDIOPATHIC (66\\%)\nB. THROMBOSIS\n(a) myeloproliferative disorder:\npolycythemia rubra vera ( $1 / 4$ ), essential thrombocytosis\n(b) hypercoagulable state:\nmnemonic: 6 P's\nParoxysmal nocturnal hemoglobinuria (12\\%)\nPlatelets (thrombocytosis)\nPill (birth control pills)\nPregnancy + Postpartum state\nPolycythemia rubra vera\nProtein C deficiency\nalso: sickle cell disease\n(c) injury to vessel wall:\nphlebitis, trauma, hepatic radiation injury, chemotherapeutic + immunosuppressive drugs in patient with bone marrow transplant, venoocclusive disease from",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 309,
            "markdown": "pyrrolizidine alkaloids (Senecio) found in medicinal bush teas in Jamaica\nC. NONTHROMBOTIC OBSTRUCTION\n(a) compression or invasion of IVC / hepatic veins:\n> benign: cirrhosis, hematoma, abscess\n> malignant: renal cell carcinoma, adrenal carcinoma, hepatoma, cholangiocarcinoma, metastasis, primary leiomyosarcoma of IVC, Hodgkin disease\n(b) membranous obstruction of suprahepatic IVC\n= IVC diaphragm (believed to be a congenital web / acquired lesion from longstanding IVC thrombosis); common in Oriental + Indian population (South Africa, India, Japan, Korea, Israel); very rare in Western countries\n(c) right atrial tumor: atrial myxoma\n(d) constrictive pericarditis\n(e) right heart failure\nD. SYSTEMIC INFLAMMATION / INFECTION\n\n1. Inflammatory bowel disease\n2. Behçet syndrome\n\nPathophysiology:\nhepatic venous thrombosis $\\rightarrow$ elevation of sinusoidal pressure $\\rightarrow$ diminished / reversed portal venous flow $\\rightarrow$ centrilobular congestion $\\rightarrow$ necrosis + atrophy\n(a) acute form (= no time for development of collateral veins) $\\rightarrow$ rapid development of hepatic necrosis\n(b) subacute / chronic form (venous thrombosis incomplete) $\\rightarrow$ peripheral atrophy + preservation of central region with caudate lobe hypertrophy (drained by accessory veins)\nIn $25 \\%$ associated with: portal vein thrombosis\nAge: all ages; $\\mathrm{M}<\\mathrm{F}$\n\n- right upper quadrant pain, lower-extremity edema\n- shortness of breath $\\leftarrow$ decreased cardiac return\n- nonspecific elevated transaminases, jaundice\n\nLocation:\nType I : occlusion of IVC $\\pm$ hepatic veins\nType II : occlusion of major hepatic veins $\\pm$\nIVC\nType III : occlusion of small centrilobar venules\n$\\sqrt{ }$ gallbladder wall thickening $>6 \\mathrm{~mm}$\n$\\sqrt{ }$ portal vein diameter $>12 \\mathrm{~mm}$ (in adults), $>8 \\mathrm{~mm}$ (in children)\nMR:\n$\\checkmark$ reduction in caliber / complete absence of hepatic veins\n$\\sqrt{ }$ \"comma\" sign = multiple comma-shaped intrahepatic flow voids $\\leftarrow$ intrahepatic collaterals\n$\\sqrt{ }$ hyperintense thrombi\nDoppler US ( $85-100 \\%$ sensitive, $85 \\%$ specific):\n$\\sqrt{ }$ one / more major hepatic veins reduced in size to $<3 \\mathrm{~mm}$ / filled with thrombus / not visualized\n$\\sqrt{ }$ stenoses of hepatic veins\n$\\sqrt{ }$ communicating intrahepatic venous collaterals",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 310,
            "markdown": "$\\sqrt{ }$ decreased / absent / reversed blood flow in hepatic veins\n$\\sqrt{ }$ flat flow / loss of cardiac modulation in hepatic veins\n$\\sqrt{ }$ demodulated portal venous flow = disappearance of portal vein velocity variations with breathing\n$\\sqrt{ }$ slow flow of $<11 \\mathrm{~cm} / \\mathrm{sec} /$ hepatofugal flow in portal vein\n$\\sqrt{ }$ portal vein congestion index $>0.1[\\mathrm{~cm} \\cdot \\mathrm{sec}]$ (= ratio between cross-sectional area $\\left[\\mathrm{cm}^{2}\\right]$ and blood flow velocity $[\\mathrm{cm} / \\mathrm{sec}])$\n$\\sqrt{ }$ portal vein thrombosis ( $20 \\%$ )\n$\\sqrt{ }$ compression of IVC by enlarged liver / caudate lobe\n$\\sqrt{ }$ sluggish / reversed / absent blood flow within IVC\n$\\sqrt{ }$ hepatic artery resistive index $>0.75$\nNUC ( ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-sulfur colloid):\n$\\sqrt{ }$ central region of normal activity (= hot caudate lobe $\\leftarrow$ venous drainage of hypertrophied caudate lobe into IVC by separate vein) surrounded by greatly diminished activity\n$\\sqrt{ }$ colloid shift to spleen + bone marrow\n$\\sqrt{ }$ wedge-shaped focal peripheral defects\nAngio (inferior venocavography, hepatic venography):\n$\\sqrt{ }$ absence of main hepatic veins\n$\\sqrt{ }$ spider web pattern of collateral + recanalized veins\n$\\sqrt{ }$ high-pressure gradient between infra- and suprahepatic portion of IVC $\\leftarrow$ enlarged liver\n$\\sqrt{ }$ stretching + draping of intrahepatic arteries with hepatomegaly\n$\\sqrt{ }$ inhomogeneous prolonged intense hepatogram with fine mottling\n$\\sqrt{ }$ large lakes of sinusoidal contrast accumulation\nPortography:\n$\\sqrt{ }$ central hepatic enhancement (normal hepatopetal flow)\n$\\sqrt{ }$ reversed portal flow in liver periphery (supplied only by hepatic artery)\n$\\sqrt{ }$ bidirectional / hepatofugal main portal vein flow\n$D x:$ liver biopsy\nRx: control of ascites with diuretics + sodium restriction; anticoagulation, thrombolytic therapy, surgery / balloon dilatation (depending on etiology); transjugular portosystemic shunt (in preparation for) orthotopic liver transplantation (for advanced cases)\n\n# Acute Budd-Chiari Syndrome ( $1 / 2$ ) \n\n$\\diamond$ Caudate lobe has not had time to hypertrophy!\n\n- TRIAD:\n- rapid onset of abdominal pain (liver congestion)\n- insidious onset of intractable ascites\n- hepatomegaly without derangement of liver function\n- jaundice\n$\\sqrt{ }$ enlarged morphologically normal liver\n$\\sqrt{ }$ splenomegaly\n$\\sqrt{ }$ ascites ( $97 \\%$ )\nNECT:\n$\\sqrt{ }$ diffusely hypoattenuating liver\n$\\sqrt{ }$ IVC + hepatic veins:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 311,
            "markdown": "$\\sqrt{ }$ narrowed lumina (without thrombus)\n$\\sqrt{ }$ hyperattenuating lumina containing thrombus (in 18-53\\%)\n$\\checkmark$ enlarged inferior right hepatic vein ( $18 \\%$ )\nCECT:\n$\\checkmark$ normal early enhancement of caudate lobe and central portion around IVC + decreased enhancement of peripheral liver ( $\\leftarrow$ portal and sinusoidal stasis) during arterial phase\n$\\checkmark$ \"flip-flop\" pattern during portal venous phase:\n$\\checkmark$ decreased attenuation (washout) of enhancing central areas\n$\\checkmark$ increasing patchy inhomogeneous enhancement in liver periphery $\\leftarrow$ contrast inflow from capsular veins\nMR:\n$\\checkmark$ peripheral liver parenchyma of moderately low SI on T1WI + moderately high SI on T2WI compared with central portion\n$\\checkmark$ diminished + mottled peripheral enhancement\n\n# Subacute Budd-Chiari Syndrome \n\n- portal hypertension, varying degrees of liver decompensation\n$\\checkmark$ diffuse peripheral hypoattenuation $\\leftarrow$ hepatocellular necrosis + steatosis\n\n\n## Chronic Budd-Chiari Syndrome ( $\\left.{ }^{2} / \\cdot\\right)$\n\n- insidious onset of jaundice, intractable ascites\n- portal hypertension, variceal bleeding\n- renal impairment (in 50\\%)\n$\\checkmark$ dysmorphic liver:\n$\\checkmark$ nonsegmental / lobar atrophy of affected liver ( $\\leftarrow$ extensive fibrosis) with diminished attenuation before + after contrast administration\n$\\checkmark$ compensatory hypertrophy of caudate lobe ( $88 \\%$ ) + central parenchymal segments of right lobe + medial segment of left lobe:\n$\\checkmark$ width of caudate + right lobe $\\geq 0.55$ (DDx: cirrhosis)\n$\\checkmark$ visualization of collateral pathways\n(a) portosystemic: paraumbilical vein\n(b) bypassing IVC: azygos, hemiazygos\n(c) intrahepatic collateral veins (almost DIAGNOSTIC): right / middle hepatic vein $\\rightarrow$ inferior right hepatic vein; hepatic vein $\\rightarrow$ portal vein\n$\\checkmark$ development of $1-4 \\mathrm{~cm}$ regenerative nodules (in areas of adequate blood supply)\n$\\checkmark$ ascites\nCECT:\n$\\checkmark$ invisible IVC $\\pm$ hepatic veins $\\leftarrow$ collapse / diminished flow rate:\n$\\checkmark$ nonvisualization of hepatic veins ( $75 \\%$ ) / vein diameter $<3 \\mathrm{~mm}$ (measured 2 cm from IVC)\n$\\checkmark \\pm$ narrowing / obstruction of intrahepatic IVC\n$\\checkmark$ progressive heterogeneous patchy enhancement radiating outward from major portal vessels\n$\\checkmark$ \"reticulated mosaic\" enhancement = diffuse patchy lobular enhancement separated by irregular linear areas of low density in central area",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 312,
            "markdown": "$\\sqrt{ }$ delayed homogeneous enhancement of entire liver after several minutes\n$\\sqrt{ }$ reversed portal venous blood flow $\\leftarrow$ increased postsinusoidal pressure produced by hepatic venous obstruction / rarely infarcts\nColor Doppler:\n$\\sqrt{ }$ PATHOGNOMONIC \"bicolored\" hepatic veins $\\leftarrow$ intrahepatic collateral pathways MR:\n$\\sqrt{ }$ absence of flow within hepatic veins\n$\\sqrt{ }$ minimal differences in SI between central and peripheral portions of liver\n$\\sqrt{ }$ intrahepatic collateral vessels\n\n# CANDIDIASIS OF LIVER \n\n$=$ almost exclusively seen in immunocompromised patients (acute leukemia, chronic granulomatous disease of childhood, renal transplant, chemotherapy for myeloproliferative disorders)\nPrevalence: at time of autopsy in $50-70 \\%$ of acute leukemia, in $50 \\%$ of lymphoma patients\n$\\diamond$ Most common systemic fungal infection in immunocompromised patients!\n\n- abdominal pain, elevated alkaline phosphatase\n- persistent fever in neutropenic patient whose leukocyte count is returning to normal\n$\\checkmark$ hepatomegaly\n$\\checkmark$ \"target\" / \"bull's-eye\" sign = multiple small hypoechoic / hypoattenuating masses with centers of increased echogenicity / attenuation distributed throughout liver\n$\\diamond$ Bull's-eye lesion becomes visible only when neutropenia resolves!\n$\\checkmark$ hyperintense lesions on T2WI\nNUC:\n$\\checkmark$ uniform uptake / focal photopenic areas\n$\\checkmark$ diminished ${ }^{67} \\mathrm{Ga}$ uptake\n$D x$ : biopsy evidence of yeast / pseudohyphae in central necrotic portion of lesion\n$D D x$ : metastases, lymphoma, leukemia, sarcoidosis, septic emboli, other infections (MAI, CMV), Kaposi sarcoma\n\n\n## CAROLI DISEASE\n\n[Jacques Caroli (1902-1979), surgeon in Paris, France]\n= COMMUNICATING CAVERNOUS ECTASIA OF INTRAHEPATIC BILE DUCTS\n$\\diamond$ Original classification as Type V choledochal cyst (Todani classification) is NO longer accepted!\n= rare congenital autosomal recessive disorder characterized by multifocal segmental saccular cystic dilatation of large intrahepatic bile ducts\nEtiology: (a) ductal plate malformation\n(b) ? perinatal hepatic artery occlusion\n(c) ? hypoplasia / aplasia of fibromuscular wall components\n\nPath: communication with biliary tree\nAge: childhood $+2^{\\text {nd }}-3^{\\text {rd }}$ decade, occasionally in infancy; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\nAssociated with: benign renal tubular ectasia, medullary sponge kidney (in $80 \\%$ ), infantile polycystic kidney disease, choledochal cyst (rare), congenital hepatic",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 313,
            "markdown": "fibrosis, cholangiocarcinoma\n\n- recurrent cramplike right upper quadrant pain\n- bouts of fever $\\leftarrow$ cholangitis $\\leftarrow$ bile stasis\n- transient jaundice $\\leftarrow$ bile stasis $\\leftarrow$ blocking stone / sludge\n- cirrhosis / portal hypertension (very rare)\n\nLocation: diffuse / segmental or lobar\nTypes:\n(1) pure form (type 1): attacks of cholangitis + intraductal stone formation\n(2) complex form (type 2) - more common: associated with hepatic fibrosis / other ductal plate malformations\n$\\sqrt{ }$ multiple small localized / diffusely scattered cysts converging toward porta hepatis communicating with bile ducts\n$\\sqrt{ }$ beaded ducts with alternating dilated and strictured segments\n$\\sqrt{ }$ sludge / pus / calculi in dilated ducts\nCT / US/ MR:\n$\\sqrt{ }$ \"central dot\" sign = enhancing fibrovascular bundle of portal vein radicles completely surrounded by cystically altered dilated intrahepatic bile ducts (IBD)\nCholangiography and MRCP (DIAGNOSTIC):\n$\\sqrt{ }$ segmental saccular $>$ fusiform beaded dilatation of intrahepatic bile ducts extending to periphery of liver up to 5 cm in diameter\n$\\sqrt{ } \\pm$ filling defects $\\leftarrow$ intraductal calculi\n$\\sqrt{ }$ bridge formation across dilated lumina\n$\\sqrt{ }$ intraluminal bulbar protrusions\n$\\sqrt{ }$ frequent ectasia of extrahepatic ducts + CBD\n$D x:$ ERCP, direct cholangiography, MRCP\nCx: (1) Bile stasis $\\rightarrow$ sludge + recurrent cholangitis\n(2) Biliary calculi (predominantly bilirubin)\n(3) Liver abscess\n(4) Septicemia\n(5) Increased risk of cholangiocarcinoma (7\\%)\n\nDDx: (1) Primary sclerosing cholangitis (multiple irregular strictures of intra- and extrahepatic bile ducts, pseudotumoral enlargement of caudate lobe, lobulated liver contour)\n(2) Recurrent pyogenic cholangitis (nonsaccular dilatation of central intra- and extrahepatic bile ducts, bile ducts tapered toward periphery)\n(3) Autosomal dominant polycystic liver disease (no communication with bile ducts)\n(4) Biliary hamartomas (no communication with bile ducts)\n(5) Microabscesses\n(6) Biliary papillomatosis\n\n# Caroli Syndrome \n\n$=$ both features of Caroli disease and congenital hepatic fibrosis\n$=$ arrest of bile duct remodeling during embryogenesis + during later development of more",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 314,
            "markdown": "peripheral biliary ramifications\n\n- hematemesis $\\leftarrow$ ruptured esophageal varices $\\leftarrow$ portal hypertension\n\n\n# CHOLANGIOCARCINOMA \n\n$=$ primary malignancy arising from cholangiocyte of biliary tract\nFrequency: $0.5-1.0 \\%$ of all cancers;\n$10 \\%$ of hepatic primary malignancies\n$\\diamond 2^{\\text {nd }}$ most common primary hepatobiliary cancer after HCC!\nAnatomic classification:\nA. INTRAHEPATIC (PERIPHERAL)\nperipheral / distal to $2^{\\text {nd }}$-order branches $8-13 \\%$\nB. PERIHILAR (CENTRAL) = Klatskin tumor\nat bifurcation / 1 st-order branches\nconfluence of hepatic ducts $10-26 \\%$\nC. EXTRAHEPATIC\ncommon hepatic duct $14-37 \\%$\nproximal CBD $15-30 \\%$\ndistal CBD $30-50 \\%$\ncystic duct $6 \\%$\nD. GALLBLADDER\n\nPath (Japanese Liver Cancer Study Group):\n(a) mass-forming (= nodular / exophytic) type:\ncommonly in peripheral cholangiocarcinoma\n\n- homogeneous sclerotic mass typically without hemorrhage / necrosis\n- central portion with variable degree of fibrosis + coagulative necrosis with scanty tumor cells\n(b) periductal infiltrating / diffuse type:\ncommonly in hilar + extrahepatic cholangiocarcinoma\n- elongated spiculated / branching growth along dilated / narrowed bile duct\n(c) intraductal tubular polypoid / papillary type:\n- infrequent slow growing tumor with relatively favorable prognosis\n- frequently associated with marked mucin production\n(d) mixed = combination of mass-forming + periductal\n\nHisto: well / moderately / poorly differentiated ductal adenocarcinoma (most common) /\npapillary / mucinous / signet-ring cell / mucoepidermoid / adenosquamous\nadenocarcinoma with abundant fibrous stroma\nUnusual manifestation:\n\n1. Mucin-hypersecreting cholangiocarcinoma\n$\\checkmark$ severe diffuse dilatation of intra- and extrahepatic bile ducts proximal + distal to tumor\n2. Squamous cell carcinoma\n$=$ metaplastic transformation of adenocarcinoma\nGenetics: mutation in p53 tumor suppressor gene + k -ras gene\nPeak prevalence: $7^{\\text {th }}$ decade; $\\mathrm{M}>\\mathrm{F}$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 315,
            "markdown": "Predisposed: conditions causing chronic biliary inflammation\n(1) Inflammatory bowel disease ( 10 x increased risk); incidence of $0.4-1.4 \\%$ in ulcerative colitis; latent period of 15 years; tumors usually multicentric + predominantly in extrahepatic sites; GB involved in $15 \\%$ (simultaneous presence of gallstones is rare)\n(2) Biliary lithiasis: cholecystolithiasis ( $20-50 \\%$ ), hepatolithiasis ( $5-10 \\%$ )\n(3) Primary sclerosing cholangitis ( $10-15 \\%$ )\n(4) Infection with liver flukes: Opisthorchis viverrini and Clonorchis sinensis infestation (Far East)\n$\\diamond$ Most common cause worldwide!\n(5) Recurrent pyogenic cholangitis $=$ hepatolithiasis\n(6) Viral infection: HIV, hepatitis B virus, hepatitis C virus, Epstein-Barr virus\n(7) Congenital biliary cystic disease: choledochal cyst / congenital hepatic cyst / congenital biliary atresia\n(8) Anomalous pancreaticobiliary junction\n(9) Ductal plate malformation:\n> Biliary hamartoma\n> Autosomal dominant polycystic disease\n> Congenital hepatic fibrosis\n> Caroli disease $\\leftarrow$ chronic biliary stasis\n(10) Papillomatosis of bile ducts\n(11) Choledochoenteric anastomosis\n(12) History of other malignancy ( $10 \\%$ )\n(13) Toxins: thorotrast exposure, polyvinyl chloride\n(14) Heavy alcohol consumption\n(15) Alpha-1 antitrypsin deficiency\n(16) Familial polyposis\n\nMR:\n$\\sqrt{ }$ moderate peripheral enhancement followed by progressive centripetal enhancement\n$\\sqrt{ }$ single / multifocal biliary strictures\n$\\sqrt{ }$ focal / diffuse ductal thickening $\\pm$ contrast enhancement\n$\\sqrt{ }$ intraductal polypoid growth\nPrognosis: median survival of 7 months, $0-10 \\% 5$-year survival\n\n# Extrahepatic Cholangiocarcinoma \n\n$=$ BILEDUCT CARCINOMA\nAge peak: $6^{\\text {th }}-7^{\\text {th }}$ decade; $\\mathrm{M} \\div \\mathrm{F}=3 \\div 2$\nIncidence: $1 \\div 100,000 ;<0.5 \\%$ of autopsies; $90 \\%$ of all cholangiocarcinomas; more frequent in Far East\nHisto: well-differentiated sclerosing adenocarcinoma ( $2 / 3$ ), anaplastic carcinoma ( $11 \\%$ ), cystadenocarcinoma, adenoacanthoma, malignant adenoma, squamous cell carcinoma, epidermoid carcinoma, leiomyosarcoma\n\n- gradual onset of fluctuating painless jaundice\n- cholangitis ( $10 \\%$ ), weight loss, fatigability\n- intermittent epigastric pain, enlarged tender liver\n- elevated bilirubin + alkaline phosphatase",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 316,
            "markdown": "# Growth pattern: \n\n(1) Infiltrating / sclerosing type ( $94 \\%$ )\n$\\sqrt{ }$ ductal wall thickening + sudden luminal obliteration\n(2) Papillary / tubular polypoid type (5-6\\%)\n$\\sqrt{ }$ intraductal polypoid mass with irregular margin $\\pm$ diffuse marked duct ectasia (mucin production)\nSpread: (a) lymphatic spread: cystic + CBD nodes ( $>32 \\%$ ), celiac nodes ( $>16 \\%$ ), peripancreatic nodes, superior mesenteric nodes\n(b) infiltration of liver ( $23 \\%$ )\n(c) peritoneal seeding $(9 \\%)$\n(d) hematogenous (extremely rare): liver, peritoneum, lung\n\nUGI:\n$\\sqrt{ }$ infiltration / indentation of stomach / duodenum\nCholangiography (PTC or ERC best modality to depict bile duct neoplasm):\n$\\sqrt{ }$ prestenotic diffuse / focal biliary dilatation ( $100 \\%$ )\n$\\sqrt{ }$ progression of ductal stricture $(100 \\%)$\n$\\sqrt{ }$ frequently long / rarely short concentric focal stricture with irregular margins (in infiltrating type):\n$\\sqrt{ }$ nipple / rattail termination\n$\\sqrt{ }$ exophytic intraductal tumor mass ( $46 \\%$ ), $2-5 \\mathrm{~mm}$ in diameter\nUS / CT:\n$\\sqrt{ }$ mural thickening / small encircling mass of bile duct at point of obstruction (in $21 \\%$ visible on US, in $40 \\%$ visible on CT):\n$\\sqrt{ }$ focal or diffuse stricture / complete obstruction of bile ducts\n$\\sqrt{ }$ dilatation of intrahepatic ducts without extrahepatic duct dilatation\n$\\sqrt{ }$ infiltrating tumor visible in $22 \\%$ on CT as highly attenuating lesion, in $13 \\%$ on US\n$\\sqrt{ }$ exophytic tumor: visible on CT as hypoattenuating mass in $100 \\%$, in $29 \\%$ on US\n$\\sqrt{ }$ polypoid intraluminal tumor: visible on US as isoechoic mass within surrounding bile in $100 \\%$, in $25 \\%$ on CT\n$\\sqrt{ }$ regional lymph node enlargement\nCECT:\n$\\sqrt{ }$ hyperattenuating lesion at delayed imaging $\\leftarrow$ delayed accumulation + washout of fibrous center\nMR:\n$\\sqrt{ }$ hypointense relative to liver parenchyma on T1WI\n$\\sqrt{ }$ hyperintense relative to liver parenchyma on T2WI\n$\\sqrt{ }$ more conspicuous on fat-suppressed MR\nAngiography:\n$\\sqrt{ }$ hypervascular tumor with neovascularity ( $50 \\%$ )\n$\\sqrt{ }$ arterioarterial collaterals along the course of bile ducts associated with arterial obstruction\n$\\sqrt{ }$ poor / absent tumor stain\n$\\sqrt{ }$ displacement / encasement / occlusion of hepatic artery + portal vein\nCx: (1) Obstruction leading to biliary cirrhosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 317,
            "markdown": "(2) Hepatomegaly\n(3) Intrahepatic (subdiaphragmatic, perihepatic) abscess $\\rightarrow$ septicemia\n(4) Biliary peritonitis\n(5) Portal vein invasion\n\nDx: endoscopic brush biopsy ( $30-85 \\%$ sensitive)\nPrognosis: median survival of 5 months; $1.6 \\% 5$-year survival; $39 \\% 5$-year survival for carcinoma of papilla of Vater\n$D D x$ : periportal lymphangitic metastasis (no ductal dilatation, diffuse involvement of both sides of liver); sclerosing cholangitis, AIDS cholangitis, benign stricture, chronic pancreatitis, edematous papilla, idiopathic inflammation of CBD\n\n# Intrahepatic Cholangiocarcinoma \n\n$=$ CHOLANGIOCELLULAR CARCINOMA\nFrequency: $2^{\\text {nd }}$ most common primary hepatic tumor after hepatoma; $1 / 3$ of all malignancies originating in the liver; $8-13 \\%$ of all cholangiocarcinomas\nHisto: adenocarcinoma arising from the epithelium of a small intrahepatic bile duct with prominent desmoplastic reaction (fibrosis); $\\pm$ mucin and calcifications\nAverage age: $50-60$ years; $\\mathrm{M}>\\mathrm{F}$\n\n- abdominal pain (47\\%); painless jaundice (12\\%)\n- palpable mass (18\\%), weight loss (18\\%)\n\nSpread: (a) local extension along duct\n(b) local infiltration of liver substance\n(c) metastatic spread to regional lymph nodes (in 15\\%)\n$\\diamond$ Biliary + vascular obstruction is typical!\n$\\checkmark$ ill-defined mass of $5-20 \\mathrm{~cm}$ in diameter\n$\\checkmark$ satellite nodules in $65 \\%$\n$\\checkmark$ punctate / chunky calcifications in $18 \\%$\n$\\checkmark$ calculi in biliary tree\n$\\checkmark$ liver atrophy is suggestive although not specific\n$\\checkmark$ fibrotic pseudocapsule + secondary capsular retraction\nUS:\n$\\checkmark$ dilated biliary tree\n$\\checkmark$ predominantly solitary homo- / heterogeneous mass\n$\\checkmark$ hyperechoic ( $75 \\%$ ) mass for tumors $>3 \\mathrm{~cm}$\n$\\checkmark$ iso- / hypoechoic ( $14 \\%$ ) mass for tumor $<3 \\mathrm{~cm}$\n$\\checkmark$ mural thickening\n$\\checkmark$ peripheral hypoechoic tumor rim (35\\%) of compressed liver parenchyma\nNECT:\n$\\checkmark$ single large predominantly homogeneous round / oval hypo- to isoattenuating dense mass with irregular margin\n$\\checkmark$ capsular retraction\n$\\checkmark$ stippled / punctate hyperattenuating foci (= hepatolithiasis)\n$\\checkmark$ dilatation of biliary tree peripheral to tumor\nCECT:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 318,
            "markdown": "$\\sqrt{ }$ hypoattenuating mass during arterial + portal venous phase\n$\\sqrt{ }$ marked homogeneous delayed enhancement at 15 minutes ( $36-74 \\%$ ):\n$\\checkmark$ progressive concentric filling in of contrast medium (late) $\\leftarrow$ slow diffusion into interstitial tumor spaces within fibrous stroma\n$\\checkmark$ \"peripheral washout\" sign = (early) minimal to moderate thin rimlike / thick bandlike ragged enhancement around tumor:\n$\\checkmark$ clearing of contrast material in rim of lesion on delayed images\n$\\checkmark$ obliteration of portal vein + atrophy of involved segment\n$\\checkmark$ satellite nodules\nMR:\n$\\checkmark$ large central heterogeneously hypo- to isointense mass on T1WI\n$\\checkmark$ variably hyperintense mass on T2WI depending on amount of mucinous material, fibrous tissue, hemorrhage, tumor necrosis:\n$\\checkmark$ hyperintense periphery (viable tumor) with irregular margin\n$\\checkmark$ large central hypointensity (fibrosis) on T2WI\n$\\checkmark$ hyperintense lesion on DWI $\\leftarrow$ suppression of high signal from vessels + bile ducts\n$\\checkmark \\pm$ DWI for small lesion\nCEMR:\n$\\checkmark$ minimal / incomplete enhancement at tumor periphery on early images $\\leftarrow$ areas of early enhancement + rapid washout indicate active neoplastic growth\n$\\checkmark$ concentric centripetal internal fill-in = prominent progressive central enhancement on equilibrium / delayed phase $\\leftarrow$ vascular fibrotic stroma in tumor center\n$\\checkmark$ intense homogeneous enhancement during arterial phase + prolonged enhancement during delayed phase in smaller lesions with less fibrosis\n$\\checkmark$ satellite nodules in $10-20 \\%$\nMR cholangiography:\n$\\checkmark$ localizing site of obstruction ( $100 \\%$ accurate)\n$\\checkmark$ determining cause of obstruction ( $95 \\%$ accurate)\nAngiography:\n$\\checkmark$ avascular / hypo- / hypervascular mass\n$\\checkmark$ stretched / encased arteries (frequent)\n$\\checkmark$ neovascularity in $50 \\%$\n$\\checkmark$ lack of venous invasion\nNUC:\n$\\checkmark$ cold lesion on sulfur colloid / IDA scans\n$\\checkmark$ segmental biliary obstruction\n$\\checkmark$ may show uptake on gallium scan\nPET:\n$\\checkmark$ ring-shaped uptake $\\leftarrow$ excessive desmoplastic response of tumor center + neovascularity at tumor periphery\n$\\checkmark$ metastases to lymph nodes, liver, and distant sites\nERCP:\n$\\checkmark$ diagnostic bile sampling with cytologic analysis\n$\\checkmark$ biliary stent placement to relieve obstruction\nPrognosis: $<20 \\%$ resectable; $30 \\% 5$-year survival",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 319,
            "markdown": "$D D x$ : (1) Metastatic adenocarcinoma (central necrosis $=$ strongly T2-hyperintense + T1hypointense)\n(2) Hemangioma (strong globular enhancement, NO ragged rim)\n(3) Sclerosing / cirrhotic HCC (NO distinguishing features)\n(4) Organizing abscess (thick enhancing wall with central cystic change)\n(5) Tuberculosis (multilayered appearance)\n\n# Intrahepatic Peripheral Cholangiocarcinoma \n\n- NO jaundice\n\nLocation: right lobe predilection\n$\\sqrt{ }$ solitary mass (nodular form) without hypoechoic halo\n$\\sqrt{ }$ diffusely abnormal liver texture (infiltrative form):\n$\\checkmark$ tumor more hypoechoic if $<3 \\mathrm{~cm}$\n$\\checkmark$ tumor more hyperechoic if $>3 \\mathrm{~cm}$\n$\\checkmark$ well-marginated cystic mass (papillary mucin-producing tumor) $\\pm$ diffuse hyperechoic flecks of tumor calcification\n$\\checkmark$ capsular retraction\n$\\checkmark$ delayed enhancement at 10 minutes\n$\\checkmark$ dilatation of bile ducts peripheral to tumor ( $31 \\%$ )\n$\\checkmark$ tumor fingers in bile duct\n$D D x$ : metastatic adenocarcinoma / leiomyosarcoma; sclerosing hepatocellular carcinoma\n\n## Klatskin Tumor\n\n[Gerald Klatskin (1910-1986), pathologist in Yale, USA]\n$=$ INTRAHEPATIC CENTRAL CHOLANGIOCARCINOMA $=$ HILAR CHOLANGIOCARCINOMA\n$=$ tumor at confluence of hepatic ducts (up to $50-70 \\%$ of all cholangiocarcinomas)\nAge: $>65$ years at presentation\nPath growth pattern: infiltrating (70\\%) / intraluminal polypoidal / mass-forming\n\n- abdominal pain, discomfort, anorexia, weight loss\n- pruritus, jaundice (late symptom)\n$\\checkmark$ direct signs of Klatskin tumor:\n$\\checkmark$ failure to demonstrate confluence of $\\mathrm{L}+\\mathrm{R}$ hepatic ducts\n$\\checkmark$ iso- to hyperechoic central porta hepatis mass / focal irregularity of ducts (for infiltrating cholangiocarcinoma)\n$\\checkmark$ polypoid / smooth nodular intraluminal mass (for papillary + nodular types of cholangiocarcinoma) with associated mural thickening\n$\\checkmark$ indirect signs of Klatskin tumor:\n$\\checkmark$ segmental dilatation with nonunion of right + left ducts at porta hepatis + normal caliber of extrahepatic ducts\n$\\checkmark$ pressure effect / encasement / invasion / obliteration of portal vein and hepatic artery\n$\\checkmark$ lobar atrophy $(14 \\%)=$ dilated crowded ducts extending to liver surface $\\pm$ geographic fatty change in one lobe\n$R x: \\quad>50 \\%$ inoperable at diagnosis $\\leftarrow$ advanced stage",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 320,
            "markdown": "Inoperability (CT and MR 75-93\\% accurate):\n(1) Invasion of right / left hepatic duct with extension to $2^{\\text {nd }}$-order biliary radicles\n(2) Atrophy of 1 hepatic lobe + involvement of contra- lateral portal vein branch / $2^{\\text {nd }}$-order biliary radicle\n(3) Vascular encasement / invasion of main portal vein or main hepatic artery\n(4) Metastatic disease: lymph node / distant\n\n# CHOLANGITIS \n\n## Acute Obstructive / Ascending Cholangitis\n\n$=$ biliary duct obstruction associated with bacterial overgrowth\nCause:\n(a) benign disease:\n\n1. Stricture from prior surgery ( $36 \\%$ ) after bile duct exploration / bilioenteric anastomosis\n2. Calculi $(30 \\%)$\n3. Sclerosing cholangitis\n4. Obstructed drainage catheter\n5. Parasitic infestation (liver fluke)\n(b) malignant disease:\n6. Ampullary carcinoma\n\n## Types:\n\n(a) Acute nonsuppurative ascending cholangitis\n\n- bile remains clear, patient nontoxic\n(b) Subacute nonsuppurative cholangitis\n$=$ Cholangitis lenta $=$ nonacute response of liver to systemic bacterial / fungal infection\n$\\diamond$ Important cause of liver failure + mortality with OLT\n(c) Acute suppurative ascending cholangitis ( $14 \\%$ )\n\nAssociated with: obstructing biliary stone or malignancy\n\n- biliary sepsis, CNS depression, lethargy, mental confusion, shock (50\\%)\n$\\checkmark$ purulent material fills biliary ducts\n$\\sqrt{ }$ marked inhomogeneous hepatic parenchymal enhancement during arterial phase $(60 \\%)$\nPrognosis: $100 \\%$ mortality if not decompressed; $40-60 \\%$ mortality with treatment; $13-16 \\%$ overall mortality rate\nOrganism: E coli (31\\%), Klebsiella pneumoniae (17\\%), Enterococcus faecalis (17\\%), Streptococcus ( $17 \\%$ )\n- recurrent episodes of sepsis + RUQ pain\n- Charcot triad ( $70 \\%$ ): fever + chills + jaundice\n- bile cultures in $90 \\%$ positive for infection\n$\\checkmark$ may have gas in biliary tree\nCECT:\n$\\checkmark$ nodular / patchy / wedge-shaped / geographic inhomogeneous transient hepatic parenchymal enhancement in periportal location on hepatic arterial phase (= hyperemic changes around bile ducts)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 321,
            "markdown": "$\\sqrt{ }$ diffuse concentric thickening of extrahepatic bile ducts, often with enhancement\n$C x$ : miliary pyogenic hepatic abscesses; portal vein thrombosis; biliary peritonitis; secondary sclerosing cholangitis\n\n# Acute Bacterial Cholangitis \n\n$=$ potentially life-threatening disease induced by acute biliary infection\nCause: obstruction of CBD by stones (in up to $80 \\%$ ), malignancy ( $10-30 \\%$ ), sclerosing cholangitis, instrumentation of biliary tree (in $18 \\%$ of transhepatic percutaneous biliary drainage catheter placement)\n$\\diamond$ Acute cholangitis occurs in $6-9 \\%$ of patients admitted for gallstone disease\nPathophysiology: increased intrabiliary pressure $\\left(\\geq 20 \\mathrm{~cm} \\mathrm{H}_{2} \\mathrm{O}\\right) \\rightarrow$ stagnant bile $\\rightarrow$ biliary bacterial contamination\nRisk factors: advanced age $>70$ years, neurologic disease, periampullary diverticulum\nOrganism: polymicrobial ( $30-80 \\%$ ); gram-negative rods ( $88 \\%$ )\n\n- Charcot triad $(75 \\%)=$ fever, pain, jaundice\n- Reynolds pentad $=$ fever, pain, jaundice, shock, lethargy\n- positive culture: bile ( $50 \\%$ ), blood ( $20-30 \\%$ )\n@ CBD:\n$\\sqrt{ }$ diffuse concentric wall thickening + enhancement\n$\\sqrt{ }$ frequently dilatation of CBD\n@ Intrahepatic bile ducts:\n$\\sqrt{ }$ central ( $38 \\%$ ), diffuse ( $16 \\%$ ), segmental ( $46 \\%$ ) dilatation\n$\\sqrt{ }$ wall thickening + enhancement (in up to $92 \\%$ during delayed-phase of fat-suppressed MRI)\n$\\sqrt{ } \\pm$ pneumobilia\n@ Liver parenchyma\nDistribution: wedge-shaped ( $72 \\%$ ) / peripheral patchy ( $14 \\%$ ) / peribiliary ( $14 \\%$ )\n$\\sqrt{ }$ increased SI on T2WI $(69 \\%) \\leftarrow$ extension of inflammation into periportal + liver tissues\n$\\sqrt{ }$ hepatic contrast enhancement: arterial only ( $58 \\%$ ), delayed only ( $16 \\%$ ), arterial and delayed ( $26 \\%$ ) phase\n$C x$ : sepsis, hepatic abscess, portal vein thrombosis, bile peritonitis\nMortality: 4-65\\%\n$R x$ : emergent endoscopic / percutaneous decompression of biliary tree; antibiotic therapy alone inadequate\n\n\n## AIDS-related Cholangitis\n\n$=$ AIDS CHOLANGIOPATHY= HIV-RELATED CHOLANGITIS\n$=$ infectious cholangitis characterized by opportunistic organisms in advanced AIDS patient with markedly depressed CD4 count of $<100 / \\mathrm{mm} 3$\nOrganism: NO definite pathogen identified in $50 \\%$\n(a) opportunistic: Cryptosporidium parvum (protozoan parasite typically infecting GI tract epithelium), CMV, Microsporidium, Mycobacterium avium complex\n\n- opportunistic organism isolated from bile (in 50\\%)\n(b) direct invasion of epithelium: Herpes simplex virus",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 322,
            "markdown": "Histo: marked periductal inflammatory response with interstitial edema + interstitial inflammatory cell infiltrates + necrotic biliary epithelium\n\n- RUQ pain, fever, nausea; jaundice (rare)\n- abnormal LFTs (esp. serum alkaline phosphatase; normal / mildly elevated bilirubin); elevated WBC count\nLocation: preferentially large intrahepatic bile ducts\nPattern: (1) combination of sclerosing cholangitis appearance + papillary stenosis (50\\%)\n(2) isolated intrahepatic sclerosing cholangitis-like appearance (20\\%)\n(3) isolated papillary stenosis $(15 \\%)$\n(4) long-segment extrahepatic duct stricture in isolation / with intrahepatic disease $(15 \\%)$\n$\\sqrt{ }$ irregular mild dilatation of intra- and extrahepatic bile ducts resembling sclerosing cholangitis\nUS:\n$\\sqrt{ }$ stricture of distal CBD / papillary stenosis $\\leftarrow$ papillitis\n$\\sqrt{ }$ echogenic nodule at the distal end of the CBD\n$\\sqrt{ }$ mural thickening of gallbladder + bile ducts\n$\\sqrt{ }$ saccular dilatations, debris, pruning of bile ducts\n$\\sqrt{ }$ periductal echogenicity\n$\\sqrt{ } \\pm$ pericholecystic fluid\nCT:\n$\\sqrt{ }$ \"pseudogallstone\" appearance = marked circumferential edema of gallbladder wall + mucosal enhancement\n$\\sqrt{ }$ periportal edema\nMR: resembling primary sclerosing cholangitis\n$\\sqrt{ }$ multiple intra- and extrahepatic biliary strictures, saccular dilatations + ductal pruning\n$\\sqrt{ }$ enhancing wall thickening of bile ducts\n$\\sqrt{ }$ isolated $1-2-\\mathrm{cm}$ long extrahepatic bile duct stricture\n$\\sqrt{ }$ irregular wall thickening of dilated CBD $\\leftarrow$ papillary stenosis\n$\\sqrt{ }$ thickened gallbladder wall $\\leftarrow$ acalculous cholecystitis\nCholangiography:\n$\\sqrt{ }$ strictures + beading of central intrahepatic bile ducts\n$\\sqrt{ }$ pruning of peripheral bile ducts\n$D D x$ : acalculous cholecystitis, papillary stenosis, sclerosing cholangitis\n$D x$ : inflammatory changes + associated pathogens in duodenal / papillary biopsy\n\n# Chemotherapy-induced Cholangitis \n\n$=$ inflammatory fibrosing process about the portal triads simulating primary sclerosing cholangitis\nPredisposed: patients with liver metastases from colon cancer\nCause: direct effect of hepatic arterial infusion with chemotherapeutic agents (eg, floxuridine) / ischemia $\\leftarrow$ thrombosis of intrahepatic arterial branches\n$\\sqrt{ }$ bile duct strictures as early as 2 months after therapy (in up to $15 \\%$ )\n$\\sqrt{ }$ stricture of common hepatic duct + sparing of distal CBD",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 323,
            "markdown": "# IgG4-related Sclerosing Cholangitis \n\n$=$ biliary manifestation of $\\operatorname{IgG} 4$ sclerosing disease\nHisto: infiltration by abundant IgG4-positive plasma cells\nAssociated with: IgG4-involvement of pancreas, kidneys, thyroid gland, salivary glands\nAge: older patient\nAccompanied by: extra- / intrapancreatic lesions (frequent)\n\n- $\\pm$ obstructive jaundice\n$R x$ : resolution under steroid therapy (often)\n- elevated serum IgG4 level\n$\\sqrt{ }$ patterns of biliary strictures:\n(a) distal intrapancreatic CBD stricture (most common)\n(b) diffuse intra- and extrahepatic bile duct strictures\n(c) hilar + distal CBD stricture\n(d) isolated hilar stricture\n$\\sqrt{ }$ long continuous multifocal strictures + prestenotic dilatation\n$\\sqrt{ }$ duct wall thickening = thick symmetric circumferential rind of enhancing tissue surrounding stricture\n$D D x$ : (1) Primary sclerosing cholangitis (multifocal + short intrahepatic biliary strictures with beaded / \"pruned-tree\" lesions)\n(2) Cholangiocarcinoma (confined to bile ducts, not affecting pancreatic duct, hepatic capsular retraction)\n(3) Pancreatic adenocarcinoma\n(4) Ischemic biliary strictures\n(5) AIDS cholangiopathy\n\n\n## Primary Sclerosing Cholangitis\n\n$=$ PSC $=$ FIBROSING CHOLANGITIS $=$ STENOSING CHOLANGITIS $=$ CHRONIC OBLITERATIVE CHOLANGITIS\n$=$ insidious progressive obliterative fibrosing inflammation of the biliary tree leading to multifocal strictures, bile duct obliteration, cholestasis, and biliary cirrhosis\nEtiology: idiopathic, ? autoimmune process (speculative); altered bile acid metabolism with increase in lithocholic acid by bacterial overgrowth\nPrevalence: $1 \\%$ as common as alcoholic liver disease\nMean age: 39 (range, 21-67) years; $<45$ years ( $2 / 3$ ); $\\mathrm{M} \\div \\mathrm{F}=7 \\div 3$\nClassification:\n(a) large-duct PSC\n(b) small duct PSC = clinical + biochemical + histologic features of PSC BUT normal appearance on cholangiography\nHisto:\nStage 1: degeneration of epithelial bile duct cells + infiltration with lymphocytes $\\pm$ neutrophils; inflammation + scarring + enlargement of periportal triads (pericholangitis)\nStage 2: fibrosis + inflammation infiltrating periportal parenchyma with piecemeal necrosis of hepatocytes; enlargement of portal triads; bile ductopenia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 324,
            "markdown": "Stage 3: portal-to-portal fibrous septa; severe degenerative changes + disappearance of bile ducts; cholestasis in periportal + paraseptal hepatocytes\nStage 4: frank cirrhosis\nAssociated with:\n(1) Inflammatory bowel disease (ulcerative colitis in 50-74\\%, Crohn disease in 13\\%)\n$\\diamond 1-4 \\%$ of patients with inflammatory bowel disease develop primary sclerosing cholangitis!\n$\\diamond 10 \\%$ of patients with PSC have Crohn disease\n(2) Cirrhosis, chronic active hepatitis, pericholangitis, fatty degeneration\n(3) Peyronie disease\n(4) Sjögren syndrome\n(5) Systemic lupus erythematosus\n(6) Rheumatoid arthritis\n\n- abnormal liver function tests: serum bilirubin, serum alkaline phosphatase, $\\gamma$ glutamyltransferase\n- progressive chronic / intermittent obstructive jaundice ( $75 \\%$ )\n- fever, night sweats, chills, RUQ pain, pruritus ( $10-15 \\%$ )\n- ANCA and antinuclear antibodies(low titers with low specificity)\n- history of previous biliary surgery $(53 \\%)+$ chronic / recurrent pancreatitis (14\\%)\n\nLocation:\n\n1. CBD almost always involved\n2. Intra- and extrahepatic ducts $(68-89 \\%)$\n3. Cystic duct $(15-18 \\%)$\n4. Intrahepatic ducts only ( $1-11-25 \\%)$\n5. Extrahepatic ducts only $(2-3 \\%)$\n$D x:$ PSC is diagnosed in patients with clinical + biochemical signs of cholestasis, typical cholangiographic imaging findings and after exclusion of secondary causes of sclerosing cholangitis.\n$\\sqrt{ }$ intrahepatic bile duct calculi ( $8-30 \\%$ ): soft black crushable stones / sandlike grit US:\n$\\checkmark$ brightly echogenic portal triads\n$\\checkmark$ echogenic biliary casts / punctate coarse calcifications along portal vein branches\n$\\checkmark$ extrahepatic ductal dilatation + choledocholithiasis\n$\\checkmark \\pm$ gallbladder wall thickening\n$\\checkmark$ gallbladder polyps (in $60 \\%$ malignant)\nCholangiography:\n$\\checkmark$ multifocal strictures with predilection for bifurcations + skip lesions (= uninvolved duct segments of normal caliber) involving intra- and extrahepatic bile ducts:\n$\\checkmark$ CLASSIC \"string-of-beads\" appearance (= alternating segments of dilatation and focal annular stenoses)\n$\\checkmark$ \"pruned tree\" appearance ( $=$ opacification of central ducts + nonvisualization of peripheral smaller radicles $\\leftarrow$ diffuse obstruction)\n$\\checkmark$ \"cobblestone\" appearance (= coarse nodular mural irregularities) in $50 \\%$\n$\\checkmark$ new strictures + lengthening of strictures between 6 months and 6 years $(<20 \\%)$\n$\\checkmark$ minimal duct dilatation $\\leftarrow$ periductal inflammation + fibrosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 325,
            "markdown": "$\\sqrt{ }$ marked ductal dilatation $(24 \\%)$\n$D D x$ : ascending cholangitis, cholangiocarcinoma\n$\\sqrt{ }$ diverticula / pseudodiverticula (PATHOGNOMONIC) = small eccentric saccular outpouchings (up to $27 \\%$ )\n$\\sqrt{ }$ ductal webs $=$ focal $1-2 \\mathrm{~mm}$ thick areas of incomplete circumferential narrowing\n$\\sqrt{ }$ angles formed between central and peripheral ducts change from acute to obtuse\n$\\sqrt{ }$ polypoid mass $(7 \\%)$\n$\\sqrt{ }$ gallbladder irregularities uncommon\n$\\sqrt{ }$ cholestasis-related choledocholithiasis\nCT:\n$\\sqrt{ }$ dilatation, stenosis, pruning (decreased arborization), beading of tortuous intrahepatic bile ducts = \"tree-in-winter\" / \"pruned tree\" appearance ( $80 \\%$ )\n$\\sqrt{ }$ wall nodularity, duct wall thickening, mural contrast enhancement of extrahepatic bile ducts $(100 \\%)$\n$\\diamond$ Periductal soft-tissue $>1.5 \\mathrm{~cm}$ thick with delayed enhancement is worrisome for cholangiocarcinoma!\n$\\sqrt{ }$ hepatic metastases + lymph nodes in porta hepatis\n$\\sqrt{ }$ subtle foci of high attenuation in intrahepatic bile ducts\n$\\sqrt{ }$ lobar atrophy in preferentially affected portions\nMR:\n$\\sqrt{ }$ enlarged central liver from macroregenerative nodules\n$\\sqrt{ }$ atrophied periphery with hyperintense wedge-shaped areas on T2WI\n$\\sqrt{ }$ dilated isolated \"floating\" bile ducts in periphery\n$\\sqrt{ }$ periportal intensity intermediate on T1WI + hyperintense on T2WI $\\leftarrow$ inflammation\nMRCP:\n@ Bile ducts\n$\\sqrt{ }$ \"beaded\" bile ducts = multifocal short-segment strictures of intra- + extrahepatic bile ducts alternating with normal bile ducts / mildly dilated duct ectasias\n$\\sqrt{ }$ peripheral pruning of intrahepatic ducts\n$\\sqrt{ }$ multifocal enhancing ductal wall thickening\n$\\sqrt{ } \\pm$ intrahepatic duct stones\n@ Liver\n$\\sqrt{ }$ peripheral wedge-shaped / reticular T2-hyperintense abnormalities\n$\\sqrt{ }$ hypertrophy of caudate lobe + medial segment of left lobe with atrophy of lateral + posterior segments\n$\\sqrt{ }$ large regenerating nodules\n$\\sqrt{ }$ multiple areas of enhancing fibrosis in liver periphery\n$\\sqrt{ } \\pm$ periportal lymph nodes\nNUC ( ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-IDA):\n$\\sqrt{ }$ multiple persistent focal areas of retention in distribution of intrahepatic biliary tree\n$\\sqrt{ }$ marked prolongation of hepatic clearance\n$\\sqrt{ }$ gallbladder visualized in only $70 \\%$\n$C x$ : (1) Biliary cirrhosis (up to $49 \\%$ ) after $>10$ years\n(2) Portal hypertension",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 326,
            "markdown": "(3) Malignancy $(10-15 \\%)$ :\n(a) cholangiocarcinoma (in 5-36\\% at autopsy / liver transplantation):\n\n- screening with tumor marker CA-19.9 > 129 U/mL ( $79 \\%$ sensitive, $99 \\%$ specific)\n(b) colorectal cancer (10- to 14 -fold increased risk compared to general population)\n(c) pancreatic cancer\n(4) Secondary recurrent bacterial cholangitis\n\nRx: (1) Palliative: ursodeoxycholic acid, dilatation of dominant strictures\n(2) Curative: liver transplantation ( $4^{\\text {th }}$ leading indication)\n\nDDx:\n(1) IgG4-related sclerosing cholangitis\n\nPrimary sclerosing cholangitis occurs in younger patients, is associated with inflammatory bowel disease, and is less acute with longer duration of symptoms compared to IgG4-related sclerosing cholangitis.\n(2) Sclerosing cholangiocarcinoma (progressive cholangiographic changes within $0.5-1.5$ years of initial diagnosis, marked ductal dilatation upstream from a dominant stricture, intraductal mass $>1 \\mathrm{~cm}$ in diameter)\n(3) Acute ascending cholangitis (history)\n(4) Recurrent pyogenic cholangitis\n(5) Primary biliary cirrhosis (disease limited to intrahepatic ducts, strictures less pronounced, pruning + crowding of bile ducts, normal AMA titer)\n(6) AIDS cholangiopathy (same cholangiographic findings)\n(7) Ischemic strictures\n\n# Recurrent Pyogenic Cholangitis \n\n$=$ PRIMARY CHOLANGITIS $=$ RECURRENT PYOGENIC HEPATITIS $=$ ORIENTAL CHOLANGIOHEPATITIS $=$ ORIENTAL CHOLANGITIS $=$ ORIENTAL INFESTATIONAL CHOLANGITIS $=$ HONG KONG DISEASE $=$ INTRAHEPATIC PIGMENTed STONE DISEASE\n$=$ progressive biliary disease characterized by recurrent episodes of bacterial cholangitis $\\leftarrow$ biliary obstruction by pigmented stones + biliary strictures + bile duct ectasia\nEtiology: ? Clonorchis sinensis infestation, coliform infection of bile, portal bacteremia, malnutrition\nPrevalence: $3^{\\text {rd }}$ most common cause of an acute abdomen in Hong Kong after appendicitis and perforated ulcer; uncommon in USA\nEpidemiology: endemic to Southeast Asia (South China, Indochina, Taiwan, Japan, Korea); Asian immigrants in USA\nStrongly associated intrabiliary infestation:\nAscaris lumbricoides, Clonorchis sinensis, Opisthorchis viverrini / felineus, Fasciola hepatica, E coli\nPathophysiology: chronic recurrent infections $\\rightarrow$ developing pigmented calculi $\\rightarrow$ cholangitic abscesses + inflammatory strictures\nPath: pericholangitis, periductal abscesses, fibrosis of bile duct walls, heavy infiltration of portal tracts by PMNs, intraductal bile pigment calculi",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 327,
            "markdown": "Age: $\\quad 20-50$ years; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\n\n- poor nutritional + low socioeconomic status of patient\n- recurrent attacks of fever, chills, abdominal pain, jaundice\n\nLocation: particularly in lateral segment of L lobe + posterior segment of R lobe + extrahepatic duct\nAssociated findings:\n$\\sqrt{ }$ gallstones\n$\\sqrt{ }$ splenomegaly\n$\\checkmark$ portal vein obstruction, varices\n$\\checkmark$ markedly dilated ( $3-4 \\mathrm{~mm}$ ) proximal intrahepatic ( $1^{\\text {st. }} \\& 2^{\\text {nd }}$-order) bile ducts (in $100 \\%$ ):\n$\\checkmark$ decreased arborization (branching) of intrahepatic radicles with abrupt tapering = \"arrowhead appearance\"\n$\\checkmark$ multifocal $<1 \\mathrm{~cm}$ long bile duct strictures ( $22 \\%$ )\n$\\checkmark$ pneumobilia (3-52\\%)\n$\\checkmark$ intra- and extrahepatic bile ducts filled with nonshadowing soft mudlike pigment (= calcium bilirubinate) stones ( $74 \\%$ ):\n$\\checkmark$ stones hyperattenuating compared to unenhanced liver parenchyma (in 90\\%)\n$\\checkmark$ stones T1-hyperintense + T2-hypointense to liver\n$\\checkmark$ disproportionate diffuse dilatation of central bile ducts involving stone-bearing and stone-free ducts $(68 \\%)$\n$\\checkmark$ thickened periportal space $\\leftarrow$ periductal inflammation + fibrosis\n$\\checkmark$ biloma\n$\\checkmark$ segmental hepatic atrophy ( $36 \\%$ ): left lobe / right posterior segments\n$\\checkmark$ hepatic abscesses\nCT:\n$\\checkmark$ abrupt nonvisualization of peripheral branches\n$\\checkmark$ enhancement of thickened bile duct wall\nERCP:\n$\\diamond$ Worsening of cholangitis / sepsis if patients do not receive antibiotics!\n$\\checkmark$ acute tapering + straightening + rigidity of bile ducts\n$\\checkmark$ decreased arborization + increased branching angle of bile ducts\nMRCP:\n$\\checkmark$ intra- / extrahepatic bile duct stones\n$\\checkmark$ multiple intrahepatic biliary strictures\n$\\checkmark$ short-segment focal extrahepatic bile duct stricture\n$\\checkmark$ localized dilatation of lobar / segmental bile ducts with predilection for lateral segment of left lobe + posterior segment of right lobe\n$\\checkmark$ wall thickening, abrupt tapering, $\\downarrow$ arborization of intrahepatic bile ducts\nCx: liver abscess ( $18 \\%$ ), splenomegaly ( $14 \\%$ ), biloma ( $4 \\%$ ), pancreatitis ( $4 \\%$ ), cholangiocarcinoma ( $2-6 \\%$ ): [peripheral ( $80 \\%$ ) or hilar / extrahepatic ( $20 \\%$ )]\nPrognosis: progressive destructive cholangiopathy + liver failure\n$R x$ : endoscopic sphincterotomy, choledochoduodenostomy, surgical resection (if disease in single segment / lobe)\n$D D x$ : (1) Caroli disease (saccular dilatation of intrahepatic bile ducts)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 328,
            "markdown": "(2) Primary sclerosing cholangitis (focal discontinuous bile duct dilatation)\n(3) Clonorchiasis (biliary ductal dilatation limited to intrahepatic bile ducts)\n\n# Secondary Sclerosing Cholangitis \n\n$=$ heterogeneous group of chronic cholestatic disorders morphologically similar to PSC Cause:\n(1) Intraductal stone disease / choledocholithiasis $\\rightarrow$ bile duct stricture $\\rightarrow$ recurrent pyogenic cholangitis\n(2) Ischemic cholangiopathy from treatment with intraarterial chemotherapy / floxuridine\n(3) Autoimmune pancreatitis\n(4) AIDS-asscociated cholangiopathy\n(5) Eosinophilic cholangitis\n(6) Previous biliary tract surgery / blunt trauma\n(7) Hepatic inflammatory pseudotumor\n(8) Congenital biliary tree anomalies\n(9) Bile duct neoplasm\n\n## CHOLECYSTITIS\n\nEtiology: (a) in 80-95\\% cystic duct obstruction by impacted calculus; $85 \\%$ disimpact spontaneously if stone $<3 \\mathrm{~mm}$\n(b) in $10 \\%$ acalculous cholecystitis\n\n## Acute Calculous Cholecystitis\n\nPathogenesis: chemical irritation from concentrated bile, bacterial infection, reflux of pancreatic secretions\nAge peak: $5^{\\text {th }}-6^{\\text {th }}$ decade; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 3$\nAssociated with: choledocholithiasis (15-25\\%)\n$\\diamond 5 \\%$ of patients presenting to ED have acute cholecystitis!\n\n- persisting ( $>6 \\mathrm{hr}$ ) RUQ pain radiating to right shoulder / scapula / interscapular area (DDx: biliary colic usually $<6$ hours)\n- nausea, vomiting, chills, fever, RUQ tenderness + guarding\n- Murphy sign = inspiratory arrest upon palpation of GB area (falsely positive in $6 \\%$ of patients with cholelithiasis)\n- $\\pm$ leukocytosis, elevated levels of alkaline phosphatase and transaminase and amylase\n- mild hyperbilirubinemia ( $20 \\%$ )\n\nUS ( $40-97 \\%$ sensitive, $64-100 \\%$ specific, $92 \\%$ PPV, $95 \\%$ NPV):\n$\\sqrt{ } \\pm$ GB wall thickening $>3 \\mathrm{~mm}(45-72 \\%$ sensitive, $76-88 \\%$ specific $)$ :\n$\\sqrt{ }$ hazy delineation of GB wall\n$\\sqrt{ }$ \"halo\" sign = GB wall lucency (in $8 \\%$ ) = 3-layered configuration with sonolucent middle layer (edema)\n$\\sqrt{ }$ striated wall thickening $(62 \\%)=$ several alternating irregular discontinuous lucent + echogenic bands within GB wall ( $100 \\%$ PPV)\n$\\sqrt{ }$ GB hydrops = distension with AP diameter $>5 \\mathrm{~cm}$ or enlargement of greater than $4 \\times 10$ cm",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 329,
            "markdown": "$\\sqrt{ }$ positive sonographic Murphy sign (in 85-88\\%)\n$=$ maximum tenderness during compression with transducer directly over gallbladder $(63-94 \\%$ sensitive, $85-93 \\%$ specific, $72 \\%$ NPV)\nFalse-negative sonographic Murphy sign:\nlack of patient responsiveness, pain medication, inability to press directly on GB (position deep to liver / protected by ribs), GB wall necrosis\n$\\sqrt{ }$ crescent-shaped / loculated pericholecystic fluid (in 20\\%) = inflammatory intraperitoneal exudate / abscess\n$\\checkmark$ gallstones ( $83-98 \\%$ sensitive, $52-77 \\%$ specific):\n$\\checkmark$ impacted gallstone in GB neck / cystic duct\n$\\checkmark$ echogenic shadowing fat within hepatoduodenal ligament $\\pm$ conspicuous color Doppler flow $\\leftarrow$ inflammation DDx: bowel gas\n$\\checkmark$ sludge\nColor Doppler US:\n$\\checkmark$ visualization of cystic artery $>50 \\%$ of the length of the gallbladder ( $30 \\%$ sensitive, $98 \\%$ specific)\nCT (* = signs with highest sensitivity+ specificity):\nDose: on average 11 mSv\nThe negative predictive value of CT for acute cholecystitis is $89 \\%$. While this is lower than for US, CT can exclude acute cholecystitis when clinical suspicion for gallbladder disease is low and clinical symptoms are nonspecific.\n@ GB size\n$\\checkmark$ distended gallbladder $>8 \\mathrm{~cm}$ long $/>4 \\mathrm{~cm}$ in diameter\n@ GB wall\n$\\checkmark$ irregular gallbladder wall\n$\\checkmark$ gallbladder wall thickness $\\geq 7 \\mathrm{~mm}^{*}$\n$\\checkmark$ gallbladder wall thickness $<2 \\mathrm{~mm}$\n$\\checkmark$ increased gallbladder wall attenuation\n$\\checkmark$ air in gallbladder wall\n$\\checkmark$ local / widespread absence of GB wall enhancement* = gangrenous acute cholecystitis\n@ GB content\n$\\checkmark$ gallstone in infundibulum\n$\\checkmark$ increased attenuation of bile\n$\\checkmark$ intraluminal membranes\n@ Hepatic pedicle ( $=$ vessels and ducts of porta hepatis)\n$\\checkmark$ hyperdense areas in fatty tissue around hepatic pedicle $=$ haziness of pericholecystic fat\n$\\checkmark$ pericholecystic fluid / effusion*\n@ Hepatic parenchyma\n$\\checkmark$ pericholecystic abscess\n$\\checkmark$ transient focal increased attenuation of liver parenchyma around gallbladder fossa on hepatic arterial phase $\\leftarrow$ hepatic arterial hyperemia + early venous drainage",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 330,
            "markdown": "@ Adjacent organs\n$\\sqrt{ }$ contact between GB wall and wall of duodenum / colon\nMR:\n$\\sqrt{ }$ T2-hyperintense thickened wall $>3 \\mathrm{~mm}$ (best seen on fat-suppressed T2WI)\n$\\sqrt{ }$ increased signal intensity within + surrounding GB on T2WI $\\leftarrow$ pericholecystic fluid\n$\\sqrt{ }$ signal void in cystic duct / gallbladder neck $\\leftarrow$ obstructing stone\n$\\sqrt{ }$ marked enhancement of gallbladder wall\n$\\sqrt{ }$ transient enhancement of pericholecystic hepatic parenchyma in $70 \\%$ (HIGHLY SPECIFIC)\nMRCP $=$ MR cholangiopancreatogram (high sensitivity):\n$\\sqrt{ }$ low-signal-intensity defect surrounded by high-signal-intensity bile on T2WI\nCholangiography:\n$\\sqrt{ }$ sharply defined filling defect in contrast-material filled lumen of cystic duct\nNUC ( $98 \\%$ sensitive, $100 \\%$ specific, $95-98 \\%$ accurate):\n$=$ functional information about cystic duct patency\nDose: on average 3.7 mSv\n$\\diamond$ Tracer uptake hinges on adequate hepatic function + fasting status\n$\\sqrt{ }$ nonvisualization of normal biliary anatomy:\n$\\sqrt{ }$ nonvisualization of GB during $1^{\\text {st }}$ hour (in $83 \\%$ )\n$\\sqrt{ }$ nonvisualization of GB by 4 hours ( $99 \\%$ specific)\n$\\sqrt{ }$ nonvisualization of GB + CBD (in 13\\%)\n$\\sqrt{ }$ \"dilated cystic duct\" sign (= radiotracer activity in a short segment of cystic duct proximal to obstructing stone) that may be mistaken for gallbladder\n$\\sqrt{ }$ \"pericholecystic rim\" sign ( $34 \\%$ sensitive) on initial images = increased hepatic activity adjacent to GB fossa: $94 \\%$ PPV for acute cholecystitis $+57 \\%$ PPV for gangrenous cholecystitis\nCause: local hepatocyte inflammation + hyperemia in transmural process $\\rightarrow$ increased perfusion to GB fossa during \"arterial phase\"\nEndpoint of imaging:\n» when tracer fills GB\n» 4 hours of delayed imaging after tracer injection\n» 45 minutes after morphine injection\nFalse-positive scans (10-12\\%)\n$=$ nonvisualization of GB without acute cholecystitis:\n(a) absent gallbladder: congenital absence of GB, post cholecystectomy\n(b) recent feeding $<4-6$ hours prior to study\n(c) sludge preventing filling of gallbladder: prolonged fasting, total parenteral nutrition, hyperalimentation\n(d) other hepatobiliary disease: chronic cholecystitis, CBD obstruction, carcinoma of GB\n(e) hepatocellular dysfunction: alcoholic liver disease, acute pancreatitis\n\nReduction to $2 \\%$ false-positive scans through:\n(1) delayed images up to 4 hours\n(2) cholecystokinin (Sincalide ${ }^{\\circledR}$ ) injection 15 minutes prior to study\n(3) morphine IV $(0.04 \\mathrm{mg} / \\mathrm{kg})$ at 40 minutes with reimaging after 20 minutes $\\rightarrow$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 331,
            "markdown": "contraction of sphincter of Oddi $\\rightarrow$ rise in intrabiliary pressure\nFalse-negative scans (4.8\\%):\n(a) acute cholecystitis without cystic duct obstruction: acalculous / rare calculous cholecystitis\n(b) extrahepatic radiotracer accumulation mistaken for gallbladder activity: duodenal diverticulum, biliary duplication cyst, gangrenous cholecystitis with accumulation in gallbladder bed, \"dilated cystic duct\" sign\n$C x$ :\nmnemonic: GAME BEG\nGangrene\nAbscess (pericholecystic)\nMirizzi syndrome\nEmphysematous cholecystitis\nBouveret syndrome ( $=$ gallstone erodes into duodenum leading to duodenal obstruction)\nEmpyema\nGallstone ileus\n\n# Gangrene of Gallbladder $=$ Gangrenous Cholecystitis \n\n$=$ common severe complication of acute cholecystitis\nFrequency: $26 \\%$ of patients with acute cholecystitis\n\n- positive Murphy sign (33\\%)\n\nUS:\n$\\sqrt{ }$ irregular / absent gallbladder wall\n$\\sqrt{ }$ shaggy, irregular, asymmetric wall (mucosal ulcers, intraluminal hemorrhage, necrosis)\n$\\checkmark$ hyperechoic foci within GB wall (microabscesses in Rokitansky-Aschoff sinuses)\n$\\checkmark$ intraluminal pseudomembranes (gangrene)\n$\\checkmark$ coarse nonshadowing nondependent echodensities ( $=$ sloughed necrotic mucosa / sludge / pus / clotted blood within gallbladder)\nCT (insensitive but highly specific):\n$\\checkmark$ intramural / intraluminal gas\n$\\checkmark$ intraluminal membranes\n$\\checkmark$ irregular / absent GB wall, lack of wall enhancement\n$\\checkmark$ pericholecystic abscess formation.\nMR:\n$\\checkmark$ interrupted \"rim\" sign = patchy enhancement of mucosa on contrast-enhanced fatsuppressed MR\nNUC:\n$\\checkmark$ radiotracer accumulation in gallbladder fossa\n$R x$ : laparoscopic cholecystectomy (frequently converted to open surgery)\n\n## Pericholecystic Abscess\n\nCause: subacute perforation of gallbladder wall subsequent to gangrene + infarction $\\leftarrow$ acute cholecystitis\nPrevalence: $2-20 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 332,
            "markdown": "# Location: \n\n(a) gallbladder bed (most common)\n$\\sqrt{ }$ area of low-level echoes in liver adjacent to GB\n(b) intramural\n$\\sqrt{ }$ small area of low-level echoes within thickened gallbladder wall\n(c) intraperitoneal\n$\\sqrt{ }$ area of low-level echoes within peritoneal cavity adjacent to gallbladder\n$R x$ : (1) Emergency operation\n(2) Antibiotic treatment + elective operation\n(3) Percutaneous abscess drainage\n\n## Perforation of Gallbladder (in 2-20\\%)\n\nAverage age: 60 years; $\\mathrm{M}>\\mathrm{F}$\nTypes:\n(1) Acute free perforation with peritonitis $\\rightarrow$ pericholecystic abscess in $33 \\%$\n(2) Subacute localized perforation $\\rightarrow$ pericholecystic abscess in $48 \\%$\n(3) Chronic perforation $\\rightarrow$ internal biliary fistula $\\rightarrow$ pericholecystic abscess in $18 \\%$\n\nLocation: most commonly at fundus $\\leftarrow$ poor blood supply\n$\\sqrt{ }$ gallstone lying free in peritoneal cavity $=$ SPECIFIC\nUS:\n$\\sqrt{ }$ sonolucent / complex collection surrounding GB\n$\\sqrt{ }$ collection in liver adjacent to gallbladder\nCT:\n$\\sqrt{ }$ \"hole\" sign = focal gallbladder wall defect\nNUC:\n$\\sqrt{ }$ extrabiliary radiotracer activity (that may be mistaken for activity within gallbladder) best appreciated with delayed imaging\nMortality: up to $15 \\%$ (attributed to delayed diagnosis)\n$C x$ : free intraperitoneal air; bile leak; abscess formation in liver / GB fossa / peritoneum; SBO\n\n## Empyema of Gallbladder\n\n$\\sqrt{ }$ multiple medium / coarse highly reflective intraluminal echoes without shadowing / layering / gravity dependence (purulent exudate / debris)\n\n## Acute Acalculous Cholecystitis\n\nFrequency: $5-15 \\%$ of all acute cholecystitis cases\nAssociated with: recent surgery in $50 \\%$\nEtiology: probably decreased blood flow within cystic artery\n(1) Debilitated patients: depressed motility / starvation in trauma, burns, surgery, total parenteral nutrition, anesthesia, positive pressure ventilation, narcotics, shock, vasoactive amines, congestive heart failure, arterio-sclerosis, polyarteritis nodosa, SLE, diabetes mellitus\n$\\diamond$ Diagnosis in the ICU patient sonographically difficult due to fasting state, medications, CHF, etc.",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 333,
            "markdown": "(2) Obstruction of cystic duct by extrinsic inflammation, lymphadenopathy, metastases\n(3) Infection (only in 50\\%): Salmonella, Helicobacter, cholera, Kawasaki syndrome, cytomegalovirus, cryptosporidiosis\n$\\checkmark$ thickened gallbladder wall $>4-5 \\mathrm{~mm}$\n$\\checkmark$ echogenic bile / sludge\n$\\checkmark$ gallbladder distension\n$\\checkmark$ pericholecystic fluid in absence of ascites\n$\\checkmark$ striated subserosal edema\n$\\checkmark$ sloughed mucosal membrane\n$\\checkmark$ Murphy sign = pain + tenderness with transducer pressure over the gallbladder (difficult to assess in ICU patient with altered mental status)\n$\\checkmark$ decreased response to cholecystokinin\n$\\checkmark$ intramural gas\nCT:\n$\\checkmark$ pericholecystic stranding (= edema)\n$\\checkmark$ decreased attenuation in adjacent liver (= perihepatitis)\nNUC: same criteria as for calculous cholecystitis\n$C x$ : gallbladder perforation, gangrene, pericholecystic abscess\n$R s$ : percutaneous cholecystostomy trial (low threshold for ICU patients)\nPrognosis: $6.5 \\%$ mortality rate\n\n# Chronic Cholecystitis \n\n$\\diamond$ Most common form of gallbladder inflammation\n$\\checkmark$ gallstones\n$\\checkmark$ smooth / irregular GB wall thickening (mean of 5 mm )\n$\\checkmark$ mean volume of 42 mL\nNUC:\n$\\checkmark$ normal GB visualization in majority of patients\n$\\checkmark$ delayed GB visualization (1-4 hours)\n$\\checkmark$ visualization of bowel prior to gallbladder ( $45 \\%$ sensitive, $90 \\%$ specific)\n$\\checkmark$ noncontractility / decreased response after CCK injection (decreased GB ejection fraction)\n\n## Emphysematous Cholecystitis\n\n$=$ variant of acute cholecystitis $\\leftarrow$ ischemia of gallbladder wall + infection with gasproducing organisms\nFrequency: $1 \\%$ of all acute cholecystitis cases\nEtiology: small-vessel disease with cystic artery occlusion, complication of acute cholecystitis\nOrganism: Clostridium perfringens, Clostridium welchii, E. coli, Bacillus fragilis\nAge: $\\quad>50$ years; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 1$ to $5 \\div 1$\nPredisposed: diabetics ( $20-50 \\%$ ), debilitating diseases; calculous ( $70-80 \\%$ ) / acalculous cystic duct obstruction\nPathophysiology: obstructive endarteritis $\\rightarrow$ ischemia $\\rightarrow$ secondary infection with anaerobes",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 334,
            "markdown": "- WBC count may be normal ( $1 / 5$ )\n- point tenderness rare (diabetic neuropathy)\n\nPlain film:\n$\\checkmark$ gas appears $24-48$ hours after onset of symptoms\n$\\checkmark$ air-fluid level in GB lumen, air in GB wall within 24-48 hours after acute episode\n$\\checkmark$ pneumobilia (rare)\nUS:\n$\\checkmark$ arclike high-level echoes outlining GB wall mimicking porcelain gallbladder / multiple stones in contracted GB\n$\\checkmark$ cholecystolithiasis ( $50 \\%$ )\nCT (most sensitive and specific imaging modality):\n$\\checkmark$ identification of gas in gallbladder lumen / wall\n$\\checkmark$ irregularity / discontinuity of gallbladder wall\n$\\checkmark$ pneumobilia, pericholecystic fluid, abscess formation\nCx: gangrene ( $75 \\%$ ); gallbladder perforation ( $20 \\%$ )\nMortality: $15 \\%$\nRx: urgent cholecystectomy; temporizing percutaneous cholecystostomy + antibiotics\nDDx: (1) Enteric fistula\n(2) Incompetent sphincter of Oddi\n(3) Air-containing periduodenal abscess\n(4) Periappendiceal abscess in malpositioned appendix\n(5) Lipomatosis of gallbladder\n\n\n# Xanthogranulomatous Cholecystitis \n\n$=$ FIBROXANTHOGRANULOMATOUS INFLAMMATION = CEROID GRANULOMAS OF THE GALLBLADDER\n$=$ uncommon severe inflammatory disease of gallbladder characterized by presence of multiple intramural nodules\nPrevalence: $1-2 \\%$\nPredisposition: gallstones, obesity, diabetes mellitus\nPathophysiology:\ncystic duct obstruction or rupture of occluded Rokitansky-Aschoff sinuses $\\rightarrow$ mucosal / mural injury $\\rightarrow$ extravasation of inspissated bile + mucin attracting histiocytes $\\rightarrow$ phagocytosis of insoluble bile lipids and cholesterol $\\rightarrow$ lipogranuloma formation $\\rightarrow$ fibrosis\nAge: $\\quad 5^{\\text {th }}+6^{\\text {th }}$ decade\nHisto: mixture of xanthoma cells with foamy histiocytes + fibroblasts + multinucleated foreign body giant cells + lymphocytes containing areas of necrosis\nMay be associated with: gallbladder carcinoma (11\\%)\n$\\checkmark$ preservation of 2-3-mm thick mucosal lining (in $82 \\%$ )\n$\\checkmark$ thickened gallbladder wall: $91 \\%$ diffuse, $9 \\%$ focal\n$\\checkmark$ infiltration of pericholecystic fat: in $45 \\%$ focal, in $54 \\%$ diffuse\n$\\checkmark$ hepatic extension ( $45 \\%$ )\n$\\checkmark$ biliary obstruction ( $36 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 335,
            "markdown": "$\\sqrt{ }$ lymphadenopathy $(36 \\%)$\nUS:\n$\\sqrt{ }$ intramural hypoechoic nodules\nCT:\n$\\sqrt{ } 5-20-\\mathrm{mm}$ small intramural hypoattenuating nodules\n$\\sqrt{ }$ poor / heterogeneous contrast enhancement\nMR:\n$\\sqrt{ }$ areas of marked T2-hyperintensity $\\leftarrow$ necrosis / abscess\n$\\sqrt{ }$ xanthogranulomas show delayed strong enhancement\n$D D x$ : gallbladder carcinoma with local spread (in $59 \\%$ focal, in $41 \\%$ diffuse thickening of gallbladder wall, multiple masses within liver)\n\n# CHOLEDOCHAL CYST \n\n$=$ CYSTIC DILATATION OF EXTRAHEPATIC BILE DUCT\n$=$ rare congenital biliary tract anomaly characterized by dilatation of all / part of the extra- / intrahepatic bile ducts without involvement of gallbladder / cystic duct\n$\\diamond$ Most common congenital lesion of bile ducts\nEtiology: ?\n(a) biliary ductal plate malformation of extrahepatic bile ducts as part of congenital fibrocystic disease\n(b) anomalous junction of pancreatic duct and CBD proximal to duodenal papilla $\\rightarrow$ higher pressure in pancreatic duct with absence of ductal sphincter $\\rightarrow$ allows free reflux of enzymes into $\\mathrm{CBD} \\rightarrow$ chemical + inflammatory changes $\\rightarrow$ weakening of CBD wall + dilatation of CBD\nClassification of malunion of pancreaticobiliary duct\nKimura type I $\\quad=$ pancreatic duct enters the proximal / mid CBD $(10-58 \\%)$ at right angle\nKimura type II $\\quad=$ CBD drains into pancreatic duct\nClassification by 5 subtypes (Todani): according to common cystic changes but probably different pathophysiologic features\n(1) Todani type I choledochal cyst confined to extrahepatic bile duct (EBD)\nCause: anomalous pancreaticobiliary union $\\rightarrow$ formation of a long frequently ectatic common channel\n(a) Todani type Ia $=$ diffuse EBD cyst\n(b) Todani type $\\mathrm{Ib}=$ focal segmental EBD cyst\n(c) Todani type Ic = fusiform CBD cyst\n(2) Todani type II choledochal cyst $=$ true diverticulum\n(3) Todani type III choledochal cyst $=$ choledochocele\n$=$ focal dilatation of intraduodenal segment of distal CBD\n(4) Todani type IV choledochal cyst $=$ multiple cysts\n(a) Todani type IVa multiple choledochal cysts\n$=$ multiple cysts of both $\\mathrm{EBD}+\\mathrm{IBD}$\n(b) Todani type IVb multiple choledochal cysts",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 336,
            "markdown": "$=$ multiple saccular dilatations of EBD only\n(5) Todani type V choledochal cyst $=$ Caroli disease\n![img-55.jpeg](img-55.jpeg)\n\nPrevalence: $1 \\div 13,000$ admissions; high prevalence in Japanese / Asian infants\nAge: $<10$ years $(60 \\%)+$ young adulthood; $80 \\%$ diagnosed in childhood; $7 \\%$ during pregnancy; occasionally detected up to $8^{\\text {th }}$ decade; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 4$\nHisto: fibrous cyst wall without epithelial lining\nAssociated with:\n(1) Dilatation / stenosis / atresia of other segments of the biliary tree (2\\%)\n(2) Gallbladder anomaly: aplasia, double GB\n(3) Failure of union of left + right hepatic ducts\n(4) Pancreatic duct + accessory hepatic bile ducts may drain into cyst\n(5) Polycystic liver disease\n\n- Classic triad in $2-38 \\%(20-30 \\%)$ of all (adult) patients:\n(1) Intermittent obstructive jaundice ( $33-50 \\%$ )\n$\\diamond$ Uncommon cause of obstructive jaundice!\n(2) Recurrent RUQ colicky pain ( $>75-90 \\%$ ), back pain\n(3) Intermittent palpable RUQ abdominal mass ( $<25 \\%$ )\n- recurrent fever, chills, weight loss, pruritus",
            "images": [
                {
                    "id": "img-55.jpeg",
                    "top_left_x": 357,
                    "top_left_y": 305,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1302,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 337,
            "markdown": "Types:\n(a) marked cystic dilatation of $\\mathrm{CBD}+\\mathrm{CHD}$\n(b) focal segmental dilatation of CBD distally\n(c) cylindric dilatation of $\\mathrm{CBD}+\\mathrm{CHD}$\n\nSize: CBD diameter of $2-15 \\mathrm{~cm}$\n$\\diamond$ The largest choledochal cyst contained 13 liters\n$\\sqrt{ }$ NO / mild peripheral intrahepatic bile duct dilatation\n$\\sqrt{ }$ may contain stones / sludge\nUGI:\n$\\sqrt{ }$ soft-tissue mass in RUQ\n$\\sqrt{ }$ anterior displacement of $2^{\\text {nd }}$ portion of duodenum + distal portion of stomach (on LAT view)\n$\\sqrt{ }$ widening of C-loop with inferior displacement of duodenum (on AP view)\nUS:\n$\\sqrt{ }$ ballooned / fusiform cyst beneath porta hepatis separate from gallbladder\n$\\diamond$ Communication with common hepatic / intrahepatic ducts needs to be demonstrated!\n$\\sqrt{ }$ abrupt change of caliber at junction of dilated segment to normal duct\n$\\sqrt{ }$ intrahepatic bile duct dilatation $(16 \\%) \\leftarrow$ stenosis\nOB-US (earliest diagnosis at 25 weeks MA):\n$\\sqrt{ }$ right-sided cyst in fetal abdomen + adjacent dilated hepatic ducts\n$D D x$ : duodenal atresia; cyst of ovary, mesentery, omentum, pancreas, liver\nNUC with HIDA:\n$\\diamond$ At times the choledochal cyst does not fill with radionuclide!\n$\\sqrt{ }$ photopenic area within liver that fills within $60 \\mathrm{~min}+$ stasis of tracer within cyst\n$\\sqrt{ }$ lack of tracer passage into small intestine\n$\\sqrt{ }$ prominent hepatic ductal activity $\\leftarrow$ dilatation of ducts\n$D D x$ : often excludes hepatic cyst, pancreatic pseudocyst, enteric duplication, spontaneous\nloculated biloma\nCholangiography / MRCP (confirms diagnosis):\n$\\sqrt{ }$ anomalous pancreaticobiliary junction with long common channel\n$\\sqrt{ }$ dilated intrahepatic bile ducts\n$\\sqrt{ }$ intraductal calculi\nCx: (1) Stones ( $8-50 \\%$ ) in gallbladder, in CBD, within cyst, in intrahepatic biliary tree, in pancreatic duct\n(2) Malignant transformation into bile duct carcinoma + gallbladder carcinoma (increasing with age, $<1 \\%$ in 1 st decade, $7-14 \\%>$ age 20 )\n(3) Recurrent acute pancreatitis ( $33 \\%$ )\n(4) Recurrent cholangitis / cholecystitis (20\\%)\n(5) Cyst rupture with bile peritonitis ( $1.8 \\%$ )\n(6) Bleeding\n(7) Biliary cirrhosis + portal hypertension\n(8) Portal vein thrombosis\n(9) Hepatic abscess",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 338,
            "markdown": "Rx: excision of cyst + Roux-en-Y hepaticojejunostomy\n$D D x$ : mesenteric, omental, ovarian, renal, adrenal, hepatic, enteric duplication cyst, pancreatic pseudocyst, hydronephrotic kidney, hepatic artery aneurysm, biloma ( $\\leftarrow$ spontaneous perforation of CBD)\n![img-56.jpeg](img-56.jpeg)\n\n# CHOLEDOCHOCELE \n\n$=$ DUODENAL DUPLICATION CYST = ENTEROGENOUS CYST OF AMPULLA OF VATER / DUODENUM $=$ INTRADUODENAL CHOLEDOCHAL CYST = TYPE III CHOLEDOCHAL CYST = DIVERTICULUM OF COMMON BILE DUCT\n$=$ cystic dilatation of distal / intramural duodenal portion of CBD with herniation of CBD into duodenum (similar to ureterocele)\nEtiology:\n(1) congenital:\n(a) originates from tiny bud / diverticulum of distal CBD (found in $5.7 \\%$ of normal population)\n(b) stenosis of ductal orifice / weakness of ductal wall\n(2) acquired:\nstone passage followed by stenosis + inflammation\nAge: 33 years (manifestation usually in adulthood)\nTypes: (a) CBD terminates in cyst, cyst drains into duodenum (common)\n(b) cyst drains into adjacent intramural portion of CBD (less common)\n\n- biliary colic, episodic jaundice, nausea, vomiting\n- bulging papilla; high amylase level within bile\n\nAssociated with: stones / sludge (frequent)\nUGI:\n$\\sqrt{ }$ smooth well-defined intraluminal duodenal filling defect in region of papilla\n$\\sqrt{ }$ change in shape with compression / peristalsis\nCholangiography (diagnostic):\n$\\sqrt{ }$ opacified smooth clublike / saclike dilatation of intramural segment of CBD prolapsed into duodenum\nCT:\n$\\sqrt{ }$ spheric dilatation of terminal bile duct protruding into duodenal lumen\n$C x$ : pancreatitis, duodenal obstruction, cholecystitis\nRx: sphincterotomy / sphincteroplasty",
            "images": [
                {
                    "id": "img-56.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 385,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 748,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 339,
            "markdown": "$D D x$ : choledochal cyst (involves more than only terminal portion of CBD)\n\n# CHOLELITHIASIS \n\n## Prevalence:\n\n25,000,000 adults in USA;\n$10-15 \\%$ of population $+2 \\%$ of children\nAge: increasing with age ( $40 \\%$ of women in $9^{\\text {th }}$ decade);\n$\\mathrm{M}+\\mathrm{F}=2 \\%+4 \\%(10 \\%+25 \\%)$ in $3^{\\text {rd }}(7^{\\text {th }}$ ) decade\nPredisposing factors: \"female, forty, fair, fat, fertile, flatulent\"\nPathogenesis: supersaturation of bile constituents, most notably cholesterol $\\leftarrow$ defects in biliary lipid metabolism; biliary dysmotility; prolonged intestinal transit; aggravated by sedentary lifestyle + diet\n(1) Hemolytic disease:\nsickle cell disease ( $7-37 \\%$ ), hereditary spherocytosis ( $43-85 \\%$ ), thalassemia, pernicious anemia ( $16-20 \\%$ ), prosthetic cardiac valves + mitral stenosis (hemolysis), cirrhosis (hemolysis $\\leftarrow$ hypersplenism), Rhesus / ABO blood group incompatibility (perinatal period)\n(2) Metabolic disorder = disruption of biliary lithogenic index: diabetes mellitus, obesity, pancreatic disease, cystic fibrosis, hypercholesterolemia, type 4 hyperlipidemia, hemosiderosis ( $20 \\%$ ), hyperparathyroidism, hypothyroidism, prolonged use of estrogens / progesterone, pregnancy\n(3) Cholestasis\n> hepatic dysfunction: hepatitis, neonatal sepsis\nbiliary tree malformation: Caroli disease\nbiliary obstruction: parasitic infection, benign / malignant strictures, foreign bodies (sutures, ascariasis)\n> prolonged fasting (total parenteral nutrition)\n> methadone intake\n(d) Intestinal malabsorption\n$\\rightarrow 10 \\mathrm{x}$ increased risk of stone formation\n> inflammatory bowel disease: Crohn disease (28-34\\%)\n> ileal resection\n> bypass surgery\n(e) Genetic predisposition = familial:\n\nNavaho, Pima, Chippewa Indians\n(f) Others\nmuscular dystrophy\n\n## Composition:\n\nA. CHOLESTEROL STONE (70\\%)\n$=$ main component of most calculi\n$\\sqrt{ }$ lucent ( $93 \\%$ ), calcified ( $7 \\%$ )\n$\\sqrt{ }$ slightly hypodense compared with bile\n(a) pure cholesterol stones ( $10 \\%$ ): yellowish, soft\n$\\checkmark$ buoyancy in contrast-enhanced bile",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 340,
            "markdown": "$\\sqrt{ }$ density of $<100 \\mathrm{HU}$\n(b) mixture of cholesterol + calcium carbonate / bilirubinate (70\\%)\n$\\checkmark$ laminated appearance\n$\\checkmark$ radiopaque on plain film ( $15-20 \\%$ )\nMR:\n$\\checkmark$ hypointense on T2WI + T1WI\n$\\checkmark$ occasionally hyperintense center on T2WI + T1WI (protein molecules)\nB. PIGMENT STONE (30\\%)\n\n- brown $($ common $)=$ granular precipitate of calcium bilirubinate containing $<25 \\%$ cholesterol (by definition)\nCause: inflammation / infection of gallbladder, status post cholecystectomy\n- black (less common) = compact \"lacquer\" of bilirubin derivatives with a high affinity for calcium carbonate\n$\\checkmark$ multiple tiny faceted / spiculated homogeneously radiopaque stones\nCT:\n$\\checkmark$ usually denser than bile\nMR:\n$\\checkmark$ hypointense on T2WI + hyperintense on T1WI (related to degree of hydration)\nC. GAS-CONTAINING GALLSTONE\n\nMechanism: dehydration of older stones leads to internal shrinkage + dendritic cracks + subsequent nitrogen gas-filling from negative internal pressure\n$\\sqrt{ }$ \"crow-foot\" = \"Mercedes-Benz\" sign = radiating streaklike lucencies within stone, also responsible for buoyancy\nD. FLOATING GALLSTONE (20-25\\%)\n(a) relatively pure cholesterol stones\n(b) gas-containing stones\n(c) rise in specific gravity of bile $(=1.03)$ from oral cholecystopaques (specific gravity of 1.06) causing stones with a specific gravity of 1.05 to float\nE. GALLBLADDER SLUDGE\n$=$ calcium-bilirubinate granules + cholesterol crystals associated with biliary stasis\nCause: prolonged fasting, parenteral nutrition, hyperalimentation, hemolysis, extrahepatic bile duct obstruction, cystic duct obstruction, acute + chronic cholecystitis\n$\\checkmark$ nonshadowing homogeneously echogenic material:\n$\\checkmark$ fluid-sludge level\n$\\checkmark$ \"sludge ball\" = tumefactive sludge:\n$\\checkmark$ slowly shifting with repositioning of patient\n$D D x$ : gallbladder cancer\nPrognosis: may cause acute cholecystitis\n$D D x$ : hemobilia with blood clot, parasitic infestation, mucus\n\n# Radiopacity: \n\n$\\checkmark$ lucent stones ( $84 \\%$ ): cholesterol ( $85 \\%$ ), pigment ( $15 \\%$ )\n$\\checkmark$ calcified stones ( $15-20 \\%$ on plain film, $60 \\%$ on CT): cholesterol (33\\%), pigment (67\\%)\n$\\diamond$ CT sensitivity highest at 140 kVp\nLocation of calcium:\n$\\checkmark$ calcium phosphate deposited centrally within cholesterol stones",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 341,
            "markdown": "$\\sqrt{ }$ calcium carbonate deposited radially within aging cholesterol / peripherally around cholesterol + pigmented stones\n\n# Gallstones in Fetus \n\nEGA: $>28$ weeks EGA\nCause: hemolytic disease, cholestasis, maternal drug use\nPrognosis: usually resolve before / after delivery\n\n## Gallstones in Neonate\n\n$\\diamond$ Rare without predisposing factors\nAssociated with: obstructive congenital biliary anomaly, total parenteral nutrition, furosemide, GI dysfunction (short-gut syndrome), prolonged fasting, phototherapy, dehydration, infection, hemolytic anemia\n\n## Gallstones in Older Children\n\nAssociated with: sickle cell disease, cystic fibrosis, malabsorption, total parenteral nutrition, Crohn disease, intestinal resection, hemolytic anemia, choledochal cyst\n\n## Gallstones in Pregnancy\n\nPrevalence: $2-4 \\%$ of pregnant patients have gallstones, $5 \\%$ develop symptoms\nAcute cholecystitis:\n» NO increased risk during pregnancy\n» $2^{\\text {nd }}$ most common condition requiring surgery (in $1 \\div 1600-10,000$ pregnancies)!\n\n## Cholecystolithiasis\n\n- asymptomatic ( $60-65 \\%$ ); become symptomatic at a rate of $1-2-4 \\%$ per year\n- biliary colic (misnomer) $\\leftarrow$ transient obstruction of cystic duct / common bile duct develops in $33 \\%$ ( $18 \\%$ overall risk in 20 years):\n$=$ acute RUQ / epigastric / LUQ / precordial / lower abdominal pain increasing over seconds / minutes + remaining fairly steady for $1-3(-6)$ hours associated with nausea + vomiting\n- no tenderness upon palpation\n\nAbdominal plain film ( $10-16 \\%$ sensitive):\n$\\checkmark$ calcified gallstones\nCT ( $80 \\%$ sensitive):\n$\\checkmark$ hyperdense calcified gallstones in $60 \\%$\n$\\checkmark$ hypodense cholesterol stones $\\leq 140 \\mathrm{HU}=$ pure cholesterol stone $(=\\geq 80 \\%$ cholesterol content):\n$\\diamond$ Inverse relationship between CT attenuation number + cholesterol content\n$\\checkmark$ gallstones isointense to bile ( $<30 \\mathrm{HU}$ ) in $21-24 \\%$ and thus undetectable by CT\nUS ( $91-98 \\%$ sensitive; in $5 \\%$ falsely negative):\n$\\checkmark$ bright ( $=$ highly reflective) echo from anterior surface of gallstone within gallbladder:\n$\\checkmark$ marked posterior acoustic shadowing\n$\\checkmark$ mobile upon repositioning of patient (may infrequently be adherent to wall)\n$\\checkmark$ reverberation artifact",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 342,
            "markdown": "$\\diamond$ Small calcifications $<2 \\mathrm{~mm}$ may not shadow\n$\\checkmark$ nonvisualization of GB + collection of echogenic echoes with acoustic shadowing (15$25 \\%)$ :\n$\\checkmark$ \"wall-echo-shadow\" = \"double-arc shadow\" sign\n$=2$ echogenic curvilinear parallel lines separated by sonolucent line (ie, anterior GB wall + bile + stone with acoustic shadowing)\n$\\checkmark$ focal nonshadowing opacities $<5 \\mathrm{~mm}$ in diameter (in $70 \\%$ gallstones)\nFalse-negative US (5\\%):\ncontracted GB, GB in anomalous / unusual location, small gallstone, gallstone impacted in GB neck / cystic duct, immobile patient, obese patient, extensive RUQ bowel gas\nPrognosis: stones $<3 \\mathrm{~mm}$ may pass through cystic duct\n$C x$ : acute cholecystitis (in $30 \\%$ ), choledocholithiasis, cholangitis, pancreatitis, duodenitis, biliary fistula, gallstone ileus, Mirizzi syndrome; cancer of GB + bile ducts ( $2-3 \\mathrm{x}$ more frequent)\n\n# Cholangiolithiasis \n\n## Choledocholithiasis\n\n$\\diamond$ Most common cause of bile duct obstruction!\nEtiology: (a) passed stones originating in GB\n(b) primary development in intra- / extrahepatic ducts (rare)\n\nFrequency: in $12-15 \\%$ of cholecystectomy patients; in $3-4 \\%$ of postcholecystectomy patients; in $75 \\%$ of patients with chronic bile duct obstruction\nRisk indicators for CBD stone:\n(1) Recent history of jaundice\n(2) Recent history of pancreatitis\n(3) Elevated serum bilirubin $>17 \\mu \\mathrm{~mol} / \\mathrm{L}$\n(4) Elevated serum amylase $>120 \\mathrm{IU} / \\mathrm{L}$\n(5) Dilated $\\mathrm{CBD}>6 \\mathrm{~mm}(16 \\%)$\n(6) Obscured bile duct\n\n- asymptomatic: $10 \\%$ of patients treated with cholecystectomy have unsuspected CBD calculi\n- recurrent episodes of right upper quadrant pain, jaundice, chills, fever ( $25-50 \\%$ )\n- elevated serum bilirubin + alkaline phosphate levels\n- elevated transaminase $(75 \\%)$\n- spontaneous passage with stones $<6 \\mathrm{~mm}$ size\n\nLocation: dependently in duct\nCholangiography (most specific technique):\n$\\checkmark$ stone visualization in $92 \\%$\n$\\checkmark$ dependent round filling defects\n$D D x$ : air bubbles, neoplasm, concentrated bile\nPeroperative cholangiography:\nprolongs operation by 30 min ;\n$4 \\%$ false-negatives; $4-10 \\%$ false-positives\nUS $(22-82 \\%$ sensitive $)$ :",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 343,
            "markdown": "$\\sqrt{ }$ stone visualization in $13-75 \\%$ (more readily with CBD dilatation + good visibility of pancreatic head)\n$\\sqrt{ }$ dilated ducts in $64-77 \\%$ / duct $<8 \\mathrm{~mm}$ in diameter in $24-36 \\%$\n$\\sqrt{ }$ increased dilatation of CBD with administration of fatty meal / cholecystokinin\n$\\sqrt{ }$ no stone in gallbladder $(1.2-11 \\%)$\nCT ( $25-90 \\%$ sensitive, $97 \\%$ specific, $94 \\%$ accurate):\n$\\diamond$ No IV / enteric contrast + thin collimation at 140 kVp improves rate of detection\n$\\sqrt{ }$ hyperattenuating stone surrounded by hypoattenuating bile + ampullary soft tissue $=$ visualized in $75-88 \\%$\n$\\sqrt{ }$ isoattenuating to surrounding bile (in 12-25%)\n$\\sqrt{ }$ often angulated + geometric with a rim of bile along stone's anterior margin\n$\\sqrt{ }$ \"target\" sign = intraluminal mass with crescentic ring (= stone of soft-tissue density) in $85 \\%$\n$\\sqrt{ }$ subtle alternating low- and high-attenuation rings (= mixed cholesterol-calcium stones)\nMRCP (pooled 95\\% sensitive, 95-99\\% specific):\n$\\diamond$ Thinner sections without intersection gaps provided by 3D isotropic MRCP\n$\\sqrt{ }$ signal void (= dark filling defect) within high SI of static fluid on moderately T2WI (TE of 100 msec ) (DDx: tumor, edematous papilla of Vater)\n$\\sqrt{ }$ no enhancement of calculus\n$\\sqrt{ }$ papillitis $\\leftarrow$ stone:\n$\\sqrt{ }$ bile duct obstruction at papilla\n$\\sqrt{ }$ smooth symmetric papillary edema\n$\\sqrt{ }$ increased enhancement of papilla\n$\\sqrt{ }$ obscured / missed calculi:\n$\\sqrt{ }$ visible SI on T1WI $\\leftarrow$ sufficient water content\n$\\sqrt{ }$ isointensity relative to bile\n$\\sqrt{ }$ stones $<2-3 \\mathrm{~mm}$ in diameter ( $<50 \\%$ sensitive)\nMRCP is highly sensitive and specific for the detection of biliary filling defects and of stones in particular. It can identify choledocholithiasis as the cause of acute pancreatitis and thus direct interventional care.\nNUC:\n$\\sqrt{ }$ delayed bowel activity beyond 2 hours\n$\\sqrt{ }$ persistent hepatic + common bile duct activity to 24 hr\n$\\sqrt{ }$ prominent ductal activity beyond 90 minutes with visualization of secondary ducts\n$C x:$ acute cholangitis, gallstone pancreatitis\n\n# Stone in Cystic Duct Remnant \n\nretained in $0.4 \\%$ after surgery for choledocholithiasis\n\n## CHRONIC GRANULOMATOUS DISEASE OF CHILDHOOD\n\n= X-linked recessive ( $60 \\%$ ) / autosomal ( $40 \\%$ ) immunodeficiency disorder characterized by neutrophil dysfunction resulting in purulent infections + granuloma formation primarily involving lymph nodes, skin, lung",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 344,
            "markdown": "Prevalence: $1 \\div 200,000$ to $1 \\div 250,000$ in USA\nNormal leukocyte function:\nphagocytosis $\\rightarrow$ activation of NADPH (nicotinamide adenine dinucleotide phosphate) oxidase $\\rightarrow$ \"respiratory burst\" = electron transfer to molecular oxygen $\\rightarrow$ formation of microbicidal free radical superoxide in phagocytic vacuole\nPathogenesis:\ndysfunctional NADPH oxidase in polymorphonuclear (PMN) leukocyte $\\rightarrow$ inability to generate hydrogen peroxide $\\rightarrow$ prolonged intracellular survival of phagocytized catalasepositive bacteria $\\rightarrow$ dissemination in reticuloendothelial system $\\rightarrow$ chronic struggle of immune system $\\rightarrow$ granuloma formation\nCatalase-positive organisms:\nmost commonly Staphylococcus, Burkholderia cepacia, Nocardia, Mycobacteria, Serratia marcescens, Klebsiella, Pseudomonas, fungi (Aspergillus, Candida)\nPath: recurrent and chronic infection $\\rightarrow$ lymphadenitis / granuloma formation / caseation / suppuration\nAge: onset within first 2 years;\n$\\mathrm{M} \\div \\mathrm{F}=6 \\div 1$ (more severe in boys)\n\n- recurrent chronic infections: lung (most common)\n- nitroblue tetrazolium test (NBT): low percentage of WBCs that reduce the yellow NBT dye to dark blue formazan after stimulation by phagocytosis / contact with endotoxin (normally > $90 \\%$ )\n@ Bone\n$\\checkmark$ osteomyelitis ( $1 / 3$ ) commonly of spine, ribs, metatarsals\n@ Chest\n$\\checkmark$ recurrent pneumonia ( $80 \\%$ )\n$\\checkmark$ lung abscess / empyema (in up to $20 \\%$ )\n$\\checkmark$ hilar lymphadenopathy\n$\\checkmark$ pleural + pericardial effusions (in up to $1 / 3$ )\n@ Liver\n$\\checkmark$ hepatosplenomegaly (in up to $90 \\%$ )\n$\\checkmark$ hepatic abscess (most common abdominal process)\n$\\checkmark$ liver calcifications\n@ GI tract\n- chronic diarrhea with malabsorption\n- vomiting, anorexia, heartburn, weight loss\n\nHisto: inflammation with granulomas and lipid-laden histiocytes of lamina propria, smooth muscle, serosa\nLocation: esophagus to rectum\n$\\checkmark$ esophageal dysmotility, esophagitis, stricture\n$\\checkmark$ gastric antral narrowing $\\pm$ gastric outlet obstruction (16\\%)\n$\\checkmark$ segmental bowel wall thickening\n$\\checkmark$ enlarged mesenteric lymph nodes $\\pm$ calcifications\n$\\checkmark$ perianal fistula + abscess\n@ GU tract\n\n- dysuria, UTI (5-15\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 345,
            "markdown": "$\\checkmark$ cystitis\n$\\checkmark$ obstruction of urethra + ureters\n@ Lymph nodes: cervical $>$ femoral $>$ inguinal\n$\\checkmark$ suppurative lymphadenitis\n@ Skin\n\n- pyoderma\n$R x$ : prophylactic long-term trimethoprim-sulfamethoxazole + interferon gamma therapy\nPrognosis: 2-5\\% mortality per year; death by pneumonia / sepsis due to Aspergillus /\nBurkholderia cepacia\n\n\n# CIRRHOSIS \n\n$=$ chronic liver disease characterized by diffuse parenchymal necrosis, regeneration and scarring with abnormal reconstruction of preexisting lobular architecture\nPathophysiology:\nsingle insult / repetitive liver injury $\\rightarrow$ hepatocyte death $\\rightarrow$ macromolecules in extracellular matrix $\\rightarrow$ activation of hepatic stellate (collagen-producing) cells by fibrogenic cytokines $\\rightarrow$ nodular regeneration + fibrotic scarring\nLiver fibrosis: = excess deposition of collagen, proteoglycans, and other macromolecules in extracellular matrix in response to repetitive liver injury\nEtiology:\nA. TOXIC / CHEMICAL\n(1) Ethanol in $75 \\%$\n(2) Aflatoxin $=$ product of fungus Aspergillus flavus in improperly stored grain and nuts\n(3) Drug-induced: prolonged methotrexate, oxyphenisatin, alpha-methyldopa, nitrofurantoin, isoniazid\n(4) Iron overload: hemochromatosis, hemosiderosis\nB. INFECTION / INFLAMMATION\n(1) Chronic viral hepatitis B\n(2) Chronic viral hepatitis $\\mathrm{C} \\leftarrow$ silent epidemic in USA in 1960s to 1980s with 4 million chronically infected\n(3) Schistosomiasis\nC. BILIARY OBSTRUCTION\n(1) Cystic fibrosis\n(2) Inflammatory bowel disease\n(3) Primary biliary cirrhosis\n(4) Obstructive infantile cholangiopathy\nD. CARDIAC / VASCULAR\n(1) Prolonged $\\mathrm{CHF}=$ cardiac cirrhosis\n(2) Hepatic venoocclusive disease\n(3) Budd-Chiari syndrome\nE. NUTRITIONAL\n(1) Intestinal bypass\n(2) Severe nonalcoholic steatosis + steatohepatitis $\\leftarrow$ obesity epidemic in USA (40 million adults, 6 million children) with $10-20 \\%$ expected to develop cirrhosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 346,
            "markdown": "(3) Abetalipoproteinemia\nF. HEREDITARY\n(1) Wilson disease\n(2) Alpha-1 antitrypsin deficiency\n(3) Juvenile polycystic kidney disease\n(4) Galactosemia\n(5) Type IV glycogen storage disease\n(6) Hereditary fructose intolerance\n(7) Tyrosinemia\n(8) Hereditary tetany\n(9) Osler-Weber-Rendu syndrome\n(10) Familial cirrhosis\nG. IDIOPATHIC / CRYPTOGENIC (15\\%)\nprobably due to nonalcoholic steatohepatitis\nCirrhosis in children:\nchronic hepatitis, congenital hepatic fibrosis, cystic fibrosis, biliary atresia, alpha-1 antitrypsin deficiency, tyrosinemia, galactosemia, hemochromatosis, Wilson disease, schistosomiasis, total parenteral nutrition\nAssociated with: anemia, coagulopathy, hypoalbuminemia, cholelithiasis, pancreatitis, peptic ulcer disease, diarrhea, hypogonadism\nPath:\n\n| Semispecific Liver Patterns in Cirrhosis |  |\n| :--: | :--: |\n| Differentiating Findings | Cause |\n| Micronodules ( $\\leq 3 \\mathrm{~mm}$ ) | Ethanol, hemochromatosis, nonalcoholic steatohepatitis |\n| Macronodules (3-15 mm) | chronic viral hepatitis B, autoimmmune hepatitis |\n| Enlargement of central liver + atrophy of periphery | Primary sclerosing cholangitis |\n| Diffuse hypertrophy + periportal halo sign | Primary biliary cirrhosis |\n\nHisto: fibrotic bridges carving liver into regenerative nodules = HALLMARK of cirrhosis\nPath:\nThe cirrhotic liver develops characteristic morphologic alterations such as (1) surface nodularity, (2) widening of fissures, (3) expansion of gallbladder fossa, (4) notching and atrophy of right lobe, (5) relative enlargement of lateral segments of left and caudate lobe.\n\n- anorexia, weakness, fatigue, weight loss, ascites\n- jaundice, continuous low-grade fever\n- bleeding from esophageal varices, hepatic encephalopathy\n\nEarly hepatic findings:\n$\\sqrt{ }$ enlarged (very early stage) / normal / shrunken liver:\n$\\sqrt{ }$ atrophy (= shrinkage) of right lobe (segments 5-8) and medial segment of left lobe (segments $4 \\mathrm{a}+4 \\mathrm{~b}$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 347,
            "markdown": "$\\sqrt{ }$ concomitant hypertrophy of lateral segment of left lobe (segments $2+3$ ) and caudate lobe (segment 1):\n$\\sqrt{ }$ ratio of width of caudate to right lobe $>0.65$ on transverse images [ $100 \\%$ specific; $26 \\%$ sensitive; $84-96 \\%$ accurate; least sensitive in alcoholic cirrhosis, most sensitive in cirrhosis caused by hepatitis B] (DDx: Budd-Chiari syndrome)\n$\\sqrt{ }$ diameter of quadrate lobe (segment 4) $<30 \\mathrm{~mm}$ (= distance between left wall of gallbladder and ascending portion of left portal vein) $\\leftarrow$ selective atrophy ( $95 \\%$ specific)\n$\\sqrt{ }$ enlargement of hilar periportal space\n$\\sqrt{ }$ \"gallbladder fossa\" sign = expansion of interlobar fissure\n$\\sqrt{ }$ associated with fatty infiltration (in early cirrhosis)\nLate hepatic changes:\n$\\sqrt{ }$ surface nodularity + indentations (regenerating nodules)\n$\\sqrt{ }$ right posterior hepatic \"notch\" sign = indentation between hypertrophied caudate + atrophied right lobe of liver (PPV 99\\%; in 2\\% of normal population)\n$\\sqrt{ }$ fibrous septa / bands\n$\\sqrt{ }$ distorted hepatic architecture\n$\\sqrt{ }$ confluent hepatic fibrosis\nExtrahepatic findings:\n$\\sqrt{ }$ signs of portal hypertension: portosystemic varices, portal vein thrombosis\n$\\sqrt{ }$ splenomegaly\n$\\sqrt{ }$ ascites $\\leftarrow$ failure of albumin synthesis, overproduction of lymph due to increased hydrostatic pressure in sinusoids / decreased splanchnic output due to portal hypertension)\n$\\sqrt{ }$ mesenteric edema\n$\\sqrt{ }$ bowel wall thickening $\\leftarrow$ edema\n$\\sqrt{ }$ lymph nodes:\n> few and small in alcoholic cirrhosis\n> large and numerous in viral hepatitis\n> numerous in primary biliary cirrhosis\nUS ( $65-80 \\%$ sensitive; DDx: chronic hepatitis, fatty infiltration):\nHepatic signs:\n$\\sqrt{ }$ surface nodularity ( $54 \\%$ sensitive, $95 \\%$ specific)\n$\\sqrt{ }$ caudate lobe hypertrophy ( $41 \\%$ sensitive, $91 \\%$ specific)\n$\\sqrt{ }$ \"portalization\" of hepatic vein waveform = dampened oscillations of hepatic veins resembling portal vein flow ( $57 \\%$ sensitive, $76 \\%$ specific)\n$\\sqrt{ }$ hepatomegaly (in 63\\%)\n$\\sqrt{ }$ increased hepatic parenchymal echogenicity in $66 \\%$ (as a sign of superimposed fatty infiltration):\n$\\sqrt{ }$ increased sound attenuation ( $9 \\%$ )\n$\\sqrt{ }$ decreased / normal definition of walls of portal venules (sign of associated fatty infiltration NOT of fibrosis)\n$\\sqrt{ }$ heterogeneous coarse (usually) / fine echotexture (in 7\\%)\n$\\sqrt{ }$ occasional depiction of isoechoic regenerative nodules\n$\\sqrt{ }$ dilatation of hepatic arteries $\\leftarrow$ increased arterial flow with demonstration of",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 348,
            "markdown": "intrahepatic arterial branches (DDx: dilated biliary radicals)\n$\\sqrt{ }$ increase in hepatic artery resistance (mean RI of $0.58-0.66$ in normals to $0.63-0.85$ in cirrhotics):\n$\\checkmark$ blunted increase in RI after meal ingestion (from $42 \\%$ in normals to $7 \\%$ in cirrhotics)\nExtrahepatic signs:\n$\\checkmark$ splenomegaly\n$\\checkmark$ ascites\n$\\checkmark$ signs of portal hypertension\nUS Elastography:\n$=$ US-based transient elastography = pulse-echo US acquisition following the wave propagation and velocity measurement of a probe-generated vibration of mild amplitude and low frequency (directly related to Young elastic modulus)\nCT:\n$\\checkmark$ native + enhanced parenchymal inhomogeneity:\n$\\checkmark$ bridging bands of fibrous scarring\n$\\checkmark$ wedge-shaped / stellate confluent fibrosis in segments IV, V and VIII with capsular retraction $(78 \\%)$\nConfluent fibrosis: broad fibrotic scar up to several cm thick with a masslike appearance\n$\\checkmark$ decreased attenuation (steatosis) in early cirrhosis\n$\\checkmark$ isodense / hyperdense (siderotic) regenerative nodules\n$\\checkmark$ nodular / lobulated liver contour\n$\\checkmark$ predominantly portal venous supply to dysplastic nodules\n$\\checkmark$ hypodense area adjacent to portal vein ( $=$ peribiliary cysts from obstructed extramural peribiliary glands)\n$\\checkmark$ rapid tapering of intrahepatic portal + hepatic venous branches\nCECT:\n$\\checkmark$ enlarged tortuous hepatic artery $\\leftarrow$ compensatory increase in arterial blood flow\n$\\checkmark$ arterioportal shunts ( $=$ trans-sinusoidal shunts in liver periphery + transplexal shunts with hypertrophy of peribiliary plexus) in hepatic arterial phase:\n$\\checkmark$ poorly demarcated transient peripheral wedge-shaped hepatic parenchymal enhancement\n$D D x$ : hepatocellular carcinoma (growth in 3- to 6-month intervals, defect on portal venous phase)\n$\\checkmark$ early retrograde enhancement of portal vein branches\n$\\checkmark$ hepatofugal flow\nCause: with occlusion of small hepatic venules, portal vein turns from a supplying vein into a draining vein\nNEMR (problem-solving tool):\n$\\checkmark$ no alteration of liver parenchyma\n$\\checkmark$ extensive parenchymal heterogeneity $\\leftarrow$ fibrosis + cirrhotic nodules + perfusion abnormalities + fat and iron deposition\n$\\checkmark$ fibrotic septa / bridges / confluent fibrosis = devoid of iron and fat even with hepatic iron overload / fat deposition:\n$\\checkmark$ hypointense reticulations on T1WI\n$\\checkmark$ T2-hyperintense $\\leftarrow$ large water content of advanced fibrosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 349,
            "markdown": "$\\sqrt{ }$ NOT hypointense on T2* (= NO iron)\n$\\sqrt{ }$ no signal loss on out-of-phase images ( $=$ NO fat)\n$\\sqrt{ }$ generalized decrease in hepatic SI on T2WI $\\leftarrow$ mild iron deposition for unknown reasons\n$\\sqrt{ }$ reticulations surround regenerative nodules typically of:\n$\\sqrt{ }$ intermediate to high SI on unenhanced T1WI\n$\\sqrt{ }$ intermediate to low SI on unenhanced T2WI\nCEMR:\n$\\sqrt{ }$ enhancement of liver fibrosis on T1WI $\\leftarrow$ Gd-contrast accumulation $\\leftarrow$ large extracellular component\n$\\sqrt{ }$ progressive enhancement on delayed images with peak during late venous + equilibrium phases\n$\\sqrt{ }$ occasional arterial hypervascularity within focal fibrosis (DDx to HCC: wedge-shaped configuration and persistence of enhancement into late venous phase)\n$\\sqrt{ }$ enhancement of usually ill-defined arterioportal shunts:\n$\\sqrt{ }$ visible only during arterial phase\n$\\sqrt{ }$ fading to isointensity in late venous phase\n$\\sqrt{ }$ areas of patchy hyperenhancement at arterial phase $\\leftarrow$ active inflammation\nMR Elastography:\n$=$ observing the effect of $40-120 \\mathrm{~Hz}$ shear waves generated by a mechanical device placed in contact with body $\\rightarrow$ increase in velocity and wavelength proportionate with greater tissue stiffness\n$\\sqrt{ }$ color-encoded quantitative liver stiffness maps of ROIs $\\leftarrow$ phase shifts in MR signal accumulate at tissue locations where gradient cycling is exactly in phase with generated mechanical wave\nMR with Superparamagnetic Iron Oxide (SPIO):\nMechanism: RES-specific contrast agent $=$ iron oxide particles $\\rightarrow$ cleared from blood through phagocytosis $\\rightarrow$ accumulate in RES cells of liver ( $80 \\%$ uptake), spleen, bone marrow\n$\\sqrt{ }$ reticulations of hepatic fibrosis with high SI on SPIO $\\leftarrow$ less iron oxide accumulation $\\leftarrow$ $\\downarrow$ Kupffer cell density\n$\\sqrt{ }$ pronounced T2* shortening + signal loss greatest on GRE $\\leftarrow$ local magnetic field inhomogeneities\nAngio:\n$\\sqrt{ }$ stretched hepatic artery branches (early finding)\n$\\sqrt{ }$ enlarged tortuous hepatic arteries $=$ \"corkscrewing\" $\\leftarrow$ increase in hepatic arterial flow\n$\\sqrt{ }$ shunting between hepatic artery and portal vein\n$\\sqrt{ }$ mottled parenchymal phase\n$\\sqrt{ }$ delayed emptying into venous phase\n$\\sqrt{ }$ pruning of hepatic vein branches (normally depiction of $5^{\\text {th }}$ order branches) $\\leftarrow$ postsinusoidal compression by developing nodules\nNUC ( ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-labeled sulfur colloid):\n$\\sqrt{ }$ high blood pool activity $\\leftarrow$ slow clearance\n$\\sqrt{ }$ colloid shift to bone marrow + spleen + lung\n$\\sqrt{ }$ shrunken liver with little or no activity + splenomegaly\n$\\sqrt{ }$ mottled hepatic uptake (pseudotumors) on colloid scan (normal activity on IDA scans!)\n$\\sqrt{ }$ displacement of liver + spleen from abdominal wall by ascites",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 350,
            "markdown": "Cx: (1) Ascites: cause / contributor to death in $50 \\%$\n(2) Portal hypertension $\\rightarrow$ bland portal vein thrombosis (in 11-16\\%)\n(3) Hepatocellular carcinoma (in $7-12 \\%$ )\n(4) Cholangiocarcinoma\n\nFatality from:\nesophageal variceal bleeding (in 25\\%), hepatorenal syndrome (10\\%), spontaneous bacterial peritonitis ( $5-10 \\%$ ), complications from treatment of ascites ( $10 \\%$ )\nDx: liver biopsy ( $0.03 \\%$ fatality rate); poor underdiagnosed Bx (in 32\\%): specimen should be at least 2 cm long + contain at least 11 portal triads\n$D D x:$\n(1) Pseudocirrhosis\n(2) Diffuse metastatic disease with desmoplastic reaction: breast, melanoma\n(3) Fulminant hepatic necrosis $\\pm$ regeneration\n(4) Noncirrhotic intrahepatic portal hypertension: nodular regenerative hyperplasia, periportal fibrosis, hepatoportal sclerosis\n\n# Nodular Lesions in Liver Cirrhosis \n\nConcept: gradual progression of regenerating (regenerative) nodule to $\\rightarrow$ low-grade dysplastic nodule $\\rightarrow$ high-grade dysplastic nodule $\\rightarrow$ dysplastic nodule with subfocus of HCC $\\rightarrow$ early HCC $\\rightarrow$ progressed HCC\nRadiologic diagnosis of HCC can be made with multiphasic CECT / CEMR\nPathophysiology:\nAs nodules dedifferentiate $\\rightarrow$ progressive decrease in portal vascularization $+\\uparrow$ blood supply via nontriadal arteries:\n\n1. Hypoenhancement during portal phase\n2. Increased number of nontriadal arteries during arterial phase (= hypervascularity)\nMR visibility vs nodule size: $>2 \\mathrm{~cm}(100 \\%), 1-2-\\mathrm{cm}(52 \\%),<1 \\mathrm{~cm}(4 \\%)$\nSensitivity of modality: MR (70-85\\%), CT (50-68\\%)\nRecommendation: US surveillance at 6-month intervals\nNodule suspicious for HCC by US requires further investigation with CECT / CEMR if:\n$\\checkmark$ nodule $>1 \\mathrm{~cm}$ is new\n$\\checkmark$ nodule enlarges over time\nChallenges for imaging:\n$\\checkmark$ nodule visualization $\\downarrow$ due to heterogeneity of fibrosis\n$\\checkmark$ heterogeneous enhancement may be mistaken for tumor\n$\\checkmark$ small nodules may demonstrate typical findings of HCC\nThe continuous histologic changes that nodules undergo result in significant overlap of enhancement patterns and findings on T1- and T2WI, complicating their imaging and histopathologic differential diagnosis.\nManagement protocol for small nodules $<2 \\mathrm{~cm}$ :\nThe likelihood of a nodule to be HCC increases with size:\n$<1 \\mathrm{~cm}$ (indeterminate) = unlikely malignant $\\rightarrow$ watch for interval growth\n$1-2 \\mathrm{~cm}=$ close monitoring with imaging + biopsies",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 351,
            "markdown": "$>2 \\mathrm{~cm}=$ likely malignant\n(a) nodule $<1 \\mathrm{~cm}$ :\nre-examine after 3 months with same imaging technique used to depict lesion initially\n> stable: return to routine screening\n> growth: evaluation with 4-phase CT / MR\n(b) nodule $\\geq 1 \\mathrm{~cm}$ :\nevaluation with 4-phase CT / MR (unenhanced, arterial, portal, and equilibrium phases)\n> typical for HCC: diagnosis confirmed\n> atypical for HCC: biopsy\n\n# Regenerative (Cirrhotic) Nodule (vast majority) \n\n$=$ heterogeneous regeneration $=$ localized proliferation of normal hepatocytes + supporting stroma with normal blood supply ( $25 \\%$ hepatic arterial $+75 \\%$ portal venous)\nMorphology:\n(a) micronodular cirrhosis ( $\\leq 3 \\mathrm{~mm}$ ): usually due to alcoholism, biliary obstruction, hemochromatosis, venous outflow obstruction, previous small-bowel bypass surgery, Indian childhood fibrosis\n(b) macronodular cirrhosis ( $3-15 \\mathrm{~mm}$, up to several cm ): usually due to chronic viral hepatitis B, Wilson disease, alpha-1 antitrypsin deficiency\n(c) mixed cirrhosis\n\nCT:\n$\\checkmark$ iso- to hyperdense on hepatic arterial phase\n$\\checkmark$ iso- to hypodense on portal venous phase\nMR:\n$\\checkmark$ variably SI relative to liver on T1WI:\n$\\checkmark$ hyperintense with lipid / protein / copper contents\n$\\checkmark$ iso- to hypointense relative to liver on T2WI\n$\\checkmark$ siderotic nodules (in $25 \\%$ ) with variable iron content:\n$\\checkmark$ hypointense on T1WI $\\leftarrow$ magnetic susceptibility\n$\\checkmark$ markedly hypointense on T2- / T2*WI\n$\\checkmark$ blooming on GRE\n\n| DDx of Liver Nodules in Cirrhosis |  |  |\n| :--: | :--: | :--: |\n| Features | Regenerative nodule / low-grade dysplasia | High-grade dysplasia / HCC |\n| Blood supply | portal venous | nontriadal arteries (loss of portal supply) |\n| Vascularity | like normal liver | hypovascular (if small) hypervascular (if large) |\n| Enhancement | like normal liver | in arterial phase |\n\n$\\checkmark$ signal loss on in-phase images\n$\\diamond$ An iron-poor focus within a siderotic nodule on T2WI suggests HCC!\n$\\checkmark$ steatotic nodules (usually multifocal):\n$\\checkmark$ hyperintense on in-phase gradient images",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 352,
            "markdown": "$\\sqrt{ }$ signal loss on out-of-phase images\nCEMR:\n$\\sqrt{ }$ Gd-enhancement similar to liver / slightly less\n$\\sqrt{ }$ NO Gd-enhancement on arterial phase images\n$\\sqrt{ }$ similar to liver on hepatobiliary specific imaging\n$\\sqrt{ }$ similar to liver on superparamagnetic iron oxide\nLesions that exhibit enhancement similar to that of adjacent liver are likely regenerative and lowgrade dysplastic nodules.\n\n# Dysplastic Nodule (15-28\\%) \n\n$=$ regenerative nodule with atypical cells\nHisto: cluster of hepatocytes $>1 \\mathrm{~mm}$ in diameter with evidence of (nuclear + cytoplasmic) dysplasia\nCause: common in hepatitis B and C, alpha-1 antitrypsin deficiency, tyrosinemia\nFrequency: in $15-28 \\%$ of explanted cirrhotic livers\n\n## Low-Grade DYsPLastic Nodule\n\n$=$ macroregenerative nodule, type I / ordinary adenomatous hyperplasia\nHisto: preserved hepatic architecture, low-grade cytologic atypia, varying numbers of portal tracts, inconstant increase in number of unpaired arterioles\nPrognosis: low malignant potential\n$\\sqrt{ }$ variable SI on T1WI, iso- / hypointense on T2WI\n$\\sqrt{ }$ enhancement similar to liver $\\leftarrow$ main blood supply from portal venous system\n$D D x$ : regenerative nodule (similar imaging features)\n$\\diamond$ No practical consequence of inability to differentiate between the two diagnoses!\n\n## High-GRade DYsPLastic Nodule\n\n$=$ macroregenerative nodule type II / adenomatous hyperplasia with atypia\nHisto: moderate cytologic + architectural atypia, reduced number of portal tracts, progressive sinusoidal capillarization, $\\uparrow$ number of unpaired arterioles\nPrognosis: premalignant\n$\\sqrt{ }$ variable SI on T1WI (depending on content)\n$\\sqrt{ }$ usually iso- / hypointense on T2WI\n$\\sqrt{ }$ mostly hypovascular $\\pm$ arterial enhancement\n$\\diamond$ Nodules with loss of portal supply and development of insufficient number of nontriadal arteries to produce hypervascularity are difficult to diagnose and responsible for the high rate of false-negative imaging results.\n\n## Dysplastic Nodule with Subfocus of HCC\n\n$=$ adenomatous hyperplasia with microscopic HCC\nFrequency: $6 \\%$ of patients with dysplastic nodules\n$\\sqrt{ }$ SI as any dysplastic nodule\n$\\sqrt{ }$ \"nodule-in-nodule\" appearance $=$ focus of high SI during arterial enhancement within dysplastic nodule",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 353,
            "markdown": "# Small Hepatocellular Carcinoma \n\n$=$ adenomatous hyperplasia with macroscopic HCC $<2 \\mathrm{~cm}$\nPrevalence: $27 \\%$ for hepatitis B, $22 \\%$ for hepatitis C\nSensitivity: $80-100 \\%$ for lesion $>2 \\mathrm{~cm} ; 50 \\%$ for lesion $1-2 \\mathrm{~cm} ; 5-33 \\%$ for lesion $<1$ cm in diameter\nHisto: abnormally high number of muscularized unpaired arterioles + capillarized vessels\n\n## Early Small Hepatocellular Carcinoma\n\nHisto: well-differentiated with invasion of portal tracts; neoplastic cells replace normal cells; $\\pm$ portal tracts; fatty change in $40 \\%$\nPrognosis: $89 \\% 5$-year survival; $8 \\%$ recurrence rate within 3 years of resection\n$\\checkmark$ high SI on T1WI\n$\\checkmark$ hypo- / isointense on T2WI\nCEMR:\n$\\checkmark$ hypo- / isointense during arterial phase $\\leftarrow$ insufficient development of unpaired arteries\n$\\checkmark$ hypointense during portal phase of enhancement $\\leftarrow$ loss of portal vascularization\n$\\diamond$ Early HCC has mostly hypovascular or equivocal findings and thus is difficult to differentiate from a high-grade dysplastic nodule. Progressed small HCC has characteristics similar to classic HCC.\n$D D x$ : high-grade dysplastic nodule (requires biopsy)\n\n## Progressed Small Hepatocellular Carcinoma\n\nHisto: no portal tracts; numerous nontriadal arteries + well-developed sinusoidal capillarization; microscopic vessel invasion in $27 \\%$\nPrognosis: $48 \\% 5$-year survival\n$\\checkmark$ well-defined homogeneous round / oval lesion\n$\\checkmark$ variable SI on T1WI\n$\\checkmark$ moderately hyperintense on T2WI\nCEMR:\n$\\checkmark$ enhancement $=$ hyperintense during arterial phase $\\leftarrow$ main blood supply from hepatic arterial system\n$\\checkmark$ washout during portal / delayed phase\n$\\diamond \\mathrm{A}>1 \\mathrm{~cm}$ nodule with arterial phase hyperenhancement and portal venous / delayed phase washout may be diagnosed as HCC by either (CECT / CEMR).\n\n## Primary Biliary Cirrhosis\n\n$=$ CHRONIC NONSUPPURATIVE DESTRUCTIVE CHOLANGITIS\nHisto: idiopathic progressive destructive cholangitis of interlobar and septal bile ducts, portal fibrosis, nodular regeneration, shrinkage of hepatic parenchyma\nAge: $\\quad 35-55$ years; $\\mathrm{M}+\\mathrm{F}=1 \\div 9$\nAssociated autoimmune disorders:\nrheumatoid arthritis, Hashimoto thyroiditis, Sjögren syndrome, scleroderma, sarcoidosis\n$\\diamond 66-100 \\%$ of patients with primary biliary cirrhosis have sicca-complex signs of the",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 354,
            "markdown": "Sjögren syndrome\n\n- fatigue, insidious onset of pruritus ( $60 \\%$ )\n- xanthelasma / xanthoma ( $25 \\%$ ); hyperpigmentation ( $50 \\%$ )\n- IgM increased ( $95 \\%$ )\n- positive antimitochondrial antibodies (AMA) in 85-100\\%\n$\\checkmark$ normal extrahepatic ducts\n$\\checkmark$ cholelithiasis in $35-39 \\%$\nCT:\n$\\checkmark$ scattered dilated intrahepatic ducts with no apparent connection to main bile ducts\n$\\checkmark$ periportal \"halo\" sign = perivascular cuffing\n$\\checkmark$ smooth capsule\n$\\checkmark$ caudate lobe hypertrophy (in $98 \\%$ ):\n$\\checkmark$ hypertrophied hyperattenuating caudate lobe surrounded by hypoattenuating rindlike right lobe (pseudotumor)\n$\\checkmark$ atrophy of lateral segment of left hepatic lobe\n$\\checkmark$ intrahepatic biliary calculi ( $20 \\%$ )F\nMR:\n$\\checkmark$ periportal \"halo\" sign (in $40 \\%$, SPECIFIC)\n$\\checkmark$ lymphadenopathy (in $62 \\%$ )\nNUC:\n$\\checkmark$ marked prolongation of hepatic ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-IDA clearance\n$\\checkmark$ uniform hepatic isotope retention\n$\\checkmark$ normal visualization of GB and major bile ducts in $100 \\%$\n$C x$ : hepatocellular carcinoma (in 5\\%)\n$D D x$ : (1) Sclerosing cholangitis (young men)\n(2) CBD obstruction\n\nPrognosis: mean survival 6 (range, 3-11) years after onset of cholestatic symptoms\n\n# Complications of End-Stage Liver Disease \n\n## Acute Respiratory Distress Syndrome\n\nPathophysiology: compromised liver function $\\rightarrow$ systemic spillover of proinflammatory substances (cytokines)\n$\\checkmark$ patchy lung opacities (early)\n$\\checkmark$ diffuse bilateral dependent lung consolidation (late)\nPrognosis: poor\n\n## Hepatopulmonary Syndrome\n\nDx: (1) Chronic liver disease\n(2) Increased alveolar-arterial oxygen gradient\n(3) Intrapulmonary vascular dilatation\n\nPrevalence: $15-20 \\%$ of cirrhotic patients\n\n- hypoxemia with progressive dyspnea, cyanosis, clubbing",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 355,
            "markdown": "| Typical MR Characteristics of Cirrhotic Liver Nodules |  |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: | :--: |\n| Lesion | T1WI | T2WI | Contrast Enhancement |  |  |\n|  | (relative to normal liver parenchyma) |  | Gadolinium CM | Hepatobiliary CM | SPIO CM |\n| Regenerative nodule | variable, hyperintense with lipid / protein / copper contents | iso- to hypointense | similar to liver parenchyma | similar to liver parenchyma | similar to liver parenchyma |\n| Low-grade dysplastic nodule | variable, often hyperintense | iso- or hypointense | similar to liver parenchyma | similar to liver parenchyma | similar to liver parenchyma |\n| High-grade dysplastic nodule | variable, often hyperintense | iso- or hypointense | usually hypovascular $\\pm$ arterial phase $\\uparrow$ | similar to liver parenchyma | similar to liver parenchyma |\n| Early HCC | variable, often hyperintense | iso- or hypointense | usually hypovascular $\\pm$ arterial phase $\\uparrow$ | $\\pm$ enhancement | $\\pm$ enhancement |\n| Progressed HCC | variable, often iso- / hyperintense | moderately hyperintense | arterial-phase $\\uparrow$, portalphase washout | $\\pm$ enhancement | $\\pm$ enhancement |\n| Large HCC | heterogeneous, predominantly hypointense | heterogeneous, predominantly hyperintense | arterial-phase $\\uparrow$ in $80-90 \\%$, portalphase washout | no enhancement | no enhancement |\n\nPathomechanism:\nelevation of unknown vasoactive substances in cirrhotic patient $\\rightarrow$ pulmonary vascular dilatation (from $8-15 \\mu \\mathrm{~m}$ to $15-500 \\mu \\mathrm{~m}$ ) $\\rightarrow$ excess perfusion for a given ventilation ( $=$ diffusion-perfusion mismatch)\n$\\sqrt{ }$ increased number of dilated arterioles + nontapering terminal branches extending to pleura $(86 \\%)$\n$\\sqrt{ }$ intrapulmonary arteriovenous shunts ( $14 \\%$ ):\n$\\sqrt{ }$ nodular dilatation of peripheral pulmonary vessels\n$\\sqrt{ } 99 \\mathrm{mTc}$ activity in brain, liver, spleen on macroaggregated albumin imaging\n$\\sqrt{ }$ bubbles in LA on microbubble echocardiography\nCXR:\n$\\sqrt{ }$ basilar nodular / reticulonodular areas of increased opacity (in 46-100\\%)\n\n# Hepatic Hydrothorax \n\n= large pleural effusion in cirrhotic patient without primary pulmonary / cardiac disease\nPrevalence: $5-10 \\%$\nMechanism: pressure gradient favors fluid movement from peritoneal to pleural cavity through small diaphragmatic defects; may occur in the absence of ascites\n\n- dyspnea, nonproductive cough, pleural chest pain, hypoxemia\n$\\sqrt{ }$ pleural fluid: right in $67-85 \\%$, left in $13-17 \\%$, bilateral in $2-17 \\%$\n\n\n## Portopulmonary Hypertension\n\nPrevalence: $2-5 \\%$ in patients with liver cirrhosis\nCause:\n(a) thromboembolic: portal venous thrombus reaches lung through spontaneous / surgically created portosystemic shunts\n(b) plexogenic: vasoconstriction from vasoactive substances (serotonin, thromboxane, interleukin I, endothelin I) that bypass the liver through portosystemic shunts\n(c) cardiogenic: high cardiac output associated with cirrhosis $\\rightarrow$ increased shear stress on pulmonary endothelial cells $\\rightarrow$ endothelial hyperplasia\n$D x$ : mean pulmonary artery pressure $>25 \\mathrm{mmHg}$; pulmonary capillary wedge pressure $<$ 15 mmHg",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 356,
            "markdown": "Prognosis: mean survival of 15 months\n\n# Pseudocirrhosis \n\n$=$ retracted tumor tissue + scarring between areas of regenerative liver parenchyma resembling macronodular cirrhosis\nCause: (1) Liver metastases treated with chemotherapy\n(2) Hepatotoxic effect of chemotherapy\n\nTime: within a few weeks or months after chemotherapy\nHisto: macronodular regenerative hyperplasia; no bridging portal fibrosis\n$\\checkmark$ lobular liver margin\n$\\checkmark$ volume loss\n$\\checkmark$ caudate hypertrophy\n$\\checkmark$ portal hypertension\n\n## Confluent Hepatic Fibrosis\n\n$=$ geographic pattern of fibrosis involving an entire segment\nPredisposed: liver cirrhosis\nLocation: mostly medial segment of left lobe + anterior segment of right lobe / both\nSite: (a) wedge-shaped at subcapsular portion (b) radiating from porta hepatis\nCT:\n$\\checkmark$ hypoattenuating lesion with volume loss:\n$\\checkmark$ overlying retraction of liver capsule\nCECT:\n$\\checkmark$ vessel crowding\n$\\checkmark$ isoattenuating / minimally hypoattenuating on arterial phase + delayed enhancement\n$\\checkmark$ delayed contrast enhancement $\\leftarrow$ pooling of contrast material within edema / nonarterial vascular channels\nMR:\n$\\checkmark$ low SI on T1WI + mildly high SI on T2WI $\\leftarrow$ edema and numerous vascular spaces\n$\\checkmark$ hypointensity during hepatobiliary phase ( $70 \\%$ )\n$D D x$ : HCC (mass effect on liver contour and adjacent blood vessels, more nodular appearance, no retraction of liver capsule, not typically geographic pattern)\n\n## CLONORCHIASIS\n\nRarely of clinical significance\nCountry: endemic to Southeast Asia: Japan, Korea, Central + South China, Taiwan, Indochina; Eastern Europe\nOrganism: Chinese liver fluke $=$ Clonorchis sinensis\nClosely related: Opisthorchis viverrini (Thailand and Laos); Opisthorchis felineus (Siberia)\nCycle: parasite cysts digested by gastric juice $\\rightarrow$ larvae migrate up the bile ducts $\\rightarrow$ remain in small intrahepatic ducts until maturity ( $10-30 \\mathrm{~mm}$ in length) $\\rightarrow$ travel to larger ducts to deposit eggs\nInfection: snail + freshwater fish serve as intermediate hosts; infection occurs by eating raw fish; hog, dog, cat, man are definite hosts",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 357,
            "markdown": "Path: (a) desquamation of epithelial bile duct lining with adenomatous proliferation of ducts + thickening of duct walls (inflammation, necrosis, fibrosis)\n(b) bacterial superinfection with formation of liver abscess\n\n- remittent incomplete obstruction + bacterial superinfection\n\nLocation: medium-sized + small intrahepatic bile ducts, primarily in subcapsular region\n$\\sqrt{ }$ diffuse uniform dilatation of small intrahepatic bile ducts + no dilatation of extrahepatic bile ducts + NO focal obstructing lesion\n$\\sqrt{ }$ diffusely thickened bile duct walls\n$\\sqrt{ }$ multiple crescent- / stiletto-shaped filling defects within bile ducts:\n$\\sqrt{ }$ echogenic focus / cast on US\nCx: (1) Bile duct obstruction $\\leftarrow$ conglomerate of worms / adenomatous proliferation of ducts\n(2) Calculus formation $\\leftarrow$ stasis / dead worms / epithelial debris\n(3) Jaundice in $8 \\% \\leftarrow$ stone / stricture / tumor\n(4) Generalized dilatation of bile ducts $(2 \\%)$\n\n# CONGENITAL BILIARY ATRESIA \n\nEtiology: ? variation of same infectious process as in neonatal hepatitis with additional component of sclerosing cholangitis or vascular injury\nPrevalence: $<10 \\div 100,000$ live births\nAge: neonate; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 1$\nHisto: periportal fibrosis, proliferation of small intrahepatic bile ducts, mixed inflammatory infiltrates\nIn $15 \\%$ associated with: polysplenia, trisomy 18\nTypes:\nI Focal = intrauterine vascular insult (extremely rare)\nII Intrahepatic biliary atresia = paucity of intrahepatic bile ducts (uncommon)\nIII Extrahepatic biliary atresia = atresia of CBD + patent intrahepatic bile ducts\n![img-57.jpeg](img-57.jpeg)\n\nSubtype $1=$ perinatal type $(66 \\%)$\n\n- jaundice develops after regression of physiologic jaundice",
            "images": [
                {
                    "id": "img-57.jpeg",
                    "top_left_x": 357,
                    "top_left_y": 1339,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1887,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 358,
            "markdown": "$\\sqrt{ }$ bile duct remnant in porta hepatis\nSubtype $2=$ embryonic / fetal type $(34 \\%)$\n\n- normal decline in bilirubin does not occur\n$\\sqrt{ }$ NO bile duct remnant in porta hepatis\nAssociated with:\npolysplenia (10-12\\%), intestinal malrotation, azygos continuation of IVC, symmetric bilobed liver, situs inversus, preduodenal portal vein, anomalous hepatic arteries, bilobed right lung, complex CHD\nUS:\n@ Liver:\n$\\sqrt{ }$ normal / increased size of liver\n$\\sqrt{ }$ normal / increased liver echogenicity\n$\\sqrt{ } \\downarrow$ visualization of peripheral portal veins $\\leftarrow$ fibrosis\n$\\sqrt{ }$ \"triangular cord\" / tubular echogenic structure in porta hepatis $\\leftarrow$ fibrous tissue $=$ PATHOGNOMONIC\n@ Gallbladder:\n$\\sqrt{ }$ nonvisualization of gallbladder\n$\\sqrt{ }$ small gallbladder $<1.5 \\mathrm{~cm}$ in length + varying degrees of luminal compromise (DDx: hepatitis)\n$\\sqrt{ }$ normal gallbladder $>1.5 \\mathrm{~cm}$ in length ( $19 \\%$ ) with atresia of CBD distal to insertion of cystic duct\n@ Bile ducts:\n$\\sqrt{ }$ NO dilatation of intrahepatic bile ducts $\\leftarrow$ panductal sclerosis\n$\\sqrt{ } \\pm$ visualization of bile duct remnant in porta hepatis (depending on type of biliary atresia)\n$\\sqrt{ }$ small focal cystic dilatation of extrahepatic bile duct (= choledochal cyst) = patent segment of CBD with other parts being occluded $\\leftarrow$ fibrosis $\\pm$ communication with gallbladder / intrahepatic bile ducts\nNUC [phenobarbital-augmented cholescintigraphy] ( $90-97 \\%$ sensitive, $60-94 \\%$ specific, $75-$ $90 \\%$ accurate):\n» preparation of patient with $5 \\mathrm{ng} / \\mathrm{kg} / \\mathrm{d}$ phenobarbital twice a day for 3-7 days to stimulate biliary secretion (via induction of hepatic enzymes + increase in conjugation + excretion of bilirubin)\n$\\sqrt{ }$ good hepatic activity within 5 minutes (infants of $<3$ months of age have a normal hepatic extraction fraction)\n$\\sqrt{ }$ NO biliary excretion:\n$\\sqrt{ }$ NO visualization of bowel on delayed images at 6 and 24 hr\n$\\sqrt{ }$ delayed clearance from cardiac blood pool\n$\\sqrt{ }$ increased renal excretion + bladder activity\n$D D x$ : severe hepatocellular dysfunction (DDx from neonatal hepatitis impossible in the absence of small bowel activity) requires liver biopsy\nMR cholangiography:\n$\\sqrt{ }$ nonvisualization of extrahepatic bile ducts\n$\\sqrt{ }$ atrophic gallbladder",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 359,
            "markdown": "$\\sqrt{ }$ periportal thickening\nCholangiography (percutaneous / endoscopic / intraoperative)\nLiver Biopsy ( $60-97 \\%$ accurate)\nRx: (1) Roux-en-Y choledochojejunostomy (20\\%);\n(2) Kasai procedure $=$ portoenterostomy $(80 \\%)$\n(a) child $<60$ days of age: $91 \\%$ success rate\n(b) child between 60 and 90 days of age: $50 \\%$ success rate $\\leftarrow$ developing cirrhosis\n(c) child $>90$ days of age: $17 \\%$ success rate\n(3) Liver transplant\n\nDDx:\n(1) Neonatal hepatitis\n(2) Sclerosing cholangitis\n(3) Alagille syndrome $=$ arteriohepatic dysplasia (abnormal facies, butterfly vertebra, pulmonic stenosis, complex CHD)\n\n# CONGENITAL HEPATIC FIBROSIS \n\n$=$ congenital cirrhosis with rapid + fatal progression\nHisto: fibrous tissue within hepatic parenchyma with excess numbers of distorted terminal interlobular bile ducts + cysts that rarely communicate with bile ducts $=$ extensive fibrosis WITHOUT regenerative nodules\nAge: early childhood $-6^{\\text {th }}$ decade; majority diagnosed in adolescence / early adulthood\nAssociated with:\nautosomal recessive polycystic kidney disease (invariably), Meckel-Gruber syndrome, vaginal atresia, tuberous sclerosis, nephronophthisis, medullary sponge kidney ( $80 \\%$ ), autosomal dominant polycystic kidney disease (rare)\n\n- liver function tests normal / mildly elevated\n- portal hypertension; predisposed to cholangitis + calculi\n$\\checkmark$ \"lollipop-tree\" = ectasia of peripheral biliary radicles\n$\\checkmark$ atrophy of right lobe + normal / enlarged medial segment of left lobe + hypertrophy of left lateral segment and caudate lobe\n$\\checkmark$ splenomegaly\n$\\checkmark$ portosystemic varices\n$\\checkmark$ enlarged hepatic artery associated with large multiacinar regenerative nodules\nCx: cirrhosis, portal hypertension, hepatocellular carcinoma, cholangiocellular carcinoma\n\n\n## CONGENITAL TRUE PANCREATIC CYST\n\n$=$ very rare entity\nCause: sequestration of primitive pancreatic duct\nAge: mostly in children $<2$ years; $\\mathrm{M}<\\mathrm{F}$\nHisto: cuboidal epithelium\n\n- usually asymptomatic palpable mass, abdominal distention\n- epigastric pain, vomiting, jaundice $\\leftarrow$ compression by cyst\n\nMay be associated with: Von Hippel-Lindau disease, Beckwith-Wiedemann syndrome,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 360,
            "markdown": "hepatorenal polycystic disease\nLocation: pancreatic body / tail\n$\\checkmark$ uniform thin-walled single / multiple cysts",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 361,
            "markdown": "# ECHINOCOCCAL DISEASE \n\n$=$ zoonotic parasitic disease endemic in pastoral regions\nAnatomy of cestode (tapeworm) in primary host:\n$3-6 \\mathrm{~mm}$ adult sexually mature flatworm attaches to small intestines of canine with hooks on rostellum (tubular beak) +4 suckers on its scolex (head); strobila (body) is composed of a colony of proglottids (segments) resembling a strip of tape; new segments are continuously produced by the proliferative neck piece pushing older segments towards tail; each segment has its own digestive tract + female and male reproductive structures (hermaphrodite); uterus of last segment filled with about 500 eggs drops off; lifespan of adult worm is $5-12$ months\nLife cycle relying on carnivores eating infected herbivores:\neggs excreted fecally by definite host ( $\\operatorname{dog} /$ fox / other carnivore) + intermediate host (sheep / rodents, other ruminants) into environment $\\rightarrow$ grazing intermediate host ingests ova $\\rightarrow$ ovum loses protective layer during digestion in duodenum $\\rightarrow$ freed embryo (oncosphere armed with 6 hooks = hexacanth) attaches to + penetrates intestinal mucosa $\\rightarrow$ migrates to liver by way of portal / lymphatic system $\\rightarrow$ oncospheres are filtered by capillaries of liver (first line of defense) $>>$ lung $>$ other organs $\\rightarrow$ intrahepatic development of oncosphere into metacestode $=$ unilocular cyst (E. cysticus) / multiple cysts (E. multilocularis) that have brood capsules attached to inside of germinal layer and produce protoscolices $\\rightarrow$ cycle completes when definitive host ingests infected viscera from intermediate host\n![img-58.jpeg](img-58.jpeg)\n\n## Echinococcus Granulosus (E. cysticus)\n\n$=$ HYDATID DISEASE ( $=$ more common unilocular form compared to E. multilocularis)\n$=$ canine tapeworm in sheep-and cattle-grazing areas $=$ zoonosis with worldwide distribution caused by larvae of echinococcus tapeworm, primarily E. granulosus\nEndemic to certain regions of the world where livestock + dogs are raised together: Australia, New Zealand, Africa (Kenya, Uganda, Sudan, Ethiopia), Eastern Europe, Russia, Mediterranean countries (Israel, Tunisia, Turkey, Italy, Spain, Croatia), China,",
            "images": [
                {
                    "id": "img-58.jpeg",
                    "top_left_x": 377,
                    "top_left_y": 1113,
                    "bottom_right_x": 1319,
                    "bottom_right_y": 1685,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 362,
            "markdown": "Japan, South America (Uruguay, Peru, Chile, Argentina), Middle East\n$\\diamond$ Reported on all continents except Antarctica!\nPrevalence: 1 million persons infected worldwide\nPrimary / definitive host (harbors adult tapeworm):\n(a) sylvatic life cycle: wolf, red fox, jackal, coyote\n(b) domestic life cycle: dog, cat\n\nSecondary / intermediate host (harbors larva stage):\n(a) sylvatic life cycle: wild ungulate (deer, moose), kangaroo, wallaby, other grazing ruminants\n(b) domestic life cycle: ungulates (= hoofed animals) like sheep, goat, swine, cattle, horse, camel\nAccidental intermediate host: human ingesting eggs\nHisto of 3-layered hydatid cyst:\nA. CYST FLUID = antigenic clear / pale yellow transudate with neutral pH containing sodium chloride, proteins, glucose, ions, lipids, polysaccharides $\\rightarrow$ may cause eosinophilia / anaphylaxis\nB. TRUE WALL OF PARASITE\n\n1. ENDOCYST $=$ thin translucent inner germinal layer (resembling wet tissue paper) gives rise to brood capsules (daughter vesicles), which may\n(a) harbor up to 400,000 protoscolices\n(b) break up into numerous self-contained daughter cysts remaining attached to cyst wall by small pedicle (brood capsule)\n(c) detach + form sediment in cyst fluid = \"hydatid sand\"\n2. ЕСТОСYST $=$ cyst membrane $=$ thin acellular laminated membrane of chitinlike substance secreted by parasite; allows passage of nutrients\nC. PERICYST (host response) = rigid outermost layer of protective zone of dense fibrous granulation tissue (fibroblasts, giant cells, eosinophils) replacing tissue necrosis $\\leftarrow$ compression by the expanding cyst; marginal vascular rim of $0.5-4 \\mathrm{~mm}$\nN.B.: The hydatid cyst consists of the endocyst, where the scolices are produced, and the pericyst, which is composed of host cells that form a peripheral layer of reactive fibrous tissue.\n\n- Tests:\n\n1. Casoni intradermal test ( $60 \\%$ sensitivity; may be falsely positive)\n2. Complement fixation double diffusion ( $65 \\%$ sensitivity)\n3. Enzyme-Linked ImmunoSorbent Assay (ELISA) ( $90 \\%$ sensitive in hydatid liver disease)\n4. Indirect hemagglutination ( $85 \\%$ sensitivity)\n\nTime to diagnosis: 51 (range, 11-81) years; chronic disease with latent stage that may last years\nAffected organs:\nliver (50-75\\%); widespread dissemination uncommon: lung (14-43\\%); peritoneum (12\\%); kidney ( $2-6 \\%$ ); spleen ( $0.9-8 \\%$ ); CNS ( $1-4 \\%$ ); orbit ( $1 \\%$ ); bone ( $0.5-4 \\%$ ); bladder; thyroid; prostate; heart\nTypes of cysts (corresponding to stages of cyst growth):\n(1) Unilocular cyst (initially):\n$\\sqrt{ }$ simple on CT",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 363,
            "markdown": "$\\sqrt{ }$ laminated wall (double line sign) / free-floating scolices (snowflakes sign) on US\n$\\sqrt{ }$ fibrous persistently hypointense rim on MR\n(2) Cyst with daughter vesicles / daughter cysts = spoke-wheel appearance\n$\\sqrt{ }$ daughter cysts of lower attenuation and less T1-hypointense compared to mother cyst\n$\\leftarrow$ free-floating scolices\n(3) Partially / completely calcified\n$\\diamond$ Only complete calcification of all layers implies death of parasite!\nRx: (1) Surgery (in $10 \\%$ recurrence)\n(2) Antihelmintics (benzimidazoles)\n(3) PAIR technique\n$=$ Puncture, Aspiration, Injection, Reaspiration\nDx: fluid analysis positive for hydatid disease in $70 \\%$ (fragments of laminated membrane in $54 \\%$; scolices in $15 \\%$; hooklets in $15 \\%$ )\nRx: injection of scolecidal agent (silver nitrate; 20 to $30 \\%$ hypertonic saline solution; $0.5 \\%$ cetrimide solution; $10 \\%$ povidone iodine; $95 \\%$ ethanol) with reaspiration\nCx: risk of anaphylactic shock ( $0.5 \\%$ ), asthma ( $3 \\%$ ), implantation of spilled protoscoleces (after rupture / following diagnostic puncture)\n\n# Hydatid Disease of Bone (1\\%) \n\nEpidemiology: occurs occasionally in USA; usually in foreign-born individuals $\\backslash$\nPath: no connective tissue barrier; daughter cysts extend directly into bone\n@ Pelvis, sacrum, rarely long tubular bones\n$\\sqrt{ }$ round / irregular regions of rarefaction\n$\\sqrt{ }$ multiloculated lesion (bunch of grapes)\n$\\sqrt{ }$ no sharp demarcation (DDx: chondroma, giant cell tumor) with secondary infection:\n$\\sqrt{ }$ thickening of trabeculae with generalized perifocal condensation\n$\\sqrt{ }$ cortical breakthrough with soft-tissue mass\n@ Vertebra\n$\\sqrt{ }$ sclerosis without pathologic fracture\n$\\sqrt{ }$ intervertebral disks not affected\n$\\sqrt{ }$ vertebral lamina often involved\n$\\sqrt{ }$ frequently involvement of adjacent ribs\n\n## Hydatid Disease of CNS (1-2-4\\%)\n\n- increased intracranial pressure and seizure\n\nLocation: subcortical parietal lobe; (rarely) dura, subarachnoid space, ventricular system, brainstem, spinal canal\n$\\sqrt{ }$ usually single large well-defined oval / round cyst in brain parenchyma similar to CSF attenuation + intensity\n$\\sqrt{ }$ occasional CHARACTERISTIC hypointense nonenhancing rim on T2WI\n$\\sqrt{ }$ multiple cysts suggest rupture of preexisting single cyst\n$\\sqrt{ }$ occasionally faint surrounding T2 hyperintense halo $\\leftarrow$ pericyst composed of inflammatory cells + fibrous tissue\n$\\sqrt{ }$ NO significant surrounding edema; NO rim enhancement",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 364,
            "markdown": "$\\sqrt{ }$ heterogeneous predominantly cystic mass + fluid-debris level $\\leftarrow$ hydatid sand\n\n# Hydatid Disease of Kidney \n\n- asymptomatic for many years until cyst size $>10 \\mathrm{~cm}$\n- flank mass + pain; dysuria\n- acute renal colic + hydatiduria from cyst rupture into collecting system (18\\%)\n\nSite: cortex of upper / lower pole; typically unilateral + solitary\nPlain film:\n$\\checkmark$ abdominal mass\n$\\checkmark$ curvilinear calcifications of pericyst (20-30\\%)\nIVP:\n$\\checkmark$ infundibular + calyceal distortion\n$\\checkmark$ obstruction; renal dysfunction\nUS:\n$\\checkmark$ unilocular cyst (DDx: simple renal cyst)\n$\\checkmark$ multiseptated daughter cysts (DDx: polycystic kidney disease)\n$\\checkmark$ thick bilayered cyst wall\n$\\checkmark$ PATHOGNOMONIC \"falling snowflake\" or \"snowstorm\" sign = multiple echogenic foci from hydatid sand dispersed with repositioning of patient\n$\\checkmark$ \"floating membranes\" = detachment of parasite wall from pericyst\n$\\checkmark$ \"wheel-spoke\" pattern = mixture of membranes + broken daughter vesicles + scolices + hydatid sand\nCT:\n$\\checkmark$ unilocular type 1 cyst (initial stage)\n$\\checkmark$ multilocular type 2 cyst (intermediate stage):\n$\\checkmark$ mixed internal attenuation\n$\\checkmark$ daughter cysts with lower attenuation\n$\\checkmark$ enhancing thick wall + internal septa\n$\\checkmark$ completely calcified type 3 cyst\nMRI:\n$\\checkmark$ hypointense rim on T2WI = dense fibrous pericyst\n$\\checkmark$ fluid hypointense on T1WI + markedly hyperintense on T2WI\n$\\checkmark$ linear intracystic structures in type 2 cyst = collapsed membranes of daughter cysts:\n$\\checkmark$ hypointense on all sequences $\\pm$ contrast enhancement\n$\\checkmark$ low SI on all pulse sequences for type 3 cyst\n$R x$ : total or partial nephrectomy / enucleation / marsupialization / cystectomy\n$C x$ : cyst rupture $\\rightarrow$ severe antigenic immune response\n\n## Hydatid Disease of Liver (60\\%)\n\nLocation: right > left lobe of liver; multiple cysts in 20\\%\nAverage size: 5 (up to 50 ) cm ; up to 16 liters of fluid\n\n- pain / asymptomatic (for years); incidental discovery in $1 / 3$\n- recurrent jaundice + biliary colic $\\leftarrow$ transient obstruction by membrane fragments + daughter cysts expelled into biliary tree; blood eosinophilia (20-50\\%)\n- urticaria + anaphylaxis $\\leftarrow$ following cyst rupture",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 365,
            "markdown": "Spread: usually disruption of hepatic cysts during invasive treatment / spontaneous rupture / traumatic rupture\nGrowth: $2-3 \\mathrm{~cm}$ annually\nPlain film:\n$\\checkmark$ peripheral crescentic / curvilinear / polycyclic calcifications (10-20-33\\%), located in pericyst\n$\\checkmark$ pneumohydrocyst (infection / communication with bronchial tree)\nUS:\n$\\diamond$ Look for membranes / peripheral daughter vesicles\n$\\checkmark$ well-defined anechoic cyst (common):\n$\\checkmark$ cyst wall of double echogenic lines separated by hypoechoic layer\n$\\checkmark$ \"snowstorm\" sign = multiple internal echogenic foci settling to most dependent portion of cyst (= hydatid sand)\n$\\checkmark$ multivesicular cyst of \"racemose\" / honeycomb appearance = multiple septa between daughter cysts inside mother cyst, CHARACTERISTIC but rare:\n$\\checkmark$ \"wheel spoke\" pattern = daughter cysts separated by echogenic material of hydatid matrix composed of broken daughter vesicles + scolices + hydatid sand\n$\\checkmark$ HIGHLY SPECIFIC serpentine linear structures within hydatid matrix\n$\\checkmark$ partial / complete detachment of endocyst from pericyst $\\leftarrow$ decreasing intracystic pressure $=$ sign of degeneration / trauma / host response / response to therapy:\n$\\checkmark$ localized split in wall with floating undulating membrane, CHARACTERISTIC but rare\n$\\checkmark$ \"water lily\" sign = complete detachment of membrane\n$\\diamond$ Floating membrane does not indicate death of parasite!\n$\\checkmark$ eggshell calcification in cyst wall (least common)\nCT:\n$\\checkmark$ well-demarcated round low-density mass of fluid attenuation of $3-30 \\mathrm{HU}$ (= mother cyst containing debris of hydatid sand + detached cyst walls):\n$\\checkmark$ round peripheral fluid collections of lower attenuation (= daughter cysts) arranged in CHARACTERISTIC wheel-spoke pattern\n$\\checkmark$ linear areas of increased attenuation = detached laminated floating membrane (after rupture of daughter cyst)\n$\\checkmark$ cyst wall of high attenuation on NECT\n$\\checkmark$ enhancement of cyst wall + septations\n$\\checkmark$ calcification of cyst wall / internal septa\nMR:\n$\\checkmark$ cyst with hypointense rim (= dense collagenous pericyst) on T1WI + T2WI\n$\\checkmark$ peripheral cysts within cyst hypointense on T1WI + hyperintense on T2WI (= daughter cysts)\n$\\checkmark$ twisted linear structures within cyst = collapsed parasitic membrane\nAngio:\n$\\checkmark$ avascular area with splaying of arteries\n$\\checkmark$ halo of increased density around cyst (inflammation / compressed liver)\nCholangiography:\n$\\checkmark$ cyst may communicate with bile ducts: right hepatic duct (55\\%), left hepatic duct",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 366,
            "markdown": "(29\\%), CHD (9\\%), gallbladder (6\\%), CBD (1\\%)\nLocal Cx:\n(1) Rupture (50-90\\%)\n(a) contained = rupture of laminated membrane of endocyst, pericyst remains intact $\\checkmark$ floating membranes\n(b) communicating = cyst contents escapes through biliary (5-15\\%) / bronchial tree\n(c) direct $=$ tear of endocyst + ectocyst + pericyst with cyst contents spilling into pleural / peritoneal cavity $\\rightarrow$ anaphylaxis, metastatic hydatidosis\n(2) Infection (5-8\\%) following rupture\n(3) Transdiaphragmatic growth $(0.6-16 \\%)$ through bare area of liver\n(a) rupture into pleural cavity\n(b) seeding in pulmonary parenchyma\n(c) chronic bronchial fistula\n(4) Perforation into hollow viscus $(0.5 \\%)$\n(5) Peritoneal seeding $(13 \\%)=$ encysted peritoneal hydatidosis\n(6) Compression of vital structures (bile ducts, portal vein)\n\nPrognosis: usually favorable (but fatal if untreated); death from cholangitis / hepatobiliary septicemia (biliary obstruction with bacterial + fungal superinfection)\n\n# Hydatid Disease of Lung (25\\%) \n\n$=$ LUNG ECHINOCOCCOSIS\nSource: (a) hematogenous spread from liver lesion\n(b) transdiaphragmatic route ( $1-16 \\%$ of hepatic disease) $=$ migration of parasite from liver to pleural cavity\nFrequency: $10-30 \\%$ of hydatid disease\n$\\diamond$ Most common site of secondary involvement in children $+2^{\\text {nd }}$ most frequent site in adults\n$\\diamond$ Coexistence of liver + lung disease in $6 \\%$\n\n- asymptomatic for months to years; eosinophilia ( $<25 \\%$ )\n- fever, chest pain, sudden cough attacks:\n- hemoptysis, bilioptysis\n- expectoration of cyst fluid / membranes / scolices\n- hypersensitivity reaction (if cyst rupture occurs)\n\nLocation: lower lobes in $60 \\%$; bilateral in $20-50 \\%$\n$\\sqrt{ }$ solitary ( $60-75 \\%$ ) / multiple ( $25-30 \\%$ ) spherical / ovoid masses with well-defined borders\n$\\sqrt{ }$ size of $1-20 \\mathrm{~cm}$ in diameter ( $16-20$ weeks doubling time)\n$\\sqrt{ }$ cyst communication with bronchial tree (= chronic bronchial fistula):\n$\\checkmark$ \"meniscus sign\", \"double arch\" sign, \"moon\" sign, \"crescent\" sign (5\\%) = thin radiolucent crescent in uppermost part of cyst $\\leftarrow$ cyst erosion into adjacent bronchioles with air dissecting between pericyst and laminated membrane\n$\\checkmark$ air-fluid level = rupture of all cyst walls with air entering the endocyst\n$\\checkmark$ Cumbo / \"onion peel\" sign = air-fluid level inside endocyst + air between pericyst",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 367,
            "markdown": "and endocyst\n$\\checkmark$ \"serpent\" sign = collapsed membranes inside cyst outlined by air (after expectoration of cyst contents)\n$\\checkmark$ \"water lily\" sign, \"sign of the camalote\" = completely collapsed crumpled cyst membrane floating on cyst fluid\n$\\checkmark$ mass within cavity = crumpled membranes fall to most dependent portion of cavity after complete expectoration of cyst fluid\n$\\checkmark$ hydropneumothorax\n$\\checkmark$ calcification of cyst wall $(0.7 \\%)$\n$\\checkmark$ rib + vertebral erosion (rare)\n$\\checkmark$ mediastinal cyst: posterior ( $65 \\%$ ), anterior ( $26 \\%$ ), middle ( $9 \\%$ ) mediastinum\nCx: pleuritis, lung abscess, parasitic pulmonary embolism, anaphylaxis $\\leftarrow$ cyst rupture, bacterial cyst superinfection (after cyst rupture)\n$D D x$ : metastasis, Wegener granulomatosis, other granulomatous diseases\n\n# Echinococcus Multilocularis \n\n$=$ E. ALVEOLARIS $=$ ALVEOLAR ECHINOCOCCOSIS\n$=$ less common but more aggressive form of echinococcal dz.\nEndemic to:\nlimited to Northern Hemisphere; western and central Europe (central + eastern France, southern Germany, western Austria, Switzerland), much of former Soviet Union, Iran, Iraq, some areas in Turkey, predominance in western and central China, northern Japan (Hokkaido Island), Midwestern USA, Arctic (Alaska, Canada, entire tundra)\nPrimary / definite host: (harbors 3-6 mm adult tapeworm)\n(a) sylvatic life cycle (predominant): red fox, wolf, coyote\n(b) domestic life cycle: dog; cat\n\nSecondary / intermediate host: (harbors larva stage)\n> sylvatic life cycle (predominant): small wild rodents (moles, lemmings, mice)\nAccidental intermediate host:\nhuman ingesting wild fruits, vegetable, water contaminated with fox / wolf feces; direct contact with fox/wolf; contact with dogs / cats that have ingested infested rodents",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 368,
            "markdown": "![img-59.jpeg](img-59.jpeg)\n\nPath: diffuse infiltrative multivesicular mass ( $=$ persistence of larval forms without cyst maturation) resembling malignancy composed of many cysts of irregular shape + size ( $<1 \\mathrm{~mm}-30 \\mathrm{~mm}$ ) associated with host reaction of fibrosis (chronic granuloma) + frequent central necrosis, cavitation, calcification; absence of clear margin between parasitic tissue + adjacent normal liver parenchyma\nHisto: daughter cysts with thick lamellar wall arising on outer surface of original cyst rarely contain scolices; cyst has darkly staining thin outer laminar membrane and nonstaining delicate inner germinal layer; surrounded by inner zone of necrosis + outer layer of histiocytes and lymphocytes\nLocation: liver (access via portal vein / lymphatics); other organs in $<1 \\%$ (lung, brain, bone)\n\n- clinical manifestation 5-20 years after infection\n- epigastric pain, jaundice, hepatomegaly, eosinophilia\n- hemoptysis, chest pain, cough with expectoration, exertional dyspnea (with lung involvement)\n- positive immunoserology for Em2 (E. multilocularis-specific native antigen isolated from metacestodes)\n$\\checkmark$ aggressive rapid growth pattern:\n$\\checkmark$ geographic infiltrating lesion with ill-defined margins\n$\\checkmark$ displacement of hepatic veins, portal vein, biliary tree\n$\\checkmark$ regional atrophy of liver with capsular retraction $\\leftarrow$ biliary / vascular invasion\n$\\checkmark$ faint / dense amorphous coalescent nodular / flame-shaped calcifications = dystrophic central calcifications scattered throughout necrotic + granulomatous tissue (33-100\\%)",
            "images": [
                {
                    "id": "img-59.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 187,
                    "bottom_right_x": 1339,
                    "bottom_right_y": 1034,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 369,
            "markdown": "$\\sqrt{ }$ metastases to lung, heart, brain (in 10\\%)\nSpread: widespread dissemination (2\\%)\n> hematogenous: lung ( $7-20 \\%$ ), brain ( $1-3 \\%$ )\n> lymphatic: abdominal lymph nodes\n> direct extension to / invasion of IVC, hepatic vein, diaphragm, trachea, lung, pericardium, esophagus, GI tract, retroperitoneum, perirenal space, peritoneum, gallbladder, pancreas, peripancreatic space, spleen, parietal wall (muscle, skin, bone $[1 \\%)$ )\nUS (initially):\n$\\sqrt{ }$ complex large heterogeneous mass mimicking a solid mass ( $70 \\%$ ):\n$\\sqrt{ }$ juxtaposed areas of internal hyper- and hypoechogenicity with irregular margins\n$\\sqrt{ }$ scattered foci of calcifications\n$\\sqrt{ }$ pseudocyst with large area of central necrosis surrounded by an irregular ringlike region of hyperechogenicity (fibrous tissue)\n$\\sqrt{ }$ \"hailstorm pattern\" = echogenic geographic ill-defined single / multiple hemangioma-like solid masses\n$\\sqrt{ }$ pseudocyst with massive necrosis\n$D D x$ : benign liver cyst, cystadenoma, cystadenocarcinoma, hydatid disease\n$\\sqrt{ }$ small calcified lesion\n$\\sqrt{ } \\pm$ irregular cystic areas\n$\\sqrt{ }$ distortion and displacement of hepatic + portal veins + biliary tree; invasion of IVC (on color Doppler)\n$\\sqrt{ }$ propensity of spread to liver hilum:\n$\\sqrt{ }$ dilatation of intrahepatic bile ducts\nCT (morphologic assessment):\n$\\sqrt{ }$ heterogeneous hypodense poorly marginated infiltrating masses\n$\\sqrt{ }$ pseudocystic necrotic regions of near water density surrounded by hyperdense solid component\n$\\sqrt{ }$ irregular ringlike region of often partly calcified fibrous tissue\n$\\sqrt{ }$ little / no enhancement\nMR (characterization of components):\n$\\sqrt{ }$ fibrosis + parasitic tissue hypointense on T1WI\n$\\sqrt{ }$ small cystic peripheral extensions + central necrosis hyperintense on T2WI\n$\\sqrt{ }$ fibrotic collagenous components hypointense on T2WI\n$\\sqrt{ }$ multivesicular structure resembling bunch of grapes / honeycomb\n$\\sqrt{ }$ lesions hypointense on DWI (DDx to malignancy)\nKodama classification:\nType $1(4 \\%)$ : multiple small cysts w/o solid component\nType 2(40\\%): multiple small cysts + solid component\nType $3(46 \\%)$ : irregular large cysts + solid component\nType $4(4 \\%)$ : solid without cysts\nType $5(6 \\%)$ : single large cyst w/o solid component\nAngio:\n$\\sqrt{ }$ intrahepatic arterial tapering + obstruction\n$C x$ : liver abscess ( $\\leftarrow$ superinfection by bacteria + fungi); secondary biliary cirrhosis;",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 370,
            "markdown": "portal hypertension $(\\rightarrow$ bleeding esophageal / duodenal varices); Budd-Chiari syndrome; obstruction of IVC; heart, lung, brain involvement\nPrognosis: $50-75 \\%$ mortality rate (higher for older age and poor local health care); death within $10-15$ years if treatment not curative\n$R x$ : radical surgery, liver transplantation, mandatory long-term benzimidazoles (antihelmintic drugs)\n$D x$ : immunohistochemical + histologic analysis, serologic tests\n$D D x$ : cholangiocarcinoma, biliary cystadenoma + cystadeno- carcinoma, hepatocellular carcinoma (biopsy!), large hemangioma (characteristic enhancement pattern), metastasis, epithelial hemangioendothelioma\n\n# Alveolar Echinococcosis of CNS \n\nAssociated with: multicystic liver disease\n$\\sqrt{ }$ heterogeneous solid / partially solid / cystic masses:\n$\\sqrt{ }$ prominent surrounding edema (common)\n$\\sqrt{ }$ heterogeneous ringlike / nodular cauliflower-like enhancement (typical)\n$\\sqrt{ }$ calcifications\n$D D x$ : cerebral neoplasm\n\n## ECTOPIC PANCREAS\n\n$=$ PANCREATIC REST / CHORISTOMA $=$ HETEROTOPIC PANCREAS $=$ MYOEPITHELIAL HAMARTOMA\n$=$ presence of abnormally located pancreatic tissue with its own ductal system and NO vascular / neural / anatomic contact with normal pancreas\nFrequency: $1-14 \\%$ of population; $\\mathrm{M}+\\mathrm{F}=2 \\div 1$\n$\\diamond$ Most common heterotopia within GI system!\n\n- usually asymptomatic in GI tract (although stenosis, ulceration, bleeding, intussusception may develop)\n- abdominal pain similar to peptic ulcer disease ( $77 \\%$ )\n- abdominal fullness ( $30 \\%$ ), melena ( $24 \\%$ )\n- functional: subject to usual pancreatic inflammatory + neoplastic disorders\n\nPathogenesis: metaplasia of multipotent endodermal cells; displacement and transplantation of pancreatic cells during embryonic development\nSite: submucosa (in $1 / 2$ ) / muscularis propria\nLocation: lesions may be multiple\n(a) proximal portion of duodenum ( $30 \\%$ ): pylorus, duodenal bulb\n(b) $2^{\\text {nd }}-4^{\\text {th }}$ portion of duodenum ( $20 \\%$ )\n(c) greater curvature of antrum $1-6 \\mathrm{~cm}$ from pylorus ( $26 \\%$ )\n\nPrevalence: $1 \\%-2 \\%$ : in $3 / 4$ submucosal\n(d) other small bowel ( $16 \\%$ ): proximal jejunum, ileum, Meckel diverticulum\n(e) rarely in: colon, esophagus, gallbladder, bile ducts, liver, spleen, umbilicus, mesentery, mesocolon, omentum, fallopian tubes\nSize: usually $0.5-2.0$ (up to 5.0 cm in its largest diameter)\n$\\sqrt{ }$ smooth cone- / nipple-shaped submucosal nodule $1-5 \\mathrm{~cm}$ (rarely $>3-4 \\mathrm{~cm}$ ) in size\n$\\sqrt{ }$ central umbilication representing orifice of filiform duct\nCT:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 371,
            "markdown": "$\\sqrt{ }$ flat / ovoid irregularly marginated intramural mass\n$\\sqrt{ }$ homogeneously enhancing with intraluminal extension ( $=$ enhancement pattern similar to pancreatic tissue)\n$\\sqrt{ } 5-20 \\mathrm{~mm}$ small cystic change in markedly thickened wall of $2^{\\text {nd }}$ part of duodenum $\\leftarrow$ pseudocysts of groove pancreatitis / cystic dystrophy of duodenum / paraduodenal wall cysts\nMR:\n$\\sqrt{ }$ area with SI similar to native pancreas\n$\\sqrt{ } \\pm$ surrounding inflammatory changes\n$\\sqrt{ }$ PATHOGNOMONIC presence of ducts on MRCP\nEndoscopic US:\n$\\sqrt{ }$ solid mass of intermediate echogenicity\nCx: biliary + intestinal obstruction, massive GI bleeding, pancreatitis, paraduodenal pancreatitis, pseudocyst, insulinoma, malignant transformation\nDDx of submucosal mass without umbilication:\nBrunner gland adenoma, leiomyoma, lymphoma\n\n# EMBRYONAL RHABDOMYOSARCOMA OF BILIARY TREE \n\n$=$ rare tumor most commonly arising from CBD\nFrequency: $1 \\%$ of liver tumors in children\nMedian age: 3 years; $<5$ years in $75 \\% ; \\mathrm{M}>\\mathrm{F}$\nPath: intraluminal biliary mass / cluster of grapelike masses (similar to rhabdomyosarcoma of bladder / vagina)\nHisto: same as sarcoma botryoides; positive reactions for muscle markers\n\n- jaundice (in $60-80 \\%$ ), abdominal distension, fever\n- hepatomegaly, malaise, nausea, vomiting\n- †levels of conjugated bilirubin + alkaline phosphatase\n\nMetastases (in up to 30\\%):\nretroperitoneal + mesenteric lymph nodes, lung\nLocation: common bile duct (most frequently) and intrahepatic bile ducts $\\rightarrow$ invasion of liver\nSize: $8-20-\\mathrm{cm}$\n$\\sqrt{ }$ bulky heterogeneous mass in porta hepatis\n$\\sqrt{ }$ intrahepatic bile duct dilatation\n$\\sqrt{ }$ regional lymphadenopathy\n$\\sqrt{ }$ displacement / invasion of duodenum, stomach, pancreas\nCholangiography:\n$\\sqrt{ }$ large bulky intraluminal mass / grapelike cluster of intraluminal masses $\\rightarrow$ focally distending common bile duct + obstructing proximal bile ducts\nUS:\n$\\sqrt{ }$ solitary heterogeneous hypoechoic mass\n$\\sqrt{ }$ multiple hypoechoic nodules separated by septa\n$\\sqrt{ }$ portal vein displacement without thrombosis\n$\\sqrt{ }$ multiple tumor arteries with low-resistance spectrum\nCT:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 372,
            "markdown": "$\\sqrt{ }$ homo- / heterogeneous hypo- / hyperattenuating mass\n$\\sqrt{ } \\pm$ prominent fluid component\n$\\sqrt{ }$ NO / intense heterogeneous globular enhancement\nMR:\n$\\sqrt{ }$ T1 hypointense + T2 hyperintense / predominantly fluid-intensity mass in CBD or biliary radicals\n$\\sqrt{ }$ heterogeneous intrahepatic mass with large areas of fluid\nMRCP:\n$\\sqrt{ }$ partially cystic mass within / adjacent to CBD causing mural irregularity of duct\nPrognosis: $78 \\%$ survival with local disease after multimodal therapy; total resection possible in $20-40 \\%$\n$D D x$ : choledochal cyst, infantile hemangioendothelioma, (intense peripheral nodular enhancement with centripetal fill-in), mesenchymal hamartoma of liver (predominantly cystic), hepatoblastoma (elevated AFP)\n\n# EPIDERMOID CYST OF SPLEEN \n\n$=$ EPITHELIAL CYST $=$ PRIMARY CYST OF SPLEEN\nFrequency: $10 \\%$ of all benign nonparasitic cysts\nCause: infolding of peritoneal mesothelium / collection of peritoneal mesothelial cells trapped within splenic sulci\nHisto:\n(1) Mesothelial lining\n(2) Squamous epithelial lining $=$ epidermoid cyst\n$=$ squamous metaplasia from embryonic inclusions within preexisting mesothelial surface epithelium\nAge: $2^{\\text {nd }}-3^{\\text {rd }}$ decade (average age of 18 years)\nMay be associated with: polycystic kidney disease\nA. Unilocular + solitary $(80 \\%)$\nB. Multiple + multilocular (20\\%)\n\nAverage size: 10 cm\n$\\sqrt{ }$ well-defined thin-walled anechoic lesion of water density\n$\\sqrt{ }$ peripheral septations / cyst wall trabeculations (in 86\\%)\n$\\sqrt{ }$ curvilinear calcification in wall ( $9-25 \\%$ )\n$\\sqrt{ }$ may contain cholesterol crystals, fat, blood\nCx: trauma, rupture, infection\n\n## EOSINOPHILIC CHOLANGIOPATHY\n\n$=$ rare benign cause of biliary obstruction\nPrevalence: 15 cases in literature\nCause: unknown\nHisto: transmural eosinophilic infiltration of biliary tract\nA. Eosinophilic cholecystitis\n\nB Eosinophilic cholangitis\nC. Both",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 373,
            "markdown": "May be associated with: multiple organ involvement (in 50\\%) of GI tract, urinary tract, bone marrow, pancreas, lymph nodes\n\n- jaundice $\\pm$ peripheral eosinophilia\n$\\sqrt{ }$ thickened bile duct wall $\\pm$ biliary dilatation\n$\\sqrt{ }$ wall irregularities in beaded pattern\n$R x:$ steroids\n$D D x$ : lymphoma, AIDS cholangiopathy, collagen vascular disease, cholangiocarcinoma, amyloidosis\n\n\n# EPITHELIOID HEMANGIOENDOTHELIOMA \n\n$=$ rare primary low-grade malignant vascular tumor of liver (soft tissue, skin, bone, lung)\nIncidence: $0.1 \\div 100,000$ annually\nAverage age: 44 (range, 25-58) years; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 3$\nMay be associated with: oral contraceptives, exposure to vinyl chloride\nPath: multifocal nodules varying in size from a few mm to several cm involving both lobes of the liver $\\leftarrow$ rapid perivascular extension along hepatic + portal veins); nodules may coalesce in liver periphery\nHisto: dendritic spindle-shaped cells + epithelioid round cells in a matrix of myxoid + fibrous stroma; neoplastic endothelial cells invade sinusoids + terminal hepatic + portal veins cutting off the tumor's blood supply; immunohistochemical stain with antibodies to factor VIII (von Willebrand factor), CD31 / CD34\n\n- in 80\\%: RUQ abdominal pain, weakness, anorexia, jaundice\n- hepatomegaly, weight loss\n\nIn 27-40\\% metastases to: lung, peritoneum, lymph nodes, bone, spleen, mesentery\nGrowth pattern:\n(a) multifocal nodular form of early stage:\n$\\sqrt{ }$ multiple predominantly peripheral nodules\n(b) diffuse form of advanced stage:\n$\\sqrt{ }$ coalescence of nodules into confluent masses\n$\\sqrt{ }$ peripheral subcapsular growth (in $75 \\%$ ) without capsular bulge\n$\\sqrt{ }$ capsular retraction (in $25-69 \\%$ ) $\\leftarrow$ fibrotic reaction\n$\\sqrt{ }$ increased tumor vascularity\n$\\sqrt{ }$ hypertrophy of uninvolved liver\nPlain film:\n$\\sqrt{ }$ hepatic calcifications within myxoid stroma (in 15\\%)\nUS:\n$\\sqrt{ }$ individual / confluent nodules or diffusely heterogeneous echotexture\n$\\sqrt{ }$ nodules with echogenicity unrelated to size:\n$\\sqrt{ }$ hypoechoic $\\leftarrow$ central core of myxoid stroma\n$\\sqrt{ }$ hyperechoic $\\pm$ hypoechoic rim\n$\\sqrt{ }$ isoechoic with hypoechoic halo\n$\\sqrt{ }$ no blood flow\nCT:\n$\\sqrt{ }$ homogeneously $\\downarrow$ attenuation $\\leftarrow$ myxoid + hyalinized stroma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 374,
            "markdown": "$\\sqrt{ }$ capsular retraction in peripheral lesion\nCECT:\n$\\sqrt{ }$ target / halo pattern = nonenhanced outer rim of avascular tissue + enhanced inner peripheral rim\n$\\sqrt{ }$ peripheral + progressive centripetal enhancement with incomplete fill-in on delayed phase\n$\\sqrt{ }$ enhanced / nonenhanced tumor center on delayed imaging\nMR:\n$\\sqrt{ }$ central hypointensity on T1WI\n$\\sqrt{ }$ \"target\" sign / concentric zones = alternating high- and low-signal-intensity rings on T2WI: $\\sqrt{ }$ central zone of fibrosis / hemorrhage / necrosis\n$\\sqrt{ }$ rim of cellular proliferation + edema\n$\\sqrt{ }$ hyperintense center + thin rim of hypointensity on T2WI\nCEMR:\n$\\sqrt{ }$ multilayered targetlike appearance with prominent rimlike enhancement\n$\\sqrt{ }$ central nodular enhancement ( $38 \\%$ )\n$\\sqrt{ }$ \"lollipop\" sign = synchronous targetlike enhancement of tumor mass + along hepatic / portal veins terminating at / near periphery\nAngio:\n$\\sqrt{ }$ hyper- and hypovascularity (dependent upon degree of sclerosis + hyalinization)\n$\\sqrt{ }$ invasion $\\pm$ occlusion of portal + hepatic veins\nNUC:\n$\\sqrt{ }$ decreased perfusion to central myxoid tumor portion + increased perfusion to cellular areas on sulfur colloid scan\n$\\sqrt{ }$ photopenic defect on static sulfur colloid scan\n$\\sqrt{ }$ NOT gallium avid\n$\\sqrt{ }$ moderate to intense uptake on PET\nPrognosis: 20\\% die within 2 years, $20 \\%$ survive for 5-28 years $\\pm$ treatment\n$R x$ : liver transplantation (without spread); radical resection; transarterial chemoembolization\n$D D x$ of single nodule: cholangiocarcinoma; confluent hepatic fibrosis in advanced cirrhosis; treated HCC, large atypical cavernous hemangioma\n$D D x$ of multiple nodules: metastatic disease, angiosarcoma\n$D D x$ of diffuse form: sclerosing carcinoma; vasoocclusive disease\n\n# FASCIOLIASIS \n\n= infection by trematode Fasciola hepatica (liver fluke)\nLife cycle:\nmiracidia infests freshwater snails $\\rightarrow$ multiply + excreted as cercariae $\\rightarrow$ ingested as contaminated water by sheep / cattle / human $\\rightarrow$ metacercariae encyst in stomach $\\rightarrow$ perforate duodenal wall $\\rightarrow$ migrate into peritoneal cavity $\\rightarrow$ perforation of liver capsule by fluke (= hepatic phase) digesting hepatocytes forming clusters of small peripheral sterile necrotic cavities + tunnel-shaped microabscesses $\\rightarrow$ parasites become established in biliary ducts (= biliary phase), mature and release eggs into bile ducts $\\rightarrow$ move into central + extrahepatic bile ducts + gallbladder to accommodate increasing size of parasite\nEndemic to: South America, Asia, Africa, Europe, USA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 375,
            "markdown": "- fever, abdominal pain, hepatomegaly, eosinophilia, biliary colic\n\nCT:\n$\\sqrt{ }$ multiple serpentine branching hypoattenuating subcapsular lesions pointing toward central liver\n$\\sqrt{ }$ \"tunnels and caves\" sign = multiple clustered hypoattenuating nodules\nUS:\n$\\sqrt{ }$ intrabiliary filling defects + biliary dilatation\n$\\sqrt{ }$ wall thickening of extrahepatic ducts and gallbladder\n\n# FATTY LIVER \n\n$=$ FATTY INFILTRATION OF THE LIVER = HEPATIC STEATOSIS\n$=$ accumulation of triglyceride droplets in hepatocytes\nN.B.: no fatty infiltration of liver parenchyma\n\nPrevalence: $15-35 \\%$ in general population; $>60 \\mathrm{~g}$ alcohol daily ( $45 \\%$ ); hyperlipidemia ( $50 \\%$ ); obesity with body mass index $>30 \\mathrm{~kg} / \\mathrm{m}^{2}(75 \\%)$; obesity coupled with high alcohol consumption $(95 \\%)$\nMechanism: injury to mitochondrial structure / processes ( $\\beta$-oxidation, energy depletion) of hepatocytes\nCause:\nA. METABOLIC DERANGEMENT\nmetabolic syndrome ( $=$ obesity, insulin resistance, hypertriglyceridemia), acute fatty liver of pregnancy, protein malnutrition (kwashiorkor, marasmus), starvation, total parenteral hyperalimentation / nutrition (TPN), malabsorption (jejunoileal bypass), glycogen storage disease, Wilson disease, glycogen synthetase deficiency, cystic fibrosis, Reye syndrome, corticosteroids, severe hepatitis, trauma, chronic illness (TB, CHF), chemotherapy\nB. HEPATOTOXINS\nalcohol, carbon tetrachloride, arsenic, phosphorus\nCommon drugs: 5-fluorouracil, irinotecan, methotrexate, amiodarone, tamoxifen, corticosteroids, antipsychotics\nC. INFLAMMATION\nchronic viral hepatitis $\\mathrm{C}>\\mathrm{B}$, chronic autoimmune hepatitis\nPath: $>5 \\%$ fat of total liver weight\nHisto: hepatocytes with large cytoplasmic fat vacuoles containing triglycerides (= steatosis)\n$\\leftarrow$ defects in free fatty acid metabolic pathways\nLocation: most pronounced + earliest around central vein\nHistopathologic analysis of biopsy specimens allows:\n(1) Grading of severity of steatosis\n(2) DDx between steatosis and steatohepatitis\n(3) Confirmation of nonalcoholic fatty liver disease / nonalcoholic steatohepatitis\n(4) Detection of unsuspected coexisting disease like viral hepatitis.\n\n- most common cause of elevated liver function tests\n\nPattern of fat deposition: diffuse (most common), focal, multifocal, perivascular, subcapsular $\\sqrt{ }$ rapid change with time (few days to $>10$ months) depending on clinical improvement (abstinence from alcohol, improved nutrition) + degree of severity + early stage",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 376,
            "markdown": "Cx: steatohepatitis (inflammatory cell injury), cirrhosis\n\n# Acute Fatty Liver of Pregnancy \n\nTime: during late 3rd trimester\n\n- slowly evolving right upper quadrant / epigastric pain\n- jaundice\n- symptoms of preeclampsia: HTN, edema, proteinuria\n$\\checkmark$ hepatomegaly + diffuse fatty change of liver\n\n\n## Diffuse Fat Deposition in the Liver\n\n$\\diamond$ Most frequently encountered pattern\n$\\checkmark$ hepatomegaly ( $75-80 \\%$ ) / normal sized liver\nPlain film:\n$\\checkmark$ \"radiolucent liver\" sign = enlarged radiolucent liver\nUS ( $60-100 \\%$ sensitive, $77-95 \\%$ specific, $85-97 \\%$ accurate):\n$\\checkmark$ liver echogenicity exceeds that of renal cortex / spleen:\n$\\checkmark$ fine (more typical) / coarse hyperechogenicity\n$\\checkmark$ increased sound attenuation:\n$\\diamond$ Attenuation of sound beam (= scattering of sound beam) is a feature of fat, NOT fibrosis\n$\\checkmark$ poor definition of posterior aspect of liver / diaphragm\n$\\checkmark$ decreased visibility of portal triads\n$\\checkmark$ poor delineation of intrahepatic architecture\n$\\checkmark$ impaired visualization of borders of hepatic vessels\nNECT (43-95\\% sensitive, $90 \\%$ specific):\nAn increase in fat content leads to a decrease in CT numbers at low energy. With higher energy levels the fat attenuation values are higher as well.\n> relative criteria with internal control:\n$\\checkmark$ attenuation of liver less than that of intrahepatic vessels (= marked steatosis)\n$\\checkmark$ density of liver at least 10 HU less than that of spleen\n$\\checkmark$ hepatosplenic attenuation difference $(\\Delta=\\mathrm{L}-\\mathrm{S})$\nThe spleen serves as a good internal control for comparison with the liver because: > splenic attenuation is unaffected by various diffuse pathologic processes > spleen is located at the same cross section as liver\nAt NECT, a normal liver has higher attenuation than a normal spleen. A lower liver attenuation suggests a diagnosis of hepatic steatosis.\n$\\Delta>5 \\mathrm{HU}$ no macrovesicular steatosis ( $0-5 \\%$ )\n$\\Delta-10$ to 5 HU mild to moderate steatosis ( $6-30 \\%$ )\n$\\Delta<-10 \\mathrm{HU}$ steatosis of $>30 \\%$\n$\\checkmark$ ratio of liver+spleen $<1$\n$\\diamond$ A hepatic attenuation index of $<0.8$ is $100 \\%$ specific for $>30 \\%$ macrovesicular steatosis\n\nThe hepatic attenuation index is an objective measure of fatty liver disease.\n> absolute criteria:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 377,
            "markdown": "$\\sqrt{ }$ liver attenuation of $<48 \\mathrm{HU}$; of $<40 \\mathrm{HU}=30 \\%$ fat\n\n| $64.4 \\pm 3.1 \\mathrm{HU}$ | $0 \\%$ fat | $41.9 \\pm 6.7 \\mathrm{HU}$ | $26-50 \\%$ |\n| :-- | :-- | :-- | :-- |\n| $59.1 \\pm 7.3 \\mathrm{HU}$ | $1-25 \\%$ | $25.0 \\pm 15.5 \\mathrm{HU}$ | $>50 \\%$ |\n\nCECT:\n$\\sqrt{ }$ absolute liver attenuation $<40 \\mathrm{HU}$ (limited sensitivity)\n$\\sqrt{ }$ liver attenuation $<$ musculature (marked steatosis)\nDual-energy CT (scans at $140+80 \\mathrm{kVp}$ ):\n$\\sqrt{ }$ hepatic steatotic attenuation changes more marked with a change in tube potential compared to normal liver\n$\\diamond$ Tube current variation (from 200 to 50 mAs ) does not affect the mean tissue attenuation values!\nNUC:\n99 mTc -sulfur colloid scan:\n$\\sqrt{ }$ diffuse heterogeneous uptake ( $68 \\%$ )\n$\\sqrt{ }$ reversal of liver-spleen uptake ( $41 \\%$ )\n$\\sqrt{ }$ increased bone marrow uptake ( $41 \\%$ )\n${ }^{133} \\mathrm{Xe}$ ventilation scan:\n$\\sqrt{ }$ increased activity during washout phase ( $38 \\%$ )\nMR ( $81 \\%$ sensitive, $100 \\%$ specific):\n$\\sqrt{ }$ slightly higher signal intensity on T1WI + T2WI; relatively insensitive ( $10 \\%$ fat by weight will alter SE signal intensities by only $5-15 \\%$ )\n$\\sqrt{ }$ signal loss on out-of-phase ( $=$ opposed-phase) compared to in-phase images / fat turns black with Dixon technique (chemical shift imaging):\nExplanation: difference in precession frequencies for protons in fat $\\left(-\\mathrm{CH}_{2}\\right)$ and water $(-\\mathrm{OH})$\n$\\sqrt{ }$ estimation of liver fat content by comparing liver tissue to spleen and muscle as internal references\n$\\sqrt{ }$ quantifiable by degree of SI loss\n$\\sqrt{ }$ chemical fat saturation sequence (usually less sensitive but superior in the presence of cirrhosis)\n$\\sqrt{ }$ MR spectroscopy (most accurate noninvasive method)\nThe advantage of MR spectroscopy is its ability to determine the absolute liver fat concentration. It has a high sensitivity for detecting small amounts of hepatic triglycerides.\n\n# Focal Fat-Sparing in Diffuse Fatty Liver \n\nCause: disturbance in portal venous flow / direct drainage of systemic blood into liver Characteristic locations:\n(a) in porta hepatis $=$ posterior edge of segment 4 anterior to portal vein bifurcation $\\leftarrow$ drainage of aberrant gastric vein\n(b) next to gallbladder bed (drainage of cystic vein)\n(c) adjacent to falciform ligament / ligamentum venosum\n(d) subcapsular skip areas\n$\\sqrt{ }$ geographic configuration",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 378,
            "markdown": "$\\sqrt{ }$ poorly delineated margins\n$\\sqrt{ }$ contrast enhancement similar to normal liver\n$\\sqrt{ }$ pseudolesion $=\\mathrm{NO}$ mass effect ( $=$ undisplaced course of intrahepatic vessels)\nUS:\n\n| Relative Frequency of Causes of Fatty Liver |  |  |  |\n| :--: | :--: | :--: | :--: |\n| Most common | Common | Rare | Congenital |\n| Alcohol overuse | Viral infection | Nutritional / dietary | Storage disorders |\n| Insulin resistance | Hepatitis C | TPN | Glycogen storage disease |\n| Obesity | Hepatitis B | Rapid weight loss | $\\mathrm{a}_{2}$-Antitrypsin deficiency |\n| Hyperlipidemia | Drug use | Starvation | Wilson disease |\n|  | Steroids | Jejunoileal bypass | Hemochromatosis |\n|  | Chemotherapy | Irradiation | Cystic fibrosis |\n|  | Amiodarone |  | Others: |\n|  | Valproic acid |  | Prader-Willi syndrome, Bardet-Biedl syndrome, Metabolic disorders |\n\n$\\sqrt{ }$ hypoechoic ovoid / spherical / sheetlike mass\nCT:\n$\\checkmark$ hyperattenuating relative to surrounding liver\nMR:\n$\\checkmark$ hyperintense on T1WI\n$\\checkmark$ lack of decrease in SI on opposed-phase gradient-echo T1WI\n$D D x:$ mass (round / ovoid shape, well-demarcated margins, no fat content, random location, mass effect + displacement of vessels, contrast uptake above that of normal liver)\n\n# Focal Fat Deposition in the Liver \n\nEtiology: (?) relative ischemia due to $\\downarrow$ portal venous flow $/ \\downarrow$ delivery of unknown substances via portal vein\nKey factor: $\\uparrow$ levels of insulin in portal venous blood\nDistribution: (a) lobar / segmental uniform lesions\n(b) lobar / segmental nodular lesions\n(c) perihilar lesions\n(d) diffuse nodular lesions $=$ multifocal\n(e) diffuse patchy lesions\n\n## Location:\n\n> periligamentous: along falciform ligament and fissure for ligamentum teres, and medial aspect of left lobe $\\leftarrow$ aberrant internal mammary + paraumbilical veins\n> perihilar: within anterior aspect of segment IV adjacent to porta hepatis $\\leftarrow$ aberrant right / left gastric veins\n> pericholecystic: $\\leftarrow$ aberrant cholecystic vein\n> subcapsular: around perforating capsular vessels\n> perivascular: predominantly in centrilobar + periportal regions $\\leftarrow$ variants of blood supply = \"third inflow\" from connections between peripheral portal radicles + systemic veins\n$\\checkmark$ fan-shaped lobar / segmental distribution with angulated / interdigitating geographic",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 379,
            "markdown": "margins\n$\\sqrt{ }$ lesions extend to liver capsule\n$\\sqrt{ }$ pseudolesion $=$ NO mass effect $\\leftarrow$ undisplaced course of vessels, no bulging of liver contour\n$\\sqrt{ }$ perivenous halo of fat (= tram- / ring-like configuration on cross sections) around hepatic veins / portal veins / both\nUS:\n$\\sqrt{ }$ hyperechoic area with poorly defined / sharp margins\n$\\sqrt{ }$ multiple / rarely single echogenic nodules simulating metastases (rare)\nCT:\n$\\sqrt{ }$ patchy areas of decreased attenuation ranging from -40 to +10 HU (DDx: liver tumor)\n$\\sqrt{ }$ NO contrast enhancement\nMR:\n$\\sqrt{ }$ high signal on T1WI + low / isointense signal on T2WI\n$\\sqrt{ }$ decreased SI on opposed-phase gradient-echo T1WI relative to in-phase imaging\nNUC with colloid:\n$\\sqrt{ }$ no significant changes on sulfur colloid images (SPECT imaging may detect focal fatty infiltration)\n$D D x$ : primary / secondary hepatic tumor; fat-containing regenerative nodules of liver cirrhosis\n\n# Hepatic Subcapsular Steatosis \n\n$=$ in patients with renal failure and insulin-dependent diabetes, insulin can be delivered in peritoneal dialysate\nPathophysiology:\nintraperitoneal insulin $\\rightarrow$ subcapsular hepatocytes exposed to higher concentration of insulin $\\rightarrow$ blocks oxidation of free\nfatty acids within hepatocytes $\\rightarrow$ preferential esterification into triglycerides $\\rightarrow$ accumulation of intracellular fat\n$\\sqrt{ }$ unique subcapsular pattern of fatty infiltration\n\n## FOCAL NODULAR HYPERPLASIA\n\n$=\\mathrm{FNH}=2^{\\mathrm{nd}}$ most common benign tumor of liver after hemangioma\nPrevalence: $0.9 \\% ; 3-8 \\%$ of all primary hepatic tumors in adult population, $2-4 \\%$ in pediatric population (typically between 2 and 5 years); twice as common as hepatocellular adenoma\nCause: (?) circulatory disturbance or reparative process in areas of focal injury $\\rightarrow$ triggers focal hepatocellular hyperplasia owing to a regional increase in blood flow\n$\\diamond$ Oral contraceptives DO NOT cause FNH, but exert a trophic effect on its growth!\nPath: localized well-delineated usually solitary ( $80-95 \\%$ ) subcapsular mass composed of numerous small nodules within an otherwise normal liver; NO true capsule; frequently central fibrous scar in area of interconnection of fibrous bands (HALLMARK); angioarchitecture typically has one / more thick-walled arteries within fibrous septa radiating from the center toward the periphery $\\rightarrow$ dividing into numerous capillaries",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 380,
            "markdown": "connected to sinusoids $\\rightarrow$ drained by large hepatic veins (NO portal veins!)\nHisto: composed of multiple spherical aggregates of hyperplastic hepatocytes often containing increased amounts of fat (in $50 \\%$ ) + triglycerides + glycogen; high number of Kupffer cells line sinusoids; proliferation of small bile ducts within fibrous septa without connection to biliary tree; difficult differentiation from regenerative nodules of cirrhosis + hepatocellular adenoma\n\n# Pathologic classification: \n\nA. Classic FNH $(80 \\%)$ :\nabnormal nodular architecture, malformed vessels, cholangiolar proliferation\nB. Nonclassic $\\mathrm{FNH}(20 \\%)$ without septa / central scar:\n$\\diamond$ Difficult to differentiate from other liver masses by imaging\n(a) telangiectatic $\\mathrm{FNH}(15 \\%)$\n(b) FNH with cytologic atypia (3\\%)\n(c) mixed hyperplastic + adenomatous $\\mathrm{FNH}(2 \\%)$\n$\\checkmark$ globally resembling hepatic adenoma\n$\\checkmark$ no prominent septa\n$\\checkmark$ vaguely lobulated contours\n$\\checkmark$ central scar (in only $4 \\%$ )\nAge peak: $3^{\\text {rd }}-4^{\\text {th }}$ decade (range, 7 months to 75 years); $\\mathrm{M} \\div \\mathrm{F}=1 \\div 2$ to $1 \\div 8$\nAssociated with: hepatic hemangioma (in 23\\%), meningioma, astrocytoma, arterial dysplasia of other organs in case of multiple FNH\n\n- initially often asymptomatic (in $50-90 \\%$ incidental discovery)\n- vague abdominal pain $(10-15 \\%) \\leftarrow$ liver capsule distention / mass effect on adjacent organs / blood flow variations\n- normal liver function + normal AFP\n- hepatomegaly / abdominal mass\n\nLocation: right lobe $\\div$ left lobe $=2 \\div 1$; multiple in $5-20 \\%$\nMean size: 4 cm in diameter; $<5 \\mathrm{~cm}$ (in $85 \\%$ )\n$\\checkmark$ well-circumscribed nonencapsulated nodular cirrhotic-like mass in an otherwise normal liver:\n$\\checkmark$ often near liver surface\n$\\checkmark$ pedunculated mass (in 5-20\\%)\n$\\checkmark$ multiple masses (in $20 \\%$ )\n$\\checkmark$ central stellate scar = central fibrous core (NOT true scar) with radiating fibrous septa containing congeries of arteriovenous malformation [congerere, Latin = to collect, heap up]\n$\\checkmark$ spoke-wheel pattern (in $50 \\%$ on average, in $80 \\%$ if $>3 \\mathrm{~cm}$ ) (DDx: fibrolamellar HCC)\n$\\checkmark$ highly vascular tumor:\n$\\checkmark$ supplied by enlarged anomalous hepatic artery\n$\\checkmark$ venous drainage always into hepatic veins (DDx: HCC drains into portal venous system in $98 \\%)$\n$\\checkmark$ hemorrhage is unlikely\n$\\checkmark$ pseudocapsule of a few mm in thickness $\\leftarrow$ surrounding compressed hepatic parenchyma, perilesional vessels, inflammatory reaction:\n$\\checkmark$ fuzzy margins",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 381,
            "markdown": "$\\sqrt{ }$ calcifications EXTREMELY rare\nNECT:\n$\\sqrt{ }$ iso- / slightly hyperattenuating homogeneous mass\nCECT (3 phases necessary!):\n> arterial phase ( $30-60 \\mathrm{sec}$ after bolus injection):\n$\\sqrt{ }$ transient intense hyperdensity of most of the lesion except for central scar\n$\\sqrt{ }$ hypodense central scar $(15-33 \\%)$\n> portal venous phase:\n$\\sqrt{ }$ early washout into hyperdense draining vein\n$\\sqrt{ }$ lesion becomes isodense\n> delayed / equilibrium phase:\n$\\sqrt{ }$ lesion remains isodense\n$\\sqrt{ }$ hyperdense central scar $\\leftarrow$ delayed washout of contrast from myxomatous scar tissue\nUS:\n$\\sqrt{ }$ iso- / mildly hypo- / mildly hyperechoic (33\\%) homogeneous mass\n$\\sqrt{ }$ hypoechoic halo (of compressed liver parenchyma / displaced hepatic vessels)\n$\\sqrt{ }$ hyperechoic central scar in $18 \\%$\nDoppler:\n$\\sqrt{ }$ enlarged afferent blood vessel with central arterial hypervascularity + centrifugal filling to the periphery in a \"spoke-wheel\" pattern\n$\\sqrt{ }$ large draining veins at tumor margins\n$\\sqrt{ }$ may show high-velocity Doppler signals with arterial pulsatility from arteriovenous shunts (DDx: hepatocellular adenoma has intratumoral venous flow)\nMR ( $70 \\%$ sensitive, $98 \\%$ specific, requires 3 phases):\n$\\sqrt{ }$ usually homogeneous signal intensity of lesion\n> T1WI:\n$\\sqrt{ }$ iso- to mildly hypointense ( $94 \\%$ )\n$\\sqrt{ }$ atypically hyperintense lesion in $6 \\%$\n$\\sqrt{ }$ T2WI: isointense / mildly hyperintense ( $94-100 \\%$ )\n$\\sqrt{ }$ central scar (more often detected than on US / CT)\n$\\sqrt{ }$ hypointense on T1WI\n$\\sqrt{ }$ hyperintense on T2WI in $75-84 \\% \\leftarrow$ edema within myxomatous tissue + vascular channels + bile ductules\n$\\sqrt{ }$ hypointense on T2WI in $25 \\% \\leftarrow$ absent / minimal edema\nCEMR (2-D / 3-D GRE):\n$\\sqrt{ }$ marked homogeneous enhancement in arterial phase fading to isointensity on delayed image\n$\\sqrt{ }$ iso- to slightly hyperintense during portal venous / delayed phase relative to liver\n$\\sqrt{ }$ occasionally slightly hyperenhancing in equilibrium phase $\\leftarrow$ entrapment of Gd-DTPA by functioning hepatocytes inside tumor followed by $1 \\%$ excretion into biliary tree\n$\\sqrt{ }$ central scar after Gd-chelate administration:\n$\\sqrt{ }$ low SI on early phase of enhancement\n$\\sqrt{ }$ late + prolonged enhancement of central scar $\\leftarrow$ enlarged interstitial space with increased fluid content (gradually taking up contrast material)\n$\\sqrt{ }$ enhancement of pseudocapsule on delayed images",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 382,
            "markdown": "$\\sqrt{ }$ homogeneously iso- to hyperintense (in $96 \\%$ ) / peripheral ring enhancement on 1-hour delayed images with hepatocyte-specific contrast agent (eg, gadobenate dimeglumine [GdBenzylOxyPropionicTetraAcetate]) (DDx: adenomas never enhance)\n$\\sqrt{ }$ less uptake of IV superparamagnetic iron oxide (ferucarbotran, mangafodipir trisodium) than surrounding liver ( $=$ uptake mechanism similar to that of sulfur colloid)\n$\\diamond$ Use iron oxide in lesions with atypical features!\nNUC:\nSulfur colloid scan:\n$\\diamond$ Only FNH contains sufficient Kupffer cells to cause uptake:\n$\\sqrt{ }$ normal uptake $(60-75 \\%)$\n$\\sqrt{ }$ increased uptake $=$ virtually DIAGNOSTIC\n$\\sqrt{ }$ cold spot $(33 \\%) \\leftarrow$ less Kupffer cells (DDx: hepatic adenoma, hemangioma, hepatoblastoma, liver herniation, hepatocellular carcinoma)\nTc-HIDA:\n$\\sqrt{ }$ increased uptake ( $90 \\%$ ), normal uptake, cold spot ( $10 \\%$ ) with delayed excretion $\\leftarrow$ biliary ductules in FNH not communicating with biliary tree\n99 mTc -tagged RBCs:\n$\\sqrt{ }$ increased uptake during early phase\n$\\sqrt{ }$ defect relative to liver on delayed images\nAngio:\n$\\sqrt{ }$ discretely marginated hypervascular mass ( $90 \\%$ ) with intense capillary blush / hypovascular ( $10 \\%$ )\n$\\sqrt{ }$ enlargement of main feeding artery with central blood supply (= \"spoke-wheel\" pattern in $33 \\%)$\n$\\sqrt{ }$ homogeneous parenchymal stain\n$\\sqrt{ }$ decreased vascularity in central stellate fibrous scar\nRx: (1) Discontinuation of oral contraceptives\n(2) Resection of pedunculated mass\n(3) Diagnostic excisional biopsy for extensive tumor (FNH seldom requires surgery)\n(4) Conservative in asymptomatic patient\n\nCx: rarely rupture with hemoperitoneum (increased incidence in patients on oral contraceptives $-14 \\%)$\n$D D x$ :\n(1) Fibrolamellar carcinoma (metastases, retroperitoneal adenopathy, tumor hemorrhage + necrosis causing pain, collagenous calcified hypointense scar on T2WI)\n(2) Hepatic adenoma ( 10 cm large tumor, symptomatic due to propensity for hemorrhage in $50 \\%$, central scar atypical, use of oral contraceptives)\n(3) Well-differentiated hepatocellular carcinoma (internal necrosis + hemorrhage, vascular invasion, metastases, persistent rim-enhancement of tumor capsule)\n(4) Giant cavernous hemangioma (larger tumor, may calcify, globular peripheral enhancement followed by centripetal filling, retention of contrast on delayed images, central scar with CSF-like behavior on MR)\n(5) Hypervascular metastasis (hypovascular during portal venous phase, in older patient)\n(6) Intrahepatic cholangiocarcinoma (less vascular, dominant large central scar, metastases)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 383,
            "markdown": "# Multiple Focal Nodular Hyperplasia Syndrome \n\n(1) Liver hemangioma\n(2) Berry aneurysm\n(3) Meningioma, astrocytoma\n(4) Systemic arterial dysplasia \\& portal vein atresia\n\n## Telangiectatic Focal Nodular Hyperplasia\n\nFrequency: $10 \\%$ of all FNH\nMean age: 38 years; women\nAssociated with: oral contraceptives (mean time, 15 years)\nMean size: 7 cm\n$\\sqrt{ }$ multiple lesions in $20-50 \\%$\n$\\checkmark$ strong arterial enhancement\n$\\checkmark$ persistent lesion enhancement $(61 \\%) \\leftarrow$ sinusoidal dilatation\n$\\checkmark$ absence of a central scar $(92 \\%)$\n$\\checkmark$ heterogeneous pattern $(43 \\%) \\leftarrow$ necrosis, sinusoidal dilatation, hemorrhagic foci MR:\n$\\checkmark$ hyperintensity on T1WI $(53 \\%) \\leftarrow$ intrasinusoidal dilatation\n$\\checkmark$ strong hyperintensity on T2WI (44\\%)\n$D D x:$ hepatic adenoma\n\n## GALLBLADDER ADENOMA\n\nIncidence: $0.15 \\%$ of cholecystectomy specimens, $4-7 \\%$ of all gallbladder polyps\n\n- usually incidental finding, rarely symptomatic\n\nMay be associated with: primary sclerosing cholangitis, gastrointestinal polyposis syndromes (Peutz-Jeghers, Gardner syndrome)\n$\\sqrt{ }$ sessile / pedunculated mass:\n$\\checkmark$ solitary (in $2 / 3$ ); $2-5$ in number (in $1 / 2$ )\n$\\checkmark$ up to 20 mm in size\n$\\checkmark$ internal vascularity at color Doppler interrogation\n$\\checkmark$ typically enhancing (DDx adenocarcinoma)\nPrognosis: dysplasia-to-carcinoma sequence\n$\\diamond$ Adenomas $>12 \\mathrm{~mm}$ in diameter may exhibit malignancy\n$D D x:$ polypoid gallbladder adenocarcinoma (NO reliable differentiation)\n\n## GALLBLADDER CARCINOMA\n\nIncidence: $0.4-4.6 \\%$ of biliary tract operations; $5^{\\text {th }}$ most common gastrointestinal malignancy worldwide (after colon, pancreas, stomach, liver, esophagus); $3 \\%$ of all intestinal neoplasms; 7,000 new cases annually in USA\n$\\diamond$ Most common biliary cancer ( 9 x more common than extrahepatic bile duct cancer)\nPrevalence: $3 \\div 100,000$ (USA)\nDemographics: most common in Israel, Bolivia, Chile, northern Japan, New Mexico\nEthnicity: Native Americans + Hispanic Americans (with increased prevalence of gallstones)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 384,
            "markdown": "Median age: 72 years; $\\mathrm{M}+\\mathrm{F}=1 \\div 3$ to $1 \\div 4$; whites $>$ blacks\n$\\diamond 85 \\%$ occur in $6^{\\text {th }}$ decade or later!\nRisk factors: gallstones; increased body mass; female gender; postmenopausal status; cigarette smoking; exposure to chemicals (rubber, automobile, wood finishing, metal fabricating industries); chronic Salmonella typhi infection\nAssociated with:\n(1) Disorder of gallbladder:\n(a) Cholelithiasis in $74-92 \\%$\n$\\diamond$ Gallbladder carcinoma occurs in only $1 \\%$ of all patients with gallstones!\n(b) Porcelain gallbladder (in 4-60\\%): prevalence of gallbladder carcinoma in 10-25\\% of autopsies\n(c) Chronic cholecystitis\n(d) Gallbladder polyp: a polyp $>2 \\mathrm{~cm}$ is likely malignant!\n(2) Disorder of bile ducts:\n(a) Primary sclerosing cholangitis (PSC)\n\nIn patients with primary sclerosing cholangitis $60 \\%$ of gallbladder polyps are malignant.\n(b) Congenital biliary anomalies: most types of choledochal cyst, cystic dilatation of biliary tree, anomalous junction of pancreaticobiliary ductal union, low insertion of cystic duct\n(3) Inflammatory bowel disease (predominantly ulcerative colitis, less common in Crohn disease)\n(4) Familial polyposis coli\n\nPath: diffusely infiltrating lesion (68\\%), intraluminal polypoid growth (32\\%)\nHisto:\n(a) adenocarcinoma ( $90 \\%$ ):\n> papillary (6\\%): densely cellular papillary fronds protruding into GB lumen with dysplasia and increased mitoses\n> intestinal type (= variant of well-differentiated adenocarcinoma with intestinal glands)\n> mucinous ( $5 \\%$, with $>50 \\%$ extracellular mucin)\n> signet-ring cell (abundant intracytoplasmic mucin)\n> clear cell (well-defined cytoplasmic borders)\n(b) rare epithelial cell types ( $10 \\%$ ): poorer prognosis\n> adenosquamous carcinoma (3\\%)\n> squamous cell carcinoma ( $1 \\%$ )\n> small (oat) cell carcinoma ( $0.5 \\%$, highly aggressive, $\\pm$ paraneoplastic Cushing syndrome)\n> undifferentiated carcinoma\n(c) nonepithelial cell types ( $2 \\%$ ):\ncarcinoid, carcinosarcoma, basal cell carcinoma, lymphoma\nModified Nevin Stage:\nI mucosa only (in situ carcinoma)\nII mucosa + muscularis invasion\nIII mucosa + muscularis + serosa\nIV gallbladder wall + lymph nodes",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 385,
            "markdown": "V hepatic / distant metastases\n\n- Early diagnosis usually unsuspected $\\leftarrow$ lack of specific signs + symptoms:\n- history of past GB disease (50\\%)\n- malaise, vomiting, weight loss; chronic RUQ pain (54-76\\%)\n- obstructive jaundice ( $35-74 \\%$ )\n- abnormal liver function tests ( $20-75 \\%$ )\n- $\\pm$ elevated $\\alpha$-fetoprotein and CEA\n\nLocation: fundus ( $60 \\%$ ), body ( $30 \\%$ ), neck ( $10 \\%$ )\nGrowth types:\n$\\sqrt{ }$ mass replacing the gallbladder ( $37-70 \\%$ ) with engulfed gallstones\n$\\sqrt{ }$ irregular eccentric thickening of GB wall ( $20-30 \\%$ ) $\\leftarrow$ submucosal spread:\n$\\sqrt{ }$ focal ( $59 \\%$ ) / diffuse ( $41 \\%$ ) wall thickening\n$D D x:$ acute / chronic inflammation (usually $<10 \\mathrm{~mm}$ )\n$\\sqrt{ }$ intraluminal polypoid / fungating \"cauliflower-like\" mass with wide base (15-25\\%)\n$\\sqrt{ }$ pericholecystic infiltration: in $76 \\%$ focal, in $24 \\%$ diffuse\n$\\sqrt{ }$ dilatation of biliary tree ( $38-70 \\%$ ):\n$\\sqrt{ }$ infiltrative tumor growth along cystic duct\n$\\sqrt{ }$ lymph node enlargement causing biliary obstruction\n$\\sqrt{ }$ intraductal tumor spread\n$\\sqrt{ }$ fine granular / punctate flecks of calcification (= mucinous adenocarcinoma)\n$\\sqrt{ }$ lymph node enlargement in porta hepatis\nN.B.: misdiagnosis by US / CT in $50 \\%$, especially in the presence of gallstones\n\nAbdominal radiograph:\n$\\sqrt{ }$ calcified gallstones\n$\\sqrt{ }$ porcelain gallbladder\n$\\sqrt{ }$ RUQ gas collection (after invasion of adjacent bowel)\nCholangiography:\n$\\sqrt{ }$ malignant stricture / obstruction of extrahepatic bile ducts / right + left bile duct confluence, intrahepatic duct of right lobe\n$\\sqrt{ }$ intraluminal GB filling defect (= tumor / stones)\n$\\sqrt{ }$ mass displacing / invading gallbladder\n$\\sqrt{ }$ intraductal filling defects (= tumor / stones)\nUS:\n$\\sqrt{ }$ gallbladder replaced by mass with irregular margins + heterogeneous echotexture (= tumor necrosis)\n$\\sqrt{ }$ immobile intraluminal well-defined round / oval polypoid mass (15-25\\%) hypoechoic relative to liver\n$D D x:$ tumefactive sludge\nClues to polypoid malignancy:\n$\\sqrt{ }$ solitary polyp $>10 \\mathrm{~mm}$\n$\\sqrt{ }$ wide polyp base\n$\\sqrt{ }$ focal wall thickening $>3 \\mathrm{~mm}$\n$\\sqrt{ }$ coexisting gallstones\n$\\sqrt{ }$ focal / diffuse thickening of gallbladder wall (20-30\\%)\n$\\sqrt{ }$ echogenic foci $=$ coexisting gallstones / wall calcifications / tumoral calcification",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 386,
            "markdown": "$\\sqrt{ }$ tumor inseparable from liver\n$\\checkmark$ hypovascular on color Doppler\nCT:\n$\\checkmark$ hypo- / isoattenuating mass in gallbladder fossa:\n$\\checkmark$ low-attenuation areas of necrosis\n$\\checkmark$ areas of enhancement ( $=$ viable tumor)\n$\\checkmark$ subtle extension beyond wall of GB\n$\\checkmark$ invasion of liver ( $40-65 \\%$ ) with protrusion of anterior surface of medial segment of left lobe\nMR:\n$\\checkmark$ hypointense mass on T1WI relative to liver\n$\\checkmark$ ill-defined early contrast enhancement\n$\\checkmark$ hyperintense mass on T2WI\n$\\checkmark$ lower apparent diffusion coefficient than for benign lesion\nPET:\n$\\checkmark$ FDG uptake within GB polyp greater than liver background\nMetastases: in $75-77 \\%$ at time of diagnosis\n(a) direct extension (most common mode): invasion of liver (34-65-89\\%), duodenum (12$15 \\%$ ), colon ( $9-15 \\%$ ), pancreas ( $6 \\%$ ), stomach, bile duct, right kidney, abdominal wall\nCause: thin GB wall with only a single muscle layer + no substantial lamina propria + perimuscular connective tissue continuous with interlobular connective tissue of liver\n(b) lymphatic spread ( $26-41-75 \\%$ ):\ncystic, pericholedochal, celiac, superior mesenteric, foramen of Winslow, paraaortic nodes, superior + posterior pancreaticoduodenal\n(c) intraperitoneal seeding (common)\n(d) hematogenous spread (less common): stomach, duodenum, liver, lung, bones, heart, pancreas, kidney, adrenal, brain\n(e) neural spread (frequent): associated with more aggressive tumors\n(f) intraductal spread (least common): particularly in papillary adenocarcinoma\n\nCx: perforation of gallbladder $\\rightarrow$ abscess formation\n$\\checkmark$ gallstones located within abscess\nPrognosis: $75 \\%$ unresectable at presentation; average survival is 6 months; $5 \\%$ ( $<5 \\%$ ) 1-year (5-year) survival rate\n$D D x$ : (1) Xanthogranulomatous cholecystitis (lobulated mass filling gallbladder + stones)\n(2) Acute / chronic cholecystitis (generalized gallbladder wall thickening $<10 \\mathrm{~mm}$ )\n(3) Liver tumor invading gallbladder fossa\n(4) Tumors from adjacent organs: pancreas, duodenum\n(5) Metastases: melanoma, leukemia, lymphoma\n(6) Polyps: cholesterol $\\sim$, hyperplastic $\\sim$, granulation polyp\n(7) Adenomyomatosis\n\n# GALLBLADDER TORSION",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 387,
            "markdown": "$=$ rare cause of abdominal pain $(1 \\div 365,520$ hospital admissions $)$\nAt risk: generalized loss of elastic + adipose tissue, kyphoscoliosis, calcification of cystic artery\nCause: abnormal / absent mesenteric fixation of GB to inferior margin of liver (\"floating GB\")\nAge: elderly; $\\mathrm{M} \\div \\mathrm{F}=16 \\% \\div 84 \\%$\nA. INCOMPLETE torsion $=$ rotation $<180^{\\circ}$\n\n- mimics biliary colic with recurrent episodes of pain\nB. COMPLETE torsion $=$ rotation $>180^{\\circ}$\n- acute RUQ pain, nausea, vomiting, $\\pm$ palpable mass\n$\\sqrt{ }$ gallbladder wall thickening + adjacent free fluid\n$\\sqrt{ }$ gallbladder hydrops $\\leftarrow$ cystic duct obstruction\n$\\sqrt{ }$ ectopic anterior / inferior GB location\n$\\sqrt{ }$ cystic duct to right of GB + tapering / twisting of cystic duct\n$C x:$ perforation $\\leftarrow$ necrosis $\\leftarrow$ impaired venous drainage\n\n\n# GLYCOGEN STORAGE DISEASE \n\n$=$ autosomal recessive diseases with varying severity and clinical syndromes (13 different types, 8 affect the liver)\n$\\diamond$ Type Ia and Ib are associated with hepatocellular carcinoma!\n$\\diamond$ Type III and IV progress to cirrhosis!\n$\\diamond$ Type I and III are associated with hepatic adenomas!\n$\\diamond$ Hepatomegaly + hypoglycemia + growth retardation + disproportional distribution of body fat in children consider glycogen storage disease!\n\n## Von Gierke Disease (Type Ia)\n\nEtiology: defect in glucose-6-phosphatase with excess deposition of glycogen in liver, kidney, intestines\n$D x$ : failure of rise in blood glucose after glucagon administration\nAge at presentation: infancy\n@ Liver\n$\\checkmark$ hepatomegaly\nUS:\n$\\checkmark$ increased liver echogenicity (glycogen / fat)\n$\\checkmark$ nephromegaly\nCT:\n$\\checkmark$ increased (glycogen) / normal / decreased (fat) parenchymal attenuation\n@ Kidney\n\n- proximal + distal tubular dysfunction; hyperuricosuria\n- focal segmental glomerulosclerosis\n- Fanconi-like syndrome\n$\\checkmark$ nephromegaly\n$\\checkmark$ increased cortical + medullary echogenicity $\\leftarrow$ nephrocalcinosis, nephrolithiasis\n$\\checkmark$ amyloidosis\n$\\checkmark$ high renal blood flow\nPrognosis: death in infancy, may survive into adulthood with early therapy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 388,
            "markdown": "Cx: (1) Hepatic adenoma (in $22-75 \\%$ of adults)\n(2) Hepatocellular carcinoma ( $10 \\%$ risk)\n\n# Pompe Disease (Type II) \n\n$=$ abnormal metabolism with enlargement of myocardial cells $\\leftarrow$ glycogen deposition; similar to endocardial fibroelastosis\nEtiology: defect in lysosomal glucosidase\n$\\sqrt{ }$ massive cardiomegaly with CHF\n$\\checkmark$ hepatomegaly\nPrognosis: sudden death in $1^{\\text {st }}$ year of life $\\leftarrow$ conduction abnormalities; survival rarely beyond infancy\n\n## Forbes / Cori Disease (Type III)\n\nCx: hepatic adenoma, cirrhosis\n\n## Anderson Disease (Type IV)\n\nCx: cirrhosis\n\n## McArdle Disease (Type V)\n\n## Hers Disease (Type VI)\n\n## HEMOCHROMATOSIS\n\n$=$ pathologic state of intracellular iron accumulation / excess iron deposition in various parenchymal organs (liver, pancreas, spleen, kidneys, heart) leading to cirrhosis with portal hypertension\n\n- Lab tests (of low sensitivity + specificity):\n- $\\uparrow$ ferritin level; $\\uparrow$ transferrin saturation index\n\nRole of imaging:\n(1) Clinically silent disease often first uncovered by imaging\n(2) Monitor effectiveness of clinical treatment noninvasively\n\nNECT ( $63 \\%$ sensitive $+96 \\%$ specific in iron overload):\n$\\checkmark$ diffuse / rarely focal increase in liver density ( $>72 \\mathrm{HU}$ )\n$\\checkmark$ depiction of portal + hepatic veins against background of hyperattenuating liver\n$\\checkmark$ dual energy CT (at $80+120 \\mathrm{kVp}$ ) can quantitate amount of iron deposition\n$\\diamond$ Superimposed steatosis reduces sensitivity!\n$\\diamond$ Wilson disease, colloidal gold treatment, long-term amiodarone treatment decreases specificity!\nMR: (skeletal muscle $=$ good SI reference)\n$\\diamond$ Effect proportional to field strength!\n@ Liver\nMRI is the best noninvasive method for measuring the level of iron in the liver with high sensitivity, specificity, positive and negative predictive values to:\n> confirm the diagnosis\n> determine severity",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 389,
            "markdown": "> monitor therapy.\nThe liver parenchyma demonstrates higher SI than the paraspinal musculature on all sequences. Slight to moderate iron overload is better identified on GRE images $\\rightarrow$ decreased SI of the liver parenchyma.\n$\\sqrt{ } \\mathrm{T} 1+\\mathrm{T} 2+\\mathrm{T} 2^{*}$ shortening proportional to iron deposition\nPhysics: paramagnetic susceptibility of ferritin and ferric ions leads to profound shortening of longitudinal relaxation time $\\mathrm{T} 1+$ transverse relaxation time T 2 , particularly $\\mathrm{T} 2^{*}$, of adjacent protons; $\\downarrow \\mathrm{SI}$ in affected organs is proportional to iron deposition\n$\\sqrt{ }$ decreased SI on in-phase compared with out-of-phase images (opposite to steatosis)\n$\\sqrt{ }$ quantification of amount of iron overload on GRE sequences with T2* weighting + progressively longer echo times\n$D x$ : liver biopsy (= standard method for diagnosis) to\n> quantify iron overload\n> determine prognosis based on level of hepatopathy\n> monitor evolution of disease\n> monitor effects of treatment\n\n# Genetic Hemochromatosis \n\n$=$ IDIOPATHIC / PRIMARY / HEREDITARY HEMOCHROMATOSIS\n$=$ genetic defect in iron transport with excessive duodenal absorption + parenchymal retention of normal intake of dietary iron favoring accumulation within non-RES organs\n$\\diamond$ Clinically more severe than transfusional hemosiderosis!\nCause: autosomal recessive disorder (abnormal HFE gene located near human-leukocyte antigen [HLA] on short arm of chromosome 6) $\\rightarrow$ excessive absorption of intestinal iron ( $2-3 \\mathrm{x}$ of normal population)\nPrevalence: $1 \\div 220$ whites of northern European ancestry; homozygote frequency of 0.25 $0.50 \\%$; heterozygote carriers in $10 \\%$\n$\\diamond$ Most common genetic disease in Caucasians in USA\nPathophysiology:\nabsorbed iron is selectively bound to transferrin; increased transferrin saturation in portal circulation favors selective iron uptake initially by periportal hepatocytes $\\rightarrow$ excess iron stored as crystalline iron oxide ( $=$ ferric oxyhydroxide $\\left[\\mathrm{Fe}_{2} \\mathrm{O}_{3}\\right]$ ) within cytoplasmic ferritin + lysosomal hemosiderin; $\\rightarrow$ spread to rest of liver, pancreas, thyroid $\\rightarrow$ cellular damage, organ dysfunction, malignancy ( $\\rightarrow$ if untreated), progression to cirrhosis, HCC, diabetes, cardiac dysfunction\nN.B.: iron overload affects parenchymal cells, NOT the reticuloendothelial system (Kupffer cells + RES cells of bone marrow + spleen)!\nOrgan distribution: liver, pancreas, heart, anterior pituitary, thyroid, synovium, skin $\\diamond$ RES cells are incapable of storing excess iron!\nAge: after middle age; female iron loss during menses and pregnancy provides some protection\n\n- asymptomatic during $1^{\\text {st }}$ decade of disease\n- symptomatic in $80-90 \\%$ if iron deposits $>10 \\mathrm{~g}$\n- hyperpigmentation $=$ bronzing of skin $(90 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 390,
            "markdown": "- hepatomegaly ( $90 \\%$ ); arthralgias ( $50 \\%$ )\n- diabetes mellitus ( $30 \\%$ ); CHF + arrhythmia ( $15 \\%$ )\n- low serum testosterone $\\rightarrow$ decreased libido, impotence\n- fatigue, amenorrhea, loss of body hair, testicular atrophy\n- liver iron index $>2$ ( $=$ liver iron concentration [ $\\mu \\mathrm{mol}$ per gram of dry weight] per patient's age)\n- serum $\\mathrm{Fe}>300 \\mathrm{mg} / \\mathrm{dL}$; serum transferrin saturation $>50 \\%$\n\nMR:\n@ Liver\n$\\sqrt{ }$ significantly hypointense T2 signals $=$ SI equal to background noise\n$\\checkmark$ hepatomegaly, fibrosis, HCC (in advanced disease)\n@ Pancreas\n$\\checkmark$ normal pancreatic signal intensity in noncirrhotics\n$\\checkmark$ pancreatic SI equal to / less than muscle (in $90 \\%$ of cirrhotic patients)\n@ Spleen\n$\\checkmark$ normal SI of spleen (in $86 \\%$ ) + bone marrow $\\leftarrow$ abnormal RES function\n@ Pituitary (in advanced disease)\n\n- hypopituitarism, hypogonadism $\\leftarrow$ gonadotroph malfunction\n$\\checkmark$ profound T2 hypointensity of adenohypophysis (anterior pituitary) similar to ICA flow void\n$\\checkmark$ decreased parenchymal enhancement on T1WI\n$\\checkmark$ diminutive pituitary height $(<4.89 \\pm 0.87 \\mathrm{~mm})$\n@ Heart (in advanced disease)\n- arrhythmia\n$\\checkmark$ congestive cardiomyopathy ( $15 \\%$ )\n$\\checkmark$ pericarditis\nCx: (1) Periportal fibrosis resulting in micronodular cirrhosis (if iron concentration $>$ $22,000 \\mu \\mathrm{~g} / \\mathrm{g}$ of liver tissue)\n$\\checkmark$ low signal intensity on long TE GRE\n(2) Hepatocellular carcinoma (14-36\\%)\n$\\checkmark$ HCC does not contain iron\n(3) Insulin-dependent diabetes mellitus ( $30-60 \\%$ ) $\\leftarrow$ insulin resistance by hepatocytes + damage of pancreatic $\\beta$-cell $\\leftarrow$ iron deposition\n(4) Hypoparathyroidism\n\nRx: phlebotomies in precirrhotic stage\nPrognosis: normal life expectancy with early diagnosis and treatment\n\n# Secondary Hemochromatosis \n\n$=$ any nongenetic cause of iron accumulation in RES organs of liver + spleen + bone marrow\n[Hemosiderosis $=$ increased iron deposition without organ damage]\nCause: acquired\n(a) Chronic hemolytic anemia $\\pm$ multiple transfusions\n$=$ erythrogenic hemochromatosis\n$=$ increased duodenal absorption of iron $\\leftarrow$ erythroid hyperplasia with ineffective erythropoiesis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 391,
            "markdown": "1. Thalassemia\n2. Congenital dyserythropoietic anemia\n3. Sideroblastic anemia $\\leftarrow$ impaired protoporphyrin production\n$\\diamond$ NOT in sickle cell anemia\nPath: no excess Kupffer cell iron\nSome types of anemia like Fanconi anemia benefit from treatment with steroids (oxymetholone, danazol, methyltestosterone) to stimulate erythropoietin production. These drugs can induce hepatocellular adenoma, HCC, and peliosis hepatis.\n(b) Myelodysplastic syndrome\n(c) Exogenous increase of iron\n> parenteral infusion\n4. Transfusional siderosis (see below)\n5. Iron overload siderosis\n> secondary to $\\uparrow$ in iron absorption\n6. Alcoholic hepatitis\n7. Hepatitis C\n8. Cirrhosis\n> excessive ingestion\n9. Bantu siderosis $=$ excessive dietary iron from food preparation in iron containers (Kaffir beer)\nOrgan distribution: RES of liver + spleen + bone marrow\nPath: iron deposition initially in RES (phagocytosis of intact RBCs) with sparing of parenchymal cells of pancreas; after saturation of RES storage capacity parenchymal cells of other organs accumulate iron\nAge: $\\quad 4^{\\text {th }}-5^{\\text {th }}$ decade; $\\mathrm{M}+\\mathrm{F}=10 \\div 1$\nMR:\n@ Liver\n$\\sqrt{ }$ signal loss in liver on T2WI\n= SI greater than background noise $\\leftarrow$ iron in Kupffer cells with sparing of parenchymal liver cells)\n@ Spleen\n$\\sqrt{ }$ splenic signal intensity less than muscle\n@ Bone marrow\n$\\sqrt{ }$ low SI of bone marrow (= siderotic marrow)\n\n# Transfusional Siderosis \n\n$=$ iron deposited in reticuloendothelial system in patients receiving $>40$ units of blood (iron storage capacity of RES $=10 \\mathrm{~g}$ of iron)\nOrgan distribution:\n> common: liver, spleen, bone marrow, lymph nodes\n> less common: adrenals, pancreas, GI tract\nmnemonic: Siderosis affects the Spleen!\n\n- abnormal iron deposition in RES is clinically of little significance (NO damage of affected organs)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 392,
            "markdown": "MR:\n$\\sqrt{ }$ low SI of bone marrow (= siderotic marrow) + spleen\n$\\sqrt{ } \\pm$ low signal intensity of liver\n$\\sqrt{ }$ normal SI of pancreas (except when storage capacity of RES exceeded)\n$D D x$ : diffuse calcification $\\leftarrow$ autosplenectomy of sickle cell anemia\nRisk: parenchymal iron deposition occurs when storage capacity of RES is exhausted\n$\\diamond$ Parenchymal iron deposition can cause organ dysfunction\n$R x$ : iron chelation therapy to remove excess iron\n\n# HEPATIC (LIVER) ABSCESS \n\n$=$ localized collection of pus in the liver $\\leftarrow$ any infectious process with destruction of the hepatic parenchyma + stroma\nTypes: pyogenic ( $85 \\%$ ), fungal ( $9 \\%$ ), amebic ( $6 \\%$ )\nLocation: multiple in $50 \\%$\n$\\diamond$ A pyogenic abscess tends to be centrally located, an amebic abscess peripherally!\n$\\sqrt{ }$ hepatomegaly\n$\\sqrt{ }$ elevation of right hemidiaphragm\n$\\sqrt{ }$ pleural effusion\n$\\sqrt{ }$ right lower lobe atelectasis / infiltration\n$\\sqrt{ }$ gas within abscess: esp. Klebsiella\nMR:\n$\\sqrt{ }$ hypointense on T1WI + hyperintense on T2WI (72\\%)\n$\\sqrt{ }$ perilesional edema ( $35 \\%$ )\n$\\sqrt{ }$ \"double target\" sign on T2WI = hyperintense center (fluid) + hypointense sharply\nmarginated inner ring (abscess wall) + hyperintense poorly marginated ring (perilesional edema)\n$\\sqrt{ }$ rim enhancement ( $86 \\%$ )\n\n## Amebic Abscess\n\nOrganism: trophozoite Entamoeba histolytica\nEtiology: spread of viable amebae from colon $\\rightarrow$ portal system $\\rightarrow$ liver\nFrequency: in $1-25 \\%$ of intestinal amebiasis\nAge: $\\quad 3^{\\text {rd }}-5^{\\text {th }}$ decade; $\\mathrm{M}+\\mathrm{F}=4 \\div 1$\n\n- amebic dysentery; amebic hepatitis ( $15 \\%$ )\n\nLocation: liver abscess (right lobe) in 2-25\\%; multiple liver abscesses in 25\\%; systemic dissemination by invasion of lymphatics / portal system (rare); liver + lung+brain $=$ $100 \\div 10 \\div 1$\nSize: $\\quad 2-12 \\mathrm{~cm}$\n$\\sqrt{ }$ nonspecific variable appearance indistinct from subacute pyogenic abscess\n$\\sqrt{ }$ nodularity of abscess wall ( $60 \\%$ )\n$\\sqrt{ }$ internal septations ( $30 \\%$ )\n$\\sqrt{ }$ NOT gas-containing (unless hepatobronchial / hepatoenteric fistula present)\n$\\sqrt{ } \\pm$ disruption of diaphragm",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 393,
            "markdown": "CT:\n$\\checkmark$ nonspecific hypoattenuating area\n$\\checkmark$ enhancing wall\nUS:\n$\\checkmark$ homogeneous hypoechoic area\n$\\checkmark$ posterior acoustic enhancement\n$\\checkmark$ well-defined smooth thin wall\nNUC:\n$\\checkmark 98 \\%$ sensitivity of sulfur colloid scan\n$\\checkmark$ photon-deficient area surrounded by rim of uptake on ${ }^{67} \\mathrm{Ga}$ scan\nAspiration:\ntypically opaque reddish / dirty brown / pink material (\"anchovy paste\" / \"chocolate sauce\"), usually sterile, parasite confined to margin of abscess\nCx: (1) Diaphragmatic disruption (rare) is strongly suggestive of amebic abscess\n(2) Fistulization into colon, right adrenal gland, bile ducts, pericardium\n\nRx: conservative treatment with chloroquine / metronidazole (Flagyl ${ }^{\\circledR}$ ); percutaneous drainage (for left hepatic abscess spontaneous rupture into pericardium with tamponade possible)\nPrognosis: resolution under therapy may take from 1 month to 2 years; permanent cysts may remain behind\n\n# Pyogenic Liver Abscess \n\n$\\diamond$ Most common type of liver abscess\nOrganism: E. coli, aerobic streptococci, Enterococcus, S. aureus, anaerobic bacteria, Klebsiella ( $45 \\%$ ); polymicrobial ( $>50 \\%$ )\nPrevalence: $0.016 \\%$\nPredisposed: steroids, immunosuppressed state, excessive antibiotics usage\nEtiology:\n(1) Cholangitic (biliary disease in $60 \\%$ ):\nascending cholangitis $\\leftarrow$ obstructive biliary tract disease (malignant / benign stricture),\nCrohn disease (sclerosing cholangitis, gallstones), cholecystitis\n(2) Pylephlebitic(= portal phlebitis $=$ portal pyemia): spread of intraabdominal sepsis $\\leftarrow$ suppurative appendicitis, colitis, diverticular disease\n(3) Disseminated sepsis via hepatic artery:\ninfarction from sickle cell disease / embolism / postembolization for primary and metastatic cancer / septicemia; indwelling arterial catheters\n(4) Contiguous spread from a local infection:\ncholecystitis, peptic ulcer, subphrenic abscess\n(5) Blunt / penetrating trauma:\nrupture, penetrating wounds, biopsy, surgery, liver transplantation, previous biliary\ninstrumentation / stent placement, radiofrequency ablation (1.4\\%)\n(6) Cryptogenic in $20-45 \\%$ :\ninvasion of cysts; superinfection of dead tissue (eg, primary / secondary hepatic tumor)\nby pyogenic intestinal flora",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 394,
            "markdown": "Path: liquefaction necrosis of liver parenchyma ( $\\rightarrow$ central fluid collections of pus) + septa of fibrotic tissue (with inflammatory infiltrates of epitheloid macrophages, lymphocytes, eosinophils, neutrophils)\nClassification by size: macroabscess ( $\\geq 2 \\mathrm{~cm}$ in diameter) microabscess ( $<2 \\mathrm{~cm}$ in diameter)\nMean age: 56-64 years; $\\mathrm{M}>\\mathrm{F}$\n\n- pyrexia (79\\%), abdominal pain (68\\%), jaundice ( $0-20 \\%$ )\n- vomiting / weight loss, malaise (39\\%)\n- nocturnal sweating ( $43 \\%$ ); positive blood culture ( $50 \\%$ )\n- $\\uparrow$ WBCs, $\\uparrow$ alkaline phosphatase\n\nLocation: solitary abscess in right lobe (40-75\\%), in left lobe (2-10\\%); multiple abscesses in $10-34-73 \\%$ (more often of biliary than hematogenous origin)\n$\\sqrt{ }$ honeycomb pattern of cluster of small abscesses at early stage\n$\\sqrt{ }$ \"cluster\" sign = coalescence of several microabscesses each $<2 \\mathrm{~cm}$ within the same anatomic area into single multiseptated larger cavity at later stage (suggests biliary origin)\nUS:\n$\\sqrt{ }$ hypoechoic round lesion with well-defined mildly echogenic rim\n$\\sqrt{ }$ posterior acoustic enhancement\n$\\sqrt{ }$ coarse clumpy debris / low-level echoes / fluid-debris level with internal movement\n$\\sqrt{ }$ intensely echogenic reflections with reverberations (from gas) in 20-30\\%\nCT ( $95 \\%$ sensitive):\n$\\sqrt{ }$ inhomogeneous hypoattenuating ( $0-45 \\mathrm{HU}$ ) single / multiloculated (multiseptated) cavity\n$\\sqrt{ }$ \"single target\" sign = hypoattenuating mass surrounded by single enhancing rim $\\leftarrow$ after cluster of small abscesses aggregate + coalesce into single larger cavity\n$\\sqrt{ }$ \"double target\" sign( $6-30 \\%$ ):\n$\\sqrt{ }$ hypoattenuating pus centrally surrounded by\n$\\sqrt{ }$ inner hyperattenuating ring $\\leftarrow$ granulation tissue\n$\\sqrt{ }$ outer hypoattenuating zone $\\leftarrow$ inflammatory edema\n$\\sqrt{ }$ air density\n$\\sqrt{ }$ segmental / wedge-shaped transient hepatic enhancement surrounding abscess $\\leftarrow$ reduced portal venous flow $\\leftarrow$ inflammation and stenosis + compensatory increase in hepatic arterial flow\nMR:\n$\\sqrt{ }$ very low SI on T1WI + very high SI on T2WI (varies with protein content)\n$\\sqrt{ }$ intense peripheral rim enhancement of capsule of variable thickness + septa\nNUC:\n$\\sqrt{ }$ photon-deficient area on sulfur colloid + IDA scan\n$\\sqrt{ }^{67} \\mathrm{Ga}$ citrate uptake in $80 \\%$\n$\\sqrt{ }^{111}$ In-tagged WBC uptake is highly specific (since WBCs normally go to liver, may need sulfur colloid test for correlation)\nCx: (1) Septicemia\n(2) Rupture into right subphrenic space\n(3) Rupture into abdominal cavity\n(4) Rupture into pericardium",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 395,
            "markdown": "(5) Empyema\n(6) Common hepatic duct obstruction\n\nMortality: $2-10 \\% ; 100 \\%$ if unrecognized / untreated\nRx: percutaneous catheter drainage for multilocular abscesses + abscesses $>5 \\mathrm{~cm}$ in diameter; surgical drainage (lower failure rate)\n\n| Patterns of Iron Deposition Related to Possible Causes of Hemochromatosis |  |  |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: | :--: | :--: |\n| Deposition <br> Pattern | Liver | Spleen | Bone <br> Marrow | Pancreas | Kidney | Cause |\n| RES | Yes | Yes | Yes | No | No | multiple transfusions |\n| Parenchymal | Yes | No | No | Yes | No | increased iron absorption: primary hemochromatosis, chronic anemia with inefficient erythropoiesis (thalassemia, congenital dyserythropoietic anemia, sideroblastic anemia) |\n| Renal | No | No | No | No | Yes | intravascular hemolysis (artificial heart valve), paroxysmal nocturnal hemoglobinuria, hemolytic crisis of sickle cell disease |\n| Mixed | Yes | Possible | Possible | Possible | Possible | chronic anemia due to ineffective erythropoiesis requiring multiple transfusions |\n\n# Microabscesses \n\nPredisposed: immunocompromised after neutrophil recovery\n$\\sqrt{ }$ \"cluster\" sign = multiple microabscesses in geographic proximity (= early stage of abscess in evolution)\n$\\sqrt{ }$ heterogeneous enhancement $\\leftarrow$ clustered coalescing abscesses\n$\\sqrt{ }$ peripheral / septal enhancement\nUS ( $79 \\%$ sensitive):\n$\\sqrt{ }$ multiple small hypoechoic nodules in liver $\\pm$ spleen\nCT ( $97 \\%$ sensitive):\n$\\sqrt{ }$ multiple well-circumscribed hepatic / splenic lesions\nMR (may be more sensitive than CT):\n$\\sqrt{ }$ T2 hyperintensity + faint restricted diffusion $\\leftarrow$ necrosis + purulent debris\n$\\sqrt{ }$ perilesional T2 hyperintensity $\\leftarrow$ edema\n$\\sqrt{ }$ dynamic gadolinium-enhanced MR may show more lesions than CT\n$D D x:$ HCC (sepsis, no peripheral / septal enhancement)\n\n## HEPATIC ADENOMA\n\n$=$ HEPATOCELLULAR ADENOMA $=$ LIVER CELL ADENOMA\n$=$ epithelial neoplasm composed of normal hepatocytes\n$\\diamond$ The most frequent hepatic tumor in young women after $>2$-year use of oral contraceptives $(4 \\div 100,000$ women annually)!\nPrevalence: half as common as FNH; increasing with duration of oral contraceptive use + size of estrogen dose\nPath: spherical benign growth with high incidence of hemorrhage + necrosis + fatty change; pseudocapsule $\\leftarrow$ compression of liver tissue containing multiple large vessels; NO scar\nHisto: hepatocytes arranged in sheets without acinar structure (no portal or central vein), separated by thin-walled sinusoids fed by large peritumoral arteries, containing increased amounts of glycogen $\\pm$ fat; few abnormally functioning Kupffer cells; NO connection with bile ducts (DDx to FNH)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 396,
            "markdown": "Peak age: 40 years; young women in childbearing age ( $90 \\%$ ); not seen in males unless on anabolic steroids; rare in children (girls $>10$ years)\nCategories: 3 distinct genetic and pathologic subtypes\n(a) inflammatory hepatocellular adenoma (most common)\n\n- frequently in obese patients + in young women with a history of oral contraceptive Risk of: hemorrhage, malignancy( $10 \\%$ )\n(b) hepatocyte nuclear factor 1 alpha (HNF-1 $\\alpha$ )-mutated hepatocellular adenoma ( $2^{\\text {nd }}$ most common)\n- woman with a history of oral contraceptive use\n(c) $\\beta$-catenin-mutated hepatocellular adenoma\n- more common in men with a history of anabolic steroid use / glycogen storage disease Risk of: malignant transformation (highest rate)\nAssociated with:\n> oral contraceptives ( 2.5 x risk after 5 -year use, 7.5 x risk after 9 -year use, 25 x risk $>9$ year use); pregnancy\n> anabolic steroids; familial diabetes mellitus; galactosemia\n> type IA (von Gierke) glycogen storage disease (adenomas in 22-60-75\\% at an early age), also in type III (Cori)\n> androgenic steroid therapy in Fanconi anemia\n$\\diamond$ Pregnancy may increase tumor growth rate + lead to tumor rupture!\n$\\diamond$ Tumor regression may occur with dietary therapy leading to normal insulin, glucagon, and serum glucose levels\n- RUQ pain as sign of mass effect ( $40 \\%$ ) / intratumoral ( $10 \\%$ ) or intraperitoneal hemorrhage $\\rightarrow$ hypovolemic shock\n- asymptomatic ( $20 \\%$ ), $\\uparrow$ liver function tests, normal AFP\n- hepatomegaly\n\nMean size: 3-5 (range, $1-15-30 \\mathrm{~cm}$ ) in diameter\nLocation: right lobe of liver in subcapsular location ( $75 \\%$ ); multiple in up to $21 \\%$\nMultiplicity: associated with glycogen storage disease / use of anabolic steroids; solitary lesion (in $70-80 \\%$ ); hepatic adenomatosis (see below)\n$\\checkmark$ spherical / ovoid well-circumscribed mass\n$\\checkmark$ frequently heterogeneous $\\leftarrow$ dilated sinusoids, blood-filled (pelioid) spaces, focal necrosis, infarction, hemorrhage, myxoid stroma, fatty change, calcifications\n$\\checkmark$ pseudocapsule ( $17-31 \\%$ )\n$\\checkmark$ intraparenchymal / pedunculated (in $10 \\%$ )\n$\\checkmark$ unusual \"nodule-in-nodule\" appearance in large tumors (DDx: hepatocellular carcinoma)\n$\\checkmark$ eccentric dystrophic calcifications (5-15\\%)\nCT:\n$\\checkmark$ round usually isoattenuating mass (without hemorrhage)\n$\\checkmark$ mass of decreased density $\\leftarrow$ gross fat $(7-10 \\%)+$ areas of necrosis ( $30-40 \\%$ )\n$\\checkmark$ hyperdense areas of fresh intratumoral hemorrhage ( $15-50 \\%$ )\nCECT:\n$\\checkmark$ transient avid homogeneous enhancement on arterial-phase images in small adenomas $(90 \\%)$ / initial peripheral enhancement with centripetal filling in larger adenomas ( $\\leftarrow$ supply by hepatic artery)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 397,
            "markdown": "$\\sqrt{ }$ iso- / hypoattenuating on portal venous + delayed-phase images\nUS:\n$\\sqrt{ }$ usually small well-demarcated nonlobulated solid heterogeneous mass of variable echogenicity:\n$\\sqrt{ }$ hyperechoic lesion with well-defined hypoechoic rim in normal surrounding liver\n$\\sqrt{ }$ echogenic in areas of fat or hemorrhage\n$\\sqrt{ }$ hypoechoic in background of diffuse fatty infiltration\n$\\sqrt{ }$ anechoic cystic areas if large\nColor Doppler:\n$\\sqrt{ }$ central vessels with triphasic pattern / continuous flat venous waveform\n$\\sqrt{ }$ peripheral peritumoral arterial + venous flow\nMR:\n$\\sqrt{ }$ heterogeneous on all pulse sequences in $88 \\%$ (indistinguishable from HCC):\n$\\diamond$ Small homogeneous adenomas (uncomplicated by hemorrhage / intracellular lipid in 4\\%) mimick FNH!\n$\\sqrt{ }$ variable intensity on T1WI:\n$\\sqrt{ }$ mildly hypointense on T1WI\n$\\sqrt{ }$ often hyperintense areas $\\leftarrow$ hemorrhage / presence of intralesional lipid-laden hepatocyte (in $35-77 \\%$ )\n$\\sqrt{ }$ signal loss with out-of-phase / fat-suppressed imaging $\\leftarrow$ intracellular lipid (DDx to FNH)\n$\\sqrt{ }$ variable heterogeneous intensity on T2WI:\n$\\sqrt{ }$ isointense / mildly hyperintense sheets of hepatocytes\n$\\sqrt{ }$ hyperintense areas of necrosis / hemorrhage in $47-77 \\%$\n$\\sqrt{ }$ pseudocapsule hypointense on T1WI, variointense on T2WI $\\pm$ delayed enhancement\n$\\sqrt{ }$ variable intensity (commonly increased) on DWI\n$\\sqrt{ }$ enhancement characteristics:\n$\\sqrt{ }$ heterogeneous hypervascularity during arterial phase (less vascular than FNH)\n$\\sqrt{ }$ iso- or hypointense on portal venous + delayed phase\n$\\sqrt{ }$ delayed washout $=$ delayed enhancing pseudocapsule\n$\\sqrt{ }$ hypointense on 1-hour delayed imaging with gadobenate dimeglumine (GdBenzylOxyPropionicTetraAcetate)\nNUC:\n$\\sqrt{ }$ photopenic lesion on sulfur colloid scan ( $\\leftarrow$ lesion composed of hepatocytes + nonfunctioning Kupffer cells) surrounded by rim of increased uptake ( $\\leftarrow$ compression of adjacent normal liver containing Kupffer cells); may show uptake equal to / slightly less than liver $(23 \\%)$\n$\\sqrt{ }$ usually increased uptake / retention on HIDA scan\n$\\sqrt{ }$ NO gallium uptake\nAngio:\n$\\sqrt{ }$ usually hypervascular mass\n$\\sqrt{ }$ homogeneous but not intense stain in capillary phase\n$\\sqrt{ }$ enlarged hepatic artery with feeders at tumor periphery ( $50 \\%$ )\n$\\sqrt{ }$ hypo- / avascular regions $\\leftarrow$ hemorrhage / necrosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 398,
            "markdown": "$\\sqrt{ }$ neovascularity\nCAVE: percutaneous biopsy carries high risk of bleeding!\nCx: (1) Spontaneous intratumoral hemorrhage (likely related to infarction as tumor outgrows blood supply) with subcapsular hematoma\n(2) Hepatic rupture + hemoperitoneum ( $41 \\%$ ) in lesions $>5 \\mathrm{~cm}$\n(3) Malignant transformation (rare) $\\leftarrow$ contiguous development of hepatocellular carcinoma\n(4) Recurrence after resection\n$R x$ : discontinuation of hormone therapy; screening for malignant degeneration with $\\alpha$ fetoprotein; surgical resection (to prevent rupture)\n$\\diamond$ Hepatocellular adenomas $>5 \\mathrm{~cm}$ in maximum dimension in males with glycogen storage disease should be surgically resected followed by detailed histopathologic review for tumor geno- and phenotypic characterization.\n$D D x$ : (1) Hepatocellular carcinoma (presence of cirrhosis / hepatitis B / hemochromatosis, positive for $\\alpha$ - fetoprotein, peripheral rim of high attenuation on delayed phase, vascular invasion)\n(2) Fibrolamellar carcinoma (eccentric scar with calcification, adenopathy)\n(3) FNH (stellate scar, homogeneous mass, NO intralesional fat / glycogen, arterial flow in spoke-wheel pattern, normal / increased uptake of ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ sulfur colloid)\n\n# Inflammatory Hepatocellular Adenoma 40-50\\% \n\n$=$ TELANGIECTATIC FOCAL NODULAR HYPERPLASIA - TELANGIECTATIC ADENOMA\nAge: young woman with a history of oral contraceptive usage; obese patient\n\n- systemic inflammatory syndrome: fever, leukocytosis, elevated serum levels of C-reactive protein\n- $\\uparrow$ serum levels of transaminase, alkaline phosphatase, $\\gamma$-glutamyl transferase; chronic anemia\nGenetics: somatic gain-of-function mutation of interleukin-6 signal transducer gene (IL6ST) located at chromosome 5 q 11\nPath: heterogeneous in appearance, with areas of congestion and frank hemorrhage; sinusoidal dilatation, peliotic areas, abnormal arteries\nHisto: intense polymorphous inflammatory infiltrates, marked sinusoidal dilatation / congestion, thick-walled arteries; tumor cells show immunoreactivity to acute phase inflammatory markers like serum amyloid A and C-reactive protein\n$\\sqrt{ }$ delayed persistent enhancement ( $85 \\%$ sensitive, $87 \\%$ specific)\nUS:\n$\\sqrt{ }$ arterial vascularity with centripetal filling + peripheral rim of sustained enhancement + central washout during late venous phase\nNECT:\n$\\sqrt{ }$ heterogeneously hyperattenuating mass\nMR:\n$\\sqrt{ }$ isointense / mildly hyperintense on T1WI with minimal / no signal drop-off on chemical shift sequences\n$\\sqrt{ }$ intense enhancement during arterial phase persisting into portal venous + delayed phase",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 399,
            "markdown": "$\\sqrt{ }$ marked diffuse T2-hyperintensity:\n$\\sqrt{ }$ higher signal intensity in periphery of lesion $\\leftarrow$ dilated sinusoids\nCx: (1) intratumoral bleeding ( $20-30 \\%$ ), esp. for tumors $>5 \\mathrm{~cm}$ in maximum diameter; subcapsular tumor with greater tendency for bleeding + rupture\n(2) $10 \\%$ risk of malignancy\n\n# HNF-1 $\\alpha$-mutated Hepatocellular Adenoma 30-35\\% \n\n$=$ usually incidentally discovered tumor (multiple in about $50 \\%$ ) occurring exclusively in female with history of oral contraceptive use in $>90 \\%$\nGenetics: nonfunctioning tumor suppressor gene located on chromosome 12q24 $\\leftarrow$ biallelic inactivating mutation of the hepatocyte nuclear factor-1 $\\alpha$ (HNF1A) gene that produces a transcription protein involved in hepatocyte differentiation\nHisto: excessive lipid accumulation in tumor hepatocytes\n$\\sqrt{ }$ diffuse intratumoral steatosis\n$\\sqrt{ }$ diffuse fatty infiltration of liver $\\leftarrow$ associated with maturity-onset diabetes of the young (MODY)\n$\\sqrt{ }$ moderate tumor enhancement during arterial phase\nUS:\n$\\sqrt{ }$ iso- to moderately increased vascularity + mixed filling during arterial phase + isoechogenicity during portal venous + delayed phases (after contrast material)\nCT:\n$\\sqrt{ }$ macroscopic fat in tumor (7\\%)\nMR:\n$\\sqrt{ }$ iso- to slightly hyperintense tumor on T2WI\n$\\sqrt{ }$ predominantly T1-hyper- / isointense\n$\\sqrt{ }$ chemical shift imaging:\n$\\sqrt{ }$ homogeneous signal drop-off ( $86 \\%$ sensitive, $100 \\%$ specific) $\\leftarrow$ intracellular steatosis\n$\\sqrt{ }$ macroscopic fat in tumor (in $35-77 \\%$ )\nPrognosis: risk of bleeding / malignancy is minimal\n\n## $\\beta$-Catenin-mutated Hepatocellular Adenoma 10-15\\%\n\nGenetics: activating mutation of $\\beta$-catenin gene encoded by catenin $\\beta 1$ gene (CTNNB1) located at chromosome $3 \\mathrm{p} 21 \\rightarrow$ uncontrolled hepatocyte proliferation\nAssociated with: male hormone administration, glycogen storage disease, familial adenomatous polyposis\nHisto: high nuclear-cytoplasmic ratio, nuclear atypia, formation of acini; strong diffuse positivity to glutamine synthase\n$\\sqrt{ }$ strong arterial enhancement\nMR:\n$\\sqrt{ }$ homo- / heterogeneous hyperintense T1 + T2 signal depending on presence of hemorrhage $\\pm$ necrosis\nPrognosis: 5-10\\% risk of HCC\nRisk factors: male sex, glycogen storage disease, anabolic steroid usage, $\\beta$-cateninmutated subtype, tumor $>5 \\mathrm{~cm}$ in maximum dimension",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 400,
            "markdown": "# Hepatic Adenomatosis \n\n$=$ rare condition with $>10$ adenomas in both hepatic lobes without history of steroid therapy / glycogen storage disease\nCause: nonalcoholic liver disease, HNF-1 $\\alpha$ gene mutation\nAge: $4^{\\text {th }}-5^{\\text {th }}$ decade; female\n\n## HEPATIC ANGIOMYOLIPOMA\n\n$=$ rare benign mesenchymal tumor\nAssociated with: tuberous sclerosis\nHisto: smooth muscle cells, fat, proliferating blood vessels\n\n- asymptomatic\n$\\checkmark$ intratumoral fat is DIAGNOSTIC\n$\\checkmark$ soft-tissue component may enhance\nUS:\n$\\checkmark$ circumscribed hyperechoic mass (DDx: hemangioma)\n$\\checkmark$ sound attenuation + subtle acoustic shadowing\n$\\checkmark$ relative hypervascularity\nCT:\n$\\checkmark$ areas of macroscopic fat\n$\\checkmark$ marked enhancement with visualization of large central vessels during arterial phase MR:\n$\\checkmark$ hyperintense areas of macroscopic fat on T1WI\n$\\checkmark$ marked decrease in SI with T1 fat suppression technique\n$\\checkmark$ intense enhancement during arterial phase with dark areas of macroscopic fat on fatsuppressed T1WI\nCx: intratumoral hemorrhage\n\n\n## HEPATIC ANGIOSARCOMA\n\n$=$ HEMANGIOENDOTHELIAL SARCOMA $=$ KUPFFER CELL SARCOMA $=$ HEMANGIOSARCOMA\nPrevalence: $0.14-0.25 \\div 1,000,000 ;<2 \\%$ of all primary liver neoplasms; most common sarcoma of liver (followed by fibrosarcoma $>$ malignant fibrohistiocytoma $>$ leiomyosarcoma)\nEtiology:\n(a) thorotrast $=$ thorium dioxide $(7-10 \\%)$ with latent period of $15-24$ years\n(b) arsenic compounds\n(c) polyvinyl chloride (latent period of 4-28 years)\n\nAssociated with: hemochromatosis, anabolic steroids, cirrhosis, von Recklinghausen disease Path:\n(a) multifocal / multinodular lesions ( $71 \\%$ ) of up to $>5 \\mathrm{~cm}$ in size\n(b) large solitary mass with hemorrhage + necrosis\n\nHisto: vascular derivation confirmed by reactivity to factor VIII-related antigen, CD31 and CD34\n(a) vessels lined with malignant endothelial cells (eg, sinusoids) causing atrophy of surrounding liver",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 401,
            "markdown": "(b) vasoformative $\\rightarrow$ forming poorly organized vessels (responsible for RBC trauma + platelet trapping)\n(c) forming solid nodules of malignant spindle cells\n\nAge: $6^{\\text {th }}-7^{\\text {th }}$ decade; $\\mathrm{M} \\div \\mathrm{F}=4 \\div 1$\n\n- abdominal pain, weakness, fatigue, weight loss, jaundice\n- spontaneous hemoperitoneum (15-27\\%)\n- microangiopathic hemolytic anemia (23\\%), thrombocytopenia (54\\%), DIC (31\\%); NO elevation of $\\alpha$-fetoprotein\nEarly metastases to:\nlung ( $23 \\%$ ), spleen ( $16-46 \\%$ ), porta hepatis nodes, portal vein, thyroid, peritoneal cavity, bone marrow (rapid metastatic spread)\n$\\diamond$ Predilection for splenic metastases!\n$\\checkmark$ portal vein invasion\n$\\checkmark$ hemorrhagic ascites\n$\\checkmark$ unifocal / multifocal / infiltrative lesion\nPlain film:\n$\\checkmark$ circumferential displacement of residual thorotrast\nNUC:\n$\\checkmark$ single / multiple photopenic areas on sulfur colloid scan\n$\\checkmark$ increased gallium uptake\n$\\checkmark$ perfusion blood pool mismatch (initial decrease followed by slow increase in RBC concentration) as in hemangioma on 3-phase red blood cell scan\nUS:\n$\\checkmark$ solid / mixed mass with anechoic areas (hemorrhage / necrosis)\n$\\checkmark$ multiple nodules\n$\\checkmark$ diffuse heterogeneous echotexture of entire liver\nCT:\n$\\checkmark$ hypodense masses with high-density regions (hemorrhage) / low-attenuation regions (old hemorrhage / necrosis)\n$\\checkmark$ focal areas of peripheral enhancement with fill-in on dynamic CT as in large hemangioma (uncommon)\nMR:\n$\\checkmark$ hypointense on T1WI with irregular areas of high signal (hemorrhage)\n$\\checkmark$ heterogeneously hyperintense on T2WI + fluid-fluid levels\nCEMR:\n$\\checkmark$ markedly heterogeneous enhancement: predominantly peripheral, progressive on delayed phase, lack of central filling\nAngio:\n$\\checkmark$ hypervascular stain around tumor periphery in late arterial phase with puddling; NO arterial encasement\nPET:\n$\\checkmark$ may demonstrate marked uptake in liver tumor\n$\\checkmark$ localization of extrahepatic disease\nCAVE: Biopsy may lead to massive bleeding in 16\\%! Have surgical backup available!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 402,
            "markdown": "Prognosis: rapid deterioration with median survival of 6 months ( 13 months under chemotherapy)\nDDx for multiple lesions: hypervascular metastases\n$D D x$ for single lesion: cavernous hemangioma, HCC (no splenic metastases)\n\n# HEPATIC CYST \n\n$\\diamond$ Second most common benign hepatic lesion after hemangioma\nPrevalence: $2-7-14 \\%$; increasing with age; $\\mathrm{M}<\\mathrm{F}$\nA. ACQUIRED HEPATIC CYST\n\nCause: trauma, inflammation, parasitic infestation, neoplasia\nB. CONGENITAL HEPATIC CYST\n\nCause: defective development of aberrant / obstructed intrahepatic bile ducts; ? derived from bile duct hamartoma\nFrequency: liver cysts detected at autopsy in $50 \\%$; in $22 \\%$ detected during life\nAge of detection: $5^{\\text {th }}-8^{\\text {th }}$ decade\nPath: no communication with biliary tree\nHisto: cyst surrounded by fibrous capsule + lined by columnar epithelium, related to bile ducts within portal triads; NO communication with bile duct\nAssociated with:\n(1) Tuberous sclerosis\n(2) Polycystic kidney disease ( $25-33 \\%$ have liver cysts)\n(3) Polycystic liver disease: autosomal dominant\n\n- simple cyst: almost always asymptomatic\n- hepatomegaly ( $40 \\%$ ); pain ( $33 \\%$ ); jaundice ( $9 \\%$ )\n\nSize of cyst: range from microscopic to huge (average 1.2 cm ; in $25 \\%$ ( $40 \\%$ ) largest cyst $<1$ $(>4) \\mathrm{cm}$; maximal size of 20 cm )\nNumber of cysts: multiple cysts spread throughout liver (in 60\\%) / solitary cyst\n$\\diamond$ Consider polycystic liver disease if $>10$ cysts\n$\\checkmark$ well-circumscribed round / ovoid unilocular lesion:\n$\\checkmark$ imperceptible wall $\\pm$ rim calcification\n$\\checkmark$ anechoic with posterior acoustic enhancement\n$\\checkmark$ very bright on T2WI\n$\\checkmark$ water attenuation ( -20 to +20 HU )\n$\\checkmark$ no enhancement\n$\\checkmark$ hypointense on T1WI, hyperintense on T2WI\n$\\checkmark$ \"cold spot\" on IDA, Ga-68, 99mTc-sulfur colloid scans\nPitfall:\n(1) Metastatic neuroendocrine tumor (can be very cystic $\\pm$ very bright on T2WI)\n(2) Cystic metastasis (in cystic primary tumor)\n\nRare $C x$ : infection, rupture, torsion, hemorrhage, malignant transformation into adenocarcinoma\n$\\checkmark$ fluid-fluid interface\n$\\checkmark$ wall thickening\n$\\checkmark$ intracystic debris $\\pm$ septations",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 403,
            "markdown": "$R x$ : sclerosing therapy with minocycline hydrochloride (Dose: 1 mg per 1-mL cyst content up to 500 mg in 10 mL of $0.9 \\%$ saline $+10 \\mathrm{~mL} 1 \\%$ lidocaine) following contrast opacification of cyst to confirm absence of communication with biliary tree / leakage into peritoneal cavity\n\n# HEPATIC HEMANGIOMA \n\n## Cavernous Hemangioma of Liver\n\n$=$ most common solid benign liver tumor ( $78 \\%$ ); $2^{\\text {nd }}$ most common liver tumor after metastases\nPrevalence: $1-4 \\%$; autopsy incidence $0.4-7.3 \\%$; increased with multiparity\nCause: ? enlarging hamartoma present since birth, ? true vascular neoplasm\nAge: rarely seen in young children; $\\mathrm{M}+\\mathrm{F}=1+2-5$\nPath: large vascular channels filled with slowly circulating blood; lined by single layer of mature flattened endothelial cells separated by thin fibrous septa; NO bile ducts; thrombosis of vascular channels commonly results in fibrosis + hemorrhage + myxomatous degeneration + calcifications\nPathophysiology: large blood volume with low blood flow\nAssociated with: (1) Hemangiomas in other organs\n(2) Focal nodular hyperplasia\n(3) Rendu-Osler-Weber disease\n(4) Klippel-Trénaunay-Weber syndrome\n(5) Von Hippel-Lindau disease\n\n- asymptomatic if tumor small ( $50-70 \\%$ )\n- may enlarge during pregnancy\n\nLocation: frequently peripheral / subcapsular in posterior right lobe of liver; $20 \\%$ are pedunculated; multiple in $10-20 \\%$\nSize: $\\quad<4 \\mathrm{~cm}(90 \\%)$\n$\\diamond$ Very small + very big lesions have the most atypical imaging features $\\leftarrow$ calcifications, fibrosis, thrombosis of tumor portions, cystic / necrotic areas within tumor!\n$\\sqrt{ }$ well-circumscribed lobulated mass\n$\\checkmark$ blood supply from hepatic artery with arterial enhancement characteristics\n$\\checkmark$ may have central area of fibrosis = areas of nonenhancement / nonfilling / cystic space (occurrence increases with age and size)\n$\\checkmark$ central septal calcifications within areas of fibrosis / phleboliths (5-20\\%)\nUS:\n$\\checkmark$ uniformly hyperechoic ( $60-70 \\%$ ) mass $\\leftarrow$ multiple interfaces created by blood-filled spaces separated by fibrous septa\n$\\checkmark$ hypoechoic mass (up to $40 \\%$ ) in larger hemangiomas / on background of fatty infiltration or liver fibrosis\n$\\checkmark$ well-defined thick / thin echogenic lobulated border\n$\\checkmark$ homogenous ( $58-73 \\%$ ) / heterogeneous $\\leftarrow$ hemorrhagic necrosis, thrombosis, scarring, myxomatous change, central fibrosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 404,
            "markdown": "$\\sqrt{ } \\pm$ hypoechoic center\n$\\sqrt{ }$ may show acoustic enhancement (37-77\\%)\n$\\sqrt{ }$ unchanged size / appearance ( $82 \\%$ ) on 1-6-year follow-up\n$\\sqrt{ }$ no Doppler signals / signals with peak velocity of $<50 \\mathrm{~cm} / \\mathrm{sec}$\n$\\sqrt{ }$ contrast enhancement\nCT (combination of precontrast images, good bolus, dynamic scanning, $88 \\%$ sensitive, 84$100 \\%$ specific):\n$\\sqrt{ }$ well-circumscribed spherical / ovoid low-density mass:\n$\\sqrt{ }$ may have areas of higher / lower density within mass\n$\\sqrt{ }$ enhancement patterns:\nType $1=$ immediate uniform enhancement (\"flash filling\"); in $42 \\%$ of hemangiomas $<1 \\mathrm{~cm}$\n$D D x$ : hypervascular tumor (does not remain hyperattenuated on delayed phase)\nType $2=$ peripheral nodular enhancement + complete fill-in on delayed images 3-30 min post IV bolus (in 55-89\\%):\n$D D x$ : metastasis (nodular / rim enhancement $\\pm$ centripetal fill-in possible)\nType $3=$ peripheral nodular enhancement + partial (24\\%) / no (2\\%) fill-in to isodensity on delayed phase in giant hemangioma $>5 \\mathrm{~cm} \\leftarrow$ thrombosis\n$\\sqrt{ }$ central scar in large lesion may not enhance at any time\nMR ( $98-100 \\%$ sensitive, $92-98 \\%$ specific, $90-95 \\%$ accurate):\n$\\sqrt{ }$ spheroid / ovoid ( $87 \\%$ ) mass with smooth well-defined lobulated margins ( $87 \\%$ ); NO capsule\n$\\sqrt{ }$ homogeneous internal architecture if $<4 \\mathrm{~cm}$, hypointense internal inhomogeneities if $>4$ $\\mathrm{cm} \\leftarrow$ fibrosis\n$\\sqrt{ }$ hypo- / isointense mass relative to liver on T1WI\n$\\sqrt{ }$ markedly hyperintense \"light bulb\" appearance ( $\\leftarrow$ slow flowing blood) increasing with echo time on heavily T2WI; more intense than spleen ( $92 \\%$ accurate)\n(DDx: hepatic cyst, hypervascular tumor, necrotic tumor, cystic neoplasm)\n$\\sqrt{ }$ for hyalinized hemangioma: only mildly hyperintense on T2WI + lack of enhancement in early phase + slight peripheral enhancement in late phase (DDx: malignant hepatic tumor)\n$\\sqrt{ }$ hyperintense on DWI $\\leftarrow$ T2 shine-through\n$\\sqrt{ }$ enhancement pattern as on CT with gadolinium-DTPA:\nType $1=$ immediate uniform enhancement at 1 sec in $40 \\%$ of small hemangiomas $<$ 1.5 cm\n\nType $2=$ peripheral nodular + interrupted enhancement (77\\%) equal to blood pool progressing centri-petally with centrally uniform enhancement\nType $3=$ peripheral nodular enhancement with centripetal progression but persistent hypointensity for giant hemangioma $>5 \\mathrm{~cm}$\n$D D x$ : hypervascular metastasis (contrast washout on $>5$ min delayed images)\nAngio (historical gold standard):\n$\\sqrt{ }$ dense opacification of well-circumscribed, dilated, irregular, punctate vascular lakes / puddles (\"cotton wool / snowy tree\" appearance) in late arterial + capillary phase",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 405,
            "markdown": "starting at periphery in ring- / C-shaped configuration\n$\\sqrt{ }$ normal-sized feeders; AV shunting (very rare)\n$\\sqrt{ }$ contrast persistence late into venous phase\nNUC ( $95 \\%$ accuracy with SPECT):\nIndication: lesions $>2 \\mathrm{~cm}$ (detectable in $70-90 \\%$ ) with atypical imaging characteristics on cross-sectional imaging\n$\\sqrt{ }$ initially cold lesion on ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-labeled RBC scans (dose of $15-20 \\mathrm{mCi}$ ) with increased activity on delayed images at $1-2$ hours\n$\\sqrt{ }$ cold defect on sulfur colloid scans\n$B x$ : may be biopsied safely provided normal liver is present between tumor + liver capsule\n$\\sqrt{ }$ nonpulsatile blood ( $73 \\%$ )\n$\\sqrt{ }$ endothelial cells without malignancy ( $27 \\%$ )\nPrognosis: no growth when $<4 \\mathrm{~cm}$ in diameter; giant cavernous hemangiomas may enlarge; may involute into hyalinized hemangioma\nCx (rare): (1) Spontaneous rupture (4.5\\%)\n(2) Abscess formation\n(3) Kasabach-Merritt syndrome (platelet sequestration)\n\nMimics:\n(1) Angiosarcoma\n(2) Epitheloid hemangioendothelioma\n(3) Treated metastasis\n(4) Neuroendocrine metastasis (bright on T2WI)\n\nDDx: hypervascular malignant neoplasm / metastasis\n\n# Giant Hepatic Cavernous Hemangioma \n\n$=$ hemangioma $>5 \\mathrm{~cm} /$ at least one dimension exceeding $8-10 \\mathrm{~cm}$ (in literature no agreement on size)\nAssociated with: coexistent smaller $<5 \\mathrm{~cm}$ hemangioma in $13 \\%$\nHisto: hemorrhage, thrombosis, extensive hyalinization, liquefaction, fibrosis; central cleft due to cystic degeneration / liquefaction\n\n- may present with spontaneous life-threatening hemorrhage (5\\%); hepatomegaly; abdominal mass\n- RUQ fullness + pain $\\leftarrow$ thrombosis in large hemangioma\n- Kasabach-Merritt syndrome (rare)\n\nUS:\n$\\sqrt{ }$ heterogeneous mass\nNECT:\n$\\sqrt{ }$ heterogeneous hypoattenuating mass with marked central areas of low attenuation\n$\\sqrt{ }$ \\pm coarse central calcification\nCECT:\n$\\sqrt{ }$ early peripheral globular enhancement\n$\\sqrt{ }$ incomplete filling of central portions\nMR:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 406,
            "markdown": "$\\sqrt{ }$ sharply marginated hypointense mass with cleftlike area of lower intensity on T1WI\n$\\sqrt{ }$ large markedly hyperintense cleftlike area ( $\\leftarrow$ cystic degeneration / liquefaction) with some hypointense internal septa inside a hyperintense mass on T2WI\nCEMR:\n$\\sqrt{ }$ peripheral nodular enhancement\n$\\sqrt{ }$ central cleftlike area remains hypointense\n$C x$ : inflammatory changes; intralesional hemorrhage; intraperitoneal hemorrhage; torsion of pedunculated lesion; Kasabach-Merritt syndrome\n$D D x$ : metastasis, HCC, cholangiocarcinoma, hepatic adenoma, FNH (smaller and less hyperintense central scar on T2WI), focal fatty infiltration\n\n# Infantile Hemangioendothelioma of Liver \n\n$=$ INFANTILE HEPATIC HEMANGIOMA = CAPILLARY / CAVERNOUS HEMANGIOMA\n$\\diamond$ Most common benign hepatic tumor during first 6 months of life!\nHisto: multiple anastomosing thick-walled vascular spaces similar to cavernous hemangioma lined by plump immature endothelial cells in single or (less often) multiple cell layers; areas of thrombi / extramedullary hematopoiesis; scattered bile ducts; involutional changes (infarction, hemorrhage, necrosis, scarring)\nClassification based on immunoreactivity to glucose transporter protein 1 (GLUT1):\n(1) Multifocal lesions staining positive for GLUT1 $\\pm$ associated arteriovenous shunts / cutaneous hemangiomas, absence of central necrosis Prognosis: proliferation followed by involution\n(2) Focal lesion WITHOUT staining for GLUT1 variably demonstrating arteriovenous shunts; often containing central areas of hemorrhage / necrosis / thrombosis Prognosis: complete involution by age 12-14 months\n(3) Diffuse disease with liver largely replaced by growing tumors causing massive hepatomegaly, secondary respiratory distress, inferior vena cava compression, abdominal compartment syndrome\nAge at presentation: $<6$ months in $85 \\%$, during $1^{\\text {st }}$ month in $33 \\%,>1$ year in $5 \\% ; \\mathrm{M} \\div \\mathrm{F}=$ $1 \\div 1.4-1 \\div 2$\nAssociated with: hemangiomas in other organs + skin in $10-15 \\%$\nPrevalence: increased with hemihypertrophy + Beckwith-Wiedemann syndrome\n\n- abdominal mass $\\leftarrow$ hepatomegaly; hemangiomas of skin\n- may present with high-output CHF $2^{\\circ}$ to AV shunts within tumor ( $8-15-25 \\%$ )\n- hemolytic anemia; Kasabach-Merritt syndrome\n- cardiac dysfunction + mental retardation $\\leftarrow$ severe hypothyroidism $\\leftarrow$ tumor produces high levels of type 3 iodothyronine deiodinase activity\nLocation in other sites:\nskin, trachea, thorax, adrenal gland, dura mater ( $10-70 \\%$ ); especially with multifocal liver tumors $\\rightarrow$ chest x-ray, brain imaging\nAverage size: 3.0 (range, $0.5-20.0$ ) cm ; multifocal lesions around 1 cm in diameter\n$\\sqrt{ }$ diffuse involvement of entire liver $\\rightarrow$ hepatomegaly\n$\\sqrt{ }$ focal single mass ( $50 \\%$ ) / multifocal masses ( $50 \\%$ )\n$\\sqrt{ }$ enlargement of celiac + hepatic arteries + proximal aorta\n$\\sqrt{ }$ rapid decrease in aortic caliber below celiac trunk",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 407,
            "markdown": "$\\sqrt{ }$ enlarged hepatic veins (increased venous flow)\nPlain film:\n$\\sqrt{ }$ fine speckled / fibrillary calcifications in 16-25\\% (DDx: hepatoblastoma, hamartoma, metastatic neuroblastoma)\n$\\sqrt{ }$ cardiomegaly + pulmonary edema with CHF\nUS:\n$\\sqrt{ }$ predominantly hypoechoic / mixed (uncommonly hyperechoic) lesion\n$\\sqrt{ }$ heterogeneous echotexture in large lesion $\\leftarrow$ central hemorrhage, necrosis + fibrosis\n$\\sqrt{ }$ multiple sonolucent areas $=$ enlarging vascular channels $\\leftarrow$ initial rapid growth (DDx: mesenchymal hamartoma):\n$\\checkmark$ vascular components demonstrated by color Duplex\n$\\sqrt{ }$ tiny echogenic foci + posterior acoustic shadowing $=$ calcifications (in 36-50\\%)\nColor Doppler:\n$\\sqrt{ }$ artery with little systolic-diastolic variation (= AV shunt)\n$\\sqrt{ }$ artery + vein with high- / low-frequency shifts\n$\\sqrt{ }$ large feeding + draining vessels within and surrounding tumor\n$\\sqrt{ }$ direct visualization of arteriovenous / portovenous shunts\nOB-US:\nTime of detection: as early as 16 weeks GA\n$\\sqrt{ }$ anasarca, ascites, pleural effusion, cardiomegaly\nCx:\n(1) Kasabach-Merritt sequence (hemolytic anemia, thrombocytopenia, and consumptive coagulopathy) in fetus\n(2) fetal hydrops $\\rightarrow$ anasarca, ascites, pleural effusion, cardiomegaly\n(3) polyhydramnios\n\n# NECT: \n\n$\\sqrt{ }$ large well-defined hypoattenuating mass(es)\n$\\sqrt{ }$ hemorrhage (not uncommon)\n$\\sqrt{ }$ speckled calcifications (in 16-50\\%)\nCECT (similar to cavernous hemangioma):\n$\\sqrt{ }$ early peripheral nodular / corrugated enhancement (72\\%)\n$\\sqrt{ }$ progressive centripetal fill-in + variable delayed central enhancement\n$\\sqrt{ }$ intense uniform enhancement in small multifocal tumors\nMR:\n$\\sqrt{ }$ heterogeneous hypointense multinodular lesion on T1WI $\\pm$ hyperintense areas of hemorrhage\n$\\sqrt{ }$ varying degrees of hyperintensity on T2WI (resembling adult hemangioma)\n$\\sqrt{ }$ decreasing SI with fibrotic replacement on T2WI\n$\\sqrt{ }$ flow voids in / adjacent to some lesions\nNUC (sulfur colloid, tagged RBC):\n$\\sqrt{ }$ increased flow in viable portions of lesion during angiographic phase\n$\\sqrt{ }$ increased activity mixed with central photopenic areas (hemorrhage, necrosis, fibrosis) on delayed tagged RBC images\n$\\sqrt{ }$ photopenic defect on delayed sulfur colloid images\nAngio (if use of embolotherapy is contemplated):",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 408,
            "markdown": "$\\sqrt{ }$ enlarged, tortuous feeding arteries and stretched intrahepatic vessels\n$\\sqrt{ }$ hypervascular tumor with inhomogeneous stain; clusters of small abnormal vessels\n$\\sqrt{ }$ pooling of contrast material in sinusoidal lakes with rapid clearing through early draining veins (AV shunting)\nPrognosis: rapid growth in first 6 months followed by regression + involution within 6-8 months; $32-90 \\%$ survival rate in complicated cases\nCx: (1) Congestive heart failure\n(2) Hemorrhagic diathesis\n(3) Obstructive jaundice\n(4) Hemoperitoneum $\\leftarrow$ rupture of tumor\n(5) Malignant transformation into angiosarcoma (rare)\n\nRx: (1) No treatment if asymptomatic\n(2) Reduction in size with steroids / radiotherapy / chemotherapy (interferon- $\\alpha-2 \\mathrm{a}$, vincristine)\n\n| Differentiation of Hemangioma from Hemangioendothelioma |  |  |\n| :-- | :-- | :-- |\n| Findings | Hemangioma | Hemangioendothelioma |\n| Presenting age | older children | $<6$ months of age |\n| Lesion size | usually $<2 \\mathrm{~cm}$ | $2-15 \\mathrm{~cm}$ |\n| Location | R lobe | L + R lobe |\n| Multiple lesions | in $10-20 \\%$ | single / multiple |\n| Signs | symptomatic | hepatomegaly, CHF |\n| US | well-defined, | varied |\n|  | hyperechoic | rarely |\n| Malignant | never | rarely |\n\n(3) Embolization\n(4) Surgical resection / liver transplantation\n\nDDx: (1) Hepatoblastoma ( $>1$ year of age, markedly elevated $\\alpha$-fetoprotein in $90 \\%$, more heterogeneous enhancement pattern)\n(2) Mesenchymal hamartoma (usually multicystic multilocular mass, hypovascular mass with enhancement of septa + solid tumor portions)\n(3) Metastatic neuroblastoma (elevated urinary catecholamines, adrenal / retroperitoneal / posterior mediastinal masses, nonenhancing multiple liver masses)\n(4) Angiosarcoma (heterogeneous SI in multifocal lesions on T2WI, lack of flow voids, central / mild peripheral enhancement)\n\n# Kasabach-Merritt syndrome (in $11 \\%$ ) \n\n[Haig Haigouni Kasabach (1898-1943) American radiologist]\n[Katharine Krom Merritt (1886-1986) American pediatrician]\n= HEMANGIOMA THROMBOCYTOPENIA SYNDROME\n$=$ consumptive thrombocytopenia with hemorrhagic diathesis $\\leftarrow$ disseminated intravascular coagulation\n\n- low platelets; hemolytic anemia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 409,
            "markdown": "- hemangioma / hemangioendothelioma / angiosarcoma $\\rightarrow$ platelet sequestration by tumor $\\rightarrow$ thrombocytopenic purpura $\\rightarrow$ increased systemic fibrinolysis\n- disseminated intravascular coagulopathy $\\rightarrow$ hemorrhage, infection, multiple organ failure Prognosis: fatal outcome in $12-24 \\%$\n$R x$ : tumor extirpation, steroid, vincristine, interferon, radiation therapy\n\n\n# HEPATIC VENO-OCCLUSIVE DISEASE \n\n$=$ occlusion of small centrilobular veins without involvement of major hepatic veins\nEtiology: radiation and chemotherapy in bone-marrow transplant patients; bush tea (alkaloid) consumption in Jamaica\n$\\sqrt{ }$ main hepatic veins + IVC normal\n$\\sqrt{ }$ bidirectional / reversed portal venous flow\n$\\checkmark$ gallbladder wall thickening\n\n## HEPATITIS\n\nCause: alcohol, medication, viral infection, NASH (nonalcoholic steatohepatitis)\n\n## Acute Hepatitis\n\n$=$ process present for $<6$ months\n\n- markedly elevated AST + ALT\n- increase in serum-conjugated bilirubin\n$\\checkmark$ hepatomegaly / normal size of liver\n$\\checkmark$ gallbladder wall thickening\n$\\checkmark$ lymphadenopathy\nCT:\n$\\checkmark$ periportal low attenuation (lymph edema)\nUS:\n$\\checkmark$ diffuse decrease in liver echogenicity\n$\\checkmark$ increased brightness of portal triads (\"starry sky\" pattern) = centrilobular pattern $\\leftarrow$ edema in hepatocytes (DDx: leukemic infiltrate, diffuse lymphomatous involvement, toxic shock syndrome)\n$\\checkmark$ edema of gallbladder fossa + gallbladder wall thickening\n$\\checkmark$ thickening + increase in echogenicity of fat within falciform ligament, ligamentum venosum, porta hepatis, periportal connective tissue",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 410,
            "markdown": "| Drugs Associated with Cholestatic Liver Injury |  |\n| :--: | :--: |\n| Drug Class | Common Agents |\n| Antibiotics |  |\n| Penicillins | amoxicillin-clavulanate |\n| Sulfonamides | trimethoprim-sulfamethoxazole |\n| Macrolides | erythromycin |\n| Tetracyclines | doxycycline |\n| Antifungals | ketoconazole |\n| Antiretrovirals |  |\n| Anti-inflammatories | diclofenac, ibuprofen |\n| Psychotropes | chlorpromazine, tricyclic antidepressants |\n| Immunosuppressives | cyclosporine, azathioprine |\n| Other | oral contraceptives, estrogens, anabolic steroids |\n\nCEMR:\n$\\checkmark$ heterogeneous enhancement during arterial phase\n$\\checkmark$ elevated T2 signal $\\leftarrow$ edema + inflammation in more severe disease\n\n# Drug-induced Acute Hepatitis \n\nDrug-induced injury is the number-one cause of acute liver failure ( $10 \\%$ of all cases of acute hepatitis).\n$\\diamond$ Most common cause of postmarketing drug withdrawals and warnings\nImplicated drugs: $>900$; especially antibiotics + analgesics\nMechanism: direct toxic effects of a drug or its metabolites\nHisto: categorized according to predominant histopathologic and biochemical features; grouped as hepatocellular / cholestatic / mixed patterns of liver injury.\nClassification: according to clinical phenotype + course\n(1) Acute hepatitis\n(2) Cholestatic hepatitis\n(3) Bland cholestasis\n(4) Sinusoidal obstructive syndrome\n(5) Steatosis (= nonalcoholic fatty liver)\n\n## Cholestatic Hepatitis\n\nMechanism: compromised perfusion of bile ducts\nCommon drugs: cyclosporine, trimethoprim-sulfamethoxazole, chlorpromazine\n$\\checkmark$ often NO radiologic findings\n$\\checkmark$ small bile ducts diminished in number\n$\\checkmark$ hepatomegaly\n$\\checkmark$ heterogeneously enhancing parenchyma\n$D D x$ : primary sclerosing cholangitis, primary biliary cirrhosis, biliary obstruction (eg, cholelithiasis, choledocholithiasis), primary sclerosing cholangitis, primary biliary cirrhosis, bile duct tumor, pancreatitis, pancreatic tumor",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 411,
            "markdown": "# Chronic Hepatitis \n\n$=$ process present for at least 6 months\nCause: autoimmune hepatitis; hepatitis B, C, D; cryptic hepatitis; chronic drug hepatitis; primary biliary cirrhosis; primary sclerosing cholangitis; Wilson disease; alpha-1 antitrypsin deficiency\nUS:\n$\\sqrt{ }$ increased liver echogenicity\n$\\sqrt{ }$ coarsening of hepatic echotexture\n$\\sqrt{ }$ silhouetting / loss of definition of portal venules = decreased visualization of walls of peripheral portal veins\n$\\sqrt{ }$ NO sound attenuation\n$C x:$ cirrhosis ( $10 \\%$ for hepatitis B; $20-50 \\%$ for hepatitis C)\n\n## Neonatal Hepatitis\n\n## Cause:\n\nA. INFECTION: virus, protozoa, spirochete, toxoplasmosis, rubella, CMV, herpes, hepatitis $\\mathrm{A} / \\mathrm{B}$, syphilis\nB. METABOLIC: alpha-1 antitrypsin deficiency, familial recurrent cholestasis, errors of metabolism $\\rightarrow$ nesidioblastosis ( $=$ acquired hyperinsulinism with beta cell hyperplasia)\nC. IDIOPATHIC\n\nAge: $\\quad 1-4$ weeks of age; $\\mathrm{M}>\\mathrm{F}$\nHisto: multinucleated giant cells with hepatic parenchymal disruption, relatively little bile within bile duct canaliculi\nUS:\n$\\sqrt{ }$ normal-sized / enlarged liver\n$\\sqrt{ }$ increase in parenchymal echogenicity\n$\\sqrt{ }$ decreased visualization of peripheral portal veins\n$\\sqrt{ }$ normal bile duct system\n$\\sqrt{ }$ gallbladder of normal size / small $\\leftarrow$ decrease in bile volume in severe hepatocellular dysfunction\n$\\sqrt{ }$ decrease in gallbladder size after milk feeding (DDx: congenital biliary atresia)\nNUC:\nTechnique: often performed after pretreatment with phenobarbital ( $5 \\mathrm{mg} / \\mathrm{kg} \\times 5$ days) to maximize hepatic function",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 412,
            "markdown": "| Viral Markers of Hepatitis |  |  |\n| :--: | :--: | :--: |\n| Virus | Tests | Interpretation |\n| HAV | Anti-HAV IgM | acute hepatitis (can remain positive for $>1$ year) due to picorna virus |\n|  | Anti-HAV IgG | past hepatitis, lifelong immunity |\n| HBV | HBsAg | acute / chronic disease due to hepadnavirus |\n|  | Anti-HBc IgM | acute infection (if titer high); chronic infection (if titer low) |\n|  | Anti-HBc IgG | past / recent HBV contact (may be only serum indicator of past infection) |\n|  | HBe | active viral replication |\n|  | Anti-HBe | low / absent replicative state (typically present in long-standing HBV carriers) |\n|  | Anti-HBs | immunity after vaccination |\n|  | HBV-DNA | active viral replication |\n| HCV | Anti-HCV | past silent (1960s-1980s) / current infection due to flavivirus |\n|  | RIBA | test for various viral components |\n|  | HCV-RNA | active viral replication |\n| HDV | Anti-HDV IgM | acute / chronic infection |\n|  | Anti-HDV IgG | chronic infection (if titer high <br> + IgM positive); past infection if titer low + IgM negative) |\n|  | HDV-RNA | active viral replication |\n| HEV | Anti-HEV IgM | acute hepatitis due to hepatitis E virus |\n|  | Anti-HEV IgG | past hepatitis |\n|  | HEV-RNA | viral replication |\n| HFV |  | due to togavirus |\n| HGV |  | due to GB virus |\n\n$\\sqrt{ }$ normal / decreased hepatic tracer accumulation\n$\\sqrt{ }$ prolonged clearance of tracer from blood pool\n$\\sqrt{ }$ bowel activity faint / delayed usually by 24 hours (best seen on lateral view; covering liver activity with lead shielding is helpful)\n$\\sqrt{ }$ gallbladder may not be visualized\nPrognosis: spontaneous remission\n$D D x$ : biliary atresia (NO small bowel activity)\n\n# Radiation Hepatitis \n\n## Acute Radiation-induced Hepatitis\n\nTime of onset: 2-6 weeks after completion of radiation therapy with dose $>3,500$ rad $(35 \\mathrm{~Gy})$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 413,
            "markdown": "- abnormal liver function tests; RUQ discomfort\n$\\checkmark$ hepatomegaly\n$\\checkmark$ ascites\nPrognosis: complete recovery in majority\n\n\n# Chronic Radiation-induced Hepatitis \n\n$\\sqrt{ }$ increased attenuation in irradiated parenchyma (no fatty infiltration)\n$\\sqrt{ }$ geographic areas of hypointensity on T1WI + hyperintensity on T2WI $\\leftarrow$ increased water content\n\n## HEPATOBLASTOMA\n\nFrequency: $3^{\\text {rd }}$ most common abdominal tumor in children; most common congenital hepatic malignancy in children $<3$ years of age\nIncidence increased with: hemihypertrophy, Beckwith-Wiedemann syndrome\nAssociated with: Gardner syndrome, familial adenomatous polyposis, type 1A glycogen storage disease, trisomy 18; other congenital GI + GU anomalies in 5\\%\nHisto:\n(a) epithelial type $=$ small cells resembling embryonal / fetal liver\n(b) mixed type = epithelial cells + mesenchymal cells (of osteoid, cartilaginous, fibrous tissue)\nPeak age: 18-24 months (range, newborn to 15 years); congenital in $4 \\%$; in $50 \\%<18$ months; $90 \\%$ by 5 years of age; $\\mathrm{M}+\\mathrm{F}=1.5 \\div 1$ to $2 \\div 1$\n$\\diamond$ Strong inverse association with birthweight\n\n- upper abdominal mass; jaundice (5\\%), pain\n- weight loss, anorexia (= loss of appetite), nausea, vomiting\n- precocious puberty in boys (production of hCG)\n- persistently + markedly elevated $\\alpha$-fetoprotein ( $90 \\%$ ): AFP is normally elevated at birth until 6 months of age\nMetastases to: lung (10-20\\%), bone, brain, lymph nodes, eye, ovary\nLocation: right lobe of the liver\nAverage size: $10-12 \\mathrm{~cm}$\n$\\checkmark$ usually solitary mass ( $80 \\%$ ), multifocal ( $20 \\%$ )\n$\\checkmark$ well-circumscribed + lobulated with septa\n$\\checkmark$ coarse chunky calcifications / osseous matrix (12-30\\%)\n$\\checkmark \\pm$ invasion / compression of portal vein + hepatic veins + IVC\nAbdominal X-ray:\n$\\checkmark$ hepatomegaly / mass $\\pm$ coarse / dense calcifications\nUS:\n$\\checkmark$ large heterogeneous solid mostly hyperechoic mass:\n$\\checkmark$ often with echogenic shadowing calcifications\n$\\checkmark$ hypoechoic fibrotic septa in spoke-wheel configuration\n$\\checkmark$ occasionally cystic areas $\\leftarrow$ necrosis / extramedullary hematopoiesis\n$\\checkmark$ well-demarcated appearance $\\leftarrow$ pseudocapsule\nCommon $C x$ : intrapartum rupture + hemorrhage, hydrops, metastases\nCT:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 414,
            "markdown": "$\\sqrt{ }$ sharply circumscribed hypoattenuating mass with peripheral rim enhancement\n$\\sqrt{ }$ speckled / amorphous calcifications (in $>50 \\%$ )\n$\\sqrt{ }$ slight enhancement of tumor but less than liver:\n$\\checkmark$ lobulated / septated (in $50 \\%$ )\nMR:\n$\\checkmark$ inhomogeneously hypointense on T1WI with hyperintense foci (= hemorrhage)\n$\\checkmark$ inhomogeneously hyperintense with hypointense bands (= fibrous septa) on T2WI\nNUC:\n$\\checkmark$ photopenic defect\nAngio:\n$\\checkmark$ hypervascular mass with dense stain\n$\\checkmark$ marked neovascularity; NO AV-shunting\n$\\checkmark$ vascular lakes may be present\n$\\checkmark$ avascular areas $\\leftarrow$ tumor necrosis\n$\\checkmark$ may show caval involvement ( $=$ unresectable)\nPrognosis: $40-60 \\%$ resectable (in $85 \\%$ following neoadjuvant chemotherapy); $30-75 \\%$ mortality; better prognosis than hepatoma; better prognosis for epithelial type than mixed type\n$D D x$ : (1) Infantile hemangioendothelioma (fine granular calcifications, $<1$ year of age, rare AFP elevation, intense nodular / corrugated peripheral enhancement + centripetal fillin on delayed images)\n(2) Mesenchymal hamartoma (predominantly cystic tumor, normal serum AFP)\n(3) Hepatocellular carcinoma ( $>5$ years of age, no calcifications, elevated serum AFP)\n(4) Metastatic neuroblastoma\n\n# HEPATOCELLULAR CARCINOMA \n\n$=$ HEPATOMA\n$=$ most common ( $90 \\%$ ) primary malignancy of the liver; most frequent primary visceral malignancy in the world; $2^{\\text {nd }}$ most frequent malignant hepatic tumor in children (39\\%) after hepatoblastoma\n$\\diamond$ Worldwide $3^{\\text {rd }}$ most common cause of death from cancer ( $2^{\\text {nd }}[6^{\\text {th }}]$ most common for men [women])!\nPrevalence: (a) in industrialized world: $0.2-0.8 \\%$\n(b) in sub-Saharan Africa, Southeast Asia, Japan, Greece, Italy: 5.5-20\\%\n\nAge-adjusted prevalence: 2.2 (women) -6.8 (men) $\\div 100,000$ in North America\nPeak age:\n(a) industrialized world: $6^{\\text {th }}-7^{\\text {th }}$ decade; $\\mathrm{M} \\div \\mathrm{F}=2.5 \\div 1$; fibrolamellar subtype (in $3-10 \\%$ ) below age 40 years\n(b) high incidence areas: $30-40$ years; $\\mathrm{M} \\div \\mathrm{F}=5 \\div 1$\n(c) in children: $>5$ years of age (peak at $12-14$ years); $\\mathrm{M} \\div \\mathrm{F}=1.8 \\div 1$ to $2.2 \\div 1$\n\nEtiology:\n\n1. Cirrhosis $(60-90 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 415,
            "markdown": ") toxic (alcohol), cardiac, biliary atresia\n\nLatent period: 8 months - 14 years from onset of cirrhosis\nIncidence of HCC with underlying cirrhosis:\n$2-7 \\%$ per year\n$>44 \\%$ in macronodular (= postnecrotic) cirrhosis $\\leftarrow$ hepatitis B virus, alcoholism, hemochromatosis\n$>6 \\%$ in micronodular cirrhosis $\\leftarrow$ alcoholism\n2. Hepatitis C virus infection (50-60\\%)\n3. Chronic hepatitis B (20\\%)\n4. Nonalcoholic steatohepatitis $\\leftarrow$ obesity\n5. Carcinogens: aflatoxin, siderosis, thorotrast, oral contraceptives / anabolic androgens\n6. Inborn errors of metabolism: hemochromatosis, Wilson disease, alpha-1 antitrypsin deficiency, galactosemia, type I glycogen storage disease (von Gierke), hereditary tyrosinemia\n\n| Prevalence of HCC in Underlying Cirrhosis |  |\n| :--: | :-- |\n| Prevalence | Cause of Cirrhosis |\n| $17-30 \\%$ | Hepatitis C infection |\n| $21 \\%$ | Hereditary hemochromatosis |\n| $10-15 \\%$ | Hepatitis B virus infection |\n| $5-8 \\%$ | Alcoholic cirrhosis |\n| $4 \\%$ | Advanced biliary cirrhosis |\n\nmnemonic: WHAT causes HCC?\nWilson disease\nHemochromatosis\nAlpha-1-antitrypsin deficiency\nTyrosinosis\nHepatitis\nCirrhosis (alcoholic, biliary, cardiac)\nCarcinogens (aflatoxin, sex hormones, thorotrast)\nPath: soft tumor due to lack of stroma, often hemorrhagic + necrotic\nHisto: HCC cells resemble hepatocytes in appearance + structural pattern (trabecular, pseudoglandular = acinar, compact, scirrhous)\n(a) expansive encapsulated HCC: collapsed portal vein branches at capsule\n(b) infiltrative nonencapsulated HCC: commonly intrasinusoidal + intravascular growth (portal venules communicate with tumoral sinusoids) $\\rightarrow$ often invasion of portal $\\pm$ hepatic veins\nGrading system (Edmondson):\nI cells similar in size to normal hepatocytes, arranged in relatively thin trabeculae; rarely acini containing bile (DDx: hepatocellular adenoma)\nII cells larger than normal hepatocytes, hyperchromatic nuclei in a greater proportion of cells; thicker trabeculae; commonly acini containing bile\nIII cells with large nuclei occupying $>50 \\%$ of cytoplasm; dominant trabeculae with solid areas $\\pm$ isolated giant and bizarre cells; bile rarely present",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 416,
            "markdown": "IV cell nuclei occupying most of the cytoplasm; mostly solid areas with little / no bile (DDx: tumor of nonhepatocellular origin)\nVascular supply: hepatic artery ( $94 \\%$ ), portal vein ( $6 \\%$ ); HCC is directly supplied by (newly formed) \"unpaired\" or \"nontriadal\" arteries ( $=$ not part of portal tracts)\n\nNatural history of HCC (suggests 3 stages):\n(1) Molecular stage consisting of sequential changes leading to cell transformation\n(2) Preclinical stage when HCC is too small to be detectable at imaging\n(3) Clinical / symptomatic stage when the tumor has reached a diameter of $4.5-8 \\mathrm{~cm}$ and develops symptoms\n\n- fever, weight loss, anorexia\n- persistent RUQ pain, hepatomegaly, ascites\n- $\\alpha$-fetoprotein elevated in $75-90 \\%$ (DDx: negative $\\alpha$-fetoprotein in cholangiocarcinoma)\n- elevated liver function tests (not helpful for diagnosis)\n- Paraneoplastic syndromes:\n(a) sexual precocity / gynecomastia\n(b) hypercholesterolemia\n(c) erythrocytosis $\\leftarrow$ tumor produces erythropoietin\n(d) hypoglycemia\n(e) hypercalcemia\n(f) carcinoid syndrome\n\nMetastases to: lung (most common $=8 \\%$ ), adrenal, lymph nodes, bone\nGrowth pattern (Eggle classification):\n(a) massive solitary pattern (27-50-59\\%):\n$\\checkmark$ large tumor bulk in one (most often right) lobe with an unclear boundary + satellite nodules\n(b) nodular pattern (15-25\\%):\n$\\checkmark$ multiple small distinct sharply marginated foci of usually $<2 \\mathrm{~cm}$ (up to 5 cm ) in both hepatic lobes\n(c) diffuse infiltrative pattern (7-26\\%)\n\nMedian tumor doubling time: 4-6 (range, 1-19) months\n$\\rightarrow 3-12$ months follow-up for indeterminate lesions\n$\\checkmark$ portal vein invasion ( $25-33-48 \\%$ )\n$\\checkmark$ arterioportal shunting (4-63\\%)\n$\\checkmark$ invasion of hepatic vein ( $16 \\%$ ) / IVC (= Budd-Chiari syndrome)\n$\\checkmark$ occasionally invasion of bile ducts\n$\\checkmark$ calcifications in ordinary HCC (2-9-25\\%); however, common in fibrolamellar (30-40\\%) and sclerosing HCC\n$\\checkmark$ hepatomegaly and ascites\n$\\checkmark$ tumor fatty metamorphosis ( $2-17 \\%$ )\n$\\checkmark$ atypical multilocular cystic mass $\\leftarrow$ necrosis / microscopic hemorrhage\nThe mural nodules in multilocular cystic HCC that correspond to viable tumor components may demonstrate the classic HCC hemodynamics of arterial enhancement and late contrast material washout at both CECT and MR imaging. This feature is critical in differentiating HCC from other cystic neoplasms. Furthermore, if \"abnormal internal vessels or a variegated pattern\" are observed",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 417,
            "markdown": "in mural nodules, it may strongly indicate HCC.\nUS ( $48 \\%$ sensitive, $98 \\%$ specific):\n$\\checkmark$ variable echogenicity:\n$\\checkmark$ hyperechoic HCC ( $13 \\%$ ) $\\leftarrow$ fatty metamorphosis or marked dilatation of sinusoids\n$\\checkmark$ hypoechoic HCC $(26 \\%) \\leftarrow$ solid tumor\n$\\checkmark$ HCC of mixed echogenicity $(61 \\%) \\leftarrow$ nonliquefactive tumor necrosis + old hemorrhage\n$\\checkmark$ Doppler peak velocity signals $>250 \\mathrm{~cm} / \\mathrm{s}$\n$\\checkmark$ calcifications (rare)\nSurveillance scan: every 6 months for high-risk patients\nNECT ( $48 \\%$ sensitive, $70 \\%$ specific):\n$\\checkmark$ hypodense mass / rarely isodense / hyperdense in fatty liver:\n$\\checkmark$ dominant mass with satellite nodules\n$\\checkmark$ mosaic pattern = multiple nodular areas with differing attenuation in larger lesion (up to $63 \\%)$\n$\\checkmark$ diffusely infiltrating neoplasm\n$\\checkmark$ encapsulated $\\mathrm{HCC}=$ circular zone of radiolucency surrounding the mass (12-32-67\\%)\nFalse-positive: confluent fibrosis, regenerative nodule\nBiphasic CECT ( $68 \\%$ sensitive):\n$\\diamond 63 \\%$ sensitivity in cirrhosis, $80 \\%$ without cirrhosis\n$\\checkmark$ enhancement during hepatic arterial phase ( $80 \\%$ )\n$\\diamond 16 \\%$ seen on arterial phase only!\n$\\checkmark$ decreased attenuation during portal venous phase with inhomogeneous areas of contrast accumulation\n$\\checkmark$ isodensity on delayed scans ( $10 \\%$ )\n$\\checkmark$ thin contrast-enhancing capsule ( $50 \\%$ ) $\\leftarrow$ rapid washout\n$\\checkmark$ wedge-shaped areas of decreased attenuation (segmental / lobar perfusion defects $\\leftarrow$ portal vein occlusion by tumor thrombus\nLipiodol ${ }^{\\circledR}$ CT ( $53 \\%$ sensitive, $88 \\%$ specific):\n$\\checkmark$ hyperdense mass detectable as small as 0.5 cm\nMR ( $81 \\%$ sensitive):\n$\\diamond$ Any solid lesion in a cirrhotic liver that is not a hemangioma is considered HCC until proven otherwise!\n$\\diamond$ Dysplastic nodules are rarely seen with imaging!\n$\\checkmark$ variable intensity on T1WI:\n$\\checkmark$ most often hypointense relative to liver\n$\\checkmark$ isointense for lesion size $<1.5 \\mathrm{~cm}$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 418,
            "markdown": "| Major Imaging Features Favoring HCC |\n| :--: |\n| $\\sqrt{ }$ masslike configuration: |\n| $\\sqrt{ }$ size $\\geq 20 \\mathrm{~mm}$ |\n| $\\sqrt{ }$ tumor capsule / pseudocapsule |\n| $=$ peripheral rim (ring) enhancement during venous phase |\n| $\\sqrt{ }$ discrete margin |\n| $\\sqrt{ }$ round shape |\n| $\\sqrt{ }$ focal deformity of liver contour |\n| $\\sqrt{ }$ displacement of intraparenchymal structures |\n| $\\sqrt{ }$ visible on nonenhanced MR, DWI, T2WI, T2* |\n| $\\sqrt{ }$ aggressive behavior |\n| $\\sqrt{ }$ interval growth: increase $\\geq 10 \\mathrm{~mm}$ in 1 year |\n| $\\sqrt{ }$ intralesional necrosis / hemorrhage |\n| $\\sqrt{ }$ prominent intralesional arteries |\n| $\\sqrt{ }$ local / vascular invasion |\n| $\\sqrt{ }$ extrahepatic metastasis |\n| $\\sqrt{ }$ arterial phase hyperenhancement: |\n| $\\sqrt{ }$ enhancement greater than surrounding liver parenchyma + compared to precontrast phase |\n| $\\sqrt{ }$ enhancement may be greater during portal venous phase |\n| $\\sqrt{ }$ venous phase hypoenhancement |\n| $=$ washout during portal venous / later phase |\n| $D D x$ : fibrotic tissue typically shows delayed enhancement (causing false appearance of hypoenhancement) of a regenerative nodule / hypertrophic pseudomass in liver cirrhosis |\n| $\\sqrt{ }$ absent $/ \\downarrow$ uptake of superparamagnetic iron oxide (SPIO) on long T2* |\n| $\\sqrt{ }$ tumor thrombus within lumen of vein: |\n| $\\sqrt{ }$ arterial phase hyperenhancement + venous phase hypoenhancement of tumor thrombus |\n| $\\sqrt{ }$ occluded vein with expanded lumen |\n| $\\sqrt{ }$ luminal enhancement not matching time of enhancement in other veins |\n| $\\sqrt{ }$ presence of arteries within lumen (in absence of cavernous transformation) |\n| $\\sqrt{ }$ markedly restricted / impeded diffusion in lumen |\n| Ancillary Features Favoring Hepatocellular Carcinoma |\n| $\\sqrt{ }$ mild to moderate T2 hyperintensity |\n| $\\sqrt{ }$ mosaic architecture |\n| $\\sqrt{ }$ high signal intensity on DWI |\n| $\\sqrt{ }$ intralesional steatosis $=\\downarrow$ SI on opposed-phase images |\n| $\\sqrt{ }$ iron sparing in an iron-overloaded liver |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 419,
            "markdown": "$\\sqrt{ }$ hyperintense areas / hyperintense lesion, particularly if $>1.5 \\mathrm{~cm}$ in diameter $\\leftarrow$ lipid / copper / glycogen / blood\n$\\diamond$ Fatty metamorphosis in a cirrhotic nodule is suspicious for HCC!\n$\\checkmark$ variable intensity on T2WI relative to liver:\n$\\checkmark$ generally hyperintense / small focus of hyperintensity\n$\\diamond$ Any hypervascular mass in cirrhosis with increased T2 signal similar to that of spleen is suspicious for HCC!\n$\\diamond$ An iron-poor focus within a siderotic nodule on T2WI suggests HCC!\n$\\checkmark$ iso- to hypointense for well-differentiated tumor\n$\\checkmark$ \"ring\" sign $(10-78 \\%)=$ typically thin + discontinuous hypointense capsule on T1WI + T2WI:\n$\\checkmark$ double layer of inner hypointensity (fibrous tissue) + outer hyperintensity ( $\\leftarrow$ compressed blood vessels + bile ducts) on T2WI in expansive type of HCC\n$\\checkmark$ may contain central scar of fibrosis / calcifications / necrosis hypointense on T1WI + T2WI\n$\\checkmark$ variable appearance on DWI:\n$\\checkmark$ often isointense for well-differentiated tumor\n$\\checkmark$ often hyperintense for moderately to poorly differentiated tumor\nCEMR:\n(a) arterial phase imaging:\n$\\checkmark$ marked homogeneous enhancement for lesion $<2 \\mathrm{~cm}$ :\n> for $1-2-\\mathrm{cm}$ lesion $\\rightarrow 3$-month follow-up;\n> for $<1-\\mathrm{cm}$ lesion $\\rightarrow 6$-month follow-up\n$\\checkmark$ heterogeneous enhancement for lesion $>2 \\mathrm{~cm}$ :\n$\\checkmark$ enhancement peripherally ( $62 \\%$ ) / centrally ( $7 \\%$ ) / mixed ( $10 \\%$ ) / no enhancement $(21 \\%)$\n$\\checkmark$ central scar without much enhancement\n(b) portal venous and equilibrium phase:\n$\\checkmark$ rapid loss of enhancement becoming isointense / hypointense ( $=$ rapid venous washout $)$\n$\\diamond$ Delayed hypointensity of an arterially enhancing mass in a cirrhotic liver is HCC unless proven otherwise!\n$\\checkmark$ progressive delayed enhancement of tumor capsule\n$\\checkmark$ \"peripheral washout\" sign = decrease of contrast material preferentially in periphery of mass while center remains hyperintense ( $\\leftarrow$ ? related to vessel distribution with central necrosis / fibrosis and peripherally viable tumor), same as in hypervascular metastasis\n$\\checkmark$ improved lesion detectability on T1WI after intravenous administration of\nsuperparamagnetic iron oxide (entrapped by Kupffer cells) + gadolinium during late hepatic arterial phase\nCharacteristic MR features for larger HCC:\n$\\checkmark$ mosaic pattern of variable SI on T1WI + T2WI $\\leftarrow$ confluent small nodules separated by thin septa + areas of tumor necrosis\n$\\checkmark$ extracapsular extension with formation of satellite nodules\n$\\checkmark$ vascular invasion:\n$\\checkmark$ lack of signal void on SE images\n$\\checkmark$ enhancing intravascular mass during arterial phase\n$\\checkmark$ intravascular filling defect during delayed phase",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 420,
            "markdown": "$\\sqrt{ }$ extrahepatic dissemination $\\rightarrow$ distant metastasis + lymph node involvement\nNUC:\n$\\sqrt{ }$ Sulfur colloid scan: single cold spot ( $70 \\%$ ), multiple defects ( $15-20 \\%$ ), heterogeneous distribution $(10 \\%)$\n$\\sqrt{ }$ Tc-HIDA scan: cold spot / atypical uptake in $4 \\%$ (delayed images)\n$\\sqrt{ }$ Gallium-scan: avid accumulation in $70-90 \\%$ (in $63 \\%$ greater, in $25 \\%$ equal, in $12 \\%$ less uptake than liver)\nAngio:\n$\\sqrt{ }$ \"thread and streak\" sign = venous and arterial channels located in and around a cast of tumor in a large branch $\\pm$ trunk of the main portal vein\n$\\sqrt{ }$ in differentiated HCC: enlarged arterial feeders, coarse neovascularity, vascular lakes, dense tumor stain, arterioportal shunts\n$\\sqrt{ }$ in anaplastic HCC: vascular encasement, fine neovascularity, displacement of vessels + corkscrew-like vessels of cirrhosis\nPrognosis: $>90 \\%$ overall mortality; $17 \\%$ resectability rate; 6 months average survival time; $0-$ $10 \\% 5$-year survival rate ( $>50 \\%$ for small HCC) $\\rightarrow$ HCC detection of $<2 \\mathrm{~cm}$ is crucial\n$C x$ : spontaneous rupture (in $7-14 \\%$ in Asia + Africa)\nRx: (1) Resection\n(2) Liver transplant (solitary lesion $<5 \\mathrm{~cm}$; up to 3 lesions $<3 \\mathrm{~cm}$; no portal / hepatic vein involvement; no metastatic disease)\n(3) Radiofrequency ablation for tumors $<3 \\mathrm{~cm}$\n(4) ${ }^{131}$ I-antiferritin IgG (remission rate $>40 \\%$ up to 3 years)\n\nDDx of hypervascular lesion:\n(1) Fibrolamellar carcinoma (central scar with calcium, homogeneous tumor without hemorrhage / necrosis)\n(2) Hepatocellular adenoma (in young woman using oral contraceptive, in child with glycogen storage disease, anabolic steroid use)\n$D D x$ : hepatocarcinoma, cholangiocarcinoma, focal nodular hyperplasia, hemangioma, hepatic adenoma, pseudolesion of cirrhotic liver (mostly $<1-\\mathrm{cm}$ enhancing foci not histologically visible)\n\n# Infiltrative Hepatocellular Carcinoma \n\n$=$ DIFFUSE HCC, CIRRHOTOMIMETIC HCC, CIRRHOSIS-LIKE HCC (masquerading as cirrhotic nodules)\n$=$ characterized by spread of minute tumor nodules throughout a lobe / entire liver with: hepatitis B virus infection, especially in Asia\n\n- elevated $\\alpha$-fetoprotein: often $>10,000 \\mathrm{ng} / \\mathrm{mL}$\n\nImaging sensitivity: $48 \\%$ for US, $68 \\%$ for CT, $81 \\%$ for MR\nWhile a macroscopic growth pattern of infiltrative HCC is uncommon, its histologic features are not unique to this type of HCC.\nInfiltrative HCC has a relatively reduced conspicuity during dynamic phases of enhancement $\\leftarrow$ its permeative infiltrative nature + presence of portal vein thrombosis, resulting in perfusion changes that can effectively conceal the tumor.",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 421,
            "markdown": "$\\sqrt{ }$ cryptic spread of distinct minute tumor nodules within hepatic lobe / entire liver:\n$\\sqrt{ }$ NO dominant nodule\n$\\sqrt{ }$ regular / distinct margin around each tumor nodule\n$\\sqrt{ }$ tumor contrast characteristics relative to liver parenchyma:\n$\\sqrt{ }$ minimal / patchy / miliary enhancement during arterial phase\n$\\sqrt{ }$ irregular heterogeneous washout $=$ hypoenhancement during portal $\\pm$ delayed phase $(51 \\%)$\n$\\sqrt{ }$ reticular appearance during venous + equilibrium phase\n$\\sqrt{ }$ lack of hepatospecific contrast agent uptake during hepatobiliary phase\n$\\sqrt{ }$ extra- / intrahepatic portal vein thrombosis (68-100\\%)\n$\\sqrt{ }$ intrahepatic biliary ductal dilatation (13-26\\%)\n$\\sqrt{ }$ spread to upper abdominal lymph nodes ( $10-22 \\%$ )\n$\\sqrt{ }$ distant metastases to lung, bone, adrenals (13-23\\%)\nMR:\n$\\sqrt{ }$ homo- / heterogeneously hypointense on T1WI\n$\\sqrt{ }$ moderately heterogeneously hyperintense on T2WI\n$\\sqrt{ }$ hyperintense on DWI with b values of $500-800 \\mathrm{sec} / \\mathrm{mm} 2$\n$\\sqrt{ }$ poorly visualized on dynamic contrast-enhanced images\n$D D x$ : (1) Confluent fibrosis\n(2) Focal hepatic steatosis\n(3) Hepatic microabscesses\n(4) Intrahepatic cholangiocarcinoma\n\nPrognosis: worst of all growth patterns\n$R x$ : infiltrative HCC is usually a contraindication for resection and transplantation due to decreased survival after surgical resection.\n\n# Fibrolamellar Carcinoma of Liver \n\n= uncommon variant of hepatocellular carcinoma arising in young adults without underlying hepatic disease\nPrevalence: $1-9 \\%$ of all HCCs; up to $35 \\%$ of HCCs in patients $<50$ years of age\nMean age: 23 (range, 5-69) years; mostly $2^{\\text {nd }}-3^{\\text {rd }}$ decade ( $85 \\%<35$ years of age); $\\mathrm{M} \\div \\mathrm{F}=$ $1 \\div 1$\nPath: desmoplastic tumor with collagen deposition $\\rightarrow$ fibrous central scar ( $60-75 \\%$ ) with calcifications $(35-55 \\%)$\nGrowth pattern:\n(a) large circumscribed nonencapsulated mass ( $80-90 \\%$ )\n(b) intrahepatic mass with satellite nodules ( $10-15 \\%$ )\n(c) bilobed mass (5\\%)\n(d) multiple diffuse masses $(<1 \\%)$\n\nHisto: large polygonal hepatocyte-like cells with coarse granular eosinophilic cytoplasm growing in sheets / cords / trabeculae separated by broad bands of fibrous stroma arranged in parallel lamellae resulting in a compartmentalized appearance\nRisk factors: NONE known; underlying cirrhosis or hepatitis in $<5 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 422,
            "markdown": "Demographics: USA $>$ Europe; rare in Japan + China; predilection for Caucasians\n\n- abdominal pain, cachexia, palpable RUQ mass, hepatomegaly\n- jaundice $(5 \\%) \\leftarrow$ biliary compression\n- gynecomastia (rare) $\\leftarrow$ conversion of androgens to estrogens by tumor-elaborated enzyme aromatase\n- $\\alpha$-fetoprotein usually negative / mildly elevated to $<200 \\mathrm{ng} / \\mu \\mathrm{L}$ (in up to $10 \\%$ ); transaminase levels $<100 \\mathrm{IU} / \\mathrm{L}$\nMean size: 13 (range, 5-20) cm in diameter\n$\\checkmark$ well-circumscribed partially / completely encapsulated solitary mass (in 80-90\\%):\n$\\checkmark$ intrahepatic ( $80 \\%$ ) / pedunculated ( $20 \\%$ )\n$\\checkmark$ prominent central fibrous scar ( $45-60 \\%$ )\n$\\checkmark$ punctate / nodular / stellate calcifications (33-68\\%):\n$\\checkmark$ centrally within scar, $<3$ in number, $<5 \\mathrm{~mm}$ in size\n$\\checkmark$ capsular retraction $(10 \\%)$\n$\\checkmark$ intratumoral hemorrhage + necrosis ( $10 \\%$ )\n$\\checkmark$ vascular invasion $(<5 \\%)$\n$\\checkmark$ mass + small peripheral satellite lesions ( $10-15 \\%$ )\n$\\checkmark$ diffuse multifocal masses $(<1 \\%)$\n$\\checkmark$ regional lymphadenopathy ( $50-70 \\%$ ) usually in hepatic hilum / hepaticoduodenal ligament\n$\\checkmark$ distant metastases ( $20 \\%$ ): lung, peritoneal implants\nAbdominal x-ray:\n$\\checkmark$ hepatomegaly $\\pm$ stellate calcifications\nUS:\n$\\checkmark$ well-defined lesion of mixed echogenicity ( $60 \\%$ ) with predominantly iso- / hyperechoic portions\n$\\checkmark$ central hyperechoic scar ( $33-60 \\%$ ) $\\pm$ shadowing calcifications\nNECT:\n$\\checkmark$ mass of heterogeneously low attenuation\n$\\checkmark$ lobulated surface contour (in $80 \\%$ )\n$\\checkmark$ prominent stellate / amorphous central scar ( $20-71 \\%$ )\nCECT:\n$\\checkmark$ enhancement of non-scar portion:\n$\\checkmark$ prominent heterogeneous arterial enhancement (in 80\\%)\n$\\checkmark$ variable attenuation in portal venous phase\n$\\checkmark$ less pronounced enhancement during equilibrium phase\n$\\checkmark$ enhancement of scar: none ( $75 \\%$ ) / delayed ( $25 \\%$ )\n$\\checkmark$ delayed enhancement of pseudocapsule of compressed liver tissue (15\\%)\nMR:\n$\\checkmark$ large well-defined lobulated mass:\n$\\checkmark$ hypointense ( $86 \\%$ ) / isointense ( $14 \\%$ ) on T1WI\n$\\checkmark$ hyperintense ( $85 \\%$ ) / isointense ( $15 \\%$ ) on T2WI\n$\\checkmark$ homogeneous ( $80 \\%$ ) / heterogeneous ( $20 \\%$ )\n$\\checkmark$ hypointense central scar on T1WI + T2WI (in 80\\%)\nCEMR:\n$\\checkmark$ early heterogeneous contrast enhancement that fades on subsequent images",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 423,
            "markdown": "$\\sqrt{ }$ central scar without enhancement\n(DDx: T2-hyperintense myxoid central scar of FNH)\nAngio:\n$\\sqrt{ }$ dense tumor stain\n$\\sqrt{ }$ enlarged feeding arteries\n$\\sqrt{ }$ NO arteriovenous / arterioportal shunting\n$\\sqrt{ }$ avascular central scar\nNUC:\n$\\sqrt{ }$ photopenic area on sulfur colloid scan $\\leftarrow$ relative lack of Kupffer cells in number + function\n$\\sqrt{ }$ increased activity during arterial phase + wash-out during delayed imaging on labeled RBC scan\n$\\sqrt{ }$ nonspecific increased activity on ${ }^{67} \\mathrm{Ga}$ scintigraphy\nPrognosis: $48 \\%$ resectability rate; average survival time of 32 months; $67 \\% 5$-year survival time\n$D D x$ : (1) Focal nodular hyperplasia (young + middle-aged woman, $<5 \\mathrm{~cm}$ in size, calcifications uncommon, isointense to liver on all CT + MR images with pronounced homogeneous enhancement during arterial phase, myxoid hyperintense central scar on T2WI with delayed enhancement, uptake of sulfur colloid / superparamagnetic iron oxide)\n(2) Large cavernous hemangioma (peripheral nodular discontinuous enhancement pattern similar to blood vessels with filling-in on delayed phase)\n(3) Hepatocellular adenoma (no central scar, heterogeneous texture $\\leftarrow$ fat + hemorrhage)\n(4) Hepatocellular carcinoma (regions of hemorrhage + necrosis, diseased adjacent liver, $\\uparrow$ AFP)\n(5) Metastasis (multifocal and visible primary)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 424,
            "markdown": "# HEPATOSPLENIC TUBERCULOSIS \n\nCause: disseminated disease\n@ micronodular-miliary involvement\n$\\checkmark$ innumerable $0.5-2.0-\\mathrm{mm}$ nodules\n$\\checkmark$ hyperechoic liver\n@ macronodular involvement (uncommon)\n$\\checkmark$ hypoattenuating nodules + irregular ill-defined margins\n$\\checkmark$ minimal central + definite peripheral enhancement\n$\\checkmark$ T1-hypointense + T2-hyperintense nodules\n$\\checkmark$ tuberculomas eventually calcify\n\n## HYPERPLASTIC CHOLECYSTOSIS\n\n$=$ variety of degenerative + proliferative changes of gallbladder wall characterized by hyperconcentration, hyperexcitability, and hyperexcretion\nFrequency: $9-30-50 \\%$ of all cholecystectomy specimens;\n\n$$\n\\mathrm{M}+\\mathrm{F}=1 \\div 6\n$$\n\nAssociated with: gallstones in $90 \\%$\n\n## Adenomyomatosis of Gallbladder\n\n$=$ ADENOMYOMATOUS HYPERPLASIA OF GALLBLADDER\n$=$ increase in number + height of mucosal folds\nPath: hyperplasia of mucosa + muscularis propria with mucosal outpouching of epitheliumlined cystic spaces into ( $46 \\%$ ) or all the way through ( $30 \\%$ ) a thickened muscular layer as tubules / crypts / 2-8 mm saccules ( $=$ intramural diverticula $=$ Rokitansky-Aschoff sinus); precipitation of cholesterol crystals in bile trapped in Rokitansky-Aschoff sinuses ( $=$ intraluminal cholesterol accumulation)\n[Rokitansky, Karl Freiherr von (1804-1878), chair of Pathological Anatomy at Vienna General Hospital, Austria]\n[Carl Aschoff(1866-1942), pathologist in Bonn, Germany]\nFrequency: $2-5 \\%$ of all cholecystectomy specimens\nAge: $\\quad>35$ years (develop with increasing age); $\\mathrm{M}+\\mathrm{F}=1 \\div 3$\nAssociated with: (1) Gallstones in $25-75 \\%$\n(2) Cholesterolosis in $33 \\%$\n\n## Types:\n\n(a) generalized form $=$ ADENOMYOMATOSIS\n$\\sqrt{ }$ \"twinkling / comet-tail\" = sound reverberation artifact between cholesterol crystals in Rokitansky-Aschoff sinuses (PATHOGNOMONIC)\nN.B.: Rokitansky-Aschoff sinuses of $<5 \\mathrm{~mm}$ cannot be resolved / identified on abdominal US\n$\\checkmark$ gallbladder wall thickening + enhancement\n$\\checkmark$ \"rosary\" sign on CT = enhancing epithelium within intramural diverticula surrounded by relatively unenhanced hypertrophied gallbladder muscularis\n$\\checkmark$ multiple tiny rounded hyperintense extraluminal cavities:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 425,
            "markdown": "$\\sqrt{ }$ \"string of beads\" sign = high-signal-intensity foci in gallbladder wall on T2WI ( $92 \\%$ specific)\n$\\checkmark$ \"pearl necklace\" sign = multiple round spaces in curvilinear intramural arrangement on MRCP\n$\\checkmark$ signal voids of intramural calculi (crystals)\n(b) segmental form\ncompartmentalization most often in neck or distal $1 / 3$\n(c) localized form in fundus\n$=$ solitary ADENOMYOMA with extraluminal diverticula-like formation\n$\\checkmark$ smooth sessile mass in GB fundus\n(d) annular form\n$\\checkmark$ \"hourglass\" configuration of GB with transverse congenital septum\n$D D x$ : polyposis, papillomatosis, adenoma, cystadenoma, gallbladder carcinoma, metastasis\n\n# Cholesterolosis \n\n$=$ abnormal deposition of triglycerides + cholesterol esters in macrophages within lamina propria (foam cells) + in mucosal epithelium\n\n## Strawberry Gallbladder\n\n$=$ LIPID CHOLECYSTITIS $=$ CHOLESTEROLOSIS\n$=$ planar form of cholesterolosis\n$=$ seedlike patchy / diffuse thickening of the villous surface pattern (disseminated micronodules)\nAssociated with: cholesterol stones in $50-70 \\%$\n\n- bright red mucosa with interposed areas of yellow lipid\n- not related to serum cholesterol level\n$\\checkmark$ radiologically not demonstrable\n\n\n## Cholesterol Polyp (90\\%)\n\n$=$ abnormal deposit of cholesterol esters and triglycerides producing a villouslike structure covered with a single layer of epithelium and attached via a delicate stalk\nNot associated with: gallstones\nPrevalence: $4 \\%$; most common ( $50 \\%$ ) fixed filling defect of gallbladder\nAge: $40-50$ years; $\\mathrm{M}+\\mathrm{F}=1 \\div 3$\nLocation: commonly in middle $1 / 3$ of gallbladder\n$\\checkmark$ small round smoothly contoured intraluminal lesion:\n$\\checkmark$ multiple (on average 8) small filling defects Size: $<10 \\mathrm{~mm}$ (rarely up to 20 mm ) in diameter\n$\\checkmark$ \"ball on the wall\" sign $\\leftarrow$ lesion attached to wall with stalk (rarely seen)\nPrognosis: NO malignant potential\n$D D x$ : papilloma, adenoma, inflammatory granuloma\n\n## INFLAMMATORY POLYP OF GALLBLADDER\n\nCause: gallstones, chronic cholecystitis\n$\\checkmark$ solitary (in $1 / 2$ ), $2-5$ polyps (in $1 / 2$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 426,
            "markdown": "$\\sqrt{ }$ usually $<10 \\mathrm{~mm}$ in diameter\nPrognosis: may incite mucosal epithelial dysplasia (NO definitively increased risk for adenocarcinoma)\n$\\diamond$ Inflammatory polyps have a nonspecific appearance so that the diagnosis may NOT be made with certainty at imaging!\n\n# INSPISSATED BILE SYNDROME \n\n$=$ uncommon cause of jaundice in neonate\nAssociated with: massive hemolysis (Rh incompatibility), hemorrhage (intraabdominal, intracranial, retroperitoneal), increased enterohepatic circulation (Hirschsprung disease, intestinal atresia, stenosis)\nUS:\n$\\sqrt{ }$ sludge in gallbladder\n$\\sqrt{ }$ sludge within bile ducts + partial / complete obstruction (affected ducts may blend with surrounding hepatic parenchyma)\n\n## INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM OF PANCREAS\n\n$=$ IPMN = MUCINOUS DUCTAL ECTASIA = DUCTECTATIC MUCINOUS CYSTIC TUMOR OF PANCREAS = INTRADUCTAL MUCIN-HYPERSECRETING NEOPLASM = MUCINOUS VILLOUS ADENOMATOSIS = MUCIN-PRODUCING PANCREATIC TUMOR\n$=$ rare intraductal tumor originating from papillary epithelial lining characterized by voluminous mucin secretions\nPath: conglomeration of communicating cysts covered by a rim of normal pancreatic parenchyma + thin fibrous capsule\nHisto: mucinous transformation of pancreatic ductal epithelium forming innumerable papillary projections within a typically dilated pancreatic ductal system that contains globules of mucus; papillae are coated with hyperplastic (= adenoma) / atypical (= borderline lesion) / malignant epithelium $\\leftarrow$ adenoma-carcinoma sequence\nPancreatic ductal imaging is essential to for classification:\n(1) establish the diagnosis of IPMN\n(2) differentiate among subtypes of IPMN like\n(a) main duct IPMN (diffuse / segmental) cystic pattern\n(b) mixed or isolated side-branch IPMN\n\nMean age: 65 years; $\\mathrm{M}>\\mathrm{F}$\n\n- recurrent episodes of dull pain / acute pancreatitis $\\leftarrow$ impaired outflow of pancreatic secretions:\n- hyperamylasemia (occasionally)\n- viscosity of fluid greater than normal serum ( $89 \\%$ sensitive, $100 \\%$ specific)\n\nLocation: frequently multifocal; 5-10\\% involve entire pancreas\n$\\diamond$ Location is an important factor for prognosis!\n$\\sqrt{ }$ communication between cystic lesion + main pancreatic duct (= most reliable diagnostic finding!):\n$\\sqrt{ }$ narrow neck at cyst-duct junction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 427,
            "markdown": "$\\sqrt{ }$ mural nodules projecting into main pancreatic duct\n$\\sqrt{ }$ protrusion of major papilla\nERCP:\n\n- spillage of thick jellylike mucin from ampulla of Vater with protrusion from bulging patulous duodenal papilla\n$\\sqrt{ }$ plugging of papilla of Vater\n$\\sqrt{ }$ elongated band- / threadlike / nodular amorphous filling defects in dilated pancreatic duct (= depiction of mucin)\n$\\sqrt{ }$ usually small mural polypoid / flat tumor\n$\\sqrt{ }$ dilated pancreatic ductal system in the absence of an obstructive ductal stricture\n$\\sqrt{ }$ communication between cyst cavity + pancreatic duct\nN.B.: escape of contrast material due to excess of mucin / patent papillary orifice hinders filling of ductal tree\nPrognosis: low-grade malignancy with better prognosis than pancreatic adenocarcinoma Signs of malignant transformation:\n$\\sqrt{ }$ lesion $>3.5 \\mathrm{~cm}$ in size with thick walls\n$\\sqrt{ }$ enhancing soft-tissue nodularity\n$D x:$ ERCP (bulging ampulla, mucin pouring from papilla, communication between pancreatic duct + cystic cavity)\n$C x:$ malignancy ( $57-92 \\%$ for main-duct IPMN $+20 \\%$ for branch-duct IPMN)\nMRCP (findings suggestive of a malignant IPMN):\n$\\sqrt{ }$ filling defects / papillary projections within a dilated pancreatic duct\n$\\sqrt{ }$ main pancreatic duct cysts + dilatation of $>15 \\mathrm{~mm}$\n$\\sqrt{ }$ branch duct dilatation $=$ enlargement by any amount\n$D D x$ : (1) Chronic obstructive pancreatitis (calcifications)\n(2) Serous / mucinous cystic tumors (NO communication with pancreatic duct, lobulated contour)\n(3) Pseudocyst (communication with duct)\n\n\n# Main Duct IPMN \n\nAge: 57 (range, 34-75) years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$\nHisto: invasive carcinoma in $60-70 \\%$\n$\\sqrt{ }$ hyperechoic, hyperdense, T2-hypointense filling defect within dilated duct (= enhancing papillary mural nodule / gravity-dependent mucin glob)\n$\\sqrt{ }$ dilatation of entire main pancreatic duct:\n(a) dilatation of entire main pancreatic duct\n$\\sqrt{ }$ homogeneous hypoechoic, hypodense, T1-hypointense and T2-hyperintense main duct\n$\\sqrt{ }$ pancreatic parenchymal atrophy\n$\\sqrt{ }$ dilatation of branch ducts (usually in pancreatic tail + uncinate process)\n$\\sqrt{ }$ dilatation of major $\\pm$ minor papilla bulging into duodenal lumen\n$\\sqrt{ } \\pm$ obstruction of $\\mathrm{CBD} \\leftarrow$ tumor / impacted mucin\nCx: pancreaticobiliary / duodenal fistula, pseudomyxoma peritonei\n$D D x$ : chronic obstructive pancreatitis (loss of T1 signal + delayed uptake of contrast $=$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 428,
            "markdown": "fibrosis)\n(b) segmental dilatation of main pancreatic duct\n$\\sqrt{ }$ cyst in pancreatic body / tail + normal remaining pancreatic parenchyma\n$\\sqrt{ }$ cyst in pancreatic head + upstream dilatation of main pancreatic duct\n$D D x$ : peripheral mucinous cystic tumor (main duct almost always normal)\n$R x$ : Whipple operation\n![img-60.jpeg](img-60.jpeg)\n\n# Branch Duct IPMN \n\nAge: 63 (range, 37-76) years; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\n$\\cdot$ usually incidental finding when tumor small\n\n- symptoms mimicking acute / chronic pancreatitis\n\nLocation: mainly in uncinate process $>>$ pancreatic tail $>$ pancreatic body\nPath: macrocystic / microcystic pattern; malignancy suggested by irregular thick wall + septa and solid nodules\nHisto: invasive carcinoma in $22 \\%$\n$\\sqrt{ }$ dilatation of multiple side branches (most commonly)\n$\\sqrt{ }$ round / ovoid small lobulated intraductal mass (frequently not visualized):\n$\\sqrt{ }$ dilated main pancreatic duct\n$\\sqrt{ }$ normal main pancreatic duct (almost always normal in small tumor)\n$\\diamond$ Secretin administration distends ducts and enhances detection of communication with main pancreatic duct!\n$\\sqrt{ }$ uni- / multilocular cyst $10-20 \\mathrm{~mm}$ large with sparse septa\n$D D x$ : mucinous cystadenoma (no communication with main pancreatic duct); pseudocyst (no intraluminal filling defects)\n$\\sqrt{ }$ grapelike locular appearance $=$ multiple thin septa separating fluid-filled lacunae\n$D D x$ : serous cystadenoma (no communication with main pancreatic duct)",
            "images": [
                {
                    "id": "img-60.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 459,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1201,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 429,
            "markdown": "$\\sqrt{ } \\pm$ severe pancreatic atrophy\n$\\sqrt{ }$ protrusion of papilla into duodenum\n$C x$ : seeding to main pancreatic duct resulting in main duct IPMN\n$R x$ : observation (for asymptomatic patient and a lesion of $<3 \\mathrm{~cm}$ ) / partial pancreatectomy\n\n# LIPOMA OF LIVER \n\nExtremely rare\n\n- asymptomatic\n\nMay be associated with: tuberous sclerosis\nSize: few $\\mathrm{mm}-13 \\mathrm{~cm}$\nUS:\n$\\sqrt{ }$ well-circumscribed echogenic mass (DDx: hemangioma, angiomyolipoma)\n$\\sqrt{ }$ striking acoustic refraction (sound velocity in soft tissue $1,540 \\mathrm{~min} / \\mathrm{sec}$, in fat 1,450 $\\mathrm{min} / \\mathrm{sec})$\nCT:\n$\\sqrt{ }$ homogeneously hypoattenuating mass\n$\\sqrt{ }$ no contrast enhancement\nMR:\n$\\sqrt{ }$ hyperintense on T1WI\n$\\sqrt{ }$ hypointense ( $=$ signal suppression) on fat-suppressed images\n$\\sqrt{ }$ NO enhancement after gadolinium chelate administration\nPrognosis: no malignant potential\n\n## LIVER TRANSPLANT\n\nCadaveric liver transplantation:\n$=$ most common type of liver transplantation in adults\nAdvantage: > full donor liver transplantation\n> usually technically successful\nDisadvantage: limited organ availability\nLiving donor liver transplantation technique:\nleft lateral hepatectomy including segments II + III\nIndications: end-stage acute / chronic liver disease\n> chronic viral hepatitis: chronic active hepatitis ( $4 \\%$ in childhood)\n> metabolic disease: alpha-1 antitrypsin deficiency ( $9 \\%$ in childhood), hemochromatosis, Wilson disease\n> cholestatic liver disease: primary biliary cirrhosis, primary sclerosing cholangitis, biliary atresia ( $52 \\%$ in childhood)\n> autoimmune hepatitis\n> cryptogenic cirrhosis ( $6 \\%$ in childhood)\n> alcoholic liver disease\n> acute fulminant hepatic failure ( $11 \\%$ in childhood): viral hepatitis, drug-induced hepatitis (eg, by acetaminophen, isoniazid), hepatotoxins (eg, mushrooms)\nEligibility for liver transplantation (Milan criteria):\nsingle tumor of $<5 \\mathrm{~cm} / \\leq 3$ tumors of 3 cm or smaller",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 430,
            "markdown": "Contraindications: AIDS, extrahepatic malignant tumors, active IVDA / alcohol abuse Frequency: 112,931 liver transplantations in US between 1988 and 2012; annually 6,000 liver transplantations; 1,500 deaths annually while awaiting transplantation\nNormal posttransplant findings\n(1) Periportal + reperfusion edema ( $21 \\%$ )\n\nCause: lymphedema in early posttransplantation period (= dilatation of lymphatic channels $\\leftarrow$ lack of normal lymphatic drainage)\n$\\sqrt{ }$ \"starry sky\" pattern = diminished liver echogenicity with accentuation of echogenic portal venules\n$\\sqrt{ }$ \"periportal collar\" of low attenuation on CT\n$\\checkmark$ resolution within weeks to months\n(2) Pneumobilia\n(3) Fluid collection around falciform ligament ( $11 \\%$ ), at vascular anastomoses (liver hilum, IVC), at biliary anastomosis, in lesser sac\n$\\checkmark$ present during $1^{\\text {st }}$ day; disappears within a few weeks\n(4) Small right pleural effusion\n(5) Peri- / subhepatic hematoma / free intraabdominal fluid\n(6) Anastomotic narrowing of IVC / portal vein\n$\\diamond$ Discrepancies in caliber between donor + recipient vessel have no pathologic significance!\n$\\checkmark$ wide range of portal vein velocities ( $15-400 \\mathrm{~cm} / \\mathrm{s}$ ) with average decrease of $20 \\%$ over next few days + normalization by 2 years\n$\\checkmark$ dampened mono- / biphasic hepatic vein waveform $\\leftarrow$ graft edema / compression by adjacent hematoma\nPrognosis: 1- and 5-year graft survival of $82 \\%$ and $65 \\%$\nVascular Complications in Liver Transplant (9\\%)\n$\\diamond$ Most frequent cause of graft loss\n\n- liver failure, bile leak, abdominal bleeding, septicemia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 431,
            "markdown": "![img-61.jpeg](img-61.jpeg)\n@) Thrombosis / stenosis of IVC / hepatic vein ( $<1 \\%$ )\n\nCause: size discrepancy between donor + recipient vessels, suprahepatic caval kinking from organ rotation, anastomotic fibrosis, neointimal hyperplasia, chronic thrombosis\n\n- pleural effusions, hepatomegaly, ascites, extremity edema\n$\\sqrt{ }$ compression of IVC $\\leftarrow$ swelling of graft\n$\\sqrt{ }$ reduction in caliber of poststenotic IVC\n$\\sqrt{ }$ prestenotic dilatation of IVC + hepatic veins\n$\\sqrt{ }$ persistent monophasic waveform (sensitive but not specific for significance of stenosis; bi- / triphasic waveform excludes significant stenosis)\n$\\sqrt{ }$ focal narrowing on B-mode imaging\n$\\sqrt{ } 3-4$-fold velocity increase compared with prestenotic segment\n$\\sqrt{ }$ intraluminal echogenic thrombus\n$\\sqrt{ }$ pressure gradient of $>5 \\mathrm{mmHg}$\n$\\sqrt{ }$ mosaic pattern of perfusion on CT / MR (Budd-Chiari)\n@ Thrombosis / stenosis of portal vein (1-3\\%)\nCause: faulty surgical technique, vessel misalignment, differences in vessel caliber creating turbulent flow, hypercoagulable state, prior portal vein surgery, prior thrombosis in recipient portal vein, increased downstream resistance $\\leftarrow$ suprahepatic stricture of IVC, decreased portal inflow\n- portal hypertension, liver failure, massive ascites, edema\n\nDuplex US of venous stenosis $>50 \\%$\n$\\sqrt{ } 3$ - to 4 -fold increase in peak systolic flow velocity compared with prestenotic segment\n$\\sqrt{ }$ poststenotic turbulence",
            "images": [
                {
                    "id": "img-61.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 189,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1009,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 432,
            "markdown": "$\\sqrt{ }$ narrowing of portal vein + poststenotic dilatation\n$\\sqrt{ }$ increase in number / caliber of collateral vessels\n$\\sqrt{ }$ filling defect / focal narrowing at anastomosis\n$R x$ : percutaneous transluminal angioplasty $\\pm$ stent placement, surgical thrombectomy, venous jump graft, creation of portosystemic shunt, retransplantation\n@ Hepatic artery\nNormal Resistive Index (RI): $0.5-0.8$\n$\\sqrt{ }<72$ hours after transplantation RI frequently $>0.8$ with return to normal in a few days\nCause: older donor age, prolonged period of cold ischemia, hepatic arterial spasm, reperfusion edema, increased portal flow ( $=$ inhibition of arterial vasodilator release)\n\n1. Hepatic artery stenosis (5-13\\%)\n\nLocation: at / near anastomosis\nCause: clamp injury, arterial spasm, intimal trauma from perfusion catheter, disruption of vasa vasorum\nTime of onset: within 3 months after transplantation\n$\\sqrt{ }$ marked focal increase in peak systolic velocity $>200-300 \\mathrm{~cm} / \\mathrm{sec}$ or $2-3 \\mathrm{x}$ of prestenotic velocity + poststenotic turbulence in $>50 \\%$ stenosis ( $30 \\%$ sensitive, $96 \\%$ specific)\n$\\sqrt{ }$ intrahepatic tardus et parvus waveform:\n$\\sqrt{ }$ slowed systolic acceleration time (SAT $>70-80 \\mathrm{msec}$ ) distal to stenosis ( $73 \\%$ sensitive)\n$\\sqrt{ }$ diminished pulsatility $(\\mathrm{RI}<0.55) \\leftarrow$ ischemia\nPitfall: intrahepatic collateral arteries $\\leftarrow$ severe aortoiliac atherosclerosis / hepatic artery stenosis)\n$D D x$ : normal in early post-transplantation period\n$\\sqrt{ }$ biliary dilatation ( $\\leftarrow$ stricture), infarction, biloma\n$C x$ : hepatic artery thrombosis, hepatic ischemia, biliary stricture, sepsis, graft loss\n$R x$ : revascularization surgery, balloon angioplasty\n2. Hepatic artery thrombosis ( $4-12-16 \\%$ in adults, $9-19-42 \\%$ in children)\n$\\diamond$ Most common vascular complication of liver transplantation ( $60 \\%$ )!\n\n# Pathophysiology: \n\nBile duct perfusion: solely by hepatic artery\nArterial bile duct supply: via retrograde collaterals from vessels at 3- and 9-o'clock positions + via gastroduodenal and superior pancreaticoduodenal arcade, which are divided during bile duct transection in donor\nHepatic artery thrombosis $\\rightarrow$ liver infarction, biliary ischemia, necrosis $\\rightarrow$ biliary stricture (anastomotic and nonanastomotic), bile leak, biliary abscess, biliary cast syndrome\n\n## Risk factors:\n\ndonor death $\\leftarrow$ intracerebral hemorrhage, donor age $>50$ years, previous liver transplant, split segmental graft, interpositional conduit for anastomosis, preexisting celiac artery stenosis\nTime of onset: usually within first 2 months\n(a) early thrombosis: $<1$ month of transplantation $\\leftarrow$ significant caliber difference between donor + recipient artery, prolonged cold ischemia of donor liver, ABO",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 433,
            "markdown": "blood type incompatibility\n(b) late thrombosis: $>1$ month of transplantation $\\leftarrow$ acute rejection / sepsis (CMV infection)\n\n- Three types of clinical presentation:\n(1) Fulminant hepatic necrosis + rapid deterioration\n(2) Bile leak, bile peritonitis, bacteremia, sepsis\n(3) Relapsing bacteremia\n\nCT / MRA / Angio:\n$\\checkmark$ abrupt cutoff of flow in hepatic artery (usually at anastomotic site)\n$\\checkmark$ nonenhancement of hepatic artery\n$\\checkmark$ decreased enhancement of hepatic parenchyma $\\leftarrow$ ischemia / infarction\nUS (54-92\\% sensitive, $64-88 \\%$ specific):\n$\\checkmark$ lack of hepatic artery flow\nFalse-positive Doppler (10\\%):\nsystemic hypotension, high-grade hepatic artery stenosis, small vessel size, severe hepatic edema (in first 72 hours after transplantation, viral hepatitis, acute rejection)\nFalse-negative Doppler:\narterial collaterals ( $\\leftarrow$ chronic thrombosis) with parvus tardus waveform (simulating proximal hepatic artery stenosis)\n$\\checkmark$ \"syndrome of impending thrombosis\":\n$\\checkmark$ loss of arterial diastolic flow\n$\\checkmark$ dampening of systolic peak\nPrognosis: thrombosis in $92 \\%$\n$\\checkmark$ multiple hypoechoic lesions in liver periphery (= infarcts)\nMortality: 27-33-58\\%; $80 \\%$ if undiagnosed\n$R x$ : thrombectomy; hepatic artery reconstruction; retransplantation ( $30 \\%$ mortality)\n3. Hepatic artery pseudoaneurysm (uncommon)\n\nLocation: at vascular anastomosis; complication of liver biopsy / angioplasty / focal infection\n$C x$ : acute shock due to massive intraperitoneal hemorrhage; portal vein fistula; biliary fistula\n$R x$ : surgical resection, embolization, exclusion by stent placement\n\n# Parenchymal Complications in Liver Transplantation \n\n1. Rejection\n$\\diamond$ Most common cause of graft failure\n$\\diamond$ Can ONLY be diagnosed with liver biopsy!\n2. Infarction ( $10 \\%$ )\n$\\checkmark$ may calcify\n$\\checkmark$ may liquefy developing into intrahepatic biloma\n3. Graft infection\n4. Posttransplant lymphoproliferative disease\n5. Neoplasms:\nskin cancer (other than melanoma), Kaposi sarcoma, NHL",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 434,
            "markdown": "# Biliary Complications in Liver Transplant (6-25-34\\%) \n\n$\\diamond 2^{\\text {nd }}$ most common cause of liver dysfunction after rejection\nTime of onset: within first 3 months\nStricture and leak $=$ the most common biliary complications\n\n1. Biliary obstruction $(15-18 \\%)$\n(a) anastomotic stricture (extrahepatic)\n\nCause: iatrogenic trauma $\\rightarrow$ ischemia + scar formation\n(b) nonanastomotic (intrahepatic) stricture\n\nCause: hepatic arterial thrombosis / stenosis (in 50\\%), prolonged preservation time, bacterial / viral cholangitis, rejection, recurrent primary sclerosing cholangitis, cholangiocarcinoma, kinking of redundant CBD, sphincter of Oddi dysfunction\n(c) tension mucocele of allograft cystic duct remnant\n\nCause: ligation of cystic duct proximally + distally\n$\\checkmark$ extrinsic mass compressing CHD\n$\\checkmark$ fluid collection adjacent to CHD\n$C x$ : ascending cholangitis\n2. Bile leak $(10-15 \\%)$\n\nBiliary leaks usually occur within the first few months after transplantation.\n(a) T-tube exit site: $50 \\%$ within 10 days\n$\\checkmark$ free leakage into peritoneal cavity\n$\\checkmark$ loculated perihepatic collection\n(b) anastomosis of choledochocholedochostomy:\n$70 \\%$ within 1 st postoperative month\n(c) bile duct necrosis (hepatic artery occlusion)\n$\\diamond$ The intrahepatic biliary epithelium is perfused solely by the hepatic artery!\n(d) after liver biopsy\n(e) common hepatic duct leak\n3. Biloma formation $(11 \\%)$\nwithin 1 st year after transplantation\nRisk factors: hepatic artery thrombosis / stenosis, hepaticojejunostomy\n4. Stone / sludge formation\n\nCause: alteration in bile composition\n\n## LYMPHOMA OF LIVER\n\nWith de novo focal liver masses the diagnosis of lymphoma is suggested by an absent history of primary malignancy, $<40$ years of age, B symptoms, splenic lesions, splenomegaly, and widespread abdominal / mediastinal lymphadenopathy.\nUS:\n$\\checkmark$ hypo- to anechoic nodules + absent posterior acoustic enhancement\n$\\checkmark \\pm$ \"target\" appearance (= central hyperechoic + peripheral hypoechoic component)\n$\\checkmark$ increased peripheral vascularity at Doppler\n$\\checkmark$ mild inhomogeneous hyperenhancement in arterial phase + contrast agent washout in portal",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 435,
            "markdown": "and late phases\nCT:\n$\\sqrt{ }$ nodules of soft-tissue attenuation\n$\\sqrt{ } \\pm$ hemorrhage + necrosis\n$\\sqrt{ }$ hypovascular during all phases of enhancement\n$\\sqrt{ } \\pm$ rim-enhancement\nMRI:\n$\\sqrt{ }$ hypo- to isointense nodules on T1WI\n$\\sqrt{ }$ moderately hyperintense nodules on T2WI\n$\\sqrt{ }$ DWI may allow earlier identification: typically restricted diffusion $\\leftarrow$ highly cellular mass (Detection rate for CT / MR is $<10 \\%$ )\nCEMR:\n$\\sqrt{ }$ hypovascular during all phases of enhancement\n$\\sqrt{ } \\pm$ minimal early enhancement\n$\\sqrt{ }$ \"target\" appearance $(15 \\%)=$ hyperintense poorly enhancing center + peripheral enhancement\nPET/CT (modality of choice for staging + treatment response):\n$\\sqrt{ }$ avid hypermetabolism\n$D D x$ : Hepatocellular carcinoma (arterial phase enhancement, delayed contrast material washout with capsular enhancement, vascular thrombosis, hypometabolic at PET)\n\n# Primary Hepatic Lymphoma (rare) \n\nIncidence: increased in immunosuppressed patients\nAssociated with: hepatitis B \\& C, Epstein-Barr virus\n\n- right upper quadrant pain, jaundice ( $50 \\%$ )\n- systemic symptoms: fever, weight loss ( $1 / 3$ )\n$\\sqrt{ }$ solid solitary liver mass $(60 \\%)$\n$\\sqrt{ }$ multiple heterogeneously enhancing liver masses with dominant mass (35-40\\%)\n$\\sqrt{ }$ diffuse infiltrating disease\n$\\sqrt{ }$ ill-defined mass in porta hepatis\n$\\sqrt{ } \\pm$ hepatic hilar lymphadenopathy\nIn primary hepatic lymphoma distant lymphadenopathy + splenomegaly / splenic lesions + bone marrow disease / leukemic blood profile should NOT occur for at least 6 months after the onset of hepatic disease.\n\nSecondary Hepatic Lymphoma (common)\nIncidence of liver involvement:\nin up to $50 \\%$ ( $60 \\%$ by autopsy) in Hodgkin disease; in up to $20 \\%$ ( $50 \\%$ by autopsy) in NHL\nPattern:\n(a) diffuse homogeneous infiltration ( $80 \\%$ ):\n$\\sqrt{ } \\pm$ hepatomegaly\n$\\sqrt{ }$ NO alteration in hepatic architecture\n(b) focal nodular lymphoma (in $10 \\%$ ):",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 436,
            "markdown": "$\\sqrt{ }$ discrete homogeneous nodules $\\pm$ miliary pattern\n(c) combination of diffuse + nodular lymphoma (3\\%)\n$\\sqrt{ }$ paraaortic, celiac, mesenteric, periportal nodes typically involved (lymphadenopathy below level of renal veins)\n$\\sqrt{ }$ splenic lesions ( $30-40 \\%$ )\n$D D x$ : Opportunistic infection (fungal microabscesses, septic emboli)\n\n# LYMPHOMA OF PANCREAS \n\nType: NHL (most commonly) with both B- and T-cell lineages\nFDG/PET: useful for staging and differentiation of primary from secondary pancreatic lymphoma\nA. PRIMARY LYMPHOMA\n\nFrequency: $<2 \\%$ of extranodal lymphoma; $0.5 \\%$ of pancreatic tumors\nMean age: 55 (range, $35-75$ ) years\nPredisposed: immunocompromised (HIV, transplant recipient)\n\n- abdominal pain ( $83 \\%$ ), weight loss ( $50 \\%$ )\n- obstructive jaundice ( $40 \\%$ ), acute pancreatitis ( $12 \\%$ )\n- palpable mass ( $58 \\%$ )\n- CLASSIC fever + chills + night sweats (in only 2\\%)\n\nLocation: pancreatic head $>$ entire gland\nMorphology:\n(a) focal well-circumscribed mass\n\nLocation: pancreatic head ( $80 \\%$ )\nSize: 8 (range, $2-15$ ) cm\n$\\sqrt{ }$ large unifocal well-circumscribed homogeneous solid mass:\n$\\sqrt{ }$ hypoattenuating on CT\n$\\sqrt{ }$ hypointense on T1WI + intermediate SI on T2WI (higher than pancreas + lower than fluid)\n$\\sqrt{ }$ infrequently with central cystic area\n$\\sqrt{ }$ faint contrast enhancement\n$\\sqrt{ }$ mild dilatation of pancreatic duct\n$D D x$ : pancreatic adenocarcinoma (with little pancreatic duct dilatation / tail atrophy)\n(b) diffuse form (simulating acute pancreatitis)\n$\\sqrt{ }$ poorly defined enlarged pancreas\n$\\sqrt{ }$ slightly lower attenuation compared with normal\n$\\sqrt{ }$ irregular peripancreatic fat infiltration\n$\\sqrt{ }$ diffusely reduced homogeneous enhancement\n$\\sqrt{ }$ hypointense on T1WI + T2WI\n$D D x$ : acute pancreatitis\n$\\sqrt{ }$ invasive growth across anatomic boundaries\n$\\sqrt{ }$ peripancreatic nodal masses:\n$\\sqrt{ }$ lymphadenopathy below level of renal veins\n$\\sqrt{ }$ anterior displacement of entire pancreas\n$\\sqrt{ }$ intact fat planes between lymph nodes and pancreas\n$\\sqrt{ }$ NO calcifications",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 437,
            "markdown": "$\\sqrt{ }$ envelopment of adjacent vessels WITHOUT vascular invasion / obstruction:\n$\\sqrt{ }$ peripancreatic vessels displaced + stretched\n$\\sqrt{ }$ uncommon dilatation of pancreatic + bile duct\nB. SECONDARY LYMPHOMA (in 30\\% of NHL)\n$\\sqrt{ }$ direct extension from peripancreatic lymphadenopathy\n$D D x$ : primary lymphoma (anterior displacement of pancreas, intact fat plane between pancreas + adjacent organs)\n$D D x$ : pancreatic adenocarcinoma (gross dilatation of main pancreatic duct, no lymph nodes below level of renal vein, vascular invasion common)\n\n# LYMPHOMA OF SPLEEN \n\nFrequency: $3^{\\text {rd }}$ most common site of abdominal involvement; may be initial manifestation in large cell lymphoma; most common site of abdominal involvement in Hodgkin disease\nN.B.: Splenic involvement is considered extranodal in NHL but nodal in Hodgkin disease!\n$\\sqrt{ }$ diffuse uniform infiltration\n$\\sqrt{ }$ ill-defined hypoenhancing foci of $<1 \\mathrm{~cm}$ in diameter become apparent after contrast enhancement in late venous and equilibrium phase\n$\\sqrt{ }$ nonspecific splenomegaly $\\leftarrow$ lymphomatous involvement / reactive process\n$\\sqrt{ }$ splenic hilar adenopathy\n$D x$ : staging laparotomy necessary as $2 / 3$ of tumor nodules $<1 \\mathrm{~cm}$ in size\n$D D x$ : disseminated fungal infection of candidiasis / aspergillosis (febrile neutropenic patient, nodules of $2-20 \\mathrm{~mm}$ in diameter, no lymphadenopathy, peripheral rimlike / central nodular enhancement)\n\n## MESENCHYMAL HAMARTOMA OF LIVER\n\n$=$ rare developmental benign cystic liver tumor characterized by proliferative extension along portal tracts; $2^{\\text {nd }}$ most common benign liver mass in children after infantile hemangioendothelioma\nPathogenesis: balanced translocation at chromosome 19q13.4 similar to undifferentiated (embryonal) sarcoma\nPath: well-marginated solitary liver mass with cysts (in $83 \\%$ ) of a few mm up to 14 cm in size containing clear amber fluid / gelatinous material; no capsule; infrequent hemorrhage and necrosis\nHisto: disordered arrangement of primitive fluid-filled mesenchyme, bile ducts, hepatic parenchyma; stromal / cystic predominance\nAge peak: 15-24 months (range, newborn to 19 years); in $95 \\%$ by 5 years of age; $\\mathrm{M} \\div \\mathrm{F}=3 \\div 2$\n\n- slow progressive painless abdominal distension\n- anorexia. nausea, vomiting, jaundice\n- $\\pm$ respiratory distress and lower extremity edema\n\nLocation: right lobe $\\div$ left lobe $=3 \\div 1 ; 20 \\%$ pedunculated\nMean size: 16 (range, 5-29) cm\n$\\sqrt{ }$ grossly discernible cysts in $80 \\%$\nUS:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 438,
            "markdown": "$\\sqrt{ }$ multiple rounded cystic areas on an echogenic background:\n$\\sqrt{ }$ low-level echoes within cysts ( $=$ gelatinous contents)\n$\\sqrt{ }$ some blood flow in solid portions + septa (color Doppler)\n$\\sqrt{ }$ may appear solidly echogenic in fetus / younger infant $\\leftarrow$ microcysts create innumerable tissue-fluid interfaces\nCT:\n$\\sqrt{ }$ multiple lucencies of variable size + attenuation (depending on composition of stromal versus cystic elements)\n$\\sqrt{ }$ hemorrhage (rare and atypical)\n$\\sqrt{ }$ enhancement of stromal component\nMR:\n$\\sqrt{ }$ varying SI (varying concentrations of protein in cystic predominance type) / hypointense on T1WI (mesenchymal predominance type)\n$\\sqrt{ }$ marked hyperintensity of cystic locules on T2WI\n$\\sqrt{ }$ solid portions of fibrosis hypointense on all sequences\nNUC:\n$\\sqrt{ }$ one / more areas of diminished uptake on sulfur colloid scan\nPrognosis: $90 \\%$ long-term survival\nRx: resection\n$D D x$ : (1) Hepatoblastoma (marked elevation of AFP, solid tumor with calcifications)\n(2) Focal form of infantile hemangioendothelioma (calcifications in $50 \\%$, marked hypervascularity)\n(3) Undifferentiated (embryonal) sarcoma (older child at 6-10 years of age, hemorrhage + necrosis)\n\n# METASTASIS TO GALLBLADDER \n\nOrgan of origin: melanoma ( $60 \\%$ ), renal cell carcinoma (late in course of disease), lymphoma (in AIDS), malignant fibrous histiocytoma, gastric cancer (in Asia)\n> in children: embryonal cell sarcoma, rhabdomyosarcoma\n$\\diamond 94 \\%$ of benign lesions are $<1 \\mathrm{~cm}$ in diameter; $88 \\%$ of malignant lesions are $>1 \\mathrm{~cm}$ in diameter!\n$D D x$ : adenocarcinoma (usually associated with gallstones, more common in women + older patients); squamous cell carcinoma; carcinosarcoma, small cell carcinoma\n\n## METASTASIS TO LIVER\n\n$\\diamond$ Most common malignant lesion of the liver\n$\\diamond$ Most common metastatic site after regional lymph nodes\nIncidence: 18-20 x greater than primary carcinoma; $22 \\%$ of all liver tumors in patients with a known malignancy ( $50 \\%$ in autopsies)\nOrgan of origin: colon (42\\%), stomach ( $23 \\%$ ), pancreas ( $21 \\%$ ), breast ( $14 \\%$ ), lung ( $13 \\%$ )\n$\\sqrt{ }$ involvement of liver + spleen typical in leukemia/lymphoma + melanoma\nin children: neuroblastoma, Wilms tumor\n\n- hepatomegaly (70\\%); abnormal liver enzymes (50-75\\%)\n\nLocation: both lobes (77\\%), right lobe (20\\%), left lobe (3\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 439,
            "markdown": "Number: multiple (50-98\\%), solitary (2\\%)\nSize: $>33 \\%$ smaller than 2 cm\nNUC:\nsensitivity of $80-95 \\%$ for lesions $>1.5 \\mathrm{~cm}$; lesions $<1.5 \\mathrm{~cm}$ are frequently missed;\nsensitivity increases with metastatic deposit size, peripheral location, and use of SPECT\nNECT:\nimportant for hypervascular tumors (eg, renal cell carcinoma, carcinoid, islet cell tumors), which may be obscured by CECT\nCECT ( $88-90 \\%$ sensitive; $99 \\%$ specific):\n$\\diamond$ Sensitivity decreases relative to NECT if scan obtained only during equilibrium phase of contrast administration\n$\\checkmark$ lesion enhancement during arterial phase $\\leftarrow$ metastases are supplied by hepatic artery\n$\\checkmark$ less enhancement during portal venous phase $\\leftarrow$ metastases have a negligible portal venous supply\n$\\checkmark$ extracellular space agents accumulate more in tumor tissue $\\leftarrow$ metastases have a larger interstitial space\nOptimal technique: bolus of contrast followed by dynamic incremental scanning\n$\\checkmark$ circumferential bead- or bandlike enhancement during arterial phase + peripheral washout on delayed images\n$\\checkmark$ no (35\\%), peripheral (37\\%), mixed (20\\%), central (8\\%) enhancement\n$\\checkmark$ complete isodense fill-in on delayed scans in 5\\% (DDx: hemangioma)\n$\\diamond$ Lesions of $\\sim 1 \\mathrm{~cm}$ can usually be detected!\nCT-Angiography (most sensitive imaging modality):\nIndication: patients with potentially resectable isolated liver metastases / preoperative before partial hepatectomy $\\rightarrow$ additional lesions are detected in $40-55 \\%$\n(1) CT arteriography $=$ angiographic catheter in hepatic artery $\\rightarrow$ detects lesions by virtue of increased enhancement\n(2) CT arterial portography $=$ angiographic catheter in SMA $\\rightarrow$ detects hypodense lesions on a background of increased enhancement of normal surroundings in portal venous phase\nCT-delayed iodine scanning:\n$=\\mathrm{CT}$ performed $4-6$ hours following administration of 60 mg iodine results in detection of additional lesions in $27 \\%$\nUS (intraoperative with palpation): $>95 \\%$ sensitive\nMR:\n$\\checkmark$ usually irregular shape and margin\n$\\checkmark$ usually hypointense on T1WI\n$\\checkmark$ heterogeneously hyperintense on DWI + T2WI\n$\\checkmark$ perilesional fat deposition $=$ metastasis from primary pancreatic insulinoma $\\leftarrow$ effect of insulin inhibiting oxidation of fatty acids + promoting accumulation of tricglycerides in hepatocytes\nCEMR:\n$\\checkmark$ arterial phase:\n$\\checkmark$ homogeneously hypervascular for metastasis $<2 \\mathrm{~cm}$\n$\\checkmark$ heterogeneous with ring enhancement if $>2 \\mathrm{~cm}$\n$\\checkmark$ thick hypovascular peripheral rim",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 440,
            "markdown": "$\\sqrt{ }$ perilesional ring enhancement $\\leftarrow$ central tumor necrosis\n$\\checkmark$ irregular peripheral wash-out during venous phase\n$\\checkmark$ delayed heterogeneous contrast retention\nRx: (1) Resection\nExclusion criteria for metastasectomy:\n(a) advanced stage of primary tumor\n(b) $>4$ metastases\n(c) extrahepatic disease\n(d) $<30 \\%$ normal liver tissue / function available after resection\n(2) Radiofrequency ablation\n\nPrognosis: $30-40 \\% 5$-year survival after resection\n\n# Calcified Liver Metastases \n\nPrevalence: $2-3 \\%$\n\n1. Mucinous carcinoma of GI tract (colon, rectum, stomach)\n2. Endocrine pancreatic carcinoma\n3. Leiomyosarcoma, osteosarcoma\n4. Malignant melanoma\n\n| Intravenous Contrast Strategies for Liver Lesions |  |  |\n| :--: | :--: | :--: |\n| Uniphasic <br> $P V P$ | Biphasic <br> $P P+P V P$ | Triphasic <br> $N E+A P+P V P$ |\n| Colorectal cancer | Pancreatic cancer | Carcinoid |\n| Gastric cancer |  | Neuroendocrine |\n| Ovarian cancer |  | Islet cell tumor |\n| Cervical cancer |  | Renal cell cancer |\n| Lymphoma |  | GIST |\n| Multiple myeloma |  | Thyroid cancer |\n|  |  | ? Breast / Melanoma |\n| $\\begin{gathered} \\mathrm{PVP}=\\text { portal venous phase } \\\\ \\mathrm{AP}=\\text { arterial phase } \\end{gathered}$ |  | $\\mathrm{PP}=$ parenchymal phase $\\mathrm{NE}=$ nonenhanced |\n\n5. Papillary serous ovarian cystadenocarcinoma\n6. Lymphoma\n7. Pleural mesothelioma\n8. Neuroblastoma\n9. Breast cancer\n10. Medullary carcinoma of the thyroid\n11. Renal cell carcinoma\n12. Lung carcinoma\n13. Testicular carcinoma\nmnemonic for mucinous adenocarcinoma: COBS\nColon carcinoma\nOvarian carcinoma\nBreast carcinoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 441,
            "markdown": "# Hypervascular Liver Metastases \n\n$=$ increased enhancement relative to normal liver during arterial phase + washout on delayed images\n\n1. Primary neuroendocrine tumor:\n(a) Pancreatic endocrine tumor\n(b) Neuroendocrine carcinoma $=$ carcinoid $(14 \\%)$\n(c) Pheochromocytoma\n2. Melanoma ( $11 \\%$ )\n3. Renal cell carcinoma ( $8 \\%$ )\n4. Breast carcinoma (some) ( $2 \\%$ )\n5. Thyroid carcinoma\n6. Choriocarcinoma\n7. Sarcomas\n8. Ovarian cystadenocarcinoma\nin ( ) number of lesions seen only during arterial phase\nmnemonic: CHIMP\nCarcinoid\nHypernephroma\nIslet cell carcinoma\nMelanoma\nPheochromocytoma\nCT:\n$\\diamond$ Triphasic scan recommended!\nDetection rate: $87 \\%$ for NECT, $78 \\%$ for hepatic arterial phase, $77 \\%$ for portal venous phase\nMR:\n$\\checkmark$ moderately hypointense on T1WI unless hemorrhagic\n$\\checkmark$ markedly hyperintense on T2WI (= cystic, necrotic)\n$\\checkmark$ hyperintense on DWI\nCEMR:\n$\\checkmark$ uniform / peripheral-rim / heterogeneous enhancement\n$\\checkmark$ \"peripheral washout\" sign = decrease of contrast material preferentially in periphery of mass while center remains hyperintense on delayed image (? related to vessel distribution with central necrosis / fibrosis and peripherally viable tumor), same as in HCC\n$\\checkmark$ hypointense / target appearance on 1-hour delayed image after Gd-\nBenzylOxyPropionicTetraAcetate\n\n## Hypovascular Liver Metastases\n\n$=$ decreased enhancement relative to normal liver\n\n1. Stomach\n2. Colon / rectum\n3. Head \\& neck",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 442,
            "markdown": "4. Pancreas\n5. Lung\n6. Breast\n7. Transitional cell carcinoma\n8. Prostate\n$\\sqrt{ }$ low SI on T1WI images + iso- to hyperintense on T2WI\n$\\sqrt{ }$ delayed enhancement during portal venous phase / (occasionally) early ring enhancement\n$\\diamond$ Most conspicuous on portal venous phase images!\n\n# Hemorrhagic Liver Metastases \n\nmnemonic: CT BcComes MR\nColon carcinoma\nThyroid carcinoma\nBreast carcinoma\nChoriocarcinoma\nMelanoma\n\n| Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: |\n| Lesion Type | Response Type |  |  |  |\n|  | Regression: complete | partial | stable | Progression |\n| MEASURABLE TARGET LESIONS <br> $=$ longest diameter of $\\geq 10 \\mathrm{~mm}$ (CT slice thickness of $\\leq 5 \\mathrm{~mm}$ ) $/ \\geq 20 \\mathrm{~mm}$ (nonhelical CT slice thickness of $>10 \\mathrm{~mm}$ ) $/ \\geq 20 \\mathrm{~mm}$ (CXR) selected on the basis of size and suitability for accurate repeated measurements ( $=2$ target lesions per organ) |  |  |  |  |\n| Measure SUM of longest diameters of target lesions <br> ( $\\leq 2$ per organ + total of $\\leq 5$ ) <br> N.B.: Fragmentation of lesion treated as separate lesions Coalescence of lesions treated as one lesion add short-axis measurement of lymph node if $\\geq 15 \\mathrm{~mm}$ to SUM of target lesions | disappearance of all | relative $\\widehat{0}$ of $\\geq 30 \\%$ $\\widehat{0}$ to $<5 \\mathrm{~mm}$ reported as 5 mm | no change | $\\geq 1$ new lesions <br> absolute $\\%$ of SUM $\\geq 5 \\mathrm{~mm}$ relative $\\%$ of SUM $\\geq 20 \\%$ new FDG PET lesion |\n| NONMEASURABLE / NONTARGET LESIONS <br> $=$ small lesions with longest diameter of $<10 \\mathrm{~mm}$, skeletal metastasis without soft-tissue component, ascites, pleural effusion, lymphangitic spread, leptomeningeal disease, inflammatory breast disease, cystic / necrotic lesion, lesion in irradiated area |  |  |  |  |\n| Note presence / absence of each nontarget lesion at baseline and follow-up | disappearance of all nontarget lesions |  | persistence of $\\geq 1$ nontarget lesions | appearance of $\\geq 1$ new lesion progression of existing nontarget lesions |\n| Lymph node with short axis $\\geq 10$ and $<15 \\mathrm{~mm}$ | short-axis $\\widehat{0}$ to $<10 \\mathrm{~mm}$ ( $=$ normal node) |  |  |  |\n\nRenal cell carcinoma\nand: lung, testicle\n$\\sqrt{ }$ hyperintense on T1WI\n\n## Echogenic Liver Metastases\n\nPrevalence: $25 \\%$\n\n1. Colonic carcinoma (mucinous adenocarcinoma) $54 \\%$\n2. Hepatoma $25 \\%$\n3. Treated breast carcinoma $21 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 443,
            "markdown": "# Liver Metastases of Mixed Echogenicity \n\nPrevalence: $37.5 \\%$\n\n1. Breast cancer $31 \\%$\n2. Rectal cancer $20 \\%$\n3. Lung cancer $17 \\%$\n4. Stomach cancer $14 \\%$\n5. Anaplastic cancer $11 \\%$\n6. Cervical cancer $5 \\%$\n7. Carcinoid $1 \\%$\n\n## Cystic Liver Metastases\n\nPathophysiology of cystic metastases:\n(a) necrosis of hypervascular metastases $\\leftarrow$ rapid growth beyond capacity of vascular supply: neuroendocrine tumor, melanoma, GIST\n(b) abundant mucin production by mucinous adenocarcinoma: colorectal / ovarian carcinoma\n(c) systemic / locoregional treatment\n\n1. Mucinous ovarian carcinoma\n2. Colonic carcinoma\n3. Sarcoma\n4. Melanoma\n5. Lung carcinoma\n6. Carcinoid tumor\nmnemonic: LC GOES\nLeiomyosarcoma (and other sarcomas)\nChoriocarcinoma\nGastric carcinoma\nOvarian carcinoma\nEndometrial carcinoma\nSmall cell carcinoma\n\n## Echopenic Liver Metastases\n\nPrevalence: $37.5 \\%$\n\n1. Lymphoma $44 \\%$\n2. Pancreas $36 \\%$\n3. Cervical cancer $20 \\%$\n4. Lung (adenocarcinoma)\n5. Nasopharyngeal cancer\n\n## T1-Hyperintense Metastasis\n\n1. Melanoma\n2. Mucinous carcinoma\n3. Carcinoid\n4. Hemorrhagic metastasis\n\n## Markedly T2-Hyperintense Metastasis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 444,
            "markdown": "1. Renal cell carcinoma\n2. Islet cell tumor\n3. Pheochromocytoma\n4. Leiomyosarcoma\n5. Necrotic metastasis\n\n# METASTASIS TO PANCREAS \n\nFrequency: $2-11 \\%$ (autopsy); $2-5 \\%$ of all malignancies\nOrgan of origin: renal cell carcinoma (30\\%), bronchogenic carcinoma (23\\%), breast carcinoma ( $12 \\%$ ), soft-tissue sarcoma + Kaposi sarcoma ( $8 \\%$ ), colonic carcinoma ( $6 \\%$ ), melanoma ( $6 \\%$ ), secondary lymphoma, ovarian cancer, HCC\nTime interval since diagnosis of primary:\n$<3$ years for most primaries; 6-12 years for RCC\n\n- asymptomatic (50-83\\%) / nonspecific clinical symptoms\n\nMorphology:\n(a) well-marginated solitary mass (50-78\\%)\n(b) multiple ovoid masses ( $5-17 \\%$ ) with discrete smooth margins\n(c) diffuse pancreatic enlargement (5-44\\%)\n\nUS:\n$\\sqrt{ }$ hypo- / hyperechoic mass\nNECT:\n$\\sqrt{ }$ hypo- / isoattenuating mass\nCECT (closely resembling enhancement pattern of primary):\n$\\sqrt{ }$ heterogeneously ( $60 \\%$ ) / homogeneously ( $17 \\%$ ) hyperattenuating relative to pancreas\n$\\sqrt{ }$ hypoattenuating relative to pancreas ( $20 \\%$ )\n$\\sqrt{ }$ isoattenuating relative to pancreas ( $5 \\%$ )\n$\\sqrt{ }$ peripheral enhancement of lesion $>1.5 \\mathrm{~cm}(70 \\%)$\n$\\sqrt{ }$ homogeneous enhancement of small lesion\nMR:\n$\\sqrt{ }$ hypointense on T1WI + hyperintense on T2WI\nConcomitant intraabdominal metastases to:\nliver (36\\%), lymph nodes (30\\%), adrenal glands (30\\%)\n$D D x$ : ductal pancreatic adenocarcinoma (uniformly hypo- / nonenhancing mass, encasement of vessels); neuroendocrine tumor\n\n## MILK OF CALCIUM BILE\n\n$=$ LIMY BILE $=$ CALCIUM SOAP\n$=$ precipitation of particulate material with high concentration of calcium carbonate, calcium phosphate, calcium bilirubinate\nAssociated with: chronic cholecystitis + gallstone obstruction of cystic duct\n$\\sqrt{ }$ diffuse opacification of GB lumen with dependent layering\n$\\sqrt{ }$ usually functionless GB on oral cholecystogram\nUS:\n$\\sqrt{ }$ intermediate features between sludge + gallstones",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 445,
            "markdown": "# MIRIZZI SYNDROME \n\n= extrinsic right-sided compression of common hepatic duct by large gallstone impacted in Hartmann pouch (at junction of cystic duct and gallbladder neck) / cystic duct remnant; accompanied by chronic inflammatory reaction\nPredisposition: long cystic duct coursing parallel to CHD; low insertion of cystic duct into CBD\n\n- jaundice, fever, right upper quadrant pain\n\nClassification (guiding surgical management):\n![img-62.jpeg](img-62.jpeg)\n\nType 1: simple obstruction of CHD by extrinsic compression without fistulization\nType 2: cholecystocholedochal fistula + erosion of CBD wall affecting $<1 / 3$ of bile duct circumference\nType 3 affecting $1 / 3$ to $2 / 3$ of bile duct circumference\nType 4 affecting $>2 / 3$ of bile duct circumference\n$\\sqrt{ }$ normal CBD\n$\\sqrt{ }$ TRIAD:\n(1) Gallstone impacted in GB neck / cystic duct\n(2) Dilatation of intrahepatic and common hepatic ducts\n(3) Smooth curved extrinsic narrowing of CHD\n\nCholangiography:\n$\\sqrt{ }$ partial obstruction of $\\mathrm{CHD} \\leftarrow$ external compression on lateral side of duct / eroding stone CT:\n$\\sqrt{ }$ gallstone not always visualized\nMR:\n$\\sqrt{ }$ cholelithiasis with stone in cystic duct\n$\\sqrt{ }$ focal stricture of CHD\n$\\sqrt{ }$ dilatation of intrahepatic bile ducts + proximal CHD\n$\\sqrt{ }$ normal caliber of distal CBD\nCx: cholecystobiliary fistula\n$R x:$ open surgery",
            "images": [
                {
                    "id": "img-62.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 550,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1115,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 446,
            "markdown": "# MUCINOUS CYSTIC NEOPLASM OF PANCREAS \n\n$=$ MACROCYSTIC ADENOMA OF PANCREAS = MUCINOUS CYSTADENOMA\n$=$ thick-walled uni- / multilocular low-grade malignant tumor composed of large mucincontaining cystic spaces\nFrequency: $10 \\%$ of pancreatic cystic neoplasm; $1 \\%$ of all pancreatic neoplasms\nMean age: 47 (range, 20-95) years; in $50 \\%$ between $40-60$ years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 9$\nPath: large smooth round / lobulated multiloculated cystic mass encapsulated by a layer of fibrous connective tissue\nHisto: cysts lined by tall columnar, mucin-producing cells subtended by a densely cellular mesenchymal stroma (reminiscent of ovarian stroma = distinguishing feature), often in papillary arrangement; lack of cellular glycogen; similar to biliary and ovarian mucinous tumors\n(a) mucinous cystadenoma\n(b) mucinous cystadenocarcinoma $=$ stratified papillary epithelium\n$\\diamond$ All mucinous cystic neoplasms should be considered low-grade malignant neoplasms!\n\n- asymptomatic; abdominal pain, anorexia\n\nLocation: often in pancreatic tail ( $90 \\%$ ) / body, head (rare)\nMean size of mass: 10-12 (range, 2-36) cm in diameter\nSize of cysts: multi- / unilocular large cysts $>2 \\mathrm{~cm}$\nNumber of cysts: usually $<6$ cysts\nA pancreatic tumor with cysts of $>2 \\mathrm{~cm}$ in diameter is a mucinous cystic neoplasm in 93$95 \\%$ !\n$\\sqrt{ }$ well-demarcated thick-walled mass with $<2 \\mathrm{~mm}$ thin septa\n$\\checkmark$ solid papillary excrescences protrude into the interior of tumor (= sign of malignancy)\n$\\checkmark$ amorphous discontinuous peripheral mural calcifications ( $10-15 \\%$ )\n$\\checkmark$ hypovascular mass with sparse neovascularity\n$\\checkmark \\pm$ vascular encasement and splenic vein occlusion\n$\\checkmark$ great propensity for invasion of adjacent organs\nUS:\n$\\checkmark$ cysts may contain low-level echoes\nCT:\n$\\checkmark$ fine internal septa + small intramural nodules may not be visible $\\pm$ contrast enhancement $\\rightarrow$ thin-section CT\n$\\checkmark$ cysts with attenuation values of water; may have different levels of attenuation within different cystic cavities\n$\\checkmark$ enhancement of cyst walls\nMR:\n$\\checkmark$ unilocular / mildly septated typically mucin-filled cystic lesion of homogeneous T1 hypointensity and T2 hyperintensity ( $=$ MR characteristics of simple fluid)\n$\\checkmark$ mildly thick enhancing septa (frequent)\n$\\checkmark$ thick delayed-enhancing fibrotic wall",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 447,
            "markdown": "$\\sqrt{ }$ pertinent negatives:\n$\\sqrt{ }$ NO communication with pancreatic duct\n$\\sqrt{ }$ NO enhancing soft-tissue components\nAngio:\n$\\checkmark$ predominantly avascular mass\n$\\checkmark$ cyst wall + solid components may demonstrate small areas of vascular blush + neovascularity\n$\\checkmark$ displacement of surrounding arteries + veins by cysts\nMetastases:\n$\\checkmark$ round thick-walled cystic lesions in liver\nPrognosis: invariably transformation into cystadenocarcinoma; 17-63\\% 5-year survival rate\n$D x$ : biopsy with adequate sampling of cyst lining mandatory to exclude foci of dysplasia / carcinoma in situ\n$R x$ : complete surgical excision (5-year survival rate of $74-90 \\%$ )\n$D D x$ :\n(1) Pseudocyst (most common pancreatic cyst): inflammatory changes in peripancreatic fat, pancreatic calcifications, temporal evolution, history of alcoholism, elevated levels of amylase\n(2) Mucinous non-neoplastic cyst\n$=$ mucinous differentiation of epithelial lining without cellular atypia + lack of surrounding ovarian stroma\n\n- no proven sex predilection\n$\\checkmark$ incidental small (rarely large) unilocular cyst $\\pm$ thick wall indistinguishable from mucinous cystadenomas\n$\\sqrt{ }$ NO ductal communication / papillary projections\n(3) Lymphangioma / hemangioma\n(4) Variants of ductal adenocarcinoma\n(a) mucinous colloid adenocarcinoma / ductectatic mucinous tumor of pancreas $=$ mucin-hypersecreting carcinoma\n(b) intraductal papillary mucinous neoplasm (IPMN) (communication with pancreatic duct)\n(c) adenosquamous carcinoma: squamous component predisposes to necrosis + cystic degeneration\n(d) anaplastic adenocarcinoma: lymphadenopathy + metastases at time of presentation\n(5) Solid and cystic papillary epithelioid neoplasm: hemorrhagic cystic changes in $20 \\%$\n(6) Cystic pancreatic endocrine tumor: hypervascular component\n(7) Cystic metastases: history of malignant disease\n(8) Atypical serous cystadenoma: smaller tumor with greater number of smaller cysts\n(9) Sarcoma\n(10) Infection: amebiasis, Echinococcus multilocularis\n\n\n# MUCINOUS CYSTADENOCARCINOMA OF PANCREAS \n\nEtiology: adenoma-carcinoma sequence\nHisto: invasive elements surrounded by ovarian-type stroma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 448,
            "markdown": "Age: older than patients with mucinous cystadenoma\nMR:\n$\\sqrt{ }>4$-cm large complex cystic pancreatic lesion\n$\\sqrt{ }$ intracystic enhancing soft tissue\n$\\sqrt{ }$ soft-tissue nodularity\n$D D x:$ Solid pseudopapillary tumor of pancreas\n$R x$ : any enhancing soft tissue within a cystic pancreatic neoplasm is an indication for resection.\n$R x$ : any enhancing soft tissue within a cystic pancreatic neoplasm is an indication for resection.\n\n# MULTIPLE BILE DUCT HAMARTOMAS \n\n$=$ BILIARY MICROHAMARTOMAS $=$ VON MEYENBURG COMPLEX\nPrevalence: $0.7 \\%$ at autopsy, $2.8 \\%$ at microscopy\nEtiology: failure of involution of embryonic interlobular bile ducts $=$ part of fibropolycystic liver disease spectrum\nPath: communication with biliary system usually obliterated\nHisto: cluster of proliferated bile ducts lined by single layer of cuboidal cells embedded in fibrocollagenous tissue with single ramified lumen\nMay be associated with: fibropolycystic liver disease\nSize: $0.1-15 \\mathrm{~mm}$\nLocation: random / scattered; periportal; multiple / solitary\n\n- asymptomatic $=$ incidental discovery\n$\\sqrt{ }$ nonspecific imaging appearance of small well-defined lesions\n$\\sqrt{ }$ variable enhancement pattern: none / rim / slow homogeneous\nCT:\n$\\sqrt{ }$ multiple scattered round / oval / irregular hypodense lesions ( $44 \\%$ occult on CT)\n$\\sqrt{ }$ rim of little peripheral / no enhancement\nUS:\n$\\sqrt{ }$ multiple small cysts / echogenic areas (if size not resolved)\n$\\sqrt{ } \\pm$ comet-tail (ring-down) artifact\nMR:\n$\\sqrt{ }$ small well-defined hypointense lesions on T1WI\n$\\sqrt{ }$ iso- / slightly hyperintense on T2WI\n$\\sqrt{ }$ no internal enhancement $\\pm$ thin rim enhancement of surrounding liver parenchyma on immediate / delayed phase\nAngio:\n$\\sqrt{ }$ multiple areas of abnormal vascularity in form of small grapelike clusters persisting into venous phase\n$D D x$ :\n\n1. Metastatic liver disease (more variable in size and attenuation / signal intensity)\n2. Simple hepatic cysts (not as numerous or uniformly small)\n3. Autosomal dominant polycystic disease (cysts usually larger and more numerous)\n4. Microabscesses\n5. Granulomata",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 449,
            "markdown": "# MULTIPLE ENDOCRINE NEOPLASIA \n\n$=$ MEN = MULTIPLE ENDOCRINE ADENOMAS (MEA)\n$=$ familial autosomal dominant adenomatous hyperplasia characterized by neoplasia of 2 or more endocrine organs\nTheory: cells of involved principal organs originate from neural crest and produce polypeptide hormones in cytoplasmic granules, which allow amine precursor uptake and decarboxylation $=$ APUD cells\nreminder:\nMEN $1=$ Wermer syndrome PiPaPanc\nMEN $2=$ Sipple syndrome (type 2A) PhePaM\n\n| Types of Multiple Endocrine Neoplasia |  |  |  |\n| :--: | :--: | :--: | :--: |\n| MEN | Type 1 | Type 2 | Type 3 |\n| Pituitary adenoma | $+$ |  |  |\n| Parathyroid adenoma | $+$ | $+$ |  |\n| Medullary thyroid carcinoma |  | $+$ | $+$ |\n| Pancreatic island cell tumor | $+$ |  |  |\n| Pheochromocytoma |  | $+$ | $+$ |\n| Ganglioneuromatosis |  |  | $+$ |\n\nMEN $3=$ Mucosal neuroma syndrome (type 2B) 4 PheMG\n\n## MEN 1 Syndrome\n\n$=$ WERMER SYNDROME\n[Paul Wermer (1898-1975), internist at Columbia University, NY]\n$=$ autosomal dominant syndrome with $95 \\%$ penetrance\nPrevalence: $1 \\div 5,000$ to $1 \\div 50,000$\nGenetics: autosomal dominant MEN1 gene defect encoding protein menin located on chromosome 11q13 = suppressor of cell proliferation\n$\\diamond$ MEN1 mutation present in $21 \\%$ of sporadic PETs\nOrgan involvement (PiPaPanc): syn- / metachronous\n» in $40 \\%$ combined involvement of parathyroid gland + pituitary gland + pancreas\n\n1. Parathyroid hyperplasia ( $97 \\%$ ): multiglandular / (occasionally) adenoma\n\n- primary HPT (in 95\\%): usually presenting feature\n\n2. Pancreatic endocrine tumor ( $30-80 \\%$ ):\n\nPath: multiple $<5 \\mathrm{~mm}$ microadenomas producing clinically insignificant active peptides $\\pm$ few macroadenomas $>5 \\mathrm{~mm}$; usually nonmalignant\n$\\diamond$ Primary cause of morbidity + mortality!\n(a) gastrinoma (in $50-60 \\%$ )\n\nLocation: duodenum $>$ pancreas\n$\\sqrt{ }$ multiple duodenal microgastrinomas ( $<5 \\mathrm{~mm}$ ) account for $>50 \\%$ of gastrinomas\n(b) insulinoma (in $10-30 \\%$ )\n\nAge: more commonly $<40$ years\nLocation: body + tail of pancreas",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 450,
            "markdown": "$\\diamond$ coexistence with gastrinomas in $10 \\%$\n(c) VIPoma\n3. Anterior pituitary gland tumor (20-65\\%)\n(a) nonfunctioning\n(b) prolactin ( $60 \\%$ ), growth hormone ( $<25 \\%$ ), adrenocorticotropic hormone (5\\%), TSH\n\n- presenting feature of the syndrome in $10 \\%$\n\n4. Thyroid neoplasm\n5. Adrenocortical hyperplasia / adenomas (up to $33-40 \\%$ )\n\n- rarely functional\n\n6. Pheochromocytoma\n7. Carcinoid $(2-5 \\%)$\n\nLocation: thymus, bronchus, stomach (30-fold increased incidence), duodenum\n$\\diamond$ Up to $4 \\%$ of patients with carcinoid have MEN\n7. Lipoma\n\nMean age: $3^{\\text {rd }}-4^{\\text {th }}$ decade; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$\n\n- usually asymptomatic\n- multiple facial angiofibromas (in $85-90 \\%$ of MEN 1 patients)\n\nMay be associated with:\nthyroid tumor (20\\%), thymoma, buccal mucosal tumor, colonic polyposis, Ménétrier disease\nScreening population: <35-year old patient with HPT, $\\geq 2$ endocrine organ tumors, 1stdegree relative of MEN 1 patient\nImaging surveillance:\nrenal US + abdominal radiograph for abdominal calculi; abdominal MR for islet cell + adrenal tumors + liver mets; pituitary MR for adenoma (every 3 years)\n$\\sqrt{ }$ typically multiple microadenomas + nonfunctioning pancreatic endocrine tumors throughout pancreas\n$\\sqrt{ }$ also often functioning tumor, most commonly gastrinoma (in $60 \\%$ ) / insulinoma (in 30\\%)\nPrognosis: premature death from neoplasia (likely due to metachronous multiplicity of pancreatic tumors)\n\n# MEN 2 Syndrome \n\n$=$ SIPPLE DISEASE $=$ MEN TYPE 2A\n[John H. Sipple (1930-), internist at SUNY in Syracuse]\n$=$ autosomal dominant cancer syndrome\nCause: genetic defect on chromosome 10\nOrgan involvement (PaMPhe):\n\n1. Parathyroid hyperplasia / neoplasia in multiple glands\n\n- $\\pm$ hyperparathyroidism (later onset than in MEN 1)\n\n2. Medullary carcinoma of thyroid (almost $100 \\%$ )\n\n- serum calcitonin commonly elevated\n\n3. Pheochromocytoma (50\\%): bilateral in 50\\%; malignant in 3\\% diagnosed before (in $10 \\%$ ) / after detection (in $17 \\%$ ) of medullary thyroid carcinoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 451,
            "markdown": "May be associated with: carcinoid tumors, Cushing disease\nScreening population: all patients with medullary thyroid cancer / pheochromocytoma, 1stdegree relative of MEN 2 patient\nImaging surveillance: abdominal MR for pheochromocytoma (every 3 years); MIBG scintigraphy (optional)\n\n# MEN 3 Syndrome \n\n$=$ MUCOSAL NEUROMA SYNDROME $=$ MEN TYPE 2B\nCause: genetic defect on chromosome 10\nOrgan involvement (MPheG):\n\n1. Medullary carcinoma of thyroid\n2. Pheochromocytoma\n3. Intestinal ganglioneuromatosis $=$ mucosal neuroma $=$ oral + intestinal neuroganglioneuromatosis\n$\\diamond$ Mucosal neuromas are PATHOGNOMONIC\n$\\diamond$ Usually precede the appearance of thyroid carcinoma + pheochromocytoma!\n\n- long slender extremities (marfanoid appearance)\n- thickened lips $\\leftarrow$ submucosal nodules\n- nodular deformity of tongue (mucosal neuromas of tongue often initially diagnosed by dentists)\n- corneal limbus thickening; prognathism\n- constipation alternating with diarrhea\n@ GI tract\n$\\sqrt{ }$ thickened / plaquelike colonic wall\n$\\sqrt{ }$ chronic megacolon $=$ dilated colon with abnormal haustral markings\n$\\sqrt{ }$ alternating areas of colonic spasm + dilatation (rarely associated with Hirschsprung disease)\n$\\sqrt{ }$ multiple submucosal neuromas throughout small bowel, may act as lead point for intussusception\n\n\n## NESIDIOBLASTOSIS\n\n$=$ PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY = CONGENITAL HYPERINSULINISM $=$ ADENOMATOUS ISLET CELL HYPERPLASIA $=$ MICROADENOMATOSIS\n$=$ tumorlike disorder characterized by proliferation of hyperfunctioning $\\beta$ cells distributed diffusely throughout pancreas or forming a focal mass\nPrevalence: $1 \\div 30,000$ to $1 \\div 50,000$, higher in Ashkenazi Jewish and Saudi Arabian populations Age: first few hours of life to $>1$ year\nPath:\n(a) diffuse adenomatosis (66-75\\%)\n$=$ nontumoral widespread increase in islet cells\nCause: genetic abnormality\n(b) focal adenomatous hyperplasia $=$ nesidioblastoma\n\n- elevated serum insulin $\\leftarrow$ unregulated release of insulin\n- severe persistent hypoglycemia (often resistent to diazoxide / somatostatin analog therapy)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 452,
            "markdown": "DDx of transient causes of hyperinsulinemic hypoglycemia:\nmaternal diabetes, Beckwith-Wiedemann syndrome\n$\\sqrt{ }$ no imaging abnormalities\n$\\sqrt{ }$ enlarged hyperechoic pancreas\n\n# NODULAR REGENERATIVE HYPERPLASIA \n\n$=$ uncommon benign liver disease defined as diffuse nodularity produced by multiple regenerating nodules surrounded by atrophic liver in the absence of fibrosis\n$\\diamond$ Difficult to diagnose at imaging $\\leftarrow$ variable nonspecific findings + similarity to other hepatocellular lesions!\nAssociated with: Budd-Chiari syndrome, collagen vascular disease, myelo- and lymphoproliferative syndrome, autoimmune disease, immunosuppressive + antineoplastic drugs\nCause: pulmonary hypertension, right-sided heart failure, passive hepatic congestion, progressive hepatic venous occlusion\nPathogenesis: increased resistance to sinusoidal blood flow $\\rightarrow$ portal hypertension $\\rightarrow$ decrease in portal venous inflow $\\rightarrow$ prolonged exposure to blood-borne hepatopoietins $\\rightarrow$ stimulation of nodular hepatocellular regeneration\nPath: lesions resemble FNH containing Kupffer cells surrounded by acinar atrophy without fibrosis\n\n- asymptomatic $(50 \\%)$\n- symptoms of portal hypertension (50\\%): esophagogastric varices, ascites, splenomegaly\n\nSize of nodules: $1-40 \\mathrm{~mm}$\nUS:\n$\\sqrt{ }$ well-circumscribed homogeneous hypo- / hyperechoic nodule, if visible at all\nCT:\n$\\sqrt{ }$ hypo- (typically) or isoattenuating nodules\n$\\sqrt{ }$ typically no enhancement / diffuse mild enhancement\n$\\sqrt{ }$ heterogeneous hepatic parenchyma\nMR:\n$\\sqrt{ }$ hypo- to iso- to hyperintense on T1WI\n$\\sqrt{ }$ iso- to minimally hypointense on T2WI (= difficult to visualize!)\n$\\sqrt{ } \\pm \\downarrow$ SI on fat-suppressed T1WI $\\leftarrow$ intracellular fat\nCEMR:\n(a) arterial phase:\n$\\sqrt{ }$ decreased enhancement relative to pancreas\n$\\sqrt{ }$ multiple small similar-sized enhancing nodules\n(b) portal venous + equilibrium phase:\n$\\sqrt{ }$ fading to isointensity\n$D D x: \\quad$ HCC rapidly washes out to hypointensity\n(b) delayed phase:\n$\\sqrt{ }$ progressive enhancement\n$\\sqrt{ }$ hyper- / isointense on 1-hour delayed images after gadobenate dimeglumine $=\\mathrm{Gd}$ BenzylOxyPropionic-TetraAcetate (Gd-BOPTA = MultiHance ${ }^{\\circledR}$ ) similar to FNH",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 453,
            "markdown": "# PANCREAS DIVISUM \n\n$=$ most common congenital anomaly of pancreatic ductal system\nCause: failure of fusion of ventral + dorsal anlage at $7^{\\text {th }}$ week of fetal life\n> ventral duct (of Wirsüng) drains ventral anlage only into major papilla corresponding to head and uncinate process\n> majority of gland empties into minor papilla via dominant dorsal duct (of Santorini) $\\pm$ focal dilatation of terminal duct segment (= santorinicele) $\\leftarrow$ relative obstruction\nVariations:\n(a) no communication between ventral + dorsal duct\n(b) incomplete divisum = filamentous communication between ducts (dominant dorsal duct syndrome)\n(c) complete absence of ventral duct\n![img-63.jpeg](img-63.jpeg)\n\nPrevalence: $4-14 \\%$ in autopsy series; $3-8 \\%$ in ERCP series; $5-10 \\%$ on MRCPs of normal population; $12-50 \\%$ in patients with idiopathic recurrent pancreatitis during childhood; in $15-20 \\%$ of unexplained acute pancreatitis\nMay be associated with: stenosis of main duct at minor papilla\nHypothesis: relative / actual functional stenosis of minor papilla $\\rightarrow$ obstruction to pancreatic exocrine secretory flow $\\rightarrow$ predisposes to nonalcoholic recurrent pancreatitis in dorsal segment\nAge: young / middle-aged adult; $\\mathrm{M}<\\mathrm{F}$\nClinically:\npancreas divisum should be suspected in young / middle-aged adult who presents with recurrent acute pancreatitis / relapsing chronic pancreatitis without any other obvious cause (like gallstones / alcohol consumption)\n\n- usually asymptomatic\n- chronic abdominal pain and acute idiopathic / chronic relapsing pancreatitis (in only 5-10\\% = clinical relevance of pancreas divisum continues to be debated!)\n$\\checkmark$ \"dominant dorsal duct\" sign = larger dorsal duct relative to smaller ventral duct\n$\\checkmark$ continuity of large dorsal pancreatic duct with duct of Santorini draining through minor (accessory) papilla (located 2 cm superior to major papilla)\n$\\checkmark$ small ventral pancreatic duct (of Wirsüng) drains a portion of pancreatic head including the uncinate process through major papilla after joining with CBD",
            "images": [
                {
                    "id": "img-63.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 710,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1146,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 454,
            "markdown": "US:\n$\\sqrt{ }$ bulky hypoechoic pancreas + peripancreatic inflammation / pseudocyst formation\nEndoscopic US ( $95 \\%$ sensitive, $97 \\%$ specific, $99 \\%$ NPV):\n$\\sqrt{ }$ absence of \"stack sign\" (= visualization of bile duct and pancreatic duct running parallel through pancreatic head)\nERCP (Retrograde Endoscopic Pancreatography): DIAGNOSTIC\n$\\sqrt{ }$ contrast injection into major papilla shows CBD + short narrow ventral pancreatic duct with early arborization and at times highly atretic\n$\\sqrt{ }$ contrast injection into minor papilla fills dominant dorsal pancreatic duct of larger caliber\n$\\sqrt{ }$ no communication between ventral + dorsal ducts\nCx: ERCP-induced pancreatitis ( $5 \\%$ risk)\nCT ( $90 \\%$ sensitive, $98 \\%$ specific, $98 \\%$ NPV):\n$\\sqrt{ }$ oblique fat cleft between ventral + dorsal pancreas ( $25 \\%$ )\n$\\sqrt{ }$ failure to see union of dorsal + ventral pancreatic ducts (rare)\nMRCP (with secretin stimulation $73-100 \\%$ sensitive, $97-100 \\%$ specific):\n$\\sqrt{ }$ noninvasive multiplanar visualization of pancreatic duct:\n$\\sqrt{ }$ visualization of main pancreatic (dorsal) duct coursing anterior to CBD before draining into duodenum\n$\\sqrt{ }$ usually prominent dorsal duct with depiction of relative functional duct obstruction\n$\\sqrt{ }$ findings of acute pancreatitis: bulky pancreas, pancreatic necrosis, peripancreatic inflammation, pseudocysts\n$\\sqrt{ }$ findings of chronic pancreatitis: significant atrophy of ventral duct and dilatation of dorsal duct\nDx: by ERCP\nRx: surgical / endoscopic minor papillotomy / sphincterotomy; insertion of stent into minor papilla\n\n# PANCREATIC ACINAR CELL CARCINOMA \n\n$=$ rare neoplasm of exocrine origin\nFrequency: $1-2 \\%$ of pancreatic exocrine tumors\nMean age: 62 (range, 40-81) years; $\\mathrm{M}+\\mathrm{F}=86 \\div 14 ; 87 \\%$ Caucasian; more common than ductal cell adenocarcinoma in pediatric age group\nPath: similar to pancreatoblastoma (= embryonic counterpart)\n\n- biliary obstruction distinctly uncommon\n- increased serum lipase $\\pm$ amylase\n- lipase hypersecretion syndrome (paraneoplastic syndrome):\n$=$ disseminated subcutaneous + intraosseous fat necrosis (usually distal to knees / elbows)\nPrevalence: $4-16 \\%$ of adult patients\nCause: systemic release of tumor-elaborated lipase\n- peripheral polyarthropathy; bone infarcts\n- painful subcutaneous nodules of fat necrosis resembling erythema nodosum\n\nLocation: anywhere in pancreas; frequently exophytic\nSize: 10 (range, $2-30$ ) cm\n$\\sqrt{ }$ soft lobulated well-defined heterogeneous mass",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 455,
            "markdown": "$\\sqrt{ }$ partial / complete thin enhancing capsule\n$\\sqrt{ }$ tumor necrosis usually present\n$\\sqrt{ }$ punctate / chunky peripheral / central tumor calcifications (33-50\\%)\n$\\sqrt{ }$ enhancement less than normal pancreas (greater than ductal adenocarcinomas + less than islet cell tumors)\n$\\sqrt{ }$ moderately vascular tumor + neovascularity + arterial and venous encasement\nPrognosis: median survival of 7-9 months; 57\\% (26\\%) [6\\%] 1-year (3-year) [5-year] survival, slightly better than for ductal adenocarcinoma\n$D D x$ : (1) pancreatic adenocarcinoma (small, irregular, locally invasive, without capsule, biliary obstruction if located in head of pancreas)\n(2) Nonfunctioning islet-cell tumor\n(3) Microcystic cystadenoma\n(4) Solid-pseudopapillary tumor\n(5) Oncocytic tumor of pancreas\n(6) Pancreatoblastoma (in children $<10$ years)\n\n# PANCREATIC DUCTAL ADENOCARCINOMA \n\n$=$ DUCT CELL ADENOCARCINOMA = PANCREATIC ADENOCARCINOMA\n$\\diamond$ Duct cells comprise only $4 \\%$ of pancreatic tissue but $85-95 \\%$ of malignant tumors of pancreas!\nIncidence: $12 \\div 100,000$ / year (in USA 43,920 new diagnoses in 2012 and 36,800 deaths $=4^{\\text {th }}$ leading cause of cancer deaths $+2^{\\text {nd }}$ most common cause (after colorectal cancer) of GI cancer-related deaths\nCause: alcohol abuse ( $4 \\%$ ), diabetes ( 2 x more frequent than in general population, particularly in females), cigarette smoking (risk factor 2 x )\nGenetic risk: hereditary pancreatitis (in 40\\%), hereditary pancreatic cancer syndrome, hereditary nonpolyposis colon carcinoma, Peutz-Jeghers syndrome, familial atypical multiple mole melanoma, BRCA2\nPath: scirrhous infiltrative adenocarcinoma with a dense cellularity + sparse vascularity\nPeak age: $7^{\\text {th }}$ (range, $4^{\\text {th }}-8^{\\text {th }}$ ) decade; $\\mathrm{M}+\\mathrm{F}=2+1$; extremely rare in children\nStage: $\\quad \\mathrm{I}=$ confined to pancreas\nII $=+$ regional lymph node metastases\nIII $=+$ distant spread\n$\\diamond$ At presentation:\n$>65 \\%$ of patients have advanced local disease / distant metastases\n$>21 \\%$ of patients have localized disease with spread to regional lymph nodes\n$>14 \\%$ of patients have tumor confined to pancreas\nGrowth: aggressive early infiltrative $\\rightarrow$ obstruction of pancreatic duct / common bile duct $\\rightarrow$ invasion of adjacent vessels\n\n## Extension:\n\n(a) local extension beyond margins of organ (68\\%): posteriorly (96\\%), anteriorly (30\\%), into porta hepatis ( $15 \\%$ ), into splenic hilum ( $13 \\%$ )\n(b) invasion of adjacent organs ( $42 \\%$ ):\nduodenum $>$ stomach $>$ left adrenal gland $>$ spleen $>$ root of small bowel mesentery",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 456,
            "markdown": "(c) local lymph node spread:\npancreaticosplenic nodes accompanying splenic artery, pancreaticoduodenal nodes, superior mesenteric preaortic nodes\nMetastases: liver (30-36\\%), regional lymph nodes $>2 \\mathrm{~cm}(15-28 \\%)$, ascites from peritoneal carcinomatosis ( $7-10 \\%$ ), lung (pulmonary nodules / lymphangitic), pleura, bone\n\n- weight loss, anorexia, fatigue, steatorrhea, hyperamylasemia\n- pain in hypochondrium radiating to back\n- obstructive jaundice ( $75 \\%$ ):\n$\\diamond$ Most frequent cause of malignant biliary obstruction!\n- painless jaundice ( $25 \\%$ )\n- acute onset diabetes ( $25-50 \\%$ )\n- spontaneous vein thrombosis (Trousseau syndrome)\n\nLocation: pancreatic head / neck / uncinate process ( $60-70 \\%$ ); pancreatic body ( $10-20 \\%$ ); pancreatic tail ( $5-10 \\%$ ); diffuse pancreatic involvement (5\\%)\n\nAverage size: $2-10 \\mathrm{~cm}$ (in $60 \\%$ between 4 and 6 cm )\nin pancreatic head: $2.5-3 \\mathrm{~cm}$\nin pancreatic body + tail: $5-7 \\mathrm{~cm}$\n$\\sqrt{ }$ poorly vascularized predominantly solid soft-tissue lesion\n$\\sqrt{ }$ delayed enhancement $\\leftarrow$ contrast material seeps gradually into tumor interstitium\n$\\sqrt{ }$ cystlike features $(8 \\%) \\leftarrow$ cystic degeneration, retention cysts, attached pseudocysts\nBarium:\nUGI:\n$\\sqrt{ }$ \"antral pad\" sign = extrinsic indentation of posteroinferior margin of antrum\n$\\sqrt{ }$ \"Frostberg inverted-3\" sign = inverted 3 contour to medial portion of the duodenal sweep\n$\\sqrt{ }$ spiculated duodenal wall + traction + fixation ( $=$ neoplastic infiltration of duodenal mucosa / desmoplastic response)\n$\\sqrt{ }$ irregular / smooth nodular mass with ampullary cancer\n$\\sqrt{ }$ diffuse tethering throughout peritoneal cavity $\\leftarrow$ intraperitoneal seeding\nBE:\n$\\sqrt{ }$ localized haustral padding / flattening / narrowing with serrated contour at inferior aspect of transverse colon / splenic flexure\nCT ( $90 \\%$ accurate for tumor detection, $89-100 \\%$ PPV for unresectability, $45-79 \\%$ NPV for resectability):\n$\\sqrt{ }$ hypoattenuating lesion best depicted during arterial phase (in $10 \\%$ nonvisualized isoattenuating tumor)\n$\\sqrt{ }$ pancreatic mass ( $95 \\%$ ) / diffuse enlargement (4\\%) / normal scan (1\\%)\n$\\sqrt{ }$ mass with central zone of diminished attenuation ( $75-83 \\%$ )\n$\\sqrt{ }$ cystic-necrotic degeneration ( $8 \\%$ )\n$\\sqrt{ }$ postobstructive pseudocyst ( $11 \\%$ )\n$\\sqrt{ }$ calcifications ( $2 \\%$ )\n$\\sqrt{ }$ indirect signs:\n$\\sqrt{ }$ atrophy of pancreatic body + tail ( $20 \\%$ )\n$\\sqrt{ }$ convex deformity of pancreatic contour",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 457,
            "markdown": "$\\sqrt{ } \\begin{aligned} & \\text { duct dilatation }(58 \\%): \\\\ & \\sqrt{ } 75 \\% \\text { biductal with pancreatic }+ \\text { bile duct obstruction }=\\text { \"double-duct\" sign of mass in }\\end{aligned}$ head of pancreas\n$\\sqrt{ } 10 \\%$ isolated to one duct:\n$\\sqrt{ }$ dilated pancreatic duct $(67 \\%)$\n$\\sqrt{ }$ dilated bile ducts $(38 \\%)$\n$\\sqrt{ }$ signs of invasion:\n$\\sqrt{ }$ obliteration of peripancreatic fat $(50 \\%)=$ pancreas lacks a capsule\n$\\sqrt{ }$ thickening of Gerota fascia (5\\%)\n$\\sqrt{ }$ local tumor extension posteriorly into splenic hilum and porta hepatis (68\\%)\n$\\sqrt{ }$ contiguous organ invasion (of duodenum, stomach, mesenteric root) in $42 \\%$\n$\\sqrt{ }$ hepatic metastases ( $75 \\%$ sensitive)\nCECT (arterial + portal phases):\n$\\sqrt{ }$ nondepicted isoattenuating pancreatic primary and metastasis (in 10\\%)\n$\\sqrt{ }$ portal phase imaging (optimal) for detecting metastatic disease to liver and for assessing peripancreatic veins\n$\\sqrt{ }$ vascular invasion:\n$\\sqrt{ }$ thickening of celiac axis / SMA $\\leftarrow$ invasion of perivascular lymphatics (in $60 \\%$ )\n$\\sqrt{ }$ dilated collateral veins $(12 \\%)$\n$\\sqrt{ }$ high probability of unresectability if circumferential contiguity of tumor to vessel $>50 \\%$ $(84 \\%$ sensitive, $98 \\%$ specific)\n$\\sqrt{ }$ deformity / thrombosis of vessel = \"teardrop\" sign of SMV on axial image\nUS:\n$\\sqrt{ }$ hypoechoic pancreatic mass\n$\\sqrt{ }$ focal / diffuse ( $10 \\%$ ) enlargement of pancreas\n$\\sqrt{ }$ contour deformity of gland; rounding of uncinate process\n$\\sqrt{ }$ dilatation of pancreatic $\\pm$ biliary duct\nEndoscopic US:\n$\\sqrt{ }$ may detect tumors of $2-3 \\mathrm{~mm}$ in diameter\n$\\sqrt{ }$ suitable for biopsy of suspect lesions\nMR ( $81 \\%$ sensitive):\n$\\sqrt{ }$ hypointense tumor on fat-suppressed T1WI $\\leftarrow$ scirrhous fibrotic nature\n$\\sqrt{ }$ iso- to minimally hypointense tumor on T2WI\n$\\sqrt{ }$ abnormally low SI of pancreatic tail + body on T1WI reducing the contrast relative to focal cancer $\\leftarrow$ atrophy / secondary chronic pancreatitis\n$\\sqrt{ }$ complex cystic areas within / adjacent to primary $\\leftarrow$ adjacent pseudocysts, internal tumor necrosis, or side-branch ductal obstruction\nCEMR:\n(superior to CT in detecting small tumors + metastases)\n$\\sqrt{ }$ tumor hypointense compared to gland\n$\\sqrt{ }$ thin peritumoral rim of greater enhancement\nMRCP:\nIndication: non-contour-deforming pancreatic mass suspected on CT; small mass of $<2 \\mathrm{~cm}$;",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 458,
            "markdown": "hepatic, peritoneal, omental metastases\n$\\sqrt{ }$ \"double duct\" sign = abrupt termination of CBD + main pancreatic duct by mass with upstream ductal dilatation\nCEMR:\n$\\sqrt{ }$ hypovascular lesion during arterial + pancreatic parenchymal phase $\\leftarrow$ desmoplastic fibrotic component\n$\\sqrt{ }$ progressive enhancement in portal venous + delayed phase $\\leftarrow$ desmoplasia with large interstitial spaces\n$\\sqrt{ }$ thin peritumoral rim of enhancement\n$\\sqrt{ }$ delayed enhancement of obstructed portion of pancreas\nPET ( $85-93 \\%$ accurate, $46-71 \\%$ sensitive, $63-100 \\%$ specific):\n$\\sqrt{ }$ intense focal FDG uptake (\"hot spot\") dependent on tumor biology + degree of desmoplastic response\n$\\sqrt{ }$ superior detection of small metastases\nPostop: wait $>6$ weeks after surgery to differentiate uptake from postoperative inflammation\nPET/CT: improves staging specificity in nonspecific or borderline lymph node enlargement seen on CT; better sensitivity ( $83 \\%-86 \\%$ ) for tumor depiction in euglycemic patients than in those with elevated glucose levels $(42 \\%-69 \\%)$\n$\\sqrt{ }$ may depict $<2 \\mathrm{~cm}$ small / isoattenuating lesions that are difficult to detect at CT\n$\\sqrt{ }$ SUV threshold of $\\geq 2.0$ ( $100 \\%$ sensitive, $76-77 \\%$ specific)\n$\\sqrt{ }$ SUV threshold of $\\geq 4.0$ (1.00 PPV, 0.94 NPV)\n$D D x$ : mass-forming pancreatitis\nAngiography ( $70 \\%$ accuracy):\n$\\sqrt{ }$ hypovascular tumor / neovascularity ( $50 \\%$ )\n$\\sqrt{ }$ arterial encasement: SMA (33\\%), splenic artery (14\\%), celiac trunk (11\\%), hepatic artery $(11 \\%)$, gastroduodenal artery ( $3 \\%$ ), left renal artery $(0.6 \\%)$\n$\\sqrt{ }$ venous obstruction: splenic vein (34\\%), SMV (10\\%)\n$\\sqrt{ }$ venous encasement: SMV (23\\%), splenic vein (15\\%), portal vein (4\\%)\nCholangiography:\n$\\sqrt{ }$ \"rat tail / nipplelike\" occlusion of CBD\n$\\sqrt{ }$ nodular mass / meniscuslike occlusion in ampullary tumors\n$\\sqrt{ }$ \"double duct\" sign = abrupt obstruction of common bile duct + pancreatic duct\nPancreatography (abnormal in 97\\%):\n$\\sqrt{ }$ abrupt obstruction of main pancreatic duct $\\leftarrow$ tumor starts in ductal epithelium producing early obstruction:\n$\\sqrt{ }$ irregular, nodular, rat-tailed, eccentric obstruction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 459,
            "markdown": "| Criteria of Resectability of Pancreatic Adenocarcinoma <br> $89-100 \\%$ positive predictive value of CT |  |\n| :-- | :--: |\n| Unresectable |  |\n| $\\sqrt{ }$ distant metastases |  |\n| $\\sqrt{ }$ SMA encasement $>180^{\\circ}$ of vessel circumference |  |\n| $\\sqrt{ }$ tumor abutment of celiac axis |  |\n| $\\sqrt{ }$ unreconstructable occlusion of SMV / portal vein |  |\n| $\\sqrt{ }$ invasion of aorta / aortic encasement |  |\n| Borderline resectable |  |\n| $\\sqrt{ }$ impingement / narrowing of SMV / portal vein |  |\n| $\\sqrt{ }$ short-segment venous occlusion allowing reconstruction |  |\n| $\\sqrt{ }$ encasement of gastroduodenal artery up to hepatic artery |  |\n| $\\sqrt{ }$ tumor abutment of SMA $\\leq 180^{\\circ}$ of vessel circumference |  |\n\n$\\sqrt{ }$ localized encasement with prestenotic upstream dilatation\n$\\sqrt{ }$ acinar defect\nPrognosis:\n$<20 \\%(2 \\%)$ [<5\\%] 1-year (3-year) [5-year] survival; 14 months ( 8 months) medial survival after curative (palliative) resection; 5 months without treatment; tumors resectable in only 8$25 \\%$ at presentation; $5-20 \\% 5$-year postoperative survival rate\nSurvival rate versus tumor size:\n$100 \\% 5$-year survival rate for tumors $<1 \\mathrm{~cm}$ without parenchymal / vascular / lymphatic invasion; $30 \\%$ for tumors $<2 \\mathrm{~cm}$\n$R x: \\quad<10-20 \\%$ are deemed surgically resectable; palliative chemoradiation\n$D x$ : biopsy with endoscopic US guidance / percutaneous (often preferred) CT-guided biopsy\n$D D x$ : focal pancreatitis, islet cell carcinoma, metastasis, lymphoma, normal variant\n\n# PANCREATIC ENDOCRINE TUMOR \n\n$=$ PET $=$ PANCREATIC NEUROENDOCRINE TUMOR $=$ PANCREATIC ISLET CELL TUMOR\n$=$ predominantly well-differentiated pancreatic / peripancreatic tumor that demonstrates endocrine differentiation\nOrigin: pluripotential stem cells in ductal epithelium; previously thought to originate from islet of Langerhans; derivatives of APUD (amine precursor uptake and decarboxylation) cell line (APUDoma)\n$\\diamond$ The term islet cell tumor is no longer acceptable because a pancreatic endocrine tumor arises from ductal pluripotent stem cells, rather than from islets of Langerhans\nGenetics: sporadic (mostly), familial syndrome (1-2\\%) with genetic alterations involving MEN1, VHL, NF1, TSC1, TSC2 genes\nMay be associated with:\nMEN 1 (= Wermer syndrome), von Hippel-Lindau syndrome, neurofibromatosis type 1, tuberous sclerosis\n$\\diamond$ Often multiple tumors that manifest at an earlier age!\nPrevalence: $1-5 \\div 100,000$ population; $1-2 \\%$ of all pancreatic neoplasms\nMean age: 47 (range, $7-83$ ) years; 25 years for MEN 1; M=F",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 460,
            "markdown": "Path: (a) small tumor: solid well-demarcated, unencapsulated\n$\\diamond<5 \\mathrm{~mm}=$ microadenoma (only microscopically identifiable) in $10 \\%$ of autopsied population\n(b) large tumor: cystic changes + necrosis + calcifications with often incomplete fibrous pseudocapsule\n> well differentiated benign endocrine tumor\n> well differentiated endocrine carcinoma\n> poorly differentiated endocrine carcinoma ( $2-3 \\%$ )\n$\\diamond$ Small tumors tend to be homogeneous, whereas large tumors are more commonly heterogeneous $\\leftarrow$ areas of cystic change, necrosis, and calcification\nHisto: sheets of uniform polygonal cells resembling normal islet cells with round / oval nuclei that have stippled, salt-and-pepper chromatin + eosinophilic granular cytoplasm + numerous stromal vessels\n(a) trabecular pattern $\\pm$ gyriform arrangement\n(b) acinar / glandular pattern\n(c) medullary / solid pattern\n(d) cystic\n(e) papillary\n(f) angiomatoid\n$\\diamond$ Endocrine differentiation confirmed with Grimelius silver stain / immunohistochemical labeling for chromogranin / synaptophysin\nCategories: size, mitotic rate, cell proliferation, invasion (Ki-67 index)\nIn order of frequency: insulinoma ( $50 \\%$ ) > gastrinoma ( $20 \\%$ ) > glucagonoma > VIPoma > somatostatinoma\nAverage time from onset of symptoms to diagnosis: 2.7 years\nClassification:\n(a) SYNDROMIC (functioning) pancreatic endocrine tumor ( $<50 \\%$ ):\n$\\diamond$ Tumor small at presentation (early symptoms)!\n$\\diamond$ Most syndromic tumors produce multiple hormones!\n$\\diamond$ Named after the predominantly secreted hormone!\n(b) NONSYNDROMIC pancreatic endocrine tumor\n\nLocation: gastrinoma triangle (most common)\nMetastases: in $60-90 \\%$ to liver $\\pm$ regional lymph nodes\n$\\diamond$ Liver metastasis are often hypervascular with ringlike enhancement during arterial phase (similar to primary)\n$\\diamond$ A hyperechoic liver metastasis is suggestive of pancreatic endocrine tumor rather than pancreatic adenocarcinoma!\nPurpose of imaging:\n(1) Localisation of known functioning PET\n$\\diamond$ To avoid the risk of negative laparotomy use CT / MR with their high sensitivity to localize the $4 \\%$ of tumors missed by intraoperative palpation + intraoperative US\n(2) Diagnosis of nonfunctioning pancreatic endocrine tumor\n(3) Surgical planning (location, number, spread of tumors)\n\n- unlikely to cause ampullary / ductal obstruction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 461,
            "markdown": "Size: mostly $1-5$ (range, $<1 \\mathrm{~cm}$ to $>20$ ) cm in diameter\n$\\diamond$ A tumor $>3 \\mathrm{~cm}$ in diameter with calcifications suggests malignancy!\n$\\sqrt{ }$ round / ovoid tumor:\n$\\sqrt{ }$ small homogeneous lesion\n$\\sqrt{ }$ large heterogeneously enhancing lesion $\\leftarrow$ cystic degeneration, necrosis, fibrosis, calcification\n$\\sqrt{ }$ marked enhancement on delayed images $\\leftarrow$ large interstitial space with loose edematous stroma + abundant blood vessels\n$\\sqrt{ }$ NO vascular encasement / duct obstruction\nUS:\n(a) transabdominal US ( $70 \\%$ sensitive)\n(b) endoscopic US ( $\\sim 95 \\%$ sensitive, $93 \\%$ specific), less sensitive for distal pancreatic body + tail\n(c) intraoperative US (combined with palpation by surgeon)\n$\\sqrt{ }$ round / ovoid mass with smooth margin $\\pm$ hyperechoic rim:\n$\\sqrt{ }$ homogeneous / heterogeneous hypoechoic\n$\\sqrt{ }$ hypervascular pattern\n$\\sqrt{ } \\pm$ enlarged peripancreatic lymph nodes\n$\\sqrt{ } \\pm$ mostly hyperechoic (occasionally hypoechoic / targetlike) liver metastases\nCT ( $71-82 \\%$ sensitive):\nMethod: high resolution + dual phase + distension of stomach and duodenum with water; MPR\n$\\diamond$ Syndromic tumors often small ( $<20 \\mathrm{~mm}$ ) + multiple and difficult to detect\n$\\sqrt{ }$ isoattenuating circumscribed solid mass:\n$\\sqrt{ }$ tendency to displace surrounding structures\n$\\sqrt{ }$ hypoattenuating partially / completely cystic PET (in 18\\%)\nCECT:\n$\\diamond$ Early imaging is ESSENTIAL for detection of small tumor:\n$\\sqrt{ }$ avid enhancement during arterial phase ( $85 \\%$ sensitive) $\\leftarrow$ hypervascularity $\\leftarrow$ rich capillary network\n$\\sqrt{ }$ late arterial (pancreatic phase) images ( $100 \\%$ sensitive)\n$\\sqrt{ }$ tumor conspicuity decreases during portal venous phase ( $11-76 \\%$ sensitive)\n$\\sqrt{ }$ hypervascular rim (in $90 \\%$ ) of cystic endocrine tumor\n$F N$ : tumor in close proximity to a vessel is easily missed\n$\\sqrt{ }$ lymph nodes + liver metastases most conspicuous during arterial phase $\\leftarrow$ hypervascularity:\n$\\sqrt{ }$ hepatic metastases often with ringlike enhancement\nMR ( $75 \\%$ sensitive):\nT1WI:\n$\\sqrt{ }$ round / oval circumscribed relatively hypointense mass with / without fat saturation T2WI:\n$\\sqrt{ }$ mostly much higher SI compared to normal pancreas\n$\\sqrt{ }$ may be of intermediate / (less commonly) low signal intensity $\\leftarrow$ substantial amounts of collagen",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 462,
            "markdown": "# CEMR: \n\n$\\sqrt{ }$ intense enhancement during arterial + capillary phase\n$\\sqrt{ }$ homogeneous / ringlike / heterogeneous enhancement\n$\\sqrt{ }$ T1-hypointense + T2-hyperintense liver metastases (best seen on T2WI with fat suppression):\n$\\sqrt{ }$ moderate to intense early ringlike enhancement\n$\\sqrt{ }$ prominent enhancement of lymph node metastases\nNUC ( $70-90 \\%$ sensitive, only $50 \\%$ sensitive for gastrinomas and insulinomas):\nUseful for: localization of known functioning tumor, DDx of pancreatic mass, evaluation for metastases / recurrence, assessment of receptor status\nSomatostatin receptor scintigraphy with ${ }^{111}$ In-octreotide:\n$\\sqrt{ }$ sensitivity highest for gastrinoma $>2 \\mathrm{~cm}+$ lowest for primary insulinoma\n$\\sqrt{ }$ whole-body scintigraphy detects tumors $>10 \\mathrm{~mm}$ in size\n$\\sqrt{ }$ predicts which patients will respond to radionuclide Rx\n$\\sqrt{ }$ monitors response to therapy\nPET:\n$\\sqrt{ }$ uptake in poorly differentiated pancreatic endocrine tumor\nAngio:\n$\\sqrt{ }$ intense vascular stain in late arterial + capillary phase\nHepatic vein sampling ( $88 \\%$ sensitive):\n$\\diamond$ performed together with pancreatic angiography\n$\\sqrt{ }$ rise in venous hormone concentration after selective injection of secretagogue (eg, calcium) into arteries supplying the pancreas\nPrognosis: $82 \\%$ (56\\%) 3-year survival rate without (with) hepatic metastases; 50-65\\% 5-year survival rate $\\diamond$ Risk of malignancy increases with tumors $>5 \\mathrm{~cm}$\nThe most reliable indicators of malignancy and poor prognosis are extrapancreatic invasion and metastatic disease defining a well-differentiated tumor as endocrine carcinoma.\n$R x$ : enucleation, partial pancreatectomy, antihormone Rx, chemo- / radionuclide therapy, chemoembolization\n$D D x$ : (1) Pancreatic ductal adenocarcinoma (hypovascular, rarely calcified, encasement of SMA + celiac trunk, common ductal involvement, rare central necrosis + cystic degeneration)\n(2) Microcystic adenoma (benign tumor, small cysts, older woman)\n(3) Metastatic tumor: renal cell carcinoma (clinical Hx)\n(4) Solid-pseudopapillary tumor of pancreas (young female, hemorrhagic areas)\n(5) Paraganglioma\n(6) Sarcoma (rare)\n\n## ACTH-producing Tumor\n\n$=$ CORTICOTROPHINOMA\n$=$ rare cause of Cushing syndrome\n\n- increased level of serum cortisol\n- impaired glucose tolerance $>$ central obesity $>$ hypertension, oligomenorrhea $>$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 463,
            "markdown": "osteoporosis $>$ purpura $>$ striae $>$ muscle atrophy\nPrognosis: almost all malignant with metastases at time of Dx\n\n# Gastrinoma \n\n$\\diamond 2^{\\text {nd }}$ most common syndromic pancreatic endocrine tumor ( $=50 \\%$ of insulinoma frequency)\nPeak age: $5^{\\text {th }}$ decade; $8 \\%$ in patients $<20$ years; $\\mathrm{M}+\\mathrm{F}=1.3 \\div 1$\nHisto: composed of G cells (in $\\alpha$ cells / $\\delta$ cells)\nGastrinoma symptomatology caused by:\n(a) islet cell hyperplasia ( $10 \\%$ )\n(b) benign adenoma ( $30 \\%$ ): $1 / 2$ solitary, $1 / 2$ multiple (especially in MEN 1 )\n(c) malignancy ( $50-60 \\%$ ) with metastases to liver, spleen, lymph nodes, bone\n\nGenetics: sporadic (usually)\n$\\diamond 20-25 \\%$ of all gastrinomas occur in MEN 1\n$\\diamond$ Most common functioning PET in MEN 1\n\n- Zollinger-Ellison syndrome\n$\\rightarrow$ only $0.1 \\%$ of all cases of peptic ulcer disease!\n- markedly $\\uparrow$ fasting serum levels of gastrin (DIAGNOSTIC): often $>1,000 \\mathrm{pg} / \\mathrm{mL}$ (normal level, $<100 \\mathrm{pg} / \\mathrm{m}$ )\n- positive secretin stimulation test\n\nLocation: usually solitary, multiple (20-40\\%)\nN.B.: previously pancreas was thought to be the most common location, but many have been peripancreatic nodal metastases from a duodenal tumor\n(a) pancreas $(20 \\%)$ : mostly in head\n(b) ectopic:\n> duodenum ( $80 \\%$ of sporadic lesions, $90 \\%$ in MEN1): frequently in gastrinoma triangle; often microadenomas of $1-2 \\mathrm{~mm}$ in size\n> peripancreatic lymph nodes / bile ducts\n> stomach, proximal jejunum\n> omentum, retroperitoneum\n> ovary\n\n## Gastrinoma triangle\n\n$=$ triangle bounded by\n(1) porta hepatis as apex of triangle ( $=$ confluence of cystic duct + common bile duct) superiorly\n(2) junction of $2^{\\text {nd }}$ and $3^{\\text {rd }}$ parts of duodenum inferiorly\n(3) neck and body of pancreas medially (OR border of pancreatic body + tail)\n\nMean size: $3-4 \\mathrm{~cm}$ (up to 15 cm ); in duodenal wall $<1 \\mathrm{~cm}$\n$\\sqrt{ }$ homogeneous ringlike enhancement\n$\\sqrt{ }$ occasionally calcifications\nAngio:\n$\\sqrt{ }$ hypervascular lesion ( $70 \\%$ )\n$\\sqrt{ }$ hepatic venous sampling after intraarterial stimulation with secretin\nEndoscopic US (useful for tumors in duodenal wall and peripancreatic lymph nodes):\n$\\sqrt{ }$ solid hypoechoic mass\nCT:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 464,
            "markdown": "$\\sqrt{ }$ transiently hyperdense on dynamic CT (majority)\nMR:\n$\\checkmark$ low-intensity mass on fat-suppressed T1WI\n$\\checkmark$ diminished central + peripheral ring enhancement\n$\\checkmark$ high-intensity mass on fat-suppressed T2WI\nNUC:\nsomatostatin receptor scintigraphy ( $58-75 \\%$ sensitive) $\\leftarrow$ high concentration of\nsomatostatin receptors\nSpread:\n$\\checkmark$ regional lymph node metastasis (may be mistaken for primary because of large size compared to primary)\n$\\checkmark$ liver metastasis (in $30 \\%$ at time of diagnosis)\nSensitivity of preoperative localization:\n$75-93 \\%$ for ${ }^{111}$ In-pentetreotide imaging, $77 \\%$ for arteriography combined with intraarterial injection of secretin, $42-63 \\%$ for transhepatic portal venous sampling for gastrin, $68-70 \\%$ for selective angiography, $35 \\%$ for CT, $25 \\%$ for US, $20 \\%$ for MR\n$R x$ : surgery curative in $30 \\%$; resection of gastrinoma triangle; medical treatment of Zollinger-Ellison syndrome\n$C x$ : frequently malignant degeneration ( $60 \\%$ ); multiple gastric carcinoid tumors from $\\uparrow$ gastrin level\n\n# Glucagonoma \n\n$\\diamond 3^{\\text {rd }}$ most common syndromic pancreatic endocrine tumor\nIncidence: $1 \\div 20,000,000$ annually (rare)\nAge: $\\quad 40-60$ (range, 19-84) years; $\\mathrm{M}=\\mathrm{F}$\nGenetics: almost always sporadic\nRarely associated with: MEN 1\nHisto: derived from A cells ( $\\alpha$ cells) of pancreatic islets\n\n- 4D (glucagonoma) syndrome\n(1) Diabetes mellitus\n$\\leftarrow$ elevated glucagon counteracting effects of insulin\n- plasma glucagon level $>1,000 \\mathrm{ng} / \\mathrm{L}$ (DIAGNOSTIC)\n(2) Dermatitis\n- necrolytic erythema migrans ( $\\left.{ }^{2} / \\cdot\\right)$\n$=$ painful highly pruritic migrating erythematous macules / papules starting in lower abdomen, groin, genitals spreading to trunk, lower extremity, buttocks, face",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 465,
            "markdown": "| Pancreatic Endocrine Tumors |  |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: | :--: |\n| Type | Frequency | Associated Syndrome | Symptoms | Average Size | Location |\n| Insulinoma | $50 \\%$ | Whipple triad | hypoglycemia, dizziness, vision changes, palpitations | $<2 \\mathrm{~cm}$ | all of pancreas |\n| Gastrinoma | $20 \\%$ | Zollinger-Ellison syndrome | peptic ulcer disease, diarrhea, esophagitis | duodenum: $<1 \\mathrm{~cm}$ pancreas: $3-4 \\mathrm{~cm}$ | duodenum $>$ pancreatic head |\n| Glucagonoma |  | 4D syndrome | necrolytic migratory erythema, diabetes, thromboembolism | $7-8 \\mathrm{~cm}$ | pancreatic tail |\n| Vipoma |  | WDHA syndrome | profuse watery diarrhea, weight loss, hypokalemia | $5-6 \\mathrm{~cm}$ | pancreatic tail |\n| Somatostatinoma |  | Inhibitory syndrome | diabetes, steatorrhea, diarrhea, cholelithiasis | $5-6 \\mathrm{~cm}$ | pancreatic head |\n| Nonfunctioning |  | none | abdominal pain, mass, weight loss | $5-6 \\mathrm{~cm}$ | all of pancreas |\n| Poorly differentiated |  | none / paraneoplastic syndrome | abdominal pain, cachexia, jaundice | 6 cm | pancreatic head |\n\nCause: unknown; ? direct effect of glucagon, prostaglandin release; ? deficiency of amino acids, zinc, vitamin B\n(3) Deep vein thrombosis (rare)\n(4) Depression\n\n- painful glossitis / stomatitis, diarrhea, weight loss, anemia\n- various neurologic + psychiatric symptoms\n- elevated glucagon levels (usually $10-20 \\mathrm{x}$ that of normal)\n- $\\pm$ elevated levels of insulin, serotonin, gastrin\n\nLocation: predominantly in pancreatic body / tail\nMean size: 6.4 (range, $2.5-25.0$ ) cm with solid + necrotic components; in $70 \\%>5 \\mathrm{~cm}$ in size\n$\\sqrt{ }$ hypervascular in $90 \\% \\rightarrow$ angiographic localization successful in $15 \\%$\n$\\sqrt{ }$ hetero- / homogeneous enhancement with areas of decreased attenuation / intensity\n$\\sqrt{ }$ uptake of ${ }^{111}$ In-pentetreotide\n$C x$ : pulmonary thromboembolism\nMalignant transformation (in 60-80\\%):\n$\\sqrt{ } 80 \\%$ chance of malignancy if tumor $>5 \\mathrm{~cm}$ in diameter\n$\\sqrt{ }$ in $50-60 \\%$ liver / lymph node metastases at time of Dx\nPrognosis: $55 \\% 5$-year survival rate; $3 / 4$ ultimately fatal\n\n# Insulinoma \n\n$\\diamond$ Most common ( $40 \\%$ ) of syndromic (functioning) PETs!\nIncidence: $2-4 \\div 1,000,000$ annually\nMean age: 47 years (range, $4^{\\text {th }}-6^{\\text {th }}$ decade); $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1.4$\nGenetics: sporadic (usually)\n$\\diamond 10-30 \\%$ of functioning pancreatic endocrine tumors are insulinomas in MEN 1\nAssociated with: MEN 1, NF1\nInsulinoma symptomatology caused by:\n(a) single benign adenoma ( $80-90 \\%$ )\n(b) multiple adenomas / microadenomatosis ( $2-10 \\%$ )\n(c) diffuse islet cell hyperplasia $=$ nesidioblastosis $(5-10 \\%)$\n(d) malignant adenoma ( $5-10 \\%$ )\nmnemonic: $10 \\%$ are associated with MEN 1",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 466,
            "markdown": "$10 \\%$ are multiple (especially in MEN 1)\n$10 \\%$ have islet cell hyperplasia\n$10 \\%$ are malignant\nHisto: composed of $\\beta$ cells (amyloid with green birefringence + Congo red stain is highly suggestive)\n\n- Whipple triad:\n[Allen Oldfather Whipple (1881-1963), professor of surgery at Columbia University]\n(1) Starvation attack (during fasting / after exercise)\n(2) Relief by IV glucose\n(3) Hypoglycemia (fasting glucose $<50 \\mathrm{mg} / \\mathrm{dL}$ )\n- neuroglycopenic symptoms: dizziness, diplopia, blurred vision, headaches, confusion, personality changes, coma\n- behavorial problems, seizures, coma in young children\n- hypoglycemia exacerbated by fasting ( $98 \\%$ sensitive) $\\rightarrow$ frequent meals to avoid symptoms\n- sweating, palpitations, tremor $\\leftarrow$ catecholamine release in response to hypoglycemia (less common); obesity\n- $\\downarrow$ fasting glucose level, $\\uparrow$ serum insulin level\n- $\\uparrow$ level of serum C-peptide (excludes exogenous source)\n- firm rubbery palpable mass at surgery (in $>90 \\%$ )\n\nLocation: even distribution throughout pancreas ( $65 \\%$ in body + tail); $1-5 \\%$ in ectopic location; $2-10 \\%$ multiple\nSize: $\\quad<1 \\mathrm{~cm}$ in $40 \\%,<1.5 \\mathrm{~cm}$ in $70 \\%,<2 \\mathrm{~cm}$ in $90 \\%$\n$\\diamond$ Early manifestation $\\leftarrow$ dramatic clinical syndrome!\n$\\checkmark$ small homogeneous hyperenhancing tumor\n$\\checkmark$ heterogeneous enhancement usually in lesions $>2 \\mathrm{~cm} \\leftarrow$ cystic change / necrosis\nUS ( $20-75 \\%$ sensitive preoperatively, $75-100 \\%$ sensitive endoscopically + intraoperatively):\n$\\checkmark$ round / oval smoothly marginated solid homogeneously hypoechoic mass\nAngio:\n$\\checkmark$ hypervascular tumor ( $66 \\%$ ) $\\rightarrow$ accurate angiographic localization in $50-90 \\%$\n$\\checkmark$ transhepatic portal venous sampling $\\rightarrow$ correct localization in $95 \\%$\n$\\checkmark$ hepatic venous sampling after intraarterial stimulation with calcium gluconate\nCECT ( $30-75 \\%$ sensitive):\n$\\diamond$ Use of coronal images is advantageous (DDx to nearby vasculature, identification of pedunculated lesion)\n$\\checkmark$ hypo- / iso- / hyperattenuating lesion\n$\\checkmark$ homogeneous hyperenhancement ( $60 \\%$ ), peripheral ring enhancement ( $30 \\%$ )\nMR:\n$\\checkmark$ low signal intensity on fat-suppressed T1WI\n$\\checkmark$ hyperintense on T2WI + dynamic contrast-enhanced + fat-suppressed inversion recovery images\n$\\checkmark$ tumors $>2 \\mathrm{~cm}$ show ring enhancement\nSomatostatin receptor scintigraphy ( $60-70 \\%$ sensitive)\nPrognosis: best among all pancreatic endocrine tumors with overall survival rate similar to general population",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 467,
            "markdown": "Malignant transformation (in 5-10\\%):\n$\\sqrt{ }$ lesion usually $>3 \\mathrm{~cm}$ in diameter\n$\\sqrt{ }$ metastases in peripancreatic lymph nodes (most often)\n$R x$ : curative surgery of visualized mass / resection of distal tail + body without visualized mass\n\n# Nonsyndromic Islet Cell Tumor \n\n$=$ NONFUNCTIONING (CLINICALLY SILENT) ICT = POORLY DIFFERENTIATED NEUROENDOCRINE TUMOR\n$\\diamond$ More common than syndromic pancreatic endocrine tumors $\\leftarrow$ below threshold of detectability / hypofunctioning / biologically inactive hormone / without clinical syndrome Frequency: $50 \\%$ of all pancreatic endocrine tumors\nGenetics: sporadic; most common pancreatic endocrine tumor in MEN 1 and VHL syndrome\nHisto: derived from either $\\alpha$ or $\\beta$ cells characterized by small poorly granular cells with high rate of proliferation and vascular invasion; positive reactivity for chromogranin-A + neurospecific enolase; no reactivity for insulin / glucagon / somatostatin\nMean age: 55 (range, 24-74) years; $\\mathrm{M}>\\mathrm{F}$; younger in MEN 1\n\n- abdominal pain, jaundice, gastric variceal bleeding\n- palpable mass, gastric outlet obstruction\n- no clinical evidence of hormone production\n- $\\uparrow$ serum chromogranin A level ( $70 \\%$ sensitive)\n\nLocation: evenly distributed throughout pancreas; anywhere in GI tract\nMean size: 5-6 (range, up to 20 ) $\\mathrm{cm} ;>5 \\mathrm{~cm}$ in $72 \\%$\n$\\diamond$ Tumor large at presentation and in $90 \\%$ malignant!\n$\\sqrt{ }$ most incidentally discovered\n$\\sqrt{ }$ heterogeneous mass with cystic + necrotic components\n$\\sqrt{ }$ coarse nodular calcifications $(20-25 \\%)$\n$\\sqrt{ }$ contrast enhancement in $83 \\%$\n$\\sqrt{ }$ hypoechoic mass\n$\\sqrt{ }$ late dense capillary stain\n$\\sqrt{ }$ large irregular pathologic vessels with early venous filling\nNUC:\n$\\sqrt{ }$ no imaging with ${ }^{111}$ In-pentetreotide $\\leftarrow$ absence of somatostatin receptor activity\n$\\sqrt{ }$ FDG PET imaging is highly accurate and preferred $\\leftarrow$ high proliferative rate\nSpread: metastases to liver + regional nodes in $60-80 \\%$ at time of diagnosis\nMalignant transformation:\n$\\sqrt{ }$ metastases at time of diagnosis in $80-100 \\%$\nPrognosis: $60 \\%$ (44\\%) 3-year (5-year) survival\n$R x$ : may respond to systemic chemotherapy\n\n## Somatostatinoma\n\nOrigin: derived from $\\delta$ cells\nPrevalence: $<2 \\%$ of all well-differentiated PETs\nMay be associated with: NF1\n> for duodenal somatostatinomas $\\rightarrow$ NF1 in $43 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 468,
            "markdown": "> for pancreatic somatostatinomas $\\rightarrow$ NF1 in $1 \\%$\nHisto: composed of D cells\nMean age: 50 years; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\n\n- inhibitory syndrome $=$ inhibitory action of somatostatin on other pancreatic + bowel peptides (growth hormone, TSH, insulin, glucagon, gastrin, pepsin, secretin)\n- diabetes, steatorrhea, diarrhea, cholelithiasis\n- hypochlorhydria, weight loss\n- elevated plasma level of somatostatin (DIAGNOSTIC)\n\nLocation: pancreatic head ( $1 / 2$ ); periampullary duodenum ( $1 / 2$ ); others in small bowel, colon, rectum\nSize: $\\quad 5-6$ (range $0.6-20$ ) cm\n$\\sqrt{ }$ hypervascular\n$\\sqrt{ }$ obstruction of duodenum\nMalignant transformation (in 50-90\\%):\n$\\sqrt{ }$ metastases in liver / lymph nodes in $50-75 \\%$ at time of initial diagnosis\n\n# VIPoma \n\n$=$ solitary tumor liberating Vasoactive Intestinal Peptide (a peptide not normally secreted by pancreatic islet cells)\nGenetics: sporadic; rarely associated with MEN 1\nPathophysiology:\nVIP stored in neurons near blood vessels $\\rightarrow$ binds to receptors on intestinal epithelial cells $\\rightarrow$ stimulates production of cyclic adenosine monophosphate (AMP) $\\rightarrow$ relaxation of vascular smooth muscle ( $=$ vasodilatation) + secretion of fluid and electrolyte into intestinal lumen $\\rightarrow$ characteristic watery diarrhea (even during fasting)\nPath: adenoma / hyperplasia\nHisto: composed of D1 cells\nAge: $\\quad 5^{\\text {th }}-6^{\\text {th }}$ decade (range, $2-83$ years); $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\n\n- WDHA syndrome = Watery Diarrhea + Hypokalemia + Achlorhydria (VIP inhibits gastrin production) $=$ Verner-Morrison syndrome\n- more recently + more accurately described as: WDHH syndrome = profuse Watery Diarrhea, Hypokalemia + Hypochlorhydria = \"pancreatic cholera\"\n- dehydration $\\leftarrow$ massive diarrhea ( $6-8 \\mathrm{~L} / \\mathrm{d}$ )\n- weight loss, abdominal pain\n- facial flushing (in some patients) $\\leftarrow$ peripheral vasodilatation mimicking carcinoid syndrome\n- $\\uparrow$ fasting serum VIP levels $>100 \\mathrm{pg} / \\mathrm{mL}$ (HIGHLY SPECIFIC)\n\nLocation:\n(a) pancreas ( $75 \\%$ ): from $\\delta$ cells predominantly in pancreatic tail $>$ body\n(b) extrapancreatic + neurogenic ( $20 \\%$ ): sympathetic ganglia of retroperitoneum + mediastinum, neuroblastoma (in children)\n(c) extrapancreatic + nonneurogenic (5\\%): esophagus, small bowel, colon, liver, kidney\n\nMean size: $\\sim 5 \\mathrm{~cm}$\n$\\sqrt{ }$ homogeneous enhancement in smaller lesion\n$\\sqrt{ }$ cystic change $\\pm$ calcifications in larger mass",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 469,
            "markdown": "$\\sqrt{ }$ mostly hypervascular tumor with solid + necrotic tissue\n$\\sqrt{ }$ dilatation of gallbladder\n$\\sqrt{ }$ uptake by ${ }^{111}$ In-pentetreotide imaging in $88 \\%$\n$\\sqrt{ }$ liver metastasis (usually at time of diagnosis)\nMalignant transformation (in 50-80\\%):\n$\\sqrt{ }$ metastases in $60-80 \\%$ at presentation\n$D D x$ : small cell carcinoma of lung / neuroblastoma may also cause WDHH syndrome\n\n# Cystic Pancreatic Neuroendocrine Tumor (PNET) \n\n$=$ uncommon manifestation (in $17 \\%$ )\nCause: tumor degeneration\nAssociated with: multiple endocrine neoplasia syndrome\nMean age: 53 years; $\\mathrm{M}=\\mathrm{F}$\n$\\sqrt{ }$ vascularized soft-tissue components\n$\\sqrt{ }$ avidly enhancing rim during arterial phase $\\leftarrow$ neoplastic neuroendocrine cells lining cyst periphery\n\n## PANCREATIC LIPOMATOSIS\n\n$=$ FATTY REPLACEMENT $=$ FATTY INFILTRATION\n$=$ deposition of fat cells in pancreatic parenchyma\nPredisposing factors:\n\n1. Atherosclerosis of elderly\n2. Obesity\n3. Steroid therapy\n4. Diabetes mellitus\n5. Cushing syndrome\n6. Chronic pancreatitis\n7. Main pancreatic duct obstruction\n8. Cystic fibrosis (most common cause in childhood)\n9. Malnutrition / dietary deficiency\n10. Hepatic disease\n11. Hemochromatosis\n12. Viral infection\n13. Shwachman-Diamond syndrome\n14. Johanson-Blizzard syndrome\n\nMatsumoto classification:\n\n* sparing of peribiliary region (in all types)\n\nIa focal fatty infiltration of pancreatic head WITH sparing of uncinate process + pancreatic body $(35 \\%)^{*}$\nIb infiltration of pancreatic head + neck + body*\nIla infiltration of uncinate process + pancreatic head WITH sparing of pancreatic body $(12 \\%)^{*}$\nIIb complete infiltration of entire pancreas $(18 \\%)^{*}$\n$\\sqrt{ }$ fatty replacement often uneven:\n$\\sqrt{ }$ increase in AP diameter of pancreatic head with focal fatty replacement $=$ lipomatous",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 470,
            "markdown": "pseudohypertrophy\n$\\sqrt{ }$ prominently lobulated external contour\nUS:\n$\\sqrt{ }$ increased pancreatic echogenicity\nCT:\n$\\sqrt{ }$ \"marbling\" of pancreatic parenchyma / total fatty replacement / lipomatous pseudohypertrophy\nDDx of diffuse fatty replacement: pancreatic agenesis (absence of ductal system)\nDDx of focal fatty replacement: neoplasm\n\n# Pancreatic Fatty Sparing \n\n= sparing of fatty change in pancreatic head + uncinate process (ventral pancreatic anlage) as initial stage in pancreatic lipomatosis\nHisto: ventral pancreatic anlage has smaller + more densely packed acini with scanty / absent interacinar fat\n$\\sqrt{ }$ absence of mass effect or ductal / vascular displacement\nUS:\n$\\sqrt{ }$ rounded / triangular hypoechoic area within pancreatic head / uncinate process + diffusely increased echogenicity in remainder of gland\nCT:\n$\\sqrt{ }$ higher-density region in pancreatic head + uncinate process with diffusely decreased attenuation of pancreatic body + tail\n\n## PANCREATIC PSEUDOCYST\n\n= collection of pancreatic secretions / hemorrhagic fat necrosis encapsulated by granulation tissue + fibrous capsule\nEtiology: (1) Acute pancreatitis (in 2-4\\%): pseudocyst develops within 4-6 weeks, matures in $6-8$ weeks\n(2) Chronic pancreatitis (in 10-15\\%): alcoholism, hyperlipidemia, hyperparathyroidism, chronic obstruction of pancreatic duct, acute exacerbation of pancreatitis\n(3) Trauma / surgery\n\nFrequency: $2-4 \\%$ in acute pancreatitis; $10-15 \\%$ in chronic pancreatitis\nLocation: $2 / 3$ within pancreas\nAtypical location (may dissect along tissue planes in $1 / 2$ ):\n(a) intraperitoneal: mesentery of small bowel / transverse colon / sigmoid colon\n(b) retroperitoneal: along psoas muscle; may present as groin mass / in scrotum\n(c) intraparenchymal: liver, spleen, kidney\n(d) mediastinal (through esophageal hiatus > aortic hiatus > foramen of Morgagni > erosion through diaphragm): may present as neck mass\nMay communicate with: duodenum, stomach, spleen\nVascularized soft-tissue elements are not a pseudocyst feature.",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 471,
            "markdown": "Plain film / contrast radiograph:\n$\\sqrt{ }$ smooth extrinsic indentation of posterior wall of stomach / inner duodenal sweep ( $80 \\%$ )\n$\\sqrt{ }$ indentation / displacement of splenic flexure / transverse colon ( $40 \\%$ )\n$\\sqrt{ }$ downward displacement of duodenojejunal junction\n$\\sqrt{ }$ gastric outlet obstruction\n$\\sqrt{ }$ splaying of renal collecting system / ureteral obstruction\nUS (pseudocyst detectable in 50-92\\%; 92-96\\% accurate):\n$\\sqrt{ }$ usually single + unilocular cyst\n$\\sqrt{ }$ multilocular in $6 \\%$\n$\\sqrt{ }$ fluid-debris level / internal echoes $\\leftarrow$ may contain sequester, blood clot, cellular debris from autolysis\n$\\sqrt{ }$ rare septations ( $=$ sign of infection / hemorrhage)\n$\\sqrt{ }$ may increase in size $\\leftarrow$ hypertonicity of fluid, communication with pancreatic duct, hemorrhage, erosion of vessel\n$\\sqrt{ }$ obstruction of pancreatic duct / CBD\nCT:\n$\\sqrt{ }$ fluid in pseudocyst $(0-30 \\mathrm{HU})$\n$\\sqrt{ }$ cyst wall calcification (extremely rare)\nMR:\n$\\sqrt{ }$ irregularly marginated (early) / well-circumscribed (after several weeks) fluid collection\n$\\sqrt{ }$ thickened enhancing wall\n$\\sqrt{ }$ hyperintense contents on T1WI $\\leftarrow$ blood products / necrotic or proteinaceous debris\n$\\sqrt{ }$ hyperintense surrounding tissues on fat-suppressed T2WI $\\leftarrow$ chemical inflammation / infection\nPancreatography:\n$\\sqrt{ }$ communication with pancreatic duct in up to $50-70 \\%$\nIndications for pseudocyst drainage:\npain, suspected infection, persistence of pseudocyst $>5 \\mathrm{~cm}$, increasing size, biliary / gastrointestinal obstruction\n$C x($ in $40 \\%)$ :\n\n1. Rupture into abdominal cavity, stomach, colon, duodenum\n2. Hemorrhage / formation of pseudoaneurysm\n3. Infection = pancreatic abscess\n\n- usually occurs $>4$ weeks after acute pancreatitis\n- symptomatology of infection\n$\\sqrt{ }$ gas bubbles (DDx: fistulous communication to GI tract)\n$\\sqrt{ }$ increase in attenuation of fluid contents\n$D x$ : transcutaneous needle aspiration\n\n4. Intestinal obstruction\n\nPrognosis: spontaneous resolution (in $20-50 \\%$ ) $\\leftarrow$ rupture into GI tract / pancreatic duct or bile duct\n$D D x$ : (1) Mucinous pancreatic cystadenoma (no significant interval change on follow-up)\n(2) Cystadenocarcinoma\n(3) Necrotic pancreatic carcinoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 472,
            "markdown": "(4) Fluid-filled bowel: small bowel, stomach\n(5) Duodenal diverticulum\n(6) Aneurysm\n\n# PANCREATIC TRANSPLANTATION \n\nComplications: sepsis, rejection, pancreatitis, pseudocyst, pancreatic abscess (22\\%), anastomotic leak\nPrognosis: $40 \\%$ survival rate $>1$ year\nGraft-vessel Thrombosis in Pancreatic Transplant (2-19\\%)\nA. Early thrombosis ( $<1$ month after transplantation)\n\nCause: technical error in fashioning anastomosis, microvascular damage $\\leftarrow$ preservation injury",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 473,
            "markdown": "![img-64.jpeg](img-64.jpeg)\n\nRx: prompt pancreatectomy\nB. Late thrombosis ( $>1$ month after transplantation)\n\nCause: alloimmune arteritis with gradual occlusion of small blood vessels US / CECT:\n$\\sqrt{ }$ venous $>$ arterial thrombosis\n\n# Rejection of Pancreatic Transplant (5-25\\%) \n\n$\\diamond$ Graft rejection is primary cause of graft loss\n$\\checkmark$ all imaging modalities are unreliable\n$D x$ : percutaneous US-guided biopsy",
            "images": [
                {
                    "id": "img-64.jpeg",
                    "top_left_x": 357,
                    "top_left_y": 189,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1515,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 474,
            "markdown": "# Acute Rejection of Pancreatic Transplant \n\nTime of onset: 1 week- 3 months\nPath: autoimmune vasculitis $\\rightarrow$ small vessel occlusion (decreased perfusion) $\\rightarrow$ infarction\n\n- focal tenderness over transplant\n- measurement of urinary + serum amylase, blood glucose (nonspecific and poor for diagnosis of rejection)\nUS (nonspecific):\n$\\checkmark$ graft enlargement + heterogeneity\n$\\checkmark$ poor margination of transplant\n$\\checkmark$ dilated pancreatic duct\n$\\checkmark$ resistive indices not helpful\n$D D x$ : acute pancreatitis, ischemia\n$C x$ : multiple episodes culminate in chronic rejection\n\n\n## Chronic Rejection of Pancreatic Transplant 4-10\\%\n\n$=$ major long-term cause of graft failure $>$ first 6 months\nPath: small vessel endarteritis $\\rightarrow$ acinar atrophy $\\rightarrow$ interstitial fibrosis\n\n- insidious progressive loss of exocrine, then endocrine function\n$\\checkmark$ shrunken / disappearing transplant\n\n\n## Graft Pancreatitis\n\nFrequency: up to $35 \\%$\nTime of onset: $<4$ weeks after transplantation\nCause: reperfusion injury\n$\\checkmark$ nonspecific enlargement + organ heterogeneity\n$\\checkmark$ peritransplant fluid\n$\\checkmark$ mural thickening of adjacent bowel\n\n## PANCREATITIS\n\n$=$ most common pancreatic disease in children + adults; one of the most common causes of morbidity + mortality worldwide\nCause:\nA. CHOLELITHIASIS (50-70\\%): acute pancreatitis (75\\%); chronic pancreatitis (20\\%)\nB. ALCOHOLISM (25\\%): acute pancreatitis (15\\%); chronic pancreatitis (70\\%)\nC. IDIOPATHIC (20\\%)\nD. METABOLIC DISORDERS\n\n1. Hypercalcemia in hyperparathyroidism (10\\%), multiple myeloma, amyloidosis, sarcoidosis\n2. Hereditary pancreatitis: autosomal dominant, only Caucasians affected, most common cause of large spherical pancreatic calcifications in childhood (in 50\\%), recurrent episodes of pancreatitis, development into pancreatic carcinoma in 20-40\\%; pronounced dilatation of pancreatic duct; pseudocyst formation (50\\%); associated with type I hypercholesterolemia\n3. Hyperlipidemia types I and V",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 475,
            "markdown": "# 4. Cystic fibrosis \n\n## E. INFECTION / INFESTATION\n\n1. Viral infection (mumps, hepatitis, Coxsackie virus, mononucleosis)\n\n| Drug-Induced Pancreatitis |  |\n| :-- | :-- |\n| Drug Class | Common Agents |\n| Antibiotics | metronidazole, tetracyclines, sulfonamides |\n| Diuretics | thiazide, furosemide, ethacrynic acid |\n| Statins | simvastatin |\n| Estrogens | oral contraceptives |\n| ACE inhibitors | captopril, lisinopril, enalapril |\n| Chemotherapeutics | azathioprine, L-asparaginase, <br> Didanosine (2',3'-dideoxyinosine) |\n| Others | sulfasalazine, mesalazine, sodium valproate, <br> phenformin, steroids, acetaminophen, <br> procainamide |\n\n2. Parasites (ascariasis, clonorchis)\nF. TRAUMA\n$\\diamond$ One of the most common causes of pancreatitis in childhood!\n3. Penetrating ulcer\n4. Blunt / penetrating trauma; nonaccidental trauma\n5. Surgery (in $0.8 \\%$ of Billroth-II resections, $0.8 \\%$ of splenectomies, $0.7 \\%$ of choledochal surgery, $0.4 \\%$ of aortic graft surgery)\nG. STRUCTURAL ABNORMALITIES\n6. Pancreas divisum\n7. Choledochocele\nH. DRUGS (3-5\\%), > 100 medications have been implicated\n\nMechanism: pancreatic duct constriction, toxic metabolites, cytotoxic effects $\\rightarrow$ insult to exocrine function and inappropriate accumulation / activation of pancreatic digestive proenzymes\nI. MALIGNANCY\n\nPancreatic carcinoma (in 1\\%), metastases, lymphoma\nJ. MULTISYSTEM CONDITIONS\n\n1. Sepsis and shock\n2. Hemolytic-uremic syndrome\n3. Reye syndrome\n4. Systemic lupus erythematosus\n\nTheories of pathogenesis:\nreflux of bile / pancreatic enzymes / duodenal succus\n(a) terminal duct segment shared by common bile duct and pancreatic duct\n(b) obstruction at papilla of Vater from inflammatory stenosis, edema / spasm of sphincter of Oddi, tumor, periduodenal diverticulum\n(c) incompetent sphincter of Oddi",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 476,
            "markdown": "# Acute Pancreatitis \n\n$=$ inflammatory disease of pancreas producing temporary changes with potential for restoration of normal anatomy and function following resolution\nIncidence: $>300,000$ hospitalizations annually in USA\n\n- acute epigastric pain radiating to back / chest (peaking after a few hours, resolving in 2-3 days); nausea, vomiting\n- $\\square$ serum amylase + lipase in blood + urine\n- increased amylase-creatinine clearance ratio\n- signs of hemorrhagic pancreatitis:\n- Cullen sign = periumbilical ecchymosis\n- Grey-Turner sign = flank ecchymosis\n- Fox sign = infrainguinal ecchymosis\n- subcutaneous nodules + fat necrosis + polyarthritis\n\nClinical definition of acute pancreatitis:\n\n| Marshall Scoring System for Acute Pancreatitis |  |  |  |\n| :--: | :--: | :--: | :--: |\n| Score | Respiratory* | Creatinine <br> $[\\mathrm{mg} / \\mathrm{dL}]$ | Systolic Pressure <br> $[\\mathrm{mmHg}]$ |\n| 0 | $>400$ | $\\leq 1.5$ | $>90$ |\n| 1 | $301-400$ | $>1.5$ to $\\leq 1.9$ | $<90$, fluid responsive |\n| 2 | $201-300$ | $>1.9$ to $\\leq 3.5$ | $<90$, not fluid responsive |\n| 3 | $101-200$ | $>3.5$ to $\\leq 5.0$ | $<90, \\mathrm{pH}<7.3$ |\n| 4 | $<101$ | $>5.0$ | $<90, \\mathrm{pH}<7.2$ |\n| $*=$ ratio of partial pressure of arterial oxygen to fraction of inspired <br> oxygen |  |  |  |\n| organ failure $=$ score $\\geq 2$ in at least 1 of 3 organ systems |  |  |  |\n\n- epigastric pain radiating to back\n- serum amylase + lipase $>3 \\mathrm{x}$ normal\n- characteristic findings on imaging\n\nClinical phases (revised Atlanta Classification System 2012):\nA. First / early clinical phase (during $1^{\\text {st }}$ week)\n\nPathology: early inflammation $\\rightarrow$ peripancreatic edema / ischemia $\\rightarrow$ resolution / permanent necrosis / liquefaction\nSeverity: based on Marshall scoring system\n(a) mild = organ failure resolves within 48 hours\n(b) severe $=$ organ failure beyond 48 hours\n\nOther useful severity markers:\n\n- hematocrit, C-reactive protein, LDH, serum / urinary trypsinogen, cytokines\n- CT severity index + pleural effusion\n$\\diamond$ Serum amylase + lipase useless to judge severity!\n\nMortality: $0 \\%$\nB. Second / late clinical phase beyond $1^{\\text {st }}$ week that may persist for weeks - months; characterized by increasing necrosis, ongoing infection, persistent multiorgan failure\n\n- bacteremia + sepsis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 477,
            "markdown": "Mortality: $5-10 \\%$ for sterile necrosis; $20-30 \\%$ for superinfection of necrosis\nRole of imaging in acute pancreatitis:\n\n1. Confirm diagnosis in clinical uncertainty\n$\\diamond$ NOT needed without signs of severe systemic inflammatory response syndrome!\n2. Find cause: cholecystolithiasis, choledocholithiasis, underlying neoplasm\n3. Document severity ( $=$ extent of necrosis) when patient's condition does not improve / deteriorates\n4. Evaluate for complications: extrahepatic biliary dilatation, splenic / portal / mesenteric vein thrombosis, varices, arterial pseudoaneurysm, pleural effusion, ascites, inflammatory changes of stomach, duodenum, small bowel, colon, spleen, kidney, ureter, liver\n5. Help to determine when to implement interventional radiologic / endoscopic / surgical treatment\n6. Monitor response to treatment\n\nDistribution:\nA. Diffuse pancreatitis $(52 \\%)$\nB. Focal pancreatitis ( $48 \\%$ ): location of head $\\div$ tail $=3 \\div 2$\n\nMorphologic subtypes:\n\n1. Interstitial edematous pancreatitis $70-80 \\%$\n2. Necrotizing pancreatitis (more severe form) $20-30 \\%$\n\nAbdominal film:\n$\\sqrt{ }$ \"colon cutoff\" sign ( $2-52 \\%)=$ dilated transverse colon with abrupt change to a gasless descending colon (inflammation via phrenicocolic ligament causes spasm + obstruction at splenic flexure impinging on a paralytic transverse colon)\n$\\sqrt{ }$ \"sentinel loop\" ( $10-55 \\%)=$ localized segment of gas-containing bowel in duodenum (in $20-45 \\%)$ / terminal ileum / cecum\n$\\sqrt{ }$ \"renal halo\" sign = water-density of inflammation in anterior pararenal space contrasts with perirenal fat; more common on left side\n$\\checkmark$ mottled appearance of peripancreatic area $\\leftarrow$ fat necrosis in pancreatic bed, mesentery, omentum\n$\\checkmark$ intrapancreatic gas bubbles $\\leftarrow$ acute gangrene / suppurative pancreatitis\n$\\checkmark$ \"gasless abdomen\" = fluid-filled bowel associated with vomiting\n$\\checkmark$ ascites\nCXR (findings in $14-71 \\%$ ):\n$\\checkmark$ pleural effusion (in $10-20 \\%$ ): usually left-sided, elevated amylase levels (in $85 \\%$ )\n$\\checkmark$ left-sided diaphragmatic elevation\n$\\checkmark$ left-sided subsegmental atelectasis (20\\%)\n$\\checkmark$ parenchymal infiltrates, pulmonary infarction\n$\\checkmark$ pulmonary edema, ARDS\n$\\checkmark$ pleural empyema, pericardial effusion\n$\\checkmark$ mediastinal abscess, mediastinal pseudocyst\n$\\checkmark$ pancreaticobronchial / -pleural / -pulmonary fistula\nUGI:\n$\\checkmark$ esophagogastric varices $\\leftarrow$ splenic vein obstruction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 478,
            "markdown": "$\\sqrt{ }$ diminished duodenal peristalsis\n$\\sqrt{ }$ widening of retrogastric space $\\leftarrow$ pancreatic enlargement / inflammation in lesser sac\n$\\sqrt{ }$ widening of duodenal sweep + downward displacement of ligament of Treitz\n$\\sqrt{ }$ enlarged tortuous + spiculated edematous rugal folds along antrum + greater curvature of stomach $(20 \\%)$\n$\\sqrt{ }$ Poppel sign = edematous swelling of papilla\n$\\sqrt{ }$ Frostberg \"inverted-3\" sign = segmental narrowing with fold thickening of duodenum\n$\\sqrt{ }$ jejunal + ileal fold thickening (proteolytic spread along mesentery)\nBE:\n$\\sqrt{ }$ narrowing, nodularity, fold distortion along inferior haustral row of transverse colon $\\pm$ descending colon\nERCP (no primary role, replaced by MRCP):\n$\\sqrt{ }$ long gently tapered narrowing of CBD\n$\\sqrt{ }$ prestenotic biliary dilatation\nIndication: CBD stone removal, pancreatic duct stent placement for stricture / disrupted duct\nCx: exacerbation of pancreatitis, bleeding, perforation of bowel\nBone films (findings in 6\\%):\nCause: metastatic intramedullary lipolysis + fat necrosis + trabecular bone destruction\nTime of onset: usually 3-6 weeks after peak of clinical pancreatitis\n$\\sqrt{ }$ punched out / permeative mottled destruction of cancellous bone + endosteal erosion\n$\\sqrt{ }$ aseptic necrosis of femoral / humeral heads\n$\\sqrt{ }$ metaphyseal infarcts, predominantly in distal femur + proximal tibia\nUS (visualization of pancreas in 62-78\\%):\n$\\sqrt{ }$ hypoechoic diffuse / focal enlargement of pancreas\n$\\sqrt{ }$ dilatation of pancreatic duct (if head focally involved)\n$\\sqrt{ }$ perivascular cloaking $=$ spread of inflammatory exudate along perivascular spaces\n$\\sqrt{ }$ extrapancreatic hypoechoic mass with good acoustic transmission (= phlegmonous pancreatitis)\n$\\sqrt{ }$ fluid collection: lesser sac ( $60 \\%$ ), $\\mathrm{L}>\\mathrm{R}$ anterior pararenal space ( $54 \\%$ ), posterior pararenal space ( $18 \\%$ ), around left lobe of liver ( $16 \\%$ ), in spleen ( $9 \\%$ ), mediastinum (3\\%), iliac fossa, along transverse mesocolon / mesenteric leaves of small intestine Fate of fluid collection:\n(a) complete resolution\n(b) pseudocyst formation\n(c) bacterial infection = abscess\n$\\sqrt{ }$ pseudocyst formation ( $52 \\%$ ): extension into lesser sac, transverse mesocolon, around kidney, mediastinum, lower quadrants of abdomen\nCT (modality of choice):\n$\\sqrt{ }$ no detectable change in size / appearance (29\\%)\n$\\sqrt{ }$ enlargement of pancreas with convex margins + indistinctness of gland + parenchymal heterogeneity:\n$\\sqrt{ }$ hypodense ( $5-20 \\mathrm{HU}$ ) mass in inflammatory pancreatitis; may persist long after complete recovery\n$\\sqrt{ }$ hyperdense areas ( $50-70 \\mathrm{HU}$ ) in hemorrhagic pancreatitis for $24-48 \\mathrm{hr}$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 479,
            "markdown": "$\\sqrt{ }$ thickening of anterior pararenal fascia\n$\\sqrt{ }$ \"halo\" sign = sparing of perirenal space\n$\\sqrt{ }$ non-contrast-enhancing parenchyma during bolus injection (= pancreatic necrosis)\n$\\sqrt{ }$ pancreatic + peripancreatic fluid collection\nMRI:\n$\\sqrt{ }$ intra- and extrapancreatic increased T2 signal\n$\\sqrt{ }$ collection consisting of fluid + nonliquefied material:\n$\\sqrt{ }$ T2-hyperintense liquefied component\n$\\sqrt{ }$ T2-hypointense nonliquefied component\n$\\sqrt{ }$ hyperintense SI on fat-saturated T1WI = hemorrhage\n$M R C P$ : to evaluate for choledocholithiasis, degree of mass effect on CBD, pancreatic duct stricture / integrity $\\pm$ communication with collection\nN.B.: secretin administration after resolution of acute inflammation to avoid exacerbation\nAngiography:\n$\\sqrt{ }$ may be normal\n$\\sqrt{ }$ hypovascular areas $(15-56 \\%)$\n$\\sqrt{ }$ hypervascularity + increased parenchymal stain (12-45\\%)\n$\\sqrt{ }$ venous compression $\\leftarrow$ edema\n$\\sqrt{ }$ formation of pseudoaneurysms (in $10 \\%$ with chronic pancreatitis): splenic artery (50\\%), pancreatic arcades, gastroduodenal artery\n$C x$ :\n\n| Balthazar CT-Severity Index for Acute Pancreatitis |  |\n| :--: | :--: |\n| Criteria | Points |\n| CT appearance |  |\n| Normal pancreas | 0 |\n| Pancreatic enlargement | 1 |\n| Pancreatic / peripancreatic inflammation | 2 |\n| 1 fluid collection | 3 |\n| $\\geq 2$ fluid collection | 4 |\n| Percentage of necrosis |  |\n| None | 0 |\n| $<30 \\%$ | 2 |\n| $30-50 \\%$ | 4 |\n| $>50 \\%$ | 6 |\n| score $0=0 \\%$ mortality; <br> scores $7-10=17 \\%$ mortality $+92 \\%$ complication rate |  |\n\n1. Pleural effusion\n2. Pseudocyst formation ( $10 \\%$ )\n3. Hemorrhagic pancreatitis ( $2-5 \\%$ )\n4. Main pancreatic duct stricture (late Cx)\n5. Disconnected pancreatic duct\n6. Peripancreatic inflammation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 480,
            "markdown": "(a) GI tract: stomach, duodenum, small bowel, colon $\\sqrt{ }$ bowel wall thickening, mural hyperenhancement\n(b) liver, spleen\n(c) kidney, ureter\n7. Displacement and compression of adjacent organs\n(a) bile duct obstruction\n> choledocholithiasis\n> mass effect $\\leftarrow$ inflammation / collection\n> stricture $\\leftarrow$ exposure to proteolytic enzymes\n(b) obstruction of stomach\n(c) duodenal stricture $\\leftarrow$ extrinsic compression by enlarged pancreatic head / adjacent fluid collection / duodenal mural edema or hemorrhage\n(d) hydronephrosis\n$\\diamond$ At risk for abdominal compartment syndrome\n8. Pancreatic ascites\n9. Venous thrombosis\n\nCause: local prothrombotic inflammatory factors, reduced venous flow, mass effect on vein from adjacent necrotic tissue / collection\nLocation: splenic vein $(19-63 \\%)>$ portal vein $(13-25 \\%)>\\operatorname{SMV}(13-14 \\%)$\n10. Pseudoaneurysm (typically late Cx )\n$=$ digestion of arterial wall by proteolytic enzymes\nFrequency: in up to $10 \\%$ of severe pancreatitis\nLocation: splenic $>$ gastroduodenal $>$ pancreatico-duodenal $>$ hepatic $>$ left gastric artery\nCx: rupture into preexisting pseudocyst, necrotic collection, gastrointestinal tract, peritoneum, pancreatic parenchyma\nMortality: $37 \\%$ for rupture, $16-50 \\%$ for surgery\n11. Hemorrhage $(1-5 \\%)$\n\nCause: erosion of vasculature, rupture of pseudoaneurysm, rupture of varices\nSource: splenic artery, portal vein, splenic vein, small peripancreatic vessels\nLocation: within pancreatic parenchyma, into fluid collection, into GI tract\nMortality: $34-52 \\%$\n12. Thoracopancreatic fistula\n(a) pancreaticopleural fistula\n(b) pancreaticopericardial fistula\n(c) pancreaticoesophageal fistula\n(d) pancreaticobronchial fistula\n(e) mediastinal pseudocyst",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 481,
            "markdown": "![img-65.jpeg](img-65.jpeg)\n\n# BILIARY PANCREATITIS \n\n$=$ gallstone / biliary sludge impaction at ampulla of Vater $\\rightarrow$ ampullary spasm $\\rightarrow$ pancreaticobiliary reflux $\\rightarrow$ obstruction of common bile duct + pancreatic duct\nAt risk: common pancreaticobiliary channel, pancreas divisum\nMR: preferred in suspected choledocholithiasis (more sensitive than CT for detecting gallstones)\n\n## Hemorrhagic Pancreatitis\n\nMR:\n$\\sqrt{ }$ elevated SI on precontrast fat-saturated T1WI\nInterstitial Edematous Pancreatitis (IEP) (70-80\\%)\n$\\sqrt{ }$ localized / diffuse enlargement of pancreas\n$\\sqrt{ }$ normal homogeneous enhancement\n$\\sqrt{ }$ normal / \"misty\" peripancreatic soft tissue\n$\\sqrt{ } \\pm$ peripancreatic fat stranding\n$\\sqrt{ }$ heterogeneous enhancement $\\rightarrow$ repeat scan 5-7 days later for definitive characterization of\n(a) interstitial edematous pancreatitis versus\n(b) pancreatic necrosis\n$\\sqrt{ } \\pm$ peripancreatic fluid collection $\\rightarrow$ eventually pseudocyst\nPrognosis: self-limiting with normalization of physical signs + laboratory values within $48-72$ hours of conservative therapy\nMortality: $1-5 \\%$\n$R x$ : NPO, gastric tube, atropine, analgesics, sedation, prophylactic antibiotics\nNecrotizing Pancreatitis (20-30\\%)\n$=$ necrosis of pancreatic parenchyma $\\pm$ peripancreatic tissues as a complication of acute pancreatitis in $25 \\%$\n\\{pancreatic phlegmon [= misnomer, NO infection!]\\}\nThe revised Atlanta Classification System subdivides collections of necrotizing pancreatitis according to time of disease onset:\n$<4$ weeks after onset without discrete wall = Acute Necrotic Collection (ANC)\n$>4$ weeks after onset with a discrete wall $=$ Walled-Off Necrosis (WON)",
            "images": [
                {
                    "id": "img-65.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 653,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 482,
            "markdown": "ANC and WON can be sterile / infected!\nThe terms pancreatic abscess, fluid collection, phlegmon are no longer accepted owing to their ambiguity.\nDefinition: necrosis = nonviable pancreatic tissue that becomes gradually liquefied Morphologic subtypes (revised Atlanta Classification System of 2012):\n(a) pancreatic parenchymal necrosis only $(<5 \\%)$\n\n- established by 48-72 hours after disease onset\n\nCT should be performed 3-5 days after presentation because parenchymal pancreatic necrosis cannot be excluded prior to 72 hours after onset!\n$\\sqrt{ }$ decreased / absent pancreatic parenchymal enhancement $=$ attenuation of $<30 \\mathrm{HU}$ during pancreatic parenchymal phase\n(b) peripancreatic fat necrosis only $(<20 \\%)$\n$\\sqrt{ }$ mixture of increased attenuation, linear stranding, and fluid collections within peripancreatic fat (DDx: acute interstitial edematous pancreatitis)\n$\\sqrt{ }$ heterogeneity outside pancreas favors peripancreatic fat necrosis with nonliquefied components $\\leftarrow$ hemorrhage, necrotic fat\n$\\sqrt{ }$ liquefied component among fat becomes more apparent after 1 week\nLocation: commonly retroperitoneum + lesser sac\n(c) pancreatic and peripancreatic necrosis ( $75-80 \\%$ )\n$\\sqrt{ }$ combined necrosis with homo- / heterogeneous fluid collections generally becoming walled off (WON) after 4 weeks\n$C x:$ pancreatic duct disruption ( $\\sim 50 \\%$ )\nMorbidity: $34-95 \\%$ due to uncontrolled infection\nMortality: $2-39 \\%$ due to systemic organ dysfunction, immunosuppression, organ failure\n\n# Pancreatic \\& Peripancreatic Fluid Collection \n\n## ACUTE PERIPANCREATIC FLUID COLLECTION (APFC)\n\n= pure extrapancreatic collection WITHOUT solid component during 1st month of interstitial edematous pancreatitis (IEP)\nCause: pancreatic / peripancreatic inflammation; rupture of small peripheral pancreatic branch\nLocation: adjacent to pancreas conforming to anatomic boundaries of retroperitoneum (extension into lesser sac, anterior pararenal space, transverse mesocolon, small bowel mesentery, retroperitoneum, pelvis)\nContent: increased amylase + lipase $\\leftarrow$ communication with pancreatic ductal system\n$\\sqrt{ }$ collection of fluid attenuation (near 0 HU ):\n$\\sqrt{ }$ homogeneous and nonenhancing\n$\\sqrt{ }$ NO discernable wall\nPrognosis: spontaneous reabsorption within first few weeks; maturation to pseudocyst\nN.B.: Refrain from percutaneous aspiration / drainage to avoid introduction of an infection!\n\n## ACUTE NECROTIC COLLECTION (ANC)\n\n= complex collection replacing pancreatic parenchyma during 1st month of necrotizing pancreatitis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 483,
            "markdown": "Content: nonliquefied + liquefied necrotic debris\n$\\diamond$ Liquefaction of necrotic tissue takes 2-6 weeks!\nLocation: intrapancreatic / extrapancreatic / both\n$\\sqrt{ }$ collection of low attenuation:\n$\\sqrt{ }$ homogeneous / heterogeneous\n$\\sqrt{ }$ loculated and nonenhancing\n$\\sqrt{ }$ NO discernable wall (= NO capsule)\n$\\sqrt{ }$ PATHOGNOMONIC content (if present) of complex heterogeneity, hemorrhage, fat\n$\\sqrt{ }$ nonliquefied component only discernable on MRI\n\n| DDx of Pancreatic \\& Peripancreatic Fluid Collections |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: |\n|  | APFC | ANC | WON | Pseudocyst |\n| Association | IEP | necrotizing pancreatitis | ANC | APFC |\n| Time [month] | $<1^{\\mathrm{a}}$ | $<1^{\\mathrm{a}}$ | $>1^{\\mathrm{a}}$ | $>1^{\\mathrm{a}}$ |\n| Location: <br> pancreatic <br> peri- <br> Content: | $+$ <br> amylase, <br> lipase | $+$ <br> liquid + solid | $+$ <br> fluid + fat | - <br> fluid <br> fluid |\n| homogeneous | $+$ | $-/+$ | - | $+$ |\n| hemorrhage | - | +/- |  |  |\n| fat | - | +/- | $+$ |  |\n| Wall: |  |  |  |  |\n| discernible | - | - | $+$ | $+$ |\n| enhancing |  |  | $+$ | $+$ |\n\n$\\sqrt{ }$ presence of pancreatic parenchymal necrosis\nPrognosis: evolution into\n(a) sterile walled-off necrosis (WON) $60 \\%$\n(b) spontaneous resolution $20 \\%$\n(c) complicated by infection $20 \\%$\n\nManagement: CT every 7-10 days to evaluate evolution of pancreatic necrosis + assess for evidence of infection / complications\n\n# WALLED-OFF NECROSIS (WON) \n\n$=$ PANCREATIC SEQUESTRATION $=$ NECROMA $=$ ORGANIZED PANCREATIC NECROSIS\n$=$ any fluid collection replacing portions of pancreatic parenchyma after $1^{\\text {st }}$ month $=$ matured late stage of acute necrotic collection (ANC)\nLocation: within pancreas / peripancreatic / both\nContent: necrotic pancreatic parenchyma + necrotic fat\n$\\sqrt{ }$ focal / diffuse well-marginated zones of unenhanced pancreatic parenchyma with irregular borders\n$\\sqrt{ }$ thick enhancing wall between necrosis and adjacent tissue\n$\\sqrt{ }$ growth of collection favors WON",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 484,
            "markdown": "$\\sqrt{ }$ pancreatic ductal dilatation unlikely $\\leftarrow$ pancreatic fluid decompresses into collection\n$\\sqrt{ }$ PATHOGNOMONIC if collection is intrapancreatic\n$\\sqrt{ }$ saponification $=$ phospholipases and proteases attack plasma membranes of fat cells $\\rightarrow$ release and hydrolyzation of triglycerides $\\rightarrow$ formation of free fatty acids $\\rightarrow$ combination with serum calcium $\\rightarrow$ precipitation as calcium soaps\n$R x:$ fluid drainage often ineffective\n$\\diamond$ Nonliquefied components require laparoscopic procedure / endoscopic necrosectomy / surgical débridement / percutaneous drain with frequently irrigated large-bore catheter\n\n# PSEUDOCYST \n\n$=$ extrapancreatic collection of fluid developing from APFC after 4 weeks\nPath: wall of fibrous / granulation tissue; absence of epithelium-lined wall\nFrequency: in $10-20 \\%$ of IEP\nLocation: adjacent / distant to pancreas\nContent: amylase + lipase without necrotic debris\n$\\sqrt{ }$ well-circumscribed round / oval peripancreatic fluid collection of homogeneously low attenuation $<15 \\mathrm{HU}$\n$\\checkmark$ well-defined enhancing wall $\\leftarrow$ fibrous / granulation tissue\n$\\diamond$ Formation of a defined wall takes about 4 weeks!\n$\\sqrt{ }$ NO nonliquefied component\n$\\sqrt{ }$ main pancreatic ductal dilatation $>3 \\mathrm{~mm}$ (frequent) $\\leftarrow$ compression of pancreatic parenchyma\n$\\checkmark$ communication with pancreatic ductal system usually seals off\n$\\checkmark$ persistent pseudocyst after drainage $\\leftarrow$ continued communication with pancreatic duct MR:\n$\\checkmark$ complex cyst dissecting along facial planes:\n$\\checkmark$ elevated internal T1 signal $=$ blood products\nPrognosis: spontaneous resolution in $44 \\% ;<4 \\mathrm{~cm}$ : resolution anticipated; $>7 \\mathrm{~cm}$ : treatment recommended; $25 \\%$ become symptomatic / infected\n$C x$ : hemorrhage, infection, spontaneous rupture into hollow viscera $\\rightarrow$ higher attenuation values\n$R x$ : percutaneous fluid drainage (retroperitoneal approach from flank)\n\n## INFECTED COLLECTION\n\n$=$ all 4 types of pancreatic fluid collection can be sterile / infected\nThe term \"pancreatic abscess\" is no longer used because a collection of pus without pancreatic necrosis does not exist!\n\nFrequency: $2-18 \\%$\nTiming: most commonly 2-4 weeks after presentation\nCause: bacterial translocation from gut into adjacent necrotic pancreatic parenchyma\n$\\diamond$ Nonliquefied material more likely to become infected!\nOrganism: (most commonly) E. coli, S. aureus, Enterococcus faecalis\n\n- (nondiagnostic) fever, tachycardia, elevated WBCs\n$\\sqrt{ }$ gas bubbles in collection $(12-22 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 485,
            "markdown": "Cause: gas-forming organism (most common: E. coli)\nMortality: $25-70 \\% \\rightarrow$ diagnosis aggressively pursued!\n$D x$ : image-guided percutaneous aspiration of fluid with positive Gram stain, positive culture for bacteria / fungal organism; $10 \\% \\mathrm{FN}$\n$R x$ : surgical débridement + antibiotics; temporizing percutaneous drainage followed by necrosectomy\nDDx of gas: cutaneous / enteric fistula, ruptured duodenum, iatrogenic gas collection $(\\leftarrow$ marsupialization, drainage procedure)\n\n# DISCONNECTED PANCREATIC DUCT SYNDROME \n\nIncidence: unknown; in up to $50 \\%$ after an episode of severe acute necrotizing pancreatitis\nCause: necrosis of ductal epithelium (commonly neck / body); therapeutic intervention $(40 \\%)$\n$\\sqrt{ }$ large intrapancreatic collection / longitudinal nonenhancing glandular necrosis (HALLMARK) of $>2 \\mathrm{~cm}$\n$\\sqrt{ }$ viable upstream pancreatic body / tail\n$\\sqrt{ }$ main pancreatic duct enters collection at $90^{\\circ}$ angle\n$\\sqrt{ }$ persistent / growing collection around pancreas\n$\\sqrt{ }$ persistent drainage of amylase-rich fluid from percutaneously placed catheter despite resolution of fluid collection\nERCP (most sensitive, associated with high morbidity):\n$\\sqrt{ }$ ductal obstruction at level of fluid collection\n$\\sqrt{ } \\pm$ extravasation of contrast material\nMRCP (secretin-enhanced):\n$\\sqrt{ }$ centrally located fluid collection\n$\\sqrt{ } \\pm$ dilatation of upstream portion of pancreatic duct and its side branches\n$C x$ : accumulation of fluid around pancreas, pancreatic ascites, pancreaticopleural fistula $\\leftarrow$ persistent leakage of pancreatic fluid from viable upstream pancreas\n$D x$ : average delay before diagnosis up to 9.3 months\n$R x$ : internal drainage, distal pancreatic resection\n\n| Cambridge Classification of Chronic Pancreatitis |  |  |\n| :--: | :--: | :--: |\n| Grade | Main Pancreatic <br> Duct | No. of Abnormal <br> Side Branches |\n| Normal | normal | none |\n| Equivocal | normal | $<3$ |\n| Mild | normal | $\\geq 3$ |\n| Moderate | abnormal | $\\geq 3$ |\n| Severe | abnormal | $\\geq 3$ |\n\n## Chronic Pancreatitis\n\n= continued inflammatory disease of pancreas characterized by scarring with irreversible permanent damage to anatomy + function primarily of the exocrine pancreas\nIncidence: $3-9 \\div 100,000$ per year (in Western countries); annually 120,000 outpatient visits",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 486,
            "markdown": "# $+50,000$ hospitalizations \n\n## Etiology:\n\n(1) Idiopathic ( $20 \\%$ ) most common cause of chronic pancreatitis in children\n(2) Chronic calcifying pancreatitis\n(3) Chronic obstructive pancreatitis\n\n- acute exacerbation of epigastric pain ( $93 \\%$ ):\ndecreasing with time due to progressive destruction of gland, usually painless after 7 years\n- jaundice ( $42 \\%$ ) from common bile duct obstruction\n- steatorrhea ( $80 \\%$ ); negative secretin stimulation test\n- diabetes mellitus ( $58 \\%$ ) $\\leftarrow$ endocrine insufficiency\n$\\sqrt{ }$ \"double-duct\" sign = dilatation of CBD and main pancreatic duct, a finding typically associated with chronic pancreatitis\n$D D x$ : pancreatic adenocarcinoma\n$\\sqrt{ }$ \"duct-penetrating\" sign = mass penetrated by an unobstructed pancreatic duct\nPlain film:\n$\\sqrt{ }$ numerous irregular calcifications (in 20-50\\% of alcoholic pancreatitis)\nPATHOGNOMONIC\nUGI:\n$\\sqrt{ }$ displacement of stomach / duodenum by pseudocyst\n$\\sqrt{ }$ shrinkage / fold induration of stomach (DDx: linitis plastica)\n$\\sqrt{ }$ stricture of duodenum\nCholangiopancreatography (most sensitive imaging modality):\n$\\sqrt{ }$ side-branch ectasia = slight ductal ectasia / clubbing of side branches (minimal disease)\n$\\sqrt{ }$ \"nipping\" = narrowing of the origins of side branches\n$\\sqrt{ }$ dilatation $>2 \\mathrm{~mm}$, tortuosity, wall rigidity, main ductal stenosis (moderate disease)\n$\\sqrt{ }$ \"beading, chain of lakes, string of pearls\" = multifocal dilatation, stenosis, obstruction of main pancreatic duct + side branches (severe disease)\n$\\sqrt{ }$ intraductal filling defects $\\leftarrow$ mucinous protein plugs / calculi / debris\n$\\sqrt{ }$ prolonged emptying of contrast material\n$\\sqrt{ }$ may have stenosis / obstruction + prestenotic dilatation of CBD\n$\\sqrt{ }$ filling of pseudocysts $(<50 \\%)$\nUS / CT:\n$\\sqrt{ }$ irregular ( $73 \\%$ ) / smooth ( $15 \\%$ ) / beaded ( $12 \\%$ ) pancreatic ductal dilatation (in 41$68 \\%)$\n$\\sqrt{ }$ small atrophic pancreas (in $10-54 \\%$ )\n$\\sqrt{ }$ pancreatic calcifications (in 4-50-68\\%)\n$\\sqrt{ }$ inhomogeneous gland with increased echogenicity ( $62 \\%$ )\n$\\sqrt{ }$ irregular pancreatic contour ( $45-60 \\%$ )\n$\\sqrt{ }$ focal ( $12-32 \\%$ ) / diffuse ( $27-45 \\%$ ) pancreatic enlargement during flare up (DDx: pancreatic carcinoma)\n$\\sqrt{ }$ mostly mild biliary ductal dilatation (29\\%)\n$\\sqrt{ }$ intra- / peripancreatic pseudocysts ( $20-34 \\%$ )\n$\\sqrt{ }$ segmental portal hypertension $\\leftarrow$ splenic vein thrombosis with splenomegaly (in 11\\%)\n$\\sqrt{ }$ arterial pseudoaneurysm formation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 487,
            "markdown": "$\\sqrt{ }$ peripancreatic fascial thickening + blurring of organ margins (16\\%)\n$\\sqrt{ }$ ascites / pleural effusion (9\\%)\n$\\sqrt{ }$ no abnormalities (7\\%)\nMR:\n$\\sqrt{ }$ loss of SI on fat-suppressed T1WI $\\leftarrow$ loss of aqueous protein in pancreatic acini $\\leftarrow$ pancreatic fibrosis\n$\\sqrt{ }$ delayed diminished heterogeneous contrast enhancement $\\leftarrow$ loss of capillary network replaced by fibrous tissue\n\n# Secretin-enhanced MRCP: \n\n$\\sqrt{ }$ side-branch ductectasia $=$ one of the EARLIEST findings of chronic pancreatitis\n$\\sqrt{ }$ main pancreatic duct strictures $\\pm$ dilatation\n$\\sqrt{ }$ pseudocyst, fistula\n$\\sqrt{ }$ loss of MPD distensibility $\\leftarrow$ reduced compliance\n$\\sqrt{ }$ loss of duct tapering in pancreatic tail\n$\\sqrt{ }$ filling defect in MPD $\\leftarrow$ duct calculus\nAngiography:\n$\\sqrt{ }$ increased tortuosity + angulation of pancreatic arcades + intrahepatic arteries (88\\%)\n$\\sqrt{ }$ luminal irregularities / focal fibrotic arterial stenoses ( $25-75 \\%$ ) / smooth beaded appearance\n$\\sqrt{ }$ irregular parenchymal stain\n$\\sqrt{ }$ venous compression / occlusion (20-50\\%)\n$\\sqrt{ }$ portoportal shunting + gastric varices without esophageal varices\n$C x$ : pancreatic carcinoma ( $2-4 \\%$ ), jaundice $\\leftarrow$ biliary stricture ( $3-46 \\%$ ), pseudocyst formation, pancreatic ascites, thrombosis of splenic / mesenteric / portal vein\n$R x$ : surgery for infected pseudocyst, GI bleeding from portal hypertension, common bile duct obstruction, gastrointestinal obstruction\n$D D x$ : pancreatic carcinoma (extrapancreatic spread)\n\n## Chronic Alcoholic Pancreatitis\n\n$=$ characterized by heterogeneous lobular distribution; typically $>8$ years of heavy ethanol abuse\nPathophysiology:\nthick pancreatic secretions with increased protein concentration $\\rightarrow$ precipitation in pancreatic ductules $\\rightarrow$ obstruction $\\pm$ calcification of protein plugs\n$\\sqrt{ }$ protein plugs / calculi within ductal system\n$\\sqrt{ }$ ductal abnormalities more severe in smaller branches\n\n## Chronic Obstructive Pancreatitis\n\nEtiology:\n\n1. Congenital lesion of pancreatic duct\n2. Trauma / surgical duct ligation\n3. Sphincter of Oddi dysfunction, ampullary stenosis\n4. Primary sclerosing cholangitis\n5. Idiopathic fibrosing pancreatitis\n6. Renal failure",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 488,
            "markdown": "7. Slow growing ampullary tumor\n8. Common pancreatic mass: intraductal papillary mucinous tumor, adenocarcinoma, metastasis\n\n| DDx of Chronic Pancreatitis from Adenocarcinoma |  |  |\n| :--: | :--: | :--: |\n| Feature | Chronic Focal Pancreatitis | Pancreatic Adenocarcinoma |\n| Dynamic enhancement | $\\checkmark$ early peak <br> $\\checkmark$ delayed wash-out | $\\checkmark$ peak @ $150-180 \\mathrm{sec}$ <br> $\\checkmark$ gradual rise |\n| DWI |  |  |\n| $\\left(b\\right.$ value of 600 <br> $\\mathrm{sec} / \\mathrm{mm}^{2}$ ) | $\\checkmark$ same as pancreas <br> $\\checkmark$ higher than normal pancreas | $\\checkmark$ hyperintense to pancreas <br> $\\checkmark$ lower than normal pancreas / pancreatitis |\n| ADC | $\\checkmark$ no uptake ( $88 \\%$ ) | $\\checkmark$ increased uptake ( $98 \\%$ ) |\n\n$\\diamond$ Acute pancreatitis occurs in 3-14\\% with average delay in cancer diagnosis by 21 months\n9. Duodenal lesion: duplication cyst, lipoma, duodenal diverticulum, duodenal adenoma\n$\\checkmark$ dilatation of main pancreatic duct\n$\\checkmark$ normal sized / focally or diffusely enlarged / small atrophic gland\n$\\checkmark$ calcifications uncommon\n\n# Autoimmune Pancreatitis AIP (1.8-11\\%) \n\n$=$ PRIMARY / CHRONIC SCLEROSING PANCREATITIS = LYMPHOPLASMACYTIC SCLEROSING PANCREATITIS = NONALCOHOLIC DUCT-DESTRUCTIVE / IDIOPATHIC DUCT-CENTRIC CHRONIC PANCREATITIS = PSEUDOTUMOROUS PANCREATITIS\n$=$ unique form of chronic pancreatitis characterized by diffuse inflammatory infiltration by T-lymphocytes and IgG4-positive plasma cells with exuberant fibrosis\nHisto: dense periductal lymphoplasmacytic infiltrates\nType 1: lymphoplasmacytic sclerosing pancreatitis with storiform fibrosis and obliterative phlebitis and high rate of relapse\n\n- biliary tract involvement (in up to $80 \\%$ )\n\nType 2: idiopathic duct centric pancreatitis with granulocytic epithelial lesions without relapse\nPrevalence: $2-5 \\%$ of chronic pancreatitis\nMean age: 56 (range, 14-77) years; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 1$\nAssociation with other autoimmune conditions:\nIgG4-related lesions similar to autoimmune pancreatitis have been identified in many extrapancreatic organs, like bile ducts, gallbladder, lymph nodes, retroperitoneum, mesentery, kidney, lung, breast, prostate gland, skin.\n\n1. Tubulointerstitial nephritis(7-35\\%)\n2. Sialadenitis ( $12-16 \\%$ )\n3. Sjögren syndrome",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 489,
            "markdown": "4. Primary sclerosing cholangitis (68-88\\%)\n5. Primary biliary cirrhosis\n6. Inflammatory bowel disease: ulcerative colitis (17\\%)\n7. Systemic lupus erythematosus\n8. Systemic lymphadenopathy\n9. Retroperitoneal fibrosis (3-8\\%)\n10. Renal involvement (3-35\\%)\n11. Chronic thyroiditis\n\nNearly $40 \\%$ of patients with IgG4-related pancreatitis also have salivary $\\pm$ lacrimal gland involvement, characterized by bilateral painless glandular swelling, which may precede / accompany pancreatitis / occur in isolation.\n\n- no / mild upper abdominal pain (35\\%), easy fatigability\n- bulging of papilla with obstructive jaundice (63-75\\%)\n- weight loss (35\\%); diabetes mellitus (42-76\\%)\n- symptoms of pancreatitis at presentation unusual (33\\%)\n- serum level of immunoglobulin G4 (IgG4) $>130 \\mathrm{mg} / \\mathrm{dL}(67-94 \\%$ sensitive, $90-100 \\%$ specific)\n- positivity for ALA (antilactoferrin antibody), ACA II (anti-carbonic anhydrase II antibody), ASMA (anti-smooth muscle antibody), ANA (antinuclear antibody)\nLocation:\n(a) diffuse form: body + tail of pancreas\n(b) focal form: head of pancreas\n(b) multifocal form: anywhere in pancreas\n\nUS:\n$\\sqrt{ }$ hypoechoic enlarged pancreas\nCT:\n$\\sqrt{ }$ widely varying imaging features depending on degree of fibrosis + inflammatory infiltrate\n$\\sqrt{ }$ \"featureless\" pancreas = loss of lobular architecture in diffusely enlarged sausageshaped pancreas (52\\%) / focal enlargement of pancreas\n$\\sqrt{ }$ homogeneously iso- / hypoattenuating parenchyma\n$\\sqrt{ }$ thin rimlike capsule (of fibrosis)\n$\\sqrt{ }$ rare calcifications / pseudocysts / vessel encasement\n$\\sqrt{ }$ minimal hypoattenuating peripancreatic halo = fat stranding of inflammatory tissue around body + tail\n$\\sqrt{ } \\pm$ involution of pancreatic tail\n$\\sqrt{ } \\pm$ regional lymphadenopathy\n$\\sqrt{ }$ diffusely narrowed pancreatic duct\n$\\sqrt{ } \\pm$ bile duct strictures with upstream ductal dilatation\n$\\sqrt{ }$ reduced enhancement during parenchymal phase (29-75\\%)\n$\\sqrt{ }$ delayed homogeneous enhancement ( $25-71 \\%$ )\nMR:\n$\\sqrt{ }$ homogeneously decreased SI on T1WI isointense relative to liver (100\\%)\n$\\sqrt{ }$ mildly hyperintense (93\\%) / variointense on T2WI",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 490,
            "markdown": "$\\sqrt{ }$ rim of low SI on T2WI with delayed enhancement\n$\\sqrt{ }$ delayed retention of contrast material $\\leftarrow$ widened extracellular extravascular space $(70-89 \\%)$\n\n# CECT /CEMR: \n\n$\\sqrt{ }$ SPECIFIC capsulelike rim / halo of low attenuation surrounding pancreas (not seen in any other pancreatic disorder) $\\leftarrow$ fluid collection / phlegmon / fibrosis (12-48\\% for CECT, $18-47 \\%$ for CEMR)\n\n## MRCP:\n\n$\\sqrt{ }$ diffuse narrowing of main pancreatic duct\n$\\sqrt{ }$ strictures of pancreaticobiliary tree\nERCP:\n$\\sqrt{ }$ focal / segmental / diffuse narrowing of main pancreatic duct + nonvisualization of side branches (CHARACTERISTIC):\n$\\sqrt{ }>3 \\mathrm{~cm}$ long stenosis of main pancreatic duct\n$\\sqrt{ }<6 \\mathrm{~mm}$ diameter of upstream portion of duct\n$\\sqrt{ }$ \"duct-penetrating sign\" = continuity of pancreatic duct highly SPECIFIC for a benign pancreatic mass\n$\\sqrt{ }$ \"ice pick sign\" = smooth tapered narrowing of upstream pancreatic duct just distal to pancreatic lesion\n$\\sqrt{ }$ smooth stricture of distal extrapancreatic CBD + dilatation of proximal duct segment $(90 \\%) \\leftarrow$ extrinsic compression\n$\\sqrt{ }$ strictures of more proximal bile ducts resembling primary sclerosing cholangitis PET:\nPET/CT is helpful in diagnosis and response assessment to corticosteroid therapy.\n$\\sqrt{ }$ longitudinal heterogeneous pattern with multiple areas of uptake within pancreas\n$\\sqrt{ }$ extrapancreatic uptake in lacrimal / salivary glands, biliary system, retroperitoneal space, prostate gland\n@ Renal manifestations\n$\\sqrt{ }$ bilateral small peripheral renal cortical nodules / round lesions / well-defined wedge-shaped lesions / patchy parenchymal lesions\n$\\sqrt{ }$ involvement of perirenal tissue, renal sinus, renal pelvic wall\n@ Pulmonary manifestations\n$\\sqrt{ }$ retroperitoneal fibrosis\n$\\sqrt{ }$ pulmonary parenchymal nodules + infiltrates\n$\\sqrt{ }$ mediastinal adenopathy\n$C x:$ diffuse sclerosis $\\rightarrow$ organ dysfunction\n$R x$ : dramatic response to corticosteroid therapy\n$D D x$ : (1) Pancreatic cancer (invasion / encasement of vessels, mass effect, abrupt narrowing of pancreatic duct + significant proximal dilatation, marked atrophy of parenchyma upstream to mass, fluid collection, IgG4-negativity)\n(2) Lymphoma\n(3) Acute pancreatitis (marked peripancreatic fat stranding, peripancreatic fat necrosis, NO peripancreatic halo)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 491,
            "markdown": "(4) Chronic pancreatitis (calcifications)\n\n# Focal Pancreatitis \n\n$=$ MASS-FORMING / PSEUDOTUMORAL PANCREATITIS\nFrequency: $5-10 \\%$ of pancreatectomies for presumed malignancy\nCause: chronic pancreatitis, autoimmune pancreatitis ( $25 \\%$ ), groove pancreatitis\n$\\diamond$ NO distinguishing morphologic features from adenocarcinoma clinically +\nradiographically $\\leftarrow$ coexistence with inflammation; adenocarcinoma may arise in chronic pancreatitis $(2 \\%[65 \\%]$ after $10[20]$ years)\n$\\sqrt{ }$ \"duct penetrating\" sign = nondilated / smooth tapering of pancreatic + bile ducts coursing through mass\n$\\checkmark$ irregularity of pancreatic duct\n$\\checkmark$ pancreatic calcifications\n$D D x$ : adenocarcinoma (abrupt interruption of smoothly dilated pancreatic duct, upstream pancreatic gland atrophy, gradual enhancement)\n\n## Groove Pancreatitis\n\n$=$ rare distinct form of chronic segmental pancreatitis characterized by inflammation + fibrous tissue formation in pancreaticoduodenal groove\nPrevalence: unknown\nLocation: groove (= potential space) between pancreatic head + duodenum + common bile duct\nCause: unknown\nTypes:\n(a) segmental form = involvement of pancreatic head + pancreaticoduodenal groove mimicking a mass\n(b) pure form = sheetlike fibrotic scar tissue in groove without involvement of pancreatic head\n\n- recurrent vomiting $\\leftarrow$ duodenal obstruction in $50 \\%$\n- symptoms of biliary obstruction (in $50 \\%$ ) rarely precede those of duodenal obstruction\n$\\checkmark$ hypoattenuating sheetlike soft-tissue density\n$\\checkmark$ hypointense on T1WI + iso- to hyperintense on T2WI\n$\\checkmark$ delayed enhancement\n$\\checkmark$ masslike appearance of pancreatic head\nHisto: chronic pancreatitis\n$\\checkmark$ long smooth segmental stricture of intrapancreatic CBD\n$\\checkmark$ widening of space between distal pancreatic duct + CBD and duodenal lumen\n$\\checkmark$ thickening $\\pm$ cystic dystrophy of duodenal wall\n$D D x$ : pancreatic adenocarcinoma (vascular invasion, no cystic lesions within mass / thickened duodenal wall)\n\n\n## Hereditary Pancreatitis $(<1 \\%)$\n\n$=$ autosomal dominant disease with recurrent attacks resulting in chronic pancreatitis\nGenetics: mutation of cationic trypsinogen genes like PRSS1 (serine peptidase) and CFTR (cystic fibrosis transmembrane regulator) gene; NO mutations in 30\\%",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 492,
            "markdown": "Age of onset: variable from 5-10 years to $6^{\\text {th }}$ decade\n$\\sqrt{ }$ pancreatic parenchymal calcifications + ductal calculi\n$\\sqrt{ }$ duct destruction with significant pancreatic atrophy\n$\\sqrt{ }$ absence of anatomic anomalies\nCx: (1) Exocrine + endocrine pancreatic insufficiency\n(2) Pancreatic cancer: 50-70-fold increased risk within 7-30 years of disease onset $\\diamond$ Endoscopic US in 6-12-month intervals starting at 30 years of age\n$D x$ : suspect after 2 attacks of acute pancreatitis without explanation like: anatomic anomalies, ampullary / MPD strictures, trauma, viral infection, gallstones, alcohol consumption, drug use, hyperlipidemia\n$D D x$ : tropical pancreatitis\n\n# Tropical Pancreatitis \n\n$=$ JUVENILE NONALCOHOLIC CHRONIC RELAPSING PANCREATITIS = JUVENILE TROPICAL PANCREATITIS = KWASHIORKOR\n$=$ variant of chronic pancreatitis with rapidly progressive course\n$\\diamond$ Most common cause of pancreatitis worldwide!\nGeography: southern state of Kerala in India, Indonesia, Asia, Africa, and South America\nEtiology:\n(1) Protein energy malnutrition $\\rightarrow$ suppression of pancreatic function\n(2) Pancreatic ductal anomalies\n(3) Food toxicity: chronic cyanide toxicity from cassava\n(4) Genetic predisposition: SPINK 1 N34S mutation, CFTR mutation\n\nMean age: 12.5 years (range, infancy to adulthood); $\\mathrm{M}+\\mathrm{F}=1.6 \\div 1$ to $5 \\div 1$\n\n- abdominal pain ( $80-90 \\%$ ), weight loss, steatorrhea\n- glucose intolerance / frank diabetes mellitus\n$\\sqrt{ }$ multiple discrete dense up to 5 cm large pancreatic calculi within dilated pancreatic duct $(80 \\%) \\pm$ extension into side branches\n$\\sqrt{ }$ pancreatic atrophy $(50 \\%)$\nCx: (1) Fibrocalculous pancreatic diabetes (within decade of onset)\n(2) Pancreatic adenocarcinoma (by 45 years, responsible for $25 \\%$ of deaths)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 493,
            "markdown": "# PANCREATOBLASTOMA \n\n$=$ INFANTILE PANCREATIC CARCINOMA\n$=$ rare childhood tumor often misdiagnosed as neuroblastoma / hepatoblastoma\nFrequency: $0.2 \\%$ of all pancreatic tumors\n$\\diamond$ Most common pancreatic tumor in young children ( $<75$ cases in literature)!\nEthnicity: $>50 \\%$ in Asians\nMean age: 4.5 (range, fetus to 9 ) years; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 1$\nMay be associated with: Beckwith-Wiedemann syndrome\nPath: displacing tumor of soft consistency with cystic spaces $\\leftarrow$ hemorrhage / cystic degeneration\nHisto: epithelial tissue in organoid arrangement of acinar, trabecular, solid formation separated by dense stromal bands; scattered islands of squamoid corpuscles (CHARACTERISTIC)\nSize: 10.6 (range, $1.5-20.0) \\mathrm{cm}$\n$\\diamond$ Organ of origin difficult to establish due to large size!\nLocation: head of pancreas ( $50 \\%$ ) uncommonly dilating the biliary tree\n\n- abdominal pain, fatigue, lethargy, weight loss, anorexia\n- early satiety, vomiting, constipation\n- asymptomatic large palpable mass (slow growing)\n- elevated serum $\\alpha$-fetoprotein (25-33\\%)\n$\\checkmark$ well-defined smooth lobulated solid / multiloculated solitary mass in region of lesser sac\n$\\checkmark \\pm$ small clustered punctate / curvilinear calcifications\n$\\checkmark$ enhancing septa\nUS:\n$\\checkmark$ well-circumscribed hypoechoic / heterogeneous mass with solid + cystic components (with echogenic internal septa)\nMR:\n$\\checkmark$ low (= foci of necrosis) to intermediate SI on T1WI\n$\\checkmark$ heterogeneous high SI on T2WI\nSpread: liver + regional lymph nodes (35\\%); lung / brain (less common); omentum, cul-de-sac, colon, spleen, kidney, adrenal (rare)\n$\\checkmark$ hyperattenuating liver metastases\n$\\checkmark$ regional lymphadenopathy difficult to detect due to large displacing mass\n$\\checkmark$ rarely vascular invasion\n$D D x$ : neuroblastoma, Wilms tumor, hepatoblastoma, NHL, solid-pseudopapillary tumor (adolescent girl)\n$R x$ : complete resection (resectable in $75 \\%$ ) + empirical adjuvant chemotherapy; recurrence after surgery in $14 \\%$\n\n\n## PAPILLARY ADENOMA OF BILE DUCTS\n\n$=$ very rare benign tumor of biliary tract\nPath: usually solitary tumor / biliary papillomatosis with papillary fronds extending into lumen",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 494,
            "markdown": "Histo: columnar epithelium supported by connective tissue from lamina propria $\\pm$ mucin production\n\n- biliary obstruction\n\nLocation: common bile duct > right / left hepatic duct\n$\\sqrt{ }$ usually small intraductal mass\n$\\sqrt{ }$ visualized at cross-sectional imaging only if large enough\n$\\checkmark$ segmental biliary ductal dilatation\nPrognosis: high rate of recurrence after surgical resection\nCx: malignant transformation (rare in solitary adenoma, significant risk in papillomatosis))\n\n# PASSIVE HEPATIC CONGESTION \n\n$=$ stasis of blood within liver parenchyma $\\leftarrow$ impaired hepatic venous drainage $\\leftarrow$ cardiac disease\nCause: CHF, constrictive pericarditis, pericardial effusion, cardiomyopathy, tricuspid / pulmonary valve disease\nPathophysiology: chronic central venous hypertension transmitted to hepatic sinusoids $\\rightarrow$ centrilobular congestion $\\rightarrow$ hepatic atrophy, necrosis, fibrosis $\\rightarrow$ irreversible cardiac cirrhosis\n\n- RUQ pain, hepatomegaly, increased abdominal girth\n- elevation of liver enzymes, jaundice\n$\\checkmark$ hepatomegaly\n$\\checkmark$ ascites, pleural effusion, pericardial effusion\n$\\checkmark$ cardiomegaly, congestive heart failure\nCECT:\n$\\sqrt{ }$ reflux of contrast from RA into IVC $\\rightarrow$ early enhancement of dilated IVC + central hepatic veins during arterial phase\n$\\checkmark$ enhancement of portal veins + hepatic arteries + immediately adjacent parenchyma (56\\%)\n$\\checkmark$ delayed antegrade enhancement of hepatic veins during portal venous phase\n$\\checkmark$ \"reticulated mosaic\" pattern = lobular patchy areas of enhancement separated by coarse linear regions of diminished attenuation ( $100 \\%$ ) during parenchymal phase\n$\\checkmark$ globally delayed enhancement (36\\%)\n$\\checkmark$ linear / curvilinear areas of poor enhancement $\\leftarrow$ delayed enhancement of small + mediumsized hepatic veins\n$\\checkmark$ large patchy peripheral areas of poor delayed enhancement\n$\\checkmark$ perivascular lymphedema = linear hypoattenuating regions encircling intrahepatic IVC / portal veins:\n$\\checkmark$ diminished periportal attenuation (24\\%)\n$\\checkmark$ diminished attenuation around intrahepatic IVC (8\\%)\n$D D x$ : Budd-Chiari syndrome (narrowed intrahepatic IVC / hepatic veins; flip-flop pattern between arterial + venous phase in acute disease; caudate lobe hypertrophy; large regenerative nodules in chronic disease)\n\n\n## PELIOSIS\n\n[ pelios, Greek = purple]",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 495,
            "markdown": "$=$ rare benign disorder characterized by cystic sinusoidal dilatation + multiple blood-filled lacunar spaces between 1 mm and several cm in diameter within organs of the RES\nCause: (a) idiopathic (in $20-50 \\%$ )\n(b) acquired:\n> chronic wasting / infection = bacillary peliosis hepatis (Bartonella henselae and quintana, TB, leprosy, AIDS)\n> hepatotoxic drugs: androgen-anabolic steroids, corticosteroids, tamoxifen citrate, chemotherapeutic agents, azathioprine, oral contraceptives, diethylstilbestrol, thorium dioxide injection, arsenic, polyvinyl chloride)\n> chronic renal failure\n> advanced malignancy: HCC, Hodgkin disease, myeloma, disseminated cancer\n> renal / cardiac transplantation\n(c) ? congenital: angiomatous malformation\n\nHisto: (1) PHLEBECTATIC peliosis hepatis (early stage)\n$=$ endothelial-lined cysts ( $=$ ? dilatation of central veins) communicating with dilated hepatic sinusoids + compression of surrounding liver\n(2) PARENCHYMAL peliosis hepatis (late stage)\n$=$ irregularly shaped cysts without lining communicating with dilated hepatic sinusoids + areas of liver cell necrosis\nAssociated with: hormonally induced benign / malignant tumors; diabetes mellitus, sprue, necrotizing vasculitis\nLocation: liver (most common), spleen, bone marrow, lymph nodes, lung\nAge: fetal life (rare) to adult life\n\n- incidentally discovered; asymptomatic\n$\\checkmark$ hepatomegaly, splenomegaly\n$\\checkmark$ small lesions remain invisible with / without contrast\nUS:\n$\\checkmark$ multiple indistinct areas of variable echogenicity:\n$\\checkmark$ hyperechoic on background of normal liver\n$\\checkmark$ hypoechoic on background of abnormal echogenic liver\n$\\checkmark \\pm$ internal vascularity\nCT:\n$\\checkmark$ focal hypoattenuating area $\\pm$ internal calcifications\n$\\checkmark$ increased attenuation in areas of hemorrhage\nCECT (variable enhancement pattern):\n$\\checkmark$ hypoattenuating relative to liver during early phase + centripetally increasing enhancement during later phases (DDx: hemangioma)\n$\\checkmark$ complete globular vessel-like enhancement during early phase\n$\\checkmark$ \"target\" sign (= central enhancement) with centrifugal progression during portal venous phase\n$\\checkmark$ homogeneously hyperintense on delayed phase\n$\\checkmark \\pm$ nonenhancing central areas of thrombosis simulating metastasis / abscess\nMR:\n$\\checkmark$ variable intensity on T1WI (typically hypointense $\\leftarrow$ subacute blood products",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 496,
            "markdown": "$\\sqrt{ }$ commonly and typically hyperintense on T2WI + central areas of increased SI $\\leftarrow$ necrosis\n$\\sqrt{ }$ mixed SI $\\leftarrow$ repeated hemorrhage (deoxyhemoglobin + methemoglobin + siderotic nodules)\n$\\sqrt{ }$ low SI during arterial phase + contrast accumulation during portal venous + delayed phases\nAngio:\n$\\sqrt{ }$ multiple small (several mm to 1.5 cm ) round collections of contrast medium scattered throughout liver in late arterial phase of hepatic arteriogram\n$\\sqrt{ } \\pm$ simultaneous opacification of hepatic veins\nPrognosis: reversible after drug withdrawal / progression to hepatic failure / intraperitoneal hemorrhage leading to death\nCAVE: inadvertent aspiration of a peliotic lesion may be fatal\n$D D x$ : hypervascular metastasis (hypo- / isoattenuating to liver in portal venous phase); hemangioma (discontinuous globular enhancement in arterial phase + centripetal progression + mass effect); liver abscess\n\n# PORCELAIN GALLBLADDER \n\n$=$ calcium carbonate incrustation of gallbladder wall\nFrequency: $\\quad 0.6-0.8 \\%$ of cholecystectomy patients; $\\mathrm{M}+\\mathrm{F}=1 \\div 5$\nHisto: (a) flakes of dystrophic calcium within chronically inflamed + fibrotic muscular wall\n(b) microliths scattered diffusely throughout mucosa, submucosa, glandular spaces, Rokitansky-Aschoff sinuses\nAssociated with: gallstones in $90 \\%$\n\n- minimal symptoms\n$\\sqrt{ }$ curvilinear (muscularis) / granular (mucosal) calcifications in segment of wall / entire wall\n$\\sqrt{ }$ nonfunctioning GB on oral cholecystogram\n$\\sqrt{ }$ highly echogenic shadowing curvilinear structure in GB fossa (DDx: stone-filled contracted GB)\n$\\sqrt{ }$ echogenic GB wall with little acoustic shadowing (DDx: emphysematous cholecystitis)\n$\\sqrt{ }$ scattered irregular clumps of echoes with posterior acoustic shadowing\nCx: $\\quad 10-20 \\%$ develop carcinoma of gallbladder\n\n\n## PORTAL HYPERTENSION\n\n$=$ portal venous pressure $>10 \\mathrm{mmHg}$\n\n- normal hepatic blood flow of $550-900 \\mathrm{~mL} / \\mathrm{min}(=25 \\%$ of cardiac output) passes through portal system $\\left({ }^{2} / 3\\right)+$ through hepatic artery $(1 / 3)$\nClassification:\nA. DYNAMIC / HYPERKINETIC PORTAL HYPERTENSION\n\nCONGENITAL / traumatic / neoplastic arterioportal fistula\nB. INCREASED PORTAL RESISTANCE\n@ Prehepatic\n> portal vein thrombosis: portal phlebitis, oral contraceptives, coagulopathy, neoplastic invasion, pancreatitis, neonatal omphalitis\n> portal vein compression: tumor, trauma, lymphadeno-pathy, portal phlebosclerosis, pancreatic pseudocyst\n@ Intrahepatic (= obstruction of portal venules)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 497,
            "markdown": "> presinusoidal\n\n1. Congenital hepatic fibrosis\n2. Idiopathic noncirrhotic fibrosis\n3. Primary biliary cirrhosis\n4. Alpha-1 antitrypsin deficiency\n5. Wilson disease\n6. Sarcoid liver disease\n7. Toxic fibrosis (arsenic, copper, PVC)\n8. Reticuloendotheliosis\n9. Myelofibrosis\n10. Felty syndrome\n11. Schistosomiasis\n12. Cystic fibrosis\n13. Chronic malaria\n> sinusoidal\n14. Hepatitis\n15. Sickle cell disease\n> postsinusoidal\n16. Cirrhosis (most frequent): Laennec cirrhosis, postnecrotic cirrhosis from hepatitis\n17. Venoocclusive disease of liver\n@ Posthepatic\n18. Budd-Chiari syndrome\n19. Constrictive pericarditis\n20. CHF (tricuspid incompetence)\n\nPathophysiology:\ncontinued elevated pressure despite formation of portal venous collateral vessels may be explained by\n(a) backward flow theory = hypodynamic flow theory\n$=$ increase in sinusoidal pressure $\\leftarrow$ deposition of collagen in spaces of Disse + hepatocyte swelling\n\n- low / stagnant portal venous flow rates\n(b) forward flow theory = hyperdynamic flow theory\n$=$ splanchnic flow increases $\\leftarrow$ mesenteric vasodilators + increase in cardiac output to preserve hepatic perfusion + intrahepatic endogenous vasoconstrictors\n- increased portal venous flow rates $>15 \\mathrm{~mL} / \\mathrm{min} / \\mathrm{kg}$\n\nFlow direction:\n(a) hepatopetal (petere, Latin = to seek)\n(b) hepatofugal (fugere, Latin = to flee) = flow reversal\n\nCause: intrahepatic arterioportal communications (inside portal triads vasa vasorum of portal veins + hepatic arteries connect via bile duct capillaries to portal v.)\n\n- elevated hepatic wedge pressure $(\\mathrm{HWP})=$ portal venous pressure; normal values seen in presinusoidal portal hypertension\n- caput medusae $=$ drainage from paraumbilical + omental veins through superficial veins of chest (lateral thoracic vein to axillary vein; superficial epigastric vein to internal mammary",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 498,
            "markdown": "vein and subclavian vein) + abdominal wall (circumflex iliac vein and superficial epigastric vein to femoral vein; inferior epigastric vein to external iliac vein)\n\n- hemorrhaging esophageal varices $(50 \\%)$\n@: Splanchnic system:\n$\\sqrt{ }$ portal vein $>13 \\mathrm{~mm}(57 \\%$ sensitive, $100 \\%$ specific)\n$\\sqrt{ }$ SMV + splenic vein $>10 \\mathrm{~mm}$; coronary vein $>4 \\mathrm{~mm}$; recanalized umbilical vein $>3 \\mathrm{~mm}$ (size of vessels NOT related to degree of portal hypertension or presence of collaterals)\n$\\sqrt{ }$ loss of respiratory increase of splanchnic vein diameters of $<20 \\%$ ( $81 \\%$ sensitive, $100 \\%$ specific)\n$\\checkmark$ portal vein aneurysm\n$\\checkmark$ portal vein thrombosis\n$\\checkmark$ cavernous transformation of portal vein\n$\\sqrt{ }$ increased echogenicity + thickening of portal vein walls\nDoppler US:\n$\\sqrt{ }$ continuous monophasic portal venous flow pattern without respiratory fluctuations\n$\\sqrt{ }$ loss of flow increase in portal venous system during expiration\n$\\sqrt{ }$ DIAGNOSTIC reduction of peak portal vein velocity to $<16 \\mathrm{~cm} / \\mathrm{sec}$ (normally 16-40 $\\mathrm{cm} / \\mathrm{sec}$ )\n\n| Spontaneous Portosystemic Shunts |  |\n| :-- | :--: |\n| Type of Varices | Frequency (\\%) |\n| Coronary venous | $80-86$ |\n| Esophageal | $45-65$ |\n| Paraumbilical | $10-43$ |\n| Abdominal wall | 30 |\n| Perisplenic | 30 |\n| Retrogastric / gastric | $2-27$ |\n| Paraesophageal | 22 |\n| Omental | 20 |\n| Retroperitoneal-paravertebral | 18 |\n| Mesenteric | 10 |\n| Splenorenal | 10 |\n| Gastrorenal | 7 |\n\n$\\sqrt{ }$ DIAGNOSTIC hepatofugal flow in main portal vein\n$\\sqrt{ }$ congestive index $>0.13 \\mathrm{~cm} \\cdot \\mathrm{sec}$ (= ratio of area of portal vein divided by flow velocity; $67 \\%$ sensitive)\n$\\sqrt{ }$ may have bidirectional / hepatofugal ( $<10 \\%$ ) flow within spontaneous splenorenal shunts (indicates high incidence of hepatic encephalopathy)\n$\\sqrt{ }$ dilated hepatic artery may demonstrate elevated resistive index $>0.78$\n@: Spontaneous portosystemic shunts / collaterals:\n$\\diamond$ Portosystemic shunts are one of the MOST SPECIFIC findings for portal hypertension!\n\n- high frequency of hepatic encephalopathy\n$\\sqrt{ }$ varices $=$ serpentine tubular rounded structures",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 499,
            "markdown": "$\\sqrt{ }$ coronary (left gastric) vein $>5-6 \\mathrm{~mm}$ (in $26 \\%$ )\n$\\sqrt{ }$ gallbladder wall varices in thickened gallbladder wall (in $80 \\%$ associated with portal vein thrombosis)\n(a) connection to SVC\n\n1. Esophageal varices\n2. Paraesophageal varices\n(b) connection to pulmonary circulation\n3. Gastropulmonary shunt (between gastric / esophageal vv. and left pericardiophrenic / inferior pulmonary vv.)\n$\\sqrt{ }$ lateral bulging of paraspinal interfaces on CXR\n$\\sqrt{ }$ obliteration of azygoesophageal recess on CXR\n$\\sqrt{ }$ cardiophrenic angle masses (with membranous obstruction of IVC)\n(c) retrograde mesenteric flow\n4. Veins of Retzius (= anastomoses between portal vein and IVC)\n> ileocolic veins $\\rightarrow$ right gonadal vein $\\rightarrow$ IVC\n> pancreaticoduodenal vein $\\rightarrow$ IVC\n> proximal small left branches of SMV $\\rightarrow$ left gonadal vein $\\rightarrow$ left renal vein\n> ileocolic veins $\\rightarrow$ directly into IVC\n(d) retroperitoneal collaterals\n5. Splenorenal / splenoadrenorenal shunt\n6. Gastrorenal shunt\n7. Mesenterorenal shunt (SMV $\\rightarrow$ right renal vein)\n8. Mesenterogonadal shunt (ileocolic vein $\\rightarrow$ right testicular vein)\n9. Splenocaval shunt (splenic vein $\\rightarrow$ left hypogastric v.)\n(e) intrahepatic shunt (portal vein $\\rightarrow$ hepatic veins)\n@) Cruveilhier-von Baumgarten syndrome (20-35\\%)\n$=$ recanalized paraumbilical veins (NOT recanalized umbilical veins)\n$\\sqrt{ }$ hypoechoic channel in ligamentum teres\n(a) size $<2 \\mathrm{~mm}$ (in $97 \\%$ of normal subjects; in $14 \\%$ of patients with portal hypertension)\n(b) size $\\geq 2 \\mathrm{~mm}(86 \\%$ sensitive for portal hypertension)\n$\\sqrt{ }$ arterial signal on Doppler US in $38 \\%$\n$\\sqrt{ }$ hepatofugal venous flow ( $82 \\%$ sensitive, $100 \\%$ specific for portal hypertension)\n@) Spleen\n$\\sqrt{ }$ splenomegaly (nonspecific; absence does NOT rule out portal hypertension)\n$\\sqrt{ }$ Gamma-Gandy nodules in $13 \\%$ (= small foci of perifollicular + trabecular hemosiderin deposits after hemorrhage):\n$\\sqrt{ }$ multiple $3-8-\\mathrm{mm}$ low-intensity (blooming) spots on FLASH / GRASS images\n$\\sqrt{ }$ multiple hyperechoic spots on US\n$\\sqrt{ }$ multiple faint calcifications on CT\n$\\sqrt{ }$ ascites (nonspecific)\nCx: Acute gastrointestinal bleeding (mortality of $30-50 \\%$ during $1^{\\text {st }}$ bleeding)\n\n# Segmental Portal Hypertension \n\n$=$ splenic vein occlusion / superior mesenteric vein occlusion",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 500,
            "markdown": "# PORTAL VEIN ANEURYSM / VARIX \n\n$=$ rare localized saccular / fusiform portal venous dilatation with a portal vein diameter of $>20$ mm\nFrequency: $3 \\%$ of all venous aneurysms; most common type of visceral venous aneurysm\nPrevalence: $0.6-4.3 \\div 1000$ patients\nCause:\n(a) congenital: diverticulum formation $\\leftarrow$ incomplete regression of distal right primitive vitelline vein; vessel wall weakness; anomalous portal vein branching\n(b) ACQUIRED: liver cirrhosis; portal hypertension $\\leftarrow$ portal vein thrombosis; trauma; surgery; pancreatitis\n\n- usually asymptomatic, pain, jaundice, gastrointestinal bleeding\n\nSite: extrahepatic portal vein $(63-77 \\%)>$ splenomesenteric venous confluence $>$ splenic vein $>$ intrahepatic portal vein branch $>$ superior mesenteric vein $>$ inferior mesenteric vein\n$\\sqrt{ }$ often solitary $(80 \\%)$ and fusiform $(97 \\%-100 \\%)$\nCx: portal hypertension, spontaneous thrombosis (28\\%), venous varix rupture, compression of adjacent biliary tree / duodenum / IVC\n\n## PORTAL VEIN THROMBOSIS\n\n$=$ PYLETHROMBOSIS\nEtiology:\nA. IDIOPATHIC (mostly): ? neonatal sepsis\nB. SECONDARY:\n(1) Cirrhosis + portal hypertension (5\\%)\n(2) Tumor invasion by: HCC (13-44\\%), pancreatic carcinoma, cholangiocarcinoma, gastric carcinoma, metastasis / extrinsic compression by tumor\n(3) Trauma: umbilical venous catheterization; Cx of splenectomy ( $7 \\%$, higher in patients with myelo-proliferative disorders); liver transplantation; percutaneous islet cell transplantation; portosystemic shunt surgery\n(4) Hypercoagulable state: blood dyscrasia; clotting disorder; estrogen therapy; severe dehydration, Trousseau\n(5) Intraperitoneal inflammatory process (portal vein phlebitis): perinatal omphalitis; pancreatitis; appendicitis; ascending cholangitis\n(6) Budd-Chiari syndrome (20\\%)\n\nAge: predominantly children, young persons\n\n- nonspecific abdominal pain, hematemesis (esophageal varices)\n- portal systemic encephalopathy\n\nTypes:\nA. BLAND portal vein thrombus\nin $11.2-15.8 \\%$ of cirrhosis with portal hypertension\nMRCP:\n$\\sqrt{ }$ NO effect on portal vein caliber\n$\\sqrt{ }$ low SI on T2WI $\\leftarrow$ hemosiderin within thrombus\nB. MALIGNANT portal vein thrombus in $44 \\%$ of HCC",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 501,
            "markdown": "MRCP:\n$\\sqrt{ }$ expansile dilatation of portal vein\n$\\sqrt{ }$ intermediate to high SI on T2WI\n$\\sqrt{ }$ arterial neovascularity contiguous with primary\n$\\sqrt{ }$ enhancement similar to primary tumor\nCourse: dependent on degree of thrombosis, extent of collateralization, duration of thrombus\n\n# Acute Portal Vein Thrombosis \n\n- may be asymptomatic\n- exacerbation of preexisting portal hypertension\n\nPlain film:\n$\\sqrt{ }$ hepatosplenomegaly\n$\\sqrt{ }$ enlarged azygos vein\n$\\sqrt{ }$ paraspinal varices\nUGI:\n$\\sqrt{ }$ esophageal varices\n$\\sqrt{ }$ thickening of bowel wall\nUS:\n$\\sqrt{ }$ echogenic material within vessel lumen ( $67 \\%$ ) / thrombus may be isoechoic\n$\\sqrt{ }$ increase in portal vein diameter $(57 \\%)$ :\n$\\sqrt{ }$ enlargement of thrombosed segment $>15 \\mathrm{~mm}(38 \\%)$\n$\\sqrt{ }$ portosystemic collateral circulation ( $48 \\%$ ): biliary and gastric tributaries of portal vein (most common)\n$\\sqrt{ }$ thickening of lesser omentum\nDoppler-US:\n$\\sqrt{ }$ NO flow on postprandial color Doppler scans:\n$\\diamond$ Malignant thrombus tends to distend vein + exhibit pulsatile flow, a bland thrombus does not!\n$\\sqrt{ }$ decrease in hepatic artery resistive index:\n$\\sqrt{ } \\mathrm{RI}<0.50$ (in acute occlusive portal vein thrombosis)\n$\\sqrt{ }$ minimal decrease / normal RI (in chronic portal vein thrombosis / nonocclusive thrombosis)\nNECT:\n$\\sqrt{ }$ thrombus usually of high attenuation\n$\\sqrt{ }$ decreased attenuation of affected hepatic parenchyma $\\leftarrow$ edema, depletion of hepatocytes, fibrosis\nCECT:\n$\\sqrt{ }$ transient high attenuation of hepatic parenchyma during hepatic arterial phase $\\leftarrow$ increased arterial flow\n$\\sqrt{ }$ partial / complete filling defect in portal vein:\n$\\sqrt{ }$ low-density center of portal vein thrombus = portal vein density $20-30 \\mathrm{HU}$ less than aortic density\n$\\sqrt{ }$ surrounded by peripheral enhancement\nMR:\n$\\sqrt{ }$ absent flow void in portal area + abnormal SI in main portal vein",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 502,
            "markdown": "$\\sqrt{ }$ hyperintense thrombus on T1WI + T2WI (if $<5$ weeks old)\n$\\sqrt{ }$ filling defect on CEMR\n$\\sqrt{ }$ iso- / hypointense bland thrombus on T1WI + T2WI\n$\\checkmark$ heterogeneous hyperintense tumor thrombus on T2WI\nAngio:\n$\\sqrt{ }$ \"thread and streaks\" sign of tumor thrombus (streaky contrast opacification of tumor vessels)\nCx: (1) Cavernous transformation (19\\%)\n(2) Hepatic infarction\n(3) Bowel infarction\n(4) Variceal bleeding $\\rightarrow$ shock\n\nPrognosis: partial / complete spontaneous resolution\n\n# Chronic Portal Vein Thrombosis \n\nPathophysiology:\ncentral part (caudate lobe + lateral segment) is well supplied by collateral venous vessels; the peripheral zone (mainly right lobe) receives less portal venous blood resulting in increased arterial inflow\n$\\sqrt{ }$ cavernous transformation (= cavernoma) of portal vein:\n$\\sqrt{ }$ presence of a racemose conglomerate network of collateral veins (= enlargement of vasa vasorum of portal vein wall) with portal venous flow linking pancreas + duodenum + gallbladder fossa\n$\\sqrt{ } \\pm$ dilated pancreaticoduodenal venous arcades $\\leftarrow$ SMV occlusion\n$\\sqrt{ } \\pm$ dilated gastric + gastroepiploic veins $\\leftarrow$ splenic vein occlusion\n$\\sqrt{ }$ segmental atrophy of affected liver segments + compensatory hypertrophy of perfused segments:\n$\\sqrt{ }$ abnormal peripheral high-attenuation patches during hepatic arterial phase\n$\\sqrt{ }$ decreased enhancement during portal venous phase\n$\\sqrt{ }$ portoportal channels intrahepatically between segments $\\leftarrow$ thrombosis of intrahepatic portal vein branches\n$\\sqrt{ }$ extensive portosystemic collateralization $\\leftarrow$ extrahepatic portal hypertension\n$\\sqrt{ }$ splenomegaly\n$\\sqrt{ }$ ascites\nNECT:\n$\\sqrt{ }$ nonvisualization of extrahepatic portal vein (= fibrotic portal vein)\n$\\sqrt{ } \\pm$ calcifications within clot / wall of portal vein\nCECT:\n$\\sqrt{ }$ peripheral scattered areas of high attenuation in liver during hepatic arterial phase\n$\\sqrt{ }$ multiple serpentine enhancing collateral vessels\nUS:\n$\\sqrt{ }$ echogenic / nonvisualized portal vein\n$\\sqrt{ }$ multiple tubular anechoic channels in hepatic hilum\nMR:\n$\\sqrt{ }$ hypointense portal vein on T1WI + hyperintense on T2WI (2-18 months old)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 503,
            "markdown": "$\\sqrt{ }$ numerous abnormal flow voids in porta hepatis\n\n# PORTOSYSTEMIC SHUNT \n\n## Congenital Portosystemic Shunt\n\n## Congenital Extrahepatic Portosystemic Shunt (CEPS)\n\n$=$ ABERNETHY MALFORMATION\n$=$ anastomosis between prehilar portomesenteric PV and a systemic vein (IVC $>$ renal / iliac / azygos vein / RA)\nAge:\nType 1: usually early childhood; $\\mathrm{M}+\\mathrm{F}=1 \\div 3$\nType 2: intrauterine to 68 years; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\nAssociated congenital anomalies:\nCHD (ASD, VSD, patent foramen ovale, patent ductus arteriosus, tetralogy of Fallot), situs ambiguous, polysplenia, malrotation, duodenal atresia, annular pancreas, skeletal anomalies, GU malformations\nCause:\nexcessive involution of periduodenal vitelline venous loop / total failure of vitelline veins to establish critical anastomoses with hepatic sinusoids / umbilical veins\nshunt due to persistence of right vitelline vein (shunt drains into retrohepatic IVC) /\nshunt due to persistence of left vitelline vein (shunt drains into IVC or RA above level of hepatic vein confluence)\nTypes (Morgan \\& Superina classification):\n\n1. Complete diversion of portal blood into systemic circulation (end-to-side shunt) with absent intrahepatic portal branches\nla SV / SMV drain separately into systemic vein = complete atresia of portal vein\nlb SV + SMV form a common trunk and drain together into a systemic vein\n2. Some portal flow is diverted into a systemic vein (side-to-side shunt) with intact intrahepatic PV\nTypes according to development of venules in portal triads:\nI absence of PV + absence of venules $=$ PV agenesis\nII absence of PV + presence of venules $=$ PV atresia\nIn suspected type 1 CEPS a liver biopsy is necessary to reveal small portal venules within portal triads (not diagnosable by imaging), a finding indicative of a type II shunt.\n\n- symptoms related to abnormal hepatic development:\n- nonspecific liver dysfunction\n- fatty degeneration + atrophy $\\rightarrow$ small liver volume\n- regenerative / hyperplastic nodules $\\rightarrow$ hepatomegaly\n- symptoms resulting from the portosystemic shunt:\n- elevated serum levels of ammonia, galactose, other toxic metabolites\n- high galactose levels are useful for screening of newborn\n- symptoms from associated congenital abnormalities\n$\\sqrt{ }$ absence of portal hypertension: NO ascites, NO varices, NO splenomegaly",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 504,
            "markdown": "Portal hypertension with its secondary signs of splenomegaly, ascites, portosystemic collaterals is not seen in CEPS.\n$\\checkmark$ polysplenia + hypersplenism (frequent)\n$\\sqrt{ } \\pm$ congenital biliary atresia, choledochal cyst, intrahepatic gallbladder\nUS:\n$\\sqrt{ }$ (often) absent / hypoplastic portal vein\n$\\sqrt{ }$ enlarged hepatic artery $=$ only vessel seen within hepatoduodenal ligament given atresia of portal vein\n\n| Bland vs. Malignant Portal Vein Thrombus |  |  |\n| :--: | :--: | :--: |\n| Findings on US, CT, MR | Bland | Malignant |\n| Echogenicity | hyperechoic (often) | heterogeneous |\n| Attenuation of filling defect | low | higher |\n| Thrombus intensity | iso- to hypo <br> $\\uparrow$ ADC | hetero on T2WI, <br> $\\downarrow$ ADC |\n| Arterialized flow in thrombus | - | + |\n| Presence of Doppler flow | - | + |\n| Contrast enhancement | - | + |\n| Adjacent tumor | none | contiguous |\n| Portal vein expansion | - | + |\n\n$\\sqrt{ }$ portal vein draining into IVC\nCT / MR angiography:\n$\\sqrt{ }$ identification of absent portal branches\n$\\sqrt{ }$ regenerative nodular hyperplasia typically has high signal intensity on T1WI (in 75\\%).\nTransrectal Portal Scintigraphy:\n» rectal administration of 123I iodoamphetamine $\\rightarrow$ absorption into IMV $\\rightarrow$ carried to liver\n$\\sqrt{ }$ simultaneous detection of isotope in liver and lungs\n$\\sqrt{ }$ abnormal portosystemic shunt index (= lung counts divided by liver counts + lung counts) $>5 \\%$\nCx: (1) Intrahepatic tumors: regenerative nodules, FNH, adenoma\n(2) Malignancy (rare): hepatoblastoma, HCC\n(3) Hepatic (portosystemic) encephalopathy (15\\%)\n(4) Hepatopulmonary syndrome $=$ hypoxemia $\\leftarrow$ ventilation-perfusion mismatch $\\leftarrow$ dilatation of intrapulmonary vessels $\\leftarrow$ diversion of vasoactive mediators into systemic circulation\n$D D x$ : (1) Portal vein thrombosis\n(2) Intrahepatic shunt\n$R x$ : determination of the type of shunt is important for the planning of definitive treatment\nIn type 1 CEPS occlusion of the shunt is not an option, because it represents the only drainage route for mesenteric and splenic venous blood. Liver transplantation is the only therapy.",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 505,
            "markdown": "# Congenital Intrahepatic Portosystemic Shunt (rare) \n\n$=$ abnormal intrahepatic connection between posthilar PV branches and HV / IVC\nCause: trauma, portal hypertension\nTypes (Park classification):\n> more common:\n\n1. Single large vessel connecting RPV to IVC\n2. One / more localized shunt(s) in one hepatic segment between peripheral PV branch + HV\n> less common:\n3. Aneurysmal communication between peripheral PV branch and hepatic veins $=$ focal varix\n4. Multiple communications between peripheral PV and HV branches in both hepatic lobes\n\n- hyperammonemia + elevated serum bile acid levels (with persistent shunt patency)\n$\\sqrt{ }$ enlarged afferent + efferent vessels contiguous with portal + hepatic veins\n$\\sqrt{ } \\pm$ abnormal round cystic structure with turbulent flow $=$ focal varix\n$\\sqrt{ }$ increased flow velocity + phasic waveforms in afferent portal vein branch $\\leftarrow$ transmitted cardiac pulsations\n$\\sqrt{ }$ continuous flow with loss of normal triphasic waveform in efferent hepatic vein branch $\\leftarrow$ increased portal venous inflow\nPrognosis: $\\pm$ spontaneous closure during $1^{\\text {st }}$ year of life; at risk for hepatic encephalopathy (in adult life)\n\n\n## Extrahepatic Portosystemic Shunt\n\n(a) congenital (rare)\n(b) acquired (most common)\n\nCause: portal venous hypertension\n\n## Portosystemic Surgical Connections\n\nA. NONSELECTIVE SHUNT\n$=$ decompression of the entire portal system with increased risk of hepatic encephalopathy\n\n1. Portocaval shunt\n$=$ portal vein $\\rightarrow$ IVC end-to-side / side-to-side",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 506,
            "markdown": "![img-66.jpeg](img-66.jpeg)\n2. Mesocaval shunt\n$=$ synthetic graft between SMV and IVC\n(a) short \"H-graft\" to posterior wall of SMV\n(b) long \"C-graft\" to anterior wall of SMV\n(c) direct mesocaval shunt dividing IVC (rare)\n3. Mesorenal shunt\n4. Mesoatrial shunt\n$=$ polytetrafluoroethylene graft between anterior wall of SMV superior to pancreas and right atrium coursing through abdomen + diaphragm into right thoracic cavity\nB. SELECTIVE SHUNT\n$=$ decompression of parts of the portal system with preservation of blood flow to the liver\n$\\diamond$ Contraindicated in patients with ascites\n\n1. Distal splenorenal shunt $=$ Warren shunt (popular)\n$=$ splenic vein $\\rightarrow$ left renal vein\nDoppler criteria for shunt patency:",
            "images": [
                {
                    "id": "img-66.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 187,
                    "bottom_right_x": 1339,
                    "bottom_right_y": 1361,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 507,
            "markdown": "$\\sqrt{ }$ increased local velocities\n$\\sqrt{ }$ turbulence + severe spectral broadening\n$\\sqrt{ }$ dilatation of recipient vein at shunt site\n$\\sqrt{ }$ phasic flow pattern in portal tributaries\n$\\sqrt{ }$ hepatofugal flow in intrahepatic portal vein branches\n$\\sqrt{ }$ reduction in size + number of portosystemic collaterals\n$\\sqrt{ }$ reduction / absence of ascites or splenomegaly\n\n# Transjugular Intrahepatic Portosystemic Shunt (TIPS) \n\n$=$ portal decompression through percutaneously established shunt with expandable metallic stent between hepatic + portal veins within the liver\nIndication: patients with esophageal + gastric variceal hemorrhage / refractory ascites $\\leftarrow$ advanced liver disease with portal hypertension, hepatorenal syndrome, hepatic hydrothorax, Budd-Chiari syndrome\nSuccess: technical in 96-99\\%, control of variceal bleeding in 94-100\\%, control of refractory ascites in $58-84 \\%$\nType of stent: 10-mm Wall stent (curved), Palmaz stent (straight), Strecker stent, spiral Z stent\n$\\diamond$ polytetrafluoroethylene (PTFE)-covered stent has a higher patency rate over time\nShunt surveillance:\nat regular 3-6-month intervals after initial assessment performed at 1 month after bare stent (Wallstent) placement / 1 month after initial placement of a covered stent\nAssessment:\nA. MORPHOLOGY\n\n1. Ascites\n2. Portosystemic collaterals\n3. Size of spleen\n4. Diameter of stent (usually $8-10 \\mathrm{~mm}$ )\n5. Configuration of stent: areas of narrowing\n6. Extension of stent into portal + hepatic veins\nB. HEMODYNAMICS\n7. Direction of flow in: extrahepatic portal vein, $\\mathrm{R}+\\mathrm{L}$ portal vein, SMV, splenic vein, all 3 hepatic veins, intrahepatic IVC, paraumbilical vein, coronary vein\n8. Peak blood flow velocity within main portal vein\n9. Peak blood flow velocity within proximal + mid + distal aspects of stent\n10. Hepatic artery: PSV, EDV, RI\n$\\sqrt{ }$ high-velocity turbulent flow ( $50-270 \\mathrm{~cm} / \\mathrm{sec}$ ) at least double that of pre-TIPS values\n$\\sqrt{ }$ superimposed cardiac + respiratory variations\n$\\sqrt{ }$ increase in hepatic artery velocities from $77 \\mathrm{~cm} / \\mathrm{sec}$ (pre-TIPS) to $119 \\mathrm{~cm} / \\mathrm{sec}$ (post-TIPS)\n$\\sqrt{ }$ reversed flow direction within portal vein branches\nCx: A. Obstruction to flow\n(1) Shunt obstruction (38\\%)\n(2) Hepatic vein stenosis\nB. Trauma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 508,
            "markdown": "(a) Vascular injury\n(1) Hepatic artery pseudoaneurysm\n(2) Arterioportal fistula\n(2) Intrahepatic / subcapsular hematoma\n(3) Hemoperitoneum $\\leftarrow$ penetration of liver capsule\n(b) Biliary injury\n(1) Transient bile duct dilatation $\\leftarrow$ hemobilia\n(2) Bile collection\nC. Stent dislodgment with embolization to right atrium, pulmonary artery, internal jugular vein\nMortality: $<2 \\%$ (intraperitoneal hemorrhage)\n\n# TIPS Malfunction / Failure \n\nCause: acute thrombosis, improper stent placement, intimal hyperplasia, change in stent configuration, bulging of liver parenchyma into shunt, iatrogenic dissection of portal vein\nPrevalence: $31 \\%$ at 1 year, $42 \\%$ at 2 years\n\n- recurrent bleeding $=$ shunt abnormality in $100 \\%$\nA. $>50 \\%$ STENOSIS (in $30-80 \\%$ within 12 months)\n$=>50 \\%$ reduction in diameter of stent lumen / portal pressure gradient $>12-15 \\mathrm{mmHg}$\nSite: hepatic vein between stent + IVC $>$ hepatic venous end $>$ in-stent $>$ portal venous end\n$\\sqrt{ }$ irregular filling defects along wall of shunt on color Doppler\n$\\diamond$ Pseudointimal hyperplasia is isoechoic to blood!\n$\\checkmark$ generalized decrease in shunt velocity:\n$\\checkmark$ portal vein inflow velocity $<30 \\mathrm{~cm} / \\mathrm{sec}$\n\n| Pre- and Post-TIPS Baseline Study <br> (under stable fasting conditions) |  |  |\n| :-- | :--: | :--: |\n|  | Pre-TIPS | Post-TIPS |\n| Portal vein velocity (cm/sec) | $10-30$ | $40-60$ |\n| Mean portal vein velocity (cm/sec) | $18 \\pm 6$ | $55 \\pm 7$ |\n| Portal pressure (mmHg) | $37 \\pm 8$ | $22 \\pm 6$ |\n| Shunt peak velocity (cm/sec) |  | $95 \\pm 58$ |\n\n$\\sqrt{ }$ maximal shunt velocity of $<60 \\mathrm{~cm} / \\mathrm{sec}$ ( $>95 \\%$ sensitive + specific)\n$\\checkmark$ gradual decrease in shunt velocity over 1-6 months $\\leftarrow$ intimal hyperplasia\n$\\checkmark$ decrease in peak flow velocity in similar location within stent $>50 \\mathrm{~cm} / \\mathrm{sec}$ relative to initial baseline study\n$\\checkmark$ decrease in maximal portal vein velocity $>33-50 \\%$ from baseline over time\n$\\checkmark$ local increase in shunt velocity:\n$\\checkmark$ velocity transition zone within stent with flow acceleration by a factor of 2\n$\\checkmark$ abnormally high velocity $>190 \\mathrm{~cm} / \\mathrm{sec}$\n$\\checkmark$ increase in peak flow velocity in similar location within stent $>50 \\mathrm{~cm} / \\mathrm{sec}$ relative to initial baseline study\n$\\checkmark$ change in flow direction:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 509,
            "markdown": "$\\sqrt{ }$ reversal of portal venous flow direction ( $100 \\%$ sensitive, $92 \\%$ specific, $71 \\%$ PPV, $100 \\%$ NPV)\n$\\checkmark$ change in flow direction in collateral veins from baseline\n$\\checkmark$ retrograde flow in RHV (developing stenosis of right hepatic venous outflow tract)\n$\\checkmark$ loss of pulsatility of portal / shunt flow:\n$\\checkmark$ venous pulsatility index (Vmax - Vmin) + Vmax $<0.16$ ( $94 \\%$ sensitive, $87 \\%$ specific)\n$\\checkmark$ developing / recurring collateral vessels (eg, recanalized umbilical vein)\n$\\checkmark$ developing / worsening ascites / splenomegaly\nB. OCCLUSION\n$\\checkmark$ absent flow within shunt\n$\\checkmark$ echogenic material within stent\n, acute cause: prolonged procedural catheterization, leakage of bile into / around stent\n, delayed cause: pseudointimal hyperplasia, stent shortening with delayed stent expansion\nTIPS revision: balloon angioplasty, recanalization, insertion of additional stent, creation of parallel stent\n\n# POSTCHOLECYSTECTOMY SYNDROME \n\n$=$ symptoms recurring / persisting after cholecystectomy\nFrequency:\nmild recurrent symptoms in $9-25 \\%$; severe symptoms in $2.6-32.0 \\%$ (result of 1,930\ncholecystectomies):\n, completely cured ( $61 \\%$ )\n, satisfactory improvement with\n(a) persistent mild dyspepsia ( $11 \\%$ )\n(b) mild attacks of pain ( $24 \\%$ )\n, failure with\n(a) occasional attacks of severe pain (3\\%)\n(b) continuous severe distress ( $1.7 \\%$ )\n(c) recurrent cholangitis $(0.7 \\%)$\n\nCause:\nA. BILIARY CAUSES\n(a) Incomplete surgery\n\n1. Gallbladder / cystic duct remnant\n2. Retained stone in cystic duct remnant ( $1 \\%$ )\n3. Overlooked CBD stone (5\\%)\n(b) Operative trauma\n4. Bile duct stricture\n5. Bile peritonitis\n6. Suture granuloma of cystic duct remnant\n(c) Bile duct pathology\n7. Fibrosis of sphincter of Oddi",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 510,
            "markdown": "2. Biliary dyskinesia\n3. Biliary fistula\n4. Cystic duct mucocele\n(d) Residual disease in neighboring structures\n5. Pancreatitis\n6. Hepatitis\n7. Cholangitis\n(e) Overlooked bile duct neoplasia\nB. EXTRABILIARY CAUSES (erroneous preoperative Dx)\n(a) Other GI tract disease:\n8. Inadequate dentition\n9. Hiatus hernia\n10. Peptic ulcer\n11. Spastic colon\n(b) Anxiety state, air swallowing\n(c) Abdominal angina\n(d) Carcinoma outside gallbladder\n(e) Coronary artery disease\n\n# PYLEPHLEBITIS \n\n$=$ ACUTE SUPPURATIVE THROMBOPHLEBITIS OF PORTAL VEIN\n[ pyle, Greek = gate]\nCause: diverticulitis, appendicitis, pancreatitis, cholangitis, inflammatory bowel disease, intraabdominal infection with territory drained by portal vein\nOrganism: gram-negative bacilli\n\n- nonspecific abdominal pain, sepsis\n\nPrognosis: $0-12 \\%(50 \\%)$ mortality if treated (untreated)\nUS:\n$\\sqrt{ }$ acute hyperechoic thrombus\n$\\sqrt{ }$ hyperechoic shadowing foci within portal venous system $=$ gas in portal vein\nCT:\n$\\sqrt{ }$ portal vein thrombus, portal vein gas\n$\\sqrt{ }$ hepatic abscesses\n$\\sqrt{ }$ low-attenuation tubular filling defect (= infected thrombus)expanding portal vein or its tributaries\n$C x$ : hepatic abscess; bowel ischemia from retrograde propagation of thrombus; residual thrombus after successful treatment (frequent)\n$R x$ : culture-specific systemic antibiotic; anticoagulation (controversial)\n\n## RICHTER SYNDROME\n\n$=$ development of large cell / diffuse histiocytic lymphoma in patients with CLL\nEtiology: transformation / dedifferentiation of CLL lymphocytes\nIncidence in CLL patients: 3-10\\%\nMedian age: 59 years",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 511,
            "markdown": "Medium time interval after diagnosis of CLL: 24 months\n\n- fever (65\\%) without evidence of infection\n- increasing lymphadenopathy + hepatosplenomegaly (46\\%)\n- weight loss ( $26 \\%$ ), abdominal pain ( $26 \\%$ )\n\nLocation: bone marrow, lymph nodes, liver, spleen, bowel, lung, pleura, kidney, dura\nPrognosis: median survival time: 4 months from diagnosis of lymphoma; 14\\% rate of remission rate\n\n# SCHISTOSOMIASIS \n\n$\\diamond$ Major cause of portal hypertension worldwide: 200 million people affected\nParasites:\n(a) parasitizing abdominal veins\n> tributaries of superior mesenteric vein\n\n1. Schistosoma mansoni: occurs in $>70$ million inhabitants of parts of Africa, Middle East, Arabic peninsula, northern part of South America, West Indies, Caribbean\n> tributaries of inferior mesenteric + superior hemorrhoidal veins\n2. Schistosoma japonicum: Far East, coastal areas of China, Japan, Formosa, Philippines, Celebes\n(b) parasitizing venules of urinary bladder\n3. Schistosoma haematobium\n\nInfection: cercariae penetrate intact human skin / buccal mucosa from contaminated fresh water (slow-moving streams, irrigation canals, paddy fields, lakes)\nCycle:\ncercariae enter lymphatics + blood system via thoracic duct $\\rightarrow$ larvae are transported into mesenteric capillaries $\\rightarrow$ mature in portal system + liver into worms $\\rightarrow$ worms mate and live in pairs within portal vein + tributaries for $10-15$ years $\\rightarrow$ female swims against blood flow to reach tributaries of superior mesenteric vein (S. mansoni) / tributaries of inferior mesenteric + superior hemorrhoidal veins (S. japonicum) $\\rightarrow$ deposits eggs in wall of intestines or urinary bladder $\\rightarrow$ eggs seed back to liver via portal vein + become trapped in periportal space or pass with feces $\\rightarrow$ hatch within water to release miracidia $\\rightarrow$ miracidia infect snail hosts $\\rightarrow$ cercariae emerge after maturation from snails\nHisto: chronic granulomatous reaction + abundant fibrosis along portal vein branches\n\n- clinically mild infection with chronic course: fever, headache, myalgia, bloody diarrhea, abdominal pain, eosinophilia\n@ Liver \\& spleen ( $10 \\%$ )\n$\\checkmark$ hepatosplenomegaly\n$\\checkmark$ normal parenchymal echogenicity + small peripheral hyperechoic foci in $50 \\%$\n$\\checkmark$ marked diffuse thickening of echogenic walls of portal venules = periportal fibrosis = clay pipe stem fibrosis\n$\\diamond$ Schistosoma infection is the most frequent cause of liver fibrosis worldwide!\nFibrosis pattern of Schistosomiasis mansoni:\nCause: periportal fibrosis most prominent in central liver (large eggs deposit within central liver)\n$\\checkmark$ \"turtleback / tortoise shell\" appearance of liver:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 512,
            "markdown": "$\\sqrt{ }$ thick fibrous bands around portal vein branches radiate from hilum perpendicularly to surface\n$\\sqrt{ }$ shrunken liver with nodular surface contour\n$\\sqrt{ }$ calcifications of large eggs (rare)\nFibrosis pattern of Schistosomiasis japonicum:\nCause: widespread peripheral periportal fibrosis (small eggs deposit near liver capsule)\n$\\sqrt{ }$ thinner fibrous bands give a more uniform polygonal \"honeycomb\" appearance resembling fish scales\n$\\sqrt{ }$ calcifications of interlobular septa (common)\n$\\sqrt{ }$ portal vein dilatation in $73 \\%$ (= presinusoidal portal hypertension)\n@ Biliary tract\n$\\sqrt{ }$ paucity of $2^{\\text {nd }}$ - and $3^{\\text {rd }}$-order biliary branches $\\leftarrow$ biliary obstruction $\\leftarrow$ bile duct proliferation $\\leftarrow$ periportal fibrosis\n$\\sqrt{ }$ irregular focally narrowed wall contours of bile ducts\n$\\sqrt{ }$ hyperechoic gallbladder bed + thickened gallbladder wall\n@ GI tract\n$\\sqrt{ }$ gastric + esophageal varices\n$\\sqrt{ }$ polypoid bowel wall masses (esp. in sigmoid)\n$\\sqrt{ }$ granulomatous colitis\n$\\sqrt{ }$ strictures with extensive pericolic inflammation\n$C x$ : ileus\n$D x$ : eggs in multiple fecal examinations\n$R x$ : praziquantel\n\n# SHWACHMAN-DIAMOND SYNDROME \n\n= rare autosomal recessive condition characterized by congenital absence of pancreatic exocrine tissue, bone marrow dysfunction, skeletal abnormalities and short stature\n$\\diamond 2^{\\text {nd }}$ most frequent cause of exocrine pancreatic insufficiency in childhood after cystic fibrosis!\nIncidence: $1 \\div 75,000$ people\n\n- pancreatic insufficiency, steatorrhea, failure to thrive\n- recurrent respiratory and skin infections $\\leftarrow$ bone marrow hypoplasia; normal electrolytes in sweat\n- trend for improvement with time\n$\\sqrt{ }$ total fatty replacement of pancreas\n$\\sqrt{ }$ metaphyseal chondrodysplasia resulting in dwarfism\n$D D x$ : cystic fibrosis (pancreatic calcifications, cyst formation, abnormal sweat test)\n\n\n## SEROUS CYSTADENOMA OF PANCREAS\n\n$=$ MICROCYSTIC CYSTADENOMA $=$ GLYCOGEN-RICH CYSTADENOMA $=$ MICROCYSTIC PANCREATIC LESION\n$=$ benign lobulated neoplasm composed of $1-20 \\mathrm{~mm}$ small honeycomb cysts containing proteinaceous fluid separated by thin connective tissue septa\nFrequency: $\\sim 50 \\%$ of all cystic pancreatic neoplasms",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 513,
            "markdown": "Path: cysts separated by fibrous septa that radiate from a central scar, which may be calcified; thin fibrous pseudocapsule\nHisto: cyst walls lined by cuboidal / flat glycogen-rich epithelial cells derived from centroacinar cells of pancreas (DDx: lymphangioma)\nTypes:\n(a) classic microcystic form\n(b) oligocystic / macrocystic form = larger + fewer serous cysts mimicking mucinous cystadenoma\nLocation: pancreatic head\n$\\sqrt{ }$ lobulated contour, lack of wall enhancement\n(c) solid form = microscopic serous cysts too small to resolve mimicking pancreatic neuroendocrine tumor\nMean age: 65 (range, 34-88) years; in $82 \\%$ over 60 years of age; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 2-4$\nAssociated with: von Hippel-Lindau syndrome\n\n- commonly incidental discovery at imaging; palpable mass\n- pain, weight loss, malaise, anorexia, fatigue, jaundice\n\nLocation: any part of pancreas affected, slight predominance for head + neck\nSize of mass: 5.0 (range, $1.4-27.0) \\mathrm{cm}$ in diameter\nSize of cysts: typically $<10$ (range, $1-20$ ) mm; uncommonly a few large cysts (in $<5 \\%$ ) / cyst up to 8 cm in diameter\nNumber of cysts: $>6$; typically innumerable\n$\\sqrt{ }$ well-demarcated lobulated mass with smooth / nodular contour\n$\\sqrt{ }$ cysts of honeycomb / bunch of grapes appearance\n$\\sqrt{ }$ prominent central stellate scar in $30 \\%$ (CHARACTERISTIC) $\\leftarrow$ fibrotic walls of collapsed centrally located cyst with tissue retraction\n$\\sqrt{ }$ amorphous central calcifications (in 18\\%) in dystrophic area of stellate central scar (\"sunburst\")\n$\\sqrt{ } \\pm$ progressive enlargement over months / years\n$\\sqrt{ }$ pancreatic duct + CBD may be displaced / encased / obstructed\nUS:\n$\\sqrt{ }$ mass as mixture of hypo- and hyperechoic areas\n$\\sqrt{ }$ may appear as solid predominantly echogenic mass $\\leftarrow$ multiple acoustic interfaces\nCT:\n$\\sqrt{ }$ attenuation values close to water\n$\\sqrt{ }$ may appear solid $\\leftarrow$ small cysts with large amount of fibrous tissue\n$\\sqrt{ }$ contrast enhancement of septa (may be misleading)\nMR:\n$\\sqrt{ }$ cluster of small hyperintense cysts on T2WI\n$\\sqrt{ }$ NO visible communication between cysts + pancreatic duct\n$\\sqrt{ }$ late enhancement of thin fibrous septa\n$\\sqrt{ }$ signal void in central scar $\\leftarrow$ coarse calcifications\n$\\sqrt{ }$ delayed enhancement of scar on contrast-enhanced FLASH\nAngio:\n$\\sqrt{ }$ hypervascular mass with dilated feeding arteries, dense tumor blush, prominent draining",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 514,
            "markdown": "veins, neovascularity, occasional AV shunting, NO vascular encasement\nPrognosis: no malignant potential\n$R x$ : surgical excision / follow-up examinations\n$D D x$ : malignant mucinous cystic neoplasm (younger age, body + tail of pancreas, $>10 \\mathrm{~cm}$ large at presentation)\n\n# SINUSOIDAL OBSTRUCTION SYNDROME \n\n$=$ SOS $=$ venoocclusive disease\n$=$ blockage of small hepatic venules\nPredisposition: stem cell / bone marrow recipients\nDrugs: myeloablative regimens (eg, busulfan plus cyclophosphamide), dacarbazine, cisplatin, oxaliplatin, carboplatin, total body irradiation\nMechanism: necrosis of sinusoidal endothelial cells $\\rightarrow$ extrusion into hepatic sinusoids $\\rightarrow$ obstruction + congestion\n\n- abdominal pain + swelling, weight gain\n- $\\pm$ elevation of serum enzyme levels\n$\\checkmark$ hepatomegaly and hepatic congestion\nCT:\n$\\checkmark$ heterogeneous hepatic attenuation\nCECT:\n$\\checkmark$ heterogeneous enhancement $\\leftarrow$ altered perfusion in areas of increased sinusoidal pressure from venous stasis\n$\\checkmark$ small obstructed hepatic venules NOT visible at imaging\nMR:\n$\\checkmark$ heterogeneous liver with areas of increased signal intensity on T2WI $\\leftarrow$ edema\n$D D x$ : graft versus host disease, viral hepatitis, sepsis\n\n\n## SOLID PSEUDOPAPILLARY TUMOR OF PANCREAS\n\n$=$ SOLID AND PAPILLARY NEOPLASM = SOLID AND CYSTIC TUMOR = PAPILLARY-CYSTIC NEOPLASM = SOLID AND PAPILLARY EPITHELIAL NEOPLASM = HAMOUDI TUMOR\n$=$ rare slow-growing low-grade malignant tumor; often misclassified as nonfunctioning pancreatic endocrine tumor, cystadenoma, or cystadenocarcinoma of pancreas\n$\\diamond$ The classification of solid pseudopapillary tumors as a cystic pancreatic lesion has lead to confusion because many tumors are completely solid. Cystic components are secondary to tumor degeneration varying in size and morphology.\nPrevalence: $1-2 \\%$ of all pancreatic tumors\nMean age: 28 (range, 2-85) years; $\\mathrm{M}+\\mathrm{F}=1+9$; predilection for black and East Asian patients\nPath: large well-encapsulated solitary mass with considerable hemorrhagic necrosis + cystic degeneration\n$\\diamond$ Small tumors are predominantly solid\nHisto: sheets + cords of cells arranged around a fibrovascular stroma\n\n- vague upper abdominal fullness, discomfort and pain\n- nausea, vomiting, gradually enlarging abdominal mass\n- jaundice (rare, even with location in pancreatic head)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 515,
            "markdown": "Location: pancreatic tail (36\\%), pancreatic head (34\\%); frequently exophytic obscuring pancreatic origin\nMean size: 6-10 (range, $0.5-34.5) \\mathrm{cm}$\n$\\sqrt{ }$ well-encapsulated inhomogeneous round / lobulated pancreatic mass with completely solid $\\pm$ cystic portions $\\leftarrow$ tumor degeneration\n$\\sqrt{ }$ may be completely cystic (when complicated by extensive necrosis + internal hemorrhage)\n$\\sqrt{ }$ compression of adjacent structures without invasion\n$\\sqrt{ }$ fluid-fluid or fluid-debris level ( $10-20 \\%$ ) $\\leftarrow$ hematocrit effect\n$\\sqrt{ } \\pm$ stippled / punctate / amorphous dystrophic calcification ( $33 \\%$ ) rimlike in tumor capsule or chunky inside tumor\n$\\sqrt{ }$ hypovascular with contrast enhancement less than pancreas / enhancement of solid tissue projecting toward center of mass\nUS:\n$\\sqrt{ }$ echogenic rim of tumor capsule\n$\\sqrt{ }$ echogenic mass with necrotic center / completely cystic with subcapsular rim of tumor\nCT:\n$\\sqrt{ }$ solid tumor component isoattenuating to pancreas\n$\\sqrt{ }$ cystic component of $20-50 \\mathrm{HU}$\n$\\sqrt{ }$ hypoattenuating tumor pseudocapsule\nMR:\n$\\sqrt{ }$ hypointense fibrous capsule on T1WI + T2WI (80-100\\%)\n$\\sqrt{ }$ solid well-circumscribed tumor:\n$\\sqrt{ }$ iso- to hypointense on T1WI compared to pancreas\n$\\sqrt{ }$ mildly increased T2 signal intensity\n$\\sqrt{ }$ foci of high SI on T1WI (in $80-100 \\%$ ) + variable T2 signal intensity $\\leftarrow$ variable hemoglobin degradation products from internal hemorrhage (DISTINCTIVE FEATURE)\n$\\sqrt{ }$ T2 signal intensity close to fluid in mostly cystic variety\nCEMR:\n$\\sqrt{ }$ enhancing soft-tissue components are uniformly present\n$\\sqrt{ }$ early peripheral heterogeneous / ring enhancement greater than pancreas (70\\%)\n$\\sqrt{ }$ gradual accumulation ( $=$ progressive fill-in) of contrast material within tumor\n$D D x$ : neuroendocrine tumor (early arterial enhancement)\n$\\sqrt{ }$ hypointense to pancreas on delayed images\nAngio:\n$\\sqrt{ }$ hypo- to avascular with displacement of vessels\n$\\sqrt{ }$ mild peripheral blush\nPrognosis: (1) excellent after excision\n(2) metastases (in 7-16\\%): omentum, lymph nodes, liver (usually solitary)\n$R x$ : complete surgical excision ( $95 \\%$ cure rate)\n$D D x$ : (1) Cystic neuroendocrine tumor (older age group, hypointense on T1, diffuse / ringlike enhancement)\n(2) Microcystic adenoma (innumerable tiny cysts, older age group)\n(3) Mucinous cystic neoplasm (large uni- / multilocular cysts, older age group)\n(4) Nonfunctioning pancreatic endocrine tumor (hypervascular)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 516,
            "markdown": "(5) Pleomorphic carcinoma of pancreas (smaller tumor in older patient)\n(6) Pancreatoblastoma (childhood tumor)\n(7) Calcified hemorrhagic pseudocyst\n\n# SPLENIC ANGIOSARCOMA \n\nPrevalence: rare, $<100$ cases in literature\nCause: usually NOT due to thorotrast or toxic exposure to vinyl chloride / arsenic as in liver angiosarcoma\nAge: $50-60$ years\n\n- splenomegaly, abdominal pain\n$\\sqrt{ }$ multiple nodules of varying size $\\rightarrow$ usually enlarging spleen\n$\\checkmark$ solitary complex mass with variable contrast enhancement\n$\\checkmark$ metastasizes to liver (in $70 \\%$ )\n$\\checkmark$ spontaneous rupture (in $33 \\%$ )\nMR:\n$\\checkmark$ focal / diffuse hypointense foci on T1WI + T2WI $\\leftarrow$ iron deposition from hemorrhage\nPrognosis: $20 \\%$ survival rate after 6 months\n\n\n## SPLENIC HAMARTOMA\n\n$=$ SPLENOMA\n$=$ rare typically single nonneoplastic lesion composed of a mixture of normal splenic elements Etiology: congenital\nMay be associated with: hamartomas elsewhere as in tuberous sclerosis\nHisto: (a) mixture of white + red pulp (most common)\n(b) white pulp subtype $=$ aberrant lymphoid tissue\n(c) red pulp subtype $=$ aberrant complex of sinusoids\n\n- asymptomatic\n\nCT:\n$\\checkmark$ attenuation equal to / hypodense to splenic tissue\n$\\checkmark$ prolonged heterogeneous enhancement\nMR:\n$\\checkmark$ heterogeneously hyperintense on T2WI\n$\\checkmark$ diffuse heterogeneous enhancement, more homogeneous on delayed images\n\n## SPLENIC HEMANGIOMA\n\nCause: congenital, arising from sinusoidal epithelium\nPrevalence: $0.03-14 \\%$ (autopsy); $\\mathrm{M}>\\mathrm{F}$\n$\\diamond$ Most common primary splenic tumor!\nAge: $20-50$ years\nHisto: proliferation of vascular channels lined by single layer of endothelium; mostly of cavernous type; may contain areas of infarction, hemorrhage, thrombosis, fibrosis\nAssociated with: generalized angiomatosis, Klippel-Trénaunay-Weber syndrome, BeckwithWiedemann syndrome, Turner syndrome",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 517,
            "markdown": "- asymptomatic or pain + fullness in LUQ\n$\\sqrt{ }$ usually small single lesion $<4 \\mathrm{~cm}$, up to 17 cm in size\n$\\sqrt{ }$ foci of speckled / snowflakelike calcifications\nUS:\n$\\sqrt{ }$ well-marginated predominantly hyperechoic lesion\nCT:\n$\\checkmark$ predominantly avascular cystic lesion\n$\\checkmark$ solid areas hypo- / isodense to normal spleen and enhancing\nMR:\n$\\checkmark$ hypo- / isointense on T1WI + hyperintense on T2WI\n$\\checkmark$ hypointense areas $\\leftarrow$ hemosiderin deposits\n$\\checkmark$ progressive centripetal enhancement with persistent uniform enhancement on delayed images\nNUC:\n$\\checkmark$ no uptake of ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-sulfur colloid\nPrognosis: slow growth, thus becoming symptomatic in adulthood\nCx: (1) Spontaneous splenic rupture (in up to 25\\%)\n(2) Kasabach-Merritt syndrome (= coagulopathy, anemia, thrombocytopenia) with large hemangioma\n(3) Portal hypertension\n(4) Malignant degeneration\n\n\n# SPLENIC INFARCTION \n\n$\\diamond$ Most common cause of focal splenic defects!\nCause:\n\n1. Embolic: bacterial endocarditis (responsible in 50\\%), atherosclerosis with plaque emboli, cardiac thrombus (atrial fibrillation, left ventricular thrombus), metastatic carcinoma\n2. Local thrombosis: sickle cell disease (leading to functional asplenia); myelo- / lymphoproliferative disorders (CML most common); polycythemia vera; myelofibrosis with myeloid metaplasia + splenomegaly; Gaucher disease; collagen vascular disease; portal hypertension\n3. Vasculitis: periarteritis nodosa\n4. Vascular compromise of splenic artery: focal inflammatory process (eg, pancreatitis); thrombus from splenic artery aneurysm; splenic torsion\n5. Therapeutic complication: transcatheter hepatic arterial embolization\nmnemonic: PSALMS\nPancreatic carcinoma, Pancreatitis\nSickle cell disease / trait\nAdenocarcinoma of stomach\nLeukemia\nMitral stenosis with emboli\nSubacute bacterial endocarditis\nAnatomy: branches of the splenic artery are noncommunicating end arteries",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 518,
            "markdown": "- LUQ pain, fever; abnormal lactate dehydrogenase levels\n- elevated erythrocyte sedimentation rate, leukocytosis\n$\\checkmark$ single / multiple focal wedge-shaped peripheral defects\n$\\checkmark$ global infarction\nUS:\n$\\checkmark$ initially ill-defined hypoechoic lesion $\\leftarrow$ inflammation, edema, necrosis\n$\\checkmark$ later increasingly well-defined echogenic lesion $\\leftarrow$ organization of infarct with fibrosis\nCT phases:\n(a) hyperacute phase (day 1)\n$\\checkmark$ mottled area of increased attenuation on NECT $\\leftarrow$ hemorrhage\n$\\checkmark$ large focal hyperattenuating lesion on CECT\n$\\checkmark$ mottled pattern of contrast enhancement\n(b) acute (days $2-4$ ) + subacute phase (days $4-8$ )\n$\\checkmark$ focal progressively more well-demarcated areas of decreased attenuation without enhancement\n(c) chronic phase (2-4 weeks)\n$\\checkmark$ size decreases + attenuation returns to normal\n$\\checkmark$ complete resolution / residual contour defect\n$\\checkmark$ areas of calcification\nCx: acute febrile illness, abscess formation, pseudocyst formation, splenic rupture, hemorrhage\n\n\n# SPLENOSIS \n\n= posttraumatic autotransplantation of splenic tissue to other sites (heterotopic splenic tissue)\nAge: young men with history of trauma / splenectomy\nTime of detection: mean age of 10 years (range, 6 months to 32 years) after trauma\nLocation: diaphragmatic surface, liver, greater omentum, small bowel serosa, parietal peritoneum, pleura after diaphragmatic rupture (attaches to peritoneal / pleural surface)\n$\\checkmark$ multiple small round / oval lobulated encapsulated sessile masses (implants)\nSize: few mm to $3 \\mathrm{~cm} \\leftarrow$ limited blood supply from local neovascularization\nUS:\n$\\checkmark$ mass of homogeneously hypoechoic echotexture\nCT:\n$\\checkmark$ isodense to normal spleen\n$\\checkmark$ attenuation identical to normal spleen in all phases of enhancement\nMR:\n$\\checkmark$ hypointense on T1WI\n$\\checkmark$ heterogeneous enhancement (red + white pulp differences)\n$\\checkmark$ hyper- / rarely hypointense ( $\\leftarrow$ iron deposition) on T2WI\nNUC:\n$\\checkmark$ uptake by ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-sulfur colloid; ${ }^{111}$ In-labeled platelets; ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-heat-damaged RBC (best detection rate without uptake by liver)\nSignificance:\n(1) protects against infection in pediatric patients",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 519,
            "markdown": "(2) may be confused with metastases / lymphoma\n(3) responsible for disease recurrence after splenectomy (eg, idiopathic thrombocytopenic purpura)\n$D D x:$ accessory spleen\n\n# SPONTANEOUS PERFORATION OF COMMON BILE DUCT \n\nPathogenesis: unknown (? CBD obstruction, localized mural malformation, ischemia, trauma)\nAge: 5 weeks to 3 years of age\n\n- vague abdominal distension, varying acholic stools\n- mild persistent hyperbilirubinemia\n\nUS:\n$\\sqrt{ }$ biliary ascites / loculated subhepatic fluid\n$\\checkmark$ localized pseudocholedochal cyst in porta hepatis\nHepatobiliary scintigraphy:\n$\\checkmark$ radioisotope diffusely throughout peritoneal cavity\n\n## THOROTRASTOSIS\n\nThorotrast $=25 \\%$ colloidal suspension of thorium dioxide; used as contrast agent between late 1920s and mid 1950s, in particular for cerebral angiography and liver spleen imaging; chemically inert with high atomic number of $90 ;>100,000$ people injected\nThorium dioxide $=$ consists of 11 radioactive isotopes (Thorium-232 is major isotope); decay by means of alpha, beta, and gamma emission; biologic half-life of 14 billion years; hepatic dose of $1,000-3,000 \\mathrm{rad}$ in 20 years\nDistribution: phagocytized by RES + deposited in liver (70\\%), spleen (30\\%), bone marrow, abdominal lymph nodes $(20 \\%)$\n$\\checkmark$ linear network of metallic density contrast material in spleen, lymph nodes, liver\n$\\checkmark$ spleen may be shrunken / nonfunctional\n$C x$ : hepatic fibrosis, angiosarcoma ( $50 \\%$ ), cholangiocarcinoma, hepatocellular carcinoma (latency period of 3-40 years; mean 26 years)\n\n## TYROSINEMIA\n\n$=$ rare autosomal recessive metabolic disorder\nCountry: increased prevalence in Canadian province of Quebec and parts of Scandinavia\nBiochemistry: deficiency of enzyme fumarylacetoacetase (last step in catabolic pathway of tyrosine, serum methionine, urinary succinylacetone); $\\uparrow$ levels of serum tyrosine as a precursor of dopamine, norepinephrine, epinephrine, melanin, thyroxin\nA. ACUTE FORM\n\n- fulminant liver failure, often by 1 year of age\nB. CHRONIC FORM\n$=$ Fanconi syndrome with renal tubular dysfunction\n- vitamin D-resistant rickets\n- intermittent porphyria-like symptoms\n- progressive liver failure in early childhood\n- anemia, abnormal liver function tests, $\\uparrow$ levels of $\\alpha$-fetoprotein",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 520,
            "markdown": "$\\sqrt{ }$ hepatosplenomegaly\n$\\sqrt{ }$ micro- and macronodular cirrhosis (early childhood):\n$\\sqrt{ }$ regenerating nodules of $2-20 \\mathrm{~mm}$ : hyper- (mostly) / iso- / hypoattenuating; hypo- / occasionally hyperechoic\n$\\sqrt{ }$ portal hypertension\n$\\sqrt{ }$ increased echogenicity (fibrosis + fatty infiltration)\n$\\sqrt{ }$ nephromegaly with uniformly thickened renal cortices\n$\\sqrt{ }$ nephrocalcinosis\nPrenatal Dx: enzyme deficiency demonstrable in hepatocytes, skin fibroblasts, lymphocytes, amniocytes\nCx: hepatocellular carcinoma (in $37 \\%$ beyond 2 years of age)\nRx: (1) Diet restricted in phenylalanine + tyrosine (alleviates kidney damage but does not prevent fatal outcome)\n(2) 2-2-nitro-4-trifluoro-methylbenzoyl-1,3-cyclohexanedione (NTBC) inhibits 4hydroxyphenylpyruvate dioxygenase + prevents formation of maleylacetoacetate and fumarylacetoacetate\n(3) Liver transplantation (before HCC develops)\n\n# UNDIFFERENTIATED SARCOMA OF LIVER \n\n$=$ UNDIFFERENTIATED EMBRYONAL SARCOMA (UES) = MALIGNANT MESENCHYMOMA / SARCOMA\n$=$ rare highly malignant tumor of children\nPrevalence: $4^{\\text {th }}-5^{\\text {th }}$ most common liver tumor in children\nAge: $\\quad<2$ months (in 5\\%); 6-10 years (in 52\\%); by 15 years (in 90\\%); up to 49 years; $\\mathrm{M} \\div \\mathrm{F}=$ $1 \\div 1$\nPath: well-demarcated predominantly solid tumor mixed with cystic gelatinous areas and foci of hemorrhage + necrosis; often with fibrous pseudocapsule\nHisto: primitive undifferentiated stellate / spindle-shaped sarcomatous cells closely packed in whorls + sheets / scattered loosely in a myxoid ground substance with foci of hematopoiesis $(50 \\%)$\n\n- painful RUQ mass and fever (5\\%)\n- mild anemia + leukocytosis (50\\%)\n- elevated liver enzymes (33\\%); normal $\\alpha$-fetoprotein\n\nSpread: lung, pleura, peritoneum\nLocation: right lobe (75\\%); left lobe (10\\%); both lobes (15\\%)\nMean size: 14 (range, 10-29) cm\n$\\diamond$ Discordant findings between US (solid) + CT and MR (cystic)!\nNUC:\n$\\sqrt{ }$ photodefect on sulfur colloid scan\nUS:\n$\\sqrt{ }$ large intrahepatic typically iso- to hyperechoic solid mass\n$\\sqrt{ }$ cystic areas up to 4 cm in diameter (foci of necrosis + old hemorrhage + cystic myxoid degeneration)\nCT:\n$\\sqrt{ }$ cystic multiseptate mass of predominantly water attenuation ( $88 \\%$ of tumor volume) due to",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 521,
            "markdown": "myxoid stroma\n$\\checkmark$ peripheral foci of soft tissue / septa of variable thickness\n$\\checkmark \\pm$ central foci of high attenuation (= hemorrhage)\n$\\checkmark$ occasional fluid-debris level\n$\\checkmark$ well-defined margins of mass $\\leftarrow$ dense enhancing peripheral rim of pseudocapsule CECT:\n$\\checkmark$ predominantly peripheral enhancement on delayed images\nMR:\n$\\checkmark$ focal mass with multiple cystic spaces, septations (best seen on MRI) and central necrosis\n$\\checkmark$ predominantly CSF signal intensity on T1WI + T2WI\n$\\checkmark$ hypointense rim on T1WI + T2WI (= fibrous pseudocapsule)\n$\\checkmark$ hyperintense areas of hemorrhage on T1WI\n$\\checkmark$ heterogeneous enhancement of solid components\nAngio:\n$\\checkmark$ hypo- / hypervascular with stretching of vessels\n$\\checkmark$ scattered foci of neovascularity\nPrognosis: frequently death within 12 months\nRx: multiagent chemotherapy followed by resection / liver transplantation\n$D D x$ : (1) Mesenchymal hamartoma (generally diagnosed by 2 years of age)\n(2) Hydatid cyst (US shows solid nature of mass, delayed enhancement of solid components, peripheral eosinophilia)\n(3) Abscess (history of travel / fever)\n(4) Hepatoblastoma (uncommonly cystic, younger age group, elevated serum AFP level)\n(5) HCC (generally solid, underlying liver disease, elevated serum AFP level)\n\n# WANDERING SPLEEN \n\n$=$ ABERRANT / FLOATING / PTOTIC / DRIFTING / DYSTOPIC / DISPLACED / PROLAPSED SPLEEN\n$=$ excessively mobile spleen on an elongated pedicle displaced from its usual position in LUQ\nIncidence: $<0.2 \\%$ / year\nCause: embryologically absent / malformed gastrosplenic + splenorenal ligaments; deficient / lax abdominal musculature (prune-belly syndrome, pregnancy)\nAge: any (higher frequency in women of childbearing age)\n\n- asymptomatic mobile abdominal / pelvic mass\n- chronic vague lower abdominal / back pain\n- nausea, vomiting, eructation, flatulence\n- acute abdomen $\\leftarrow$ splenic infarction $\\leftarrow$ splenic torsion\n$\\checkmark$ empty splenic fossa + associated soft-tissue mass in center of abdomen / pelvis\n$\\checkmark$ inverted malpositioned stomach\n$\\checkmark$ splenic hilum often located anteriorly\n$\\checkmark$ displaced large spleen $\\leftarrow$ congestion during torsion\n$C x$ :\n\n1. Splenic torsion\n(a) with prolonged venous occlusion: perisplenitis, localized peritonitis, adhesions,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 522,
            "markdown": "venous thrombosis, hypersplenism\n\n- abdominal pain, nausea, vomiting\n- fever, leukocytosis, palpable mass\n$\\checkmark$ ectopic location + increased size\n$\\checkmark$ abnormal ovoid / round contour of spleen\n$\\checkmark$ whorled appearance of twisted splenic pedicle\n$\\checkmark$ adjacent inflammatory changes + free fluid\nCT:\n$\\checkmark$ low attenuation with heterogeneous enhancement\nUS:\n$\\checkmark$ NO flow within spleen on Doppler US\n$\\checkmark$ elevated resistive index in proximal splenic artery\n(b) with arterial occlusion: hemorrhagic infarction, subcapsular / intrasplenic hemorrhage, gangrene, abscess formation, degenerative cysts, functional asplenism, bowel obstruction, necrosis of pancreatic tail\n\n2. GI complications:\n@ Stomach: compression, distension, volvulus, traction diverticulum, varices\n@ Small bowel: dilatation, obstruction\n@ Colon: compression, volvulus, laxity, ptosis\nRx: 1. Splenectomy ( $4 \\%$ postsplenectomy sepsis)\n3. Splenopexy\n4. Conservative treatment (if asymptomatic)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 523,
            "markdown": "# ABDOMEN AND GASTROINTESTINAL TRACT \n\n## DIFFERENTIAL DIAGNOSIS OF GASTROINTESTINAL AND ABDOMINAL DISORDERS\n\n## ACUTE ABDOMEN IN CHILD\n\nThe majority of ER visits for acute abdominopelvic diseases do not require administration of IV contrast for MRI diagnosis\n\n1. Intussusception\n2. Appendicitis\n3. Obstruction (previous surgery, hernia)\n4. Acute gastroenteritis\n5. Basilar pneumonia\n\n## RIGHT LOWER QUADRANT PAIN\n\nA. Inflammation / Infection\n\n1. Acute appendicitis\n\nA normal or even nonvisualized appendix at CT virtually allows exclusion of appendicitis\n2. Crohn disease\n3. Infectious enterocolitis\n4. Neutropenic colitis\n5. Diverticulitis (colon, cecum, Meckel, appendix)\n(a) Colonic diverticulitis\n(b) Right colonic diverticulitis\n(c) Appendiceal diverticulitis\n(d) Meckel diverticulitis\n(e) Ileal diverticulitis\nB. Malignancy\n\n1. Adenocarcinoma: perforation\n2. Lymphoma\nC. Omental / mesenteric conditions\n3. Epiploic appendagitis\n4. Omental infarction\n5. Mesenteric adenitis\nD. Miscellaneous\n6. Ingestion of nondigestable foreign body\n7. Intussusception\n8. Cecal volvulus\n9. Ischemic colitis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 524,
            "markdown": "# E. Ovarian disorders \n\n1. Hemorrhagic ovarian cyst\n2. Pelvic endometriosis\n3. Torsion of ovary\n4. Ovarian hyperstimulation syndrome\n5. Ruptured dermoid\nF. Tubal disorders\n6. Ectopic pregnancy\n7. Hydrosalpinx\n8. Tubo-ovarian abscess\nG. Uterine disorders\n9. Degenerating / torsed leiomyoma\n10. Ovarian vein syndrome\n11. Hematometra\nH. Urinary tract disorders\n12. Nephro- and ureterolithiasis\n13. Cystitis\n\n## HEMOPERITONEUM\n\nA. Traumatic hemoperitoneum\nB. Nontraumatic hemoperitoneum\n(a) Spontaneous hemoperitoneum\n\n1. Highly vascular neoplasm: hepatocellular carcinoma ( $10-15 \\%$ ), hepatic angiosarcoma, metastases (lung carcinoma, renal cell carcinoma, melanoma), hepatic adenoma (!)\nRisk factors: large size of mass; peripheral / subcapsular location; $\\uparrow$ vascularity Pathophysiology: invasion of vessels; $\\uparrow$ intratumoral pressure; venous congestion $\\leftarrow$ venous thrombosis; lack of autoregulation of tumor vessels\n2. Splenomegaly $\\rightarrow$ splenic rupture:\nviral infection (CMV, malaria, EBV); congenital disease; metabolic abnormality (Gaucher disease, amyloidosis); neoplasm (leukemia, lymphoma, hemangiomatosis, angiosarcoma)\n3. Gynecologic causes:\nhemorrhagic ovarian cyst (usually corpus luteal / follicular cyst); ectopic pregnancy; HELLP syndrome; endometriosis; uterine rupture\n4. Vascular lesion:\nruptured arterial aneurysm (abdominal aorta, splenic artery, hepatic artery); ruptured pseudoaneurysm (of hepatic, splenic, gastroduodenal artery) in pancreatitis\n(b) iatrogenic\n5. Anticoagulation (more commonly bleeding into psoas / rectus muscle)\n6. Blood dyscrasias\n7. Invasive procedure / surgery\n\n## GASTROINTESTINAL HEMORRHAGE",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 525,
            "markdown": "Incidence: $1-2 \\%$ of all hospital admissions ( 300,000 annually); increasing with age Age: $>65$ years (in $70 \\%$ ); $\\mathrm{M}+\\mathrm{F}=2 \\div 1$\n$\\diamond$ Upper GI bleed affects younger, lower GI bleed older patients!\nMortality: $10-40 \\%$ (highest for variceal bleeding); increases with age, shock, comorbidity Prognosis: in $75-80 \\%$ spontaneous resolution; in $25 \\%$ recurrence\n\nMassive acute GI bleeding can be intermittent from minute to minute. Failure to demonstrate active bleeding may therefore not prove cessation of bleeding!\n\n- positive fecal occult blood test: Hemoccult ${ }^{\\circledR}$\n- iron deficiency anemia $\\leftarrow$ slow intermittent bleed\n- hematemesis $=$ vomiting of fresh blood\n- coffee-ground vomit $\\leftarrow$ partially digested dark blood\n- melena $=$ black tarry stool\n- hematochezia $=$ red blood per rectum chézein, Greek $=$ defecate\n\nEndoscopy ( $98 \\%$ sensitive, $100 \\%$ specific):\n$1^{\\text {st }}$ line tool for diagnosis + therapy of upper GI bleed.\nCause not identified in $20 \\%$ of lower $+14 \\%$ of upper GI bleed\nNUC ( $93 \\%$ sensitive, $95 \\%$ specific):\nCTA (increasing use, sequential to unenhanced CT):\nA 3-phase CT angiogram (CTA = unenhanced + arterial + portal venous phase) provides the best and most reproducible results in acute gastrointestinal bleeding with a high degree of accuracy regarding location and cause!\nN.B.: Barium / oral contrast may mask acute bleeding site!\n$\\sqrt{ }$ hyperattenuating blood clot on unenhanced phase\n$\\sqrt{ }$ extravascular blush best seen in portal venous phase $\\leftarrow$ enlarging focus of extravasation with higher attenuation\n$\\checkmark$ varied bleed morphology: linear jetlike / swirled / circular ellipsoid / pooled cloudshaped / fluid-contrast level\n$\\checkmark$ cause of hemorrhage identified in $80 \\%$\n\n| Imaging of Acute Gastrointestinal Bleeding |  |  |\n| :--: | :--: | :--: |\n| Modality | Bleeding Rate [mL/min] | Sensitivity [estimates] |\n| Endoscopy |  | $\\begin{aligned} & 95 \\% \\text { (upper GI bleed) } \\\\ & 53 \\% \\text { (lower GI bleed) } \\end{aligned}$ |\n| ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-labeled RBCs | $>0.1$ | $88 \\%$ |\n| 3-phase CT angio | $>0.35$ | $\\begin{aligned} & 91 \\% \\text { (active bleed) } \\\\ & 46 \\% \\text { (obscure bleed) } \\end{aligned}$ |\n| Catheter angiogram | $>0.5$ | $\\begin{aligned} & 63 \\% \\text { (upper GI bleed) } \\\\ & 39 \\% \\text { (lower GI bleed) } \\end{aligned}$ |\n\nSource:\nA. UPPER GASTROINTESTINAL HEMORRHAGE (70\\%)\n$=$ bleeding site proximal to ligament of Treitz\nIncidence: $0.1 \\%$ of all hospital admissions\nMortality: $10 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 526,
            "markdown": "- hematemesis, coffee-ground emesis, melena\n- hematochezia (with rapid bleeding)\n$\\diamond$ Preferred method $=$ endoscopy!\n@ Esophagogastric junction\n\n1. Esophageal varices (17-30\\%): $40 \\%$ mortality\n2. Mallory-Weiss syndrome ( $7-14 \\%$ ): low mortality\n@ Stomach\n3. Acute hemorrhagic gastritis (17-27\\%)\n4. Gastric ulcer $(10 \\%)$\n5. Pyloroduodenal ulcer (17-25\\%)\n\nMortality: $<10 \\%$ if under age $60 ;>35 \\%$ if over age 60\n@ Other causes:\n(a) neoplasm (2-5\\%)\n(b) vascular lesion (2-3\\%): visceral artery aneurysm, AV malformation, vascularenteric fistula\nAverage mortality: $8-10 \\%$\n$R x:$\n(1) Transcatheter embolization (method of choice) abundant collaterals except for postoperative stomach\n(2) Intraarterial vasopressin infusion ( $0.2-0.4 \\mathrm{U} / \\mathrm{min}$ )\n\nPrognosis: controls $73 \\%$ of gastric mucosal bleeding; high recurrence rate\nB. LOWER GASTROINTESTINAL HEMORRHAGE (30\\%)\n$=$ bleeding site distal to ligament of Treitz\nIncidence: $0.02 \\%$ of all hospital admissions\nAge: 200 x more likely in 80 - than in 20 -year-old\nMortality: $3.6 \\%$\n@ Small intestine\ntumor (eg, leiomyoma, hemangioma, metastases), ulcer, diverticula (eg, Meckel\ndiverticulum), inflammatory bowel disease (eg, Crohn disease), vascular\nmalformation, visceral artery aneurysm, aortoenteric fistula\n@ Colorectal $(70 \\%)$\n> massive bleeding\n\n1. Diverticulum (20-55\\%)\n2. Colonic angiodysplasia (3-40\\%)\n3. Biopsy\n> low-rate bleeding\n4. Benign / malignant tumor (8-26\\%)\n5. Inflammatory bowel disease (6-22\\%)\n6. Mesenteric varices\n$R x:$\n(1) Intraarterial vasopressin infusion\n\nPrognosis: $90 \\%$ initial control rate; $30 \\%$ control rate for recurrent bleeding\n(2) Transcatheter embolization requires superselective catheterization using microcatheters + microembolic agents\n$C x: \\quad 25 \\%$ risk of bowel infarction + stricture",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 527,
            "markdown": "# Obscure GI Bleed \n\n$=$ persisting / recurring bleeding from GI tract without obvious cause after EGD + colonoscopy\nIncidence: $5-20 \\%$ without identifiable bleeding source\nTagged RBC scanning is the most sensitive technique for detecting active arterial + venous bleeding sites over a prolonged period and is useful for intermittent bleeding!\n\n## Upper Gastrointestinal Lesion\n\n1. Cameron lesion\n$=$ ulcer in hiatal hernia sac with incidence of $5.3 \\%$\n2. Fundic varices\n3. Peptic ulcer\n4. Angiectasia\n5. Gastric antral vascular ectasia\n6. Dieulafoy lesion\n[Paul Georges Dieulafoy (1839-1911), French physician and surgeon, chief of HôtelDieu de Paris]\n$=$ exulceratio simplex $=$ uncommon developmental large tortuous $1-5 \\mathrm{~mm}$ submucosal arteriole that erodes and bleeds\nLocation: on lesser curvature of stomach within 6 cm of GE junction ( $75 \\%$ ), duodenum ( $14 \\%$ ), colon (5\\%)\n\n## Middle Gastrointestinal Lesion\n\n(a) in patient $<40$ years of age\n\n1. Tumor\n2. Meckel diverticulum\n3. Dieulafoy lesion\n4. Crohn disease\n5. Celiac disease\n(b) in patient $>40$ years of age\n6. Angiectasia\n7. NSAID enteropathy\n8. Celiac disease\n(c) uncommon lesion\n9. Hemobilia\n10. Hemosuccus pancreaticus\n11. Aortoenteric fistula\n\n## Lower Gastrointestinal Lesion\n\n1. Angiectasia\n2. Neoplasm\n\n## Gastrointestinal Bleeding in Infant\n\n(1) Peptic ulcer\n(2) Varices",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 528,
            "markdown": "(3) Ulcerated Meckel diverticulum\n\n# Gastrointestinal Bleeding in Child \n\n(1) Meckel diverticulum\n(2) Juvenile polyp\n(3) Inflammatory bowel disease\n(4) Clotting disorder\n(5) Arteriovenous malformation\n\n## Intramural Hemorrhage\n\nA. VASCULITIS\n\n1. Henoch-Schönlein purpura\nB. TRAUMA\neg, complication of colonoscopic polypectomy\nC. COAGULATION DEFECT\n2. Anticoagulant therapy\n3. Thrombocytopenia\n4. Disseminated intravascular coagulation\nD. DISEASE WITH COAGULATION DEFECT\n5. Hemophilia\n6. Leukemia, lymphoma\n7. Multiple myeloma\n8. Metastatic carcinoma\n9. Idiopathic thrombocytopenic purpura\nE. ISCHEMIC BOWEL DISEASE (often fatal)\n\n- abdominal pain\n- melena\n\nSite: submucosal / intramural / mesenteric\n$\\sqrt{ }$ \"stacked coin\" / \"picket fence\" appearance of mucosal folds $\\leftarrow$ symmetric infiltration of submucosal blood\n$\\sqrt{ }$ \"thumbprinting\" = rounded polypoid filling defect $\\leftarrow$ focal accumulation of hematoma in bowel wall\n$\\checkmark$ separation + uncoiling of bowel loops\n$\\checkmark$ narrowing of lumen + localized filling defects (= asymmetric hematoma)\n$\\checkmark$ no spasm / irritability\n$\\checkmark$ mechanical obstruction + proximal distension of loops\nUS:\n$\\sqrt{ }$ homogeneously hypoechoic symmetric thickening of a long stretch of affected bowel segment\n$\\sqrt{ } \\pm$ preservation of mural stratification\n$\\sqrt{ }$ marked luminal narrowing\n$\\sqrt{ }$ normal / diminished / absent vascularity at Doppler\n$C x$ : lead point for intussusception\nPrognosis: resolution within 2-6 weeks",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 529,
            "markdown": "# Scintigraphy for Gastrointestinal Bleeding \n\nDetection depends on:\n(1) Rate of hemorrhage\n$\\diamond$ If bleeding not detectable by RBC scintigraphy, it will not be detectable by angiography!\n\n- RBC scan detects bleeding as low as $0.1 \\mathrm{~mL} / \\mathrm{min}$\n- Catheter angiography requires bleeding rates of $\\geq 0.5 \\mathrm{~mL} / \\mathrm{min}$ : $63 \\%(39 \\%)$ sensitive for upper (lower) GI bleed\n$\\diamond$ Only $50 \\%$ of angiograms will be positive after a positive scintigram!\n$\\diamond$ A positive scintigram increases likelihood of a positive angiogram from $22 \\%$ to $53 \\%$ !\n$\\diamond$ A hemodynamically unstable patient with systolic pressures $<100 \\mathrm{mmHg}$ should go to angiography!\n(2) Continuous versus intermittent bleeding: most GI hemorrhages are intermittent\n(3) Site of hemorrhage in reference to specific vascular territory: eg, celiac, superior mesenteric, inferior mesenteric artery\n(4) Characteristics of radionuclide agent\n\n\n## 99m Tc-Labeled Autologous RBCs (In Vistro Labeling Preferred)\n\n$\\diamond$ Generally preferred and accepted most sensitive imaging method for lower GI bleeding\n$\\diamond$ Serves to triage patients for angiography as a negative exam predicts a negative arteriogram\nIndications: acute / intermittent arterial or venous bleeding; NOT useful in occult bleeding\nPharmacokinetics:\n» remains in vascular system for a prolonged period\n» liver + spleen activity are low allowing detection of upper GI tract hemorrhage\n» low target-to-background ratio (high activity in great vessels, liver, spleen, kidneys, stomach, colon; probably related to free pertechnetate fraction)\nDose: $10-25 \\mathrm{mCi}$\nImaging:\n(a) flow imaging at 1 frame every 2 sec for 60 seconds immediately after radiotracer injection\n(b) functional imaging at a rate of 1 frame per minute for up to 90 minutes presented as cine clips\n(c) additional delayed static images at $2,4,6,12$ hours up to $24 / 36 \\mathrm{hr}$ as needed, each time coupled with cine loop\n$\\diamond$ Patient can be reimaged within 24 hours without relabeling RBCs when initial scintigram negative!\nLocalization of bleeding site:\nmay be difficult $\\leftarrow$ (1) rapid transit time (bowel motility can be reduced with 1 mg glucagon IV) or $\\leftarrow$ (2) too widely spaced time intervals; overall $83 \\%$ positive\ncorrelation with angiography\n$\\sqrt{ }$ progressive tracer accumulation over time in abnormal location\n$\\sqrt{ }$ change in appearance over time $\\leftarrow$ bowel peristalsis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 530,
            "markdown": "$\\sqrt{ }$ bleeding site conforms to bowel anatomy (localizing information may be misleading $\\leftarrow$ forward / backward peristalsis)\nSensitivity:\nin $83-93 \\%$ correctly identified bleeding site ( $50-85 \\%$ within $1^{\\text {st }}$ hour, may become positive in $33 \\%$ only after $12-24$ hours); collection as small as 5 mL may be detected; superior to sulfur colloid\n» $50 \\%$ sensitivity for blood loss $<500 \\mathrm{~mL} / 24$ hours\n»> $90 \\%$ sensitivity for blood loss $>500 \\mathrm{~mL} / 24$ hours\nFalse positives (5\\%):\n(a) free pertechnetate fraction: physiologic uptake in stomach + intestine, renal pelvis + bladder\n$\\diamond$ Spot view of thyroid shows contamination!\n(b) hepatic hemangioma, accessory spleen, varices, inflammation, isolated vascular process (AVM, venous / arterial graft)\nFalse negatives: $9 \\%$ for bleeding of $<500 \\mathrm{~mL} / 24$ hours\n\n# GASTRIC BLEEDING \n\nInitial test: sampling of gastric content via nasogastric tube / upper endoscopy\nCause: varices, peptic ulcer, angiectasia, gastritis\n$\\checkmark$ frequently stationary position of radiotracer\nFalse positives:\n(a) inefficient labeling with free ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ pertechnetate in normal gastric mucosa\n(b) accumulation in accessory spleen / hepatic hemangioma overlapping stomach\n$\\checkmark$ absence of peristaltic motion\n\n## Small Bowel Bleeding\n\nOther tests: upper + lower endoscopy, double-balloon enteroscopy, capsule endoscopy\nCause: tumor, Meckel diverticulum, Dieulafoy lesion, angiectasia, Crohn disease, celiac disease, hemobilia, aortoenteric fistula\nFalse positives: inflammatory process with hyperemic accumulation of radiotracer (= fixed activity seen on initial flow images)\n\n## Colonic Bleeding\n\nInitial test: ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-labeled autologous RBCs\nCause: diverticulosis, angiodysplasia, neoplasm, internal hemorrhoids\nFalse positives: activity in penis / ureter / bladder\n$\\diamond$ Lateral / \"tail-on-detector\" view!\n\n## ${ }^{99 \\mathrm{~m}}$ Tc-Sulfur Colloid\n\nIndication: bleeding must be active at time of tracer administration; length of active imaging can be increased by fractionating dose\n» Disappearance half-life of 2.5-3.5 minutes (rapidly cleared from blood by RES + low background activity)\n» Active bleeding sites detected with rates as low as $0.04-0.1 \\mathrm{~mL} /$ minute\n» Not useful for upper GI bleeding (interference from high activity in liver + spleen) or bleeding near hepatic / splenic flexure",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 531,
            "markdown": "Dose: $10 \\mathrm{mCi}(370 \\mathrm{MBq})$\nImaging:\nevery image should have $500,000-1,000,000$ counts with oblique + lateral images as necessary\n(a) every 5 sec for 1 minute (\"flow study\" = radionuclide angiogram)\n(b) 60 -second images at $2,5,10,15,20,30,40,60 \\mathrm{~min}$; study terminated if no abnormality up to 30 minutes\n(c) delayed images at $2,4,6,12$ hours\n$\\sqrt{ }$ extravasation of tracer seen in active bleeding\nSpecificity: almost $100 \\%$ (rarely false-positive results due to ectopic RES tissue)\nFalse positives: transplanted kidney, ectopic splenic tissue, modified marrow uptake, male genitalia, arterial graft, aortic aneurysm\n\n# 99m Tc-Pertechnetate \n\nIndication: bleeding from functioning heterotopic gastric mucosa in Meckel diverticulum / intestinal duplication; consider in adults up to age 25 years; independent of bleeding rate\nPathophysiology: tracer accumulation in mucus-secreting cells\n$\\diamond$ Avoid barium GI studies + endoscopy + irritating bowel preparation prior to study!\nDose: $5-10 \\mathrm{mCi}(185-370 \\mathrm{MBq})$\nImaging:\n(a) radionuclide angiogram $2-3 \\mathrm{sec} /$ frame for $1^{\\text {st }}$ minute\n(b) sequential 5-minute images up to 20 minutes with $500,000-1,000,000$ counts per image\nSensitivity: $>80 \\%$\nenhanced by\n» fasting for 3-6 hours to reduce gastric secretions passing through bowel\n» nasogastric tube suction to remove gastric secretions\n» premedication with pentagastrin ( $6 \\mu \\mathrm{~g} / \\mathrm{kg}$ SQ 15 min before study) to stimulate gastric secretion of pertechnetate\n» premedication with cimetidine ( 300 mg qid x 48 hours) to reduce release of pertechnetate from mucosa\n» voiding just prior to injection\nFalse positives:\nbowel inflammation (Barrett esophagus, duodenal ulcer, ulcerative colitis, Crohn disease), enteric duplication, hemangioma, AV malformation, aneurysm, volvulus, intussusception, urinary obstruction, uterine blush\nFalse negatives:\nulcerated epithelium\n\n## Heterotopic gastric mucosa\n\n$=$ epithelial lesion\n\n1. Esophagus\n2. Duodenum\n3. Small bowel",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 532,
            "markdown": "4. Meckel diverticulum\n5. Duplication cyst\n\n# GI ABNORMALITIES IN CHRONIC RENAL FAILURE AND RENAL TRANSPLANTATION \n\n@ Esophagus\n\n1. Esophagitis: candida, CMV, herpes\n@ Stomach \\& duodenum\n2. Gastritis\n$\\checkmark$ thickened gastric folds (38\\%)\n$\\checkmark$ edema + erosions\nCause:\n(a) imbalance of gastrin levels + gastric acid secretion due to\n(1) reduced removal of gastrin from kidney with loss of cortical mass\n(2) impaired acid feedback mechanism\n(3) hypochlorhydria\n(b) opportunistic infection (eg, CMV)\n3. Gastric ulcer $(3.5 \\%)$\n4. Duodenal ulcer $(2.4 \\%)$\n5. Duodenitis $(47 \\%)$\n@ Colon\nMore severely + frequently affected after renal transplantation\n6. Progressive distention + pseudoobstruction\n\nContributing factors: dehydration, alteration of diet, inactivity, nonabsorbable antacids, high-dose steroids\n2. Ischemic colitis\n(a) primary disease responsible for end-stage renal disease: eg, diabetes, vasculitis\n(b) trauma of renal transplantation\n3. Diverticulitis\n\nContributing factors: chronic obstipation, steroids, autonomic nervous dysfunction\n4. Pseudomembranous colitis\n5. Uremic colitis = nonspecific colitis\n6. Spontaneous colonic perforation\n\nCause: nonocclusive ischemia, diverticula, duodenal + gastric ulcers\n@ Pancreas\n\n1. Pancreatitis\n\nCause: hypercalcemia, steroids, infection, immunosuppressive agents, trauma\n@ General\n\n1. GI hemorrhage\n\nCause: gastritis, ulcer, colonic diverticula, ischemic bowel, infectious colitis, pseudomembranous colitis, nonspecific cecal ulceration\n2. Bowel perforation: in $1-4 \\%$ of transplant recipients\n3. Opportunistic infection\n\nOrganism: Candida, herpes, CMV, Strongyloides",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 533,
            "markdown": "4. Malignancy\n(a) skin tumors\n(b) lymphoma\n\n# IMMUNE-MEDIATED GASTROENTEROCOLITIS \n\n1. Celiac disease\n2. Eosinophilic esophagitis\n3. Eosinophilic gastroenteritis\n\n## ENTEROPATHY\n\n## Protein-losing Enteropathy\n\nA. DISEASE WITH MUCOSAL ULCERATION\n\n1. Carcinoma\n2. Lymphoma\n3. Inflammatory bowel disease\n4. Peptic ulcer disease\nB. HYPERTROPHIED GASTRIC RUGAE\n5. Ménétrier disease\nC. NONULCERATIVE MUCOSAL DISEASE\n6. Celiac disease\n7. Tropical sprue\n8. Whipple disease\n9. Allergic gastroenteropathy\n10. Gastrocolic fistula\n11. Villous adenoma of colon\nD. LYMPHATIC OBSTRUCTION\n12. Intestinal lymphangiectasia\nE. HEART DISEASE\n13. Constrictive pericarditis\n14. Tricuspid insufficiency\n\n## Malabsorption\n\n$=$ deficient absorption of any essential food materials within small bowel\nA. PRIMARY MALABSORPTION\n$=$ the digestive abnormality is the only abnormality present\n\n1. Celiac disease $=$ nontropical sprue\n2. Tropical sprue\n3. Disaccharidase deficiencies\nB. SECONDARY MALABSORPTION\n$=$ occurring during course of gastrointestinal disease\n(a) enteric\n4. Whipple disease\n5. Parasites: hookworm, Giardia, fish tapeworm\n6. Mechanical defects: fistulas, blind loops, adhesions, volvulus, short circuits",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 534,
            "markdown": "4. Neurologic: diabetes, functional diarrhea\n5. Inflammatory: enteritis (viral, bacterial, fungal, nonspecific)\n6. Endocrine: Zollinger-Ellison syndrome\n7. Drugs: neomycin, phenindione, cathartics\n8. Collagen disease: scleroderma, lupus, polyarteritis\n9. Lymphoma\n10. Benign + malignant small bowel tumors\n11. Vascular disease\n12. CHF, agammaglobulinemia, amyloid, abetalipoproteinemia, intestinal lymphangiectasia\n\n| Causes of Radiographic Malabsorption Pattern |  |\n| :--: | :--: |\n| General | Specifics |\n| Abnormal digestion |  |\n| $\\downarrow$ digestive juices | pancreatic / hepatic / biliary insufficiency |\n| $\\uparrow$ digestive juices | Zollinger-Ellison gastrinoma, VIPoma |\n| bowel disease | lactose intolerance, Crohn disease, celiac disease, tropical sprue, chronic ischemia |\n| short small bowel | resection, bypass, Roux-en-Y |\n|  | dysmotility, narcotics, psychotropics, |\n| long small bowel | hypothyroidism, radiation and chemotherapy |\n| Abnormal ingestion |  |\n| high fat intaker | binge eating, enteric tube feeding |\n| cathartics, nonabsorbable sugar | MiraLAX ${ }^{\\circledR}$, lactulose, mannitol, sorbitol, maltitol |\n\n(b) gastric\nvagotomy, gastrectomy, pyloroplasty, gastric fistula (to jejunum, ileum, colon)\n(c) pancreatic\npancreatitis, pancreatectomy, pancreatic cancer, cystic fibrosis\n(d) hepatobiliary\nintra- and extrahepatic biliary obstruction, acute + chronic liver disease\n\n# Roentgenographic Signs in Malabsorption \n\n$\\sqrt{ }$ SMALL BOWEL WITH NORMALFOLDS + FLUID\n\n1. Maldigestion (deficiency of bile salt / pancreatic enzymes)\n2. Gastric surgery\n3. Alactasia\n$\\sqrt{ }$ SMALL BOWEL WITH NORMAL FOLDS + WET\n4. Sprue\n5. Dermatitis herpetiformis\n$\\sqrt{ }$ DILATED DRY SMALL BOWEL\n6. Scleroderma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 535,
            "markdown": "2. Dermatomyositis\n3. Pseudoobstruction: no peristaltic activity\n$\\sqrt{ }$ DILATED WET SMALL BOWEL\n4. Sprue\n5. Obstruction\n6. Blind loop\n$\\sqrt{ }$ THICKENED STRAIGHT FOLDS + DRY SMALL BOWEL\n7. Amyloidosis: malabsorption is unusual\n8. Radiation\n9. Ischemia\n10. Lymphoma (rare)\n11. Macroglobulinemia (rare)\n$\\sqrt{ }$ THICKENED STRAIGHT FOLDS + WET SMALL BOWEL\n12. Zollinger-Ellison syndrome\n13. Abetalipoproteinemia: rare inherited disease characterized by CNS damage, retinal abnormalities, steatorrhea, acanthocytosis\n$\\sqrt{ }$ THICKENED NODULAR IRREGULAR FOLDS + DRY SMALL BOWEL\n14. Lymphoid hyperplasia\n15. Lymphoma\n16. Crohn disease\n17. Whipple disease\n18. Mastocytosis\n$\\sqrt{ }$ THICKENED NODULAR IRREGULAR FOLDS + WET SMALL BOWEL\n19. Lymphangiectasia\n20. Giardiasis\n21. Whipple disease (rare)\n\n# Small Bowel Nodularity with Malabsorption \n\nmnemonic: What Is His Main Aim? Lay Eggs, By God\nWhipple disease\nIntestinal lymphangiectasia\nHistiocytosis\nMastocytosis\nAmyloidosis\nLymphoma, Lymph node hyperplasia\nEdema\nBlood\nGiardiasis\n\n## PET IMAGING OF GI TRACT\n\n## GI Cancers with Low / Variable FDG Uptake\n\n1. Any well-differentiated cancer\n2. Mucinous carcinoma\n3. Early MALT lesion",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 536,
            "markdown": "4. Hepatocellular carcinoma\n\n# Pathologic Uptake in GI Tract \n\nPreparation: for bowel loop distension a neutral oral contrast agent containing sorbitol and $0.1 \\%$ barium sulfate (Volumen ${ }^{\\circledR}$ ) is recommended\n@ Esophagus\n\n1. Reflux esophagitis\n2. Radiation esophagitis\n3. Barrett esophagus\n4. Glycogenic acanthosis\n5. Esophageal cancer\n@ Stomach\n6. Gastritis (NSAID, Helicobacter pylori)\n7. GIST\n8. Lymphoma\n9. Adenocarcinoma (variable)\n@ Small bowel\n10. Inflammatory bowel disease\n11. GIST\n12. Lymphoma\n13. Metastases (melanoma)\n@ Colon\n14. Inflammatory enterocolitis\n15. Appendicitis, diverticulitis, abscess\n16. Colon cancer\n\nAbnormal Uptake of Bone Agents in Ascitic, Pleural, Pericardial Effusion\n\n1. Uremic renal disease\n2. Infection\n3. Malignant effusion\n\n## ABDOMINAL MASS\n\n## Abdominal Mass in Neonate\n\nA. RENAL $(55 \\%)$\n\n1. Hydronephrosis ( $25 \\%$ )\n2. Multicystic dysplastic kidney ( $15 \\%$ )\n3. Polycystic kidney\n4. Mesoblastic nephroma\n5. Renal vein thrombosis\nB. GENITAL ( $15 \\%$ )\n6. Ovarian cyst\n7. Hydrometrocolpos\nC. GASTROINTESTINAL ( $15 \\%$ )\n8. Duplication",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 537,
            "markdown": "2. Volvulus\n3. Cystic meconium peritonitis\n4. Mesenteric cyst\nD. NONRENAL RETROPERITONEAL (10\\%)\n5. Adrenal hemorrhage\n6. Neuroblastoma\n7. Teratoma\nE. HEPATOBILIARY (5\\%)\n8. Hemangioendothelioma\n9. Choledochal cyst\n10. Hydrops of gallbladder\n\n# Abdominal Mass in Infant \\& Child \n\nA. RENAL $(55 \\%)$\n\n1. Wilms tumor $(22 \\%)$\n2. Hydronephrosis ( $20 \\%$ )\n3. Cystic renal mass\n4. Congenital anomaly\nB. NONRENAL RETROPERITONEAL (23\\%)\n5. Neuroblastoma $(21 \\%)$\n6. Teratoma\nC. GASTROINTESTINAL (18\\%)\n7. Appendiceal abscess ( $10 \\%$ )\n8. Hepatobiliary (6\\%)\nD. GENITAL (4\\%)\n9. Ovarian cyst / teratoma\n10. Hydrometrocolpos\n\n## Abdominal Wall Mass\n\nA. TUMOR\n(a) benign\n\n1. Desmoid tumor / fibromatosis\n2. Lipoma\n3. Neuroma\n4. Hemangioma\n(b) malignant\n5. Metastatic implants\n6. Primary malignancy\n7. Lymphoma\nB. COLLECTION\n8. Hematoma / seroma\n9. Abscess\nC. HERNIA / REPAIR\n10. Incisional hernia\n11. Retained surgical material",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 538,
            "markdown": "3. Suture granuloma\n4. Keloid\n5. Endometriosis\n\n# ABNORMAL INTRAABDOMINAL AIR \n\n## Abnormal Air Collection\n\n1. Abnormally located bowel $=$ Chilaiditi syndrome\n$=$ symptomatic hepatodiaphragmatic interposition of colon between liver and chest wall\nPrevalence: $0.025 \\%-0.28 \\%$\nCause: increased colonic mobility, reduced liver volume, lax suspensory ligament, phrenic nerve palsy, obesity\n2. Pneumoperitoneum\n3. Retropneumoperitoneum perforation of duodenum / rectum / ascending + descending colon, diverticulitis, ulcerative disease, endoscopic procedure\n4. Gas in bowel wall gastric pneumatosis, phlegmonous gastritis, endoscopy, rupture of lung bulla\n5. Gas within abscess located in subphrenic, renal, perirenal, hepatic, pancreatic space, lesser sac\n6. Gas in biliary system = pneumobilia\n7. Gas in portal venous system\n\n## Pneumoperitoneum\n\n## Cause:\n\nA. DISRUPTION OF WALL OF HOLLOW VISCUS\n(a) trauma\n(b) iatrogenic perforation\n(c) diseases of GI tract\n\n1. Perforated gastric / duodenal ulcer\n2. Perforated appendix\n3. Ingested foreign-body perforation\n4. Diverticulitis: ruptured Meckel diverticulum / sigmoid diverticulum, jejunal diverticulosis)\n5. Necrotizing enterocolitis with perforation\n6. Inflammatory bowel disease: eg, toxic megacolon\n7. Obstruction $\\dagger$ (gas traversing intact mucosa): neoplasm, imperforate anus, Hirschsprung disease, meconium ileus\n8. Ruptured pneumatosis cystoides intestinalis $\\dagger$ with \"balanced pneumoperitoneum\" ( $=$ free intraperitoneal air acts as tamponade of pneumatosis cysts thus maintaining a balance between intracystic air + pneumoperitoneum)\n9. Idiopathic gastric perforation = spontaneous perforation in premature infants: congenital gastric muscular wall defect\nB. THROUGH PERITONEAL SURFACE\n(a) transperitoneal manipulation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 539,
            "markdown": "1. Abdominal needle biopsy / catheter placement\n2. Mistaken thoracentesis / chest tube placement\n3. Endoscopic biopsy\n(b) extension from chest $\\dagger$\n4. Pneumothorax: ventilation, chest injury\n5. Dissection from pneumomediastinum: positive pressure breathing, rupture of bulla / bleb, chest surgery\n6. Bronchopleural fistula\n(c) intraperitoneal rupture of urinary bladder with indwelling Foley catheter / retrograde cystography\n(d) penetrating abdominal injury\nC. THROUGH FEMALE GENITAL TRACT $\\dagger$\n(a) iatrogenic\n7. Perforation of uterus / vagina\n8. Culdocentesis\n9. Rubin test $=$ tubal patency test\n10. Pelvic examination\n(b) spontaneous\n11. Intercourse, orogenital insufflation\n12. Douching\n13. Knee-chest exercise, water skiing, horseback riding\nD. INTRAPERITONEAL\n14. Gas-forming peritonitis\n15. Rupture of abscess\n\nNote $\\dagger=$ asymptomatic spontaneous pneumoperitoneum without peritonitis\n$\\sqrt{ }$ air in lesser peritoneal sac\n$\\sqrt{ }$ gas in scrotum $\\leftarrow$ open processus vaginalis\nLarge collection of gas:\n$\\sqrt{ }$ \"abdominal distension, NO gastric air-fluid level\n$\\sqrt{ }$ \"football\" sign = large pneumoperitoneum outlining entire abdominal cavity\n$\\sqrt{ }$ \"double wall / bas-relief\" sign = Rigler sign\n[Leo Rigler (1896-1979), radiologist in Minneapolis, USA]\n$=$ air outlining the luminal + serosal surface of the bowel wall with patient in supine position (usually requires $>1,000 \\mathrm{~mL}$ of free intraperitoneal gas + intraperitoneal fluid)\n$\\sqrt{ }$ \"telltale triangle\" sign = triangular air pocket between 3 loops of bowel\n$\\sqrt{ }$ depiction of diaphragmatic muscle slips $=$ two or three $6-13-\\mathrm{cm}$ long and $8-10-\\mathrm{mm}$ wide arcuate soft-tissue bands directed vertically inferiorly + arching parallel to diaphragmatic dome superiorly\n$\\sqrt{ }$ outline of ligaments of anterior inferior abdominal wall:\n$\\sqrt{ }$ \"inverted V\" sign = outline of both lateral umbilical ligaments (containing inferior epigastric vessels)\n$\\sqrt{ }$ outline of medial umbilical ligaments (= obliterated umbilical arteries)\n$\\sqrt{ }$ \"urachus\" sign = outline of middle umbilical ligament",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 540,
            "markdown": "RUQ gas (best place to look for small collections):\n$\\sqrt{ }$ single large area of hyperlucency over the liver\n$\\sqrt{ }$ oblique linear area of hyperlucency outlining the posteroinferior margin of liver\n$\\sqrt{ }$ \"doge's cap\" sign = triangular collection of gas in Morison pouch (posterior hepatorenal space)\n$\\sqrt{ }$ outline of falciform ligament $=$ long vertical line to the right of midline extending from ligamentum teres notch to umbilicus; most common structure outlined\n$\\sqrt{ }$ \"ligamentum teres\" sign = air outlining fissure of ligamentum teres hepatis (= posterior free edge of falciform ligament) seen as vertically oriented sharply defined slitlike / oval area of hyperlucency between $10^{\\text {th }}$ and $12^{\\text {th }}$ rib within $2.5-4.0 \\mathrm{~cm}$ of right vertebral border $2-7 \\mathrm{~mm}$ wide and $6-20 \\mathrm{~mm}$ long\n$\\sqrt{ }$ ligamentum teres notch $=$ inverted V-shaped area of hyperlucency along undersurface of liver\n$\\sqrt{ }$ \"saddlebag / mustache / cupola\" sign = gas trapped below central tendon of diaphragm\n$\\sqrt{ }$ parahepatic air $=$ gas bubble lateral to right edge of liver\nUS ( $85.7 \\%$ sensitive, $99.6 \\%$ specific):\n$\\sqrt{ }$ enhancement of peritoneal stripe\nNote: normal peritoneal stripe $=$ single / double hyperechoic line deep to anterior abdominal wall\n$\\sqrt{ }$ posterior shadowing / reverberation artifacts depending on amount of free air\n$D D x$ : intraluminal bowel gas (associated with normal overlying peritoneal stripe)\n\n# Iatrogenic Pneumoperitoneum \n\n1. Laparotomy / laparoscopy (58\\%)\nabsorbed in 1-24 days dependent on initial amount of air introduced and body habitus ( $80 \\%$ in asthenic, $25 \\%$ in obese patients)\n$\\diamond$ After 3 days free air should be followed with suspicion!\n2. Leaking surgical anastomosis\n3. Peritoneal dialysis\n4. Feeding tube placement\n5. Endoscopic perforation\n6. Enema tip injury\n7. Use of gynecologic instruments\n8. Vigorous respiratory resuscitation\n9. Diagnostic pneumoperitoneum\n10. Diagnostic peritoneal lavage\n\n## Miscellaneous Causes of Pneumoperitoneum\n\n1. Drugs: steroids, NSAID\n2. Pneumatosis coli / intestinalis\n3. Entry through female genital tract: douching, sexual intercourse, insufflation\n\n## Spontaneous Pneumoperitoneum\n\n1. Perforated peptic ulcer\n2. Ischemia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 541,
            "markdown": "3. Bowel obstruction\n4. Toxic megacolon\n5. Inflammation: appendicitis, tuberculosis, necrotizing enterocolitis\n6. Benign pneumoperitoneum of systemic sclerosis\n7. Malignancy ( $8-10 \\%$ ): colorectal carcinoma ( $3-10 \\%$ ), gastrointestinal lymphoma\n\nCT\n$\\checkmark$ depiction of primary malignancy + site and extent of perforation\n$\\checkmark$ pneumoperitoneum\n$\\checkmark$ extravasation of bowel content + oral contrast\n$\\checkmark$ contained leak\n$\\checkmark$ gas within tumor\n$\\checkmark$ formation of enteroenteric fistula\n\n# Traumatic Pneumoperitoneum \n\n(a) Blunt trauma\n(b) Penetrating trauma:\n\n1. Perforating foreign body: eg, thermometer injury to rectum, vaginal stimulator in rectum\n2. Barotrauma:\n(a) compressor air directed toward anus\n(b) pulmonary barotrauma\n(c) mechanical ventilation\n\n## Pseudopneumoperitoneum\n\n$=$ process mimicking free air\nA. ABDOMINAL GAS\n$=$ presence of gas confined to inner layer of abdominal wall but external to parietal peritoneum\n(a) gastrointestinal gas\n\n1. \"Pseudo-wall\" sign = apposition of gas-distended bowel loops\n2. Chilaiditi syndrome\n3. Diaphragmatic hernia\n4. Diverticulum of esophagus / stomach / duodenum\n(b) extraintestinal gas\n5. Retroperitoneal air: eg, rectal injury\n6. Subdiaphragmatic abscess\nB. CHEST\n7. Pneumothorax\n8. Empyema\n9. Irregularity of diaphragm\n10. Rib fracture\nC. FAT\n11. Subdiaphragmatic intraperitoneal fat\n12. Interposition of omental fat between liver + diaphragm\n\n## Pneumoretroperitoneum",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 542,
            "markdown": "# Cause: \n\n(1) Traumatic rupture: usually duodenum\n(2) Perforation of duodenal ulcer\n(3) Gas abscess of pancreas (usually extends into lesser sac)\n(4) Urinary tract gas: trauma, infection\n(5) Dissected mediastinal air\n$\\sqrt{ }$ kidney outlined by gas\n$\\sqrt{ }$ outline of psoas margin $\\pm$ gas streaks in muscle bundles\n\n## Pneumatosis Intestinalis\n\n$=$ PNEUMATOSIS CYSTOIDES INTESTINALIS = BULLOUS EMPHYSEMA OF THE INTESTINE = INTESTINAL GAS CYSTS = PERITONEAL LYMPHOPNEUMATOSIS\n$=$ cystic / linear gas collection in bowel wall\nCause:\n$\\diamond$ Attributed to at least 58 causative factors!\nA. BOWEL NECROSIS / GANGRENE\n$\\diamond$ Most common + life-threatening cause!\nPathogenesis: damage + disruption of mucosa with entry of gas-forming bacteria into bowel wall (cysts contain $50 \\%$ hydrogen = evidence of bacterial origin)\nNecrotizing enterocolitis, ischemia + infarction (mesenteric thrombosis), neutropenic colitis, sepsis, volvulus, strangulation, emphysematous gastritis, caustic ingestion\n\n| Drugs Associated with Pneumatosis Intestinalis |  |\n| :--: | :--: |\n| Drug Class | Common Agents |\n| Corticosteroids |  |\n| Chemotherapeutics |  |\n| Cytotoxic agents | methotrexate, etoposide, daunorubicin, cytarabine, fluorouracil, paclitaxel |\n| Tyrosine kinase inhibitor | imatinib |\n| Immunosuppressants |  |\n| Antidiabetics |  |\n| a-glucosidase inhibitors | voglibose, acarbose, miglitol |\n| Others | lactulose, sorbitol |\n\n## B. MUCOSAL DISRUPTION\n\nPathogenesis: increased intestinal gas pressure $\\rightarrow$ overdistension and dissection of gas into bowel wall\n(a) intestinal obstruction: pyloric stenosis, annular pancreas, imperforate anus, Hirschsprüng disease, meconium plug syndrome, obstructing neoplasm\n(b) intestinal trauma: endoscopy $\\pm$ biopsy, biliary stent perforation, sclerotherapy, bowel surgery, postoperative bowel anastomosis, penetrating / blunt abdominal trauma, trauma of child abuse, intracatheter jejunal feeding tube, barium enema\n(c) infection / inflammation: peptic ulcer disease, intestinal parasites, tuberculosis,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 543,
            "markdown": "peritonitis, inflammatory bowel disease (Crohn disease, ulcerative colitis, pseudomembranous colitis), neutropenic colitis, toxic megacolon, generalized sepsis; rotavirus gastroenteritis (in children)\n(d) ruptured jejunal diverticula, Whipple disease, systemic amyloidosis\nC. INCREASED MUCOSAL PERMEABILITY\n\nPathogenesis: defects in lymphoid tissue of bowel wall allows bacterial gas to enter bowel wall\n(a) immunotherapy: graft-versus-host disease, organ transplantation, bone marrow transplantation\n(b) others: AIDS enterocolitides, steroid therapy, chemotherapy, radiation therapy, collagen vascular disease (scleroderma, systemic lupus erythematosus, periarteritis dermatomyositis), intestinal bypass enteropathy, diabetes mellitus\nD. PULMONARY DISEASE\n\nPathogenesis: alveolar rupture with air dissecting interstitially along bronchovascular bundles to mediastinum and retroperitoneally along vascular supply of viscera\nCause: chronic obstructive pulmonary disease (chronic bronchitis, emphysema, bullous disease of lung), asthma, cystic fibrosis, chest trauma (barotrauma from mechanical ventilation with positive end-expiratory pressure, chest tube), increased intrathoracic pressure associated with retching + vomiting\nE. IDIOPATHIC\n\nPath:\n(a) microvesicular type $=10-100-\\mathrm{mm}$ cysts / bubbles within lamina propria\n$\\sqrt{ }$ radiolucent clusters of cysts along contour of bowel wall (best demonstrated on CT)\n$\\sqrt{ }$ segmental mucosal nodularity\n$D D x$ : polyposis at 3D CT colonography\n(b) linear / curvilinear type $=$ streaks of gas oriented parallel to bowel wall\n\nLocation: small bowel $>$ colon; may be discontinuous with spread to distant sites along mesentery\nPneumatosis in small bowel / colon should be treated as an emergent finding until life-threatening causes such as bowel ischemia and impending perforation are excluded.\nSite: subserosa $>$ submucosa $>>$ muscularis propria $>$ mesentery; mesenteric side $>>$ antimesenteric side\n$\\sqrt{ }$ primary radiologic finding:\n$\\sqrt{ }$ linear / cystic gas collection within bowel wall paralleling mucosa\n$\\sqrt{ }$ secondary radiologic findings:\n$\\sqrt{ } \\pm$ pneumoperitoneum / pneumoretroperitoneum (asymptomatic large pneumoperitoneum may persist for months / years)\n$\\sqrt{ } \\pm$ gas in mesenteric + portal vein\n$\\sqrt{ }$ free fluid\nMR:\n$\\sqrt{ }$ hypointense signal on 2-D dual-echo GRE MRI with blooming artifact $\\leftarrow$ effect of air on local magnetic field\nUS:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 544,
            "markdown": "$\\sqrt{ }$ echogenic reverberation artifacts within bowel wall\n$D D x$ : \"pseudopneumatosis\" intestinalis from foreign bodies / staples within bowel wall, tiny bubbles of air trapped between bowel folds, misregistration of air bubbles outside ultrasound beam\nPrognosis:\nwide spectrum from innocuous to fatal; clinical outcome impossible to predict based on radiologic features\n$\\diamond$ Linear gas collections probably have a more severe connotation\n$\\diamond$ Pneumatosis of the colon is likely clinically insignificant\n$\\diamond$ Extent of pneumatosis is inversely related to severity of disease\n$\\diamond$ Bowel wall thickening + perienteric soft-tissue stranding $=$ signs of life-threatening ischemia\n\n# Soap-bubble Appearance in Abdomen of Neonate \n\n1. Feces in infant fed by mouth\n2. Meconium ileus:\ngas mixed with meconium, usually RLQ\n3. Meconium plug:\ngas in and around plug, in distribution of colon\n4. Necrotizing enterocolitis: submucosal pneumatosis\n5. Atresia / severe stenosis: pneumatosis\n6. Hirschsprung disease: impacted stool, sometimes pneumatosis\n\n## ABDOMINAL CALCIFICATIONS \\& OPACITIES\n\n## Opaque Material in Bowel\n\nmnemonic: CHIPS\nChloral hydrate\nHeavy metals: lead\nIron\nPhenothiazines\nSalicylates\n\n## Diffuse Peritoneal Calcifications\n\n(a) systemic mineral imbalance (\"metastatic\")\n\n1. Uremia\n2. Hyperparathyroidism + paraneoplastic HPT\n(b) dystrophic $\\leftarrow$ tissue injury / aging / disease\n$>$ neoplasm\n3. Cystadenoma / serous adenocarcinoma of ovary\n$\\checkmark$ granular, sandlike psammomatous calcifications\n4. Pseudomyxoma peritonei\n(a) pseudomucinous adenoma of ovary\n(b) mucocele of appendix\n5. Undifferentiated abdominal malignancy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 545,
            "markdown": ") infection\n\n1. Tuberculous peritonitis\n$\\sqrt{ }$ mottled calcifications simulating residual barium\n2. Pneumocystis carinii infection\n> inflammation\n3. Meconium peritonitis\n4. Peritoneal dialysis with sclerosing peritonitis\n$\\checkmark$ sheetlike calcifications surrounding bowel and mesentery\n5. Oil granuloma\n$\\checkmark$ annular / plaquelike calcifications\n\n# Focal Alimentary Tract Calcifications \n\nA. ENTEROLITHS $=$ fecalith $=$ coprolith\n[faex, Latin = dregs; kopros, Greek = dung]\n\n1. Appendicolith: in $10-15 \\%$ of acute appendicitis\n2. Stone in Meckel diverticulum\n3. Diverticular stone\n4. Rectal stone\n5. Proximal to partial obstruction: TB, Crohn disease\nB. MESENTERIC CALCIFICATIONS\n6. Dystrophic calcification of omental fat deposits + appendices epiploicae $\\leftarrow$ infarction / pancreatitis / TB\n7. Cysts: mesenteric cyst, hydatid cyst\n8. Calcified mesenteric lipoma\nC. INGESTED FOREIGN BODIES\nD. TUMOR\n9. Mucocele of appendix\n$\\checkmark$ crescent-shaped / circular calcification\n10. Mucinous adenocarcinoma of stomach / colon\n$=$ COLLOID CARCINOMA\n$\\checkmark$ small mottled / punctate calcifications in primary site $\\pm$ in regional lymph node metastases, adjacent omentum, metastatic liver foci\n11. Gastric / esophageal leiomyoma: calcifies in $4 \\%$\n12. Lipoma\n\n## Foreign Objects in Abdominal Cavity\n\nA. INTRALUMINAL OBJECT\n(a) pathologic condition\n\n1. Bezoar\n2. Gallstone\n(b) dislodged stent and tube\n3. Biliary stent (in up to $6 \\%$ )\n4. Feeding tube\n(c) ingestion of diagnostic device\n5. pH meter capsule (Bravo ${ }^{\\mathrm{TM}} \\mathrm{pH}$ capsule)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 546,
            "markdown": "$\\sqrt{ } 6 \\times 5.5 \\times 25 \\mathrm{~mm}$ metallic device\n2. Endoscopic video capsule\n$\\sqrt{ } 11 \\times 26 \\mathrm{~mm}$ metallic device\n(d) accidental / nonaccidental ingestion\nB. EXTRALUMINAL OBJECT\n\n1. Prosthetic mesh for hernia repair:\n$>0.44 \\mathrm{~mm}$ thick polypropylene\n$\\sqrt{ }$ line of attenuation similar to muscle\n$>1-\\mathrm{mm}$ thick polytetrafluoroethylene\n$\\sqrt{ }$ line of increased attenuation\n2. Dropped gallstone $=$ perforation / spillage: during laparoscopic cholecystectomy (in up to $30 \\%$ )\n3. Dropped surgical clip\n4. Migrated / perforated IUD ( $1 \\div 1,000$ insertions)\n\nCx in $15 \\%$ : bowel obstruction, perforation of bowel / urinary bladder / mesentery, rectal stricture, rectouterine fistula\n5. Hepatic packing with sponges (for $36-48$ hours)\n6. Bioabsorbable sponge for hemostasis: Gelfoam ${ }^{\\circledR}$, Surgicel ${ }^{\\circledR}$, microfibrillar collagen\n$\\sqrt{ }$ usually absorbed within $7-14$ days\n$\\sqrt{ }$ mimick abscess due to numerous gas pockets\nPacking agents mimic an abscess when imaged prior to absorption by 7-14 days post surgery.\n7. Urethral bulking agent:\n$>$ collagen: attenuation similar to soft tissue\n$>$ carbon-coated microbeads: $1500-2000 \\mathrm{HU}$\n8. Retained surgical material ( $1 \\div 1000-1500$ surgeries): sponge ( $69 \\%$ ), instrument ( $31 \\%$ )\n\nAt risk: emergency surgery, unplanned change of procedure, obesity\nA radiopaque marker on the scout image provides an important clue, but can be distorted by folding, disintegrate over time, or can be misinterpreted (as a calcification / oral contrast agent).\n\n# Mimicks of Foreign Bodies: \n\n1. Heterotopic mesenteric ossification\n\nCause: trauma, repeated intraabdominal surgeries\nHisto: mature trabeculae\n$\\sqrt{ }$ multiple high-density linear branching structures within mesentery extending to peritoneal surface\n$\\sqrt{ }$ trabecular architecture unchanged over time\n$C x$ : small bowel obstruction\n$D D x$ : (1) Dystrophic calcifications\n(2) Extravasation of oral contrast (change in configuration, pooling following gravity, less dense over time)\n(3) Osseous metaplasia (trabecular architecture)\n2. Heterotopic ossification in surgical incisions\n$=$ subtype of traumatic myositis ossificans\nPrevalence: $25 \\%$ of abdominal incisions",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 547,
            "markdown": "Location: vertical midline abdominal incisions (mainly), esp. in linea alba $\\sqrt{ }$ trabecular architecture\n3. Bogota bag\n$=$ clear sterilized plastic bag used for temporary abdominal closure to monitor secondary peritonitis\n$\\sqrt{ }$ linear high-attenuation area along the direction of the surgical incision\n\n# Abdominal Wall Calcifications \n\nA. IN SOFT TISSUES\n\n1. Hypercalcemic states\n2. Idiopathic calcinosis\nB. IN MUSCLE\n(a) parasites:\n3. Cysticercosis $=$ Taenia solium\n$\\sqrt{ }$ round / slightly elongated calcifications\n4. Guinea worm = dracunculiasis\n$\\checkmark$ stringlike calcifications up to 12 cm long\n(b) injection sites from quinine, bismuth, calcium gluconate, calcium penicillin\n(c) myositis ossificans\nC. IN SKIN\n5. Soft-tissue nodules: papilloma, neurofibroma, melanoma, nevi\n6. Scar:\n$\\checkmark$ linear density\n7. Colostomy / ileostomy\n8. Tattoo markings\n\n## Abdominal Vascular Calcifications\n\nA. ARTERIES\n\n1. Atheromatous plaques\n2. Arterial calcifications in diabetes mellitus\nB. VEINS\nphleboliths = calcified thrombus, generally seen below interspinous line\n3. Normal / varicose veins\n4. Hemangioma\nC. LYMPH NODES\n5. Histoplasmosis / tuberculosis\n6. Chronic granulomatous disease\n7. Residual lymphographic contrast\n8. Silicosis\n\n## ABNORMAL INTRAABDOMINAL FLUID\n\n## Ascites\n\nAscites collects in well-defined areas of stasis / arrested flow:\n(1) deep pelvic recesses: retrouterine space / pouch of Douglas in women, retrovesical space in",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 548,
            "markdown": "men\n(2) right lower quadrant: near termination of small bowel mesentery at ileocecal junction\n(3) superior aspect of the sigmoid mesocolon\n(4) right paracolic gutter\n\n# Cause: \n\nA. TRANSUDATE (most common cause)\n(1) Cirrhosis ( $75 \\%$ ): poor prognostic sign\n(2) Hypoproteinemia\n(3) CHF\n(4) Constrictive pericarditis\n(5) Chronic renal failure\n(6) Budd-Chiari syndrome\nB. EXUDATE\n(1) Carcinomatosis ( $2^{\\text {nd }}$ most common cause)\n(2) TB peritonitis ( $3^{\\text {rd }}$ most common cause)\n(3) Polyserositis\n(4) Pancreatitis\n(5) Meigs syndrome\nC. HEMORRHAGIC / CHYLOUS FLUID\n\nEarly signs (accumulation in pelvis):\n$\\sqrt{ }$ round central density in pelvis + ill-defined bladder top\n$\\sqrt{ }$ thickening of peritoneal flank stripe\n$\\sqrt{ }$ space between properitoneal fat and gut $>3 \\mathrm{~mm}$\nLate signs:\n$\\sqrt{ }$ Hellmer sign = medial displacement of lateral liver margins\n$\\sqrt{ }$ medial displacement of ascending + descending colon\n$\\sqrt{ }$ obliteration of hepatic + splenic angles\n$\\sqrt{ }$ bulging flanks\n$\\sqrt{ }$ gray abdomen\n$\\sqrt{ }$ floating centralized loops\n$\\sqrt{ }$ separation of loops\n\n## High-density Ascites\n\n1. Tuberculosis: $20-45 \\mathrm{HU}$; may be lower\n2. Ovarian tumor\n3. Appendiceal tumor\n\n## Neonatal Ascites\n\nA. GASTROINTESTINAL\n(a) perforation of hollow viscus\n\n1. Meconium peritonitis\n(b) inflammatory lesions\n2. Meckel diverticulum\n3. Appendicitis\n(c) cyst rupture",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 549,
            "markdown": "1. Mesenteric cyst\n2. Omental cyst\n3. Choledochal cyst\nB. PORTOHEPATIC\n(a) extrahepatic portal vein obstruction\n4. Atresia of veins\n5. Compression by mass\n(b) intrahepatic portal vein obstruction\n6. Portal cirrhosis: neonatal hepatitis\n7. Biliary cirrhosis: biliary atresia\n(c) bile leakage\n8. Biliary obstruction\n9. Biliary perforation\nC. URINARY TRACT\n$\\diamond$ Urine ascites (most common cause): lower urinary tract obstruction + upper urinary tract rupture: posterior / anterior urethral valves, ureterovesical / ureteropelvic junction obstruction, renal / bladder rupture, anterior urethral diverticulum, bladder diverticula, neurogenic bladder, extrinsic bladder mass\nD. GENITAL\n10. Ruptured ovarian cyst\n11. Hydrometrocolpos\nE. HYDROPS FETALIS\n12. Immune hydrops\n13. Nonimmune hydrops: usually cardiac causes\nF. MISCELLANEOUS\n14. Chylous ascites\n15. Lymphangiectasia\n16. Congenital syphilis, trauma\n17. Idiopathic\n\n# Chylous Ascites \n\nIN ADULTS:\n\nIN CHILDREN:\n\n1. Inflammatory process $35 \\%$\n2. Tumor $30 \\%$\n3. Idiopathic $23 \\%$\n4. Trauma $11 \\%$\n5. Congenital $1 \\%$\n6. Congenital $39 \\%$\n7. Inflammatory process $15 \\%$\n8. Trauma $12 \\%$\n9. Tumor $3 \\%$\n10. Idiopathic $33 \\%$\n\n## Fluid Collections\n\nmnemonic: BLUSCHINGS\nBiloma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 550,
            "markdown": "Lymphocele, Lymphangioma, Lymphoma (almost anechoic by US)\nUrinoma\nSeroma\nCyst: pseudocyst, peritoneal inclusion cyst\nHemorrhage, Hematoma: aneurysm, AVM\nInfection, Infestation: empyema, abscess, Echinococcus\nNeoplasm (necrotic)\nG I tract: dilated loops, ileus, duplication\nSerosa: ascites, pleural fluid, pericardial effusion\n\n# Fluid Collection in Lesser Sac \n\nA. Inflammatory exudate\n\n1. Acute pancreatitis\n2. Cholecystitis\n3. Perforated gastric ulcer\n4. Left perinephric abscess\n5. Ascending pelvic inflammation (rare): appendicitis, diverticulitis\nB. Hemorrhage\n6. Injury of liver / spleen\n7. Hemorrhagic pancreatitis\n8. Bleeding from ruptured neoplasms\nC. Postoperative fluid: gastric / hepatobiliary surgery\n[D. Ascitic transudate (most common + associated with fluid elsewhere in peritoneal cavity): hepatic / renal failure]\n\n## Intraabdominal Cyst in Childhood\n\n1. Omental cyst: greater omentum / lesser sac, multilocular\n2. Mesenteric cyst: between leaves of small bowel mesentery\n3. Choledochal cyst\n4. Intestinal duplication\n5. Ovarian cyst\n6. Pancreatic pseudocyst\n7. Cystic renal tumor\n8. Abscess\n9. Meckel diverticulum: communication with GI tract\n10. Lymphangioma\n11. Mesenteric lymphoma\n12. Intramural tumor\n\n## DYSPHAGIA\n\n$=$ OROPHARYNGEAL IMPAIRMENT = SWALLOWING DYSFUNCTION\nPrevalence: $22 \\%$ in adult primary care population, $\\mathrm{M}+\\mathrm{F}=1 \\div 4 ; 13 \\%$ in general population; in up to $50 \\%$ of nursing home residents\nPredisposed: gastroesophageal reflux disease (GERD), stroke, Alzheimer disease, multiple sclerosis, amyotrophic lateral sclerosis, Parkinson disease",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 551,
            "markdown": "Neuromuscular disorders and structural abnormalities increase with age. Look for a cause of dysphagia in elderly patients.\n\n# Cause: \n\n(1) Cerebrovascular accident: stroke (most common cause in adults), cerebral palsy, Wallenberg syndrome (lateral medullary syndrome)\n$\\diamond 29-64 \\%$ of stroke patients become dysphagic; $20 \\%$ die from aspiration pneumonia\n(2) Brain tumor\n(3) Neuromuscular disease: myasthenia gravis, Eaton-Lambert syndrome, amyotrophic lateral sclerosis, muscular dystrophy, myotonic dystrophy, oculopharyngeal muscular dystrophy\n(4) Neurodegenerative disorder: Parkinson disease, Alzheimer disease, aging-related changes, Huntington disease, progressive supranuclear palsy\n(5) Demyelinating diseases: multiple sclerosis\n(6) Connective tissue disease: dermatomyositis, polymyositis, Sjögren syndrome, lupus erythematosus, rheumatoid arthritis, scleroderma\n(7) Metabolic disorder: hyperthyroidism, hypothyroidism, diabetes mellitus\n(8) infection: poliomyelitis, neurosyphilis, encephalitis, meningitis, sarcoidosis\n(9) GI disorder:\n> esophageal diverticulum\n> focal esophageal narrowing\n> extrinsic esophageal compression\n> lower esophageal sphincter hypertension\n(10) Trauma: head and neck surgery, radiation therapy, spinal cord injury, traumatic brain injury\n(11) Medications\n\n- weight loss, slow eating, change in dietary habits\n- recurrent pneumonia\n\nEsophagography: anatomic and functional information about pharynx, esophagus, gastroesophageal junction (GEJ), gastric cardia, esophageal motility, gastroesophageal reflux\nModified barium swallow (standard of reference, performed with a swallowing / speech therapist):\nswallowing function + response to therapeutic measures and necessary dietary requirements\n$C x$ : dehydration, malnutrition, aspiration, pneumonia, death\n$D D x$ : odynophagia, globus sensation, heartburn\n\n## Oropharyngeal Dysphagia\n\n$=$ sensation of blockage / discomfort in throat\nCommon cause: stroke, head \\& neck surgery, radiation Rx\nPathophysiology:\n> structural: Zenker diverticulum, tumor, web, extrinsic mass, cervical spine disease\n> functional:\n(a) laryngeal penetration or aspiration",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 552,
            "markdown": "- coughing / choking before / during / after swallow $\\rightarrow$ aspiration pneumonia\n(b) soft-palate insufficiency\n- nasal voice / nasal regurgitation\n(c) abnormal oral phase of swallowing\n- food dribbling, difficulty in chewing\n(d) cricopharyngeal dysfunction\n- \"wet\" voice during / after meal\n- increased oral secretions, drooling\n- chronic low-level secretions: esp. bronchial, chest\n- difficulty initiating a swallow, hoarseness, dyspnea\n\nCx: respiratory problems, malnutrition, dehydration, bronchial spasms, airway obstruction\n\n# Substernal / Esophageal Dysphagia \n\n= sensation of discomfort / blockage localized to between thoracic inlet and xiphoid process Pathophysiology:\n> structural: ring stricture, extrinsic mass, tumor in esophagus / proximal stomach\n> functional: esophageal motility abnormality, gastroesophageal reflux disease (GERD)\n\n- sensation of food sticking in chest / throat\n- dysphagia primarily for solids\n- oral or pharyngeal regurgitation\n\n\n## MECHANICAL INTESTINAL OBSTRUCTION\n\n$=$ occlusion / constriction of bowel lumen\nPrevalence: $20 \\%$ of acute abdominal admissions\n$>80 \\%$ small bowel obstruction\n$>20 \\%$ large bowel obstruction\n\n## Disturbances in Motility \\& Transit\n\n1. Irritable bowel syndrome\n2. Functional dyspepsia\n3. Gastroparesis\n4. Bloating / chronic idiopathic constipation\n\n## Air Progression in Neonates\n\nstomach within minutes after birth\nentire small bowel within 3 hours\nsigmoid colon after 8-9 hours\n\n## Cause of Absent Gas in Neonate\n\n1. GI obstruction\n2. Mechanical ventilation in severe respiratory distress\n3. Continuous gastric suction\n\n## Cause of Delayed Passage of Gas in Neonate\n\n1. Traumatic delivery",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 553,
            "markdown": "2. Septicemia\n3. Hypoglycemia\n4. Brain damage\n\n# Passage of Meconium \n\nA. NORMAL\n> in $94 \\%$ within 24 hours\n> in $99 \\%$ within 48 hours\nExceptions: prematurity, severely asphyxiated term infants\nB. DELAYED PASSAGE\n\n1. Hirschsprung disease\n2. Ileal / jejunal atresia\n3. Meconium ileus\n4. Meconium plug syndrome\n5. Colon atresia\n6. Imperforate anus\n\n## Common Causes of Obstruction in Children\n\nTime of presentation:\nNursery\nintestinal atresia, midgut volvulus, meconium ileus, Hirschsprí disease, small bowel atresia with meconium ileus, meconium $\\square$ syndrome, small left colon syndrome, imperforate anus, obstru from duplication cyst\nFirst 3 months\n$6-24$ months\nChildhood\nhypertrophic pyloric stenosis, inguinal hernia, Hirschsprung disease, midgut volvulus\nileocolic intussusception\nappendicitis\n\n## Terminology:\n\nHigh obstruction $=$ proximal to midileum\n$\\diamond$ Rarely needs further radiologic evaluation\n\n- bilious vomiting (after first feeding)\n- abdominal distention\n$\\sqrt{ }$ few dilated bowel loops\nLow obstruction $=$ distal ileum / colon\n$\\diamond$ More difficult to accurately localize\n$\\diamond$ Requires contrast enema examination to diagnose microcolon, position of cecum, level of obstruction\n- abdominal distention + vomiting\n- failure to pass meconium\n$\\sqrt{ }$ many dilated intestinal loops\n\n\n## Intestinal Obstruction in Neonate\n\n- abdominal distension, vomiting, failure to pass meconium\n\n1. Duodenal atresia ( $50 \\%$ ), stenosis ( $40 \\%$ ), web ( $10 \\%$ )\n2. Midgut volvulus",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 554,
            "markdown": "3. Jejunal / ileal atresia\n4. Meconium ileus\n5. Meconium plug syndrome\n6. Hirschsprung disease\n7. Necrotizing enterocolitis\n\n# Neonatal Obstruction with Microcolon \n\n1. Ileal atresia\n2. Distal jejunal atresia\n3. Meconium ileus\n\n## Neonatal Obstruction with Normal Colon\n\n1. Meconium plug\n2. Hirschspring disease\n\n## Intestinal Obstruction in Infant \\& Child\n\n1. Hypertrophic pyloric stenosis\n2. Appendicitis\n3. Intussusception\n\n## Gastric Outlet Obstruction\n\nA. CONGENITAL LESION\n\n1. Antral mucosal diaphragm $=$ antral web\n2. Gastric duplication: usually along greater curvature, abdominal mass in infancy\n3. Hypertrophic pyloric stenosis\nB. MALIGNANT NARROWING (most common cause)\n4. Antral carcinoma: cause in adults in $30-35 \\%$\n5. Scirrhous carcinoma of pyloric channel\n6. Pancreatic adenocarcinoma\n7. Primary duodenal tumor\n8. Primary biliary tumor\n9. Lymphoma (rarely)\nC. INFLAMMATORY NARROWING\n10. Peptic ulcer disease: significantly decreased over last 30 years due to advances in diagnosis + treatment\n11. Corrosive gastritis\n12. Crohn disease, sarcoidosis, syphilis, tuberculosis\nD. OTHERS\n13. Prolapsed antral polyp / mucosa\n14. Bezoar\n15. Gastric volvulus\n16. Postoperative stomal edema\n\nAbdominal plain film:\n$\\sqrt{ }$ large smoothly marginated homogeneous mass displacing transverse colon + small bowel inferiorly\n$\\sqrt{ }$ one / two air-fluid levels",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 555,
            "markdown": "# Duodenal Obstruction \n\nA. CONGENITAL\n\n1. Annular pancreas\n2. Peritoneal bands $=$ Ladd bands\n3. Aberrant vessel\nB. INFLAMMATORY NARROWING\n4. Chronic duodenal ulcer scar\n5. Acute pancreatitis: phlegmon, abscess, pseudocyst\n6. Acute cholecystitis: perforated gallstone\nC. INTRAMURAL HEMATOMA\n7. Blunt trauma (accident, child abuse)\n8. Anticoagulant therapy\n9. Blood dyscrasia\nD. TUMORAL NARROWING\n10. Primary duodenal tumors\n11. Tumor invasion: pancreas, right kidney, lymph node enlargement\nE. EXTRINSIC COMPRESSION\n12. Aortic aneurysm\n13. Pseudoaneurysm\nF. OTHERS\n14. Superior mesenteric artery syndrome: extensive burns, body cast, rapid weight loss, prolonged bed rest\n15. Bezoar (in gastrectomized patient)\nmnemonic: VA BADD TU BADD\nchild\nVolvulus\nAtresia\nBands\nAnnular pancreas\nDuplication\nDiverticulum\nadult\nTumor\nUlcer\nBands\nAnnular pancreas\nDuplication\nDiverticulum\n\nAbdominal plain film:\n$\\sqrt{ }$ \"double-bubble\" sign = air-fluid levels in stomach + duodenum\n$\\sqrt{ }$ frequently normal $\\leftarrow$ absence of gas from vomiting\n\n## Jejunal and Ileal Obstruction\n\n$=$ SMALL BOWELOBSTRUCTION (SBO)\nFrequency: accounts for $20 \\%$ of all surgical admissions\nMortality: $5.5 \\%$ due to strangulation (paradigm: \"Never let the sun rise or set on an obstructed small bowel\")\nCause:\nA. CONGENITAL\n\n1. Jejunal atresia\n2. Ileal atresia / stenosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 556,
            "markdown": "3. Enteric duplication: located on antimesenteric side, mostly in ileum\n4. Midgut volvulus: arrest in rotation + fixation of small bowel during fetal life\n5. Mesenteric cyst from meconium peritonitis: located on mesenteric side\n6. Meckel diverticulum\nB. EXTRINSIC BOWEL LESION\n7. Fibrous adhesions ( $50-80 \\%$ ): previous surgery ( $80 \\%$ ) peritonitis ( $15 \\%$ ), congenital / uncertain cause (5\\%)\n$\\diamond$ Postoperative adhesions are the most common cause!\n$\\checkmark$ abrupt change in bowel caliber\n$\\checkmark$ no other apparent cause at transition point\n8. Hernia ( $10 \\%$ ): internal / external\n9. Volvulus\n10. Mass: extrinsic neoplasm (most commonly due to advanced peritoneal carcinomatosis), abscess, aneurysm, hematoma, endometriosis\nC. LUMINAL OCCLUSION\n(a) swallowed:\n11. Foreign body: in children or in mentally disturbed / disabled patients\n12. Bezoar\n13. Gallstone\n14. Inspissated milk\n15. Bolus of Ascaris lumbricoides\n(b) after birth:\n16. Meconium ileus:\n$\\checkmark$ microcolon in cystic fibrosis\n17. Meconium ileus equivalent\n(c) other:\n18. Intussusception ( $<5 \\%$ in adults)\n19. Tumor (rare): eg, lipoma\nD. INTRINSIC BOWEL WALL LESION\n(a) neoplasm $(<2 \\%)$\n20. Adenocarcinoma\n21. Carcinoid tumor\n22. Lymphoma\n23. Gastrointestinal stromal tumor\n(b) inflammatory lesion\n24. Crohn disease (acute bowel wall thickening, chronic cicatricial stenosis, postsurgical)\n25. Tuberculous enteritis\n26. Eosinophilic gastroenteritis\n27. Parasitic disease\n(c) vascular insufficiency\n28. Ischemia: arterial / venous occlusion\n29. Radiation enteropathy: 1 year post radiation\n(d) intramural hemorrhage\n30. Blunt trauma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 557,
            "markdown": "2. Henoch-Schönlein purpura\n3. Anticoagulants\n(e) strictures\n4. Surgical anastomosis\n5. Irradiation\n6. Potassium chloride tablets\n7. Massive deposition of amyloid\n\nPlain abdominal radiograph ( $50-66 \\%$ sensitive):\n$\\diamond$ High sensitivity only for high-grade obstruction!\nResults: diagnostic in 50-60\\%; equivocal in 20-30\\%; normal / nonspecific / misleading in $10-20 \\%$\n$\\sqrt{ }$ \"candy cane\" appearance in erect position $=>2-3$ distended small bowel loops with gas-fluid levels ( $>3-5$ hours after onset of obstruction):\n$\\sqrt{ }$ gas-fluid levels $>2.5 \\mathrm{~cm}$ wide\n$\\checkmark$ gas-fluid levels differing $>2 \\mathrm{~cm}$ in height from one another within same bowel loop\n$\\checkmark$ disparity in size between obstructed loops and contiguous small bowel loops of normal caliber beyond site of obstruction\n$\\checkmark$ small bowel positioned in center of abdomen\n$\\checkmark$ little / no gas + stool in colon with complete mechanical obstruction after 12-24 hours\n$\\checkmark$ \"stretch\" sign = erectile valvulae conniventes completely encircle bowel lumen\n$\\checkmark$ \"stepladder appearance\" in low obstruction (the greater the number of dilated bowel loops, the more distal the site of obstruction)\n$\\checkmark$ \"string-of-beads\" indicate peristaltic hyperactivity to overcome mechanical obstruction\n$\\checkmark$ hyperactive peristalsis / aperistalsis = fatigued small bowel\nCAVE: little / no gas in small bowel $\\leftarrow$ fluid-distended loops may lead one to overlook obstruction\nLocation of obstruction:\n(a) valvulae conniventes high + frequent $=$ jejunum\n(b) valvulae conniventes sparse / absent = ileum\n\nPlain abdominal radiographic categories:\n\n1. Normal\n$=$ absence of small intestinal gas / gas within 3-4 variably shaped loops $<2.5 \\mathrm{~cm}$ in diameter\n2. Mild small bowel stasis\n$=$ single / multiple loops of $2.5-3.0 \\mathrm{~cm}$ in diameter with $\\geq 3$ air-fluid levels\n3. Probable SBO pattern\n$=$ dilated multiple gas- / fluid-filled loops with air-fluid levels + moderate amount of colonic gas\n4. Definite SBO pattern\n$=$ clearly disproportionate gaseous / fluid distension of small bowel relative to colon\nUGI:\n$\\checkmark$ \"snake head\" appearance = active peristalsis forms bulbous head of barium column in an attempt to overcome obstruction\n$\\checkmark$ barium appears in colon $>12 \\mathrm{hr}$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 558,
            "markdown": "Enteroclysis for adhesive obstruction:\n$\\sqrt{ }$ abrupt change in caliber of bowel with normal caliber / collapsed bowel distal to obstruction\n$\\sqrt{ }$ stretched folds of normal pattern\n$\\sqrt{ }$ angulated + fixed bowel segment\nEnteroclysis categories of SBO (Shrake):\n(a) low-grade partial SBO\n$=$ sufficient flow of contrast material through point of obstruction so that fold pattern beyond obstruction is readily defined\n(b) high-grade partial SBO\n$=$ stasis + delay in arrival of contrast so that contrast material is diluted in distended prestenotic loop with minimal contrast in postobstructive loop leading to difficulty in defining fold pattern after transition point\n(c) complete SBO\n$\\sqrt{ }$ no passage of contrast material beyond point of obstruction 3-24 hours after start of examination\nCT ( $66 \\%$ accurate, $78 \\%$ specific, $63 \\%$ sensitive [81-100\\% sensitive for high-grade obstruction, $48 \\%$ sensitive for low-grade partial obstruction]):\n$\\sqrt{ }$ small bowel dilatation $>2.5 \\mathrm{~cm}$ proximally with normal-caliber / collapsed loops distally:\n$\\sqrt{ }$ \"small bowel feces\" sign (in $7-8 \\%$ ) = gas bubbles mixed with particulate matter immediately proximal to transition point (DDx: cystic fibrosis)\n$\\sqrt{ }$ discrepant caliber at transition zone from dilated to nondilated bowel:\n$\\sqrt{ }$ point of transition = triangular beak immediately beyond dilated segment\n$\\sqrt{ }$ level of obstruction best determined by relative lengths of dilated versus collapsed bowel\n$\\sqrt{ }$ incomplete obstruction = passage of enteric contrast material through transition zone:\n$\\sqrt{ }$ high-grade obstruction $=50 \\%$ difference in caliber between proximal dilated loops + distal collapsed bowel\n$D D x$ : adynamic ileus (distension of entire small bowel)\nUS ( $89 \\%$ accuracy):\n@ bowel motion in acute stage:\n$\\sqrt{ }$ hyperperistalsis of bowel with back-and-forth movement of intraluminal contents + thin gut wall\n@ bowel motion in late stage (= prolonged obstruction):\n$\\sqrt{ }$ aperistalsis $\\pm$ thick edematous bowel wall\n$\\sqrt{ }$ small bowel loops dilated $>3 \\mathrm{~cm}$\n$\\sqrt{ }$ length of dilated segment $>10 \\mathrm{~cm}$\n$\\sqrt{ }$ colon collapsed\n$\\sqrt{ }$ level of obstruction determined by:\n(a) location of dilated bowel loops:\n$\\sqrt{ }$ bowel distal to obstructing lesion often smaller in diameter than more proximal loops\n$\\sqrt{ }$ caliber of loops distal to obstructing lesion dependent on completeness of obstruction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 559,
            "markdown": "(b) pattern of valvulae conniventes\n$\\sqrt{ }$ signs of bowel infarction:\n$\\sqrt{ }$ free fluid between dilated small bowel loops\n$\\checkmark$ aperistalsis\n$\\checkmark$ wall thickness of distended bowel segment $>3 \\mathrm{~mm}$\n\n# Strangulated Obstruction \n\n$=$ impaired circulation / ischemia of obstructed segment mainly $\\leftarrow$ delay in establishing diagnosis / surgical Rx\nPrevalence: $10 \\%$ of patients with SBO\nAt risk: patients with acute complete / high-grade SBO; risk increases over time TRIAD:\n(1) closed-loop obstruction of the involved segment (majority of cases)\n(2) mechanical obstruction proximal to the involved segment\n(3) venous congestion of the involved loop\n\nCT (63-100\\% detection rate):\n$\\checkmark$ slight circumferential thickening of bowel wall:\n$\\checkmark$ increased wall attenuation\n$\\checkmark$ \"target / halo\" sign\n$\\checkmark$ serrated beaklike narrowing at site of obstruction ( $32-100 \\%$ specific) = closed loop with regional mesenteric vascular engorgement + bowel wall thickening at the obstructed segment\n$\\checkmark$ unusual course of mesenteric vasculature\n$\\checkmark$ vascular compromise of affected bowel:\n$\\checkmark$ poor / lack of enhancement of bowel wall ( $100 \\%$ SPECIFIC)\n$\\checkmark$ delayed prolonged enhancement of bowel wall\n$\\checkmark$ mesenteric haziness $\\leftarrow$ edema ( $95 \\%$ specific)\n$\\checkmark$ diffuse engorgement of mesenteric vasculature\n$\\checkmark$ localized mesenteric fluid / hemorrhage\n$\\checkmark$ large amount of ascites\n$\\checkmark$ pneumatosis intestinalis\n$\\checkmark$ gas in portal vein\nPrognosis: $20-37 \\%$ mortality rate (compared with $5-8 \\%$ for a recently reduced simple obstruction) due to delay in diagnosis: $8 \\%(25 \\%)$ for surgery performed in $<36$ $(>36)$ hours\n\n## Closed-LoOP ObSTRuCtion\n\n$=$ obstruction at two adjacent points along the course of the bowel at a single site usually with involvement of mesentery\nPathophysiology: impaired venous $\\pm$ arterial flow\n$\\diamond$ Most common cause of strangulation!\nCause: adhesion (75\\%), incarcerated hernia\n$\\checkmark$ fixation of bowel loop = no change in position:\n$\\checkmark$ \"coffee bean\" sign = gas-filled loop\n$\\checkmark$ \"pseudotumor\" = fluid-filled loop",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 560,
            "markdown": "$\\sqrt{ } \\mathrm{U}$ - or C-shaped dilated bowel loop on CT\n$\\sqrt{ }$ increasing intraluminal fluid\n$\\sqrt{ }$ \"beak\" sign = fusiform tapering of bowel ending at point of obstruction on CT / UGI\n$\\sqrt{ }$ \"whirl\" sign = twisting of bowel + mesentery $\\leftarrow$ rotation of bowel around fixed point of obstruction on CT:\n$\\sqrt{ }$ stretched engorged mesenteric vessels converging toward site of obstruction / torsion $\\pm$ delayed enhancement\n$C x:$ volvulus\n\n# Acquired Small Bowel Obstruction in Childhood \n\nmnemonic: AAIMM\nAdhesions\nAppendicitis\nIntussusception\nIncarcerated hernia (most common in infancy)\nMalrotation\nMeckel diverticulum\n\n## Small Bowel Obstruction in Adulthood\n\nmnemonic: SHAVIT\nStone (gallstone ileus)\nHernia (21\\%)\nAdhesion (49\\%)\nVolvulus\nIntussusception\nTumor (16\\%)\n\n## SBO in Virgin Abdomen of Adulthood\n\n1. Bowel ischemia including ischemic stricture\n2. Primary small bowel neoplasm\n3. Metastatic small bowel neoplasm\n4. Extrinsic abdominal mass\n5. Internal / abdominal wall hernia\n6. Crohn disease\n\n## Colonic Obstruction\n\nFrequency: $25 \\%$ of all intestinal obstructions\nCause:\nA. NEONATAL COLONIC OBSTRUCTION\n\n1. Meconium plug syndrome\n2. Colonic atresia\n3. Anorectal malformation: rectal atresia, imperforate anus\n4. Hirschsprung disease\n5. Functional colonic immaturity (especially in premies + infants of mothers treated with magnesium or high doses of sedatives / opiates, children with septicemia, hypothyroidism, hypoglycemia, diabetic mothers)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 561,
            "markdown": "> small left colon syndrome\n$>$ meconium plug syndrome\nB. LUMINAL OBTURATION\n\n1. Fecal impaction\n$\\checkmark$ bubbly pattern of large mass of stool\n2. Fecaloma\n3. Gallstone (in sigmoid narrowed by diverticulitis)\n4. Intussusception\nC. BOWEL WALL LESION\n(a) malignant ( $60-70 \\%$ of obstructions) predominantly in sigmoid\n(b) inflammatory\n5. Crohn disease\n6. Ulcerative colitis\n7. Mesenteric ischemia\n8. Sigmoid diverticulitis (15\\%)\n$\\checkmark$ stenotic segment $>6 \\mathrm{~cm}$\n9. Acute pancreatitis\n(c) infectious:\n> infectious granulomatous process\n10. Actinomycosis\n11. Tuberculosis\n12. Lymphogranuloma venereum\n> parasitic disease\n13. Amebiasis\n14. Schistosomiasis\n(d) wall hematoma:\nblunt trauma, coagulopathy\nD. EXTRINSIC\n(a) mass impression\n15. Endometriosis\n16. Large tumor mass: prostate, bladder, uterus, tubes, ovaries\n17. Pelvic abscess\n18. Hugely distended bladder\n19. Mesenteritis\n20. Poorly formed colostomy\n(b) severe constriction\n21. Volvulus (3rd most common cause): sigmoid colon, cecum, transverse colon, compound volvulus ( $=$ ileosigmoid knot)\n22. Hernia: transverse colon in diaphragmatic hernia, sigmoid colon in left inguinal hernia\n23. Adhesion\n\nAbdominal plain-film patterns:\n(a) dilated colon only $=$ competent ileocecal valve\n(b) dilated small bowel $(25 \\%)=$ incompetent ileocecal valve\n(c) dilated colon + dilated small bowel $=$ ileocecal valve obstruction $\\leftarrow$ cecal",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 562,
            "markdown": "overdistension\n$\\sqrt{ }$ gas-fluid levels distal to hepatic flexure (fluid is normal in cecum + ascending colon); sign not valid with diarrhea / saline catharsis / enema\n$\\sqrt{ }$ cecum most dilated portion (in $75 \\%$ of cases); critical at 10 cm diameter (high probability for impending perforation)\n$\\diamond$ The lower the obstruction, the more proximal the distension!\nBE: Emergency barium enema of unprepared colon in suspected obstruction!\nContraindicated in toxic megacolon, pneumatosis intestinalis, portal vein gas, extraluminal gas\n\n# ILEUS \n\n[ileus = stasis / inability to push fluid along (term does not distinguish between mechanical and nonmechanical causes)]\n$=$ ADYNAMIC / PARALYTIC / NONOBSTRUCTIVE ILEUS\n$=$ derangement impairing proper distal propulsion of intestinal contents\nCause:\n$>$ in neonate:\n\n1. Hyperbilirubinemia\n2. Intracranial hemorrhage\n3. Aspiration pneumonia\n4. Necrotizing enterocolitis\n5. Aganglionosis\n> in child / adult:\n6. Postoperative ileus\n\n- usually resolves by $4^{\\text {th }}$ postoperative day\n\n2. Visceral pain: obstructing ureteral stone, common bile duct stone, twisted ovarian cyst, blunt abdominal / chest trauma\n3. Intraabdominal inflammation / infection: peritonitis, appendicitis, cholecystitis, pancreatitis, salpingitis, abdominal abscess, hemolytic-uremic syndrome, gastroenteritis\n4. Ischemic bowel disease\n5. Anticholinergic drugs: atropine, propantheline, morphine + derivatives, tricyclic antidepressants, dilantin, phenothiazines, hexamethonium bromide\n6. Neuromuscular disorder: diabetes, hypothyroidism, porphyria, lead poisoning, uremia, hypokalemia, amyloidosis, urticaria, sprue, scleroderma, Chagas disease, vagotomy, myotonic dystrophy, CNS trauma, paraplegia, quadriplegia\n7. Systemic disease: septic / hypovolemic shock, urticaria\n8. Chest disease: lower lobe pneumonia, pleuritis, myocardial infarction, acute pericarditis, CHF\n9. Retroperitoneal disease: hemorrhage (spine trauma), abscess\nmnemonic: Remember the P's\nPancreatitis\nPendicitis\nPeptic ulcer\nPerforation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 563,
            "markdown": "Peritonitis\nPneumonia\nPorphyria\nPostoperative\nPotassium paucity\nPregnancy\nPyelonephritis\n\n- intestinal sounds decreased / absent; abdominal distension\n$\\sqrt{ }$ large + small bowel $\\pm$ gastric distension\n$\\sqrt{ }$ decreased small bowel distension on serial films\n$\\sqrt{ }$ delayed but free passage of contrast material\nUS:\n$\\sqrt{ }$ patent dilated fluid filled bowel lumen\n$\\sqrt{ }$ minimal peristalsis\n$R x:$ not amenable to surgical correction\n\n\n# Localized lleus \n\n$=$ isolated distended loop of small / large bowel\n$=$ SENTINELLOOP\nOften associated with: adjacent acute inflammatory process\nEtiology:\n\n1. Acute pancreatitis: duodenum, jejunum, transverse colon\n2. Acute cholecystitis: hepatic flexure of colon\n3. Acute appendicitis: terminal ileum, cecum\n4. Acute diverticulitis: descending colon\n5. Acute ureteral colic: GI tract along course of ureter\n\n## Intestinal Pseudoobstruction\n\nA. Transient pseudoobstruction\n\n1. Electrolyte imbalance\n2. Renal failure\n3. Congestive heart failure\nB. Acute colonic pseudoobstruction\nC. Chronic pseudoobstruction\n4. Scleroderma\n5. Amyloidosis\nD. Idiopathic pseudoobstruction\n6. Chronic intestinal pseudoobstruction syndrome\n7. Megacystis-microcolon-intestinal-hypoperistalsis syndrome\n\n## ESOPHAGUS\n\n## Esophageal Contractions\n\n$\\diamond$ Esophageal motor activity needs to be evaluated in recumbent position without influence of gravity!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 564,
            "markdown": "PERISTALTIC EVENT $=$ coordinated contractions of esophagus\nPERISTALTIC SEQUENCE $=$ aboral stripping wave clearing esophagus\n\n# Primary Esophageal Peristalsis \n\n$=$ orderly peristaltic sequence with progressive aboral stripping traversing entire esophagus with complete clearance of barium; centrally mediated (medulla) swallow reflex via glossopharyngeal + vagal nerve; initiated by swallowing\n$\\sqrt{ }$ rapid wave of inhibition followed by slower wave of contraction\n$\\diamond$ Normal peristaltic sequence will be interrupted by repetitive swallowing before peristaltic sequence is complete!\n\n## Secondary Esophageal Peristalsis\n\n$=$ local peristaltic wave identical to primary peristalsis but elicited through esophageal distension $=$ sensorimotor stretch reflex\n$\\diamond$ Esophageal motility can be evaluated with barium injection through nasoesophageal tube despite patient's inability to swallow!\n\n## Tertiary Esophageal Contractions\n\n$=$ nonpropulsive esophageal motor event characterized by disorderly up-and-down movement of bolus without clearing of esophagus\nCause:\n\n1. Presbyesophagus\n2. Diffuse esophageal spasm\n3. Hyperactive achalasia\n4. Neuromuscular disease:\ndiabetes mellitus, parkinsonism, amyotrophic lateral sclerosis, multiple sclerosis, thyrotoxic myopathy, myotonic dystrophy\n5. Obstruction of cardia:\nneoplasm, distal esophageal stricture, benign lesion, S/P repair of hiatal hernia\n$\\diamond$ Tertiary activity does not necessarily imply a significant motility disturbance!\nAge: in 5-10\\% of normal adults during $4^{\\text {th }}-6^{\\text {th }}$ decade\n(a) nonsegmental $=$ partial luminal indentation\n\nLocation: in lower $2 / 3$ of esophagus\n$\\sqrt{ }$ spontaneous repetitive nonpropulsive contraction\n$\\sqrt{ }$ \"yo-yo\" motion of barium\n$\\sqrt{ }$ \"corkscrew\" appearance $=$ scalloped configuration of barium column\n$\\sqrt{ }$ \"rosary bead\" / \"shish kebab\" configuration = compartmentalization of barium column\n$\\sqrt{ }$ no lumen-obliterating contractions\n(b) segmental = luminal obliteration (rare)\n$\\sqrt{ }$ \"curling\" = erratic segmental contractions\n$\\sqrt{ }$ \"rosary-bead\" appearance\n\n## Abnormal Esophageal Peristalsis\n\nA. PRIMARY MOTILITY DISORDERS\n\n1. Achalasia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 565,
            "markdown": "2. Diffuse esophageal spasm\n3. Presbyesophagus\n4. Chalasia\n5. Congenital tracheoesophageal fistula\n6. Intestinal pseudoobstruction\nB. SECONDARY MOTILITY DISORDERS\n(a) connective tissue disease\n7. Scleroderma\n8. SLE\n9. Rheumatoid arthritis\n10. Polymyositis\n11. Dermatomyositis\n12. Muscular dystrophy\n(b) chemical / physical injury\n13. Reflux / peptic esophagitis\n14. S/P vagotomy\n15. Caustic esophagitis\n16. Radiotherapy\n(c) infection\n> fungal: Candidiasis\n> parasitic: Chagas disease\n> bacterial: TB, diphtheria\n> viral: Herpes simplex\n(d) metabolic disease\n17. Diabetes mellitus\n18. Amyloidosis\n19. Alcoholism\n20. Electrolyte disturbances\n(e) endocrine disease\n21. Myxedema\n22. Thyrotoxicosis\n(f) neoplasm\n(g) drug-related: atropine, propantheline, curare\n(h) muscle disease\n23. Myotonic dystrophy\n24. Muscular dystrophy\n25. Oculopharyngeal dystrophy\n26. Myasthenia gravis (= disturbed motility only in striated muscle of upper $1 / 3$ of esophagus)\n$\\checkmark$ persistent collection of barium in upper third of esophagus\n$\\checkmark$ findings reversed by cholinesterase inhibitor edrophonium (Tensilon ${ }^{\\circledR}$ )\n(i) neurologic disease\n27. Parkinsonism\n28. Multiple sclerosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 566,
            "markdown": "3. CNS neoplasm\n4. Amyotrophic lateral sclerosis\n5. Bulbar poliomyelitis\n6. Cerebrovascular disease\n7. Huntington chorea\n8. Ganglioneuromatosis\n9. Wilson disease\n10. Friedreich ataxia\n11. Familial dysautonomia (Riley-Day)\n12. Stiff-man syndrome\n\n# Diffuse Esophageal Dilatation \n\n$=$ ACHALASIA PATTERN = MEGAESOPHAGUS\nA. ESOPHAGEAL MOTILITY DISORDER\n\n1. Idiopathic achalasia\n2. Chagas disease: patients commonly from South America; often associated with megacolon + cardiomegaly\n3. Postvagotomy syndrome\n4. Scleroderma\n5. Systemic lupus erythematosus\n6. Presbyesophagus\n7. Ehlers-Danlos syndrome\n8. Diabetic / alcoholic neuropathy\n9. Anticholinergic drugs\n10. Idiopathic intestinal pseudoobstruction = degeneration of innervation\n11. Amyloidosis: associated with macroglossia, thickened small bowel folds\n12. Esophagitis\nB. DISTAL OBSTRUCTION\n13. Infiltrating lesion of distal esophagus / gastric cardia (eg, carcinoma) = pseudoachalasia\n14. Benign stricture\n15. Extrinsic compression\nmnemonic: MA'S TACO in a SHell\nMuscular disorder (eg, myasthenia gravis)\nAchalasia\nScleroderma\nTrypanosomiasis (Chagas disease)\nAmyloidosis\nCarcinoma\nObstruction\nStricture (lye, potassium, tetracycline)\nHiatal hernia\n\n## Air Esophagram\n\n1. Normal variant",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 567,
            "markdown": "2. Scleroderma\n3. Distal obstruction: tumor, stricture, achalasia\n4. Thoracic surgery\n5. Mediastinal inflammatory disease\n6. S/P total laryngectomy: esophageal speech\n7. Endotracheal intubation + PEEP\n\n# Abnormal Esophageal Folds \n\nA. TRANSVERSE FOLDS\n\n1. Feline esophagus\nfrequently seen with gastroesophageal reflux; normally found in cats\n$\\sqrt{ }$ transient contraction of longitudinally oriented muscularis mucosae\n2. Fixed transverse folds\n$\\leftarrow$ scarring from reflux esophagitis\n$\\checkmark$ stepladder appearance in distal esophagus\nB. LONGITUDINAL FOLDS\nnormal: $1-2 \\mathrm{~mm}$ wide, best seen in collapsed esophagus\n$\\sqrt{ }>3 \\mathrm{~mm}$ with submucosal edema / inflammation\n3. Gastroesophageal reflux\n4. Opportunistic infection\n5. Caustic ingestion\n6. Irradiation\n\nDDx: (1) Varices\n$\\sqrt{ }$ tortuous / serpentine folds that can be effaced by esophageal distension\n(2) Varicoid carcinoma\n$\\sqrt{ }$ fixed rigid folds with abrupt demarcation due to submucosal spread\n\n## Esophageal Inflammation\n\nA. CONTACT INJURY\n(a) reflux related\n\n1. Peptic ulcer disease\n2. Barrett esophagus\n3. Scleroderma (patulous LES)\n4. Nasogastric intubation\n(b) caustic\n5. Foreign body\n6. Corrosives\n(c) thermic\nhabitual ingestion of excessively hot meals / liquids\nB. RADIATION INJURY\nC. INFECTION\n7. Candidiasis\n8. Herpes simplex virus / CMV\n9. Diphtheria\nD. SYSTEMIC DISEASE",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 568,
            "markdown": "(a) dermatologic disorders\n\n- blistering of skin + mucous membranes in response to minor trauma\n\n1. Epidermolysis bullosa dystrophica\n\nHisto: intraepidermal bullae\n2. Benign mucous membrane pemphigoid\n$=$ rare disease of unknown cause\nHisto: subepidermal bullae without acantholysis\nAge: $4^{\\text {th }}$ decade; $\\mathrm{M}<\\mathrm{F}$\n$\\checkmark$ esophageal lesions (in $2-13 \\%$ ) most frequent at sites of relative stasis (aortic knob, carina, GE junction):\n$\\checkmark$ thin smooth webs arising from anterior aspect\n$\\checkmark$ stenoses of variable length\n3. Pemphigus vulgaris\n(b) others:\n4. Crohn disease\n5. Graft-versus-host disease\n6. Behçet disease\n7. Eosinophilic gastroenteritis\n\n# Esophageal Ulcer \n\nA. PEPTIC\n\n1. Reflux esophagitis: scleroderma\n2. Barrett esophagus\n3. Crohn disease\n4. Dermatologic disorders: benign mucous membrane pemphigoid, epidermolysis bullosa dystrophica, Behçet disease\nB. INFECTIOUS\n5. Herpes\n6. Cytomegalovirus\nC. CONTACT INJURY / EXTERNAL INJURY\n7. Corrosives: alkali, strictures in $50 \\%$\n8. Alcohol-induced esophagitis\n9. Drug-induced esophagitis\n10. Radiotherapy: smooth stricture at $>4,500 \\mathrm{rad}$\n$\\checkmark$ shallow / deep ulcers conforming to radiation portal\n11. Nasogastric tube\n$\\checkmark$ elongated stricture in middle $1 / 3+$ distal $1 / 3$\n12. Endoscopic sclerotherapy\nD. MALIGNANT\n13. Esophageal carcinoma\n\nLocation:\n@ Upper esophagus\n\n1. Barrett ulcer in islets of gastric mucosa\n@ Midesophagus\n2. Herpes esophagitis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 569,
            "markdown": "2. CMV esophagitis\n3. Drug-induced esophagitis\n@ Distal esophagus\n4. Reflux esophagitis\n5. CMV esophagitis\n\nDDx:\n(1) Sacculation\n$=$ outpouching in distal esophagus due to asymmetric scarring in reflux esophagitis\n(2) Esophageal intramural pseudodiverticula\n(3) Artifact\n(a) tiny precipitates of barium\n(b) transient mucosal crinkling in inadequate distension\n(c) irregular Z-line\n\n# Small Esophageal Ulcer ( $<1 \\mathrm{~cm}$ ) \n\n1. Herpes simplex virus type I\n2. Drug-induced\n3. Reflux esophagitis\n4. Behçet disease\n5. Benign mucous membrane pemphigoid\n6. Acute radiation change\n\n## Large Esophageal Ulcer (> 1 cm )\n\n1. Cytomegalovirus\n2. Human immunodeficiency virus\n3. Carcinoma\n4. Drug-induced\n5. Barrett esophagus\n6. Sclerotherapy for varices\n\n## Double-barrel Esophagus\n\n1. Dissecting intramural hematoma from emetogenic injury\n2. Mallory-Weiss tear: trauma, esophagoscopy (in $0.25 \\%$ ), bougienage (in $0.5 \\%$ ), ingestion of foreign bodies, spontaneous (bleeding diathesis)\n3. Intramural abscess\n4. Intraluminal diverticulum\n5. Esophageal duplication (if communication with esophageal lumen present)\n\n## Esophageal Diverticulum\n\n1. Zenker diverticulum (pharyngoesophageal)\n2. Killian-Jamieson diverticulum\n3. Interbronchial diverticulum\n$=$ traction diverticulum\n$=$ response to pull from fibrous adhesions following lymph node infection (TB), contains all 3 esophageal layers\nLocation: usually on right anterolateral wall of interbronchial segment",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 570,
            "markdown": "$\\sqrt{ }$ calcified mediastinal nodes\n4. Interaorticobronchial diverticulum\n$=$ thoracic pulsion diverticulum\nLocation: on left anterolateral wall between inferior border of aortic arch + upper margin of left main bronchus\n5. Epiphrenic diverticulum (rare)\n\nLocation: usually on lateral esophageal wall, right $>$ left, in distal 10 cm\n$\\sqrt{ }$ often associated with hiatus hernia\n$C x$ : overflow aspiration\n6. Intramural esophageal pseudodiverticulosis\n$\\sqrt{ }$ outpouching from mucosal glands\n\n# Tracheobronchoesophageal Fistula \n\n$=$ ESOPHAGORESPIRATORY FISTULA\nLocation: esophagotracheal $52-57 \\%$\nesophagobronchial $37-40 \\%$\nesophagopulmonary $3-11 \\%$\nCXR:\n$\\sqrt{ }$ recurrent pulmonary consolidation\n$\\sqrt{ }$ lung abscess\n$\\sqrt{ }$ pleural effusion\nEsophagography:\n$\\diamond$ Use low-osmolar hydrosoluble contrast material\n$\\sqrt{ }$ may confirm $\\mathrm{Dx}+$ identify site of fistula\nCT:\n$\\sqrt{ }$ oral contrast in airway lumen + lung parenchyma\n$\\sqrt{ }$ surrounding soft-tissue thickening\nA. CONGENITAL\n\n1. Congenital tracheoesophageal fistula\nB. MALIGNANCY (in $60 \\%$ )\n2. Lung cancer\n$\\diamond \\operatorname{In}<1 \\%$ of patients with lung cancer\n3. Metastases to mediastinal lymph nodes\n4. Esophageal cancer\n$\\diamond$ In $5-10 \\%$ of patients with advanced esophageal cancer\nLocation: middle $1 / 3$ of esophagus\n5. Treatment of mediastinal malignancy by radiation, chemotherapy, laser, esophageal stent placement\nC. TRAUMATIC\n6. Instrumentation: esophagoscopy, bougienage, pneumatic dilatation\n7. Blunt (\"crush injury\") / penetrating chest trauma\n8. Surgery\n9. Foreign-body perforation\n10. Corrosives",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 571,
            "markdown": "6. Postemetic rupture $=$ Boerhaave syndrome\nD. INFECTIOUS / INFLAMMATORY\n7. TB, syphilis, histoplasmosis, actinomycosis, Crohn disease\n8. Perforated diverticulum\n9. Pulmonary sequestration / cyst\n\n# Long Smooth Esophageal Narrowing \n\n1. Congenital esophageal stenosis\n2. Surgical repair of esophageal atresia\n$\\sqrt{ }$ interruption of primary peristaltic wave at anastomosis\n$\\sqrt{ }$ secondary contractions may produce retrograde flow with aspiration\n$\\sqrt{ }$ impaction of food\n3. Caustic burns = alkaline burns\n4. Alendronate (= inhibitor of osteoclastic activity)\n5. Gastric acid: reflux, hyperemesis gravidarum\n6. Intubation: reflux + compromise of circulation\n7. Radiotherapy for esophageal carcinoma; tumor of lung, breast, or thymus; lymphoma; metastases to mediastinal lymph nodes\nOnset of stricture: usually $4-8$ months post Rx\nDose: $3,000-5,000 \\mathrm{rad}$\n8. Postinfectious: moniliasis (rare)\n\n## Focal Esophageal Narrowing\n\n1. Esophageal web\n$=1-2-\\mathrm{mm}$ thick (vertical length) area of complete / incomplete circumferential narrowing\n2. Esophageal ring\n$=5-10-\\mathrm{mm}$ thick (vertical length) area of complete / incomplete circumferential narrowing\n3. Esophageal stricture\n$=>10 \\mathrm{~mm}$ in vertical length\nmnemonic: LETTERS MC\nLye ingestion\nEsophagitis\nTumor\nTube (prolonged nasogastric intubation)\nEpidermolysis bullosa\nRadiation\nSurgery, Scleroderma\nMoniliasis\nCongenital\n\n## Upper \\& Midesophageal Stricture\n\nIn the setting of hiatal hernia and gastroesophageal reflux, a focal stricture in the midesophagus is highly suggestive of Barrett esophagus.\n\n1. Barrett esophagus",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 572,
            "markdown": "2. Mediastinal radiation therapy\n3. Caustic esophagitis\n4. Drug-induced stricture\n5. Esophageal intramural pseudodiverticulosis\n6. Dermatologic disorder: benign mucous membrane pemphigoid, epidermolysis bullosa dystrophica, erythema multiforme major\n7. Graft-versus-host disease\n8. Congenital esophageal stenosis\n$=$ tracheobronchial remnant / cartilaginous ring in esophageal wall\n9. Metastatic cancer (from subcarinal nodes / left mainstem bronchus)\n\nDDx: Primary carcinoma: squamous cell carcinoma\n\n# Lower Esophageal Narrowing \n\nmnemonic: SPADE\nScleroderma\nPresbyesophagus\nAchalasia; Anticholinergics\nDiffuse esophageal spasm\nEsophagitis\n\n## Long Distal (Lower) Esophageal Stricture\n\nA. SEVERE ACID EXPOSURE\n\n1. Nasogastric intubation\n2. Zollinger-Ellison syndrome\n3. Alkaline reflux esophagitis\nB. INFLAMMATION\n4. Crohn disease\n\nShort Distal (Lower) Esophageal Stricture\n\n1. Reflux-induced (\"peptic\") esophagitis\n2. Scleroderma\n3. Carcinoma (adenocarcinoma)\n4. Crohn disease\n5. Schatzki ring\n\n## Esophageal Filling Defect\n\nA. BENIGN TUMORS\n$<1 \\%$ of all clinical esophageal tumors; $20 \\%$ at autopsy\n(a) Subepithelial tumor ( $75 \\%$ )\n$=$ nonepithelial, intramural\n\n1. Leiomyoma ( $50 \\%$ of all benign tumors)\n$\\diamond$ Most common subepithelial mass in esophagus\n2. Granular cell myoblastoma\n3. Lipoma, fibroma, lipoma, fibrolipoma, myxofibroma, hamartoma, hemangioma, lymphangioma, neurofibroma, schwannoma\n$\\sqrt{ }$ primary wave stops at level of tumor",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 573,
            "markdown": "$\\sqrt{ }$ proximal esophageal dilatation + hypotonicity\n$\\sqrt{ }$ rigid esophageal wall at site of tumoral implant\n$\\sqrt{ }$ disorganized / altered / effaced mucosal folds around defect\n$\\sqrt{ }$ tumor shadow on tangential view extending beyond esophageal margin\n(b) Mucosal tumor $(25 \\%)=$ epithelial, intraluminal\n\n1. Squamous papilloma\n$=$ most common benign mucosal tumor; rarely multiple (as in esophageal papillomatosis)\n$\\checkmark$ small sessile slightly lobulated polyp\n$\\checkmark$ average size of 4 mm\n2. Fibrovascular polyp\n3. Inflammatory esophagogastric polyp\n$=$ sentinel polyp = bulbous tip of thickened gastric fold\nCause: sequelae of chronic reflux esophagitis\nPrognosis: no malignant potential\n4. Adenoma\n$=$ originates in Barrett mucosa\n$\\checkmark$ rare sessile / pedunculated polyp\n$C x$ : malignant degeneration\n5. Glycogen acanthosis\nB. MALIGNANT TUMORS\n$\\diamond 80 \\%$ of esophageal neoplasms are malignant!\n6. Esophageal cancer\n7. Carcinoma of cardia (= gastric cancer)\n8. Metastases: malignant melanoma, lymphoma ( $<1 \\%$ of gastrointestinal lymphomas), stomach, lung, breast\nC. VASCULAR\n9. Varices\nD. INFECTION / INFLAMMATION\n10. Candida / herpes esophagitis\n11. Drug-induced inflammatory reaction\nE. CONGENITAL / NORMAL VARIANT\n12. Prolapsed gastric folds\n13. Esophageal duplication cyst ( $0.5-2.5 \\%$ of all esophageal tumors)\nF. FOREIGN BODIES\n14. Retained food particles: chicken bone, fish bone, pins, coins, small toys, meat\n15. Undissolved effervescent crystals\n16. Air bubbles\n\n# Esophageal Mucosal Nodules / Plaques \n\nplaque $=$ discrete irregular / ovoid elevation barely protruding above mucosal surface nodule $=$ small more rounded elevation\n\n1. Candida esophagitis\n2. Reflux esophagitis (early stage)\n3. Barrett esophagus",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 574,
            "markdown": "4. Glycogen acanthosis\n5. Superficial spreading carcinoma\n6. Esophageal varices\n7. Artifacts: undissolved effervescent agent, air bubbles, debris\n\n# Extrinsic Esophageal Impression \n\n## Cervical Causes of Esophageal Impression\n\nA. OSSEOUS LESIONS\n\n1. Anterior marginal osteophyte / DISH\n2. Anterior disk herniation\n3. Cervical trauma + hematoma\n4. Osteomyelitis\n5. Bone neoplasm\nB. ESOPHAGEAL WALL LESIONS\n(a) muscle\n6. Cricopharyngeus\n7. Esophageal web\n(b) vessel\n8. Pharyngeal venous plexus\n9. Lymph node enlargement\nC. ENDOCRINE ORGANS\n10. Thyroid / parathyroid enlargement (benign / malignant)\n11. Fibrotic traction after thyroidectomy\nD. Retropharyngeal / mediastinal abscess\n\n## Thoracic Causes of Esophageal Impression\n\nA. NORMALINDENTATIONS aortic arch, left mainstem bronchus, left inferior pulmonary vein, diaphragmatic hiatus\nB. ABNORMAL VASCULATURE right-sided aortic arch, cervical aortic arch, aortic unfolding, aortic tortuosity, aortic aneurysm, double aortic arch (\"reverse S\"), coarctation of aorta (\"reverse figure 3\"), aberrant right subclavian artery = arteria lusoria (semilunar / bayonet-shaped imprint upon posterior wall of esophagus), aberrant left pulmonary artery (between trachea + esophagus), anomalous pulmonary venous return (anterior), persistent truncus arteriosus (posterior)\nC. CARDIAC CAUSES\n(a) enlargement of chambers\nleft atrial / left ventricular enlargement: mitral disease\n(esophageal displacement backward + to the right)\n(b) pericardial mass\npericardial tumor / cyst / effusion\nD. MEDIASTINAL CAUSES mediastinal tumor, lymphadenopathy (metastatic, tuberculous), inflammation, cyst\nE. PULMONARY CAUSES pulmonary tumor, bronchogenic cyst, atypical pulmonary fibrosis (retraction)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 575,
            "markdown": "# F. ESOPHAGEAL ABNORMALITIES \n\n1. Esophageal diverticulum\n2. Paraesophageal hernia\n3. Esophageal duplication",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 576,
            "markdown": "# STOMACH \n\n## Gastroesophageal Reflux\n\n$89 \\%$ correlation with acid reflux test\nCause:\n(1) Decreased pressure of lower esophageal sphincter\n(a) transient-complete relaxation of LES\n(b) low resting pressure of LES\n(2) Transient increase in intraabdominal pressure\n(3) Short intraabdominal esophageal segment\n\nAge of children: usually 6-9 months, up to 2 years\n\n- poor weight gain, vomiting, aspiration, choking\n- asthmatic episodes, stridor, apnea\n\nDetection: upper GI examination with barium, distal esophageal sphincter pressure measurements, $24-\\mathrm{hr} \\mathrm{pH}$ probe measurement in distal esophagus (gold standard), radionuclide examination\nPreparation: 4-hour / overnight fasting; abdominal sphygmomanometer (for adults)\nDose: $\\quad 0.5-1.0 \\mathrm{mCi}{ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-sulfur colloid in 300 mL of acidified orange juice ( 150 mL juice $+150 \\mathrm{~mL} 0.1 \\mathrm{~N}$ hydrochloric acid) followed by \"cold\" acidified orange juice\nImaging: at $30-60$-second intervals for $30-60 \\mathrm{~min}$ images taken in supine position from anterior; sphygmo-manometer inflated at $20,40,60,80,100 \\mathrm{mmHg}$\nInterpretation:\nReflux (in \\%) = [counts esophageal - counts background $]$ / counts gastric) $\\cdot 100$\n$\\sqrt{ }$ up to $3 \\%$ magnitude reflux is normal\n$\\sqrt{ }$ evidence of pulmonary aspiration (valuable in pediatric age group)\n$C x$ : reflux esophagitis secondary to\n(a) delayed clearance time of esophageal acid load: tertiary / repetitive esophageal contractions, supine position of refluxor, aspiration of saliva, stimulation of salivary flow, stretched phrenoesophageal membrane in hiatal hernia\n(b) delayed gastric emptying: increased intragastric pressure (gastric outlet obstruction), viral gastropathy, diabetes\nPrognosis in childhood:\n(1) Self-limiting process with spontaneous resolution by end of infancy (in majority of patients)\n(2) Persistent symptoms until age $4(1 / 3$ of patients)\n(3) Death from inanition / recurrent pneumonia (5\\%)\n(4) Cause of recurrent respiratory infections, asthma, failure to thrive, esophagitis, esophageal stricture, chronic blood loss, sudden infant death syndrome (SIDS)\nRx: (1) Conservative therapy:\navoidance of food + drugs that decrease pressure in LES, elevation of head during sleep, acid neutral-ization, cimetidine / ranitidine (reduction of acid production), metoclopramide / domperidone (increase sphincter pressure + promote gastric emptying)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 577,
            "markdown": "# (2) Antireflux surgery \n\n## Gastric Emptying\n\n$\\diamond$ Rates of gastric emptying vary widely between subjects and even in the same subject at different times\nDose: $\\quad 0.5-1 \\mathrm{mCi}$\n(a) ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-sulfur colloid cooked with egg white / liver pâté as solid food\n(b) ${ }^{111}$ In-DTPA in milk, water, formula, juice for simultaneous measurement of liquid phase Imaging: 1-minute anterior abdominal images obtained at $0,10,30,60,90 \\mathrm{~min}$ in erect position if dual-head camera available; anterior and posterior imaging performed with geometric mean activity calculated\nPharmacokinetics:\n$79 \\%$ tracer activity in stomach for solid phase at 10 minutes; $65 \\%$ at 30 minutes; $33 \\%$ at 60 minutes; $10 \\%$ at 90 minutes\nNormal result: $50 \\%$ of activity in stomach at time zero; should empty by $60 \\pm 30$ minutes\n$\\checkmark$ acutely delayed emptying in stress (pain, cold), drugs (morphine, anticholinergics, LDOPA, nicotine, $\\beta$-adrenergic antagonists), postoperative ileus, acute viral gastroenteritis, hyperglycemia, hypokalemia\n$\\checkmark$ chronically delayed gastric emptying in gastric outlet obstruction, postvagotomy, gastric ulcer, chronic idiopathic intestinal pseudoobstruction, GE reflux, progressive systemic sclerosis, dermatomyositis, spinal cord injury, myotonia dystrophica, familial dysautonomia, anorexia nervosa, hypothyroidism, diabetes mellitus, amyloidosis, uremia\n$\\checkmark$ abnormally rapid gastric emptying after gastric surgery, Z-E syndrome, duodenal ulcer disease, malabsorption (pancreatic exocrine insufficiency / celiac sprue)\n\n## Emergent Gastric Conditions\n\nMural stratification favors inflammation. Focal / nodular gastritis requires endoscopy and biopsy to exclude malignancy.\nA. INFLAMMATION\n\n1. Emphysematous gastritis\n2. Peptic ulcer disease\n3. Marginal ulcer\nB. OBSTRUCTION\n4. Gastric Volvulus\n5. Peptic ulcer disease\n6. Malignancy\n7. Bezoar\n8. Bouveret syndrome\n9. Slipped gastric band\n10. Vertical band gastroplasty\nC. PERFORATION\n11. Peptic ulcer disease\n12. Malignancy\n13. Gastric banding",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 578,
            "markdown": "4. Penetrating trauma\nD. HEMORRHAGE\nE. ISCHEMIA\n\n# Gastric Tumor \n\n## Gastric Tumor Classification based on Cell Origin (WHO)\n\nA. Epithelial (vast majority of gastric tumors)\n\nWall layer: mucosa\nB. Nonepithelial = intramural = submucosal\n$\\diamond$ Don't use \"submucosal\" in the sense of \"deep to mucosa\" because submucosa is its own specific layer\nWall layer: submucosa, muscularis propria, serosa\nCECT:\n$\\checkmark$ prominent enhancement of gastric mucosa during arterial phase\n$\\checkmark$ enhancement of entire gastric wall during later phases without identification of distinct wall layers\n\n## Gastric Tumor Classification based on Biologic Behavior\n\nA. MALIGNANT (10-15\\%)\n(a) epithelial / mucosal tumor\n\n1. Adenocarcinoma ( $>95 \\%$ )\n2. Lymphoma, MALT\n3. Carcinoid tumor\n(b) mesenchymal tumor (50\\%)\n4. Sarcoma: leiomyosarcoma, Kaposi sarcoma\n5. Metastasis to stomach\nB. BENIGN (85-90\\%)\n(a) epithelial / mucosal tumor (50\\%)\n6. Hyperplastic polyp\n7. Adenomatous polyp\n8. Brunner gland hyperplasia\n(b) mesenchymal tumor ( $50 \\%$ )\n\n## Mesenchymal Tumor of Stomach\n\n$=$ nonepithelial / intramural\nA. GIST\nB. SOMATIC SOFT TISSUE TUMOR\n(a) smooth muscle tumor\n\n1. True leiomyoma\n2. True leiomyosarcoma\n3. Plexiform fibromyxoma\n(b) neural tumor ( $4 \\%$ of all benign gastric tumors)\n4. Schwannoma\n5. Neurofibroma\n6. Plexosarcoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 579,
            "markdown": "(c) lipocytic tumor\n\n1. Lipoma\n2. Liposarcoma\n(d) vascular / perivascular tissue\n$\\diamond 2 \\%$ of all benign gastric tumors\n3. Glomus tumor (most common)\n4. Hemangioma\n5. Lymphangioma\n(e) inflammatory tumor\n6. Inflammatory fibroid polyp\n7. Inflammatory myofibroblastic tumor\n$\\diamond$ Carcinoid tumor originates from Kulchitsky cell within gastric mucosa $=$ epithelial origin. Tumor bulk is often submucosal, so they should be included in DDx of submucosal gastric tumors.\n\n# Mesenchymal Gastric Tumor by Location \n\nSome tumors are seen more frequently in certain parts of the stomach $\\rightarrow$ tumor location is important for DDx\n@ gastric cardia: leiomyoma\n@ gastric body: GIST, schwannoma\n@ gastric antrum: glomus tumor, inflammatory fibroid polyp, lipoma, ectopic panc\n\n## Calcified Gastric Tumor\n\n1. Mucinous adenocarcinoma:\nmiliary / punctate\n2. Stromal tumors:\namorphous calcifications\n3. Hemangioma:\nclusters of phleboliths\n\n## Multiple Gastric Tumors\n\n1. Carcinoid tumors\n2. Hyperplastic polyps\n3. Adenomatous polyps: familial adenomatous polyposis syndrome\n4. Hamartomatous polyps: Peutz-Jeghers syndrome\n5. Multiple hamartomas: Cowden disease\n6. Metastases (usually intramural)\n\n## Congenital Gastric Obstruction\n\n## A. COMPLETE OBSTRUCTION\n\n1. Gastric atresia\n\nFrequency: $<1 \\%$ of all GI obstructions\nMay be associated with: epidermolysis bullosa\nSite: antrum + pylorus\n\n- regurgitation of bile-free vomitus within first few hours after birth\n$\\checkmark$ \"single bubble\" appearance of air in stomach\n$\\checkmark$ membranous mucosal diaphragm\n\n2. Congenital peritoneal bands\n3. Annular pancreatic tissue",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 580,
            "markdown": "4. Gastric volvulus\nB. PARTIAL GASTRIC OUTLET OBSTRUCTION\n\n- cyclic transient postprandial vomiting\n\n1. Incomplete prepyloric diaphragm\n2. Antral stenosis\n3. Aberrant pancreatic tissue in gastric antrum\n4. Antral duplication cyst\n\n# Widened Retrogastric Space \n\nA. PANCREATIC MASS (most common cause)\n\n1. Acute + chronic pancreatitis\n2. Pancreatic pseudocyst\n3. Pancreatic cystadenoma + carcinoma\nB. OTHER RETROPERITONEAL MASS\n4. Sarcoma\n5. Renal tumor, adrenal tumor\n6. Lymph node enlargement\n7. Abscess, hematoma\nC. GASTRIC MASS\n8. Leiomyoma, leiomyosarcoma\nD. OTHERS\n9. Aortic aneurysm\n10. Choledochal cyst\n11. Obesity\n12. Postsurgical disruptions + adhesions\n13. Ascites\n14. Gross hepatomegaly + enlarged caudate lobe\n15. Hernia involving omentum\n\n## Gas within Stomach Wall\n\nA. NONINFECTIOUS\n\n1. Interstitial gastric emphysema\n$=$ gas accumulation in submucosa / subserosa / or both\nCause: air from an extrinsic source\n(a) obstructive ( $\\leftarrow$ raised intragastric pressure): gastric outlet obstruction, volvulus, overinflation during gastroscopy, profuse severe vomiting\n(b) pulmonary ( $\\leftarrow$ rupture + dissection of subpleural blebs in bullous emphysema along esophageal wall / mediastinum): pulmonary emphysema\n(c) traumatic ( $\\leftarrow$ mucosal trauma): instrumentation of stomach, recent gastroduodenal surgery, endoscopy ( $1.6 \\%$ )\n\n- benign clinical course with spontaneous resolution\n$\\sqrt{ }$ linear lucency conforming to contour of a thin-walled distended stomach\n\n2. Cystic pneumatosis\n$=$ PNEUMATOSIS CYSTOIDES INTESTINALIS\nCause: similar to interstitial gastric emphysema",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 581,
            "markdown": "- little / no gastrointestinal symptoms\n$\\sqrt{ }$ multiple $1-2-\\mathrm{mm}$ gas-filled cysts in wall of stomach and intestines\nB. INFECTIOUS\n\n1. Emphysematous gastritis\npredisposed: corrosive gastritis, acid ingestion, severe necrotizing gastroenteritis, gastric ulcer disease with intramural perforation, gastric carcinoma, volvulus, gastric infarction\n\n# Gastric Atony \n\n$=$ gastric retention in the absence of mechanical obstruction\nPathophysiology: reflex paralysis\n\n- abdominal distension, vomiting\n- vascular collapse (decreased venous return)\n$\\sqrt{ }$ large stomach filled with air + fluid (up to $7,500 \\mathrm{~mL}$ )\n$\\sqrt{ }$ retention of barium\n$\\sqrt{ }$ absent / diminished peristaltic activity\n$\\checkmark$ patulous pylorus\n$\\checkmark$ frequently dilated duodenum\n$D D x$ : gastric volvulus, pyloric stenosis\n\n\n## Acute Gastric Atony\n\n(may develop within 24-48 hours)\n\n1. Acute gastric dilatation $\\leftarrow$ decreased arterial perfusion $\\leftarrow$ ischemia / CHF in old patients, usually fatal\n2. Postsurgical atony, ureteral catheterization\n3. Immobilization: body cast, paraplegia, postoperative state\n4. Abdominal trauma: especially back injury\n5. Severe pain: renal / biliary colic, migraine headaches, severe burns\n6. Infection: peritonitis, pancreatitis, appendicitis, subphrenic abscess, septicemia\n\n## Chronic Gastric Atony\n\n1. Neurologic abnormalities: brain tumor, bulbar poliomyelitis, vagotomy, tabes\n2. Muscular abnormalities: scleroderma, muscular dystrophy\n3. Drug-induced atony: atropine, morphine, heroin, ganglionic blocking agents\n4. Electrolyte imbalance: diabetic ketoacidosis, hypercalcemia, hypocalcemia, hypokalemia, hepatic coma, uremia, myxedema\n5. Diabetes mellitus $=$ gastroparesis diabeticorum $(0.08 \\%$ incidence $)$\n6. Emotional distress\n7. Lead poisoning\n8. Porphyria\n\n## Narrowing of Stomach\n\n$=$ linitis plastica type of stenosis\nA. MALIGNANCY\n\n1. Scirrhous gastric carcinoma (involving portion / all of stomach)\n2. Hodgkin lymphoma, NHL",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 582,
            "markdown": "3. Metastatic involvement $\\leftarrow$ carcinoma of breast, pancreatic carcinoma, colonic carcinoma\nB. INFLAMMATION\n4. Chronic gastric ulcer disease with intense spasm\n5. Pseudo-Billroth-I pattern of Crohn disease\n6. Sarcoidosis\n$\\checkmark$ polypoid appearance, pyloric hypertrophy\n$\\checkmark$ gastric ulcers, duodenal deformity\n7. Eosinophilic gastritis\n8. Polyarteritis nodosa\n9. Stenosing antral gastritis / hypertrophic pyloric stenosis\nC. INFECTION\n10. Tertiary stage of syphilis\n$\\checkmark$ absent mucosal folds + peristalsis\n$\\checkmark$ no change over years\n11. Tuberculosis (rare)\n$\\checkmark$ hyperplastic nodules / ulcerative lesion / annular lesion\n$\\checkmark$ pyloric obstruction, may cross into duodenum\n12. Histoplasmosis\n13. Actinomycosis\n14. Strongyloidiasis\n15. Phlegmonous gastritis\n16. Toxoplasmosis\nD. TRAUMA\n17. Corrosive gastritis\n18. Radiation injury\n19. Gastric freezing\n20. Hepatic arterial chemotherapy infusion\nE. OTHERS\n21. Perigastric adhesions: normal mucosa, no interval change, normal peristalsis\n22. Amyloidosis\n23. Pseudolymphoma\n24. Exogastric mass: hepatomegaly, pancreatic pseudocyst\nmnemonic: SLIMRAGE\nScirrhous carcinoma of stomach\nLymphoma\nInfiltration from adjacent neoplasm\nMetastasis (breast carcinoma)\nRadiation therapy\nAcids (corrosive ingestion)\nGranulomatous disease (TB, sarcoidosis, Crohn)\nEosinophilic gastroenteritis\nAntral Narrowing\nmnemonic: SPICER",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 583,
            "markdown": "Sarcoidosis, SyphilisPeptic ulcer disease\nInfection: TB, chronic granulomatous disease of childhood\nCancer (linitis plastica), Crohn disease, Caustic ingestion\nEosinophilic gastritis\nRadiation\nAntral Pad Sign\n$=$ extrinsic impression of the posteroinferior wall of antrum\n\n1. Pancreatic cancer in head / body\n2. Pancreatitis\n3. Pancreatic pseudocyst\n4. Normal / distended gallbladder (patient in RAO position)\n\n# Intramural-extramucosal Lesion of Stomach \n\n$\\checkmark$ sharply delineated marginal / contour defect\n$\\checkmark$ stretched folds over intact mucosa\n$\\checkmark$ acute angle at margins\n$\\checkmark$ may ulcerate centrally\n$\\checkmark$ may become pedunculated and acquire polypoid appearance over years\nA. NEOPLASTIC\n\n1. Leiomyoma $48 \\%$\n2. Neurogenic tumor $14 \\%$\n3. Heterotopic pancreas $12 \\%$\n4. Fibrous tumor $11 \\%$\n5. Lipoma $7 \\%$\n6. Hemangioma $7 \\%$\n7. Glomus tumor rare\n8. Carcinoid\n9. Metastatic tumor\nB. INFLAMMATION / INFECTION\n10. Granuloma\n(1) Foreign-body granuloma\n(2) Sarcoidosis\n(3) Crohn disease\n(4) Tuberculosis\n(5) Histoplasmosis\n11. Eosinophilic gastritis\n12. Tertiary syphilis: infiltrative / ulcerative / tumorous type\n13. Echinococcal cyst\nC. PANCREATIC ABNORMALITIES\n14. Ectopic pancreas\n15. Annular pancreas\n16. Pancreatic pseudocyst\nD. DEPOSITS",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 584,
            "markdown": "1. Amyloid\n2. Endometriosis\n3. Localized hematoma\nE. OTHERS\n4. Varices: ie, fundal\n5. Duplications ( $4 \\%$ of all GI tract duplications)\n\n# Gastric Filling Defect \n\nA. INTRINSIC WALL LESIONS\n(a) benign (most common)\n\n1. Polyp: hyperplastic, adenomatous, villous, hamar- tomatous (Peutz-Jeghers syndrome, Cowden disease)\n2. Leiomyoma\n3. Granulomatous lesion\n(1) Eosinophilic granuloma\n(2) Crohn disease\n(3) Tuberculosis\n(4) Sarcoidosis\n4. Pseudolymphoma = benign reactive proliferation of lymphoid tissue\n5. Extramedullary hematopoiesis\n6. Ectopic pancreas\n7. Gastric duplication cyst\n8. Intramural hematoma\n9. Esophagogastric herniation\n(b) malignant\n10. Gastric carcinoma, lymphoma\n11. Gastric sarcoma: leiomyosarcoma, liposarcoma, leiomyoblastoma\n12. Gastric metastases: melanoma, breast, pancreas, colon\nB. EXTRINSIC IMPRESSION ON STOMACH\nin $70 \\%$ nonneoplastic (extrinsic pseudotumors in 20\\%)\n(a) normal organ: organomegaly, tortuous aorta, heart, cardiac aneurysm\n(b) benign mass: cysts of pancreas, liver, spleen, adrenal, kidney, gastric duplication, postoperative deformity (eg, Nissen fundoplication)\n(c) malignant mass: enlarged celiac nodes\n(d) inflammatory lesion: left subphrenic abscess / hematoma\n> lateral displacement: enlarged liver, aortic aneurysm, enlarged celiac nodes\n> medial displacement: splenomegaly, mass in colonic splenic flexure, cardiomegaly, subphrenic abscess\nC. INTRALUMINAL GASTRIC MASS\n13. Bezoar\n14. Foreign bodies: food, pills, blood clot, gallstone\nD. TUMOR OF ADJACENT ORGAN\n15. Pancreatic carcinoma + cystadenoma\n16. Liver carcinoma\n17. Carcinoma of gallbladder",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 585,
            "markdown": "4. Colonic carcinoma\n5. Renal carcinoma\n6. Adrenal carcinoma\n7. Lymph node involvement\nE. THICKENED GASTRIC FOLDS\n\n# Filling Defect of Gastric Remnant \n\nA. IATROGENIC surgical deformity / plication defect, suture granuloma\nB. INFLAMMATORY bile reflux gastritis, hyperplastic polyps\nC. INTUSSUSCEPTION\n\n1. Jejunogastric intussusception\n(efferent loop in $75 \\%$, afferent loop in $25 \\%$ )\n(a) acute form: high intestinal obstruction, left hypochondriac mass, hematemesis\n(b) chronic / intermittent form: may be self-reducing\n$\\checkmark$ \"coiled spring\" appearance of gastric filling defect\n2. Gastrojejunal / gastroduodenal mucosal prolapse\n\n- often asymptomatic, bleeding partial obstruction\nD. NEOPLASTIC\n\n1. Gastric stump carcinoma: $>5$ years after resection for benign disease; $15 \\%$ (20\\%) within $10(20)$ years\n2. Recurrent carcinoma $(10 \\%) \\leftarrow$ incomplete removal of gastric cancer\n3. Malignancy at anastomosis: incomplete resection\nE. INTRALUMINAL MATTER: bezoar\nmnemonic: PUBLICS\nPolyp (hyperplastic polyp due to bile reflux)\nUlcer (anastomotic)\nBezoar, Blind loop syndrome\nLoop (afferent loop syndrome)\nIntussusception at gastrojejunostomy\nCancer (recurrent, residual, de novo)\nSurgical deformity, Suture granuloma\n\n## Thickened Gastric Folds\n\nA. INFLAMMATION / INFECTION\n\n1. Inflammatory gastritis:\nalcoholic, hypertrophic, antral, corrosive, postirradiation, gastric cooling\n2. Crohn disease\n3. Sarcoidosis\n4. Infectious gastritis:\nbacterial invasion, bacterial toxins from botulism, diphtheria, dysentery, typhoid fever, anisakiasis, TB, syphilis\n5. Pseudolymphoma\nB. MALIGNANCY\n6. Lymphoma\n7. Gastric carcinoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 586,
            "markdown": "# C. INFILTRATIVE PROCESS \n\n1. Eosinophilic gastritis\n2. Amyloidosis\nD. PANCREATIC DISEASE\n3. Pancreatitis\n4. Direct extension from pancreatic carcinoma\nE. OTHERS\n5. Zollinger-Ellison syndrome\n6. Ménétrier disease\n7. Gastric varices\nmnemonic: ZEAL VOLUMES C3P3\n![img-67.jpeg](img-67.jpeg)\n\nZollinger-Ellison syndrome\nAmyloidosis\nLymphoid hyperplasia\nVarices\nOperative defect\nLymphoma\nUlcer disease (peptic)",
            "images": [
                {
                    "id": "img-67.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 666,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1663,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 587,
            "markdown": "Ménétrier disease\nEosinophilic gastroenteritis\nSyphilis\nCrohn disease, Carcinoma, Corrosive gastritis\nPancreatitis, Pancreatic carcinoma,\nPostradiation gastritis\n\n# Bull's-eye Lesion \n\nA. PRIMARY NEOPLASMS\n\n1. Leiomyoma, leiomyosarcoma\n2. Lymphoma\n3. Carcinoid\n4. Primary carcinoma\nB. HEMATOGENOUS METASTASES\n5. Malignant melanoma\n$\\sqrt{ }$ usually spares large bowel\n6. Breast cancer $(15 \\%)$\n$\\sqrt{ }$ scirrhous appearance in stomach\n7. Cancer of lung\n8. Renal cell carcinoma\n9. Kaposi sarcoma\n10. Bladder carcinoma\nC. ECTOPIC PANCREAS\nin duodenum / stomach\nD. EOSINOPHILIC GRANULOMA\nmost frequently in stomach\n\n## Complications of Postoperative Stomach\n\n1. Filling defect of gastric remnant\n2. Retained gastric antrum\n3. Dumping syndrome\n4. Afferent loop syndrome\n5. Stomal obstruction\n(a) temporary reversible: edema of suture line, abscess / hematoma, potassium deficiency, inadequate electrolyte replacement, hypoproteinemia, hypoacidity\n(b) late mechanical: stomal ulcer ( $75 \\%$ )\nmnemonic: LOBULATING\nLeaks (early)\nObstruction (early)\nBezoar\nUlcer: especially marginal\nLoop: afferent loop syndrome\nAnemia: macrocytic $\\leftarrow$ decreased intrinsic factor\nTumor (? increased incidence)\nIntussusception",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 588,
            "markdown": "Not feeling well after meals: dumping syndrome\nGastritis: bile reflux\n\n# Transpyloric Disease \n\n$=$ LESIONS INVOLVING STOMACH AND DUODENUM\n\n1. Lymphoma: in up to $40 \\%$ of patients with lymphoma\n2. Gastric carcinoma: in $5-25 \\%$, but 50 x more common than lymphoma\n3. Peptic ulcer disease\n4. Tuberculosis: in $10 \\%$ of gastric TB\n5. Crohn disease: pseudo-Billroth-I pattern\n6. Strongyloidiasis\n7. Eosinophilic gastroenteritis\n\nTranspyloric spread by itself does not make a diagnosis of lymphoma because of the higher incidence of gastric cancer!\n\n## DUODENUM\n\n## Congenital Duodenal Obstruction\n\n- bile-stained vomiting delayed until after first feeding and increasing progressively\n\n1. Duodenal atresia / severe stenosis\n2. Annular pancreas\n3. Midgut volvulus\n4. Duodenal web\n5. Ladd bands\n6. Preduodenal portal vein\n7. Duodenal duplication cyst\n\nSevere duodenal obstruction is characterized by 2 air-fluid levels on the upright view (\"double bubble sign\"), the largest below the left hemidiaphragm (= gastric distention), the smaller on the right side of the spine ( $=$ dilated proximal duodenum).\n\n## Extrinsic Pressure Effect on Duodenum\n\nA. BILE DUCTS\nnormal impression, dilated CBD, choledochal cyst\nB. GALLBLADDER\nnormal impression, gallbladder hydrops, Courvoisier phenomenon, gallbladder carcinoma, pericholecystic abscess\nC. LIVER\nhepatomegaly, hypertrophied caudate lobe, anomalous hepatic lobe, hepatic cyst, hepatic tumor\nD. RIGHT KIDNEY\nbifid collecting system, hydronephrosis, multiple renal cysts, polycystic kidney disease, hypernephroma\nE. RIGHT ADRENAL\nadrenal carcinoma, enlargement in Addison disease",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 589,
            "markdown": "# F. COLON \n\nduodenocolic apposition $\\leftarrow$ anomalous peritoneal fixation, carcinoma of hepatic flexure\nG. VESSELS\nlymphadenopathy, duodenal varices, dilated arterial collaterals, aortic aneurysm, intramural / mesenteric hematoma\n\n## Widened Duodenal Sweep\n\nA. NORMAL Variant\nB. PANCREATIC LESION\n\n1. Acute pancreatitis\n2. Groove pancreatitis\n3. Pancreatic pseudocyst\n4. Pancreatic carcinoma\n5. Metastasis to pancreas\n6. Pancreatic cystadenoma\nC. VASCULAR LESION\n7. Lymph node enlargement: lymphoma, metastasis, inflammation\n8. Cystic lymphangioma of the mesentery\nD. RETROPERITONEAL MASS\n9. Aortic aneurysm\n10. Choledochal cyst\n\n## Thickened Duodenal Folds\n\nA. INFLAMMATION\n(a) within bowel wall:\n\n1. Peptic ulcer disease\n2. Zollinger-Ellison syndrome\n3. Crohn disease (regional enteritis)\n4. Lymphoid hyperplasia\n5. Uremia\n6. Celiac disease\n(b) surrounding bowel wall: pancreatitis, cholecystitis\nB. INFECTION\ngiardiasis, TB, strongyloidiasis, disseminated histoplasmosis\nC. NEOPLASIA\nlymphoma, metastases to peripancreatic nodes\nD. DIFFUSE INFILTRATIVE DISORDER\n\nWhipple disease, amyloidosis, mastocytosis, eosinophilic enteritis, intestinal lymphangiectasia\nE. VASCULAR DISORDER\nduodenal varices, mesenteric arterial collaterals, intramural hemorrhage (trauma, Schönlein-Henoch purpura), chronic duodenal congestion (CHF, portal venous hypertension); lymphangiectasia\nF. HYPOPROTEINEMIA\nnephrotic syndrome, Ménétrier disease, protein-losing enteropathy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 590,
            "markdown": "# G. GLANDULAR ENLARGEMENT \n\nBrunner gland hyperplasia, cystic fibrosis\nmnemonic: BAD HELP\nBrunner gland hyperplasia\nAmyloidosis\nDuodenitis: Z-E syndrome, peptic ulcer\nHemorrhage\nEdema, Ectopic pancreas\nLymphoma\nPancreatitis, Parasites\n\n## Duodenal Filling Defect\n\nA. EXTRINSIC gallbladder impression, CBD impression, gas-filled diverticulum\nB. INTRINSIC TO WALL\n(a) benign neoplastic mass\n\n1. Adenoma\n2. Leiomyoma\n3. Lipoma\n4. Hamartoma (Peutz-Jeghers syndrome)\n5. Prolapsed antral polyp\n6. Brunner gland adenoma\n7. Villous adenoma\n8. Islet cell tumor\n9. Gangliocytic paraganglioma\n(b) malignant neoplastic mass\n10. Carcinoid tumor\n11. Adenocarcinoma\n12. Ampullary cancer\n13. Lymphoma\n14. Sarcoma\n15. Metastasis: stomach, pancreas, gallbladder, colon, kidney, melanoma\n16. Retroperitoneal lymph node involvement\n(c) nonneoplastic mass\n17. Papilla of Vater\n18. Choledochocele\n19. Duplication cyst\n20. Pancreatic pseudocyst\n21. Duodenal varix\n22. Mesenteric artery collaterals\n23. Intramural hematoma\n24. Inflammatory mass: adjacent abscess, stitch abscess\n25. Ectopic pancreas, heterotopic gastric mucosa\n26. Prolapsed antral mucosa\n27. Brunner gland hyperplasia\n28. Benign lymphoid hyperplasia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 591,
            "markdown": "13. Flexural pseudopolyp\nC. INTRALUMINAL\n14. Blood clot\n15. Foreign body: fruit pit, gallstone, feeding tube\n\n# Duodenal Tumor \n\n## Benign Duodenal Tumors\n\n$=$ typically small polyps $<2 \\mathrm{~cm}$ in diameter\n\n1. GIST $27 \\%$\n2. Leiomyoma ?\n3. Adenomatous polyp $21 \\%$\n> villous adenoma\n> tubular adenoma\n> Brunner gland adenoma $17 \\%$\n4. Lipoma $21 \\%$\n5. Angiomatous tumor $6 \\%$\n6. Ectopic pancreas $2 \\%$\n7. Duodenal cyst $2 \\%$\n8. Neurofibroma $2 \\%$\n9. Hamartoma $2 \\%$\n\n## Malignant Duodenal Tumors\n\n1. Duodenal adenocarcinoma (73\\%)\n2. Periampullary carcinoma\n$=$ tumor arising within 1 cm from papilla of Vater\nOrigin: ampulla, pancreas, bile duct, duodenum\nAt risk: familial adenomatous polyposis\n$\\sqrt{ }$ may not be seen at CT / MR due to small size\n$\\sqrt{ }$ hypovascular polypoid mass at ampulla\nAssociated with: \"double duct\" sign $\\leftarrow$ biliary and pancreatic ductal dilatation\nPrognosis: ampullary ca. (best), pancreatic ca. (worst)\n3. Malignant GIST (14\\%)\nmost often beyond $1^{\\text {st }}$ portion of duodenum\n$\\sqrt{ }$ up to 20 cm in size\n$\\sqrt{ }$ frequently ulcerated exophytic mass\n4. Carcinoid ( $11 \\%$ )\n5. Lymphoma ( $2 \\%$ )\n$\\sqrt{ }$ marked wall thickening\n$\\sqrt{ }$ bulky periduodenal lymphadenopathy\n6. APUDoma\n7. Metastasis\n8. Leiomyosarcoma\n\n## Enlargement of Papilla of Vater",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 592,
            "markdown": "[Abraham Vater (1684-1751), anatomist in Wittenberg, Germany]\nA. Normal variant\nidentified in $60 \\%$ of UGI series; atypical location in $3^{\\text {rd }}$ portion of duodenum in $8 \\% ; 1.5$ cm in diameter in $1 \\%$ of normals\nB. Papillary edema\n\n1. Impacted stone\n2. Pancreatitis (Poppel sign)\n3. Acute duodenal ulcer disease\n4. Papillitis\nC. Perivaterian neoplasms\n$=$ tumor mass + lymphatic obstruction\n5. Adenocarcinoma\n6. Adenomatous polyp (premalignant lesion)\n$\\sqrt{ }$ irregular surface + erosions\nD. Lesions simulating enlarged papilla\n7. Benign spindle cell tumor\n8. Ectopic pancreatic tissue\n\n# Duodenal Narrowing \n\nA. DEVELOPMENTAL ANOMALY\n\n1. Duodenal atresia\n2. Congenital web / duodenal diaphragm\n3. Intraluminal diverticulum\n4. Duodenal duplication cyst\n5. Annular pancreas\n6. Midgut volvulus, peritoneal bands (Ladd bands)\nB. INTRINSIC DISORDER\n(a) inflammation / infection\n7. Postbulbar ulcer\n8. Crohn disease\n9. Sprue\n10. Tuberculosis\n11. Strongyloidiasis\n(b) intramural tumor\n12. GIST $(90 \\%)$\n13. Lipoma, leiomyoblastoma\n14. Hemangioma, lymphangioma\n15. Ectopic pancreatic rest, Brunner gland hamartoma\n16. Duodenal carcinoma, periampullary carcinoma\nC. DISEASE IN ADJACENT STRUCTURES\n17. Pancreatitis, pseudocyst, pancreatic carcinoma\n18. Cholecystitis\n19. Contiguous abscess\n20. Metastases to pancreaticoduodenal nodes: lymphoma, lung cancer, breast cancer\nD. TRAUMA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 593,
            "markdown": "1. Duodenal rupture\n2. Intramural duodenal hematoma\nE. VASCULAR\n3. Superior mesenteric artery syndrome\n4. Aorticoduodenal fistula\n5. Preduodenal portal vein (anterior to descending duodenum)\n\n# Dilated Duodenum \n\nMegaduodenum $=$ marked dilatation of entire C-loop\nMegabulb $=$ dilatation of duodenal bulb only\nA. VASCULAR COMPRESSION\nsuperior mesenteric artery syndrome, abdominal aortic aneurysm, aorticoduodenal fistula\nB. PRIMARY DUODENAL ATONY\n(a) scleroderma, dermatomyositis, SLE\n(b) Chagas disease, aganglionosis, neuropathy, surgical / chemical vagotomy\n(c) focal ileus: pancreatitis, cholecystitis, peptic ulcer disease, trauma\n(d) altered emotional status, chronic idiopathic intestinal pseudoobstruction\nC. INFLAMMATORY / NEOPLASTIC INDURATION OF MESENTERIC ROOT\n\nCrohn disease, tuberculous enteritis, pancreatitis, peptic ulcer disease, strongyloidiasis, metastatic disease\nD. FLUID DISTENSION\nceliac disease, Zollinger-Ellison syndrome\n\n## Benign Wall Thickening of Duodenum\n\n1. Cystic dystrophy of duodenal wall\n$=$ dilatation of pancreatic ducts in ectopic pancreatic tissue within wall of $2^{\\text {nd }}$ portion of duodenum $\\leftarrow$ duct obstruction\n2. Pancreatic hamartoma\n3. Paraduodenal wall cyst\n4. Myoadenomatosis\n5. Groove pancreatitis\n\n## Postbulbar Ulceration\n\n1. Benign postbulbar peptic ulcer ( $10 \\%$ )\n2. Zollinger-Ellison syndrome\n3. Gastrointestinal stromal tumor (GIST)\n4. Malignant tumors:\n(a) primary\nadenocarcinoma, lymphoma, sarcoma\n(b) contiguous spread\npancreas, colon, kidney, gallbladder\n(c) hematogenous spread\nmelanoma, Kaposi sarcoma\n(d) lymphogenic spread\nmetastases to periduodenal lymph nodes",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 594,
            "markdown": "5. Granulomatous disease: Crohn disease, TB, CMV\n6. Aorticoduodenal fistula\n7. Mimickers: ectopic pancreas, diverticulum\n\n# SMALL BOWEL \n\n## Anatomic Predilection for Intestinal Involvement\n\n@ proximal jejunum\n@ distal ileum\n@ mesenteric border\n@ antimesenteric border\n\ndiverticulosis, giardiasis, adenocarcinoma, Whipple disease, Z-E syndrome, celiac disease\nCrohn disease, TB, infectious enteritis, lymphoma, carcinoid, metastases diverticulosis, Crohn disease, mesenteric hematoma, intraperitoneal spread of tumor\nMeckel diverticulum, sacculations in scleroderma, hematogenous metastases\n\n## Increased Fluid within Small Bowel\n\n1. Ingestion\n2. Resection / removal of stomach\n3. Small-bowel obstruction\n4. Enteritis\n5. Malabsorption: celiac disease, Whipple disease\n6. Peritoneal carcinomatosis\n\n## Small Bowel Diverticula\n\nA. TRUE DIVERTICULA\n(a) Duodenal diverticula\n\n1. Racemose diverticula: bizarre, lobulated\n2. Giant diverticula\n3. Intraluminal diverticula: result of congenital web / diaphragm\n(b) Jejunal diverticulosis\n(c) Meckel diverticulum\nB. PSEUDODIVERTICULA\n4. Scleroderma\n5. Crohn disease\n6. Lymphoma\n7. Mesenteric ischemia\n8. Communicating ileal duplication\n9. Giant duodenal ulcer\n\n## Small Bowel Ulcer\n\nAphthous Ulcers of Small Bowel\nA. INFECTION\n\n1. Yersinia enterocolitis ( $25 \\%$ )\n2. Salmonellosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 595,
            "markdown": "3. Tuberculosis\n4. Rickettsiosis\nB. INFLAMMATION\n5. Crohn disease ( $22 \\%$ )\n6. Behçet disease\n7. Reiter syndrome\n8. Ankylosing spondylitis\n\n# Large Nonstenotic Ulcers of Small Bowel \n\n1. Primary nonspecific ulcer $47 \\%$ incidence\n2. Yersiniosis $33 \\%$\n3. Crohn disease $30 \\%$\n4. Tuberculosis $18 \\%$\n5. Salmonellosis / shigellosis $7 \\%$\n6. Meckel diverticulum 5\\%\n\n## Multiple Small Bowel Ulcers\n\nA. DRUGS\n\n1. Potassium tablets\n2. Steroids\n3. Nonsteroidal antiinflammatory drugs\nB. INFECTION / INFLAMMATION\n4. Bacillary dysentery\n5. Ischemic enteritis\n6. Ulcerative jejunoileitis as complication of celiac disease\nC. TUMOR\n7. Neoplasms\n8. Intestinal lymphoma\n\n## Cavitary Small Bowel Lesion\n\nA. PRIMARY TUMOR\n\n1. Lymphoma (exoenteric form)\n2. Leiomyosarcoma (exoenteric form)\n3. Primary adenocarcinoma\nB. METASTASIS\n4. Malignant melanoma\n5. Lung cancer\nC. INFLAMMATION\n6. Diverticulitis with abscess: Meckel, jejunal\n7. Communicating duplication cyst\n\n## Separation of Bowel Loops\n\nA. INFILTRATION OF BOWEL WALL / MESENTERY\n(a) inflammation / infection\n\n1. Crohn disease\n2. TB",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 596,
            "markdown": "3. Radiation injury\n4. Retractile mesenteritis\n5. Intraperitoneal abscess\n(b) deposits\n6. Intestinal hemorrhage / mesenteric vascular occlusion\n7. Whipple disease\n8. Amyloidosis\n(c) tumor\n9. Carcinoid tumor: local release of serotonin responsible for muscular thickening + fibroplastic proliferation $=$ desmoplastic reaction\n10. Primary carcinoma of small bowel (unusual presentation)\n11. Lymphoma\n12. Neurofibromatosis\nB. ASCITES / INTRAPERITONEAL BLEEDING hepatic cirrhosis (75\\%), peritonitis, peritoneal carcinomatosis, congestive heart failure, constrictive pericarditis, primary / metastatic lymphatic disease\nC. EXTRINSIC MASS\n13. Intraperitoneal spread of tumor: peritoneal mesothelioma, mesenteric tumors (fibroma, lipoma, fibrosarcoma, leiomyosarcoma, malignant mesenteric lymphoid tumor, metastases)\n14. Interloop abscesses / loculated fluid collection\n15. Endometriosis\n16. Retractile mesenteritis (fibrosis, fatty infiltration, panniculitis)\n17. Mesenteric fat deposits\n18. Fibrofatty proliferation: Crohn disease, mesenteric panniculitis\n\n# Normal Small Bowel Folds \\& Diarrhea \n\n1. Pancreatic insufficiency\n2. Lactase deficiency\n3. Lymphoma / pseudolymphoma\n\n## Dilated Small Bowel \\& Normal Folds\n\nmnemonic: SOS\nSprue\nObstruction\nScleroderma\nA. EXCESSIVE FLUID\n(a) mechanical obstruction $\\leftarrow$ adhesion, hernia, neoplasm\n$\\sqrt{ }$ \"string-of-beads\" sign = air bubbles between mucosal folds in a fluid-filled small bowel\n$\\sqrt{ }$ \"pseudotumor\" sign = closed-loop obstruction\n(b) malabsorption syndromes\n\n1. Celiac disease, tropical + nontropical sprue\n2. Lactase deficiency\nB. BOWEL WALL PARALYSIS",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 597,
            "markdown": "$=$ functional ileus $=$ adynamic ileus\n\n1. Surgical vagotomy\n2. Chemical vagotomy from drug effects: atropine-like substances, morphine, L-dopa, glucagon\n3. Chagas disease\n4. Metabolic: hypokalemia, diabetes\n5. Intrinsic + extrinsic intraabdominal inflammation\n6. Chronic idiopathic pseudoobstruction\n\nABNORMAL SMALL BOWEL CALIBER \\& CONTOUR\n![img-68.jpeg](img-68.jpeg)\n\n# C. VASCULAR COMPROMISE \n\n1. Mesenteric ischemia: atherosclerosis\n2. Acute radiation enteritis\n3. Amyloidosis\n4. SLE\nD. BOWEL WALL DESTRUCTION",
            "images": [
                {
                    "id": "img-68.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 585,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1694,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 598,
            "markdown": "1. Lymphoma\n2. Scleroderma: smooth muscle atrophy\n3. Dermatomyositis\n\n# Abnormal Small Bowel Folds \n\n## Abnormal Folds + Increased Intraluminal Fluid\n\n1. Malabsorption syndrome\n2. Crohn disease, infectious enteritis\n3. Parasitic infestation / giardiasis\n4. Ischemia proximal to an obstruction\n5. Zollinger-Ellison syndrome\n6. Lymphangiectasia, mesenteric lymphadenopathy\n\n## Thickened Folds of Stomach \\& Small Bowel\n\n1. Lymphoma\n2. Crohn disease\n3. Eosinophilic gastroenteritis\n4. Zollinger-Ellison syndrome\n5. Ménétrier disease\n6. Cirrhosis = gastric varices + hypoproteinemia\n7. Amyloidosis\n8. Whipple disease\n9. Systemic sclerosis\n\n## Thickened Smooth Folds $\\pm$ Dilatation\n\nA. EDEMA\n(a) hypoproteinemia\n\n1. Cirrhosis\n2. Nephrotic syndrome\n3. Protein-losing enteropathy: celiac disease, Whipple disease\n(b) increased capillary permeability\n4. Angioneurotic edema $=$ angioedema\n5. Gastroenteritis\n(c) increased hydrostatic pressure\n6. Portal venous hypertension\n(d) Zollinger-Ellison syndrome\nB. HEMORRHAGE\n(a) vessel injury\n7. Ischemia\n8. Infarction\n9. Trauma\n(b) vasculitis\n10. Connective tissue disease\n11. Henoch-Schönlein purpura\n12. Thrombangiitis obliterans, irradiation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 599,
            "markdown": "(c) hypocoagulability\n\n1. Hemophilia\n2. Anticoagulant therapy\n3. Hypofibrinogemia\n4. Circulating anticoagulants\n5. Fibrinolytic system activation\n6. Idiopathic thrombocytopenic purpura\n7. Coagulation defects: leukemia, lymphoma, multiple myeloma, metastatic carcinoma\n8. Hypoprothrombinemia\nC. LYMPHATIC BLOCKAGE\n9. Tumor infiltration: lymphoma, pseudolymphoma\n10. Irradiation\n11. Mesenteric fibrosis\n12. Intestinal lymphangiectasia\n13. Whipple disease\nD. DEPOSITS\n14. Eosinophilic enteritis\n15. Pneumatosis intestinalis\n16. Amyloidosis\n17. Abetalipoproteinemia\n18. Crohn disease\n19. Graft-versus-host disease\n20. Immunologic deficiency: hypo- / dysgammaglobulinemia\n\n# Thickened Irregular Folds $\\pm$ Dilatation \n\nA. INFLAMMATION\n\n1. Crohn disease\nB. NEOPLASTIC\n2. Lymphoma, pseudolymphoma\nC. INFECTION\n(a) protozoan: giardiasis, strongyloidiasis, hookworm\n(b) bacterial: Yersinia enterocolitica, typhoid fever, TB\n(c) fungal: histoplasmosis\n(d) AIDS-related infection\nD. IDIOPATHIC\n(a) lymphatic dilatation\n3. Lymphangiectasia\n4. Inflammatory process, tumor growth, irradiation fibrosis\n5. Whipple disease\n(b) cellular infiltration\n6. Eosinophilic enteritis\n7. Mastocytosis\n(c) deposits\n8. Zollinger-Ellison syndrome",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 600,
            "markdown": "2. Amyloidosis\n3. Alpha chain disease: defective secretory IgA system\n4. A- $\\beta$-lipoproteinemia: recessive, retinitis pigmentosa, neurologic disease\n5. A- $\\alpha$-lipoproteinemia\n6. Fibrocystic disease of the pancreas\n7. Polyposis syndrome\nmnemonic: G. WILLIAMS\nGiardiasis\nWhipple disease, Waldenström macroglobulinemia\nIschemia\nLymphangiectasia\nLymphoma\nInflammation\nAmyloidosis, Agammaglobulinemia\nMastocytosis, Malabsorption\nSoft-tissue neoplasm: carcinoid, lipoma\n\n# Tethered Folds \n\n$=$ indicative of desmoplastic reaction\n$\\sqrt{ }$ kinking, angulation, tethering, separation of bowel loops\n\n1. Carcinoid\n2. Postoperative in Gardner syndrome\n3. Retractile mesenteritis\n4. Hodgkin disease\n5. Peritoneal implants\n6. Endometriosis\n7. Tuberculous peritonitis\n8. Mesothelioma\n9. Postoperative adhesions\n\n## Atrophy of Small Bowel Folds\n\n1. Chronic malabsorption: celiac disease\n2. Chronic ischemic changes: radiation injury, amyloidosis\n3. Crohn disease in burned-out stage\n4. Parasitic infestation: strongyloidiasis\n5. Graft-versus-host disease\n\n## Ribbonlike Small Bowel\n\n$=$ featureless / tubular nature of small bowel with effacement of folds\n\n1. Graft-versus-host disease\n2. Celiac disease\n3. Small bowel infection: eg, viral enteritis\n4. Injury from radiation / corrosive medication\n5. Allergy: eg, soybeans\n6. Ischemia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 601,
            "markdown": "7. Amyloid, mastocytosis\n8. Lymphoma, pseudolymphoma\n9. Crohn disease\n\n# Delayed Small Bowel Transit \n\n$=$ transit time $>6 \\mathrm{hr}$\nmnemonic: SPATS DID\nScleroderma\nPotassium (hypokalemia)\nAnxiety\nThyroid (hypothyroidism)\nSprue\nDiabetes (poorly controlled)\nIdiopathic\nDrugs (opiates, atropine, phenothiazine)\n\n## Constricting Lesion of Small Bowel\n\n1. Primary adenocarcinoma (proximal jejunum)\n2. Carcinoid (distal ileum)\n3. Lymphoma, metastasis\n4. Endometriosis\n5. Adhesion, mucosal diaphragm\n6. Strictures: Crohn disease, radiation enteritis, ischemia, potassium chloride tablets\n\n## Multiple Stenotic Lesions of Small Bowel\n\n1. Crohn disease\n2. End-stage radiation enteritis\n3. Metastatic carcinoma\n4. Endometriosis\n5. Eosinophilic gastroenteritis\n6. Tuberculosis\n7. Drug-induced (eg, potassium chloride tablets, NSAIDs)\n\n## Featureless bowel\n\n1. Crohn disease\n2. Chronic graft-versus-host disease\n3. Radiation therapy\n\n## Small Bowel Filling Defects\n\n## Solitary Filling Defect of Small Bowel\n\nA. INTRINSIC TO BOWEL WALL\n(a) benign neoplasm: leiomyoma ( $97 \\%$ ), adenoma, lipoma, hemangioma, neurofibroma\n(b) malignant primary: adenocarcinoma, lymphoma (desmoplastic response), sarcoma, carcinoid\n(c) metastases: $\\leftarrow$ melanoma, lung, kidney, breast",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 602,
            "markdown": "(d) inflammation: inflammatory pseudotumor\n(e) infection: parasites\nB. EXTRINSIC TO BOWEL WALL\n\n1. Duplication cyst\n2. Endometrioma\nC. INTRALUMINAL\n3. Gallstone ileus\n4. Parasites: ascariasis, strongyloidiasis\n5. Inverted Meckel diverticulum\n6. Blood clot\n7. Foreign body, bezoar, pills, seeds\n\n# Multiple Filling Defects of Small Bowel \n\nA. POLYPOSIS SYNDROMES\n\n1. Peutz-Jeghers syndrome\n2. Gardner syndrome\n3. Disseminated gastrointestinal polyposis\n4. Generalized gastrointestinal juvenile polyposis\n5. Cronkhite-Canada syndrome\nB. BENIGN TUMORS\n6. Multiple simple adenomatous polyps\n7. Hemangioma, blue rubber bleb nevus syndrome\n8. Leiomyoma, neurofibroma, lipoma\n9. Nodular lymphoid hyperplasia\n$=$ normal terminal ileum in children + adolescents; may be associated with dysgammaglobulinemia\n$\\sqrt{ }$ symmetric fairly sharply demarcated filling defects\n10. Varices ( $=$ multiple phlebectasia in jejunum, oral mucosa, tongue, scrotum)\nC. MALIGNANT TUMORS\n11. Carcinoid tumor\n12. Lymphoma\n(a) primary lymphoma (rarely multiple)\n(b) secondary lymphoma: GI involvement in $63 \\%$ of disseminated disease; $19 \\%$ in small intestine\n13. Kaposi sarcoma\n14. Subepithelial metastases: melanoma $>$ lung $>$ breast $>$ choriocarcinoma $>$ kidney $>$ stomach, uterus, ovary, pancreas\nD. INTRALUMINAL\n15. Gallstones\n16. Foreign bodies, food particles, seeds, pills\n17. Parasites: ascariasis, strongyloidiasis, hookworm, tapeworm\n\n## Sandlike Lucencies of Small Bowel\n\n1. Waldenström macroglobulinemia\n2. Mastocytosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 603,
            "markdown": "3. Histoplasmosis\n4. Nodular lymphoid hyperplasia\n5. Intestinal lymphangiectasia\n6. Eosinophilic gastroenteritis\n7. Lymphoma\n8. Crohn disease\n9. Whipple disease\n10. Yersinia enterocolitis\n11. Cronkhite-Canada syndrome\n12. Cystic fibrosis\n13. Food particles / gas bubbles\n14. Strongyloides stercoralis\n\n# Small Bowel Tumors \n\nPrevalence: $1 \\div 100,000 ; 1 \\%-2 \\%$ of all GI neoplasms\nMalignant + benign $=3 \\div 2$\nSymptomatic malignant +symptomatic benign $=3 \\div 1$\nLocation of small bowel primaries:\nileum ( $41 \\%$ ), jejunum ( $36 \\%$ ), duodenum ( $18 \\%$ )\n\n- pain, obstruction, anorexia, weight loss\n- bleeding, perforation, jaundice\n\nIn order of frequency:\nadenocarcinoma $>$ carcinoid tumor $>$ lymphoma $>$ GIST\nROENTGENOGRAPHIC APPEARANCE:\n(1) pedunculated intraluminal tumor, usually originating from mucosa\n$\\checkmark$ smooth / irregular surface without visible mucosal pattern\n$\\checkmark$ moves within intestinal lumen twice the length of the stalk\n(2) sessile intraluminal tumor without stalk, usually from tissues outside mucosa\n$\\checkmark$ smooth / irregular surface without visible mucosal pattern\n(3) intra- / extramural tumor\n$\\checkmark$ base of tumor greater than any part projecting into the lumen\n$\\checkmark$ mucosal pattern visible, may be stretched\n(4) serosal tumor\n$\\checkmark$ displacement of adjacent loops\n$\\checkmark$ small bowel obstruction (rare)\n$\\checkmark$ coil-spring pattern of intussusceptum\nCT:\n$\\checkmark$ abnormalities associated with small bowel tumors ( $90 \\%$ )\n$\\checkmark$ small bowel wall $>1.5 \\mathrm{~cm}$ thick\nCx: small-bowel obstruction (in up to 10\\%)\n\n## Benign Small Bowel Tumors\n\n- asymptomatic $(80 \\%)$\n- melena, intermittent abdominal pain, weakness\n- palpable abdominal mass (20\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 604,
            "markdown": "# Types: \n\n1. GIST $36-49 \\%$\n2. Adenoma $15-20 \\%$\n3. Lipoma $14-16 \\%$\n4. Hemangioma $13-16 \\%$\n5. Lymphangioma $5 \\%$\n\nLocation: duodenum $>$ jejunum $>$ ileum\n6. Neurogenic tumor $1 \\%$\n7. Hamartomatous polyps (Peutz-Jeghers syndrome)\n8. Hyperplastic polyp\n\n## Malignant Small Bowel Tumors\n\nAt risk: Crohn disease, celiac disease, polyposis syndromes, history of small-bowel diverting surgery\n\n- asymptomatic $(10-30 \\%)$\n- pain due to intermittent obstruction $(80 \\%)$\n- weight loss $(66 \\%)$\n- gastrointestinal blood loss (50\\%)\n- palpable abdominal mass ( $50 \\%$ )\n\n\n## Primary Malignant Small Bowel Tumor\n\n1. Adenocarcinoma $40 \\%$\n2. Carcinoid $33 \\%$\n3. Lymphoma $16-17 \\%$\n4. GIST $9-10 \\%$\n\n5 Vascular malignancy $1 \\%$\n6. Fibrosarcoma $0.3 \\%$\n\nSecondary Malignant Small Bowel Tumor\n$\\diamond$ Most common neoplasm of small intestines!\n\n## CECUM\n\n## Ileocecal Valve Abnormalities\n\nA. BENIGN NEOPLASM\n\n1. Lipomatosis of ileocecal valve: predominantly in female $>40$ years of age\n$\\checkmark$ symmetric stellate / rosette pattern\n2. Lipoma\n3. Adenomatous polyp, villous adenoma\n4. Lymphoid hyperplasia\nB. PRIMARY MALIGNANT NEOPLASM\n5. Adenocarcinoma of cecum\n\nIncidence: $25 \\%$ of colonic adenocarcinomas\n2. Ileal carcinoid tumor\n3. Lymphoma\n4. GIST (rare)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 605,
            "markdown": "# C. SECONDARY MALIGNANT NEOPLASM \n\n1. Adenocarcinoma of terminal ileum / appendix\n2. Direct invasion from ovarian neoplasm / intraperitoneal seeding\n3. Metastasis\nD. IDIOPATHIC INFLAMMATION\n4. Crohn disease\n5. Ulcerative colitis\n$\\checkmark$ patulous valve, fixed in open position\nE. INFECTIOUS CONDITION\n6. Tuberculosis\n7. Infectious ileocecitis\n8. Typhlitis\nF. PROLAPSE\n(a) antegrade: indistinguishable from lipomatosis / prolapsing mucosa / neoplasm\n(b) retrograde\nG. INTUSSUSCEPTION\nH. OTHERS\n9. Cathartic abuse\n10. Ischemic necrosis of cecum\n11. Volvulus\n12. Ileocecal duplication cyst\n\n## Coned Cecum\n\nA. INFLAMMATION\n\n1. Crohn disease\n$\\checkmark$ involvement of ascending colon + terminal ileum\n2. Ulcerative colitis\n$\\checkmark$ backwash ileitis (in $10 \\%$ )\n$\\checkmark$ gaping ileocecal valve\n3. Appendicitis\n4. Typhlitis\n5. Perforated cecal diverticulum\nB. INFECTION\n6. Tuberculosis\n$\\checkmark$ colonic involvement more prominent than that of terminal ileum\n7. Amebiasis\n$\\checkmark$ involvement of cecum in $90 \\%$ of amebiasis\n$\\checkmark$ thickened ileocecal valve fixed in open position\n$\\checkmark$ reflux into normal terminal ileum\n$\\checkmark$ skip lesions in colon\n8. Actinomycosis\n\n- palpable abdominal mass\n- indolent sinus tracts in abdominal wall\n\n4. Blastomycosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 606,
            "markdown": "5. Anisakiasis\n6. Typhoid, Yersinia\n\n# C. TUMOR \n\n1. Adenocarcinoma of the cecum\n\nFrequency: $25 \\%$ of colon cancers; $95 \\%$ of malignant cecal masses are adenocarcinomas\n$\\checkmark$ large polypoid bulky mass causing asymmetric wall thickening\n$\\checkmark$ mild pericolic fat infiltration\n$\\checkmark$ rarely obstructing\n$\\checkmark$ may act as lead point for intussusception\n2. Metastasis to cecum\n\n| CT Features of Ileocecal Disease |  |  |  |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: | :--: | :--: | :--: |\n| Feature | Adenocarcinoma | Lymphoma | Crohn Disease | Infectious <br> Ileitis | Ischemia / <br> Typhlitis | Cecal diverticulitis |  |\n| Stratified bowel wall | - | - | + (if acute) | $+$ | $+$ | $+$ |  |\n| Bowel wall thickening | severe irregular eccentric | severe smooth $\\pm$ symmetric | mild, rarely $>2 \\mathrm{~cm}$, <br> symmetric | mild / marked, <br> symmetric | mild / marked, symmetric | mild smooth <br> concentric |  |\n| Length | focal | segmental | segmental | segmental | segmental |  | focal |\n| Fat stranding | minimal | $0 /-$ | $+$ | $+$ | $+$ | $++$ |  |\n| Transition to normal | abrupt | gradual | smooth | smooth | smooth | smooth | smooth |\n| Fluid | - | - | occasional | occasional | occasional | mesenteric root |  |\n| Lymphadenopathy | regional | bulky retroperitoneal | regional | regional | - | $\\pm$ |  |\n| Others | mets | cavitary mass, solid organ + other GI sites involved | skip lesions, creeping fat, fistula, abscess | diarrhea | pneumatosis | inflamed diverticulum |  |\n\n## Cecal Filling Defect\n\n## A. ABNORMALITIES OF THE APPENDIX\n\n1. Acute appendicitis / appendiceal abscess\n2. Crohn disease\n3. Inverted appendiceal stump / appendiceal intussusception\n4. Mucocele\n5. Myxoglobulosis\n6. Appendiceal neoplasm: carcinoid tumor ( $90 \\%$ ), leiomyoma, neuroma, lipoma, adenocarcinoma, metastasis\n\n## B. COLONIC LESION\n\n1. Ameboma\n2. Primary cecal neoplasm\n3. Ileocolic intussusception\n4. Lipomatosis of ileocecal valve\n\n## C. UNUSUAL ABNORMALITIES\n\n1. Ileocecal diverticulitis (in $50 \\%<$ age 30 years)\n2. Solitary benign ulcer of the cecum\n3. Adherent fecolith: eg, in cystic fibrosis\n4. Endometriosis\n5. Burkitt lymphoma\nmnemonic: CECUM TIP SALE",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 607,
            "markdown": "Carcinoma\nEnteritis\nCarcinoid\nUlcerative colitis\nMucocele of appendix\nTuberculosis\nIntussusception\nPeriappendiceal abscess\nStump of the appendix\nAmeboma\nLymphoma\nEndometriosis\n\n# Pericecal Fat-stranding on CT \n\n1. Appendicitis\n2. Crohn disease\n3. Tuboovarian abscess\n4. Cecal diverticulitis\n5. Perforated cecal carcinoma\n\n## APPENDIX\n\n## Primary Neoplasm of the Appendix\n\n1. Mucocele:\nmucinous adenoma $44 \\%$\nadenocarcinoma $23 \\%$\n2. Colonic-type adenocarcinoma $13 \\%$\n3. NHL\n4. Carcinoid tumor\n\n## Appendiceal Intussusception\n\n1. Mucocele\n2. Endometrioma\n3. Fecolith\n4. Foreign body\n5. Polyp: juvenile, inflammatory\n6. Papilloma\n7. Adenoma / adenocarcinoma\n8. Carcinoid tumor\n9. Postappendectomy stump\n\n## COLON\n\n## Colon Cutoff Sign\n\n= abrupt termination of colonic gas column at splenic flexure with decompression of the",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 608,
            "markdown": "distal colon due to spasm + obstruction at the splenic flexure impinging on a paralytic transverse colon\nA. IMPINGEMENT VIA PHRENICOCOLIC LIGAMENT\n\n1. Acute pancreatitis / postpancreatitic stricture\n2. Pancreatic / gastric carcinoma\n3. Hemorrhage from rupture of splenic artery / abdominal aortic aneurysm\nB. COLONIC DISEASE\n4. Colon cancer\n5. Mesenteric thrombosis\n6. Ischemic colitis\n7. Perforated appendicitis (in 20\\%)\nN.B.: amputation of gas at the hepatic flexure $\\leftarrow$ spastic ascending colon\n\n# Colonic Thumbprinting \n\n$=$ sharply defined fingerlike marginal indentations at contours of wall\n\n1. ISCHEMIA $=$ Ischemic colitis occlusive vascular disease, hypercoagulability state, hemorrhage into bowel wall (bleeding diathesis, anticoagulants), traumatic intramural hematoma\n2. INFLAMMATION ulcerative colitis, Crohn colitis\n3. INFECTION\nacute amebiasis, schistosomiasis, strongyloidiasis, cytomegalovirus (in renal transplant recipients), pseudomembranous colitis\n4. MALIGNANT LESIONS\nlocalized primary lymphoma, hematogenous metastases\n5. MISCELLANEOUS\nendometriosis, amyloidosis, pneumatosis intestinalis, diverticulosis, diverticulitis, hereditary angioneurotic edema\nmnemonic: PSALM II\nPseudomembranous colitis\nSchistosomiasis\nAmebic colitis\nLymphoma\nMetastases (to colon)\nIschemic colitis\nInflammatory bowel disease\n\n## Colonic Urticaria Pattern\n\nA. OBSTRUCTION\n\n1. Obstructing carcinoma\n2. Cecal volvulus\n3. Colonic ileus\nB. ISCHEMIA\nC. INFECTION / INFLAMMATION\n4. Yersinia enterocolitis\n5. Herpes",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 609,
            "markdown": "3. Crohn disease\nD. URTICARIA\n\n# Colonic Ulcers \n\nA. IDIOPATHIC\n\n1. Ulcerative colitis\n2. Crohn colitis\nB. ISCHEMIC\n3. Ischemic colitis\nC. TRAUMATIC\n4. Radiation injury\n5. Caustic colitis\nD. NEOPLASTIC\n6. Primary colonic carcinoma\n7. Metastases: prostate, stomach, lymphoma, leukemia\nE. INFLAMMATORY\n8. Pseudomembranous colitis\n9. Pancreatitis\n10. Diverticulitis\n11. Behçet disease\n12. Solitary rectal ulcer syndrome\n13. Nonspecific benign ulceration\nF. INFECTION\n(a) protozoan\n14. Amebiasis\n15. Schistosomiasis\n16. Strongyloidiasis\n(b) bacterial\n17. Shigellosis, salmonellosis\n18. Staphylococcal colitis\n19. Tuberculosis\n20. Gonorrheal proctitis\n21. Yersinia colitis\n22. Campylobacter fetus colitis\n(c) fungal\nhistoplasmosis, mucormycosis, actinomycosis, candidiasis\n(d) viral\n23. Lymphogranuloma venereum\n24. Herpes proctocolitis\n25. Cytomegalovirus (transplants)\n\nAphthous Ulcers of Colon\n\n1. Crohn disease\n2. Amebic colitis\n3. Yersinia enterocolitis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 610,
            "markdown": "Organism: gram-negative\n\n- fever, diarrhea, RLQ pain\n\nLocation: terminal ileum\n$\\sqrt{ }$ thickened folds + ulceration\n$\\sqrt{ }$ lymphoid nodular hyperplasia\n4. Salmonella, shigella infection\n5. Herpes virus infection\n6. Behçet disease\n7. Lymphoma\n8. Ischemia\n\n# Multiple Bull's-eye Lesions of Colonic Wall \n\nmnemonic: MaCK CLaN\nMelanoma and\nCarcinoma\nKaposi sarcoma\nCarcinoid\nLymphoma and\nNeurofibromatosis\n\n## Double-tracking of Colon\n\n$=$ longitudinal extraluminal tracks paralleling the colon\n\n1. Diverticulitis: generally $3-6 \\mathrm{~cm}$ in length\n2. Crohn disease: generally $>10 \\mathrm{~cm}$\n3. Ulcerative colitis\n4. Primary carcinoma: wider + more irregular\n\n## Pseudomembranous Colitis\n\n$=$ endoscopically diagnosed colonic infection / inflammation characterized by pseudomembranes consisting of an exudate of necrotic cells on a denuded mucosa\n\n1. Clostridium difficile\n2. Ischemic colitis: acute / subacute\n3. Staphylococcus\n4. Shigella\n5. Pseudomonas aeruginosa\n6. Drugs: chlorpropamide, mercuric compounds, gold, NSAIDs\n\n## Accordion Sign\n\n$=$ gross irregular polypoid thickening of colonic wall with wide separation of inner + outer walls\n\n1. Radiation-induced colitis\n2. Ischemic colitis\n3. Infectious colitis: Clostridium difficile, tuberculosis\n4. Typhlitis, neutropenic colitis\n5. Inflammation: Crohn disease, ulcerative colitis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 611,
            "markdown": "$\\diamond$ The only 2 conditions with wall thickening $>10 \\mathrm{~mm}$\n6. Lymphangiectasia\n7. Intramural hemorrhage\n\n# Colonic Narrowing \n\nA. CHRONIC STAGE OF ANY ULCERATING COLITIS\n(a) inflammatory:\n\n1. Ulcerative colitis\n2. Crohn colitis\n3. Solitary rectal ulcer syndrome\n4. Nonspecific benign ulcer\n(b) infectious:\n5. Amebiasis\n6. Schistosomiasis\n7. Bacillary dysentery\n8. Tuberculosis\n9. Fungal disease\n10. Lymphogranuloma venereum\n11. Herpes zoster\n12. Cytomegalovirus\n13. Strongyloides\n(c) ischemic\n14. Ischemic colitis\n(d) traumatic\n15. Radiation injury\n16. Cathartic colon\n17. Caustic colitis\nB. MALIGNANT LESION\n(a) primary\n18. Colonic carcinoma: annular / scirrhous\n19. Complication of ulcerative colitis + Crohn colitis\n(b) metastatic:\n$\\leftarrow$ prostate, cervix, uterus, kidney, stomach, pancreas, primary intraperitoneal sarcoma\n> hematogenous (eg, breast)\n> lymphangitic spread\n> peritoneal seeding\nC. EXTRINSIC PROCESS\n(a) inflammation\n20. Retractile mesenteritis\n21. Diverticulitis\n22. Pancreatitis\n(b) deposits\n23. Amyloidosis\n24. Endometriosis\n25. Pelvic lipomatosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 612,
            "markdown": "# D. POSTSURGICAL \n\n1. Adhesive bands\n2. Surgical anastomosis\nE. NORMAL\n3. Cannon point\n\n## Localized Colonic Narrowing\n\nmnemonic: SCARED CELL-MATE\nSchistosomiasis\nCarcinoid\nActinomycosis\nRadiation\nEndometriosis\nDiverticulitis\nColitis\nExtrinsic lesion\nLymphoma\nLymphogranuloma venereum\nMetastasis\nAdenocarcinoma\nTuberculosis\nEntamoeba histolytica\n\n## Microcolon\n\nmnemonic: Mla MicroColicA\nMeconium ileus, Meconium peritonitis (cystic fibrosis)\nIleal / jejunal atresia\nMegacystis-microcolon-hypoperistalsis syndrome\nColonic atresia (distal to atretic segment)\nAganglionosis (Hirschsprung disease)\n\n## Colonic Filling Defects\n\n## Subepithelial Lesion of Colon\n\n## Subepithelial Neoplasm of Colon\n\n$=$ masslike protrusion into lumen covered by normal overlying mucosa at optical colonoscopy\nA. Neoplasm with intramural origin\n\n1. Lipoma\n2. Carcinoid\n3. Lymphoma\n4. Hemangioma\n5. GIST\n6. Hematogenous metastasis:\nmelanoma $>$ lung $>$ breast",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 613,
            "markdown": "7. Other primary tumor (rare):\nleiomyoma, schwannoma, leiomyosarcoma, ganglioneuroma, granular cell tumor\nB. Neoplasm with extramural origin\n8. Direct invasion by extracolonic tumor: gastric adenocarcinoma\n9. Peritoneal carcinomatosis\n10. Appendiceal tumor\n\n# Subepithelial Nonneoplastic Lesion of Colon \n\nA. Intramural origin\n(a) vascular lesion:\n\n1. Internal hemorrhoid\n2. Rectal varix\n3. Venous malformation\n(b) cystic lesion:\n4. Colonic duplication cyst\n5. Lymphangioma\n6. Colitis cystica profunda\n(c) others:\n7. Lymphoid polyp / hyperplasia\n8. Intramural hematoma\n9. Pneumatosis cystoides coli\nB. Extramural origin\n10. Endometriosis\n11. Extrinsic impression: uterus, adnexa, aorta, common iliac artery, adjacent GI tract\n12. Presacral lesion\n\n## Single Colonic Filling Defect\n\nA. BENIGN TUMOR\n\n1. Polyp\n(hyperplastic, adenomatous, villous adenoma, villoglandular); most common benign tumor\n2. Lipoma\n\nMost common intramural tumor; $2^{\\text {nd }}$ most common benign tumor; $\\mathrm{M}<\\mathrm{F}$\nLocation: ascending colon + cecum $>$ left side of colon\n3. Carcinoid: $10 \\%$ metastasize\n4. Spindle cell tumor\n(leiomyoma, fibroma, neurofibroma); $4^{\\text {th }}$ most common benign tumor; rectum $>$ cecum\n5. Lymphangioma, hemangioma\nB. MALIGNANT TUMOR\n(a) primary tumor: carcinoma, sarcoma\n(b) secondary tumor: metastases (breast, stomach, lung, pancreas, kidney, female genital tract), lymphoma, invasion by adjacent tumors\nC. INFECTION\n\n1. Ameboma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 614,
            "markdown": "2. Polypoid granuloma: schistosomiasis, TB\nD. INFLAMMATION\n3. Inflammatory pseudopolyp: ulcerative colitis, Crohn disease\n4. Periappendiceal abscess\n5. Diverticulitis\n6. Foreign-body perforation\nE. NONSESSILE INTRALUMINAL BODY\n7. Fecal impaction\n8. Foreign body\n9. Gallstone\n10. Bolus of Ascaris worms\nF. MISCELLANEOUS\n11. Endometriosis\n$3^{\\text {rd }}$ most common benign tumor\nLocation: sigmoid colon, rectosigmoid junction (at level of cul-de-sac)\n\n- may cause bleeding (after invasion of mucosa)\n\n2. Localized amyloid deposition\n3. Suture granuloma\n4. Intussusception\n5. Pseudotumor: $\\leftarrow$ adhesions, fibrous bands\n6. Colitis cystica profunda\n\n# Multiple Colonic Filling Defects \n\nA. NEOPLASMS\n(a) polyposis syndrome\n(b) hematogenous metastases: from breast, lung, stomach, ovary, pancreas, uterus\n(c) multiple tumors\n> benign: neurofibromatosis, colonic lipomatosis, multiple hamartoma syndrome (Cowden disease)\n> malignant: lymphoma, leukemia, adenocarcinoma\nB. INFLAMMATORY PSEUDOPOLYPS\nulcerative colitis, Crohn colitis, ischemic colitis, amebiasis, schistosomiasis, strongyloidiasis, trichuriasis\nC. ARTIFACTS\nfeces, air bubbles, oil bubbles, mucous strands, ingested foreign body (eg, corn kernels)\nD. MISCELLANEOUS\nnodular lymphoid hyperplasia, lymphoid follicular pattern, hemorrhoids, diverticula, pneumatosis intestinalis, colitis cystica profunda, colonic urticaria, submucosal colonic edema $\\leftarrow$ obstruction, cystic fibrosis, amyloidosis, ulcerative pseudopolyps, proximal to obstruction\nmnemonic: MILL P3\nMetastases (to colon)\nIschemia (thumbprinting)\nLymphoma\nLymphoid hyperplasia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 615,
            "markdown": "Polyposis\nPseudopolyposis (with inflammatory bowel disease)\nPneumatosis cystoides\n\n# Carpet Lesions of Colon \n\n$=$ flat lobulated lesions with alteration of surface texture + little / no protrusion into lumen\nLocation: rectum $>$ cecum $>$ ascending colon\nCause:\nA. NEOPLASM\n\n1. Tubular / tubulovillous / villous adenoma\n2. Familial polyposis\n3. Adenocarcinoma\n4. Submucosal tumor spread $\\leftarrow$ adjacent carcinoma\nB. MISCELLANEOUS\n5. Nonspecific follicular proctitis\n6. Biopsy site\n7. Endometriosis\n8. Rectal varices\n9. Colonic urticaria\n\n## Colonic Polyp\n\nTerminology:\n\n1. Polyp\n$=$ mass projecting into the lumen of a hollow viscus above level of mucosa; usually arises from mucosa, may derive from submucosa / muscularis propria\n(a) neoplastic polyp: adenoma / carcinoma\n(b) nonneoplastic: hamartoma / inflammatory polyp\n2. Pseudopolyp\n$=$ scattered island of inflamed edematous mucosa on a background of denuded mucosa\n(a) pseudopolyposis of ulcerative colitis\n(b) \"cobblestoning\" of Crohn disease\n3. Postinflammatory (filiform) polyp\n$=$ fingerlike projection of submucosa covered by mucosa on all sides following healing + regeneration of inflammatory (most common in ulcerative colitis) / ischemic / infectious bowel disease\n4. Adenomatous polyp\n$\\diamond$ Most commonly seen neoplastic polyp\nHisto: tubular > villous > tubulovillous adenoma\n5. Hyperplastic polyp\n$\\diamond$ Most commonly seen nonneoplastic polyp\n6. Pedunculated polyp\n$=$ attachment to wall via stalk\n7. Sessile polyp\n$=$ attachment to wall via broad base\n8. Flat polyp",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 616,
            "markdown": "$=$ mass with height $>1 / 2$ its width\n\n# RECTUM \\& ANUS \n\n## Rectal Disease\n\nA. NEOPLASIA\n\n1. Rectal polyp\n2. Rectal cancer\n3. Multiple lymphomatous polyposis\nB. INFLAMMATION\n4. Ulcerative colitis\n5. Perianal fistula of Crohn disease\n6. Solitary rectal ulcer syndrome\n7. Pseudomembranous colitis\nC. EXTRAMUCOSAL LESION\n8. Serosal metastasis\n9. Lymph node metastasis\n10. Leiomyoma\n11. Perirectal abscess\n12. Uterine leiomyosarcoma invading rectal wall\n\n## Rectal Narrowing\n\n1. Pelvic lipomatosis + fibrolipomatosis\n2. Lymphogranuloma venereum\n3. Radiation injury of rectum\n4. Chronic ulcerative colitis\n\n## Enlarged Presacral Space\n\nNormal width: $<5 \\mathrm{~mm}$ in $95 \\%$; abnormal width $>10 \\mathrm{~mm}$\nA. RECTAL INFLAMMATION / INFECTION\nulcerative colitis, Crohn colitis, idiopathic proctosigmoiditis, radiation therapy\nB. RECTAL INFECTION\n\n1. Proctitis: TB, amebiasis, lymphogranuloma venereum, radiation, ischemia\n2. Diverticulitis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 617,
            "markdown": "| Differential Diagnosis of Colonic Polyps |  |  |\n| :--: | :--: | :--: |\n|  | Single Polyp | Multiple Polyps |\n| Neoplastic ( $10 \\%$ ) |  |  |\n| epithelial (adenomatous) | Tubular adenoma | Familial multiple polyposis |\n|  | Tubulovillous adenoma | Adenomatosis of GI tract |\n|  | Villous adenoma | Gardner syndrome Turcot syndrome |\n| nonepithelial | Carcinoid |  |\n|  | Leiomyoma |  |\n|  | Lipoma |  |\n|  | Hemangioma, lymphangioma |  |\n|  | Fibroma, neurofibroma |  |\n| Nonneoplastic ( $90 \\%$ ) |  |  |\n| unclassified hamartomatous | Hyperplastic polyp Juvenile polyps | Hyperplastic polyposis Juvenile polyposis |\n|  |  | Peutz-Jeghers syndrome |\n|  |  | Cronkhite-Canada syndrome |\n| inflammatory | Benign lymphoid polyp | Ulcerative colitis |\n|  | Fibroid granulation polyp |  |\n\n# C. BODY FLUIDS / DEPOSITS \n\n1. Hematoma: surgery, sacral fracture\n2. Pus: perforated appendix, presacral abscess\n3. Serum: edema, venous thrombosis\n4. Deposit of fat: pelvic lipomatosis, Cushing disease\n5. Deposit of amyloid: amyloidosis\nD. SACRAL TUMOR\n6. Sacrococcygeal teratoma, anterior sacral meningocele\n7. Chordoma, metastasis to sacrum\nE. PRESACRAL TUMOR (see below)\nF. MISCELLANEOUS\n8. Inguinal hernia containing segment of colon\n9. Colitis cystica profunda\n10. Pelvic lipomatosis\n\n## Presacral Tumor\n\n$=$ mass effect on posterior wall of rectum\nA. OSTEOCHONDRAL\n\n1. Giant cell tumor",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 618,
            "markdown": "2. Ewing sarcoma\n3. Osteosarcoma of spine\n4. Chondrosarcoma\n5. Aneurysmal bone cyst\nB. NEUROGENIC\n6. Neurofibroma\n7. Schwannoma\n8. Paraganglioma\n9. Sacrococcygeal chordoma\n10. Dural ectasia\n11. Anterior myelomeningocele\nC. MESENCHYMAL\n12. Hemangioma\n13. Myelolipoma\n14. Solitary fibrous tumor\n15. Castleman disease\n16. Retroperitoneal fibrosis\n17. GIST\n18. Lipoma\nD. MALIGNANT RECTAL TUMOR\n19. Colorectal carcinoma\n20. Cloacogenic carcinoma\n21. Lymphoma\n22. Sarcoma\n23. Hemangioendothelioma\n24. Lymph node metastases\n25. Prostatic carcinoma, bladder tumors, cervical cancer, ovarian cancer\nE. CONGENITAL / DEVELOPMENTAL\n(a) developmental cyst:\n26. Epidermoid, dermoid\n27. Rectal duplication cyst\n28. Tailgut cyst\n(b) germ cell tumor:\n29. Sacrococcygeal teratoma\n30. Yolk sac tumor\n31. Embryonal cell carcinoma\n(d) lymphoproliferative disorder\nF. INFECTIOUS / INFLAMMATORY\nG. POSTTRAUMATIC\n\n# Lesions of Ischiorectal Fossa \n\nA. CONGENITAL AND DEVELOPMENTAL ANOMALIES\n\n1. Gartner duct cyst\n2. Klippel-Trénaunay syndrome\n3. Tailgut cyst",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 619,
            "markdown": "# B. INFLAMMATORY AND HEMORRHAGIC LESIONS \n\n1. Fistula in ano\n2. Ischiorectal / perirectal abscess\n3. Extraperitoneal pelvic hematoma\n4. Rectal perforation\nC. SECONDARY NEOPLASM\nper direct extension / hematogenous spread:\nanorectal / prostatic / pelvic / sacral tumor; lung cancer; melanoma; lymphoma\nD. PRIMARY NEOPLASM\n5. Aggressive angiomyxoma\n6. Lipoma\n7. Plexiform neurofibroma\n8. Anal adenocarcinoma\n9. Squamous cell carcinoma\n\n## MURAL STRATIFICATION OF INTESTINAL TRACT\n\n$=$ bowel wall thickening with abnormal separation of bowel layers on cross-sectional imaging $=$ visualization of layers of bowel wall at contrast-material-enhanced CT\nCECT:\n$\\sqrt{ }$ \"double halo / target\" sign = trilaminar appearance during late arterial phase:\n$\\sqrt{ }$ contrast enhancement of inner layer:\n(1) mucosa + (2) muscularis mucosae\n$\\sqrt{ }$ nonenhanced interposed layer of (3) submucosa with various degrees of attenuation:\n> blood attenuation $\\leftarrow$ hemorrhage\n> soft-tissue attenuation $\\leftarrow$ inflammatory cells\n> low attenuation $\\leftarrow$ pus\n> water attenuation $\\leftarrow$ intramural edema\n> fat attenuation $\\leftarrow$ past / chronic inflammation\n$\\sqrt{ }$ contrast enhancement of outer layer:\n(4) muscularis propria + (5) serosa\n\n## Cause:\n\n$\\diamond$ Tumor has NOT been reported to cause stratification!\nA. BOWEL WALL EDEMA\n$\\sqrt{ }$ low-density / water-density separation\n\n1. Ulcerative colitis ( $50 \\%$ ): rectum\n2. Proximal to obstructing tumor / intussusception\n3. Angioedema\nB. INFLAMMATORY CELL INFILTRATE\n4. Crohn disease (in up to $50 \\%$ )\n5. Mycobacterium tuberculosis\n6. Eosinophilic enteritis\n7. Cytomegalovirus\n8. Clostridium difficile\n9. Entamoeba histolytica",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 620,
            "markdown": "7. Vibrio cholerae\n8. Shigella\n9. Escherichia coli\nC. BOWEL ISCHEMIA / INFARCTION\n10. Arterial obstruction: thromboembolism, plaque thrombus\n11. Peripheral vasculopathy\n12. Venous obstruction: thrombosis, bowel torsion, closed-loop obstruction\n13. Hypoperfusion: proximal arterial stenosis potentiated by myocardial infarction, bradycardia, dehydration\nN.B.: closed-loop obstruction with signs of bowel infarction is a surgical condition!\n$\\sqrt{ }$ signs of bowel infarction:\n$\\sqrt{ }$ free peritoneal fluid\n$\\checkmark$ asymmetric bowel wall enhancement\n$\\checkmark$ persistent enhancement of bowel wall / segmental arteries\n$\\checkmark$ arterial / venous filling defects\n$\\checkmark$ increased density of mesentery\n$\\checkmark$ bowel obstruction\nD. INTESTINAL WALL HEMORRHAGE\n14. Anticoagulation\n15. Blood dyscrasia: thrombocytopenic purpura\n16. Blunt trauma\n$\\checkmark$ \"snow-cone\" appearance of duodenum\n\n# Segmental Mural Stratification of Small Bowel \n\n1. Small-vessel vasculitis\n2. Small-vessel ischemia\n3. Chemotherapy-induced enteritis\n4. Radiation therapy\n5. ACE inhibitor-induced angioedema\n\n## Bowel Wall Thickening in Children\n\nA. INFECTION\n\n1. Gastroenteritis\n2. Enterocolitis\n3. Pseudomembranous colitis\n4. Hemolytic-uremic syndrome\n5. Chronic granulomatous disease\nB. TRAUMA\n6. Duodenal hematoma\n7. Hypoperfusion complex\nC. NEOPLASM\n8. Lymphoma\n9. GIST\n10. Neurogenic tumors: mesenteric plexiform neurofibroma associated with neurofibromatosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 621,
            "markdown": "4. Vascular tumors: hemangioma\n5. Colon cancer ( $2^{\\text {nd }}$ decade of life)\n6. Langerhans cell histiocytosis\nD. INFLAMMATION\n7. Crohn disease\n8. Ulcerative colitis\n9. Typhlitis\n10. Inflammatory pseudotumor\n\nThe degree of wall thickening is significantly greater in Crohn disease than in ulcerative colitis!\nE. AUTOIMMUNE\n(a) Collagen vascular disease\n\n1. SLE\n2. Scleroderma\n(b) Vasculitis:\n3. Periarteritis nodosa\n4. Henoch-Schönlein purpura\nF. Mechanical\n5. Mesenteric ischemia\n6. Intussusception\n7. Acute appendicitis\n8. Meckel diverticulum\n9. Radiation enteritis\nG. OTHERS\n10. Celiac disease\n11. Lactose intolerance\n12. Eosinophilic gastroenteritis\n13. Hypoproteinemia\n14. Graft-versus-host disease\n\n# Fat halo sign \n\n$=$ layer of fat attenuation ( -18 to -64 HU ) in submucosa sandwiched between inner + outer layer of soft-tissue attenuation of a thickened bowel wall\n\n1. Chronic inflammatory bowel disease: ulcerative colitis ( $61 \\%$ ), Crohn disease ( $8 \\%$ )\n2. Graft-versus-host disease\n3. Cytoreductive therapy\n4. Asymptomatic obese patient\n\n## Hyperattenuating Bowel Wall\n\n$=$ hemorrhage secondary to\n\n1. Trauma\n2. Henoch-Schönlein purpura\n3. Vasculitis\n\n## Prolonged Contrast Coating of Bowel Wall\n\nfor hours to days",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 622,
            "markdown": "Cause: incorporation of barium into submucosal layer through mucosal ulcers\n\n1. Graft-versus-host disease\n2. Ischemic bowel\n\n# Aphthous Ulcer \n\n$=$ ulcer crater surrounded by a rim of edema overlying submucosal lymphoid follicle\n\n1. Crohn disease\n2. Yersinia enterocolitis\n3. Tuberculosis\n4. Amebiasis\n5. Ischemic enteritis\n\n## Hypervascular Subepithelial (Submucosal) Mass\n\n1. Neuroendocrine tumor\n2. Gastrointestinal stromal tumor\n3. Glomus tumor\n4. Hemangioma\n5. Angiosarcoma: extremely rare in GI tract\n6. Kaposi sarcoma\n7. Peripheral nerve sheath tumor\n8. Hypervascular metastasis\n9. Heterotopic pancreatic tissue\n\nThe term subepithelial is favored over submucosal because lesions in this category do not necessarily arise from the submucosa, but can arise from any layer of the GI wall (intramural) or intraabdominal structures (extramural).\n\n## POLYPOSIS SYNDROMES\n\n$=$ more than 100 polyps in number\nMode of transmission:\nA. HEREDITARY\n(a) autosomal dominant\n\n1. Familial (multiple) polyposis\n2. Gardner syndrome\n3. Peutz-Jeghers syndrome\n4. Juvenile polyposis coli\n(b) autosomal recessive\n5. Turcot syndrome\nB. NONHEREDITARY\n6. Cronkhite-Canada syndrome\n7. Juvenile polyposis\n$D D x$ : polyposis look-alikes on barium studies\n8. Postinflammatory polyposis\n9. Lymphoid hyperplasia\n10. Multiple lymphomatous polyposis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 623,
            "markdown": "4. Metastases\n5. Pneumatosis coli\n6. Disseminated gastrointestinal polyps\n7. Multiple adenomatous polyps\n\n# Adenomatous Polyposis Syndromes \n\n1. Familial (multiple) polyposis\n2. Gardner syndrome\n3. Turcot syndrome\n\n## Hamartomatous Polyposis Syndromes\n\n1. Peutz-Jeghers syndrome* (polyp with central core of smooth muscle)\n2. Cowden disease*\n3. Juvenile polyposis*\n4. Cronkhite-Canada syndrome\n5. Bannayan-Riley-Ruvalcaba syndrome\n\n* = increased prevalence of coexisting adenomas and adenoma-carcinoma sequence\n\n\n## PERITONEUM\n\n## Lesion of Serosal Membranes\n\nA. PRIMARY NEOPLASM\n(a) malignant\n\n1. Malignant pleural mesothelioma\n2. Malignant peritoneal mesothelioma\n3. Primary serous papillary carcinoma of peritoneum $=$ serous cystadenocarcinoma of ovary\n(b) benign\n4. Adenomatoid tumor\n5. Benign multicystic mesothelioma\n6. Desmoplastic small round cell tumor\n7. Localized fibrous tumor of pleura\n8. Leiomyomatosis peritonealis disseminata\nB. SECONDARY NEOPLASM (more common)\n\nSpread by: direct extension from an adjacent visceral organ / transcoelomic dissemination / permeation of underlying lymphatics\n(a) pleura: lung, breast, thymus, ovary, pancreas, thyroid, gastrointestinal tract, kidney\n(b) peritoneum: pseudomyxoma peritonei\nC. NONNEOPLASTIC LESION\n\n1. Pleural plaque\n2. Pleural fibrosis\n3. Pericardial cyst\n4. Sclerosing encapsulating peritonitis\n5. Sclerosing mesenteritis\n6. Peritoneal inclusion cyst",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 624,
            "markdown": "# Peritoneal Mass \n\nA. SOLID MASS\n\n1. Peritoneal mesothelioma\n2. Peritoneal carcinomatosis\nB. INFILTRATIVE PATTERN\n3. Peritoneal mesothelioma\nC. CYSTIC MASS\n4. Multicystic mesothelioma\n5. Pseudomyxoma peritonei\n6. Bacterial / mycobacterial infection\n\n## Intraperitoneal Solid Abdominal Mass in a Child\n\n## LOCALIZED MASS\n\n1. Inflammatory myofibroblastic tumor\n2. Castleman disease\n3. Mesenteric fibromatosis\n4. Benign mesenchymal mass: lymphatic malformation, infantile hemangioma\n\nDiffuse Peritoneal Disease\n\n1. Desmoplastic small round cell tumor\n2. Burkitt lymphoma (NHL)\n3. Rhabdomyosarcoma\n\n## Multiple Peritoneal Masses\n\nA. METASTATIC NEOPLASM\n\n1. Peritoneal metastases $=$ carcinomatosis\n2. Pseudomyxoma peritonei\n3. Lymphomatosis = body cavity-based lymphoma\n4. Sarcomatosis\n\nCause: unusual hematogenous metastases, GIST\nB. TUMORLIKE CONDITIONS\n\n1 Endometriosis\n2. Gliomatosis peritonei\n3. Osseous metaplasia = heterotopic mesenteric ossification\n4. Cartilaginous metaplasia\n5. Splenosis\nC. INFECTION / INFLAMMATION\n\n1. Granulomatous peritonitis\n\nCause: TB, Histoplasma, Pneumocystis, talc, barium, meconium, bowel contents, ruptured ovarian cyst, bile, gallstones\n3. Sclerosing encapsulating peritonitis\n2. Inflammatory pseudotumor\n\n## Diffuse Peritoneal Masses in Children\n\n1. Desmoplastic small round cell tumor",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 625,
            "markdown": "2. Rhabdomyosarcoma\n3. Metastatic germ cell tumor\n4. Gliomatosis peritonei\n5. Metastatic retroperitoneal tumor:\n(a) Neuroblastoma\n(b) Wilms tumor\n6. Malignant mesothelioma\n7. Peritoneal carcinomatosis\n8. Peritoneal seeding of intracranial tumors through ventriculoperitoneal shunt\n\n# Peritoneal Calcifications \n\n1. Tuberculosis\n2. Amyloidosis\n3. Hyperparathyroidism\n4. Pseudomyxoma peritonei\n5. Peritoneal carcinomatosis\n6. Meconium peritonitis\n\n## MESENTERY \\& OMENTUM\n\n## Short Mesentery\n\n$=$ shortened line of fixation\n\n1. Malrotation + midgut volvulus\n2. Omphalocele\n3. Gastroschisis\n4. Congenital diaphragmatic hernia\n5. Asplenia + polysplenia\n\n## \"Apple peel\" Small Bowel\n\n$=$ distal small intestines spirals around its vascular supply resembling an apple peel resulting in a very short intestine\n\n1. Proximal jejunal atresia\n2. Absence of distal superior mesenteric artery\n3. Shortening of small bowel distal to atresia\n4. Absence of dorsal mesentery\n\nCx: propensity toward necrotizing enterocolitis\nPrognosis: high mortality\n\n## Whirlpool Sign of Small Bowel Mesentery\n\n1. Midgut volvulus\n2. Internal hernia\n3. Adhesions\n4. Surgical disruption of normal anatomy\n\n## Omental Mass",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 626,
            "markdown": "$\\diamond 33 \\%$ of primary omental tumors are malignant!\n$\\diamond$ Secondary neoplasms are more frequent than primary!\nA. SOLID MASS\n(a) benign\n\n1. Leiomyoma\n2. Lipoma\n3. Neurofibroma\n(b) malignant\n4. Leiomyosarcoma\n5. Liposarcoma\n6. Fibrosarcoma\n7. Lymphoma\n8. Peritoneal mesothelioma\n9. Hemangiopericytoma\n10. Metastases\n(c) Infection: tuberculosis\nB. CYSTIC MASS\n11. Hematoma\n12. Cystic mesothelioma\n\n# Omental Cake \n\n$=$ replacement of normal fat of the greater omentum by a soft-tissue density\nA. INTRAPERITONEAL TUMOR SPREAD\n\n1. Peritoneal metastases from abdominal organs\nmnemonic: COPUBS\nColon\nOvary\nPancreas\nUterus\nBladder\nStomach\n2. Metastases from extraabdominal organs: malignant melanoma, breast, lung\nB. INFLAMMATION\n3. Tuberculosis\n4. Crohn disease\n5. Phlegmonous pancreatitis\n6. Granulomatous enterocolitis\nC. BENIGN TUMOR\n7. Desmoid fibroma\n8. Extramedullary hematopoiesis\nD. MALIGNANT TUMOR\n9. Mesothelioma\n10. Lymphomatosis\nE. OTHER\n11. Hemoperitoneum",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 627,
            "markdown": "2. Liver cirrhosis with portal hypertension\n\n# Mesenteric Mass \n\nA. ROUND SOLID MASS\n$\\diamond$ Benign primary tumors $>>$ malignant primary tumors\n$\\diamond$ Secondary neoplasms are more frequent than primary\n$\\diamond$ Cystic tumors are more common than solid tumors!\n$\\diamond$ Malignant solid tumors have a tendency to be located near root of mesentery, benign solid tumors in periphery near bowel!\n\n1. Metastases: especially $\\leftarrow$ colon, ovary (most frequent neoplasm of mesentery)\n2. Lymphoma\n3. Leiomyosarcoma: more frequent than leiomyoma\n4. Neural tumor : neurofibroma, ganglioneuroma\n5. Lipoma (uncommon), lipomatosis, liposarcoma\n6. Fibrous histiocytoma\n7. Hemangioma\n8. Desmoid tumor (most common primary)\n9. Desmoplastic small round cell tumor of peritoneum\nB. ILL-DEFINED MASS\n10. Metastases (ovary)\n11. Lymphoma\n12. Fibromatosis, fibrosing mesenteritis (associated with Gardner syndrome)\n13. Lipodystrophy\n14. Mesenteric panniculitis\nC. STELLATE MASS\n15. Peritoneal mesothelioma\n16. Retractile mesenteritis\n17. Fibrotic reaction of carcinoid\n18. Radiation therapy\n19. Desmoid tumor\n20. Hodgkin disease\n21. Tuberculous peritonitis\n22. Ovarian metastases\n23. Diverticulitis\n24. Pancreatitis\n$\\diamond$ A calcified mesenteric mass suggests carcinoid tumor!\nD. LOCULATED CYSTIC MASS ( $2 / 3$ )\n25. Cystic lymphangioma (most common)\n26. Pseudomyxoma peritonei\n27. Cystic mesothelioma\n28. Mesenteric cyst\n29. Mesenteric hematoma\n30. Benign cystic teratoma\n31. Cystic spindle cell tumor (= centrally necrotic leiomyoma / leiomyosarcoma)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 628,
            "markdown": "# Benign Fibrous Tumor of Mesentery \n\n1. Mesenteric fibromatosis\n2. Sclerosing mesenteritis\n3. Inflammatory pseudotumor\n4. Extrapleural solitary fibrous tumor\n\n## Mesenteric / Omental Cysts\n\n$=$ \"Bubbles of the belly\"\n$\\diamond$ The first step is to determine the organ of origin!\n\n1. Lymphangioma\n2. Nonpancreatic pseudocyst\n$=$ sequelae of mesenteric / omental hematoma / abscess\nPath: thick-walled, usually septated cystic mass with hemorrhagic / purulent contents\n3. Duplication cyst\n4. Mesothelial cyst\n5. Enteric cyst\n6. Cystic metastasis\n7. Cystic mesothelioma\n\n## Mesenteric Edema / Congestion\n\n$\\sqrt{ }$ increase of mesenteric fat attenuation to -40 to -60 HU\n$\\sqrt{ }$ loss of sharp interfaces between mesenteric vessels + fat\nA. SYSTEMIC FLUID OVERLOAD\n\n1. Hypoalbuminemia\n2. Liver cirrhosis\n3. Nephrosis\n4. Heart failure\nB. LOCAL VESSEL DISEASE\n5. Portal vein thrombosis\n6. Mesenteric vein / artery thrombosis\n7. Vasculitis\n8. SMA dissection\nC. CELL INFILTRATE\n9. Malignant neoplasm\n10. Inflammation\n11. Trauma: small hemorrhage\n\n## Comb Sign\n\n$=$ vascular dilatation of vasa recta + interconnected arterial arcades aligned as the teeth of a comb\n$\\sqrt{ }$ multiple tubular tortuous opacities on mesenteric side of ileum\n\n1. Crohn disease\n2. Ulcerative colitis\n3. Vasculitis: Lupus, polyarteritis nodosa, Behçet disease, Henoch-Schönlein syndrome, microscopic polyangiitis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 629,
            "markdown": "4. Mesenteric thromboembolism\n5. Strangulated bowel obstruction\n\n# Fat Ring Sign \n\n$=$ fat-stranding of the fat plane surrounding the root of mesenteric vessels\nA. BENIGN\n\n1. Mesenteric panniculitis\n2. Mesenteric lipodystrophy\n3. Retractile mesenteritis\nB. MALIGNANT\n4. Carcinoid\n5. Desmoid tumor\n6. Lymphoma\n\n## Misty Mesentery Sign\n\n$=$ subtle increased attenuation in the mesentery at CT often associated with small borderline-sized lymph nodes\n\n1. Normalcy (common finding!)\n2. Mesenteric panniculitis\n3. Hemorrhage\n4. Edema\n5. Malignancy\n\n## Abdominal Fat Necrosis\n\n1. Epiploic appendagitis\n2. Omental infarction\n3. Encapsulated fat necrosis\n4. Fat saponification from pancreatitis $=$ retroperitoneal fat necrosis\n\nMimicks:\n\n1. Focal lipohypertrophy\n\nCause: insulin injections into subcutaneous tissue in insulin-dependent diabetics\n2. Lipodystrophy\n$=$ heterogeneous group of disorders interfering with normal distribution of adipose tissue\n3. Liposarcoma\n\n## Umbilical Tumor\n\nA. PRIMARY (38\\%)\nbenign / malignant neoplasm, skin tumor\nB. METASTASES ( $30 \\%$ )\n$=$ \"Sister Joseph nodule\"\n\n- firm painful nodule\n- $\\pm$ ulceration with serosanguinous / purulent discharge\n\nCause: gastrointestinal cancer ( $50 \\%$ ), undetermined ( $25 \\%$ ), ovarian cancer, pancreatic cancer, small cell carcinoma of lung (very rare)\nSpread:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 630,
            "markdown": "(a) direct extension from anterior peritoneal surface\n(b) extension along embryonic remnants: falciform, median umbilical, omphalomesenteric ligaments\n(c) hematogenous\n(d) retrograde lymphatic flow from inguinal, axillary, paraaortic nodes\n(e) iatrogenic: laparoscopic tract, tract of percutaneous needle biopsy\nC. NONNEOPLASTIC\n\n1. Endometriosis (32\\%)\n2. Granuloma\n3. Incarcerated hernia\n\n# Omphalomesenteric Duct Anomalies \n\n1. Meckel Diverticulum (98\\%)\n2. Omphalomesenteric fistula\n3. Omphalomesenteric sinus\n4. Omphalomesenteric duct cyst\n5. Omphalomesenteric ligament\n\n## ABDOMINAL LYMPHADENOPATHY\n\n## Regional Patterns of Lymphadenopathy\n\n@ Retrocrural nodes\nAbnormal size: $>6 \\mathrm{~mm}$\nCommon cause: lung carcinoma, mesothelioma, lymphoma\n@ Gastrohepatic ligament nodes\n$=$ superior portion of lesser omentum suspending stomach from liver\nAbnormal size: $>8 \\mathrm{~mm}$\nCommon cause: carcinoma of lesser curvature of stomach, distal esophagus, lymphoma, pancreatic cancer, melanoma, colon + breast cancer\n$D D x$ : coronary varices\n@ Porta hepatis nodes\n$=$ in porta hepatis extending down hepatoduodenal ligament, anterior + posterior to portal vein\nAbnormal size: $>6 \\mathrm{~mm}$\nCommon cause: carcinoma of gallbladder + biliary tree, liver, stomach, pancreas, colon, lung, breast, chronic hepatitis C\n$C x$ : high extrahepatic biliary obstruction\n@ Pancreaticoduodenal nodes\n$=$ between duodenal sweep + pancreatic head anterior to IVC\nAbnormal size: $>10 \\mathrm{~mm}$\nCommon cause: lymphoma, pancreatic head, colon, stomach, lung, breast cancer\n@ Perisplenic nodes\n$=$ in splenic hilum\nAbnormal size: $>10 \\mathrm{~mm}$\nCommon cause: NHL, leukemia, small bowel neoplasm, ovarian cancer, carcinoma of",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 631,
            "markdown": "right / transverse colon\n@ Retroperitoneal nodes\n$=$ periaortic, pericaval, interaortocaval\nAbnormal size: $>10 \\mathrm{~mm}$\nCommon cause: lymphoma, renal cell, testicular, cervical, prostatic carcinomas\nAs with malignant retroperitoneal fibrosis, metastatic retro-peritoneal adenopathy typically elevates the aorta off the underlying vertebral body (exceptions have been reported)\n@ Celiac and superior mesenteric artery nodes\n$=$ preaortic nodes\nNormal size: 4.6 mm mean maximum short-axis diameter\nAbnormal size: $>10 \\mathrm{~mm}$\nCommon cause: lymphoma, any intraabdominal neoplasm, TB, atypical mycobacterial infection, Whipple disease\n@ Ileocecal nodes\n$=$ along ileocolic artery\nCommon cause: mesenteric lymphadenitis, appendicitis, diverticulitis, Crohn disease, SLE, HIV infection\n@ Pelvic nodes\n$=$ along common, external + internal iliac vessels\nAbnormal size: $>15 \\mathrm{~mm}$\nCommon cause: carcinoma of bladder, prostate, cervix, uterus, rectum\n\n# Low-attenuation Abdominal Adenopathy \n\n$=$ ENLARGED LYMPH NODE WITH LOW-DENSITY CENTER\n$\\sqrt{ }$ rim-enhancing nodules + central necrosis\n\n1. Mycobacterial infection (TB, M. avium-intracellulare)\n2. Pyogenic infection\n3. Whipple disease\n4. Lymphoma\n5. Metastatic disease after radiation + chemotherapy\n6. Lymphangioleiomyomatosis\n7. Neurofibromatosis type I\n8. Cavitating mesenteric lymph node syndrome\n\n## PARASITIC INFESTATION\n\nA. PROTOZOA = one cell parasites\n[protos, Greek = foremost, earliest; zoion, Greek = animal]\n(a) genitourinary\n\n1. Trichomoniasis\n2. Chlamydomonas\n(b) intestinal\n3. Giardiasis\n4. Amebiasis\n5. Cryptosporidiosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 632,
            "markdown": "(c) blood\n\n1. Malaria\n2. Giardiasis\n3. Trypanosomiasis\n4. Tuberculosis\n5. Toxoplasmosis\n6. Filariasis\n7. Leishmaniasis\nB. PLATYHELMINTHES $=$ flatworms\n(a) cestodes (= tapeworms) [cestus, Latin = belt, girdle]\n8. Echinococcus granulosus\n9. Echinococcus multilocularis\n10. Cysticercosis\n(b) trematodes (flukes) [trema, Greek = hole; odes, Greek = like]\n11. Clonorchiasis\n12. Fascioliasis\n13. Paragonimiasis\n14. Schistosomiasis\n> S. haematobium (GU tract) $>95 \\%$\n> S. mansoni, S. japonicum (GI tract) $<5 \\%$\nC. NEMATODES = roundworms [nema, Greek = thread; odes, Greek = like]\n15. Strongyloidiasis (= pinworm)\n16. Ascariasis\n17. Trichuriasis\n18. Toxocariasis\n19. Angiostrongylosis\n> other hookworms: Ancylostoma duodenale, Necator americanus\n> other pinworm: Enterobius vermicularis (formerly Oxyuris vermicularis)\n\n# Helminthiasis \n\n$=$ infestation caused by Platyhelminthes and Nematoda\nIncidence: 2 billion people affected worldwide\nGeography: > endemic: in developing countries and places with poor sanitation > nonendemic: through immigration and travel\n\n- iron-deficiency anemia, seizures\n- chronic diarrhea, portal hypertension\n\nTransmission: active penetration of skin by larvae from soil / fecal-oral route / vector arthropods\n(a) larval penetration:\n\n1. Schistosomiasis\n2. Strongyloidiasis\n(b) fecal-oral route:\n3. Fascioliasis\n4. Ascariasis\n5. Trichuriasis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 633,
            "markdown": "4. Cysticercosis\n5. Echinococcosis\n6. Toxocariasis\n7. Angiostrongylosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 634,
            "markdown": "# ANATOMY AND FUNCTION OF ABDOMEN AND GASTROINTESTINAL TRACT \n\n## GASTROINTESTINAL HORMONES\n\n## Cholecystokinin\n\n$=\\mathrm{CCK}=33$ amino acid residues (former name: Pancreozymin); the 5 C-terminal amino acids are identical to those of gastrin, causing similar effects as gastrin; 2.5 -min serum half-life Produced in: duodenal + upper intestinal mucosa\nReleased by: fatty acids, some amino acids (phenylalanine, methionine), hydrogen ions Effects:\n@ Stomach\n(1) weakly stimulates HCl secretion\n(2) given alone: inhibits gastrin $\\rightarrow \\downarrow$ in HCl production\n(3) stimulates pepsin secretion\n(4) stimulates gastric motility\n@ Pancreas\n(1) stimulates secretion of pancreatic enzymes (= Pancreozymin)\n(2) stimulates bicarbonate secretion: weakly by direct effect; strongly through potentiating effect on secretin\n(3) stimulates insulin release\n@ Liver\n(1) stimulates water + bicarbonate secretion\n@ Intestine\n(1) stimulates secretion of Brunner glands\n(2) increases motility\n@ Biliary tract\n(1) strong stimulator of gallbladder contraction with maximum effect within 5-15 min + return to basal size in 1 hour\n(2) relaxation of sphincter of Oddi\n\nMedication:\nsincalide (KINEVAC ${ }^{\\circledR}$ ) = synthetic C-terminal octapeptide of the hormone cholecystokinin",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 635,
            "markdown": "| Gastrointestinal Endocrine Cells |  |  |\n| :--: | :--: | :--: |\n| Cell Type | Location | Secretory Product |\n| G-cell (gastrin cell) | gastric antrum, duodenum | gastrin |\n| ECL-cell (enterochromaffin -like cell) | gastric fundus and body | histamine |\n| D-cell (somatostatin -producing cell) | stomach, duodenum, jejunum, colon, rectum | somatostatin |\n| EC-cell (enterochromaffin cell) | stomach, duodenum, jejunum, colon, rectum | serotonin, motilin, substance $P$ |\n| CCK-cell (cholecystokinin cell) | duodenum, ileum | cholecystokinin |\n| GIP-cell (gastric inhibitory polypeptide cell) | duodenum, ileum | gastric <br> inhibitory <br> polypeptide |\n| M-cell (motilin cell) | duodenum, jejunum | motilin |\n| S-cell (secretin cell) | duodenum, jejunum | secretin |\n| PP-cell (pancreatic polypeptide cell) | duodenum | pancreatic polypeptide |\n| L-cell (enteroendocrine cell) | jejunum, ileum, colon, rectum | polypeptide YY |\n| N-cell (neurotensin cell) | jejunum, ileum | neurotensin |\n\nUse: may be used to empty gallbladder about 30 minutes (to 4 hours) before tracer injection in patients on prolonged fasting (gallbladder atony + retained bile and sludge) $\\leftarrow$ absence of endogenously produced CCK\nDose for hepatobiliary scintigraphy:\npackage insert: with slow IV injection of $0.01 \\mu \\mathrm{~g} / \\mathrm{kg}$ KINEVAC ${ }^{\\circledR}$ over 3 minutes\n(concentration of $1 \\mu \\mathrm{~g} / \\mathrm{mL}$ ) the response is too variable\npreferred: IV infusion of $0.01 \\mu \\mathrm{~g} / \\mathrm{kg}$ KINEVAC ${ }^{\\circledR}$ over $30-60$ minutes\nUseful in: (a) patient fasting $>24$ hours / on total parenteral nutrition\n(b) acalculous cholecystitis\n(c) chronic GB dysfunction\n(d) GB ejection fraction\n\nSide effect: increase in biliary-to-bowel transit time, dizziness, flushing, nausea, abdominal cramps, urge to defecate\nContraindications:\nacute pancreatitis, acute cholecystitis, obstruction of cystic duct / CBD, appendicitis, peritonitis, pyloric stenosis, peptic ulcer\n\n# Gastrin \n\n$=17$ amino acid peptide amide",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 636,
            "markdown": "PENTAGASTRIN = acyl derivative of the biologic active C-terminal tetrapeptide amide\nProduced in: antral cells +G cells of pancreas\nReleased by:\n(a) vagal stimulation, gastric distension\n(b) short-chain alcohol: ethanol, propanol\n(c) amino acids: glycine, $\\beta$-alanine\n(d) caffeine\n(e) hypercalcemia\nmediated by neuroendocrine cholinergic reflexes\nInhibited by: drop in pH of antral mucosa to $<3.5$\nEffects:\n@ Stomach:\n(1) stimulation of gastric HCl secretion from parietal cells, which in turn\n(2) increases pepsinogen production by chief cells through local reflex\n(3) increase in antral motility\n(4) trophic effect on gastric mucosa $\\rightarrow$ parietal cell hyperplasia\n@ Pancreas\n(1) strong increase in enzyme output\n(2) weakly stimulates fluid + bicarbonate output\n(3) stimulates insulin release\n@ Liver\n(1) water + bicarbonate secretion\n@ Intestine\n(1) stimulates secretion of Brunner glands\n(2) increases motility\n@ Gallbladder\n(1) stimulates contraction\n@ Esophagus\n(1) increases resting pressure of LES\n\n# Glucagon \n\nProduced in: $\\alpha$ cells (and $\\beta$ cells) of pancreas\nReleased by: low blood glucose levels\nEffects:\n@ Intestines\n(1) lowers pressure of GE sphincter\n(2) hypotonic effect on duodenum $>$ jejunum $>$ stomach $>$ colon\n@ Hormones\n(1) releases catecholamines from adrenal gland $\\rightarrow$ paralysation of intestinal smooth muscle\n(2) increases serum insulin + glucose levels $\\rightarrow$ mobilization of hepatic glycogen\n@ Biliary tract\n(1) increases bile flow\n(2) relaxes gallbladder + sphincter of Oddi\n\nDose for radiologic imaging: 1 mg maximum",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 637,
            "markdown": "$\\diamond$ IV administration causes a quick response + rapid dissipation of action!\n$\\diamond$ IM administration prolongs onset + increases length of action!\nHalf-life: 3-6 min\nSide effects: nausea + vomiting, weakness, dizziness (delayed onset of 1.5-4.0 hours after IM administration)\nContraindication:\n(1) hypersensitivity / allergy to glucagon: urticaria, periorbital edema, respiratory distress, hypotension, coronary artery spasm (?), circulatory arrest\n(2) known hypertensive response to glucagon\n(3) pheochromocytoma: glucagon stimulates release of catecholamines\n(4) insulinoma: insulin-releasing effect may result in hypoglycemia\n(5) glucagonoma\n(6) poorly controlled diabetes mellitus\n\n# Secretin \n\n$=27$-amino acid polypeptide hormone\nProduced in: duodenal mucosa\nReleased by: hydrogen ions providing a $\\mathrm{pH}<4.5$ (usually increase in postprandial intraluminal acidity)\nThe physiologic effects of secretin include secretion of bicarbonate-rich fluid from pancreatic ductal cells and transient increase in the sphincter of Oddi tone, which improves depiction of the pancreatic duct.\n\n## Effects:\n\n@ Stomach\n(1) inhibits release of gastrin $\\rightarrow \\downarrow$ in HCl secretion\n(2) stimulates pepsinogen secretion by chief cells (potent pepsigogue)\n(3) decreases gastric and duodenal motility + contraction of pyloric sphincter\n@ Pancreas\n(1) increases alkaline bicarbonate-rich pancreatic secretions $(\\mathrm{NaHCO} 3=$ sodium bicarbonate)\n» bicarbonate $=2 \\mathrm{x}$ as much carbonate ( CO 3 ) per sodium ion in sodium bicarbonate $(\\mathrm{NaHCO} 3)$ as in sodium carbonate $(\\mathrm{Na} 2 \\mathrm{CO} 3)$; crucial role in physiological pH buffering\n(2) weakly stimulates enzyme secretion\n(3) stimulates insulin release\n@ Liver\n(1) stimulates water + HCO3- secretion (most potent choleretic)\n@ Intestine\n(1) stimulates secretion of Brunner glands\n(2) inhibits motility\n@ Esophagus\n(1) opens LES\n@ Sphincter of Oddi\n(1) transient increase in muscle tone used in SOM (sphincter of Oddi manometry)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 638,
            "markdown": "| Common Indications for Secretin Use during MRCP |  |\n| :--: | :--: |\n| Clinical | Indication |\n| Acute recurrent pancreatitis, severe necrotizing pancreatitis | Integrity of MPD |\n| Chronic pancreatitis | Duct stricture / stone |\n|  | Pancreatic excretory volume estimate |\n| Pancreatic cystic neoplasm | Side-branch IPMN vs. other cystic neoplasm / pseudocyst |\n| Postoperative pancreas | Pancreaticoenteric anastomosis patency |\n|  | Estimate pancreatic exocrine reserve |\n|  | Duct dilatation / filling defect / leak |\n| Suspected duct anomaly | Pancreas divisum + variants |\n|  | Pancreaticobiliary junction anomaly |\n\n# Secretin Stimulation Test SST \n\nIndication: (1) Exocrine pancreas dysfunction\n(2) Gastrinoma versus peptic ulcer disease\n(3) Identification of ampulla of Vater + accessory papilla during ERCP\n\nDrug: purified synthetic human secretin ChiRhoStim ${ }^{\\circledR}$, ChiRhoClin ${ }^{\\circledR}$\nDose: $0.2-0.4 \\mu \\mathrm{~g} / \\mathrm{kg}$ IV ( $\\sim 16 \\mu \\mathrm{~g}$ for adult) over 1 minute to avoid side effect of abdominal pain\nInitial test dose: for possible allergic reaction\nPeak effect: usually at 3-5 minutes after injection\n$\\sqrt{ } \\uparrow$ main pancreatic duct (MPD) diameter by $>1 \\mathrm{~mm}$\n$\\sqrt{ } \\uparrow$ visibility of side branches of MPD\n$\\sqrt{ } \\uparrow$ T2 SI in duodenum $\\leftarrow$ excretion of pancreatic fluid\nAdverse effects: (in $0.5 \\%$ ) nausea, flushing, abdominal pain, vomiting, mild acute pancreatitis\nDx of gastrinoma:\nrelease of gastrin from gastrinoma cells is increased $\\rightarrow$ increased serum gastrin level of $200 \\mathrm{ng} / \\mathrm{L}$ above baseline ( $90 \\%$ sensitive + specific)\nN.B.: normally secretin inhibits release of gastrin\n\n## Dx of chronic pancreatitis:\n\naspiration of intestinal secretions via tube passed into duodenum for 1 hour analyzing volume, pH , bicarbonate concentration in 15 -minute aliquots ( $75 \\%$ sensitive $+90 \\%$ specific for chronic pancreatitis)\nContraindication: acute pancreatitis\n\n## Somatostatin SS\n\n$=$ growth hormone-inhibiting hormone (GHIH); somatotropin release-inhibiting factor (SRIF); somatotropin release-inhibiting hormone (SRIH)\nProduced in: many tissues; principally in nervous + digestive systems",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 639,
            "markdown": "Action: inhibits secretion of several other hormones like growth hormone (GH), thyroid stimulating hormone (TSH), cholecystokinin, insulin\nReleased by: raised levels of other hormones (feed back); $\\uparrow$ blood glucose + amino acids (food intake)\nInhibited by: reduced levels of other hormones (feed back)\nEffects:\n@ Hypothalamus\ninhibits pituitary gland $\\rightarrow \\downarrow$ secretion of $\\mathrm{GH}+\\mathrm{TSH}$\n$R x$ : treatment of acromegaly\n@ Pancreas\nfood intake $\\rightarrow \\downarrow$ secretion of insulin + glucagon\n@ GI tract\n(a) local reduction of gastric secretion\n(b) gastrointestinal motility\n(c) inhibits secretion of gastrin + secretin\n\n# EMBRYOLOGY OF ALIMENTARY TRACT \n\nOrigin: pouchlike extension of the yolk sac\nDivision: (1) foregut supplied by celiac artery for bronchopulmo-nary system, stomach, pancreas, proximal duodenum\n(2) midgut supplied by superior mesenteric artery (SMA) representing axis of gut rotation: mid-duodenum, jejunum, ileum, appendix, ascending colon, midtransverse colon\n(3) hindgut supplied by inferior mesenteric artery: mid-transverse colon, rectum\nat 4 weeks: short straight featureless tube\n$1 \\underline{\\text { st }}$ rotation:\n(a) duodenum rotates cephalocaudal $90^{\\circ}$ counterclockwise to a position at right of SMA\n(b) colon rotates $90^{\\circ}$ to left of SMA\nat 6 weeks: rapid growth of intraabdominal organs (expansion of liver + GI tract) $\\rightarrow$ bowel herniates into umbilical cord = physiologic umbilical herniation\n2nd rotation:\n(a) duodenum rotates another $90^{\\circ}$ (completes $180^{\\circ}$ ) counter-clockwise beneath SMA to a position at left of SMA\n(b) colon does not rotate\nat 10 weeks: bowel returns to abdominal cavity\n3rd rotation:\n(a) duodenum rotates another $90^{\\circ}$ (completes $270^{\\circ}$ ) counter-clockwise with duodenojejunal junction resting to left of spine\n(b) colon rotates $180^{\\circ}$ counterclockwise until cecum is located in RLQ by $12^{\\text {th }}$ week\n\n## Peritoneal fixation of bowel:\n\n> broad-based mesentery extending from ligament of Treitz to ileocecal valve\n> colon fuses with retroperitoneum in RLQ with the exception of the most caudal part\n> duodenum fixes to retroperitoneum in LUQ\nChange in fetal nutrition from yolk sac to placenta:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 640,
            "markdown": "> during $5^{\\text {th }}$ to $7^{\\text {th }}$ weeks $\\rightarrow$ regressing omphalomesenteric duct\n![img-69.jpeg](img-69.jpeg)\n\n# ARTERIAL SUPPLY OF BOWEL \n\n$\\diamond$ Bowel receives $20 \\%$ of resting cardiac output ( $2 / 3$ for intestinal mucosa) which increases up to $35 \\%$ in postprandial phase\nInfluence of food:\ncarbohydrates $\\rightarrow$ earliest + fast rise\nfat + proteins $\\rightarrow$ slower + large rise\n\n## Celiac Trunk\n\nLocation: at $\\sim \\mathrm{T} 12=$ superior border of pancreatic body\nSupplies: from distal esophagus to descending duodenum\nBranches: common hepatic a. (CHA), left gastric a. (LGA), splenic artery (SpA) with considerable variations in branching pattern\n> CHA branching from SMA (hepatomesenteric type)\n> direct branching of CHA / LGA / SpA from aorta\n> replaced left hepatic artery\n> replaced right hepatic artery\nAnastomosis: to SMA via gastroduodenal artery as the $1^{\\text {st }}$ branch off the celiac trunk\n\n## Superior Mesenteric Artery (SMA)\n\nSupplies: transverse + descending duodenum, jejunum, ileum, large bowel to splenic flexure\nAnastomosis: with IMA via marginal artery of Drummond, arcade of Riolan\n\n## Inferior Mesenteric Artery (IMA)\n\nSupply for: colon from splenic flexure to rectum\nAnastomoses: with lumbar branches of abdominal aorta, sacral artery, internal iliac arteries\n\n## Arterial Arcades\n\nup to 4 arcades are formed by these arteries which continue toward the periphery as\n\n1. Primary parallel circuits for\na. muscularis propria",
            "images": [
                {
                    "id": "img-69.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 259,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 789,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 641,
            "markdown": "b. submucosa\nc. mucosa\n2. Serial circuits of\na. resistance arterioles\nb. precapillary sphincters\nc. capillaries\nd. postcapillary sphincters\ne. venous capacitance vessels\n![img-70.jpeg](img-70.jpeg)",
            "images": [
                {
                    "id": "img-70.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 550,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1269,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 642,
            "markdown": "![img-71.jpeg](img-71.jpeg)",
            "images": [
                {
                    "id": "img-71.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1335,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 643,
            "markdown": "![img-72.jpeg](img-72.jpeg)\n\n# MESENTERIC VENOUS SYSTEM \n\n## Venae Rectae\n\n$=$ multiple small veins along bowel wall that join to form venous arcades\n\n## Superior Mesenteric Vein\n\nDrainage for: small bowel, proximal colon to splenic angle\nFormed by: jejunoileal, ileocolic, right colic, middle colic, pancreaticoduodenal veins\n\n## Inferior Mesenteric Vein\n\nDrainage for: splenic flexure, descending colon, sigmoid colon, part of rectum\nFormed by: left colic, sigmoid, rectosigmoid, right and left superior rectal veins\nConnects to: SMV directly / splenic vein / angle of splenoportomesenteric confluence\n\n## ESOPHAGUS",
            "images": [
                {
                    "id": "img-72.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 187,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1346,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 644,
            "markdown": "# Esophageal Division \n\n1. Upper third\ncricopharyngeus to superior margin of aortic arch\n2. Middle third\nsuperior margin of aortic arch to inferior pulmonary vein\n3. Lower third\ninferior pulmonary vein to gastroesophageal junction\n\n## Cricopharyngeus Muscle\n\n$=$ main component of upper esophageal sphincter\n$\\sqrt{ }$ normally closed between swallows\n$\\sqrt{ }$ relaxes and opens completely for bolus passage to occur in conjunction with elevation of larynx and pharyngeal constrictors\n$\\sqrt{ }$ prominent posterior indentation on barium column $\\leftarrow$ incidental / sign of dysphagia\nMay be associated with:\npharyngeal constrictor muscle weakness, failure of laryngeal elevation, Zenker diverticulum, response esophageal spasm or GERD\n\n## Lower Esophageal Anatomy\n\n## A. Esophageal Vestibule\n\n$=$ saccular termination of lower esophagus with upper boundary at tubulovestibular junction + lower boundary at esophagogastric junction\n$\\sqrt{ }$ collapsed during resting state\n$\\sqrt{ }$ assumes bulbous configuration with swallowing\n(a) tubulovestibular junction $=$ A level $=$ junction between tubular and saccular esophagus\n(b) phrenic ampulla $=$ bell-shaped part above diaphragm (term should be discarded because of dynamic changes of configuration)\n(c) submerged segment $=$ infrahiatal part of esophagus\n$\\sqrt{ }$ widening / disappearance is indicative of gastroesophageal reflux disease (GERD)\n\n## B. Gastroesophageal Junction\n\nFunction: regulates flow of food + fluid between esophagus and stomach; key defense against gastroesophageal reflux\nBarrier: (1) Intrinsic smooth muscle of LES\n(2) Extrinsic striated muscle of crural diaphragm\n(3) clasp + sling fibers of gastric cardia\n\nSite: at upper level of gastric sling fibers, straddles cardiac incisura demarcating the left lateral margin of GE junction\nC. Z-line $=$ B level $=$ zigzag-shaped squamocolumnar junction line\n$\\diamond$ Not acceptable criterion for locating GE junction\nSite: $1-2 \\mathrm{~cm}$ above gastric sling fibers\n\n## D. Lower Esophageal Sphincter\n\n$=$ physiologic $2-4-\\mathrm{cm}$ high pressure zone corresponding to esophageal vestibule\n$\\sqrt{ }$ tightly closed during resting state\n$\\sqrt{ }$ assumes bulbous configuration with swallowing",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 645,
            "markdown": "# Muscular Rings of Esophagus \n\n## A Ring\n\n$=$ contracted / hypertrophied muscles in response to incompetent GE sphincter\n\n- rarely symptomatic / dysphagia\n\nLocation: at tubulovestibular junction = superior aspect of vestibule\n$\\sqrt{ }$ usually 2 cm proximal to GE junction at upper end of vestibule\n$\\sqrt{ }$ varies in caliber during the same examination, may disappear on maximum distension\n$\\sqrt{ }$ broad smooth narrowing with thick rounded margins\n$\\sqrt{ }$ visible only if tubular esophagus above + vestibule below are distended\n![img-73.jpeg](img-73.jpeg)\n\n## B Ring\n\n$=$ sling fibers representing a U -shaped thickening of inner muscle layers with open arm of U toward lesser curvature $=$ inferior aspect of vestibule\nLocation: $<2 \\mathrm{~cm}$ from hiatal margins\n$\\sqrt{ }$ only visible when esophagogastric junction is above hiatus\n$\\sqrt{ }$ thin ledge-like ring just below the mucosal junction (Z-line)\n\n## Layers of Intestinal Wall by Ultrasound\n\n$=$ gut signature\n\n1. Mucosa echogenic\n$\\sqrt{ }$ hyperechoic interface of balloon + mucosa\n2. Muscularis mucosae hypoechoic\n$\\sqrt{ }$ hypoechoic mucosa + muscularis mucosa\n3. Submucosa echogenic / hyperechoic\n4. Muscularis propria hypoechoic\n5. Serosa echogenic / hyperechoic\n\nMost benign conditions preserve the gut signature involving long segments of bowel, while malignant",
            "images": [
                {
                    "id": "img-73.jpeg",
                    "top_left_x": 357,
                    "top_left_y": 611,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1260,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 646,
            "markdown": "conditions destroy the gut signature involving short segments of bowel.\nAggressive inflammatory processes cause focal disruption of the gut signature.\n\n# SWALLOWING FUNCTION \n\nPreparation: refrain from smoking for 12 hours + from eating for $>4$ hours before examination\nProvide info on baseline anatomy + swallow physiology: for oral cavity, pharynx, larynx, upper esophagus during deglutition\nTechnique:\nVideofluoroscopic Swallow Study (VFSS) = modified barium swallow study to assess handling of bolus; usually performed together with swallowing / speech pathologist\n» patient seated upright in lateral + AP positions\n» incremental increase in radiopaque bolus volume + texture of various consistencies like nectar liquid, honey liquid, pureed food, soft solid food, hard solid food (commercially available: E-Z Paque liquid, Varibar ${ }^{\\circledR}$ thin liquid, nectar, honey, pudding, graham cracker cookie with pudding)\nDocument patient behavior + reaction:\nepisode of refusal, cough, silent aspiration, apnea, bradycardia\nCNS involved: cranial nerves V, VII, IX, X, XII; 5 cervical nerves; cortical + subcortical pathways; midbrain; brainstem\nMuscles involved: 32 groups of muscles\nDevelopmental: swallowing as early as 11 weeks GA; suckling at 18-24 weeks GA; nonnutritive sucking at 27-28 weeks GA; single breath sucking at $35-36$ weeks GA\nPhases:\n\n1. Oral preparatory phase\n$\\checkmark$ food chewed + mixed with saliva\n2. Oral phase\n$\\checkmark$ bolus propelled posteriorly to tongue\nPath:\n(a) spillage from mouth\n(b) small bolus formation\n(c) tongue tremor\n(d) incomplete tongue elevation\n(e) early spillage into valleculae prior to initiation of swallow\n3. Pharyngeal phase\n$\\checkmark$ elevation of soft palate + valleculae (to seal nasopharynx)\n$\\checkmark$ elevation of larynx (to close vestibule)\n$\\checkmark$ relaxation of cricopharyngeal muscle\n$\\checkmark$ contraction of lateral pharyngeal wall\nAt videofluoroscopy carefully evaluate mechanisms to prevent aspiration: superior + anterior elevation of larynx, closure of larynx, and epiglottic tilt.\nPath:\n(a) nasopharyngeal reflux",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 647,
            "markdown": "(b) laryngeal penetration $=$ contrast material enters laryngeal vestibule\n\nCause: delayed elevation of larynx\n(c) tracheal aspiration $=$ contrast material enters airway below vocal cord level into proximal trachea\nCause: delayed elevation of larynx, delayed pharyngeal transit time, decreased clearance of bolus with residual in vallecula and pyriform sinus spilling into larynx + trachea\n4. Esophageal phase\n$\\sqrt{ }$ contraction of cricopharyngeal muscle\n$\\sqrt{ }$ bolus transfer into esophagus\nPath: cricopharyngeal achalasia (with reflux of bolus into oropharynx / pooling in pyriform sinus)\n\n# STOMACH \n\n## Segmental Anatomy of Stomach\n\n1. Cardia\n2. Fundus\n\nDependency: most superior portion when upright most dependent portion when supine\n$\\sqrt{ }$ stomach bubble on CXR\n$\\sqrt{ }$ accumulation of intraluminal contents on CT\n3. Body\n(a) lesser curvature: left and posteriorly on CT\n(b) greater curvature: right and anteriorly on CT\n$\\sqrt{ } \\leq 5 \\mathrm{~mm}$ in thickness (in distended state)\n» Incisura angularis\n= transition to antral-type mucosa\n$\\diamond$ Most common site for gastric ulcers!\n4. Antrum\n$=$ thickest gastric segment $\\leftarrow$ most muscular\n$\\sqrt{ } \\leq 12 \\mathrm{~mm}$ in thickness (in distended state)\n$\\sqrt{ }$ exhibits the most peristalsis\n$\\sqrt{ }$ may display mural stratification on CECT\n5. Pylorus\n\nInadequate gastric distention limits diagnostic evaluation and may create a false appearance of thickening or may obscure true disease.\nWhen evaluating abnormal gastric wall thickening in a nondistended stomach, supplementary findings can be helpful in identifying disease.\n\n## Trilaminar Gastric Wall on CECT\n\n1. Mucosa:\n2. Submucosa:\n3. Muscularis propria:\n4. Serosa\navid enhancement\nlow in attenuation\nhigh in attenuation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 648,
            "markdown": "Suspicious findings:\n$\\checkmark$ focal / eccentric gastric wall thickening\n$\\checkmark$ low attenuation / nodularity of gastric wall\n$\\checkmark$ mucosal hyperenhancement\n$\\checkmark$ adjacent fat stranding\n\n# Gastric Cells \n\n1. Chief cells = peptic / zymogenic cells\n\nLocation: body + fundus\nproduce: pepsinogen\n2. Parietal cells = oxyntic cells\n\nLocation: body + fundus\nproduce: $\\mathrm{H}+, \\mathrm{Cl}-$, intrinsic factor, prostaglandins\n3. Mucous neck cells\nproduce: mucoprotein, mucopolysaccharide, aminopolysaccharide sulfate\n4. Argentaffine cells $=$ enteroendocrine cells\n\nLocation: body + fundus\nproduce: glucagon-like substance (A-cells), somatostatin (D-cells), vasoactive intestinal polypeptide (D1-cells), 5-hydroxytryptamine (EC-cells)\n5. G-cells\n\nLocation: pylorus\nproduce: gastrin\n\n## Effect of Bilateral Vagotomy\n\n$=$ cholinergic denervation\n(1) decreased MOTILITY of stomach + intestines\n(2) decreased GASTRIC SECRETION\n(3) decreased TONE OF GALLBLADDER + bile ducts\n(4) increased TONE OF SPHINCTERS (Oddi + lower esophageal sphincter)\n\n## Pylorus\n\n[pyloros, Greek = gatekeeper]\n$=$ fan-shaped specialized circular muscle fibers with:\n(a) distal sphincteric loop = right canalis loop\n$\\checkmark$ corresponds to radiologic pyloric sphincter\n(b) proximal sphincteric loop = left canalis loop\n$\\checkmark 2 \\mathrm{~cm}$ proximal to distal sphincteric loop on greater curvature (seen during complete relaxation)\n(c) torus\n$=$ fibers of both sphincters converge on the lesser curvature side to form a muscular prominence; prolapse of mucosa between sphincteric loops produces a niche simulating ulcer\n$\\checkmark$ pyloric channel $5-10 \\mathrm{~mm}$ long, wall thickness of $4-8 \\mathrm{~mm}$\n$\\checkmark$ concentric indentation of the base of the duodenal bulb",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 649,
            "markdown": "![img-74.jpeg](img-74.jpeg)\n\n# SMALL BOWEL \n\n$\\diamond$ Longest tubular organ in body measuring $550-600 \\mathrm{~cm}$ (18-22 feet) in length\nSegments and Length:\n> duodenum of $25-30 \\mathrm{~cm}$ in length\n> mesenteric small bowel:\n» jejunum: 10-12 feet in length (= proximal 60\\%)\n» ileum: 6-8 feet in length (= distal 40\\%)\nMesentery: 15 cm long between ligament of Treitz (musculus suspensorius duodeni) + ileocecal junction\n\n## Duodenum\n\n$=1^{\\text {st }}$ part of small intestine from pylorus to lig. of Treitz\n[Václav (Wenzel) Treitz (1819-1872), Director of the Institute of Pathological Anatomy in Prague]\nBorders:\n(a) posterior: external edge of IVC, medial surface of right kidney + hilum, psoas muscle\n(b) anterior: right transverse colon, mesocolon, floating small bowel loops\n(c) medial: pancreatic head\n(d) lateral: right hepatic lobe, gallbladder neck, ascending colon\n\n## Duodenal Segments\n\n$1^{\\text {st }}$ segment $=$ duodenal bulb + short postbulbar segment:\nCourse: passes backward + upward toward neck of GB\nLocation: intraperitoneal\n$\\sqrt{ }$ freely movable $\\leftarrow$ intraperitoneal\n$2^{\\text {nd }}$ segment $=$ descending duodenum\n$=$ gentle curve from superior to inferior duodenal flexures with attachment to head of pancreas\nLength: $7-10-\\mathrm{cm}$-long tube\nDiameter: $35-40-\\mathrm{mm}$\nLocation: retroperitoneal in anterior pararenal space between posterior parietal peritoneum and anterior perirenal fascia of Gerota\nOpenings:",
            "images": [
                {
                    "id": "img-74.jpeg",
                    "top_left_x": 598,
                    "top_left_y": 189,
                    "bottom_right_x": 1094,
                    "bottom_right_y": 631,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 650,
            "markdown": "(a) major papilla (Vater) $\\leftarrow$ hepatopancreatic ampulla $\\leftarrow$ junction of $\\mathrm{CBD}+$ main pancreatic duct\n(b) minor duodenal papilla $=$ opening 2 cm above ampulla $\\leftarrow$ accessory pancreatic duct of Santorini\n$3^{\\text {rd }}$ segment $=$ horizontal / transverse segment\nCourse: runs $10-12 \\mathrm{~cm}$ horizontally to the left\nLocation: retroperitoneal crossing in front of IVC + aorta + lumbar spine; posterior to mesenteric vessels\n$4^{\\text {th }}$ segment $=$ ascending portion\nCourse: runs $2-3 \\mathrm{~cm}$ upward to the left\nLocation: retroperitoneal ascending to level of duodenojejunal junction\nVARIATIONS:\n(1) \"mobile duodenum\" / \"water-trap duodenum\"\n$=$ long postbulbar segment with undulation / redundancy\n(2) duodenum inversum / duodenum reflexum\n$=$ distal duodenum ascends to the right of spine to the level of duodenal bulb + then crosses spine horizontally + fixated in normal location\n\n# Small Bowel Folds \n\n$\\diamond$ Circumferential small bowel folds (= folds of Kerckring\n[Theodor (or Dirk) Kerckring (Kerckeringh, Kerckerinck) (1638-1693), Dutch anatomist and chemical physician]\n$=$ valvulae conniventes $=$ plicae circulares $)=2$ mucosal layers around a core of submucosa\nA. WALL THICKNESS\n$\\diamond$ Small bowel wall thickness $>3 \\mathrm{~mm}$ at CT is abnormal!\nB. NORMAL FOLD THICKNESS\n@ jejunum 1.7-2.0 $\\mathrm{mm}>2.5 \\mathrm{~mm}$ pathologic\n@ ileum $1.4-1.7 \\mathrm{~mm}>2.0 \\mathrm{~mm}$ pathologic\nC. NORMAL NUMBER OF FOLDS\n@ jejunum 4-7 / inch\n@ ileum 2-4 / inch\nD. NORMAL FOLD HEIGHT\n@ jejunum 3.5-7.0 mm\n@ ileum $2.0-3.5 \\mathrm{~mm}$\nE. NORMAL LUMEN DIAMETER\n@ upper jejunum $3.0-4.0 \\mathrm{~cm}>4.5 \\mathrm{~cm}$ pathologic\n@ lower jejunum $2.5-3.5 \\mathrm{~cm}>4.0 \\mathrm{~cm}$ pathologic\n@ ileum $2.0-2.8 \\mathrm{~cm}>3.0 \\mathrm{~cm}$ pathologic\nRULE OF 3's:\n$\\diamond$ Wall thickness $<3 \\mathrm{~mm}$\n$\\diamond$ Valvulae conniventes $<3 \\mathrm{~mm}$\n$\\diamond$ Diameter $<3 \\mathrm{~cm}$\n$\\diamond$ Air-fluid levels $<3$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 651,
            "markdown": "# Normal Bowel Caliber \n\n$\\diamond$ Small bowel gradually tapers in diameter from duodenojejunal junction to terminal ileum! mnemonic: 3-6-9-12\n3 cm maximal size of small bowel\n$><3 \\mathrm{~cm}$ in jejunum (up to 4 cm during enteroclysis)\n$><2 \\mathrm{~cm}$ in ileum (up to 3 cm during enteroclysis)\n$\\diamond<25 \\mathrm{~mm}$ on CT\n6 cm maximal size of transverse colon\n9 cm maximal size of cecum\n12 cm maximal caliber of cecum before it may burst\n\n## Small Bowel Peristalsis\n\nA. INCREASED\n\n1. Vagal stimulation\n2. Acetylcholine\n3. Anticholinesterase (eg, neostigmine)\n4. Cholecystokinin\nB. DECREASED\n5. Atropine (eg, Pro-Banthine ${ }^{\\circledR}$ )\n6. Bilateral vagotomy\n\n## Ileocecal Valve\n\n$=$ ICV $=$ COLIC VALVE $=$ VALVULA COLI\nComposition: symmetric upper + lower lip formed by intrusion of circular muscle layer of ileum into lumen of large intestine\nFrenula of ICV: narrow membranous ridges at medial and lateral end of aperture where lips meet\nFunction: modulation of flow of luminal contents from ileum into colon $\\rightarrow$ minimizing rapid anterograde passage / retrograde flow; minimal sphincteric action (common barium reflux into terminal ileum)\nLocation: within a cecal fold along medial aspect of cecum\nEndoscopic classification:\n(a) labial\n$=$ slitlike opening\n(b) papillary\n$=$ dome shaped opening\n(c) lipomatous\n$=$ substantial deposit of fat within lips\n\n## COLON\n\n## Colon Transit Time\n\nSitzmarks diagnostic test:\nIndication: adults with severe constipation but otherwise normal GI examination\n\n1. Withhold laxatives / enemas / suppositories for 5 days\n2. On day 0 patient takes 1 gelatin capsule (contains 24 radiopaque polyvinyl chloride markers of $1 \\times 4.5 \\mathrm{~mm}$ ) with water\n$\\diamond$ All markers are usually in colon by 12 hours",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 652,
            "markdown": "3. Take KUB on day 5 to determine location + extent of marker elimination\n$> \\geq 19$ markers ( $80 \\%$ ) expelled $=$ grossly normal colonic transit time\n> markers scattered about the colon = colonic hypomotility / inertia\n> markers in rectum / rectosigmoid = functional outlet obstruction (eg, internal rectal prolapse / anismus)\n$>5(20 \\%)$ retained need follow-up KUB on day 7\n\n# Colonic Wall Thickness \n\n$<3 \\mathrm{~mm}=$ normal\n$3-4 \\mathrm{~mm}=$ indeterminate\n$>4 \\mathrm{~mm}=$ pathologic\n\n## Cecum\n\n$=1^{\\text {st }}$ part of large intestine\nLocation: most commonly in right iliac fossa below ileocecal valve, resting on iliac + greater psoas muscles\nSize: $\\quad 6.25 \\mathrm{~cm}$ long; 7.5 cm wide\nAttachment: to iliac fossa laterally + medially by peritoneal cecal folds\nLayers: thickened bands of longitudinal muscle (= teniae coli) contiguous with distal colon + converging at base of vermiform appendix to form a complete outer longitudinal layer of muscle\n$\\sqrt{ }$ considerable mobility $\\leftarrow$ usually almost entirely enveloped by peritoneum\n\n## Appendix\n\nAverage length: $8-10 \\mathrm{~cm}$\nWall thickness of normal appendix: $<2 \\mathrm{~mm}$\nDiameter of normal appendix: $<6 \\mathrm{~mm}$\nLocation: 2.5 cm inferior to ileocecal valve with its own short triangular mesentery (= mesoappendix)\nFunction: well-developed lymphoid organ (in childhood) of immunologic importance\n$\\sqrt{ }$ collapsed or partially filled with fluid / contrast material / air\nMR (visualized in up to $65-90 \\%$, even in pregnant women):\n$\\diamond$ Oral preparation with 300 mL of GastroMARK ${ }^{\\circledR}+300 \\mathrm{~mL}$ of READICAT ${ }^{\\circledR} 21-1.5$ hours before MRI study\n$\\sqrt{ }$ hyperintense center + hypointense wall on T2WI\n$\\sqrt{ }$ predominantly low signal intensity on T1WI\n\n## RECTUM\n\n$=$ last segment of GI tract\nOrigin: derived from fetal hindgut\nBoundaries: sigmoid colon and anus\nPeritoneal investment: proximal portion only\nBlood supply: superior + middle hemorrhoidal arteries\nVenous drainage:\n> proximal rectum: drained by inferior mesenteric vein",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 653,
            "markdown": ") distal rectum + anorectal junction: drained by internal iliac / inferior mesenteric vein (IMV)\n$\\diamond 2$ hematogenous metastatic patterns of rectal cancer:\n(1) liver metastasis $\\leftarrow$ via IMV + portal venous system / via endolymphatic spread along course of IMV\n(2) lung metastasis $\\leftarrow$ via internal iliac veins + IVC\n\nRectosigmoid junction:\nsuperior aspect of rectum = line formed by confluence of taeniae coli muscles on serosal surface of sigmoid (surgical definition); less precise; sacral promontory / peritoneal reflection\nendoscopically: extension to 12 cm above anal verge\nAnorectal junction: inferior aspect of rectum corresponding to dentate line (anatomic definition)\n\n# ANAL CANAL \n\n$=2.5-4.0 \\mathrm{~cm}$ long terminal part of GI tract extending from anorectal junction to anus\nDentate / pectinate line:\n$=5-10 \\mathrm{~mm}$ wide line dividing upper $2 / 3$ and lower $1 / 3$ of anal canal marking transitional zone between columnar epithelium of GI tract and squamous epithelium of anoderm\nDivision:\n> upper $2 / 3$ of canal\n\n1. Zona columnaris = upper half of canal lined by simple columnar epithelium\n\n- longitudinal folds joined together into anal valves\n> lower $1 / 3$ of canal\n\n2. Zona hemorrhagica $=$ lined by stratified non-keratinized squamous epithelium\n3. Zona cutanea $=$ lined by stratified keratinized squamous epithelium\n\nBorder between zona hemorrhagica and cutanea:\nHilton's white line / pecten of Jon Stroud\n\n## Anal Verge\n\n$=$ distal end of anal canal forming transitional zone between epithelium of moist hairless modified skin of anal canal + dry perianal skin\n\n## INTESTINAL FUNCTION\n\n## Intestinal Gas\n\nA. INFLUX\n\n1. Aerophagia 2 L\n2. Liberation from intestinal tract\n(a) neutralization of bicarbonate in secretions $\\left(\\mathrm{CO}_{2}\\right) 8 \\mathrm{~L}$\n(b) bacterial fermentation $\\left(\\mathrm{CO}_{2}, \\mathrm{H}_{2}, \\mathrm{CH}_{4}, \\mathrm{H}_{2} \\mathrm{~S}\\right) 15 \\mathrm{~L}$\n3. Diffusion from blood $\\left(\\mathrm{N}_{2}, \\mathrm{O}_{2}, \\mathrm{CO}_{2}\\right)$\nB. EFFLUX",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 654,
            "markdown": "![img-75.jpeg](img-75.jpeg)\n\n1. Diffusion from intestines into blood and expulsion from lung 50 L\n2. Expulsion from anus 2 L\n\n# Intestinal Fluid \n\nA. INFLUX\n\n1. Oral ingestion 2.5 L\n2. Intestinal secretions 8.2 L\nsaliva 1.5 L\nbile 0.5 L\ngastric secretions 2.5 L\npancreatic secretions 0.7 L\nintestinal secretions 3.0 L\nB. EFFLUX\n3. Peranal 0.1 L\n4. Intestinal resorption (primarily in ileum + ascending colon) 10.6 L\n\n## Intestinal Transit Time\n\ngreatly affected by type of diet\nMeasurement techniques:",
            "images": [
                {
                    "id": "img-75.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 189,
                    "bottom_right_x": 1319,
                    "bottom_right_y": 1183,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 655,
            "markdown": "(1) Breath tests: hydrogen; urea-labeled ${ }^{13} \\mathrm{C}$\n(2) Scintigraphy\n(3) Radiopaque markers\n(4) Ingestible wireless motility capsule (measuring pH , pressure, temperature)\n$\\diamond$ It takes $\\sim 2$ hours for a contrast bolus to reach ileocecal valve following esophagram and radiographs of the stomach!\nNormal Transit Times:\nStomach:\n$2-5$ hours\nSmall bowel:\n$2.5-6.0$ hours\nColon:\n$5-60$ hours\nWhole gut:\n$10-73$ hours\nWhile it may not be possible to diagnose a specific disease that produces a change in bowel motility, alterations in motility may be used in support of a diagnosis and disease severity.\n\n# PELVIC FLOOR \n\n$=$ musculofascial diaphragm inserted on pelvic bones\nFunction:\n> static support to visceral organs: opposing gravity + increased abdominal pressure\n> active closure of urogenital hiatus: permitting emptying and continence mechanisms\nPelvic sling: extends obliquely from coccyx toward posterior levator plate just behind anorectal junction\nPelvic floor: (3 layers from cranial to caudal)\n(a) endopelvic fascia:\n$=$ network of connective tissue that lies deep to peritoneum and supports pelvic organs\n> peritoneal reflection fused to underlying connective tissue\n> pubocervical fascia (between bladder + vagina)\n> sacrouterine-cardinal ligament complex\n» fascia anteriorly around vagina + uterus\nFunction: supports vaginal cuff by pulling cervix and upper vagina superiorly + posteriorly toward sacrum\n» fusion posteriorly with prerectal fascia\nFunction: prevents pelvic floor descent\n> arcus tendineus fasciae pelvis (ATFP) and arcus tendineus levatoris ani (ATLA)\n$=$ connective tissue condensations of obturator + levator ani fascia that runs obliquely on pelvic sidewall from pubic symphysis (cranially) to ischial spine (caudally)\nFunction: provide lateral support by anchoring organs to pelvic side wall MR:\n$\\sqrt{ }$ too thin to be recognized except for its condensations: cardinal lig., uterosacral ligament, urethral ligament\n$\\sqrt{ }$ integrity inferred by efficiency of provided support\n(b) muscular pelvic diaphragm\nconsisting mainly of levator ani complex made of\n(1) puboperineal\n(2) pubovaginal",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 656,
            "markdown": "(3) puboanal component\n$\\sqrt{ }$ nonvisualized U -shaped sling inserting on inner pubis + passing around anorectal junction (AXIAL plane)\n$\\sqrt{ }$ encloses urogenital hiatus (= space for urethra + vagina + anal canal)\n(4) puborectalis muscle\n$\\sqrt{ }$ encircles urogenital hiatus\n$\\sqrt{ }$ responsible for angle between rectum + anal canal\n(5) iliococcygeus muscle\n$\\sqrt{ }$ thin sagittally oriented fan-shaped structure\n$\\sqrt{ }$ curved shape with inferior concavity (COR plane)\n$\\sqrt{ }$ inserts laterally to pelvic sidewalls on ATLA\n$\\sqrt{ }$ inserts medially to pelvic organs\n$\\sqrt{ }$ forms posteriorly raphe with attachment to external anal sphincter $\\rightarrow$ anococcygeal ligament\nFunction: at rest tonically contracted\n$\\Rightarrow$ acting as an anterior sling drawing urethra anteriorly and superiorly relative to bladder base $\\rightarrow$ acute angle between bladder neck and urethra\n$\\Rightarrow$ anus is drawn anterosuperiorly $\\rightarrow$ acute angle between anus and rectum crucial for gross fecal continence\n(c) urogenital diaphragm\n$=$ diamond-shaped structure consisting of two triangles with transverse perineus muscle as common base\n» anterior triangle: apex at symphysis pubis; sides at pubic bones penetrated by: urethra + vagina\n» posterior triangle: apex at tip of coccyx penetrated by: anus\n> connective tissue $=$ perineal membrane (mainly)\n$\\sqrt{ }$ visible on MRI as hypointense connective tissue condensation (= perineal body) at insertion of perineus muscle and external anal sphincter interposed between vaginal vestibule and anal canal\n> deep transverse perineus muscle\noriented transversely just deep to pelvic diaphragm and anterior to anorectal junction anchors: external anal sphincter, muscles of urogenital diaphragm, puborectalis muscle, sacrouterine- cardinal ligament complex, prerectal fascia\n\n# PERITONEUM \n\nDefinitions:\nLigament $=$ formed by two folds of peritoneum supporting a structure within the peritoneal cavity\nOmentum $=$ specialized structure connecting stomach to an additional structure: liver, duodenum, colon\nMesentery $=$ two peritoneal folds connecting a portion of bowel to the retroperitoneum\n\n## Peritoneal Fluid",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 657,
            "markdown": "Changes in intraperitoneal hydrostatic pressure and anatomic arrangement of the peritoneal recesses result in transcoelomic migration of fluid toward the undersurface of the diaphragm.\nClearance: by subphrenic submesothelial lymphatics augmented by continual circulation of fluid upward to subdiaphragmatic spaces\nCause of motion: fluctuations in intraabdominal pressure during respiration + intestinal peristalsis\nReproducible circulatory pathway:\n> Initially toward gravity-dependent spaces:\n(1) deep pelvic recesses (= pouch of Douglas in women / retrovesical space in men)\n(2) lateral paravesical spaces\n> Later cephalad ascension to right subdiaphragmatic space:\n(3) right paracolic gutter $\\rightarrow$ right subdiaphragmatic space\n(4) shallow left paracolic gutter\n(a) NO connection to left subdiaphragmatic space $\\leftarrow$ interruption by phrenicocolic ligament\n(b) NO connection between left and right subdiaphragmatic spaces $\\leftarrow$ falciform ligament\n> Caudal redirection into pelvis:\n(5) by inframesocolic compartment\n> Serving as watersheds: all mesenteries = transverse mesocolon, small bowel mesentery, sigmoid mesocolon, peritoneal attachments of ascending + descending colon\n\n# Small Bowel Mesentery \n\nComposition: fatty extraperitoneal connective tissue, SMA \\& SMV and their branches, nerves, lymphatics\nInvestment: reflection of posterior parietal peritoneum\nFunction: suspension for 20-25 feet of jejunal + ileal loops\nRoot: $\\quad 15 \\mathrm{~cm}$ long fan-shaped bare area extending obliquely from point of terminal duodenum to cecum in right iliac fossa\nAttachment: from duodenojejunal flexure over head of pancreas $+3^{\\text {rd }}$ part of duodenum obliquely across aorta, IVC, right ureter, right psoas major muscle\nVascular landmarks: superior mesenteric vessels + branches\nRelationship: continuous with anterior pararenal space and root of transverse mesocolon at uncinate process\n\n## Peritoneal Spaces\n\nA. RIGHT SUPRAMESOCOLIC SPACE\nforms perihepatic space + lesser sac\n\n1. Right subphrenic / subdiaphragmatic space\n\nLocation: between right hepatic lobe + diaphragm\n> limited posteriorly by right superior reflection of coronary ligament + right triangular ligament\n2. Right subhepatic / hepatorenal space: divided into\n(a) anterior right subhepatic space:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 658,
            "markdown": "Location: posterior to porta hepatis\n$\\sqrt{ }$ communicates with lesser sac via epiploic foramen (= foramen of Winsløw) [Jacob Benignus Winsløw (1669-1760)], danish-born professor of anatomy at the Jardin du Roi, Paris, France]\n(b) posterior right subhepatic space\n$=$ Morison pouch $=$ hepatorenal fossa\n[James Rutherford Morison (1853-1939), British surgeon and professor at the University of Durham]\n$\\diamond$ Most dependent portion of the abdomen in supine patient!\nThe right subhepatic space is an important site of fluid collections resulting from liver injuries because it is the most gravity-dependent space at this site.\n3. Bare area of liver\n\nLocation: between reflections of right + left coronary ligaments\n$\\sqrt{ }$ continuous with right anterior pararenal space\n4. Lesser sac / omental bursa\n![img-76.jpeg](img-76.jpeg)\n(a) superior recess:",
            "images": [
                {
                    "id": "img-76.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 842,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1903,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 659,
            "markdown": "$\\checkmark$ surrounds medial aspect of caudate lobe\n$\\checkmark$ separated from splenic recess by gastropancreatic fold\n(b) splenic recess:\n$\\checkmark$ extends across midline to splenic hilum\n(c) inferior recess:\n$\\checkmark$ separates stomach from pancreas + transverse mesocolon\n$\\checkmark$ anteriorly covered by lesser omentum\nCompartments: separated by gastropancreatic fold $\\leftarrow$ elevation of posterior parietal peritoneum by left gastric artery into\n> smaller medial compartment\n, larger lateral compartment\nB. LEFT SUPRAMESOCOLIC SPACE forms\n\n1. Left subphrenic space artificially divided into\n(a) immediate subphrenic space: between diaphragm + gastric fundus\n(b) perisplenic space: bounded inferiorly by phrenicocolic ligament\n(c) subhepatic space $=$ gastrohepatic recess: located between lateral segment of left\nhepatic lobe + stomach; separated from right subphrenic space by falciform ligament\nC. PARACOLIC SPACES\n2. Right + left paracolic gutter\n\nLocation: lateral to ascending + descending colon\nD. INFRAMESOCOLIC SPACES\n\n1. Right inframesocolic space\n\nLocation: medial to ascending colon\n$\\checkmark$ limited inferiorly by attachment of small bowel mesentery to cecum\n2. Left inframesocolic space\n\nLocation: medial to descending colon\n$\\checkmark$ communicates freely with pelvis\n3. Superior + inferior ileocecal recesses\n\nLocation: above + below terminal ileum\n4. Intersigmoid recess\n\nLocation: along undersurface of sigmoid mesocolon\n5. Retrocecal space\n\n- present only if peritoneum reflects posterior to cecum\n\n\n# Suspensory Ligaments of Liver \n\n1. Triangular Ligaments outline bare area of liver\n(a) Right triangular ligament\n\nOrigin: fusion of inferior + superior reflections of right coronary ligament\n$\\checkmark$ long ligament dividing posterior aspect of right perihepatic space into right subphrenic space + posterior right subhepatic space\n(b) Left triangular ligament\n\nOrigin: fusion of inferior + superior reflections of left coronary ligament\nLocation: along superior aspect of left hepatic lobe\n$\\checkmark$ short noncompartmentalizing ligament",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 660,
            "markdown": "# 2. Falciform ligament \n\n$=$ sickle-shaped fold composed of two layers of peritoneum\n$\\sqrt{ }$ incomplete barrier to fluid transfer from right subphrenic to left perihepatic space\n$\\sqrt{ }$ continuous with fissure for ligamentum venosum\nOrigin: remnant of the most anterior part of the ventral mesentery\nRelationship: ventral surface of liver to anterior abdominal wall; its right layer continues into the superior layer of the coronary ligament, its left layer continues into the anterior layer of the left triangular ligament\nContent: ligamentum teres (= obliterated umbilical vein) in its free inferoposterior margin, recanalized paraumbilical veins\n\n## Peritoneal Ligaments of Stomach\n\n1. Lesser omentum\n\nOrigin: remnants of dorsal portion of ventral mesentery\nFormed by: gastrohepatic + hepatoduodenal ligaments\n(a) Gastrohepatic ligament\n$=$ wedge-shaped ligament arising in fissure of ligamentum venosum\nRelationship: lesser curvature of stomach to fissure of ligamentum venosum (anterior to caudate lobe at medial aspect of liver); subperitoneal areolar tissue of gastrohepatic ligament continues into liver as Glisson capsule\nContent: adipose tissue, left gastric artery, coronary vein, lymph nodes\nVascular landmark: anastomotic arcade formed by right + left gastric artery \\& vein along lesser curvature of stomach\n(b) Hepatoduodenal ligament\n$=$ double-layered tubular peritoneum $=$ free edge of lesser omentum\nInsertion: between $1^{\\text {st }}$ and $2^{\\text {nd }}$ portions of duodenum\nContents: portal triad (main portal vein, proper hepatic artery, common hepatic duct): gallbladder neck; part of cystic duct; ventral anlage of pancreas (until $8^{\\text {th }}$ embryonic week)\nVascular landmarks: proper hepatic artery, portal vein, right gastric vein draining into portal vein\n$\\rightarrow$ forms inferior edge of gastrohepatic ligament\n$\\rightarrow$ forms anterior margin of epiploic foramen\n> extends from proximal duodenum to porta hepatis\n2. Gastrophrenic ligament\n\nOrigin: anterosuperior portion of dorsal mesentery\nContent: short gastric vessels, varices after splenic vein thrombosis, route of subperitoneal spread of pancreatic exudate\n$\\rightarrow$ courses through immediate subphrenic space\n$\\rightarrow$ suspends stomach from dome of diaphragm\n3. Greater omentum\n\nOrigin: anteroinferior portion of dorsal mesentery becomes redundant $\\leftarrow$ growth + rotation of stomach in utero; formed by double reflection of dorsal mesogastrium thus composed of 4 layers of peritoneum\nAttachment: greater curvature of stomach",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 661,
            "markdown": "Content: epiploic artery \\& vein $\\leftarrow$ gastroepiploic arcade\nFunction: containment of intraperitoneal infections\n$\\checkmark$ inferior continuation of gastrocolic ligament with apronlike extension in anterior abdominal cavity\n4. Gastropancreatic ligament\n\nOrigin: formed by proximal left gastric artery\nRelationship: posterior aspect of gastric fundus to retroperitoneum\n$\\rightarrow$ partially separates superior recess of lesser sac from splenic recess\n5. Gastrocolic ligament / supracolic omentum\n$=$ portion of peritoneum between greater gastric curvature and transverse colon\n$\\rightarrow$ forms portion of anterior border of lesser sac\n$\\rightarrow$ forms superior aspect of greater omentum\nRelationship: greater curvature of stomach to superior aspect of transverse colon\nContiguity: gastrosplenic ligament (on left); transverse mesocolon (posteriorly and on right)\nContent: R and L gastroepiploic arteries form anastomotic arcade along greater curvature of stomach = anatomic landmark for gastrocolic ligament\n\n# Peritoneal Ligaments of Spleen \n\n1. Phrenicocolic ligament\n$=$ major suspensory ligament of spleen\nRelationship: proximal descending colon to left hemidiaphragm\n$\\rightarrow$ separates left subphrenic space from left paracolic gutter\n2. Splenorenal ligament\n$=$ major suspensory ligament of spleen\nOrigin: most posterior + lateral aspect of dorsal mesentery where it didn't fuse with posterior parietal layer of peritoneum\nRelationship: retroperitoneum (anterior to left kidney) to splenic hilum = anterior pararenal space to posterior aspect of spleen\nContiguity: with gastrocolic ligament\nVascular landmarks: distal splenic artery, proximal splenic vein, splenorenal collateral vessels in portal hypertension\nContent: pancreatic tail, splenic vessels\n$\\rightarrow$ forms left posterolateral boundary of lesser sac\n3. Gastrosplenic ligament\n\nOrigin: remnant of dorsal mesentery\nRelationship: posterolateral wall of gastric fundus and greater curvature to splenic hilum\nContiguity: with splenorenal ligament medially and posteriorly\nVascular landmarks: left gastroepiploic vessels; proximal segment of L gastroepiploic vessels\nContent: short gastric vessels\n$\\rightarrow$ forms lateral boundary of lesser sac\n\n## Ligaments of Abdomen\n\nThe transverse mesocolon divides the peritoneum into the supramesocolic and inframesocolic spaces.",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 662,
            "markdown": "# > above transverse mesocolon: \n\nA. VENTRAL MESENTERY gives rise to:\n\n1. Falciform ligament\n2. Right triangular ligament\n3. Left triangular ligament\n4. Gastrohepatic ligament\n5. Hepatoduodenal ligament\nB. DORSAL MESENTERY gives rise to:\n6. Gastrophrenic ligament\n7. Gastropancreatic ligament\n8. Phrenicocolic ligament\n9. Gastrosplenic ligament\n10. Splenorenal ligament\n11. Gastrocolic ligament\n\n## > below transverse mesocolon:\n\nA. VENTRAL MESENTERY regresses\nB. DORSAL MESENTERY\n\nOrigin: during progression of foregut rotation, dorsal mesoduodenum + dorsal mesogastrium fuse with parietal layer of peritoneum pushing head and body of pancreas into retroperitoneum\nContiguity: laterally with splenorenal + phrenicocolic ligaments; anteriorly with root of small bowel mesentery (over uncinate process), greater omentum + gastrocolic ligament\nSignificance: bare areas establish contiguity between pancreas and transverse colon up to splenic flexure, spleen, and small bowel allowing for subperitoneal spread\n$\\sqrt{ }$ pericolitis with relative sparing of mucosa and submucosa ( $15 \\%$ ) $\\leftarrow$ acute\npancreatitis with direct spread of pancreatic enzymes\nCx: colonic perforation\nMortality: increased to $40 \\%$\n\n1. Transverse mesocolon\n$=$ peritoneal fold that suspends transverse colon from retroperitoneum along infraampullary duodenum + anteroinferior edge of pancreas\nRelationship: transverse colon to pancreas\nVascular landmarks:\nmiddle colic artery \\& vein, gastrocolic trunk, left middle colic v. to splenic v. / inferior mesenteric $v$.\n$\\sqrt{ }$ forms posteroinferior border of lesser sac\nContent: internal hernia after Roux-en-Y gastric bypass, spread of pancreatic cancer rendering it inoperable",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 663,
            "markdown": "![img-77.jpeg](img-77.jpeg)\n\n# 2. Small bowel mesentery \n\n$\\sqrt{ }$ suspends small bowel from retroperitoneum\nLocation: ligament of Treitz to ileocecal valve\nContent: superior mesenteric vessels + lymph nodes\n3. Sigmoid mesocolon\n$=$ peritoneal ligament that attaches sigmoid colon to posterior pelvic wall\nContent: sigmoid + hemorrhoidal vessels\n4. Greater omentum (see above)\n\nTumors and fluid collections may spread across the peritoneal ligaments ( $=$ subperitoneal spread) to involve several contiguous organs.\n\n## INGUINAL CANAL\n\n$=$ narrow diagonal tunnel lined by aponeuroses of the 3 abdominal wall muscles\nCourse: from deep inguinal ring (superiorly posterolateral) to superficial inguinal ring (inferiorly anteromedial)\nContent: (a) male: spermatic cord covered by fascia from all 3 abdominal wall muscle aponeuroses comprising:\n> ductus / vas deferens\n> testicular artery\n> pampiniform plexus\n> genital branch of the genitofemoral nerve\n(b) female:\n> round ligament of uterus\n> ilioinguinal nerve to labia majora\nAnterior wall: aponeuroses of the external + internal oblique mm .",
            "images": [
                {
                    "id": "img-77.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 893,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 664,
            "markdown": "Superior wall: aponeuroses of internal oblique and transversus abdominis muscles\nPosterior wall: transversalis fascia and conjoint tendon of internal oblique + transversalis fascia medially at the pectineal line\nInferior wall: inguinal ligament of Poupart (= folded-up lower border of the external oblique aponeurosis\n[François Poupart (1616-1708), French physician, anatomist, entomologist in Paris, France]\n\n# Deep / Internal Inguinal Ring \n\n$=$ gap in the transversalis fascia just superior to the inguinal ligament + lateral and posterior to inferior epigastric vessels\n\n## Superficial / External Inguinal Ring\n\n$=$ opening in the external oblique aponeurosis just superior + lateral to the pubic tubercle\n\n## Inguinal Ligament\n\n$=$ extends from anterior superior iliac spine to the pubic tubercle\n\n## ANATOMY OF LYMPH NODES\n\n## Paraaortic Nodes\n\n## Lateroaortic Nodes\n\n1. Lateroaortic (on left of aorta)\n2. Aortocaval (between aorta + IVC)\n3. Laterocaval (on right of IVC)\n4. Precaval (in front of IVC)\n5. Retrocaval (behind IVC)\n\n## Preaortic Nodes\n\n## Retroaortic Nodes\n\n## Iliac Nodes\n\n## Common Iliac Nodes\n\n1. Lateral common iliac nodes\n$=$ extension of lateral chain of external iliac nodes\nLocation: lateral to common iliac artery\n2. Median common iliac nodes\n\nLocation: triangular area between both common iliac arteries from bifurcation of aorta to bifurcation of common iliac arteries\n3. Medial common iliac nodes\n\nLocation: lumbosacral fossa (bordered posteromedially by vertebrae, anterolaterally by psoas muscle, anteromedially by common iliac vessels)\n\nInternal Iliac = Hypogastric Nodes",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 665,
            "markdown": "accompany each visceral branch of internal iliac artery\n\n1. Junctional nodes\n\nLocation: at junction between internal + external iliac nodes\n2. Sacral + promontory nodes\n\nLocation: central location of presacral space\n\n# External Iliac Nodes \n\n1. Lateral chain\n\nLocation: lateral relative to external iliac artery)\n2. Middle chain\n\nLocation: between external iliac artery + vein)\n3. Medial chain = obturator nodes\n\nLocation: medial + posterior to external iliac vein)\n\n## Inguinal nodes\n\ndemarcated from external iliac nodes by inguinal ligament\n\n1. Superficial inguinal nodes\n\nLocation: subcutis anterior to inguinal ligament along femoral vein + saphenous vein\nSaphenofemoral junction node $=$ sentinel node\n2. Deep inguinal nodes\n\nLocation: along common femoral artery + vein",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 666,
            "markdown": "![img-78.jpeg](img-78.jpeg)",
            "images": [
                {
                    "id": "img-78.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1322,
                    "bottom_right_y": 1830,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 667,
            "markdown": "![img-79.jpeg](img-79.jpeg)",
            "images": [
                {
                    "id": "img-79.jpeg",
                    "top_left_x": 0,
                    "top_left_y": 0,
                    "bottom_right_x": 1698,
                    "bottom_right_y": 2197,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 668,
            "markdown": "# GASTROINTESTINAL AND ABDOMINAL DISORDERS \n\n## ABDOMINAL COMPARTMENT SYNDROME\n\nCause: pathologic elevation of intraabdominal pressure\n\n- diminished respiratory function, diminished cardiac output\n\nCT:\n$\\sqrt{ }$ dense infiltration of the retroperitoneum out of proportion to peritoneal disease\n$\\sqrt{ }$ accumulation of retroperitoneal fluid\n$\\sqrt{ }$ extrinsic compression of IVC by retroperitoneal hemorrhage / exudate\n$\\sqrt{ }$ massive abdominal distension\n$\\sqrt{ }$ renal compression\n$\\sqrt{ }$ inguinal herniation\n$\\sqrt{ }$ enhancing bowel thickening\n$R x$ : emergent surgical decompression\n\n## ACHALASIA\n\n$=$ absence of primary esophageal peristalsis (= unorganized peristalsis) + failure of lower esophageal sphincter to relax\nEtiology: (a) idiopathic: abnormality of Auerbach plexus / medullary dorsal nucleus; ? neurotropic virus, ? gastrin hypersensitivity\n(b) Chagas disease\n\n- often increase in lower esophageal sphincter pressure\n$\\sqrt{ }$ megaesophagus $=$ dilatation of esophagus beginning in upper $1 / 3$, ultimately entire length\n$\\sqrt{ }$ absence of primary peristalsis below level of cricopharyngeus\n$\\sqrt{ }$ nonperistaltic contractions\n$\\sqrt{ }$ \"bird-beak\" / \"rat tail\" deformity = V-shaped conical and symmetric tapering of stenotic segment with most marked narrowing at GE junction\n$\\sqrt{ }$ Hurst phenomenon = temporary transit through cardia when hydrostatic pressure of barium column is above tonic LES pressure\n$\\sqrt{ }$ sudden esophageal emptying after ingestion of carbonated beverage (eg, Coke)\n$\\sqrt{ }$ \"vigorous achalasia\" = numerous tertiary contractions in nondilated distal esophagus of early achalasia\n$\\sqrt{ }$ prompt relaxation of LES upon amyl nitrite inhalation (smooth-muscle relaxant)\nCXR:\n$\\sqrt{ }$ right convex opacity behind right heart border; occasionally left convex opacity if thoracic aorta tortuous\n$\\sqrt{ }$ right convex opacity may be tethered by azygos arch allowing for greater dilatation above + below\n$\\sqrt{ }$ air-fluid level $\\leftarrow$ stasis in thoracic esophagus filled with retained secretions + alimentary residue\n$\\sqrt{ }$ small / absent gastric air bubble",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 669,
            "markdown": "$\\sqrt{ }$ anterior displacement + bowing of trachea (LAT view)\n$\\sqrt{ }$ patchy bilateral alveolar opacities $\\leftarrow$ acute / chronic aspiration pneumonia (M. fortuitumchelonei infection)\n$C x:$ esophageal carcinoma in $2-7 \\%$ (usually midesophagus)\n$R x$ : pneumatic dilatation / surgical myotomy\n$D D x$ : (1) Neoplasm (separation of gastric fundus from diaphragm, normal peristalsis, asymmetric tapering)\n(2) Peptic stricture of esophagus\n\n# Secondary Achalasia \n\n$=$ carcinoma of cardia / gastric fundus invading esophagus\nAge: $\\quad>50$ years\n\n- duration of symptoms for $<6$ months\n$\\sqrt{ }$ irregular / asymmetric narrowing\n$\\sqrt{ }$ abrupt transition\n$\\sqrt{ }$ associated fundal lesion\n\n\n## Pseudoachalasia\n\n- more abrupt onset of symptoms, weight loss\n\nCause: primary or metastatic tumor\nLocation: distal esophagus + GE junction\n$\\sqrt{ }$ dilated esophagus\n$\\sqrt{ }$ irregular luminal narrowing with lobulated margins\n$D D x$ : achalasia (tapered beaklike narrowing of distal esophagus + GE junction)\n\n## ADENOMA OF SMALL BOWEL\n\nLocation: duodenum (21\\%), jejunum (36\\%), ileum (43\\%) esp. ileocecal valve\nHisto:\n(1) Hamartomatous polyp ( $77 \\%$ ): multiple in $47 \\%, 1 / 5$ of multiple lesions associated with Peutz-Jeghers syndrome\n(2) Adenomatous polyp (13\\%): may have malignant potential\n(3) Polypoid gastric heterotopic tumor ( $10 \\%$ )\n\n## ADENOMATOUS COLONIC POLYP\n\n$=$ EPITHELIAL POLYP\nMost common benign colonic tumor (68-79\\%)\nPredisposed: previously detected polyp / cancer; family history of polyps / cancer; idiopathic inflammatory bowel disease; Peutz-Jeghers syndrome; Gardner syndrome; familial polyposis\nPrevalence: $3 \\%(10 \\%)[26 \\%]$ in $3^{\\text {rd }}(7^{\\text {th }}))\\left[9^{\\text {th }}\\right]$ ] decade\nLocation: sigmoid ( $26-38 \\%$ ); rectum ( $21-34 \\%$ ); descending colon ( $6-18 \\%$ ); transverse colon ( $12-13 \\%$ ); ascending colon ( $9-12 \\%$ ); multiple in $35-50 \\%$ (usually $<5-10$ in number)\nHisto:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 670,
            "markdown": "1. Tubular adenoma $(75 \\%)$\n$=$ cylindrical glandular formation lined by stratified columnar epithelium + containing nests of epithelium within lamina propria\n$\\sqrt{ }$ usually $<10 \\mathrm{~mm}$ in diameter\n$\\sqrt{ }$ often pedunculated if $>10 \\mathrm{~mm}$\nMalignant potential: $<10 \\mathrm{~mm}$ in $1 \\% ; 10-20 \\mathrm{~mm}$ in $10 \\% ;>20 \\mathrm{~mm}$ in $35 \\%$\n2. Tubulovillous adenoma $(15 \\%)$\n$=$ mixture between tubular + villous adenoma\nMalignant potential: $<10 \\mathrm{~mm}$ in $4 \\% ; 10-20 \\mathrm{~mm}$ in $7 \\% ;>20 \\mathrm{~mm}$ in $46 \\%$\n3. Villous adenoma $(10 \\%)$\n$=$ thin frondlike surface projections (\"villous fronds\")\n\n- potassium depletion\n$\\sqrt{ }$ often $>20 \\mathrm{~mm}$ in diameter with papillary surface\n$\\sqrt{ }$ often broad-based sessile lesion\nMalignant potential: $<10 \\mathrm{~mm}$ in $10 \\% ; 10-20 \\mathrm{~mm}$ in $10 \\% ;>20 \\mathrm{~mm}$ in $53 \\%$\nAdenoma size versus incidence of malignancy:\n$<5 \\mathrm{~mm}$ in $0.5 \\% ; 5-9 \\mathrm{~mm}$ in $1 \\% ; 10-20 \\mathrm{~mm}$ in $5-10 \\%$;\n$>20 \\mathrm{~mm}$ in $10-50 \\%$ malignant\n$\\diamond$ Invasive carcinoma ( $=$ penetration of muscularis mucosa):\n(a) rare in a pedunculated adenoma of $<15 \\mathrm{~mm}$\n(b) in $30 \\%$ of villous adenomas of $>50 \\mathrm{~mm}$\n$\\diamond$ All polyps $>10 \\mathrm{~mm}$ should be removed!\n$\\diamond$ Time for adenoma-carcinoma sequence probably averages $10-15$ years!\nProbability of coexistent colonic growth:\n> synchronous adenoma in $50 \\%$\n> metachronous adenoma in $30-40 \\%$\n> synchronous adenocarcinoma in $1.5-5 \\%$\n> metachronous adenocarcinoma in $5-10 \\%$\n- asymptomatic ( $75 \\%$ ), diarrhea, abdominal pain\n- peranal hemorrhage ( $67 \\%$ )\n\nColonoscopy: incomplete in $16-43 \\%$\nBE:\nSensitivity of DCBE in detecting polyps:\n$<10 \\mathrm{~mm} 80-83 \\% ;>10 \\mathrm{~mm} 96-97 \\%$; all $84-88 \\%$; rate of detection of polyps $<10 \\mathrm{~mm}$ higher with DCBE than SCBE\n$\\sqrt{ }$ sessile flat / round polyp\n$\\sqrt{ }$ pedunculated polyp: stalk $>2 \\mathrm{~cm}$ in length almost always indicative of a benign polyp\n$\\sqrt{ }$ suggestive of malignancy: irregular lobulated surface, broad base ( $=$ width of the base greater than height), retraction of colonic wall ( $=$ dimpling / indentation / puckering at base of tumor), interval growth\n$\\sqrt{ }$ lacelike / reticular surface pattern CHARACTERISTIC for villous adenoma (occasionally in tubular adenoma)\n$D D x$ : (1) Nonneoplastic: hyperplastic polyp, inflammatory pseudopolyp, lymphoid tissue, ameboma, tuberculoma, foreign-body granuloma, malakoplakia, heterotopia,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 671,
            "markdown": "hamartoma\n(2) Neoplastic subepithelial: lipoma, leiomyoma, neurofibroma, hemangioma, lymphangioma, endothelioma, myeloblastoma, sarcoma, lymphoma, enteric cyst, duplication, varix, pneumatosis, hematoma, endometriosis\n\n# ADENOCARCINOMA OF SMALL BOWEL \n\nFrequency: $35-40 \\%$ of primary malignant neoplasms of small bowel; $\\sim 50 \\mathrm{x}$ less common than colonic carcinoma\n$\\diamond$ Most common primary tumor of small bowel\nRisk factors: familial adenomatous polyposis (FAP), Crohn disease, sprue, Peutz-Jeghers syndrome, hereditary nonpolyposis colon cancer syndrome (Lynch syndrome), congenital bowel duplication, ileostomy, duodenal / jejunal bypass surgery\nHisto: mostly moderately to well differentiated; may arise in villous tumors / de novo; no correlation between size and invasiveness\n\n- vague mild abdominal pain, anemia, weight loss\n- nausea, vomiting, anorexia\n\nLocation: duodenum ( $54 \\%$, especially near ampulla) $>$ jejunum ( $28 \\%$ ) $>$ ileum ( $18 \\%$ )\n> in familial adenomatous polyposis: duodenum\n> in celiac disease: jejunum\n$>$ in Crohn disease: ileum\n$\\sqrt{ }$ variety of shapes:\n$\\checkmark$ annular stricture with \"overhanging edges\" (60\\%)\n$\\checkmark$ lobulated / ovoid polypoid sessile mass ( $41 \\%$ )\n$\\diamond$ Duodenal tumors tend to be papillary / polypoid!\n$\\checkmark$ ulcerated plaque / mass (27\\%)\nCT:\n$\\checkmark$ soft-tissue mass with heterogeneous attenuation\n$\\checkmark$ moderate contrast enhancement\n$C x$ : progressive small bowel obstruction; intussusception; perforation (rare)\nPrognosis: poor (often disseminated at time of presentation); 30\\% 5-year survival rate\n$D D x$ : lymphoma (lymphadenopathy more bulky)\n\n## Duodenal Adenocarcinoma\n\n$=$ rare tumor that typically abuts but spares / only partially involves the major duodenal papilla\nPrevalence: $1.7 \\div 1,000,000 ; \\mathrm{M}<\\mathrm{F}$\nLocation: most often in $2^{\\text {nd }}+3^{\\text {rd }}$ portion $=$ periampullary neoplasm\n(a) suprapapillary: apt to cause obstruction +GI bleeding\n(b) peripapillary: extrahepatic jaundice\n(c) intrapapillary: GI bleeding\n\nPredisposed: familial adenomatous polyposis syndrome, Crohn disease, celiac disease, neurofibromatosis\nMay be associated with: Peutz-Jeghers syndrome\n$\\checkmark$ eccentric duodenal wall thickening $\\pm$ ulceration:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 672,
            "markdown": "$\\sqrt{ }$ annular lesion with relatively short segment involvement\n$\\sqrt{ }$ fungating polypoid / intraluminal mass\n$\\sqrt{ }$ gradual luminal narrowing (most common)\n$\\sqrt{ }$ luminal obstruction + gastric distention $\\leftarrow$ larger tumor\n$\\sqrt{ } \\pm$ biliary dilatation\nCT / MR:\n$\\sqrt{ }$ hypovascular during all phases\nMetastases: to regional lymph nodes ( $\\left.{ }^{2} / \\cdot\\right)$\n$D D x$ : other periampullary lesions\n\n# AFFERENT LOOP SYNDROME \n\n$=$ PROXIMAL LOOP / BLIND LOOP SYNDROME\n$=$ partial intermittent obstruction of afferent loop leading to overdistension of loop by gastric juices after Billroth-II gastrojejunostomy\nCause: gastrojejunostomy with left-to-right anastomosis (= proximal jejunal loop attached to greater curvature instead of lesser curvature), mechanical factors (intussusception, adhesion, kinking), inflammatory disease, neoplastic infiltration of local mesentery or anastomosis, idiopathic motor dysfunction\n\n- postprandial epigastric fullness relieved by bilious vomiting\n- vitamin B12 deficiency with megaloblastic anemia\n- afferent loop with abnormal bacterial flora (Gram negative, resembling colon in quality + quantity)\nAbdominal plain film:\n$\\sqrt{ }$ normal in $85 \\%$ (no air in lumen of afferent loop)\nUGI:\n$\\sqrt{ }$ preferential emptying of stomach into proximal loop\n$\\sqrt{ }$ proximal loop stasis\n$\\sqrt{ }$ regurgitation\nCT:\n$\\sqrt{ }$ rounded water-density masses adjacent to head + tail of pancreas forming a U-shaped loop\n$\\sqrt{ }$ oral contrast material may not enter loop\n$\\sqrt{ }$ may result in biliary obstruction (increased pressure at ampulla)\n$R x$ : antibiotic therapy\n\n\n## AIDS\n\n$\\diamond$ Gastrointestinal involvement $\\leftarrow$ opportunistic infections + AIDS-associated neoplasms!\n$\\diamond$ Pathologic abnormalities at multiple sites with single / several opportunistic organisms are frequent!\nA. VIRAL PATHOGENS\n\n## 1. Cytomegalovirus infection\n\n$\\diamond$ Most common cause of life-threatening opportunistic viral infection in AIDS patients!\nOrganism: double-stranded DNA virus of herpes family\nInfection: ubiquitous among humans occurring at an early age in populations with poor sanitation + crowded living conditions",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 673,
            "markdown": "$\\diamond$ Result of reactivation of latent virus in previously infected host!\nPrevalence: $13 \\%$ of all GI diseases in AIDS patients\nPath: infection of endothelial cells $\\rightarrow$ small vessel vasculitis $\\rightarrow$ hemorrhage, ischemic necrosis, ulcer\nHisto: large mononuclear epithelial / endothelial cells that contain intranuclear / cytoplasmatic inclusions with surrounding inflammation\nLocation: colon $>$ small bowel (terminal ileum) $>$ esophagus $>$ stomach\n@ Esophagus\n$\\checkmark$ single / multiple large superficial ulcers\n@ Small bowel\n$\\checkmark$ luminal narrowing $\\leftarrow$ marked bowel wall thickening\n$\\checkmark$ diffuse irregular fold thickening $\\leftarrow$ thrombosis and ischemia $\\leftarrow$ vasculitis\n$\\checkmark$ penetrating ulcer $\\pm$ perforation\n$\\checkmark$ CMV pseudotumor (uncommon)\n@ Colon (CMV colitis)\n\n- hematochezia, crampy abdominal pain, fever\n$\\checkmark$ toxic megacolon\n$\\checkmark$ discrete small well-defined nodules (similar to lymphoid nodular hyperplasia) throughout colon\n$\\checkmark$ aphthous ulcers on background of normal mucosa\n$\\checkmark$ marked bowel wall thickening\n$\\checkmark$ \"double-ring / target\" sign on CT $\\leftarrow$ increased submucosal edema\n$\\checkmark$ ascites\n$\\checkmark$ inflammation of pericolonic fat + fascia\nRx: ganciclovir (effective in 75\\%)\n\n2. Herpes simplex virus infection\n$\\diamond$ Result of reactivation of latent virus in previously infected host\nOrganism: neurotropic DNA virus of herpes family\nPrevalence: $70 \\%$ for type $1,16 \\%$ for type 2 (endemic in USA); type 2 much more common in AIDS\nInfection: direct inoculation through mucous membrane contact; from dormant state in root ganglia reactivated + transported via efferent nerves to mucocutaneous surface\nLocation: oral cavity, esophagus, rectum, anus\n$\\checkmark$ multiple small discrete ulcers\n3. Human immunodeficiency virus infection\n$\\diamond$ Not an AIDS-defining illness!\nInfection: acute HIV-infection with transient immunosuppression / during AIDS\n$\\sqrt{>}$ 2-cm large solitary ulcer in the mid- or distal esophagus (HIV-infected cells $\\rightarrow$ alterations in cytokines $\\rightarrow$ infiltration of inflammatory cells into submucosa and destruction of mucosa\nRx: corticosteroids\nB. FUNGAL PATHOGENS\n4. Candidiasis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 674,
            "markdown": "$\\diamond$ The absence of thrush does NOT exclude the diagnosis of candida esophagitis!\nOrganism: commensal fungus Candida albicans\nPrevalence: $10-20 \\%$ (in USA); up to $80 \\%$ in developing countries\nLocation: oral cavity, esophagus\n$\\checkmark$ discrete linear / irregular longitudinally oriented filling defects in esophagus\n$C x$ : disseminated systemic candidiasis (rare; indicative of granulocytopenia from chemotherapy / direct inoculation via catheter)\n2. Histoplasmosis\n\nOrganism: dimorphic opportunistic fungus\nPrevalence: $10 \\%$ GI involvement with disseminated histoplasmosis in AIDS patients\nLocation: colon $>$ terminal ileum\n$\\checkmark$ segmental inflammation / apple core lesion / bowel stricture\n$\\checkmark$ hepatosplenomegaly\n$\\checkmark$ mesenteric lymphadenopathy\n$\\checkmark$ diffuse hypoattenuation of spleen\nC. PROTOZOAN PATHOGENS\n\n# 1. Cryptosporidiosis \n\n$\\diamond$ One of the most common causes of enteric + biliary disease in AIDS patients!\nOrganism: intracellular parasite Cryptosporidium\nPrevalence: isolated in $6 \\%$ of all patients with AIDS; in $16 \\%$ (in USA) + in up to $48 \\%$\n(in developing countries) of patients with diarrhea\n\n- severe choleralike debilitating diarrhea with fluid loss of $10-17 \\mathrm{~L} / \\mathrm{d}$\n\nLocation: jejunum $>$ other small bowel $>$ stomach $>$ colon\n$\\checkmark$ Cryptosporidium antritis $=$ area of focal gastric thickening + ulceration\n$\\checkmark$ small bowel dilatation $\\leftarrow$ increased secretions\n$\\checkmark$ regular fold thickening + effacement $\\leftarrow$ atrophy, blunting, fusion, loss of villi\n$\\checkmark$ \"toothpaste\" appearance of small bowel (mimicking sprue)\n$\\checkmark$ dilution of barium $\\leftarrow$ hypersecretion\n$\\checkmark$ marked antral narrowing $\\leftarrow$ extensive inflammation\n$\\checkmark$ AIDS-related cholangitis\n$D x$ : microscopic identification in stool / biopsy\n2. Pneumocystosis\n$\\diamond$ Likely to occur in patients treated with aerosolized pentamidine!\nOrganism: eukaryotic microbe Pneumocystis carinii\nPrevalence: pulmonary infection in $75 \\%$ of AIDS patients; in $<1 \\%$ dissemination\nLocation: liver, spleen, lymph nodes\n$\\checkmark$ hepatic + splenic + nodal punctate calcifications\n$\\checkmark$ multiple tiny echogenic foci in spleen\n$\\checkmark$ multiple low-attenuation lesions of varying size in spleen (foamy eosinophilic material) $\\rightarrow$ subsequently progressive rimlike / punctate calcifications\nD. BACTERIAL PATHOGENS\n\n## 1. Tuberculosis\n\n$\\diamond$ Most common cause of serious HIV-related infection worldwide with tendency to occur earlier than other AIDS-defining opportunistic infections!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 675,
            "markdown": "Prevalence: $4 \\%$ (in USA) $+43 \\%$ (in developing countries) of HIV-infected persons\nInfection: swallowing of infected sputum; hematogenous spread from pulmonary focus; direct extension from lymph node\nLocation: lymph nodes, liver, spleen, peritoneum, GI tract (especially ileum, colon, ileocecal valve)\n$\\sqrt{ }$ low-attenuation mesenteric lymphadenopathy $\\leftarrow$ suggestive of necrosis\n$\\checkmark$ segmental ulceration\n$\\checkmark$ inflammatory stricture\n$\\checkmark$ hypertrophic lesion resembling polyp or mass\n2. Mycobacterium avium complex infection\n= PSEUDO-WHIPPLE DISEASE IN AIDS\n$\\diamond$ Most common opportunistic infection of bacterial origin in AIDS patients!\n$\\diamond$ Most common nontuberculous mycobacterial infection in AIDS patients!\nOrganism: facultative intracellular acid-fast bacillus M. avium / M. intracellulare\nInfection: invasion of Peyer patches + adjacent mesenteric lymph nodes\nHisto: true granulomas with Langhans giant cells and caseous necrosis are rare because infection occurs in patients with advanced disease and a CD4 cell count of $<100 / \\mu \\mathrm{L}$\n\n- diarrhea, malabsorption (similar clinical picture as in Whipple disease caused by Mycobacterium avium-intracellulare)\nLocation: jejunum (most common)\n$\\checkmark$ mild dilatation of middle + distal small bowel\n$\\checkmark$ wall thickening of small bowel loops\n$\\checkmark$ diffuse irregular thickening of mucosal fold and nodularity without ulceration\n$\\checkmark$ mesenteric + retroperitoneal lymphadenopathy:\n$\\checkmark$ homogeneous $1.0-1.5 \\mathrm{~cm}$ nodes of soft-tissue attenuation causing segmental separation of small bowel loops\n$\\checkmark$ necrotic mesenteric nodes of low attenuation (= pseudo-Whipple disease)\n$\\checkmark$ hepatosplenomegaly\n$\\checkmark$ multiple tiny echogenic foci in liver + spleen (occasionally large hypoechoic / lowattenuation lesions)\nDx: (1) Visualization of large numbers of intracellular acid-fast bacilli in foamy histiocytes of tissue specimen\n(2) Tissue culture\n\nDDx: Whipple disease (positive with periodic acid-Schiff stain just like M. avium, but not with acid-fast stain, responsive to tetracyclines)\nE. OTHER INFECTIONS\n\n1. Bacillary angiomatosis\n\nOrganism: rickettsia Bartonella henselae\nHisto: characteristic pattern of vascular proliferation with bacilli\nLocation: cutis (mimicking Kaposi sarcoma), liver, spleen, lymph nodes\n$\\checkmark$ peliosis (= blood-filled cystic spaces) of liver / spleen\n$\\checkmark$ abdominal lymphadenopathy with contrast enhancement\n2. Isospora belli",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 676,
            "markdown": "$\\diamond$ Infection resembles cryptosporidiosis\nOrganism: protozoan pathogen\nHisto: oval oocysts within bowel lumen / epithelial cells; localized inflammation; fold atrophy\nLocation: small intestine\n\n- severe watery diarrhea\n$\\checkmark$ fold thickening\nF. AIDS-ASSOCIATED NEOPLASMS\n\n1. Kaposi sarcoma\n2. Non-Hodgkin lymphoma\n$\\diamond 2^{\\text {nd }}$ most common AIDS-associated neoplasm\nPrevalence: in $4-10 \\%$ of AIDS patients ( 60 x higher risk compared with general population); occurs in all AIDS risk groups\nHisto: multiclonal B-cell lymphoma of high / intermediate grade\n\n- at initial presentation widely disseminated disease often with extranodal involvement\n\nLocation: CNS, bone marrow, GI tract (stomach, small bowel)\n@ Stomach\n$\\checkmark$ circumferential / focal wall thickening\n$\\checkmark$ mural mass $\\pm$ ulceration\n@ Small bowel\n$\\checkmark$ diffuse / focal wall thickening\n$\\checkmark$ excavated mass\n$\\checkmark$ solitary / multiple liver lesions\nDifferential diagnostic considerations:\n\n1. Splenomegaly (31-45\\%)\n\nCause: nonspecific (most), lymphoma, infection (M. avium-intracellulare, P. carinii)\n2. Lymphadenopathy $(21-60 \\%)$\n\nCause: reactive hyperplasia (most), Kaposi sarcoma, lymphoma, infections\nSize: $<3 \\mathrm{~cm}$ in diameter (in 95\\%)\n3. Hepatomegaly (20\\%)\n\nCause: nonspecific, hepatitis, fatty infiltration, lymphoma, Kaposi sarcoma\n4. AIDS-related cholangiopathy:\n\nOrganism: CMV, Cryptosporidium\n$\\checkmark$ papillary stenosis of CBD\n$\\checkmark$ dilatation of extra- and intrahepatic bile ducts\n$\\checkmark$ periductal fibrosis\n$\\checkmark$ strictures + irregularities of bile ducts resembling primary sclerosing cholangitis\n$\\checkmark$ intraluminal polypoid filling defects\n5. AIDS-related esophagitis:\n\nOrganism: Candida, herpes simplex, CMV\n$\\checkmark$ giant esophageal ulcer: HIV (76\\%), CMV (14\\%)\n$\\checkmark$ esophageal fistula / perforation: TB, actinomycosis\n6. Gastritis\n\nOrganism: CMV (GE junction + prepyloric antrum), Cryptosporidium (antrum)\n7. AIDS enteritis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 677,
            "markdown": "Organism: Cryptosporidium, M. avium complex\n8. AIDS colitis\n> ischemic bowel\n> acute appendicitis\n> neutropenic colitis\n> pseudomembranous colitis\n> infectious colitis / ileitis\n9. Bowel obstruction\n(a) infection\n(b) intussusception: Kaposi sarcoma, lymphoma\n\n# AMEBIASIS \n\n$=$ primary infection of colon by protozoan Entamoeba histolytica\nOrganism: free-living protozoa widespread in water, soil, air\nCountries: worldwide distribution, most common in warm climates; South Africa, Egypt, India, Asia, Central + South America (20\\%); USA (5\\%)\nRoute: ingestion of cysts in contaminated food / water $\\rightarrow$ cyst dissolves in small bowel $\\rightarrow$ trophozoites settle in colon; invasion of bowel wall $\\leftarrow$ proteolytic enzymes and hyaluronidase that lyse intestinal epithelium; may embolize into portal venous + systemic blood system\nHisto: amebic invasion of mucosa + submucosa causing tiny ulcers, which spread beneath mucosa + merge into larger areas of necrosis; mucosal sloughing; secondary bacterial infection\n\n- asymptomatic for months / years; fever, headache, nausea\n- acute attacks of diarrhea (= loose mucoid bloodstained stools)\n\nLocation: (areas of relative stasis) right colon + cecum ( $90 \\%$ ) > hepatic + splenic flexures > rectosigmoid\nBE:\n$\\sqrt{ }$ loss of normal haustral pattern with granular appearance $\\leftarrow$ edema, punctate ulcers\n$\\sqrt{ }$ \"collarbutton\" ulcers\n$\\sqrt{ }$ cone-shaped cecum\n$\\sqrt{ }$ several cm long stenosis of bowel lumen in transverse colon, sigmoid colon, flexures (result of healing + fibrosis); in multiple segments\n$\\sqrt{ }$ ileocecal valve thickened + fixed in open position with reflux\n$\\sqrt{ }$ involvement of distal ileum ( $10 \\%$ ):\n$\\diamond$ Amebiasis spares terminal ileum (in USA)\n$\\sqrt{ }$ ameboma $=$ hyperplastic granuloma with bacterial invasion of amebic abscess; usually annular + constricting / intramural mass / cavity continuous with bowel lumen; shrinkage under therapy in 3-4 weeks\nCT/US:\n$\\sqrt{ }$ amebic liver abscess of \"anchovy sauce\" content\n$\\sqrt{ }$ pericarditis, pericardial effusion\nCXR (consequences of subdiaphragmatic abscess):\n$\\sqrt{ }$ elevation of right hemidiaphragm",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 678,
            "markdown": "$\\sqrt{ }$ pleural effusion $\\leftarrow$ transdiaphragmatic spread of infection / sterile sympathetic effusion\n$\\sqrt{ }$ airspace consolidation $\\pm$ cavitation\n$D x:$ stool examination / rectal biopsy\nCx: (1) Toxic megacolon with perforation\n(2) Amebic abscess in liver (2\\%), brain, lung, pericolic, ischiorectal, subphrenic space\n(3) Intussusception in children $\\leftarrow$ ameboma\n(4) Fistula formation: colovesical, rectovesical, rectovaginal, enterocolic, hepatobronchial, bronchobiliary\n\n# AMYLOIDOSIS \n\n= group of heterogeneous disorders caused by interstitial deposits of an insoluble fibrillar protein-polysaccharide in various organs impairing tissue function $\\rightarrow$ hypoxia, mucosal edema, hemorrhage, ulceration, mucosal atrophy, muscle atrophy\nCause: (a) prolonged antigenic stimulation of RES by chronic infection\n(b) disorder of immunoincompetence\n(c) aging\n(d) idiopathic\n\nHisto: amorphous eosinophilic hyaline material deposited around terminal blood vessels, stains with Congo red + crystal violet; green birefringence under polarizing light; amyloid fibrils have $\\beta$-pleated sheet structure ( $=\\beta$ fibrilloses)\nBiochemical classification:\n\n1. AL amyloidosis\n( $\\mathrm{A}=$ amyloidosis, $\\mathrm{L}=$ light chain immunoglobulin)\n\n- monoclonal protein in serum + urine\n- occurs in primary amyloidosis + myeloma-associated amyloidosis\n\nHisto: massive deposits in muscularis mucosae + submucosa\n$\\sqrt{ }$ thickening of folds with polyps / large nodules\n2. SAA amyloidosis ( $\\mathrm{S}=$ secondary, $\\mathrm{AA}=$ amyloid A)\n\n- occurs in secondary = reactive amyloidosis\n- cardiomyopathy with restrictive ventricular filling\n\nHisto: expansion of lamina propria\n$\\sqrt{ }$ coarse mucosal pattern + innumerable fine granular elevations\n3. AF amyloidosis ( $\\mathrm{A}=$ amyloid, $\\mathrm{F}=$ familial)\n\n- AF prealbumin as precursor of fibrils\n- occurs in familial amyloidosis\n\n4. AS amyloidosis ( $\\mathrm{A}=$ amyloid, $\\mathrm{S}=$ senile)\n\n- AS prealbumin as precursor of fibrils\n- occurs in senile amyloidosis\n$\\sqrt{ }$ massive amyloid deposition\n\n5. AH amyloidosis ( $\\mathrm{A}=$ amyloid, $\\mathrm{H}=$ hemodialysis)\n\n- $\\beta_{2}$ microglobulin as precursor of fibrils\n\n6. AE amyloidosis ( $\\mathrm{A}=$ amyloid, $\\mathrm{E}=$ endocrine)\n\n- calcitonin produced by medullary thyroid carcinoma is precursor of fibrils",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 679,
            "markdown": "7. Transthyretin (ATTR)-related hereditary amyloidosis\n\n- cardiomyopathy with restrictive ventricular filling\n\n8. $\\beta 2$-microglobulin (Abeta2M)-derived dialysis-related amyloidosis\n\nReimann classification (1935):\n\n1. Primary = idiopathic amyloidosis\n$=$ amyloid immunoglobulin light chain (AL) disease\n$=$ probably autosomal dominant inheritance with immunologically determined dysfunction of plasma cells (clonal B-cell dyscrasia)\n\n- absence of discernible preceding / concurrent disease\n\nLocation: (predominant involvement of connective tissues + mesenchymal organs): heart $(90 \\%)$, lung ( $30-70 \\%$ ), liver ( $35 \\%$ ), spleen ( $40 \\%$ ), kidneys ( $35 \\%$ ), adrenals, tongue ( $40 \\%$ ), GI tract ( $70 \\%$ ), skin + subcutis ( $25 \\%$ ), skeletal muscle, joints\n$\\checkmark$ tendency for nodular deposition\nPrognosis: $1 / 3$ eventually develop multiple myeloma / B-cell lymphoma / Waldenström macroglobulinemia / other plasma cell neoplasia\n2. Secondary amyloidosis (most common form)\n$=$ amyloid-associated disease\n\n- following / coexistent with prolonged infectious / inflammatory processes\n\nCause: rheumatoid arthritis (in 20\\%), Still disease, TB, chronic osteomyelitis, leprosy, chronic pyelonephritis, bronchiectasis, ulcerative colitis, Crohn disease, familial Mediterranean fever, lymphoreticular malignancy, Waldenström macroglobulinemia\nLocation: spleen, liver, kidneys ( $>80 \\%$ ), breast, tongue, GI tract, connective tissue\n$\\checkmark$ small amyloid deposits\n3. Amyloidosis associated with multiple myeloma\n\n- may precede development of multiple myeloma\n\nFrequency: $10-15 \\%$\n$\\checkmark$ primary amyloidosis with osteolytic lesions in myelomatous disease\n4. Tumor-forming / organ-limited amyloidosis\n\n- related to primary type\n(a) hereditary = familial amyloidosis\n(b) senile amyloidosis (limited to heart / brain / pancreas / spleen)\n$\\checkmark$ large localized masses\nClassification by distribution:\n\n1. Localized (organ-limited) amyloidosis (10-20\\%)\n$=$ deposition of abnormal proteins in one organ\nCause: usually primary (rarely secondary) form of amyloidosis; attributed to tissue-based immunocyte dyscrasia\n$R x$ : supportive / localized management\n$D x$ : (1) NO monoclonal protein in serum / urine\n(2) negative bone marrow biopsy\n(3) NO evidence of systemic involvement\n2. Systemic amyloidosis ( $80-90 \\%$ )\n$=$ deposition of abnormal proteins in wide variety of organs",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 680,
            "markdown": "Prognosis: progressive \\& fatal (kidney / heart failure)\nDx: (1) bioptic proof of amyloid deposits in subcutaneous fat / rectal mucosa / bone marrow\n(2) monoclonal protein in urine, serum\n$\\diamond$ GI involvement more common in primary than in secondary amyloidosis!\n\n- malabsorption (diarrhea, protein loss); occult GI bleeding\n- intestinal pseudo-obstruction; macroglossia\n@ Esophagus ( $11 \\%$ )\n$\\checkmark$ loss of peristalsis\n$\\checkmark$ megaesophagus\n@ Stomach ( $37 \\%$ )\n- postprandial epigastric pain + heartburn\n- acute erosive hemorrhagic gastritis\n(a) diffuse infiltrative form\n$\\checkmark$ small-sized stomach with rigidity + loss of distensibility simulating linitis plastica $\\leftarrow$ thickening of gastric wall\n$\\checkmark$ effaced rugal pattern\n$\\checkmark$ diminished / absent peristalsis\n$\\checkmark$ marked retention of food\n(b) localized infiltration (often located in antrum)\n$\\checkmark$ irregularly narrowed + rigid antrum\n$\\checkmark$ thickened rugae\n$\\checkmark$ superficial erosions / ulcerations\n(c) amyloidoma $=$ well-defined submucosal mass\n@ Small bowel ( $74 \\%$ )\n(a) diffuse form (more common)\n$\\checkmark$ irregular diffuse thickening of valvulae conniventes of entire small bowel associated with:\n$\\checkmark 2-3-\\mathrm{mm}$ micronodules $\\leftarrow$ ischemia\n$\\checkmark$ 6-10-mm nodules $\\leftarrow$ deposition of fibrillar protein in submucosa + lamina propria\n$\\checkmark$ broadened flat undulated mucosal folds (mucosal atrophy)\n$\\checkmark$ \"jejunalization\" of ileum\n$\\checkmark$ impaired intestinal motility\n$\\checkmark$ small bowel dilatation\n(b) localized form (less common)\n$\\checkmark$ multiple pea- / marble-sized deposits\n$\\checkmark$ pseudoobstruction = physical + plain-film findings suggesting mechanical obstruction with patent large + small bowel on barium examination $\\leftarrow$ involvement of myenteric plexus\nCx: small bowel infarction\n@ Colon (27\\%)\n$\\checkmark$ pseudopolyps in colon\n@ Liver\nPath: extracellular deposition of amyloid in the spaces of Disse (= narrow gaps between",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 681,
            "markdown": "endothelial linings of sinusoids and hepatocytes of hepatic lamina) with progressive encroachment on hepatic parenchymal cells + sinusoids\n\n- hepatic function usually preserved\n\nCT:\n$\\checkmark$ hepatomegaly\n$\\checkmark$ regions of low attenuation with decreased contrast enhancement\n@: Spleen\nHisto: (a) nodular form involving lymph follicles\n(b) diffuse form infiltrating red pulp\n$\\checkmark$ discrete masses\n$\\checkmark$ splenomegaly (4-13\\%)\nMR:\n$\\checkmark$ T2 values significantly lower than normal\n@: Bone\n$\\checkmark$ bone cysts\n$C x$ : spontaneous splenic rupture (from vascular fragility + acquired coagulopathy)\n$D x$ : by rectal / gingival biopsy\n$D D x$ : Whipple disease, intestinal lymphangiectasia, lymphosarcoma\n\n# ANGIODYSPLASIA OF COLON \n\n$=$ VASCULAR ECTASIA = ARTERIOVENOUS MALFORMATION (not a true AVM)\nCause: age-related degenerative dilatation of normal vessels in submucosa of bowel wall\nTheory: colonic contractions result in dilatation of colonic veins, venules and capillaries forging multiple small arteriovenous communications\nAssociated with: aortic stenosis (20\\%); NOT related to extraintestinal angiomatous lesions\nPrevalence: most common vascular lesion of GI tract!\nat autopsy: $2 \\%$\nat colonoscopy: $0.8 \\%$ (at age $>50$ years)\n$\\diamond$ Up to $40 \\%$ of lower GI bleeding in over age 60\nAge: majority $>55$ years; $\\mathrm{M}=\\mathrm{F}$\nLocation: (a) cecum + ascending colon (74\\%)\n(b) jejunum, ileum (15\\%)\n(c) descending + sigmoid colon (? 25\\%)\n\nSite: usually at antimesenteric border\n\n- chronic intermittent low-grade / occasionally massive bleeding\n\nNUC ( ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-labeled RBCs):\n$\\checkmark$ focus of tracer accumulation at site of bowel hemorrhage migrating with peristalsis\nBE:\n$\\checkmark$ no abnormality $\\leftarrow$ soft submucosal lesion\nCT:\n$\\checkmark$ avidly enhancing plaque / nodule during enteric phase fading during delayed phase of CT arteriography\n$\\checkmark$ early draining vein during arterial phase",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 682,
            "markdown": "NUC:\n$\\sqrt{ }$ increased tracer accumulation of ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-labeled RBC\nAngio:\n$\\sqrt{ }$ \"arterial tuft\" = cluster / tangle of vessels during arterial phase along antimesenteric border\n$\\sqrt{ }$ early opacification of draining ileocolic vein\n$\\sqrt{ }$ densely opacified dilated tortuous ileocolic vein into late venous phase\n$\\sqrt{ }$ contrast extravasation into bowel lumen (unusual)\nPrognosis: spontaneous cessation of bleeding in $80 \\%$, recurrent bleeding in $85 \\%$\n$R x$ : surgical excision\n\n# ANISAKIASIS \n\n$=$ parasitic disease of GI tract\nCause: ingestion of Anisakis larvae present in raw / undercooked fish (mackerel, cod, pollack, herring, whiting, bonito, squid) consumed as sashimi, sushi, ceviche, lomi-lomi\nOrganism: worm with straight / serpentine / circular threadlike appearance\n$\\diamond$ Site of penetration by larvae determines clinical form!\n@ Gastric anisakiasis\n\n- acute gastric pain, nausea, eosinophilia\n- vomiting a few hours after ingestion (DDx: acute gastritis, peptic ulcer, neoplasia, food poisoning)\n$\\sqrt{ }$ mucosal edema\n$\\sqrt{ }$ about 3 cm long threadlike filling defects (= larvae)\n@ Intestinal anisakiasis\n- diffuse abdominal tenderness / colicky abdominal pain, nausea, vomiting (DDx: acute appendicitis, regional enteritis, intussusception, ileus, diverticulitis, neoplasia)\n- leukocytosis without eosinophilia (frequent)\n\nHisto: marked edema, eosinophilic infiltrates, granuloma formation\n$\\sqrt{ }$ thickened folds\n$\\sqrt{ }$ disappearance of Kerckring folds\n$\\sqrt{ }$ thumbprinting / saw-tooth appearance\n$\\sqrt{ }$ irregular luminal narrowing\n$\\sqrt{ }$ eosinophilic ascites (DDx: eosinophilic gastroenteritis, hypereosinophilic syndrome)\n$C x$ : ileus\n@ Colonic anisakiasis (rare)\n$D D x$ : colonic tumor\n\n## ANORECTAL MALFORMATION\n\n$=$ complex group of congenital anomalies involving distal anus, rectum, urinary and genital tracts\nPrevalence: $1 \\div 5,000$ live births; $\\mathrm{M}>\\mathrm{F}$\nCause: abnormal development of urorectal septum in early fetal life\nEmbryology:\n$>3^{\\text {rd }}$ and $4^{\\text {th }}$ week GA: dorsal part of yolk sac folds are incorporated into embryo forming the primitive hindgut that consists of distal part of transverse, descending and sigmoid colon,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 683,
            "markdown": "rectum, superior portion of anal canal, epithelium of urinary bladder, and most of the urethra\n> $4^{\\text {th }}$ week GA: coronal sheet of mesenchyme ( $=$ urorectal septum $=$ transverse rectovesical septum) $\\rightarrow$ descends caudally between allantois and hindgut $\\rightarrow$ divides primitive cloaca into urogenital sinus ventrally and anorectal canal dorsally; cloacal membrane separates cloaca from amniotic cavity\nDisturbance leads to: ectopic anal orifice / fistula\n> $5^{\\text {th }}$ week GA: urorectal septum develops forklike infoldings (Tourneux and Rathke folds) of lateral cloacal walls\n$>7^{\\text {th }}$ week GA:\n(a) urorectal septum fuses with cloacal membrane creating a urogenital membrane ventrally + anal membrane dorsally\n(b) perineum is formed by fusion of urorectal septum + cloacal membrane\n(c) secondary occlusion of anorectal canal by adhesion of wall + formation of an epithelial plug at anus\n> 9th week GA: cloacal membrane ruptures by apoptosis forming a ventral urogenital and a dorsal anal orifice\nDisturbance leads to: abnormal anus in normal position\nIn 48-70\\% associated with other congenital anomalies:\n(1) GU anomalies ( $20-60 \\%$ ): vesicoureteral reflux; hydronephrosis; bi- / unilateral renal agenesis; renal dysplasia; renal ectopia; horseshoe kidney; polycystic kidney; renal duplication; megaureter; bladder exstrophy; micropenis; hypospadia (3.1\\%); double uterus / vagina; vulvogenital atresia; ambiguous genitalia\n(2) Spine (30\\%): lumbosacral segmentation anomalies with sacral agenesis, vertebral dysplasia, spina bifida; tethered cord; myelomeningocele $(0.5 \\%)+$ occult myelodysplasia\n(3) GI anomalies ( $11 \\%$ ): esophageal atresia $\\pm$ tracheoesopha-geal fistula ( $4 \\%$ ); duodenal, jejunal, ileal atresia / stenosis; absent colon; intestinal malrotation; volvulus; Meckel diverticulum\n(4) Cardiovascular anomalies (8\\%): tetralogy of Fallot; ASD; VSD, dextrocardia; coarctation of aorta\n(5) Musculoskeletal: hip dislocation / dysplasia; fusion of iliac bones; Madelung deformity; arthrogryposis; clubfoot; polydactyly; syndactyly; limb deficiency\n(6) Abdominal wall ( $2 \\%$ )\n(7) Cleft lip-cleft palate $(1.6 \\%)$\n(8) Down syndrome $(1.5 \\%)$\n(9) Others $(8 \\%)$\n\nMost common associated syndromes:\n(1) VACTERL\n(2) Omphalocele, Exstrophy of bladder, Imperforate anus, Spinal defect (OEIS)\n(3) Müllerian + Renal agenesis + Cervicothoracic Somite dysplasia (MURCS)\n(4) Chromosomopathies: Trisomy 13, 18 and 21; uniparental disomy 16; deletion of 22q11.2 and 13 q\n(5) Numerous other syndromes: caudal regression, Down, fetal alcohol, Ivemark, KlippelFeil, Opitz, etc.\nWingspread Classification (1984):",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 684,
            "markdown": "1. Low: anal stenosis, anocutaneous (rectoperineal / rectovestibular) fistula Rx: corrective surgery on day $2-3$ of life $\\pm$ colostomy\n2. Intermediate: anal agenesis without fistula / with rectourethral bulbar fistula\n\n- passage of meconium through vagina / with urine\n$R x:$ descending colostomy on day 3 of life\n\n3. High: rectal atresia; anorectal agenesis without fistula / rectourethral prostatic fistula\n\n- passage of meconium through vagina / with urine\n\nKrickenbeck Classification (2005):\n\n1. Anal stenosis; imperforate anus without fistula / (1) rectoperineal fistula or (2) rectovestibular\n2. Anal / anorectal agenesis without fistula / (3) rectourethral bulbar, (4) rectourethral prostatic or (5) rectovesical fistula\nOB-US:\n$\\diamond$ Prenatal diagnosis made rarely (in only 16\\%)!\n$\\checkmark$ oligohydramnios ( $26 \\%$ ) + distended bladder\n$\\checkmark$ abdominal / pelvic cystic mass ( $52 \\%$ ) $\\leftarrow$ distended bladder + septate fluid-filled vagina\n$\\checkmark$ fetal hydronephrosis ( $49 \\%$ )\n$\\checkmark$ fetal ascites $(22 \\%)$\n$\\checkmark$ intestinal distension ( $18 \\%$ )\nTransperineal US:\n$\\checkmark$ bowel-skin distance on midline SAG (rectal pouch to anus)\n$<15 \\mathrm{~mm}$ : low type of anorectal malformation\n$>15 \\mathrm{~mm}$ : high type of anorectal malformation\n$\\checkmark$ linear tract / fistula may be identified\nHigh-pressure distal colostography:\n> Foley catheter through colostomy into distal colon\n> gentle traction on inflated balloon for sealing\n> manual injection of hydrosoluble contrast material until patient voids\nMR:\n> transverse images through pubococcygeal plane ( $=$ upper border of symphysis pubis + upper border of os coccyx)\n> coronal images perpendicular to pubococcygeal plane\n$\\checkmark$ position of rectal pouch\n$\\checkmark$ size + morphology + development of levator ani muscle group (levator prostate m. /\nsphincter vaginae m., puborectalis m., pubococcygeus m., iliococcygeus muscle) + external anal sphincter (subcutaneous, superficial and deep layer)\n(1) Rectal atresia\n$=$ open anus + atretic rectal segment superior to anus + no fistula\n(2) Ectopic anus\n$=$ fistulous opening of bowel $\\leftarrow$ failure of terminal bowel to descend normally\nSite of arrest: high / low colon arrest = above / below puborectal sling\n\n- most common anomaly of anorectal segment\n- anal dimple + external sphincter in normal position\n\nLocation of fistula: perineum, vestibule, vagina, urethra, bladder, cloaca\n$\\sqrt{ }$ low small bowel / colonic obstruction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 685,
            "markdown": "$\\sqrt{ }$ \"M\" line accurately represents level of puborectal muscle $=$ line drawn horizontally through junction of lower $1 / 3$ and upper $2 / 3$ of ischium on lateral radiograph\n(3) Imperforate anus\n$=$ blind ending of terminal bowel + no fistula\n(4) Cloacal malformation\n(5) Cloacal exstrophy\n\n# ANTRAL-MUCOSAL DIAPHRAGM \n\n$=$ ANTRAL WEB\nAge range: 3 months to 80 years\nAssociated with: gastric ulcer (30-50\\%)\n\n- symptomatic if opening $<1 \\mathrm{~cm}$\n\nLocation: usually 1.5 cm from pylorus (range $0-7 \\mathrm{~cm}$ )\n$\\sqrt{ }$ constant symmetric band of $2-3 \\mathrm{~mm}$ thickness traversing the antrum perpendicular to long axis of stomach\n$\\sqrt{ }$ \"double bulb\" appearance (in profile)\n$\\sqrt{ }$ concentric / eccentric orifice\n$\\sqrt{ }$ normal peristaltic activity\n\n## APPENDICITIS\n\nPrevalence: $>250,000$ cases annually; $1-4 \\%$ in children with acute abdominal pain\nLifetime risk: $7-9 \\%$ in Western world population\nEtiology: obstruction of appendiceal lumen by lymphoid hyperplasia (60\\%), fecolith (33\\%), foreign body ( $4 \\%$ ), stricture, tumor, parasite; Crohn disease (in 25\\%)\nCause: luminal obstruction from\n(a) fecolith $(11-52 \\%)=$ hard crushable concretions from inspissation of fecal material + inorganic salts\n(b) appendiceal calculus $=$ hard noncrushable calcified stone $(7-15 \\%)$\n(c) lymphoid hyperplasia\n(d) foreign body\n(e) parasite\n(f) primary tumor: carcinoid, adenocarcinoma, Kaposi sarcoma, lymphoma\n(g) metastatic tumor: colon cancer, breast cancer\n\n## Pathogenesis:\n\ncontinued secretion of mucus in appendiceal obstruction $\\rightarrow$ elevates intraluminal pressure + distends lumen $\\rightarrow$ venous engorgement $\\rightarrow$ arterial compromise $\\rightarrow$ tissue ischemia (after intraluminal pressure exceeds capillary perfusion pressure)\nPeak age: $2^{\\text {nd }}$ decade; thereafter declining incidence; $\\mathrm{M}+\\mathrm{F}=3 \\div 2$ (in teens / young adults, thereafter $1 \\div 1$ )\n$\\diamond$ Rare under the age of 2 years!\n\n- $80 \\%$ clinical accuracy ( $78-92 \\%$ in males, $58-85 \\%$ in females):\n\nDiagnostic dilemma (in 20-35\\%):\nin elderly, ovulating women, infants / young children\n$\\diamond 32-45 \\%$ rate of misdiagnosis in women $20-40$ years!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 686,
            "markdown": "$\\diamond 5-25 \\%$ false-negative appendectomy rate for children!\n\n- pain:\n- mild poorly localized visceral pain of 4-6 hours duration referred to epigastrium + periumbilical region\n- crampy pain migrates into RLQ pain over appendix $=\\mathrm{McBurney} \\operatorname{sign}(72 \\%)$ and becomes continuous + more severe (somatic pain)\n- anorexia, nausea, vomiting ( $40 \\%$ )\n- afebrile / low-grade fever (56\\%)\n$\\diamond$ Suspect perforation with temperature $>38.3^{\\circ} \\mathrm{C}$\n- leukocytosis with left shift ( $88 \\%$ )\n\nClinical scoring system: \"MANTRELS\" score of up to 10\nMigration of pain to RLQ 1\nAnorexia 1\nNausea and vomiting 1\nTenderness in RLQ 2\nRebound pain 1\nElevated temperature 1\nLeukocytosis 2\nShift of WBC count to left 1\n\n# Location: \n\n(a) base of appendix (usually): posteromedial wall of cecum +3 cm below ileocecal valve\n$\\diamond$ Appendix + ileocecal valve are on the same side of cecum\n(b) tip of appendix: retrocecal, subcecal, retroileal, preileal, within pelvis ( $30 \\%$ ), extraperitoneal $(5 \\%)$\n(c) appendicitis in hernia sac ( $0.13 \\%$ ): inguinal hernia (Amyand hernia), femoral hernia (de Garengeot hernia)\n(d) during pregnancy: cecum and appendix increasingly elevated out of pelvis by gravid uterus\n$\\diamond$ Cecal tilt angle of $>90^{\\circ}$ (on sagittal MR image) $\\rightarrow$ appendix in right upper quadrant\nAbdominal plain film (abnormalities seen in $<50 \\%$ ):\n$\\diamond$ Plain-film findings become more distinctive after perforation, while clinical findings subside / simulate other diseases!\n$\\checkmark$ usually laminated calcified appendicolith in RLQ (in 7-15\\%):\n$\\diamond$ Appendicolith + abdominal pain $\\rightarrow 90 \\%$ probability of acute appendicitis $\\rightarrow$ high probability for gangrene / perforation!\n$\\checkmark$ cecal changes:\n$\\checkmark$ thickening of cecal wall\n$\\checkmark$ water-density mass + paucity / absence of intestinal gas in RLQ (in $24 \\%$ of perforations)\n$\\checkmark$ \"cecal ileus\" = gas-fluid level in cecum with gangrene $\\leftarrow$ local paralysis\n$\\checkmark$ \"colon cutoff\" sign = amputation of gas at the hepatic flexure (in $20 \\%$ of perforations) $\\leftarrow$ spastic ascending colon\n$\\checkmark$ small bowel obstruction pattern = small bowel dilatation with air-fluid levels (in $43 \\%$ of perforations)\n$\\checkmark$ extraluminal gas (in $33 \\%$ of perforations):\n$\\checkmark$ gas loculation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 687,
            "markdown": "$\\sqrt{ }$ mottled bacteriogenic gas\n$\\sqrt{ }$ pneumoperitoneum (rare)\n$\\sqrt{ }$ loss of fat planes:\n$\\sqrt{ }$ focal increase in thickness of lateral abdominal wall in $32 \\% \\leftarrow$ edema between properitoneal fat line + cecum\n$\\sqrt{ }$ loss of properitoneal fat line\n$\\sqrt{ }$ loss of pelvic fat planes around the bladder / right obturator $\\leftarrow$ fluid / pus in cul-de-sac\n$\\sqrt{ }$ loss of definition of right inferior hepatic outline $\\leftarrow$ free peritoneal fluid\n$\\sqrt{ }$ distortion of psoas margin + flank stripes\n$\\sqrt{ }$ scoliosis $\\leftarrow$ muscle irritation\nBE / UGI (accuracy $50-84 \\%$ ):\n$\\sqrt{ }$ failure to fill appendix with barium: normal in up to $35 \\%$\n$\\sqrt{ }$ indentation along medial wall of cecum $\\leftarrow$ edema at base of appendix / matted omentum / periappendiceal abscess\nOral contrast material within the appendix excludes acute appendicitis.\nCT ( $87-100 \\%$ sensitive, $89-98 \\%$ specific, $93-98 \\%$ accurate, $92-98 \\%$ PPV, $95-100 \\%$ NPV):\n$\\sqrt{ }$ normal appendix visualized in $67-100 \\%$ :\n$\\sqrt{ } 1-2 \\mathrm{~cm}$ below ileocecal junction from posteromedial aspect of cecum with a diameter of up to 10 mm\n$\\diamond$ Nonvisualization of the appendix in a patient with RLQ pain virtually excludes acute appendicitis!\n$\\sqrt{ }$ abnormal appendix:\nAn $\\uparrow$ appendiceal caliber alone is not a reliable indicator for appendicitis. However, an $\\uparrow$ between serial CTs suggests early acute appendicitis, even without adjacent fat stranding.\n$\\sqrt{ }$ distended appendiceal lumen $>7 \\mathrm{~mm}$ in diameter\n$\\sqrt{ }$ circumferential wall thickening\n$\\sqrt{ }$ homogeneously enhancing wall $\\pm$ mural stratification (= \"target\" sign)\n$\\sqrt{ }$ appendicolith $=$ homogeneous / ringlike calcification $(25 \\%)$\n$\\sqrt{ }$ periappendicular inflammation ( $98 \\%$ ):\n$\\sqrt{ }$ linear streaky densities in periappendicular / pericecal / mesenteric / pelvic fat\n$\\sqrt{ }$ subtle clouding of mesentery\n$\\sqrt{ }$ local fascial thickening\n$\\sqrt{ }$ free peritoneal fluid\n$\\sqrt{ }$ localized + mesenteric lymphadenopathy\n$\\sqrt{ }$ marked terminal ileal wall thickening\n$\\sqrt{ }$ peritonitis\n$\\sqrt{ }$ small-bowel obstruction\n$\\sqrt{ }$ circumferential / focal cecal apical thickening ( $80 \\%$ ):\n$\\sqrt{ }$ \"arrowhead\" sign = funnel of contrast medium in cecum symmetrically centering about occluded orifice of appendix ( $30 \\%$ sensitive, $100 \\%$ specific)\n$\\sqrt{ }$ perforated appendix:\n$\\sqrt{ }$ defect in the enhancing appendiceal wall\n$\\sqrt{ }$ nonvisualization of appendix $\\leftarrow$ fragmentation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 688,
            "markdown": "$\\sqrt{ }$ phlegmon $=$ diffuse substantial inflammation of periappendiceal fat with ill-defined fluid collections (DDx: ileocolitis with secondary inflammation of appendix)\n$\\sqrt{ }$ pericecal / mesenteric / interloop / pelvic abscess = poorly encapsulated single / multiple fluid collections containing air / extravasated contrast material\n$\\sqrt{ }$ extraluminal appendicolith\n$\\sqrt{ }$ extraluminal air\nFalse-negative CT:\n(a) overlapping range in maximal appendiceal diameter between inflamed + uninflamed appendix\n(b) appendix mistaken for unopacified bowel\n(c) distal appendicitis $=$ inflammation limited to tip\n$\\sqrt{ }$ abnormal tip of appendix with NORMAL proximal appendix and cecal apex\nFalse-positive CT:\n(a) cystic fibrosis (= appendiceal thickening of up to 15 mm )\n(b) Crohn disease\n(c) Cancer of the appendix\n\nSecondary / reactive appendicitis can be caused by cecal / terminal ileal diverticulitis, terminal ileitis, active Crohn disease, colitis, or an acute gynecologic process.\nGraded-compression US ( $85 \\%$ sensitive, $92 \\%$ specific, $78-96 \\%$ accurate, $91-94 \\%$ PPV, 89$97 \\% \\mathrm{NPV}$ ):\n$\\diamond$ Nondiagnostic study in $4 \\% \\leftarrow$ inadequate RLQ compression\n$\\diamond$ Useful in ovulating women + infants / children (false-negative appendectomy rate in males $15 \\%$, in females $35 \\%$ )\n$\\diamond$ Normal appendix visualized in $2 \\%$ of normal adults, but in $50 \\%$ of normal children\n$\\sqrt{ }$ noncompressibility of tubular appendix:\n$\\sqrt{ }$ absence of peristalsis must be confirmed $\\rightarrow$ NOT to mistake small bowel for appendix\n$\\sqrt{ }$ blind-ending bulbous tip must be demonstrated $\\rightarrow$ NOT to miss distal appendicitis\n$\\sqrt{ }$ laminated wall with target appearance of $\\geq 6 \\mathrm{~mm}$ in outer wall diameter on cross section ( $81 \\%$ specific, $98 \\%$ PPV, $98 \\%$ NPV) / mural wall thickness $\\geq 2 \\mathrm{~mm}$\n$\\sqrt{ }$ lumen may be distended with anechoic / hyperechoic material\n$\\sqrt{ }$ pericecal / periappendiceal fluid\n$\\sqrt{ }$ increased periappendiceal echogenicity (= inflammatory infiltration of mesoappendix / pericecal fat)\n$\\sqrt{ }$ enlarged mesenteric lymph nodes\n$\\sqrt{ }$ loss of wall layers $=$ gangrenous appendix\n$\\sqrt{ }$ perforated appendix (23-73\\%):\n$\\sqrt{ }$ loss of echogenic submucosal layer\n$\\sqrt{ }$ appendix no longer visualized ( $40-60 \\%$ )\n$\\sqrt{ }$ loculated periappendiceal / pelvic fluid collection $\\pm$ gas bubbles $\\leftarrow$ abscess\n$\\sqrt{ }$ prominent hyperechoic mesoappendix / pericecal fat\n$\\sqrt{ }$ visualization of appendicolith $(6 \\%)=$ bright echogenic focus with clean distal acoustic shadowing\n$\\sqrt{ }$ gas bubbles localized to perforation site\n$\\sqrt{ }$ hypoechoic zones with poor margination within inflamed fat $\\leftarrow$ phlegmonous appendicitis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 689,
            "markdown": "$\\sqrt{ }$ sympathetic thickening of adjacent terminal ileum + ascending colon\nFalse-negative US:\n(a) failure to visualize appendix\n> inability of adequate compression\n> aberrant location of appendix: eg, retrocecal\n> appendiceal perforation\n(b) early inflammation limited to appendiceal tip\n\nFalse-positive US:\n(a) normal appendix mistaken for appendicitis\n(b) alternate diagnosis: Crohn disease, pelvic inflammatory disease, inflamed Meckel diverticulum\n(c) spontaneous resolution of acute appendicitis\n\nColor Doppler US:\n$\\sqrt{ }$ increased conspicuity ( $=$ increase in size + number) of circumferential vessels in and around the wall of the appendix $\\leftarrow$ hyperemia\n$\\sqrt{ }$ decreased resistance of arterial waveforms\n$\\sqrt{ }$ continuous / pulsatile venous flow\n$\\sqrt{ }$ decreased / no perfusion = gangrenous appendicitis\nMR ( $97-100 \\%$ sensitive, $92-94 \\%$ specific, $93 \\%$ accurate):\n$\\sqrt{ }$ appendiceal diameter $>6-7 \\mathrm{~mm}$ on single-shot fast SE without luminal air / oral contrast material\n$\\sqrt{ }$ appendiceal wall thickness $>2 \\mathrm{~mm}$, hypointense on T1WI and hyperintense on T2WI\n$\\sqrt{ } \\pm$ high luminal SI on T2WI $\\leftarrow$ fluid-filled lumen\n$\\sqrt{ }$ periappendiceal bands of high SI on fat-saturated images $\\leftarrow$ edema / fluid / abscess\n$\\sqrt{ }$ thickened wall of cecum\n$\\sqrt{ }$ (occasionally) focal area of low signal intensity in appendiceal lumen on all sequences $=$ appendicolith\nNegative predictive value: $100 \\%$\n$\\sqrt{ }$ normal appendix visualized in $80 \\%$ of pregnant women:\n$\\sqrt{ }$ tubular structure $\\leq 6 \\mathrm{~mm}$\n$\\sqrt{ }$ intermediate signal intensity isointense to muscle\n$\\sqrt{ }$ central low SI (air / oral contrast) with blooming effect on T2*\n$\\sqrt{ }$ progressive cranial displacement of appendix + cecum during pregnancy\nPrognosis:\n(1) Abortive appendicitis $=$ mild acute appendicitis that resolves spontaneously in an early stage of disease (after relief of inciting obstruction) in $8-15 \\%$\n\n- low C-reactive protein\n$\\sqrt{ }$ inflamed appendix that returns to normal within 1 week\nPrognosis: $50 \\%$ recurrence rate\n(2) Recurrent appendicitis $(10-38 \\%)=$ repeated similar episodic attacks of RLQ pain $\\rightarrow$ appendectomy showing acute inflammation; in $70 \\%$ within a year after first event\n(3) Chronic appendicitis $(1 \\%)=$ RLQ pain of $>3$ weeks + no alternative diagnosis + chronic active inflammation on histology $\\rightarrow$ relief of symptoms after appendectomy\n(4) Mortality rate of $1 \\%$ (associated with perforation)\n\nCx: perforation (13-30-73\\%), abscess formation, peritonitis, wound infection, sepsis,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 690,
            "markdown": "infertility, adhesions, bowel obstruction, death\n$R x:$ an appendicolith is sufficient evidence to perform prophylactic appendectomy in asymptomatic patients ( $50 \\%$ have perforation / abscess formation at surgery)\n$D D x: \\diamond$ Only $22-38 \\%$ of children referred for suspected appendicitis actually have appendicitis\nNonsurgical mimickers: mesenteric adenitis, terminal infectious ileitis-ileocecitis (Yersinia, Salmonella, Campylobacter) / inflammation (Crohn disease)\nClinical mimickers: appendiceal mucocele, neoplasm\n\n# BANNAYAN-RILEY-RUVALCABA SYNDROME \n\n$=$ RUVALCABA-MYHRE-SMITH SYNDROME\nCause: autosomal dominant transmission\n\n- pigmented genital lesions\n$\\checkmark$ hamartomatous intestinal polyps (in $45 \\%$ ): usually in distal ileum + colon\n$\\checkmark$ macrocephaly\n$\\checkmark$ subcutaneous and visceral lipomas + hemangiomas\n\n\n## BARRETT ESOPHAGUS\n\n$=$ BARRETT SYNDROME\n[Norman Rupert Barrett (1903-1979), surgeon at St. Thomas Hospital in London, president of Thoracic Surgeons of Great Britain and Ireland in 1962]\n$=$ progressive replacement of stratified squamous epithelium by metaplastic columnar epithelium (Barrett epithelium) containing goblet cells but no parietal cells\nCause: chronic gastroesophageal reflux (GERD) $\\rightarrow$ reflux esophagitis $\\rightarrow$ epithelial injury $\\rightarrow$ epithelial metaplasia\nContributing factors:\ndelayed acid clearance, reduced acid sensitivity, hiatal hernia, duodenogastroesophageal reflux, reduced LES pressure, transient LES relaxation, alcohol, tobacco, obesity, chemotherapy, scleroderma ( $37 \\%$ ), genetic influence, S/P repair of esophageal atresia / esophagogastric resection / Heller esophagomyotomy\nHisto: (1) specialized columnar epithelium (proximal)\n(2) junctional-type epithelium (distal to (1))\n(3) fundic-type epithelium (most distally)\n\nPrevalence: in general $0.3-4 \\%$; in $7-10 \\%$ of patients with advanced chronic reflux esophagitis\nAssociated with: moderate + severe esophagitis ( $94 \\%$ ); NO / mild esophagitis (6\\%)\nAge: $0-15$ years and $40-88$ years (mean of 55 years); $\\mathrm{M}>\\mathrm{F}$; mainly among Whites\n\n- asymptomatic; dysphagia $\\leftarrow$ esophageal stricture\n- signs of reflux esophagitis: heartburn, substernal chest pain, regurgitation\n- low-grade upper intestinal bleeding\n\nLocation: middle to lower esophagus\n$\\diamond$ A stricture in the mid- to upper esophagus is less common but more specific for Barrett esophagus\nN.B.: the squamocolumnar junction is irregular and lies $>2-3 \\mathrm{~cm}$ orad from the GE junction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 691,
            "markdown": "Distribution: circumferential / focal\n> mucosal changes:\n$\\sqrt{ }$ fine reticular / granular mucosal pattern (3-30\\%) resembling areae gastricae of the stomach located at distal aspect of midesophageal stricture:\n$\\sqrt{ }$ netlike web of thin linear / intersecting barium-filled grooves or crevices surrounding small tufts of mucosa (DDx: reflux esophagitis, acanthosis, leukoplakia, superficial spreading carcinoma, moniliasis / herpes simplex / CMV esophagitis)\n$\\sqrt{ }$ thickened irregular mucosal folds ( $28-86 \\%$ )\n$\\sqrt{ }$ large deep wide-mouthed peptic ulcer (= Barrett ulcer) at upwardly displaced squamocolumnar junction / within columnar epithelium\n$\\sqrt{ }$ uptake of ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-pertechnetate by columnar epithelium\n> scarring:\n$\\sqrt{ }$ several-cm-long stricture ( $71 \\%$ ) in lower esophagus ( $60 \\%$ ) or upper to midesophagus below level of aortic arch ( $40 \\%$ ) [DDx: peptic stricture without Barrett esophagus]:\n$\\sqrt{ }$ ringlike constrictions / smooth tapered segments of concentric narrowing in midesophagus\n$\\sqrt{ }$ hiatal hernia $(75-94 \\%)$\n> functional:\n$\\sqrt{ }$ gastroesophageal reflux $(45-63 \\%)$\n$\\sqrt{ }$ distal esophageal widening $(34-66 \\%) \\leftarrow$ abnormal motility\n$D x$ : velvety pinkish red appearance of gastric-type mucosa extending from gastric mucosa into distal esophagus (endoscopy with biopsy)\n$C x$ : (1) Ulceration $\\pm$ penetration into mediastinum\n(2) Stricture\n(3) Adenocarcinoma: annual risk of $0.12 \\%$ (40-fold higher risk than in general population)\n$\\sqrt{ }$ plaquelike / focal irregularity / nodularity / sessile polyps\n$R x$ : (1) Stop smoking, avoid bedtime snacks + foods that lower LES pressure, lose excess weight\n(2) Suppress gastric acidity: antacids, $\\mathrm{H}_{2}$-receptor antagonists (cimetidine, ranitidine, famotidine), $\\mathrm{H}+\\mathrm{K}+$-adenosintriphosphatase inhibitor (omeprazole)\n(3) Improve LES pressure: metoclopramide, bethanechol\n(4) Esophageal resection in high-grade dysplasia\n\n# BEZOAR \n\n[padzahr, Persian = antidote, counterpoison]\n$=$ persistent concretions of foreign matter composed of accumulated ingested material in intestines\nPathophysiology: usually formed in stomach $\\rightarrow$ passing into small bowel as part / whole $\\rightarrow$ impaction\nFrequency: $0.4 \\%$ (large endoscopic series)\nEtiology: material unable to exit stomach because of large size, indigestibility, gastric outlet obstruction, poor gastric motility (diabetes, mixed connective tissue disease,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 692,
            "markdown": "myotonic dystrophy, hypothyroidism)\n\n# Predisposition: \n\nprevious gastric surgery (vagotomy, pyloroplasty, antrectomy, partial gastrectomy), inadequate chewing, missing teeth, dentures, massive overindulgence of food with high fiber contents\n\n- anorexia, bloating, early satiety / may be asymptomatic\n$\\checkmark$ well-defined focal ovoid mass of soft-tissue attenuation\n$\\checkmark$ mottled gas pattern\nCx: partial / complete small bowel obstruction\n$D D x$ : \"small bowel feces\" sign (amorphous, affects longer segment, related to adhesion)\n\n\n## Phytobezoar\n\n$=$ poorly digested fibers, skin + seeds of fruits and vegetables usually forming in stomach, $\\pm$ impaction in small bowel\nFrequency: $55 \\%$ of all bezoars\n\n- history of recent ingestion of pulpy foods\n\nFood: oranges, persimmons (most common, unripe persimmons contain the tannin shibuol that forms a gluelike coagulum after contact with dilute acid)\nSite of impaction: stomach, jejunum, ileum\n$\\sqrt{ }$ intraluminal filling defect without constant site of attachment to bowel wall\n$\\checkmark$ interstices filled with barium\n$\\checkmark$ coiled-spring appearance (rare)\nCx: decubitus ulceration + pressure necrosis of bowel wall, perforation, peritonitis\n$D D x$ : lobulated / villous adenoma, leiomyosarcoma, metastatic melanoma, intussusception\n\n## Trichobezoar\n\n[ trikho, thrix, Greek = hair]\nin $80 \\%<$ age 30 years, almost exclusively in females\nAssociated with: gastric ulcer in $24-70 \\%$\n\n## BLUE RUBBER BLEB NEVUS SYNDROME\n\n$=$ BEAN SYNDROME\n[William Bennett Bean (1909-1989), head of internal medicine at University of Iowa College of Medicine]\n$=$ rare familial disorder characterized by multiple cutaneous + musculoskeletal + gastrointestinal venous malformations predominantly afflicting GI tract (but also liver, spleen, heart, skeletal muscle, lung, kidney, thyroid, eyes, CNS)\nIncidence: $>200$ cases\nEtiology: sporadic / autosomal dominant\nPath: thin layer of connective tissue + single layer of endothelial cells surrounding bloodfilled ectatic vessels\n\n- blue to black soft rubbery painless $0.1-5.0 \\mathrm{~cm}$ cutaneous lesions evacuating under pressure + slow refilling (commonly present at birth $\\pm$ increase in size and number with age) $=$ cutaneous venous malformations\n- iron deficiency anemia $\\leftarrow$ chronic spontaneous hemorrhage",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 693,
            "markdown": "$\\sqrt{ }$ multiple polypoid filling defects of various sizes throughout small bowel $\\leftarrow$ venous malformations\n$\\sqrt{ }$ intermittent small bowel obstruction $\\leftarrow$ chronic bleeding\n$\\sqrt{ }$ multiple phleboliths\nMR:\n$\\sqrt{ }$ hyperintense lesions on T2WI $\\leftarrow$ slow flow / thrombosis\nCx: intussusception, volvulus; GI hemorrhage; chronic coagulation disorders; hemothorax; hypercalcemia; pressure erosion of bone, osseous + soft-tissue hypertrophy $\\leftarrow$ hypervascularity\n$D D x$ :\n(1) Maffucci syndrome (dyschondroplasia + osteochondromas + vascular malformations)\n(2) Klippel-Trénaunay-Weber syndrome (port wine stain, vascular malformations, limb hypertrophy)\n(3) Kasabach-Merritt syndrome (large vascular malformations + consumptive coagulopathy)\n(4) Kaposi sarcoma\n(5) Peutz-Jeghers syndrome (congenital polyposis + melanotic cutaneous lesions)\n(6) Gardner syndrome (soft-tissue tumors + sebaceous cysts)\n\n# BLUNT ABDOMINAL TRAUMA \n\nCT is imaging method of choice for evaluation of stable patients\nUS imaging in the detection of intraabdominal injury:\n$86 \\%$ sensitive, $99 \\%$ specific, $98 \\%$ accurate\n\n## Traumatic Hemoperitoneum\n\nPrevalence: 29-34\\% of patients with abdominal visceral injury have NO hemoperitoneum $\\leftarrow$ intraparenchymal laceration / contusion without penetration of organ capsule\nLocation: paracolic gutters, pelvis\n$\\diamond$ Most dependent portions in supine position: pouch of Morison (hepatorenal fossa) and pouch of Douglas (pelvic cul-de-sac)\n$\\checkmark$ hematocrit effect of fresh blood $=$ sedimented RBCs in the dependent portion of a hemoperitoneum\n\nNECT (negative predictive value of $99.6 \\%$ ):\n$\\sqrt{ }$ high-attenuation ascites $(\\sim 30-45 \\mathrm{HU}) \\leftarrow$ high protein content of unclotted extravascular blood\n$\\sqrt{ }$ \"sentinel clot\"(clotted blood attenuation typically $45-70 \\mathrm{HU}$ ) marks anatomic site + suggests source of bleeding\nCECT:\n$\\sqrt{ }$ high-density site of contrast extravasation $\\leftarrow$ active ongoing bleeding\n$\\sqrt{ }$ extravasation always surrounded by lower-density hematoma (DDx: extravasated oral contrast is not surrounded by lower-density material)\nCT findings requiring intervention:\n(1) Solid-organ injury with active arterial extravasation\n(2) Diaphragmatic injury",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 694,
            "markdown": "(3) Bowel and mesenteric injury\n(4) Injury to major vessel\n(5) Intraperitoneal bladder rupture\n\nUS:\n$\\sqrt{ }$ usually anechoic fluid accumulation in subhepatic space (= Morison pouch) > pouch of Douglas / paravesical space $>$ between bowel loops\n$D D x$ : bowel contents, urine, bile, ascites\n$\\sqrt{ }$ hemoperitoneum score $=$ depth of largest fluid collection in $\\mathrm{cm}+1$ point for each additional site with fluid (score of $\\leq 2$ managed conservatively)\n$\\sqrt{ }$ hyperechoic / occasionally isoechoic masses $\\leftarrow$ intraperitoneal clot\nPrognosis: $17 \\%$ of patients without hemoperitoneum require surgical / angiographic intervention\n$\\diamond$ Small pockets of fluid of $10-15 \\mathrm{HU}$ found in pelvis in $3-5 \\%$ of male trauma patients WITHOUT organ injury!\n$\\diamond$ Peritoneal lavage cannot quantify amount of hemoperitoneum $\\rightarrow 19-39 \\%$ rate of nontherapeutic surgeries\n$\\diamond$ The rate of bleeding + presence of active extravasation have the most direct effect on patient care decisions!\n$D D x$ of free intraperitoneal fluid $<20 \\mathrm{HU}$ :\nhemoperitoneum in anemic patient; simple ascites; bile; succus entericus in small bowel perforation; intraperitoneal urine from ruptured bladder\n\n# Hypovolemia = Hypoperfusion Complex \n\n$=$ manifestation of tenuous hemodynamic instability even after aggressive resuscitation efforts with IV fluids\n$\\sqrt{ }$ \"collapsed cava\" sign = persistent flattening of infrahepatic IVC + flattening of renal veins $\\leftarrow$ decreased venous return\nN.B.: abort CT examination as shock is imminent!\n$\\sqrt{ }$ small hypodense spleen $\\leftarrow$ decreased enhancement\n$\\sqrt{ }$ small aorta + mesenteric arteries $\\leftarrow$ intense vasoconstriction\n$\\sqrt{ }$ shock bowel:\n$\\sqrt{ }$ dilatation of fluid-filled intestines\n$\\sqrt{ }$ diffuse concentric thickening of small bowel\n$\\sqrt{ }$ intense enhancement $\\leftarrow$ vasoconstricted mesenteric vessels\n$\\sqrt{ }$ sparing of colon\n$\\sqrt{ }$ shock nephrogram $=$ increased enhancement of kidneys + lack of renal contrast excretion\n$\\sqrt{ }$ marked enhancement of adrenal glands\n$\\sqrt{ }$ intense pancreatic enhancement\n$\\sqrt{ }$ pancreatic + retroperitoneal edema\n\n## Fluid Overload\n\n$\\sqrt{ }$ diffuse thickening + edema of bowel wall\n$\\sqrt{ }$ distended IVC + hepatic veins\n$\\sqrt{ }$ heterogeneous \"nutmeg\" appearance of liver\n$\\sqrt{ }$ \"periportal collar\" = concentric halo of low attenuation around portal veins",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 695,
            "markdown": "| CECT Attenuation Values of Fluid* |  |\n| :--: | :--: |\n| $H U$ | Description |\n| $0-15-20$ | bile, urine, intestinal contents |\n| $30-45$ | fresh nonclotted blood (high proteinaceous content (less with low hematocrit / hemorrhage after 48 hour) |\n| $45-70-100$ | clotted blood (close to bleeding site $=$ sentinel clot sign); hematocrit effect ( $=$ sedimentation of RBCs with high attenuation) |\n| $85-(132)-370$ | active arterial contrast extravasation surrounded by large hematoma |\n| * during IV contrast administration and assuming an initially normal hematocrit without significant dilution from intraperitoneal fluid (ascites, urine, succus, lavage fluid) |  |\n| $D D x$ : (1) Water-soluble enteric contrast in ascites $=$ bowel perforation |  |\n| (2) IV contrast during urographic phase $=$ urinary ascites |  |\n\n# Blunt Trauma to Duodenum \n\n$\\checkmark$ retroperitoneal hematoma\n$\\checkmark$ stranding of retroperitoneal fatty tissue\n$\\checkmark$ thickening of duodenal wall\n\n1. Duodenal contusion\n$\\checkmark$ edema / hematoma of the duodenal wall\n$\\checkmark$ intramural gas accumulations\n$\\checkmark$ focal duodenal wall thickening $>4 \\mathrm{~mm}$\n$R x:$ conservative\n2. Hematoma of the duodenal wall\n3. Duodenal perforation and disruption\n$\\checkmark$ retroperitoneal collection of contrast (infrequent)\n$\\checkmark$ extraluminal gas\n$\\checkmark$ lack of continuity of duodenal wall\n\n## Blunt Trauma to Spleen (40\\%)\n\n$\\diamond$ Most frequently injured intraperitoneal organ in blunt abdominal trauma ( $40 \\%$ of abdominal organ injuries)\nAssociated with: other solid visceral / bowel injuries (29\\%); lower rib fractures in $44 \\%$, injury to left kidney in $10 \\%$, injury to left diaphragm in $2 \\%$\n$\\diamond 20 \\%$ of left rib fractures have splenic injury!\n$\\diamond 25 \\%$ of left renal injury have splenic injury!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 696,
            "markdown": "| Scoring of Duodenal Injury (1990) American Association for the Surgery of Trauma |  |  |\n| :--: | :--: | :--: |\n| Grade | Injury | Description |\n| I | hematoma laceration | involvement of single portion of duodenum |\n| II | hematoma laceration | involvement of $>1$ portion; disruption of $<50 \\%$ of circumference |\n| III | laceration | disruption of $50-75 \\%$ of circumference of $2^{\\text {nd }}$ segment, disruption of $50-100 \\%$ of circumference of $1 \\mathrm{st}, 3^{\\text {rd }}, 4^{\\text {th }}$ segment |\n| IV | laceration | disruption of $>75 \\%$ of circumference of $2^{\\text {nd }}$ segment or involvement of ampulla / distal CBD |\n| V | disruption | massive disruption of duodenopancreatic complex / duodenal devascularization |\n| The extent of transections cannot be reliably evaluated with CT! |  |  |\n\nTechnique: scanning delay of $60-70 \\mathrm{sec}$ to avoid heterogeneous splenic enhancement CECT ( $95 \\%$ accurate):\n$\\diamond$ CT not reliable to determine need for surgical intervention!\n$\\checkmark$ hemoperitoneum $\\leftarrow$ disruption of splenic capsule\n$\\checkmark$ \"sentinel clot\" (= area of $>60 \\mathrm{HU}$ adjacent to spleen) as sensitive predictor of injury $=$ perisplenic hematoma\n$\\checkmark$ active extravasation:\n$\\checkmark$ high-attenuation blush ( $80-370 \\mathrm{HU}$ )\n$\\checkmark$ focal high-attenuation area in / emanating from injured splenic parenchyma\n$\\checkmark$ growing larger with time (delayed phase imaging!)\nN.B.: active extravasation of contrast material requires emergent surgery in 83-93\\%\n$\\checkmark$ mottled parenchymal enhancement $=$ contusion\n$\\checkmark$ hypoattenuating line connecting opposing visceral surfaces = linear parenchymal defect $=$ splenic laceration:\n$\\checkmark$ almost always associated with hemoperitoneum\n$\\checkmark$ crescentic region of low attenuation along splenic margin flattening / indenting / compressing the normal parenchyma $=$ subcapsular hematoma\n$\\checkmark$ round hypodense inhomogeneous region $\\pm$ hyperdense clot $=$ intrasplenic hematoma\n$\\checkmark$ hypoattenuating hematoma with complete separation of splenic fragments $=$ laceration traversing two capsular surfaces $=$ splenic fracture\n$\\checkmark$ multiple lacerations = \"shattered spleen\"\nUS:\n$\\checkmark$ hyperechoic intraparenchymal region (= acute hematoma / laceration)\n$\\checkmark$ anechoic intralesional collection (= brisk hemorrhage)\n$\\checkmark$ diffusely heterogeneous parenchymal pattern containing hyper- and hypoechoic areas (= extensive splenic injury)\n$\\checkmark$ loss of normal organ contour $\\leftarrow$ perisplenic clot\nSequelae:\n(1) scar / fibrosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 697,
            "markdown": "(2) splenic pseudocyst (20-30 HU)\n(3) Vascular injury: pseudoaneurysm, AV fistula\n(4) delayed splenic rupture\n$=$ hemorrhage $>48$ hours after trauma\n\n| Categories of Splenic Injury (1994 Revision) American Association for the Surgery of Trauma |  |  |\n| :--: | :--: | :--: |\n| Grade | Injury | Description |\n| I | hematoma | subcapsular $<10 \\%$ of surface area |\n|  | laceration | capsular tear $<1 \\mathrm{~cm}$ of parenchymal depth |\n| II | hematoma | subcapsular $10-50 \\%$ of surface area; intraparenchymal $<5 \\mathrm{~cm}$ in diameter |\n|  | laceration | $1-3 \\mathrm{~cm}$ deep without involvement of trabecular vessel |\n| III | hematoma | subcapsular $>50 \\%$ of surface area; ruptured subcapsular / parenchymal hematoma; intraparenchymal $>10 \\mathrm{~cm} /$ expanding |\n|  | laceration | $>3 \\mathrm{~cm}$ parenchymal depth / involvement of trabecular vessels |\n| IV | laceration | involvement of segmental / hilar vessels with devascularization of $>25 \\%$ |\n| V | laceration | completely shattered spleen |\n|  | vascular | total splenic devascularization |\n| $\\checkmark$ Does not consider amount of hemoperitoneum, active bleeding, pseudoaneurysm, AV fistula |  |  |\n| N.B.: grade III or higher require more often surgical therapy! |  |  |\n\nCause: subcapsular hematoma\nPrevalence: $0.3-20 \\%$ of blunt splenic injuries\nTime of onset: in $70 \\%$ within 2 weeks of injury; in $90 \\%$ within 4 weeks of injury\nPrognosis: splenectomy / splenorrhaphy; $80-90 \\%$ success in nonoperative management\n$R x$ : up to $91 \\%$ of stable patients can be treated conservatively with observation; transcatheter embolization\n$\\diamond$ Preservation of spleen and its immune function $=$ standard of care\nDDx: (1) Normal lobulation / splenic cleft (smoothly contoured, medially located)\n(2) Adjacent unopacified jejunum simulating splenic tissue\n(3) Early differential enhancement of red and white pulp (scan obtained within 2050 seconds)\n(4) Perisplenic fluid from ascites / urine / succus / bile / lavage\n\n# Blunt Trauma to Liver (20\\%) \n\nPrevalence: $2^{\\text {nd }}$ most frequently injured abdominal viscus\nAssociated with: splenic injury in $45 \\%$\n\n- clinical manifestation often delayed by days / weeks\n\nLocation: right (posterior segment) $>$ left lobe\nSite: perivascular, paralleling right + middle hepatic arteries + posterior branches of right",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 698,
            "markdown": "portal vein, avulsion of right hepatic vein from IVC (13\\%)\n$\\diamond$ Left lobe injuries are more often associated with damage to duodenum, pancreas, transverse colon\nCECT:\n$\\sqrt{ }$ liver laceration $=$ predominantly irregular linear branching / round regions of low attenuation:\n(a) superficial $\\leq 3 \\mathrm{~cm}$ deep; (b) $>3 \\mathrm{~cm}$ in depth\n$\\diamond$ Most frequently identified injury pattern\nAssociated with:\n> retroperitoneal hematoma surrounding IVC $\\leftarrow$ posterosuperior segment VII laceration of bare area\n> hematoma involving adrenal gland\n> biloma $\\leftarrow$ laceration extending into porta hepatis\n$D D x$ : (1) beam-hardening artifact from adjacent ribs / from air-contrast level in stomach\n(2) Focal fatty infiltration\n\n| Categories of Liver Injury (1994 Revision)* <br> American Association for the Surgery of Trauma |  |  |\n| :--: | :--: | :--: |\n| Grade | Injury | Description |\n| I | hematoma | subcapsular $<10 \\%$ of surface area |\n|  | laceration | capsular tear $<1 \\mathrm{~cm}$ of parenchymal depth |\n| II | hematoma | subcapsular $10-50 \\%$ of surface area; intraparenchymal $<10 \\mathrm{~cm}$ in diameter |\n|  | laceration | $1-3 \\mathrm{~cm}$ deep and $<10 \\mathrm{~cm}$ long |\n| III | hematoma | subcapsular $>50 \\%$ of surface area; ruptured subcapsular / parenchymal; intraparenchymal $>10 \\mathrm{~cm} /$ expanding |\n|  | laceration | $>3 \\mathrm{~cm}$ parenchymal depth |\n| IV | laceration | parenchymal disruption 25-75\\% of lobe; $1-3$ Couinaud segments in single lobe |\n| V | laceration | disruption $>75 \\%$ of single lobe; $>3$ Couinaud segments in single lobe |\n|  | vascular | juxtahepatic venous injury (HV, IVC) |\n| VI | vascular | hepatic avulsion |\n| * Active bleeding, pseudoaneurysm, AV fistula are not considered! |  |  |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 699,
            "markdown": "![img-80.jpeg](img-80.jpeg)\n\n# $\\sqrt{ }$ liver hematoma: \n\n$\\sqrt{ }$ hyperattenuating mass in acute phase of 54 (range, 28-82) HU decreasing over time $\\leftarrow$ clotted blood:\n> intraparenchymal hematoma: single / multiple\n> subcapsular hematoma: lenticular / elliptical configuration flattening underlying liver margin\nResolution: usually within 6-8 weeks\n$\\sqrt{ }$ active (potentially life-threatening) liver hemorrhage:\n$\\sqrt{ }$ focal hyperattenuating area during early phase of 155 (range, 91-274) HU $\\leftarrow$ extravasated contrast material\nPrognosis: $75 \\%$ become hemodynamically unstable\n$R x$ : angiographic embolization\n$D D x$ : focal hyperdense area of $80-350 \\mathrm{HU}$ during early phase $\\leftarrow$ pseudoaneurysm / AV fistula\n$\\sqrt{ }$ major (life-threatening) hepatic venous injury\n$=$ liver laceration or hematoma extending into major hepatic vein / IVC\n$\\diamond 3.5 \\mathrm{x}$ more frequently associated with arterial bleeding\n$\\sqrt{ }$ focal / diffuse periportal tracking (in up to $22 \\%$ )\n$=$ areas of low attenuation paralleling portal vein + its branches $2^{\\circ}$ to\n> dissecting hemorrhage / bile\n> dilated engorged periportal lymphatics $\\leftarrow \\uparrow$ central venous pressure $\\leftarrow$ vigorous IV fluid administration / tension pneumothorax / pericardial tamponade\n$\\sqrt{ }$ flat IVC\n$=$ AP diameter $<1 / 4$ of IVC width not caused by external compression\nCause: hypovolemia, poor fluid resuscitation, shock\n$\\sqrt{ }$ hypodense wedge extending to liver surface $=$ focal hepatic devascularization\n$\\sqrt{ }$ hemoperitoneum $\\leftarrow$ violation of liver capsule with inability of liver veins to contract\n$\\sqrt{ }$ intrahepatic / subcapsular gas, usually $\\leftarrow$ necrosis\nUS:",
            "images": [
                {
                    "id": "img-80.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 187,
                    "bottom_right_x": 1319,
                    "bottom_right_y": 798,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 700,
            "markdown": "$\\sqrt{ }$ localized area of increased intraparenchymal echogenicity (= acute hematoma / laceration)\n$\\sqrt{ }$ widespread heterogeneous liver echogenicity + absence of normal vascular pattern (= global parenchymal injury)\n$C x:$ in $5-23 \\%$\n(1) delayed hemorrhage(2-6\\%)\n(2) abscess $(0.6-4 \\%) \\leftarrow$ superinfection of hematoma / biloma / devascularized hepatic parenchyma\n(3) pseudoaneurysm ( $1 \\%$ ) $\\rightarrow$ hemobilia, melena, hematemesis (decompression into biliary system)\n(4) bile peritonitis\n(5) biliary fistula: external (to skin / hollow viscus), internal (to intestine / bronchus), biliovascular (to hepatic artery, portal / hepatic vein)\n$R x:$ conservative treatment in up to $80 \\%$ in adults $+97 \\%$ in children; transcatheter embolization\nPrognosis: healing in 1-6-15 months; 4-12\\% mortality\n\n# Blunt Trauma to Gallbladder (2\\%) \n\nAssociated with: injury to liver ( $91 \\%$ ), duodenum (54\\%), spleen (54\\%)\n$\\sqrt{ }$ pericholecystic fluid (extraperitoneal location of GB)\n$\\sqrt{ }$ free intraperitoneal fluid\nCECT:\n$\\sqrt{ }$ blurred contour of GB\n$\\sqrt{ }$ focal thickening / discontinuity of GB wall\n$\\sqrt{ }$ intraluminal enhancing mucosal flap\n$\\sqrt{ }$ blood within GB lumen $=$ attenuation $>50 \\mathrm{HU}$\n$\\sqrt{ }$ mass effect on adjacent duodenum\n$\\sqrt{ }$ collapsed $\\mathrm{GB} \\leftarrow \\mathrm{~GB}$ rupture\n$\\sqrt{ }$ focal periportal tracking $\\leftarrow$ GB rupture\nUS:\n$\\sqrt{ }$ focal hypoechoic thickening\n$\\sqrt{ }$ echogenic mass within GB lumen\n\n## Blunt Trauma to GI Tract (5\\%)\n\n$\\diamond 3^{\\text {rd }}$ most common type of injury from blunt trauma to abdominal organs\nCause in children: MVA (lap belts), bicycle handle bar, child abuse\nMay be associated with: Chance fracture; traumatic hernia (disruption of the rectus abdominis m.)\nMechanism:\n(1) crush / compression injury: direct force; near spine\n(2) burst injury: sudden increase in intraluminal pressure\n(3) shear injury: rapid deceleration at points of transition between mobile and fixed bowel portions\nLocation: jejunum distal to ligament of Treitz $>$ duodenum $>$ ascending colon at ileocecal valve $>$ descending colon $>$ distal ileum near ileocecal valve",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 701,
            "markdown": "- Classic triad (in only 33\\%):\n- abdominal pain + tenderness ( $100 \\%$ sensitive)\n- abdominal rigidity; absent / decreased bowel sounds\n- $\\uparrow$ temperature + heart rate; $\\downarrow$ urine output over 24 hours\n- lap belt ecchymosis (not highly correlated)\n- Lavage: $90 \\%$ sensitive for hemoperitoneum $\\rightarrow$ compromises interpretation of CT exam\nN.B.: clinical signs + symptoms may be delayed for 24 hours (increasing mortality to 65\\%)\n\nUS:\n$\\sqrt{ }$ nonspecific free intraabdominal fluid ( $86 \\%$ sensitive, $98 \\%$ specific)\nNECT:\n$\\sqrt{ }$ abdominal wall injury: SQ fat stranding (\"seat belt\" sign) $\\leftarrow$ hematoma $\\leftarrow$ tear\n$\\sqrt{ }$ extraintestinal free air ( $30-60 \\%$ sensitive, $95 \\%$ specific):\n$\\checkmark$ intraperitoneal air: small gas bubbles anteriorly near liver / trapped within leaves of mesentery (with small bowel perforation) / porta hepatis\n$\\checkmark$ retroperitoneal air (with disruption of duodenum / rectum / colon)\n$D D x$ of free air:\n$\\diamond$ Most bowel perforations have no free gas due to:\n(a) spontaneous seal of perforation\n(b) developing ileus $\\rightarrow$ no passage of gas\n(c) rapid reabsorption of small gas collections\n$\\checkmark$ intramural air\n$\\checkmark$ hypodense free fluid ( $90-100 \\%$ sensitive, $15-25 \\%$ specific), particularly in interloop\nlocation $\\leftarrow$ perforation\n$D D x$ : parenchymal organ injury / osseous injury / large vessel injury / bladder perforation\n$\\sqrt{ }$ \"sentinel clot\" sign adjacent to bowel\nCECT ( $84-94 \\%$ sensitive, $84-99 \\%$ accurate):\n@ bowel injury (CT $94 \\%$ sensitive, $88 \\%$ accurate)\nLocation: small bowel (proximal jejunum, distal ileum) $>$ colon $>$ stomach\n$\\checkmark$ extravasation of oral contrast material ( $8-15 \\%$ sensitive, $100 \\%$ specific), densest near perforation\n$D D x$ : hyperattenuating blood, extravasating vascular contrast material, leak of contrast material $\\leftarrow$ ruptured urinary tract\n$\\checkmark$ focal discontinuity of bowel wall = direct evidence ( $5-10 \\%$ sensitive, $100 \\%$ specific)\n$\\checkmark$ focal bowel wall thickening $>3 \\mathrm{~mm}$ (= intramural hematoma [55-75\\% sensitive, $90 \\%$ specific] / vascular compromise and inflammation $\\leftarrow$ spilling of bowel contents):\n$\\checkmark \\pm$ intestinal obstruction / ileus\n$D D x$ : lack of bowel distension\n$\\checkmark$ abnormal bowel wall enhancement ( $10-15 \\%$ sensitive, $90 \\%$ specific):\n$\\checkmark$ hyperdense contrast enhancement of injured bowel wall $\\leftarrow$ delayed venous transit time $(20 \\%)$\n$\\checkmark$ lack of bowel wall enhancement $(13 \\%) \\leftarrow$ bowel infarct, highly SPECIFIC",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 702,
            "markdown": "$\\sqrt{ }$ duodenal submucosal / subserosal hematoma $\\rightarrow$ gastric outlet obstruction\n@ mesenteric injury (CT $96 \\%$ sensitive, $96 \\%$ accurate)\n$\\sqrt{ }$ mesenteric contrast extravasation $(17 \\%)$\n$\\sqrt{ }$ mesenteric vascular beading $(39 \\%)=$ change in caliber\n$\\sqrt{ }$ abrupt termination of mesenteric artery / vein ( $35 \\%$ )\n$\\sqrt{ }$ mesenteric infiltration ( $70-77 \\%$ sensitive, $40-90 \\%$ specific $=$ haziness + fat\nstranding $=$ streaky hyperattenuating infiltration / fluid at mesenteric root $\\leftarrow$\nhemorrhage + inflammatory response\n$D D x$ : retractile mesenteritis\n$\\sqrt{ }$ mesenteric rent $\\rightarrow$ internal hernia\n$\\sqrt{ }$ mesenteric hematoma ( $39 \\%$ )\n$\\sqrt{ }$ mesenteric pseudoaneurysm\n$C x$ : peritonitis, sepsis, hemorrhage\nPrognosis: delay in diagnosis by 8-12 hours increases morbidity + mortality from peritonitis + sepsis\n$R x$ : surgery based on clinical assessment alone has a $40 \\%$ negative laparotomy rate\n\n| CT in Blunt Trauma to Bowel and Mesentery |  |  |\n| :--: | :--: | :--: |\n| Specific CT Findings |  | Less Specific Findings |\n| Bowel | Free intraperitoneal air | Bowel wall thickening |\n|  | Bowel discontinuity | Abnormal wall enhancement |\n|  | Extraluminal contrast | Mesenteric fat stranding / <br> fluid / air |\n| Mesentery | Extravasation | Mesenteric fat stranding |\n|  | Vascular beading | Mesenteric hematoma |\n|  | Abrupt vessel termination | Abnormal bowel wall thickening / enhancement |\n\n# Blunt Trauma to Pancreas (3\\%) \n\nMechanism: compression against vertebral column with shear across pancreatic neck\nFrequency: $<10 \\%$ of childhood trauma\nCause: motor vehicle accident ( $\\rightarrow$ compression by seat belt /steering wheel), fall onto handle bars of a bicycle, child abuse\n\n| Scoring of Pancreatic Injury (1990) American Association for the Surgery of Trauma |  |  |\n| :--: | :--: | :--: |\n| Grade | Injury | Description |\n| I | hematoma | minor contusion without duct injury |\n|  | laceration | superficial laceration without duct injury |\n| II | hematoma | major contusion without duct injury |\n|  | laceration | major laceration without duct injury |\n| III | laceration | distal transection / parenchymal injury with duct injury |\n| IV | laceration | proximal transection / parenchymal injury involving ampulla / bile duct |\n| V | disruption | massive disruption of pancreatic head |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 703,
            "markdown": "Associated with: injury to liver ( $47 \\%$, typically left lobe), spleen (28\\%), stomach (42\\%), duodenum ( $19 \\%$, typically in younger patients), major vessel ( $41 \\%$ ), kidney $(23 \\%)$\nClassification:\nI minor contusion / hematoma, capsule + major duct intact\nII parenchymal injury without major duct injury\nIII major ductal injury\nIV severe crush injury\n\n- epigastric/ diffuse abdominal pain, vomiting\n- leukocytosis, $\\uparrow$ serum amylase activity\n\nLocation: pancreatic body $(65 \\%)>$ tail / head\nCT ( $70-95 \\%$ sensitive):\n$\\checkmark$ within first 12 hours normal CT findings in $20-40 \\% \\rightarrow$ repeat CT at $24-48$ hours\n$\\checkmark$ posttraumatic pancreatitis:\n$\\checkmark$ edema / fluid in peripancreatic fat\n$\\checkmark$ focal / diffuse pancreatic enlargement\n$\\checkmark$ irregularity of pancreatic contour\n$\\checkmark$ focal area of low-attenuation / enlargement\n(1) contusion = diffuse / localized hypoattenuating area within normally enhancing parenchyma\n(2) laceration (actual site of laceration difficult to visualize)\nN.B.: pancreatic laceration of $>50 \\%$ of pancreatic diameter suggests ductal injury. Evaluation of the integrity of the main pancreatic duct remains the critical role of MRCP!\n(3) transection (fracture) = hypoattenuating linear findings with separated parenchyma\n$\\checkmark$ pancreatic hematoma $=$ mixed / slightly hyperattenuating lesion within margins / in contact with parenchyma\n$\\checkmark$ fluid / blood accumulation:\n(a) alongside superior mesenteric artery\n(b) in transverse mesocolon / lesser sac\n(c) fluid between pancreas and splenic vein (in up to $90 \\%$ )\n$\\checkmark$ thickening of anterior pararenal fascia\nMorbidity: $11-62 \\%$\nMortality: $5 \\%$\nRx: I + II conservative management\nIII + IV need for surgery within 24 hours\nendoscopic stent placement for duct injury\n$C x:$ pancreatic fistula ( $23 \\%$ ), posttraumatic pancreatitis ( $10 \\%$ ), pseudocyst (5\\%), pseudoaneurysm, pneumonia, abscess (increases mortality to 20\\%)\n\n# BOERHAAVE SYNDROME \n\n[Herman Boerhaave (1668-1738), professor of clinical medicine, botany and chemistry at the University of Leiden, Netherlands]\n$=$ spontaneous emetogenic injury resulting in rupture of esophagus $\\rightarrow$ extrusion of gastric content into mediastinum / pleural space",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 704,
            "markdown": "Frequency: $1 \\div 6,000$ persons\nAge: middle-aged men (in $50 \\%$ with history of alcoholism / heavy drinking)\nCause: violent retching $\\leftarrow$ food bolus impaction\nPathophysiology:\nincomplete cricopharyngeal relaxation during sudden increase in intraabdominal pressure while vomiting $\\rightarrow$ abrupt increase in intraluminal esophageal pressure (barotrauma) in the presence of a moderate to large amount of gastric contents $\\rightarrow$ complete transmural disruption of esophageal wall\n\n# - Mackler triad: \n\n- episode of severe retching + forceful vomiting\n- sudden excruciating chest pain (substernal, left chest, neck, pleuritic, epigastric); subcutaneous emphysema\n- odynophagia, tachypnea, cyanosis, fever, shock\n- No hematemesis (blood escapes outside esophageal lumen)\n$\\sqrt{ }$ rent of $2-5 \\mathrm{~cm}$ in length\nLocation: $3-6 \\mathrm{~cm}$ above diaphragm ( $=2-3 \\mathrm{~cm}$ above GE junction), predominantly in left posterolateral wall\nCXR:\n$\\sqrt{ }$ mediastinal widening\n$\\sqrt{ }$ air-fluid level within mediastinum\n$\\sqrt{ }$ extravasation of contrast into mediastinum / pleura\n$\\sqrt{ }$ pneumomediastinum (single most important plain-film finding), pneumopericardium, subcutaneous air:\n$\\sqrt{ }$ \"V\" sign of Naclerio = localized mediastinal emphysema with air between lower thoracic aorta + diaphragm\n[Emil A. Naclerio (1915-1985), thoracic surgeon at Harlem and Columbus Hospitals in New York City]\n$\\sqrt{ }$ pleural effusion on left $>>$ right side / hydropneumothorax\n$\\sqrt{ }$ subcutaneous emphysema\n$\\sqrt{ }$ patchy pulmonary infiltrate\nEsophagography(modality of choice):\nTechnique: initially hydrosoluble contrast medium (in 10\\% falsely negative) followed by barium if negative\n$\\sqrt{ }$ submucosal collection\n$\\sqrt{ }$ extravasation of contrast material\n$\\sqrt{ }$ esophagopleural fistula (most commonly on left)\nThe use of hydrosoluble contrast material is preferred over barium in suspected esophageal rupture $\\rightarrow$ risk for mediastinitis as a result of irritation caused by barium.\nCT:\n$\\sqrt{ }$ esophageal wall thickening\n$\\sqrt{ }$ supradiaphragmatic periesophageal air collection\n$\\sqrt{ }$ mediastinal fluid collection + pneumomediastinum\n\n\n## BRUNNER GLAND HAMARTOMA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 705,
            "markdown": "[Johann Conrad Brunner (1653-1727), Swiss professor of anatomy and physiology at the University of Heidelberg, Germany]\nTerminology:\nBrunner gland hamartoma $\\leq 5 \\mathrm{~mm}$ in diameter\nBrunner gland hyperplasia $>5 \\mathrm{~mm}$ in diameter\nPrevalence: $1.2 \\%$ of all gastric polyps; $5 \\%$ of all duodenal masses\nEtiology: response to gastric acid in duodenum $\\rightarrow$ glands protect duodenal epithelium + optimize pH for pancreatic enzyme activity\nHisto: diffusely enlarged hyperplastic glands of Swiss cheese appearance and variable amounts of adipose + smooth muscle + lymphoid tissue + sclerosis\nPhysiology: mucosal + submucosal Brunner glands contain mucous + serous cells $\\rightarrow$ secrete a clear viscous alkaline mucus into crypts of Lieberkühn\nAge: manifest in middle age; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\n\n- incidental / symptomatic (abdominal pain)\n\nMORPHOLOGIC TYPES:\n\n1. Diffuse nodular hyperplasia: throughout duodenum\n2. Circumscribed nodular hyperplasia: in suprapapillary portion\n3. Single glandular adenoma with polypoid tumorlike dimensions\n\nLocation: duodenum ( $70 \\%$ bulb, $26 \\% 2^{\\text {nd }}$ portion, $4 \\% 3^{\\text {rd }}$ portion); prepyloric region (distribution of duodenal glands from vicinity of pylorus to proximal $2 / 3$ of duodenum)\nMean size: 2.0 (range, $0.5-6.0$ ) cm ; rarely up to 11 cm\nUGI:\n$\\sqrt{ }$ multiple nodular filling defects (usually limited to $1^{\\text {st }}$ portion of duodenum) with \"cobblestone appearance\" (most common finding)\n$D D x$ : polyposis syndromes, lymphoid hyperplasia, heterotopic gastric mucosa, nodular duodenitis\n$\\checkmark$ smooth single mass $\\pm$ central ulceration\n$D D x$ : adenomatous polyp, lipoma, leiomyoma, leiomyosarcoma, lymphoma, ectopic pancreatic tissue, GIST, carcinoid tumor, adenocarcinoma, pancreatic neoplasm, ampullary neoplasm\nEndoscopic US:\n$\\diamond$ Guides appropriate depth of endoscopic biopsy!\n$\\checkmark$ heterogeneous echogenicity with various amounts of solid + cystic components\nNECT:\n$\\checkmark$ isoattenuating relative to pancreas\nCECT:\n$\\checkmark$ hypoattenuating relative to pancreas (portal venous phase)\n$\\checkmark$ peripheral rim enhancement (of duodenal mucosa)\nCx: GI bleeding (chronic melena, hematemesis), intestinal obstruction, intussusception\n\n# BURKITT LYMPHOMA \n\n$=$ highly aggressive B-cell lymphoma usually found in children or immunocompromised adults [initially described in a 7-year old Ugandan child in 1958 by Denis Parsons Burkitt (19111993), Irish surgeon on Medical Research Council in London]",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 706,
            "markdown": "Prevalence: $1-2 \\%$ of all NHLs; $1-5 \\%$ of primary gastrointestinal NHLs in adults\n$\\diamond$ Most common (30-50\\%) type of pediatric NHL in children $<15$ years in USA and western Europe.\nOrigin: undifferentiated small noncleaved B-cell-derived lymphocyte\nHisto: uniform deeply basophilic medium-sized cells containing round nuclei with distinct chromatin and multiple nucleoli; characteristic \"starry sky\" pattern (= scattered macrophages containing apoptotic cellular debris on a basophilic background) at light microscopy; $99 \\%$ proliferation index\nGenetics: translocation of c-Myc oncogene with one of immuno- globulin genes, most frequently $\\mathrm{t}(8 ; 14)(\\mathrm{q} 24 ; \\mathrm{q} 32)$\nGrowth rate: fastest growing of all human tumors with a doubling time of about 24 hours\nRx: dramatic response to chemotherapy\nPrognosis: 90-98\\% 5-year survival rate in children with localized disease: 75-89\\% 2-year disease-free survival rate in children with advanced disease; $50-70 \\%$ survival in adults\n\n# Endemic / African Form of Burkitt Lymphoma \n\nEndemic in areas with malaria:\nsub-Saharan Africa, New Guinea (exposure to Plasmodium falciparum has a synergistic effect causing a marked decrease in T-cell surveillance)\nIncidence in central Africa:\n$50-80 \\%$ of all childhood neoplasms\nAssociated with: Epstein-Barr virus infection in 95\\% (implicated as B-cell mitogen in oncogenesis); malaria\nAge: $\\quad 3-10$ years\n@ Mandible > maxilla / facial bones\n\n- jaw mass; exophthalmos (orbital extension)\n$\\checkmark$ grossly destructive lesion, spicules of bone growing at right angles\n$\\checkmark$ large soft-tissue mass\n@ Other skeleton (multifocal in 10\\%)\n$\\checkmark$ reminiscent of Ewing tumor / reticulum cell sarcoma\n$\\checkmark$ lamellated periosteal reaction around major long bones\n\n\n## Sporadic / American Form of Burkitt Lymphoma\n\n$=$ NONENDEMIC FORM OF BURKITT LYMPHOMA\n$=$ typically manifests with bulky disease because of its rapid doubling time\nIncidence in Europe + North America:\n$35-45 \\%$ of all pediatric NHL; $3 \\%$ of all childhood tumors\nMedian age: 8 (range, 6-15) years; $1 / 3$ between 5 and 9 years; unusual in children $<5$ years; most frequently in white boys\n\n- paraplegia; NO peripheral leukemia\n- Epstein-Barr virus genome found in only a minority\n$\\diamond$ Widespread extraintestinal disease at presentation (mesenteric $\\pm$ retroperitoneal",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 707,
            "markdown": "lymphadenopathy) in $70 \\%$ !\n@ Gastrointestinal tract (22-69\\%)\n\n- abdominal mass, intestinal obstruction\n- acute abdominal complaints (30-40\\%)\n\nLocation: terminal ileum, ileocecal region (Peyer patches), mesentery $>>$ stomach, colon\n$\\sqrt{ }$ well-defined sharply marginated homogeneous large abdominal and pelvic masses $(31-64 \\%)$ :\n$\\checkmark$ encasement of bowel and mesenteric vessels\n$\\checkmark$ invading bowel wall $\\rightarrow$ obstruction\n$\\checkmark$ central necrosis in large tumor\n$\\checkmark \\pm$ enlarged abdominal lymph nodes\n$\\checkmark$ malignant ascites $(25 \\%-63 \\%)$\n$\\checkmark$ peritoneal thickening / nodularity ( $42 \\%$ ) along liver capsule and peritoneal reflections\n$\\leftarrow$ intraperitoneal seeding\n$\\checkmark$ usually intraabdominal extranodal involvement with sparing of spleen\nBarium:\n$\\checkmark$ displacement of bowel loops by a large mass\n$\\checkmark$ abnormally separated bowel loops $\\leftarrow$ extensive bowel wall thickening\n$\\checkmark$ narrowing of distal ileum\nUS:\n$\\checkmark$ large hypoechoic masses $\\pm$ engulfing of bowel / mesenteric vessels\n$\\checkmark$ cystic central areas $\\leftarrow$ necrosis\n$\\checkmark$ omental caking (unusual)\nCT:\n$\\checkmark$ bowel wall thickening / mural masses\n$\\checkmark$ \"sandwich\" sign = enhancing vessels surrounded by mildly enhancing confluent mesenteric mass\nMR:\n$\\checkmark$ isointense to muscle on T1WI + T2WI:\n$\\checkmark$ homogeneous T1 hypointensity\n$\\checkmark$ heterogeneous intermediate-to-high SI on T2WI\n$\\checkmark$ intense homogeneous enhancement\n$\\checkmark$ bright round-to-ovoid lesions $>10 \\mathrm{~mm}$ in size with restricted diffusion $\\leftarrow$ lymph node involvement\nPET/CT:\n$\\checkmark$ highly FDG avid\n$C x$ : intussusception, aneurysmal dilatation, perforation\n$\\diamond$ Most common cause of intussusception in children $\\geq 4$ years\n$\\diamond$ Intussusception and aneurysmal dilatation of bowel suggest lymphoma.\n@ Abdominal organs\n$\\checkmark$ multiple hypoechoic / hypoattenuating lesions of liver + spleen\n$\\checkmark$ periportal hypoattenuation\n@ Genitourinary tract $(20 \\%)$\nInvolvement of: kidneys, retroperitoneum, ovary, uterus",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 708,
            "markdown": "$\\checkmark$ multiple hypoechoic / hypoattenuating renal masses / diffuse renal enlargement (5\\%)\n$\\checkmark$ hydronephrosis ( $28 \\%$ )\n$\\checkmark$ retroperitoneal Burkitt may extend into spinal canal\n@ Chest\n$\\checkmark$ pleural effusion (most common chest abnormality)\n@ CNS\n$\\checkmark$ meningeal infiltration (most commonly)\n$\\checkmark$ cavernous sinus invasion\n$\\checkmark$ supra- and parasellar tumor\n$\\checkmark$ epidural spinal mass $\\pm$ spinal cord compression\n@ Others\nsalivary glands, thyroid, bone marrow\n\n# Immunodeficiency-associated Burkitt Lymphoma \n\nPrevalence: in up to $40 \\%$ of NHLs in HIV-positive patients\nPrognosis: $50-70 \\%$ survival in adults\n\n## CARCINOID SYNDROME\n\n$=$ constellation of clinical findings related to secretion of serotonin + other vasoactive peptides by tumor\nFrequency:\n> in 7-9\\% of small bowel carcinoids (most commonly in ileal carcinoids) $\\leftarrow$ metastases to liver + retroperitoneal Lnn.\n> in only $0.7 \\%$ of pulmonary carcinoids $\\leftarrow$ rarely metastasize to liver\n> in $2-5 \\%$ of pulmonary carcinoids $\\rightarrow$ developing hepatic metastases during follow-up period\nCause: excess serotonin + tachykinin levels in systemic circulation produced by some carcinoids\nAssociated with: hepatic / retroperitoneal metastases\nSerotonin metabolism:\nnormally, platelets take up + store circulating serotonin; excess serotonin is inactivated by liver, lung, brain and transformed to 5-hydroxyindoleacetic acid (5-HIAA)\nPathophysiology:\nvasoactive substances enter systemic circulation by escaping hepatic degradation $\\rightarrow$ thus bypassing hepatic metabolic pathway to 5-HIAA with\n(a) metastases to liver / retroperitoneal nodes\n(b) primary pulmonary / ovarian carcinoids\n\n- attacks precipitated / exacerbated by ingestion of food / alcohol emotional stress, exercise\n- colicky abdominal pain, recurrent intractable diarrhea ( $70 \\%$ )\n- asthmatic wheezing $\\leftarrow$ bronchospasm ( $15 \\%$ ) caused by tachykinin + bradykinin; excess 5HIAA in urine\n- nausea \\& vomiting, fever, hypotension (vasomotor instability)\n- right-sided endocardial fibroelastosis ( $40-50 \\%$ )\n- skin changes:\n- cutaneous facial flushing + sweating (rare)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 709,
            "markdown": "- desquamative skin lesions (5\\%)\n- pellagra ( $7 \\%$ ) from niacin deficiency $\\leftarrow$ preferential conversion of dietary tryptophan to serotonin rather than niacin\n- multiple telangiectasias ( $25 \\%$ )\n\nPrognosis: carcinoid syndrome has a higher morbidity \\& mortality than does the tumor itself!\n\n# CARCINOID TUMOR OF GI TRACT \n\n$=$ NEUROENDOCRINE TUMOR OF GI TRACT\n[Karzinoide, German = carcinoma-like]\n$=$ group of well-differentiated tumors of the diffuse endocrine system outside pancreas + thyroid\nCommonality: neuroendocrine cells share several antigens with nerve elements (neuroendocrine markers)\nNeuroendocrine system:\n$\\diamond$ The majority of neuroendocrine tumors occur within the gastroenteropancreatic (GEP) axis\n(a) adrenal medulla, pancreatic islets, paraganglia\n(b) parathyroid, pituitary, thyroid C cells\n(c) others:\n> GI tract: from hypopharynx to rectum (67-85\\%)\n> tracheobronchial system (10-29\\%)\n> biliary tract, gallbladder, liver\n> kidney, urethra, ovary, testis, skin (8\\%)\nInheritance: sporadic (mostly) / part of complex familial endocrine cancer syndrome (MEN 1, NF 1)\nFrequency: $\\quad 1.9 \\div 100,000$ annually worldwide $2^{\\text {nd }}$ most common primary tumor of small bowel\nOrigin: enteroendocrine cells that populate mucosa + submucosa; belong to APUDomas (like pheochromocytoma, medullary carcinoma of thyroid, islet cell tumors of pancreas)\nAverage age: 61 years; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 1$\nPath: firm white / yellow / grey firm submucosal nodule arising from argentophil Kulchitsky cells of epithelial origin in the crypts of Lieberkühn (= argentaffinoma $\\leftarrow$ affinity for silver stain marking serotonin-containing granules of enterochromaffin EC-cells); invasion of mesentery incites an intense fibrotic reaction\nOften the tumor bulk is subepithelial, and they should be included in the DDx of submucosal tumors.\nHisto: solid acinar / insular nests of closely packed monomorphic cells, uniform in size, arranged in trabecular / glandular rosette pattern; cytoplasma contains argyrophil secretory granules arranged in distinctive \"salt and pepper\" pattern of nuclear chromatin; low-grade malignancy resembling adenocarcinoma without its aggressive behavior; malignant through invasion of muscularis\nImmunohisto: chromogranin, synaptophysin, neuron-specific enolase, protein gene product 9.5, peptide markers for serotonin and gastrin\nClassification based on malignant potential:\n\n1. Well-differentiated neuroendocrine tumor (typical carcinoid tumors) $\\rightarrow$ low-grade malignancy\n2. Well-differentiated neuroendocrine carcinoma (atypical carcinoid tumor) with metastases",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 710,
            "markdown": "$\\rightarrow$ more aggressive\n3. Poorly differentiated neuroendocrine carcinoma of high-grade malignancy $\\rightarrow$ poor prognosis\n(a) Large cell neuroendocrine carcinoma (LCNEC)\n(b) Small cell lung carcinoma (SCLC) = majority\n\nBiochemistry:\ntumor elaborates excessive amounts of vasoactive substances + neuropeptides (1) ACTH (2) histamine (3) bradykinin (4) kallikrein (5) prostaglandin (6) substance P (7) neurokinin-A (8) serotonin (= 5-hydroxytryptamine $\\leftarrow 5$-hydroxytryptophan $\\leftarrow$ tryptophan), which is metabolized (inactivated) in liver by monamine oxidase into 5-hydroxyindole acetic acid (5HIAA) and excreted in urine; 5-hydroxytryptophan is destroyed in pulmonary circulation Associated with: other synchronous / metachronous malignancies ( $36 \\%$ at necropsy), especially gastrointestinal adenocarcinoma; neurofibromatosis type 1\n\n- asymptomatic (66\\%), abdominal pain / bowel obstruction (19\\%)\n- nausea, weight loss (16\\%), palpable mass (14\\%), GI bleeding\n- elevated serum chromogranin-A (most common marker)\n- elevated urinary 5-HIAA (hydroxyindole acetic acid)\n- carcinoid syndrome\n\nRULE OF $1 / 2: \\quad 2 / 3$ occur in small bowel\n$\\diamond 1 / 3$ have metastases\n$\\diamond 1 / 3$ are multiple\n$\\diamond 1 / 3$ have a second malignancy\n$\\diamond 1 / 3$ have carcinoid syndrome\nMetastases ( $\\sim 40 \\%$ at time of presentation):\nmesenteric lymph nodes, liver (in $90 \\%$ of patients with carcinoid syndrome), peritoneum, lung, bone (osteoblastic)\n$\\diamond$ Symptomatic metastases $\\leftarrow$ midgut carcinoids in $75 \\%$\n(a) incidence versus tumor size\ntumor of $<1 \\mathrm{~cm}$ (in $75 \\%$ ) metastasizes in $2 \\%$\ntumor of $1-2 \\mathrm{~cm}$ (in $20 \\%$ ) metastasizes in $50 \\%$\ntumor of $>2 \\mathrm{~cm}$ (in $5 \\%$ ) metastasizes in $85 \\%$\n(b) incidence versus location\ntumor in ileum (in 28\\%) metastasizes in 35\\%\ntumor in appendix (in 46\\%) metastasizes in 3\\%\ntumor in rectum (in 17\\%) metastasizes in $1 \\%$\n\n| Visualization of Liver Metastases |  |  |\n| :-- | :--: | :--: |\n|  | best seen at | present at |\n| NECT | $35 \\%$ | $3 \\%$ |\n| CECT in HAP | $35 \\%$ | $14 \\%$ |\n| CECT in PVP | $30 \\%$ | $3 \\%$ |\n| HAP $=$ hepatic arterial-dominant phase of triple phase CT |  |  |\n| PVP $=$ portal venous-dominant phase of triple phase CT |  |  |\n\nLocation within GI tract:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 711,
            "markdown": "$\\diamond 30 \\%$ are multicentric (Examine entire bowel!)\n@ Small bowel ( $42 \\%$ )\nFrequency: $25 \\%$ of all small bowel tumors\nLocation: ileum ( $91 \\%$ ); jejunum ( $7 \\%$ ), duodenum ( $2 \\%$ ); multiple in 15-29-41\\%\n@ Rectum ( $27 \\%$ )\n@ Appendix ( $24 \\%$ )\n@ Stomach ( $9 \\%$ )\n@ Colon ( $5 \\%$ )\n@ Esophagus ( $0.05 \\%$ )\nLocation outside GI tract:\n@ Respiratory tract ( $20-30 \\%$ )\n@ Others: thyroid, pancreas, biliary tract, teratomas (ovarian, sacrococcygeal, testicular)\nSite: intramural mass / intraluminal polypoid nodule\nUGI:\n$\\sqrt{ }$ small smooth submucosal mass (usually $<2 \\mathrm{~cm}$ ) impinging eccentrically on lumen\n$\\sqrt{ } \\pm$ ulceration of overlying gastric / intestinal mucosa\n$\\sqrt{ }$ desmoplastic fibrotic response of mesentery $\\leftarrow$ high levels of serotonin $\\leftarrow$ local production by nodal metastases:\n$\\sqrt{ }$ angulation + kinking of loops $\\rightarrow$ obstruction (DIAGNOSTIC)\n$\\sqrt{ }$ spiculated / tethered appearance of mucosal folds\n$\\sqrt{ }$ matting of multiple loops\n$\\sqrt{ }$ separation of loops $\\leftarrow$ large mesenteric metastases\nCT:\n$\\sqrt{ }$ primary tumor:\n$\\sqrt{ }$ small subepithelial avidly enhancing polyp during early phase, often in ileum (dual-phase imaging with water as oral contrast / CT enteroclysis)\n$\\sqrt{ }$ may become isodense after slow contrast infusion / in portal-venous phase\n$\\sqrt{ }$ enhancing carpet lesions mimicking Crohn disease\n$\\sqrt{ }$ regional lymph node metastases:\n$\\sqrt{ }$ focal conglomerate mesenteric mass often larger than primary tumor\n$\\sqrt{ }$ low-density lymphadenopathy $\\leftarrow$ necrosis\n$\\sqrt{ }$ mesenteric carcinoid tumor (metastasis):\n$\\sqrt{ }$ \"sunburst\" appearance $=$ stellate radiating pattern and beading of mesenteric neurovascular bundles $\\leftarrow$ fibrosis + desmoplastic reaction\n$\\sqrt{ }$ containing calcifications (in up to $70 \\%$ )\n$\\sqrt{ }$ thickening + retraction + shortening of mesentery\n$\\sqrt{ }$ displacement + kinking + separation of adjacent bowel loops\n$\\sqrt{ }$ asymmetric / concentric segmental thickening of adjacent bowel loops $\\leftarrow$ bowel ischemia $\\leftarrow$ encasement of mesenteric vessels\n$\\sqrt{ }$ characteristically hyperattenuating + necrotic liver metastases (best visualized during early arterial phase!)\nMR:\n$\\sqrt{ }$ mesenteric tumor isointense to muscle on T1WI + T2WI\nAngio:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 712,
            "markdown": "$\\sqrt{ }$ \"sunburst\" appearance:\n$\\sqrt{ }$ kinking of small- and medium-sized vessels of a stellate configuration\n$\\sqrt{ }$ simulated hypervascularity with thickening + foreshortening of mesenteric vessels $\\leftarrow$ fibrotic retraction\n$\\sqrt{ }$ mesenteric ischemia:\n$\\sqrt{ }$ arterial branch stenoses from encasement of medium-sized vessels $\\leftarrow$ elastic vascular sclerosis with locally elevated serotonin levels\n$\\sqrt{ }$ venous occlusion / mesenteric varices\n$\\sqrt{ }$ tumor may be identified as hypervascular mass\nNUC (initial procedure of choice for):\n(a) localization of occult primary tumor\n(b) staging\n(c) identification of receptor status for octreotide Rx\n(1) ${ }^{111}$ In-pentetreotide somatostatin-receptor scintigraphy ( $80-100 \\%$ of carcinoids contain 5 somatostatin receptor subtypes)\nSensitivity: $80-90 \\%$ (improved with SPECT-CT fusion)\n$\\sqrt{ }$ higher frequency of radiotracer uptake in midgut carcinoids + with elevated serotonin levels\n(2) ${ }^{123} \\mathrm{I}-/ 131 \\mathrm{I}$-MIBG scintigraphy\n\nSensitivity: $55-70 \\%$ (lower than for ${ }^{111}$ In-pentetreotide)\n$\\sqrt{ }$ type I uptake mechanism for guanethidine\nPrognosis: slow progression with average survival time of 3.2 years after diagnosis of liver metastases; 5-year survival of $65 \\%$ for localized disease $+36 \\%$ for distant metastatic disease\nRx: resection; somatostatin / SMS 201-995; chemoembolization of hepatic arteries\n$D D x$ : oat-cell carcinoma, pancreatic carcinoma, medullary thyroid carcinoma, retractile (sclerosing) mesenteritis, desmoplastic carcinoma / lymphoma\n\n# Gastric Carcinoid (9\\%) \n\nFrequency: $2 \\%$ of all gastric malignancies\nOrigin: (enterochromaffin-like) ECL-cell arising from oxyntic (gastric-acid-secreting) mucosa\n[ oxyno, Greek = make sour / acid, to sharpen]\nLocation: gastric body and fundus\n$\\sqrt{ }$ one / more small $1-4-\\mathrm{cm}$ subepithelial masses:\n$\\sqrt{ }$ bull's eye appearance when ulcerated\n$\\sqrt{ }$ one / more sessile / pedunculated polyps\n$\\sqrt{ }$ avid enhancement in early arterial phase\nType 1 gastric ECL-cell carcinoid ( $74-80 \\%$ )\nMean age: 63 years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 2.5$\nAssociated with: autoimmune chronic atrophic gastritis\nPath: multiple $<1 \\mathrm{~cm}$ mucosal nodules in gastric fundus / body\nHisto: positive stain for chromogranin A + synaptophysin\n\n- often incidental finding during imaging for dyspepsia / chronic atrophic gastritis:\n- hypergastrinemia $\\leftarrow$ antral G-cell hyperplasia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 713,
            "markdown": "- $\\pm$ achlorhydria and pernicious anemia\n$\\sqrt{ }$ multiple / solitary polyps of $<1 \\mathrm{~cm}$ in diameter in fundus\nPrognosis: tendency for benign biologic behavior; nodal + hepatic metastatic spread in $5 \\%$\nType 2 gastric ECL-cell carcinoids (5-10\\%)\nMean age: 50 years; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\nAssociated with: Zollinger-Ellison syndrome in MEN 1\n$\\diamond 30 \\%$ of patients with MEN 1 have gastric carcinoid tumors $\\leftarrow$ altered tumor suppression contributes to development of carcinoids from ECL-cell hyperplasia\nPath: multiple mucosal nodules of variable size\n- hypergastrinemia $\\rightarrow$ abdominal pain, recurrent peptic ulcers, diarrhea; hypertrophic hypersecretory gastritis\n$\\checkmark$ multiple masses of variable size on diffuse gastric wall thickening\nPrognosis: local nodal metastatic spread in 10-30\\%\nTypes 1 and 2 of gastric carcinoids are associated with hypergastrinemia causing proliferation of enterochromaffin- like cells $\\rightarrow$ developing often multiple carcinoid tumors.\nType 3 gastric ECL-cell carcinoids (13\\%)\n$=$ sporadic carcinoid NOT associated with hypergastrinemia\nMean age: 55 years; $\\mathrm{M}+\\mathrm{F}=3 \\div 1$\nPath: solitary $>2 \\mathrm{~cm}$ mass in gastric body + fundus\n- bleeding, abdominal pain, anorexia, weight loss\n$\\checkmark$ usually solitary submucosal tumors $\\pm$ ulceration\nPrognosis: metastases at clinical presentation in 50-70\\%; 20\\% 5-year survival\nDDx of solitary tumor: adenocarcinoma, lymphoma, GIST\n\n\n# Duodenal Carcinoid (2\\%) \n\nMean age: 53 (range, 19-90) years; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\nAssociated with:\n(1) Multiple endocrine neoplasia\n(2) Neurofibromatosis type 1 for periampullary carcinoids often containing somatostatinproducing D-cells\nA. G-cell (gastrin-producing) carcinoid (62\\%)\n$\\diamond$ in $1 / 3$ functioning tumor ( $=$ gastrinoma) that produces Zollinger-Ellison syndrome\n$\\diamond 85 \\%$ of sporadic gastrinomas in \"gastrinoma triangle\"\n$\\diamond 90 \\%$ of MEN 1 patients develop multiple G-cell carcinoids\n\n- abdominal pain + diarrhea ( $50 \\%$ ) $\\leftarrow$ hypergastrinemia\n- nausea, vomiting, positive secretin stimulation test\n- bleeding from multiple + recurrent peptic ulcers\n- gastroesophageal reflux $\\leftarrow$ excess acid production\nB. D-cell (somatostatin-producing) carcinoid (21\\%)\n\nAssociated with: neurofibromatosis 1 (in up to 50\\%)\nPath: $1-2 \\mathrm{~cm}$ polypoid nodules in submucosa / infiltrative intramural masses $\\pm$ ulceration\nHisto: densely calcified concentrically laminated psammoma bodies (= psammomatous",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 714,
            "markdown": "somatostatinoma); positive stains for neuron-specific enolase, chromogranin A, synaptophysin, somatostatin; immunoreactivity for gastrin\nLocation: around ampulla of Vater\n\n- jaundice, pancreatitis $\\leftarrow$ obstruction of bile duct\n- hemorrhage\n- somatostatin effects (rare): steatorrhea, diarrhea, diabetes mellitus, hypochlorhydria, anemia, cholelithiasis\nUGI:\n$\\sqrt{ }$ well-defined round intraluminal polypoid mass ( $52 \\%$ ) / intramural mass ( $39 \\%$ ) $\\pm$ focal ulceration\nCT:\n$\\sqrt{ }$ arterial phase enhancement + loss of enhancement during delayed phase\n$\\sqrt{ }$ metastasis to peripancreatic lymph nodes / liver (in $60-80 \\%$ at time of diagnosis)\nN.B.: positive gastrointestinal contrast material may mask small duodenal mural lesions\n\n\n# Jejunal and Ileal Carcinoid (42\\%) \n\nMean age: 65 years; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\nAssociated with: synchronous / metachronous malignancies (29\\%): GI adenocarcinoma (most common)\n\n- often asymptomatic\n- local symptoms: small bowel obstruction, ischemia, bleeding\n- long history of intermittent crampy abdominal pain, weight loss, fatigue, abdominal distension, diarrhea, nausea, vomiting\nPath: small firm $<3.5 \\mathrm{~cm}$ intramural nodule $\\pm$ protrusion into lumen; multiple in $30 \\%$; infiltrative growth into subserosa + mesentery stimulating desmoplastic reaction $\\rightarrow$ multifocal stenoses and occlusions of arteries + veins $\\rightarrow$ intestinal ischemia\nSBFT:\n$\\sqrt{ }$ solitary / multifocal small polypoid nodules / mucosal elevations $\\pm$ ulceration\n$\\sqrt{ }$ fixed rigid curved segment of small bowel\nUS:\n$\\sqrt{ }$ smooth intraluminal hypoechoic oval masses interrupting submucosal layer\n$\\sqrt{ }$ thickening + puckering of muscularis propria\n$\\sqrt{ }$ retraction of wall, invasion of serosa\n$\\sqrt{ }$ mesenteric metastases of similar echogenicity to primary $\\pm$ calcification\nCT:\n> primary tumor\n$\\sqrt{ }$ large polypoid intramural lesion\n$\\sqrt{ }$ concentric / asymmetric hypoattenuating mural thickening (\"target / halo\" sign) $\\leftarrow$ intestinal ischemia / infiltrating tumor with desmoplastic fibrosis\n$\\sqrt{ }$ hypervascular nodular wall thickening smooth submucosal mass\n$\\sqrt{ }$ \"hairpin turn\" = kinking / curvature of a thickened distorted intestinal wall\n> metastatic disease (in $60 \\%$ at time of diagnosis):\n$\\sqrt{ }$ large enhancing local mesenteric lymph nodes / masses often exceeding the primary mass in size:\n$\\sqrt{ }$ stellate mesenteric desmoplastic reaction of \"spoke-wheel / sunburst\" appearance",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 715,
            "markdown": "NOT associated with a mass $=$ mesenteric soft-tissue stranding and distortion of mesenteric vessels $\\leftarrow$ fibrosis rather than tumor infiltration\n$\\checkmark$ well-defined margins $\\pm$ necrosis\n$\\checkmark$ faint stippled / coarse dense / diffuse calcifications ( $70 \\%$ )\n$\\checkmark$ miliary peritoneal implants / large masses / mesenteric caking\n$\\checkmark$ hypervascular liver metastases during arterial phase $\\pm$ central necrosis\n$C x$ : intussusception\nDDx for carcinoids of small intestines:\nmetastatic disease, primary intestinal adenocarcinoma, lymphoma, GIST, Crohn disease, localized ischemic enteritis\n\n# Appendiceal Carcinoid ( $<10 \\%-24 \\%$ ) \n\nCommonly benign: slow growth, rarely metastasizing\nIncidence at surgery: $0.03-0.70 \\%$\n\n- mostly asymptomatic\n- symptoms of appendicitis (30-50\\%)\n\nAge: any; $\\mathrm{M}<\\mathrm{F}$\nSite: tip ( $70 \\%$ ), middle ( $20 \\%$ ), base ( $10 \\%$ ) of appendix\nSize: usually $<1 \\mathrm{~cm}$, rarely $>2 \\mathrm{~cm}$\n$\\checkmark$ focal soft-tissue mass / diffuse circumferential thickening\n$\\checkmark$ invasion of mesoappendix ( $11 \\%$ )\nUS:\n$\\checkmark$ persistent fluid-distended appendix without typical signs of appendicitis\n\n## Colorectal Carcinoid\n\nFrequency: $<1 \\%$ of all rectal cancers\nMean age: 66 years (56 years for rectal location)\nLocation: rectum (27\\%) >> cecum / ascending colon (5\\%)\n\n- mostly asymptomatic / abdominal pain, weight loss\n- carcinoid syndrome (NOT with common rectal carcinoids)\n$\\checkmark$ polypoid intramural mass $\\pm$ intussusception\n$\\checkmark \\pm$ ulceration of large tumor\nPrognosis: metastatic in $10 \\%$\n\n\n## CATHARTIC COLON\n\n$=$ prolonged use of stimulant-irritant cathartics ( $>15$ years) $\\rightarrow$ chronically increased muscular activity + tonus $\\rightarrow$ neuromuscular incoordination\nAgents: castor oil, senna, phenolphthalein, cascara, podophyllum, aloin\nLocation: involvement of colon proximal to splenic flexure\n$\\checkmark$ effaced mucosa with flattened smooth surface\n$\\checkmark$ diminished / absent haustrations\n$\\checkmark$ \"pseudostrictures\" = typically smoothly tapered areas of narrowing $\\leftarrow$ sustained tonus of circular muscles\n$\\checkmark$ poor evacuation of barium\n$\\checkmark$ flattened + gaping ileocecal valve",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 716,
            "markdown": "$\\sqrt{ }$ shortened but distensible ascending colon\n$D D x$ : \"burned-out\" ulcerative colitis with right-sided predominance (very similar)\n\n# CHAGAS DISEASE \n\n[Carlos Chagas (1879-1934), physician in Rio de Janeiro, Brazil]\n= damage of ganglion cells by neurotoxin liberated from protozoa Trypanosoma cruzi resulting in aperistalsis of GI tract + dilatation\nHisto: decreased number of cells in medullary dorsal motor nucleus + Wallerian degeneration of vagus + decrease / loss of argyrophilic cells in myenteric plexus of Auerbach\nPeak age: $\\quad 30-50$ years; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\n\n- foul breath, regurgitation, intermittent / persistent dysphagia\n- odynophagia (= fear of swallowing), aspiration\n- Mecholyl test: abnormal response indicative of deficient innervation; 2.5-10 mg methacholine subcutaneously followed by severe tetanic nonperistaltic contraction $2-5$ minutes after injection, commonly in distal half of esophagus, accompanied by severe pain\n@ Dilatative cardiomyopathy (myocarditis)\n@ Megacolon (bowels move at intervals of 8 days to 5 months)\nCx: impacted feces, sigmoid volvulus\n@ Esophagus: changes as in achalasia\n\n\n## Trypanosomiasis\n\n[ trypano, Greek = borer; soma, Greek = body]\nOrganism: unicellular parasitic flagellate Trypanosoma cruzi transmitted via vector\nTransmission: acquired by insect bite from the Reduviidae family (genera Triatoma, Rhodnius, and Panstrongylus); trypomastigotes inoculation occurs through rubbing of reduviid bug feces into a bite or other skin defect\n$\\diamond$ Endemic to Central + South America (esp. eastern Brazil) with 24 million people infected\n\n- acute febrile illness, acute myocarditis (uncommon)\n- facial / unilateral palpebral edema (\"Romaña\" sign)\n@ Heart: chronic myocarditis\nHisto: focal / diffuse loss of myocytes, fibrosis, focal atrophy, conduction system involvement\n- bundle branch block $\\rightarrow$ complete atrioventricular block\n$\\checkmark$ severe cardiomegaly $\\leftarrow$ dilated cardiomyopathy\n$\\checkmark$ pulmonary edema, septal lines, pleural effusion $\\leftarrow$ chronic heart failure\n@ GI tract: esophagus, colon\n- achalasia, megacolon\n$D x$ : direct visualization of trypomastigotes in blood smear; serologic test for chronic manifestation\n\n\n## CHALASIA\n\n= continuously relaxed sphincter with free reflux in the absence of a sliding hernia\nEtiology: elevated submerged segment\nCause:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 717,
            "markdown": "(1) Delayed development of esophagogastric region in newborns\n(2) Scleroderma, Raynaud disease\n(3) $\\mathrm{S} / \\mathrm{P}$ forceful dilatation / myotomy for achalasia\n$\\sqrt{ }$ free / easily induced reflux\n\n# CLOSTRIDIUM DIFFICILE COLITIS \n\n$=$ ANTIBIOTIC-ASSOCIATED COLITIS = PSEUDOMEMBRANOUS COLITIS\n$=$ nosocomial epidemic / endemic acute infectious colitis $\\leftarrow$ Clostridium difficile toxins\nEtiologic agent: toxin A (enterotoxin) + toxin B (cytotoxin) produced by C. difficile\nCause: unopposed overgrowth of gram-positive Clostridium difficile $\\leftarrow$ decrease in normal intestinal flora\nPredisposed:\n(a) complication of broad-spectrum antibiotics: tetracycline, extended-spectrum penicillins (azlocillin, mezlocillin, piperacillin, ticarcillin, carbenicillin, mecillinam), aminopenicillins (ampicillin, amoxicillin), clindamycin, lincomycin, chloramphenicol, cephalosporins, metronidazole, vancomycin\n(b) complication of some chemotherapeutic agents: methotrexate, fluorouracil\n(c) following abdominal surgery / renal transplantation / irradiation\n(d) prolonged hypotension / hypoperfusion of bowel\n(e) shock, uremia\n(f) proximal to colonic obstruction\n(g) debilitating diseases: lymphosarcoma, leukemia, advanced HIV infection\n(h) immunosuppressive therapy with actinomycin D\n\nHisto: pseudomembranes ( $=$ exudate composed of leukocytes, fibrin, mucin, sloughed necrotic epithelium held in columns by strands of mucus) on a partially denuded colonic edematous mucosa (mucosa generally intact); reactive edema in lamina propria, submucosa, and eventually subserosa\nClinical manifestations of C. difficile infection:\n(1) Absence of symptoms (majority)\n(2) Antibiotic-associated colitis without pseudomembrane formation\n(3) Pseudomembranous colitis\n(4) Fulminant colitis\n\n- profuse watery diarrhea, abdominal cramps, tenderness\n- fever, fecal blood, leukocytosis\n- less common: chronic diarrhea, dehydration, toxic megacolon, hyperpyrexia, leukemoid reaction, hypoalbuminemia with anasarca\nLocation: pancolitis (most commonly); rectum ( $95 \\%$ ); confined to right + transverse colon (5-$27-40 \\%)$\n$\\diamond$ Radiographic abnormalities in $32 \\%+$ positive stool toxin assay!\nPlain film:\n$\\sqrt{ }$ adynamic ileus pattern = moderate gaseous distension of small bowel + colon:\n$\\sqrt{ }$ small bowel ileus $(20 \\%)$\n$\\sqrt{ }$ colonic ileus $(32 \\%)$\n$\\sqrt{ }$ nodular haustral thickening ( $18 \\%$ ):",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 718,
            "markdown": "$\\sqrt{ }$ \"thumbprinting\" = \"transverse banding\" = wide perpendicular bands $\\leftarrow$ marked thickening + distortion of haustral folds (most prominent in transverse colon) $\\leftarrow$ submucosal hemorrhage + edema\n$\\sqrt{ }$ diffusely shaggy + irregular surface $\\leftarrow$ confluent pseudomembranes\n$\\sqrt{ }$ ascites $(7 \\%)$\nBE (CONTRAINDICATED in severe cases):\nFluoroscopic enemas should be avoided in a patient with pseudomembranous colitis $\\leftarrow$ risk for perforation\n$\\sqrt{ }$ pseudoulcerations $=$ barium filling clefts between pseudomembranes\n$\\sqrt{ }$ irregular ragged polypoid contour of colonic wall\n$\\sqrt{ }$ discrete multiple plaquelike lesions of $2-4 \\mathrm{~mm}$ in size (DDx: polyposis, nodular form of lymphoma)\nN.B.: risk of colonic perforation in toxic megacolon!\n\nCT ( $85 \\%$ sensitive, $48 \\%$ specific):\n$\\sqrt{ }$ NO colonic abnormality (12-39\\%)\n$\\sqrt{ }$ substantial irregular eccentric colonic wall thickening:\n$\\sqrt{ }$ wall thickness usually $>4 \\mathrm{~mm}$ with a mean of 14.7 (range, $3-32$ ) mm in 61-88\\%\nThe degree of wall thickening in C. difficile colitis is greater than in any other infectious or inflammatory process involving the bowel except for Crohn disease.\n$\\sqrt{ }$ segmental / diffuse involvement of entire colon\n$\\sqrt{ }$ mural hypoattenuation $\\leftarrow$ edema\n$\\sqrt{ }$ mural hyperattenuation $\\leftarrow$ acute inflammation\n$\\sqrt{ }$ thumbprinting thickened $\\leftarrow$ edematous haustra\n$\\sqrt{ }$ \"accordion\" sign $(51-70 \\%)=$ enteric contrast material trapped between distorted thickened closely spaced transverse edematous haustra of low attenuation (simulating intramural tracts), TYPICAL in severe cases\n$\\sqrt{ }$ smooth (44\\%) / irregular / polypoid (17\\%)\n$\\sqrt{ }$ \"target\" sign = submucosal edema + homogeneous mucosal enhancement $\\leftarrow$ hyperemia (best seen during arterial enhancement)\n$\\sqrt{ }$ colonic dilatation frequent $\\leftarrow$ transmural inflammation\n$\\sqrt{ }$ usually DISPROPORTIONATELY mild pericolonic stranding (42\\%) relative to marked wall thickening\n$\\sqrt{ }$ ascites in severe cases $(15-35 \\%)$\n$\\sqrt{ }$ pneumatosis coli $\\pm$ portal vein gas in severe cases\nDx: (1) Stool assay for Clostridium difficile cytotoxin (detects toxin B): cumbersome to perform\n(2) Enzyme immunoassay test (up to $33 \\%$ false-negative results): detection of toxin A + B\n(3) Stool culture ( $95 \\%$ sensitive): not available for 2 days\n(4) Pseudomembranes of adherent yellow plaques $2-10 \\mathrm{~mm}$ in diameter on proctosigmoidoscopy\nCx: peritonitis, toxic megacolon (if dilatation $>6 \\mathrm{~cm}$ ), perforation\nPrognosis: 1.1-3.5\\% overall mortality; most patients recover within 2 weeks",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 719,
            "markdown": "Rx: (1) Discontinuation of suspected antibiotic\n(2) Administration of vancomycin / metronidazole (response within 3-4 days)\n(3) Attention to fluid and electrolyte balance\n(4) Life-saving partial colectomy required in $<1 \\%$\n\nDDx: acute stage of ulcerative / Crohn colitis, infectious colitis (eg, enterohemorrhagic E. coli), ischemic colitis, radiation colitis, colonic wall hemorrhage, colonic lymphangiectasia, leukemic infiltration, diverticulitis\n\n# COLITIS CYSTICA PROFUNDA \n\n$=$ rare benign chronic condition characterized by dilated sub- mucosal mucin-filled cysts lined by normal colonic epithelium\nEtiology: probably related to chronic inflammation\nAssociated with: solitary rectal ulcer syndrome (as localized polypoid variant)\nAge: primarily disease of young adults\n\n- brief periods of bright red rectal bleeding\n- mucous / bloody discharge, intermittent diarrhea\n\nLocation:\n(a) localized to rectum (most commonly) / sigmoid\n(b) generalized colonic process (less common)\n$\\sqrt{ }$ nodular polypoid / cauliflower-like lesions $<2 \\mathrm{~cm}$ in size, containing no gas\n$\\sqrt{ }$ spiculations mimicking ulcers (barium-filled clefts between nodules)\n$D D x$ : pneumatosis (rarely affects rectum)\n\n## COLONIC ATRESIA\n\nFrequency: less common than ileal atresia\nPlain radiograph:\n$\\sqrt{ }$ massive dilatation of colon proximal to obstruction\n$\\sqrt{ }$ mottled pattern of gas + feces proximal to point of atresia\n$D D x$ : often indistinguishable from obstruction of distal ileum\nBE:\n$\\sqrt{ }$ functional microcolon\n$\\sqrt{ }$ obstruction to retrograde flow of barium\nUS:\n$\\sqrt{ }$ dilated hyperechoic distal small bowel + proximal colon $\\leftarrow$ retained meconium\n\n## COLORECTAL CARCINOMA\n\nMost common cancer of GI tract; $3^{\\text {rd }}$ most commonly diagnosed malignancy in developed countries in men (after lung and prostate cancer) and women (after lung + breast cancer); $2^{\\text {nd }}$ leading cause of cancer deaths\nIncidence: 136,830 new cases annually with 50,310 deaths in USA (2014); 11\\% of all newly diagnosed cancers; $13 \\%$ of all cancer deaths; $3 \\div 100,000$ in 30-34-year-olds; $532 \\div 100,000$ for $>85$-year-olds\nLifetime probability: $4-6 \\%$ of any White person\nRisk factors:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 720,
            "markdown": "1. Personal history of colonic adenoma / carcinoma\n> malignancy in $5 \\%$ of tubular adenomas\n> malignancy in $30-40 \\%$ of villous adenomas\nProof of adenoma-carcinoma sequence:\n(a) frequent coexistence of adenoma + carcinoma\n(b) similar distribution within colon\n(c) consistent proportional prevalence in population having varied magnitudes of colon cancer risk\n(d) increased frequency of carcinoma in patients with adenomas\n(e) reduction of cancer incidence following endoscopic removal of polyps\n(f) all patients with familial adenomatous polyposis syndrome develop colon carcinoma if colon not removed\n(g) similarity of DNA + chromosomal constitution\n$\\diamond 93 \\%$ of colorectal carcinomas arise in adenomatous polyps\n$\\diamond$ A patient with one adenoma has a $9 \\%$ chance of having a colorectal carcinoma in the next 15 years!\n$\\diamond$ It takes about 7 years for a $1-\\mathrm{cm}$ adenoma to become an invasive cancer!\n$\\diamond 5 \\%$ of $5-\\mathrm{mm}$ adenomas develop into invasive cancers ( $5 \\mathrm{~mm}=$ critical mass of intraepithelial neoplasia)!\n2. Family history of benign / malignant colorectal tumors in 1 st-degree relative (3-5 x risk)\n3. Personal history of ovarian / endometrial / breast cancer\n4. Dysplasia of colon within flat mucosa\n5. Inflammatory bowel disease:\n(a) Ulcerative colitis ( $3-5 \\%$ incidence; cumulative incidence of $26 \\%$ after 25 years of colitic symptoms)\n(b) Crohn disease affecting the colon + rectum (particularly in bypassed loops / in vicinity of chronic fistula)\nTime delay: $>8-10$ years of colitis\nUnderlying lesion: dysplasia within flat mucosa\n6. Prominent lymphoid follicular pattern\n7. Pelvic irradiation\n8. Ureterosigmoidostomy\n\nEnvironmental risk factors:\n(a) low fiber diet: prevents rapid transit time $\\rightarrow$ increasing contact time between potential toxins and colonic mucosa\n(b) increased ingestion of fat + animal protein\n(c) obesity\n(d) asbestos worker\n\nGenetic risk factors ( $6 \\%$ of colorectal carcinomas):\n(a) familial adenomatous polyposis syndrome:\nfamilial polyposis, Gardner syndrome, Turcot syndrome\nAge: $\\sim 40$ years\n(b) certain hamartomatous polyposis syndromes:\n\nPeutz-Jeghers syndrome, juvenile polyposis, Cowden disease\n(c) hereditary nonpolyposis colon cancer syndrome",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 721,
            "markdown": "$=$ Lynch syndrome\nScreening recommendations (American Cancer Society):\nas / more effective than mammographic screening\n(a) for persons $>50$ years of age: annual fecal occult-blood test + sigmoidoscopy / BE every $3-5$ years\n(b) for $1^{\\text {st }}$-degree relatives of patients with colon cancer screening should start at age 40\n\nMedian age: 71 years for colon cancer; 69 years for rectal cancer; $\\mathrm{M}+\\mathrm{F}=3 \\div 2$\nHisto:\n(1) Adenocarcinoma with varied degrees of differentiation (>90\\%)\n(2) Mucinous carcinoma (uncommon)\n(3) Squamous cell carcinoma + adenoacanthoma (rare)\n\nMetastases (lymphatic / hematogenous venous):\n\n1. Liver ( $75 \\% ; 15-20 \\%$ at time of surgery) $\\leftarrow$ portal venous drainage route\n2. Mesentery + mesenteric nodes $(10-15 \\%)$\n3. Adrenal $(10-14 \\%)$\n4. Lung $(5-50 \\%)$\n5. Ovary $(3-8 \\%)=$ Krukenberg tumor\n6. Psoas muscle tumor deposit\n7. Peritoneal metastases:\n(a) malignant ascites: usually associated with poorly differentiated colonic carcinoma\n(b) pseudomyxoma peritonei ( $<5 \\%$ ): low-grade colonic adenocarcinoma\n8. Bone $(5 \\%)$\n9. Brain $(5 \\%)$\n$\\diamond$ Because of the absence of lymphatics in the lamina propria colon cancer will not metastasize until it penetrates the muscularis mucosa!\n\n- rectal bleeding, iron deficiency anemia\n- change in bowel habits / caliber of stools\n- obstruction (poor prognostic indicator), hydronephrosis (13\\%)\n- positive fecal occult blood testing ( $2-6 \\%$ positive-result rate; $5-10 \\%$ positive predictive value; fails to detect $30-50 \\%$ of colorectal carcinomas + up to $75 \\%$ of adenomas):\n\nHemoccult ${ }^{\\circledR}$ (hematein), HemoQuant ${ }^{\\circledR}$ (porphyrins), HemeSelect ${ }^{\\mathrm{TM}}$ (hemoglobin)\n\n- progressive elevation of carcinoembryonic antigen (CEA) $>10 \\mu \\mathrm{~g} / \\mathrm{L}$ indicative of recurrent / metastatic disease\n- watery diarrhea + potassium depletion / excessive secretion of mucus + hypoalbuminemia (in large mucin-secreting villous tumor)\nLocation: \"aging gut\" = number of right-sided lesions increasing with age (\"changing distribution\")\n(a) left colon $(52-61 \\%)$ :\nrectum (15-33-41\\%), sigmoid (20-37\\%), descending colon (10-11\\%)\n$\\sqrt{ }$ commonly annular strictures with obstruction\n(b) right colon:\ntransverse colon ( $12 \\%$ ), ascending colon ( $8-16 \\%$ ), cecum ( $8-10 \\%$ )\n$\\sqrt{ }$ commonly polypoid lesions with chronic bleeding + intussusception\n(c) rectum: $1 / 3$ of all colorectal cancers\n\nColonoscopy: cecum not visualized in $10-36 \\%$; fails to detect $12 \\%$ of colonic polyps ( $10 \\%$ in",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 722,
            "markdown": "areas never reached by colonoscope)\n$C x$ : perforation in $0.2 \\%(0.02 \\%$ for BE$)$; death in $1 \\div 5,000(1 \\div 50,000$ for BE$)$\nBE:\n\n| Detection of Colonic Polyps on Barium Enemas |  |  |\n| :--: | :--: | :--: |\n| Sensitivity | Polyp $>1 \\mathrm{~cm}$ | Polyp $<1 \\mathrm{~cm}$ |\n| Single contrast barium enema | $77-94 \\%$ | $82-97 \\%$ |\n| Double contrast barium enema | $18-72 \\% \\%$ | $61-83 \\%$ |\n\n$\\sqrt{ }$ fungating polypoid carcinoma:\n\n- chronic bleeding, intussusception\n$\\sqrt{ }$ annular ulcerating carcinoma $=$ \"apple core lesion\"\n$=$ annular constriction $\\leftarrow$ tumor grows along lymphatic channels that parallel circular muscle fibers of inner layer of the muscularis propria; longitudinal growth is limited with abrupt transition to normal mucosa\n- colonic obstruction\n$\\sqrt{ }$ \"saddle lesion\" = growth characteristics between polypoid mass + annular constricting lesion\n$\\sqrt{ }$ scirrhous carcinoma (signet-ring type)\n$=$ long-segment stricture without significant mucosal abnormality similar to linitis plastica $\\leftarrow$ diffuse circumferential + longitudinal tumor infiltration within loose submucosal tissue between muscularis mucosa and muscularis propria\n- often seen in ulcerative colitis\n$\\sqrt{ }$ curvilinear / mottled calcifications are CHARACTERISTIC of mucinous adenocarcinoma (rare)\nCT ( $48-90 \\%$ staging accuracy, $25-73 \\%$ for lymph node mets):\n$\\sqrt{ }$ marked asymmetric colonic wall thickening involving a short segment\n$\\sqrt{ }$ low-density mass + low-density lymph nodes in mucinous adenocarcinoma (if $>50 \\%$ of tumor composed of extracellular mucin)\n$\\sqrt{ }$ abrupt change from normal to abnormal segment of colon\n$\\sqrt{ }$ psammomatous calcifications in mucinous adenocarcinoma\n$\\sqrt{ }$ signs of Lnn involvement: single lymph node $>1 \\mathrm{~cm}$ in diameter / cluster of $\\geq 3$ nodes $<1$ $\\mathrm{cm} /$ node of any size within mesentery\n$\\diamond$ Screening CT colonography: $55-94 \\%$ sensitive for polyps $>10 \\mathrm{~mm}$\n\n| CT Staging of Colorectal Cancer <br> (poor accuracy compared with Astler-Coller classification) |  |\n| :-- | :-- |\n| Stage 1 | intramural polypoid mass |\n| Stage 2 | thickening of bowel wall |\n| Stage 3 | slight invasion of surrounding tissues |\n| Stage 4 | massive invasion of surrounding tissue <br> + adjacent organs / distant metastases |\n\nMR: (staging accuracy of $73 \\%, 40 \\%$ sensitivity for lymph node metastases)\nPrognosis:\n5-year survival rate of $40-50 \\%$ (unchanged over past 40 years); $83-90 \\%(70 \\%)[33 \\%]$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 723,
            "markdown": "$\\{5 \\%\\}$ with Duke A (B) [C] \\{D\\}\nRecurrence in $1 / 3$ of patients:\n(a) local recurrence at line of anastomosis ( $60 \\%$ ): within 1 \\{2\\} year after resection in $50 \\%\\{70-80 \\%\\}$\n(b) distant metastases $(26 \\%)$\n(c) local recurrence + metastases $(14 \\%)$\n\n| Staging of Colorectal Cancer <br> (UICC-AJCC Colorectal Cancer Staging System) |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: |\n| Stage |  | Grouping |  | 5-year Survival |\n| 0 | Tis | N0 | M0 | $>95 \\%$ |\n| I | T1 | N0 | M0 | $75-100 \\%$ |\n|  | T2 | N0 | M0 |  |\n| II | T3 | N0 | M0 | $50-75 \\%$ |\n|  | T4 | N0 | M0 |  |\n| III | any T | N1 | M0 | $30-50 \\%$ |\n|  | any T | N2,3 | M0 |  |\n| IV | any T | any N | M1 | $<10 \\%$ |\n| Legend: |  |  |  |  |\n| Tis | carcinoma in situ |  |  |  |\n| T1 | invasion of submucosa |  |  |  |\n| T2 | invasion of muscularis propria |  |  |  |\n| T3 | invasion of subserosa / pericolic tissue |  |  |  |\n| T4 | invasion of visceral peritoneum / other organs |  |  |  |\n| N1 | 1-3 pericolic Lnn |  |  |  |\n| N2 | $>4$ pericolic Lnn |  |  |  |\n| N3 | any Lnn along course of a vascular trunk |  |  |  |\n\n# Risk after detection of colon cancer: \n\n$5 \\%$ for synchronous colon cancer\n$14 \\%$ for synchronous cancer with \"sentinel polyp\"\n$35 \\%$ for additional adenomatous polyp\n$3 \\%$ for metachronous colon cancer\n$4 \\%$ for extracolonic malignancy\nCx: (1) Obstruction (frequently in descending + sigmoid colon) $\\leftarrow$ relatively larger caliber of right colon allows growth to a larger size before becoming symptomatic by obstruction\n(2) Perforation (in up to $10 \\%$ )\n(a) at site of mass: subacute process $\\leftarrow$ slow gradual infiltration of bowel wall\n(b) proximal to mass: necrosis of stercoral ulcer / increased pressure proximal to obstruction\n(3) Intussusception ( $50 \\%$ of all adult intussusceptions): intestinal lymphoma, GI tumor, metastatic disease\n(4) Abscess formation: intraperitoneal (in majority); localized paracolic; extension to flank, thigh, trunk\n(5) Fistula formation\n(6) Pneumatosis cystoides intestinalis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 724,
            "markdown": "(7) Pseudomyxoma peritonei $\\leftarrow$ low-grade adenocarcinoma of colon\n(8) Ischemic colitis (in 7\\%)\n\nCause: (1) severe colonic distention $\\leftarrow$ mechanical obstruction (2) stagnated bowel contents $\\rightarrow$ bacterial overgrowth (3) mechanical vascular occlusion (4) invasion of mesenteric root vessels\n$\\sqrt{ }$ concentric $\\sim 1 \\mathrm{~cm}$ thickening of bowel wall\n$D D x$ : tumoral segment (irregular thickening of bowel wall by an average of 2 cm )\nRx: (1) Local surgical excision / polypectomy for stage I disease\n(2) Right / left hemicolectomy with eventual anastomosis of proximal + distal excision sites\n(3) Low anterior resection: $>2 \\mathrm{~cm}$ of rectum must remain to anastomose the colon\n(4) Abdominoperineal resection with colostomy for low rectal carcinoma\n(5) Adjuvant chemotherapy for stage II disease (fluorouracil / levamisole)\n\nDDx: (1) Prolapsing ileocecal valve (change on palpation)\n(2) Spasm (intact mucosa, released by propantheline bromide)\n(3) Diverticulitis\n\n# Cecal Adenocarcinoma \n\n- often grow asymptomatic for a long time\n$\\sqrt{ }$ often large polypoid bulky tumor\n$\\sqrt{ }$ marked wall thickening + mild pericolic infiltration\n$\\sqrt{ }$ involvement of distal ileum ( $10 \\%$ )\nCx: (1) Obstruction (rare): often large tumor within capacious cecum\n(2) Intussusception $\\leftarrow$ tumor as lead point\n\n\n## Signet Ring Carcinoma (2.6\\%)\n\n$=$ variant of mucin-secreting adenocarcinoma\nAge: younger patients\nHisto: $>50 \\%$ of cells have a cell nucleus that is displaced to periphery by large amount of intracytoplasmic mucin\nSpread: peritoneal surfaces + lymph nodes (more readily); hepatic parenchymal metastases (less frequent)\n$\\sqrt{ }$ often elongated infiltrating mass $>5 \\mathrm{~cm}$ in length mimicking underlying colonic inflammatory process\n$\\sqrt{ }$ concentric rigid wall thickening of scirrhous / linitis plastica appearance\n$D x$ : mucosal surface may appear intact endoscopically $\\rightarrow$ requires deep-tissue biopsies\nPrognosis: poor $\\leftarrow$ aggressive tumor + frequent local recurrence\n$D D x$ : colonic Crohn disease / ischemic colitis\n\n## Lynch Syndrome\n\n$=$ HEREDITARY NONPOLYPOSIS COLORECTAL CANCER SYNDROME (HNPCC)\n$=$ autosomal dominant disorder with high incidence of colorectal cancers + increased incidence of synchronous and metachronous colorectal cancers\nAmsterdam criteria:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 725,
            "markdown": "(a) $\\geq 3$ family members of whom 2 are $1^{\\text {st }}$ degree relatives of the $3^{\\text {rd }}$ family member\n(b) family members in $\\geq 2$ generations\n(c) one family member diagnosed $<50$ years of age\n\nLynch I = no associated extracolonic cancer\nLynch II = associated with extracolonic malignancy:\ntransitional cell carcinoma of ureter + renal pelvis; adenocarcinoma of endometrium, stomach, small bowel, pancreas, biliary tract, brain; hematologic malignancy; carcinoma of skin + larynx\nEtiology: autosomal dominant abnormality of chromosome 2 with defect in DNA replication-repair process\n(a) accelerated adenoma-carcinoma sequence\n(b) dysplasia in flat mucosa of colon\n\nPrevalence: $5-10 \\%$ of patients with colon cancer; 5 x more common than familial adenomatous polyposis syndrome\nMean age: 45 years\nLocation: $70 \\%$ proximal to splenic flexure\nPrognosis: better stage for stage of other cancers (5-year survival rate of $65 \\%$ versus $44 \\%$ in sporadic cases)\nSurveillance: colonoscopy every 1-2 years from ages 22-35\n\n# Rectal Cancer \n\nIncidence: 40,340 rectal cancers annually in USA (2005); 0.01\\% national screening average\n\n- gastrointestinal bleeding, change in bowel habit\n\n| Pathologic Staging of Rectal Cancer (modified Dukes = Astler-Coller classification) and TNM |  |  |  |\n| :--: | :--: | :--: | :--: |\n| Astler-Coller/TNM |  | Description | 5-year Survival |\n| A T1 N0 M0 |  | limited to submucosa | $80 \\%$ |\n| B |  | involvement of muscularis propria |  |\n| $\\mathrm{B}_{1}$ T2 N0 M0 |  | limited to muscularis propria | $70 \\%$ |\n| $\\mathrm{B}_{2}$ T3 N0 M0 |  | transmural extension | $60-65 \\%$ |\n| T3a |  | $<5 \\mathrm{~mm}$ beyond m. propria |  |\n| T3b |  | $5-10 \\mathrm{~mm}$ beyond m. propria |  |\n| T3c |  | $>10 \\mathrm{~mm}$ beyond m. propria |  |\n| C |  | Lymph node metastases |  |\n| $\\mathrm{C}_{1}$ T2 N1 M0 |  | nodes (+), into muscularis | $35-45 \\%$ |\n| $\\mathrm{C}_{2}$ T3 N1 M0 |  | nodes (+), transmural | $25 \\%$ |\n| T4 |  | invasion of adjacent organs |  |\n| T4a |  | penetration of visceral peritoneum |  |\n| D M1 |  | distant metastasis | $<25 \\%$ |\n\nTwo hematogenous metastatic patterns of rectal cancer:\n(1) liver metastasis $\\leftarrow$ via IMV + portal venous system / via endolymphatic spread along course of IMV\n(2) lung metastasis $\\leftarrow$ via internal iliac veins + IVC",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 726,
            "markdown": "Hematogenous metastasis:\ndual venous drainage into portal + systemic veins\n$\\sqrt{ }$ may have lung metastases without liver metastases\nRisk of recurrence:\n$5 \\%$ for T 1\n$10 \\%$ for $\\mathrm{T} 233 \\%$ for $\\mathrm{T} 1, \\mathrm{~N} 1+\\mathrm{T} 2 \\mathrm{~N} 1$\n$25 \\%$ for T3 $66 \\%$ for T3N1\n$50 \\%$ for T4\nStaging accuracy:\nDigital rectal examination: 68-75-83\\%; limited to lesions within 10 cm of anal verge\n, CT: $48-72-92 \\%$, better for more extensive regional spread; $25-73 \\%$ for lymph node involvement\n, MR: 74-84-93\\% with tendency for overstaging\n, Transrectal ultrasound: 64-77-94\\% with tendency for overstaging; limited to nonstenotic lesions $<14 \\mathrm{~cm}$ from anal verge; $50-83 \\%$ sensitivity for involved lymph nodes\n, PET: $97 \\%$ sensitive for recurrence\nTransrectal US ( $81 \\%$ accuracy):\nNormal layers $=$ gut signature: $\\rightarrow$ see GI anatomy\n$\\sqrt{ }$ hypoechoic mass disrupting rectal wall:\n$\\sqrt{ }$ NO interruption of hyperechoic submucosa $=$ tumor confined to mucosa + submucosa\n$\\sqrt{ }$ NO interruption of hyperechoic serosa $=$ tumor confined to rectal wall\n$\\sqrt{ }$ break in outermost hyperechoic layer = tumor penetrates into perirectal fat\n$\\sqrt{ }$ irregular serrated outer border of muscularis propria (pseudopodia through serosa)\n$\\sqrt{ }$ hypoechoic perirectal lymph nodes $\\leftarrow$ tumor involvement",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 727,
            "markdown": "# COLONIC VOLVULUS \n\n$=$ most common form of volvulus\nFrequency: $2 \\%$ of bowel obstruction; $11 \\%$ of intestinal volvulus\nColonic volvulus often has a characteristic appearance at conventional radiography, which may be sufficient for a diagnosis in a large percentage of patients!\n\n## Cecal Volvulus (25-40\\%)\n\n$=$ VOLVULUS OF CECUM\n$\\diamond$ Surgical EMERGENCY $\\leftarrow$ threat of bowel ischemia + bowel perforation!\n$=$ twisting of cecum along its long axis $\\leftarrow$ closed-loop obstruction $\\leftarrow$ excess mobility\nFrequency: $25-40 \\%$ of all cases of colonic volvulus\nCause: acquired / congenitally poor fixation of right colon to posterior parietal peritoneum (malrotation + long mesentery) $\\rightarrow$ mobile cecum ( $10-25 \\%$ of population)\nTrigger: sudden distension by trauma, pregnancy, distal colonic obstruction, pressure, colonic atony, constipation, mesenteric / pelvic mass, recent colonoscopy, previous laparotomy with adhesions, congenital cecal duplication cyst\nPathophysiology of vascular compromise:\n(1) Acute mesenteric torsion + strangulation $\\rightarrow$ arterial and venous obstruction\n(2) Gradual distension + increase in intraluminal pressure $\\rightarrow$ interferes with perfusion $\\rightarrow$ perforation in $65 \\%$\nTypes: I = axial torsion $(40 \\%)=$ cecum twists in axial plane rotating along its long axis\n$\\checkmark$ cecum occupies right lower quadrant\nII = loop twist $(40 \\%)=$ cecum twists and inverts\n$\\checkmark$ cecum occupies left upper quadrant\nIII = cecal bascule (20\\%) [bascule, French = seesaw]\n$=$ anteromedial + upward folding of cecum over ascending colon WITHOUT twist\nCause: loose mesentery, ? related to adhesion\n$\\checkmark$ dilated cecum anterior to ascending colon\nAge peak: $20-40$ years; $\\mathrm{M}>\\mathrm{F}$\n\n- gradual onset of acute cramping abdominal pain\n- distention, constipation, vomiting\n\nPlain film (DIAGNOSTIC in $<50 \\%$ ):\n$\\checkmark$ air- or fluid-filled dilated small bowel\n$\\checkmark$ collapsed left colon\n$\\checkmark$ cecal gaseous distension:\n$\\checkmark$ \"kidney-shaped\" distended cecum inverts + rotates into left upper quadrant (type II)\n$\\checkmark$ dilated cecum rotates upward + anterior to ascending colon without twisting (type III)\n$D D x:$ gastric distension, SBO, sigmoid volvulus\nBE (for confirmation of plain film findings):\n$\\checkmark$ \"bird beak\" sign = tapering of afferent + efferent bowel loops pointing to point of torsion\n$\\checkmark$ \"coffee bean\" sign = dilated air- and fluid-filled cecum with haustral creases\n$\\checkmark$ decompressed distal colon\n$\\checkmark$ inability to reflux much contrast material into dilated proximal colon and terminal ileum",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 728,
            "markdown": "CT:\n$\\sqrt{ }$ cecum ectopically positioned in upper mid + left abdomen\n$\\sqrt{ }$ \"whirlpool / whirl\" sign = twisted loop of bowel with its mesentery + ileocecal vessels (NOT in type III)\n$\\sqrt{ }$ \"coffee bean / bird beak\" sign\nCx: (1) Cecal distension $>10-12 \\mathrm{~cm} \\rightarrow$ means risk of bowel perforation / infarction\n(2) Abdominal compartment syndrome $=$ increase in abdominal pressure diminishes respiratory function + cardiac output\n\nSigmoid Volvulus (60-75\\%)\n= VOLVULUS OF SIGMOID COLON\nCause: sigmoid twist on mesenteric axis\nAt risk: chronic constipation, redundancy of sigmoid colon $\\leftarrow$ high-fiber diet, pregnancy, Chagas disease, hospitalization / institutionalization\nAge: usually in elderly $>70$ years / psychiatrically disturbed\nDegree of torsion: $360^{\\circ}(50 \\%), 180^{\\circ}(35 \\%), 540^{\\circ}(10 \\%)$\n![img-81.jpeg](img-81.jpeg)\n\nPlain film:\n$\\sqrt{ }$ \"northern exposure\" sign = greatly distended paralyzed loop with fluid-fluid levels arising out of pelvis and extending toward diaphragm beyond level of transverse colon mainly on left side (on film in UPRIGHT position)\n$\\sqrt{ }$ \"coffee-bean sign\" = distinct midline crease corresponding to mesenteric root of large gas-distended sigmoid colon (on film in SUPINE position)\n$\\sqrt{ }$ \"white stripe\" sign = obliquely oriented center line of the U-shaped closed-loop appearance\n$\\sqrt{ }$ \"three-line\" sign = obliquely oriented outer wall + center lines of the U-shaped closedloop appearance\nBE (thin water-soluble contrast material):\n$\\sqrt{ }$ \"bird-of-prey\" sign = tapered beaklike distal aspect of twist on barium enema\n$\\sqrt{ }$ enema may help achieve reduction of volvulus\nCT:",
            "images": [
                {
                    "id": "img-81.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 877,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1397,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 729,
            "markdown": "$\\sqrt{ }$ \"whirl\" sign = tightly torsed mesentery formed by twisted afferent + efferent loop\n\n# Volvulus of Transverse Colon \n\nFrequency: $<5-10 \\%$ of all cases of colonic volvulus\nCause: abnormal fixation of a long transverse colon\nPrognosis: highest mortality of all cases of colonic volvulus $\\leftarrow$ rare + unsuspected occurrence\n$\\checkmark$ characteristic beaklike tapering at level of twist\n$\\checkmark$ \"whirl\" sign adjacent to transverse colon\n\n## CONGENITAL ESOPHAGEAL ATRESIA \\& TRACHEOESOPHAGEAL FISTULA\n\n= complex of congenital anomalies characterized by failed / incomplete formation of the tubular esophagus or an abnormal communication between esophagus + trachea\nCause: developmental disorder in formation and separation of primitive foregut into trachea + esophagus / vascular compromise\nEmbryology:\nprimitive foregut tube develops lateral wall folds that may incompletely connect at any point leaving a fistulous communication; occurs at $3^{\\text {rd }}-5^{\\text {th }}$ week of intrauterine life\nPrevalence: $1 \\div 2,000-4,000$ livebirths; most common sporadic congenital anomaly diagnosed in childhood\nRisk of recurrence in sibling: $1 \\%$\nAssociated anomalies (17-56-70\\%):\n\n1. Gastrointestinal ( $20-25 \\%$ ): imperforate anus, pyloric stenosis, duodenal atresia, annular pancreas\n2. Cardiac ( $15-39 \\%$ ): patent ductus arteriosus, ASD, VSD, right-sided aortic arch (5\\%)\n3. Musculoskeletal ( $24 \\%$ ): radial ray hypoplasia, vertebral anomalies\n4. Genitourinary ( $12 \\%$ ): unilateral renal agenesis\n5. Chromosomal ( $3-19 \\%$ ): trisomy $18,21,13$\n$\\diamond$ Trisomy 18 is present in $75-100 \\%$ of fetuses + in $3-4 \\%$ of neonates with esophageal atresia!\nmnemonic: ARTICLES\nAnal atresia\nRenal anomalies\nTracheoesophageal fistula (TEF)\nIntestinal atresia / malrotation\nCardiac anomaly: PDA, VSD\nLimb anomalies: radial ray hypoplasia, polydactyly\nEsophageal atresia\nSpinal anomalies\nmnemonic: VACTERL\nVertebral anomalies\nAnal atresia\nCardiac malformations",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 730,
            "markdown": "Tracheo-\nEsophageal fistula\nRenal anomalies\nLimb anomalies\n$\\diamond$ At least 3 anomalies must be present to suggest VACTERL!\nPrevalence: $1 \\div 10,000$ to $1 \\div 40,000$ live births\n\n- drooling from excessive accumulation of pharyngeal secretions (esophageal atresia $=\\mathrm{EA}$ )\n- obligatory regurgitation of ingested fluids (EA)\n- aspiration with coughing + choking during feeding (TEF)\n- recurrent pneumonia + progressive respiratory distress of variable severity in neonate (TEF)\n\nLocation: between upper $1 / 3+$ lower $1 / 3$ of esophagus just above carina\n@ Mediastinum\n$\\sqrt{ }$ \"coiled tube\" = inability to pass feeding tube into stomach (esophageal atresia)\n$\\sqrt{ }$ retrotracheal air-distended pouch of proximal esophagus causing compression / displacement of trachea\n$\\sqrt{ }$ non- / hypoperistaltic esophageal segment $(6-15 \\mathrm{~cm})$ in midesophagus\n$\\sqrt{ }$ food impaction\n@ Abdomen\n$\\sqrt{ }$ gasless abdomen $\\leftarrow$ esophageal atresia $\\pm$ proximal TEF $=$ types $\\mathrm{A}+\\mathrm{B}$\n$\\sqrt{ }$ abdomen distended by bowel gas in $90 \\% \\leftarrow$ distal TEF / H-type fistula $=$ types $\\mathrm{C}+\\mathrm{D}$\n@ Chest\n$\\sqrt{ }$ bronchopneumonia with patchy airspace opacity, esp. in dependent upper lobes (in 50\\%)\nOB-US (anomalies not identified before 24 weeks GA):\n$\\sqrt{ }$ polyhydramnios in $33-60 \\%$ :\n$\\diamond$ TEF with esophageal atresia $=$ cause of polyhydramnios in only $3 \\%$ !\n$\\sqrt{ }$ absence of fluid-distended stomach (in $10-41 \\%$; in remaining cases TEF / gastric secretions allow some gastric distension)\n$\\sqrt{ }$ reduced intraluminal fluid in fetal gut\n$\\sqrt{ }$ small abdomen (birth weight $<10^{\\text {th }}$ percentile in $40 \\%$ )\n$\\sqrt{ }$ distended proximal pouch of atretic esophagus\n$\\sqrt{ } \\pm$ single umbilical artery\nCx after repair:\n(1) Anastomotic leak\n(2) Recurrent TEF\n(3) Aspiration pneumonia $2^{\\circ}$ to\n(a) esophageal stricture\n(b) disordered esophageal motility distal to TEF\n(c) gastroesophageal reflux\n\nDDx: pharyngeal pseudodiverticulum (traumatic perforation of posterior pharynx from finger insertion into oropharynx during delivery / tube insertion)\n\n# Esophageal Atresia without Fistula = EA Type A \n\nFrequency: $8-10 \\%$\nAssociated anomalies: in 17\\% (mostly Down syndrome + other atresias of GI tract)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 731,
            "markdown": "# Esophageal Atresia (EA) with Fistula \n\nAssociated anomalies: in 30\\% (mostly cardiovascular)\nType B = esophageal atresia + proximal TEF\nFrequency: $0.9-1 \\%$\nType $\\mathbf{C}=$ esophageal atresia + distal TEF\nFrequency: 53-86\\%\nType $\\mathbf{D}=$ esophageal atresia + proximal and distal TEF\nFrequency: $1-2.1 \\%$\n\n## Tracheoesophageal Fistula without Atresia\n\n$=$ H-SHAPED FISTULA $=$ Type $\\mathbf{E}$\nFrequency: $6-10 \\%$\nAssociated anomalies: in 23\\% (mostly cardiovascular)\n\n- feeding difficulties with choking\n- diagnosis may not be made for several years\n$\\sqrt{ }$ fistula courses forward and upward from esophagus\nmnemonic: No TEF, P, D, P+D, H - 10,1,80,1,10\ntype $\\mathrm{A}=$ esophageal atresia - no TEF $=10 \\%$\ntype $\\mathrm{B}=$ esophageal atresia - prox TEF $=1 \\%$\ntype $\\mathrm{C}=$ esophageal atresia - dist TEF $=80 \\%$\ntype $\\mathrm{D}=$ esophageal atresia - prox + dist $=1 \\%$\ntype $\\mathrm{E}=\\mathrm{H}$-type fistula - no atresia $=10 \\%$\n\n\n## CONGENITAL ESOPHAGEAL STENOSIS\n\n$=$ rare developmental anomaly\nPrevalence: $1 \\div 25,000$ to $1 \\div 50,000$ live births\nForms:\n(1) Tracheobronchial remnant\n$=$ incomplete embryologic separation of primitive foregut from respiratory tract\nMay be associated with: esophageal atresia and tracheoesophageal fistula\nLocation: lower $1 / 3$ of esophagus\n$\\sqrt{ }$ ringlike constriction\n(2) Fibromuscular stenosis\n\nLocation: middle $1 / 3$\n$\\sqrt{ }$ segmental stricture with a smooth tapered area of concentric narrowing of 1 cm in length\n$\\sqrt{ }$ circumferential wall thickening on CT\n(3) Membranous diaphragm\n\nLocation: middle $1 / 3$ of esophagus\n$\\sqrt{ }$ weblike stenosis\n\n- dysphagia, vomiting, respiratory symptoms\n\nDDx: stricture $\\leftarrow$ trauma / reflux esophagitis / ingestion of toxic substance\n\n## CONGENITAL INTESTINAL ATRESIA\n\nPrevalence: $1 \\div 300$ livebirths",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 732,
            "markdown": "Cause: usually sporadic vascular accidents (primary / secondary to volvulus or gastroschisis)\nLocation: jejunum + ileum ( $70 \\%$ ), duodenum ( $25 \\%$ ), colon ( $5 \\%$ ); may involve multiple sites\n$\\sqrt{ }$ \"triple bubble\" sign = intraluminal gas in stomach + duodenal bulb + proximal jejunum as PATHOGNOMONIC sign for jejunal atresia\n$\\sqrt{ }$ \"bulbous bowel segment\" sign with curvilinear termination = dilated loop of bowel just proximal to site of atresia $\\leftarrow$ prolonged impaction of intestinal contents\n$\\sqrt{ }$ gasless lower abdomen: gut usually air-filled by 4 h after birth\n$\\sqrt{ }$ meconium peritonitis $(6 \\%)$\n$\\sqrt{ }$ polyhydramnios (in $50 \\% \\leftarrow$ duodenal / proximal jejunal atresia; rarely in ileal / colonic atresia)\nPrognosis: $88 \\%$ survival for isolated atresia\n\n# CRICOPHARYNGEAL ACHALASIA \n\n= hypertrophy of cricopharyngeus muscle (= upper esophageal sphincter) with failure of complete relaxation\nEtiology:\n\n1. Normal variant without symptoms: seen in $5-10 \\%$ of adults\n2. Compensatory mechanism to gastroesophageal reflux\n3. Neuromuscular dysfunction of deglutition\n(a) primary neural disorders:\nbrainstem disorder (bulbar poliomyelitis, syringomyelia, multiple sclerosis, amyotrophic lateral sclerosis); central / peripheral nerve palsy; cerebrovascular occlusive disease; Huntington chorea\n(b) primary muscle disorder:\nmyotonic dystrophy; polymyositis; dermatomyositis; sarcoidosis; myopathies $\\leftarrow$ steroids / thyroid dysfunction; oculopharyngeal myopathy\n(c) myoneural junction disorder:\nmyasthenia gravis; diphtheria; tetanus\n\n- mostly asymptomatic, dysphagia\n$\\diamond$ Cineradiography / videotape recording required for demonstration!\n$\\sqrt{ }$ distension of proximal esophagus + pharynx\n$\\sqrt{ }$ smoothly outlined shelf- / liplike projection posteriorly at level of cricoid (= pharyngoesophageal junction = level of C5-6)\n$\\sqrt{ }$ barium may overflow into larynx + trachea\nCx: Zenker diverticulum\nRx: cricopharyngeal myotomy\n\n\n## COWDEN DISEASE\n\n$=$ MULTIPLE HAMARTOMA-NEOPLASIA SYNDROME\n$=$ autosomal dominant disease with high penetrance characterized by multiple hamartomas + neoplasms of endodermal, ectodermal, mesodermal origin\nPrevalence: 160 cases reported\nCause: susceptibility gene on long arm of chromosome 10 (10q23.2)\nAge: $2^{\\text {nd }}$ decade",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 733,
            "markdown": "@ Mucocutaneous lesions\n\n- facial papules, oral papillomas (lips, gingiva, tongue)\n- palmoplantar keratosis, acral keratosis\n@ CNS neoplasia\n- macrocephaly\n$\\checkmark$ meningioma, glioma\nAssociated with: dysplastic cerebellar gangliocytoma\n@ Breast lesions (in 50\\%):\n$\\checkmark$ fibrocystic disease + fibroadenomas\n$\\checkmark$ breast cancer ( $20-30 \\%$ ): often bilateral + ductal\n@ GI tract\n$\\checkmark$ multiple hamartomatous polyps (in $30-60 \\%$, commonly in rectosigmoid)\n@ Thyroid abnormalities (in 60-70\\%):\n$\\checkmark$ adenomas + goiter\n$\\checkmark$ follicular thyroid adenocarcinoma (3-4\\%)\n@ Genitourinary lesions\n$\\checkmark$ multiple randomly distributed 1-6-mm hyperechoic avascular masses (= lipomatosis)\n@ Skeletal abnormalities\n\n\n# CROHN DISEASE \n\n[Burrill Crohn (1884-1983), gastroenterologist in New York, USA]\n$=$ REGIONAL ENTERITIS\n$=$ chronic relapsing inflammatory disorder with prolonged unpredictable course characterized by discontinuous + asymmetric involvement of entire GI tract\nCause: unknown; ? diet, smoking, stress, infection, genetics, autoimmune abnormality Genetic susceptibility:\n(1) homozygosity for Nod-2 gene (= intracellular protein in lymphocytes) responsible for binding bacterial endotoxins + initiating a cascade that produces TNF- $\\alpha$ (= tumor necrosis factor-alpha)\n(2) increased mucosal permeability for enteric bacteria\n\nIncidence: 3.1-14.6+100,000 annually; high in Caucasians + Jews; 25\\% during pediatric period\n$\\diamond 10,000-40,000$ new cases annually in USA\nPath: transmural (= full-thickness) bowel inflammation with obstructive lymphedema + submucosal lymphoid hyperplasia; aphthous ulcer progresses to longitudinal ulceration typically along mesenteric border; extension into mesentery + adjacent lymph nodes $\\rightarrow$ formation of perienteric sinuses + fistulas + abscesses\n\nIn Crohn disease the $1^{\\text {st }}$ macroscopic feature to appear is a mucosal aphthous ulceration $=\\mathrm{a}$ pinpoint ulcer / erosion of mucosa overlying a submucosal lymphoid follicle.\nHisto: (a) acute: neutrophilic infiltration, crypt abscesses\n(b) chronic: villous atrophy\n\nNoncaseating granulomas with Langhans giant cells and epithelioid cells, edema, fibrosis (in 30\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 734,
            "markdown": "Age peaks: $2^{\\text {nd }}$ decade $+5^{\\text {th }}-7^{\\text {th }}$ decade (bimodal distribution); $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$\n\n- recurrent episodes of diarrhea, colicky / steady abdominal pain\n- low-grade fever, weight loss, anorexia, occult blood + anemia\n- perianal abscess / fistula ( $40 \\%$ ), malabsorption ( $30 \\%$ )\n\nAssociated with: erythema nodosum, pyoderma gangrenosum\nRx: (a) lifestyle changes: cessation of smoking\n(b) medical: aminosalicylates, corticosteroids; probiotics + antibiotics (modulation of enteric flora); purine synthesis inhibitors like azathioprine +6 -mercapto-purine (downregulation of inflammatory response); infliximab (chimeric antibody binding to TNF- $\\alpha$ )\n(c) surgical: resection at some point $(60-70 \\%)$\n\nOutcome: chronic active disease ( $13 \\%$ ), chronic intermittent disease ( $73 \\%$ ), in remission for many years $(10 \\%)$\n\n# Intestinal Manifestations of Crohn Disease \n\nPhases: may coexist\n(a) Earliest changes\n$\\sqrt{ }$ nodular enlargement of lymphoid follicles\n$\\sqrt{ }$ blunting / flattening / distortion / straightening / thickening of valvulae conniventes $\\leftarrow$ obstructive lymphedema, usually first seen in terminal ileum\n$\\sqrt{ }$ aphthous ulcers = nodules with shallow central barium collection up to 5 mm in diameter\nLocation: duodenal bulb, $2^{\\text {nd }}$ portion of duodenum, terminal ileum\n(b) Advanced nonstenotic phase\n$\\sqrt{ }$ skip lesions $(90 \\%)=$ PATHOGNOMONIC discontinuous involvement with intervening normal areas\n$\\sqrt{ }$ straightening + rigidity of small bowel loops with luminal narrowing $\\leftarrow$ spasm + submucosal edema:\n$\\sqrt{ }$ separation + displacement of small bowel loops $\\leftarrow$ lymphedematous wall thickening + increase in mesenteric fat + enlarged mesenteric lymph nodes + abscess formation after perforation\n$\\sqrt{ }$ inflammatory adhesions\n$\\sqrt{ }$ thick + blunted small bowel folds $\\leftarrow$ inflammatory infiltration of lamina propria + submucosa:\n$\\sqrt{ }$ \"string\" sign = reversible incomplete filling $\\leftarrow$ edema and spasm $\\leftarrow$ irritability from severe ulceration\n$\\sqrt{ }$ linear mesenteric border ulcers parallel to shortened concave / straight mesenteric border (nearly PATHOGNOMONIC):\n$\\sqrt{ }$ antimesenteric border sacculations = bulging area of normal wall opposite affected scarred wall on mesenteric side = pseudosacculations\n$\\sqrt{ }$ transmural ulcer formation $\\rightarrow$ sinus, fistula, perienteric abscess\n$\\sqrt{ }$ cobblestone appearance $=$ ulceronodular pattern of serpiginous longitudinal + transverse ulcers separated by areas of edematous residual mucosal islands:\n$\\sqrt{ }$ diffuse mucosal granularity $\\leftarrow 0.5-1-\\mathrm{mm}$ round lucencies ( $=$ blunted + fused villi",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 735,
            "markdown": "seen EN FACE)\n$\\sqrt{ }$ pseudopolyps $=$ islands of hyperplastic mucosa between denuded mucosa\n(c) Stenotic / obstructive phase\n$\\sqrt{ }$ \"string\" sign = irreversible severe narrowing of bowel loop $\\leftarrow$ marked fibrous thickening of intestinal wall $=$ stricture (in $21 \\%$, most frequently in terminal ileum) in combination with severe edema + spasm\n$\\sqrt{ }$ normal proximal loops may be dilated with stasis ulcers + fecoliths\n(d) Reparative phase\n$\\sqrt{ }$ mucosal denudation ( $\\leftarrow$ mucosal atrophy) with focal areas of sparing\n$\\sqrt{ }$ extensive sessile / pedunculated / filiform postinflammatory regenerative polyposis\nUS:\nTechnologic advances in US allow improved visualization of small bowel and mesentery, especially in the pediatric population.\n@ bowel wall\n$\\sqrt{ }$ \"pseudokidney / target\" sign = circumferential continuous / intermittent diffusely thickened hypoechoic bowel wall (22-65-89\\%) of 5-20 mm (DDx: ulcerative colitis)\n$\\sqrt{ }$ loss of normal layering $\\leftarrow$ transmural edema, inflammation, fibrosis\n$\\sqrt{ }$ echolucent interruptions of the normally echogenic submucosa\n$\\sqrt{ }$ decreased peristalsis / aperistalsis $\\leftarrow$ ganglioneuritis / alteration in interstitial cells of Cajal\n$\\sqrt{ }$ luminal narrowing:\n$\\sqrt{ }$ noncompressible rigid and fixed bowel segment\n$\\sqrt{ }$ upstream distention with fluid-filled loops ( $12 \\%$ )\n> inflammatory stricture with little fibrosis:\n$\\sqrt{ }$ loss of normal bowel wall stratification\n$\\sqrt{ }$ hypoechoic bowel wall $\\leftarrow$ mural hyperemia\n$\\sqrt{ }$ increased vascularity of gut wall and adjacent fat on color Doppler\n> fibrotic stricture:\n$\\sqrt{ }$ maintained gut signature\n$\\sqrt{ }$ prominently echogenic submucosa $\\leftarrow$ collagen deposition\n$\\sqrt{ }$ NO increase in wall vascularity\n@ perienteric findings on US\n$\\sqrt{ }$ small amount of intraperitoneal free fluid\n$\\sqrt{ }$ hypertrophy of mesenteric adipose tissue $\\rightarrow$ separation of bowel loops\n$\\sqrt{ }$ echogenic ectopic \"creeping fat / fat wrapping\" (= inflammatory and fibrous tissue) around active region of inflammation extending to antimesenteric surface\n$\\sqrt{ }$ \"comb\" sign = increased mesenteric blood flow $\\leftarrow$ engorgement of vasa recta\n$\\sqrt{ }$ increased number $\\pm$ increased size of visualized lymph nodes\n$\\sqrt{ }$ inflammatory mass = phlegmon ( $14 \\%$ ) without a discernible wall / walled-off abscess $(4 \\%)$\n$\\sqrt{ }$ hypoechoic fistulous tract from serosal surface of bowel that may contain echogenic gas / debris\nCT:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 736,
            "markdown": "(iii) bowel wall:\n$\\sqrt{ }$ mucosal hyperenhancement $=$ segmental hyperattenuation of well-distended small bowel loops during late arterial / enteric phase (best seen with bowel lumen distended by negative contrast):\n$\\sqrt{ }$ \"target\" sign of active inflammation\n$\\sqrt{ }$ mural stratification:\n$\\sqrt{ }$ \"double halo\" configuration $(50 \\%)=$ trilaminar mural stratification $=$ enhancing mucosa + serosa sandwiching submucosa of decreased attenuation:\n$\\sqrt{ }$ water-density edema $=$ active inflammation\n$D D x$ : radiation enteritis, ischemia, mesenteric venous thrombosis, acute pancreatitis\n$\\sqrt{ }$ fat deposition $=$ abnormally low attenuation of submucosa in long-standing disease\n$\\sqrt{ }$ bowel wall thickening:\n$\\sqrt{ }$ mean thickness of 11 (range, $10-20$ ) mm in $82 \\%$\n$D D x$ : mean of 8 mm for ulcerative colitis\n$\\sqrt{ }$ asymmetric thickening affecting predominantly mesenteric border\n$\\sqrt{ }$ bowel wall thickening of homogeneous density\n$D D x$ : ulcerative colitis of heterogeneous density\n$\\sqrt{ }$ skip areas of bowel wall thickening\n$\\sqrt{ }$ luminal narrowing + proximal dilatation (CT enterography / enteroclysis are highly sensitive):\n$\\sqrt{ }$ reversible enhancing inflammatory stricture\n$\\sqrt{ }$ irreversible stricture with lack of enhancement + loss of mural stratification\n(iii) par- / peri- / extraenteric findings on CT\n$\\sqrt{ }$ \"comb\" sign = hyperemic engorged tortuous vasa recta leading to actively inflamed bowel segment\n$\\sqrt{ }$ mesenteric fat stranding (= transmural extension of inflammation across serosa with engorgement of hyperemic vasa recta)\n\n| CT Findings of Acute and Chronic Crohn Disease |  |\n| :-- | :-- |\n| Active Crohn Disease | Inactive Crohn Disease |\n| $\\uparrow$ C-reactive protein level | $\\sqrt{ }$ submucosal fat deposition |\n| $\\sqrt{ }$ mural hyperenhancement | $\\sqrt{ }$ pseudosacculation |\n| $\\sqrt{ }$ mural stratification $\\leftarrow$ intramural | $\\sqrt{ }$ perienteric fibrofatty |\n| edema | proliferation |\n| $\\sqrt{ }$ mesenteric fat stranding | $\\sqrt{ }$ fibrotic strictures |\n| $\\sqrt{ }$ comb sign |  |\n\n$\\sqrt{ }$ \"creeping fat / fat wrapping\" sign = almost PATHOGNOMONIC massive fibrofatty proliferation of mesentery along mesenteric border ( $40 \\%$ ) $\\leftarrow$ production of tumor necrosis factor a sustaining the inflammatory process:\n$\\sqrt{ }$ fat attenuation elevated by $20-60 \\mathrm{HU}$\n$\\sqrt{ }$ separation of small bowel loops (mass effect)\n$\\sqrt{ }$ remains present in clinically quiescent disease",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 737,
            "markdown": "$\\sqrt{ }$ pseudosacculation of antimesenteric border $\\leftarrow$ asymmetric fibrosis of the mesenteric border $\\leftarrow$ inflammation of mesenteric border of involved segment\n$\\sqrt{ }$ mild mesenteric lymphadenopathy ( $18 \\%$ ) with nodes $3-8 \\mathrm{~mm}$ small\n$\\diamond$ Consider lymphoma / carcinoma with lymph nodes $>10 \\mathrm{~mm}$ !\n$\\checkmark$ fistulization / sinus tract $(15-40 \\%)$\n$\\checkmark$ mesenteric phlegmon / abscess formation in $15-20 \\%$ (DDx: postoperative blind loop)\nMR:\n$\\checkmark$ aphthous ulcers + intestinal fold thickening\n$\\checkmark$ bowel wall thickening $>3 \\mathrm{~mm}$ correlating with Crohn disease activity index\n$\\checkmark$ fissuring undermining transmural ulcers\n$\\checkmark$ PATHOGNOMONIC linear ulcers paralleling mesenteric border\n$\\checkmark$ cobblestoning\n$\\checkmark$ layered pattern of intense enhancement $\\leftarrow$ inner + outer enhancing rings (= hyperemic mucosa + serosa) with low-signal-intensity ring ( $=$ submucosal edema) in between correlating well with Crohn disease activity index\n$D D x$ : \"halo\" sign of chronic inflammatory bowel disease (low-signal-intensity ring of fat hypertrophy + fibrosis in submucosa)\n$\\checkmark$ \"creeping fat / fat wrapping\" sign of fat proliferation\n$\\checkmark$ \"comb\" sign\n$\\checkmark$ mural abscess with rimlike enhancement\n$\\checkmark$ serosal hypervascularity = nestlike lesions of tiny serpentine hyperintense enhancing vessels adjacent to serosal surface\n$\\checkmark$ hypointense chronic fibrotic stricture on T1WI + T2WI\n$\\checkmark$ pseudosacculation on antimesenteric side\nPrognosis: recurrence rate of up to $39 \\%$ after resection (commonly at the site of the new terminal ileum, most frequently during first 2 years after resection); mortality rate of $7 \\%$ at 5 years, $12 \\%$ at 10 years after $1^{\\text {st }}$ resection\nCx: (1) Fistula (ileoileal $>$ ileocecal $>$ ileosigmoid)\n(2) Intramural sinus tracts\n(3) Abscess in up to $20 \\%$ (DDx: acute appendicitis)\n(4) Small bowel obstruction ( $15 \\%$ )\n(5) Free perforation $(1-2 \\%)$\n(6) Toxic megacolon\n(7) Hydronephrosis, generally on right side $\\leftarrow$ ureteric compression\n(8) Adenocarcinoma in ileum / colon (particularly in bypassed loops / in vicinity of chronic fistula)\nPatients with Crohn disease are at increased risk for developing adenocarcinoma in affected intestinal segments ( $4-20 \\mathrm{x}$ that of general population, with a prevalence of up to $1.8 \\%$ )\n(9) Lymphoma in large + small bowel\n\nDDx: (1) Yersinia (in terminal ileum, resolution within 3-4 months)\n(2) Tuberculosis (more severe involvement of cecum, pulmonary TB)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 738,
            "markdown": "(3) Actinomycosis, histoplasmosis, blastomycosis, anisakiasis\n(4) Segmental infarction (acute onset, elderly patient)\n(5) Radiation ileitis (appropriate history)\n(6) Lymphoma (no spasm, luminal narrowing is uncommon, tumor nodules)\n(7) Carcinoid tumor (tumor nodules)\n(8) Eosinophilic gastroenteritis\n(9) Potassium stricture\n\nLocation: terminal ileum + ileocecal region (most common)\n@ Esophagus ( $3 \\%$ )\n$\\sqrt{ }$ \"aphthous\" ulcers (early) = discrete superficial ulcers with punctate collections of barium surrounded by halo of edema\n$\\checkmark$ esophagitis, stricture, fistula (late)\n$D D x$ : superficial spreading esophageal carcinoma\n@ Stomach $(1-2 \\%)=$ granulomatous gastritis\n$\\checkmark$ aphthous ulcers (= pinpoint erosions)\n$\\checkmark$ pseudo-post Billroth-I appearance\n$\\checkmark$ \"ram's horn\" sign = poorly distensible smooth tubular narrowed antrum + widened pylorus + narrow duodenal bulb\n$\\checkmark$ cobblestone appearance of mucosa\n$\\checkmark$ antral-duodenal fistula\n@ Duodenum (4-20\\%) almost always associated with gastric involvement\nLocation: duodenal bulb + proximal half of duodenum\nUGI:\n$\\checkmark$ superficial aphthoid erosions (early lesion)\n$\\checkmark$ thickened nodular folds, cobblestone pattern\n$\\checkmark$ deep linear ulcer + sacculations of opposing wall\n$\\checkmark$ multiple eccentric duodenal stenoses with outward ballooning / sacculation between areas of stricture in stenotic phase of Crohn disease $\\leftarrow$ healing of deep ulcerations with scarring + fibrosis\nCT:\n$\\checkmark$ mural thickening, mucosal hyperemia, periduodenal soft-tissue stranding\n@ Small bowel $(80 \\%)=$ REGIONAL ENTERITIS\nLocation: terminal ileum (alone / in combination in $95 \\% \\leftarrow$ high concentration of lymphoid tissue; jejunum / ileum ( $15-55 \\%$ ); sparing of terminal ileum in $1 \\%$\n$\\checkmark$ picket fence pattern = diffuse irregular segmental thickening + slight nodularity of circular folds\n$\\checkmark$ aphthous ulcers\n$\\checkmark$ reduction in / distortion of folds $\\leftarrow$ ulceration\n$\\checkmark$ cobblestone mucosa\n$\\checkmark$ commonly associated with medial cecal defect\n@ $\\operatorname{Colon}(22-70 \\%)$\n$=$ GRANULOMATOUS COLITIS $=$ CROHN COLITIS\nLocation: particularly on right side with rectum + sigmoid frequently spared; isolated",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 739,
            "markdown": "to colon (in 20\\%)\n$\\sqrt{ }$ feces completely absent / present only in one colonic segment\n$\\sqrt{ }$ tiny $1-2-\\mathrm{mm}$ nodular filling defects (lymphoid follicular pattern)\n$\\sqrt{ }$ aphthous ulcers of \"target / bull's-eye\" appearance\n$\\sqrt{ }$ \"transverse stripe\" sign $=1-\\mathrm{cm}$-long straight stripes representing contrast medium within deep grooves of coarse mucosal folds\n$\\sqrt{ }$ long fistulous tracts parallel to bowel lumen\n![img-82.jpeg](img-82.jpeg)\n@ Appendicitis (20\\%)\n@ Rectum (14-50\\%)\n$\\sqrt{ }$ deep / collarbutton ulcers\n$\\sqrt{ }$ rectal sinus tracts\n\n# Fistulizing Crohn Disease \n\n$=$ PENETRATING CROHN DISEASE\nFrequency: $35 \\%$ at some time during course of disease with a $20-40 \\%$ lifetime risk\n$\\diamond$ Crohn disease is $3^{\\text {rd }}$ most common cause of fistula / sinus tracts (DDx: iatrogenic [most common cause], diverticula [2 $2^{\\text {nd }}$ most common cause])!\nTypes:\nA. Internal fistula\n$\\sqrt{ }$ hyperenhancing tracts\n(a) enteroenteric:\n\n- asymptomatic\n\nSite: most frequently between ileum + cecum\n(b) interloop abscess\n(d) enterovesical",
            "images": [
                {
                    "id": "img-82.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 499,
                    "bottom_right_x": 1339,
                    "bottom_right_y": 1232,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 740,
            "markdown": "(e) enterogenital: rectovaginal fistula\nB. External / enterocutaneous fistula ( $8-21 \\%$ )\n$=$ perineal fistula (rectum-to-skin in $54 \\%$ )\n$\\sqrt{ }$ isoattenuating tract relative to anorectum\n$\\sqrt{ }$ positive oral contrast material may better depict fistulous tract BUT obscure mucosal hyperenhancement\n\n| Crohn Disease versus Ulcerative Colitis |  |  |\n| :--: | :--: | :--: |\n|  | Crohn Disease | Ulcerative Colitis |\n| Wall | $\\sim 11-13 \\mathrm{~mm}$ thick | $\\sim 8 \\mathrm{~mm}$ thick |\n|  | eccentric (mesenteric) | symmetric |\n|  | segmental | continuous |\n| Distribution | terminal ileum | rectum |\n|  | right colon | left colon |\n| Inflammation | transmural | NOT transmural |\n| CT signs | mesenteric comb |  |\n|  | halo | halo |\n|  | creeping mesenteric fat |  |\n|  | perirectal fat proliferation | perirectal fat proliferation |\n| $C x$ | fistulae | NO fistulae |\n|  | abscesses |  |\n\n# Extraintestinal Manifestations of Crohn Disease \n\n@ Hepatobiliary\n\n1. Fatty infiltration of liver $\\leftarrow$ steroid therapy, hyperalimentation\n2. Hepatic abscess (rare): $\\mathrm{M}+\\mathrm{F}=3 \\div 1$\n3. Gallstones ( $15-34 \\%$ ): predominantly cholesterol;\n\nRisk: 3-5 x higher risk than expected; risk correlates with length of diseased ileum/ resected ileum / duration of disease\nCause: interrupted enterohepatic circulation with malabsorption of bile salts in terminal ileum\n4. Acute cholecystitis\n5. Primary sclerosing cholangitis $(1 \\%)+$ hepatoma\n6. Bile duct + gallbladder carcinoma\n7. Pancreatitis\n@ Genitourinary\n\n1. Urolithiasis ( $5-10 \\%$ ): oxalate (steatorrhea $\\rightarrow$ excess colonic absorption of oxalate) / urate stones\n2. Hydronephrosis\n3. Renal amyloidosis\n4. Focal cystitis\n5. Ileoureteral / ileovesical fistula (5-20\\%)\n@ Musculoskeletal",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 741,
            "markdown": "- digital clubbing $(11-40 \\%)$\n- mild self-limiting seronegative peripheral migratory arthritis (15-22\\%): may precede bowel disease in $10 \\%$; severity + course correlates well with severity of intestinal disease; resection of diseased bowel leads to regression of symptoms\n\n1. Hypertrophic osteoarthropathy\n2. Ankylosing spondylitis (in 3-16\\%)\n$\\diamond$ Axial skeletal involvement usually precedes onset of GI symptoms!\n\n- in severity / course unrelated to activity level of bowel disease\n$\\checkmark$ symmetric bilateral sacroiliitis\n$\\checkmark$ spondylitis with syndesmophytes\n\n3. Peripheral erosive arthritis\n$\\checkmark$ small marginal erosions\n$\\checkmark$ periostitis\n$\\checkmark$ propensity for osseous ankylosis\n4. Avascular necrosis of femoral head $\\leftarrow$ steroid Rx\n5. Pelvic osteomyelitis (contiguous involvement)\n6. Septic arthritis\n7. Muscle abscess\n8. Retarded skeletal growth + maturation\n@ Erythema nodosum, uveitis\n\n# CRONKHITE-CANADA SYNDROME \n\n$=$ nonneoplastic nonhereditary polyps (as in juvenile polyposis) associated with ectodermal abnormalities; no familial predisposition\nPrevalence: $>100$ cases described\nHisto: hamartomatous polyps resemble juvenile / retention polyps = multiple cystic spaces filled with mucin $\\leftarrow$ degenerative changes; expansion + inflammation of lamina propria\nAge: 62 (range, 42-75) years; $\\mathrm{M}<\\mathrm{F}$\n\n- exudative protein-losing enteropathy\n- diarrhea $\\leftarrow$ disaccharidase deficiency, bacterial overgrowth in small intestine\n- severe weight loss, anorexia, abdominal pain\n- brownish macules of hand + feet, nail atrophy, alopecia\n$\\checkmark$ multiple polyps\n$\\checkmark$ thickened gastric rugae\nLocation: stomach ( $100 \\%$ ); small bowel ( $>50 \\%$ ); colon ( $100 \\%$ )\nPrognosis: rapidly fatal in women within 6-18 months $\\leftarrow$ cachexia; tendency toward remission in men\n\n\n## DESMOPLASTIC SMALL ROUND CELL TUMOR\n\n$=$ INTRAABDOMINAL DESMOPLASTIC SMALL ROUND CELL TUMOR OF PERITONEUM\n$=$ rare highly malignant tumor belonging to a generic group of small round blue cell tumors (like Ewing sarcoma, neuroblastoma, Wilms tumor, rhabdomyosarcoma, primitive neuroendocrine tumor)\nPrevalence: $<50$ cases in literature",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 742,
            "markdown": "Median age: 21 (range, 5-30) years; $\\mathrm{M} \\div \\mathrm{F}=4-9 \\div 1$\nOrigin: mesothelial / submesothelial / subserosal mesenchyme of the abdominal cavity\nPath: multinodular unencapsulated mass with focal cystic areas / necrosis / hemorrhage; common serosal implants\nHisto: island clusters of small blue cells embedded in a dense desmoplastic fibrous stroma; immunohistochemically positive for epithelial, neural, muscular markers (cytoplasmic keratin + desmin)\nGenetics: chromosomal translocation $\\mathrm{t}(11 ; 22)(\\mathrm{p} 13 ; \\mathrm{q} 12)$ creating a unique fusion protein of WT1 (Wilms tumor gene) and EWS (Ewing sarcoma family gene)\n\n- palpable intraabdominal mass $(64 \\%)$\n- abdominal pain ( $52 \\%$ ), increased abdominal girth ( $8 \\%$ )\n\nLocation: mesentery (particularly retrovesical / rectouterine spaces), retroperitoneum, paratesticular region, posterior mediastinum, pleura, meninges, bone, salivary glands\nSpread to: omentum, retroperitoneal and mesenteric lymph nodes, liver, lung, bone (in 50\\% at initial presentation)\nAverage size: 11.2 (range, $3-22$ ) cm\n$\\sqrt{ }$ multiple scattered necrotic peritoneal, omental, and serosal round / ovoid masses without a clear organ of origin\n$\\checkmark$ usually single dominant ( $>10 \\mathrm{~cm}$ ) mass in the retrovesical / retrouterine space / peritoneum / omentum\n$\\checkmark$ diffuse nodular peritoneal thickening + omental caking\n$\\checkmark$ tumor spread to serosal surface of liver + spleen (common)\n$\\checkmark$ small punctate peritoneal calcifications\n$\\checkmark$ cystic areas in mass $\\leftarrow$ intratumoral necrosis / hemorrhage\n$\\checkmark$ heterogeneous enhancement\n$\\checkmark$ scant malignant ascites (37\\%)\nUS:\n$\\checkmark$ hyper- / hypoechoic mass $\\leftarrow$ depending on degree of necrosis + hemorrhage\n$\\checkmark \\pm$ echogenic shadowing calcifications\n$\\checkmark$ heterogeneous internal vascularity\nCT:\n$\\checkmark$ small masses of low attenuation ( $24-36 \\mathrm{HU})+$ uniform enhancement\n$\\checkmark$ larger ( $>10 \\mathrm{~cm}$ ) mass with central area of low attenuation + heterogeneous enhancement $\\leftarrow$ necrosis, old hemorrhage\n$\\checkmark$ small punctate / amorphous calcifications ( $30 \\%$ )\n$\\checkmark$ hypoattenuating metastases to liver, abdominal and retroperitoneal lymph nodes\nMR:\n$\\checkmark$ mass typically hypo- to isointense on T1WI + heterogeneously iso- to hyperintense on T2WI compared with skeletal muscle\n$\\checkmark$ foci of T1-hyperintensity $\\leftarrow$ intratumoral hemorrhage\n$\\checkmark$ occasional areas of T2-hypointensity $\\leftarrow$ densely cellular components / dense desmoplastic stroma\nCEMR:\n$\\checkmark$ modest heterogeneous enhancement\n$\\checkmark$ nonenhancing central foci $\\leftarrow$ hemorrhage / necrosis / fibromyxoid component",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 743,
            "markdown": "PET (PET/CT 96\\% sensitive, 98\\% specific):\n$\\sqrt{ }$ mean standardized uptake value of 11.1 (range, 3.7-15.0)\nCx: hydronephrosis, bowel obstruction\nPrognosis: mean survival time of 17 months\n$D D x$ :\n(1) in infants / adolescents: rhabdomyosarcoma; neuroblastoma; mesenteric carcinoid; Burkitt lymphoma\n(2) in adults: diffuse omental / peritoneal carcinomatosis ( $\\leftarrow$ carcinoma of stomach, colon, ovary, pancreas); melanoma; leiomyosarcoma; lymphoma; desmoid tumor; mesothelioma; tumefactive tuberculosis; actinomycosis; Castleman disease; splenosis\n\n# DIAPHRAGM DISEASE \n\n$=$ small bowel webs $\\leftarrow$ NSAIDs\nEffect of NSAID: gastric irritation, ulceration of small intestines\nFrequency: in $10 \\%$ of patients receiving long-term NSAIDs\nPath: foci of submucosal fibrosis with interruption of adjacent muscularis mucosae\n\n- blood + protein loss, intermittent intestinal obstruction\n\nLocation: ileum $>$ jejunum\nEnteroclysis:\n$\\sqrt{ }$ multiple concentric diaphragm-like strictures\n$D D x$ : Crohn disease\n\n## DIFFUSE ESOPHAGEAL SPASM\n\nAge: more common in patients $>50$ years\n\n- severe intermittent chest pain $\\pm$ dysphagia while swallowing\n\nLocation: primarily in distal $2 / 3$ of esophagus\n$\\sqrt{ }$ compartmentalization of esophagus by numerous tertiary contractions\n$\\sqrt{ }$ multiple spontaneous uncoordinated esophageal contractions, often intermittent\n$\\sqrt{ }$ CLASSIC corkscrew appearance $\\rightarrow$ may obliterate esophageal lumen\n$D x$ : extremely high pressures on manometry\n\n## DISACCHARIDASE DEFICIENCY\n\n$=$ enzyme deficiencies for any of the disaccharides (maltose, lactose, etc.)\nA. PRIMARY\nB. SECONDARY to other diseases (eg, Crohn disease)\n\nPathophysiology:\n(a) unabsorbed disaccharides $\\rightarrow$ produce osmotic diarrhea\n(b) bacterial fermentation $\\rightarrow$ produces short-chain volatile fatty acids causing further osmotic + irritant diarrhea\n$\\checkmark$ normal small bowel series without added lactose\n$\\checkmark$ abnormal small bowel series done with lactose ( 50 g added to $600 \\mathrm{~cm}^{3}$ of barium suspension)\n$\\checkmark$ small + large bowel distension\n$\\checkmark$ dilution of barium\n$\\checkmark$ shortening of transit time",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 744,
            "markdown": "# DISTAL INTESTINAL OBSTRUCTION SYNDROME \n\n$=$ DIOS $=$ MECONIUM ILEUS EQUIVALENT\n$=$ accumulation and impaction of viscid fecal material adherent to intestinal wall in distal part of ileum + proximal part of colon [viscum, Latin = birdlime, sticky, slimy, glutinous]\nPrevalence: $10-24 \\% \\%$ of older child / young adult with cystic fibrosis; $2 \\%$ in patients $<5$ years of age\nCause: tenacious intestinal mucus, steatorrhea $\\leftarrow$ pancreatic insufficiency, undigested food remnants, disordered intestinal motility with increase in intestinal transit time, fecal stasis\nRisk factors: pancreatic insufficiency, history of meconium ileus / DIOS, dehydration, lung transplantation\nAge: $2^{\\text {nd }}-3^{\\text {rd }}$ decade of life\n\n- recurrent acute bouts of colicky periumbilical / RLQ pain and vomiting $\\leftarrow$ fecal impaction / constipation\n- palpable cecal mass\n$\\sqrt{ }$ bubbly granular ileocecal soft-tissue mass in RLQ\n$\\sqrt{ }$ partial / complete small bowel obstruction $\\leftarrow$ puttylike fecal material in terminal ileum / right colon\n$\\checkmark$ thickening of mucosal folds\n$\\checkmark$ cystic fibrosis of lung\nCT:\nLocation: cecum $>$ ascending colon $>$ transverse colon $>$ descending colon (contiguous involvement)\n$\\sqrt{ }$ diffuse colonic thickening\n$\\sqrt{ }$ mural striation $(50 \\%)$\n$\\sqrt{ }$ mesenteric soft-tissue infiltration ( $100 \\%$ )\n$\\sqrt{ }$ increased pericolonic fat $(60 \\%)$\n$C x$ : intussusception, volvulus, perforation, ischemia\n$R x$ : rehydration, stool softeners, oral polyethylene glycol-electrolyte solution (GoLYTELY ${ }^{\\circledR}$ ), increasing dose of pancreatic enzyme supplements, mucolytic agents ( N -acetylcysteine) orally / with Gastrografin ${ }^{\\circledR}$ enema\n$D D x$ : severe constipation (subacute presentation), appendicitis, partial intestinal obstruction (adhesion / stricture from previous bowel surgery)\n\n\n## DIVERTICULAR DISEASE OF COLON\n\n$=$ saccular outpouching $\\leftarrow$ overactivity of smooth muscle causes herniation of mucosa + submucosa through a defect in the muscle layer of the colon\nFrequency: $\\quad 5-10 \\%$ in $5^{\\text {th }}$ decade; $33-48 \\%$ over age $50 ; 50-65 \\%$ past $7^{\\text {th }}$ decade; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$; most common affliction of colon in developed countries\nCause: decreased fecal bulk (= diet high in refined fiber + low in roughage)\nLocation: in $80 \\%$ in sigmoid (= narrowest colonic segment with highest pressure); in $17 \\%$ distributed over entire colon; in $4-12 \\%$ isolated to cecum / ascending colon\n\n## Prediverticular Disease of Colon",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 745,
            "markdown": "$=$ longitudinal + circular smooth muscle thickening with redundancy of folds $\\leftarrow$ myostatic contracture\n$\\sqrt{ }$ \"saw-tooth\" sign = crowding + thickening of haustral folds $\\leftarrow$ shortening of colonic segment\n$\\checkmark$ plump marginal indentations\n$\\checkmark$ superimposed muscle spasm (relieved by antispasmodics)\n![img-83.jpeg](img-83.jpeg)\n$D D x$ : hemorrhage; ischemia; radiation changes; pseudomembranous colitis\n\n# Colonic Diverticulosis \n\n$=$ acquired herniations of mucosa + muscularis mucosae through the muscularis propria with wall components of mucosa, submucosa, serosa = false diverticula of pulsion type\nLocation: predominantly left-sided colon\nSite:\n(a) lateral diverticula arise between mesenteric + antimesenteric teniae on opposite sides\n(b) antimesenteric intertaenial diverticula opposite of mesenteric side\nN.B.: intramural type vasa recta (= nutrient arteries) pass through circular muscle (= weakness in muscular wall) $\\rightarrow$ carried over fundus of diverticulum as it enlarges\n$\\sqrt{ }$ size: initially tiny ( $3-10-\\mathrm{mm}$ ) V -shaped protrusions increasing up to several cm in diameter\n$\\checkmark$ bubbly appearance of air-containing diverticula\n$\\checkmark$ residual barium within diverticula from previous study\n$\\checkmark$ spiky irregular outline (antimesenteric intertaenial ridge is typical site for intramural diverticula)\n$\\checkmark$ smooth dome-shaped appendages with a short neck\n$\\checkmark$ may be pointed, attenuated, irregular with variable filling\n$\\checkmark$ circular line with sharp outer edge + fuzzy blurred inner edge (EN FACE view in double contrast BE)",
            "images": [
                {
                    "id": "img-83.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 464,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1159,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 746,
            "markdown": "US:\n$\\sqrt{ }$ thin-walled round / oval outpouching containing echogenic material that often produces distal acoustic shadowing $\\leftarrow$ air / feces\n$\\sqrt{ }$ peridiverticular perienteric fat of normal echogenicity\n$\\sqrt{ }$ thickened muscularis propria $\\leftarrow$ hypertrophy\nCT:\n$\\sqrt{ }$ rounded outpouchings containing air $\\pm$ contrast material (= diverticula)\n$\\sqrt{ }$ circumferential sawtooth-like thickening of colonic haustra + distorted luminal contour (= muscular hypertrophy)\n$C x$ : bleeding (usually right colon), diverticulitis (usually sigmoid colon)\n\n# Giant Colonic Diverticulum (rare) \n\nAge: after $6^{\\text {th }}$ decade\nPath:\n(1) Inflammatory diverticulum (66\\%): wall of dense fibrous tissue + chronic inflammatory cells + foreign body giant cells\n(2) Pseudodiverticulum (22\\%): colonic muscularis propria ends abruptly at neck of pseudodiverticulum $\\leftarrow$ degeneration of mucosal lining of a pseudodiverticulum\n(3) True diverticulum ( $12 \\%$ ): wall contains all colonic layers $\\leftarrow$ communicating bowel duplication cyst\n\n- abdominal pain, nausea, vomiting, fever, constipation, diarrhea, melena\n\nLocation: sigmoid ( $93 \\%$ )\nBE:\n$\\sqrt{ }$ opacification by barium (in $60 \\%$ )\nCT:\n$\\sqrt{ }$ large gas-, fluid-, stool-filled cavity + thin regular wall\n$\\sqrt{ }$ no contrast enhancement / wall thickening unless inflamed\n$\\sqrt{ } \\pm$ wall calcifications $\\leftarrow$ chronic inflammation\n$C x$ : perforation, abscess formation\n$D D x$ : volvulus, bowel duplication, Meckel / duodenal diverticulum, infected pancreatic pseudocyst, emphysematous cholecystitis, emphysematous cystitis, vesicoenteric fistula, abscess\n\n## Colonic Diverticulitis\n\n$=$ perforation of diverticulum with intramural / localized pericolic inflammatory mass\nFrequency: $5 \\%$ of population; in $10-35 \\%$ of diverticular disease\nAge: in $5-10 \\%>45$ years of age, in $80 \\%>85$ years of age (frequency increasing with age)\nPathogenesis: mucosal abrasion from inspissated fecal material $\\rightarrow$ perforation of thin wall\n\n- evenly distributed lower abdominal pain\n- local and rebound tenderness + mass in LLQ (typically)\n- nausea, fever ( $25 \\%$ ), leukocytosis ( $36 \\%$ )\n- clinical misdiagnosis rate of $34-67 \\%$\n\nLocation: sigmoid colon ( $95 \\%$ ), cecum (4\\%)\n$\\sqrt{ }$ localized ileus",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 747,
            "markdown": "$\\sqrt{ } \\pm$ pattern of small bowel obstruction $\\rightarrow$ kinking / edema if small bowel adheres to abscess\n$\\sqrt{ }$ extraluminal gas in abscess / fistula\n$\\sqrt{ }$ pneumoperitoneum (rare)\nBE ( $77-86 \\%$ sensitive):\n$\\sqrt{ }$ focal area of eccentric luminal narrowing caused by pericolic / intramural inflammatory mass:\n$\\sqrt{ }$ annular lesion mimicking carcinoma\n$\\sqrt{ }$ marked thickening + distortion of mucosal folds\n$\\sqrt{ }$ tethered spiculated mucosal folds\n$\\sqrt{ }$ centrally amputated diverticulum\n$\\sqrt{ }$ extraluminal contrast $=$ peridiverticulitis:\n$\\sqrt{ }$ \"double-tracking\" $=$ pericolonic longitudinal sinus tract\n$\\sqrt{ }$ pericolonic collection $=$ peridiverticular abscess\n$\\sqrt{ }$ fistula to bladder / small bowel / vagina\nCT (79-93\\% sensitive, $77 \\%$ specific):\n$\\sqrt{ }$ inflamed diverticulum:\n$\\sqrt{ }$ pericolic fat stranding $=$ poorly marginated hazy area of $\\uparrow$ attenuation $\\pm$ fine linear strands within mesocolic fat $(98 \\%)$\n$\\sqrt{ }$ diverticula $(84 \\%)=$ flask-shaped structures projecting through colonic wall, filled with air / barium / fecal material\n$\\sqrt{ }$ \"centipede\" sign = hyperemic engorged vasa recta\n$\\sqrt{ }$ bowel wall thickening:\n$\\sqrt{ }$ circumferential bowel wall thickening of $>4 \\mathrm{~mm}(70 \\%)$ and up to 2 cm\n$\\sqrt{ }$ colonic wall thickening extending $>5 \\mathrm{~cm}$ in length\n$\\sqrt{ }$ \"double halo\" sign = mural stratification = enhancement pattern with inner hyperdense layer + thickened hypodense middle layer + outer hyperdense layer\n$\\sqrt{ }$ focally thickened + inflamed colonic wall\n$\\sqrt{ }$ \"arrowhead\" sign = funnel of intraluminal contrast medium / air in focally thickened colonic wall centering about occluded orifice of inflamed diverticulum (27\\%)\n$\\sqrt{ }$ pneumatosis\n$\\sqrt{ }$ fluid collection:\n$\\sqrt{ }$ fluid at root of sigmoid mesentery\n$\\sqrt{ }$ fluid $\\pm$ air of peritonitis $(16 \\%)$\n$\\sqrt{ }$ frank abscess $(47 \\%)=$ central liquid / gas\n$\\sqrt{ }$ tract formation:\n$\\sqrt{ }$ fistula formation (14\\%): most commonly colovesical, also colovaginal, coloenteric, colocutaneous\n$\\sqrt{ }$ intramural sinus tracts $(9 \\%)$\n$\\sqrt{ }$ fecolith\n$\\sqrt{ }$ colonic obstruction $(12 \\%)$\n$\\sqrt{ }$ ureteral obstruction $(7 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 748,
            "markdown": "| CT Findings of Diverticulitis versus Malignancy |  |\n| :--: | :--: |\n| Diverticulitis | Malignancy |\n| $\\sqrt{ }$ long segment of involvement $>10 \\mathrm{~cm}$ | $\\sqrt{ }$ focal concentric mass |\n| $\\sqrt{ }$ double halo / target sign | $\\sqrt{ }$ overhanging shoulders |\n| $\\sqrt{ }$ fat stranding adjacent to a thickened wall | $\\sqrt{ }$ enlarged pericolic nodes |\n\nUS ( $85-98 \\%$ sensitive, $80-97 \\%$ specific):\n$\\sqrt{ }$ thickening of bowel wall $>4 \\mathrm{~mm}$ (= distance measured between echogenic lumen interface and serosa)\n$\\sqrt{ }$ round / oval hypo- / hyperechoic focus protruding from colonic wall + focal disruption of normal layer continuity $\\pm$ internal acoustic shadowing\n$\\sqrt{ }$ regionally $\\uparrow$ echogenicity adjacent to colonic wall $\\pm$ ill-defined hypoechoic zones $\\leftarrow$ inflamed pericolic fat\n$\\sqrt{ }$ increased mural vascularity at color Doppler US\n$\\sqrt{ }$ pericolic abscess\nMR:\n$\\sqrt{ }$ chronic colonic wall thickening in affected area\n$\\sqrt{ }$ increased SI in pericolonic fat associated with diverticulum on fat-suppressed T2WI\nPrognosis: (a) self-limiting (usually) = fecolith + pus evacuate into colonic lumen in 12 days\n(b) transmural perforation\n(c) superficial ulceration\n(d) chronic abscess\n$C x$ : (1) Colonic obstruction\n(2) Fistula to bladder / vagina / small bowel\n(3) Free perforation (rare)\n(4) Abscess\n\nDDx: (1) Colonic neoplasm (shorter segment, heaped-up margins, ulcerated mucosa, loss of mural enhancement pattern, pericolic lymph nodes)\n(2) Crohn colitis (double-tracking longer than 10 cm )\n$R x$ : antibiotics, surgery (in $25 \\%$ ), percutaneous abscess drainage\n\n# Right Colonic Diverticulitis \n\n$=$ reliably benign self-limiting condition\nCause: often congenital solitary true diverticulum\nFrequency: $1 \\div 34$ to $1 \\div 300$ appendectomies\nAge: any; peak prevalence at $35-45$ years of age\n\n- protracted mild pain mimicking appendicitis\n- palpable mass in $33 \\%$\n$\\sqrt{ }$ solitary diverticulum containing a $12-\\mathrm{mm}$ fecolith surrounded by inflamed fat\n$\\sqrt{ }$ marked circumferential colonic wall thickening\nCx: pericolonic abscess",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 749,
            "markdown": "Prognosis: spontaneous evacuation into colonic lumen\n$R x$ : conservative; NO indication for surgery\n$D D x:$ appendicitis\n\n# CECAL DIVERTICULITIS $(5 \\%)$ \n\n$=$ usually true diverticulum containing all layers of colonic wall\n\n- generally asymptomatic\n- clinically indistinguishable from acute appendicitis\n\nLocation: near ileocecal valve ( $80 \\%$ )\n$\\sqrt{ }$ inflammatory changes adjacent to diverticulum\n$\\sqrt{ }$ normal-appearing appendix\n\n## Appendiceal Diverticulitis\n\n$=$ insidious onset of inflammation of uncommon usually acquired diverticulum of appendix Appendiceal diverticulum: mostly pseudodiverticulum ( $=$ herniation of mucosa through muscularis)\nPathogenesis: ?; increased intraluminal pressure $\\leftarrow$ proximal obstruction Highly associated with: appendiceal neoplasms Age: usually $>30$ years of age\n\n- lacks migratory pain of classic appendicitis\n\nSite: along mesenteric border of distal $1 / 3$ of appendix; single / multiple\nSize: $<5 \\mathrm{~mm}$\n$\\sqrt{ }$ round outpouching beyond margin of appendix\n$\\sqrt{ }$ may contain fluid / air / enhancing soft tissue\n$\\sqrt{ }$ prominent enhancement of diverticular wall with surrounding fat stranding\n$\\sqrt{ }$ increased diameter of wall-thickened hyperenhancing appendix (mimicks acute appendicitis)\n$C x$ : perforation\n\n## Colonic Diverticular Hemorrhage\n\n$\\diamond$ Not related to diverticulitis\nFrequency: in 3-25-47\\% of diverticulosis\nLocation: $75 \\%$ located in ascending colon (larger neck + dome of diverticula)\n\n- massive rectal hemorrhage without pain\n$\\sqrt{ }$ extravasation of radionuclide tracers\n$\\sqrt{ }$ angiographic contrast pooling in bowel lumen\nPrognosis: spontaneous cessation of bleeding in $75 \\%$, recurrent bleeding in $25 \\%$\n$R x$ :(1) transcatheter infusion of vasoconstrictive agents (Pitressin ${ }^{\\circledR}$ )\n(2) embolization with Gelfoam ${ }^{\\circledR}$\n\n\n## DUMPING SYNDROME\n\n$=$ early postprandial vascular symptomatology of sweating, flushing, palpitation, feeling of weakness and dizziness\nPathophysiology: rapid entering of hypertonic solution into jejunum $\\rightarrow$ resulting in fluid shift from blood compartment into small bowel",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 750,
            "markdown": "Frequency: $1-5 \\% ; \\mathrm{M}+\\mathrm{F}=2 \\div 1$\n$\\diamond$ Roentgenologic findings not diagnostic!\n$\\sqrt{ }$ rapid emptying of barium into small bowel (= loss of gastric reservoir function)\n$R x$ : lying down, diet\n$D D x$ : late postprandial hypoglycemia ( $90-120 \\mathrm{~min}$ after eating)\n\n# DUODENAL ATRESIA \n\n$=$ most common cause of congenital duodenal obstruction; $2^{\\text {nd }}$ most common site of gastrointestinal atresias after ileum\nPrevalence: $1 \\div 10,000 ; \\mathrm{M}+\\mathrm{F}=1 \\div 1$\nEtiology: defective vacuolization of duodenum between $6^{\\text {th }}$ and $11^{\\text {th }}$ weeks of fetal life; rarely from vascular insult (extent of obstruction usually involves larger regions with vascular insult)\nAge at presentation: first few days of life\n\n- persistent bilious vomiting a few hours after birth / following 1st feeding (75\\%)\n- rapid deterioration $\\leftarrow$ loss of fluids + electrolytes\n\nAssociated anomalies (in 50-60\\%):\nIn $30-52 \\%$ isolated sporadic anomaly\n(1) Down syndrome (20-33\\%)\n$\\diamond 25 \\%$ of fetuses with duodenal atresia have Down syndrome\n$\\diamond<5 \\%$ of fetuses with Down syndrome have duodenal atresia\n(2) $\\mathrm{CHD}(8-30-50 \\%)$ : endocardial cushion defect, VSD\n![img-84.jpeg](img-84.jpeg)\n(3) Gastrointestinal anomalies (26\\%):\n\nesophageal atresia, biliary atresia, duodenal duplication, imperforate anus, small bowel atresia, malrotation, Ladd bands, Meckel diverticulum, transposed liver, annular pancreas $(20 \\%)$, preduodenal portal vein\n(4) Urinary tract anomalies (8\\%)\n(5) Vertebral + rib anomalies (37\\%)\n\nLocation: (a) usually distal to ampulla of Vater (80\\%)\n(b) proximal duodenum (20\\%)",
            "images": [
                {
                    "id": "img-84.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 1113,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1599,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 751,
            "markdown": "$\\sqrt{ }$ \"double bubble\" sign = gas-fluid levels in duodenal bulb + gastric fundus\n$\\sqrt{ }$ total absence of intestinal gas in small / large bowel\n$\\sqrt{ }$ colon of normal caliber\nOB-US (usually not identified prior to 24 weeks GA):\n\n- $\\pm$ elevated AFP\n$\\sqrt{ }$ \"double bubble\" sign = simultaneous distension of stomach $+1^{\\text {st }}$ portion of duodenum; continuity of fluid between stomach + duodenum must be demonstrated\n$\\sqrt{ }$ increased gastric peristalsis\n$\\sqrt{ }$ polyhydramnios in $3^{\\text {rd }}$ trimester ( $100 \\%$ )\nPrognosis: $36 \\%$ mortality in neonates\n$D D x$ : (1) Prominent incisura angularis $\\rightarrow$ bidissection of stomach\n(2) Choledochal cyst\n(3) Annular pancreas\n(4) Peritoneal bands\n(5) Intestinal duplication\n$C x$ : prematurity $(40 \\%) \\leftarrow$ preterm labor $\\leftarrow$ polyhydramnios\n\n\n# DUODENAL DIVERTICULUM \n\nFrequency: $1-5 \\%$ of GI studies; $22 \\%$ of autopsies\nA. PRIMARY / FALSE DIVERTICULUM\n$=$ mucosal prolapse through muscularis propria\nSite: posteriorly ( $8 \\%$ ), lateral wall ( $4 \\%$ )\nB. SECONDARY / TRUE DIVERTICULUM\n$=$ all layers of duodenal wall as complication of duodenal / periduodenal inflammation\nLocation: almost invariably in $1^{\\text {st }}$ portion of duodenum\n\n- mostly asymptomatic\n$\\sqrt{ }$ may be fluid-filled (mimicking pancreatic pseudocyst)\n$\\sqrt{ }$ may contain foci of air (mimicking pancreatic abscess)\n$\\sqrt{ }$ contains normal bowel gas / oral contrast material directly communicating with adjacent duodenum\nCx: (1) Perforation + peritonitis\n(2) Bowel obstruction\n(3) Obstruction of bile duct / pancreatic duct\n(4) Bleeding\n(5) Diverticulitis\n\n\n## Intraluminal Duodenal Diverticulum\n\n$=$ congenital lesion $\\leftarrow$ elongation of an incomplete duodenal diaphragm\nAge at presentation: young adult\n\n- easy satiety, vomiting, upper abdominal cramping pain\n\nLocation: $2^{\\text {nd }}-3^{\\text {rd }}$ portion of duodenum near ampulla of Vater\n$\\sqrt{ }$ barium-filled sac within duodenal lumen of \"windsock, comma, teardrop\" appearance (PATHOGNOMONIC picture):",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 752,
            "markdown": "$\\sqrt{ }$ anchored to lateral wall of duodenum\n$\\sqrt{ }$ \"halo\" sign = duodenal mucosa covers outer + inner wall of diverticulum\n$\\sqrt{ }$ fluid- / contrast material filled duodenum with thin diverticular wall on CT / MR\n\n# DUODENAL HEMATOMA \n\nCause: blunt abdominal trauma: deceleration injury, endoscopy; bleeding diathesis; anticoagulation therapy\nMechanism: duodenal compression between spine + anterior abdominal wall by seatbelt / handlebar / nonaccidental injury\nAge: $80 \\%$ in children / young adults\nAssociated with: pancreatic injury in $50-98 \\%$, mesenteric and abdominal wall hematoma, spinal fracture\nPath: mural hematoma with blood dissecting along submucosal compartment $\\leftarrow$ separation of mucosa from loose submucosa\nLocation: $2^{\\text {nd }} / 3^{\\text {rd }}$ portion of duodenum\nUGI:\n$\\sqrt{ }$ circumferential / eccentric duodenal narrowing $\\leftarrow$ extrinsic compression\n$\\sqrt{ }$ large filling defect completely occupying + dilating lumen\nCT:\n$\\sqrt{ }$ hyperattenuating (= acute trauma) thickened duodenal wall\n$\\sqrt{ }$ eccentric mass protruding into the bowel lumen\nMortality: $30 \\%$\nCx: bowel obstruction, perforation\nRx: conservative\n\n## DUODENAL ULCER\n\nIncidence: 60,000 hospitalizations in USA (2006); 2-3 x more frequent than gastric ulcers; $\\mathrm{M}+\\mathrm{F}=3 \\div 1$\nPathophysiology: too much acid in duodenum from\n(a) abnormally high gastric secretion\n(b) inadequate neutralization\n\nPredisposed: cortisone therapy, severe cerebral injury, after surgery, chronic obstructive pulmonary disease\n\n## Location:\n\n(a) bulbar ulcer ( $95 \\%$ ):\n\n$$\n\\begin{aligned}\n& \\text { anterior wall }(50 \\%) \\text {, posterior wall }(23 \\%) \\text {, inferior wall } \\\\\n& (22 \\%), \\text { superior wall }(5 \\%) \\\\\n& \\sqrt{ } \\text { bulbar deformity in } 85 \\%\n\\end{aligned}\n$$\n\n(b) postbulbar ulcer (3-5\\%): medial wall\n\nUGI:\n$\\sqrt{ }$ round collection of barium in a niche + radiolucent halo of edema + circumferential / eccentric luminal narrowing $\\leftarrow$ spasm (in acute phase)\n$\\sqrt{ }$ frequently $<1 \\mathrm{~cm}$ round / ovoid ( $5 \\%$ linear) ulcer niche\n$\\sqrt{ }$ \"kissing ulcers\" = ulcers opposite from each other on anterior + posterior wall (in acute",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 753,
            "markdown": "stage)\n$\\sqrt{ }$ giant duodenal ulcer $>2 \\mathrm{~cm}$ (rare) with higher morbidity + mortality; may be overlooked by simulating a normal / deformed scarred duodenal bulb\n$\\sqrt{ }$ \"cloverleaf deformity, hourglass stenosis\" (in healed stage) with prestenotic dilatation of recesses\nCT:\n$\\sqrt{ }$ outpouching of duodenal wall + adjacent mural thickening + periduodenal fat stranding (acute)\n$\\sqrt{ }$ radiating folds with central punctate / small linear deposit of contrast material (chronic)\n$\\sqrt{ }$ eccentric luminal narrowing + smooth round wall indentation (chronic)\n$C x$ : (1) Obstruction $(5 \\%) \\leftarrow$ edema + spasm (in acute phase) / scarring + fibrosis (subsequent to ulcer healing)\n\n- postprandial nausea \\& vomiting\n(2) Perforation ( $10-13 \\%$ ): anterior $>$ posterior wall; fistula to gallbladder\n(3) Penetration $(<5 \\%)=$ sealed perforation\n(4) Hemorrhage ( $15 \\%$ ): melena $>$ hematemesis\n\nPrognosis: healing $\\rightarrow$ development of scar\n$R x$ : antral resection (Billroth I) + vagotomy\n\n# DUODENAL VARICES \n\n$=$ dilated collateral veins $\\leftarrow$ portal hypertension (posterior superior pancreaticoduodenal vein)\n$\\sqrt{ }$ lobulated filling defects (best demonstrated in prone position, maximal luminal distension will obliterate them)\n$\\sqrt{ }$ commonly associated with fundal + esophageal varices\n\n## DUODENAL WEB\n\n$=$ failure of recanalization process in primitive foregut between $9^{\\text {th }}-11^{\\text {th }}$ week GA\nMay be associated with: Down syndrome, annular pancreas, midgut malrotation, imperforate anus\n\n## Types:\n\n(1) Duodenal atresia / complete imperforate web\n(2) Windsock web = imperforate intraluminal duodenal diverticulum (IDD)\n\nThe shape of the wall of the imperforate intraluminal duodenal diverticulum is affected by peristalsis in the same way a windsock moves with the wind.\n(3) Perforated duodenal web $=$ IDD with central / eccentric opening\n\n- symptoms of pancreatitis $\\pm$ duodenal obstruction\n\nCT / MR:\n$\\sqrt{ }$ fluid- / contrast-filled blind-ending saccular structure\n$\\sqrt{ }$ thin enhancing diverticular wall\n$C x$ : pancreatitis $\\leftarrow$ reflux of duodenal contents through papilla of Vater\n\n## DUPLICATION CYST\n\n$=$ GASTROINTESTINAL DUPLICATION CYST",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 754,
            "markdown": "$=$ uncommon congenital anomaly found anywhere along mesenteric side of alimentary tract from tongue to anus\nFrequency: $15 \\%$ of pediatric abdominal masses are gastrointestinal duplication cysts\nTheories of formation:\n(1) Abortive twinning\n(2) Persistent embryologic diverticula\n(3) Split notochord\n(4) Aberrant luminal recanalization (Bremer): foregut epithelium grows and obliterates lumen (solid stage for esophagus, small bowel, colon) during $6^{\\text {th }}$ week GA; $\\rightarrow$ later produces secretions that form vacuoles in the intercellular space; $\\rightarrow$ vacuoles line up longitudinally and coalesce to form new lumen; $\\rightarrow$ failure of an aberrant vacuole to coalesce creates a wall cyst\n(5) Intrauterine vascular accident (Favara) associated with alimentary tract atresia in 9\\%\n\nAge: presentation often in $1^{\\text {st }}$ year of life / early childhood\nPath: (a) cystic sphere ( $80 \\%$ ) WITHOUT bowel communication\n(b) cystic tubule ( $20 \\%$ ) communicating with bowel lumen\nlocated in / immediately adjacent to gastrointestinal tract; shares a common muscle wall + blood supply; has a separate mucosal lining; cyst contents usually serous\nHisto: wall of smooth muscle lined with alimentary tract mucosa; ectopic mucosa; squamous, transitional, ciliated mucosa; lymphoid aggregates; ganglion cells\n$\\diamond$ Gastric mucosa + pancreatic tissue are the only ectopic tissues of clinical importance!\n\n- mostly asymptomatic, palpable abdominal mass\n- respiratory distress (with esophageal duplication)\n- nausea, emesis $\\leftarrow$ partial / complete obstruction\n\nLocation: distal ileum (30-33\\%), esophagus (17-20\\%), colon (13-30\\%), jejunum (10-13\\%), stomach ( $7 \\%$ ), pylorus ( $4 \\%$ ), duodenum ( $4-5 \\%$ ), ileocecal junction ( $4 \\%$ ), rectum $(4 \\%)$\n$\\diamond$ In $7-15 \\%$ concomitant duplications elsewhere within the alimentary tract!\nSite: on mesenteric aspect of alimentary canal\nMorphology:\n(a) large spherical / saccular cyst ( $82 \\%$ )\n(b) small intramural cyst\n(c) tubular sausage-shaped cyst ( $18 \\%$ ): commonly along small + large bowel; frequently communicates with lumen of adjacent gut\nBE:\n$\\sqrt{ }$ mass extrinsic to bowel lumen\nUS:\n$\\sqrt{ }$ elongated tubular / spherical cystic mass with \"double-wall / muscular rim\" sign:\n$\\sqrt{ }$ \"muscular rim\" sign (= echogenic inner mucosal lining + hypoechoic outer rim) in $47 \\%$\n$\\sqrt{ }$ sonolucent content with good through transmission $\\leftarrow$ clear fluid\n$\\sqrt{ }$ echogenic content $\\leftarrow$ hemorrhage + inspissated material\n$\\sqrt{ }$ cyst paralleling normal bowel lumen\nCT:\n$\\sqrt{ }$ smoothly rounded fluid-filled cyst / tubular structure",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 755,
            "markdown": "$\\sqrt{ }$ thin slightly enhancing wall\nMR:\n$\\sqrt{ }$ heterogeneous SI of intracystic fluid on T1WI + homogeneous high SI on T2WI\nCx: (1) Bowel obstruction by intussusception $\\leftarrow$ cyst at ileocecal junction\n(2) Small bowel volvulus $\\leftarrow$ weight of duplication\n(3) Bleeding $\\leftarrow$ gastric mucosa / pressure necrosis of adjacent mucosa by cyst expansion\n/ from intussusception\n$\\sqrt{ }$ area of high attenuation $\\leftarrow$ hemorrhage / proteinaceous material\n(4) Infection\n$\\sqrt{ }$ thick enhancing wall / septum + surrounding inflammation\n(5) Malignant transformation\n$\\sqrt{ }$ enhancing solid focus within cyst\n(6) Perforation\n\nRx: surgical excision\n$D D x:$\n(1) Omental cyst (greater omentum / lesser sac, multilocular)\n(2) Mesenteric cyst (between leaves of small bowel mesentery)\n(3) Choledochal cyst\n(4) Ovarian cyst\n(5) Pancreatic pseudocyst\n(6) Cystic renal tumor\n(7) Abscess\n(8) Meckel diverticulum (communicates with GI tract)\n(9) Lymphangioma\n(10) Mesenteric lymphoma\n(11) Intramural tumor\n\n# Esophageal Duplication Cyst (10-20\\%) \n\narises from foregut\nFrequency: $10-20 \\%$ of all alimentary tract duplications; $0.5-2.5 \\%$ of all esophageal masses; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 1$\nPath: contains ectopic gastric mucosa in $43 \\%$\nHisto: contains no cartilage, lined by alimentary tract mucosa\nAssociated with: vertebral anomalies (spina bifida, hemivertebra, fusion defects), esophageal atresia, small bowel duplication (18\\%)\nLocation: adjacent to esophagus / within esophageal musculature at any level, paraspinal position; $\\mathrm{R} \\div \\mathrm{L}=2 \\div 1$; in right pleural space detached from esophagus (rare)\nA. CERVICAL ESOPHAGUS (23\\%)\n\n- asymptomatic enlarging lateral neck mass\n- upper airway obstruction in newborn\n$D D x$ : thyroglossal duct cyst, branchial cleft cyst, cystic hygroma, cervical tumor, cervical lymphadenopathy\nB. MIDESOPHAGUS (17\\%)\n- severe upper airway obstruction in early infancy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 756,
            "markdown": "$D D x$ : bronchogenic cyst, neurenteric cyst, intramural esophageal tumor\nC. DISTALESOPHAGUS $(60 \\%)$\n\n- frequently asymptomatic\n\nLocation: paraspinal\n$D D x$ : bronchogenic cyst, neurenteric cyst, intramural esophageal tumor\n$\\checkmark$ thick-walled closed spherical cyst, almost never communicating\nCXR:\n$\\checkmark$ posterior mediastinal mass $\\pm$ air-fluid level\n$\\checkmark$ lobar consolidation + central cavitation $\\leftarrow$ autodigestion of lung tissue by gastric secretions\n$\\checkmark$ thoracic vertebral anomalies\nUGI:\n$\\checkmark$ displacement of esophagus by paraesophageal mass\n$\\checkmark$ intramural extramucosal mass\nUS:\n$\\checkmark$ hypoechoic fluid-filled cyst + layered wall:\n$\\checkmark$ inner echogenic layer (mucosa) and outer hypoechoic layer (muscle)\nCT:\n$\\checkmark$ sharply marginated homogeneous near-water density mass without enhancement\n$\\checkmark$ contrast-enhancing cyst wall\nCx: (1) Peptic ulceration $\\leftarrow$ gastric mucosa\n(2) Perforation $\\leftarrow$ penetrating ulcer\n(3) Hematemesis $\\leftarrow$ erosion into esophagus\n(4) Hemoptysis + autodigestion of pulmonary tissue $\\leftarrow$ erosion into tracheobronchial tree\n\n# Thoracoabdominal Duplication \n\n$=$ FOREGUT DUPLICATION\n$=$ long tubular cyst closed at its cranial end, passing through diaphragm in its own hiatus, in $60 \\%$ communicating with normal duodenum / jejunum / ileum\nFrequency: $2 \\%$ of all alimentary tract duplications\nAssociated with: thoracic vertebral anomalies\nHisto: gastric mucosa in $29 \\%$\nSymptomatic age: $50 \\%$ during neonatal period; $80 \\%$ within $1^{\\text {st }}$ year of life\n\n- severe respiratory distress, chest pain, GI bleeding, anemia\n$\\checkmark$ tubular right posterior mediastinal mass $\\pm$ air\n$\\checkmark$ thoracic vertebral anomaly\n$\\checkmark$ contrast material may enter through distal connection\n\n\n## Gastric Duplication Cyst (7\\%)\n\n$=$ intramural gastric cyst lined with secretory epithelium\nFrequency: $7 \\%$ of all alimentary tract duplications\nPath: noncommunicating spherical cyst (majority); may communicate with aberrant pancreatic duct; ectopic pancreatic tissue found in $37 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 757,
            "markdown": "Symptomatic age: infancy; in $75 \\%$ detected before age 12; $\\mathrm{M}+\\mathrm{F}=1 \\div 2$\n\n- pain $\\leftarrow$ overdistension of cyst, rupture with peritonitis, peptic ulcer formation, internal pancreatitis\n- vomiting, anemia, fever\n- symptoms mimicking congenital hypertrophic pyloric stenosis (if duplication in antrum / pylorus)\nMost common site: greater curvature ( $65 \\%$ )\n$\\checkmark$ paragastric cystic mass up to 12 cm in size, indenting greater curvature\n$\\checkmark$ seldom communicates with main gastric lumen at one / both ends\n$\\checkmark$ may enlarge + ulcerate\n$\\sqrt{ } 99 \\mathrm{~mTc}$ uptake\nUS:\n$\\checkmark$ cyst with two wall layers: inner echogenic layer of mucosa + outer hypoechoic layer of muscle\n$\\checkmark$ clear / debris-containing fluid\nCx: (1) Partial / complete small bowel obstruction\n(2) Relapsing pancreatitis (with ductal communication)\n(3) Ulceration, perforation, fistula formation\n\nDDx: pancreatic cyst, pancreatic pseudocyst, mesenteric cyst, leiomyoma, adenomatous polyp, hamartoma, lipoma, neurofibroma, teratoma\n\n# Small Bowel Duplication Cyst \n\nFrequency: most common of all alimentary tract duplications\nSymptomatic age: neonatal period ( $1 / 3$ ); $<2$ years of age (in $72 \\%$ )\nPath: contains ectopic gastric mucosa in $24 \\%$; ectopic pancreatic tissue in jejunum ( $8 \\%$ )\nMay be associated with: small bowel atresia\n\n- neonatal bowel obstruction, intussusception, palpable mass\n- acute abdominal pain, GI hemorrhage (may be painless)\n\nLocation: ileum (33\\%), jejunum ( $10 \\%$ ), ileocecal ( $4 \\%$ )\nSite: on mesenteric side\n$\\checkmark$ low small bowel obstruction $\\pm$ soft-tissue mass\n$\\checkmark$ cyst may serve as lead point for intussusception\n$D D x$ : mesenteric cyst, pancreatic pseudocyst, omental cyst, exophytic hepatic cyst, ovarian cyst\n\n## Duodenal Duplication Cyst $(5 \\%)$\n\nPath: noncommunicating spherical cyst; may contain ectopic gastric mucosa in $21 \\%$, small bowel mucosa, pancreatic tissue\n\n- obstructive symptoms, palpable abdominal mass\n- hemorrhage $\\leftarrow$ peptic ulceration\n- jaundice $\\leftarrow$ biliary obstruction\n- pancreatitis $\\leftarrow$ ectopic pancreatic tissue\n\nLocation: $1^{\\text {st }}+2^{\\text {nd }}$ portion of duodenum\nSite: on mesenteric side of anterior wall\n$\\checkmark$ mass in concavity of duodenal C-loop",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 758,
            "markdown": "$\\sqrt{ }$ compression + displacement of $1^{\\text {st }} / 2^{\\text {nd }}$ portion of duodenum superiorly + anteriorly Cholangiography:\n$\\sqrt{ }$ may communicate with pancreatic ductal system through the aberrant duct of an accessory lobe\n$C x$ : pancreatitis $\\leftarrow$ perforation of duplication cyst\n$D D x$ : pancreatic cyst, pancreatic pseudocyst, choledochal cyst, choledochocele, duodenal intramural tumor, pancreatic tumor\n\n# Colorectal Tubular Duplication (6\\%) \n\n$=$ DUPLICATION OF THE HINDGUT\n$=$ double-barreled duplication involving part / all of large bowel with \"twin\" segment on mesenteric / antimesenteric side\nSymptomatic age: neonatal period / infancy; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 2$\nMay be associated with:\nrectogenital / rectourinary fistula; duplication of internal / external genitalia; vertebral anomalies; multisystem congenital anomaly complex\n\n- bowel obstruction / constipation\n- passage of feces through vagina\n$\\sqrt{ }$ simultaneous opacification of true + twin colon\n$\\sqrt{ }$ duplication may terminate at\n(a) $2^{\\text {nd }}$ functional anus\n(b) imperforate perineal orifice\n(c) fistulous communication with GU tract\n\n\n## Colonic Duplication Cyst (7-13\\%)\n\n$=$ CYSTIC COLONIC DUPLICATION\nFrequency: $13 \\%$ of all alimentary tract duplications\nPath: closed spherical cyst; contains gastric mucosa in $2 \\%+$ ectopic pancreatic tissue in $5 \\%$\n\n- abdominal mass, bowel obstruction / constipation\n- GI hemorrhage\n\nLocation: cecum ( $40 \\%$ ) $\\pm$ intussusception\n$\\sqrt{ }$ air / intestinal matter can enter cyst ( $20 \\%$ )\n\n## Double Appendix\n\n## Rectal Duplication Cyst (4\\%)\n\nPath: spherical fluid-filled cyst; may contain duodenal / gastric mucosa + pancreatic tissue\nHisto: (a) 2 layers of smooth muscle,\n(b) continuity with rectum,\n(c) mucosal lining similar to rectal mucosa\n$\\diamond$ May contain ectopic gastric mucosa, urothelial mucosa, and pancreatic tissue\nSite: presacral space posterior to rectum / anus\nSymptomatic age: childhood\n\n- constipation + fecal soiling",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 759,
            "markdown": "- intractable excoriation of perianal skin (with chronic perianal fistula); palpable retrorectal / retroanal mass\n$\\sqrt{ }$ cystic mass: may be echogenic $\\leftarrow$ solid material $\\pm$ gas from communication with rectum\n$\\sqrt{ }$ spherical cystic lesion that may communicate internally with anorectal lumen / externally with skin surface $(20 \\%)$\n$D D x$ : (1) Anterior meningocele, sacrococcygeal teratoma, retrorectal abscess, pilonidal cyst, sacral bone tumor\n(2) Tailgut cyst (no smooth muscle layer)\n\n\n# ENCAPSULATED FAT NECROSIS \n\nCause: traumatic or ischemic insult $\\rightarrow$ fat degeneration $\\rightarrow$ organization within a thin / thick fibrous capsule\n\n- may be focally tender at palpation\n\nLocation: anywhere in body (1st described in breast)\nCT:\n$\\sqrt{ }$ mild mass effect on adjacent structures\n$\\sqrt{ }$ weak enhancement of capsule\n$\\sqrt{ } \\pm$ inflammatory fat stranding + calcification\nPrognosis: decrease in size over time\n$D D x$ : Liposarcoma (invasion of adjacent organs, no history of surgery, increase in size over time); Failed kidney transplant replaced by fat\n\n## ENTERIC CYST\n\n$=$ cyst lined by gastrointestinal mucosa without bowel wall\nEtiology: migration of small bowel / colonic diverticulum into mesentery / mesocolon\nPath: unilocular thin smooth-walled cyst with serous contents lined by enteric epithelium + thin fibrous wall\nUS:\n$\\sqrt{ }$ hypoechoic cystic mass, occasionally with septations\n$D D x$ : Duplication cyst (reduplication of bowel wall)\n\n## ENTEROCOLITIS\n\n$=$ inflammation / infection of small intestine + colon\n\n## Infectious Enterocolitis (Infectious Colitis)\n\n$=$ INFECTIOUS ILEOCECITIS\n$=$ self-limited relatively common clinical condition\nCause:\n(a) bacterium: Campylobacter jejuni $>$ Salmonella enteritidis $>$ Yersinia enterocolitica + Shigella, E. coli, Staphylococcus, Chlamydia trachomatis, amebiasis, tuberculosis\n(b) fungus: histoplasmosis, mucormycosis, actinomycosis\n(c) virus: herpesvirus, CMV, rotavirus\n\nPath: bacterial infection limited to mucosa + submucosa of ileum and right colon; layers intact",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 760,
            "markdown": "Age childhood: rotavirus, E. coli, Salmonella, Shigella, Campylobacter\n\n- acute crampy right lower quadrant pain, positive stool culture\n- diarrhea: absent / mild / profuse / bloody (dysentery)\n\nLocation:\nproximal small bowel: Giardia and Strongyloides, MAI\ndistal small bowel: Salmonella, Shigella, Yersinia, Campylobacter, Anisakis\ndistal ileum and cecum: tuberculosis, typhlitis, amebiasis\npancolitis: Clostridium difficile, cytomegalovirus, E. coli\nascending colon: Yersinia, Salmonella, Entamoeba\ndescending + sigmoid colon: schistosomiasis, Shigella\nrectosigmoid: herpes simplex virus, gonorrhea, Chlamydia trachomatis\n(lymphogranuloma venereum), Treponema pallidum (gay bowel syndrome)\nAssociations:\nlymphadenopathy + splenomegaly: Salmonella\nCT:\n$\\sqrt{ }$ enhancing circumferential hypodense mural thickening\n$\\checkmark$ homogeneous wall enhancement\n$\\sqrt{ }$ \"empty colon\" sign = absence of luminal contents\n$\\checkmark$ pericolic fat stranding OFTEN absent with infections\n$\\checkmark \\pm$ multiple air-fluid levels\n$\\checkmark \\pm$ small amount of ascites\n$\\checkmark \\pm$ adjacent lymphadenopathy\n$\\checkmark$ NO involvement of appendix / NO abscess / NO fistula\n$\\checkmark$ NO obstruction\nspecific signs:\n$\\checkmark$ thumbprinting / accordion sign $\\leftarrow$ C. difficile\n$\\checkmark$ target sign $\\leftarrow$ Salmonella, Shigella\n$D x$ : clinical (may lead to unnecessary surgery!)\n\n# E. coli Infection in Childhood \n\nunlike in adults E. coli infection may result in hemolytic-uremic syndrome\n\n## Inflammatory Enterocolitis\n\nA. PRIMARY: inflammatory bowel disease (ulcerative colitis, Crohn disease), vasculitis\nB. SECONDARY: chemotherapy, radiation therapy, graft versus host disease, angiotensinconverting enzyme inhibitor-induced enteritis\nAge: teen, young adult; $2^{\\text {nd }}$ peak in adulthood\n\n- tenesmus, diarrhea, weight loss\n- extraintestinal features: large joint arthritis, erythema nodosum, pyoderma gangrenosum\n\n\n## Necrotizing Enterocolitis\n\n$=\\mathrm{NEC}=$ ischemic bowel disease $\\leftarrow$ hypoxia, perinatal stress, infection (endotoxin), congenital heart disease\nFrequency: most common GI emergency in premature infants in $1-5 \\%$ of neonates in ICU;",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 761,
            "markdown": "in $10 \\%$ of neonates weighing $<1500 \\mathrm{~g}$;\nin $10 \\%$ of full-term neonates with CHD\nAge: in $90 \\%$ within first 10 days of life\nPathophysiology:\nprematurity $\\rightarrow$ mucosal injury consisting of mucosal ulceration + widespread transmural necrosis $\\rightarrow$ infection, immature immunity, release of vasoconstrictors, inflammatory mediators $\\rightarrow$ passage of bacteria + toxins into bowel wall $\\rightarrow$ increased blood flow + intramural gas $\\rightarrow$ intestinal ischemia $\\rightarrow$ overwhelming sepsis\nOrganism: not yet isolated; often occurs in miniepidemics within nursery\nRisk factors: prematurity ( $50-80 \\%$ ), perinatal asphyxia, PDA, indomethacin, Hirschsprung disease, bowel obstruction (small bowel atresia, pyloric stenosis, meconium ileus, meconium plug syndrome)\n\n- feeding intolerance, abdominal distension, bilious emesis\n- blood-streaked stools (in 50\\%); explosive diarrhea\n- mild respiratory distress, generalized sepsis with shock\n\nLocation: usually in terminal ileum (most commonly involved), cecum, right colon; rarely in stomach, upper bowel\nPlain Abdominal Radiography:\n$\\diamond$ Must include horizontal beam cross-table radiograph!\n$\\diamond$ Large bowel may be impossible to differentiate from small bowel!\n$\\checkmark$ loss of mosaic multifaceted bowel gas pattern (no longer normal array of polygons caused by impression of gas-filled loops on adjacent loops)\n$\\checkmark$ distension of small bowel and colon (loops wider than vertebral body of L1) $\\pm$ air-fluid levels, commonly in RLQ (1st and most common sign in $90 \\%$ ):\n$\\checkmark$ change from generalized dilatation to asymmetric distribution\n$\\checkmark$ \"fixed\" bowel = persistent abnormal loop of bowel without change on supine vs. prone films / for $>24$ hours\n$\\checkmark$ bowel wall thickening + \"thumbprinting\"\n$\\checkmark$ pneumatosis intestinalis ( $19-80-98 \\%$ ):\n$\\checkmark$ black lines of intramural gas often accompanied by white lines representing lifted off mucosa + submucosa\n> in curvilinear shape ( $=$ subserosal) or\n> bubbly / cystic ( $=$ submucosal gas collection from gas-forming organisms / dissection of intraluminal gas)\n$\\checkmark$ may disappear within 12 hours\n$\\checkmark$ \"bubbly\" appearance of bowel $\\leftarrow$ gas in wall / intraluminal gas / fecal matter (intraluminal contents are composed of blood, sloughed colonic mucosa, intraluminal gas, some fecal material)\n$\\checkmark$ gas in portal venous system in up to $30 \\%$ (frequently transient, does not imply hopeless outcome):\n$\\checkmark$ linear branching radiolucent vessels extending into periphery of liver\n$\\checkmark$ pneumoperitoneum (immediate surgery required):\n$\\checkmark$ triangular lucencies between loops of bowel anterior to liver beneath abdominal wall on cross-table view\nUS:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 762,
            "markdown": "$\\sqrt{ }$ small individual foci / granular speckled accumulation of hyperechoic gas in dependent portion of bowel wall (DDx: intraluminal gas that changes in position $\\leftarrow$ peristalsis, respiration, patient position, abdominal compression)\n$\\checkmark$ portal venous gas:\n$\\checkmark$ echogenic foci within portal vein moving with blood flow\n$\\checkmark$ sharp bidirectional spikes on Doppler spectrum, audible as crackles\n$\\checkmark$ focal / diffuse linear branching pattern of hyperechoic gas in portal veins\n$\\checkmark$ pneumoperitoneum:\n$\\checkmark$ hyperechoic foci of dirty shadowing between anterior surface of liver + abdominal wall / between bowel loops\n$\\checkmark$ fluid:\n$\\checkmark$ ascites $\\pm$ low-level echoes / septations $\\leftarrow$ suggestive of perforation\n$\\checkmark$ localized intraabdominal fluid collection (= abscess)\n$\\checkmark$ increased intraluminal fluid\n$\\checkmark$ absent peristalsis\n$\\checkmark$ bowel wall thickness (normal, 1.1-2.6 mm):\n$\\checkmark$ \"zebra\" pattern = bowel wall thickening + increased echogenicity of valvulae conniventes $\\leftarrow$ edema\n$\\checkmark$ bowel wall thinning\n$\\checkmark$ bowel wall perfusion by color Doppler:\n$\\checkmark$ hyperemia: \"zebra\" pattern (hyperemic valvulae), \"Y\" pattern (distal mesenteric + subserosal vessels), \"ring\" pattern (circumferential flow around entire bowel wall)\n$\\checkmark$ absent flow $\\leftarrow$ transmural bowel necrosis\nN.B.: Barium enema contraindicated! May be used judiciously in selected cases with radiologic + clinical doubt!\nCx: (1) Inflammatory stricture after healing in $10-30 \\%$, in $30 \\%$ multiple, in $80 \\%$ in left colon (BE follow-up in survivors)\n(2) Bowel perforation in $12-32 \\%$\n\nPrognosis: $20-40 \\%$ mortality (in $64 \\%$ with perforation)\n$R x$ : bowel rest with nasogastric tube, antibiotics, total parenteral nutrition with adequate hydration, surgery\n\n# Neutropenic Colitis (Typhlitis) \n\n$=$ ILEOCECAL SYNDROME [ typhlos, Greek = blind sac = cecum]\n$=$ acute inflammation of cecum, appendix, and occasionally terminal ileum typically in immunosuppressed condition ( $=$ neutropenic patients undergoing chemotherapy for malignancy / during posttransplantation period)\nCause: ? probably multifactorial: leukemic / lymphomatous infiltrate, ischemia, mucosal hemorrhage, focal pseudomembranous colitis, infection (esp. CMV)\nHisto: edema + ulceration of entire bowel wall $\\rightarrow$ transmural necrosis $\\rightarrow$ perforation possible\nOrganism: CMV, Pseudomonas, Candida, Klebsiella, E. coli, B. fragilis, Enterobacter, C. difficile\nPredisposed: common in childhood leukemia, aplastic anemia, lymphoma,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 763,
            "markdown": "immunosuppressive therapy (eg, renal transplant), cyclic neutropenia, myelodysplastic syndrome, clinical AIDS\n\n- abdominal pain, may be localized to RLQ\n- watery / bloody diarrhea; fullness / palpable mass in RLQ\n- fever, neutropenia; hematochezia / occult blood\n\nLocation: right colon (cecum + appendix + ascending colon); distal ileum + transverse colon may become secondarily involved\n\nThe length of cecum and right colon involved by typhlitis is generally much greater than that associated with appendicitis.\nN.B.: Risk of bowel perforation with colonoscopy / contrast enema examination!\n$\\sqrt{ }$ fluid-filled masslike density in RLQ\n$\\checkmark$ distension of nearby small bowel loops\n$\\checkmark$ thumbprinting of ascending colon\n$\\checkmark$ circumferential thickening of cecal wall $>4 \\mathrm{~mm}$\n$\\checkmark$ occasionally pneumatosis\nCT (preferable examination due to risk of perforation):\n$\\checkmark$ cecal distension\n$\\checkmark$ circumferential segmental wall thickening ( $>1-3 \\mathrm{~mm}$ ) of cecum $\\pm$ terminal ileum\n$\\checkmark$ decreased bowel wall attenuation $\\leftarrow$ edema + necrosis\n$\\checkmark$ severe stranding of adjacent fat + thickening of fascial planes $\\leftarrow$ pericolonic inflammation\n$\\checkmark \\pm$ pericolonic fluid + intramural pneumatosis\nCx: (1) Perforation\n$\\checkmark$ pneumatosis coli\n$\\checkmark$ pneumoperitoneum\n(2) Abscess formation\n$\\checkmark$ pericolic fluid collection\nPrognosis: up to $50 \\%$ mortality $\\leftarrow$ necrosis, rupture, peritonitis\nRx: (1) Early aggressive medical support (high doses of antibiotics + IV fluids), bowel rest, total parenteral nutrition, electrolyte replacement prior to development of transmural necrosis\n(2) Surgery for uncontrollable GI bleeding, obstruction, abscess, transmural necrosis, free perforation, uncontrollable sepsis\n$D D x$ : (1) Leukemic / lymphomatous deposits (more eccentric thickening)\n(2) Appendicitis with periappendicular abscess (normal cecal wall thickness)\n(3) Diverticulitis\n(4) Inflammatory bowel disease\n\n# EOSINOPHILIC GASTROENTEROPATHY \n\n## Eosinophilic Esophagitis\n\n$=$ manifestation of immune-mediated inflammation (allergy) in genetically susceptible individuals",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 764,
            "markdown": "$\\diamond$ Leading cause of emergency department visits for esophageal food impaction (in up to $50 \\%)$\nIncidence: $1 \\div 10,000[2-6 \\div 10,000]$ annually in children [adults]\nPrevalence: $4 \\div 10,000[27 \\div 10,000]$ in child [adult]\nPeak age: $3^{\\mathrm{rd}}+4^{\\text {th }}$ decade; $\\mathrm{M} \\div \\mathrm{F}=3 \\div 1$\nHisto: PATHOGNOMONIC infiltration of squamous epithelium with $>15-20$ eosinophils per high-power field\n\n- chronic nonprogressive dysphagia with solid foods ( $70 \\%$ )\n- gastroesophageal reflux / heartburn ( $38 \\%$ )\n- vomiting, regurgitation, hematemesis, weight loss\n- history of atopy; asthma, atopic dermatitis, eczema\n\nSeasonal occurrence: symptoms in late summer and fall\nPathophysiology:\nhypersensitivity reaction to inhaled / ingested allergens $\\rightarrow$ Th2 type immune response ( $=$ cytokines like interleukin $4,5,10,13$ ) $\\rightarrow$ excessive eosinophils $\\rightarrow$ release of cytotoxic chemicals (eg, transforming growth factor beta) $\\rightarrow$ muscular contractions $\\rightarrow$ fibrotic strictures\nUGI:\n$\\sqrt{ }$ smooth long-segment stricture without ulceration + mild mucosal irregularity (most common finding)\n$\\sqrt{ }$ \"ringed esophagus\" = multiple fixed rings appearing as closely stacked indentations on esophageal lumen\n$\\sqrt{ }$ stricture with an irregular ulcerated lumen / granular mucosa\n$\\sqrt{ }$ small-caliber esophagus $\\rightarrow$ diameter of $<20 \\mathrm{~mm}$\nLocation: mid / distal esophagus\nAssociated with: hiatal hernia, reflux esophagitis\nCT:\n$\\sqrt{ }$ diffuse mural thickening (nonspecific)\n$\\sqrt{ }$ occasionally impacted food\nDx: (1) Endoscopy\n\n- esophageal rings (a) fixed (= \"esophageal trachealization\" (b) transient (= \"felinization\")\n- linear / longitudinal mucosal grooves\n- white plaques mimicking candidiasis\n- pale fragile mucosa (\"crepe paper mucosa\") $\\rightarrow$ may fracture with passage of endoscope $\\rightarrow$ risk of esophageal perforation\n$R x$ : dietary modification ( $98 \\%$ positive response in children); oral corticosteroids + leukotriene and eotaxin inhibitors; esophageal dilatation (for symptomatic stricture with $\\uparrow$ risk of perforation)\n(2) Biopsy ( $30 \\%$ complication rate)\n\nCx: spontaneous esophageal rupture\n$D D x$ : peptic / radiation-induced stricture (indistinguishable)\n\n# Eosinophilic Gastroenteritis \n\n$=$ uncommon occasionally self-limited form of gastroenteritis with remissions +",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 765,
            "markdown": "exacerbations characterized by infiltration of eosinophilic leukocytes into wall of GI tract\nPrevalence: $1 \\div 100,000$\nCause:\n(a) primary $=$ idiopathic\n(b) secondary $=$ result of systemic condition\n\n1. Hypereosinophilic syndrome\n2. Celiac disease\n3. Crohn disease\n4. Churg-Strauss syndrome\n5. Helminthic infection\n6. Drugs: enalapril, gemfibrozil, cyclosporine\n\nHisto: fibrous tissue + eosinophilic infiltrate of gastrointestinal mucosa\nPeak age: $3^{\\text {rd }}-5^{\\text {th }}$ decade; $\\mathrm{M} \\div \\mathrm{F}=1.4 \\div 1$\nA. EOSINOPHILIC GRANULOMA\nB. EOSINOPHILIC GASTROENTERITIS\n$=$ diffuse type\n$=$ eosinophilic infiltration of mucosa ( $58 \\%$ ), submucosa, muscular layer, serosa of small intestine $\\pm$ stomach by mature eosinophils (? gastric pendant to Löffler syndrome)\n\n- history of atopy + systemic / food allergy ( $75 \\%$ )\n- usually marked peripheral eosinophilia ( $75-100 \\%$ )\n- local symptoms:\n- recurrent episodes of abdominal pain / cramps\n- diarrhea, vomiting, bowel obstruction, acute pancreatitis\n- GI bleed, hematemesis $\\leftarrow$ ulceration\n- systemic symptoms:\n- malabsorption, protein-losing enteropathy $\\rightarrow$ hypoproteinemia, iron-deficiency anemia\n- weight loss, anorexia, failure to thrive\n- delayed puberty, amenorrhea\n\nLocation: entire small bowel (particularly jejunum), distal stomach, omentum, mesentery\nLayer of involvement: (a) mucosa + submucosa (58\\%)\n(b) muscularis ( $30 \\%$ )\n(c) serosa $(12 \\%)$\n@ Small bowel $(100 \\%)$\n$\\sqrt{ }$ separation of small bowel loops\n(a) mucosal type\n$\\sqrt{ }$ mucosal fold thickening, polyps, nodular thickening, ulcers\n$\\sqrt{ }$ \"araneid limblike\" sign = \"spider leg\" appearance $\\leftarrow$ diffuse mucosal thickening with contrast material in mucosal sinuses\n(b) submucosal type\n$\\sqrt{ }$ \"halo\" sign = layered appearance of bowel wall $\\leftarrow$ submucosal edema\n(c) muscular type\n$\\sqrt{ }$ strictures, bowel wall thickening, intestinal obstruction\n$\\sqrt{ }$ concentric hypoattenuating bowel wall thickening\n$\\sqrt{ }$ reduced distensibility + narrowing of lumen\n$\\sqrt{ }$ motility disturbance $\\rightarrow$ small-bowel obstruction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 766,
            "markdown": "$\\checkmark$ effacement of mucosal pattern\n(c) serosal type\n$\\checkmark$ ascites with peripheral eosinophilia\n$\\checkmark$ pleural effusion\n$\\checkmark$ peritoneal stranding, omental thickening\n$\\checkmark$ mesenteric lymphadenopathy with central necrosis\n$\\checkmark$ clustering of small bowel loops\n$\\checkmark$ serosal enhancement\n$D D x:$ lymphoma\n@ Stomach ( $80 \\%$; almost always limited to antrum)\n$\\sqrt{ }$ \"wet stomach\"\n(a) mucosal type\n$\\checkmark$ enlarged gastric rugae / cobblestone nodules / polyps\n$\\checkmark$ ulcers (rare)\n(b) muscular type\n$\\checkmark$ thickened + rigid wall with narrowed gastric antrum / pylorus\n$\\checkmark$ bulky intraluminal mass up to 9 cm in size\n$C x$ : pyloric / gastric outlet obstruction\n$D D x$ : hypertrophic gastritis, lymphoma, carcinoma\nPrognosis: tendency toward spontaneous remission (in $1 / 3$ ) with frequent relapse\n$R x$ : corticosteroids / removal of sensitizing agent; dietary modification\n\n# Eosinophilic Colitis \n\n$=$ non-IgE-mediated allergic disease\nCause: allergy to cow's milk / soy proteins\nAge: infants, young adults\nIn 50\\% associated with: atopic disease\n\n- abdominal pain\n(a) mucosal disease\n- bloody diarrhea\n(b) muscular disease\n$\\checkmark$ volvulus, intussusception, perforation\n(c) serosal disease\n$\\checkmark$ ascites\n$\\checkmark$ segmental / diffuse colonic wall thickening, wall edema\n$\\checkmark$ pericolonic fat stranding\n$D x$ : increased eosinophils in colonic wall + negative workup for other causes of tissue eosinophilia\n$R x$ : dietary modification (child); corticosteroid / immunosuppressive therapy (adult)\nPrognosis: waxing and waning course\n\n\n## EPIPLOIC APPENDAGITIS\n\n$=$ rare self-limiting inflammation of one of 50-100 epiploic / omental appendages\n$\\diamond 40$ times more common than Meckel diverticulitis!\n$\\diamond$ Relatively unknown amongst clinicians and almost never suspected preoperatively!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 767,
            "markdown": "Epiploic appendage: small benign 5-50 mm long outpouching of visceral peritoneum containing fat and small blood vessels + arising from serosal surface of colon adjacent to tenia coli\nCause: (a) primary: torsion (exercise) $\\rightarrow$ venous thrombosis Blood supply: 2 arteries +1 draining vein\n(b) secondary: inflammation of adjacent organ (eg, diverticulitis, appendicitis, cholecystitis)\nAssociated with: obesity, rapid recent weight loss, hernia, unaccustomed exercise\nAge: $4^{\\text {th }}-5^{\\text {th }}$ decade; $\\mathrm{M}>\\mathrm{F}$\nHisto: acute infarction with fat necrosis, inflammation, thrombosed vessels with hemorrhagic suffusion\n\n- abrupt onset of very localized nonmigratory LLQ abdominal pain (RLQ in 50\\%) + rebound tenderness, gradually resolving over 3-7 days\n- less frequent: nausea, vomiting, altered bowel function, fever\n- palpable mass ( $10-30 \\%$ ); $\\pm$ peritoneal signs\n- normal / mildly increased (7\\%) WBCs; NO fever\n\nLocation: sigmoid $>$ descending $>$ right hemicolon $>$ appendix\n$\\diamond$ Most commonly mimicks acute diverticulitis!\nSite: anterolaterally / (occasionally) anteromedially between colon + abdominal wall\nSize: $1.0-3.5-5.0 \\mathrm{~cm}$ in diameter\n$\\sqrt{ }$ oval fatty lesion commonly adjacent to sigmoid colon:\n$\\sqrt{ }$ stranding of periappendigeal fat\n$\\sqrt{ }$ thickening of parietal peritoneum\nCT:\n$\\sqrt{ }$ pericolic oval-shaped pedunculated mass of fat attenuation ( $\\sim-60 \\mathrm{HU}$ ):\n$\\sqrt{ }$ hyperattenuating $2-3 \\mathrm{~mm}$ peripheral rim ( $=$ thickening of adjacent visceral peritoneal lining) in $93 \\%$\n$\\sqrt{ }$ \"central dot\" sign / linear focus of high attenuation (= engorged / thrombosed vein / central hemorrhage / necrosis)\n$\\sqrt{ } \\pm$ (often peripheral) calcification $\\leftarrow$ fat necrosis\n$\\sqrt{ }$ eccentric minimal colonic wall thickening\nUS:\n$\\sqrt{ }$ solid hyperechoic noncompressible oval mass at site of maximal tenderness\n$\\sqrt{ }$ hypoechoic margin ( $93 \\%$ )\n$\\sqrt{ }$ absence of central blood flow on color Doppler\nMR:\n$\\sqrt{ }$ focal lesion with signal intensity of fat\n$\\sqrt{ }$ enhancing rim around oval fatty lesion\nCx: adhesion, bowel obstruction, intussusception, peritonitis, abscess, intraperitoneal calcified loose body (after twisting off its pedicle)\nPrognosis: spontaneous resolution within 2 weeks clinically + within 6 months on CT\nRx: conservative management with NSAID\nDDx: (1) Torsion / infarction of greater omentum = epiploic appendagitis \"on steroids\"\n(2) Sclerosing mesenteritis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 768,
            "markdown": "(3) Diverticulitis\n(4) Appendicitis\n(5) Primary tumor / metastasis of mesocolon\n\n# ESOPHAGEAL CANCER \n\nIncidence: $4-10 \\%$ of all gastrointestinal malignancies ( $3^{\\text {rd }}$ most common) worldwide; $1 \\%$ of all cancers; 16,910 cases with 15,690 deaths annually (USA, 2016); 5.8 cases per 100,000 people; $\\mathrm{M} \\div \\mathrm{F}=4 \\div 1$\nHigh-risk regions: Iran, parts of Africa, Italy, China\nAt risk: tobacco + alcohol use (synergistic effect); diet low in fresh fruit + vegetables and high in nitrosamines; achalasia (risk factor of $1,000 \\mathrm{x}$ ), asbestosis, Barrett esophagus, celiac disease, radiation exposure, acid / lye burn (risk factor of $1,000 \\mathrm{x}$ ), Plummer-Vinson syndrome, tannins, alcohol, tobacco, history of oral / pharyngeal cancer, tylosis palmaris et plantaris (defect in tylosis esophageal cancer gene on chromosome 17q25) mnemonic: BELCH SPAT\n\nBarrett esophagus\nEtOH abuse\nLye stricture\nCeliac disease\nHead and neck tumor\nSmoking\nPlummer-Vinson syndrome\nAchalasia, Asbestosis\nTylosis\nCancer Staging (American Joint Commission on Cancer):\nTNM system:\nTis high-grade dysplasia\nT1a tumor invades lamina propria / muscularis mucosae\nT1b tumor invades submucosa\nT2 tumor invades muscularis propria\nT3 tumor invades adventitia\nT4 tumor invades adjacent structures\nT4a resectable (pleura, pericardium, diaphragm)\nT4b unresectable (aorta, vertebra, trachea)\nN0 no regional Lnn metastasis\nN1 1-2 regional Lnn metastasis\nN2 3-6 regional Lnn metastasis\nN3 $\\geq 7$ regional Lnn metastasis\nStage I = T1 N0 M0 Stage III = T3 N1 M0\nStage IIA = T2/3 N0 M0 or T4,N0/1,M0\nStage IIB = T1/2 N1 M0 Stage IV = T1-4 N0/1 M1\nT4a cancers are resectable in spite of $\\leftarrow$ invasion of pleura, peritoneum, pericardium, diaphragm.\nT4b cancers are unresectable $\\leftarrow$ invasion of aorta, carotid a. + v., azygos v., trachea, left main",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 769,
            "markdown": "bronchus, vertebral body.\nLymph node map:\n1 supraclavicular 9 inferior pulmonary lig.\n2 L paratracheal - L/R 10 hilar L / R\n3P posterior mediastinal 15 diaphragmatic\n4 tracheobronchial angle 16 paracardial\n5 aortopulmonary 17 left gastric (resectable)\n6 anterior mediastinal 18 common hepatic\n7 subcarinal 19 splenic\n8L lower paraesophageal 20 celiac (unresectable)\n8 M middle paraesophageal\nRegional lymph nodes include any paraesophageal lymph nodes from cervical nodes to celiac nodes.\nLnn status is based on location of primary:\n$\\mathrm{Nl}=$ locoregional periesophageal Lnn disease\nM1a = metastasis to cervical / celiac nodes\nM1b = distant nonregional Lnn disease\n(a) in proximal esophageal cancer:\n\nM1a = cervical Lnn involvement\nM1b = all other distant metastases\n(b) in middle esophageal cancer:\n\nM1a = none available\nM1b = metastasis to cervical / celiac axis Lnn\n![img-85.jpeg](img-85.jpeg)\n(c) in distal esophageal cancer:\n\nN1 = gastric Lnn involvement\nM1a = celiac axis Lnn involvement\nM1b = all other distant metastases",
            "images": [
                {
                    "id": "img-85.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 1192,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1786,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 770,
            "markdown": "CT ( $30-60 \\%$ sensitive, $46-58 \\%$ accurate):\n$\\checkmark$ intrathoracic/ abdominal lymph node $>10 \\mathrm{~mm}$\n$\\checkmark$ supraclavicular lymph node with short axis $>5 \\mathrm{~mm}$\nUS ( $72-80 \\%$ accurate):\n$\\checkmark$ homogeneously hypoechoic central pattern\n$\\checkmark$ round lymph node with a short axis of $>10 \\mathrm{~mm}$\nPET:\n$\\checkmark 51-84 \\%$ sensitivity for locoregional lymph nodes\n$\\checkmark$ up to $90 \\%$ sensitive for metastatic lymph node\nCT staging (Moss):\nStage 1 intraluminal tumor / localized wall thickening of $3-5 \\mathrm{~mm}$\nStage 2 localized / circumferential wall thickening $>5 \\mathrm{~mm}$\nStage 3 contiguous spread into adjacent mediastinum (trachea, thyroid, larynx, bronchi, aorta, lung, pericardium, diaphragm)\n$\\checkmark$ loss of fat planes (nonspecific $\\leftarrow$ cachexia, often still resectable)\n$\\checkmark$ mass in contact with aorta $>90^{\\circ}$ arc (in $20-70 \\%$ still resectable)\n$\\checkmark$ displacement / compression of airway ( $90-100 \\%$ accuracy for invasion)\n$\\checkmark$ esophagotracheal / -bronchial fistula (unresectable)\n$\\checkmark$ pericardial thickening, pericardial effusion, loss of pericardial fat plane, indentation of heart\nStage 4 distant metastases\n$\\checkmark$ enlarged abdominal lymph nodes $>10 \\mathrm{~mm}(12-85 \\%$ accuracy $)$\n$\\checkmark$ hepatic, pulmonary, adrenal metastases\n$\\checkmark$ direct erosion of vertebral body\n$\\checkmark$ tumor $>3 \\mathrm{~cm}$ wide $=$ high frequency of extraesophageal spread\nEndoscopic US (most accurate modality for T staging):\n$\\diamond$ Can differentiate T1mucosal (suitable for local ablative therapy) from T1 submucosal invasion\nAccuracy: $75-82 \\%$ for T1, 64-82\\% for T2, 89-94\\% for T3, 88-100\\% for T4\nHisto:\n(1) Squamous cell carcinoma ( $50-70 \\%$ )\n(2) Adenocarcinoma ( $30-50 \\%$ )\n(3) Spindle-cell carcinoma ( $0.5-2.8 \\%$ )\n(4) Sarcoma: GIST, leiomyo-, rhabdomyo-, fibrosarcoma\n(5) Mucoepidermoid carcinoma, adenoid cystic carcinoma\n(6) Neuroendocrine neoplasm / small cell carcinoma (1\\%)\n(7) Malignant lymphoma\n(8) Secondary tumor involvement from: thyroid, larynx\n(9) Metastasis from: breast, melanoma, GI tract\n\n- dysphagia ( $87-95 \\%$ ) of $<6$ months' duration\n- weight loss ( $71 \\%$ ), retrosternal pain ( $46 \\%$ ), regurgitation ( $29 \\%$ )\n\nLocation: upper $1 / 3(15-20 \\%)$; middle $1 / 3(37-44 \\%)$; lower $1 / 3(38-43 \\%)$\nAn esophagogastric junction tumor is considered an esophageal cancer if\n(a) the epicenter is within lower thoracic esophagus / at esophagogastric junction, or",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 771,
            "markdown": "(b) the epicenter is within proximal 5 cm of the stomach extending into the esophagus.\n\nRadiologic types:\n(1) Polypoid / fungating form (most common)\n$\\sqrt{ }$ sessile / pedunculated tumor with lobulated surface\n$\\sqrt{ }$ protruding, irregular, polycyclic, overhanging, steplike \"apple core\" lesion\n(2) Ulcerating form\n$\\sqrt{ }$ large ulcer niche within bulging mass\n(3) Infiltrating form\n$\\sqrt{ }$ gradual narrowing with smooth transition (DDx: benign stricture)\n(4) Varicoid form = superficial spreading carcinoma\n$=$ uncommon pattern of dissemination via vasculature + lymphatic system to submucosa\nHisto: longitudinal extension of squamous cell carcinoma confined to mucosa /\nsubmucosa $\\rightarrow$ secondary intramural tumor deposits\nLocation: middle + distal segments of esophagus\n$\\sqrt{ }$ focal area of confluent tortuous / serpentine longitudinal mucosal nodules / plaques\nsimulating downhill esophageal varices:\n$\\sqrt{ }$ NO change during respiration / patient repositioning\n$D D x:$ Candida esophagitis\n\n# Metastases: \n\n(a) lymphogenic: anterior jugular chain + supraclavicular nodes (primary in upper $1 / 3$ ); paraesophageal + subdia-phragmatic nodes (primary in middle $1 / 3$ ); mediastinal + paracardial + celiac trunk nodes (primary in lower $1 / 3$ )\nN.B.: (1) mucosal + muscular lymphatic plexuses intercommunicate\n(2) lymph may flow upward / downward\n(b) hematogenous: liver $>$ lung $>$ bone $>$ adrenal gland $>$ kidney $>$ brain\n\nCXR:\n$\\sqrt{ }$ widened azygoesophageal recess with convexity toward right lung (in $30 \\%$ of distal + midesophageal cancers)\n$\\sqrt{ }$ thickening of posterior tracheal stripe + right paratracheal stripe $>3-4 \\mathrm{~mm}$ (in $11 \\%$ if tumor is located in upper third of esophagus)\n$\\sqrt{ }$ tracheal deviation ( $10 \\%$ )\n$\\sqrt{ }$ widened mediastinum\n$\\sqrt{ }$ posterior tracheal indentation / mass\n$\\sqrt{ }$ retrocardiac mass\n$\\sqrt{ }$ esophageal air-fluid level\n$\\sqrt{ }$ lobulated mass extending into gastric air bubble\n$\\sqrt{ }$ repeated aspiration pneumonia $\\leftarrow$ tracheoesophageal fistula\nBarium:\n$\\sqrt{ }$ plaquelike / polypoid / ulcerated lesion for superficial lesion\n$\\sqrt{ }$ irregular luminal narrowing, ulceration, abrupt shouldered margins for advanced lesion\n$\\sqrt{ }$ elevated lesion + rigidity of esophageal wall indicate subepithelial tumor extension\nEndoscopic US:\n$\\sqrt{ }$ homo- / heterogeneous mass\n$\\sqrt{ }$ disruption of esophageal wall layers (staging accuracy of $84 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 772,
            "markdown": "$\\sqrt{ }$ round well-defined lymph node $>10 \\mathrm{~mm}$ in diameter ( $92 \\%$ accuracy if combined with fineneedle aspiration)\nCT:\n$\\sqrt{ }$ asymmetric / circumferential localized thickening of esophageal wall / soft-tissue mass\n$\\sqrt{ }$ peak enhancement in late arterial phase (at 35 seconds)\n$\\sqrt{ }$ mediastinal / aortic invasion:\n$\\sqrt{ }$ loss of intervening fat planes\n$\\sqrt{ }$ displacement / indentation of trachea\n$\\sqrt{ }$ tumor in contact with $>90^{\\circ}$ of aortic circumference\n$\\sqrt{ }$ distant metastases (to liver, lung, bone)\nPET:\n$\\sqrt{ }$ avid uptake of primary (unless confined to mucosa) and of metastases (unless microscopic involvement)\n$\\diamond$ Primary tumor NOT identified in up to $20 \\%$ ( $33 \\%$ sensitive compared with $81 \\%$ for endoscopic ultrasound)\nRole of PET:\n$\\diamond$ Cost effective in prevention of noncurative surgery!\n(1) Initial staging + detection of unresectable distant disease $\\leftarrow$ locoregional metastases $(32-41 \\%$ sensitive)\n(2) Monitoring effectiveness of therapy (after 2 weeks)\n$=$ allows prediction of response to neoadjuvant therapy after only 2 cycles (not sufficiently reliable!)\nN.B.: many FPs $\\leftarrow$ posttreatment esophagitis and ulceration, motion artifacts at level of diaphragm, prior mucosal biopsy during EGD\n(3) Monitoring conversion from nonsurgical to surgical lesion\n(4) Follow-up after definitive treatment ( $=$ restaging $)$\n> local recurrence ( $100 \\%$ sensitive, $57 \\%$ specific)\n> recurrent regional disease ( $92 \\%$ sensitive, $83 \\%$ specific)\n$>$ distant metastases ( $95 \\%$ sensitive, $80 \\%$ specific)\n$C x$ : fistula formation to trachea ( $5-10 \\%$ ) / bronchi / mediastinum\nPrognosis: $18.4 \\% 5$-year survival rate (2012); $0 \\% 5$-year survival rate for cancer of cervical esophagus; $2 / 3$ incurable at presentation; survival rate higher for adenocarcinoma versus squamous cell cancer\nMean survival time:\n90 days with subdiaphragmatic lymphadenopathy\n180 days with local invasion + abdominal metastases\n480 days without evidence of invasion / metastases\nRx: (1) Chemotherapy (fluorouracil, cisplatin, bleomycin sulfate, mitomycin) + surgery\n(2) Chemotherapy + irradiation ( $\\sim 4,000 \\mathrm{cGy}$ )\n(3) Chemotherapy + irradiation + surgery\n\nOperative mortality: $3-8 \\%$\n\n# Squamous Cell Carcinoma (SCC) of Esophagus \n\n$=$ malignant tumor of epithelial cells with stratified squamous differentiation progressing",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 773,
            "markdown": "from precursor lesion of intraepithelial neoplasia\nPrevalence: $1.8 \\div 100,000$ in USA ( $\\downarrow$ probably due to declining tobacco consumption); $20 \\div 100,000$ in southern Africa + eastern Asia\n$\\diamond$ Most common esophageal neoplasm worldwide!\nHisto: nests of squamous epithelial cells penetrate beyond basement membrane with little desmoplastic response; tumor grade does NOT affect prognosis; intramural metastases in up to $16 \\%$\nPeak age: $60-74$ years; $\\mathrm{M} \\div \\mathrm{F}=65 \\div 35$; Blacks $\\div$ Whites $=4 \\div 1$\n\n- asymptomatic with superficial cancer ( $85 \\%$ )\n- progressive dysphagia, odynophagia, weight loss\n- chest pain (unrelated to swallowing)\n\nLocation: middle $>$ lower $>$ upper third of esophagus\nBarium:\n$\\checkmark$ plaquelike / polypoid / ulcerated lesion for superficial lesion\n$\\checkmark$ irregular luminal narrowing, ulceration, abrupt shouldered margins for advanced lesion\n$\\checkmark$ elevated lesion + rigidity of esophageal wall indicate subepithelial tumor extension\nEndoscopic US:\n$\\checkmark$ homo- / heterogeneous mass\n$\\checkmark$ disruption of esophageal wall layers $\\rightarrow$ staging accuracy of $84 \\%$\n$\\checkmark$ round well-defined lymph node $>10 \\mathrm{~mm}$ in diameter ( $92 \\%$ accuracy if combined with fine-needle aspiration)\nCT:\n$\\checkmark$ asymmetric / circumferential localized thickening of esophageal wall / soft-tissue mass\n$\\checkmark$ peak enhancement in late arterial phase ( 35 seconds)\n$\\checkmark$ mediastinal / aortic invasion:\n$\\checkmark$ loss of intervening fat planes\n$\\checkmark$ displacement / indentation of trachea\n$\\checkmark$ tumor in contact with $>90^{\\circ}$ of aortic circumference\n$\\checkmark$ distant metastases (to liver, lung, bone)\nPET:\n$\\checkmark$ avid uptake of primary (unless confined to mucosa) + of metastases (unless microscopic involvement)\nCx: esophageal obstruction, tracheoesophageal fistula\nPrognosis: overall 5-year survival rate of $10 \\%$\n\n# Spindle Cell Carcinoma of Esophagus \n\n$=$ (METAPLASTIC) CARCINOSARCOMA $=$ PSEUDOSARCOMA $=$ PSEUDOSARCOMATOUS CA. $=$ POLYPOID SQUAMOUS CARCINOMA $=$ SARCOMATOID CARCINOMA $=$ SCC WITH SPINDLE-CELL COMPONENT\nPrevalence: $0.5-2.8 \\%$ of all malignant esophageal tumors\nHisto: squamous + sarcomatous elements\nPath: bulky polypoid intraluminal mass with scalloped smooth / ulcerated surface\nAge: $\\quad>45$ years; $\\mathrm{M} \\div \\mathrm{F}=4 \\div 1$ to $9 \\div 1$\n\n- pain, dysphagia, weight loss\n\nLocation: usually middle + distal esophagus",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 774,
            "markdown": "$\\sqrt{ }$ rapid growth $=$ doubling time of $2.2-5.0$ months\nEsophagram:\n$\\sqrt{ }$ large bulky smoothly lobulated intraluminal mass\n$\\sqrt{ }$ cupola / domed appearance of superior tumor edge\n$\\sqrt{ }$ expands esophageal lumen to an average diameter of 8 cm without obstruction\n$\\sqrt{ }$ ulceration rare; may be polypoid + pedunculated\nCT:\n$\\sqrt{ }$ expansile hypoattenuating intraluminal mass\n$\\sqrt{ } \\pm$ focal esophageal wall thickening at attachment site\nPrognosis: similar to SCC with 20\\% 5-year survival\nSpread (in 38-50\\%): lung, liver\nDDx: fibrovascular polyp, myofibroma, pedunculated lipoma, leiomyoma, lymphoma, adenocarcinoma, leiomyosarcoma, fibrosarcoma, rhabdomyosarcoma, melanoma, oat cell carcinoma\n\n# Adenocarcinoma of Esophagus \n\n$=$ malignant epithelial neoplasm that almost always arises from\n(a) malignant degeneration of underlying columnar-lined epithelium (Barrett epithelium)\n) occasionally from\n(b) ectopic gastric mucosa in esophagus\n(c) submucosal / deep esophageal glands\n(d) gastric adenocarcinoma involving GE junction\n\nPrevalence: marked $\\uparrow$ from $18 \\%$ (in 1984) to $63 \\%$ (in 2008) of all malignant esophageal tumors surpassing squamous cell carcinoma in USA\n$\\diamond 2^{\\text {nd }}$ most common malignant tumor of esophagus in most countries!\n$\\diamond 2,500$ new cases annually\nPath: grossly infiltrating / polypoid / ulcerative lesion\nHisto: sequence of progressively severe epithelial dysplasia $\\rightarrow$ mostly well / moderately well differentiated invasive carcinoma with columnar or cuboidal cells in tubular / glandular / cribriform patterns; $\\pm$ mucinous / signet-ring cell subtypes\nPeak age: $7^{\\text {th }}$ decade; $\\mathrm{M} \\div \\mathrm{F}=85 \\div 15$; Whites $\\div$ Blacks $=5 \\div 1$\n\n- asymptomatic (most)\n- symptoms of gastroesophageal reflux disease (GERD)\n\nLocation: $75 \\%$ in lower $1 / 3$ of esophagus with marked tendency to extend to gastric cardia + fundus\n\nAdenocarcinoma and SCC have similar morphologic findings. However, adenocarcinomas usually involve the lower $1 / 3$ of the esophagus with a tendency to invade the stomach.\n$\\sqrt{ }$ imaging features identical to SCC\nPrognosis: overall 5-year survival rate of $42 \\%$ after resection compared to $30 \\%$ for SCC\n\n## ESOPHAGEAL INTRAMURAL PSEUDODIVERTICULOSIS\n\n$=$ dilated excretory ducts of deep mucous glands\nEtiology: uncertain\nPrevalence: about 100 cases in world literature",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 775,
            "markdown": "In $90 \\%$ associated with:\ndiabetes, alcoholism, any severe esophagitis (most often reflux / Candida), esophageal stricture\nSite: diffuse / segmental involvement\n$\\sqrt{ }$ multiple tiny rounded / flask-shaped barium collections in longitudinal rows parallel to long axis of esophagus:\n$\\sqrt{ }$ appear to \"float\" outside esophagus without apparent communication with lumen\n$\\checkmark$ esophageal stricture:\n$\\checkmark$ short stricture in distal esophagus (common)\n$\\checkmark$ long stricture in cervical / upper thoracic esophagus (classic)\n\n# ESOPHAGEAL TRAUMA \n\n## Cause:\n\nA. EXTRALUMINAL:\n(1) Blunt trauma $=$ closed chest trauma $(10 \\%)$\n\nFrequency: $1 \\%$ of all blunt chest trauma\nLocation:\n(a) cervical / upper thoracic esophagus ( $82 \\%$ )\n(b) just above gastroesophageal junction along left posterolateral wall\n(2) Penetrating trauma\nB. INTRALUMINAL:\n(1) Iatrogenic injury = complication of instrumentation (most common cause, 55\\%): endoscopy, dilatation of stricture + stent placement, bougie, disruption of suture line following surgical anastomosis (gastric fundoplication, esophageal myotomy), attempted intubation, thyroidectomy, anterior cervical diskectomy, left atrial radiofrequency ablation\n(2) Barotrauma $=$ spontaneous rupture $=$ Boerhaave syndrome $(15 \\%)$\n(4) Foreign body impaction ( $14 \\%$ ): coin, aluminum pop-tops, metallic button, safety pin, invisible plastic toy leading to perforation (in pediatric age group)\n(5) Intrinsic esophageal disease: Barrett ulcer, caustic / infectious esophagitis, esophageal carcinoma\n\n- abrupt onset of retrosternal chest pain (similar to acute myocardial infarction / aortic dissection)\n- dysphagia, odynophagia, hematemesis\n\n\n## Intramural Dissection of the Esophagus\n\n$=$ SUBMUCOSAL DISSECTION = INTRAMURAL RUPTURE OF ESOPHAGUS = DISSECTING INTRAMURAL HEMATOMA\n$=$ mucosal tear with dissecting hemorrhage into submucosa + involvement of venous plexus\nCause: recent instrumentation, forceful vomiting, spontaneous hemorrhage (anticoagulant therapy, coagulopathy), aortoesophageal fistula, spontaneous\nAge: middle-aged; $\\mathrm{M}<\\mathrm{F}$\n\n- hematemesis\n\nLocation: usually posterior",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 776,
            "markdown": "Site: distal $\\leftarrow$ lack of striated muscle\n$\\checkmark$ well-defined focal filling defect = intramural hematoma simulating retained solid material within lumen\n$\\checkmark$ luminal narrowing of the esophagus\n$\\checkmark$ \"double-barrel esophagus\" = mucosal flap with submucosal distribution of gas / contrast\n$\\checkmark$ \"mucosal stripe\" sign = dissected mucosa floating within lumen\n$\\checkmark$ eccentric / concentric nonenhancing hyperattenuating mass within esophageal wall\nCT:\n$\\checkmark$ symmetric / asymmetric esophageal wall thickening\n$\\checkmark$ well-defined nonenhancing intramural esophageal mass of high attenuation\nPrognosis: progression to frank esophageal rupture / resolution within a few weeks\n\n# Transmural Perforation of the Esophagus \n\n$=$ ESOPHAGEAL PERFORATION = ESOPHAGEAL RUPTURE\n\n- rapid onset of overwhelming sepsis: fever, tachycardia, hypotension, shock\n\nPlain film (normal in 9-12\\%):\n$\\checkmark$ extensive pneumomediastinum\n$\\checkmark$ \"V\" sign of Naclerio = extrapleural air within lower mediastinum between parietal pleura + diaphragm (usually on left)\n$\\checkmark$ subcutaneous emphysema of the neck\n$\\checkmark$ delayed widening of the mediastinum $\\leftarrow$ mediastinitis\n$\\checkmark$ hydrothorax (after rupture into pleural cavity), usually unilateral on left side\n$\\checkmark$ hydropneumothorax (often initially missed)\n$\\checkmark$ left lower lobe atelectasis\n$\\checkmark$ confirmation with contrast study ( $90 \\%$ of contrast esophagrams are positive)\nEsophagography (modality of choice for evaluating esophageal rupture):\n(1) Water-soluble contrast (in $10 \\%$ false-negative result)\n(2) Barium (if result with water-soluble material negative)\n$\\checkmark$ extravasation of oral contrast material into mediastinum $\\pm$ pleural space\nCT (modality of choice for penetrating trauma):\n$\\checkmark$ focal extraluminal air collection at site of tear ( $92 \\%$; most useful sign)\n$\\checkmark$ periesophageal / mediastinal hematoma / fluid ( $92 \\%$ )\n$\\checkmark$ pleural effusion $(75 \\%)$\n$\\checkmark$ esophageal wall thickening\nCx: (1) Acute mediastinitis\n(2) Obstruction of SVC\n(3) Mediastinal abscess\n\nPrognosis: $20-60 \\%$ mortality; $90 \\%$ after 48 hours\nMed. emergency: up to $80 \\%$ survive if primary closure is performed within 24 hours after perforation\n\n## Upper / Midesophageal Perforation\n\nLocation: at level of cricopharyngeus muscle (most frequent)\n$\\checkmark$ widening of upper mediastinum",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 777,
            "markdown": "$\\sqrt{ }$ right-sided hydrothorax\n\n# Distal Esophageal Perforation \n\nFrequency: more common (but not in blunt chest trauma)\nCause: biopsy, dilatation of stricture, Boerhaave syndrome\n$\\sqrt{ }$ left-sided hydrothorax\n$\\sqrt{ }$ little mediastinal changes\n\n## ESOPHAGEAL VARICES\n\n$=$ plexuses formed by (1) dilated subepithelial and submucosal veins + (2) dilated venae commitantes of vagus nerve outside tunica muscularis\n$\\diamond$ Most common and clinically important collateral vessels of the intrathoracic portosystemic collateral system\nAnatomy:\n(a) anterior branch connected to left gastric vein\n(b) posterior branch connected to azygos + hemiazygos system\n\nExamination Technique:\n(a) small amount of barium (not to obscure varices)\n(b) relaxation of esophagus (not to compress varices): refrain from swallowing because succeeding swallow initiates a primary peristaltic wave that lasts for 10-30 seconds; sustained Valsalva maneuver precludes from swallowing\n(c) in LAO projection with patient recumbent / in Trendelenburg position $\\pm$ Valsalva maneuver / deep inspiration\nLocation: lower esophagus\nPlain film:\n$\\sqrt{ }$ lobulated masses in posterior mediastinum (visible in 5-8\\% of patients with varices)\n$\\sqrt{ }$ silhouetting of descending aorta\n$\\sqrt{ }$ abnormal convex contour of azygoesophageal recess at level of gastroesophageal junction\nUGI:\n$\\sqrt{ }$ thickened sinuous interrupted mucosal folds (earliest sign)\n$\\sqrt{ }$ tortuous radiolucencies of variable size + location\n$\\sqrt{ }$ \"worm-eaten\" smooth lobulated filling defects\n$\\sqrt{ }$ findings may be accentuated after sclerotherapy\nCT ( $>90 \\%$ detection rate):\n$\\sqrt{ }$ nodular thickening of esophageal wall + lobulated outer contour\n$\\sqrt{ }$ scalloped enhancing nodular masses protruding into esophageal lumen\n$\\sqrt{ }$ right- / left-sided soft-tissue masses (= paraesophageal varices)\n$\\sqrt{ }$ marked enhancement following dynamic CT\n$C x$ : variceal hemorrhage at a rate of $10-30 \\%$ per year; $20-35 \\%$ mortality with exsanguination in $10-15 \\%$\n$D D x$ : varicoid carcinoma of esophagus\n\n## Uphill Esophageal Varices\n\n$=$ collateral blood flow from portal vein $\\rightarrow$ azygos vein $\\rightarrow$ into SVC (usually lower esophagus drains via left gastric vein into portal vein)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 778,
            "markdown": "Cause:\n(a) intrahepatic obstruction from cirrhosis\n$\\diamond$ In $<5 \\%$ of patients with portal hypertension\n(b) splenic vein thrombosis (usually gastric varices)\n(c) obstruction of hepatic veins\n(d) IVC obstruction below hepatic veins\n(e) IVC obstruction above hepatic vein entrance / CHF\n(f) marked splenomegaly / splenic hemangiomatosis (rare)\n$\\sqrt{ }$ varices in lower $1 / 2$ of esophagus\n\n# Downhill Esophageal Varices \n\n$=$ collateral blood flow from $\\mathrm{SVC} \\rightarrow$ azygos vein $\\rightarrow$ into IVC / portal venous system (upper esophagus usually drains via azygos vein into SVC)\nCause: obstruction of superior vena cava distal to entry of azygos vein (= superior vena cava syndrome) most commonly due to lung cancer, lymphoma, retrosternal goiter, thymoma, mediastinal fibrosis\n$\\sqrt{ }$ varices in upper $1 / 3$ of esophagus\n\n## Paraesophageal Varices\n\n$=$ part of intrathoracic portosystemic collateral network\n\n- endoscopically not visible\n$\\diamond$ NOT connected to esophageal varices!\nAnatomy: supplied by posterior branch of coronary (= left gastric) vein draining into azygos + hemiazygos vv. + vertebral plexus\nMay be associated with: subcutaneous collateral vessels in chest wall\nCXR:\n$\\sqrt{ }$ lateral bulging of paraspinal interfaces with obliteration of azygoesophageal recess + descending thoracic aortic interface (in 5-8\\%)\nCT:\n$\\sqrt{ }$ dilated collateral vessels surrounding esophagus + descending thoracic aorta\n\n\n## Cardiophrenic Angle Varices\n\n$=$ dilated pericardiophrenic veins mimicking a tumor\nCause: membranous obstruction of IVC (frequent in cirrhosis)\nCXR:\n$\\checkmark$ undulating masses along cardiac borders\n$\\checkmark$ widening of both paraspinal interfaces\nCECT:\n$\\checkmark$ enhancing pseudotumor (vascular nature)\n\n## ESOPHAGEAL WEB\n\n$=$ complete / incomplete circumferential narrowing caused by $1-2-\\mathrm{mm}$ thick (vertical length) shelf-like filling defect projecting into esophageal lumen\nAge: middle-aged females\n? Association with:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 779,
            "markdown": "Plummer-Vinson syndrome $=$ Paterson-Kelly syndrome (iron deficiency anemia, stomatitis, glossitis, dysphagia, thyroid disorder, spoon-shaped nails), benign mucous membrane pemphigoid, epidermolysis bullosa dystrophica, GERD\nCause:\nmnemonic: BIEP\nB-ring (Schatzki ring)\nIdiopathic ( $=$ symptomatic transverse mucosal fold)\nEpidermolysis bullosa\nPlummer-Vinson disease\nPath: hyperkeratosis + chronic inflammation of submucosa\nHisto: mucosal membrane covered by squamous epithelium on superior + inferior surfaces\n\n- mostly asymptomatic (unless severely stenosing)\n\nLocation: in cervical esophagus near cricopharyngeus (most common) > thoracic esophagus at squamocolumnar junction of distal esophagus (Schatzki) > lower hypopharynx; occasionally multiple\nSite: often anteriorly located\n$\\sqrt{ }$ visualized during maximal distension (in $1 / 10$ of a second)\n$\\sqrt{ }$ arises at right angles from anterior esophageal wall\n$\\sqrt{ }$ thin delicate membrane of uniform thickness of $<3 \\mathrm{~mm}$\n$C x$ : high risk of upper esophageal + hypopharyngeal (postcricoid) carcinoma\nRx: (1) Balloon dilatation\n(2) Bougienage during esophagoscopy\n\nDDx: Stricture (circumferential + thicker $>1-2$-mm thick [vertical length] area of complete / incomplete circumferential narrowing)\n\n# ESOPHAGITIS \n\n## Acute Esophagitis\n\n## Cause:\n\nmnemonic: CRIER\nCorrosives, Crohn disease\nReflux\nInfection, Intubation\nEpidermolysis bullosa\nRadiation therapy\n$\\sqrt{ }$ thickened $>3-\\mathrm{mm}$ wide folds with irregular lobulated contour\n$\\sqrt{ }$ mucosal nodularity $\\leftarrow$ multiple ulcers + intervening edema\n$\\sqrt{ }$ erosions\n$\\sqrt{ }$ vertically oriented ulcers usually $3-10 \\mathrm{~mm}$ in length\n$\\sqrt{ }$ inflammatory esophagogastric polyp $=$ proximal gastric fold extending across esophagogastric junction (rare)\n$\\sqrt{ }$ abnormal motility\nCT:\n$\\sqrt{ }$ diffuse esophageal thickening",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 780,
            "markdown": "$\\checkmark$ submucosal edema\n$\\checkmark$ mucosal enhancement\n\n# Candida Esophagitis \n\n$=$ MONILIASIS $=$ CANDIDIASIS\n$\\diamond$ Most common cause of infectious esophagitis!\nOrganism: C. albicans, C. tropicalis; endogenous (majority) / transmitted by another human / animal; often discovered in diseased skin, GI tract, sputum, female genital tract, urine with an indwelling Foley catheter\nPredisposed:\n(a) individuals with depressed immunity: hematologic disease, renal transplant, leukemia, chronic debilitating disease, diabetes mellitus, steroids, chemotherapy, AIDS, radiotherapy\n$\\diamond$ Most common type of fungi found with opportunistic infections!\n(b) delayed esophageal emptying: scleroderma, strictures, achalasia, S/P fundoplication\n(c) antibiotics\n\nPath: patchy, creamy-white plaques covering a friable erythematous mucosa\nHisto: mucosal plaques $=$ necrotic epithelial debris + fungal colonies\n\n- severe odynophagia ( $=$ painful swallowing from segmental spasm); dysphagia ( $=$ difficulty swallowing)\n- intense retro- / substernal pain\n- associated with thrush ( $=$ oropharyngeal moniliasis) in $20-50-80 \\%$\n\nLocation: predilection for upper $1 / 2$ of esophagus\n$\\sqrt{ }$ involvement of long esophageal segments:\n$\\sqrt{ }$ \"cobblestone\" appearance $=$ mucosal nodularity in early stage $\\leftarrow$ growth of colonies on surface\n$\\checkmark$ longitudinal plaques $=$ grouping of tiny $1-2-\\mathrm{mm}$ nodular filling defects with linear orientation (= heaped-up areas of mucosal plaques)\n$\\checkmark$ shaggy / fuzzy / serrated contour $\\leftarrow$ coalescent plaques, pseudomembranes, erosions, ulcerations, intramural hemorrhage) in fulminant candidiasis of AIDS\n$\\checkmark$ narrowed lumen $\\leftarrow$ spasm, pseudomembranes, marked edema\n$\\checkmark$ \"intramural diverticulosis\" = multiple tiny indentations + protrusions\n$\\checkmark$ sluggish / absent primary peristalsis\n$\\checkmark$ strictures (rare)\n$\\checkmark$ mycetoma resembling large intraluminal tumor (rare)\nDiagnostic sensitivity: endoscopy (97\\%), double contrast (88\\%), single contrast (55\\%)\nCx: (1) Systemic candidiasis (\"microabscesses\" in liver, spleen, kidney)\n(2) Gastric bezoar $\\leftarrow$ large fungus ball (after long-standing esophageal candidiasis)\n\nRx: ketoconazole / fluconazole\n$D D x$ : glycogen acanthosis, reflux esophagitis, superficial spreading carcinoma, artifacts (undissolved effervescent crystals, air bubbles, retained food particles), herpes esophagitis, acute caustic ingestion, intramural pseudo-diverticulosis, squamous papillomatosis, Barrett esophagus, epidermolysis bullosa, varices",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 781,
            "markdown": "# Caustic Esophagitis \n\n$=$ CORROSIVE ESOPHAGITIS\nCorrosive agents: [= strong acids or strong bases]\nhydrochloric acid, lye (sodium hydroxide), washing soda (sodium carbonate), household cleaners, iodine, silver nitrate, household bleaches, Clinitest ${ }^{\\circledR}$ tablets (tend to be neutralized by gastric acid)\n$\\diamond$ Severity of injury dependent on contact time + concentration of corrosive material!\nAssociated with: injury to pharynx + stomach ( $7-8 \\%$ ): antral burns more common with acid (buffering effect of gastric acid on alkali)\nLocation: middle + lower thirds of esophagus\nStage I : acute necrosis from protein coagulation\n$\\checkmark$ mucosal blurring (edema)\n$\\checkmark$ diffusely atonic + dilated esophagus\n$\\checkmark$ tertiary contractions / spasm\nStage II : frank ulceration in 3-5 days\n$\\checkmark$ ulceration + pseudomembranes\nStage III : scarring + stricture from fibroblastic activity\n$\\checkmark$ long segmental stricture after 10 days when acute edema subsides ( $7-30 \\%$ )\n$\\checkmark$ one / more strictures usually $1-3$ months after initial injury in unpredictable location\n$\\checkmark$ entire esophagus reduced to filiform structure\nCx: (1) Esophageal / gastric perforation during ulcerative stage\n(2) Squamous cell carcinoma in injured segment\n\nRx: dilatation procedure / esophageal replacement surgery\n\n## Chronic Esophagitis\n\n$\\checkmark$ luminal narrowing with tapered transition to normal + proximal dilatation\n$\\checkmark$ circumferential / eccentric stricture\n$\\checkmark$ sacculations $=$ pseudodiverticula\n\n## Drug-induced Esophagitis\n\n$=$ contact esophagitis $\\leftarrow$ oral medications $=$ \"pill esophagitis\"\nAgents: potassium chloride, antibiotics (tetracycline, doxycycline), quinidine, nonsteroidal antiinflammatory agents (aspirin), ascorbic acid, ferrous sulfate $\\left(\\mathrm{FeSO}_{4}\\right)$, alprenolol chloride, emepronium bromide, alendronate ( $=$ inhibitor of osteoclastic activity)\nEsophageal injury is usually caustic $\\leftarrow$ drug's chemical reaction upon direct contact with the esophageal mucosa:\n(a) Antibiotics (doxycycline, tetracycline) are acidic resulting in a chemical mucosal burn\n(b) Ferrous sulfate and potassium chloride cause injury $\\leftarrow$ hyperosmolarity + changes in local blood flow\nHisto: inflammatory changes + granulation tissue; sometimes with foreign material $\\pm$ dyskeratotic cells indicative of apoptosis of squamous epithelial cells\n\n- history of taking medication with little / no water immediately before going to bed; severe odynophagia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 782,
            "markdown": "- rapid clinical improvement after withdrawal of offending agent\n\nLocation: midesophagus at site of normal extrinsic impressions by aortic arch / left mainstem bronchus / left atrium\nEsophagram:\n$\\sqrt{ }$ single ulcer / localized cluster of multiple tiny ulcers (more common) distributed circumferentially:\n$\\sqrt{ }$ EN FACE: central punctate collections of barium surrounded by a radiolucent halo ( $=$ mound of edema)\n$\\sqrt{ }$ IN PROFILE: elongated flat plaquelike filling defects\n$\\sqrt{ }$ superficial solitary / several discrete ulcers with sharply delineated margins with commonly normal surrounding mucosa\nCT:\n$\\sqrt{ }$ ulcers may be invisible\nEsophageal ulcers induced by medications are frequently small and discrete often corresponding to the direct site of contact.\nPrognosis: ulcers heal within 7-10 days after cessation of offending medication\n$D D x$ : herpes esophagitis (immunosuppressed patient, less localized); reflux esophagitis (heartburn, distal esophagus near GE junction); Crohn esophagitis\n\n# Reflux Esophagitis \n\n$=$ esophageal inflammation $\\leftarrow$ reflux of acid-peptic contents of the stomach\nPrevalence: in $20 \\%$ of gastroesophageal reflux\nPathophysiology: reflux occurs if resting pressure of LES $<5 \\mathrm{mmHg}$ (may be normal event if followed by rapid clearing)\nHisto: basal cell hyperplasia with wall thickening + thinning of epithelium, mucosal edema + erosions, inflammatory infiltrate\nDeterminants: (1) Frequency of reflux\n(2) Adequacy of clearing mechanism\n(3) Volume of refluxed material\n(4) Potency of refluxed material\n(5) Tissue resistance\n\nReflux preventing features:\n(1) Lower esophageal sphincter\n(2) Phrenoesophageal membrane\n(3) Length of subdiaphragmatic esophagus\n(4) Gastroesophageal angle of His $\\left(70-110^{\\circ}\\right)$\n\nMay be associated with: sliding hiatal hernia (in $>90 \\%$ ), scleroderma, nasogastric intubation\n\n- heartburn, epigastric discomfort, choking, globus hystericus\n- retrosternal pain, thoracic / cervical dysphagia\n\nSite: usually lower $1 / 3$ to lower $1 / 2$ with continuous disease extending proximally from GE junction\nLength: usually $1-4 \\mathrm{~cm}$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 783,
            "markdown": "Consider a malignant tumor when a distal esophageal stricture is present in the absence of a hernia!\n$\\sqrt{ }$ initial esophageal insult:\n$\\sqrt{ }$ smooth tapered segment of concentric esophageal narrowing $\\leftarrow$ edema / spasm / stricture\n$\\sqrt{ }$ poorly defined tiny mucosal elevations (\"mucosal granularity\") on thickened / nodular longitudinal folds in early stages $\\leftarrow$ mucosal edema + inflammation\n$\\sqrt{ }$ single marginal ulcer / erosion at / adjacent to GE junction\n$\\sqrt{ }$ multiple areas of superficial ulceration in distal esophagus\n$\\sqrt{ }$ prominent mucosal fold ending in polypoid protuberance within hiatal hernia / cardia\n> effect of secondary esophageal scarring:\n$\\sqrt{ }$ asymmetric narrowing $\\leftarrow$ asymmetric scarring\n$\\sqrt{ } 1$ to 2 sacculations $\\leftarrow$ outward ballooning of esophageal wall between areas of fibrosis (DDx: ulcer)\n$\\sqrt{ }$ \"felinization\" = \"stepladder\" appearance of longitudinal scarring = fixed transverse ridges with barium trapped in between (DDx: \"feline\" esophagus)\n$\\sqrt{ }$ focal cluster of intramural pseudodiverticula\n$\\sqrt{ }$ very short segment of ringlike narrowing at the GE junction above a hiatal hernia (DDx: Schatzki ring)\n> effect on esophageal function:\n$\\sqrt{ }$ interruption of primary peristalsis at inflamed segment\n$\\sqrt{ }$ nonperistaltic waves in distal esophagus following deglutition ( $85 \\%$ )\n$\\sqrt{ }$ incomplete relaxation of LES ( $75 \\%$ ), incompetent sphincter ( $33 \\%$ )\n$\\sqrt{ }$ acid test $=$ abnormal motility elicited by acid barium ( pH 1.7 )\nNUC (pertechnetate):\n$\\sqrt{ }$ esophageal activity $\\leftarrow$ Barrett esophagus activity similar to ectopic gastric mucosa\nReflux tests:\n\n1. Reflux of barium in RPO position, may be elicited by coughing / deep respiratory movements / swallowing of saliva + water / anteflexion in erect position: only in $50 \\%$ accurate\n2. Water-siphon test: in $5 \\%$ false negative; large number of false positives\n3. Tuttle test $=$ measurement of esophageal $\\mathrm{pH}: 96 \\%$ accurate\n4. Radionuclide gastroesophageal reflux test (typically combined with gastric emptying test):\nTechnique: ROI drawn over distal esophagus + compared with time-activity curve over stomach, scaled to $4 \\%$\n$\\sqrt{ }$ esophageal activity $>4 \\%$ stomach activity\nCx of reflux:\n(a) from acid + pepsin acting on esophageal mucosa:\n5. Motility disturbance\n6. Stricture\n7. Schatzki ring\n8. Barrett esophagus\n9. Iron-deficiency anemia\n10. Reflux / peptic esophagitis\n(b) from aspiration of gastric contents",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 784,
            "markdown": "1. Acute aspiration pneumonia\n2. Mendelson syndrome\n3. Pulmonary fibrosis\n\n# Viral Esophagitis \n\nPredisposed: immunocompromised, eg, underlying malignancy, debilitating illness, radiation treatment, steroids, chemotherapy, AIDS\n\n## Cytomegalovirus Esophagitis\n\nOrganism: member of herpesvirus group\nAssociated with: AIDS\n\n- severe odynophagia\n$\\sqrt{ }$ diffusely normal mucosal background\n$\\sqrt{ }$ one / more giant ovoid flat ulcers (up to several cm in size) near gastroesophageal junction\n$\\sqrt{ }$ discrete small superficial ulcers indistinguishable from herpes esophagitis (uncommon)\n$R x$ : ganciclovir (relatively toxic)\n$D x$ : endoscopic brushings, biopsy specimen, cultures\n\n\n## Herpes Esophagitis\n\n$\\diamond 2^{\\text {nd }}$ most common cause of opportunistic infection!\nOrganism: Herpes simplex virus type I (DNA core virus) secreted in saliva of $2 \\%$ of healthy population\nAge: $15-30$ years; usually males\nPredisposed: immunocompromised patient with HIV, organ transplant, and on chemotherapy; may occur in immunocompetent patient\n\n- history of recent exposure to sexual partners with herpetic lesions on lips / buccal mucosa\n- flulike prodrome of 3-10 days (headaches, fever, sore throat, upper respiratory symptoms, myalgia)\n- severe acute dysphagia / odynophagia\n\nMay be associated with: oropharyngeal herpetic lesions / oropharyngeal candidiasis\nLocation: midesophagus (level of left main bronchus)\n$\\sqrt{ }$ initially vesicles / blisters that subsequently rupture\n$\\sqrt{ }$ multiple small discrete superficial punctate / round / linear / serpentine / stellate (often \"diamond-shaped\") punched-out ulcers surrounded by radiolucent halo of edematous mucosa (in $>50 \\%$ )\n$\\sqrt{ }$ intervening mucosa normal (without plaques)\n$\\sqrt{ }$ multiple plaquelike lesions (only with severe infection)\n$D x$ : rising serum titer for HSV type I, viral culture, biopsy (immunofluorescent staining for HSV antigen, demonstration of intranuclear inclusions)\n$R x$ : oral / intravenous acyclovir\nPrognosis: resolution of symptoms in 3-14 days\n$D D x$ : drug-induced esophagitis, Crohn disease, esophageal intramural pseudodiverticulosis\n\n## Human Immunodeficiency Virus Esophagitis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 785,
            "markdown": "- maculopapular rash + ulcers of soft palate (occasionally)\n- recent seroconversion / known AIDS\n$\\sqrt{ }$ one / more giant ( $>1 \\mathrm{~cm}$ ) flat ovoid / diamond-shaped ulcers (at time of seroconversion) indistinguishable from CMV esophagitis\n$D x$ : per exclusion (brushings, biopsies, cultures negative for CMV)\n$R x$ : oral steroids\n$D D x$ : CMV esophagitis, mycobacterial esophagitis, actinomycosis, potassium chloride, quinidine, caustic ingestion, nasogastric intubation, radiation therapy, endoscopic sclerotherapy\n\n\n# FAMILIAL ADENOMATOUS POLYPOSIS \n\n$=$ FAMILIAL MULTIPLE POLYPOSIS\nFrequency: $1 \\div 7,000$ to $1 \\div 24,000$ live births\nGenetics: autosomal dominant disease with $80 \\%$ penetrance; gene localized on chromosome 5; sporadic occurrence in $1 / 3$\nPath: tubular / villotubular adenomatous polyps; usually about 1,000 adenomas\nAge: polyps appear around puberty\n\n- family history of colonic polyps ( $66 \\%$ )\n$\\diamond$ Screening of family members after puberty!\n- clinical symptoms begin during $3^{\\text {rd }}-4^{\\text {th }}$ decade (range, 5-55 years)\n- vague abdominal pain, weight loss, diarrhea, bloody stools\n- protein-losing enteropathy (occasionally)\n\nAssociated (1) Hamartomas of stomach in $49 \\%$\nwith:\n(2) Adenomas of duodenum in $25 \\%$\n(3) Periampullary carcinoma\n(4) Desmoid tumors in $9-18 \\%: 1000 \\mathrm{x}$ fold increased risk; multiple desmoids in $40 \\%$\n$\\sqrt{ }$ \"carpet of polyps\" = myriad of $2-3 \\mathrm{~mm}$ (up to 2 cm ) polypoid lesions\n@ Colon ( $100 \\%$ ): more numerous in distal colon; always affecting rectum\n$\\sqrt{ }$ normal haustral pattern\n@ Stomach (5\\%)\n@ Small bowel $(<5 \\%)$\n$C x$ : malignant transformation of adenomas: colon $>$ stomach $>$ small bowel in $12 \\%$ [30\\%]\n$\\{100 \\%\\}$ by $5[10]\\{20\\}$ years after diagnosis; carcinomatous development usually at age\n$20-40$ years; multiple carcinomas in $48 \\%$\n$\\diamond 331$-fold increased risk of small bowel adenocarcinoma compared to general population after colectomy\n$\\diamond$ Periampullary carcinoma is the most common cause of death after prophylactic colectomy!\n$R x$ : prophylactic total colectomy in late teens / early twenties before symptoms develop\n(1) Permanent ileostomy\n(2) Continent endorectal pull-through pouch\n(3) Kock pouch (= distal ileum formed into a one-way valve by invaginating the bowel",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 786,
            "markdown": "at skin site)\n$D D x$ : other polyposes, lymphoid hyperplasia, lymphosarcoma, ulcerative colitis with inflammatory pseudopolyps\n\n# FIBROVASCULAR POLYP OF ESOPHAGUS \n\n$=$ HAMARTOMA $=$ LIPOMA $=$ FIBROMA $=$ FIBROLIPOMA $=$ FIBROMYXOMA $=$ FIBROEPITHELIAL POLYP\n$=$ intraluminal esophageal polyp\nPrevalence: $1-2 \\%$ of benign esophageal tumors\nCause: over time enlarging loose submucosal tissue in Laimer triangle just inferior to cricopharyngeus\n[Eduard Laimer (1857-1934), anatomist in Graz, Austria]\nPath: elongated intraluminal mass of fibrous + adipose tissue of varying proportions covered by normal squamous epithelium\nAge: 53 (range, 1-88) years; $\\mathrm{M}>\\mathrm{F}$\n\n- dysphagia (69\\%), cough, respiratory distress\n- regurgitation of polyp into mouth, foreign-body sensation\n\nSite: near level of cricopharyngeus / lower hypopharynx\nSize: 7 cm long at time of presentation extending inferiorly as far as into the stomach\nBarium:\n$\\checkmark$ giant sausage-shaped intraluminal mass originating from cervical esophagus (pedicle usually not identified)\nCT / MR:\n$\\checkmark$ heterogeneous mass with areas of soft-tissue and fat attenuation\n$\\sqrt{ } \\pm$ punctate calcifications (occasionally)\nThe cross-sectional appearance of fibrovascular polyps depends on the proportions of fat and fibrous tissue.\n$C x$ : asphyxia + sudden death $\\leftarrow$ after regurgitation of polyp into pharynx / mouth\n$R x$ : surgical removal ( $10 \\%$ recurrence)\n\n## FOREIGN BODY INGESTION\n\n## Cause:\n\n(a) accidental: patients with altered mental status / dentures\n(b) nonaccidental: \"body packing\" to smuggle illicit drugs (swallowed, inserted into vagina / rectum)\n\n- pain, excessive salivation, cough, difficulty breathing\n- nausea, vomiting\n\nType:\n(a) NONDIGESTABLE FOOD COMPONENT: fish / chicken bone, toothpick\n(b) HIGH-DENSITY DEVICE: coin, toy, key, battery, jewelry, pin, needle, nail, razor blade, clip, denture, dislodged tooth, crown\nLocation of intraluminal lodgement:\nesophagus ( $68 \\%$ ), stomach ( $11.6 \\%$ ), small bowel ( $3.3 \\%$ ), colon ( $11.6 \\%$ )\n> trapped in appendix, diverticula, proximal to stricture: calcified seeds + pits, birdshot CT:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 787,
            "markdown": "$\\sqrt{ }$ wood difficult to recognize:\n$\\sqrt{ }$ air attenuation in acute phase mimicking bubbles of gas\n$\\sqrt{ }$ becoming progressively isoattenuating in subacute phase\n$\\sqrt{ }$ hyperattenuating $\\leftarrow$ granulomatous reaction\n$\\sqrt{ }$ calcified in chronic phase\n$\\sqrt{ } \\pm$ pneumoperitoneum (rare $\\leftarrow$ progressive impaction of foreign body in intestinal wall surrounded by fibrin. omentum, bowel loops that prevent leakage of gas)\nCx: (1) Perforation( $<1 \\%$ ): fish / chicken bone, toothpick\nLocation: predominantly in ileocecal region, rectosigmoid, areas of bowel narrowing, angulation, pouching, diverticula, adhesions, surgical anastomosis\n(2) Toxic effect / liquefaction necrosis: button battery\n$\\diamond$ Any battery lodged in esophagus should be removed promptly!\nRx: most foreign bodies are amenable to endoscopic removal\n\n# GALLSTONE ILEUS \n\n[misnomer: mechanical obstruction, not ileus]\nFrequency: $\\quad 0.4-5.0 \\%$ of all intestinal obstructions $\\leftarrow$ risk increases with age $=20 \\%$ [24\\%] of obstruction in patients $>65$ [ $>70$ ] years; in 1 of 6 perforations; develops in $0.3-$ $0.5 \\%$ of patients with cholelithiasis\nEtiology: biliary disease ( $90 \\%$ ), peptic ulcer disease, cancer, trauma\n$\\diamond$ Most eroded gallstones are excreted uneventfully!\nMechanism: cholecystoenteric fistula / following endoscopicinct spherotomy\nAge: average $65-75$ years; $\\mathrm{M}+\\mathrm{F}=1 \\div 4-1 \\div 7$\n\n- previous history of gallbladder disease\n- intermittent episodes of acute colicky abdominal pain (20-30\\%)\n- nausea, vomiting, fever, distension, obstipation\n\nLocation: terminal ileum ( $60 \\%$ ), proximal ileum / distal jejunum (26\\%), distal ileum (10\\%), sigmoid colon\n\nThe most obstructive gallstones are $>2.5 \\mathrm{~cm}$ in diameter and located in ileum ( $60 \\%$ ) / jejunum ( $26 \\%$ ). The terminal ileum is the narrowest segment and thus the most likely site of obstruction.\n$\\sqrt{ }$ Rigler triad on plain film (in 15\\%), on CT (in 78\\%):\n\n1. Partial / complete intestinal obstruction (usually in small bowel), \"string of rosary beads\" $=$ multiple small amounts of air trapped between dilated + stretched valvulae conniventes (in $86 \\%$ )\n2. Pneumobilia (in $69 \\%$ )\n3. Ectopic calcified gallstone in lower abdomen (in $25 \\%$ ): stones are commonly $>2.5 \\mathrm{~cm}$ in diameter\n$\\sqrt{ }$ change in position of previously identified gallstone\nUGI / BE:\n$\\sqrt{ }$ smooth polypoid filling defect ( $=$ gallstone) at site of obstruction\n$\\sqrt{ }$ well-contained localized barium collection lateral to first portion of duodenum (bariumfilled collapsed GB + possibly biliary ducts)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 788,
            "markdown": "# Fistulous communication: \n\ncholecystoduodenal ( $60 \\%$ ), choledochoduodenal, cholecystocolic, choledochocolic, cholecystogastric\nCT ( $91 \\%$ sensitive):\n$\\sqrt{ }$ air / enteric contrast in GB (fistula from GB to duodenum)\n$\\sqrt{ }$ thickened duodenal wall\n$\\sqrt{ }$ gallstone at transition point of bowel obstruction\n$C x$ : recurrent gallstone ileus in $5-10 \\%$ (additional silent calculi more proximally)\n$R x$ : removal of stone(s) + cholecystectomy + fistula repair\nPrognosis: high mortality of up to $18 \\%$\n\n## Bouveret Syndrome\n\n[Léon Bouveret (1850-1929), French internist in Lyon]\n$=$ gastric outlet obstruction $\\leftarrow$ impacted gallstone in duodenum / pylorus $\\leftarrow$ cholecystoenteric fistula\nAge: most commonly in elderly woman\n\n- nausea, vomiting, epigastric pain\n\nCT:\n$\\sqrt{ }$ obstructing ectopic gallstone in distal stomach / duodenum\n$\\sqrt{ }$ air in gallbladder / biliary tree\nMortality rate: $12-33 \\%$\n\n## GANGLIOCYTIC PARAGANGLIOMA\n\n$=$ rare benign tumor of the GI tract\nFrequency: $<100$ cases reported\nOrigin: pancreatic endocrine rest that remained when the ventral primordium rotated around the duodenum\nAge: $50-60$ years of age; $\\mathrm{M}+\\mathrm{F}=2 \\div 1$\nLocation: almost exclusively in $2^{\\text {nd }}$ portion of duodenum near ampulla of Vater on medial / lateral wall of duodenum\n\n- GI hemorrhage, abdominal pain\n$\\sqrt{ }$ polypoid smooth-surfaced intraluminal mass\n$\\sqrt{ }$ homogeneously enhancing mural / extrinsic solid mass of soft-tissue attenuation\n$\\sqrt{ }$ well-circumscribed hypoechoic mass contiguous with bowel\n$\\sqrt{ }$ no biliary duct dilatation\n$D D x$ : adenocarcinoma (biliary duct dilatation, hypovascular), leiomyosarcoma (cystic internal hemorrhage / necrosis), hemangioma, duplication cyst, choledochal cyst, lipoma, hamartoma, inflammatory fibroid polyp (distal small bowel), lymphoma (isolated in stomach and ileum)\n\n\n## GARDNER SYNDROME\n\n[Eldon John Gardner (1909-1989), geneticist at Utah State University in Logan, Utah]\n$=$ autosomal dominant disease with variable penetrance as a variant of familial adenomatous polyposis characterized by a triad of",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 789,
            "markdown": "(1) Colorectal polyposis\n(2) Osteomas\n(3) Soft-tissue tumors\n\nIncidence: $1 \\div 14,000$\nCause: mutation in tumor suppressor gene APC (adenomatous polyposis coli gene) on chromosome 5q21 to 5q22; in $20 \\%$ new mutation\n$\\diamond$ Familial polyposis + Gardner syndrome may occur in the same family!\nHisto: adenomatous polyps $\\rightarrow$ malignant transformation\nAge: 15-30 years (range, 2 months - 70 years)\nAverage life expectancy: 35-40 years\nAssociated with: ? MEA complex\n(1) Periampullary / duodenal carcinoma (12\\%)\n(2) Papillary thyroid carcinoma: often multicentric\n(3) Adrenal adenoma / carcinoma\n(4) Parathyroid adenoma\n(5) Pituitary chromophobe adenoma\n(6) Pancreatic neoplasm (4 x of general population)\n(7) Hepatoblastoma ( 800 x of general population)\n(8) Hepatocellular carcinoma\n(9) Carcinoid, adenoma of small bowel\n(10) Nasal angiofibroma\n(11) Retroperitoneal leiomyoma\n$\\diamond$ Lifelong screening for malignancies!\n$\\diamond$ Extraintestinal manifestations occur usually earlier than in intestinal polyposis!\n\n- skin pigmentation\n- cramping abdominal pain, weight loss, diarrhea\n@ Polyposis\nLocation: colon (100\\%), stomach (5-68\\%), duodenum (90\\%), ampulla of Vater, small bowel $(<5 \\%)$\n$\\checkmark$ multiple colonic polyps appearing during puberty, increasing in number during $3^{\\text {rd }}-4^{\\text {th }}$ decade\n$\\checkmark$ lymphoid hyperplasia of terminal ileum\n$\\checkmark$ hamartomas of stomach\n$\\checkmark$ intussusception\nCx: small bowel / colonic obstruction; malignant transformation\n@ Soft-tissue tumors\n(a) sebaceous / epidermoid inclusion cysts: scalp, back, face, extremities\n(b) fibroma, lipoma, leiomyoma, neurofibroma\n(c) desmoid tumors (3-10-34\\%)\n\nLocation: abdominal wall; extra- / intraabdominal\n$\\diamond$ Tend to occur after colectomy\n$\\checkmark$ peritoneal adhesions $\\leftarrow$ desmoplastic tendency\n$\\checkmark$ mesenteric fibrosis, retroperitoneal fibrosis\n\n- urinary tract obstruction, bowel obstruction\n\nPrognosis: frequent recurrence ( $1 / 3$ ) after resection / radiation therapy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 790,
            "markdown": "(d) mammary fibromatosis\n(e) marked keloid formation, hypertrophied scars (anterior abdominal wall) arise 1-3 years after surgery\n@ Osteomatosis of membranous bone (50\\%)\nLocation: calvarium, mandible ( $81 \\%$ ), maxilla, ribs, long bones\n@ Long bones\nLocation of osteomas: paranasal sinuses; outer table of skull (frequent); mandible (at angle)\n$\\checkmark$ slight shortening + bowing\n$\\checkmark$ endosteal cortical thickening\n$\\checkmark$ may have solid periosteal cortical thickening\n$\\checkmark$ wavy cortical thickening of superior aspect of ribs\n$\\checkmark$ osteomas / exostoses may protrude from periosteal surface\n@ Teeth\n$\\checkmark$ odontoma, unerupted / supernumerary teeth, hypercementosis\n$\\checkmark$ tendency toward numerous caries $\\rightarrow$ dental prosthesis at early age\nCx: malignant transformation of colonic polyps in $100 \\%$ (average age at death is 41 years if untreated); high incidence of carcinoma of duodenum / ampulla of Vater\nProphylaxis: gastrointestinal surveillance, thyroid screening, ophthalmologic evaluation for retinal pigmentation anomalies; screening of family members starting at age 15\n$R x$ : prophylactic total colectomy at about 20 years of age\n\n# GASTRIC CARCINOMA \n\n$\\checkmark 4^{\\text {th }}$ most common cancer worldwide (most prevalent malignancy in Korea, China, Japan), $6^{\\text {th }}$ leading cause of cancer deaths\nPrevalence: declining with 24,000 cases annually in USA\nRisk factors: smoking, nitrites, nitrates, pickled vegetables\nPredisposing factors:\nH. pylori gastritis, chronic atrophic gastritis, adenomatous + villous polyp ( $7-27 \\%$ are malignant), gastrojejunostomy, partial gastrectomy (Billroth II > Billroth I), pernicious anemia (risk factor of 2), Ménétrier disease (?)\nHisto: adenocarcinoma ( $95 \\%$ ); rarely squamous cell carcinoma / adenoacanthoma\nStaging (American Joint Committee on Cancer):\nT1 tumor invades lamina propria / submucosa\nT2 tumor invades muscularis propria / subserosa\nT3 tumor penetrates serosa (= visceral peritoneum)\nT4a invasion of adjacent contiguous tissues\nT4b invasion of adjacent organs, diaphragm, abdominal wall\nN1 involvement of 1-6 perigastric nodes within 3 cm of primary along greater / lesser curvature\nN2 involvement of 7-15 regional nodes $>3 \\mathrm{~cm}$ from primary along branches of celiac axis\nN3 $>15$ paraaortic, hepatoduodenal, retropancreatic, mesenteric nodes",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 791,
            "markdown": "M1 distant metastases\n$\\diamond$ Endoscopic US is the most reliable method for T staging with a diagnostic rate of $78 \\%-$ $93 \\%$ !\nLocation: mostly distal third of stomach + cardia; $60 \\%$ on lesser curvature, $10 \\%$ on greater curvature; esophagogastric junction in 30\\%; transpyloric spread in 5-25\\% (for lymphoma $40 \\%$ )\nProbability of malignancy of an ulcer:\nat lesser curvature $10-15 \\%$, at greater curvature $70 \\%$, in fundus $90 \\%$\nMorphology:\n\n1. Polypoid / fungating carcinoma\n2. Ulcerating / penetrating carcinoma ( $70 \\%$ )\n3. Infiltrating / scirrhous carcinoma ( $5-15 \\%)=$ linitis plastica\n\nHisto: frequently signet ring cell type + increase in fibrous tissue\nLocation: antrum, fundus + body (38\\%)\n$\\sqrt{ }$ firmness, rigidity, reduced capacity of stomach, aperistalsis in involved area\n$\\sqrt{ }$ granular / polypoid folds with encircling growth\n4. Superficial spreading carcinoma\n$=$ confined to mucosa / submucosa; 5-year survival of $90 \\%$\n$\\sqrt{ }$ patch of nodularity\n$\\sqrt{ }$ little loss of elasticity\n5. Advanced bulky carcinoma\n\nThe depth of mural invasion and presence of extragastric lesions can be determined with endoscopic US and CT.\n\n- GI bleeding, abdominal pain, weight loss\n\nUGI:\n$\\sqrt{ }$ rigidity\n$\\sqrt{ }$ filling defect\n$\\sqrt{ }$ amputation of folds $\\pm$ ulceration $\\pm$ stenosis\n$\\sqrt{ }$ miliary / punctate calcifications $\\leftarrow$ mucinous adenocarcinoma\nCT:\n$\\sqrt{ }$ irregular nodular luminal surface\n$\\sqrt{ }$ asymmetric thickening of folds\n$\\sqrt{ }$ mass of uniform density / varying attenuation\n$\\sqrt{ }$ wall thickness $>6 \\mathrm{~mm}$ (with gas distension) and 13 mm (with positive contrast material distension):\n$\\sqrt{ }$ diffuse low attenuation in mucinous carcinoma\n$\\sqrt{ }$ increased density in perigastric fat\n$\\sqrt{ }$ enhancement exclusively in linitis plastica type\n$\\sqrt{ }$ nodules of serosal surface $\\leftarrow$ dilated surface lymphatics\n$\\sqrt{ }$ diameter of esophagus at gastroesophageal junction larger than adjacent aorta (DDx: hiatal hernia)\n$\\sqrt{ }$ lymphadenopathy below level of renal pedicle (3\\%)\nMetastases:\n\n1. Direct invasion: along peritoneal ligaments",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 792,
            "markdown": "(a) gastrocolic lig.: transverse colon, pancreas\n(b) gastrohepatic + hepatoduodenal ligament: liver\n2. Lymphatic: to local lymph nodes\n$\\sqrt{ }$ short-axis diameter of $8-10 \\mathrm{~mm}$\n$\\sqrt{ }$ nearly round shape\n$\\sqrt{ }$ central necrosis\n$\\sqrt{ }$ marked / heterogeneous enhancement\n3. Hematogenous: to liver (most common), adrenals, ovary, bone (1.8\\%), lymphangitic carcinomatosis of lung (rare)\n4. Peritoneal seeding\n> on rectal wall $=$ Blumer shelf\n[George Blumer (1872-1962), surgeon at Albany Medical College, Cooper Medical College, University of California Medical School, Yale University]\n> on ovaries $=$ Krukenberg tumor\n[Friedrich Ernst Krukenberg (1871-1946), thesis of doctorate on peculiar ovarian tumors, ophthalmologist in Halle, Germany]\n5. left supraclavicular lymph node $=$ Virchow node\n[Rudolph Carl Virchow (1821-1902), chair of pathology at university of Würzburg and Charité Hospital in Berlin, Germany, editor of Archiv für pathologische Anatomie und Physiologie und für klinische Medizin]\nPrognosis: mean survival time of $7-8$ months\n> $85 \\% 5$-year survival in stage T1\n> $52 \\% 5$-year survival in stage T2\n> $47 \\% 5$-year survival in stage T3\n> $17 \\% 5$-year survival in stage N1-2\n$>5 \\% 5$-year survival in stage N3\n\n# Early Gastric Cancer (20\\%) \n\n$=$ invasion limited to mucosa + submucosa (T1 lesion) regardless of lymph node involvement Classification of Japan Research Society for Gastric Cancer:\n\n| Type | I | protruded type $=>5 \\mathrm{~mm}$ in height with protrusion into gastric lumen $(10-20 \\%)$ |\n| :--: | :--: | :--: |\n| Type | II | superficial type $=<5 \\mathrm{~mm}$ in height |\n|  | IIa | slightly elevated surface ( $10-20 \\%)$ |\n|  | IIb | flat / almost unrecognizable (2\\%) |\n|  | IIc | slightly depressed surface ( $50-60 \\%)$ |\n| Type | III | excavated / ulcerated type (5-10\\%) |\n\nPrognosis: 5-year survival rate of $85-100 \\%$\n\n## Advanced Gastric Cancer (T2 lesion and higher)\n\n## Bormann classification:\n\nType 1 broad-based elevated polypoid lesion\nType 2 elevated lesion + ulceration + well-demarcated margin\nType 3 elevated lesion + ulceration + ill-defined margin",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 793,
            "markdown": "Type 4 ill-defined flat lesion\nType 5 unclassified, no apparent elevation\nPrognosis: 5-year survival rate of $7-27 \\%$\nCx: perforation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 794,
            "markdown": "# GASTRIC DIVERTICULUM \n\n$\\diamond$ stomach is the least common site of diverticula\nFrequency: $1 \\div 600$ to $1 \\div 2,400$ of UGI studies\nEtiology: (a) traction $\\leftarrow$ scarring / periantral inflammation $=$ true diverticulum\n(b) pulsion (less common) = false diverticulum\n\nAge: beyond 40 years\nOften associated with: aberrant pancreas in antral location\nLocation: juxtacardiac on posterior wall ( $75 \\%$ ), prepyloric ( $15-22 \\%$ ), greater curve (3\\%)\n$\\sqrt{ }$ pliability + varying degrees of distension\n$\\sqrt{ }$ NO mass, edema or rigidity of adjacent folds\n$D D x$ : small ulcer in intramural-extramucosal mass\n\n## GASTRIC POLYP\n\nFrequency: $1.5-5 \\%$, most common benign gastric tumor\nAssociated with: hyperacidity + ulcers, chronic atrophic gastritis, gastric carcinoma\nA. NONNEOPLASTIC\n\n1. Inflammatory polyp of stomach ( $75-90 \\%$ )\n= HYPERPLASTIC POLYP = REGENERATIVE POLYP\nHisto: cystically dilated glands lined by gastric epithelium + acute and chronic inflammatory infiltrates in lamina propria\nAssociated with: chronic atrophic gastritis, pernicious anemia\nLocation: predominantly in fundus + body; usually multiple\n$\\checkmark$ sharply delineated polyp with smooth circular border\n$\\checkmark$ \"Mexican hat\" sign = stalk seen en face overlying the head of polyp\n$\\checkmark$ sessile / pedunculated\n$\\checkmark$ usually $<2 \\mathrm{~cm}$ in diameter without progression\n$\\checkmark$ no contour defect of stomach\nPrognosis: no malignant potential\n2. Hamartomatous polyp of stomach (rare)\n\nHisto: densely packed gastric glands + bundles of smooth muscle\nAssociated with: Peutz-Jeghers syndrome\n$\\checkmark$ sessile / pedunculated\n$\\checkmark$ usually $<2 \\mathrm{~cm}$ in diameter\n3. Retention polyp of stomach (rare)\n\nHisto: dilated cystic glands + stroma\nAssociated with: Cronkhite-Canada syndrome\nB. NEOPLASTIC\n\n1. Adenomatous polyp of stomach ( $10-20 \\%$ )\n= true neoplasm with malignant potential ( $10-80 \\%$, increasing with size)\nAge: increasing incidence with age; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 1$\nHisto: intestinal metaplasia (common) + marked cellular atypism\nAssociated with: Gardner syndrome; coexistent with gastric carcinoma in 35\\%\nLocation: more commonly in antrum (antrum spared in Gardner syndrome)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 795,
            "markdown": "$\\sqrt{ }$ broad-based elliptical / mushroom-shaped polyp $\\pm$ pedicle; usually solitary\n$\\sqrt{ }$ usually $>2 \\mathrm{~cm}$ in diameter (in $80 \\%$ )\n$\\sqrt{ }$ smooth / irregular lobulated contour\n2. Villous polyp of stomach (rare)\n$\\sqrt{ }$ trabeculated / lobulated slightly irregular contour\n$C x$ : malignant transformation\n$D D x$ : (1) Ménétrier disease (antrum spared)\n(2) Eosinophilic polyp (peripheral eosinophilia, linitis plastica appearance, small bowel changes)\n(3) Lymphoma\n(4) Carcinoma\n\n# GASTRIC ULCER \n\n## Benign Gastric Ulcer (95\\%)\n\n## Cause:\n\nA. HORMONAL\n\n1. Zollinger-Ellison syndrome\n2. Hyperparathyroidism (in 1.3-24.0\\%)\nduodenum+stomach $=4 \\div 1 ; \\mathrm{M}+\\mathrm{F}=3 \\div 1$\n$\\diamond$ Duodenal ulcers predominate in females!\n$\\diamond$ Gastric ulcers predominate in males!\n\n- absence of gastric hypersecretion\n\n3. Steroid-induced ulcer\ngastric $>$ duodenal location; frequently multiple + deep ulcers; commonly associated with erosions\n\n- bleeding (in $1 / 3$ )\n\n4. Stress, severe prolonged illness\n5. Cerebral disease $=$ Cushing ulcer\n6. Curling ulcer (burns) (in $0.09-2.60 \\%$ )\n7. Retained gastric antrum\n8. Uremia\nB. INFLAMMATION\n9. Peptic ulcer disease\n10. Gastritis\n11. Radiation-induced ulcer\n12. Intubation\n13. Stasis ulcer proximal to pyloric / duodenal obstruction\nC. BENIGN MASS\n14. Leiomyoma\n15. Granulomatous disease\n16. Pseudolymphoma (lymphoid hyperplasia)\nD. DRUGS\n\nASA: greater curvature",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 796,
            "markdown": "Pathophysiology: disrupted mucosal barrier (H. pylori) with vulnerability to acid + secretion of large volume of gastric juice containing little acid\nIncidence: $5 \\div 10,000 ; 100,000$ annually (USA)\nAge peak: $55-65$ years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$\nMultiplicity:\n(a) multiple in $2-8 \\%$ ( $17-24 \\%$ at autopsy), especially in patients on aspirin\n(b) coexistent duodenal ulcer in $5-64 \\%$; gastric + duodenal $=1 \\div 3[1 \\div 7]$ in adults [children]\n\n- abdominal pain: in $30 \\%$ at night, $25 \\%$ precipitated by food\n\nLocation: lesser curvature at junction of corpus + antrum within 7 cm from pylorus; proximal half of stomach in older patients (geriatric ulcer); adjacent to GE junction within hiatal hernia\n$\\sqrt{ }$ ulcer size usually $<2 \\mathrm{~cm}$ (range $1-250 \\mathrm{~mm}$ ); in $4 \\%>4 \\mathrm{~cm}$\n$\\sqrt{ }$ round / ovoid / linear shape\n$\\sqrt{ }$ Haudek niche $=$ conical / collar button-shaped barium collection projecting outside gastric contour (profile view)\n$\\sqrt{ }$ Hampton line $=1-\\mathrm{mm}$ thin straight lucent line traversing the orifice of the ulcer niche (seen on profile view + with little gastric distension) = ledge of touching overhanging gastric mucosa of undermined benign ulcer\n$\\sqrt{ }$ ulcer collar $=$ smooth thick lucent band interposed between the niche and gastric lumen $\\leftarrow$ thickened rim of edematous gastric wall in well-distended stomach\n$\\sqrt{ }$ ulcer mound $=$ smooth, sharply delineated, gently sloping extensive tissue mass surrounding a benign ulcer $\\leftarrow$ edema + lack of wall distensibility in well-distended stomach\n$\\sqrt{ }$ ulcer crater $=$ round / oval barium collection with smooth border on dependent side (viewed en face)\n$\\sqrt{ }$ halo defect $=$ wide lucent band symmetrically surrounding ulcer $\\leftarrow$ extensive ulcer mound (viewed en face)\n$\\sqrt{ }$ ring shadow: ulcer on nondependent side (en face view)\n$\\sqrt{ }$ radiating thick folds extending directly to crater edge fusing with effaced marginal fold of ulcer collar / halo of ulcer mound\n$\\sqrt{ }$ incisura defect $=$ smooth, deep, narrow, sharp indentation on greater curvature opposite a niche on lesser curvature at / slightly below the level of the ulcer $\\leftarrow$ spastic contraction of circular muscle fibers\nPrognosis: healing in $50 \\%$ by 3 weeks, in $100 \\%$ by $6-8$ weeks; slower healing in older patients; only complete healing proves benignancy\nCx: (1) Bleeding\n(2) Perforated ulcer\n(a) anterior wall / curvatures $\\rightarrow$ into peritoneal space\n(b) posterior wall $\\rightarrow$ into lesser sac\n$\\sqrt{ }$ free intraperitoneal fluid / gas\n$\\sqrt{ }$ extraluminal oral contrast material\n$\\sqrt{ }$ wall discontinuity\n(3) Fistula\n$\\diamond$ Most common cause of gastrocolic fistula!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 797,
            "markdown": "# Benign Postbulbar Peptic Ulcer (10\\%) \n\nCause: Helicobacter pylori infection\nAge: adulthood; $\\mathrm{M} \\pm \\mathrm{F}=7 \\div 1$\nSite: majority on medial wall of proximal descending duodenum (upper $2^{\\text {nd }}$ portion above major papilla of Vater)\n\n- localized epigastric pain 2-4 hours after meal\n- hemorrhage in $66 \\%$\n$\\checkmark$ edema + spasm may obscure ulcer\n$\\checkmark$ smooth rounded indentation of lateral wall\n$\\checkmark$ incisura pointing to ulcer\n$\\checkmark$ occasionally barium reflux into common bile duct\n$\\checkmark$ ring stricture\n$\\checkmark$ stress- and drug-induced ulcers heal without deformity\n\n\n## Malignant Gastric Ulcer (5\\%)\n\n## Cause:\n\n1. Gastric carcinoma\n2. Lymphoma ( $2 \\%$ of all gastric neoplasms)\n$\\checkmark$ multiple ulcers with aneurysmal appearance\n3. Leiomyosarcoma, neurogenic sarcoma, fibrosarcoma, liposarcoma\n4. Metastases\n(a) hematogenic: malignant melanoma, breast cancer, lung cancer\n(b) per continuum: pancreas, colon, kidney\n\nLocation: anywhere within stomach; fundal ulcers above level of cardia are usually malignant\n$\\checkmark$ ulcer location within gastric lumen, ie, not projecting beyond expected margin of stomach (profile view)\n$\\checkmark$ eccentrically located ulcer within the tumor\n$\\checkmark$ irregularly shaped ulcer\n$\\checkmark$ shallow ulcer with width greater than depth\n$\\checkmark$ nodular ulcer floor\n$\\checkmark$ abrupt transition between normal mucosa + abnormal tissue at some distance (usually 2-4 cm ) from ulcer edge\n$\\checkmark$ rolled / rounded / shouldered edges surrounding ulcer\n$\\checkmark$ nodular irregular folds approaching ulcer with fused / clubbed / amputated tips\n$\\checkmark$ rigidity / lack of distensibility\n$\\checkmark$ associated large irregular mass\n$\\checkmark$ Carman \"meniscus\" sign = lenticular barium collection in ulcer crater trapped by heaped up edges; convex relative to lumen on profile view under compression; found in specific type of ulcerating carcinoma, but seen only rarely\n[Russell Daniel Carman (1875-1926), professor of radiology at St. Louis and Washington university and head of Mayo section on roentgenology in 1913, president of RSNA and ARRS]\n$\\checkmark$ Kirklin meniscus complex $=$ Carman sign (appearance of crater) + radiolucent slightly elevated rolled border",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 798,
            "markdown": "Prognosis: partial healing may occur\n\n| Gastric Ulcer |  |  |\n| :-- | :-- | :-- |\n| Sign | Benign | Malignant |\n| Crater | round, ovoid | irregular |\n| Radiating folds | symmetric | nodular, clubbed, fused |\n| Areae gastricae | preserved | destroyed |\n| Projection | outside lumen | inside lumen |\n| Ulcer mound | smooth | rolled edge |\n\n# GASTRIC VARICES \n\nCause: portal hypertension (varices seen in 2-78\\%); splenic vein obstruction $\\leftarrow$ pancreatitis, pancreatic carcinoma, pseudocyst\nLocation: (a) esophagogastric junction (most common)\n(b) along lesser curvature (in $11-75 \\%$ of patients with portal hypertension / cirrhosis)\nFeeding vessels:\n\n1. Left gastric vein (between splenic vein + stomach)\n2. Short gastric veins (between spleen + fundus)\n3. Retrogastric vein (between splenic vein +GE junction)\n\n- increased prevalence of portosystemic encephalopathy\n$\\sqrt{ }$ barium study ( $65-89 \\%$ rate of detection):\n$\\sqrt{ }$ lobulated folds / polypoid masses in fundus\n$\\sqrt{ }$ endoscopy: most practical method\n$\\sqrt{ }$ splenic portography\n$\\sqrt{ }$ hepatofugal blood flow along SMV into left gastric + splenic vein\n$C x$ : variceal bleeding in $3-10-36 \\%$\n$\\diamond$ Gastric varices bleed less frequently but more severely than esophageal varices!\nDDx of small intramural subepithelial mass:\ncarcinoid tumor, glomus tumor, ectopic pancreas (all usually with stronger enhancement)\n\n\n## GASTRIC VOLVULUS\n\n$\\diamond$ SURGICALEMERGENCY!\n$=$ abnormal torsion (twisting) of stomach, usually $>180^{\\circ} \\rightarrow$ complete obstruction $\\rightarrow$ ischemia $\\rightarrow$ perforation\n$\\diamond$ Use the term organoaxial / mesenteroaxial rotation if obstruction not present!\nThe term gastric volvulus implies at least $180^{\\circ}$ gastric rotation WITH gastric outlet obstruction.\nOrganoaxial / mesenteroaxial rotation alone do not define volvulus. Coronal images are often more diagnostic than axial images alone.\n\n## Degrees of torsion:\n\n(1) Partial / incomplete volvulus = chronic form (common)\n$=$ rotation of stomach $<180^{\\circ}$ without vascular compromise\n\n- may be asymptomatic",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 799,
            "markdown": "$\\sqrt{ }$ ingested contrast may pass through stomach\n(2) COMPLETE volvulus $=$ acute form\n$=$ rotation of stomach $>180^{\\circ}$\n$\\diamond$ Surgical emergency $\\leftarrow$ increased risk of ischemia, necrosis, perforation, shock\n$\\checkmark$ stomach becomes dilated + fills with fluid\n$\\checkmark$ oral contrast is retained in stomach\nEtiology:\n(a) abnormality of suspensory ligaments\n(b) unusually long gastrohepatic + gastrocolic mesenteries\n\nAnatomy of ligaments:\ngastrohepatic lig. at lesser curvature; gastrosplenic + gastrocolic ligg. at greater curvature; gastrophrenic lig. at posterior fundus; attachment to esophagus at gastroesophageal junction; attachment to duodenum at pylorus\nPredisposing factors:\nparaesophageal hernia (33\\%), ligamentous laxity (sliding hernia), eventration of diaphragm, phrenic nerve paralysis, splenic abnormalities (asplenia, polysplenia, splenomegaly, prior splenectomy), Bochdalek hernia (in children)\nPeak age: $40-50$ years (in $20 \\%$ in infants $<1$ year of age); most often in elderly with hiatal hernia; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\n\n- may be acute / chronic-recurrent\n- Borchardt triad:\n[Moritz Borchardt (1868-1948), Chief Surgeon at the Rudolf-Virchow and Moabit Public Hospitals in Berlin]\n- sudden onset severe of epigastric pain + distension\n- intractable retching ( $=$ vigorous attempts to vomit) without production of vomitus\n- inability to pass nasogastric tube into stomach\n\nCXR:\n$\\checkmark$ massively distended stomach in LUQ extending into chest /retrocardiac location (= intrathoracic stomach)\n$\\checkmark$ unexpected location of stomach gas bubble\n$\\checkmark$ paucity of distal gas\n$\\checkmark$ air-fluid levels in mediastinum / upper abdomen\nEsophagram:\n$\\checkmark$ incomplete / absent entrance of barium into stomach\n$\\checkmark$ displaced gastroesophageal junction\n$\\checkmark$ barium demonstrates area of twist\nClassification:\nA. PRIMARY without diaphragmatic defect\nB. SECONDARY with diaphragmatic defect\n\nTypes:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 800,
            "markdown": "![img-86.jpeg](img-86.jpeg)\nA. ORGANOAXIAL VOLVULUS ( $\\left.{ }^{2} / \\cdot\\right)$\n\nAxis of rotation: around the long axis of stomach connecting GE junction and pylorus\nCause: ligamentous laxity allowing stomach to move abnormally along its long axis + long-standing posttraumatic / paraesophageal hiatal hernia\nAge: usually in adulthood\nAssociated with: diaphragmatic defect (hiatal hernia, diaphragmatic eventration / rupture\n/ large Bochdalek hernia) $\\rightarrow$ migration of stomach into thorax $=$ organoaxial position with twist of $<180^{\\circ}$\n$\\sqrt{ }$ horizontally oriented stomach with a single air-fluid level:\n$\\sqrt{ }$ \"mirror-image\" stomach = greater curvature to right of lesser curvature (in vertically oriented stomach)\nCT:\n$\\sqrt{ }$ antrum moves anterosuperiorly + fundus rotates posteroinferiorly:\n$\\sqrt{ }$ gastroesophageal junction lower than normal\n$\\sqrt{ }$ \"upside-down\" stomach = lesser curvature below greater curvature\n$\\sqrt{ }$ distortion of duodenum",
            "images": [
                {
                    "id": "img-86.jpeg",
                    "top_left_x": 357,
                    "top_left_y": 187,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1306,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 801,
            "markdown": "# B. MESENTEROAXIAL VOLVULUS ( $1 / 3$ ) \n\nAxis of rotation: around short axis that bisects greater and lesser curvatures $=$ the site of mesenteric attachment (gastrohepatic omentum) $\\rightarrow$ twisting vascular supply\nCause: abnormal laxity / absence of peritoneal attachments $\\leftarrow$ abnormal fusion of fetal mesenteries\nAge: usually in childhood\nMay be associated with: wandering spleen\n\n- idiopathic chronic / intermittent course: asymptomatic / postprandial pain, belching, bloating, vomiting, early satiety\n- associated with severe obstruction (of pyloric antrum) $\\pm$ strangulation (rare)\n$\\checkmark$ fundus rotates posteroinferiorly\n$\\checkmark$ usually partial volvulus\n$\\checkmark$ no underlying diaphragmatic defect\nCT:\n$\\checkmark$ antrum moves above gastroesophageal junction:\n$\\checkmark$ \"right-side up\" stomach = antrum / pylorus rotates anterosuperiorly and from right to left\nC. COMBINATION (2\\%)\n\nCx: intramural emphysema, gastric ischemia / gangrene, necrosis, perforation, mediastinitis, peritonitis, shock, gastric ulceration, hemorrhage, pancreatic necrosis, omental avulsion, splenic rupture\nMortality: $30-42-80 \\%$ in acute volvulus; $10-13 \\%$ in chronic volvulus\nRx: open / laparoscopic gastropexy + repair of diaphragmatic hernia\n$D D x$ : incarcerated hiatal hernia, gastric atony, acute gastric dilatation, pyloric obstruction\n\n## GASTRITIS\n\n$=$ common condition often resulting in submucosal edema and hyperplasia of gastric mucosa\nCause: Helicobacter pylori infection (most common), nonsteroidal anti-inflammatory drugs (NSAIDs), alcohol, systemic illness\n\n- epigastric pain, nausea, vomiting, loss of appetite\n\nDistribution: focal / segmental / diffuse\nCT:\n$\\checkmark$ gastric wall / fold thickening (best appreciated when stomach distended)\n$\\checkmark$ mural stratification (best during arterial phase):\n$\\checkmark$ diffuse submucosal low attenuation $\\leftarrow$ edema\n$\\checkmark$ mucosal hyperemia\n\n## Corrosive Gastritis\n\nAgents:\n(a) acid, formaldehyde\n\n- clinically usually silent\n\nLocation: esophagus usually unharmed, severe gastric damage, duodenum may be involved (newer potent materials cause atypical distribution)\n(b) alkaline",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 802,
            "markdown": "Location: pylorus + antrum most frequently involved\nA. ACUTE CHANGES (edema + mucosal sloughing)\n$\\sqrt{ }$ marked enlargement of gastric rugae + erosions / ulceration\n$\\sqrt{ }$ complete cessation of motor activity\n$\\sqrt{ }$ gas in portal venous system\n$C x:$ perforation\nB. CHRONIC CHANGES\n$\\sqrt{ }$ firm thick nonpliable wall\n$\\sqrt{ }$ stenotic / incontinent pylorus (if involved)\n$\\sqrt{ }$ gastric outlet obstruction (cicatrization) after 3-10 weeks\n\n# Drug-induced Gastropathy \n\nCause: NSAIDs (most common worldwide); chemotherapy with cytotoxic agents; alcohol\nMechanism for NSAID:\nweakening of mucosal defense mechanisms with increase in acid and pepsin $\\leftarrow$ reduced prostaglandin synthesis $\\leftarrow$ inhibition of cyclooxygenase COX enzyme (COX-1 = constitutive enzyme important for basal mucosal blood flow + pH balance; COX-2 = inducible enzyme important in maintaining perfusion for mucosal integrity)\nLocation: gastric body and antrum along greater curvature (= dependent position as function of gravity)\n$\\sqrt{ }$ single / multiple discrete punched-out ulcers with sharply defined smooth border:\n$\\sqrt{ }$ central punctate collection of barium surrounded by radiolucent halo corresponding to mound of edema\n$\\sqrt{ }$ linear serpiginous barium collection ( $=$ incomplete erosion) surrounded by halo of edema\n$\\sqrt{ }$ (occasionally) deep ulcer penetrating through muscularis mucosae with involvement of submucosa\n$D D x$ : infection, inflammation, malignancy (focal wall thickening $>5 \\mathrm{~mm}$, perigastric tissue abnormalities, lymphadenopathy)\n\n## Emphysematous Gastritis\n\n= rare but severe form of widespread phlegmonous gastritis subsequent to mucosal disruption characterized by gas in wall of stomach\nCause of mucosal disruption:\ningestion of toxic / corrosive substances (37\\%), alcohol abuse (22\\%), gastroenteritis ( $15 \\%$ ), recent abdominal surgery ( $15 \\%$ ), gastric infarction, necrotizing enterocolitis, ulcer, acute pancreatitis, adenocarcinoma of stomach, phytobezoar, leukemia, diabetes mellitus, disseminated strongyloidiasis, gastric mucormycosis, after ingestion of large amounts of carbonated beverages\nHisto: bacterial invasion of submucosa + subserosa\nOrganism: hemolytic streptococcus, Clostridium welchii, Clostridium perfringens, E. coli, S. aureus, enterobacter, P. aeruginosa, Klebsiella pneumoniae, Candida\n\n- explosive onset of severe abdominal pain\n- nausea, diarrhea, chills, fever, leukocytosis\n- bloody foul-smelling emesis $\\pm$ PATHOGNOMONIC vomiting of a necrotic cast of stomach $\\leftarrow$ dissection along plane of muscularis mucosae",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 803,
            "markdown": "Plain radiographs:\n$\\sqrt{ }$ innumerable small gas bubbles silhouetting the stomach in a mottled fashion without positional change\n$\\sqrt{ }$ thickening of rugal folds\n$\\sqrt{ } \\pm$ portal venous gas\nGI:\n$\\sqrt{ }$ cobblestone appearance of mucosa on upper GI\n$\\sqrt{ }$ intramural penetration of contrast material\nCT:\n$\\sqrt{ }$ gastric wall thickening (DDx: emphysematous gastritis)\n$\\sqrt{ }$ intramural gas $\\rightarrow$ dissecting into gastric veins + portal venous system\n$C x$ : cicatricial stenosis ( $21 \\%$ ), sinus tract formation\nPrognosis: $60-80 \\%$ mortality\n$R x$ : broad-spectrum antibiotics + intravenous fluids; emergent surgery for acute perforation\n$D D x$ : benign gastric emphysema (recent gastric procedure), gastric ischemia, caustic ingestion\n\n# Erosive Gastritis \n\n$=$ HEMORRHAGIC GASTRITIS\nFrequency: $0.5-10.0 \\%$ of GI studies\nEtiology (in 50\\% without causative factors):\n(1) Peptic disease: emotional stress, alcohol, acid, corrosives, severe burns, antiinflammatory agents (aspirin, steroids, phenylbutazone, indomethacin)\n(2) Infection: herpes simplex virus, CMV, Candida\n(3) Crohn disease: aphthoid ulcers identical in appearance to varioliform erosions\n\nHisto: epithelial defect not penetrating beyond muscularis mucosae\n\n- $10-20 \\%$ of all GI hemorrhages (usually without significant blood loss); vague dyspepsia, ulcerlike symptoms\nLocation: antrum, rarely extending into fundus; aligned on surface of gastric rugal folds\n$\\sqrt{ }$ varioliform complete erosion $(95 \\%)=$ tiny fleck of barium surrounded by radiolucent halo (\"target lesion\") $<5 \\mathrm{~mm}$, usually multiple\n$\\sqrt{ }$ incomplete erosion $(5 \\%)=$ linear streaks / dots of barium without surrounding mound of edema / inflammation\n$\\sqrt{ }$ nodularity / scalloping of prominent antral folds\n$\\sqrt{ }$ contiguous duodenal disease may be present\n$\\sqrt{ }$ limited distensibility, poor peristalsis / atony, delayed gastric emptying\n\n\n## Phlegmonous Gastritis\n\nEtiology: septicemia, local abscess, postoperative stomach, complication of gastric ulcer / cancer\nOrganism: Streptococcus\nPath: multiple gastric wall abscesses $\\pm$ communication with lumen\n\n- severe fulminating illness, patient may vomit pus\n\nLocation: usually limited to stomach not extending beyond pylorus; submucosa is the most severely affected gastric layer",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 804,
            "markdown": "$\\sqrt{ }$ barium dissection into submucosa + serosa\n\n# GASTROENTERITIS \n\n$=$ \"stomach bug / stomach virus / stomach flu\"\n$=$ infection involving stomach + small intestine\n$\\diamond$ Most common cause of bowel wall thickening\nOrganism:\n(a) bacteria: Escherichia coli, Shigella, Salmonella, Yersinia, Campylobacter, Staphylococcus\n(b) viruses: Rotavirus (very common in winter, between 6 months to 2 years of age), norovirus, Herpes, Cytomegalovirus\n(c) parasites: amebiasis in underdeveloped countries\n\nIngestion: consumption of contaminated water, sharing personal objects\n\n- diarrhea, vomiting, abdominal cramping\n\n\n## GASTROINTESTINAL STROMAL TUMOR\n\n$=$ GIST $=$ SPINDLE CELL / EPITHELIOID TUMOR\nOrigin: c-KIT-positive interstitial cell of Cajal of myenteric plexus (= pacemaker cell for gut movement)\n$\\diamond$ Most common solid mesenchymal neoplasm of GI tract!\n$\\diamond$ Most common intramural subepithelial neoplasm of GI tract!\nIncidence: $<1 \\%$ of all gastrointestinal tumors; $7-20 \\div 1,000,000$ annually; $4500-6000$ new cases annually (USA); increased prevalence in NF1\nMedian age: $55-65$ years; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\nHisto: spindle cell ( $70-80 \\%$ ) / epithelioid ( $20-30 \\%$ ) morphology / mixture of both\n> expresses transmembrane receptor tyrosine kinase encoded by c-KIT gene (CD117) in $95 \\% ; 70 \\%$ of GISTs coexpress CD34\nLocation: usually solitary\nA. GI TRACT anywhere between esophagus and anus:\n> stomach $(60-70 \\%)$\n> small intestine ( $20-30 \\%$ ): jejunum $>$ duodenum $(9 \\%)>$ ileum\n> periampullary ( $3-5 \\%)$\n$>$ anorectum $(5-7 \\%)$\n$>$ colon $(4 \\%)$ : rare in appendix\n> esophagus $(2 \\%)$\n$\\diamond 75 \\%$ of mesenchymal tumors in the esophagus are leiomyomas and $25 \\%$ GIST\nB. EXTRAINTESTINAL (rare): peritoneum ( $4 \\%$ ), omentum; mesentery; retroperitoneum\n\nSite: muscularis propria has greatest density of cells of Cajal; endophytic / exophytic to bowel\nN.B.: leiomyomas arise from muscularis mucosae!\n\n- early satiety, indigestion, bloating, vague abdominal pain\n$\\diamond$ often not detected until late in their progression\n- gastrointestinal bleeding $\\leftarrow$ mucosal ulceration: hematemesis, melena, hematochezia, anemia\n- subtle nonspecific broad-based lesion at optical colonoscopy\n\nAssociated with: neurofibromatosis type 1, familial GIST, Carney triad\nSpread: (in $50 \\%$ at presentation)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 805,
            "markdown": "(a) intraperitoneal: adjacent organ invasion, ascites, omentum, peritoneum\n(b) hematogenous: liver metastasis\n\n- All GISTs are potentially malignant (30\\%)!\n- Lymphadenopathy (rare)!\n\nStaging criteria: based on tumor size, dissemination status, mitotic rate\nMean size: 8.6 cm\n@: Stomach $(60 \\%)$\nFrequency: $2-3 \\%$ of all gastric tumors; most common location of GIST\n\n- nausea, vomiting, weight loss\n- abdominal pain + distension, intestinal obstruction\n\nUGI:\n$\\sqrt{ }$ well-circumscribed mass up to 30 cm in size\n$\\sqrt{ }$ features of subepithelial mass:\n$\\sqrt{ }$ lesion margin obtuse / at right angle with gastric wall (in profile)\n$\\checkmark$ smoothly circumscribed (en face)\n$\\checkmark$ smooth mucosal surface (common)\n$\\checkmark$ mucosal ulceration (in up to $60 \\%$ )\n$\\checkmark$ polypoid intraluminal mass (in 14\\%)\nUS:\n$\\sqrt{ }$ large well-defined predominantly solid mass with variable echogenicity, often exophytic\n$\\sqrt{ }$ thick echogenic rim (occasionally)\n$\\sqrt{ }$ central hypoechoic areas $=$ regions of necrosis\nCT:\n(a) small $<3 \\mathrm{~cm}$ tumor:\n$\\sqrt{ }$ well-defined smooth-walled homogeneous soft-tissue mass with moderate degree of enhancement\n$\\checkmark$ attenuation similar to muscle\nCT features of GISTs $<3 \\mathrm{~cm}$ overlap with those of other intramural subepithelial masses.\n(b) large tumor:\n$\\sqrt{ }$ large heterogeneous mass with prominent extraluminal location $=$ exoenteric growth with displacement of adjacent organs + vessels\n$\\sqrt{ }$ extragastric extension into gastrohepatic / gastrosplenic ligament / lesser sac (in $86 \\%)$\n$\\checkmark$ prominent intraluminal component (rare)\n$\\checkmark$ irregular lobulated margin\n$\\checkmark$ mucosal ulceration ( $50 \\%$ )\n$\\checkmark$ central areas of low attenuation $\\leftarrow$ hemorrhage, necrosis, cyst formation\n$\\sqrt{ }$ large cavity containing air / air-fluid level / oral contrast medium that communicates with gastric lumen (common)\n$\\checkmark$ rarely calcified (in 3\\%)\n$\\checkmark$ Features of metastatic lesions from GIST are similar to those of the primary tumor!\nCECT:\n$\\sqrt{ }$ tumor vessels visible within tumor",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 806,
            "markdown": "$\\checkmark$ hypervascular mass with heterogeneous enhancement\n$\\checkmark$ peripheral enhancement in $92 \\%$ (corresponding to viable tumor)\nCT Findings suggestive of Malignant GIST:\n$\\checkmark$ lesion $>5 \\mathrm{~cm}$\n$\\checkmark$ heterogeneous enhancement\n$\\checkmark$ gastric location\n$\\checkmark$ metastases\n$\\checkmark$ cystic-necrotic component\nMR:\n$\\checkmark$ solid tumor portion hypointense on T1WI + intermediate intense to hyperintense on T2WI\n$\\checkmark$ heterogeneous enhancement of large tumors $\\leftarrow$ central necrosis + cavitation\n$\\checkmark$ tumoral hemorrhage varies from high to low SI on T1WI + T2WI depending on age PET:\n$\\checkmark$ high sensitivity for detection unless extensively necrotic\n$D D x$ : leiomyoma, leiomyosarcoma, schwannoma, neurofibroma, carcinoid\nWith any hypervascular intramural subepithelial mass $>3 \\mathrm{~cm}$ GIST should be considered first in the DDx.\n@ Small intestine ( $30 \\%$ )\n$\\diamond 2^{\\text {nd }}$ most common site of involvement after stomach\nLocation: ileum ( $50 \\%$ )\n@ Periampullary region (3-5\\%)\n@ Anorectum\n$\\checkmark$ expansion of rectal wall $\\rightarrow$ focal mural mass\nCx: extension into ischiorectal fossa, prostate, vagina\n@ Extraintestinal\nAge: 31-82 years; $\\mathrm{M}+\\mathrm{F}=1 \\div 2$\nLocation: mesentery, omentum, retroperitoneum\n$C x$ : bowel obstruction (rare)\nRx: (1) Surgery for localized primary\n(2) Imatinib mesylate (= tyrosine kinase inhibitor) inhibits growth of GIST ( $\\pm$ paradoxical enlargement $\\leftarrow$ tumor hemorrhage / necrosis)\nResponse to treatment:\n$\\checkmark$ decrease in tumor attenuation by $>15 \\% \\leftarrow$ myxoid degeneration + hemorrhage + necrosis\n$\\checkmark$ decrease in tumor size by $>10 \\%$\n$\\checkmark$ apparent \"new liver lesions\" = lesions initially isodense to hepatic parenchyma become hypodense + visible $\\rightarrow$ no metabolic activity on PET\n$D D x$ : new lesions of progressive disease show metabolic activity\n\n# GLIOMATOSIS PERITONEI \n\n$=$ benign mature glial implants throughout peritoneum\nCause: ? rupture of ovarian teratoma / metaplasia of peritoneal tissue",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 807,
            "markdown": "Associated with: solid / immature ovarian teratomas, ventriculoperitoneal shunts\nHisto: benign mature glial tissue with delicate fibrillar processes and scattered supporting cells\nClue: teratoma with fat and calcifications in one ovary\nCT:\n$\\checkmark$ peritoneal nodules + masses of soft-tissue density\n$\\checkmark$ omental caking\n$\\checkmark$ ascites\n$\\checkmark$ adnexal / pelvic mass suggestive of teratoma\nMR:\n$\\checkmark$ multilobular masses of homogeneously high SI on T2WI\n$D D x$ : peritoneal carcinomatosis (indistinguishable)\n\n# GIARDIASIS \n\n$=$ overgrowth of commensal parasite Giardia lamblia\nOrganism:\nGiardia lamblia (flagellated protozoan); often harmless contaminant of duodenum + jejunum in motile form (= trophozoite) attached to mucosa by suction disk, nonmotile form (= cyst) shed in feces; capable of pathogenic behavior with invasion of gut wall\nFrequency: $\\quad 1.5-2.0 \\%$ of USA population, in 3-20\\% of children in parts of southern USA; infests $4-16 \\%$ of inhabitants of tropical countries\nPredisposed: altered immune mechanism (dysgammaglobulinemia, nodular lymphoid hyperplasia of ileum)\nHisto: blunted villi (may be misdiagnosed as celiac disease especially in children), cellular infiltrate of acute + chronic inflammation in lamina propria\n\n- abdominal pain, weight loss, failure to thrive (especially in children)\n- spectrum from asymptomatic to severe debilitating diarrhea\n- steatorrhea $=$ reduced fat absorption (related to number of organisms) simulating celiac disease\nLocation: most pronounced in duodenum + jejunum\n$\\sqrt{ }$ irregular distorted segmental thickening of mucosal folds in duodenum + jejunum (+ normal ileum) $\\leftarrow$ mucosal edema\n$\\checkmark$ marked spasm + irritability with rapid change in direction + configuration of folds\n$\\checkmark$ hypersecretion with blurring + indistinctness of folds\n$\\checkmark$ hyperperistalsis $\\rightarrow$ rapid transit time\n$\\checkmark$ segmentation of barium $\\leftarrow$ motility disturbance + excess intraluminal fluid\n$\\checkmark \\pm$ lymphoid hyperplasia (associated with immunoglobulin deficiency state)\n$D x$ : (1) Detection of Giardia lamblia cysts in formed feces or trophozoites in diarrheal stools\n(2) Trophozoites in duodenal aspirate / jejunal biopsy\n$D D x$ : hookworm Strongyloides infection\n$R x$ : quinacrine (Atabrine ${ }^{\\circledR}$ )\n\n\n## GLOMUS TUMOR OF STOMACH",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 808,
            "markdown": "$=$ rare benign vascular tumor that originates from glomus body\nGlomus body: modified smooth muscle cells functioning as neuromyoarterial receptors that regulate temperature ( $=$ unique arteriovenous shunt) $\\rightarrow$ therefore most abundant in dermis / subcutis of extremities, particularly beneath fingernails\nFrequency: $2 \\%$ of all benign gastric tumors\n$\\diamond$ Most common benign vascular gastric tumor\nPath: dilated irregularly shaped thin-walled vessels (= modified capillaries) covered by nests / strands / sheets of glomus cells arising in muscularis propria\nHisto: sheets of monotonous round cells interspersed with numerous delicate vessels\nMedian age: 55 years; $\\mathrm{M} \\div \\mathrm{F}=3 \\div 7$\n\n- asymptomatic / upper GI bleeding\n\nLocation: gastric antrum\nSize: $1-4 \\mathrm{~cm}$ in diameter\n$\\sqrt{ }$ solitary smooth intramural / intraluminal subepithelial mass $\\pm$ mucosal ulceration\n$\\sqrt{ }$ change in shape + size during fluoroscopy (similar to lipoma)\n$\\sqrt{ }$ tiny flecks of calcifications (occasionally)\n$\\sqrt{ }$ CHARACTERISTIC strong peripheral homogeneous enhancement in arterial + portal venous phases with prolonged enhancement in delayed phase similar to portal vein / IVC / descending aorta\n$\\sqrt{ }$ SPECIFIC peripheral nodular enhancement pattern + delayed filling-in (reminiscent of hemangioma)\nOn CT easily differentiated from lipomas because of dense arterial enhancement persisting into delayed phase.\n$D D x$ : lipoma, hemangioma, GIST, carcinoid tumor, ectopic pancreas, metastasis\n\n# GLYCOGEN ACANTHOSIS \n\n$=$ benign degenerative condition with accumulation of cellular glycogen within squamous epithelial lining of esophagus\nFrequency: in up to $15 \\%$ of endoscoped patients\nEtiology: unknown\nAge: middle-aged / elderly individuals\nHisto: hyperplasia + hypertrophy of squamous mucosal cells $\\leftarrow$ increased glycogen; no malignant potential\n\n- asymptomatic white oval mucosal plaques of $2-15 \\mathrm{~mm}$ in diameter on otherwise normal appearing mucosa\nLocation: middle (common) / upper esophagus, in random distribution\n$\\sqrt{ }$ multiple $1-3-\\mathrm{mm}$ rounded nodules / plaques\n$D x$ : biopsy\n$D D x$ : candida esophagitis (lesions disappear under treatment in contrast to glycogen acanthosis), reflux esophagitis\n\n\n## GRAFT-VERSUS-HOST DISEASE\n\n$=\\mathrm{T}$ lymphocytes from donor bone marrow cause selected epithelial damage of recipient target",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 809,
            "markdown": "organs\nBone marrow transplantation for treatment of:\nleukemia, lymphoma, aplastic anemia, immunologic deficit, metabolic disorders of\nhematopoietic system, some metastatic disease\nFrequency: $30-70 \\%$ of patients with allogeneic (= donor genetically different from host) transplant\nTime interval from hematopoietic stem cell transplantation:\n(a) acute GVH: less than 100 days\n(b) chronic GVH: within 100 days\n\nTarget organs: skin, liver, GI tract (small bowel)\n@ Skin\n\n- maculopapular rash on face, trunk, extremities\n- cholestatic jaundice\n@ Liver\n- elevation of hepatic enzymes $\\pm$ liver failure\n$\\sqrt{ }$ thickening of gallbladder wall $\\pm$ pericholecystic fluid\n$\\sqrt{ }$ biliary sludge\n$\\sqrt{ }$ dilatation of common bile duct\n$\\sqrt{ }$ enhancement of wall of gallbladder and CBD\nVeno-occlusive disease $=$ sinusoidal obstructive syndrome:\nHisto: centrilobular hemorrhagic necrosis, venular obliteration, sinusoidal congestion, fibrosis\n$\\sqrt{ }$ portal hypertension + fluid retention\n$\\sqrt{ }$ painful hepatomegaly\n@ GI tract\n- profuse secretory diarrhea $\\pm$ hemorrhage, weight loss\n- abdominal cramping, fever, nausea, vomiting\n\nPath: severe mucosal atrophy / destruction\nLocation: distal ileum $>$ other small bowel $>$ colon\nPlain film:\n$\\sqrt{ }$ separation of bowel loops $\\leftarrow$ wall thickening\n$\\sqrt{ }$ air-fluid levels + small bowel dilatation\n$\\sqrt{ }$ decreased luminal gas\nBarium:\n$\\sqrt{ }$ shaggy fold thickening\n$\\sqrt{ }$ \"ribbon bowel\" = small bowel fold effacement with tubular appearance (DDx: viral enteritis, ischemia, celiac disease, radiation, soybean allergy)\n$\\sqrt{ }$ \"toothpaste / leadpipe / moulage\" sign = featureless segment of bowel (chronic stage)\n$\\sqrt{ }$ loss of haustration, spasm, edema, ulceration, granular mucosal pattern of colon (simulating ulcerative colitis)\n$\\sqrt{ }$ small bowel \"cast\" HIGHLY SUGGESTIVE = prolonged coating of abnormal bowel for hours to days $\\leftarrow$ incorporation of barium into submucosal layer through mucosal ulcers",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 810,
            "markdown": "$\\sqrt{ }$ circular collections of contrast material on cross section + parallel tracks on longitudinal section\n$\\sqrt{ }$ severely decreased transit time\nCT:\n$\\sqrt{ }$ moderate bowel wall thickening $<5.5-8.0 \\mathrm{~mm}$ : small bowel involved in $75-100 \\%$\n$\\sqrt{ }$ discontinuous involvement (in 41-54\\%)\n$\\sqrt{ }$ strictly right colonic involvement (uncommon)\n$\\sqrt{ }$ fluid-filled distended bowel: colon $>8 \\mathrm{~cm}$, small bowel $>3 \\mathrm{~cm}$\n$\\sqrt{ }$ barium (from prior contrast enema weeks ago) may become incorporated into bowel wall\nN.B.: oral contrast material should not be given!\n$\\sqrt{ }$ misty mesentery $=$ mesenteric fat stranding without lymphadenopathy\n$\\sqrt{ }$ ascites\nCECT:\n$\\sqrt{ }$ abnormally enhancing thin layer of mucosa diffusely involving thickened bowel segments $\\leftarrow$ mucosal replacement by highly vascular granulation tissue\nN.B.: negative oral contrast agent makes hyperattenuating mucosa more conspicuous\n$\\sqrt{ }$ engorgement of vasa recta $=$ \"comb\" sign\nCx: infection with opportunistic organisms, eg, Candida albicans, herpes virus, invasive fungal organisms, CMV, Varicella-zoster virus, Epstein-Barr virus, hepatitis viruses, Rotavirus, Adenovirus, Coxsackie virus A and B, P. carinii, pneumococcus\nPrognosis: fatal in up to $15 \\% \\leftarrow$ opportunistic infection\nRx: steroids + cyclosporine\n$D D x$ :\n(a) $0-30$ days: typhlitis, C. difficile colitis\n(b) 31-100 days: viral gastroenteritis / hepatitis, pneumatosis cystoides intestinalis, thrombotic microangiopathy\n(c) $>100$ days: posttransplantation lymphoproliferative disease\n\n# GRANULAR CELL TUMOR \n\n$=$ GRANULAR CELL MYOBLASTOMA (misnomer coined in 1926, thought to derive from muscle cells)\n$=$ rare mostly benign neoplasm, occasionally locally invasive + metastasizing\nOrigin: Schwann cell (positive for S-100 marker protein)\nPath: infiltrative margins\nHisto: nests of ovoid / polygonal cells with small dark regular nuclei and abundant cytoplasm filled with eosinophilic PAS-positive and diastase-resistant granules (= autophagic vacuoles containing cellular debris); separated by collagen bundles; interspersed with branching thin-walled blood vessels\nAge: $5^{\\text {th }}$ decade; $\\mathrm{M}<\\mathrm{F}$\nLocation: tongue (most common), subcutaneous tissue (6-8\\%), oropharynx, GI tract (5-8\\%), skin, bronchial wall, biliary tract ( $1 \\%$ ), breast (5\\%)\n\n## Granular Cell Tumor of Gastrointestinal Tract",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 811,
            "markdown": "Site: distal esophagus (2\\%); in 10\\% multiple lesions in esophagus; in 9-16\\% involving additional organs\nSize: mostly small tumors $<2 \\mathrm{~cm}$ incidentally discovered at autopsy / endoscopy\n$\\sqrt{ }$ small subepithelial mass; hypoechoic on US\nCT:\n$\\sqrt{ }$ moderately enhancing soft-tissue mass with thickening of esophageal wall + partially narrowing esophageal lumen\n$C x$ : malignant degeneration $(1-3 \\%)$\n$R x$ : endoscopic / surgical removal if $>1 \\mathrm{~cm}$ in size\n$D D x$ : leiomyoma\n\n# Granular Cell Tumor of Chest \n\nAge: middle-aged, esp. Black women\n$\\sqrt{ }$ endobronchial lesion in major bronchi\n\n## Granular Cell Tumor of Breast\n\nPrevalence: $1 \\div 1,000$ of primary breast tumors; $5-8 \\%$ of all granular cell tumors; $78 \\%$ in African-Americans\nMean age: 34 (range, 20-59) years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 9$\nLocation: more commonly in upper inner rather than upper outer quadrant\nSite: breast parenchyma, hypodermis, dermis\nSize: $\\quad 1-3 \\mathrm{~cm}$\n\n- asymmetric painless hard lump with slow growth\n- skin fixation / skin retraction / nipple inversion / ulceration mimick malignancy; often fixed to pectoralis fascia\nMammo:\n$\\sqrt{ }$ round well-demarcated mass / indistinct density / spiculated mass\n$\\sqrt{ }\\pm$ calcifications (rare)\nUS:\n$\\sqrt{ }$ well-circumscribed / angular / ill-defined spiculated mass\n$\\sqrt{ }$ posterior acoustic enhancement / shadowing\n$\\sqrt{ }$ stellate extensions $\\leftarrow$ tumor insinuating itself into surrounding breast tissue:\n$\\sqrt{ }\\pm$ associated skin thickening / retraction (with dermal location)\n$\\sqrt{ }$ surrounding hyperechoic halo $\\leftarrow$ infiltrative growth pattern\nMR:\n$\\sqrt{ }$ low to high SI on T2WI + low to intermediate SI on T1WI\n$\\sqrt{ }$ hyperintense rim on T2WI\n$\\sqrt{ }$ homogeneous enhancement of varying kinetics / rapid peripheral enhancement\n$D x$ : Fine-needle aspirate may be difficult to interpret!\n$R x$ : wide local excision\n$D D x$ : carcinoma, lymphoma, metastasis\n\n\n## HELICOBACTER PYLORI INFECTION\n\nOrganism: worldwide gram-negative spiral-shaped bacillus [formerly Campylobacter pylori]\nPrevalence: increasing with age; in $>50 \\%$ of Americans $>60$ years of age",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 812,
            "markdown": "Path: surface epithelial damage + inflammation with mucosal infiltration by neutrophils, plasma cells, lymphoid nodules\nLocation: gastric antrum $>$ proximal half of stomach\nSite: beneath mucus layer on surface epithelial cells\n\n- asymptomatic (vast majority); dyspepsia, epigastric pain\n$\\checkmark$ gastritis ( $75 \\%$ prevalence of H. pylori):\n$\\checkmark$ thickened gastric folds\n$\\checkmark$ polypoid gastritis mimicking malignant tumor\n$\\checkmark$ enlarged areae gastricae\n$\\checkmark$ gastric ulcer ( $60-80 \\%$ prevalence of H. pylori)\n$\\checkmark$ duodenal ulcer ( $90-100 \\%$ prevalence of H. pylori)\nDx: (1) Endoscopic brushings + biopsy\n(2) Breath test measuring urease activity after ingestion of carbon 14 N -labeled urea\n(3) Serologic test for IgG antibodies\n\nRx: triple therapy (= bismuth + metronidazole + tetracycline / amoxicillin) results in $95 \\%$ cure rate after 2 weeks of therapy\n\n# HEMANGIOMA OF GASTROINTESTINAL TRACT \n\n$=$ unusual single / multiple vascular tumors anywhere in GI tract\nFrequency: $7-10 \\%$ of all benign small bowel tumors\nIncreased incidence in (if multiple):\nMaffucci syndrome, Klippel-Trénaunay syndrome, blue rubber-bleb nevus syndrome, Osler-Weber-Rendu disease, Turner syndrome, tuberous sclerosis\nCommonly associated with: cutaneous hemangiomas / telangiectasias\nAge: any; commonly during infancy / early childhood\n\n- symptomatic ( $80 \\%$ ):\n- acute intermittent severe bleeding (melena)\n- acute / chronic life-threatening anemia\n- intestinal obstruction, intussusception, perforation\n\nPath: submucosal soft infiltrative polypoid mass\nHisto: cavernous / capillary / mixed\nLocation: jejunum (55\\%), ileum (42\\%), duodenum (2\\%); rare in stomach + colon (mostly rectosigmoid)\nSite: submucosal vascular plexus\n$\\checkmark$ polypoid intramural intraluminal subepithelial mass\n$\\checkmark$ sessile nodular compressible intraluminal filling defect\n$\\checkmark$ segmental transmural circumferential bowel wall thickening $=$ diffuse infiltrating abnormality extending into surrounding tissue ( $=$ hemangiomatosis)\n$\\checkmark \\pm$ virtually PATHOGNOMONIC phleboliths in intestinal wall $\\leftarrow$ calcified thrombi\nCECT:\n$\\checkmark$ well-circumscribed avidly enhancing often intraluminal lobulated mass of mixed attenuation supplied by large artery\n$\\checkmark$ slow diffuse enhancement + vascular engorgement within adjacent mesentery around mass lesion",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 813,
            "markdown": "Rx: resection $\\leftarrow$ risk of massive gastrointestinal bleeding\nPrognosis: involution during childhood\n$D D x:$ GIST, glomus tumor, metastasis\n\n# HERNIA \n\n$=$ ABDOMINALHERNIA\n$=$ protrusion of an organ / fascia of an organ through the wall of the cavity that normally contains it\nPrevalence: $2^{\\text {nd }}$ most common cause $(=10 \\%)$ of SBO\nNomenclature: according to anatomic site of its orifice\n$C x$ : (1) bowel obstruction\n(2) incarceration (= irreducible hernia)\n[incarcerare, Latin = to imprison]\n(3) strangulation (= constriction of blood flow)\n[ strangulare, Latin = to choke]\n\n## External Hernia\n\n$=$ bowel extending outside the abdominal cavity\nFrequency: $95 \\%$ of all hernias\n$\\diamond 5 \\%$ lifetime risk for spontaneous abdominal hernias\nLocation:\n@ Ventral = Anterior abdominal wall hernia\n$=$ protrusion of part of peritoneal sac through defect in muscle layers of anterior abdominal wall\nContent: fat, omentum, bowel\n\n- abdominal bulge $\\pm$ Valsalva maneuver\n$\\diamond$ Look for multiple hernias (present in 18-22\\%)!\n$\\sqrt{ }$ small-bowel loops extending beyond fascial plane of anterior abdominal wall on lateral view\n$\\sqrt{ }$ provocative (Valsalva) maneuver facilitates detection\n$\\sqrt{ }$ luminal narrowing at entry + exit site of hernia orifice\n$\\sqrt{ }$ fluoroscopic manipulation to document reducibility\n\n1. Umbilical hernia (most common)\n$=$ usually small protrusion of abdominal contents / fat into anterior abdominal wall via umbilical ring\nPrevalence: $4 \\%$ of all hernias; $\\mathrm{M}<\\mathrm{F}$\nCause: failed closure of umbilical ring, obesity, multiple pregnancies, intraabdominal mass, liver failure, increased intraabdominal pressure, weak abdominal wall\n$\\sqrt{ }$ may contain fat / small bowel / colon\n$C x$ : strangulation, incarceration\n$D D x$ : paraumbilical, spigelian, epigastric, incisional hernia\n2. Periumbilical hernia\n$\\sqrt{ }$ large defect through linea alba $\\leftarrow$ diastasis of rectus abdominis muscle at",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 814,
            "markdown": "umbilicus\n3. Epigastric / hypogastric hernia\n$\\sqrt{ }$ in linea alba above / below umbilicus\n4. Postoperative / incisional $(0.5-14.0 \\%$, most common type)\n5. Parastomal hernia\n$\\sqrt{ }$ one / more intestinal loops alongside loop of ileum / colon leading to stoma\n6. Trocar site hernia\n\nFrequency: $1-3.6 \\%$\n$\\sqrt{ }$ often Richter type hernia\n7. Spigelian hernia\n[Adriaan van den Spiegel = Adrianus Spigelius (1578-1625) Flemish anatomist and botanist working in Padua, Italy]\nFrequency: $2 \\%$ of anterior abdominal hernias\n$=$ acquired ventrolateral hernia through defect in aponeurosis between transverse and rectus muscle of abdomen at junction of semilunar + arcuate lines below umbilicus\n$\\sqrt{ }$ hernia sac dissects laterally to rectus abdominis muscle through a fibrous groove ( $=$ semicircular / spigelian line)\n$\\sqrt{ }$ hernia sac lies beneath an intact external oblique aponeurosis\n8. Interparietal / interstitial\n$=$ hernia sac located in fascial plane between abdominal muscles NOT connected to SQ tissue\n@ Diaphragmatic hernia\n\n1. Bochdalek hernia\n2. Morgagni hernia\n@ Lumbar\nLocation: defect in lumbar muscles below $12^{\\text {th }}$ rib + above iliac crest\n3. Superior lumbar triangle (Grynfeltt-Lesshaft)\n[Joseph C. Grynfeltt (1840-1913), French surgeon\nPeter Frantsevich Lesshaft (1837-1909), Russian physician]\nBorders: quadratus lumborum muscle (medially), internal oblique muscle (laterally), $12^{\\text {th }}$ rib (superiorly)\n4. Inferior lumbar triangle (Petit hernia)\n[Jean Louis Petit (1674-1750), inventor of the tourniquet, director of the French Royal Academy of Surgery]\nBorders: external oblique muscle (anteriorly), iliac crest (inferiorly), latissimus dorsi muscle (posteriorly)\n@ Pelvic floor\n5. Perineal hernia (rare)\n(a) anterior perineal hernia $=$ defect of urogenital diaphragm anterior to superficial transverse perineal $\\mathrm{m} .+$ lateral to bulbocavernosus $\\mathrm{m} .+$ medial to ischiocavernosus m . (only in females)\n(b) posterior perineal hernia $=$ defect in levator ani $m$. / between levator ani $m$. and coccygeus m . posterior to superficial transverse perineal m .",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 815,
            "markdown": "$\\sqrt{ }$ defecating proctography\n2. Obturator foramen\n$\\sqrt{ }$ hernia between pectineus + external obturator mm.\n3. Sciatic foramen\n@ Groin\n\n1. Inguinal hernia\n$\\diamond$ Most common type ( $80 \\%$ ) of spontaneous abdominal wall hernia; $\\mathrm{M}>\\mathrm{F}$\n$\\sqrt{ }$ superior + medial to pubic tubercle\nPubic tubercle:\n$=$ superior border of medial portion of superior pubic ramus\n$=$ attachment point of inguinal ligament\n(a) Direct inguinal hernia\n$=$ defect in Hesselbach triangle (bounded by inguinal ligament inferiorly, inferior epigastric artery superolaterally, fused aponeuroses of internal oblique + transverse abdominal muscles medially)\n[Franz Kaspar Hesselbach (1759-1816), surgeon and anatomist in Würzburg, Germany]\nCause: acquired weakening of transversalis fascia\nFrequency: increases with age\n$\\sqrt{ }$ medial to inferior epigastric vessels\n$\\sqrt{ }$ hernia contains bowel, mesenteric fat, vessels\n$C x:$ low risk of strangulation allows for conservative management + monitoring\n![img-87.jpeg](img-87.jpeg)\n(b) Indirect inguinal-scrotal hernia\n$\\diamond$ Most common hernia in children $\\leftarrow$ failure of obliteration of processus vaginalis\nAge: preterm neonates (most common)\nPrevalence: higher in preterm neonates\nLocation: $\\mathrm{R}>\\mathrm{L}$\n\n- clinically inapparent contralateral hernia (88\\%)\n$\\sqrt{ }$ lateral to inferior epigastric vessels originating at deep inguinal ring",
            "images": [
                {
                    "id": "img-87.jpeg",
                    "top_left_x": 377,
                    "top_left_y": 1144,
                    "bottom_right_x": 1319,
                    "bottom_right_y": 1628,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 816,
            "markdown": "$\\sqrt{ }$ US visualization of air-bubble movement / intestinal peristalsis / vascularity $\\sqrt{ }$ hernia containing omentum mimicks lipoma\n$C x$ : moderate risk of strangulation ( $2 \\%$ )\n(c) Littré hernia $=$ inguinal hernia containing Meckel diverticulum [Alexis Littré (1654-1726), French physician and anatomist in Montpellier and Paris]\n(d) Amyand hernia\n[Claudius Amyand (1680-1740), English surgeon who performed first successful appendectomy in 1735]\n$=$ appendix within inguinal hernia\nFrequency: $1 \\%$ of all inguinal hernias\n$D D x$ : iliopsoas bursa distended by hip joint effusion\n2. Femoral hernia $(5 \\%)$\n$\\diamond 2^{\\text {nd }}$ most common type (5\\%) of spontaneous abdominal wall hernias, $\\mathrm{R}>\\mathrm{L} ; \\mathrm{M} \\circ \\mathrm{F}$ $=1 \\div 4$ to $1 \\div 6$\n$\\checkmark$ enters femoral canal through femoral ring\nFemoral ring:\n$=$ most proximal part of femoral canal\nBorders: inguinal lig. (anteriorly), pectineal lig. (posteriorly), femoral vein (laterally)\n$\\checkmark$ lies in femoral triangle:\nBorders: deep to deep fascia of thigh, inguinal lig., sartorius m., adductor longus m.\n$\\checkmark$ inferior and lateral to pubic tubercle\n$\\checkmark$ medial to femoral vein within femoral canal\n$\\checkmark$ posterior to inguinal ligament\n$C x$ : highest ( $40 \\%$ ) rate of (ischemic) strangulation / (irreducible) incarceration of all hernias\n3. Richter hernia $=$ Partial enterocele\n[August Gottlieb Richter (1742-1812), surgeon and professor ordinarius in Göttingen, Germany]\n$=$ entrapment of antimesenteric border of bowel in hernia orifice, usually seen in older women with femoral hernias\n\n- no palpable mass $=$ difficult to diagnose\n$\\checkmark$ localized outpouching, possibly incarcerated\n$\\checkmark$ partial obstruction with patent bowel lumen",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 817,
            "markdown": "| Categorization of Internal Hernias |  |\n| :--: | :--: |\n| Type of Orifice | Category of Hernia |\n| Normal foramen | foramen of Winslow |\n| Unusual peritoneal fossa / <br> recess into retroperitoneum | paraduodenal <br> pericecal <br> intersigmoid <br> pelvic internal |\n| Abnormal opening in <br> mesentery / peritoneal <br> ligament | small bowel mesentery <br> greater omentum <br> lesser sac (except Winslow) <br> transverse mesocolon <br> transmeso- and intramesosigmoid <br> falciform ligament <br> broad ligament <br> Roux-en-Y anastomosis |\n\n4. De Garengeot hernia\n[René-Jacques Croissent de Garengeot (1683-1759), surgeon-major of the king's regiment of infantry, France]\n$=$ appendix within femoral hernia sac\nFrequency: $\\quad 0.5-3.3 \\%$ of all femoral hernias\n\n# Internal Hernia \n\n$=$ herniation of bowel through a defect of peritoneum (= peritoneal foramen / recess / fossa), omentum, mesentery or adhesive band into a compartment of the abdominal cavity\nInternal hernias are divided into 3 categories on the basis of the type of hernia orifice: (1) normal foramen, (2) unusual peritoneal fossa / recess into the retroperitoneum, and (3) abnormal opening in a mesentery / peritoneal ligament.\nFrequency: $5 \\%$ of all hernias, responsible for $<1 \\%$ of mechanical small bowel obstruction Cause of defect: congenital, surgery, trauma, inflammation, circulation\nClassification of internal hernias:\n(a) retroperitoneal: usually congenital containing a hernia sac\n\n1. Paraduodenal (ligament of Treitz) $53 \\%$\n2. Pericecal / ileocolic $13 \\%$\n3. Foramen of Winslow $8 \\%$\n4. Intersigmoid $6 \\%$\n5. Supravesical $6 \\%$\n\nAn internal hernia is diagnosed by its saclike closed-loop appearance and displacement of vessels and surrounding structures around the hernia orifice and sac.\n(b) anteperitoneal:\nsmall group of hernias without a peritoneal sac\n\n1. Transmesenteric (transverse / sigmoid mesocolon) $8 \\%$\n2. Transomental $1-4 \\%$\n3. Pelvic (including broad ligament)\n\n- epigastric discomfort, periumbilical pain",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 818,
            "markdown": "- recurrent episodes of distension and nausea $\\leftarrow$ intestinal obstruction (made worse by eating + standing and relieved by fasting + assuming a recumbent position)\nN.B.: clinically apparent only when incarcerated $\\rightarrow$ delay in diagnosis may lead to strangulation\n$\\checkmark$ bowel configuration:\n$\\sqrt{ }$ saclike mass / cluster of dilated obstructed bowel loops\n$\\checkmark$ displacement of other abdominal organs\n![img-88.jpeg](img-88.jpeg)\n$\\checkmark$ mesenteric changes:\n$\\checkmark$ engorged, stretched, displaced mesenteric vascular pedicle\n$\\checkmark$ dilated bowel loops with converging vessels at entrance of hernial orifice $\\rightarrow$ impaired venous drainage\nCx: volvulus\n\n\n# Paraduodenal Hernia (53\\%) \n\n$=$ entrapment of small intestine into a congenital fossa\n$\\diamond$ Most common type of internal hernia\n(a) LEFT through fossa of Landzert ( $3 / 4$ )\n[Theodor Bernhard Landzert (1833-1889), Russian anatomist]\nAutoptic frequency: $2 \\%$\nCause: failure of part of descending mesocolon to fuse with posterior parietal peritoneum\nLocation: to the left of $4^{\\text {th }}$ portion of duodenum at duodenojejunal junction $=$ confluent zone of descending mesocolon + transverse mesocolon + small bowel mesentery\n\n- frequently asymptomatic\n$\\checkmark$ cluster of dilated small-bowel loops between pancreas + stomach to the left of ligament of Treitz:\n$\\checkmark$ displacement of gastric wall anteriorly\n$\\checkmark$ displacement of duodenojejunal flexure and transverse colon inferiorly\n$\\checkmark$ engorged crowded vessels at entrance of hernia sac\nCT:",
            "images": [
                {
                    "id": "img-88.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 508,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1009,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 819,
            "markdown": "$\\sqrt{ }$ encapsulated bowel loop causes anteromedial displacement of IMV + left colic artery (= landmarks of the right margin of the descending mesocolon)\n(b) RIGHT through mesentericoparietal fossa of Waldeyer ( $1 / 4$ )\n\nCause: failure of part of ascending mesocolon to fuse with posterior parietal peritoneum\nPredisposed: nonrotation of small bowel\nLocation: behind the root of small bowel mesentery caudal to SMA and inferior to $3^{\\text {rd }}$ portion of duodenum on right side\nCT:\n$\\sqrt{ }$ encapsulated bowel loop displacing the right colic vein (= landmark of left margin of the ascending mesocolon) anteriorly\n$\\sqrt{ }$ looping of small intestine behind SMA + SMV below transverse portion of duodenum\nwith nonrotation:\n$\\sqrt{ }$ SMV located ventral + to left of SMA\n$\\sqrt{ }$ absence of normal $3^{\\text {rd }}$ portion duodenum\nCx: partial / complete obstruction of small intestine (50\\%)\n\n# Lesser Sac Hernia (1-8\\%) \n\n$=-$ FORAMEN OF WINSLØW HERNIA\n$=3-\\mathrm{cm}$ vertical slit beneath upper part of right border of lesser sac and cephalad to duodenal bulb\nLocation: anterior to IVC + posterior to hepatoduodenal ligament (portal vein + CBD + hepatic artery)\nPredisposing factors:\n(1) Enlarged foramen of Winslow\n(2) Excessively mobile intestinal loops $\\leftarrow$ long mesentery / persistence of ascending mesocolon\nInvaginated gut:\n(a) small bowel ( $60-70 \\%$ ): ileum $>$ jejunum, Meckel diverticulum\n(b) colon ( $25-30 \\%$ ): terminal ileum, cecum, appendix, ascending colon\n(c) rare: transverse colon, gallbladder, greater omentum\n\nPlain film:\n$\\sqrt{ }$ gas-containing bowel loops in central upper abdomen\n$\\sqrt{ }$ distended small bowel loops occupying space between stomach + liver\n$\\sqrt{ } \\pm$ cecum + ascending colon absent from usual location\nUGI:\n$\\sqrt{ }$ dilatation of small bowel loops with obstruction in RUQ\nBE:\n$\\sqrt{ } \\pm$ narrowing / obstruction at hepatic flexure of colon\nCT:\n$\\sqrt{ }$ retrogastric air-fluid collection in lesser sac:\n$\\sqrt{ } \\geq 2$ bowel loops in high subhepatic spaces\n$\\sqrt{ }$ \"beak\"-shape herniated viscera pointing toward foramen of Winslow\n$\\sqrt{ }$ mesenteric vessel between IVC + main portal vein",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 820,
            "markdown": "$\\sqrt{ }$ crowded mesenteric vessels between ascending portion of duodenum + pancreatic head\n$\\checkmark$ anteriorly compressed portal vein\n$\\checkmark$ absence of ascending colon in right gutter\n\n# Pericecal Hernia (13\\%) \n\n4 recesses: superior + inferior ileocecal recess, retrocecal recess, paracolic sulci\n$\\sqrt{ }$ saclike appearance of ileal loops in right paracolic gutter lateral to cecum + posterior to ascending colon\n$\\checkmark$ displacement of cecum + ascending colon anteriorly / medially\n\n## Falciform Ligament Hernia\n\nCause: abnormal opening in falciform ligament\n$\\checkmark$ closed-loop intestine in front of / slightly caudal to liver\n\n## Transmesenteric Hernia (8\\%)\n\nCause:\n(a) in childhood (35\\%): congenital mesenteric defect $2-5 \\mathrm{~cm}$ in diameter\n\nLocation: close to ligament of Treitz / ileocecal valve\n(b) in adulthood: surgery / trauma / inflammation\n$\\checkmark$ proximal small bowel dilatation $=$ mechanical SBO\nCT:\n$\\checkmark$ clustering of small bowel loops\n$\\checkmark$ engorged, stretched, crowded mesenteric vascular pedicle\n$\\checkmark$ displacement of main mesenteric trunk to the right\n$C x:$ small bowel volvulus\n\n## Transomental Hernia (1-4\\%)\n\nType 1: herniation without sac through a free greater omentum (more common)\n$=$ slitlike opening $2-10 \\mathrm{~cm}$ in diameter\nType 2: herniation into lesser sac through gastrocolic lig.\n$\\checkmark$ closed-loop intestine without saclike appearance, located in most anterior portion of peritoneal cavity\n$\\checkmark$ omental vessels run vertically around hernia orifice\n$\\checkmark$ clinical + radiologic findings almost identical to transmesenteric hernia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 821,
            "markdown": "![img-89.jpeg](img-89.jpeg)\n\n# Sigmoid Mesocolon Hernia (6\\%) \n\nTypes: intra-, transmeso-, intermesosigmoid subtypes\n$\\sqrt{ }$ hernia orifice between sigmoid colon and left psoas major muscle in LLQ\n$\\checkmark$ small bowel loops posterolateral to sigmoid colon\n$\\sqrt{ } \\pm$ herniation sac $\\pm$ splaying of sigmoid arteries and veins\n\n## Internal Supravesical Hernia\n\n$\\sqrt{ }$ saclike herniated intestine located anterolaterally to compressed urinary bladder (= retropubic space of Retzius)\n\n## Iatrogenic Hernia\n\n## TRANSMESOCOLIC HERNIA\n\nCause: fenestration of transverse mesocolon in construction of Roux-en-Y loop\n$\\checkmark$ cluster of small-bowel loops ( $70 \\%$ )\n$\\checkmark$ clustered small bowel outside colon compressed against abdominal wall without overlying omental fat $(85 \\%)$\n$\\checkmark$ central displacement of colon ( $92 \\%$ )\n$\\checkmark$ displacement of mesenteric trunk ( $85 \\%$ )\n$\\checkmark$ engorged mesenteric vessels ( $85 \\%$ )\n\n## Hernia through Broad Ligament (4-5\\%)\n\n$=$ congenital / acquired hernia after laceration / fenestration during surgery or during pregnancy $(85 \\%)$\nCT:\n$\\checkmark$ cluster of dilated small bowel loops with air-fluid levels in pelvic cavity",
            "images": [
                {
                    "id": "img-89.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 965,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 822,
            "markdown": "compressing rectosigmoid dorsolaterally and uterus ventrally\n$\\sqrt{ }$ mesenteric vessels of herniated intestine penetrate broad ligament (coronal MPR)\n$\\sqrt{ }$ enlarged distance between uterus and ovary deviating in opposite directions\n\n# Hiatal Hernia \n\nCause: delay in descent of stomach keeping hiatus large (in children)\nAssociated with: diverticulosis ( $25 \\%$ ), reflux esophagitis ( $25 \\%$ ), duodenal ulcer ( $20 \\%$ ), gallstones $(18 \\%)$\n\n## Sliding Hiatal Hernia (99\\%)\n\n$=$ AXIAL HERNIA $=$ CONCENTRIC HERNIA\n$=$ esophagogastric junction ( $=$ termination point of converging gastric folds) $>1.5 \\mathrm{~cm}$ above diaphragmatic hiatus ( $=$ pinched appearance of gastric folds) with portion of peritoneal sac forming part of wall of hernia\nEtiology: rupture of phrenicoesophageal membrane $\\leftarrow$ repetitive stretching with swallowing\nFrequency: increasing with age\n$\\sqrt{ }$ reducible in erect position\n$\\sqrt{ }$ epiphrenic bulge $=$ entire vestibule + sleeve of stomach are intrathoracic\n$\\sqrt{ }$ distance between B ring (if visible) + hiatal margin $>2 \\mathrm{~cm}$\n$\\sqrt{ }$ peristalsis ceases above hiatus $\\rightarrow$ end of peristaltic wave delineates esophagogastric junction\n$\\sqrt{ }$ tortuous esophagus having an eccentric junction with hernia\n$\\sqrt{ }$ numerous coarse thick gastric folds within suprahiatal pouch ( $>6$ longitudinal folds)\n$\\sqrt{ } \\pm$ gastroesophageal reflux\nCT:\n$\\sqrt{ }$ dehiscence of diaphragmatic crura $>15 \\mathrm{~mm}$\n$\\sqrt{ }$ pseudomass within / above esophageal hiatus\n$\\sqrt{ }$ increase in fat surrounding distal esophagus $\\leftarrow$ herniation of omentum through phrenicoesophageal lig.\n$D D x$ : normal temporary cephalad motion of esophago-gastric junction by $1-2 \\mathrm{~cm}$ into chest $\\leftarrow$ contraction of longitudinal muscle during esophageal peristalsis\n\n## Paraesophageal Hernia (1\\%)\n\n$=$ ROLLING HIATAL HERNIA $=$ PARAHIATAL HERNIA\n$=$ portion of stomach superiorly displaced into chest with GE junction remaining in subdiaphragmatic position\nCause: absence of gastrosplenic + gastrocolic ligaments; complication of Nissen fundoplication\n$\\sqrt{ }$ cardia in normal position\n$\\sqrt{ }$ herniation of portion of stomach anterior to esophagus\n$\\sqrt{ }$ frequently nonreducible\n$\\sqrt{ }$ may be associated with gastric ulcer of lesser curvature at level of diaphragmatic hiatus\n$C x$ : organoaxial volvulus, colonic herniation\n\n## Totally Intrathoracic Stomach",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 823,
            "markdown": "$=$ defect in central tendon of diaphragm in combination with slight volvulus in transverse axis of stomach behind heart (organoaxial rotation)\n$\\checkmark$ cardia may be intrathoracic (usually) / subdiaphragmatic\n$\\checkmark$ great gastric curvature either on right / left side\n\n# Congenitally Short Esophagus \n\n(not true hernia, very rare)\n$=$ gastric ectopy by lack of lengthening of esophagus\n$\\checkmark$ nonreducible intrathoracic gastric segment (in erect / supine position)\n$\\checkmark$ cylindrical / round intrathoracic segment with large sinuous folds\n$\\checkmark$ short straight esophagus\n$\\checkmark$ circular narrowing at gastroesophageal junction, frequently with ulcer\n$\\checkmark$ gastroesophageal reflux\n\n## HETEROTOPIC PANCREAS\n\n$=$ pancreatic tissue at aberrant sites that lack a vascular / ductal connection to main pancreatic body\nOrigin: detachment of branching bud during embryonic gastrointestinal rotation\nPrevalence: $1-15 \\%$ (autoptic)\n\n- usually asymptomatic\n- occasionally abdominal pain, GI bleeding, obstruction\n\nLocation: upper part of GI tract near pancreas in prepyloric antrum of stomach along greater curvature $(90 \\%)$\nSite: submucosa / muscularis propria\n$\\checkmark$ flat ovoid intramural subepithelial nodule of $<3 \\mathrm{~cm}$\n$\\checkmark$ intraluminal growth $\\pm$ central umbilication ( $=$ orifice of rudimentary pancreatic duct)\nCT:\n$\\checkmark$ mass with irregular border\n$\\checkmark$ usually homogeneously enhancing mass with attenuation similar to pancreas\n$\\checkmark$ occasionally poor enhancement (if pancreatic acini remain a minor component of the mass)\nDifferentiation of heterotopic pancreas from other subepithelial masses is crucial to avoid unnecessary resection. Its typical location, flat-ovoid shape, intraluminal growth, and irregular border are helpful characteristics.\n\nRare Cx: pancreatitis, pseudocyst, cystic dystrophy, insulinoma, malignant transformation\n\n## HETEROTOPIC MESENTERIC OSSIFICATION\n\n$=$ OSSEOUS METAPLASIA of mesentery and peritoneum\nCause: trauma, repeated intraabdominal operative procedures\nPathogenesis: ? metaplasia of submesothelial mesenchyme; implantation of osteoblasts or periosteum during trauma / procedures\nHisto: core of reactive myofibroblasts with hemorrhage + fat necrosis, osteoblastic activity, focal \"lace-like\" osteoid (DDx: extraskeletal osteosarcoma)\nLocation: mesentery with extension to peritoneal surface\n$\\checkmark$ multiple linear-branching structures of high-attenuation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 824,
            "markdown": "$\\sqrt{ }$ trabecular architecture\n$D D x$ :\n(1) Extravasation of oral contrast (changing configuration on serial images, pooling in gravity-dependent locations, becoming less dense with time)\n(2) Dystrophic calcifications (typically irregular /punctate / coarse calcifications without trabecular architecture)\n\n# HIRSCHSPRÜNG DISEASE \n\n[Harald Hirschsprung (1830-1916), pediatrician and chief physician of Queen Louisa Hospital for Children in Cøpenhagen, Denmark]\n$=$ AGANGLIONOSIS OF THE COLON = AGANGLIONIC MEGACOLON\n$=$ complete / partial functional colonic obstruction $\\leftarrow$ absence of parasympathetic ganglia in muscle (myenteric = Auerbach plexus) + submucosal layers (submucosal = Meissner plexus) [Leopold Auerbach (1828-1897), German anatomist and professor of neuropathology at the University of Breslau]\n[Georg Meissner (1829-1905), professor of anatomy and physiology in Basel, Freiburg and Göttingen, Germany]\nEtiology: arrest of craniocaudal migration of neural crest cells along vagal trunks during $5^{\\text {th }}-$ $12^{\\text {th }}$ week $\\rightarrow$ relaxation failure of the aganglionic segment\nPrevalence: $1 \\div 5,000-8,000$ live births; $15-20 \\%$ of all neonatal bowel obstructions; usually sporadic; familial in $4 \\%$\nAge: during first 6 weeks of life of a full-term infant ( $70-80 \\%$ ); extremely rare in premature infants; usually manifest by 5 years of age; $\\mathrm{M}+\\mathrm{F}=4-9 \\div 1$\nAssociated with: trisomy 21 (in 2\\%)\nLocation: at varying distances proximal to anus, usually rectosigmoid (in $80 \\%$ ) and rectum\n(a) ultrashort segment (= internal sphincter) (very rare)\n(b) short segment disease $(80 \\%)$\n(c) long segment disease $(15 \\%)$\n(d) total colonic aganglionosis (5\\%)\n(e) skip aganglionosis = sparing of rectum (very rare)\n\n- failure to pass meconium within first 48 hours of life\n- intermittent constipation + paradoxical diarrhea ( $25 \\%$ )\n- bilious vomiting, abdominal distension\n- rectal manometry with absence of spike activity\n$\\checkmark$ generalized gaseous distension of bowel loops\nBE (study of choice):\n$\\checkmark$ \"transition zone\":\n$\\checkmark$ inverted cone-shaped colon at transition between abnormal + normal bowel (MOST CHARACTERISTIC):\n$\\checkmark$ dilated stool-filled large + small bowel aborally from transition zone\n$\\checkmark$ distal aganglionic segment of normal size + free of stool (apparent in $50 \\%$ during $1^{\\text {st }}$ week of life)\n$\\checkmark$ normal-appearing rectum in $33 \\%$\n$\\checkmark$ short patent colon usually of normal caliber\n$\\checkmark$ marked retention of barium on delayed postevacuation films after 12-24 hours",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 825,
            "markdown": "$\\sqrt{ } 10-15-\\mathrm{cm}$ segment of persistent corrugated / convoluted rectum (= abnormal uncoordinated contractions of the aganglionic portion of colon) in $31 \\%$ (DDx: colitis, milk allergy, normal intermittent spasm of rectum)\nN.B.: avoid digital exam / cleansing enema prior to radiographic studies!\n\nOB-US:\n$\\sqrt{ }$ dilated small bowel / dilated colon\nCT:\n$\\sqrt{ }$ narrow transition zone + aboral colonic distension on SAG reformatted view of lower abdomen + pelvis\nCx: (1) Necrotizing enterocolitis\n(2) Cecal perforation $\\leftarrow$ stasis, distension, ischemia\n(3) Obstructive uropathy\n\nDx: full-thickness biopsy of rectum ( $\\uparrow$ acetylcholinesterase activity)\nRx: (1) Swenson pull-through procedure\n(2) Duhamel operation\n(3) Soave procedure\n\n# HYPERPLASTIC POLYP OF COLON \n\n$=$ intestinal metaplasia consisting of mucous glands lined by a single layer of columnar epithelium; NO malignant potential\nPath: infolding of epithelium into the glandular lumen\nLocation: rectosigmoid\n$\\sqrt{ }$ smooth rounded sessile elevation\n$\\sqrt{ }$ usually $<5 \\mathrm{~mm}$ in diameter\n\n## HYPERTROPHIC PYLORIC STENOSIS (HPS)\n\n= idiopathic hypertrophy and hyperplasia of circular muscle fibers of pylorus with proximal extension into gastric antrum\nEtiology: inherited as a dominant polygenic trait; increased incidence in firstborn boys; acquired rather than congenital condition\n\n## Infantile Form of Hypertrophic Pyloric Stenosis\n\nAge: manifestation between $3^{\\text {rd }}-12^{\\text {th }}$ week of life; peak presentation during $4^{\\text {th }}$ week",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 826,
            "markdown": "![img-90.jpeg](img-90.jpeg)\n\nFrequency: $3 \\div 1,000$ births; $\\mathrm{M} \\div \\mathrm{F}=4-5 \\div 1 ; 5 \\mathrm{x}$ fold increase in $1^{\\text {st }}$-degree relatives\n\n- nonbilious projectile vomiting (sour formula / clear gastric contents) $\\rightarrow$ progression over a period of several weeks after birth $(15-20 \\%)$\n- palpable olive-shaped mass ( $80 \\%$ sensitive in experienced hands, up to $14 \\%$ false positive)\n- nasogastric aspirate $>10 \\mathrm{~mL}(92 \\%$ sensitive, $86 \\%$ specific $)$\n\nAbdominal radiograph:\n$\\diamond$ A normal radiograph does not exclude HPS!\n$\\checkmark$ fluid-filled distended stomach after 2 hours of fasting\n$\\checkmark$ little bowel gas\nUGI ( $95 \\%$ sensitivity):\n$\\diamond$ Imaging confirmation is sought by most clinicians to differentiate from gastroesophageal reflux!\nBenefit: complete anatomic evaluation of stomach and duodenum; functional assessment of gastroesophageal reflux\nPrecautions: (1) Empty stomach via nasogastric tube before study\n(2) Remove contrast at end of study\n$\\checkmark$ elongation + narrowing of pyloric canal ( $2-4 \\mathrm{~cm}$ in length):\n$\\checkmark$ \"string\" sign = passing of small barium streak through elongated pyloric channel (MOST SPECIFIC SIGN)\n$\\checkmark$ \"double / triple track\" sign = crowding of mucosal folds in pyloric channel\n$\\checkmark$ Twining recess $=$ \"diamond\" sign $=$ transient triangular tentlike cleft / niche in midportion of pyloric canal with apex pointing inferiorly $\\leftarrow$ mucosal bulging between two separated hypertrophied muscle bundles on the greater curvature side within pyloric channel\n$\\checkmark$ abnormal configuration of antrum:\n$\\checkmark$ \"pyloric teat\" = outpouching along lesser curvature due to disruption of antral peristalsis\n$\\checkmark$ \"shoulder\" sign = impression of hypertrophied muscle on distended gastric antrum\n$\\checkmark$ \"antral beaking\" = mass impression upon antrum with streak of barium pointing toward pyloric channel",
            "images": [
                {
                    "id": "img-90.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 721,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 827,
            "markdown": "$\\sqrt{ }$ \"olive pit\" sign = impression of pyloric muscle upon antrum with a tiny amount of barium at orifice seen en face\n$\\checkmark$ Kirklin sign = \"mushroom\" sign = indentation of base of duodenal bulb (in 50\\%)\n$\\checkmark$ gastric distension with fluid\n$\\checkmark$ active gastric hyperperistalsis:\n$\\checkmark$ \"caterpillar\" sign = gastric hyperperistaltic waves\nUS (method of choice $\\leftarrow$ direct visualization of HPS):\n$\\checkmark$ \"target\" sign = hypoechoic ring of hypertrophied pyloric muscle around echogenic mucosa centrally on cross-section\n$\\checkmark$ elongated pylorus with thickened muscle:\n$\\checkmark$ pyloric muscle wall thickness $\\geq 3.0-3.2 \\mathrm{~mm}$\n$\\checkmark$ pyloric volume $>1.4 \\mathrm{~cm}^{3}\\left(=1 / 4 \\pi \\mathrm{x}\\right.$ [maximum pyloric diameter]2 x pyloric length); most criteria independent of contracted or relaxed state ( $33 \\%$ false negative)\n$\\checkmark$ pyloric length $(\\mathrm{mm})+3.64 \\mathrm{x}$ muscle thickness $(\\mathrm{mm}) \\geq 25 \\mathrm{~mm}$\n$\\checkmark$ pyloric transverse diameter $\\geq 13 \\mathrm{~mm}$ with pyloric channel closed\n$\\checkmark$ elongated pyloric canal $\\geq 16-17 \\mathrm{~mm}$ in length\n$\\checkmark$ \"cervix\" sign = indentation of muscle mass on fluid-filled antrum on longitudinal section\n$\\checkmark$ \"antral nipple\" sign = redundant pyloric channel mucosa protruding into gastric antrum\n$\\checkmark$ exaggerated peristaltic waves\n$\\checkmark$ delayed gastric emptying of fluid into duodenum\nPitfalls: gastric antrum mistaken for HPS (ingestion of Pedialyte ${ }^{\\circledR}$ improves definition of anatomic landmarks)\nCx: hypochloremic metabolic alkalosis\nRx: pyloromyotomy\nPrognosis: $2 \\%$ mortality\n$D D x$ :\n\n1. Infantile pylorospasm\n$=$ temporary thickening of pyloric muscle\n$\\checkmark$ variable muscle thickness between 1.5 and 3.0 mm\n$\\checkmark$ variable caliber of antral narrowing\n$\\checkmark$ antral peristalsis\n$\\checkmark$ delayed gastric emptying (assure adequate length of real-time observation)\n$\\checkmark$ elongation of pylorus\n$\\checkmark$ gastric content / fluid passes through pyloric channel\nPrognosis: resolves in several days / ? early stage of evolving pyloric stenosis\nRx: effective with metoclopramide / Bentyl ${ }^{\\circledR}$\n2. Gastritis / milk allergy\n$\\checkmark$ circumferential / eccentric thickening of antral mucosa $>2-3 \\mathrm{~mm}$\n3. Duodenal obstruction from midgut volvulus\n$\\checkmark$ distended descending duodenum\n$\\checkmark$ reversal of SMA and SMV relationship\n$\\checkmark$ \"whirlpool\" sign = twisting of small bowel mesentery\n4. Gastric diaphragm\n\n# Adult Form of Hypertrophic Pyloric Stenosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 828,
            "markdown": "Cause: secondary to mild infantile form\n\n- acute obstructive symptoms uncommon\n- nausea, intermittent vomiting, postprandial distress, heartburn\n\nAssociated with:\n(1) Peptic ulcer disease (in $50-74 \\%$ ) $\\leftarrow$ prolonged gastrin production $\\leftarrow$ stasis of food\n(2) Chronic gastritis ( $54 \\%$ )\n$\\checkmark$ persistent elongation $(2-4 \\mathrm{~cm})+$ concentric narrowing of pyloric channel\n$\\checkmark$ parallel + preserved mucosal folds\n$\\checkmark$ antispasmodics show no effect on narrowing\n$\\checkmark$ proximal benign ulcer ( $74 \\%$ ), usually near incisura\n\n# Focal Pyloric Hypertrophy \n\n$=$ TORUS HYPERPLASIA\n$=$ localized muscle hypertrophy on lesser curvature\n$=$ milder atypical form of HPS\n$\\checkmark$ flattening of distal lesser curvature\n\n## ILEAL DIVERTICULOSIS\n\n$=$ acquired mucosal herniation of bowel at sites of vascular entry\n\n- usually asymptomatic\n\nAge: $>40$ years; $\\mathrm{M}>\\mathrm{F}$\nSite: mesenteric border of terminal ileum $<7.5 \\mathrm{~cm}$ from ileocecal valve\n$C x$ : perforation, bleeding, small bowel obstruction\n$D D x$ : acute appendicitis\n\n## IMPERFORATE ANUS\n\nPrevalence: $1 \\div 5,000$ live births\nA. LOW ANOMALY (55\\%)\n$=$ bowel has passed through levator sling\n\n- fistula to perineum / vulva\n$R x$ : readily reparable\nB. INTERMEDIATE DEFECT (least common)\n$=$ bowel ends within levator muscle as a result of abnormality in posterior migration of rectum\n- fistula opening low in vagina / vestibule\n$R x: 2-/ 3$-stage operation\nC. HIGH ANOMALY\n$=$ bowel ends above levator sling; $\\mathrm{M}>\\mathrm{F}$\n- fistulous connection to perineum / vagina / posterior urethra $\\rightarrow$ air in bladder in males / air in vagina in females\n$C x$ : associated malformations more common + more severe\n$R x$ : multiple surgical procedures\n$\\checkmark$ distance between rectal air and skin will not accurately outline the extent of atretic rectum and anus $\\leftarrow$ varying length during crying with increase in abdominal pressure + contraction of",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 829,
            "markdown": "levator ani muscle\nUS:\n$\\sqrt{ } \\leq 15 \\mathrm{~mm}$ distance between anal dimple + distal rectal pouch on transperineal images $\\rightarrow$ indicates low lesion\nOB-US (earliest detection by 20-29 weeks GA):\n\n- absent / low disaccharidase level in amniotic fluid\n$\\sqrt{ }$ dilated colon in lower pelvis with U- / S-shaped configuration $\\pm$ intraluminal calcifications\n$\\sqrt{ }$ normal amniotic fluid (unless also TEF)\n$\\sqrt{ }$ absence of anal characteristics (= hypoechoic circular rim with central echogenic stripe)\n\n\n# INFLAMMATORY FIBROID POLYP \n\n$=$ VANEK TUMOR = EOSINOPHILIC GRANULOMA = SUBMUCOSAL FIBROMA = FIBROUS POLYPOID LESION\n$=$ unusual benign chronic inflammatory lesion\n$\\diamond$ Unrelated to eosinophilic granuloma of lung / bone\nPath: arises in submucosa\nHisto: spindle cells arranged in whorls around blood vessels with prominent inflammatory cells, particularly eosinophils\nImmunohisto: stains for CD34; diffusely positive for vimentin\n\n- usually asymptomatic, NO peripheral eosinophilia\n- abdominal pain, GI bleeding $\\leftarrow$ mucosal ulceration\n\nLocation: almost exclusively in stomach: gastric antrum ( $75 \\%$ ) > gastric body $>$ fundus\nSize: $2-5 \\mathrm{~cm}$ in diameter\n$\\sqrt{ }$ intraluminal subepithelial polypoid mass / pedunculated polyp with smooth / slightly lobulated contour\n$C x$ : intermittent gastric outlet obstruction\n$R x$ : endoscopic resection\n$D D x$ : adenomatous polyp, intraluminal GIST, carcinoid tumor, schwannoma\n\n## INFLAMMATORY MYOFIBROBLASTIC TUMOR\n\n$=$ PLASMA CELL GRANULOMA = INFLAMMATORY PSEUDOTUMOR = INFLAMMATORY FIBROSARCOMA\n$=$ XANTHOMATOUS PSEUDOTUMOR = HISTIOCYTOMA = XANTHOGRANULOMA = FIBROXANTHOMA\n$=$ PSEUDOLYMPHOMA\n$=$ rare neoplasm of intermediate biologic behavior with a low rate $(<5 \\%)$ of metastases based on cytogenetic studies.\nGenetics: rearrangement in anaplastic lymphoma kinase (ALK) gene = tyrosine receptor kinase oncogene (in $50-70 \\%$ )\nAge: any; young adult and child; $\\mathrm{M}<\\mathrm{F}$\nPath: solitary multilobular circumscribed solid mass\nHisto: myofibroblastic spindle cell proliferation in a loosely myxoid to dense collagenous stroma surrounded by a prominent inflammatory cell infiltrate composed of polyclonal plasma cells, lymphocytes, eosinophils and nonnecrotizing epithelial cell granulomas\nImmunohisto: spindle cells reactive with anaplastic lymphoma kinase (ALK) + smooth muscle actin",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 830,
            "markdown": "- fever, weight loss, anemia, thrombocytosis, polyclonal hypergammaglobulinemia (in 25\\%)\n- abdominal pain $\\leftarrow$ mass effect (most common)\n\nLocation: abdominal cavity (mesentery, GI tract), lung, salivary glands, larynx, mediastinum, retroperitoneum, solid organs\nMean size: 7-8 (range, 1-20) cm in diameter\n$\\sqrt{ }$ nonspecific varied imaging finding depending on site of origin and composition of inflammatory infiltrate and fibrosis\n@ mesentery / omentum\n$\\checkmark$ bulky well-demarcated homo- / heterogeneous spherical / multilobulated mass\nUS:\n$\\checkmark$ ill- / well-defined heterogeneous hypo- / hyperechoic solid mass of mixed echotexture\n$\\checkmark \\pm$ shadowing echogenic calcifications / central hypoechoic regions\n$\\checkmark$ prominent vascularity with low-resistance arterial waveform on color Doppler\nCT:\n$\\checkmark$ hypo- / isoattenuating compared with skeletal muscle depending on amount of myxoid / collagenous stroma\n$\\checkmark$ variably heterogeneous / peripheral enhancement / nonenhancing\n$\\checkmark$ peritoneal dissemination + lymphadenopathy (rare)\n$\\checkmark$ (rarely) aggressive intramural masses $\\pm$ invasion through gastric wall into peritoneal cavity / nearby organs\nMR:\n$\\checkmark$ typically T1-hypointense relative to skeletal muscle and hyperintense on T2WI\n$\\checkmark$ densely fibrotic tumor may be dark on both sequences\nPET/CT:\n$\\checkmark$ useful in detecting primary tumor, local recurrence, distant metastases\n$R x:$ complete surgical resection $\\rightarrow$ propensity for local recurrence\n$D D x$ : (1) Desmoplastic small round cell tumor (diffuse involvement of peritoneal cavity)\n(2) Castleman disease (diffuse intense enhancement)\n(3) Mesenteric fibromatosis (may encase bowel wall and SMA, family history of colonic polyps)\n(4) Burkitt lymphoma (typically diffuse at presentation, rapid doubling rate)\n(5) Lipoblastoma (young child, fat attenuation)\n(6) Lymphatic malformation (large cystic component, chylous ascites)\n(7) Infantile hemangioma ( $<1$ year of age, intense uniform enhancement, enlarged feeding and draining vessels)\n(8) Others: GIST, solitary fibrous tumor, schwannoma, multiple myeloma, solitary plasmacytoma\n\n# INTESTINAL LYMPHANGIECTASIA \n\nA. CONGENITAL LYMPHANGIECTASIA\n$=$ PRIMARY PROTEIN-LOSING ENTEROPATHY\n$=$ generalized congenital malformation of lymphatic system with atresia of the thoracic duct + gross dilatation of small bowel lymphatics; usually sporadic; may be inherited",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 831,
            "markdown": "Age: presentation before 30 years\n\n- asymmetric generalized lymphedema $\\leftarrow$ protein-losing enteropathy with hypoproteinemia\n- chylous pleural effusions ( $45 \\%$ )\n- diarrhea ( $60 \\%$ ), steatorrhea ( $20 \\%$ ), vomiting ( $15 \\%$ )\n- abdominal pain ( $15 \\%$ ) + distension\n- decreased albumin + globulin, lymphocytopenia ( $90 \\%$ )\n- decreased serum fibrinogen, transferrin, ceruloplasmin\nB. ACQUIRED LYMPHANGIECTASIA\n\nCauses leading to dilatation of intestinal lymphatics:\n\n1. Mesenteric adenitis\n2. Retroperitoneal fibrosis\n3. Diffuse small bowel lymphoma\n4. Pancreatitis\n5. Pericardial effusion with obstruction of thoracic duct\n\n- peripheral edema / anasarca (KEY SYMPTOM)\n- chylous + serous effusion; malabsorption\n- diarrhea, vomiting, abdominal pain, steatorrhea\n- hypoproteinemia $\\leftarrow$ protein loss into intestinal lumen\n\nPath: dilatation of lymph vessels in mucosa + submucosa + abundance of foamy fat-staining macrophages (DDx to Whipple disease: negative for PAS)\n$\\sqrt{ }$ marked irregular diffuse symmetric thickening of folds in jejunum + ileum $\\leftarrow$ dilated intestinal lymphatics + hypoproteinemic edema\n$\\checkmark$ micronodularity $\\leftarrow$ dilated lacteal vessels in submucosa + lamina propria\n$\\checkmark$ slight separation + rigidity of folds\n$\\checkmark$ dilution of barium column $\\leftarrow$ considerable increase in intestinal secretions from malabsorption\n$\\checkmark$ no / mild dilatation of bowel\nLymphangiogram (not always diagnostic):\n$\\checkmark$ hypoplasia of lower extremity lymphatics\n$\\checkmark$ occlusion of thoracic duct / large tortuous thoracic duct\n$\\checkmark$ obstruction of cisterna chyli with backflow into mesenteric + intestinal lymphatics\n$\\checkmark$ hypoplastic lymph nodes\n$D x$ : small bowel biopsy (dilated lymphatics in lamina propria + vascular core)\n$R x$ : low-fat diet with medium-chain triglycerides (direct absorption into portal venous system)\n$D D x$ : (1) Whipple disease (more segmentation + fragmentation, wild folds)\n(2) Amyloidosis (edema + secretions usually absent)\n(3) Hypoalbuminemia (less pronounced symmetric thickening of folds, less prominent secretions)\n\n# INTESTINAL PSEUDOOBSTRUCTION \n\n$=$ decreased ability of intestines to push food through\n$\\diamond$ Clinical and radiological findings similar to true intestinal obstruction\n$\\checkmark$ dilation of various parts of the bowel\nA. Primary (idiopathic or inherited)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 832,
            "markdown": "# B. Secondary (due to another disease) \n\n## Colonic Pseudoobstruction\n\n$=$ PSEUDOMEGACOLON $=$ ADULT MEGACOLON $=$ ADYNAMIC ILEUS $=$ FUNCTIONAL OBSTRUCTION $=$ IDIOPATHIC LARGE-BOWEL OBSTRUCTION $=$ OGILVIE SYNDROME\n[Sir William Heneage Ogilvie (1887-1971), English surgeon at Guy's Hospital, London]\nX-ray:\n$\\checkmark$ nonspecific findings of gaseous distention of colon\n$\\checkmark$ cecal diameter $>12 \\mathrm{~cm} \\rightarrow$ colonic decompression\nBE:\n$\\diamond$ Avoid if cecal perforation is suspected!\n$R x$ : nasogastric suction, enemas, neostigmine, colonoscopic decompression\n$D D x$ : mechanical obstruction, paralytic ileus\n\n## Acute Colonic Pseudoobstruction\n\n$=$ rare clinical disorder with signs \\& symptoms \\& radiographic appearance of an acute large bowel obstruction but without mechanical obstruction\nPathogenesis:\nimbalance in autonomic nervous system (sympathetic overactivity + parasympathetic suppression) after recent significant medical illness / surgical procedure\nCause: retroperitoneal trauma, especially fracture (11-52\\%), pelvic / abdominal / cardiothoracic surgery ( $20 \\%$ ), infection ( $10 \\%$ ), cardiac disease [MI, CHF] (10\\%)\nIn $50 \\%$ associated with:\nmetabolic imbalance (hypokalemia, hypocalcemia, hypo-magnesemia), drugs (narcotic analgesics, antidepressants, antipsychotic, calcium channel blockers, narcoleptics)\nAge: $>60$ years / younger patient with spinal disorder; $\\mathrm{M}>\\mathrm{F}$\n\n- abdominal pain ( $80 \\%$ ), abdominal distension\n- nausea \\& vomiting ( $80 \\%$ ), obstipation ( $40 \\%$ ), diarrhea\n- fever ( $37 \\%$ ), bowel sounds present\n$\\sqrt{ }$ massively dilated colon, especially cecum + right hemicolon (occasionally extending to rectum)\n$\\checkmark$ normal haustral markings\n$\\checkmark$ \"colon cut-off\" sign $\\leftarrow$ lack of gas in distal colon\n$\\checkmark$ small bowel air-fluid levels\n$\\checkmark$ absence of obstructive lesion on enema\n$C x$ : cecal perforation\nPrognosis: $15-45 \\%$ mortality\n$R x$ : nasogastric + rectal suctioning; neostigmine; colonic decompression (if cecum exceeds 10 cm )\n$D D x$ : toxic megacolon, mechanical obstruction\n\n\n## Chronic Colonic Pseudoobstruction\n\n$=$ recurrent or persistent pseudobstruction of colon\nPath: atrophic changes + decreased numbers of intramural ganglia (= sign of irreversible intramural plexus damage)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 833,
            "markdown": "- chronic constipation, repeated obstructive symptoms\n\nCT:\n$\\sqrt{ }$ marked colonic dilatation: cecum ( $4-10 \\mathrm{~cm}$ ), transverse colon (8.2-13.7 cm)\n$\\sqrt{ }$ intermediate transitional zone at / adjacent to splenic flexure (= transition zone of innervation from vagal to sacral nerves for proximal versus distal colon)\n$\\diamond$ Rarely accompanied by perforation!\n![img-91.jpeg](img-91.jpeg)\n\n# Chronic Intestinal Pseudoobstruction Syndrome \n\n$=$ nonpropulsive intestine characterized by impaired response to intestinal dilatation without definable cause; ? autosomal dominant\nCause:\n(1) Reduced density of interstitial cells of Cajal in colon (= intestinal pacemaker cells)\n(2) Neuropathic disorder: amyloidosis, diabetes, multiple sclerosis, brainstem tumor, stroke, spinal cord injury, Parkinsonism, paraneoplastic syndromes (antineuronal nuclear antibodies)\n(3) Myopathy: scleroderma\n(4) Medication: anticholinergic antidepressant, calcium channel blocker, alpha-2 adrenergic agonists\nAge: neonatal period / delayed for months + years, $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\n\n- recurrent attacks of nausea \\& vomiting (83\\%)",
            "images": [
                {
                    "id": "img-91.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 464,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1386,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 834,
            "markdown": "- abdominal pain ( $74 \\%$ ), abdominal distension (57\\%)\n- constipation (36\\%), diarrhea (29\\%)\n- persistently decreased peristalsis\n$\\checkmark$ esophageal dilation + hypoperistalsis (lower third)\n$\\checkmark$ excessive duodenal dilation (DDx: megaduodenum, superior mesenteric artery syndrome)\n$\\checkmark$ mild to marked gaseous distension of proximal small bowel\n$\\checkmark$ ligament of Treitz may be placed lower than usual\n$\\checkmark$ delayed transit of barium through affected segments\n$\\checkmark$ disordered motor activity (on fluoroscopy)\n$\\checkmark$ small bowel air-fluid levels + distension\n$\\checkmark$ disturbed intestinal transit\n\n\n# INTUSSUSCEPTION \n\n$=$ telescope-like invagination or prolapse of a segment of intestinal tract ( $=$ intussusceptum $=$ donor loop) into the lumen of the adjacent intestinal segment ( $=$ intussuscipiens $=$ receiving loop)\n$\\diamond$ The intussuscipiens contains the folded intussusceptum with entering limb + returning limb + their mesentery\nClassification by Location: enteroenteric, ileocolic, ileocecal, colocolic\nClassification by Cause: benign, malignant, idiopathic, $\\pm$ lead point\n\n## Intussusception in Children (94\\%)\n\nPrevalence: $2-4+1,000$ live births; most common abdominal emergency of early childhood $\\diamond$ Leading cause of acquired bowel obstruction in childhood!\nEtiology:\n(1) Idiopathic (over 95\\%): mucosal edema + lymphoid hyperplasia (= enlarged Peyer patches) following viral gastroenteritis; predominantly at ileocecal valve\n(2) Lead point (5\\%):\n(a) infants $<30$ days of age: Meckel diverticulum (most common), duplication cyst\n(b) children $>3$ years of age: Burkitt lymphoma, polyp in Peutz-Jeghers syndrome, polypoid hemangioma, enterogenous cyst, ectopic pancreas, suture granuloma, periappendicitis, Henoch-Schönlein purpura, coagulopathy, cystic fibrosis, inspissated meconium\nmnemonic: H DIMPL\nHenoch-Schönlein purpura\nDuplication cyst\nIdiopathic (= hypertrophied lymphoid tissue)\nMeckel diverticulum\nPolyp\nLymphosarcoma\nAge: peak incidence between 6 months and 2 years; 3-9 months (40\\%); $<1$ [ $<2$ ] $\\{>3\\}$ years $(50 \\%)[75 \\%]\\{<10 \\%\\} ; \\mathrm{M}+\\mathrm{F}=2+1$\n\n- classic triad:\n(1) Abrupt onset of acute colicky abdominal pain ( $94 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 835,
            "markdown": "(2) Red \"currant jelly\" stools / hematochezia (66\\%) usually only after $>48$ hours duration\n(3) Palpable abdominal mass (59\\%) / vomiting (91\\%)\n\n- diarrhea, restlessness, pallor, fever\n\nLocation: ileocolic (75-95\\%) > ileoileocolic (9\\%) > ileoileal (4\\%) > colocolic\nTip of intussusceptum: transverse colon + hepatic flexure + ascending colon (90\\%)\nPlain film ( $40-90 \\%$ accurate):\n$\\diamond$ Air within cecum excludes diagnosis of ileocecal intussusception!\nCAVE: Sigmoid colon may be mistaken for cecum as it is often positioned in RLQ in infants and children!\n$\\checkmark$ no abnormality in $25 \\%$\n$\\checkmark$ abdominal soft-tissue mass ( $50-60 \\%$ ), usually in RUQ:\n$\\checkmark$ \"target\" sign = concentric lucent rim surrounding a soft-tissue mass $\\leftarrow$ mesenteric fat of intussusceptum\n$\\checkmark$ \"meniscus\" sign = crescent of intraluminal colonic gas outlining the apex of the intussusceptum\n$\\checkmark$ loss of inferior hepatic margin\nThe target and meniscus signs are the most specific radiographic findings of an intussusception.\n$\\checkmark$ little air in small intestine:\n$\\checkmark$ paucity of gas in RLQ / pelvis\n$\\checkmark$ gasless lower abdomen\n$\\checkmark$ air in displaced appendix\n$\\checkmark$ small bowel obstruction for several hours ( $25 \\%$ ):\n$\\checkmark$ dilated loops of small bowel\n$\\checkmark$ stacked air-fluid levels\n$\\checkmark$ pneumoperitoneum (usually $>2-3$ days of symptoms)\nAntegrade barium study:\n$\\checkmark$ \"coiled spring\" appearance\n$\\checkmark$ beaklike abrupt narrowing of barium column demonstrating a central channel\nDiagnostic Enema:\nIndication: unusual age of child ( $<2$ months, $>4$ years), high fever, peritoneal signs\nContraindication: free air\n$\\checkmark$ \"meniscus\" sign = convex intracolic mass = rounded apex of intussusceptum protrudes into contrast column\n$\\checkmark$ \"coiled spring\" sign = edematous mucosal folds of returning limb of intussusceptum outlined by contrast material within lumen of colon\nUS ( $98 \\%$ sensitive, $98 \\%$ specific, $99 \\%$ NPV):\n$\\checkmark$ readily detectable mass over $5.0 \\times 2.5 \\mathrm{~cm}$\n$\\checkmark$ \"crescent-in-doughnut / target / bull's eye\" sign (on TRANSVERSE scan) = concentric rings of alternating hypoechoic + hyperechoic layers ( $=$ intussuscipiens) with central hyperechoic portion ( $=$ mesentery of intussusceptum)\n$\\checkmark$ \"pseudokidney / sandwich / hay fork\" sign (on LONGITUDINAL scan) = hypoechoic layers on each side of echogenic center of mesenteric fat\n$\\checkmark$ peritoneal fluid trapped inside intussusception in $<15 \\%$ (associated with irreducibility + ischemia)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 836,
            "markdown": "$\\sqrt{ }$ echogenic mesentery contains lymph nodes + ceco-appendiceal complex close to base of intussusception\n$\\sqrt{ }$ color Doppler demonstrates mesenteric vessels dragged between entering + returning wall of intussusceptum:\n$\\diamond$ Absence of blood flow within the intussusceptum $\\rightarrow$ suggests bowel necrosis (47\\%)!\n$\\diamond$ Presence of blood flow within the intussusceptum is a good predictor of reducibility!\nCT:\n$\\sqrt{ }$ sausage-shaped / targetoid mass of \"multiple concentric rings\" $=3$ concentric cylinders:\n(a) central $=$ canal + wall of intussusceptum\n(b) middle $=$ crescent of mesenteric fat\n(c) outer $=$ returning intussusceptum + intussuscipiens\n$\\sqrt{ }$ enhancing vessels within mesenteric fat\n$\\sqrt{ }$ proximal obstruction\n$C x$ : vascular compromise $\\leftarrow$ incorporation of mesentery (hemorrhage, infarction, acute inflammation)\n\n# Hydrostatic / Pneumatic Reduction \n\n$<1 \\%$ mortality if reduction occurs $<24$ hours after onset!\nOverall success rate: $70-85 \\%$\nContraindications: pneumoperitoneum, peritonitis, hypovolemic shock, severe dehydration\n$\\diamond$ Obtain abdominal radiograph to document absence of perforation before reduction!\nTechnique:\n» Sedation (debated) with morphine sulfate ( $0.2 \\mathrm{mg} / \\mathrm{kg} \\mathrm{IM}$ ) / fentanyl citrate IV (straining increases intraluminal pressure of distended colon)\n» Anal seal with 24-F Foley catheter + balloon inflation to size equal to interpediculate distance of L5; balloon pulled down to levator sling; taped to buttocks; both buttocks firmly taped together\n» $60 \\% \\mathrm{wt} / \\mathrm{vol}$ barium sulfate with container between $24-36$ inches above level of anus\n» Extensive reflux into small bowel desirable to exclude residual ileoileal intussusception\n$\\diamond$ Maximally 3 attempts for 3 minutes each\n$\\diamond$ Manual manipulation increases colonic pressure\n$\\diamond$ Reduction should be accomplished within 10 minutes\n\"Rule of 3s\":\n(1) 3.5 feet $(105 \\mathrm{~cm})$ above table $(=120 \\mathrm{mmHg})$\n(2) 3 attempts\n(3) 3 minutes between attempts $\\rightarrow$ delay allows venous congestion + edema to subside\nAlternative medium:\n(1) $1 \\div 4$ Gastrografin ${ }^{\\circledR}$-water solution raised to a height of 5 feet $(150 \\mathrm{~cm})$\n(2) Air (METHOD OF CHOICE): delivers higher intra-colonic pressures, faster, easier, less fluoroscopic time, barium-free colon in case of surgery, smaller tears, less contamination of peritoneal cavity",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 837,
            "markdown": "(3) Ultrasound-guided saline enema: NO limit to procedure time, low perforation rate Decreased Success Rate:\n(1) Duration of symptoms $>48$ hours\n(2) Significant dehydration\n(3) Radiographic signs of small bowel obstruction\n(4) Patient age $<3$ months or $>5$ years\n(5) Fluid trapped between layers of intussusception by US\n(6) Absence of color flow within intussusception\n\nCx: perforation ( $0.4-3.0 \\%$, colonic bursting pressure $\\sim 200 \\mathrm{mmHg}$ ); reduction of nonviable bowel; incomplete reduction; missed lead point\nPrognosis: $10-15 \\%$ rate of recurrence within first few days\n\n# Intussusception in Adults (5-6\\%) \n\nFrequency: accounts for $1 \\%$ of all bowel obstructions; $0.05 \\%$ of CT exams\nIn adults a lead point intussusception involving the small bowel is generally due to a benign condition and less often due to a neoplasm (usually a metastatic lesion).\n\n## Etiology:\n\nA. SPECIFIC CAUSE $(80 \\%)$ :\n\n1. Tumor: benign ( $1 / 3$; lipoma, leiomyoma, adenomatous polyp), malignant ( $1 / 5$; lymphoma, metastasis)\n2. Postsurgical changes ( $1 / 3$ ): adhesions adjacent to sutures / submucosal bowel edema / discoordinated motility\n3. Invaginated (= inverted) Meckel diverticulum\n4. Prolapsed gastric mucosa\n5. Aberrant pancreas\n6. Foreign body, feeding tube\n7. Chronic ulcer: TB, typhoid\n8. Prior gastroenteritis\n9. Gastroenterostomy, trauma\nspontaneous without anatomic lead point:\nceliac disease, scleroderma, Whipple disease, fasting, anxiety, agonal state\nB. IDIOPATHIC $(20 \\%)$\n\n| Causes of Adult Intestinal Lead Point Intussusception |  |  |\n| :--: | :--: | :--: |\n| Cause | Small Bowel | Large Bowel |\n| Benign | lipoma, adenomatous polyp, Meckel diverticulum | lipoma, adenomatous polyp |\n| Malignant | metastasis, lymphoma, adenocarcinoma | adenocarcinoma, <br> lymphoma, metastasis |\n| Idiopathic | postoperative adhesion, motility disorder | postoperative adhesion, motility disorder |\n\n- recurrent episodes of colicky pain, nausea, vomiting\n- abdominal tenderness, distension, change in bowel habits",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 838,
            "markdown": "- palpable mass (in up to $50 \\%$ ), bloody stool (in majority)\n\nLocation: ileoileal ( $40 \\%$ ) > ileocolic ( $15 \\%$ ), colocolic\nsmall bowel ( $55 \\%$ ): nonneoplastic ( $43 \\%$ ), benign neoplasm ( $40 \\%$ ), malignant neoplasm $(17 \\%)$\ncolon ( $45 \\%$ ): malignant neoplasm ( $48 \\%$ ), benign neoplasm ( $21 \\%$ ), nonneoplastic ( $31 \\%$ )\nPrognosis: self-limiting if intussusception $<3.5 \\mathrm{~cm}$ in length\n\n# Transient (Idiopathic) Intussusception \n\n$=$ temporary short-lived intussusception without clinical significance incidentally detected on abdominal CT\nCause: idiopathic; celiac disease, Crohn disease\n\n- asymptomatic\n\nLocation: small bowel, especially jejunum\n$\\sqrt{ }<3.5 \\mathrm{~cm}$ in length\n$\\sqrt{ }$ NO intestinal obstruction, NO lead point\n\n## ISCHEMIC COLITIS\n\n$=$ most common manifestation of ischemic injury to GI tract ( $50 \\%$ ) characterized by acute onset\n\n+ rapid clinical and radiographic evolutionary changes\n\nTypes:\n\n1. Occlusive / thromboembolic ischemic colitis ( $80 \\%$ )\n2. Nonocclusive ischemic colitis $(20 \\%)$\n$=$ major mesenteric vessels usually patent\n(a) low systemic flow state: hypovolemic shock, severe heart failure, arrhythmia, renal insufficiency, sepsis\n(b vasoconstricting drugs: cardiotonics, NSAID, amphetamines, cocaine\n3. Venous insufficiency\n\nPathophysiology:\ndecrease in blood flow to $20 \\%$ of normal flow associated with small vessel disease\n(hypoxia) + reperfusion injury when blood flow is reestablished; injury more severe if\nterminal vascular branches obstructed rather than proximal mesenteric arcades\nPath:\n(a) injury of mucosa + submucosa (the 2 most sensitive layers to ischemia) $\\rightarrow$ mucosal congestion, patchy necrosis, ulcerations, submucosal edema, hemorrhage\n$\\diamond$ Early mucosal injury is reversible!\n(b) injury of muscularis propria (after severe + prolonged ischemia) $\\rightarrow$ can lead to transmural necrosis $\\rightarrow$ fibrotic stricture, perforation, severe sepsis\nPrecipitating factors:\n(a) bowel obstruction: volvulus, carcinoma (proximal dilatation with increased intraluminal pressure and reduced blood flow)\n(b) thrombosis: myocardial infarction, oral contraceptives, collagen vascular disease, sickle cell disease, hemolytic-uremic syndrome\n(c) trauma: aortoiliac reconstruction ( $2 \\%$ ) with ligation of IMA, cardiac surgery\n(d) idiopathic / spontaneous: mainly in elderly",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 839,
            "markdown": "mnemonic: VINTS\nVasculitis\nIncarceration (hernia, volvulus)\nNonocclusive ischemia (shock, CHF)\nThrombosis (atherosclerosis, emboli, polycythemia vera, hyperviscosity)\nSpontaneous\nAge: usually $>50$ years; $\\mathrm{M}=\\mathrm{F}$\n\n- abrupt onset of lower abdominal pain + rectal bleeding\n- abdominal tenderness, diarrhea, lack of sepsis\n- negative stool cultures\n\nLocation: segmental involvement of any part of colon; left colon (46-90\\%); right colon (30\\%); entire colon ( $11 \\%$ ); transverse colon ( $9 \\%$ ); sigmoid colon ( $4 \\%$ ); rectum spared most commonly affected \"watershed\" segments:\n(a) Griffith point $(80 \\%)=$ junction between distribution of superior + inferior mesenteric arteries at splenic flexure\n(b) point of Sudeck = anastomotic plexus between inferior mesenteric artery + hypogastric vascular supply at rectosigmoid junction\nMean length of segmental involvement: 19 cm\nPlain film (usually normal):\n$\\sqrt{ }$ segmental thumbprinting = marginal indentations on mesenteric side (rare finding on plain film)\nBE (in $90 \\%$ abnormal):\n$\\diamond$ Double contrast BE is more sensitive than single contrast BE which may efface thumbprinting!\n$\\checkmark$ thumbprinting $(75 \\%) \\leftarrow$ submucosal hemorrhage + edema\n$\\checkmark$ transverse ridging $=$ markedly enlarged mucosal folds with some preserved wall pliability $\\leftarrow$ spasm\n$\\checkmark$ serrated mucosa $\\leftarrow$ inflammatory edema + superficial longitudinal / circumferential ulcerations\n$\\checkmark$ deep penetrating ulcers (late)\nCT (detection rate of $26-39 \\%$ ):\n$\\checkmark$ symmetric / lobulated segmental thickening of colonic wall between 2 and 20 (mean 8 ) mm :\n$\\checkmark$ shaggy configuration + alternating layers of high and low attenuation (= \"double halo\" sign) + marked pericolic streakiness of edema (wet appearance in $61 \\%$ )\n$\\checkmark$ sharply defined homogeneously enhancing wall + mild mural thickening (dry appearance in $33 \\%$ )\n$\\checkmark$ hyperattenuating mucosa in early stage $\\leftarrow$ hemorrhage\n$\\checkmark$ blood clot in SMA / SMV\n$\\checkmark$ loss of haustral markings\n$\\checkmark$ irregular narrowed atonic lumen (= thumbprinting)\n$\\checkmark$ curvilinear collection of intramural gas (pneumatosis coli in $6 \\%$ ) $\\rightarrow$ suggests bowel infarction\n$\\checkmark$ portal + mesenteric venous gas\n$\\checkmark$ pneumo- and retropneumoperitoneum ( $=$ the only PATHOGNOMONIC sign of transmural",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 840,
            "markdown": "necrosis)\nCECT:\n$\\checkmark$ hyperenhancing mucosa in early stage $\\leftarrow$ hyperemia\n$\\checkmark$ reduced / absent enhancement in later stage $\\leftarrow$ intense vasospasm accompanied by bowel dilatation\n$\\checkmark$ absent opacification in SMA / SMV distribution\nUS:\n$\\checkmark$ circumferential hypoechoic $>3 \\mathrm{~mm}$ thick bowel wall\n$\\checkmark$ variable loss of mural stratification (= indistinct layers)\n$\\checkmark$ abrupt transition from ischemic to normal bowel\n$\\checkmark$ absent / diminished color flow in bowel wall = indicator of severity of ischemia ( $82 \\%$ sensitive, $92 \\%$ specific)\n$\\checkmark$ absence of arterial signals; however, blood flow on Doppler may represent reperfusion of gut wall\n$\\checkmark$ usually unaltered perienteric fat\n$\\checkmark$ commonly associated with:\n$\\checkmark$ ascites, luminal bowel distention\n$\\checkmark$ pneumatosis intestinalis, gas within portal veins\nAngio (findings similar to inflammatory disease):\n$\\checkmark$ normal / slightly attenuated arterial supply\n$\\checkmark$ mild acceleration of arteriovenous transit time\n$\\checkmark$ small tortuous ectatic draining veins\nPrognosis:\n(1) Transient ischemia $=$ complete resolution within $1-3$ months ( $76 \\%$ )\n(2) Stricturing ischemia $=$ incomplete delayed healing\n$\\checkmark$ narrowed foldless segment of several cm in length with smooth tapering margins\n(3) Gangrene with necrosis + perforation (extremely uncommon)\n(4) Mortality rate of $11-36 \\%$\n\nDDx of dry appearance: ulcerative / granulomatous colitis\n$D D x$ of wet appearance: pseudomembranous colitis, CMV colitis\n\n# Ischemic Necrosis of Cecum \n\n$=$ rare spontaneous potentially life-threatening entity\nAssociated with: chronic heart disease, cardiopulmonary bypass surgery, systemic chemotherapy, cholesterol embolization, aortitis syndrome\nAge: elderly\nCT:\n$\\checkmark$ circumferential cecal wall thickening\n$\\checkmark$ mural stratification pattern $\\leftarrow$ submucosal edema\n$\\checkmark$ mild pericolic stranding with normal appendix and absence of diverticula\n$\\checkmark$ isolated pneumatosis coli\n$\\checkmark$ mesenteric / portal venous gas\n$\\checkmark$ pneumoperitoneum\n\n## JEJUNAL ATRESIA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 841,
            "markdown": "$\\diamond$ Air may be injected through nasogastric tube\n$\\diamond$ BE to exclude $2^{\\text {nd }}$ and $3^{\\text {rd }}$ areas of atresia\nCause: intrauterine ischemic injury to developing gut\nAge: majority presenting during $1^{\\text {st }}$ day of life\nIn $25 \\%$ associated with: malrotation, volvulus, gastroschisis, omphalocele\n\n- bilious vomiting, abdominal distension, failure to pass meconium\n\nPlain film:\nN.B.: difficult to tell colon from small bowel in neonate\n$\\checkmark 2-3$ dilated bowel loops\n$\\checkmark$ absence of gas in lower portion of abdomen\nBE:\nPurpose: to exclude large-bowel causes of obstruction, show anatomical size of colon, demonstrate meconium ileus\n$\\sqrt{ }$ microcolon / small colon / colon of normal caliber (due to sufficient intestinal secretions in remaining small bowel)\n$C x:$ meconium peritonitis $(5 \\%)$\n\n# JEJUNAL DIVERTICULAR DISEASE \n\n$=$ JEJUNAL DIVERTICULOSIS\n$=$ rarest form of gastrointestinal diverticular disease\nCause: disordered contractions of smooth muscle results in increased intraluminal pressure and mucosal herniation ( $=$ pulsion diverticula $=$ false diverticula)\nFrequency: $0.5-1.1-2.3 \\%$ on UGI; $0.3-4.5 \\%$ of autopsy series; $\\mathrm{M}>\\mathrm{F}$\nAge: $6^{\\text {th }}-7^{\\text {th }}$ decades\nLocation: $80 \\%$ in jejunum, $15 \\%$ in ileum (usually solitary), $5 \\%$ in jejunum + ileum\nSite: on mesenteric border near entrance of vasa recti\n\n- intermittent upper abdominal pain, flatulence, episodes of diarrhea (30\\%)\n\nSize: a few millimeters to $>10 \\mathrm{~cm}$\nPlain film:\n$\\checkmark$ air-fluid levels in multiple diverticula\n$\\checkmark$ slight dilatation of intestinal loops in area of diverticula\nBE:\n$\\checkmark$ may not fill (narrow neck / stagnant secretions)\n$\\checkmark$ trapped barium on delayed film after 24 hours\n$C x:$\n(1) Blind loop syndrome with bacterial overgrowth\n\n- steatorrhea, diarrhea, malabsorption, weight loss\n- megaloblastic anemia $\\leftarrow$ overgrowth of coliform bacteria leads to deconjugation of bile acids + intraluminal metabolism of vitamin $\\mathrm{B}_{12}$\n(2) Free perforation $=$ leading cause of pneumoperitoneum without peritonitis ( $21-40 \\%$ mortality)\n(3) Hemorrhage (few cases)\n(4) Diverticulitis\n(5) Intestinal obstruction: enterolith ileus",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 842,
            "markdown": "# JUVENILE POLYPOSIS \n\n$=$ rare autosomal dominant disease with variable penetrance characterized by development of multiple ( $>5$ ) juvenile polyps in GI tract\n$\\diamond$ Most common familial / nonfamilial colonic polyp in children (75\\%)!\nCategories:\nA. JUVENILE POLYPOSIS OF INFANCY\n\nAge: 4-6 years (range $1-10$ years); $\\mathrm{M} \\div \\mathrm{F}=3 \\div 2$\n\n- protein-losing enteropathy, hemorrhage\n$\\sqrt{ }$ intussusception\nB. COLONIC \\& GENERALIZED JUVENILE POLYPOSIS\n\nAge: in $85 \\%$ manifested by 20 years of age\nPath: hamartomatous polyps; adenomas may coexist\nHisto: little / no smooth muscle; hyperplasia of mucous glands; retention cysts develop with obstruction of gland orifices (multiple mucin-filled spaces); edematous inflamed expanded lamina propria\n$D D x$ : familial adenomatous polyposis, Peutz-Jeghers syndrome\n\n- rectal bleeding ( $95 \\%$ ) most commonly as intermittent bright red hematochezia; abdominal pain\n$\\leftarrow$ intussusception\n- anemia, diarrhea, constipation; prolapse of polyp / rectum (rare)\n\nLocation: rectosigmoid ( $80 \\%$ ); rare in small bowel + stomach; not in esophagus\n$\\sqrt{ }$ solitary polyp ( $75 \\%$ ); multiple polyps ( $1 / 2$ ) of smooth round contour\n$\\sqrt{ }$ lesion of pinpoint size / up to several cm in diameter\n$\\sqrt{ }$ invariably on stalk of variable length\n$D x$ : (1) Any number of polyps with family history\n(2) Polyps throughout the GI tract\n(3) $>5-10$ polyps in colon\n\nCx: colorectal cancer by 35 years of age (in 15\\%)\n$D D x$ : solitary juvenile polyps ( $<5$ polyps, $1 \\%$ prevalence in children)\n\n## KAPOSI SARCOMA\n\n[Moritz Kaposi (1837-1902), dermatologist in Vienna, Austria]\n$=$ multicentric low-grade malignant vascular neoplasm originating from endothelial cells of lymphatic / blood vessels\nCause: Human herpes virus type $8\\left(\\mathrm{HHV}_{8}\\right)$ and other cofactors (eg, cytokine-induced growth)\nFrequency: most common AIDS-related neoplasm (40-50\\%); in 51\\% of homosexual / bisexual men with AIDS; rare in hemophiliacs; $\\mathrm{M} \\div \\mathrm{F}=50 \\div 1$\nHisto: proliferation of spindle cells with numerous extravasated RBCs located in clefts between stromal cells\nAlmost always associated with: cutaneous disease\nVariants:\nA. IMMUNE DYSREGULATION\n\n1. Classic (sporadic / Mediterranean) Kaposi sarcoma\n\nAge: $50-80$ years; $\\mathrm{M} \\div \\mathrm{F}=10 \\div 1$ to $15 \\div 1$\nGeography: eastern European, Mediterranean, Askenazi Jews",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 843,
            "markdown": "2. Endemic (African) Kaposi sarcoma\n\nGeography: East Africa, Central Africa\nAge: 30-40 years; $\\mathrm{M} \\div \\mathrm{F}=13 \\div 1$ to $17 \\div 1$\nB. IMMUNOSUPPRESSIVE STATE\n3. Iatrogenic (organ transplant-related) Kaposi sarcoma\n\nPrevalence: $6 \\%$ of all organ transplant recipients and others on immunosuppressive therapy\nMean development time: 21 months\n4. AIDS-related (epidemic) Kaposi sarcoma\n\nPrevalence: up to $50 \\%$ in lifetime of homosexual male $>$ IV drug user $>$ hemophiliac $>$ woman\n@ Skin ( $66 \\%$, most frequent site)\n\n- multiple bluish red slightly elevated skin lesions\n@ Mucosal disease (56\\%)\nSite: intraoral, pharyngeal, laryngeal, nasal cavity\n$\\checkmark$ multiple nodular cutaneous / mucosal lesions\n$\\checkmark$ nonspecific MR: low T1 + high T2 signal intensity\n$\\checkmark$ CHARACTERISTIC avid enhancement\n@ Lymph node involvement ( $13-80 \\%, 2^{\\text {nd }}$ most frequent site):\n$\\checkmark$ hyperattenuating lymphadenopathy $\\leftarrow$ vascularity: peripancreatic, porta hepatis, retroperitoneal, mesenteric, inguinal, pelvic\nAssociated with: high frequency of GI tract involvement\n@ GI tract ( $40-50 \\%$ of AIDS-related Kaposi sarcomas; $3^{\\text {rd }}$ most frequent site):\n- usually clinically silent\n- concurrent with / after cutaneous disease\n$\\diamond$ GI tract is the only site of involvement in $<5 \\%$ !\nLocation: anywhere within GI tract; often multifocal\n$\\checkmark$ thickened nodular folds\n$\\checkmark$ single / multiple polypoidal $0.5-3.0-\\mathrm{cm}$ subepithelial nodules / masses:\n$\\checkmark \\pm$ central umbilication / ulceration (common) = \"bull's-eye\" / \"target\" lesions on BE\n$\\checkmark$ infiltrating linitis plastica lesion (rare)\n$\\checkmark$ mass enhancement greater than adjacent mucosa $\\leftarrow$ high tumor vascularity\n@ Liver \\& spleen ( $34 \\%$ at autopsy)\n$\\checkmark$ multiple $5-12-\\mathrm{mm}$ nodules hyperechoic on US, hypoattenuating on NECT/CECT indistinguishable from multiple hemangiomas\n$D D x$ : metastatic disease, fungal microabscesses, multiple areas of bacillary angiomatosis (= swollen venous lakes in liver)\n$\\checkmark$ splenomegaly\nPrognosis: infrequently contribute to morbidity + mortality\n@ Lung (18-47\\% of patients with cutaneous sarcoma):\n$=$ late complication of AIDS\nSite: bilateral symmetric peribronchovascular axial interstitium ( $91 \\%$ ); middle / lower lung zones $(92 \\%)$\n$\\checkmark$ coarsening of bronchovascular bundles:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 844,
            "markdown": "$\\checkmark$ tram track opacities\n$\\checkmark$ peribronchial cuffing\n$\\checkmark$ septal lines $(38-71 \\%)$\n$\\checkmark$ interlobular septal thickening + fissural nodularity\n$\\checkmark$ numerous perihilar ill-defined asymmetric coalescent clusters of consolidation $\\pm$ air bronchograms in $45 \\%$ (= confluent tumor)\n$\\checkmark$ small ( $50 \\%$ ) / large ( $28 \\%$ ) pulmonary nodules $\\leftarrow$ tumor proliferation extending into parenchyma:\n$\\checkmark$ \"halo\" sign = ground-glass opacities surrounding nodule\n$\\checkmark$ pleural effusion (33-67\\%), chylothorax (rare)\n$\\checkmark$ moderate lymphadenopathy ( $10-35 \\%$, late in disease): axillary, mediastinal, hilar\n$\\checkmark$ thoracic wall masses\n@ Musculoskeletal system\n$\\checkmark$ lytic cortical lesion\n$\\checkmark$ subcutaneous nodules\n$D x:$ endoscopic visualization + biopsy of mass of red-purple color\n\n# KILLIAN-JAMIESON DIVERTICULUM \n\n$=$ rare pulsion diverticulum through muscular gap in anterolateral wall of proximal cervical esophagus inferior to cricopharyngeus muscle\nCause: tightness of cricopharyngeal (= upper esophageal) sphincter $\\rightarrow$ retrograde reflux with increased pressure on relative sidewall weakness\nAge: usually $>60$ years (same as for Zenker diverticulum)\n\n- almost all asymptomatic\n\nLocation: muscular gap at Killian-Jamieson triangle just below cricopharyngeal muscle more inferiorly than Zenker diverticulum; bilateral in $25 \\%$\n$\\checkmark$ predominantly left lateral + anterior outpouching from cervical esophagus\n$C x:$ overflow aspiration\n\n## LADD BANDS\n\n$=$ PERITONEAL BANDS\n$=$ congenital fibrous stalk of peritoneal tissue\nAttachment:\n(a) normal: fixates right side of colon to peritoneal wall\n(b) malrotation: from RUQ ( $\\leftarrow$ malpositioned cecum / hepatic flexure) to right paracolic gutter extending across anterior surface of $2^{\\mathrm{nd}} / 3^{\\mathrm{rd}}$ portion of duodenum\nAssociated with: malrotation\n$C x$ : duodenal obstruction at its $2^{\\text {nd }}$ portion (even without volvulus)\n$\\checkmark$ oblique termination of duodenal contrast column\n\n## LEIOMYOMA\n\nN.B.: In older literature synonymous with GIST (far more frequent, variable risk of progression and metastasis)\nPath: arising from muscularis propria",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 845,
            "markdown": "Histo: low to moderate cellularity, intersecting fascicles of spindle cells with eosinophilic cytoplasm, desmin globules (occasionally)\n\n- negative for c-KIT, strongly diffusely positive for desmin + smooth muscle actin (DDx to GIST)\n@ Stomach (rare)\nLocation: gastric cardia\n$\\sqrt{ }$ low-attenuation mass with endoluminal growth pattern\n$\\sqrt{ }$ central ulceration for tumor $>2 \\mathrm{~cm}$ in diameter\nSize: $1.3-4.7 \\mathrm{~cm}$\n$D D x:$ GIST, schwannoma\n\n\n# Leiomyoma of Esophagus \n\n$\\diamond$ Most common benign subepithelial tumor of esophagus; 50 x less common than esophageal carcinoma\nFrequency: $1 \\div 1,119$ (autopsy study); $50 \\%$ of all benign esophageal tumors\nHisto: interlacing / palisading pattern of spindle cells with eosinophilic cytoplasm; areas of dense collagen may become calcified\nRARE: cystic degeneration, necrosis, ulceration\nAge: $\\quad 4-81$ years; $3 \\%$ in children; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 1$\n\n- usually asymptomatic (due to slow growth)\n- dysphagia, odynophagia, dyspepsia usually for $>2$ years\n- hematemesis if large (rare)\n\nSite: frequently lower + mid $1 / 3$ of esophagus (smooth muscle portion); intramural ( $97 \\%$ ); multiple leiomyomas in $3-4 \\%$\nSize: usually $<3 \\mathrm{~cm}$ (range, $2-15) \\mathrm{cm}$\nLeiomyomas have typical findings of an intramural mass $=$ smooth-surfaced crescent-shaped filling defect forming right or slightly obtuse angles with the esophageal wall.\n$\\checkmark$ smooth slightly lobulated well-defined intramural mass\n$\\checkmark$ homogeneous contrast enhancement\n$\\checkmark$ may have coarse calcifications (DDx: GIST)\nBarium:\n$\\checkmark$ smooth-surfaced crescent-shaped filling defect forming right / slightly obtuse angles with esophageal wall\n$\\checkmark$ deformity of lumen\n$\\checkmark$ occasionally encircling wall $\\rightarrow$ short stricture\nCAVE: high percentage misdiagnosed as extrinsic lesion!\nEndoscopic US ( $89 \\%$ accuracy):\n$\\checkmark$ homogeneous hypoechoic mass in muscularis mucosae / submucosa / muscularis propria\n$\\checkmark$ intact overlying mucosa\nCT:\n$\\checkmark$ homogeneous mediastinal mass in mid to lower esophagus\n$\\checkmark$ iso- / hypoattenuating to muscle\nMR:\n$\\checkmark$ slightly hyperintense mass on T2WI",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 846,
            "markdown": "PET:\n$\\sqrt{ }$ usually negative $\\leftarrow$ low mitotic rate\n$R x$ : endoscopic resection, surgical enucleation, observation\nDDx: (1) GIST (positive for CD117 + CD34, central low attenuation, 10 x less frequent than leiomyoma)\n(2) Duplication cyst ( $2^{\\text {nd }}$ most common benign lesion of esophagus, manifestation during childhood, may communicate with lumen)\n(3) Granular cell tumor (often multiple, less common)\n(4) Lymphoma; metastasis\n\n# Esophageal Leiomyomatosis \n\nMean age: 11 (range, 6-18) years; $\\mathrm{M}>\\mathrm{F}$\nCause: (1) Sporadic (50\\%)\n(2) Familial disease (20\\%): leiomyomas of uterus, vulva, tracheobronchial tree, small bowel, rectum\n(3) Alport syndrome (30\\%) = nephritis, high-frequency sensorineural hearing loss, congenital cataract $\\leftarrow$ germline deletion of collagen IV subunit genes on X-chromosome\nSite: distal $1 / 3$ or $1 / 2$ of esophagus $\\pm$ extension into proximal stomach\n\n- slowly progressive dysphagia over years\n$\\sqrt{ }$ smooth tapered narrowing of distal esophagus over an average length of 6 cm\n$\\sqrt{ }$ decreased / absent esophageal peristalsis\n$\\sqrt{ }$ smooth relatively symmetric defect at cardia $\\leftarrow$ thickened muscle bulging into gastric fundus\nCT:\n$\\sqrt{ }$ marked circumferential wall thickening of up to 4 cm by mass with relatively low soft-tissue attenuation\n$D D x$ : (1) Primary achalasia (shorter narrowed segment)\n(2) Secondary achalasia (older individual, recent onset of dysphagia)\n(3) Stricture from reflux esophagitis\n(4) Idiopathic muscular hypertrophy of the esophagus (in late adulthood, corkscrew appearance of esophagus with nonperistaltic contractions, cardia rarely involved)\n\n\n## Leiomyoma of Small Bowel\n\n$\\diamond$ Most common benign tumor of small bowel\nLocation: duodenum ( $21 \\%$ ), jejunum ( $48 \\%$ ), ileum ( $31 \\%$ ); single in $97 \\%$\nSite: mainly serosal ( $50 \\%$ ), mainly intraluminal ( $20 \\%$ ), intramural ( $10 \\%$ )\nSize: $\\quad<5 \\mathrm{~cm}(50 \\%), 5-10 \\mathrm{~cm}(25 \\%),>10 \\mathrm{~cm}(25 \\%)$\n$\\sqrt{ }$ small ulcer + large barium-filled cavity $\\leftarrow$ central necrosis + communication with lumen\n$\\sqrt{ }$ hypervascular\n\n## LEIOMYOSARCOMA\n\nFrequency: $6 \\%$ of all soft tissue sarcomas\nOrigin: smooth muscle cells within walls of blood vessels (most frequent); undifferentiated",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 847,
            "markdown": "mesenchymal cells\nMean age: 50 years\nLocation: head \\& neck (nasal cavity, paranasal sinuses), skin, cervical esophagus, larynx CT:\n$\\checkmark$ bulky mass remodelling bone\n$\\checkmark$ little enhancement, uncommon calcifications\nMR:\n$\\checkmark$ iso- to hypointense relative to muscle on T1WI\n$\\checkmark$ variably hyperintense relative to muscle on T2WI\n$\\checkmark$ prominent contrast enhancement\n\n# Leiomyosarcoma of Small Bowel \n\nLocation: duodenum (26\\%), jejunum (34\\%), ileum (40\\%)\n$\\checkmark$ usually $>6 \\mathrm{~cm}$ in size\n$\\checkmark$ nodular mass: intraluminal ( $10 \\%$ ), intraluminal pedunculated (5\\%), intramural (15\\%), chiefly extrinsic ( $66 \\%$ )\n$\\checkmark$ mucosa may be stretched + ulcerated ( $50 \\%$ )\n$\\checkmark$ may show central ulcer pit / fistula communicating with a large necrotic center\n$\\checkmark$ intussusception\n\n## Leiomyosarcoma of Stomach\n\nFrequency: $0.1-3.0 \\%$ of all gastric malignancies\nAge: $\\quad 10-73$ years; $\\mathrm{M}>\\mathrm{F}$\nHisto: pleomorphism, hypercellularity, mitotic figures, cystic degeneration, necrosis\n\n- GI bleeding (from ulceration), obstruction\n\nMetastases:\n(a) hematogenous to liver, lung, peritoneum; rarely to bone + soft tissue\n(b) direct extension into omentum, retroperitoneum\n(c) lymph nodes (rare)\n\nLocation: $90 \\%$ in fundus / body of stomach\nSite: anterior / posterior wall; endo- / exogastric\nAverage size: 12 cm\n$\\checkmark$ intramural mass; large mass tends to be exogastric\n$\\checkmark$ very frequently ulcerated\n$\\checkmark$ may be pedunculated\nCT:\n$\\checkmark$ lobulated irregular outline\n$\\checkmark$ heterogeneous exogastric mass with central zones of low density $\\leftarrow$ necrosis with liquefaction\n$\\checkmark$ air / positive contrast within tumor $\\leftarrow$ ulceration\n$\\checkmark$ dystrophic calcifications\n\n## Carney Triad\n\nTriad of (1) Gastric GIST\n(2) Functioning extraadrenal paraganglioma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 848,
            "markdown": "(3) Pulmonary chondroma\n\nPrevalence: 24 patients reported; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 11$\n\n# LIPOMA \n\n$=$ benign submucosal tumor composed of mature adipose tissue surrounded by a fibrous capsule\n$\\diamond$ Most common subepithelial tumor in colon!\nFrequency: in colon in $0.25-4.40 \\%$ (autopsy); $2-3 \\%$ of all benign gastric tumors\n\n- asymptomatic; may become symptomatic if $>2 \\mathrm{~cm}$\n- crampy pain, hemorrhage (rare) $\\leftarrow$ ulcerated overlying mucosa\n- \"pillow\" sign on optical colonoscopy = pale yellow protrusion, soft on probing\n\nLocation: colon (particularly cecum + ascending colon) $>$ duodenum $>$ ileum $>$ stomach (gastric antrum) $>$ jejunum $>$ esophagus\nSite: endoluminal-submucosal ( $90 \\%$ ); subserosal ( $10 \\%$ )\nSize: average 4 cm , up to 30 cm\n$\\sqrt{ }$ smooth broad-based, sharply outlined, round / ovoid globular mass of $1-3 \\mathrm{~cm}$ in diameter\n$\\sqrt{ }$ short thick pedicle in $1 / 3 \\leftarrow$ repeated peristaltic activity (= lead point for intussusception)\n$C x$ : pedunculated lesion (rare) may prolapse through pylorus $\\rightarrow$ intermittent gastric outlet obstruction\nRadiography:\n$\\sqrt{ } \\pm$ marked radiolucency\nFluoroscopy:\n$\\sqrt{ }$ change in shape + size on compression $\\leftarrow$ softness:\n$\\sqrt{ }$ \"squeeze\" sign = sausage-shaped mass on postevacuation radiographs\nCT:\n$\\sqrt{ }$ well-circumscribed spheric / ovoid subepithelial mass of uniform fat density ( -20 to -120 HU)\n$\\sqrt{ }$ density increases with inflammation $\\leftarrow$ ulceration\nMR:\n$\\sqrt{ }$ high fat SI on all sequences\n$\\sqrt{ }$ loss of SI on fat-suppressed images\nCx: (1) Intussusception (rare)\n(2) Central ulceration $\\leftarrow$ pressure necrosis of overlying mucosa by large lipoma (rare)\n\nPrognosis: NO liposarcomatous degeneration\n$R x$ : none; endoscopic / surgical resection if $>2 \\mathrm{~cm}$\n$D D x$ : lipomatosis of ileocecal valve (more common, symmetric enlargement of valve)\n\n## LYMPHANGIOMA\n\n$=$ congenital malformation of lymphatic vessels $\\rightarrow$ sequestered embryonic lymphatic vessels that have failed to communicate with the rest of the lymphatic / venous system\nPath: usually multiloculated large thin-walled cystic mass with chylous / serous / hemorrhagic fluid contents\nLocation: head \\& neck ( $95 \\%$ ); abdomen (mesentery, rarely affecting GI tract); retroperitoneum $(<1 \\%)$\n\n- well-defined often compressible cystic submucosal lesion at colonoscopy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 849,
            "markdown": "$\\sqrt{ }$ CHARACTERISTIC involvement of multiple compartments\n$\\sqrt{ }$ proximal bowel dilatation (in partial bowel obstruction)\nUS:\n$\\sqrt{ }$ elongated multiseptated cystic mass with lobules\n$\\sqrt{ }$ fluid anechoic / with internal echoes / sedimentation\nCT:\n$\\sqrt{ }$ cystic mass with contents of water- to fat-density (chyle)\nMR:\n$\\sqrt{ }$ T1-hypointense + T2-hyperintense $\\leftarrow$ serous content\n$\\sqrt{ }$ hyperintense on T1WI + T2WI $\\leftarrow$ hemorrhage / fat\n$R x:$ surgery (difficult due to intimate attachment to bowel wall)\n\n# LYMPHOGRANULOMA VENEREUM \n\n$=\\mathrm{LGV}=$ sexually transmitted disease caused by virus Chlamydia trachomatis producing a nonspecific granulomatous inflammatory response in infected mucosa (mononuclear cells + macrophages), perirectal lymphatic invasion\nLocation: rectum $\\pm$ extension to sigmoid + descending colon\n$\\mathrm{M} \\div \\mathrm{F}=3.4 \\div 1.0$\n$\\sqrt{ }$ narrowing + shortening + straightening of rectosigmoid\n$\\sqrt{ }$ widening of retrorectal space\n$\\sqrt{ }$ irregularity of mucosa + ulcerations\n$\\sqrt{ }$ paracolic abscess\n$\\sqrt{ }$ fistula to pericolic area, rectum, vagina (common)\n$R x:$ tetracyclines effective in acute phase before scarring has occurred\n\n## LYMPHOID HYPERPLASIA\n\nFrequency: normal variant in $13 \\%$ of BE examinations\nHisto: hyperplastic lymph follicles in lamina propria (Peyer patches) $\\leftarrow$ probably compensatory attempt for immunoglobulin deficiency\nEtiology:\n(1) Normal in child / young adult\n(2) Self-limiting local / systemic inflammation / infection / allergy\n(3) May be related to immunodeficiency / dysgammaglobulinemia with small bowel involvement\nAge: (a) generally in children $<2$ years\n(b) in adults invariably associated with late onset immunoglobulin deficiency (IgA, IgM)\nAssociated with: splenomegaly, large tonsils, eczematous dermatitis, achlorhydria, pernicious anemia, acute pancreatitis, colonic carcinoma\nAt risk for:\n(1) Good syndrome ( $10 \\%$ )\n$=$ gastric carcinoma + benign thymoma + lymphoid hyperplasia\n(2) Respiratory infections\n(3) Giardia lamblia infection ( $90 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 850,
            "markdown": "(4) Functional thyroid abnormalities\n\nLocation: primarily jejunum, may involve entire small bowel, ascending colon + hepatic flexure, seldom in sigmoid / rectum\n\n- malabsorption (diarrhea + steatorrhea)\n- low serum concentrations of $\\mathrm{IgA}, \\mathrm{IgG}, \\mathrm{IgM}$\n$\\checkmark$ mucosa studded with innumerable $1-3-\\mathrm{mm}$ small uniform polypoid lesions\n$\\checkmark$ lesions may be umbilicated (uncommon)\n\n\n# LYMPHOMA OF GASTROINTESTINAL TRACT \n\n$=$ PRIMARY LYMPHOMA OF BOWEL\nIncidence: worldwide $1 \\div 100,000$ per year: $4-20 \\%$ of all NHL; $0.9 \\%$ of all GI tumors; $10 \\%$ of patients with abdominal lymphoma have bowel involvement\n$\\diamond$ Most common extranodal manifestation of NHL (up to 20\\% of all NHL cases)!\n$\\diamond$ Most common gastrointestinal tumor in children!\n$\\diamond$ Extremely rare in Hodgkin disease!\nDx: (1) No palpable superficial nodes (2) Normal CXR (3) Normal WBC count (4)\nLymphoma limited to alimentary tract with involvement of only regional nodes (5) No involvement of liver or spleen\nManifestation:\nA. LOCALIZED (in early disease):\nlymphoid elements in lamina propria and submucosa\nB. DIFFUSE (advanced stage after dissemination)\n\nRisk factors: infection with HIV / Helicobacter pylori, long-standing celiac disease, systemic lupus erythematosus, inflammatory bowel disease (2-3-fold increase), immunosuppression (solid organ transplantation, 5-fold increase with immunosuppressive treatment of patients with inflammatory bowel disease)\nPredisposed: Arabs + Middle Eastern Jews\nAssociated with: celiac disease\nAge: 1st peak $<10$ years $+2^{\\text {nd }}$ peak 53 years; $\\mathrm{M} \\div \\mathrm{F}=3 \\div 2$\nHisto:\n(1) B-cell lymphoma (most common): in stomach\n\nDiffuse large B-cell lymphoma is most commonly found in stomach $>$ ileum + characterized by diffusely infiltrative nodular lesions with extensive ulcerations.\n(2) T-cell lymphoma (in celiac disease / peripheral T-cell lymphoma): in small intestine\n(3) Extranodal marginal zone B-cell lymphoma formerly:\n(a) low-grade Mucosa-Associated Lymphoid Tissue 50-72\\% of all primary gastric lymphomas (see below)\n(b) Immunoproliferative small intestinal disease\n$=$ Mediterranean / Middle Eastern lymphoma\n$=$ special form of MALT lymphoma in young patients of poor socioeconomic status with suspected infectious etiology\nMay be associated with: enlargement of extraabdominal lymph nodes, malabsorption\n\n- abdominal pain, weight loss",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 851,
            "markdown": "| Classification of GI Tract Lymphoma (WHO 2007) |  |\n| :-- | :--: |\n| Type of Lymphoma | Frequency |\n| B cell |  |\n| Diffuse large B-cell lymphoma | $38-57 \\%$ |\n| Extranodal marginal zone B-cell lymphoma | $23-48 \\%$ |\n| Mantle cell lymphoma (polyposis) | $<1-13 \\%$ |\n| Follicular lymphoma (in duodenum, jejunum) | $2-12 \\%$ |\n| Burkitt lymphoma (in children) | $1-5 \\%$ |\n| Hodgkin lymphoma | $<1 \\%$ |\n| T cell | $3 \\%$ |\n| Enteropathy-associated T-cell lymphoma |  |\n\nLymphomas are a heterogeneous group of neoplasms with varying sites of GI involvement + varying gross and histologic features $\\rightarrow$ wide spectrum of imaging findings\n\n# Radiographic morphology: \n\n1. Polypoid / nodular (47\\%)\n$\\sqrt{ }$ enlarged nodular folds with a range of nodule sizes\n$\\sqrt{ }$ solitary / multiple smooth subepithelial polypoid masses that may ulcerate\n$\\sqrt{ }$ cobblestone pattern $\\leftarrow$ lymphomatous polyps\n$\\sqrt{ }$ normal / thickened surrounding tissue\n$\\sqrt{ }$ sprue pattern $\\rightarrow$ may cause intussusception\n$\\sqrt{ }$ multiple lymphomatous polyposis\n$=$ rare disorder characterized by numerous small polypoid lesions covering long segments of GI tract, typically a manifestation of mantle cell lymphoma\n2. Single ulcerative mass $(42 \\%)$\n$\\sqrt{ }$ circumferential bulky mass in intestinal wall, often extending into mesentery + regional nodes\n$\\sqrt{ }$ asymmetric bowel wall involvement $\\pm$ exophytic component\n$\\sqrt{ } \\pm$ intussusception\n$\\sqrt{ }$ obstruction unusual $\\leftarrow$ tumor soft and pliable without desmoplastic response\n$C x$ : fistula, perforation\n$D D x$ : simple peptic ulcer, superficial carcinoma\n3. Circumferential / constrictive diffusely infiltrative ( $11 \\%$ )\n$\\sqrt{ }$ focal / diffuse thickening of bowel wall\n$\\sqrt{ }$ decreased / absent peristalsis\n$\\sqrt{ } \\pm$ hose- / tubelike segments of luminal narrowing with obstruction (rare) $\\leftarrow$ desmoplastic response (rare)\n$\\sqrt{ } \\pm$ ulceration with considerable excavation\n$D D x$ : adenocarcinoma (shorter segment of involvement, more abrupt transition from tumor to normal bowel)\n4. Aneurysmal / cavitary\n$\\sqrt{ }$ nonperistaltic segment with circumferential dilatation $\\leftarrow$ destruction of muscularis propria + autonomic plexus forming large cavity:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 852,
            "markdown": "$\\sqrt{ }$ large mass with only small intramural component\n$\\sqrt{ }$ irregular lobulated margin $\\pm$ small nodules at margin of involved segment\n$\\sqrt{ }$ tumor involvement of mesentery $\\rightarrow$ cavitated endoexoenteric mass filled with enteric contrast:\n$\\sqrt{ } \\pm$ ulcer + fistula + aneurysmatic dilatation\n$D D x$ : gastrointestinal stromal tumor (GIST), perforated colonic adenocarcinoma, metastatic disease (especially melanoma)\n5. Mixed\n$\\sqrt{ }$ alternating constriction + dilatation with involvement of a lengthy segment\n\n| Staging of Primary Gastrointestinal Tract Lymphoma <br> (Consensus Conference in Laguano, 1993) |  |\n| :--: | :--: |\n| Stage | Involvement |\n| I | tumor confined to gastrointestinal tract as single <br> primary site / multiple noncontiguous lesions |\n| II | tumor extends into abdominal cavity from primary <br> gastrointestinal site |\n| $\\mathrm{II}_{1}$ | local nodal involvement |\n| $\\mathrm{II}_{2}$ | distant nodal involvement |\n| III | penetration through serosa to involve adjacent <br> organs/tissues |\n| IV | disseminated extranodal involvement / GI tract <br> lesion with supradiaphragmatic nodal involvement |\n\n6. Mesenteric / retroperitoneal adenopathy\n$\\sqrt{ }$ single / multiple extraluminal masses displacing bowel\n$\\sqrt{ }$ ill-defined confluent mass engulfing + encasing multiple loops of adjacent bowel\n$\\sqrt{ }$ \"sandwich configuration\" = mass surrounding mesenteric vessels that are separated by perivascular fat\n$\\sqrt{ }$ conglomerate mantle of retroperitoneal + mesenteric mass\nCT staging:\nStage I tumor confined to bowel wall\nStage II limited to local nodes\nStage III widespread nodal disease\nStage IV disseminated to bone marrow, liver, other organs\n\n- abdominal pain, weight loss\n\nLocation: $10-25 \\%$ of NHL are extranodal; stomach ( $50 \\%$ ) > small bowel > ileocecal region\n$(\\leftarrow$ Peyer patches $)>$ colon + rectum $(0.4 \\%)>$ esophagus; multicentric in $10-50 \\%$\nSite: originates in submucosa / deep mucosal layer $\\rightarrow$ may be missed at endoscopy\nCT:\n$\\sqrt{ }$ mild to moderate homogeneous circumferential thickening of stomach / bowel wall:\n$\\sqrt{ }$ hypo- / isoattenuating compared with normal bowel\n$\\sqrt{ }$ enhances less than normal bowel\n$\\sqrt{ } \\pm$ luminal constriction, dilatation, cavitation\n$\\sqrt{ }$ typically bulky diffuse regional / mesenteric adenopathy\n$\\sqrt{ }$ enlargement of spleen",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 853,
            "markdown": "MR:\n$\\sqrt{ }$ wall thickening $\\pm$ polypoid / ulcerated lesions:\n$\\sqrt{ }$ heterogeneous increased T2 signal intensity\n$\\sqrt{ }$ homogeneous intermediate T1 signal intensity\n$\\sqrt{ }$ mild to moderate enhancement\n$\\sqrt{ } \\uparrow$ SI at DWI (ADC values higher than in gastric cancer)\nLymphadenopathy extending below renal hila or of bulky character makes lymphoma a likely diagnosis!\nPrognosis: 71-82\\% [0\\%] 2-year survival rate in isolated bowel lymphoma [stage IV disease with bowel involvement]\nCx during chemotherapy: perforation ( $9-40 \\%$ ), hemorrhage\n$D D x$ : Secondary Intestinal Lymphoma (as part of generalized systemic process)\n@ Esophagus ( $<1 \\%$, least common site of GI involvement)\nHisto: predominantly B-cell type / MALT\nEsophagram:\n$\\checkmark$ predominantly subepithelial infiltration\n$\\checkmark$ mucosal ulceration\nEsophagram / CT:\n$\\checkmark$ polypoid mass / nodularity\nCx: perforation, fistulization\n@ Stomach ( $50-70 \\%$, most frequently involved site of GI tract)\nFrequency:\naccounting for only $1-5 \\%$ of all gastric malignancies; most common site of extranodal lymphoma ( $25 \\%$ ); isolated primary gastric malignancy in $10 \\%$; NHL $\\div$ Hodgkin disease $=$ $10 \\div 1$\nHisto:\n(a) low-grade Mucosa-Associated Lymphoid Tissue = MALT lymphoma (in 50-70\\%)\n$\\rightarrow$ development to high-grade B-cell lymphoma over time\nGastric extranodal marginal zone B-cell lymphoma is usually a superficial spreading lesion confined to mucosa + submucosa occurring anywhere in the stomach and often multifocal.\n(b) diffuse large B-cell lymphoma\n\nLocation: no predilection for any particular gastric region\nSite: arises in lymphoid tissue of lamina propria $\\leftarrow$ chronic Helicobacter pylori gastritis (normally gastric mucosa has no lymphoid tissue!)\nDirect extension into: pancreas, spleen, transverse colon, liver\n\n- epigastric pain, dyspepsia\n$\\checkmark$ gastric lymphoma is suggested by multiple polypoid tumors with central ulceration (\"bull's eyes\"), giant cavitating lesion, or extensive infiltration with gastric fold thickening!\n$\\checkmark$ pliant gastric wall\n$\\checkmark$ duodenum often affected when antrum involved\n$\\checkmark$ circumscribed mass with endogastric / exogastric ( $25 \\%$ ) growth\n$\\checkmark$ abnormal bulge in gastric contour that fills with oral contrast material\n$\\checkmark$ infiltrative pattern with broad tortuous thickened folds (diffuse form)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 854,
            "markdown": "$\\checkmark$ polypoid / nodular pattern\n$\\checkmark$ cavitary pattern with large irregular bull's-eye ulcer\n$\\checkmark$ luminal narrowing / loss of gastric distensibility (rare)\nCT:\n$\\checkmark$ diffuse involvement of entire stomach ( $50 \\%$ ), typically more than half of gastric circumference\n$\\checkmark$ segmental involvement $(15 \\%)$\n$\\checkmark$ ulcerated mass $(8 \\%)$\n$\\checkmark$ average wall thickness of $4-5 \\mathrm{~cm}$\n$\\checkmark$ luminal irregularity $(66 \\%)$\n$\\checkmark$ hyperrugosity $(58 \\%)$\n$\\checkmark$ perigastric adenopathy (in $50-60 \\%$ )\nPrognosis: 55\\% 5-year survival rate after resection; MALT may regress completely after antibiotic therapy\n$D D x$ : gastric adenocarcinoma (milder more focal wall thickening, tumor infiltration beyond gastric wall = perigastric fat plane not likely preserved, greater tumor enhancement, luminal narrowing, mural rigidity, linitis plastica, smaller lymph nodes above the level of renal veins)\n@: Small bowel ( $20-30 \\%$ of all abdominal lymphomas)\nFrequency: $2^{\\text {nd }}$ most common site of GI tract involvement; with $20 \\%$ most common small bowel malignancy; most common cause of intussusception in children $>6$ years\nLocation: ileum ( $51 \\%$ ) > jejunum ( $47 \\%$ ) > duodenum ( $2 \\%$ ); solitary ( $75-90 \\%$ ) vs. multiple sites $(10-25 \\%)$\nSite: arising from lymphoid patches of Peyer\n$\\checkmark$ nodular / multiple polypoid pattern\n$\\checkmark$ single mass\n$\\checkmark$ plaquelike thickening of wall $>5[>10] \\mathrm{cm}$ in length in $80 \\%$ [20\\%] (DDx: Crohn disease)\n$\\checkmark$ irregular segmental thickening of valvulae with corrugated appearance\n$\\checkmark$ exophytic $=$ endoexoenteric mass\n$\\checkmark$ mesenteric / retroperitoneal adenopathy\nUS:\n$\\checkmark$ hypo- to anechoic circumferential wall thickening\n$\\checkmark$ destruction of mural stratification\n$\\checkmark$ nodular / bulky tumor\n$\\checkmark$ aneurysmal dilatation of the lumen $\\leftarrow$ destruction of autonomic nerve plexus\n$\\checkmark$ bowel obstruction (rare) $\\leftarrow$ no desmoplastic response\n$\\checkmark$ loss of peristalsis $=$ late sign\n$\\checkmark$ intussusception\n$C x$ : perforation into adjacent mesentery $\\rightarrow$ formation of confined usually sterile abscess\n@ Terminal ileum \\& cecum\n$\\diamond$ Most common site of primary lymphoma of small and large bowel $\\leftarrow$ Peyer patches\n$\\checkmark$ single $1.5-7.0 \\mathrm{~cm}$ long / multiple segments of usually marked circumferential symmetric wall thickening:\n$\\checkmark$ gradual transition to normal bowel",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 855,
            "markdown": "$\\sqrt{ }$ homogeneous attenuation + poor enhancement\n$\\sqrt{ }$ polypoid lesion of variable size $\\rightarrow$ possible lead point for intussusception\n$\\sqrt{ }$ may extend into appendix\nCx: ulceration $\\rightarrow$ fistulous tract to adjacent bowel loops\nDDx: GIST\n@ Colon ( $1.5 \\%$ of all abdominal lymphomas)\nFrequency: less commonly involved than stomach / small bowel\nHisto: nearly all non-Hodgkin B-cell lymphoma\nRisk factors: immunosuppression (AIDS, organ transplant recipient), inflammatory bowel disease\nLocation: ileocecal region most commonly involved ( $85 \\%$ ) > rectosigmoid region\n\n- nonspecific $\\pm$ gastrointestinal bleeding\n$\\sqrt{ }$ solitary bulky mass $>$ diffuse infiltration $>$ multifocal polypoid lesions\n$\\sqrt{ }$ gross mural circumferential / nodular wall thickening in a long segment (with an average length of 5 cm )\n$\\sqrt{ }$ annular mass $\\pm$ ulceration\n$\\sqrt{ }$ paradoxical dilatation $\\leftarrow$ submucosal lymphoid infiltration weakens muscularis propria\n$\\sqrt{ }$ slight enhancement\n$\\sqrt{ }$ massive often absent regional + distant mesenteric + retroperitoneal adenopathy\n$R x$ : surgical resection followed by adjuvant chemotherapy\n$D D x$ : neutropenic colitis (contiguous involvement of cecum + ascending colon, mural stratification of affected segment)\n\n| Distinguishing CT Findings of |\n| :-- |\n| Colonic Lymphoma versus Adenocarcinoma |\n| $\\sqrt{ }$ extension into terminal ileum |\n| $\\sqrt{ }$ well-defined margins + preservation of fat planes |\n| $\\sqrt{ }$ no invasion of adjacent structures |\n| $\\sqrt{ }$ perforation without desmoplastic reaction |\n| $\\sqrt{ }$ severe luminal narrowing |\n| without obstruction and with preserved pliability |\n\n# Diffuse Large B-Cell Lymphoma (38-57\\%) \n\nPrimary GI diffuse large B-cell lymphoma affects commonly stomach $>$ ileum and is characterized by diffusely infiltrative and nodular lesions with extensive ulcerations.\n$\\diamond$ Most common type of GI lymphoma in adults!\nTransformation from: extranodal marginal zone lymphoma (concomitant in $>1 / 3$ )\nPah: lymphomatous cells involve the bowel wall from submucosa to serosa + may directly invade adjacent structures\nGrowth pattern: exophytic + annular ( $\\pm$ intraluminal) with full-thickness involvement of bowel wall\nLocation: stomach (most common) > distal ileum\n@ Stomach\nBarium:\n$\\sqrt{ }$ diffusely thickened folds / bulky masses",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 856,
            "markdown": "$\\sqrt{ }$ deep areas of ulceration / cavitation (frequent)\nCT:\n$\\checkmark$ gastric wall thickness of $>1-8 \\mathrm{~cm}$\n$\\checkmark$ thin band of mucosal enhancement during early arterial phase\n$\\checkmark$ delayed homogeneous enhancement of bulky submucosal mass\n$\\checkmark \\pm$ low-attenuation areas of necrosis\n$\\checkmark$ abdominal lymphadenopathy (most)\nPET:\n$\\checkmark$ FDG avidity in $97 \\%$\n@ Small bowel\n$\\checkmark$ segmental aneurysmal dilatation ( $=$ luminal diameter $>4 \\mathrm{~cm}$ in area of thickened bowel wall) in $31 \\% \\leftarrow$ weakened muscularis propria + destruction of autonomic nerve plexus\nCx: (1) Perforation $\\leftarrow$ absence of desmoplastic response\n(2) Obstruction (uncommon)\n\nDDx: (1) Adenocarcinoma\n(2) Inflammation / infection (preserved wall stratification)\n\n# Extranodal Marginal Zone B-Cell Lymphoma (23-48\\%) \n\n$=$ low-grade Mucosa-Associated Lymphoid Tissue $=$ MALT lymphoma\n$=$ low-grade lymphoma involving cells that arise from the marginal zone surrounding lymphoid follicles\nAge: $\\quad>50$ years; $\\mathrm{M} \\div \\mathrm{F}=1.2 \\div 1$\nLocation: stomach ( $85 \\%$ ), small bowel (Mediterranean lymphoma) and colon ( $12 \\%$ ), esophagus (rare)\nPathophysiology: gram-negative Helicobacter pylori infection $\\rightarrow$ chronic gastritis $\\rightarrow$ reactive lymphoid follicles $\\rightarrow$ MALT lymphoma\nUpper GI:\n$\\sqrt{ }<1 \\mathrm{~cm}$ round often confluent mucosal nodules $(30-52 \\%) \\leftarrow$ focal enlargement of the lamina propria\n$\\checkmark$ shallow ulcer + thickened folds / focal mass (39-50\\%)\nCT:\n$\\checkmark$ segmental ( $<50 \\%$ of stomach) mild thickening of gastric wall (between 5 and 10 mm )\n$\\checkmark$ abdominal lymphadenopathy ( $14-24 \\%$ )\nCECT:\n$\\checkmark$ iso- / hypoattenuating compared with normal gastric wall\nPET (limited):\n$\\checkmark$ difficult to discern $\\leftarrow$ indolent growth pattern + background GI accumulation (FDG uptake in only $71 \\%$ )\n\n## Follicular Lymphoma (2-12\\%)\n\n$=$ low-grade indolent tumor that does not require treatment\n$\\diamond$ Most common nodal lymphoma in Western countries\nMedian age: 56 (range, 26-81) years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$\nGenetics: CD10 positive; overexpression of anti-apoptotic proteins (in $90 \\%$ ) $\\leftarrow$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 857,
            "markdown": "translocation $\\mathrm{t}(14 ; 18)(\\mathrm{q} 32 ; 21)$\nLocation: duodenum, jejunum\n$\\sqrt{ }$ multiple scattered / confluent small-bowel nodules of varying size\nCT (polyps may not be recognizable due to small size):\n$\\checkmark$ bowel wall thickening (in 15\\%)\nPET (only $46 \\%$ sensitive)\nProgression: may develop into diffuse large B-cell lymphoma\nPrognosis: 98 months median relapse-free survival\n\n# Mantle Cell Lymphoma (9-13\\%) \n\n$=$ aggressive form of lymphoma\nHisto: pregerminal center-type lymphomatous cells that arise from inner mantle zone of lymphoid follicle\nGenetics: overexpression of immunohistochemical marker cyclin D1 $\\leftarrow$ translocation $\\mathrm{t}(11 ; 14)(\\mathrm{q} 13 ; \\mathrm{q} 32)$\nMean age: 62 years\nLocation: ileum $>$ ascending colon $>$ rectum\n$\\checkmark$ lymphomatous polyposis (most common form):\n$=$ numerous small polyps / nodules throughout GI tract of up to 4 cm in size\nCT (polypoid nature of nodules may not be apparent):\n$\\checkmark$ nonobstructive bowel wall thickening + mass formation\n$\\checkmark$ abdominal lymphadenopathy (most)\n$\\checkmark$ extra-abdominal involvement\nPrognosis: poor; median survival of 3-4 years\n$D D x$ : (1) Inherited polyposis (family history, in childhood / early adulthood, mucocutaneous pigmentation, fibromatosis, osteomas, dental anomalies)\n(2) Blood-borne metastases: breast, lung, malignant melanoma, lymphoma (usually larger lesions, more sporadic, submucosal masses, bull's-eye / target appearance with central ulcer)\n(3) Extranodal marginal zone B-cell lymphoma\n(4) Follicular lymphoma\n\nRx: autologous stem cell transplantation\n\n## Peripheral T-Cell Lymphoma\n\nFrequency: 5-30\\% of all NHL\nAge: middle age + elderly\nHisto: mature T-cell phenotype\nLocation: bone marrow, skin, lung, liver, GI tract (3\\%)\nSite: small intestine ( $64 \\%$, esp. duodenum + jejunum)\n\n- $\\pm$ malabsorption\n$\\checkmark$ multifocal bowel involvement\n$\\checkmark$ mild $(<1 \\mathrm{~cm}) / 1-2 \\mathrm{~cm}$ gastric / bowel thickening\n$\\checkmark$ polypoid mass (rare; common in B-cell lymphoma)\n$\\checkmark$ thickened plaques, ulcers, strictures",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 858,
            "markdown": "$\\sqrt{ }$ nonbulky lymphadenopathy (bulky in B-cell lymphoma)\n$\\sqrt{ }$ hepatosplenomegaly\nT-cell lymphoma compared with large B-cell lymphoma\n(a) more frequently involves proximal small bowel\n(b) more likely shows multifocal involvement\n(c) has a higher frequency of perforation.\n\nCx: bowel perforation with pneumoperitoneum ( $41-50 \\%$ compared with $<30 \\%$ in B-cell lymphoma)\n\n# Enteropathy-associated T-cell Lymphoma \n\nFrequency: 3\\% of all primary gastrointestinal NHL\nClassification:\nType I ( $80-90 \\%)$ :\nStrongly associated with: celiac disease\nType II:\n$=$ Monomorphic CD56+ intestinal lymphoma\nLymphoma may develop any time during the course of celiac disease, including the time of initial diagnosis.\n\nMedian age: 50s; $\\mathrm{M}>\\mathrm{F}$\nLocation: particularly in proximal small bowel: jejunum / proximal ileum\n\n| DDx of Peripheral T-Cell versus Large B-Cell Lymphoma |  |  |\n| :-- | :-- | :-- |\n| Feature | T-cell Lymphoma | B-cell Lymphoma |\n| Small bowel involvement | proximal | distal |\n| Multifocality | $50-72 \\%$ | $10-25 \\%$ |\n| Perforation | $41-50 \\%$ | $<30 \\%$ |\n| $\\checkmark$ polypoid mass | rare | common |\n| Bowel wall character | thickened plaque, | exophytic |\n|  | ulcer, stricture | annular mass |\n| Lymphadenopathy | nonbulky | bulky |\n\nBarium:\n$\\checkmark$ thickened nodular folds, ulcers, strictures\nCT:\n$\\checkmark$ circumferential wall thickening\n$\\checkmark \\pm$ accompanying lymphadenopathy\n$\\checkmark \\pm$ infiltration of mesenteric fat\nPET:\n$\\checkmark$ FDG uptake in $86-100 \\%$\nPrognosis: poor\nCx: intestinal perforation ( $16 \\%$ in Type I, 33\\% in Type II)\n$D D x$ : (1) Diffuse large B-cell lymphoma\n(2) Refractory celiac disease (no FDG uptake)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 859,
            "markdown": "2860",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 860,
            "markdown": "# LYMPHOMA OF THE MESENTERY \n\n$\\diamond$ Most common malignancy involving the mesentery and omentum and most common cause of mesenteric masses\n$\\diamond$ NHL is $3^{\\text {rd }}$ most common malignancy in children $<15$ years\n$\\diamond$ Mesentery involved in $30-50 \\%$ of NHL $+4-5 \\%$ of Hodgkin dz.\nIncidence of NHL: 1100 children annually in USA\nAssociated with: retroperitoneal lymphadenopathy\n$\\sqrt{ }$ \"sandwich\" sign = mesenteric lymphadenopathy surrounding mesenteric vessels:\n$\\checkmark$ round / oval soft-tissue opacities\n$\\checkmark$ irregular masses / lobulated cake-like heterogeneous mass with areas of low attenuation necrosis\n$\\checkmark$ mildly enhancing\n$\\checkmark$ \"misty mesentery\" = mesenteric fat stranding (especially after chemotherapy)\n$\\checkmark$ direct extension into small bowel\n$\\checkmark$ displacement of small\n$D D x$ : sclerosing mesenteritis, inflammatory infectious / noninfectious disease\n\n## MALIGNANT MELANOMA\n\n$=$ develops from melanocytes derived from neural crest cells, arising in preexisting benign nevi (in $20 \\%$ )\nFrequency: $1 \\%$ of all cancers; increasing at $3.9 \\%$ annually\nPeak prevalence: $40-60$ years of age\nRisk factors: dysplastic mole, atypical melanocytic hyperplasia, xeroderma pigmentosum, melanoma in first-degree relative, sun-sensitive phenotype, excessive sun exposure\nPrimary sites: skin, mucous membranes, leptomeninges, eye\n\n- areas of red / white / blue in addition to brown and black colors of benign nevi\n- irregular borders with notching + striking protrusions\n@ Skin primary\nClark staging:\nLevel I all tumor cells above basement membrane (in situ lesion)\nLevel II tumor extends to papillary dermis\nLevel III tumor extends to interface between papillary + reticular dermis\nLevel IV tumor extends between bundles of collagen of reticular dermis\nLevel V tumor invasion of subcutaneous tissue (in $87 \\%$ metastatic)\nBreslow staging:\nthin $<0.75 \\mathrm{~mm}$ depth of invasion\nintermediate $0.76-3.99 \\mathrm{~mm}$ depth of invasion\nthick $>4.00 \\mathrm{~mm}$ depth of invasion\nMetastases:\nLatent period of 2-20 years after initial diagnosis (most commonly 2-5 years)\nPrimary site: head + neck ( $79 \\%$ ), eye ( $77 \\%$ ), GU system ( $67 \\%$ ), GI tract (in up to $60 \\%$ )\n@ Lymphadenopathy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 861,
            "markdown": "> in $23 \\%[75 \\%]$ with level II + IV [V]\n\n- sentinel node biopsy:\n$\\checkmark$ intraoperative intradermal injection of dye\n$\\checkmark$ preoperative lymphoscintigraphy\n@ Bone $(7-17 \\%)$\nPrevalence: $30-40 \\%$ at autopsy\n- often initial manifestation of recurrence, poor prognosis\n\nLocation: axial skeleton ( $80 \\%$ ), ribs ( $38 \\%$ )\n$\\checkmark$ predominantly osteolytic\nMR of melanotic melanoma:\n$\\checkmark$ hypo- / isointense on T1WI + T2WI + STIR images (most commonly)\n$\\checkmark$ hyperintense on T1WI + hypointense on T2WI $\\leftarrow$ T1-shortening effect of the paramagnetic metals iron + copper bound to melanin\n$D D x$ : melanotic / amelanotic hemorrhagic tumor (hyper-intense on T1WI + iso- / hyperintense on T2WI)\n@ Lung ( $70 \\%$ at autopsy): most common site of relapse\n\n- respiratory failure $\\rightarrow$ most common cause of death\n@ Liver (17-23\\%; 58-66\\% at autopsy)\n$\\checkmark$ single / multiple lesions $0.5-15 \\mathrm{~cm}$ in size\n$\\checkmark$ larger lesion often necrotic\n$\\checkmark$ may be partially calcified\n@ Spleen ( $1-5 \\% ; 33 \\%$ at autopsy)\n$\\checkmark$ single / multiple lesions of variable size\n$\\checkmark$ solid / cystic\n@ GI tract + mesentery (4-8\\%)\n- abdominal pain, GI bleeding\n\nLocation: small intestine (35-70\\%) > colon (14-20\\%) > stomach (7-20\\%)\n$\\checkmark$ multiple hypervascular subepithelial nodules:\n$\\checkmark$ \"bull's-eye / target\" appearance on BE = central ulceration $\\leftarrow$ tendency to outgrow blood supply\n$\\checkmark$ localized to antimesenteric border of bowel wall $\\leftarrow$ embolic metastases to intramural rami of vasa recta\n$\\checkmark$ irregular amorphous cavity (exoenteric growth) in larger lesion $\\leftarrow$ necrosis, hemorrhage, degenerative change\n$\\checkmark$ intussusception ( $10-20 \\%$ )\n@ Kidney (up to $35 \\%$ at autopsy)\n@ Adrenal ( $11 \\%$, up to $50 \\%$ at autopsy)\n@ Subcutis\nPrognosis: $30-40 \\%$ eventually die from this tumor\n\n# MALLORY-WEISS SYNDROME \n\n[George Kenneth Mallory (1900-1986), professor of pathology at Boston University]\n[Soma Weiss (1898-1942), hungarian born physician-in-chief at Peter Bent Brigham Hospital in Boston]",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 862,
            "markdown": "$=$ mucosal $\\pm$ submucosal partial thickness tear of distal esophagus $\\pm$ gastric cardia with involvement of venous plexus\nPathophysiology: violent retching $\\rightarrow$ projection of gastric contents against lower esophagus (similar to Boerhaave syndrome)\nAge: $\\quad 30-60$ years; $\\mathrm{M}>\\mathrm{F}$\nPredisposed: excessive alcohol consumption\n\n- history of repeated retching / vomiting prior to hematemesis\n- massive painless hematemesis\n\nLocation: at / above / below ( $76 \\%$ ) esophagogastric junction\n$\\sqrt{ } 1-4 \\mathrm{~cm}$ longitudinal collection of barium (single tear in $77 \\%$, multiple tears in $23 \\%$ )\n$\\sqrt{ }$ extravasation of barium\nAngio:\n$\\checkmark$ bleeding site at gastric cardia\n$D D x:$ peptic ulcer / ulcerative gastritis\n$R x:$ supportive\n\n# MALROTATION \n\n= abnormal position of small + large bowel $\\leftarrow$ narrow mesenteric attachment $\\leftarrow$ arrest in the embryologic development of gut rotation + fixation\nFrequency: $\\quad 1 \\div 500$ births\nAge: in symptomatic cases: $75 \\%$ in newborns $+90 \\%$ in $1^{\\text {st }}$ year of life; 5 years average delay in diagnosis; incidental diagnosis in adults\nEmbryology:\nNormal fixation: in LUQ at ligament of Treitz (an extension of the right crus of diaphragm + fibrous tissue around celiac artery, located to left of L2) + RLQ fixation of cecum\nAbnormal fixation of mesentery: its upper point below the normal position of ligament of Treitz, its lower point superior + medial to normal cecal position\n$\\diamond$ Usually isolated anomaly!\nAssociated syndromes:\napple-peel intestinal atresia, Cornelia de Lange, Cantrell, cat-eye, chromosomal abnormalities (trisomy 13, 18,21), Coffin-Siris, familial intestinal malrotation, heterotaxy (asplenia, polysplenia), Marfan, Meckel, mobile cecum, prune belly\nAssociated anomalies:\nabsence of kidney \\& ureter, biliary atresia, congenital diaphragmatic hernia (Bochdalek), duodenal web / stenosis / atresia, gastroschisis, Hirschsprung disease, imperforate anus, intestinal pseudo-obstruction, intussusception, malabsorption, Meckel diverticulum, omphalocele, pyloric stenosis, IVC anomalies, short pancreas, preduodenal portal vein",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 863,
            "markdown": "![img-92.jpeg](img-92.jpeg)\n\n- symptoms of partial / complete proximal bowel obstruction $\\leftarrow$ volvulus / peritoneal (Ladd) bands / internal hernia:\n- bilious vomiting ( $77 \\%$ of neonates; in $39 \\%$ within $1^{\\text {st }}$ week of life $\\pm$ abdominal distension\n- recurrent attacks of vomiting + distension (in older children)\n- insidious onset in adulthood with chronic nonspecific symptoms $\\leftarrow$ intermittent volvulus\n\nBarium meal \\& barium enema ( $93-100 \\%$ sensitive):\nPurpose: guess the location of abnormal peritoneal fixation from position of bowel!\n$\\checkmark$ normal position of duodenum:\n$\\sqrt{1}^{\\text {st }}$ portion courses posteriorly\n$\\sqrt{2}^{\\text {nd }}$ portion courses inferiorly\n$\\sqrt{3}{ }^{\\text {rd }}$ portion courses anteriorly and over spine\n$\\sqrt{4}^{\\text {th }}$ portion courses upward to lie at horizontal plane of duodenal bulb or up to 1 vertebral body height inferior\n$\\sqrt{ }$ clearly abnormal position of duodenum ( $81 \\%$ ):\n$\\sqrt{ }$ duodenum + jejunum to the right of spine ( $30 \\%$ )\n$\\sqrt{ }$ corkscrew duodenum + jejunum ( $29 \\%$ )\n$\\sqrt{ }$ duodenojejunal junction low + in midline ( $22 \\%$ )\n$\\sqrt{ }$ unusual abnormal position of duodenum ( $16 \\%$ ):\n$\\sqrt{ }$ duodenojejunal junction over right pedicle\n$\\sqrt{ }$ duodenojejunal junction to left of spine but low\n$\\sqrt{ }$ duodenal redundancy to right of spine\n$\\sqrt{ }$ Z-shape configuration of duodenum + jejunum\n$\\sqrt{ }$ small bowel on right + colon on left side of abdomen (in $0.2 \\%$ incidental finding in adults)\n$\\sqrt{ }$ abnormal position of duodenum + cecum ( $84 \\%$ )\n$\\sqrt{ }$ normal position of duodenum ( $3 \\%$ )",
            "images": [
                {
                    "id": "img-92.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 957,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 864,
            "markdown": "$\\sqrt{ }$ normal position of cecum (in 5-20\\%)\n$D D x:$ mobile cecum ( $15 \\%$ )\n$15 \\%$ FP rate:\n$\\sqrt{ }$ inferior displacement of duodenojejunal junction by distended stomach\n$\\sqrt{ }$ wandering duodenum = longer meandering course\n$\\sqrt{ }$ mobile duodenum\n$\\sqrt{ }$ duodenum inversum\n$\\sqrt{ }$ displacement of duodenojejunal junction $\\leftarrow$ renal agenesis, enlargement of spleen, liver transplantation (with cutting of lig. of Treitz), scoliosis, with manual palpation due to lax ligaments in children $<4$ years\n$3-6 \\%$ FN rate: due to misinterpretation of duodenal course\nCT:\n$\\sqrt{ }$ SMV positioned to left of SMA ( $80 \\%$ )\n$\\sqrt{ }$ aplastic / hypoplastic uncinate process of pancreas\nCx: (1) Midintestinal / midgut volvulus\n(2) Duodenal obstruction\n(3) Ladd bands\n(4) Internal herniation\n\nMortality: 3-5\\%\nRx: Ladd procedure\n\n# Nonrotation \n\n$=$ midgut loop returns to peritoneal cavity without rotation resulting in weak peritoneal fixation\nFrequency: common\n\n- generally asymptomatic: often incidental finding in older children + adults\n$\\sqrt{ }$ SMA to right of SMV\n$\\sqrt{ }$ large intestine on left + small intestine on right\n$C x$ : volvulus with \"whirl\" sign around SMA $\\leftarrow$ local clockwise rotation\n\n\n## Incomplete Rotation\n\n$=$ failure of midgut loop to complete final $90^{\\circ}$ of rotation\n\n- prearterial segment of midgut reenters abdomen first toward left side\n$\\sqrt{ }$ cecum just inferior to pylorus\n$C x$ : duodenal obstruction $\\leftarrow$ peritoneal bands pass over duodenum)\n\n\n## Reversed Rotation\n\nFrequency: rare\n\n- postarterial segment of midgut reenters abdomen first\n$=$ cecum migrates first passing behind SMA toward right thus unwinding the normal counterclockwise rotation of the first stage with additional final $90^{\\circ}$ clockwise rotation\n$\\sqrt{ }$ duodenum anterior to SMA\n$\\sqrt{ }$ transverse colon behind duodenum + SMA\n$C x$ : obstruction of transverse colon $\\leftarrow$ pressure from SMA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 865,
            "markdown": "# MASTOCYTOSIS \n\n$=$ URTICARIA PIGMENTOSA\n$=$ rare systemic disease with mast cell proliferation in skin and RES (lamina propria of small bowel, bone marrow, lymph nodes, liver, spleen) associated with eosinophils + lymphocytes\nAge: $<6$ months old (in $50 \\%$ )\nAssociated with: myeloproliferative disorders, acute nonlymphatic leukemia, malignant lymphoma, mast cell leukemia\n\n## Categories:\n\nI indolent mastocytosis (most frequent)\nII mastocytosis associated with myeloproliferative / myelodysplastic hematologic disorder\nIII aggressive / lymphadenopathic mastocytosis with eosinophilia\nIV mast cell leukemia (rare)\n\n- diarrhea, malabsorption, steatorrhea, anorexia\n- urticaria pigmentosa $=$ cutaneous form (in $80-90 \\%$ ):\n- hyperpigmented skin lesions exhibiting \"wheal and flare\" phenomenon when disturbed\n- abdominal pain, nausea, vomiting\n- hypotension with tachycardia, asthma, flushing, headache, gastrointestinal upset with diarrhea, pruritus $\\leftarrow$ liberation of histamine / prostaglandin D2\ncaused by: physical exertion, heat, certain foods, alcohol, nonsteroidal antiinflammatory drugs\n- pancytopenia $\\leftarrow$ chronic neutropenia\n@: Skeletal involvement $(70 \\%)$\n- bone and joint pain\n\nPredilected sites: skull, spine, ribs, pelvis, humerus, femur\n$\\sqrt{ }$ multiple scattered well-defined sclerotic foci with focal / diffuse involvement $\\leftarrow$ release of histamine by mast cells promotes osteoblastic activity\n$\\sqrt{ }$ often alternating with areas of bone rarefaction $=$ osteoporosis $\\leftarrow$ release of heparin + prostaglandin by mast cells activates osteoclasts\n@: Reticuloendothelial system\n$\\sqrt{ }$ hepatomegaly\n$\\sqrt{ }$ splenomegaly (43-61\\%)\n$\\sqrt{ }$ lymphadenopathy: retroperitoneal, periportal, mesenteric\n$\\sqrt{ }$ Budd-Chiari hepatic venoocclusive disease\n$\\sqrt{ }$ reversed portal venous flow\n$\\sqrt{ }$ cavernous transformation of portal vein\n@: Abdomen\n\n- nausea, vomiting, diarrhea\n$\\sqrt{ }$ thickening of omentum + mesentery\n$\\sqrt{ }$ ascites:\n(a) transudative $\\leftarrow$ liver disease\n(b) exudative $\\leftarrow$ mast cell proliferation of peritoneum\n@: Small bowel\n$\\sqrt{ }$ diffuse irregular thickening of distorted folds\n$\\sqrt{ }$ generalized $2-3-\\mathrm{mm}$ sandlike mucosal nodules $\\leftarrow$ infiltration by mast cells, lymphocytes,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 866,
            "markdown": "plasma cells\n$\\sqrt{ }$ urticaria-like lesions of gastric + intestinal mucosa\n$D x$ : skin / bone marrow biopsy; jejunal biopsy demonstrates an excess of mast cells\nCx: (1) Peptic ulcer disease (release of histamine increases gastric acid secretion)\n(2) Leukemia\n$R x$ : antihistamines, histamine decarboxylase inhibitors, sodium chromoglycase; steroids; splenectomy (for symptomatic splenomegaly / hypersplenism)\n$D D x$ : carcinoid, pheochromocytoma\n\n# MECKEL DIVERTICULUM \n\n$=$ remnant of omphalomesenteric ( $=$ vitelline) duct, which usually obliterates by $5^{\\text {th }}$ embryonic week\n[Johann Friedrich Meckel, the Younger (1781-1833), chairman of surgery and pathological anatomy at University of Halle, Germany]\n$\\diamond$ Most common congenital abnormality of the GI tract!\nFrequency: $2-3 \\%$ of autopsies\nAge: majority in children $<10$ years of age; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$\nPath: true diverticulum with all layers of intestinal wall $\\pm$ connection to umbilicus by fibrous band / omphalomesenteric ligament\nHisto: contains ectopic mucosa: gastric / pancreatic / colonic\nFrequency of heterotopic gastric mucosa: $2 / 3$ overall; $1 / 2$ in symptomatic patients; in $>$ $95 \\%$ with GI hemorrhage\nLocation: within terminal 6 feet of ileum ( $=30-60-100 \\mathrm{~cm}$ from ileocecal valve); in $94 \\%$ on antimesenteric side (DDx to ileal diverticulosis on mesenteric side); near midline ( $\\pm$ tip attached to umbilicus)\nAverage length: $2-3 \\mathrm{~cm}$\nRULE OF 2s: (1) In $2 \\%$ of population\n(2) Symptomatic usually before age 2\n(3) Located within 2 feet of ileocecal valve\n(4) Two inches (up to 8 cm ) in length\n(5) Contains 2 types of heterotopic mucosa\n\n- usually asymptomatic\n- symptomatic (in $2-4 \\%$ ) because of complications\n\nCT:\n$\\checkmark$ fluid- or air-filled blind-ending pouch (without Cx) $\\pm$ particulate matter\n$\\checkmark$ isolated small bowel obstruction\n$\\checkmark$ intussusception with small bowel obstruction\n$\\checkmark$ inverted diverticulum:\n$\\checkmark$ central intraluminal area of entrapped fat\n$\\checkmark$ surrounded by thick collar of soft-tissue attenuation\n$\\checkmark$ volvulus\n$\\checkmark$ inflammatory mass attached to adjacent small bowel\n$\\checkmark$ intradiverticular enteroliths (3-10\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 867,
            "markdown": "$\\sqrt{ }$ luminal extravasation of contrast material from bleeding\n$\\sqrt{ }$ nodular / polypoid intraluminal mass\nNUC = \"Meckel scan\" ( $>85 \\%$ sensitive, $>95 \\%$ specific, $>83-88 \\%$ accurate):\n$\\diamond 99 \\mathrm{~m} T \\mathrm{C}$-pertechnetate is excreted by mucoid cells of gastric mucosa and not dependent on the presence of parietal cells\nN.B.: sensitivity drops after adolescence, because patients who are asymptomatic throughout childhood are less likely to have ectopic gastric mucosa\nPreparation:\n» No irritative measures for 48 hour (contrast studies, endoscopy, cathartics, enemas, drugs irritating GI tract)\n» Fasting for 3-6 hours $\\rightarrow$ results in decreased gastric secretion + diminished bowel peristalsis\n» Evacuation of bowel + bladder prior to study\nDose: $\\quad 5-10-20 \\mathrm{mCi}(100 \\mu \\mathrm{Ci} / \\mathrm{kg}) 99 \\mathrm{~m} \\mathrm{Tc}$-pertechnetate (adult dose!)\nRadiation dose: $\\quad 0.54 \\mathrm{rad} / 2 \\mathrm{mCi}$ for thyroid; $0.3 \\mathrm{rad} / 2 \\mathrm{mCi}$ for large intestine; $0.2 \\mathrm{rad} / 2 \\mathrm{mCi}$ for stomach\nImaging: immediate continuous anterior imaging for $30-45$ minutes / serial images in 5-10minute intervals for up to 1 hour\n$\\sqrt{ }$ small focal collection of tracer in RLQ appearing at the same time / shortly after gastric activity\n$\\checkmark$ tracer activity increases in intensity with time parallel to that of stomach\n$\\checkmark$ improved visualization through\n(a) pentagastrin $\\rightarrow$ stimulates uptake ( $6 \\mu \\mathrm{~g} / \\mathrm{kg} \\mathrm{SC} 20$ minutes prior to pertechnetate)\n(b) cimetidine $\\rightarrow$ inhibits secretion (maximum $300 \\mathrm{mg} /$ dose IV 1 hour prior to pertechnetate)\n(c) glucagon $\\rightarrow$ decreases peristalsis ( $50 \\mu \\mathrm{~g} / \\mathrm{kg}$ IM 5-10 minutes prior to pertechnetate)\n$\\checkmark$ poor visualization with use of perchlorate + atropine $\\rightarrow$ depressed uptake\nFalse-positive results:\n(1) Ectopic gastric mucosa in gastrogenic cyst, enteric duplication, normal small bowel, Barrett esophagus\n(2) Increased blood pool in AVM, hemangioma, hypervascular tumor, aneurysm\n(3) Duodenal ulcer, ulcerative colitis, Crohn disease, appendicitis, laxative abuse\n(4) Intussusception, intestinal obstruction, volvulus\n(5) Urinary tract obstruction, calyceal diverticulum\n(6) Anterior meningomyelocele\n(7) Poor technique\nmnemonic: HA GUIDI\nHemangioma\nAppendicitis\nGastric ectopia\nUrinary obstruction\nIntussusception\nDuplication of bowel\nInflammatory bowel disease",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 868,
            "markdown": "False-negative results:\n(1) Insufficient mass of ectopic gastric mucosa\n(2) Dilution of intraluminal activity $\\leftarrow$ hemorrhage / hypersecretion\nmnemonic: MIS\nMalrotation of ileum\nIrritable bowel in RLQ $\\rightarrow$ rapid transit\nSmall amount of ectopic gastric mucosa\nEnteroclysis:\n$\\sqrt{ }$ elongated, smoothly marginated, clublike, intraluminal mass parallel to long axis of distal ileum = inverted Meckel diverticulum (20\\%)\n$\\sqrt{ } 0.5-20-\\mathrm{cm}$-long blind pouch on the antimesenteric border of ileum with junctional fold pattern\nAngio ( $59 \\%$ accuracy):\n$\\sqrt{ }$ presence of vitelline artery (= anomalous end branch of superior mesenteric artery) is PATHOGNOMONIC\nCx (in 4-20-40\\%):\n(1) Painless GI bleeding: in children $<5$ years of age $\\leftarrow$ ulceration (in $95 \\% \\leftarrow$ heterotopic gastric mucosa)\n(2) Acute diverticulitis ( $30 \\%$ ) in adults secondary to\n(a) acid secretion from ectopic gastric mucosa\n(b) obstruction of diverticulum by enterolith / foreign body\n(3) Intestinal obstruction in older child / adult secondary to\n(a) volvulus $\\leftarrow$ omphalomesenteric diverticulum attached to umbilicus by fibrous band\n(b) inflammatory adhesion\n(c) Intussusception\n(d) Littré hernia\n(4) Perforation\n(5) Neoplasm (rare):\n(a) malignant tumor: carcinoid, carcinoma, sarcoma\n(b) benign tumor: GIST, leiomyoma\n(6) Chronic abdominal pain\n\n# MECONIUM ILEUS \n\n$=$ small bowel obstruction $\\leftarrow$ desiccated meconium pellets impacted in distal ileum\nAge: may develop in utero (in 15\\%)\nAssociated with:\ncystic fibrosis with tenacious + sticky meconium $\\leftarrow$ deficiency of pancreatic secretions (in almost $100 \\%$ )\n$\\diamond$ Virtually all infants with meconium ileus prove to have cystic fibrosis\n$\\diamond 10-15 \\%$ of infants with cystic fibrosis present with meconium ileus!\n$\\diamond$ Earliest clinical manifestation of cystic fibrosis!\n\n- abdominal distension, bilious emesis\n- failure to pass meconium within 48 hours\n$\\sqrt{ }$ numerous dilated small bowel loops without air-fluid levels (fluid not present)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 869,
            "markdown": "$\\sqrt{ }$ \"bubbly\" / \"frothy\" appearance of intestinal contents\n$\\sqrt{ }$ \"soap-bubble\" / \"applesauce\" appearance in RLQ (in 50-66\\%) $\\leftarrow$ admixture of gas with meconium\n$\\sqrt{ }$ multiple round / oval filling defects in distal ileum + colon\n$\\sqrt{ }$ functional microcolon $\\leftarrow$ unused colon in antenatal obstruction\nOB-US:\n$\\sqrt{ }$ unusual echogenic intraluminal areas in small bowel (DDx: normal transient inspissated meconium)\n$\\sqrt{ }$ usually polyhydramnios\n$\\sqrt{ }$ fluid-filled dilated small bowel\nCx (in 40-50\\%): volvulus, ischemia, necrosis, stenosis, atresia, perforation, meconium peritonitis, pseudocyst\nRx: (1) Nonionic contrast media enema (because of risk of bowel perforation)\n(2) $17 \\%$ Hypaque ${ }^{\\circledR} /$ Conray $^{\\mathrm{TM}}$ enema mixed with acetylcysteine (Mucomyst ${ }^{\\circledR}$ )\n(3) Gastrografin ${ }^{\\circledR}$ enema with Tween 80 (attention to fluid + electrolyte balance)\n\nDDx: Hirschsprüng disease, small bowel atresia with meconium ileus, meconium plug syndrome, small left colon syndrome, imperforate anus, obstruction from duplication cyst\n\n# MECONIUM PERITONITIS \n\n$=$ sterile chemical peritonitis $\\leftarrow$ perforation of bowel proximal to high-grade / complete obstruction that seals in utero due to inflammatory response\nFrequency: $1 \\div 35,000$ livebirths\nAge: antenatal perforation after $3^{\\text {rd }}$ month of gestation\nCause:\n(1) Atresia $\\leftarrow$ to ischemic event ( $50 \\%$ )\n(a) of small bowel: usually ileum or jejunum\n(b) of colon (uncommon)\n(2) Bowel obstruction ( $46 \\%$ )\n(a) meconium ileus\n(b) volvulus, internal hernia\n(c) intussusception, congenital bands, Meckel diverticulum\n(d) microcolon\n(3) Hydrometrocolpos\n$\\diamond$ Meconium peritonitis $\\leftarrow$ cystic fibrosis diagnosed in utero in $8 \\%+$ at birth in $15-40 \\%$ !\n$\\diamond$ Intraperitoneal meconium may calcify within 24 hours!\nTypes:\nA. FIBROADHESIVE TYPE (most common):\n$=$ intense chemical reaction of peritoneum, which seals off the perforation\n\n- no evidence for active leak at birth\n$\\sqrt{ }$ dense mass with calcium deposits\n$\\sqrt{ }$ calcific plaques scattered throughout peritoneal cavity\nB. CYSTIC TYPE\n$=$ cystic cavity formed by fixation of bowel loops surrounding the perforation site, which",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 870,
            "markdown": "continues to leak meconium\n$\\sqrt{ }$ cyst outlined by calcific rim\nC. GENERALIZED TYPE\n\n- perforation occurs immediately antenatally\n- active leakage of bowel contents\n$\\sqrt{ }$ complicated ascites\n$\\sqrt{ }$ intraabdominal calcifications (CONSPICUOUSLY ABSENT in cystic fibrosis):\n$\\checkmark$ peripherally calcified pseudocysts\n$\\checkmark$ small flecks of calcifications scattered throughout abdomen\n$\\checkmark$ larger aggregates of calcifications along inferior surface of liver / flank / processus vaginalis / scrotum\n$\\checkmark$ obstructive roentgen signs following birth\n$\\checkmark$ separation of bowel loops by fluid\n$\\checkmark$ microcolon $=$ \"unused colon\"\n$\\checkmark$ meconium hydrocele producing labial mass\nUS:\n$\\checkmark$ highly echogenic linear / clumped foci with posterior acoustic shadowing in scrotum\n$\\checkmark$ \"snowstorm appearance\" = highly echogenic material throughout abdomen in between bowel loops\n$\\checkmark$ ill- / well-defined homo- / heterogeneous encysted collections of meconium\nOB-US ( $>18$ weeks EGA):\n$\\checkmark$ polyhydramnios (64-71\\%)\n$\\checkmark$ fetal ascites (54-57\\%)\n$\\checkmark$ bowel dilatation (27-29\\%)\n$\\checkmark$ intraabdominal bright echogenic mass\n$\\checkmark$ multiple linear / clumped foci of scattered calcifications (85\\%); may develop within 12 hrs to 8 days after perforation\n$\\checkmark$ meconium pseudocyst = well-defined hypoechoic mass surrounded by an echogenic calcified wall (= contained perforation)\n$D D x$ : (1) Intraabdominal teratoma\n(2) Fetal gallstones\n(3) Isolated liver calcifications\n\nMortality: up to $62 \\%$\nPrognosis: generally good; surgery may not be required when perforation site is completely healed\n\n# MECONIUM PLUG SYNDROME \n\n$=$ local inspissation of meconium leading to low colonic obstruction; probably related to small left colon syndrome as part of the same spectrum of functional immaturity\nAge: newborn infant (symptomatic within first 24 hours of life)\nCause: cystic fibrosis ( $25 \\%$ ), Hirschsprung disease, prematurity, maternal magnesium sulfate treatment\n\n- abdominal distension, vomiting, failure to pass meconium\n$\\checkmark$ distended transverse + ascending colon + dilated small bowel (proximal to obstruction)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 871,
            "markdown": "$\\sqrt{ }$ small left colon with change in caliber at splenic flexure\n$\\sqrt{ }$ occasionally bubbly appearance in colon (DDx: submucosal air in necrotizing enterocolitis)\n$\\sqrt{ }$ presacral pseudotumor $\\rightarrow$ no gas in rectum\nBE:\n$\\sqrt{ }$ double-contrast effect $=$ barium between meconium plug + colonic wall\n$R x:$ water-soluble enema\n$D D x:$ Hirschsprüng disease\n\n# MELANOSIS COLI \n\n$=$ benign brown-black discoloration of colonic mucosa\nFrequency: $10 \\%$ of autopsies\nCause: ? chronic anthracene cathartic usage\n\n- asymptomatic\n$\\checkmark$ nonspecific colonic wall thickening (in severe cases)\n$D x:$ endoscopic\nPrognosis: no malignant potential\n\n\n## MéNéTRIER DISEASE\n\n[Pierre Eugène Ménétrier (1859-1935), pathologist in Paris, France]\n$=$ GIANT HYPERTROPHIC GASTRITIS = HYPERPLASTIC GASTROPATHY\n$=$ rare disease characterized by excessive mucus production and\nTRIAD of (1) Giant mucosal hypertrophy + hypersecretion\n(2) Hypoproteinemia\n(3) Hypochlorhydria\n\nPrevalence: $<1 \\div 200,000$\nCause: ? overproduction of polypeptide growth factor $\\alpha \\rightarrow$ increasing gastric mucus production + inhibiting gastric acid secretion\nPath: mucosal thickness up to 6.0 mm (normal: $0.6-1.0 \\mathrm{~mm}$ )\nHisto: hyperplasia of glandular tissue + microcyst formation\nAge: bimodal distribution in children $<10$ years ( $\\leftarrow$ CMV infection) and adults $20-70$ years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 3$\nAssociated with: benign gastric ulcer (13-72\\%)\n\n- epigastric pain, vomiting, anorexia, asthenia, weight loss\n- gastrointestinal bleeding, diarrhea\n- protein-losing enteropathy with hypoalbuminemia $\\leftarrow$ loss of albumin into gastric lumen and increased loss of enteric protein + peripheral edema\n- absent / decreased acid secretion ( $>50 \\%$ ) $\\leftarrow$ reduction in number of parietal + chief cells\n\nLocation: throughout fundus + body, particularly prominent along greater curvature; relative sparing of antrum (involved in 46\\%) (DDx to lymphoma: usually in antrum)\n$\\sqrt{ }$ markedly enlarged ( $>1 \\mathrm{~cm}$ in fundus + body with frequent sparing of antrum) and tortuous gastric rugae (no longer parallel to long axis of stomach) resembling cerebral convolutions in spite of adequate gastric distension\n$\\sqrt{ }$ marked hypersecretion (mucus) $\\rightarrow$ may dilute barium + impair coating of mucosa\n$\\sqrt{ }$ preserved pliability of stomach",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 872,
            "markdown": "CT:\n$\\sqrt{ }$ thickened mucosa projecting into gastric lumen + smooth serosal contour\n$\\sqrt{ }$ nodular symmetric folds\n$C x$ : increased risk of thromboembolic disease\n$R x$ : anticholinergics, prostaglandins, proton pump inhibitors, prednisone, histamine-2 blockers; gastrectomy\n$D D x$ : lymphoma (usually in distal stomach + lesser curvature, enlarged nodes, splenomegaly); polypoid variety of gastric carcinoma (rigid gastric folds, mass, ulcer); acute gastritis (H. pylori, CMV, histoplasmosis); infiltrative disease (sarcoidosis, amyloidosis); chronic gastritis; Zollinger-Ellison syndrome (postbulbar ulcer); gastric varices (serpentine form, change in shape and size, confined to cardia + fundus)\n\n# MESENTERIC FIBROMATOSIS \n\n$=$ INTRAABDOMINAL FIBROMATOSIS $=$ ABDOMINAL DESMOID\n$=$ part of the spectrum of deep fibromatosis\nIncidence: $2-4 \\div 1,000,000$ annually\nMean age: 41 (range, 14-75) years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$\nPath: nonencapsulated well-circumscribed mass $\\pm$ infiltrative margins within muscularis propria\nHisto: uniform wavy spindle-shaped fibroblasts in a typically uninflamed abundant dense collagenous stroma $\\pm$ myxoid foci; tentacular melting insinuation into / through muscularis propria of bowel wall; keloidal fiber formation, thick-walled small arteries, thin-walled veins, perivascular microhemorrhages; absent / scant mitoses; NO necrosis\nAssociated with: Gardner subtype of familial adenomatous polyposis (in 5-13\\%)\nRisk factor: history of abdominal surgery (during past 4 years) in patients with familial adenomatous polyposis ( $83 \\%$ )\n\n- family history of Gardner syndrome / hereditary colon cancer\n- abdominal pain, palpable abdominal mass\n\nLocation: small bowel mesentery ( $2 / 3$ ) near origin of SMA $>$ omentum, ileocolic mesentery, transverse / sigmoid mesocolon, omentum, peritoneal ligaments\nSize: most 5-10 (up to 30) cm in diameter\nBarium / Enteroclysis:\n$\\checkmark$ displacement of small bowel segments\n$\\checkmark$ mucosal ulceration $\\leftarrow$ compromised mesenteric vasculature\n$\\checkmark$ luminal narrowing / dilatation\n$\\checkmark$ distorted thickened / effaced small bowel folds\nUS:\n$\\checkmark$ solid well-circumscribed heterogeneous mass with variable internal echogenicity (predominantly hypoechoic)\nCT:\n$\\checkmark$ homogeneous soft-tissue attenuation $\\leftarrow$ highly collagenous stroma similar to skeletal muscle\n$\\checkmark$ hypoattenuating mass $\\leftarrow$ myxoid stroma\n$\\checkmark$ striated / whorled appearance $\\leftarrow$ alternating collagenous + myxoid areas",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 873,
            "markdown": "$\\sqrt{ }$ bowel tethering $=$ bowel encasement\n$\\sqrt{ }$ encasement of superior mesenteric vessels\nCECT:\n$\\sqrt{ }$ mild homogeneous to heterogeneous enhancement\n$\\sqrt{ }$ absent enhancement in myxoid lesion\n$\\sqrt{ }$ similar / greater enhancement compared to muscle in fibrous lesion\n$\\sqrt{ }$ occasionally marked enhancement\nMR:\n$\\sqrt{ }$ hypo- or isointense signal compared to muscle on T1WI\n$\\sqrt{ }$ heterogeneously intermediate / high SI on T2WI $\\leftarrow$ depending on cellularity + amount of collagen versus myxoid stroma\nPET:\n$\\sqrt{ }$ low to moderate heterogeneous uptake\n$\\sqrt{ }$ mean SUV of 4.54 (maximally up to 8.30 )\nCx: gastrointestinal bleeding, small bowel obstruction, fistula formation, bowel perforation\nPrognosis: proclivity for local recurrence\nRx: wide surgical excision, less radical surgery / medical therapy with antiestrogens / cytotoxic chemotherapy, postoperative irradiation\n$D D x$ : (1) Malignancy: lymphoma, metastatic disease, soft-tissue sarcoma (lipo-, fibro-, leiomyo-sarcoma, malignant fibrous histiocytoma)\n(2) Small-bowel GIST (areas of hemorrhage + necrosis, more cellular without abundant collagenous stroma, positive for CD117 + CD34)\n(3) Abdominal fibromatosis (commonly in young women)\n(4) Castleman disease\n(5) Desmoplastic small round cell tumor\n\n# MESENTERIC LYMPHADENITIS \n\n## Primary Mesenteric Adenitis\n\n$=$ clinical entity with symptoms related to benign inflammation of lymph nodes without identifiable acute inflammatory condition\nCause: probable infection of the terminal ileum by Yersinia enterocolitica, Y. pseudotuberculosis, viral\nAge: children, young adults\n\n- nausea, vomiting, diarrhea, fever, leukocytosis\n- diffuse / RLQ pain + tenderness\n\nLocation: usually RLQ (immediately anterior to right psoas muscle in $78 \\%$, small bowel mesentery in $56 \\%$ )\n$\\sqrt{ }$ cluster of $(>3)$ enlarged $(>5 \\mathrm{~mm})$ mesenteric lymph nodes without an identifiable acute inflammatory condition\n$\\sqrt{ }$ isolated ileal wall thickening ( $33 \\%$ )\n$\\sqrt{ }$ colonic wall thickening ( $18 \\%$ )\nN.B.: visualization of entire normal appendix is necessary to differentiate from acute appendicitis!\nDx: diagnosis of exclusion",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 874,
            "markdown": "$D D x$ : Secondary mesenteric adenitis as in appendicitis (enlarged nodes immediately anterior to right psoas muscle in $40-82 \\%$, nodes less numerous + smaller)\n\n# Secondary Mesenteric Adenitis \n\nCause:\n(a) local condition: appendicitis, Crohn disease, diverticulitis\n(b) systemic condition: lupus erythematosus, HIV\n\nAge: adults (far more frequent than for primary adenitis)\n\n## MESENTERIC ISCHEMIA\n\n$=$ BOWELISCHEMIA\nClassification of bowel ischemia by the American Gastroenterological Association in 2000:\n» MESENTERIC ISCHEMIA\nA. ACUTE MESENTERIC ISCHEMIA\n(a) arterial $(90 \\%)$\n> occlusive mesenteric infarction ( $\\left.{ }^{3} / \\cdot\\right)$\n\n1. SMA embolus\nmajor: above origin of ileocecal artery\nminor: distal to origin of ileocecal artery\n2. SMA thrombosis\n> nonocclusive mesenteric ischemia ( $1 / 2$ )\n3. Splanchnic vasoconstriction $\\leftarrow$ low flow state\n(b) venous $(10 \\%)$ :\n4. Mesenteric vein thrombosis\nB. CHRONIC MESENTERIC ISCHEMIA\n» COLONIC ISCHEMIA\nEtiology:\n(a) arterial occlusion / compromise: atheromatous disease, thromboembolic disease, dissecting aortic aneurysm, fibromuscular hyperplasia, arteritis, hypoperfusion (shock, hypovolemia), endotoxin shock, disseminated intravascular coagulation, direct trauma, aortic surgery, stent placement, therapeutic embolization, radiation, antiphospholipid antibody syndrome\n> occlusive mesenteric infarction ( $90 \\%$ mortality)\n5. Embolus ( $40-50 \\%$ )\n6. SMA thrombosis ( $20-40 \\%$ ) at origin + site of atherosclerotic narrowing (ostium stenosis)\n> nonocclusive mesenteric ischemia ( $10 \\%$ mortality)\n7. Preexisting atherosclerosis $\\rightarrow$ low-flow state\n8. Bowel vasoconstriction = vasospasm (reflex hypotension, digitalis, ergot preparation, vasopressin, amphetamine, cocaine), pheochromocytoma, familial dysautonomia\n9. Shock bowel = diffuse small bowel ischemia in hypovolemia and hemorrhagic / cardiogenic / septic shock $\\leftarrow$ increased bowel permeability to macromolecules + albumin",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 875,
            "markdown": "$\\sqrt{ }$ diffuse bowel wall thickening\n$\\sqrt{ }$ persistent increased enhancement on $\\mathrm{CT} \\leftarrow$ slowed perfusion and washout + interstitial leakage of contrast material\n$\\sqrt{ }$ accumulation of intraluminal fluid $\\leftarrow$ failed resorption capacity\nArterial involvement:\nSMA (5\\%); celiac artery (4\\%); IMA (11\\%)\n(b) venous occlusion ( $<10 \\%$ ): young patient, often following abdominal surgery\n\nLocation: SMV $>$ inferior mesenteric vein $>$ portal vein\n(c) systemic low flow state ( $30 \\%$ ): myocardial infarction, CHF, intraoperative hypotension, arrhythmia, hypovolemia, shock, renal / hepatic disease\n(d) bowel obstruction: strangulation by adhesions or bands $\\pm$ mesenteric vein thrombosis, incarceration of hernia, volvulus, intussusception, pronounced overdistension (prestenotic, distension colitis), ischemic colitis $\\leftarrow$ endoscopy / enemas / colonic carcinoma (1-7\\%)\n(e) vasculitis: polyarteritis nodosa ( $50-70 \\%$ )\n$\\sqrt{ }$ relatively long segment of bowel involved\n$\\sqrt{ }$ multiple skip areas in nonsegmental distribution\n$\\sqrt{ }$ involvement of duodenum is indicative\n(f) abdominal inflammation: pancreatitis, appendicitis, diverticulitis, diffuse peritonitis, parasitic infestation\n(g) cytotoxic drugs: long-term immunosuppressive drugs for rejection, chemotherapy for leukemia / lymphoma\n(h) radiation: $>4,500 \\mathrm{cGy}$\nin children:\nmidgut volvulus, CHD, incarcerated hernia, sickle cell disease (occasionally), necrotizing enterocolitis\nPathophysiology: ischemia leads to\n$\\rightarrow$ inflammatory response (cytokines, platelet-activating factor, tumor necrosis factor released from activated neutrophils, platelets, mast cells, endothelial cells)\n$\\rightarrow$ breakdown of mucosal barrier from\n> mild superficial necrosis limited to mucosa (mucosal ulcer) = partial mural bowel ischemia, to\n> life-threatening continuous necrosis of all bowel wall layers = transmural bowel infarction\n$\\rightarrow$ invasion of bacteria with bacteremia + sepsis\n$\\rightarrow$ strictures\nDistribution:\n> small bowel, ascending colon, proximal $2 / 3$ of transverse colon $\\leftarrow$ SMA / SMV\n> descending colon, sigmoid colon $\\leftarrow$ IMA / IMV\n> splenic flexure, rectosigmoid junction $\\leftarrow$ watershed zones\n\n# Acute Mesenteric Ischemia \n\nCause:\n(a) acute occlusive SMA embolus (in $>50 \\%$ ): usually lodges at bifurcation of middle colic artery + SMA\n(b) SMA thrombosis ( $4-18 \\%$; nonocclusive in $25 \\%$ ): frequently involves the proximal",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 876,
            "markdown": "SMA\n(c) SMA dissection $\\leftarrow$ cystic medial necrosis, fibromuscular dysplasia\n(d) venous occlusion in $5-10-15 \\% \\leftarrow$ hypercoagulability, trauma, portal hypertension, infection, carcinoma, oral contraceptives\n\n- first crampy, then continuous abdominal pain with acute event\n- cardiac disease predisposing to embolization\n- gut emptying (vomiting / bloody diarrhea)\n- gross rectal bleeding, WBC $>12,000 / \\mu 1$ with left shift $(80 \\%)$\n\nLocation: (a) any segment of small bowel\n(b) cecum (most common), distal transverse colon, splenic flexure\n\nConsequences:\ndependent on magnitude of insult, duration of process, adequacy of collaterals\nA. REVERSIBLE ISCHEMIA\n\n1. Complete restitution of bowel wall $\\leftarrow$ abundant collaterals\n2. Healing with fibrosis + stricture formation\nB. IRREVERSIBLE ISCHEMIA\n3. Transmural infarction with bowel perforation\n\nBowel infarction develops with thrombosis of the small distal mesenteric venous branches.\nPlain film:\n$\\sqrt{ }$ gasless abdomen $\\leftarrow$ fluid-filled loops from exudation ( $21 \\%$ )\n$\\checkmark$ bowel distension to splenic flexure ( $=$ perfusion territory of SMA) in $43 \\%$\n$\\checkmark$ \"thumbprinting\" $(36 \\%)=$ thickening of bowel wall + valvulae $\\leftarrow$ edema\n$\\checkmark$ small bowel pseudoobstruction (most frequently in thrombosis)\n$\\checkmark$ pneumatosis = dissection of luminal gas into bowel wall (28\\%)\n$\\checkmark$ mesenteric + portal vein gas (14\\%)\n$\\checkmark$ ascites (14\\%)\nBarium:\n$\\checkmark$ \"scalloping / thumbprinting\" = thickening of bowel wall + valvulae\n$\\checkmark$ \"picket fencing\" = marked thickening of bowel wall\n$\\checkmark$ separation + uncoiling of loops\n$\\checkmark$ narrowed lumen\n$\\checkmark$ circumferential ulcer\nCT (26-73-82\\% sensitive):\n@ Bowel wall thickness\n$\\checkmark$ circumferential bowel wall thickening (28-52-96\\%) > 3-5 mm depending on degree of distension:\n$\\checkmark$ \"halo / target\" sign = stratification into 3 layers = inner mucosa and outer muscularis propria (rings of high attenuation) separated by layer of low attenuation (submucosal edema $\\pm$ hemorrhage $\\pm$ superinfection) in\n> ischemic colitis ( $94 \\%$ )\n> reversible mesenteric ischemia ( $80 \\%$ )\n> mesenteric infarction ( $26-38 \\%$ )\n$\\diamond$ The least specific sign!\n$\\diamond$ NO correlation with the severity of ischemic damage",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 877,
            "markdown": "$\\sqrt{ }$ thinning of bowel wall (in acute arterioocclusive transmural infarction) if it becomes gangrenous\n$\\sqrt{ }$ bowel wall attenuation on NECT:\n$\\sqrt{ }$ decreased, usually homogeneously $\\leftarrow$ edema\n$\\sqrt{ }$ increased $\\leftarrow$ hemorrhage\n@ Bowel wall enhancement\n$\\sqrt{ }$ diminished enhancement of bowel wall $\\leftarrow$ compromised blood flow\n$\\sqrt{ }$ absent enhancement of bowel wall (in $18 \\%, 62 \\%$ sensitive, $96 \\%$ specific)\n$\\sqrt{ }$ engorgement of mesenteric vessels $=$ venous congestion $\\leftarrow$ stasis\n$\\sqrt{ }$ increased wall enhancement $\\leftarrow$ hyperemia in outflow obstruction from mesenteric venous occlusion / during reperfusion after arteriogenic bowel ischemia / in shock bowel) as a good prognostic indicator ( $33 \\%$ sensitive, $71 \\%$ specific)\n$\\sqrt{ }$ delayed + persistent enhancement $\\leftarrow$ delayed venous return and arteriospasm\n@ Bowel diameter\n(a) early reflex spastic ileus\n$\\sqrt{ }$ contracted gasless bowel in mild mucosal ischemia\n(b) intermediate reflex hypotonic ileus\n$\\sqrt{ }$ dilated gas-filled bowel with paper-thin wall\n(c) late paralytic ileus\n$\\sqrt{ }$ focal / diffuse bowel dilatation (10-56-91\\%) with gas (43\\%) / fluid (29\\%) interruption of peristaltic activity $\\leftarrow$ destruction of intramural nerves + intestinal musculature / irreversible transmural ischemic damage\n$\\sqrt{ }$ no enhancement\n$\\sqrt{ }$ pneumatosis\n@ Vascular signs\n(a) arterial occlusion:\n$\\sqrt{ }$ hyperattenuating SMA on NECT\n$\\sqrt{ }$ filling defect with ring enhancement on CECT\n$\\sqrt{ }$ thumbprinting $(26 \\%)=$ thickening of bowel wall\n$\\sqrt{ }$ lack of bowel wall enhancement with arterial occlusion\n$\\sqrt{ }$ concurrent embolic infarction of kidney / spleen\n(b) venous thrombosis ( $15 \\%$ ):\n$\\sqrt{ }$ enlarged diameter + increased attenuation of SMV on NECT\n$\\sqrt{ }$ filling defect in SMV / portal vein thrombosis on CECT\n$\\sqrt{ }$ thumbprinting $(64 \\%)=$ thickening of bowel wall\n$\\sqrt{ }$ \"waterlogging\" with marked contrast enhancement of mesentery + bowel wall\n$\\sqrt{ }$ pneumatosis intestinalis (in $6-28 \\%, 3-14 \\%$ specific)\n$=$ dissection of luminal gas into bowel wall across compromised mucosa signaling irreversible disease:\n$\\sqrt{ }$ small isolated gas bubbles within wall\n$\\sqrt{ }$ broad rims of air dissecting the entire bowel wall into two layers\n$\\diamond$ Sign of transmural bowel infarction in $78 \\%$\n$\\sqrt{ }$ gas in portal vein (5-13-36\\%) / in mesenteric vein (28\\%) = propagation of intramural gas into mesenteric venous system\n$\\diamond$ Sign of transmural bowel infarction in $81 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 878,
            "markdown": "@ Extramural signs\n$\\sqrt{ }$ increased attenuation of mesenteric fat from mesenteric edema (in $68 \\%, 58 \\%$ sensitive, $79 \\%$ specific)\n$\\sqrt{ }$ mesenteric fluid ( $88 \\%$ sensitive, $90 \\%$ specific)\n$\\sqrt{ }$ ascites (in $43-88 \\%, 75 \\%$ sensitive, $76 \\%$ specific)\n$\\sqrt{ }$ pneumoperitoneum $(7 \\%)=$ perforation of infarcted bowel segment\n$C x$ : bowel necrosis $\\leftarrow$ occlusion of small vasa recta disallowing collateral flow\nCommon pitfalls:\n(1) Spastic colon misinterpreted as simple contraction, (issue resolved by repeat CT with enema)\n(2) Widely distended colonic segment with a wall thickness of $3-5 \\mathrm{~mm}$ misinterpreted as normal\n(3) Small bowel dilatation + air-fluid levels misinterpreted as ileus / pseudoobstruction\n\nAngio (AP and LAT views):\n$\\sqrt{ }$ occlusion / vasoconstriction / vascular beading\n$\\sqrt{ }$ embolus lodged at major branching points distal to first 3 cm of SMA\nRx for nonocclusive mesenteric ischemia:\nvia SMA catheter slow injection of 60 mg papaverine followed by papaverine infusion of $1 \\mathrm{mg} /$ minute\nNUC:\n(a) IV / IA ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-sulfur colloid / labeled leukocytes, Ga-citrate, ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-pyrophosphate: $\\sqrt{ }$ tracer accumulation 5 hours after onset of ischemia (more intense uptake with transmural infarcts)\n(b) intraperitoneal injection of 133 Xe in saline $\\rightarrow$ absorbed by intestine:\n$\\sqrt{ }$ decreased washout with abnormal perfusion of strangulated bowel\nPrognosis:\n(1) Massive infarction of small + large bowel if mesenteric embolization occurs proximal to middle colic artery (= limited collateral flow)\n(2) Focal segments of intestinal ischemia if mesenteric embolization occurs distal to middle colic artery (= good collateral flow)\nLocal $C x$ : bleeding, intestinal perforation, abscess formation, peritonitis\nSystemic Cx: hemoconcentration, acidosis, DIC, bone marrow suppression, multiple organ failure (including heart + kidneys)\nMortality: $70-80-92 \\%$ for intestinal infarction\n$D D x$ : typhlitis, Crohn disease, infectious / ulcerative colitis, proctosigmoiditis, sigmoid diverticulitis, other causes of pneumatosis intestinalis / portal venous gas\n\n# Chronic Mesenteric Ischemia \n\n$=$ ABDOMINAL/INTESTINALANGINA\n$=$ intermittent mesenteric ischemia in severe arterial stenosis with inadequate collateralization provoked by food ingestion\n\n- postprandial abdominal pain 15-20 minutes after food intake $\\leftarrow$ \"gastric steal\" diverting blood flow away from intestine\n$\\diamond$ Pain out of proportion to physical findings\n- fear of eating large meals, weight loss, malabsorption",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 879,
            "markdown": "- reflex emptying of bowel after eating\n\nBarium:\n(a) Subacute:\n$\\sqrt{ }$ flattening of one border\n$\\sqrt{ }$ pseudosacculation / pseudodiverticula on antimesenteric border\n(b) Chronic:\n$\\sqrt{ } 7-10-\\mathrm{cm}$-long smooth pliable strictures\n$\\sqrt{ }$ dilatation of gut between strictures\n$\\sqrt{ }$ thinned + atrophic valvulae\nCx: obstruction\nDuplex US:\n$\\sqrt{ }$ celiac trunk occlusion + retrograde perfusion of hepatic artery through SMA\n$\\sqrt{ }$ PSV $>300 \\mathrm{~cm} / \\mathrm{sec}$ and EDV $>45 \\mathrm{~cm} / \\mathrm{sec}$ in SMA\n$\\sqrt{ }$ peak systolic velocity $>160 \\mathrm{~cm} / \\mathrm{sec}$ in celiac trunk for $>50 \\%$ stenosis ( $57 \\%$ sensitivity, $100 \\%$ specificity) during fasting state\n\n# Mesenteric Vein Thrombosis \n\nCause:\nA. PRIMARY / IDIOPATHIC (20\\%)\nB. SECONDARY (with predisposing condition):\n(1) Infection: acute pancreatitis (24\\%), sepsis, colonic diverticulitis, appendicitis, peritonitis, abdominal abscess\n(2) Inflammatory bowel disease ( $2 \\%$ )\n(3) Trauma, postoperative state: Roux-en-Y gastric bypass $>$ Nissen fundoplication $>$ partial colectomy $>$ cholecystectomy $>$ appendectomy, pancreaticoduodenectomy $(27 \\%)$\n(4) Mechanical: volvulus, bowel obstruction\n(5) Myeloproliferative neoplasm: chronic myelogenous leukemia, polycythemia vera, essential thrombocythemia, primary myelofibrosis\n(6) Inheritable hypercoagulable state\n(7) Paraneoplastic thromboembolism\n(8) Tumor invasion: pancreatic cancer, HCC\n(9) Miscellaneous causes: oral contraceptives (5\\%), pregnancy, chemotherapy\n\nThe location of thrombus is often determined by the underlying cause. Hematologic disorders affect small venous branches with progression into larger trunks.\nLocation: SMV $>\\operatorname{IMV}(6 \\%)$\n\n- usually subacute symptomatology over 1-4 weeks\n- abdominal pain with rebound / guarding (acute MVT)\n- nausea, vomiting, diarrhea\n- hematemesis, hematochezia (after bowel necrosis)\n$\\sqrt{ }$ ileus\n$\\sqrt{ }$ ascites\n$\\sqrt{ }$ bowel wall thickening (64\\%) with \"thumbprinting\nCT:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 880,
            "markdown": "> mural signs:\n$\\sqrt{ }$ pneumatosis intestinalis $\\leftarrow$ bowel infarction\n$\\sqrt{ }$ hypoattenuated circumferential bowel wall thickening $\\leftarrow$ intramural edema / hemorrhage\n\nBowel wall thickening is more pronounced in venous congestion than in arterial occlusion.\n$\\sqrt{ }$ \"halo / target\" sign = abnormally enhancing bowel wall with mural stratification into 2 or 3 thickened layers:\n$\\sqrt{ }$ hyperattenuating inner ring (= mucosa) + outer ring (= muscularis propria) separated by hypoattenuating middle ring (= submucosal edema)\n$\\sqrt{ }$ abnormal wall enhancement:\n$\\sqrt{ }$ increased / normal wall enhancement $\\leftarrow$ preserved arterial inflow\n$\\sqrt{ }$ decreased enhancement $\\leftarrow$ impeded arterial inflow\n$\\diamond$ Highly SPECIFIC for venous bowel infarction!\n> vascular signs:\n$\\sqrt{ }$ portomesenteric venous gas $\\leftarrow$ bowel infarction\n$\\sqrt{ }$ hypoattenuating lumen surrounded by well-defined rim-enhancing venous wall $\\leftarrow$ partial / complete venous filling defect\n$\\sqrt{ }$ enlargement of major vein $\\leftarrow$ displacement of venous wall by acute thrombus\n$\\sqrt{ }$ engorgement of small mesenteric veins $\\leftarrow$ venous congestion $\\leftarrow$ thrombosis\n$\\sqrt{ }$ venous collateral circulation\nUpstream venous collateralization occurs more readily with thrombosis of large mesenteric veins than with thrombosis of venae rectae / arcades.\n> extramural-nonvascular signs:\n$\\sqrt{ }$ mesenteric haziness $\\leftarrow$ venous congestion + superimposed inflammatory edema + ascites\n$\\sqrt{ }$ bowel dilatation $\\leftarrow$ interrupted intestinal peristalsis / loss of contractile function $\\leftarrow$ transmural infarction\n$\\sqrt{ }$ free intraperitoneal air $\\leftarrow$ perforated infarcted bowel\nUS:\n$\\sqrt{ }$ dilated vein with echogenic thrombus\nCx: bowel ischemia $\\rightarrow$ infarction\nBowel infarction develops in thrombosis of the small distal mesenteric venous branches lacking collaterals.\nMortality: $12-50 \\%$\n\n# MESOTHELIAL CYST \n\n$=$ MESENTERIC / OMENTAL CYST\nEtiology: failure of mesothelial peritoneal surfaces to coalesce\nPath: unilocular thin-walled cyst usually with serous, occasionally chylous / hemorrhagic fluid contents\nHisto: lined by mesothelial cells + surrounded by thin layer of fibrous tissue\nLocation: small bowel, mesentery (78\\%), mesocolon\n\n- asymptomatic",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 881,
            "markdown": "$\\sqrt{ }$ single cyst up to several cm in size\n$\\sqrt{ }$ omental cysts may be pedunculated\nCT:\n$\\sqrt{ }$ near-water density / soft-tissue density\n$\\sqrt{ } \\pm$ fluid levels related to fat + water components\n$C x$ : torsion, hemorrhage, intestinal obstruction\n$D D x$ : lymphangioma (septations)\n\n# METASTASIS TO GASTROINTESTINAL TRACT \n\nGI metastases closely resemble the primary tumor. The radiologic appearance depends mainly on histologic characteristics of the primary / secondary lesion like degree of vascularity relative to growth rate.\n\n## Hypervascular Metastasis\n\n1. Malignant melanoma\n2. Breast cancer\nuncommon:\n3. Renal cell carcinoma\n4. Choriocarcinoma\n5. Neuroendocrine carcinoma\n6. Mesenchymal sarcoma\n\n## Metastasis to Colon\n\nSpread:\n(1) Hematogenous (embolic)\n$\\sqrt{ }$ subepithelial masses / bull's-eye lesions\n$\\sqrt{ }$ diffusely infiltrating lesions mimicking inflammatory bowel disease\n(2) Direct invasion by contiguous tumor\n> ovary inferior border of sigmoid\n> left kidney splenic flexure\n> pancreatic tail splenic flexure\n> pelvis (uterus, bladder) anterior border of rectum\n> prostate rectosigmoid\n(3) Direct invasion along mesenteric reflections\n> stomach transverse colon superior margin\n> pancreas transverse colon inferior margin\n> omental cake transverse colon superior margin\n(4) Intraperitoneal seeding\n\nOrigin: ovarian, gastric, colonic, pancreatic cancers (most commonly)\nClassic sites of seeding:\n> pouch of Douglas (50\\%): anterior border of rectosigmoid\n> lower small bowel mesentery ( $40 \\%$ ): medial border of cecum\n> sigmoid mesocolon ( $20 \\%$ ): superior border of sigmoid colon\n> right paracolic gutter ( $10 \\%$ ): lateral border of ascending colon",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 882,
            "markdown": "# Metastasis to Small Bowel \n\nOrigin: colon $>$ stomach $>$ breast $>$ ovary $>$ uterine cervix $>$ melanoma $>$ lung $>$ pancreas Spread:\n(1) Intraperitoneal seeding: primary mucinous tumor of ovary, appendix, colon; breast cancer\n(2) Hematogenous dissemination with submucosal deposits: malignant melanoma, breast carcinoma, lung carcinoma, Kaposi sarcoma\n(3) Direct extension from adjacent neoplasm: ovary, uterus, prostate, pancreas, colon, kidney\n$\\checkmark$ fixation + tenting + transverse stretching (= across long axis) of folds $\\leftarrow$ mesenteric + peritoneal infiltration (most common form)\nUGI:\n$\\checkmark$ single mass protruding into lumen resembling annular carcinoma\n$\\checkmark$ \"bull's-eye\" lesions = multiple polypoid masses with sizable ulcer craters\n$\\checkmark$ obstruction from kinking / annular constriction / large intraluminal mass\n$\\checkmark$ compression by direct extension of primary tumor / involved nodes\nCT:\n$\\checkmark$ soft-tissue density nodules / masses\n$\\checkmark$ sheets of tissue causing thickening of bowel wall + mesenteric leaves\n$\\checkmark$ fixation + angulation of bowel loops (in tumors with desmoplastic response)\n$\\checkmark$ ascites\n\n## Metastasis to Stomach\n\nOrgan of origin:\n(a) by hematogenous spread: malignant melanoma, breast cancer, lung ca., colon ca., prostate carcinoma, leukemia, secondary lymphoma\n$\\checkmark$ one / more subepithelial masses\n$\\checkmark$ target / bull's-eye lesion if centrally ulcerated\n$\\checkmark$ giant cavitated lesion\n$\\checkmark$ linitis plastica (usually in breast cancer)\n(b) by direct invasion\n> Barrett cancer: gastric fundus\n> Pancreatic cancer: stomach / duodenal sweep\n> Colonic cancer: greater gastric curvature\n\n- Omental cake: greater gastric curvature\n- GI bleeding + anemia ( $40 \\%$ )\n- epigastric pain\n$\\checkmark$ solitary mass $(50 \\%)$\n$\\checkmark$ multiple nodules $(30 \\%)$\n$\\checkmark$ linitis plastica ( $20 \\%$ ): especially in breast cancer\n$\\checkmark$ multiple umbilicated nodules: malignant melanoma\n\n\n## MIDGUT VOLVULUS\n\n$=$ torsion of entire gut around SMA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 883,
            "markdown": "$\\diamond$ MEDICAL EMERGENCY requiring immediate surgery!\nCause: malrotation\nAge: most common in neonate / young infant (= acute intestinal obstruction); occasionally in older child / adult (= chronic intestinal obstruction)\nIn 20\\% associated with: (1) Duodenal atresia\n(2) Duodenal diaphragm\n(3) Duodenal stenosis\n(4) Annular pancreas\n\nPathophysiology:\nmalrotation $\\rightarrow$ abnormally short root of small bowel mesentery $\\rightarrow$ abnormal mobility of midgut $\\rightarrow$ torsion of mesentery; degree of twisting can change $\\leftarrow$ natural movement of bowel and determines symptomatology; severe volvulus $\\rightarrow$ obstruction of SMV + SMA (= twist of 3 $1 / 2$ turns) $\\rightarrow$ bowel necrosis\n\n- acute symptoms within first 3 weeks of life in $75 \\%$ : HALLMARK postprandial intermittent projectile bilious vomiting ( $60-80 \\%$ ); abdominal distension; shock\n- intermittent obstructive symptoms in older child: recurring attacks of nausea, vomiting, and abdominal pain with spontaneous reduction\n- failure to thrive $\\leftarrow$ hypoproteinemic gastroenteropathy $\\leftarrow$ result of lymphatic + venous obstruction\n- \"currant jelly\" stools / melena (implying vascular compromise)\n\nPlain film:\n$\\diamond$ A normal abdominal radiograph does not exclude the Dx!\n$\\checkmark$ dilated air-filled duodenal bulb + paucity of gas distally\n$\\checkmark$ \"double bubble\" sign = air-fluid levels in stomach + duodenum\n$\\checkmark$ isolated collection of gas-containing bowel loops distal to obstructed duodenum = gasfilled volvulus $=$ closed-loop obstruction $\\leftarrow$ nonresorption of intestinal gas $\\leftarrow$ obstruction of mesenteric veins\nUGI (preferred method, $54 \\%$ sensitive):\nN.B.: First exclude perforation on plain films!\n$\\diamond$ UGI not needed if complete obstruction shown on plain film\n$\\diamond$ Nasogastric tube desirable $\\rightarrow$ to decompress fluid-filled stomach with NG tube tip positioned in antropyloric region\n$\\checkmark$ vertically oriented duodenum that does NOT cross midline with most of small bowel on right side of abdomen\n$\\checkmark$ dilated proximal duodenum terminates in a distinctive conical / beaked shape\n$\\checkmark$ duodenal-fold thickening + thumbprinting $\\leftarrow$ mucosal edema + hemorrhage\n$\\checkmark$ duodenojejunal junction (ligament of Treitz) located lower than duodenal bulb + usually below and to the right of expected position at / to left of L1 pedicle\n$\\checkmark$ malrotation = spiral course of midgut (= jejunoileal) loops beyond point of obstruction = \"apple-peel / twisted ribbon / corkscrew\", \"spiral\" appearance (in 81\\%)\nBE:\n$\\checkmark$ abnormally high position of cecum (with isoosmolar water-soluble contrast enema, which is distinguishable from barium suspension used for subsequent UGI)\nCT:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 884,
            "markdown": "$\\sqrt{ }$ whorled mesentery $=$ clockwise wrapping of small bowel loops + adjacent mesenteric fat + SMV and tributaries + SMA branches converging to the point of torsion $=$ swirling of vessels in mesenteric root (during volvulus)\n$\\sqrt{ }$ SMV to left of / posterior to SMA = transposition / reversal of SMA-to-SMV relationship normal position; SMV to the right of SMA\nCAVE: reversal may be seen without malrotation; vessel location may be normal with malrotation\n$\\sqrt{ }$ inability to visualize $3^{\\text {rd }}$ part of duodenum across midline from right to left\n$\\sqrt{ }$ right- sided small bowel + left-sided colon\n$\\checkmark$ chylous mesenteric cyst $\\leftarrow$ interference with lymphatic drainage\n$\\checkmark$ small bowel dilatation + mucosal hyperattenuation $\\leftarrow$ global small-bowel ischemia\nUS:\n$\\sqrt{ }$ clockwise \"whirlpool sign\" = color Doppler depiction of SMV wrapping clockwise around superior mesenteric artery\n$\\checkmark$ distended proximal duodenum with arrowhead-type compression over spine\n$\\checkmark$ superior mesenteric vein to the left of SMA\n$\\checkmark$ thick-walled bowel loops below duodenum + to the right of spine associated with free intraperitoneal fluid\n$\\checkmark$ narrowed mesenteric pedicle\nAngio:\n$\\sqrt{ }$ \"barber pole\" sign = spiraling of SMA\n$\\checkmark$ tapering / abrupt termination of mesenteric vessels\n$\\checkmark$ marked vasoconstriction + prolonged contrast transit time\n$\\checkmark$ absent venous opacification / dilated tortuous SMV\nCx: (1) Intestinal ischemia in distribution of SMA with occlusion of lymphatics + SMV + $\\mathrm{SMA} \\rightarrow$ bloody diarrhea, ileus, abdominal distension\n(2) Bowel necrosis $\\rightarrow$ surgery $\\rightarrow$ short-gut syndrome $\\rightarrow$ dependence on total parenteral nutrition\nMortality: 3-5\\%\nDDx: (1) Hypertrophic pyloric stenosis (same age group, no bilious vomiting)\n(2) Ladd bands\n\n# MUCOCELE OF APPENDIX \n\n## Mucocele of Appendix\n\nmucocele $=$ macroscopic descriptive term for cystic dilatation of appendix / gallbladder / sinus cavity / salivary gland caused by an accumulation of mucin\nEtiology:\n(1) Simple mucocele $(20 \\%)=$ retention cyst $=$ cystic dilatation of lumen $\\leftarrow$ obstruction by fecolith, foreign body, endometriosis, adhesions, postoperative scarring following appendectomy, volvulus, carcinoid, appendiceal carcinoma, carcinoma of cecum $\\sqrt{ }$ mild luminal dilatation rarely $>2 \\mathrm{~cm}$ in diameter\n(2) Focal / diffuse mucosal hyperplasia (5-25\\%)\n(3) Mucinous cystadenoma $\\leftarrow$ hyperplasia with epithelial atypia $(50-63 \\%)=$ mucin-",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 885,
            "markdown": "secreting tumor\n$\\sqrt{ }$ marked luminal distention\nCx: perforation with mucous seeding (in 20\\%)\n(4) Mucinous cystadenocarcinoma with stromal invasion (11-20\\%)\n$\\sqrt{ }$ severe appendiceal distention by mucin\nCx: $6 \\%$ risk of perforation + peritoneal implantations\n(5) Cystic fibrosis with accumulation of thick mucus\n\nPrevalence: $0.07-0.25 \\%$ of appendectomy specimens; $8 \\%$ of appendiceal tumors\nMean age: 55 years; $\\mathrm{M}+\\mathrm{F}=1 \\div 4$ to $1 \\div 1$\nAssociated with: colonic adenocarcinoma (6-fold risk), mucin-secreting tumor of ovary\n\n- asymptomatic ( $25 \\%$ ), $\\pm$ acute / chronic RLQ pain\n- palpable mass in right lower quadrant (in up to $50 \\%$ )\n- altered bowel habits, weight loss, vomiting\n- $\\pm$ elevated CEA, CA 19-9, CA 125\n\nSize: up to 25 cm\nBE / plain film:\n$\\sqrt{ }$ globular, smooth-walled, broad-based mass invaginating into cecum\n$\\sqrt{ }$ nonfilling of the appendix on BE\n$\\sqrt{ }$ frequent peripheral punctate / rimlike calcifications (\"porcelain appendix\")\nCT:\n$\\sqrt{ }$ round sharply defined paracecal mass with homogeneous content of near-water / softtissue attenuation (depending on amount of mucin)\n$\\sqrt{ }$ NO adjacent inflammation\n$\\sqrt{ }$ calcifications of appendiceal wall $(<50 \\%)$\nUS:\n$\\sqrt{ }$ purely cystic / cystic with gravity-dependent fine internal echoes / complex cystic mass with high-level echoes\n$\\sqrt{ }$ SPECIFIC sign of multiple echogenic layers of protein macroaggregates / inspissated mucoid material along dilated appendix\n$\\sqrt{ } \\pm$ acoustic shadowing if calcifications present\nMR:\n$\\sqrt{ }$ hyperintense tumor on T2WI\n$\\sqrt{ }$ variably hypo- to isointense on T1WI depending on mucin concentration\n$\\sqrt{ }$ soft-tissue thickening, infiltration of perifocal fat, irregular mucocele wall = signs of malignancy / secondary inflammation / both\nNUC:\n$\\sqrt{ }$ intense early gallium uptake $\\leftarrow$ affinity to acid mucopolysaccharides of mucus\nCx: (1) Rupture $\\rightarrow$ pseudomyxoma peritonei\n(2) Torsion $\\rightarrow$ gangrene + hemorrhage\n(3) Herniation into cecum $\\rightarrow$ bowel obstruction\n(4) Intussusception\n(5) Right ureteral obstruction\n\nRx: appendectomy; hemicolectomy (suspected malignancy)\n$D D x$ : appendicitis, periappendiceal abscess, mesenteric cyst, enteric duplication cyst, right",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 886,
            "markdown": "ovarian cyst, cystic ovarian neoplasm, hydrosalpinx, tubo-ovarian abscess\n\n# Myxoglobulosis \n\n$=$ rare variant of mucocele characterized by clusters of pearly white mucous balls ( $=$ intraluminal globules) intermixed with mucus\n\n- usually asymptomatic, may appear as acute appendicitis\n$\\sqrt{ }$ multiple mobile $1-10-\\mathrm{mm}$ small rounded annular nonlaminated calcified spherules (PATHOGNOMONIC)\n$D D x$ : inverted appendiceal stump (of inversion-ligation technique), acute appendicitis, cecal carcinoma, phleboliths, calcified lymph nodes\n\n\n## OMENTAL INFARCTION\n\n$=$ rare cause of self-limiting abdominal pain\nPathophysiology:\n(a) torsion (rare cause) $\\rightarrow$ interruption of blood supply to omentum $\\rightarrow$ venous thrombosis\n(b) trauma $\\rightarrow$ thrombosis $\\rightarrow$ insufficiency of omental veins\n\nPredisposing factors: obesity, strenuous activity, CHF, digitalis administration, trauma, recent abdominal surgery\nA. PRIMARY (idiopathic) OMENTAL INFARCTION (15\\%)\n\nCause: bifid omentum, accessory omental tissue, variant vascular supply, marathon running $\\rightarrow$ physiologic shunting with splanchnic vasoconstriction\nMay be associated with: hypercoagulable state, CHF, vasculitis\nPath: hemorrhagic infarction $\\leftarrow$ vascular compromise $\\leftarrow$ (a) tenuous blood supply to right edge of omentum, (b) kinking of veins\n\n- precipitated by coughing, straining, overeating, marathon running\n\nAge: pediatric patients\nLocation: commonly RLQ on inferior right side of omentum\nB. SECONDARY OMENTAL INFARCTION (more common)\n\nCause: postoperative omental adhesion, omental mass, vascular damage related to trauma / inflammation / hernia\nAge: adult, $\\mathrm{M}>\\mathrm{F}$\n\n- subacute RLQ / RUQ abdominal pain of a few days duration\n- clinical mimicker of acute appendicitis, cholecystitis but in the ABSENCE of GI symptoms of nausea, vomiting, fever\n- slightly elevated WBC\n\nLocation: mostly between anterior abdominal wall and transverse / ascending colon / cecum\nSite: right inferior portion of omentum $>$ left\nSize: diameter $>5 \\mathrm{~cm}$\nCT:\n$\\checkmark$ solitary encapsulated triangular / oval fatty mass:\n$\\checkmark$ soft-tissue stranding adjacent to ascending colon = haziness of fat anterior to colon (early / mild infarction)\n$\\checkmark$ internal heterogeneity $\\leftarrow$ soft-tissue stranding adjacent to ascending colon\n$\\checkmark$ whorled pattern of concentric linear fat stranding (in torsion)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 887,
            "markdown": "$\\sqrt{ }$ NO enhancement\n$\\sqrt{ }$ omental torsion (rare) with swirling of vessels in omentum\n$\\sqrt{ }$ absent / (rarely) mild thickening of adjacent bowel wall corresponding to site of focal tenderness\nUS:\n$\\sqrt{ }$ nonmobile noncompressible hyperechoic tender mass\nPET:\n$\\sqrt{ }$ mild uptake of 18 F -fluorodeoxyglucose (FDG)\n$D x:$ clinically difficult; often $1^{\\text {st }}$ suggested by radiologist\n$C x$ : omental abscess (rare)\n$R x:$ supportive\n$D D x$ : epiploic appendagitis ( $<5 \\mathrm{~cm}$ in diameter, peripheral hyperdense rim, \"central dot\" sign); diverticulitis (bowel wall thickening)\n\n# PELVIC FLOOR DYSFUNCTION \n\n$=$ heterogeneous group of disorders presenting with pelvic pain, pressure, dyspareunia, incontinence, incomplete emptying, gross organ protrusion\nPrevalence: $10-50 \\%$ of middle-aged / older women increasing with age; $10 \\%$ requiring surgery\nCause: injury to pelvic floor from surgery / childbirth, denervation of musculature, fascial defect, abnormal synthesis / degradation of collagen\nRisk factors: age, menopause, multiparity, complicated vaginal delivery, obesity, collagenrelated disorder, hysterectomy\n![img-93.jpeg](img-93.jpeg)",
            "images": [
                {
                    "id": "img-93.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 1150,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1966,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 888,
            "markdown": "![img-94.jpeg](img-94.jpeg)\n\nMidsagittal pelvic MR:\n» Draw 3 lines:\n(1) Pubococcygeal line from inferior margin of symphysis to junction C1-C2\n(2) H-line (Hiatus of levator ani) along puborectalis muscle sling for structures passing through pelvic floor\n$\\sqrt{ }$ linear distance measured during straining\n(3) M-line (Muscular pelvic floor) line from point of posterior puborectalis muscle perpendicular to pubococcygeal line\n» HMO evaluation:\n(1) Hiatal size (H-line measurement)\n$\\sqrt{ }$ hiatal enlargement $>6 \\mathrm{~cm}$\nGrading: normal $<6 \\mathrm{~cm}$, mild $6-8 \\mathrm{~cm}$, moderate $8-10 \\mathrm{~cm}$, severe $>10 \\mathrm{~cm}$\n(2) Pelvic floor descent (M-line measurement)\n$\\sqrt{ }$ pelvic floor descent $>2 \\mathrm{~cm}$\nGrading: normal $<2 \\mathrm{~cm}$, mild $2-4 \\mathrm{~cm}$, moderate $4-6 \\mathrm{~cm}$, severe $>6 \\mathrm{~cm}$\n(3) Organ prolapse (any distance below H-line):\n$=$ shortest distance between the most caudal aspect of an organ and H line during Valsalva maneuver\nGrading: mild / small $<2 \\mathrm{~cm}$; moderate $2-4 \\mathrm{~cm}$; severe / large $\\geq 4 \\mathrm{~cm}$\nDefecography / Evacuation Proctography:\nevacuation time $=15$ (range $5-40$ ) seconds\nanorectal angle $=$ angle formed between central axis of anal canal + line parallel to posterior wall of rectum\n$\\sqrt{ } 90^{\\circ}$ at rest and during voluntary contraction (squeeze maneuver)",
            "images": [
                {
                    "id": "img-94.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 189,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1003,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 889,
            "markdown": "$\\sqrt{ }$ more obtuse during defecation straining (void)\nanorectal junction $=$ point of taper of distal rectal ampulla as it merges with the anal canal; position of anorectal junction referenced to plane of ischial tuberosities $=0-3.5 \\mathrm{~cm}$; elevation during squeeze of $0-4.5 \\mathrm{~cm}$; elevation during void of $-3.0-0 \\mathrm{~cm}$\nrectovaginal space $=$ space between vagina and rectum\nperineum $=$ area between external genital organs and anal verge\n\n# Pelvic Floor Relaxation \n\n$=$ weakening of pelvic floor support structures consisting of muscles and connective tissue (= pelvic sling) $\\rightarrow$ pelvic floor dysfunction at rest + during activities with $\\uparrow$ intraabdominal pressure (like coughing, sneezing, urination, defecation)\nComponents: hiatal enlargement + pelvic floor descent\n$R x$ : surgical mesh reconstruction\n\n| Grade | Hiatal Enlargement | Pelvic Floor Descent |\n| :-- | :--: | :--: |\n| 0 (normal) | $<6 \\mathrm{~cm}$ | $0-2 \\mathrm{~cm}$ |\n| 1 (mild) | $6-8 \\mathrm{~cm}$ | $2-4 \\mathrm{~cm}$ |\n| 2 (moderate) | $8-10 \\mathrm{~cm}$ | $4-6 \\mathrm{~cm}$ |\n| 3 (severe) | $\\geq 10 \\mathrm{~cm}$ | $\\geq 6 \\mathrm{~cm}$ |\n\n## Pelvic Floor Prolapse\n\n$=$ abnormal protrusion of a pelvic organ(s) through its respective hiatus\nCause: failure of support structures, perineal hiatal weakening\n\n## Cystocele\n\n$=$ prolapse / herniation of bladder through its respective hiatus on anterior vaginal wall\nCause: defect in pubocervical fascia attaching to arcus tendineus fasciae pelvis (ATFP) anterolaterally + to cervix posteriorly\n\n- vaginal bulging $\\rightarrow$ difficult intercourse / dyspareunia\n- simple stress urinary incontinence (may be masked in severe case by a kink at the bladder neck $\\leftarrow$ transverse orientation of urethra)\nVoiding video urodynamic study:\n$\\checkmark$ uncovers urge incontinence from detrusor instability\n$\\checkmark$ uncovers stress urinary incontinence masked by urethral hypermobility\nMR:\n$\\checkmark$ downward + clockwise bladder rotation $\\leftarrow$ posterior bladder wall descends disproportionately more than anterior wall (in severe case)\n$\\checkmark$ descent of bladder base below pubococcygeal line\n$\\checkmark$ urethral prolapse ( $=$ urethral hypermobility)\n$R x$ : pessary: sutures and mesh to approximate original fascial support $\\pm$ incontinence surgery (sling procedure)\n\n\n## CYSTOURETHROCELE\n\n$C x$ : ureteral obstruction / hydronephrosis $\\leftarrow$ entrapment of ureters $\\leftarrow$ high degree of muscular pelvic floor relaxation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 890,
            "markdown": "# Bladder Outlet Obstruction \n\nCause: surgical repair for stress urinary incontinence, urethral hypermobility, bladder outlet compression by prolapsing uterus or rectocele, kinking of urethra / bladder outlet in patients with cystocele\n\n- voiding hesitancy, required positional voiding, required manual reduction of prolapse for voiding, frank urinary retention occasionally requiring catheterization\n\n\n## Genital Prolapse\n\n$=$ UTERINE AND VAGINAL VAULT PROLAPSE\nCause: muscle damage + stretching (laxity) / tearing of uterosacral ligaments\n\n- bulging vaginal mass outside external genitalia\n- dyspareunia, urinary retention, back pain\n\nMR:\n$\\checkmark$ descent of vaginal fornix and uterus below PCL\n$\\checkmark$ progressive uterine retroversion $\\rightarrow$ subsequent prolapse\n$\\checkmark$ loss of banana-shaped vaginal axis (= loss of elevation of distal vagina by ligaments and muscles)\n$R x$ : pessary, pelvic floor exercises, hysterectomy, vaginal repair\n$C x$ : insidious progressive ureteral obstruction\n\n## UTERINE PROCIDENTIA\n\n$=$ uterus prolapse completely outside of hiatus\n\n## Enterocele\n\n$=$ CUL-DE-SAC HERNIA\n$=$ herniation of peritoneal membrane protruding between uterosacral ligaments at apex of vagina through rectovaginal space (cul-de-sac) and posterior perineum + extending distally into rectovaginal septum, separating rectum from vagina\n(a) simple $=$ no associated vaginal vault prolapse\n(b) complex $=$ associated with other forms of anterior / posterior vaginal vault prolapse\n\nContent: fat (= peritoneocele), small bowel (= true enterocele), sigmoid colon (= sigmoidocele)\nAt risk: hysterectomy $\\leftarrow$ interrupted continuity of pubo-cervical + rectovaginal parts of endopelvic fascia\n\n- symptoms of bowel obstruction, vaginal pressure, dyspareunia, low back pain\n- difficult to diagnose on physical examination\n\nCystocolpoproctography:\n$\\diamond$ fails to demonstrate up to $20 \\%$ of enteroceles\nMR: superior to cystocolpoproctography\n$R x$ : requires peritoneal approach to surgical repair\n\n## Sigmoidocele\n\nEvacuation Proctography:\n$\\checkmark$ prolapse of sigmoid colon between rectum and vagina\nGrading: (1) above pubococcygeal line; (2) between pubococcygeal + ischiococcygeal line; (3) below ischiococcygeal line",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 891,
            "markdown": "Cx: obstruction of rectum\n\n# Peritoneocele \n\n$=$ MESENTEROCELE\ncontaining liquid / bowel / omentum / mesenteric fat\nEvacuation Proctography:\n$\\sqrt{ }$ extension of rectouterine excavation to below upper third of vagina\n\n## Rectocele\n\n$=$ bulging / outpouching of anterior rectal wall anterior to transverse perineus muscle into posterior vaginal wall\nCause: defect in pre- and pararectal fascia and rectovaginal septum\n\n- often missed at physical examination\n- impaired emptying $\\rightarrow$ need for digital assistance\n\nEvacuation proctography:\n$\\sqrt{ }$ measurement of anteroposterior depth of convex wall protrusion extending beyond expected margin of normal rectal wall\n$\\checkmark$ rectal mucosal prolapse, solitary rectal ulcer\n$\\checkmark$ incomplete emptying of anterior rectoceles\nMR:\n$\\checkmark$ distance of anterior / posterior rectal wall from anal canal axis\nGrading: small $<2 \\mathrm{~cm}$; moderate $2-4 \\mathrm{~cm}$; large $>4 \\mathrm{~cm}$\n$C x$ : obstructed defecation $\\leftarrow$ dissipation of vector force during straining\n$R x$ : rectovaginal fascia repair / posterior fixation of rectum $\\pm$ sigmoid / rectal resection\n\n## Rectal Prolapse\n\n$=$ descent / infolding of mucosa or entire thickness of rectal wall through anal verge\nCause: chronic straining + fascial disruption\n$C x$ : obstructed defecation $\\rightarrow$ pudendal neuropathy $\\rightarrow$ fecal incontinence; external anal sphincter atrophy\n\n## Rectal Intussusception\n\n$=$ descent of the entire (full wall) thickness of the rectal wall into anal canal; starting 611 cm above anus\nTypes: internal (intrarectal / intra-anal) or external\n$\\checkmark$ infolding of $<3 \\mathrm{~mm}$ in width $/>3 \\mathrm{~mm}$ in width / intraluminal narrowing / descent into anal canal / external prolapse\n$\\checkmark$ accompanied by formation of a circular indentation forming a ring pocket\n\n## PERITONEAL MESOTHELIOMA\n\n$=$ MALIGNANT MESOTHELIOMA\n$=$ uncommon only primary tumor of peritoneum arising from mesothelial cells lining peritoneal cavity\nFrequency: 12-33\\% of all mesotheliomas; 6\\%-10\\% of all malignant mesotheliomas\nMedian age: 50 (range, 55-66) years; $\\mathrm{M}>>\\mathrm{F}$\nAssociated with: high levels of asbestos exposure (50-70\\%), esp. exposure to erionite (=",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 892,
            "markdown": "mineral fiber found in Turkey); therapeutic irradiation; exposure to simian virus 40 ; (rarely) chronic pleural / peritoneal irritation\nOrigin: (a) expectoration of inhaled asbestos fibers $\\rightarrow$ swallowed $\\rightarrow$ penetration of bowel wall into lymphatics + splanchnic circulation\n(b) arise solely from peritoneum ( $35 \\%$ )\n\nSpread: intraperitoneal along serosal surfaces; direct invasion of liver, pancreas, bladder, bowel\nLocation: pleura ( $67 \\%$ ), peritoneum ( $30-40 \\%$ ), pericardium ( $2.5 \\%$ ), processus vaginalis $(0.5 \\%)$\nPath:\n(1) Focal (localized) form\n$\\sqrt{ }$ large mass, usually in upper abdomen + scattered peritoneal nodules in anterior parietal peritoneum becoming confluent and cakelike\nPrognosis: good following complete surgical excision\n(2) Diffuse (desmoplastic) form\n$\\sqrt{ }$ diffuse thickening of mesentery, omentum, peritoneum, bowel wall WITHOUT definable mass + spread along serosal surfaces encasing solid / hollow visceral organs\nPrognosis: highly aggressive + incurable\nHisto: epithelial, sarcomatous, mixed (biphasic / bimorphic) with submesothelial tumor infiltration\n\n- abdominal pain / discomfort, nausea, anorexia, weight loss\n- abdominal distention / increasing abdominal girth\n$\\sqrt{ }$ lymphadenopathy (rare)\nUGI:\n$\\checkmark$ separation of small bowel loops from one another\n$\\checkmark$ absence of normal peristaltic movements\nCT:\n$\\checkmark$ nodular irregular thickening of peritoneal surfaces / localized masses\n$\\checkmark$ stellate mesentery (common) $=$ thick neurovascular bundles\n$\\checkmark$ increased attenuation in mesenteric fat\n$\\checkmark$ perivascular soft-tissue thickening\n$\\checkmark$ rigidity of vascular bundle\n$\\checkmark$ pleated thickening of mesenteric leaves $\\leftarrow$ infiltrating sheets of tissue\n$\\checkmark$ bowel wall thickening $\\leftarrow$ tumor extension to visceral peritoneal surface\n$\\checkmark$ foci of calcifications (rare)\n$\\checkmark$ disproportionately small amount of ascites of near-water density\n$\\checkmark$ omental involvement:\n$\\checkmark$ finely infiltrated fat with smudged appearance\n$\\checkmark$ discrete omental nodules\n$\\checkmark$ omental cake\n$\\checkmark$ pleural plaque (in $50 \\%$ )\nCECT:\n$\\checkmark$ homo- / heterogeneous enhancement $\\leftarrow$ intratumoral mucinous component / cystic degeneration / necrosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 893,
            "markdown": "MR:\n$\\sqrt{ }$ tumor of intermediate to low SI on T1WI\n$\\checkmark$ tumor of intermediate to high SI on T2WI\nNUC:\n$\\checkmark$ diffuse uptake of 67Gallium\nCx: bowel obstruction\nPrognosis: extremely poor $\\leftarrow$ advanced disease at presentation (most patients die within 1 year)\n$D D x$ : peritoneal carcinomatosis (indistinguishable); nonneoplastic condition (eg, tuberculosis)\n\n# Multicystic / Cystic Mesothelioma \n\n$=$ BENIGN MULTICYSTIC MESOTHELIOMA $=$ PERITONEAL INCLUSION CYST $=$ PERITONEAL PSEUDOCYST $=$ MULTILOCULAR INCLUSION CYST $=$ ENTRAPPED OVARIAN CYST $=$ INFLAMMATORY CYST OF THE PELVIC PERITONEUM\n$=$ accumulation of ovarian fluid contained by peritoneal adhesion / (?) rare benign neoplasm without metastatic potential but tendency for local recurrence\nCause: endometriosis; pelvic inflammatory disease; trauma; prior pelvic surgery in $30-100 \\%$ (time delay of 6 months to 20 years)\nOrigin: serosal lining of peritoneum, pleura, pericardium\nPathogenesis: extensive pelvic adhesions $\\rightarrow$ impaired peritoneal clearing $\\rightarrow$ accumulation of ovulated fluid\nPath: multiple translucent thin-walled cysts that grow along pelvic peritoneum in grapelike clusters adherent to surface of ovary; intermediate form between benign adenomatoid tumor + malignant peritoneal mesothelioma\nHisto: cyst lined by hyperplastic mesothelial cells and fibroglandular tissue with chronic inflammation; filled with watery fluid; positive for calretinin and cytokeratins\n$\\diamond$ Not associated with asbestos exposure!\nMean age: 37 years (premenopausal with active ovaries); $\\mathrm{M}+\\mathrm{F}=1 \\div 5$\n\n- chronic or intermittent lower abdominal / pelvic pain\n- abdominal distention, tenderness. palpable mass\n- dyspareunia, constipation, urinary hesitancy \\& frequency\n\nLocation:\n(a) woman: typically in cul-de-sac, along peritoneal surface of uterus and rectum / omentum\n(b) men: peritoneal surface of bladder + rectum\n(c) upper abdomen: multifocal cysts / freely floating cyst / unilocular cyst\n\nSize: $\\quad 13 \\mathrm{~cm}$ of mean diameter\nUS:\n$\\sqrt{ }$ single / multiloculated cyst conforming to the shape of the peritoneal cavity + contiguous with normal ovary:\n$\\sqrt{ }$ \"ovary-in-cyst\" sign = normal-appearing ipsilateral ovary entrapped by loculated fluid\n$\\checkmark$ unusual geometric shape with anatomic boundaries\n$\\checkmark$ NO cyst wall\n$\\checkmark$ cyst content usually anechoic $\\pm$ echoes from debris / hemorrhage",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 894,
            "markdown": "$\\sqrt{ }$ septa:\n$\\sqrt{ }$ thin fibrous septa + mesothelial strands (common) resembling a spider web\n$\\sqrt{ }$ NO septal calcification\n$\\sqrt{ } \\pm$ nodular excrescences / thick polypoid incomplete septations\nCT:\n$\\sqrt{ }$ watery fluid attenuation\n$\\sqrt{ }$ soft-tissue attenuation $\\leftarrow$ innumerable small cysts / thick-walled cyst\n$\\sqrt{ }$ septal enhancement\nMR:\n$\\sqrt{ }$ signal pattern typical of serous fluid = low on T1WI, high on T2WI\n$\\sqrt{ }$ enhancement of septa only\n$\\sqrt{ }$ may contain hemorrhage\n$C x$ : infertility\n$R x$ : surgery ( $27-50 \\%$ risk of recurrence)\nPrognosis: good\nDDx: Paraovarian cyst (ovoid cyst outside ovary), Hydrosalpinx (visible folds, located outside ovary), Lymphangioma, Intraperitoneal inclusion cyst, Mesenteric cyst, Ovarian cystadenoma / cystadenocarcinoma\n\n# PERITONEAL METASTASES \n\n$=$ PERITONEAL CARCINOMATOSIS\n$=$ relatively common intraabdominal spread of malignant tumors\nOrigin: (a) common: ovary, GI primary (stomach, colon)\n(b) less common: pancreas, uterus, bladder, appendix\n\nTime of onset:\nin $55 \\%$ at time of diagnosis of nongynecologic primary;\nin $70 \\%$ at time of staging laparotomy for ovarian cancer\n\n- usually asymptomatic at onset\n- abdominal enlargement $\\leftarrow$ ascites\n- abdominal pain $\\leftarrow$ bowel obstruction\n\nPath: tumor nodules studding peritoneal surface; transperitoneal spread with fibrotic host response $\\rightarrow$ replacement of omental fat $=$ omental caking + ovarian metastasis ( $=$ Krukenberg tumor)\nHisto: adenocarcinoma with abundant mucin + signet ring morphology (most frequent)\n$\\sqrt{ }$ new onset ascites / massive ascites\n$\\sqrt{ }$ loculated fluid collections in peritoneal cavity\n$\\sqrt{ }$ enhancement of peritoneum\n$\\sqrt{ }$ nodules in areas of relative stasis / arrested flow of peritoneal fluid\nLocation of arrested flow / stasis of peritoneal fluid:\nrectouterine recess (pouch of Douglas), retrovesical space, subhepatic space, right\nsubdiaphragmatic space, root of small bowel mesentery, ileocecal junction, superior aspect\nof sigmoid mesocolon, right paracolic gutter\n$\\diamond$ Stasis areas $=$ sites of occult tumor\n$\\sqrt{ }$ desmoplastic reaction at (a) anterior border of rectum (Blumer shelf), (b) mesenteric side of",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 895,
            "markdown": "terminal ileum\n$\\sqrt{ }$ occasionally sheetlike growth pattern encasing intraperitoneal viscera (DDx: malignant mesothelioma)\nUS:\n$\\sqrt{ }$ ascites: anechoic / with low-level echoes of particulate matter (= proteinaceous exudate)\n$\\sqrt{ }$ hypoechoic tumor nodule / sheetlike mass on visceral / parietal surface\n$\\sqrt{ }$ echogenic plaquelike omentum floating in ascites / adherent to anterior abdominal wall\nCT $(25-50 \\%$ sensitive for tumors $<1 \\mathrm{~cm})$ :\n$\\sqrt{ }$ small nodular densities studding peritoneal surface\n$\\sqrt{ }$ pleated / stellate small bowel mesentery:\n$\\sqrt{ }$ increased density of linear network in mesenteric fat (= fluid within leaves of mesentery)\n$\\sqrt{ }$ apparent thickening of mesenteric vessels (= tumor infiltration of perivascular spaces)\n$\\sqrt{ }$ \"omental cake\" = thickening of greater omentum\n$\\sqrt{ }$ adnexal mass of cystic / soft-tissue density (= Krukenberg tumor) $\\leftarrow$ transperitoneal spread\n$\\sqrt{ }$ lobulated mass in pouch of Douglas\n$\\sqrt{ }$ calcified peritoneal implants in serous cystadenocarcinoma of ovary (in up to $40 \\%$ with stage III / IV disease)\nMR ( $85-90 \\%$ sensitive for tumors $<1 \\mathrm{~cm}$ ):\n$\\sqrt{ }$ maximal enhancement of peritoneal implants at $5-10 \\mathrm{~min}$\nPET (controversial utility):\n$\\sqrt{ }$ diffuse uptake spreading uniformly throughout abdomen and pelvis obscuring visceral outlines\n$\\sqrt{ }$ discrete foci of uptake anteriorly within abdomen / dependently within pelvis\n$C x:$ small bowel obstruction\n\n# PEUTZ-JEGHERS SYNDROME \n\n[Johannes Peutz (1886-1957), internist in Den Haag, Holland]\n[Harold Jeghers (1904-1990), internist in Boston, USA]\n$=$ rare syndrome characterized by intestinal polyposis and mucocutaneous pigmentation (= hamartomatosis)\nCause: mutation to serine / threonine kinase 11 (STK11) tumor suppressor gene on chromosome 19p13.3\nGenetics: autosomal dominant with incomplete penetrance; often spontaneous mutations\nFrequency: $\\quad 1 \\div 7,000$ live births; in $50 \\%$ familial, in $50 \\%$ sporadic; most frequent of polyposis syndromes to involve small intestines\nAge: at presentation 25 (range $10-30$ ) years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$\nPath: multiple small sessile / large pedunculated polyps\nHisto: benign hamartomatous (?) polyp with a smooth muscle core arising from muscularis mucosae and arborizing (treelike) extension into lamina propria of polyp (CHARACTERISTIC); misplaced epithelium (= pseudoinvasion) in submucosa, muscularis propria, sub-serosa frequently surrounding mucin-filled spaces\n\n- mucocutaneous pigmentation (similar to freckles):\n$=1-5-\\mathrm{mm}$ small elongated melanin spots on mucous membranes (lower lips, gums, palate) + facial skin (nose, cheeks, perioral, periorbital) + volar aspects of toes and fingers ( $100 \\%$ ),",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 896,
            "markdown": "noticeable in first few years of life\n$\\diamond$ NO potential to become malignant\n\n- intermittent cramping abdominal pain $\\leftarrow$ small bowel intussusception (in $47 \\%$ )\n- rectal bleeding, melena ( $30 \\%$ ), acute blood loss, chronic hypochromic microcytic anemia $\\leftarrow$ ulcerated polyps\n- prolapse of polyp through anus\n\nLocation: small bowel (jejunum + ileum $>$ duodenum) $>$ colon $>$ stomach; mouth + esophagus spared\n@ Small bowel ( $>95 \\%$ )\n$\\sqrt{ }$ multiple usually broad-based polyps separated by wide areas of intervening flat mucosa\n$\\checkmark$ multilobulated surface of larger polyps\n$\\checkmark$ myriad of $1-2-\\mathrm{mm}$ nodules of up to several $\\mathrm{cm}=$ carpet of polyps\n$\\checkmark$ intussusception usually confined to small bowel\n@ Colon + rectum ( $30 \\%$ )\n$\\checkmark$ multiple scattered $1-30-\\mathrm{mm}$ polyps; NO carpeting\n@ Stomach + duodenum ( $25 \\%$ )\n$\\checkmark$ diffuse involvement with multiple polypoid lesions:\n$\\checkmark$ small / large, sessile / pedunculated polyps\n@ Extraintestinal sites: kidney, ureter, gallbladder, bronchial tree, nasal passages\n$\\checkmark$ adenoma of bronchus + urinary bladder\nCx:\n$\\diamond$ Approximately $60 \\%$ lifetime incidence of malignancy!\n(1) Gastrointestinal adenocarcinoma:\n\nFrequency: $2-3 \\%$\nMean age: 40 years of age\nLocation: stomach, duodenum, colon; small bowel (least common)\n(2) Carcinoma of pancreas ( $13 \\%$ )\n(3) Carcinoma of breast ( $50 \\%$ risk by 60 years of age similar to BRCA1 / BRCA2): commonly bilateral + ductal\n(4) Ovarian tumor (5\\%), commonly bilateral: sex cord-stromal tumor of ovary (almost in $100 \\%$ of patients), mucinous cystic tumor, cystadenoma, granulosa cell tumor\n(5) Testicular tumor: Sertoli cell tumor\n(6) Endometrial cancer: adenoma malignum of cervix\n(= minimal deviation adenocarcinoma = low-grade mucinous tumor of cervix)\n(7) Transient intussusception (pedunculated polyp as lead point) $\\rightarrow$ spontaneous reduction or SBO\nRx: (1) Endoscopic removal of all polyps $>5 \\mathrm{~mm}$\n(2) Surgery is reserved for obstruction, severe bleeding, malignancy\n(3) Surveillance screening: hemoglobin level; regular breast, gynecologic, testicular examinations; pelvic, testicular, pancreatic US; endoscopy of upper and lower GI tract; small bowel capsule endoscopy\nPrognosis: decreased life expectancy (risk of cancer approaching $40 \\%$ by 40 years of age)\n$D D x$ : familial adenomatous polyposis, juvenile polyposis (similar age), Cowden disease, Cronkhite-Canada syndrome",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 897,
            "markdown": "# PNEUMATOSIS CYSTOIDES COLI \n\n$=$ cystic / linear gas collection in colonic wall\nLocation: submucosal / subserosal\n\n## Primary Pneumatosis Cystoides Coli\n\n$=$ benign condition\nLocation: favors left-sided colon\n\n- simulates polyposis at colonoscopy $\\rightarrow$ release of gas with cyst puncture\n$\\sqrt{ }$ marked cluster of air-filled cysts in wall of colon\n\n\n## Secondary Pneumatosis\n\n$\\sqrt{ }$ more linear gas collection\n\n## POSTCRICOID DEFECT\n\n$=$ variable defect seen commonly in the fully distended cervical esophagus; no pathologic value Etiology: redundancy of mucosa over rich postcricoid submucosal venous plexus\nFrequency: in $80 \\%$ of normal adults\nLocation: anterior aspect of esophagus at level of cricoid cartilage\n$\\sqrt{ }$ tumor- / weblike lesion with variable configuration during swallowing\n$D D x$ : subepithelial tumor, esophageal web (persistent configuration)\n\n## POSTINFLAMMATORY POLYPOSIS\n\n$=$ PSEUDOPOLYPOSIS\n$=$ reepithelialized inflammatory polyps as sequelae of mucosal ulceration\nEtiology: ulcerative colitis ( $10-20 \\%$ ); granulomatous colitis (less frequent); schistosomiasis (endemic); amebic colitis (occasionally); toxic megacolon\nPathogenesis: ulcerative undermining of strips of mucosa with reepithelialization of denuded surfaces of tags + bowel wall\nLocation: most common in left hemicolon, may occur in stomach / small intestine\n$\\sqrt{ }$ sessile + frondlike appearance (often)\n$\\sqrt{ }$ filiform polyposis $=$ multiple wormlike projections only attached at their bases (CHARACTERISTIC)\nPrognosis: NO malignant potential\n$D D x$ : familial polyposis (polyps terminate in bulbous heads)\n\n## PRESBYESOPHAGUS\n\n$=$ defect in primary peristalsis + LES relaxation associated with aging\nFrequency: $15 \\%[50 \\%]\\{85 \\%\\}$ in $7^{\\text {th }}[8^{\\text {th }}]\\{9^{\\text {th }}\\}$ decade\nAssociated with: hiatus hernia, reflux\n\n- usually asymptomatic\n$\\sqrt{ }$ impaired / no primary peristalsis\n$\\sqrt{ }$ often repetitive nonperistaltic tertiary contractions in distal esophagus\n$\\sqrt{ }$ mild / moderate esophageal dilatation\n$\\sqrt{ }$ poor LES relaxation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 898,
            "markdown": "$D D x$ : diabetes, diffuse esophageal spasm, scleroderma, esophagitis, achalasia, benign stricture, carcinoma\n\n# PROGRESSIVE SYSTEMIC SCLEROSIS \n\n$=$ PSS $=$ chronic multisystem autoimmune disorder of connective tissues (collagen-vascular disease) characterized by a widespread pathophysiologic triad of\n(1) Autoimmune disease-induced inflammation\n(2) Microvascular damage\n(3) Fibrosis (= overproduction of collagen $\\rightarrow$ exuberant interstitial fibrosis with atrophy + sclerosis of many organ systems\n$=$ SCLERODERMA $=$ variety of skin disorders associated with hardening of skin\nby extent of cutaneous involvement divided into 2 subgroups with different autoantibody profile + survival rate:\n(a) DIFFUSE SCLERODERMA\n> skin changes proximal to elbow / knee\n> tendency to involve older women\n> interstitial pulmonary fibrosis more severe\n> organ failure more likely\n(b) LIMITED SCLERODERMA (formerly CREST syndrome)\n> pulmonary arterial hypertension more common + more severe\n> CREST features more common\n\n- CREST: Calcinosis cutis\n\nRaynaud phenomenon\nEsophageal dysmotility\nSclerodactyly\nTelangiectasia\nMay be associated with:\nother connective tissue diseases (especially SLE and polymyositis / dermatomyositis)\nEtiology: unknown; autoimmune condition with genetic predisposition, may be initiated by environmental antigen (eg, toxic oil syndrome in Spain $\\leftarrow$ ingestion of adulterated rapeseed oil / ingestion of L-tryptophan)\nIncidence: $\\quad 0.6-122.0 \\div 1,000,000$ people annually (higher rates in USA + Australia and among blacks)\nPrevalence: $\\quad 19-75 \\div 100,000$ people\nPeak age: $\\quad 45-64$ years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 3$ to $1 \\div 8$\nHisto: vasculitis + submucosal fibrosis with deposition of collagen in longitudinal layer of muscularis propria + smooth muscle atrophy (initially hypertrophy and finally atrophy of collagen fibers)\n\n- antinuclear antibodies $(30-80 \\%)$ :\n- centromere antibody (ACA) specific for limited disease\n- anti-topoisomerase-1 (= antiScl-70) identifies patients with diffuse cutaneous disease\n- antibodies to extracellular matrix proteins and type I + IV collagen; rheumatoid factor (35\\%), LE cells (5\\%)\n- weakness, generalized debility",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 899,
            "markdown": "Increased risk: lung cancer, breast cancer\nStages:\n(a) inflammatory phase (several weeks)\n\n- erythema, pruritus, nonpitting edema\n- fatigue, arthralgia, myalgia\n(b) fibrotic phase (several months to years)\n- inflexible skin, loss of function of affected limbs\n- contractures, atrophy\n\nPrognosis: 50-67\\% 5-year survival rate;\n$\\diamond$ Highest mortality among collagen vascular disease $\\leftarrow$ pulmonary arterial hypertension!\n\n# Cardiac Scleroderma \n\nHisto: sclerosis of cardiac muscle (= myocardial fibrosis)\n\n- arrhythmia\n$\\sqrt{ }$ pericardial effusion (pericarditis)\n$\\sqrt{ }$ congestive heart failure\n$C x:$ cor pulmonale\nGastrointestinal Scleroderma (in 40-45\\%)\n$\\diamond 3^{\\text {rd }}$ most common manifestation of scleroderma (after skin changes + Raynaud phenomenon)\n$\\diamond$ May precede other manifestations!\nPath: collagen deposition primarily in tunica muscularis $\\rightarrow$ smooth muscle atrophy + fibrosis\n- abdominal pain, diarrhea\n- multiple episodes of pseudoobstruction\n$\\sqrt{ }$ hepatomegaly\n@ Esophagus (in 42-97\\%)\n$\\diamond$ First GI tract location to be involved!\nSite: distal $2 / 3$ (striated muscle in upper $1 / 3$ )\n- dysphagia (50\\%), heartburn (30\\%)\n> functional:\n$\\sqrt{ }$ hypotonia / atony + hypokinesia / aperistalsis in lower $2 / 3$ of esophagus (dysmotility in $>50 \\%$ ):\n$\\sqrt{ }$ absent primary peristalsis of esophagus below level of aortic arch\n$\\sqrt{ }$ chalasia (= patulous lower esophageal sphincter)\n$\\sqrt{ }$ mild to moderate dilatation of esophagus\n$\\sqrt{ }$ thin / vanished longitudinal folds\n$\\sqrt{ }$ deficient esophageal emptying in recumbent position\n$\\sqrt{ }$ gastroesophageal reflux ( $70 \\%$ )\n$\\sqrt{ }$ normal peristalsis above aortic arch $\\leftarrow$ striated muscle in proximal $1 / 3$ of esophagus\n> severe inflammation \\& scarring from reflux esophagitis $\\leftarrow$ poor clearance of peptic acid reflux:\n$\\sqrt{ }$ erosions + superficial ulcers ( $=$ asymptomatic reflux esophagitis: NO protective esophageal contraction)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 900,
            "markdown": "$\\sqrt{ }$ fusiform stricture usually $4-5 \\mathrm{~cm}$ above GE junction\n$\\sqrt{ }$ esophageal shortening + sliding hiatal hernia\n$C x$ : peptic stricture, Barrett metaplasia, adenocarcinoma, aspiration pneumonia\n@ Stomach (less frequent involvement)\n$\\sqrt{ }$ gastric dilatation\n$\\sqrt{ }$ decreased motor activity + delayed emptying\n@ Small bowel (in up to $45 \\%$ )\n$\\diamond$ PSS progresses rapidly once small intestine is involved!\n\n- decreased small bowel motility with delayed intestinal transit time $\\rightarrow$ stasis $\\rightarrow$ bacterial overgrowth $\\rightarrow$ diarrhea $\\rightarrow$ malabsorption\n$\\sqrt{ }$ pseudo-obstruction = marked dilatation of small bowel (in particular duodenum = megaduodenum, jejunum) simulating small bowel obstruction CAVE: misdiagnosis of obstruction may lead to exploratory surgery!\n$\\sqrt{ }$ abrupt cutoff at SMA level $\\leftarrow$ atrophy of neural cells with hypoperistalsis\n$\\sqrt{ }$ prolonged transit time with barium retention in duodenum up to 24 hours\n$\\sqrt{ }$ \"hidebound / accordion\" pattern ( $60 \\%$ ) = sharply defined folds of normal thickness with decreased intervalvular distance (valvular packing = tightly packed folds) within dilated segment $\\leftarrow$ predominant involvement of circular muscle: $\\sqrt{ }$ normal mucosal fold pattern\n$\\sqrt{ }$ pseudodiverticula $(10-40 \\%)=$ asymmetric sacculations with squared tops + broad bases on mesenteric side $\\leftarrow$ eccentric smooth muscle atrophy\n$\\sqrt{ }$ pneumatosis cystoides intestinalis + pneumoperitoneum (occasionally)\n$\\sqrt{ }$ excess fluid with bacterial overgrowth (= \"pseudo-blind loop syndrome\")\n$C x$ : transient intussusception without anatomic lead point\n@ Colon (up to $40-50 \\%$ )\n- constipation (common), may alternate with diarrhea\n$\\sqrt{ }$ pseudosacculations + wide-mouthed \"diverticula\" on antimesenteric side $\\rightarrow$ formed by repetitive bulging through atrophic areas in transverse + descending colon\n$\\sqrt{ }$ eventually complete loss of haustrations (simulating cathartic colon)\n$\\sqrt{ }$ marked dilatation (may simulate Hirschsprung disease)\n$\\sqrt{ }$ stercoral ulceration $\\leftarrow$ retained fecal material\n$C x$ : life-threatening barium impaction\n$D D x$ : (1) Dermatomyositis (similar radiographic findings)\n(2) Sprue (increased secretions, segmentation, fragmentation, dilatation most significant in midjejunum, normal motility)\n(3) Obstruction (no esophageal changes, no pseudodiverticula)\n(4) Idiopathic intestinal pseudoobstruction (usually in young people)\n\n\n# Localized Scleroderma \n\n$=$ MORPHEA [morpheus, Greek = form, structure]\n$=$ inflammatory disease that leads to diffuse / localized fibrotic atrophic skin hardening + may affect MSK system\n\n- characterized by ABSENCE OF\n- Raynaud phenomenon; digital sclerosis / necrosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 901,
            "markdown": "- nailfold capillary changes; involvement of internal organs\n- arthralgia $(9-17 \\%)$\n\nMay be associated with: musculoskeletal scleroderma\n\n# Musculoskeletal Scleroderma \n\n- edema of distal portion of extremities\n- thickened inelastic waxy skin most prominent about face + extremities, symmetrical polyarthralgias $(50-80 \\%)$\n- Raynaud phenomenon (may precede other symptoms by months / years)\n- atrophy + thickening of skin and musculature ( $78 \\%$ )\n@ Fingers\n- \"sausage digit\" = edema of digits associated with loss of transverse skin folds + lack of definition of subcutaneous fat\n$\\sqrt{ }$ \"tapered fingers\" = sclerodactyly = atrophy + resorption of soft tissues of fingertips + soft-tissue calcifications\n$\\sqrt{ }$ acroosteolysis $(63-80 \\%)$\n$=$ \"penciling\" / \"autoamputation\" = resorption of distal phalanges of hand beginning at volar aspect of terminal tufts with proximal progression\n@ Subcutaneous calcinosis ( $25-58 \\%$ )\nLocation: extensor surface, areas with pressure / friction\n$\\sqrt{ }$ calcinosis = punctate soft-tissue calcifications of fingertips, axilla, ischial tuberosity, forearm, elbow (over pressure area), lower leg, face\n$\\sqrt{ }$ calcifications around tendons, bursae, within joints\n@ Arthritis\n- stiffness in small joints, occasionally in knee, shoulder, wrist; lack of motility $\\rightarrow$ eventually contractures\n$\\sqrt{ }$ arthritis of interphalangeal joints of hands ( $25 \\%$ )\nLocation: 1st CMC, MCP, DIP, PIP\n$\\sqrt{ }$ central / marginal erosions ( $50 \\%$ ):\n$\\sqrt{ }$ resorption of palmar aspect of terminal phalanges (most frequent sign)\n$\\sqrt{ }$ bony erosions of carpal bones (trapezium), distal radius + ulna, mandible, ribs, lateral aspect of clavicle, humerus, acromion, mandible, cervical spine\n$\\sqrt{ }$ joint-space narrowing (late)\n$D D x$ : rheumatoid, psoriatic, erosive arthritis\n$\\sqrt{ }$ soft-tissue swelling $\\pm$ periarticular osteoporosis\n$\\sqrt{ }$ NO significant osteoporosis\n$\\sqrt{ } \\pm$ flexion contractures of fingers (from tendon sheath inflammation + fibrosis)\n@ Ribs\n$\\sqrt{ }$ erosion of superior aspect of ribs\n@ Teeth\n$\\sqrt{ }$ widening of periodontal membrane\n\n\n## Pulmonary Scleroderma (10-66\\%)\n\n$\\diamond$ Organ involvement with the most significant morbidity!\n$\\diamond$ Usually develops within first 3 years of disease",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 902,
            "markdown": "Path: almost $100 \\%$ involvement in autopsy series\nHisto: thickening of basement membrane of alveoli (= fibrosing alveolitis) + small arteries and veins; pattern of usual interstitial pneumonia (UIP) / nonspecific interstitial pneumonitis (NSIP)\n\n- slightly productive, mostly dry cough, atypical chest pain\n- exertional progressive dyspnea, fatigue, hematemesis\n- pulmonary function abnormalities in the absence of frank roentgenographic changes ( TYPICAL DISSOCIATION of clinical, functional, and radiologic evidence)\nLocation: peripherally, most prominent at both lung bases (where blood flow greatest) CXR:\n$\\checkmark$ bibasilar pulmonary fibrosis:\nFrequency: $20-65 \\%$ on CXR, up to $90 \\%$ on HRCT\n$\\checkmark$ fine / coarse reticulations / diffuse interstitial infiltrates\n$\\checkmark$ subpleural fibrocystic spaces (= honeycombing)\n$\\checkmark$ low lung volumes $\\leftarrow$ progressive volume loss\n$\\checkmark$ alveolar changes $\\leftarrow$ aspiration of refluxed gastric contents with disturbed esophageal motility / mineral oil taken to combat constipation:\n$\\checkmark$ aspiration pneumonia\n$\\checkmark$ bronchiolitis\n$\\checkmark$ dilated esophagus with air esophagram (DDx: achalasia, mediastinitis) with increased frequency of aspiration pneumonia\n$\\checkmark$ pleural reaction / effusion distinctly uncommon\nHRCT:\nPattern: Nonspecific interstitial pneumonia $>$ UIP\n$\\checkmark$ areas of patchy ground-glass attenuation\n$\\checkmark$ poorly defined subpleural centrilobular nodules\n$\\checkmark$ reticular pattern of attenuation\n$\\checkmark$ traction bronchiectasis + bronchiolectasis; mucous plugs\n$\\checkmark$ honeycombing\nRx: cyclophosphamide + low-dose prednisolone\nPrognosis: ground-glass opacities irreversible even after therapy $\\leftarrow$ fibrosis NOT inflammation\nCx: (1) Progressive pulmonary fibrosis\n(2) Pulmonary arterial hypertension (10-16-33\\%)\n(3) Aspiration pneumonia\n(4) Increased incidence of lung cancer\n\nRenal Scleroderma (25\\%)\nOnset: common within 3 years\nHisto: fibrinoid necrosis of afferent arterioles (also seen in malignant hypertension)\n\n- hypertensive renal crisis\n$\\checkmark$ renal cortical necrosis\n$\\checkmark$ spotty inhomogeneous nephrogram $\\leftarrow$ constriction + occlusion of arteries",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 903,
            "markdown": "$\\sqrt{ }$ concomitant arterial ectasia\n$C x$ : renal failure (from nephrosclerosis)\n\n# PROLAPSED ANTRAL MUCOSA \n\n$=$ prolapse of hypertrophic + inflammatory mucosa of gastric antrum into duodenum resulting in pyloric obstruction\n$\\sqrt{ }$ mushroom- / umbrella- / cauliflower-shaped filling defect at duodenal base\n$\\sqrt{ }$ filling defect varies in size + shape\n$\\sqrt{ }$ redundant gastric rugae can be traced from pyloric antrum through pyloric channel\n$\\sqrt{ }$ gastric hyperperistalsis\n\n## PSEUDOMYXOMA PERITONEI\n\n$=$ \"jelly belly\" = \"gelatinous ascites\"\n= slow insidious accumulation of large amounts of thick mucinous or gelatinous material on peritoneal surfaces\nIncidence: $1 \\div 1,000,000$ annually\nMean age: 49 (range, 23-83) years; M $<\\mathrm{F}$\nEtiology:\nA. DISSEMINATED PERITONEAL ADENOMUCINOSIS (majority)\n\nOrigin: appendix\n$=$ benign / borderline / low-grade malignant epithelial cells from ruptured mucocele of the appendix without invasion of stroma\n$R x$ : amenable to surgical debulking\nPrognosis: 50\\% 5-year survival\nB. OVARIAN PSEUDOMYXOMA PERITONEI\n\nOrigin: ovary\n= mucinous tumor, cystadenoma, tumor with low malignant potential, invasive carcinoma that arises in ovarian mature cystic teratoma\nC. PERITONEAL MUCINOUS CARCINOMATOSIS (rare)\n$=$ invasive high-grade moderately / poorly differentiated mucinous carcinoma\nOrigin: carcinoma of GI tract (colon $<5 \\%$, stomach, appendix), gallbladder, pancreas, uterus, common bile duct, urachal duct, omphalomesenteric duct\nPrognosis: $10 \\% 5$-year survival\nIn most cases of pseudomyxoma peritonei the source is an appendiceal mucinous tumor!\n\n- slowly progressive massive abdominal distension\n- recurrent abdominal pain, weight loss\n$\\sqrt{ }$ thickening of peritoneal + omental surfaces\n$\\sqrt{ }$ omental cake\n$\\sqrt{ }$ posterior fixation of bowel loops + mesentery\n$\\sqrt{ }$ voluminous septated / loculated pseudoascites\n$\\sqrt{ }$ several thin-walled cystic masses of different size throughout abdominal cavity:\n$\\sqrt{ }$ Hellmer sign = focal collection of mucin in right subhepatic space displacing tip of liver medially\n$\\sqrt{ }$ central displacement of ascending + descending colon and lateral displacement of",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 904,
            "markdown": "properitoneal fat stripe with mucin in paracolic gutter\n$\\checkmark$ central displacement of intestine\n$\\checkmark$ scalloped contour of liver + spleen\n$\\checkmark$ annular / semicircular calcifications (rare but highly suggestive)\nCT:\n$\\checkmark$ intraperitoneal collection of very low attenuation (common) / soft-tissue density (rare)\n$\\checkmark$ may contain enhancing septa $\\pm$ calcifications\n$\\checkmark$ discrete hypoattenuating masses (infrequent)\nUS:\n$\\checkmark$ hypoechoic collection (common) / more solid appearance (rare)\n$\\checkmark$ nonmobile echoes from proteinaceous / bloody / fibrinous exudate\n$\\checkmark$ echogenic septations\nPrognosis: $25-65 \\%$ median 5-year survival rate\nCx: bowel obstruction\n$R x$ : often requires repeated laparotomies for drainage; need for multiple surgical debulkings\n$D D x$ : ascites, peritoneal metastases, pancreatitis with pseudocysts, pyogenic peritonitis, widespread echinococcal disease\n\n# RADIATION INJURY \n\n$=$ obliterative endarteritis with irradiation in excess of $4,000-4,500 \\mathrm{rad}$\nFrequency: 5\\%; increased risk after pelvic surgery\nRadiosensitivity: small bowel mucosa (most sensitive) > rectum\n$\\checkmark$ radiographic changes within field of radiation only\n\n## Radiation Esophagitis\n\n$=$ from high doses of mediastinal radiation (usually $>5,000 \\mathrm{cGy}$ ); Adriamycin ${ }^{\\circledR}$ can potentiate effects of radiation as low as 500 cGy\n\n- progressive dysphagia $4-8$ months after completion of radiation therapy\n$\\checkmark$ smooth relatively long segment of concentric tapered narrowing within a preexisting radiation portal\n$D D x$ : involvement by recurrent tumor\n\n\n## Radiation Gastritis\n\n$\\diamond$ Permanent radiographic findings of radiation injury appear 1 month to 2 years after therapy\n$\\checkmark$ gastric ulceration + deformity (pylorus)\n$\\checkmark$ enlargement + effacement of gastric folds\n$\\checkmark$ antral narrowing + rigidity (similar to linitis plastica)\n\n## Radiation Enteritis\n\n$\\diamond$ Permanent radiographic findings of radiation injury appear $>1-2$ years following irradiation\nPredisposed: women (cancer of cervix, endometrium, ovary), patients with bladder cancer\n\n- crampy abdominal pain (from intermittent obstruction)\n- persistent diarrhea, occult intestinal hemorrhage\n\nLocation: ileum; concomitant radiation damage to colon / rectum",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 905,
            "markdown": "@ ACUTE radiation enteropathy\n$\\sqrt{ }$ mucosal hyperenhancement\n$\\sqrt{ }$ irregular nodular thickening of folds with straight transverse course $\\pm$ ulcerations\n$\\sqrt{ }$ separation of adjacent bowel loops by $>2 \\mathrm{~mm}$\n@ CHRONIC radiation enteropathy (after months to years)\n$\\sqrt{ }$ thickened bowel wall with luminal narrowing\n$\\sqrt{ }$ multiple strictures + partial mechanical obstruction\n$\\sqrt{ }$ serrated bowel margin\n$\\sqrt{ }$ shortening of small bowel\n$\\sqrt{ }$ fixation + immobilization of bowel loops with similar radiographic appearance between examinations $\\leftarrow$ dense desmoplastic response to irradiation\nCT:\n$\\sqrt{ }$ increased attenuation of mesentery\n$D D x$ : Crohn disease, lymphoma, ischemia, hemorrhage\n\n# Radiation Injury of Rectum \n\n$\\diamond$ Manifestation of radiation colitis can occur up to 15 years following irradiation Predisposed: $90 \\%$ in women (with carcinoma of cervix)\n\n- tenesmus, diarrhea, bleeding, constipation\n$\\sqrt{ }$ ridgelike appearance of mucosa $\\leftarrow$ submucosal fibrosis\n$\\sqrt{ }$ irregularly outlined ulcerations (rare)\nCT:\n$\\sqrt{ }$ narrowed partially distensible rectum\n$\\sqrt{ }$ thick homogeneous rectal wall\n$\\sqrt{ }$ \"target\" sign = submucosal circumferential lucency\n$\\sqrt{ }$ proliferation of perirectal fat $>10 \\mathrm{~mm}$\n$\\sqrt{ }$ thickening of perirectal fascia\n$\\sqrt{ }$ \"halo\" sign = increase in pararectal fibrosis\nCx: (1) Obstruction\n(2) Colovaginal / coloenteric fistula formation\n\n\n## RECTAL POLYP\n\nPrevalence: $7-50 \\%$ (more common in older patients)\nPath: hyperplastic+adenomatous polyps $=1 \\div 4$\n$\\sqrt{ }$ tends to flatten out with air distention\n\n## Hyperplastic Rectal Polyp\n\nSize: usually $<5 \\mathrm{~mm}$\n$\\sqrt{ }$ not visible adjacent to rectal balloon\n\n## Adenomatous Rectal Polyp\n\n$\\sqrt{ }$ sessile $>$ pedunculated $>$ flat\n$\\sqrt{ }$ carpetlike nodular appearance (for villous adenoma)\n$\\sqrt{ }$ underdistended / redundant rectal mucosa may simulate villous adenoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 906,
            "markdown": "# RETAINED GASTRIC ANTRUM \n\nCause: retention of endocrinologically active gastric antrum in continuity with pylorus + duodenum\nPathophysiology: bathing of antrum in alkaline duodenal juice $\\rightarrow$ stimulates secretion of gastrin\nAssociated with: gastric ulcers in $30-50 \\%$\n$\\sqrt{ }$ duodenogastric reflux of barium through pylorus (DIAGNOSTIC)\n$\\sqrt{ }$ giant marginal ulcer / several marginal ulcers usually on jejunal side of anastomosis (large false-negative + false-positive rates; correct-positive rate of $28-60 \\%$ )\n$\\sqrt{ }$ large amount of secretions\n$\\sqrt{ }$ edematous mucosa of jejunal anastomotic segment\n$\\sqrt{ }$ lacy / cobweblike small bowel pattern (hypersecretion)\nCx: gastrojejunocolic fistula\n\n## SCHATZKI RING\n\n$=$ LOWER ESOPHAGEAL MUCOSAL RING\n[Richard Schatzki (1901-1992), chief of radiology at University Hospital in Leipzig and associate clinical professor of radiology at Harvard Medical School and at Mount Auburn Hospital, Cambridge, MA]\n$=$ constant lower esophageal ring (mucosal thickening) presumed to result from reflux esophagitis $=$ thin annular peptic stricture\nFrequency: $6-14 \\%$ of population; old age $>$ young age; $\\mathrm{M}>\\mathrm{F}$\nHisto: usually squamous epithelium on upper surface + columnar epithelium on undersurface; may be covered totally by squamous epithelium or columnar epithelium\nAssociated with: hiatal hernia (typical)\n\n- asymptomatic (if ring $>20 \\mathrm{~mm}$ ), dysphagia (if ring $<12 \\mathrm{~mm}$ )\n\nLocation: near the squamocolumnar junction; in region of B ring at inferior margin of lower esophageal sphincter\nHeight: $1-3 \\mathrm{~mm}$\n$\\sqrt{ }$ nondistensible concentric transverse ring of shelflike projection with smooth symmetric margins\n$\\sqrt{ }$ constant shape + size\n$\\sqrt{ }$ visible only with adequate distension of esophagogastric region and when located above the esophageal hiatus of diaphragm\n$\\sqrt{ }$ best demonstrated in prone position during arrested deep inspiration with Valsalva maneuver while solid barium column passes through esophagogastric region\n$\\sqrt{ }$ short esophagus + intrahiatal / intrathoracic gastric segment $=$ sliding hiatal hernia if Schatzki ring located $1-2 \\mathrm{~cm}$ above diaphragmatic hiatus\nPrognosis: decrease in caliber over 5 years (in 25-33\\%)\nCx: impaction of food bolus (associated with severe chest pain)\nRx: (1) Proper mastication of food\n(2) Endoscopic rupture\n(3) Esophageal dilatation (radiographically often lack of caliber change after successful dilatation)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 907,
            "markdown": "$D D x$ : Annular peptic stricture (usually thicker, asymmetric, irregular surface, associated with thickened esophageal folds, serration of esophageal margins)\n\n# SCHWANNOMA OF GI TRACT \n\n$=$ rare benign nerve sheath tumor arising from Schwann cell\nFrequency: $0.2 \\%(4 \\%)$ of all (benign) gastric tumor; $2-7 \\%$ of gastrointestinal mesenchymal tumors\nOrigin: myenteric plexus within muscularis propria of GI tract\nHisto: well-circumscribed unencapsulated tumor characterized by interlacing bundles of spindle cells with wavy cigar-shaped nuclei + collagen; peripheral cuff of peritumoral lymphoid aggregates; areas of hypo- and hypercellularity (Antoni A \\& B) and Verocay bodies (= lining up of nuclei) are less frequent\nImmunohisto: strong + diffuse stain for S-100 protein\nAge: $3^{\\text {rd }}-5^{\\text {th }}$ decade; $\\mathrm{M}<\\mathrm{F}$\nLocation: stomach $(60-70 \\%)>$ colon $>$ rectum\nSite: submucosa + muscularis propria\n\n- usually incidental endoscopic finding\n- GI bleeding, abdominal pain, obstructive symptoms\n$\\sqrt{ }$ discrete submucosal mass with exophytic / intramural growth\nNECT:\n$\\sqrt{ }$ low attenuation $\\leftarrow$ dense spindle cell composition\n$\\sqrt{ }$ homogeneous attenuation in spite of relatively large size (!)\n$\\sqrt{ }$ uncommonly calcified\nCECT:\n$\\sqrt{ }$ no / minimal enhancement during arterial phase\n$\\sqrt{ }$ delayed enhancement during equilibrium phase\nCx: (1) Ulceration $\\leftarrow$ pressure necrosis of overlying mucosa\n(2) Central necrosis $\\leftarrow$ outgrowing its blood supply\n\nDDx: GIST, leiomyoma, lymphoma\nAbsence of hemorrhage / necrosis / cavity formation helps distinguish schwannomas from more heterogeneous GIST\n\n## SCLEROSING MESENTERITIS\n\n$=$ CHRONIC FIBROSING MESENTERITIS $=$ MULTIFOCAL SUBPERITONEAL SCLEROSIS $=$ SCLEROSING LIPOGRANULO-MATOSIS = PRIMARY LIPOSCLEROSIS OF THE MESENTERY = LIPOSCLEROTIC MESENTERITIS = LIPOGRANULOMA OF THE MESENTERY = ISOLATED LIPODYSTROPHY = SYSTEMIC NODULAR PANNICULITIS= RETROPERITONEAL XANTHOGRANULOMA = MESENTERIC WEBERCHRISTIAN DISEASE\n$=$ rare idiopathic disorder characterized by tumorlike masses in mesentery composed of chronic nonspecific inflammation, fat necrosis, and fibrosis\nEtiology: ? trauma, previous surgery, ischemia\nPath: solitary / multifocal well-demarcated / diffusely infiltrating (mesenteric thickening) process",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 908,
            "markdown": "Histo: chronic mesenteric inflammation with lipid-laden macrophages (=lipophages) + plasma cells + eosinophils, fat necrosis and fibrosis $\\diamond$ NO penetration of muscularis propria!\nStages: based on predominant histopathologic finding in affected mesentery\n(1) Mesenteric lipodystrophy\n(2) Mesenteric panniculitis\n(3) Retractile mesenteritis\n\nAverage age: 60 (range, $7-87$ years); $\\mathrm{M}+\\mathrm{F}=2 \\div 1$\nAssociated with:\n(1) Gardner syndrome, familial polyposis\n(2) Fibrosing mediastinitis, retroperitoneal fibrosis\n(3) Lymphoma, lymphosarcoma (in 15-69\\%)\n(4) Carcinoid tumor\n(5) Metastatic gastric / colonic carcinoma\n(6) Whipple lipodystrophy\n(7) Weber-Christian disease\n\n- asymptomatic / abdominal pain, palpable abdominal mass\n- symptoms of intestinal obstruction / ischemia\n- nausea, vomiting, weight loss, pyrexia, diarrhea\n- $\\uparrow$ WBC, $\\uparrow$ erythrocyte sedimentation rate\n\nLocation: root of small bowel mesentery, colonic mesocolon\nSite: extending toward mesenteric border; affecting submucosal fat; sparing mucosa\nPathophysiology: inflammatory infiltrate $\\rightarrow$ obstruction of mesenteric lymphatics + mesenteric vessels $\\rightarrow$ submucosal edema + luminal narrowing\nSite: small bowel mesentery; occasionally mesocolon, sigmoid mesentery, omentum, retroperitoneum\nPlain film:\n$\\sqrt{ }$ soft-tissue mass with calcifications\n$\\sqrt{ } \\pm$ thumbprinting $\\leftarrow$ vascular congestion\n$\\sqrt{ }$ SBO: intestinal dilatation, fluid levels, fluid-filled bowel\nUGI / Enteroclysis:\n$\\sqrt{ }$ compression / distortion of duodenum near ligament of Treitz\n$\\sqrt{ }$ separation of small bowel loops with fixation + kinking + angulation $\\leftarrow$ shortening + retraction of mesentery\n$\\sqrt{ }$ irregular fold thickening of small bowel $\\leftarrow$ reactive mural thickening\n$\\sqrt{ }$ narrowing + thumbprinting of colon (occasionally)\nCT:\n$\\sqrt{ }$ well-demarcated / ill-defined mesenteric mass:\n$\\sqrt{ }$ heterogeneous texture of fat density:\n$\\sqrt{ }$ misty attenuation interspersed with\n$\\sqrt{ }$ soft-tissue density (= fibrous tissue)\n$\\sqrt{ }$ single mesenteric root mass (= fibroma)\n$\\sqrt{ }$ multiple nodules throughout mesentery (= fibromatosis)\n$\\sqrt{ }$ multiple cystic masses in mesentery (= loose myxomatous composition / lymphatic",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 909,
            "markdown": "cysts):\n$\\checkmark$ tumoral pseudocapsule $=$ peripheral band of soft-tissue attenuation at the edge of affected mesentery\n$\\checkmark \\pm$ small $<5 \\mathrm{~mm}$ lymph nodes within lesion\n$\\checkmark$ \"fat ring\" sign = preservation of fat as a halo of low attenuation surrounding nondisplaced mesenteric vessels\n$\\checkmark$ punctate / coarse calcifications (uncommon)\n$\\checkmark$ mesenteric thickening with fine stellate pattern (= radiating strands of fibrosis) extending to bowel border\n$\\checkmark$ retraction of small bowel loops (= desmoplastic response)\n$\\checkmark$ rarely associated with retroperitoneal lymphadenopathy\nUS:\n$\\checkmark$ heterogeneous mass with hypo- and hyperechoic features\nMR:\n$\\checkmark$ low to intermediate SI on T1WI + very low signal on T2WI\n$\\checkmark$ high SI on T2WI (= predominant myxomatous change)\n$D x$ : surgical / percutaneous biopsy; diagnosis supported by absence of pancreatitis / inflammatory bowel disease\nPrognosis: usually benign self-limited course with complete spontaneous resolution\n$C x$ : compression of mesenteric vessels + formation of collateral vessels $\\pm$ small bowel ischemia; partial / complete obstruction of small intestines\n$R x$ : steroids + chemotherapy (cyclophosphamide, azathioprine); surgical resection for obstruction\n$D D x$ : (1) Mesenteric fibromatosis = abdominal desmoid (infiltrating melting insinuation into muscularis propria)\n(2) Mesenteric lymphoma (no calcifications unless treated, no compressive narrowing of vessels, no \"fat-ring\" sign, no pseudocapsule); lymphosarcoma\n(3) Lipogenic liposarcoma of mesentery\n(4) Inflammatory pseudotumor\n(5) Mesenteric carcinoid (uptake with octreotide and somatostatin scintigraphy, elevated levels of serum serotonin + urine 5-hydroxyindoleacetic acid, carcinoid syndrome with liver metastases, mural thickening / small bowel masses)\n(6) Carcinomatosis; pseudomyxoma peritonei $\\leftarrow$ metastatic gastric / colonic adenocarcinoma\n(7) Crohn disease with fibrofatty proliferation\n(8) Pyogenic peritonitis\n(9) Whipple disease (polymerase chain reaction to verify causative bacillus, easily curable with antibiotics)\n\nMesenteric Lipodystrophy (1st stage)\n$=$ degeneration and necrosis of mesenteric fat\nPath: diffuse mesenteric thickening (42\\%); solitary (32\\%) / multiple (26\\%) discrete mesenteric masses\nHisto: sheets of foamy macrophages with scattered lymphocytic infiltration replacing",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 910,
            "markdown": "mesenteric fat\n\n- asymptomatic\n$\\sqrt{ } \\pm$ chylous ascites\nPrognosis: spontaneous recovery\n\n\n# Mesenteric Panniculitis ( $2^{\\text {nd }}$ stage) \n\n$=$ predominantly chronic inflammatory stage of mesenteritis\nPath: diffuse mesenteric thickening with puckering of mesenteric surface $\\leftarrow$ desmoplastic reaction; adherent mass(es) in root of mesentery; fat necrosis\nHisto: infiltrate of plasma cells, foreign body giant cells, foamy macrophages\n\n- crampy abdominal pain; bowel disturbances; low-grade fever\n- nausea + vomiting; malaise; mild weight loss\n- poorly defined mass (50\\%) / abdominal fullness\n$\\sqrt{ }$ \"misty mesentery\" = mesenteric fat stranding\n\n\n## Retractile Mesenteritis ( $3^{\\text {rd }}$ stage)\n\n$=$ predominantly fibrotic stage of mesenteritis\nHisto: collagen deposition, fibrosis, inflammation; calcifications $\\leftarrow$ fat necrosis\n$\\sqrt{ }$ narrowing of bowel loop with spiculations $\\rightarrow$ intestinal obstruction\n$D D x$ : may be indistinguishable from neoplasia\n\n## SCLEROSING PERITONITIS\n\n$=$ ENCAPSULATING PERITONEAL SCLEROSIS = PERITONITIS CHRONICA FIBROSA INCAPSULATA = PERITONEAL FIBROSING SYNDROME\n$=$ bowel partially / totally encased / wrapped in thick fibrous membrane forming several compartments that contain loops of small bowel\nCause: ?; idiopathic, chronic irritation of peritoneum\nAssociated with:\ncontinuous ambulatory peritoneal dialysis ( $0.7 \\%$ increasing to $19.4 \\%$ after 8 years);\nventriculoperitoneal shunt; peritoneo-venous shunt; tuberculosis; sarcoidosis; SLE; familial\nMediterranean fever; protein S deficiency; liver transplantation; fibrogenic foreign material;\nGI malignancy; luteinized ovarian thecoma; $\\beta$-blocker practolol\n\n- recurrent episodes of small bowel obstruction\n- weight loss, nausea, anorexia\n$\\sqrt{ }$ smooth thickening + enhancement of peritoneum\n$\\sqrt{ }$ \"abdominal cocoon\" = encasement of small bowel loops by a fibrocollagenous capsule:\n$\\sqrt{ }$ central clustering of fixated small bowel loops\n$\\sqrt{ }$ mantle of soft-tissue attenuation\n$\\sqrt{ }$ peritoneal calcifications of parietal and visceral peritoneum\n$\\sqrt{ }$ mural fibrosis + thickening of small bowel along its antimesenteric wall $\\rightarrow$ adhesions $\\rightarrow$ narrowing of bowel lumen $\\rightarrow$ small bowel obstruction\n$\\sqrt{ }$ formation of loculated fluid collections\n$C x$ : small bowel necrosis + perforation\n$D D x$ : tuberculosis, amyloidosis, hyperparathyroidism, pseudomyxoma peritonei, peritoneal carcinomatosis, meconium peritonitis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 911,
            "markdown": "# SMALL BOWEL VOLVULUS \n\n$=$ rare life-threatening SURGICALEMERGENCY\nCause: adhesive bands, internal hernia, external hernia\nPathophysiology:\nclosed-loop obstruction $\\rightarrow$ bacterial overgrowth $\\rightarrow$ accelerated fluid sequestration + gas production $\\rightarrow$ increased intraluminal pressure + dilatation $\\rightarrow$ compromise of vascular supply to intestinal wall $\\rightarrow$ hemorrhagic infarction $\\rightarrow$ necrosis $\\rightarrow$ perforation\n$\\checkmark$ poor / absent enhancement of bowel wall\n$\\checkmark$ \"spoke wheel\" sign = radial peripheral distribution of distended fluid-filled small-bowel loops around central engorged thickened mesenteric vessels ( $75 \\%$ )\n$\\checkmark$ two collapsed adjacent bowel loops $=$ site of constriction $(35 \\%)$\n$\\checkmark$ U-shaped configuration of distended fluid-filled small-bowel loops = radial arrangement of incarcerated fluid-filled dilated loop at periphery of tightly twisted mesentery ( $30 \\%$ )\n$\\checkmark$ \"triangular\" sign = fusiform tapering of collapsed loop at site of constriction on longitudinal section through loop ( $15 \\%$ )\n$\\checkmark$ \"whirl\" sign = swirling appearance of twisted mesentery ( $10 \\%$ )\nCx: (1) Bowel ischemia in $46 \\%$ due to closed-loop obstruction + torsion of mesenteric vessels\n(2) Bowel necrosis\n\nMortality: $9 \\%$\n\n## SMALL LEFT COLON SYNDROME\n\nCause: transient functional colonic obstruction $\\leftarrow$ immaturity of mesenteric plexus\nAge: newborn infant\nAssociated with: maternal diabetes mellitus (most common), maternal substance abuse; NOT related to cystic fibrosis\n$\\checkmark$ colonic caliber becomes abruptly diminutive distal to splenic flexure\n$\\checkmark$ bowel dilatation proximal to splenic flexure\n$\\checkmark \\pm$ meconium plug (as a result and NOT the cause of obstruction)\nPrognosis: gradual resolution of functional immaturity over days to weeks\n\n## SOLITARY RECTAL ULCER SYNDROME\n\n$=$ MUCOSALPROLAPSE SYNDROME\n$=$ rare condition frequently associated with chronic constipation and pelvic floor dyssynergia\nRelated disorders with common pathogenesis:\nhamartomatous inverted polyp, colitis cystica profunda\nCause: prolapse of anterior rectal wall resulting in mucosal ischemia $\\leftarrow$ traumatization of rectal mucosa by anal sphincter during defecation (rectal straining / prolapse)\nAge: young patients (especially women)\nPath: small / large, single / multiple shallow ulcers; $25 \\%$ broad- based, $18 \\%$ patchy granular / velvety hyperemic mucosa; rectal stenosis through confluent circumferential lesion\nHisto: obliteration of lamina propria mucosae by fibromuscular proliferation of muscularis mucosae, streaming of fibroblasts + muscle fibers between crypts, misplaced mucosal glands deep to muscularis mucosae; diffuse increase in mucosal collagen",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 912,
            "markdown": "- chronic rectal bleeding, passage of mucus\n- disordered painful defecation, tenesmus\n\nBE:\n$\\checkmark$ central ulceration on anterior rectal wall $\\rightarrow$ regional inflammation $\\rightarrow$ mass effect in surrounding tissue mimicking rectal neoplasm at endoscopy:\n$\\checkmark$ polypoid lesion / nodules (polypoid type)\n$\\checkmark$ flat granular mucosa (flat type)\n$\\checkmark$ thickened valves of Houston without ulcer\n$\\checkmark$ stricture\nEvacuation proctography:\n$\\checkmark$ failure of anorectal angle to open while straining\n$\\checkmark$ excessive perineal descent\nPrognosis:\n(1) Little change over time\n(2) Considerable change in appearance of lesion\n(3) Transfusions necessitated by massive blood loss\n\nDx: rectal biopsy\n$D D x$ : invasive rectal carcinoma, Crohn disease\n\n# SPRUE \n\n$=$ classic disease of malabsorption\nPath: villous atrophy (truncation) + crypt hyperplasia (elongation of crypts of Lieberkühn responsible for water + electrolyte absorption + mucin production) + marked mononuclear round cell infiltration of lamina propria and epithelium (plasma cells, mast cells, lymphocytes, eosinophils)\n[Johann Nathanael Lieberkühn (1711-1756), physician inventor of microscopic examination of intestine at Leiden University]\nPathophysiology: loss of villi $\\rightarrow$ decreased absorption of fluid + crypt hyperplasia $\\rightarrow$ production of fluid $\\rightarrow$ chronic excess fluid in small bowel lumen\nLocation: patchy involvement of duodenum + jejunum $>$ ileum $>$ cecum (decreasing severity toward the distal small intestine)\nUGI:\n$\\checkmark$ nodularity in fold-free duodenum (= duodenitis)\n$\\checkmark$ \"bubbly bulb\" = peptic duodenitis = mucosal inflammation, gastric metaplasia, Brunner gland hyperplasia\nSmall bowel follow-through:\n$\\checkmark$ small bowel dilatation is HALLMARK in untreated celiac disease ( $70-95 \\%$ ), best seen in mid + distal jejunum $\\leftarrow$ intestinal hypomotility; degree of dilatation related to severity of disease\n$\\checkmark$ hypersecretion-related artifacts:\n$\\checkmark$ air-fluid levels in small bowel (rare)\n$\\checkmark$ segmentation = breakup of normal continual barium column creating large masses of barium in dilated segments separated by stringlike strands from adjacent clumps $\\leftarrow$ excessive fluid; best seen on delayed films",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 913,
            "markdown": "$\\sqrt{ }$ flocculation $=$ coarse granular appearance of small clumps of disintegrated barium excess fluid best seen at periphery of intestinal segment; occurs especially with steatorrhea\n$\\sqrt{ }$ fragmentation $=$ scattering $=$ faint irregular stippling of residual barium resembling snowflakes associated with segmentation $\\leftarrow$ excessive fluid\n$\\sqrt{ }$ \"moulage\" sign $(50 \\%)=$ smooth contour with effaced featureless folds resembling tubular wax mold $\\leftarrow$ atrophy of the folds of Kerckring; CHARACTERISTIC of sprue if seen in duodenum + jejunum\n$\\sqrt{ }$ slow / normal / short transit time:\n$\\sqrt{ }$ nonpropulsive asynchronous peristalsis (flaccid + poorly contracting loops)\n$\\sqrt{ }$ normal / thickened / effaced mucosal folds (depending on degree of hypoproteinemia)\n$\\sqrt{ }$ colonlike haustrations in well-filled jejunum $\\leftarrow$ spasm + cicatrization from transverse ulcers\n$\\sqrt{ }$ transient nonobstructive small bowel intussusception ( $20 \\%$ ) without anatomic lead point Enteroclysis:\n$\\sqrt{ }$ flip-flop pattern = \"reversal\" sign = reversed jejunoileal fold pattern with featureless jejunum $\\leftarrow$ villous atrophy + compensatory hypertrophy of folds in ileum:\n$\\sqrt{ }$ decreased number of folds in proximal jejunum ( $<3$ folds per inch) $\\leftarrow$ loss of mucosal surface area\n$\\sqrt{ }$ \"jejunization\" of ileal loops = increased number of folds in distal ileum ( $>5$ folds per inch) as adaptive response to increased absorptive capability $=$ SPECIFIC\n$\\sqrt{ }$ tubular featureless lumen\n$\\sqrt{ }$ mosaic pattern $=1-2-\\mathrm{mm}$ polygonal islands of mucosa surrounded by barium-filled distinct grooves $(10 \\%)$\nCT:\nCT patterns of celiac disease are small bowel and colonic malabsorption patterns and prominent mesenteric lymph nodes of the small bowel.\n@ Small bowel malabsorption pattern:\n$\\sqrt{ }$ small bowel dilatation + increased fluid content:\n$\\sqrt{ }$ progressive dilution of enteric contrast material\n$\\sqrt{ }$ flocculation (= precipitating small flecks of barium)\n$\\sqrt{ }$ laminar flow $=$ trilaminar appearance of intraluminal barium separated by a middle layer of low attenuation formed by intrinsic intestinal fluid mimicking intussusception\n$\\sqrt{ }$ flaccid dilated small bowel:\n$\\sqrt{ }$ nonobstructing telescoping of small bowel loops\n$\\sqrt{ }$ transient small bowel intussusception (in up to $20 \\%$ )\n@ Colonic malabsorption pattern:\n$\\sqrt{ }$ colonic distension (= stagnant hypotonic colon):\n$\\sqrt{ }$ excessive colonic gas accumulation $\\leftarrow$ undigested sugar + fat are processed by gasproducing bacteria\n$\\sqrt{ }$ fluid-filled colon $\\leftarrow$ reduction of absorptive capacity\n$\\sqrt{ }$ cecal plume (= feathering) of fluid\n$\\sqrt{ }$ steatorrhea $=$ stool of fat attenuation (lung windows!)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 914,
            "markdown": "$\\sqrt{ }$ colonic geodes $=$ round spheres of hard rocklike aggregations of fat + fluid + air, which may calcify peripherally with stasis $\\leftarrow$ fat saponification\n@ Mesenteric lymph node prominence\n$\\sqrt{ }$ mild to moderate mesenteric lymphadenopathy $\\leftarrow$ follicular hyperplasia $\\leftarrow$ proliferation of reactive B and T lymphocytes (mimicking lymphoma):\nLocation: predominantly upper small bowel mesentery\n$D D x$ : Crohn disease + mesenteric adenitis (node prominence usually near terminal ileum)\n$\\sqrt{ }$ lymph nodes of low attenuation (in up to $12 \\%$ )\n$\\checkmark$ cavitating lymph nodes (see below)\n@ Structural intestinal changes\n$\\checkmark$ small bowel wall thickening $\\leftarrow$ inflammation:\n$\\checkmark$ straightening of valvulae conniventes\n$\\checkmark$ fold separation\n$\\checkmark$ reversal of jejunoileal fold pattern (COR reformats!):\n$\\checkmark$ jejunal villous atrophy\n$\\checkmark$ ileal jejunization ( $63 \\%$ sensitive, $100 \\%$ specific)\nN.B.: $>5$ folds per inch in jejunum $+<3$ folds per inch in ileum excludes celiac disease\n$\\checkmark$ colonic fold thickness $>4 \\mathrm{~mm} \\leftarrow$ inflammation\n$\\checkmark$ mesenteric hyperemia $=$ engorgement of mesenteric vessels (during severe active inflammation)\n$\\checkmark$ mesenteric panniculitis / misty mesentery\n$\\checkmark$ intramural fat $\\leftarrow$ sign of chronic inflammation\nLocation: duodenum + jejunum > right colon\n@ Structural extraintestinal changes\n$\\checkmark$ ascites\n$\\checkmark$ small atrophic spleen $=$ hyposplenism $(30-50 \\%)$\n$\\checkmark$ adenopathy (see above)\n$\\checkmark$ celiac-associated T-cell lymphoma\nUS:\n$\\checkmark$ moderately dilated fluid-filled small intestine\n$\\checkmark$ thickening of small bowel wall\n$\\checkmark$ hyperperistalsis ( $82 \\%$ )\n$\\checkmark$ dilated superior mesenteric artery + portal vein\n$\\checkmark$ liver steatosis $\\leftarrow$ metabolic derangement from malabsorption\n$\\checkmark$ mesenteric + retroperitoneal lymphadenopathy ( $12 \\%$ )\n$\\checkmark$ slight ascites ( $76 \\%$ )\n$D x$ : (1) Clinical presentation\n(2) Jejunal / duodenal biopsy with typical histopathologic features\n(3) Improvement of clinical symptoms + intestinal function within 2 weeks of a glutenfree $\\operatorname{diet}(70 \\%)$\n(4) Improvement of small bowel histology after $>3-6$ months of a gluten-free diet\n\nCause for relapse: hidden dietary gluten, diabetes, bacterial overgrowth, intestinal ulceration,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 915,
            "markdown": "# development of lymphoma \n\nImaging is important in detecting various complications of celiac disease like lymphoma, ulcerative jejunoileitis, cavitary mesenteric lymph node syndrome, adenocarcinoma of small bowel, SCC of esophagus and pharynx.\n$C x$ :\n(1) Malignant tumors (in up to $14 \\%$ )\n\n- recurrent diarrhea / abdominal pain in previously asymptomatic patients under glutenfree diet\n$\\diamond$ Malignant tumors are the most common cause of death\n(a) $\\mathrm{NHL}(18 \\%$ of cancers in celiac disease $)$ :\n$\\diamond 8 \\%$ of patients with sprue develop lymphoma\n$\\diamond$ history of celiac disease for $>20$ years\nType: enteropathy-associated T-cell lymphoma (85-90\\%) + extraintestinal lymphoma (mostly Hodgkin disease)\nPeak prevalence: $7^{\\text {th }}$ decade\nLocation: terminal ileum (most common)\n$\\sqrt{ }$ luminal narrowing with mucosal destruction (= ulcer with shouldering of margins)\n$\\sqrt{ }$ irregularly thickened nodular folds\n$\\sqrt{ }$ exophytic mass\n$\\sqrt{ }$ focal aneurysmal bowel dilatation\n$\\sqrt{ }$ florid lymphadenopathy\n(b) adenocarcinoma of small bowel (7\\%), rectum, stomach\n(c) squamous cell carcinoma of esophagus (in $4 \\%$ ) during $6^{\\text {th }}-7^{\\text {th }}$ decade\n(d) esophageal cancer\n(e) melanoma\n(f) other malignancies of oropharynx, ovaries, testicles, thyroid, breast, lungs\n(2) Ulcerative jejunoileitis (rare)\n$=$ multiple chronic benign ulcers\nAge: $5^{\\text {th }}-6^{\\text {th }}$ decade\nLocation: jejunum $>$ ileum $>$ colon\n- response to gluten-free diet ceases\n$\\sqrt{ }$ sausage appearance of small bowel $\\leftarrow$ circumferential bowel wall thickening\n$\\sqrt{ }$ fold thickening + ulceration $\\rightarrow$ stricture formation $\\rightarrow$ intestinal obstruction\n$C x$ : hemorrhage, perforation, lymphoma\nPrognosis: frequently fatal\n$R x$ : small bowel resection\n$D D x$ : enteropathy-associated T-cell lymphoma (may coexist, impossible to differentiate)\n(3) Cavitating mesenteric lymph node syndrome (rare)\n\nPath: multiple pseudocystic lymph nodes containing chylous fluid (thin milky fluid / thick creamy material) + thin peripheral rim of fibrous material and scant elements of atrophic lymph node structures\n\n- refractory weight loss, fatigue, diarrhea\n- target cells + Howell-Jolly bodies in peripheral blood smear (= signs of hyposplenism)\n\nLocation: confined to jejunoileal mesentery",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 916,
            "markdown": "$\\sqrt{ }$ multiple $2-7-\\mathrm{cm}$ large lymph nodes with a central cavity of low attenuation $\\pm$ fat-fluid levels\n$\\checkmark$ splenic atrophy\n$\\checkmark$ villous atrophy of small intestinal mucosa\nPrognosis: usually fatal\n(4) Sigmoid volvulus (rare)\n(5) CEC syndrome (in late stage of disease)\n$=$ Celiac disease + Epilepsy + Cerebral calcification\nCountries: Italy, Spain, Argentina\n\n- intractable epilepsy\n$\\sqrt{ }$ cerebral occipital calcifications identical to Sturge-Weber syndrome (without portwine nevus)\n$D D x$ :\n(1) Esophageal hypoperistalsis: scleroderma, idiopathic pseudoobstruction\n(2) Gastric abnormalities: Zollinger-Ellison syndrome, chronic granulomatous disease, eosinophilic enteritis, amyloidosis, malignancy\n(3) Tiny nodular defects on thickened folds: Whipple disease, intestinal lymphangiectasia, Waldenström macroglobulinemia\n(4) Small 1-3-mm nodules: lymphoid hyperplasia associated with giardiasis and immunoglobulin deficiency disease, diffuse lymphoma\n(5) Small nodules of varying sizes: systemic mastocytosis, amyloidosis, eosinophilic enteritis, Cronkhite-Canada syndrome\n(6) Bowel wall narrowing, kinking, scarring, ulceration: regional enteritis, bacterial / parasitic infection, carcinoid, vasculitis, ischemia, irradiation\n\n\n# Celiac Disease \n\n$=$ CELIAC SPRUE $=$ NONTROPICAL SPRUE $=$ GLUTEN-SENSITIVE ENTEROPATHY\n[ coeliac, Greek = abdominal]\n$=$ common chronic inflammatory intestinal autoimmune disorder of multifactorial etiology induced in genetically susceptible individuals\nCountries: North America, Europe, Australia, India, Pakistan, Middle East, Cuba\nIncidence: $1 \\div 100$ to $1 \\div 500 ; 1-3 \\%$ of general population in Europe and USA; $1 \\div 200$ Americans with 60,000 new cases annually; $<10 \\%$ actually diagnosed with bioptic proof in $2-13 \\div 100,000$ adults annually\nAge: childhood by age 2 years; 30-40 [40-60] years with $\\mathrm{M}<\\mathrm{F}[\\mathrm{M}>\\mathrm{F}]$\nCause: multifactorial; excessive T-cell-mediated immunity to ingested dietary gluten Irritating agent: gliadin polypeptides in wheat, rye, barley, oats, other grains\nGenetics: HLA-DR3-DQ2 heterodimer haplotype (encoded by DQA1 + DQB1 alleles), HLA-DR4-DQ8 haplotype confers an $\\uparrow$ risk; detected in $15 \\%$ of $1^{\\text {st }}$-degree relatives (concordance rate of $76 \\%$ for monozygotic twins $+11 \\%$ for dizygotic twins)\nAssociated with: type 1 diabetes (juvenile diabetes), autoimmune thyroid disease, Addison disease, Sjögren syndrome, SLE\nPathophysiology:\nanti-tissue transglutaminase antibodies destroy villous extracellular matrix + epithelial",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 917,
            "markdown": "cells $\\rightarrow$ progressive villus inflammation $\\rightarrow$ nodular + thickened duodenal and jejunal folds; villous truncation + crypt hyperplasia $\\rightarrow$ chronic fluid excess in small bowel lumen $\\rightarrow$ stretching of small bowel $\\rightarrow$ delayed transit\n\n- asymptomatic (silent, latent, atypical, subclinical): $<10 \\%$ of cases are properly diagnosed with an average delay of $20-60$ years from onset of symptoms\n- intestinal symptoms:\n- severe chronic diarrhea ( $<20 \\%$ ) / constipation ( $15 \\%$ )\n- failure to thrive, lassitude, fatigue, vomiting\n- weight loss (5\\%), overweight ( $39 \\%$ ), obese ( $13 \\%$ )\n- crampy abdominal pain ( $\\leftarrow$ intussusception), distension\n- flatulence, steatorrhea (CLASSIC but found only in minority of patients)\n- extraintestinal symptoms:\n- dermatitis herpetiformis (= pruritic bullous skin rash), aphthous stomatitis, alopecia\n- anemia from iron / folate / vitamin B12 deficiency\n- hepatitis, hypertransaminasemia (elevated alkaline phosphatase + liver enzymes), cholangitis\n- coagulopathy, guaiac-positive stools from bleeding diathesis, prolonged prothrombin time\n- peripheral neuropathy, depression, cerebellar ataxia, dementia, seizures\n- short stature, pubertal delay, infertility\n- idiopathic osteopenia with bone pain; arthralgia\n- dental enamel defects ( $10-40 \\%$ )\n- low serum levels of cholesterol, calcium, albumin\n- Serologic testing for antibodies to gliadin + endomysium in screening + monitoring compliance\n- anti-tissue transglutaminase IgA antibodies ( $D D x$ : juvenile diabetes, inflammatory bowel disease, arthritides)\n- antiendomysial antibodies\n\nSmall bowel follow-through: mostly replaced by endoscopy, antibody testing, CT enteroclysis!\n$\\sqrt{ }$ features of malabsorption pattern in celiac disease include duodenitis, dilution, dilatation, slow transit, flocculation, moulage, reversal of jejunal-ileal fold pattern, and transient small bowel intussusception.\nWith delay in diagnosis for $>10$ years at risk for:\niron deficiency anemia, lactose intolerance, osteoporosis with increase in fracture risk, miscarriage, low birth weight, lymphoma, seizures, depression\n$D x: \\quad \\operatorname{IgA}$ autoantibodies for tissue transglutaminase, antiendomysial antibodies, HLA-DQB1 typing\nRx: gluten-free diet: corn, rice, tapioca, soya, millet, vitamin supplements\n\n# Tropical Sprue \n\nEtiology: infectious agent cured with antibiotics; geographic distribution (India, Far East, Puerto Rico)\nAge: any age group\n\n- glossitis, hepatosplenomegaly",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 918,
            "markdown": "- macrocytic anemia + leukopenia\n\nPrognosis: spontaneous resolution after months / years\n$R s: \\quad$ responds well to folic acid + broad-spectrum antibiotics",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 919,
            "markdown": "# STRONGYLOIDIASIS \n\n[ strongylos, Greek = round; eidos, Greek = form]\nOrganism: helminthic parasite Strongyloides stercoralis ( 2.2 mm long, $50 \\mu \\mathrm{~m}$ in diameter); capable of reproducing within (primary) human host [ stercus, Latin = excrement]\nPrevalence: 30-35 million cases globally; $0.4-4 \\%$ in USA\nCountry: tropical + subtropical regions, parts of Europe, southeastern USA (endemic in eastern Kentucky, rural Tennessee), Puerto Rico\nPrimary host: humans\nInfection: filiform larva enters body through skin/mucous membranes (from contaminated soil) Cycle:\nfilariform larva penetrates skin $\\rightarrow$ passes from subcutaneous / submucosal sites via lymphatic + venous circulation to lung $\\rightarrow$ larva breaks into alveolar spaces and ascends bronchi + trachea;\nlarva swallowed $\\rightarrow$ settles in duodenum + upper jejunum (lives in tunnels between enterocytes) $\\rightarrow$ larva matures into parasitic female adult worm $\\rightarrow$ produces eggs through parthenogenesis ( $=$ asexual reproduction $) \\rightarrow$ worm deposits eggs into the intestinal lumen $\\rightarrow$ ova hatch immediately into nonmigratory rhabditiform larvae (1st larval stage) $\\rightarrow$ excreted in feces\n[ parthenos, Greek = virgin; genesis, Greek = creation]\nAutoinfection (endogenous reinfection):\nrhabditiform larva may remain in intestines long enough to metamorphose into infective\nfilariform larva $\\rightarrow$ penetrates intestinal mucosa / perianal skin $\\rightarrow$ reenters venous system repeating life cycle in same host\nPath: edema + inflammation of intestinal wall $\\leftarrow$ invasion by larvae; flattening of villi; ova in mucosal crypts\nHisto: intact larvae seen with Gömöri methenamine silver stain\n\n- asymptomatic for many years (in majority)\n- midepigastric pain mimicking peptic ulcer disease\n- severe malnutrition (malabsorption, steatorrhea), weight loss\n- larva currens $=$ recurrent allergic pruritic cutaneous skin reaction at site of larval penetration within 24 hours in area of buttocks + upper thighs in patients with autoinfection\n- worms, larvae, eggs in stool\n- peripheral blood eosinophilia (extremely common)\n- elevated levels of immunoglobulin E\n@ Intestine\n$\\sqrt{ }$ paralytic ileus (due to massive intestinal infestation):\n$\\sqrt{ }$ mild to moderate dilatation of proximal $2 / 3$ of duodenum + jejunum\n$\\sqrt{ }$ edematous irregular mucosal folds\n$\\sqrt{ }$ ulcerations\n$\\sqrt{ }$ stricture of $3^{\\text {rd }}+4^{\\text {th }}$ part of duodenum\n$\\sqrt{ }$ rigid pipestem appearance + irregular narrowing of duodenum (in advanced cases)\n@ Lung\n$\\sqrt{ }$ transient pulmonary opacities",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 920,
            "markdown": "Dx: filariform larvae in stool (single stool sample in $70 \\%$ negative), sputum samples / bronchial washings / bronchial / lung biopsy specimens, CNS samples\n$R x$ : thiabendazole ( $90 \\%$ efficacy rate)\nPrognosis: high mortality in undernourished patients\n$D D x$ : Crohn disease, lymphoma, tuberculosis, other causes of enterocolitis\n\n# Strongyloides Hyperinfection Syndrome \n\n$=$ life-threatening parasitic infestation $=$ chronic pathway of continuous autoinfection $\\rightarrow$ widespread dissemination + extensive tissue invasion in immunocompromised host with malignancy, autoimmune disease, malnutrition\n\n- gram-negative bacteremia, septicemia $\\leftarrow$ spillage of gut organisms into bloodstream at time of larval penetration of intestinal wall)\n- crampy abdominal pain, nausea, diarrhea\n- persistent vomiting, hematemesis\n$\\sqrt{ }$ thickened colonic wall $\\leftarrow$ florid transmural granulomatous inflammatory colitis caused by invasive larvae\n@ Heart, skeletal muscle, lymph nodes, liver\n- endocarditis, peritonitis\n@ CNS\n(a) meningitis $\\leftarrow$ larvae in pia arachnoid\n(b) global ischemia, atrophy, microinfarcts $\\leftarrow$ capillary obstruction\n@ Lung\nHisto: foreign body reaction resulting in inflammatory pneumonitis + pulmonary hemorrhage\n- $\\pm$ dyspnea, cough, sputum production, wheezing\n- hemoptysis\n$\\sqrt{ }$ fine miliary nodules (rare)\n$\\sqrt{ }$ diffuse reticulonodular interstitial opacities\n$\\sqrt{ }$ ill-defined patchy fleeting (migratory) airspace consolidation typically resolving in 1-2 weeks\n$\\sqrt{ }$ bilateral segmental / lobar opacities (with heavy infestation) $\\leftarrow$ extensive pneumonia: $\\sqrt{ }$ cavitation + abscess formation $\\leftarrow$ superimposed bacterial infection\n$\\sqrt{ }$ adult ARDS may develop\n$\\sqrt{ }$ pleural effusion\nPrognosis: $70 \\%$ mortality in AIDS patients\n\n\n## TAILGUT CYST\n\n$=$ RETRORECTAL CYSTIC HAMARTOMA\nCause: incomplete regression of embryonic tailgut ( $=$ the portion distal to future as yet undeveloped anus)\nAverage age: 35 years; $\\mathrm{M}<\\mathrm{F}$\nHisto: several types of epithelia + elements of intestinal epithelium, smooth muscle within cyst wall\n\n- asymptomatic / urinary frequency",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 921,
            "markdown": "- rectal / perineal pain, painless rectal bleeding\n- fever, acute pelvic pain $\\leftarrow$ secondary infection\n\nLocation: retrorectal / midline presacral space $\\pm$ extension into ischiorectal fossa\n$\\sqrt{ }$ well-defined thin-walled multicystic / unilocular cyst within perirectal space adhering to sacrum / rectum\n$\\sqrt{ }$ clear fluid / mucoid fluid with internal echoes\n$\\sqrt{ }$ mild enhancement of uncomplicated cyst\n$\\sqrt{ }$ thick enhancing wall $\\pm$ surrounding inflammation / air-fluid level $\\leftarrow$ secondary infection\nCx: (1) Repeated perirectal abscesses, recurring anorectal fistula (secondary infection)\n(2) Degeneration into mucinous adenocarcinoma (rare)\n$\\diamond$ Asymmetric irregular wall thickening and heterogeneous enhancement raises suspicion for malignant change within a duplication cyst.\n$R x:$ complete surgical excision\n$D D x: \\quad$ (1) Epidermoid / dermoid cyst\n(2) Rectal duplication cyst\n(3) Anterior meningocele\n(4) Cystic lymphangioma\n\n# TOXIC MEGACOLON \n\n$=$ acute transmural fulminant colitis characterized by neurogenic loss of motor tone + rapid development of nonobstructive colonic dilatation + loss of haustra\nEtiology:\n\n1. Ulcerative colitis (most common, in $<5 \\%$ )\n2. Crohn disease\n3. Amebiasis, salmonellosis\n4. Pseudomembranous colitis\n5. Ischemic colitis\n\nPathogenesis: inflammation that extends deep beneath colonic mucosa $\\rightarrow$ damage to muscularis propria $\\rightarrow$ colonic dilatation and loss of haustra\nHisto: widespread sloughing of mucosa + thinning of frequently necrotic muscle layers\n\n- systemic toxicity, profuse bloody diarrhea\n$\\sqrt{ }$ colonic ileus with marked dilatation of transverse colon $>5.5-6.0 \\mathrm{~cm} \\leftarrow$ gas influx into nondependent colonic segment in supine patient\n$\\sqrt{ }$ few air-fluid levels\n$\\sqrt{ }$ increasing caliber of colon on serial radiographs without redundancy\n$\\sqrt{ }$ loss of normal colonic haustra + interhaustral folds\n$\\sqrt{ }$ coarsely irregular mucosal surface\n$\\sqrt{ }$ pseudopolyposis $=$ mucosal islands in denuded ulcerated colonic wall\n$\\sqrt{ }$ pneumatosis coli\nUS:\n$\\sqrt{ }$ colonic dilatation $>6 \\mathrm{~cm}$\n$\\sqrt{ }$ marked decrease in colonic wall thickness to $<2 \\mathrm{~mm}$\n$\\sqrt{ }$ increased free fluid",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 922,
            "markdown": "CT:\n$\\sqrt{ }$ distended colon filled with large amounts of fluid + air\n$\\sqrt{ }$ distorted haustral pattern\n$\\sqrt{ }$ irregular nodular contour of thinned wall\n$\\sqrt{ }$ intramural air / small collections (= pneumatosis coli)\n$C x:$ perforation $\\pm$ pneumoperitoneum; rectal carcinoma\nBE: CONTRAINDICATED due to risk of perforation\nMorbidity: from electrolyte disturbance, fluid loss, hemorrhage, perforation\nPrognosis: $20 \\%$ mortality\n\n# TUBERCULOSIS OF ABDOMEN \n\n$\\diamond$ Most common manifestation of extrapulmonary tuberculosis (solid viscera $>$ GI tract)\nEndemic in: sub-Saharan Africa and Southeast Asia\nOrganism: M. tuberculosis, M. bovis, M. avium-intracellulare\n\n## Tuberculous Abdominal Lymphadenopathy (55-66\\%)\n\nFrequency: 55-66\\% of patients with abdominal TB\nLocation: mesenteric, peripancreatic, omental, retroperitoneal\n$\\sqrt{ }$ enlarged node with hypoattenuating center ( $40-60 \\%$ ) + hyperattenuating enhancing rim $\\leftarrow$ caseous necrosis\n$\\checkmark$ conglomerate lymph node masses of mixed attenuation\n$\\checkmark$ enlarged lymph nodes of homogeneous attenuation\n$\\sqrt{ }>3$ normal / mildly enlarged homogeneous lymph nodes\n$\\sqrt{ }$ NO obstruction of bile ducts / GI tract, / urinary tract (if present consider alternative diagnosis)\n\n## Tuberculous Peritonitis (33\\%)\n\n$\\diamond$ Most common presentation of abdominal tuberculosis (in 33\\%) associated with widespread abdominal disease!\nCause: hematogenous spread / rupture of mesenteric node / rupture of GI deposit / fallopian tube involvement\nTypes:\nA. WET TYPE $(90 \\%)=$ exudative ascites\n\n- large amount of freely distributed / loculated viscous fluid\n$\\sqrt{ }$ high-density ascites of $20-45 \\mathrm{HU} \\leftarrow$ high protein contents + leukocytes\n$\\sqrt{ }$ mildly thickened smooth peritoneum\n$\\sqrt{ }$ pronounced peritoneal enhancement\n$\\sqrt{ } 5-\\mathrm{mm}$ macronodules in mesentery\n$\\sqrt{ }$ thin omental line $\\leftarrow$ fibrous wall covering the infiltrated omentum\n$\\sqrt{ }$ calcifications\nB. FIBROTIC-FIXED TYPE $(60 \\%)=$ large cakelike masses with separation + fixation of bowel loops\n$\\sqrt{ }$ irregular mottled masses of soft-tissue density in omentum + mesentery (common)\n$\\sqrt{ }$ separation / fixation of matted loops of bowel\n$\\sqrt{ }$ loculated ascites (occasionally)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 923,
            "markdown": "C. DRY / PLASTIC TYPE $(10 \\%)=$ large mesenteric caseous adenopathy + adhesions\n$\\sqrt{ }$ enhancing peritoneal thickening + caseous nodules\n$\\sqrt{ }$ dense adhesions $\\leftarrow$ fibrous peritoneal reaction\n$\\sqrt{ }$ smudged / caked / thickened / masslike omentum\nCx: small bowel obstruction $\\leftarrow$ adhesions from serosal tubercles\nDDx: disseminated peritoneal malignancy, nontuberculous peritonitis, mesothelioma\n\n# Tuberculosis of GI tract (rare) \n\nRarely encountered in Western Hemisphere; increased incidence in AIDS; usually associated with pulmonary tuberculosis (in 6-38\\%)\nEtiology:\n(1) Ingestion of tuberculous sputum\n(2) Hematogenous spread from tuberculous focus in lung to submucosal lymph nodes\n$\\diamond$ Radiographic evidence of pulmonary TB in $<50 \\%$\n(3) Primary infection by cow milk (Mycobacterium bovis)\n\nPath:\n(a) ulcerative form (most frequent): ulcers with their long axis perpendicular to axis of intestine, undermining + pseudopolyps\n(b) hypertrophic form: thickening of bowel wall (transmural granulomatous process)\n\nAge: $\\quad 20-40$ years\n\n- weight loss, abdominal pain ( $80-90 \\%$ ), nausea, vomiting\n- tuberculin skin test negative in most patients with primary intestinal TB\n\nLocation: ileocecal region (cecum $>$ terminal ileum) $>$ ascending colon $>$ jejunum $>$ appendix $>$ duodenum $>$ stomach $>$ sigmoid $>$ rectum\n$\\diamond$ Skip areas of luminal narrowing + ileocecal valve involvement strongly suggest TB!\n@Ileocecal area ( $80-90 \\%$ )\n$\\diamond$ Most commonly affected bowel segment!\nCause: relative stagnation of intestinal contents + abundance of lymphoid tissue (Peyer patches)\n$\\sqrt{ }$ irregular thickened nodular folds in terminal ileum\n$\\sqrt{ }$ Stierlin sign = rapid emptying (= hypermotility) of narrowed (spastic) terminal ileum into shortened rigid obliterated cecum on BE (earliest manifestation)\n$\\sqrt{ }$ thickened ileocecal valve $\\leftarrow$ mass effect of edema\n$\\sqrt{ }$ Fleischner sign = \"inverted umbrella\" defect = wide gaping patulous ileocecal valve associated with narrowing of the immediately adjacent terminal ileum\n$\\sqrt{ }$ deep fissures + large shallow linear / stellate ulcers with CHARACTERISTIC elevated margins following the orientation of lymphoid follicles (ie, longitudinal in terminal ileum and transverse in colon)\n$\\sqrt{ }$ sinus tracts (rare) / enterocutaneous fistulas / perforation\n$\\sqrt{ }$ symmetric annular \"napkin ring\" stenoses\nCT:\n$\\sqrt{ }$ asymmetric circumferential wall thickening of ileocecal valve + medial wall of cecum + terminal ileum\n$\\sqrt{ }$ exophytic extension engulfing terminal ileum",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 924,
            "markdown": "$\\sqrt{ }$ localized massive mesenteric lymphadenopathy with central areas of low attenuation\n$D D x$ : Crohn disease, amebiasis, cecal carcinoma\n@ Colon\nSite: segmental colonic involvement, esp. on right side\n$\\sqrt{ }$ rigid contracted cone-shaped shrunken cecum $\\leftarrow$ spasm / transmural fibrosis\n$\\sqrt{ }$ shortened \"amputated\" cecum $\\leftarrow$ retraction of cecum out of iliac fossa $\\leftarrow$ fibrosis of mesocolon\n$\\sqrt{ }$ spiculations + wall thickening\n$\\sqrt{ }$ diffuse ulcerating colitis + pseudopolyps\n$\\sqrt{ }$ short hourglass strictures\n$D D x$ : ulcerative colitis, Crohn disease, amebiasis (spares terminal ileum), colitis of bacillary dysentery, ischemic colitis, pseudomembranous colitis\n@ Gastroduodenal\nSite: simultaneous involvement of antrum + pylorus + duodenum\n$\\sqrt{ }$ stenotic pylorus with gastric outlet obstruction\n$\\sqrt{ }$ narrowed antrum (= linitis plastica appearance)\n$\\sqrt{ }$ antral sinus tract / fistula\n$\\sqrt{ }$ multiple large and deep ulcerations on lesser curvature simulating peptic ulcer disease\n$\\sqrt{ }$ thickened duodenal folds with irregular contour / dilatation\n$D D x$ : carcinoma, lymphoma, syphilis\n@ Esophagus\n$\\diamond$ Least common GI tract manifestation\nCause: secondary involvement from adjacent tuberculous lymphadenitis / primary TB\nLocation: level of carina\n$\\sqrt{ }$ deep ulceration\n$\\sqrt{ }$ stricture\n$\\sqrt{ }$ mass\n$\\sqrt{ }$ intramural dissection / fistula formation $\\rightarrow$ sinus tract formation\n\n# TRICHURIASIS \n\n$\\diamond 3^{\\text {rd }}$ most common roundworm infection in humans\nOrganism: Trichuris trichiura\nInfection: fecal-oral route\nCycle: after elimination in feces eggs become embryonate and infective within 15 to 30 days $\\rightarrow$ ingestion of eggs $\\rightarrow$ release of larvae in small intestine $\\rightarrow$ larvae mature during migration to cecum + ascending colon $\\rightarrow$ adult worms attaches to mucosa\nBarium enema:\n$\\sqrt{ }$ small elongated filling defects\n$D x$ : stool sample\n$D D x$ : lymphoid hyperplasia, aphthous ulcers\n\n## TURCOT SYNDROME\n\n$=$ autosomal recessive disease with\n(a) colonic polyposis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 925,
            "markdown": "(b) CNS tumors (especially supratentorial glioblastoma, occasionally medulloblastoma)\n\nAge: symptomatic during $2^{\\text {nd }}$ decade\nHisto: adenomatous polyps\n\n- diarrhea, seizures\n$\\sqrt{ }$ multiple $1-30-\\mathrm{mm}$ polyps in colon + rectum\nCx: malignant transformation of colonic polyps in $100 \\%$\nPrognosis: death from brain tumor in $2^{\\mathrm{nd}}+3^{\\mathrm{rd}}$ decade\n\n\n# ULCERATIVE COLITIS \n\n$=$ common idiopathic superficial inflammatory bowel disease with continuous concentric + symmetric colonic involvement\nEtiology: ? hypersensitivity / autoimmune disease\nIncidence: $2-14 \\div 100,000$ annually\n$\\diamond 7,000-46,000$ new cases annually in USA\nPrevalence: 37-246 100,000 in North America\nPath: predominantly mucosal + submucosal inflammation with neutrophilic infiltrates + exudate + edema + crypt abscesses (HALLMARK) resulting in shallow ulceration\nAge peaks: 15-25 years $+50-60$ years (bimodal distribution); $\\mathrm{M} \\div \\mathrm{F}=1.3 \\div 1$\n\n- alternating periods of remission + exacerbation\n- chronic diarrhea, rectal bleeding, abdominal pain / cramps\n- electrolyte depletion, fever, systemic toxicity (malaise)\n\nExtracolonic manifestations:\n\n- iritis, erythema nodosum, pyoderma gangrenosum\n- pericholangitis, chronic active hepatitis, primary sclerosing cholangitis, fatty liver, thrombotic complications\n- spondylitis, peripheral arthritis, coincidental rheumatoid arthritis (10-20\\%)\n\nLocation: begins in rectum (proctitis in $55 \\%$, rectum spared in $4 \\%$ ) with proximal progression, left-sided colitis ( $30 \\%$ ), pancolitis ( $15 \\%$ ); relatively uniform symmetric involvement of bowel\n@ Rectosigmoid in 95\\% (diagnosed by rectal biopsy); continuous circumferential involvement often limited to left side of colon\n@ Colitis extending proximally to splenic flexure = universal colitis\n@ Terminal ileum in 10-25\\% (= \"backwash ileitis\")\nPlain film:\n$\\checkmark$ hyperplastic mucosa, polypoid mucosa, deep ulcers\n$\\checkmark$ diffuse dilatation with loss of haustral markings\n$\\checkmark$ toxic megacolon\n$\\checkmark$ free intraperitoneal gas\n$\\checkmark$ complete absence of fecal residue $\\leftarrow$ inflammation\nBE:\n(a) acute stage\n$\\checkmark$ narrowing + incomplete filling $\\leftarrow$ spasm + irritability\n$\\checkmark$ fine mucosal granularity $=$ stippling of barium coat $\\leftarrow$ diffuse mucosal edema + hyperemia + superficial erosions",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 926,
            "markdown": "$\\sqrt{ }$ spicules + serrated bowel margins $=$ tiny superficial ulcers\n$\\sqrt{ }$ \"collar button\" ulcers = undermining of ulcers\n$\\sqrt{ }$ \"double-tracking\" = longitudinal submucosal ulceration over several cm\n$\\sqrt{ }$ hazy / fuzzy quality of bowel contour $\\leftarrow$ excessive secretions / mucin production\n$\\sqrt{ }$ \"thumbprinting\" = symmetric thickening of colonic folds\n$\\sqrt{ }$ pseudopolyps $=$ scattered islands of edematous mucosa + reepithelialized granulation tissue within areas of denuded mucosa\n$\\sqrt{ }$ widening of presacral space\n$\\sqrt{ }$ obliterated rectal folds $=$ valves of Houston $(43 \\%)$\n(b) subacute stage\n$\\sqrt{ }$ distorted irregular haustra\n$\\sqrt{ }$ inflammatory polyps $=$ sessile frondlike / rarely pedunculated lesions (= localized mucosal inflammation resulting in polypoid protuberance)\n$\\sqrt{ }$ coarse granular mucosa (= mucosal replacement by granulation tissue)\n(c) chronic stage\n$\\sqrt{ }$ shortening of colon with depression of flexures $\\leftarrow$ reversible spasm of longitudinal muscle\n$\\sqrt{ }$ \"leadpipe\" colon = rigidity + symmetric narrowing of lumen on BE:\n$\\leftarrow$ hypertrophic regeneration of muscularis mucosae\n$\\leftarrow$ contraction of enlarged muscle layer\n$\\leftarrow$ strictures compromising luminal distensibility\n$\\leftarrow$ fat deposition within submucosal layer\n$\\sqrt{ }$ widening of haustral clefts / complete loss of haustrations $\\leftarrow$ hypertrophy of muscularis mucosae + fibrosis (DDx: cathartic colon)\n$\\sqrt{ }$ \"burnt-out colon\" = fairly distensible colon WITHOUT haustral markings + without mucosal pattern\n$\\sqrt{ }$ hazy / fuzzy quality of bowel contour $\\leftarrow$ excessive secretions\n$\\sqrt{ }$ postinflammatory polyps $(12-19 \\%)=$ small sessile nodules / long wormlike branching + bridging outgrowths (= filiform polyposis)\n$\\sqrt{ }$ \"backwash ileitis\" $(5-30 \\%)$ involving $4-25 \\mathrm{~cm}$ of terminal ileum with patulous ileocecal valve + absent peristalsis + granularity\nUS:\n$\\sqrt{ }$ thickening, hyperemia, loss of haustra\n$\\sqrt{ }$ preserved mural stratification\nCT/MR:\nCT enterography is not used for the diagnosis or staging of ulcerative colitis as it is less sensitive than endoscopy and principally assesses the small bowel.\n$\\diamond$ Often normal early in course of disease!\n$\\sqrt{ }$ colonic wall thickening $3.5-11.6 \\mathrm{~mm}$ (normal $<3 \\mathrm{~mm}$; indeterminate $=3-4 \\mathrm{~mm}$; pathologic $>4 \\mathrm{~mm})$\n$\\sqrt{ }$ mural stratification:\n$\\sqrt{ }$ submucosal stripe $=$ enhancement of mucosa but not submucosa\n$\\sqrt{ }$ dilatation of vasa recta\n$\\sqrt{ }$ inflammatory pseudopolyp",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 927,
            "markdown": "$\\sqrt{ }$ widening of presacral space $\\leftarrow$ perirectal extramural fat proliferation\nMural stratification, dilatation of vasa recta, colonic wall thickening, and inflammatory pseudopolyps are seen in both ulcerative colitis and Crohn colitis!\nNUC:\n$\\sqrt{ }$ positive on ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-hexamethylpropylene amine (HMPAO)-labeled leukocytes\nDx: colonoscopy\nCx:\n(1) Toxic megacolon (in 5\\%) (DDx: granulomatous / ischemic / amebic colitis)\n$\\diamond$ Most common cause of death in ulcerative colitis!\n$\\diamond$ Develops within 3 months of diagnosis (in 30\\%)\n(2) Colonic adenocarcinoma (3-5\\%):\n\nRisk: starts after 8-10 years of disease onset; risk progresses at $0.5-1.0 \\%$ annually for $10-20$ years + at $0.9 \\%$ per year thereafter; higher risk with pancolitis + onset of disease in $<15$ years of age\n\n| DDx of Crohn Disease versus Ulcerative Colitis |  |  |\n| :--: | :--: | :--: |\n|  | Crohn Disease | Ulcerative Colitis |\n| mnemonic: | LUCIFER M |  |\n| Location | right | left |\n| Ulcers | deep | shallow |\n| Contraction | - | $+$ |\n| Ileocecal valve | thickened | gaping |\n| Fistulae | $+$ | - |\n| Eccentricity | $+$ | - |\n| Rate of carcinoma | $(\\uparrow)$ | $\\uparrow \\uparrow$ |\n| Megacolon | unusual | $+$ |\n| Skip lesions | $+$ | - |\n| Pseudopolyps | $+$ | - |\n| Abscess / fistula | $+$ | - |\n| Fibrofatty proliferation | $+$ | - |\n| Full thickness enhancement | $+$ (transmural) | - (mucosal + submucosal |\n| Increased SI of mucosa | $+$ | - |\n| Submucosal stripe | - | $+$ |\n| Wall thickening | $+(11 \\mathrm{~mm})$ | $+(8 \\mathrm{~mm})$ |\n| Wall enhancement | $+$ | $+$ |\n| Increased SI of pericolic fat | $+$ | $+$ |\n| Comb sign | $+$ | $+$ |\n| Loss of haustrations | $\\pm$ | $+$ |\n| Enlarged lymph nodes | $+$ | $+$ |\n\nUsually associated with: total colitis\nLocation: rectosigmoid $>$ descending colon, distal transverse colon",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 928,
            "markdown": "$\\sqrt{ }$ narrowed segment of $2-6 \\mathrm{~cm}$ in length with eccentric lumen + irregular contour + flattened rigid tapered margins $=$ scirrhous carcinoma\n$\\sqrt{ }$ annular / polypoid carcinoma\nPrognosis: synchronous lesions in 35\\%\n$\\diamond$ Surveillance is recommended!\n(3) Colonic strictures ( $10 \\%$ )\n\nSmooth contour with fusiform pliable tapering margins, usually short + single stricture; commonly in sigmoid / rectum / transverse colon; usually after minimum of 5 years of disease; rarely cause for obstruction (DDx: colonic carcinoma)\n(4) Perforation\n\nDDx: (1) Familial polyposis (no inflammatory changes)\n(2) Cathartic colon (more extensive in right colon)\n\n# VILLOUS ADENOMA \n\n$\\sqrt{ }$ solitary sessile polypoid mass with numerous frondlike projections of reticular \"soap bubble\" appearance $\\leftarrow$ retention of contrast material in clefts between tumor projections\n\n## Villous Adenoma of Colon\n\nFrequency: $7 \\%$ of all colonic tumors\nAge: presentation late in life; $\\mathrm{M}=\\mathrm{F}$\nLocation: rectum + sigmoid ( $75 \\%$ ), cecum, ileocecal valve; $2 \\%$ of all tumors in rectum + colon\nAssociated with: other GI tumors (25\\%)\n\n- sensation of incomplete evacuation, rectal bleeding, weakness\n- excretion of copious amounts of thick mucus, fatigability\n- diarrhea + electrolyte depletion syndrome in $4 \\%$ (dehydration, hypokalemia, hyponatremia)\n$\\sqrt{ }$ may completely encircle the colon\n$\\sqrt{ }$ broad-based sessile bulky tumor often $>20 \\mathrm{~mm}$ in diameter:\n$\\sqrt{ }$ innumerable papillary mucosal projections (\"villous fronds\") with reticular / granular surface pattern (if villous elements constitute $>75 \\%$ of tumor, diagnosis can be made on BE):\n$\\checkmark$ spongelike corrugated appearance (= barium within interstices)\n$\\checkmark$ striated \"brushlike\" surface\n$\\sqrt{ }$ soft pliable tumor with change in shape:\n$\\sqrt{ }$ apparent decrease in size on postevacuation films\nCT:\n$\\sqrt{ }$ heterogeneous low attenuation on $\\mathrm{CT} \\leftarrow$ capacious mucin becoming trapped within papillary projections + crevices\nPrognosis: higher malignant potential than tubular adenoma\n$C x$ : malignant transformation / invasion (in $36 \\%$ ) related to size of tumor $<5 \\mathrm{~cm}(9 \\%) ;>5$ $\\mathrm{cm}(55 \\%) ;>10 \\mathrm{~cm}(100 \\%)$\n\n\n## Villous Adenoma of Duodenum\n\nPrevalence: $1 \\%[50 \\%]$ of all [benign] duodenal neoplasms; more common in colon + rectum",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 929,
            "markdown": "Average age: 56 years; $\\mathrm{M}=\\mathrm{F}$\nAssociated with: Gardner syndrome, familial adenomatous polypoid syndrome\n\n- asymptomatic, vague dyspepsia, bowel obstruction (rare)\n- occult upper GI bleeding, anemia, $\\pm$ obstructive jaundice\n\nLocation: $2^{\\text {nd }}$ duodenal segment near major papilla of Vater\nSize: $\\quad 3-9 \\mathrm{~cm}$\n$\\sqrt{ }$ sessile soft mostly nonobstructive mass\n$\\sqrt{ }$ \"lace\" / \"soap bubble\" pattern $\\leftarrow$ frondlike projections\n$\\sqrt{ }$ preservation of peristaltic activity + bowel distensibility\nCT:\n$\\sqrt{ }$ variegated attenuation + variable enhancement patterns\n$\\sqrt{ }$ CHARACTERISTIC surface gyral pattern for large tumor\nCx: bowel obstruction\nPrognosis: $30 \\%-60 \\%$ risk for malignant transformation\n\n# WALDENSTRÖM MACROGLOBULINEMIA \n\n= low-grade lymphoid malignancy (= plasma cell dyscrasia) composed of mature plasmacytoid lymphocytes with production of abnormal monoclonal IgM protein\nIncidence: $0.53 \\div 100,000$ annually; frequency $10-15 \\%$ of multiple myeloma\nHisto: macroglobulin proteinaceous hyaline material fills lacteals in lamina propria of small bowel villi with secondary lymphatic distension + edema\nMean age: 63 years; $\\mathrm{M}>\\mathrm{F}$\n\n- fatigue, weight loss, diarrhea, steatorrhea, malabsorption\n- anemia, bleeding diathesis, IgM elevation\n- hyperviscosity syndrome (20\\%) = bleeding, visual changes, neurologic abnormalities\n@ Small bowel (rarely involved)\n$\\sqrt{ }$ small bowel dilatation\n$\\sqrt{ }$ diffuse irregular thickening of valvulae conniventes with spikelike configuration (jejunum + proximal ileum)\n$\\sqrt{ }$ granular surface of punctate $1-2-\\mathrm{mm}$ nodules (deposition of immunoglobulin M in submucosa + lamina propria)\n@ Bone marrow involvement (91-98\\%)\n(a) diffuse replacement of bone marrow (56\\%)\n(b) variegated replacement of bone marrow (35\\%)\n$\\sqrt{ }$ compression fractures of spine (48\\%)\n$\\sqrt{ }$ diffuse demineralization of spine\n$\\sqrt{ }$ lytic lesions on bone surveys (in up to 20\\%)\nMR (pre- and postcontrast T1WI preferred):\n$\\sqrt{ }$ marrow iso- / hypointense to muscle on T1WI\n$\\sqrt{ }$ enhancement of abnormal marrow on T1WI\n@ Lymph nodes\n$\\sqrt{ }$ lymphadenopathy (43\\%)\n@ Liver \\& spleen\n$\\sqrt{ }$ hepatosplenomegaly",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 930,
            "markdown": "Dx: (1) Characteristic M-spike in serum / urine electrophoresis\n(2) Abnormal lymphoplasmacytoid cells in bone marrow / lymph nodes\n\nPrognosis: may occasionally progress to full-blown lymphoma\n$D D x$ : multiple myeloma (lymphadenopathy rare, lytic lesions in $31 \\%$ )\n\n# WHIPPLE DISEASE \n\n[George Whipple (1878-1976), pathologist in Rochester, USA]\n$=$ INTESTINAL LIPODYSTROPHY\n$=$ sporadically occurring chronic bacterial multisystem disease\nEtiology: infection with gram-positive bacterium (Tropheryma whipplei) closely related to actinobacteria; in $1-11 \\%(12-26 \\%)$ of fecal samples in healthy population (sewage workers) in Europe\nIncidence: 30 cases annually\nGenetics: whites of European heritage predisposed $\\rightarrow$ colonization of bacterium throughout GI tract + lymphoreticular system + CNS\nHisto: PAS-positive material (periodic acid Schiff) = glycoprotein (from bacterial cell wall) within foamy macrophages in the submucosa of the jejunum + fat deposits within intestinal submucosa and lymph nodes causing lymphatic obstruction + dilatation\nMean age: 50 years (range, $4^{\\text {th }}-6^{\\text {th }}$ decade); $\\mathrm{M}+\\mathrm{F}=8 \\div 1$; Caucasians\n\n- 4 cardinal symptoms:\n- recurrent migratory arthralgias / nondeforming arthritis\n- chronic steatorrhea $\\leftarrow$ malabsorption\n- weight loss $\\rightarrow$ severe wasting\n- abdominal pain $\\rightarrow$ abdominal distention $\\leftarrow$ ascites and lymphadenopathy (late finding)\n- polyserositis, low-grade fever\n- generalized peripheral lymphadenopathy (50\\%)\n- hyperpigmentation of skin similar to Addison disease\n- pale shaggy yellow plaques / erosions in postbulbar duodenum on endoscopy\n\nOrgan involvement: small bowel (particularly jejunum), lymph nodes, heart valves, joints, CNS, liver, lung, eyes, skin (virtually every organ system)\n@ MSK (67\\%) arthritis may precede Whipple disease up to 10 years (10\\%)\n@ Abdomen (15\\%)\n$\\sqrt{ }$ moderate irregular diffuse fold thickening of jejunum + duodenum + (to a lesser degree) ileum $\\leftarrow$ mucosal and submucosal infiltration by Whipple bacilli + PAS- positive macrophages + lymphatic obstruction\n$\\sqrt{ }$ micronodularity ( $=$ swollen villi) + wild mucosal pattern\n$\\sqrt{ }$ hypersecretion, segmentation, fragmentation (occasionally if accompanied by hyperproteinemia)\n$\\sqrt{ }$ NO / minimal distension of small bowel\n$\\sqrt{ }$ NO rigidity of folds, NO ulcerations\n$\\sqrt{ }$ NORMAL transit time\n$\\sqrt{ }$ hepatosplenomegaly\n$\\sqrt{ }$ mesenteric and retroperitoneal nodes of low attenuation are CHARACTERISTIC of Whipple disease",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 931,
            "markdown": "CT:\n$\\sqrt{ }$ bulky $3-4-\\mathrm{cm}$ low-density lymph nodes in mesenteric root + retroperitoneum $\\leftarrow$ lymphatic obstruction and intranodal deposition of extracellular lipids\n$\\sqrt{ }$ thickening of small bowel wall\n$\\sqrt{ }$ hepatosplenomegaly\n$\\sqrt{ }$ ascites\n$\\sqrt{ }$ pneumatosis intestinalis\n$\\sqrt{ }$ pleuropericarditis\n$\\sqrt{ }$ sacroiliitis\nUS:\n$\\sqrt{ }$ echogenic lymph nodes\n@ CNS (33\\%)\nLocation: mesial temporal lobe, midbrain, thalamus, hypothalamus\n$\\sqrt{ }$ patchy nodular enhancement\n$\\sqrt{ }$ hyperintense regions on FLAIR $\\leftarrow$ atrophy / gliosis\n$D x$ : endoscopically guided biopsy of small bowel mucosa, abdominal / peripheral lymph node biopsy\n$R x$ : long-term broad-spectrum antibiotics (tetracycline) with $17-35 \\%$ relapse rate; long-term trimethoprim-sulfamethoxazole\n$D D x$ : (1) Sprue (marked dilatation, no fold thickening, pronounced segmentation + fragmentation)\n(2) Intestinal lymphangiectasia (thickened folds throughout small bowel)\n(3) Amyloidosis\n(4) Lymphoma\n\n# YERSINIOSIS \n\nOrganism: Gram-negative bacillus Yersinia enterocolitica\n\n- self-limited diarrhea\n\nLocation: usually confined to terminal ileum\n$\\sqrt{ }$ irregular segmental thickening of folds\n$\\sqrt{ } \\pm$ aphthous ulcers / larger area of ulceration\n\n## ZENKER DIVERTICULUM\n\n$=$ PHARYNGOESOPHAGEAL DIVERTICULUM\n[Friedrich Albert von Zenker (1825-1898), German pathologist, Dresden city hospital and chair at Erlangen University]\n$=$ outpouching of posterior hypopharyngeal wall $=$ pulsion diverticulum with herniation of mucosa + submucosa through muscle bundles (pseudodiverticulum)\nPrevalence: $0.01-0.11 \\%$ (overall); higher in elderly women\n$\\diamond$ Most common diverticulum of UGI tract!\nEtiology: cricopharyngeal dysfunction (cricopharyngeal achalasia / premature closure) $\\rightarrow$ increased intraluminal pressure (pulsion diverticulum)\nAssociated with: hiatal hernia, gastroduodenal ulcer, midesophageal diverticulum, esophageal spasm, achalasia, GERD",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 932,
            "markdown": "Age: $>60$ years ( $50 \\%$ occur in $7^{\\text {th }}-8^{\\text {th }}$ decade); $\\mathrm{M} \\div \\mathrm{F}=1 \\div 3$\n\n- compressible neck mass, noisy deglutition, chronic cough\n- upper esophageal dysphagia ( $98 \\%$ ), weight loss\n- regurgitation + aspiration of undigested food\n- halitosis (= foul breath)\n\nLocation: pharyngoesophageal junction in midline of Killian dehiscence / triangle of Laimer (= focal hypopharyn-geal weakness at cleavage plane between inferior pharyngeal constrictor $\\mathrm{m}_{+}+$cricopharyngeus m . or between oblique + transverse fibers of cricopharyngeus m.), at level of C5-6\n[Gustav Killian (1860-1921), laryngologist and founder of bronchoscopy, ordinarius for throat and nose disease in Freiburg, Germany]\nBarium pharyngography:\n$\\sqrt{ }$ posterior + inferior barium extension in upper half of semilunar depression on posterior wall of esophagus in midline / slightly toward left (above cricopharyngeal m.)\n$\\sqrt{ }$ barium-filled sac extending caudally behind + usually to left of esophagus\n$\\sqrt{ }$ partial / complete obstruction of esophagus from external pressure of sac contents $\\rightarrow$ dysphagia\n$\\sqrt{ }$ partial barium reflux from diverticulum into hypopharynx\n$\\sqrt{ }$ continual growth with successive enlargement\nCXR:\n$\\sqrt{ }$ air-fluid level in superior mediastinum\nCx: overflow aspiration pneumonia ( $30 \\%$ ); esophageal perforation; carcinoma ( $0.48 \\%$ )\n$R x:$ surgical excision + cricopharyngeal myotomy\n\n# ZOLLINGER-ELLISON SYNDROME \n\n[Robert Milton Zollinger (1903-1992), chairman of surgery at Ohio State University, editor in chief of Am J Surg 1958-1986]\n(Edwin Homer Ellison (1918-1970), chairman of surgery at Marquette University, Milwaukee]\n$=$ peptic ulcer diathesis $\\leftarrow$ marked hypersecretion of gastric acid $\\leftarrow$ gastrin-secreting islet cell neoplasm (gastrinoma)\nIncidence: $0.1 \\%$ of all peptic ulcer disease\nCause:\nA. GASTRINOMA ( $90 \\%$ )\n$=$ gastrin-producing non- $\\beta$ islet cell tumor of pancreas\nB. PSEUDO Z-E SYNDROME $=$ COWLEY SYNDROME\n$=$ antral G-cell hyperplasia $(10 \\%)=$ increase in number of G-cells in gastric antrum\n\n- lack of gastrin elevation after secretin injection\n- exaggerated gastrin elevation after protein meal\n\nAge: middle age; $\\mathrm{M}>\\mathrm{F}$\n\n- clinical tetrad:\n(1) Gastric hypersecretion: refractory response to histamine stimulation test concerning HCl concentration; increased basal secretion ( $>60 \\%$ of augmented secretion is diagnostic)\n(2) Hypergastrinemia $>1000 \\mathrm{ng} / \\mathrm{L}$ (during fasting)\n(3) Hyperacidity with basal acid output $>15 \\mathrm{mEq} / \\mathrm{hr} /$ occasionally hypoacidity",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 933,
            "markdown": "(4) Diarrhea ( $30 \\%$ ), steatorrhea ( $40 \\%$ ) $\\leftarrow$ malabsorption $\\leftarrow$ inactivation of pancreatic lipase + damage to small bowel mucosa $\\leftarrow$ large volumes of gastric acid with low pH ; may be sole complaint in $10 \\%$, frequently nocturnal\n\n- epigastric pain ( $90 \\%$ ): mild nonspecific to severe recurrent intractable pain, gastroesophageal reflux, heartburn\n- ulcer perforation with GI bleeding ( $30 \\%$ )\n- positive secretin stimulation test\n- $\\uparrow$ fasting serum levels of gastrin (DIAGNOSTIC): often $>1,000 \\mathrm{pg} / \\mathrm{mL}(<100 \\mathrm{pg} / \\mathrm{mL}$ is normal)\n$\\checkmark$ peptic ulcers\n$\\diamond$ An unusual location in postbulbar duodenum / proximal jejunum + atypical course should suggest the diagnosis!\nLocation: duodenal bulb ( $65 \\%$ ) + stomach ( $20 \\%$ ), jejunum near ligament of Treitz ( $25 \\%$ ), duodenal C-loop (5\\%), distal esophagus (5\\%)\nMultiplicity: solitary ulcer ( $90 \\%$ ), multiple ulcers ( $10 \\%$ )\n$\\checkmark$ recurrent / intractable ulcers\n$\\checkmark$ marginal ulcers in postgastrectomy patient\n(a) on gastric side of anastomosis\n(b) on mesenteric border of efferent loop\n$\\checkmark$ prominence of areae gastricae $\\leftarrow$ hyperplasia of parietal cells\n$\\checkmark$ enlarged thickened rugal folds in gastric fundus + upper body\n$\\checkmark$ sluggish gastric peristalsis $\\leftarrow$ ? hypokalemia\n$\\checkmark$ \"wet stomach\" = dilution of barium with poor coating by excess secretions in nondilated nonobstructed stomach\n$\\checkmark$ gastroesophageal reflux (common) + esophagitis\nLocation: unusually long strictures in distal esophagus (may be initial manifestation of disease)\nCause: increased acidity of peptic acid reflux\n$\\checkmark$ dilatation of duodenum + upper small bowel $\\leftarrow$ fluid overload\n$\\checkmark$ thickened folds in duodenum + jejunum $\\leftarrow$ edema\n$\\checkmark$ rapid small-bowel transit time\nmnemonic: FUSED\nFolds: thickened gastric folds\nUlcers: often multiple, postbulbar\nSecretions increased (refractory to histamine)\nEdema: of proximal small bowel\nDiarrhea\nCx: (1) Malignant islet cell tumor (in 60\\%)\n(2) Liver metastases will continue to stimulate gastric secretion\n\nRx: (1) Control of gastric hypersecretion:\n(a) $\\mathrm{H}_{2}$-receptor antagonist: cimetidine, ranitidine, famotidine\n(b) Hydrogen-potassium adenosine triphosphatase inhibitor (omeprazole)\n(2) Resection of gastrinoma if found (because of malignant potential)\n(3) Total gastrectomy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 934,
            "markdown": "![img-95.jpeg](img-95.jpeg)",
            "images": [
                {
                    "id": "img-95.jpeg",
                    "top_left_x": 103,
                    "top_left_y": 151,
                    "bottom_right_x": 1613,
                    "bottom_right_y": 2046,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 935,
            "markdown": "# DIFFERENTIAL DIAGNOSIS OF UROGENITAL DISORDERS \n\n## RENAL FAILURE\n\n$=$ reduction in renal function\n\n- rise in serum creatinine $>2.5 \\mathrm{mg} / \\mathrm{dL}$\n\n\n## Acute Renal Failure (ARF)\n\n$=$ clinical condition associated with rapid steadily increasing azotemia $\\pm$ oliguria ( $<500 \\mathrm{~mL}$ urine per day) over days / weeks\nEtiology:\nA. PRERENAL\n$=$ renal hypoperfusion $\\leftarrow$ systemic illness\n\n1. Fluid + electrolyte depletion\n2. Hemorrhage\n3. Hepatic failure + hepatorenal syndrome\n$\\sqrt{ }$ abnormally elevated resistive index\n4. Congestive heart failure\n5. Sepsis\n$\\sqrt{ }$ resistive index $<0.75$ in $80 \\%$ of kidneys\nFrequency: $70 \\%$ of community-acquired ARF (glomerulonephritis); $40 \\%$ of hospitalacquired ARF (acute tubular necrosis)\nB. RENAL (most common)\n6. Acute tubular necrosis: ischemia, nephrotoxins, radiographic contrast, hemoglobulinuria, myoglobulinuria, myocardial infarction, burns\n$\\sqrt{ }$ resistive index $\\geq 0.75$ in $91 \\%$ of kidneys\n7. Acute glomerulonephritis + small vessel disease: acute poststrep glomerulonephritis, rapidly progressive glomerulonephritis, lupus, polyarteritis nodosa, Schönlein-Henoch purpura, subacute bacterial endocarditis, serum sickness, Goodpasture syndrome, malignant hypertension, hemolytic uremic syndrome, drug-related vasculitis, abruptio placentae\n$\\sqrt{ }$ normal resistive index $<0.70$\n8. Acute tubulointerstitial nephritis: drug reaction, pyelonephritis, papillary necrosis $\\sqrt{ }$ abnormal resistive index\n9. Intrarenal precipitation: hypercalcemia, urate, myeloma protein\n10. Arterial / venous obstruction\n11. Acute cortical necrosis\nC. POSTRENAL (5\\%)\n$=$ result of outflow obstruction (rare)\n12. Prostatism",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 936,
            "markdown": "2. Tumors of bladder, retroperitoneum, pelvis\n3. Calculus\n$\\sqrt{ }$ hydronephrosis\n$\\diamond 30-35 \\%$ of acutely obstructed kidneys ( $<36$ hours) have no hydronephrosis!\nD. CONGENITAL\nbilateral renal agenesis / dysplasia / infantile polycystic kidney disease, congenital nephrotic syndrome, congenital nephritis, perinatal hypoxia\nFrequency: ATN + prerenal disease account for $75 \\%$ of acute renal failure; 5-7\\% of all hospitalized patients\n\n- asymptomatic\n- elevated creatinine normal range: $0.5-1.0 \\mathrm{mg} / \\mathrm{dL}$ (about $45-90 \\mu \\mathrm{~mol} / \\mathrm{L}$ ) for women $+0.7-$ $1.2 \\mathrm{mg} / \\mathrm{dL}(60-110 \\mu \\mathrm{~mol} / \\mathrm{L})$ for men\nPrognosis: $20-70 \\%$ mortality\n\n\n# Chronic Renal Failure (CRF) \n\n$=$ decrease in renal function over months / years\nIncidence: end-stage renal disease in $0.01 \\%$ of USA population; annually 85,000 patients undergo hemodialysis $+8,000$ renal transplantations\nEtiology:\nA. INFLAMMATION / INFECTION\n\n1. Glomerulonephritis\n2. Chronic pyelonephritis\n3. Tuberculosis\n4. Sarcoidosis\nB. VASCULAR\n5. Renal vascular disease\n6. Bilateral renal vein thrombosis\nC. DYSPROTEINEMIA\n7. Myeloma\n8. Amyloid\n9. Cryoglobulinemia\n10. Waldenström macroglobulinemia\nD. METABOLIC\n11. Diabetes\n12. Gout\n13. Hypercalcemia\n14. Hyperoxaluria\n15. Cystinosis\n16. Fabry disease\n17. Calcinosis\nE. CONGENITAL\n18. Polycystic kidney disease\n19. Multicystic dysplastic kidney\n20. Medullary cystic disease\n21. Alport syndrome",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 937,
            "markdown": "5. Infantile nephrotic syndrome\nF. MISCELLANEOUS\n6. Hepatorenal syndrome\n7. Radiation\n\n# Musculoskeletal Manifestations of CRF \n\n1. Renal osteodystrophy = combination of $2^{\\circ} \\mathrm{HPT}$, osteoporosis, osteosclerosis, osteomalacia, soft-tissue and vascular calcifications\n2. Aluminum toxicity ( $1-30 \\%$ )\n3. Amyloid deposition\n\nPath: amyloid consists of $\\beta 2$-microglobulin\nOrgans: bone, tenosynovium (carpal tunnel syndrome), vertebral disk, articular cartilage + capsule, ligament, muscle\n4. Destructive spondyloarthropathy ( $15 \\%$ )\n$\\sqrt{ }$ diskovertebral junction erosion + sclerosis\n$\\sqrt{ }$ vertebral body compression\n$\\sqrt{ }$ disk space narrowing\n$\\sqrt{ }$ Schmorl node formation\n$\\sqrt{ }$ lack of osteophytosis\n$\\sqrt{ }$ facet involvement with subluxation\n5. Tendon rupture\n6. Crystal deposition disease\n\nType: calcium hydroxyapatite, CPPD, calcium oxalate, monosodium urate\n7. Osteomyelitis + septic arthritis\n8. Avascular necrosis (in up to $40 \\%$ )\n\n## DIABETES INSIPIDUS\n\n$=$ characterized by daily production of very large volume of dilute urine (specific gravity $<$ $1.005,<200 \\mathrm{mOsm} / \\mathrm{L})$\n\n## Pituitary Diabetes Insipidus\n\n$=$ HYPOTHALAMIC DIABETES INSIPIDUS\n$=$ VASOPRESSIN-SENSITIVE DIABETES INSIPIDUS\n$=$ vasopressin $(\\mathrm{ADH})$ production is reduced to $<10 \\%$\nCause:\nA. IDIOPATHIC $(27 \\%)$\nseptooptic dysplasia / rare familial (autosomal dominant X-linked) / sporadic disorder\nHisto: atrophic supraoptic nucleus\n\n- never associated with anterior pituitary dysfunction\nB. PITUITARY DESTRUCTION BY TUMOR / INFILTRATIVE DISORDER (32\\%):\nin childhood: hypothalamic glioma, tuber cinereum hamartoma, craniopharyngioma, Langerhans histiocytosis, germinoma, leukemia, complication of meningitis\nin adulthood: sarcoidosis, TB, metastasis\n- in $60 \\%$ associated with anterior pituitary dysfunction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 938,
            "markdown": "C. PITUITARY DESTRUCTION BY SURGERY (20\\%)\n\n- always associated with anterior pituitary dysfunction\nD. HEAD INJURY (17\\%)\n- in $20 \\%$ associated with anterior pituitary dysfunction\n$\\diamond$ A lesion in the posterior pituitary will NOT produce diabetes insipidus, because it is simply the storage space for vasopressin\n\n\n# Psychogenic Water Intoxication \n\n$=$ compulsive intake of large amounts of fluid $\\rightarrow$ inhibits normal vasopressin production\n\n- water deprivation test\n\n\n## Nephrogenic Diabetes Insipidus\n\n$=$ poor reabsorption of water in collecting ducts $\\leftarrow$ end-organ resistance to vasopressin\nCause:\nA. CONGENITAL\n\n1. Rare X-linked recessive genetic disorder with unresponsiveness of tubules + collecting system to vasopressin (in infants + young males) with variable expression\n2. Autosomal dominant form (rare)\nB. ACQUIRED = nephrogenic DI syndrome\n$=$ disorders affecting the medulla / distal nephrons:\nmedullary + polycystic disease, sickle cell nephropathy, postobstructive uropathy, reflux nephropathy, chronic uremic nephropathy, unilateral renal artery stenosis, acute tubular necrosis, drug toxicity, analgesic nephropathy, hypokalemic + hypercalcemic nephropathy, amyloidosis, sarcoidosis\n\n- symptoms in infancy:\n- vomiting $\\leftarrow$ hypernatremic dehydration\n- mental retardation\n- caloric growth failure $\\leftarrow$ water favored over formula\n- symptoms after infancy:\n- increased fluid intake; avoiding urination\n$\\sqrt{ }$ bilateral hydroureteronephrosis\n$R x$ : thiazide diuretics, low-salt diet, encouragement of frequent micturition, indomethacin\n\n\n## PRIMARY ALDOSTERONISM\n\n$=$ inappropriate autonomous hypersecretion of aldosterone WITHOUT activation of renin-angiotensin-aldosterone axis\nFrequency: $5-15 \\%$ of unselected hypertensive patients\n$\\diamond$ Most common cause of secondary hypertension!\nBiochemistry: mineralocorticoid production in zona glomerulosa\nCause: (main role of radiology)\n(1) Aldosterone-producing adenoma (APA) 33-66\\%)\n\nAge: often found in patients $<40$ years\nSize: $<2 \\mathrm{~cm}$ (usually)\n$R x$ : adrenalectomy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 939,
            "markdown": "(2) Bilateral adrenal hyperplasia (BAH) 33-66\\%\n\nAge: often found in older patients $>40$ years\n$\\checkmark$ enlargement of both adrenal glands\nRx: aldosterone antagonists (eplerenone)\n(3) Unilateral adrenal hyperplasia $<1 \\%$\n\nRx: adrenalectomy\n(4) Adrenal carcinoma rare\n(5) Type 1 familial hyperaldosteronism rare\n(5) Type 2 familial hyperaldosteronism rare\n\n- hypertension\n- hyperaldosteronism, suppressed renin, hypernatremia\n- abnormal aldosterone $(\\uparrow)$-renin $(\\downarrow)$ ratio, metabolic alkalosis\n- failure to suppress plasma aldosterone levels by oral salt-loading / IV administration of saline solution / fluorocortisone\nCT ( $40-100 \\%$ sensitive) \\& MR ( $70-100 \\%$ sensitive):\n$\\checkmark$ small adrenal nodule:\n$\\checkmark$ macronodule $>10 \\mathrm{~mm}$\n$\\checkmark$ micronodule $<10 \\mathrm{~mm}$\n$\\checkmark$ mean adrenal limb width $\\geq 5 \\mathrm{~mm}=\\mathrm{BAH}$\nAdrenal vein sampling:\n$=$ blood samples taken from IVC + both adrenal veins during infusion of adrenocorticotropic hormone\n$\\checkmark$ cortisol ratio of adrenal vein $+\\mathrm{IVC}>2 \\div 1$\n$\\checkmark$ lateralization ratio $=$ adrenal vein $\\div$ adrenal vein:\n$\\checkmark>4=$ aldosterone hypersecretion\n$\\checkmark<3=\\mathrm{BAH}$\nNUC ( ${ }^{131}$ Iodine-6- $\\beta$-iodomethylnorcholesterol $=$ NP-59 or Selenium-75-6- $\\beta$ selenomethylcholesterol):\n> dexamethasone depression increases sensitivity\n$\\checkmark$ unilateral early uptake $<5$ days $=$ APA\n$\\checkmark$ symmetric early uptake $<5$ days $=\\mathrm{BAH}$\n$\\checkmark$ symmetric late uptake $>5$ days $=$ normal\n\n\n# HYPERCALCEMIA \n\nmnemonic: SHAMPOO DIRT\nSarcoidosis\nHyperparathyroidism, Hyperthyroidism\nAlkali-milk syndrome\nMetastases, Myeloma\nPaget disease\nOsteogenesis imperfecta\nOsteopetrosis\nD vitamin intoxication\nImmobility",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 940,
            "markdown": "Renal tubular acidosis\nThiazides\n\n# POLYCYTHEMIA \n\nCause: increased level of erythropoietin (acting on erythroid stem cells) $\\leftarrow$ decrease in pO2; erythropoietin precursor is produced in juxtaglomerular epithelioid cells of kidney + converted in blood\nA. RENAL\n(a) intrarenal\n\n1. Vascular impairment\n2. Renal cell carcinoma (5\\%)\n3. Wilms tumor\n4. Benign fibroma\n5. Simple cyst (14\\%)\n6. Polycystic kidney disease\n(b) postrenal\n7. Obstructive uropathy (14\\%)\nB. EXTRARENAL\n(a) liver disease\n8. Hepatoma\n9. Regenerating hepatic cells\n(b) adrenal disease\n10. Pheochromocytoma\n11. Aldosteronoma\n12. Cushing disease\nC. CNS DISEASE\n13. Cerebellar hemangioblastoma\nD. LARGE UTERINE MYOMAS\n\nPertinent negatives: NOT in renal vein thrombosis, multicystic dysplastic kidney, medullary sponge kidney\n\n## ARTERIAL HYPERTENSION\n\nA. PRIMARY / ESSENTIAL HYPERTENSION (85-90\\%)\nB. SECONDARY HYPERTENSION\n(a) Renal parenchymal disease (5-10\\%)\n(b) Potentially curable secondary hypertension (1-2\\%)\n$>$ vascular\n\n1. Renovascular disease $0.18-4.4 \\%$\n2. Coarctation $0.6 \\%$\n> hormonal\n3. Pheochromocytoma $0.04-0.2 \\%$\n4. Cushing syndrome $0.3 \\%$\n5. Primary aldosteronism $0.01-0.4 \\%$\n6. Hyperthyroidism",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 941,
            "markdown": "5. Myxedema\n> renal\n6. Unilateral renal disease\n\n# Renovascular Hypertension \n\n$=$ normalization of blood pressure following nephrectomy / reestablishment of normal renal blood flow (Diagnosis made in retrospect)\nPrevalence: $1-5 \\%$ of general population; $2^{\\text {nd }}$ most common cause of potentially curable hypertension\nPathophysiology:\nusually $>50 \\%$ stenosis at any level in renovascular bed $\\rightarrow$ mildly reduced pressure in glomerular afferent arteriole (pressure falls precipitously in $>80 \\%$ stenosis); reduced pressure $\\rightarrow$ stimulates release of renin $\\rightarrow$ followed by angiotensin-II and aldosterone causing\n(a) constriction of efferent glomerular arterioles\n(b) increase in systemic hypertension\n(c) sodium retention\n\nCause:\n\n1. Atherosclerosis ( $60-90 \\%$ ) in individuals $>50$ years\n2. Fibromuscular dysplasia ( $10-35 \\%$ ) in women $<40$ years\n3. Neurofibromatosis\n4. Pheochromocytoma\n5. Fibrous bands: congenital stenosis, retroperitoneal fibrosis, postradiation artery stenosis\n6. Arteritis: Buerger disease, polyarteritis nodosa, Takayasu disease, thrombangiitis obliterans, syphilitic arteritis\n7. Arteriovenous malformation / fistula\n\n- renin-mediated hypertension $\\leftarrow$ renal ischemia distal to fistula\n\n8. Thromboembolic disease: eg, atrial fibrillation, prosthetic valve thrombi, cardiac myxoma, paradoxical emboli, atheromatous emboli\n9. Renal artery aneurysm\n10. Extrinsic compression: eg, renal cyst, neoplasm, chronic subcapsular hematoma (= Page kidney)\n11. Middle aortic syndrome, aortic dissection, dissecting aortic aneurysm\n12. Posttraumatic renovascular hypertension\n(a) occlusion of main renal artery\n(b) significant stenosis by intimal flap\n(c) severe renal contusion\n(d) segmental renal artery branch injury\n$\\diamond$ Renal artery stenosis in $77 \\%$ of hypertensive patients!\n$\\diamond$ Renal artery stenosis in $32-49 \\%$ of normotensive patients!\n$\\diamond$ After restoration of normal renal blood flow $15-20 \\%$ of patients remain hypertensive!\nClinical findings that suggest renovascular disease:\n13. Onset of $\\mathrm{HTN}<30$ years and $>50$ years of age",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 942,
            "markdown": "2. Hypertension refractory to therapy\n3. Accelerated / malignant hypertension\n4. Unexplained large increases in blood pressure above previously controlled / baseline values\n5. Symptomatic hypertension\n\nRx: (1) Relieving renal artery stenosis\n(2) Angiotensin-converting enzyme inhibitor\n\n# Hypertension in Children \n\nPrevalence: $1-3 \\%$\n\n1. Coarse renal cortex scarring $36 \\%$\n2. Glomerulonephritis $23 \\%$\n3. Coarctation of aorta $10 \\%$\n4. Renovascular disease $10 \\%$\n5. Polycystic renal disease $6 \\%$\n6. Hemolytic-uremic syndrome $4 \\%$\n7. Catecholamine excess: pheochromocytoma, neuroblastoma 3\\%\n8. Renal tumor $2 \\%$\n9. Essential hypertension $3 \\%$\n\n## Renin Elevation\n\n1. Juxtaglomerular cell tumor\n2. Wilms tumor\n3. Hypernephroma\n4. Lung cancer\n5. Paraovarian tumor\n6. Fallopian tube adenocarcinoma\n7. Epithelial liver hamartoma\n8. Orbital hemangiopericytoma\n9. Pancreatic cancer\n10. Angiolymphoid hyperplasia\n\n## ARTERIAL HYPOTENSION\n\nCause: intrarenal hypovolemia, primary vasoconstriction, reduced glomerular filtration, depletion of intratubular urine volume\n$\\diamond$ May occur as a contrast reaction!\n$\\diamond$ Urogram reverts to normal after reversion of hypotension!\n$\\sqrt{ }$ bilateral small smooth kidneys (compared with size on preliminary films)\n$\\sqrt{ }$ increasingly dense nephrogram\n$\\checkmark$ usually NO opacification of collecting system\n$\\checkmark$ initially opacification of collecting system if hypotension occurs during contrast injection\n\n## URINARY TRACT INFECTION\n\n$=$ pure growths of $>100,000$ organisms $/ \\mathrm{mL}$ urine",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 943,
            "markdown": "Prevalence: $3 \\%$ of girls $+1 \\%$ of boys during first 10 years of life\nUnderlying radiologic abnormality:\n\n1. Vesicoureteral reflux $=$ VUR $(30-40 \\%)$\n2. Obstructive uropathy $(8 \\%)$\n3. Reflux nephropathy / scar formation (6\\%)\n$\\diamond$ The prevalence of an underlying radiologic abnormality depends on age, sex, and frequency of previous infections!\nImaging objective:\n4. Identify patients at risk for reflux nephropathy\n5. Detect reflux nephropathy / scars\n6. Detect obstructive uropathy\n7. Minimize radiation, morbidity, and cost\n\nVCUG:\nfor children $<5$ years of age with infection; normal results in $60-70 \\%$\nRenal cortical scintigraphy (DMSA / glucoheptonate): to detect acute pyelonephritis (risk for scarring) / scar; VUR poses twice the risk of cortical defects than without VUR\n\n# CILIOPATHY \n\n$=$ DISORDER OF PRIMARY CILIA (cilia line ducts of kidney + liver and are integral to proper renal + hepatic development\n\n1. Autosomal recessive polycystic kidney disease\n2. Autosomal dominant polycystic kidney disease\n3. Medullary cystic disease\n4. Multicystic kidney disease\n5. Meckel-Gruber syndrome\n6. Joubert syndrome\n7. Orodigitofacial syndrome\n8. Asphyxiating thoracic dysplasia\n9. Chondroectodermal dysplasia\n10. Short-rib polydactyly syndrome\n11. Sensenbrenner syndrome (cranioectodermal dysplasia)\n12. Weyers acrofacial dysostosis (nail anomalies, polydactyly, oral-facial defects)\n\n## GAS IN URINARY TRACT\n\nA. RENALEMPHYSEMA $=$ renal / perirenal gas\n\n1. Emphysematous pyelonephritis\n2. Emphysematous pyelitis\n3. Gas-forming perinephric abscess\n4. Perinephric emphysema\nB. BLADDER\n5. Emphysematous cystitis\nC. TRAUMA\n6. Penetrating trauma\n7. Ureterosigmoidostomy, ileal conduit, catheterization with vesicoureteral reflux,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 944,
            "markdown": "percutaneous procedure\nCAVE: anomalous posterior position of colon\n3. Infarction of renal carcinoma: therapeutic / spontaneous\nD. FISTULA TO URINARY TRACT\n\nConnection: bronchus / cutis / GI tract (colon $>$ duodenum $>$ stomach $>$ small bowel $>$ appendix)\n\n1. Inflammation: chronic purulent renal infection, diverticulitis, Crohn disease\n2. Neoplastic: colonic carcinoma\n\n# RETROPERITONEUM \n\n$70-80 \\%$ of primary retroperitoneal neoplasms are malignant accounting for $0.1-0.2 \\%$ of all malignancies in the body.\n\n## Primary Malignant Tumor of Retroperitoneum\n\n1. Lymphoma most common retroperitoneal malignancy (33\\%)\n2. Retroperitoneal liposarcoma most common primary retroperitoneal sarcoma (33\\%)\n$\\sqrt{ }$ contrast enhancement of thick irregular nodular septa\n3. Leiomyosarcoma\n$2^{\\text {nd }}$ most common primary retroperitoneal sarcoma (28\\%)\nA retroperitoneal mass with extensive necrosis and contiguous involvement of a vessel is highly suggestive of a leiomyosarcoma.\n4. Malignant fibrous histiocytoma $3^{\\text {rd }}$ most common primary retroperitoneal sarcoma $(19 \\%)$\n$\\sqrt{ }$ dystrophic calcifications in $25 \\%$\n\n## Mantle-like Soft-tissue Mass Surrounding Aorta\n\n1. Lymphoma\n$\\checkmark$ homogeneous mass with irregular lobular margins\n$\\checkmark$ \"floating aorta\" sign (= anterior displacement of aorta)\n2. Retroperitoneal fibrosis\n$\\checkmark$ tethering of ureters + IVC\n3. Erdheim-Chester disease\n$\\checkmark$ perinephric fibrosis + bone lesions\n\n## Cystic Retroperitoneal Masses\n\nA. NEOPLASTIC\n\n1. Cystic degeneration of solid neoplasm:\n> paraganglioma\n> schwannoma (neurilemmoma)\n» ancient schwannoma\n> leiomyosarcoma\n2. Cystic teratoma\n3. Retroperitoneal lymphangioma ( $1 \\%$ of all retroperitoneal neoplasms)\n4. Lymphangiomatosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 945,
            "markdown": "5. Lymphangiomyomatosis\n6. Cystadenoma / cystadenocarcinoma: mucinous / serous\n7. Cystic mesothelioma\nB. CYSTS:\n8. Müllerian cyst\n\n- obese woman under hormonal replacement therapy\n\n2. Epidermoid cyst\n\nLocation: midline presacral\n$\\checkmark$ unilocular\n3. Tailgut cyst\n4. Pseudocyst\n\n- Hx of acute pancreatitis, elevated amylase level\nC. NONNEOPLASTIC: hematoma, urinoma, lymphocele\n\n\n# Cystic Mass with Areas of Solid Enhancement \n\n1. Myxoid liposarcoma\n2. Schwannoma\n3. Neurofibroma\n\nNeurogenic tumors are common along sympathetic ganglia in the paraspinal region and in adrenal medulla / organ of Zuckerkandl (paraaortic bodies). Less commonly neurogenic tumors occur in urinary bladder, abdominal wall, bowel wall, or gallbladder.\n\n## Cystic Mass with Slowly Progressive Enhancement\n\n1. Lymphangioleiomyoma\n2. Urinoma\n\n## Low-density Retroperitoneal Mass\n\n1. Lipoma\n$\\checkmark$ sharply marginated, homogeneously fatty mass\n2. Lymphangioma\n$\\checkmark$ similar to lipoma if enough fat content\n3. Renal angiomyolipoma\n4. Adrenal myelolipoma\n5. Xanthogranulomatous pyelonephritis\n6. Metastatic retroperitoneal tumors\n7. Renal cell carcinoma\n8. Fibrosarcoma, fibrous histiocytoma, mesenchymal sarcoma, malignant teratoma\n$\\checkmark$ density close to muscle\n9. Retroperitoneal liposarcoma\n10. Lipoblastoma\n11. Hibernoma\n\n## Fat-containing Presacral Mass\n\n1. Lipoma\n2. Lipomatosis\n3. Liposarcoma: infiltrative growth",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 946,
            "markdown": "# 4. Teratoma: younger individual \n\n5. Myelolipoma: elderly patient\n\nThe differentiation of presacral myelolipoma from other fat-containing lesions may not always be possible with imaging alone.\n\n## Heterogeneous Fat-containing Retroperitoneal Mass\n\n1. Dedifferentiated Liposarcoma\n2. Myelolipoma\n$\\sqrt{ }$ positive for erythroid elements on ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-sulfur colloid\n3. Angiomyolipoma\n\n| Classification of Solid Retroperitoneal Masses by Tissue Component |  |  |\n| :--: | :--: | :--: |\n| Description | Benign | Malignant |\n| Hematologic / lymphoid |  | most common retroperitoneal malignancy |\n|  |  | lymphoma, posttransplant lymphoproliferative disease, extramedullary plasmacytoma |\n| Mesodermal |  | $0.1-0.2 \\%$ of all malignancies |\n| adipose tissue | lipoma, pelvic lipomatosis, hibernoma, myelolipoma, angiomyolipoma <br> $\\diamond$ The deeper + more centrally located a fatty mass resides the more likely it is malignant! | liposarcoma, myxoid liposarcoma, lipoblastoma |\n| connective tissue | fibroma | malignant fibrous histiocytoma, fibrosarcoma, chondrosarcoma, synovial cell sarcoma |\n| smooth muscle | leiomyoma | leiomyosarcoma |\n| striated muscle | rhabdomyoma | rhabdomyosarcoma |\n| blood vessels | hemangioma, hemangiopericytoma | angiosarcoma |\n| perivascular epithelioid cells | perivascular epithelioid cell tumor (PEcoma): angiomyolipoma, lymphangioleiomyomatosis, clear cell \"sugar\" tumor, clear cell myomelanocytic tumor, pigmented melanotic tumor | malignant pericytoma, sarcoma of perivascular cells |\n| interstitial cells of Cajal | GIST |  |\n| primitive mesenchyme | myxoma | myxosarcoma, malignant mesenchymoma |\n| notochordal remnant | chordoma |  |\n| miscellaneous | fibromatosis, desmoid tumor, angiomyofibroblastoma, xanthogranuloma |  |\n| Neurogenic |  |  |\n| nerve sheath | schwannoma, neurofibroma, neurofibromatosis | malignant peripheral nerve sheath tumor, neurogenic sarcoma, neurofibrosarcoma |\n| sympathetic ganglionic cells | ganglioneuroma, ganglioneuroblastoma | neuroblastoma |\n| chromaffin tissue $=$ paraganglionic cells | paraganglioma, pheochromocytoma | malignant paraganglioma / pheochromocytoma |\n| Germ cell, sex cord |  |  |\n| germ cell | mature teratoma, immature teratoma | seminoma, malignant teratoma, embryonal carcinoma, yolk sac tumor, choriocarcinoma, mixed germ cell tumor |\n| sex cord stromal | granulosa cell tumor, thecoma, Sertoli-Leydig cell tumor |  |\n\n## Vascular Retroperitoneal Mass\n\n## A. INFLAMMATORY\n\n## B. LYMPHOPROLIFERATIVE\n\n1. Lymphoma\n2. Unicentric Castleman disease",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 947,
            "markdown": "# C. MESENCHYMAL TUMOR \n\n1. Sarcoma\n2. Solitary fibrous tumor\n3. Leiomyoma\n4. GIST\n5. Hemangiopericytoma\n6. Congenital pelvic AVM\nD. OTHERS\n7. Carcinoid\n8. Retroperitoneal paraganglioma\n\n## Calcified Retroperitoneal Mass\n\nA. NONTUMORAL\n\n1. Exuberant callus formation\n2. Posttraumatic calcified hematoma\n3. Myositis ossificans\n4. Foreign body granuloma\n5. Encapsulated textiloma / gossypiboma\n(gossypium, Latin = cotton)\nCause: retained surgical sponge, gauze, towel\nB. BENIGN NEOPLASM\n6. Ganglioneuroma\n7. Schwannoma\n8. Paraganglioma\n9. Hemangioma\n10. Mature teratoma\nC. MALIGNANT NEOPLASM\n11. Malignant fibrous histiocytoma\n12. Dedifferentiated liposarcoma\n13. Leiomyosarcoma\n14. Malignant mesenchymoma\n15. Malignant teratoma\n16. Extraskeletal osteosarcoma\n17. Chondrosarcoma\n18. Ewing sarcoma\n\n## Retroperitoneal Fluid\n\n1. Traumatic injury to: pancreas, duodenum, renal collecting system\n2. Retroperitoneal hemorrhage\n3. Hypoperfusion shock complex\n4. Abdominal compartment syndrome\n5. Resuscitation effect\n\n## Disorders of Perirenal Space\n\nA. PRIMARY LESION",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 948,
            "markdown": "(a) benign\n\n1. Extramedullary hematopoiesis\n2. Extraadrenal myelolipoma\n3. Castleman disease\n4. Erdheim-Chester disease\n(b) malignant\n5. Lymphoma / leukemia\n6. Metastasis (lung)\nB. RENAL LESION WITH EXTENSION\n(a) benign\n7. Angiomyolipoma\n8. Xanthogranulomatous pyelonephritis\n9. Leiomyoma\n10. Hemangioma\n11. Lymphangioma\n(b) malignant\n12. Renal cell carcinoma\nC. RETROPERITONEAL LESION WITH EXTENSION\n(a) BENIGN\n13. Retroperitoneal fibrosis\n(b) MALIGNANT\n14. Lymphoma / leukemia\n15. Metastatic lymphadenopathy\n16. Malignant fibrous histiocytoma\n17. Liposarcoma\n18. Plasma cell neoplasm\n\n# Solitary Perirenal Mass \n\nA. benign\n\n1. XGP\n2. Castleman disease\n3. Hemangioma\n4. Leiomyoma\nB. malignant\n5. RCC\n6. Malignant fibrous histiocytoma\n7. Lymphoma / leukemia\nC. BORDERLINE\n8. Hemangiopericytoma\n9. GIST\n\n## Rindlike Perirenal Mass\n\n1. Lymphoma\n2. Retroperitoneal fibrosis\n3. Erdheim-Chester disease",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 949,
            "markdown": "# Multiple Perirenal Masses \n\n1. Metastases: malignant melanoma; cancer of lung, breast, prostate\n2. Plasma cell neoplasm: multiple myeloma, plasmacytoma, plasma cell leukemia\n\n## Fat-containing Perirenal Mass\n\n1. Angiomyolipoma\n2. Retroperitoneal liposarcoma\n3. Extramedullary hematopoiesis\n4. Extraadrenal myelolipoma\n\n## ADRENAL GLAND\n\n## Functioning Adrenal Mass\n\n1. Cushing syndrome and Cushing disease\n2. Primary aldosteronism\n3. Pheochromocytoma\n\n## Adrenal Medullary Disease\n\n1. Neuroblastoma\n2. Ganglioneuroblastoma\n3. Ganglioneuroma\n4. Pheochromocytoma\n\n## Adrenal Cortical Disease\n\n1. Adrenocortical hyperplasia\n2. Adrenocortical adenoma\n3. Adrenocortical carcinoma\n4. Cushing syndrome\n5. Conn syndrome\n6. Adrenogenital syndromes\n\n## Adrenocortical Hyperfunction\n\n1. Adrenogenital syndrome\n2. Conn syndrome $=$ hyperaldosteronism\n3. Cushing syndrome $=$ hypercortisolism\n\n## Bilateral Adrenal Masses\n\n1. Metastases $(50 \\%)$\n2. Lymphoma ( $50 \\%$ of secondary lymphomas, $50 \\%$ bilateral)\n3. Adenoma $(20 \\%)$\n4. Pheochromocytoma ( $10 \\%$ )\n5. Myelolipoma (5-13\\%)\n6. Adrenocortical carcinoma (2-6\\%)\n7. Hemorrhage\n8. Granulomatous infection (usually bilaterally asymmetric)\n9. Hyperplasia (usually bilaterally symmetric)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 950,
            "markdown": "mnemonic: 4 H PM\nHodgkin disease\nHyperplasia\nHemorrhage\nHistoplasmosis / TB\nPheochromocytoma\nMetastasis\n\n# Granulomatous Disease \n\nOrganism: tuberculosis, histoplasmosis, blastomycosis\n$\\checkmark$ usually bilateral homogeneous adrenal enlargement in acute phase\n$\\checkmark$ sometimes cystic / calcified adrenals in chronic phase\nCx: tuberculous adrenal atrophy $\\rightarrow$ adrenal hypofunction $\\rightarrow$ Addison disease\n\n## Incidental Unilateral Adrenal Mass = Incidentaloma\n\n$=$ incidental discovery of a clinically silent adrenal mass of $>10 \\mathrm{~mm}$ in a patient without known cancer\nPrevalence: $4-9 \\%$ of all CT exams (in $0.2 \\%$ of patients $20-29$ years, in $7 \\%$ of elderly); 1.0$4.2 \\%$ of population\nConcern for: primary adrenal cortical carcinoma, metastasis, Cushing disease, pheochromocytoma, aldosteronoma versus nonfunctioning adenoma\n$\\diamond$ With a Hx of malignancy an adrenal nodule is a metastasis in merely 26$36 \\%$ !\n$\\diamond 97-98 \\%$ of incidentalomas are benign and insignificant!\n$\\diamond$ Most adenomas can be accurately characterized by NECT + MR $\\pm$ CECT\n$\\diamond$ Follow-up imaging has a limited role\n$\\diamond$ Biopsy only if CT + MR do NOT indicate adenoma / PET-CT suggests metastasis\nmnemonic: PLAN My HAM\nPheochromocytoma (6\\%)\nLymphoma\nAdenoma ( $71 \\%$ ): functioning ( $1 \\%$ )\nNeuroblastoma\nMyelolipoma\nHemorrhage\nAdenocarcinoma (4\\%)\nMetastasis (2-3\\%)\n\n## Bilaterality of Adrenal Incidentaloma\n\nFrequency: in $<30 \\%$ of adenomas\n$D D x$ : metastasis, lymphoma, infection, hyperplasia, hemorrhage\n\n## Morphologic Criteria of Adrenal Incidentaloma\n\n(a) Size of lesion (too unreliable as only criterion)\n\nPrinciple: Larger lesions are more likely malignant and more likely symptomatic!\n> with known malignancy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 951,
            "markdown": "$<3 \\mathrm{~cm}: 87 \\%$ are benign\n$>3 \\mathrm{~cm}: 95 \\%$ are malignant\n> without known malignancy\n$>4 \\mathrm{~cm}: 70 \\%$ are malignant\n$>6 \\mathrm{~cm}: 85 \\%$ are malignant\n$R x:$ excision for incidentaloma $>5 \\mathrm{~cm}$\n(b) Change in size\n$\\diamond$ Any increase in size after 6 months can be considered malignant!\nCAVE: rare adenomas + myelolipomas can slightly increase in size\n(c) Margin of lesion\n$\\diamond$ Irregular borders usually indicate malignancy!\n$\\diamond$ Multinodularity is usually benign!\n(d) Internal texture\n$\\diamond$ Large necrotic areas signify malignancy\n$\\diamond$ Small metastases are often homogeneous\nProblematic features of any adrenal mass: diffusely heterogeneous attenuation / focal areas of low attenuation / thickened wall\n\n# LIPID-SENSITIVE IMAGING OF AdRENAL INCIDENTALOMA \n\nPrinciple: a benign adrenal mass contains intracytoplasmic fat, a malignancy does not Substrate: cholesterol, fatty acids, neutral fat\nDistribution: $70 \\%$ of adenomas are lipid-rich; $30 \\%$ of adenomas are lipid-poor + indeterminate\nNECT attenuation $\\left(\\mathrm{HU}_{\\text {NECT }}\\right)$ :\n$\\diamond$ dependent on scanner type + scanning technique!\nROI: in center of mass covering at least $50 \\%$ of cross-sectional area\n$\\leq 10 \\mathrm{HU}_{\\text {NECT }}=$ benign lipid-rich adenoma / cyst\n$>10 \\mathrm{HU}_{\\text {NECT }}=$ indeterminate / lipid-poor adenoma\nSensitivity for adenomas: $56-71 \\%$\nSpecificity for adenomas: $98 \\%$\nFalse-positive rate: $4 \\%$\nFor all practical purposes $\\mathrm{a}<3 \\mathrm{~cm}$ homogeneous lesion that measures $\\leq 10 \\mathrm{HU}$ at NECT is an adrenocortical adenoma!\nCT histogram for NECT / CECT:\n$\\sqrt{ }>10 \\%$ of pixel count below 0 HU indicates adenoma (sensitivity of $71 \\%$ for NECT, $12 \\%$ for CECT)\nChemical shift imaging MR (CSI):\nPhysics: fat protons precess at lower frequency than water protons\nUseful: if lesion $<30 \\mathrm{HU}$ on NECT\n(a) qualitatively (and effective):\n$\\sqrt{ }$ fat + water summate to intermediate SI on in-phase images\n$\\sqrt{ }$ fat + water signals cancel each other out to a low signal intensity on out-ofphase images\n\nMost adenomas show a significant decrease in signal intensity on the out-of-phase images!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 952,
            "markdown": "(b) quantitative method (rarely used in practice)\n$\\sqrt{ }$ adrenal-to-spleen SI ratio (SIR) $<0.71$\nSIR $=\\mathrm{SIR}_{\\text {in-phase }}+\\mathrm{SIR}_{\\text {opposed-phase }}$\n$\\sqrt{ }$ signal intensity index (SII) $>16.5 \\%$\nSII $=\\left(\\mathrm{SI}_{\\text {in-phase }}-\\mathrm{SI}_{\\text {opposed-phase }}\\right)+\\mathrm{Slin}$-phase x 100\nResults: on average $67 \\%$ of all indeterminate adrenal adenomas $>10 \\mathrm{HU}$ are lipid rich on CSI:\n$100 \\%$ of adenomas measuring $10-20 \\mathrm{HU}$\n$75 \\%$ of adenomas measuring $20-30 \\mathrm{HU}$\n$13 \\%$ of adenomas measuring $\\geq 30 \\mathrm{HU}$\nIndeterminate: lipid-poor adenomas with low lipid-to-water proton ratio per voxel\n\n# Perfusion Imaging of AdRenal Incidentaloma by CT \n\n$=$ CT washout scan (most effective test)\nPrinciple: malignant vessels have an increased capillary permeability with prolonged retention of contrast material\nInput values:\n» 60 -second scan $\\left(\\mathrm{HU}_{\\text {CECT } 1 \\text { min }}\\right)$\n» 15 -minute delayed scan $\\left(\\mathrm{HU}_{\\text {CECT } 15 \\text { min }}\\right)$\n» $\\pm$ precontrast CT $\\left(\\mathrm{HU}_{\\text {NECT }}\\right)$\n(a) Relative Percentage Washout (RPW) (if unenhanced CT not available)\n$=\\left[\\mathrm{HU}_{\\text {CECT } 1 \\text { min }}-\\mathrm{HU}_{\\text {CECT } 15 \\text { min }}\\right] /\\left[\\mathrm{HU}_{\\text {CECT } 1 \\text { min }}\\right] \\cdot 100 \\%$\nwashout $>60 \\%=$ lipid-poor adenoma\nwashout $\\leq 60 \\%=$ indeterminate mass\nResults: $96 \\%$ sensitive $+100 \\%$ specific\n\n| Absolute and Relative Washout of Adrenal Masses |  |  |\n| :--: | :--: | :--: |\n|  |  |  |\n| S/olar DH et al.: Radiology 2005; 234:479-485 |  |  |\n| Adrenal Mass | Absolute <br> Washout [\\%] | Relative <br> Washout [\\%] |\n| Adenoma | $62 \\pm 17$ | $108 \\pm 87$ |\n| Adrenocortical carcinoma | $34 \\pm 9$ | $13 \\pm 12$ |\n| Pheochromocytoma | $22 \\pm 12$ | $14 \\pm 7$ |\n| Metastasis | $31 \\pm 16$ | $19 \\pm 11$ |\n\n(b) Absolute Percentage Washout (APW) (if unenhanced CT available)\n$=[\\mathrm{HUCECT} 1 \\mathrm{~min}-\\mathrm{HUCECT} 15 \\mathrm{~min}] /[\\mathrm{HUCECT} 1 \\mathrm{~min}-\\mathrm{HUNECT}] \\cdot 100 \\%$\nwashout $>40 \\%=$ lipid-poor adenoma\nwashout $\\leq 40 \\%=$ indeterminate mass\nResults: $88 \\%$ sensitive $+96 \\%$ specific\nLesions with RPW of $<40 \\% / \\mathrm{APW}$ of $<60 \\%$ are almost always malignant!\n$\\diamond$ A mass with absolute enhancement $>110-120 \\mathrm{HU}+\\mathrm{APW}$ of $>60 \\%+\\mathrm{RPW}$ of $>40 \\%$ suggests a pheochromocytoma\n\n## Functional Imaging with 18F-FDG PET\n\nPrinciple: FDG trapped intracellularly by metabolically active malignant lesion",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 953,
            "markdown": "Use: modality of choice in known malignancy\n$\\diamond 50 \\%$ of incidentalomas in cancer patients represent metastatic disease!\nInternal reference organ: liver\nSUV: $>4$ for metastatic disease $\\leftarrow$ lung, colon, melanoma, lymphoma\n$F N$ : pulmonary carcinoid, lung cancer with strong bronchioloalveolar component, hemorrhagic / necrotic tumor, lesion $<10 \\mathrm{~mm}$ in size\nFP: $\\quad 5 \\%$ of adrenal adenomas, pheochromocytoma, adrenal endothelial cyst, inflammation, infection\nResults: 93-100\\% sensitive, $80-100 \\%$ specific, $99 \\%$ accurate\n\n# ENDOCRINOLOGIC FUNCTION TEST IN INCIDENTALOMA \n\nUse: recommended for lesions $>4 \\mathrm{~cm}$\nFrequency: $6 \\%$\nYield:\n$>94 \\%$ nonfunctioning adrenal adenoma\n$>6 \\%$ functioning adrenal adenoma\n» cortisol production $(5 \\%) \\rightarrow$ Cushing syndrome\n» aldosterone $(<2 \\%) \\rightarrow$ Conn syndrome\n» catecholamines $\\rightarrow$ pheochromocytoma\n» sex hormone ( $1 \\%$ )\n\n## AdRENAL BIOPSY\n\nIndication: inconclusive / contradictory adrenal imaging with high clinical suspicion for metastasis from an underlying extraadrenal malignancy\nDiagnostic accuracy: 83-96\\%\nInsufficient material: $4-19 \\%$\nCx: bleeding, pneumothorax, infection, tumor tracking in $8-12 \\%$\nN.B.: several deaths reported after Bx of pheochromocytoma\n\n## Adrenal Mass with specific CT Attenuation\n\n1. Acute hemorrhage: $50-90 \\mathrm{HU}$\n2. Adrenal myelolipoma: fat attenuation\n3. Adrenal cyst: fluid attenuation\n\n## Fat-containing Adrenal Mass\n\n(a) intracellular fat $\\rightarrow$ SI loss on out-of-phase images\n\n1. Adrenal adenoma\n(b) macroscopic fat $\\rightarrow$ SI loss on fat-saturated images\n2. Myelolipoma\n\n## Adrenal Mass with Small Foci of Fat\n\n$\\diamond$ Not every adrenal mass with a small amount of fat is a myelolipoma!\n\n1. Myelolipoma\n2. Adrenocortical adenoma with myelolipomatous changes\n3. Adrenocortical carcinoma\n4. Pheochromocytoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 954,
            "markdown": "# Small Unilateral Adrenal Tumor \n\n1. Cortical adenoma (in $1-9 \\%$ of autopsies)\n$\\sqrt{ }<10 \\mathrm{HU}$ imply an adenoma (in $96 \\%$ )\n2. Metastasis\n3. Pheochromocytoma\n4. Asymmetric hyperplasia\n5. Granulomatous disease (TB, histoplasmosis)\n$\\sqrt{ }$ diffuse enlargement / discrete mass\n$\\sqrt{ } \\pm$ central cystic changes $\\pm$ calcification\n6. Myelolipoma\n\n## Large Solid Adrenal Mass\n\nLarge tumors $\\geq 6 \\mathrm{~cm}$ are highly suspicious for malignancy!\n\n1. Adrenocortical carcinoma\n2. Pheochromocytoma\n3. Neuroblastoma / ganglioneuroma\n4. Myelolipoma\n5. Metastasis\n6. Hemorrhage\n7. Inflammation\n8. Abscess (eg, histoplasmosis, tuberculosis)\n9. Hemangioma\n\n## Malignant Adrenal Mass\n\n1. Adrenocortical carcinoma\n2. Angiosarcoma\n3. Lymphoma\n4. Malignant pheochromocytoma\n5. Neuroblastoma\n6. Metastasis\n7. Collision tumor\n$=$ concomitant benign adenoma + metastasis\nFrequency: in $2 \\%$ of patients with known primary\nN.B.: Percutaneous biopsy may be falsely negative $\\leftarrow$ sampling of the benign component!\n\n## Benign Adrenal Lesion\n\n1. Adenoma\n2. Myelolipoma\n3. Adrenal cyst\n4. Adrenal hemorrhage\n5. Ganglioneuroma\n6. Schwannoma\n7. Hemangioma\n8. Lymphangioma of adrenal gland",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 955,
            "markdown": "9. Granuloma\n10. Pheochromocytoma\n11. Adenomatoid tumor\n12. Oncocytoma of adrenal gland\n\n# Adrenal Tumor in Childhood \n\n1. Neuroblastoma (most common extracranial solid tumor)\n2. Pheochromocytoma\n3. Adrenocortical carcinoma\n4. Lymphoma\n\n## Cystic Adrenal Mass\n\n1. Pseudocyst: old hemorrhage / infarction\n2. Vascular cystic space (endothelial lining): lymphangioma, hemangioma\n3. True cyst (epithelial lining): glandular cyst, embryonal cyst, mesothelial inclusion cyst\n4. Parasitic cyst: hydatid cyst\n5. Hemorrhagic complication / degeneration of a tumor:\ncystic adenoma, cystic pheochromocytoma, cystic adenomatoid tumor, cystic\nadrenocortical carcinoma, schwannoma with cystic degeneration\n6. Neuroblastoma (rare)\n7. Cortical adenoma with low density\n\n## Adrenal Calcification\n\nA. TUMOR\n\n1. Neuroblastoma\n2. Pheochromocytoma\n3. Adrenal adenoma\n4. Adrenal carcinoma\n5. Dermoid\nB. VASCULAR\n6. Hemorrhage (neonatal, sepsis)\nC. INFECTION\n7. Tuberculosis\n8. Histoplasmosis\n9. Waterhouse-Friderichsen syndrome\nD. ENDOCRINE\n10. Addison disease (TB)\nE. OTHERS\n11. Wolman disease\n\n## Adrenal Hemorrhage\n\n## Unilateral Adrenal Hemorrhage\n\nA. TRAUMA ( $80 \\%$ )\nB. BLEEDING INTO UNDERLYING ADRENAL TUMOR\n\n1. Pseudocyst",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 956,
            "markdown": "2. Myelolipoma\n3. Hemangioma\n4. Pheochromocytoma\n5. Adrenocortical adenoma / carcinoma\n6. Metastasis: bronchogenic carcinoma, angiosarcoma, melanoma\n\n# Bilateral Adrenal Hemorrhage \n\nA. NEONATAL STRESS\n$\\diamond$ Most common neonatal lesion of adrenal gland\n\n1. Difficult labor / delivery: forceps / breech delivery\n2. Asphyxia / hypoxia $\\leftarrow$ prematurity\n3. Septicemia\n4. Hemorrhagic disorders: DIC, hypoprothrombinemia\n5. Extracorporeal membrane oxygenation (in 4\\%)\n6. Thrombus extending from renal vein thrombosis\n\nPredisposed: infants large for gestational age, infants of diabetic mothers\nAge: $1^{\\text {st }}$ week of life\nSite: $\\mathrm{R}+\\mathrm{L}=7+3$; bilateral in $10 \\%$\nB. ADULT STRESS\n\nPathophysiology:\nstress $\\rightarrow$ severalfold $\\uparrow$ in endogenous secretion of adrenocorticotropic hormone $\\rightarrow$\n$\\uparrow$ in adrenal vascularity; $\\uparrow$ in catecholamines, thrombin, fibrin, endotoxin during shock $\\rightarrow$ venoconstriction + venous thrombosis $\\rightarrow$ intraglandular hemorrhage\n\n1. Surgery: orthotopic liver transplantation\n2. Sepsis: Waterhouse-Friderichsen syndrome (= fulminant meningococcemia);\n\nPseudomonas infection; other gram-negative organisms\n3. Burns\n4. Hypotension\n5. Pregnancy\n6. Cardiovascular disease\n7. Exogenous adrenocorticotropic hormone\n8. Exogenous steroids\nC. HEMORRHAGIC DIATHESIS \\& COAGULOPATHY\n\n1. Anticoagulant therapy (heparin, coumadin): during initial 3 weeks\n2. Disseminated intravascular coagulopathy\n3. Antiphospholipid syndrome $\\pm$ systemic lupus erythematosus (hypercoagulable state causes adrenal vein thrombosis + venous infarction)\n\n## KIDNEY\n\n## Developmental Renal Anomalies\n\n## Numerary Renal Anomaly\n\n1. Supernumerary kidney\n2. Complete / partial renal duplication",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 957,
            "markdown": "3. Abortive calyx\n4. Unicaliceal (unipapillary) kidney\n\n# Renal Underdevelopment \n\n1. Congenital renal hypoplasia\n2. Renal agenesis\n3. Renal dysgenesis\n\n## Renal Ectopia\n\nNormal location of kidneys: $1^{\\text {st }}-3^{\\text {rd }}$ lumbar vertebra\nPrevalence: $0.2 \\%$ (autopsy series)\nCause: failure of kidney to ascend by 8 weeks GA\nAt risk of: infection, calculi, hydronephrosis $\\leftarrow$ UPJ obstruction\n$\\sqrt{ }$ unusual developmental \"funny-looking calyces\" often misinterpreted as obstructive\n$\\sqrt{ }$ loop-to-loop colon = abnormal looped configuration of colon occupying the renal fossa\n\n## Longitudinal Renal Ectopia\n\nLocation: pelvic, sacral, lower lumbar level, intrathoracic; $\\mathrm{L}>\\mathrm{R}$\n$\\sqrt{ }$ must demonstrate aberrant arteries\n$D D x$ : displacement through diaphragmatic hernia (nonaberrant); hypermobile kidney\n\n## Pelvic Kidney\n\n$=$ ectopic kidney $\\leftarrow$ failure of renal ascent\nPrevalence: $1 \\div 725$ births\nMay be associated with:\n(1) Vesicoureteral reflux\n(2) Hydronephrosis $\\leftarrow$ abnormally high insertion of ureter into renal pelvis\n(3) Hypospadia (common)\n(4) Contralateral renal agenesis\n$\\sqrt{ }$ blood supply via iliac vessels / aorta\n$\\sqrt{ }$ nonrotation $=$ anteriorly positioned renal pelvis (common)\n\n## Crossed Renal Ectopia\n\n$=$ kidney located on opposite side of midline from its ureteral orifice; usually $\\mathrm{L}>\\mathrm{R}$ and crossed kidney inferior to normal kidney\n(a) fused (common)\n(b) separate (rare)\n\nCause: ? faulty development of ureteral bud, vascular obstruction of renal ascent\nAssociated with: obstruction urolithiasis, infection, reflux, megaureter, hypospadia, cryptorchidism, urethral valves, multicystic dysplasia\n$\\sqrt{ }$ invariably aberrant renal arteries\n$\\sqrt{ }$ distal ureter inserts into trigone on the side of origin\n\n## Renal Fusion Anomalies\n\n$=$ \"lump / cake, disk, horseshoe\"\n$C x$ : aberrant arteries may cross and obstruct ureter",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 958,
            "markdown": "# Horseshoe Kidney \n\n$=$ fusion of lower renal poles with isthmus across midline anterior to aorta\nPrevalence: $1 \\div 400$ live births\nAssociated with: vertebral, anorectal, tracheal, esophageal malformations\n$\\sqrt{ }$ anomalous vascular supply\n$\\sqrt{ }$ anomalous renal rotation\n$C x$ : varying degrees of obstruction, stone formation, infection\n\n## Disc / Pancake Kidney\n\n$=$ bilateral fused pelvic kidneys\nAssociated with: abnormal testicular descent, tetralogy of Fallot, vaginal agenesis, sacral agenesis, caudal regression, anal anomalies\n\n## Renal Malrotation\n\n$\\sqrt{ }$ collecting structures may be positioned ventrally (most common), lateral (rare), dorsal (rarer), transverse (along AP axis)\n$\\sqrt{ }$ \"funny-looking calices\" = developmental usually nonobstructive ectasia\n\n## Absent Renal Outline on Plain Film\n\nA. ABSENT KIDNEY\n\n1. Congenital absence\n2. S/P nephrectomy\nB. SMALL KIDNEY\n3. Renal hypoplasia\n4. Renal atrophy\nC. RENALECTOPIA\n5. Pelvic kidney\n6. Crossed fused ectopia\n7. Intrathoracic kidney\nD. OBLITERATION OF PERIRENAL FAT\n8. Perirenal abscess\n9. Perirenal hematoma\n10. Renal tumors\n\n## Perinephric Fat Stranding\n\n$\\sqrt{ }$ nonspecific perirenal cobwebs\nPathophysiology: engorged lymphatics, edema, fluid extravasation from pyelosinus\n\n1. Acute obstructing renal calculus: ureteral colic\n2. Infection\n3. Infarction\n4. Neoplasm\n5. Trauma\n6. Renal vein thrombosis\n\n## Nonvisualized Kidney on Excretory Urography\n\nA. ABSENCE OF KIDNEY",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 959,
            "markdown": "1. Agenesis\n2. Surgical absence\n3. Renal ectopia\nB. LOSS OF PERFUSION\n4. Chronic infarction\n5. Unilateral renal vein thrombosis\nC. TRAUMA\n6. Thrombosis of main renal artery\n7. Severe contusion $\\rightarrow$ renal vasospasm\n8. Avulsion of renal pedicle\nD. HIGH-GRADE URINARY OBSTRUCTION\n9. Hydronephrosis\n10. Ureteropelvic junction obstruction\nE. REPLACED NORMAL RENAL PARENCHYMA\n11. Multicystic dysplastic kidney\n12. Unilateral polycystic kidney disease\n13. Renal tumor (RCC, TCC, Wilms tumor)\n14. Xanthogranulomatous pyelonephritis\n\n# Faceless Kidney \n\n$=$ absence of normal components of renal sinus (renal parenchyma, fat and collecting system) on cross-sectional imaging\n\n1. Duplicated collecting system\n2. Urothelial renal tumor (TCC, SCC)\n3. Lymphoma of kidney\n4. Inflammatory / infectious mass\n\n## Unilateral Large Smooth Kidney\n\nA. PRERENAL\n(a) arterial: acute arterial infarction\n(b) venous: acute renal vein thrombosis\nB. INTRARENAL\n(a) congenital: duplicated pelvicaliceal system, crossed fused ectopia, multicystic dysplastic kidney, adult polycystic kidney (in $8 \\%$ unilateral)\n(b) infectious: acute bacterial nephritis\n(c) adaptation: compensatory hypertrophy\nC. POSTRENAL\n(a) collecting system: obstructive uropathy\nmnemonic: AROMA\nAcute pyelonephritis\nRenal vein thrombosis\nObstructive uropathy\nMiscellaneous (compensatory hypertrophy, duplication)\nArterial obstruction (infarction)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 960,
            "markdown": "# Bilateral Large Kidneys \n\nAverage renal length by x-ray: $\\mathrm{M}=13 \\mathrm{~cm} ; \\mathrm{F}=12.5 \\mathrm{~cm}$\n\n1. PROTEIN DEPOSITION amyloidosis, multiple myeloma\n2. INTERSTITIAL FLUID ACCUMULATION acute tubular necrosis, acute cortical necrosis, acute arterial infarction, renal vein thrombosis\n3. CELLULAR INFILTRATION\n(a) Inflammatory cells: acute interstitial / bacterial nephritis\n(b) Malignant cells: leukemia / lymphoma, bilateral Wilms tumor, nephroblastomatosis\n4. PROLIFERATIVE / NECROTIZING DISORDERS\n(a) Glomerulonephritis (GN) acute (poststreptococcal) GN, rapidly progressive GN, idiopathic membranous GN, glomerulosclerosis, lobular GN, IgA nephropathy, membranoproliferative GN, glomerulosclerosis related to heroin abuse\n(b) Multisystem disease polyarteritis nodosa, systemic lupus erythematosus, Wegener granulomatosis, allergic angiitis, diabetic glomerulosclerosis, Goodpasture syndrome (lung hemorrhage + glomerulonephritis), Schönlein-Henoch syndrome (anaphylactoid purpura), thrombotic thrombocytopenic purpura, focal glomerulonephritis associated with subacute bacterial endocarditis\n5. URINE OUTFLOW OBSTRUCTION bilateral hydronephrosis: congenital / acquired\n6. HORMONAL STIMULUS acromegaly, compensatory hypertrophy, nephromegaly associated with cirrhosis / hyperalimentation / diabetes mellitus\n7. DEVELOPMENTAL bilateral renal duplication, horseshoe kidney, polycystic kidney disease\n8. MISCELLANEOUS acute urate nephropathy, glycogen storage disease, hemophilia, sickle cell disease, Fabry disease, physiologic response to contrast material and diuretics\nmnemonic: FOG P\nFluid: edema of kidney (ATN, acute cortical necrosis)\nOther: leukemia, acromegaly, sickle cell anemia, bilateral duplication, acute urate nephropathy\nGlomerular disease: acute GN, lupus, polyarteritis nodosa, diabetes mellitus\nProtein deposition: multiple myeloma, amyloidosis\n\n## Bilateral Small Kidneys\n\nA. PRERENAL $=$ VASCULAR\n\n1. Arterial hypotension (acute)\n2. Generalized arteriosclerosis\n3. Atheroembolic disease\n4. Benign \\& malignant nephrosclerosis\nB. INTRARENAL\n5. Hereditary nephropathies: medullary cystic disease, hereditary chronic nephritis (Alport syndrome)\n6. Chronic glomerulonephritis\n7. Amyloidosis (late)\nC. POSTRENAL\n8. Papillary necrosis\nD. CAUSES OF UNILATERAL SMALL KIDNEY above causes occurring bilaterally",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 961,
            "markdown": "mnemonic: CAPE HANA\nChronic glomerulonephritis\nArteriosclerosis\nPapillary necrosis\nEmbolic disease $\\leftarrow$ atherosclerosis\nHypotension\nAlport syndrome\nNephrosclerosis\nAmyloidosis (late)\n\n# Unilateral Small Kidney \n\nA. PRERENAL $=$ VASCULAR\n\n1. Lobar infarction\n2. Chronic infarction\n3. Renal artery stenosis\n4. Radiation nephritis\nB. INTRARENAL $=$ PARENCHYMAL\n5. Congenital hypoplasia\n6. Multicystic dysplastic kidney (in adult)\n7. Postinflammatory atrophy\nC. POSTRENAL = COLLECTING SYSTEM\n8. Reflux nephropathy = chronic atrophic pyelonephritis\n9. Postobstructive atrophy\nmnemonic: RIP R HIP\nReflux atrophy\nIschemia: renal artery stenosis\nPostobstructive atrophy\nRadiation therapy\nHypoplasia: congenital\nInfarction\nPostinflammatory atrophy\n\n## Increased Echogenicity of Renal Cortex\n\n$=$ RENALMEDICAL DISEASE\n$=$ diffuse increase in cortical echogenicity with preservation of corticomedullary junction\nPath: deposition of collagen / calcium in interstitial, glomerular, tubular, vascular disease\n$\\sqrt{ }$ echointensity of cortex greater than liver / spleen $\\pm$ equal to renal sinus\n$\\sqrt{ }$ renal size may be normal; enlarged kidneys suggest active stage of renal disease; small kidneys suggest chronic + often end-stage renal disease\nCause:\n\n1. Acute / chronic glomerulonephritis\n2. Renal transplant rejection\n3. Lupus nephritis\n4. Hypertensive nephrosclerosis\n5. Renal cortical necrosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 962,
            "markdown": "6. Methemoglobulinuric renal failure\n7. Alport syndrome\n8. Amyloidosis\n9. Diabetic nephrosclerosis\n10. Nephrotoxin-induced acute tubular necrosis\n11. End-stage renal disease\n\n# Hyperechoic Renal Pyramids in Children \n\nA. MEDULLARY NEPHROCALCINOSIS\nB. METABOLIC DISEASE\n\n1. Gout\n2. Lesch-Nyhan syndrome (urate)\n3. Fanconi syndrome\n4. Glycogen storage disease (distal RTA)\n5. Wilson disease (distal RTA)\n6. Alpha-1 antitrypsin deficiency\n7. Tyrosinemia\n8. Cystinosis\n9. Oxalosis\n10. Crohn disease\nC. HYPOKALEMIA\n11. Primary aldosteronism\n12. Pseudo-Bartter syndrome\nD. PROTEIN DEPOSITS\n13. Infant dehydration with presumed Tamm-Horsfall proteinuria\n14. Toxic shock syndrome\nE. VASCULAR CONGESTION\n15. Sickle cell disease\nF. INFECTION\n16. Candida / CMV nephritis\n17. AIDS-associated Mycobacterium avium-intracellulare\nG. FIBROSIS OF RENAL PYRAMIDS\nH. CYSTIC MEDULLARY DISEASE\n18. Medullary sponge kidney\n19. Congenital hepatic fibrosis with tubular ectasia\nI. INTRARENAL REFLUX\n20. Chronic pyelonephritis\n\n## Hyperechoic Pyramids in Neonate\n\n1. Transient hyperechogenicity (4-58\\%): resolves within 10 days or longer in prematurity Cause: uncertain\n2. Obstructed hydronephrosis\n3. Ischemia: ATN, medullary / cortical necrosis, renal vein thrombosis\n4. Infection: candida\n5. Polycystic kidney disease: ADPKD, Beckwith-Wiedemann syndrome",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 963,
            "markdown": "6. Metabolic\n\n# Iron Accumulation in Kidney \n\nA. RENAL CORTEX\n\n1. Paroxysmal nocturnal hemoglobulinuria (= intravascular extrasplenic hemolysis)\n2. Sickle cell anemia\nB. RENAL MEDULLA\n3. Hemorrhagic fever with renal syndrome (uncommon viral illness caused by Hantavirus)\n\nTriad: (1) Renal medullary hemorrhage\n(2) Right atrial hemorrhage\n(3) Necrosis of anterior pituitary\n\n## Cold Defect on Renal Scintigraphy\n\nmnemonic: CHAT SIN\nCyst\nHematoma\nAbscess\nTumor\nScar\nInfarct\nNeoplasm\n\n## Abnormal Uptake of Bone Agents within Kidneys\n\n1. Effect of chemotherapeutic drugs: bleomycin, cyclophosphamide, doxorubicin, mitomycin C, 6-mercaptopurine\n2. S/P radiation therapy\n3. Metastatic calcification\n4. Pyelonephritis\n5. Acute tubular necrosis\n6. Iron overload\n7. Multiple myeloma\n8. Renal vein thrombosis\n9. Ureteral obstruction\n\n## Incidental Urinary Tract Abnormalities during Bone Scintigraphy\n\n$>50 \\%$ of injected dose of ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-MDP is excreted by 3 hours\nA. Bilateral diffuse increased uptake\n$=$ uptake greater than that of lumbar spine\n(a) excess tissue calcium\n\n1. Hyperparathyroidism\n2. Hypercalcemia\n3. Osteosarcoma metastatic to kidney\n(b) tissue damage\n4. Drug-induced nephrotoxicity\n> chemotherapy: eg, cyclophosphamide, vincristine, doxorubicin, bleomycin,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 964,
            "markdown": "mitomycin-C, S-6-mercaptopurine, mitoxantrone\n> aminoglycosides\n$>$ amphotericin B\n2. Radiation therapy\n3. Necrotic renal cell carcinoma (rare)\n4. Renal metastasis (rare)\n5. Acute pyelonephritis\n6. Acute tubular necrosis\n7. Multiple myeloma\n(c) iron overload\n\n1. Sickle cell anemia\n2. Thalassemia major\n\nmnemonic: RICH CON\nRadiation therapy to kidney\nIron overload\nChemotherapy (cytoxan, vincristine, doxorubicin)\nHyperparathyroidism\nCalcification (metastatic), Carcinoma\nObstruction (urinary)\nNephritis, Normal variant\nB. Bilateral decreased renal uptake\n(a) loss of renal function\n\n1. End-stage renal disease\n(b) increased osteoblastic activity (= superscan)\nC. Focally decreased renal uptake\n(a) space-occupying lesion replacing renal parenchyma\n2. Abscess\n3. Cyst\n4. Primary / metastatic renal neoplasm\n(b) scar\n5. Infarct\n6. Chronic pyelonephritis\n7. Partial nephrectomy\nD. Uni- / bilateral focally increased GU uptake $\\leftarrow$ urine accumulation\n8. Normal upper pole calyces: in supine position\n9. Urinary tract diversion / ileal conduit\n10. Urinoma\nE. Change in location of kidney\n11. Congenital anomaly: eg, pelvic kidney\n\n# Depression of Renal Margins \n\n1. Fetal lobation\n$\\checkmark$ notching between normal calyces\n2. Splenic impression\n$\\checkmark$ flattened upper outer margin of left kidney",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 965,
            "markdown": "3. Chronic atrophic pyelonephritis\n$\\sqrt{ }$ indentation over clubbed calyces\n4. Renal infarct\n$\\sqrt{ }$ normal calyces\n5. Chronic renal ischemia\n$\\sqrt{ }$ normal calyces\n\n# Enlargement of Iliopsoas Compartment \n\nA. INFECTION\n(a) from retroperitoneal organs\n\n1. Renal infection\n2. Complicated pancreatitis\n3. Postoperative aortic graft infection\n(b) from spine\n4. Osteomyelitis / postoperative complication of bone surgery\n5. Diskitis / postoperative complication $\\leftarrow$ disk surgery\n(c) from GI tract\n6. Crohn disease\n7. Appendicitis\n(d) others\n8. Pelvic inflammatory disease / postpartum infection\n9. Sepsis\nB. HEMORRHAGE\n10. Coagulopathy and anticoagulant therapy\n11. Ruptured aortic aneurysm\n12. Postoperative aneurysm repair / other surgery / trauma\nC. NEOPLASTIC DISEASE\n(a) extrinsic\n13. Lymphoma\n14. Metastatic lymphadenopathy\n15. Bone metastases with soft-tissue involvement\n16. Retroperitoneal sarcoma\n(b) intrinsic\n17. Muscle tumors\n18. Nervous system tumors\n19. Lipoma / liposarcoma\nD. MISCELLANEOUS\n20. Pseudoenlargement of psoas muscle compared with de facto atrophy of contralateral side in neuromuscular dz\n21. Fluid collection: urinoma, lymphocele, pancreatic pseudocyst, enlargement of iliopsoas bursa\n22. Pelvic venous thrombosis\n$\\sqrt{ }$ diffuse swelling of all muscles (edema)\n\n## RENAL MASS",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 966,
            "markdown": "# Renal Tumors in Adults by Histology (WHO 2004) \n\nA. Renal cell tumor\nB. Metanephric tumor\nC. Mesenchymal tumor\n(a) benign:\n\n1. Angiomyolipoma\n2. Leiomyoma of kidney\n3. Hemangioma of kidney\n4. Lymphangioma of kidney\n5. Juxtaglomerular cell tumor\n6. Renomedullary interstitial cell tumor\n7. Solitary fibrous tumor\n8. others: lipoma, schwannoma\n(b) malignant:\n$\\diamond$ Primary renal sarcomas account for $1-3 \\%$ of all malignant renal tumors!\n9. Leiomyosarcoma of kidney (50-60\\%)\n10. Others: synovial sarcoma, osteosarcoma, fibrosarcoma, rhabdomyosarcoma, angiosarcoma, malignant fibrous histiocytoma, solitary fibrous tumor\nD. Mixed mesenchymal and epithelial tumor\nE. Neuroendocrine tumor\nF. Germ cell tumor\n\n## Renal Mass in Neonate\n\nA. UNILATERAL\n\n1. Multicystic kidney (15\\%)\n2. Hydronephrosis (25\\%)\n(a) UPJ obstruction\n(b) upper moiety of duplication\n3. Renal vein thrombosis\n4. Mesoblastic nephroma\n$\\diamond$ Most common primary renal neoplasm in $1^{\\text {st }}$ month of life\n5. Rare: Wilms tumor, teratoma\n![img-96.jpeg](img-96.jpeg)\nB. BILATERAL",
            "images": [
                {
                    "id": "img-96.jpeg",
                    "top_left_x": 183,
                    "top_left_y": 1526,
                    "bottom_right_x": 1506,
                    "bottom_right_y": 1909,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 967,
            "markdown": "1. Hydronephrosis\n2. Polycystic kidney disease\n3. Multicystic kidney + contralateral hydronephrosis\n4. Nephroblastomatosis\n5. Bilateral multicystic kidney\n\n# Renal Tumors in 1st Decade of Life \n\n1. Wilms tumor\n2. Cystic nephroma and cystic partially differentiated nephroblastoma\n3. Mesoblastic nephroma\n4. Clear cell sarcoma\n5. Rhabdoid tumor\n6. Ossifying renal tumor of infancy\n7. Renal cell carcinoma\n8. Angiomyolipoma\n9. Metanephric stromal tumor\n\n## Renal Mass in Older Child\n\nA. SINGLE MASS\n(a) single solid mass\n\n1. Wilms tumor $87 \\%$\n2. Clear cell sarcoma of kidney $6 \\%$\n3. Mesoblastic nephroma $2 \\%$\n4. Rhabdoid tumor $2 \\%$\n5. Renal cell carcinoma $<0.5 \\%$\n6. Teratoma\n7. Intrarenal neuroblastoma\n(b) single cystic mass\n8. Focal hydronephrosis\n9. Multilocular cystic nephroma\n10. Traumatic cyst, abscess\nB. MULTIPLE MASSES\n11. Nephroblastomatosis\n12. Multiple Wilms tumors\n13. Angiomyolipoma\n14. Lymphoma $(<0.5 \\%)$\n15. Leukemia\n16. Adult polycystic kidney disease\n17. Abscesses\n\n## Bilateral Renal Masses\n\nA. MALIGNANT TUMOR\n\n1. Malignant lymphoma / Hodgkin disease\n2. Metastases\n3. Renal cell carcinoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 968,
            "markdown": "4. Wilms tumor\nB. BENIGN TUMOR\n5. Angiomyolipoma\n6. Nephroblastomatosis\nC. CYSTS\n7. Adult polycystic kidney disease\n8. Acquired cystic kidney disease\n\n# Unilateral Renal Mass \n\n## Solid Renal Mass\n\nA. TUMORS\n(a) primary malignant:\n> epithelial tumor of renal parenchyma: adenocarcinoma ( $83 \\%$ ), papillary neoplasm ( $14 \\%$ ), chromophobe carcinoma ( $4 \\%$ ), renal neuroendocrine tumors (carcinoid, small cell carcinoma), Wilms tumor (6\\%)\n> epithelial tumor of renal pelvis: TCC (8\\%), squamous cell carcinoma\n> medullary tumor: renal medullary carcinoma, renal collecting duct carcinoma $=$ Bellini duct carcinoma ( $1 \\%$ )\n> renal sarcoma ( $2 \\%$ )\nin horseshoe kidney:\nadenocarcinoma (45\\%), Wilms tumor (28\\%), transitional cell carcinoma (20\\%)\n(b) secondary malignant: malignant lymphoma / Hodgkin disease, metastases, invasive transitional cell carcinoma\n(c) benign: adenoma, oncocytoma, hamartoma (mesoblastic nephroma, angiomyolipoma, myolipoma, lipoma, leiomyoma, fibroma), hemangioma\nB. INFLAMMATORY MASSES\nacute focal pyelonephritis, renal abscess, malakoplakia, xanthogranulomatous\npyelonephritis, tuberculoma\n\n## Fluid-filled Renal Lesion\n\nA. CYSTS\n\n1. Simple renal cyst\n$\\checkmark$ simple fluid attenuation of $0-20 \\mathrm{HU}$\n2. Complicated renal cyst\n3. Inherited cystic disease:\nmulticystic dysplastic kidney disease (Potter type II), multilocular cystic nephroma\n4. Focal hydronephrosis\nB. VASCULAR\n5. Arteriovenous malformation\n6. Arteriovenous fistula\nC. CYSTIC MASS\n7. Renal cell carcinoma\n$\\diamond$ Lesions $<1 \\mathrm{~cm}$ often cannot be clearly characterized!\n$\\diamond$ Lesions $1-1.5 \\mathrm{~cm}$ can often be ignored, particularly in elderly / patients with significant",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 969,
            "markdown": "other disease\n\n# Calcified Renal Mass \n\n$\\diamond$ A calcified renal mass is malignant in $75 \\%$ of cases!\n$\\diamond$ Lesions with\n(a) nonperipheral calcifications are malignant in $87 \\%$ !\n(b) peripheral calcifications are malignant in $20 \\%$ !\nA. MALIGNANT TUMOR\n\n1. Renal cell carcinoma (calcifies in $8-20 \\%$ )\n$\\checkmark$ calcifications generally nonperipheral, sometimes along fibrous capsule\n2. Wilms tumor\n3. Transitional cell carcinoma (rare)\n4. Osteosarcoma of renal capsule\n5. Metastasis\nB. INFECTION\n6. Abscess\n$\\diamond$ Tuberculous abscess frequently calcifies!\n$\\diamond$ Pyogenic abscess rarely calcifies!\n7. Echinococcal cyst\n$\\diamond$ Renal involvement in $3 \\%$ of hydatid disease;\n$\\diamond 50 \\%$ of echinococcal cysts calcify\n8. Xanthogranulomatous pyelonephritis\n$\\checkmark$ large obstructive calculus in $>70 \\%$\nC. CYSTS\n$\\diamond$ Calcification is related to prior hemorrhage / infection!\n9. Simple renal cyst (calcifies in $1-3 \\%$ )\n$\\checkmark$ thin peripheral \"eggshell\"-like calcification\n10. Multicystic dysplastic kidney (in adult)\n11. Autosomal dominant polycystic kidney disease\n12. Milk of calcium: cyst, caliceal diverticulum, obstructed hydrocalyx\n$D D x$ : residual pantopaque used in cyst puncture\nD. VASCULAR\n13. Subcapsular / perirenal hematoma\n14. Renal artery aneurysm\n$\\checkmark$ circular cracked eggshell appearance\n15. Congenital / posttraumatic arteriovenous malformation\n16. Arteriosclerosis: in severe atherosclerotic disease, diabetes mellitus, hyperparathyroidism\n17. Sloughed papilla: in papillary necrosis\n18. Hemangioma\n\n## Avascular Mass in Kidney\n\nmnemonic: CHEAT\nCyst\nHematoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 970,
            "markdown": "Edema\nAbscess\nTumor\n\n# Growth Pattern of Renal Lesions \n\n## Renal Lesion with Expansile Growth Pattern\n\n1. Renal cell carcinoma\n2. Oncocytoma\n3. Angiomyolipoma\n4. Juxtaglomerular tumor\n5. Metastatic tumor: eg, lymphoma\n6. Mesenchymal tumor\n\n## Renal Lesions with Infiltrative Growth Pattern\n\nImaging hallmarks:\n$\\checkmark$ growth initially respects renal contour\n$\\checkmark$ invasion of normal structures\n$\\checkmark$ poorly defined interface between normal renal parenchyma and lesion\n$\\checkmark$ enlarged kidney with preservation of reniform shape\nIVP:\n$\\checkmark$ decreased / absent nephrogram\nAngio:\n$\\checkmark$ vascular encasement, pruning, amputation\n$\\checkmark$ no vascular displacement\nCT:\n$\\checkmark$ poorly marginated area of diminished enhancement\n$\\checkmark$ encasement of collecting system without displacement\n$\\checkmark$ replacement of renal sinus fat\nUS:\n$\\checkmark$ poorly circumscribed hypo- / hyperechoic regions\nA. NEOPLASM\n(a) lymphoproliferative\n\n1. Lymphoma / leukemia\n2. Extramedullary plasmacytoma\n(b) epithelial tumor of renal parenchyma\n3. Renal cell carcinoma (unusual)\n4. High-grade and sarcomatoid type of RCC\n(c) epithelial tumors of the renal pelvis\n5. Invasive transitional cell carcinoma\n$\\checkmark$ mass arises from collecting system\n6. Squamous cell carcinoma\n(d) medullary tumor of uncertain cell origin\n7. Collecting duct carcinoma\n8. Renal medullary carcinoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 971,
            "markdown": "(e) metastases: esp. lung cancer\n(f) renal sarcomas\n(g) pediatric tumor\n\n1. Mesoblastic nephroma\n2. Rhabdoid tumor of the kidney\n3. Nephroblastomatosis\n4. Primitive neuroectodermal tumor\n5. Wilms tumor (unusual)\nB. INFLAMMATION\n6. Bacterial pyelonephritis\n7. Xanthogranulomatous pyelonephritis\n8. Renal parenchymal malakoplakia\n\n# Local Bulge in Renal Contour \n\nA. CYST\n\n1. Simple renal cyst\nB. TUMOR\n2. Adenocarcinoma\n3. Angiomyolipoma\n4. Pseudotumor\nC. INFECTION\n5. Subcapsular abscess\n6. XGP\nD. TRAUMA\n7. Subcapsular hematoma\nE. DILATED COLLECTING SYSTEM\n\n## Hyperechoic Renal Nodule\n\nA. MALIGNANT TUMOR\n\n1. Renal cell carcinoma\n2. Angiosarcoma\n3. Liposarcoma\n4. Undifferentiated sarcoma\n5. Lymphoma\nB. BENIGN TUMOR\n6. Angiomyolipoma\n7. Lipoma\n8. Oncocytoma\n9. Cavernous hemangioma\nC. INFARCT\nD. HEMATOMA\n\nFocal Area of Increased Renal Echogenicity\nA. NONNEOPLASTIC\n\n1. Chronic renal infarction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 972,
            "markdown": "2. Acute focal bacterial nephritis\nB. BENIGN TUMOR\n3. Angiomyolipoma\n4. Cavernous renal hemangioma\n5. Oncocytoma\nC. MALIGNANCY\n6. Renal cell carcinoma\n7. Angiosarcoma\n8. Undifferentiated sarcoma\n9. Metastasis\n\n# Hyperattenuating Renal Mass on NECT \n\n$=$ attenuation higher than\n(a) renal parenchyma $(>40 \\mathrm{HU})$\n(b) $>20 \\mathrm{HU}$ (more restrictive definition)\n\n## Pathogenesis:\n\n(a) elevated iron content\n(b) blood breakdown products, high protein content, colloid formation\n(c) infection\n(d) transient iodine accumulation in cyst\n(e) completely solid mass\n(f) diffuse microcalcifications\nA. BENIGN\n\n1. Complicated benign cyst: hemorrhagic, protein-rich, gelatinous (most common), eg, in autosomal dominant polycystic kidney disease\n2. Hematoma, renal contusion\n3. Vascular abnormality: AVM, pseudoaneurysm, aneurysm, thrombosed renal vein\n4. Focal inflammation: focal bacterial nephritis\n5. Angiomyolipoma ( $4-5 \\%$ without fat)\n6. Metanephric adenoma\n7. Leiomyoma\nB. MALIGNANT\n8. Malignant multiseptate cyst: multilocular cystic nephroma, cystic renal cell carcinoma\n9. Renal cell carcinoma ( $2 \\%$ hyperattenuating)\n10. Papillary renal cell carcinoma\n11. Lymphoma (rare)\n12. Oncocytoma (rare)\n13. Metastasis from thyroid carcinoma\n\n## Fat-containing Renal Mass\n\n1. Angiomyolipoma\n2. Lipoma, liposarcoma\n3. Teratoma\n4. Wilms tumor\n5. Xanthogranulomatous pyelonephritis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 973,
            "markdown": "6. Oncocytoma engulfing renal sinus fat\n7. Renal cell carcinoma\n(a) invasion of perirenal fat\n(b) intratumoral metaplasia into fatty marrow (in $32 \\%$ of RCCs $<3 \\mathrm{~cm}$ in diameter)\n$\\diamond$ If a lesion contains fat + calcium RCC is likely, NOT angiomyolipoma!\n\n# Renal Pseudotumor \n\n$=$ normal renal tissue mimicking a renal mass\nA. PRIMARY / CONGENITAL\n\n1. Large column of Bertin\n$=$ LARGE SEPTUM / CLOISON OF BERTIN = LARGE CLOISON = FOCAL CORTICAL HYPERPLASIA = BENIGN CORTICAL REST = FOCAL RENAL HYPERTROPHY\n$=$ persistence of normal septal cortex / excessive infolding of cortex usually in the presence of partial or complete duplication\nLocation: between upper and interpolar portion\n$\\sqrt{ }$ mass $<3 \\mathrm{~cm}$ in largest diameter\n$\\sqrt{ }$ lateral indentation of renal sinus\n$\\sqrt{ }$ \"deformation\" of adjacent calyces + infundibula\n$\\sqrt{ }$ mass continuous with renal cortex\n$\\sqrt{ }$ enhancement pattern like renal cortex\n$\\sqrt{ }$ echogenicity similar to cortex\n2. Dromedary hump\n$=$ SUBCAPSULAR NODULE $=$ SPLENIC BUMP\nCause: prolonged pressure by spleen during fetal development\nLocation: in mid portion of lateral border of left kidney\n$\\sqrt{ }$ triangular contour + elongation of middle calyx\n$\\sqrt{ }$ enhancement pattern like renal cortex\n3. Hilar lip\n$=$ SUPRA- / INFRAHILAR BULGE\n$=$ medial part of kidney above / below sinus\nLocation: most frequently medial to left kidney just above renal pelvis (on transaxial scan)\n$\\sqrt{ }$ enhancement pattern like cortex with medulla\n4. Fetal lobation\n$=$ PERSISTENT CORTICAL LOBATION = REN LOBATUS\n$=14$ individual lobes with centrilobar cortex located around calyces\n5. Lobar dysmorphism complete diminutive lobe situated deep within renal substance with its own diminutive calyx in its central portion = calyx of nonresorbed normal junctional parenchyma between upper + lower subkidneys\nB. ACQUIRED\n6. Nodular compensatory hypertrophy areas of unaffected tissue in the presence of focal renal scarring from chronic atrophic pyelonephritis (= reflux nephropathy), surgery, trauma, infarction\n$\\sqrt{ }$ hypertrophy usually evident within 2 months; less likely to occur $>$ age 50",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 974,
            "markdown": "$\\sqrt{ }$ \"mass\" enhances identically to renal parenchyma\n$D D x$ : accessory spleen, medial lobule of spleen, splenosis, normal / abnormal bowel, pancreatic disease, gallbladder, adrenal abnormalities\n$D x$ : static radionuclide imaging / renal arteriography / CT\n\n# Pseudokidney Sign \n\n= sonographic mass of reniform appearance with a central hyperechoic region surrounded by a hyperechoic region\n\n1. Intussusception\n2. Necrotizing enterocolitis\n3. Midgut volvulus\n4. Sigmoid volvulus\n5. Crohn disease\n\nFalse-positive:\nfeces in colon, perforated Meckel diverticulum with malrotation + Ladd bands, psoas muscle, hematoma\n\n## RENAL CYSTIC DISEASE\n\n## Potter Classification\n\n$=$ POTTER SYNDROME\n$=$ any renal condition associated with severe oligohydramnios\n\n- peculiar facies with wide-set eyes, parrot-beak nose, pliable low-set ears, receding chin\n\nType I : infantile PCKD\nType II : multicystic dysplastic kidney disease, multilocular cystic nephroma\nIla: kidneys of normal / increased size\nIIb : kidneys reduced in size\nType III : adult PCKD, tuberous sclerosis, medullary sponge kidney\nType IV : small cortical cysts / cystic dysplasia $\\leftarrow$ ureteropelvic junction obstruction\n\n## Renal Cystic Disease\n\nA. GENETIC CYSTIC DISEASE\n\n1. Autosomal dominant polycystic kidney disease\n2. Autosomal recessive polycystic kidney disease\n3. Medullary sponge kidney\n4. Medullary cystic disease\n5. Glomerulocystic kidney disease\nB. OBSTRUCTIVE CYSTIC DISEASE\n6. Multicystic dysplastic kidney\n7. Segmental / focal renal dysplasia\n8. Familial renal dysplasia\nC. ACQUIRED CYSTIC DISEASE\n9. Simple cyst\n10. Parapelvic cyst\n11. Acquired cystic disease of uremia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 975,
            "markdown": "4. Infectious cysts: TB, Echinococcus, abscess\n5. Medullary necrosis\n6. Pyelogenic cyst\n7. Lithium-induced nephropathy\nD. CYSTS ASSOCIATED WITH SYSTEMIC DISEASE\n8. Tuberous sclerosis\n9. Von Hippel-Lindau disease\nE. CYSTIC TUMORS\n10. Multilocular cystic nephroma\n11. Cystic Wilms tumor\n12. Cystic renal cell carcinoma\n13. Mixed epithelial and stromal tumor\n\nFocal Renal Cystic Disease\n\n1. Mixed epithelial and stromal tumor\n2. Multilocular cystic nephroma\n3. Pyelocalyceal diverticulum\n\nAcquired Multifocal Cystic Renal Disease\n\n1. Glomerulocystic kidney disease\n2. Lithium-induced nephropathy\n3. Acquired cystic kidney disease\n4. Multicystic dysplastic kidney\n5. Localized cystic renal disease\n6. Renal sinus cyst\n\n# Cystic Kidney Infection \n\n1. Renal abscess\n2. Renal aspergillosis\n3. Renal echinococcosis\n\n## Renal Cystic Disease in Adults\n\nA. HEREDITARY\n\n1. Autosomal dominant polycystic kidney disease\n2. Von Hippel-Lindau disease\n3. Tuberous sclerosis complex\n4. Medullary cystic kidney disease\nB. NONHEREDITARY\n5. Acquired cystic kidney disease\n6. Medullary sponge kidney\n7. Multicystic dysplastic kidney\n8. Localized renal cystic disease\n\n## Syndromes with Multiple Cortical Renal Cysts\n\n1. Von Hippel-Lindau syndrome\n2. Tuberous sclerosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 976,
            "markdown": "3. Meckel-Gruber syndrome\n4. Jeune syndrome\n5. Zellweger syndrome $=$ cerebrohepatorenal syndrome\n6. Conradi syndrome $=$ chondrodysplasia punctata\n7. Orofacialdigital syndrome\n8. Trisomy 13\n9. Turner syndrome\n10. Dandy-Walker malformation\n\n# Multiloculated Renal Mass \n\n$=>3-4$ septations\n$R x:$ most multiloculated renal masses are treated with excision / nephrectomy\nA. NEOPLASTIC DISEASE\n\n1. Cystic renal cell carcinoma\n2. Multilocular cystic renal tumor\n(a) adult cystic nephroma\n(b) cystic partially differentiated nephroblastoma\n3. Cystic Wilms tumor\n4. Necrotic tumor\n(a) mesoblastic nephroma\n(b) clear cell sarcoma\nB. RENAL CYSTIC DISEASE\n5. Localized renal cystic disease\n6. Septated cyst\n7. Multicystic dysplastic kidney\n8. Segmental multicystic dysplasia\n9. Complicated cyst\nC. INFLAMMATORY DISEASE\n10. Echinococcus\n11. Segmental XGP\n12. Abscess\n13. Malakoplakia\nD. VASCULAR LESIONS\n14. AV fistula\n15. Organizing hematoma\n\n## ABNORMAL NEPHROGRAM\n\n## Absence of Nephrogram\n\n## Global Absence of Nephrogram\n\nPathophysiology: complete renal ischemia $\\leftarrow$ occlusion of main renal artery\n\n1. Injury to vascular pedicle during blunt abdominal trauma\n2. Thromboembolic disease\n3. Renal artery dissection: spontaneous, traumatic, iatrogenic",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 977,
            "markdown": "# Segmental Absence of Nephrogram \n\nA. SPACE-OCCUPYING PROCESS\n\n1. Neoplasm\n2. Cyst\n3. Abscess\nB. FOCAL RENAL INFARCTION\n4. Arterial embolus / thrombosis\n5. Vasculitis, collagen-vascular disease\n6. Sickle cell anemia\n7. Septic shock\n8. Renal vein thrombosis\n\n## Rim Nephrogram\n\n$=$ rim of cortex receiving collateral blood flow from capsular, peripelvic, and periureteric vessels\n$\\diamond$ Most specific indicator of renovascular compromise!\n$\\sqrt{ } 2-4-\\mathrm{mm}$ peripheral band of cortical opacification\nCause: 1. Acute total main renal artery occlusion: in $50 \\%$ of cases with renal infarction\n2. Renal vein thrombosis\n3. Acute tubular necrosis\n4. Severe chronic urinary obstruction\n$D D x$ : severe hydronephrosis (rim / shell nephrogram surrounding dilated calyces)\n\n## Unilateral Delayed Nephrogram\n\nA. OBSTRUCTIVE UROPATHY\nB. REDUCTION IN RENAL blood flow\n\n1. Renal artery stenosis\n2. Renal vein thrombosis\n\n## Striated Nephrogram\n\n$=$ streaky linear bands of alternating hyper- and hypoattenuation parallel to axis of tubules + collecting ducts during excretory phase\nCause:\nstasis of contrast material in dilated collecting ducts on background of edematous renal parenchyma $\\leftarrow$ diminished concentration of contrast material in tubules $\\leftarrow$ ischemia + tubular obstruction by inflammatory cells + debris\nA. UNILATERAL\n\n1. Acute ureteric obstruction\n2. Acute bacterial nephritis / pyelonephritis\n3. Renal contusion\n4. Renal vein thrombosis\nB. BILATERAL\n5. Acute pyelonephritis\n6. Intratubular obstruction: Tamm-Horsfall proteinuria, rhabdomyolysis with myoglobinuria",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 978,
            "markdown": "3. Systemic hypotension\n4. Autosomal recessive PCKD\n5. Medullary sponge kidney\n6. Medullary cystic disease\nmnemonic: CHOIR BOY\nContusion\nHypotension (systemic)\nObstruction (ureteral)\nIntratubular obstruction\nRenal vein thrombosis\nBacterial nephritis (acute)\nObstruction (ureteral) — it is so common!\nYes, also cystic diseases: infantile PCKD, medullary cystic disease, medullary sponge kidney\n\n# Persistent Nephrogram \n\nA. BILATERAL GLOBAL\n\n1. Systemic hypotension\n2. Intratubular obstruction from protein:\n\nTamm-Horsfall, Bence-Jones, myoglobin\n3. Tubular damage by contrast material\nB. UNILATERAL GLOBAL\n\n1. Renal artery stenosis\n2. Renal vein thrombosis\n3. Urinary tract obstruction\nC. SEGMENTAL\n4. Obstructed moiety of duplicated collecting system\n5. Obstructing renal calculus\n6. Obstructing neoplasm\n7. Focal stricture\n8. Focal parenchymal disease: tubulointerstitial infection\n\n## Abnormal Nephrogram due to Impaired Perfusion\n\nA. SYSTEMIC HYPOTENSIVE REACTION as a reaction to contrast material / cardiac failure / dehydration / shock\nPathophysiology:\ndrop in perfusion pressure after contrast reaches kidney $\\rightarrow$ increased salt + water reabsorption and slowed tubular transit\n$\\checkmark$ prolonged bilateral dense nephrograms $=$ persistent increasing nephrogram\n$\\checkmark$ decrease in renal size\n$\\checkmark$ loss of pyelogram after initial opacification\nNUC (use of glomerular filtration agent [eg, ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-DTPA] preferred)\n$\\checkmark$ prolonged cortical transit + reduced excretion\nB. RENAL ARTERY STENOSIS\n$\\checkmark$ decreased nephrographic opacity + rim nephrogram",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 979,
            "markdown": "$\\checkmark$ hyperconcentration in collecting system\n$\\checkmark$ ureteral notching\nNUC (glomerular filtration agent [eg, ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-DTPA] preferred):\n$\\checkmark$ decreased perfusion with prolonged excretory phase\nC. IMPAIRED PERFUSION OF SMALL ARTERIES\n\nTrueta shunting $=$ transient rerouting of blood flow from cortex to medulla\nCause:\n(a) reflex vasospasm during arterial angiography $\\leftarrow$ catheter trauma / pressure injection of highly concentrated contrast medium\n(b) chronic renal disorders: collagen vascular disease, malignant nephrosclerosis, chronic glomerulonephritis\n(c) necrotizing vasculitis (polyarteritis nodosa), scleroderma, hypertensive nephrosclerosis\nCT, Angio:\n$\\checkmark$ inhomogeneous opacification of cortex\n$\\checkmark$ spotted nephrogram\nIVP:\n$\\checkmark$ irregular cortical nephrogram $=$ spotted nephrogram (DDx: scleroderma, hypertensive nephrosclerosis)\nD. ACUTE VENOUS OUTFLOW OBSTRUCTION in renal vein thrombosis\n$\\checkmark$ obstructive nephrogram\n$\\checkmark$ progressive increase in opacity of entire kidney\n\n# Abnormal Nephrogram due to Impaired Tubular Transit \n\nNUC: before decrease in renal function $\\rightarrow$ use of glomerular filtration agent (eg, 99mTcDTPA); with decrease in renal function $\\rightarrow$ use of plasma flow agents (eg, 99 mTc - $\\mathrm{MAG}_{3}$ / 123 I-Hippuran ${ }^{\\circledR}$ ) is preferred\nCause:\nA. EXTRARENAL: ureteric obstruction (eg, stone)\n$\\checkmark$ obstructive nephrogram\nNUC:\n$\\checkmark$ continuous increase in renal activity\n$\\checkmark$ dilatation of collecting system\nB. INTRARENAL\n(a) segmental: limb of duplication system, caliceal obstruction, interstitial edema $\\checkmark$ segmental nephrogram\n(b) protein precipitation: Tamm-Horsfall protein (a normal mucoprotein product of proximal nephrons), Bence-Jones protein (multiple myeloma), uric acid precipitation (acute urate nephropathy), myoglobulinuria, hyperproteinuric state\n$\\checkmark$ striated nephrogram\nNUC:\n$\\checkmark$ prolonged cortical transit time + prolonged excretory phase\n\n## Abnormal Nephrogram due to Abnormal Tubular Function\n\nPathophysiology:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 980,
            "markdown": "# A. PROXIMAL TUBULE \n\nFunction: reabsorbs almost all of glucose, amino acids, phosphate, bicarbonate\n\n- glycosuria: Toni-Fanconi syndrome\n- aminoaciduria: cystinuria\n- phosphaturia: phosphate diabetes, thiazides\n- HCO3- wasting: proximal renal tubular acidosis\nB. DISTALTUBULE\n\nFunction: absorbs most of water\n\n- diabetes insipidus, secretes $\\mathrm{H}+$\n- distal renal tubular acidosis\n\n1. Acute tubular necrosis\n$\\checkmark$ immediate persistent nephrogram (common)\n$\\checkmark$ progressive increasing opacity (rare)\n2. Contrast-induced renal failure\n\n## Striated Angiographic Nephrogram\n\n$=$ random patchy densities reflecting redistribution of blood flow from the cortical vasculature to vasa recta of medulla\n\n1. Obliterative diseases of renal microvasculature: polyarteritis nodosa, scleroderma, necrotizing angiitis, catheter-induced vasospasm\n2. Acute bacterial nephritis\n3. Renal vein thrombosis\n\n## Increasingly Dense Nephrogram\n\n$=$ initially faint nephrogram becoming increasingly dense over hours to days\nMechanism:\n(a) diminished plasma clearance of contrast material\n(b) leakage of contrast material into renal interstitial space\n(c) increase in tubular transit time\n\nCause:\nA. VASCULAR = diminished perfusion\n\n1. Systemic arterial hypotension (bilateral)\n2. Severe main renal artery stenosis (unilateral)\n3. Acute tubular necrosis (in 33\\%):\n$\\leftarrow$ contrast material nephrotoxicity\n4. Acute renal vein thrombosis\nB. INTRARENAL\n5. Acute glomerular disease\nC. COLLECTING SYSTEM\n6. Intratubular obstruction\n(a) uric acid crystals = acute urate nephropathy\n(b) precipitation of Bence-Jones protein = myeloma nephropathy\n(c) Tamm-Horsfall protein: in severely dehydrated infants / children\n7. Acute extrarenal obstruction: ureteral calculus",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 981,
            "markdown": "# Vicarious Contrast Material Excretion during IVP \n\n$=$ biliary contrast material detected radiographically following intravenous administration of contrast material\nNormal contrast excretion:\n$<2 \\%$ of urographic dose of diatrizoates + iothalamates are handled by hepatobiliary excretion\nPathophysiology: increase in protein binding $\\leftarrow$ prolonged intravascular contact + acidosis\nCause:\n\n1. Uremia (reduction in glomerular filtration + uremia-associated acidosis)\n2. Acute unilateral obstruction (increase in circulation time + transient intracellular acidosis)\n3. Spontaneous urinary extravasation (prolonged vascular contact of contrast material)\n\n## RENAL DOPPLER\n\nA. NORMAL RENAL DOPPLER\n$\\sqrt{ }$ resistive index (RI) of $0.70=$ upper limit of normal\nElevation of RI:\n> significant systemic hypotension\n> markedly decreased heart rate\n> perinephric / subcapsular fluid collection\n> in neonates + infants\nB. RENAL MEDICAL DISEASE\n\nElevation of RI:\nmore likely with vascular / tubulointerstitial process: less likely with glomerular disease\nMay be useful in predicting clinical outcome in:\n> hemolytic-uremic syndrome\n> acute renal failure\n> nonazotemic patients with severe liver disease\nC. RENAL ARTERY STENOSIS\nD. RENAL VEIN THROMBOSIS\n\n## COLLECTING SYSTEM\n\n## Spontaneous Urinary Contrast Extravasation\n\n$=$ SPONTANEOUS PYELORENAL BACKFLOW\nEtiology: physiologic \"safety valve\" for obstructed urinary tract with pressures of 80-100 mmHg in collecting system $\\leftarrow$ ipsilateral ureteral obstruction $\\leftarrow$ distal stone impaction; pressure is proportional to degree + duration of acute obstruction + dose of contrast material\nPrevalence: $0.1-18 \\% ; \\mathrm{M}>\\mathrm{F}$ (male ureter less compliant)\nCriteria: absence of\n(a) recent ureteral instrumentation\n(b) previous renal / ureteral surgery\n(c) destructive urinary tract lesion",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 982,
            "markdown": "(d) external trauma\n(e) external compression\n(f) pressure necrosis due to stone\n\nTypes:\n\n1. Pyelotubular backflow\n$=$ opacification of terminal portions of collecting ducts ( $=$ papillary ducts $=$ ducts of Bellini) as a physiologic phenomenon (in $13 \\%$ with low osmolality + in $0.4 \\%$ with high osmolality contrast media), wrongly termed \"backflow\"\n$\\sqrt{ }$ wedge-shaped brushlike lines from calyx toward periphery\n2. Pyelosinus backflow\n$=$ contrast extravasation from ruptured fornices along infundibula, renal pelvis, proximal ureter; most common form\nCx: urinoma, retroperitoneal fibrosis\n3. Pyelointerstitial backflow\n$=$ contrast flow from pyramids into subcapsular tubules\n4. Pyelolymphatic backflow\n$=$ contrast extravasation into periforniceal + peripelvic lymphatics\n$\\sqrt{ }$ visualization of small lymphatics draining medially\n5. Pyelovenous backflow\n$=$ forniceal rupture into interlobar / arcuate veins; rare\n\n# Widened Collecting System \\& Ureter \n\n## Fetal pyelectasis:\n\nAP diameter of renal pelvis $<5 \\mathrm{~mm}<20$ weeks MA\n$<8 \\mathrm{~mm} 20-30$ weeks MA\n$<10 \\mathrm{~mm}>30$ weeks MA\nA. OBSTRUCTIVE UROPATHY\nB. NONOBSTRUCTIVE WIDENING\n(a) congenital\n\n1. Megacalycosis\n= underdevelopment of papillae; usually unilateral\n2. Congenital primary megaureter\n$=$ widened ureter with normally tapered distal end\n3. Megacystis-megaureter syndrome\n4. Prune-belly syndrome\n5. Bardet-Biedl syndrome\n6. Beckwith-Wiedemann syndrome\n7. Megalourethra\n(b) increased urine volume\n8. High-flow states: diabetes insipidus, osmotic diuresis, dehydrated patient undergoing rehydration, unilateral kidney\n9. Vesicoureteral reflux\n(c) atony of renal collecting system\n10. Infection: ie, acute pyelonephritis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 983,
            "markdown": "2. Pregnancy\n3. Retroperitoneal fibrosis\n(d) overdistended urinary bladder\n(e) previous long-standing significant obstruction: dilatation remains in spite of relief of obstruction\n\n# Caliceal Abnormalities \n\nA. OPACIFICATION OF COLLECTING TUBULES\n\n1. Pyelorenal backflow\n2. Medullary sponge kidney\nB. PAPILLARY CAVITY\n3. Papillary necrosis\n4. Caliceal diverticulum\n5. Tuberculosis / brucellosis\nC. LOCALIZED CALIECTASIS\n6. Reflux nephropathy = chronic atrophic pyelonephritis\n7. Compound calyx\n8. Hydrocalyx\n9. Congenital megacalyx\n10. Localized postobstructive caliectasis\n11. Localized tuberculosis / papillary necrosis\nD. GENERALIZED CALIECTASIS\n12. Postobstructive atrophy\n13. Congenital megacalices\n14. Obstructive uropathy (hydronephrosis)\n15. Nonobstructive hydronephrosis\n16. Diabetes insipidus\n\n## Filling Defect in Collecting System\n\nmnemonic: 6 C\"'s \\& 2 P's\nClot\nCancer\nCyst\nCalculus\nCandida + other fungi\nCystitis cystica\nPolyp\nPapilla (sloughed)\n\n## Nonopaque Intraluminal Mass in Collecting System\n\nA. NONOPAQUE CALCULUS uric acid, xanthine, matrix $\\sqrt{ }$ smooth, rounded, not attached\nB. TISSUE SLOUGH\n\n1. Papillary necrosis\n2. Cholesteatoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 984,
            "markdown": "3. Fungus ball = conglomeration of fibrillar hyphae\n4. Inspissated debris (\"mucopus\")\nC. VASCULAR\n5. Blood clot: history of hematuria\n$\\checkmark$ change in appearance over time\nD. FOREIGN MATERIAL\n6. Air from bladder via reverse peristalsis, direct trauma, renoalimentary fistula\n7. Foreign matter\n\n# Mucosal Mass in Collecting System \n\nA. NEOPLASTIC\n(a) benign tumor\n\n1. Aberrant papilla = papilla without calyx protruding into major infundibulum\n2. Endometriosis\n3. Fibroepithelial polyp\n(b) malignant tumor\n> uroepithelial tumors\n4. Transitional cell carcinoma ( $85-91 \\%$ )\n5. Squamous cell carcinoma ( $7-10-15 \\%$ )\n\nPredisposing factors: calculi (50-60\\%), chronic infection, leukoplakia, phenacetin abuse\n$\\checkmark$ infiltrating / superficially spreading\n3. Mucinous adenocarcinoma\n$=$ metaplastic transformation\n4. Sarcoma (extremely rare)\n> metastases: breast (most common), melanoma, stomach, lung, cervix, colon, prostate\nB. INFLAMMATION / INFECTION\n\n1. Tuberculosis\n2. Candidiasis\n3. Schistosomiasis\n4. Pyeloureteritis cystica\n5. Leukoplakia\n6. Malakoplakia\n7. Xanthogranulomatous pyelonephritis\nC. VASCULAR\n(a) submucosal hemorrhage\n8. Trauma\n9. Anticoagulant therapy\n10. Acquired circulating anticoagulants\n11. Complication of crystalluria / microlithiasis\n$\\checkmark$ thumbprinting with progressive improvement\n(b) vascular notching\n12. Ureteropelvic varices\n13. Renal vein occlusion",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 985,
            "markdown": "3. IVC occlusion\n4. Vascular malformation\n5. Retroaortic left renal vein\n6. \"Nutcracker\" effect on left renal vein between aorta and SMA\n7. Polyarteritis nodosa\nD. PROMINENT MUCOSAL FOLDS\n8. Redundant longitudinal mucosal folds of intermittent hydronephrosis: UPJ obstruction, vesicoureteral reflux / after relief of obstruction\n9. Chemical / mechanical irritation\n10. Urticaria: Stevens-Johnson syndrome $=$ erythema multiforme bullosa\n11. Leukoplakia $=$ squamous metaplasia\n12. Ureteral diverticulosis $=$ rupture of the roofs of cysts in ureteritis cystica\n\n# Effaced Collecting System \n\nA. EXTRINSIC COMPRESSION\n(a) Uni- / bilateral global enlargement of renal parenchyma\n(b) Renal sinus masses\n\n1. Hemorrhage\n2. Parapelvic cyst\n3. Sinus lipomatosis\nB. SPASM / INFLAMMATION\n(a) infection\n4. Acute pyelonephritis\n5. Acute bacterial nephritis\n6. Acute tuberculosis\n(b) hematuria\nC. INFILTRATION\n7. Malignant uroepithelial tumors\nD. OLIGURIA\n8. Antidiuretic state\n9. Renal ischemia\n10. Oliguric renal failure",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 986,
            "markdown": "# RENAL SINUS \n\n## Renal Sinus Mass\n\nA. TUMOR\n(a) renal pelvis\n\n1. Transitional cell carcinoma $(90 \\%)$\n2. Squamous cell carcinoma $(9 \\%)$\n3. Mucinous adenocarcinoma $(1 \\%)$\n(b) renal parenchyma\n4. Renal cell carcinoma\n5. Multilocular cystic nephroma\n6. Plasmacytoma\n(c) mesenchymal tumor (rare): hemangioma, lipoma, angiomyolipoma, fibroma, leiomyoma, neurogenic tumor, teratoma; sarcomas (eg, leiomyosarcoma)\n(d) retroperitoneal\n7. Lymphoma\n8. Metastasis to sinus lymph nodes\n9. Myeloid metaplasia\nB. NONTUMOROUS CONDITION\n(a) fat\n10. Sinus lipomatosis\n(b) fluid\n11. Renal sinus cyst\n12. Urinoma\n(c) vessels\n13. Renal artery aneurysm\n$\\checkmark$ annular calcifications in $>50 \\%$\n$D D x$ : renal calculus\n14. Arteriovenous communication\n15. Renal varix\n\n## Hypoechoic Renal Sinus\n\nA. SOLID\n\n1. Fibrolipomatosis\n2. Column of Bertin\n3. Duplex kidney\n4. TCC / RCC\nB. CYSTIC\n5. Renal sinus cysts\n6. Caliectasis\n7. Dilated veins, varix\n8. Aneurysm, arteriovenous malformation\n\n## RENAL CALCIFICATION",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 987,
            "markdown": "# Retroperitoneal Calcification \n\nA. NEOPLASM\n\n1. Wilms tumor (in $10 \\%$ )\n2. Neuroblastoma (in 50\\%): fine granular / stippled / amorphous\n3. Teratoma: cartilage / bone / teeth, pseudodigits, pseudolimbs\n4. Cavernous hemangioma: phleboliths\nB. INFECTION\n5. Tuberculous psoas abscess\n6. Hydatid cyst\n7. Alkaline-encrusted cystitis and pyelitis\nC. TRAUMA\n8. Old hematoma\n\n## Nephrocalcinosis\n\n$=$ diffuse fine radiologically demonstrable calcifications deposited as calcium salts in renal parenchyma\n$D D x$ : Nephrolithiasis (= \"kidney stones\" = renal calculi = radiopaque / nonradiopaque hard crystalline minerals formed within lumen of the urinary tract (renal collecting system, ureter, bladder $=$ urolithiasis)\nnephros, Greek = kidney; lithos, Greek = stone; calx, Latin = lime; calculus, Latin = pebble; osis, Greek = abnormal condition = \"full of\"\nPrevalence: $0.1-6 \\% ; \\mathrm{M}>\\mathrm{F}$\nCause:\nmnemonic: MARC\nMedullary sponge kidney\nAlkali excess\nRenal medullary / cortical necrosis, RTA\nChronic glomerulonephritis\nHyperoxaluria, Hypercalcemia, Hypercalciuria\n\n## Medullary Nephrocalcinosis ( $95 \\%$ )\n\n$=$ calcifications involving the distal convoluted tubules in the loops of Henle\nFrequency: $95 \\%$ of all nephrocalcinoses\nCause:\nA. HYPERCALCIURIA\n(a) endocrine\n\n1. Hyperparathyroidism in $5 \\%\\left(1^{\\circ}>>2^{\\circ}\\right)$\n2. Paraneoplastic syndrome of lung + kidney $\\leftarrow$ ectopic parathormone production\n3. Cushing syndrome\n4. Diabetes insipidus\n5. Hyperthyroidism / hypothyroidism\n6. Glycogen storage disease Type I\n(b) alimentary\n7. Absorptive hypercalcemia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 988,
            "markdown": "2. Milk-alkali syndrome $=$ excess calcium + alkali $\\leftarrow$ milk + antacids\n3. Hypervitaminosis D\n4. Beryllium poisoning\n(c) osseous\n5. Osseous metastases, multiple myeloma\n6. Prolonged immobilization\n7. Progressive senile osteoporosis\n(d) renal\n8. Medullary sponge kidney\n9. Distal renal tubular acidosis (in $73 \\%$ of primary RTA)\n10. Chronic glomerulonephritis\n11. Bartter syndrome tubular disorder with potassium + sodium wasting, hyperplasia of juxtaglomerular apparatus, hyperaldosteronism, hypokalemic alkalosis, and normal blood pressure\n(e) drug therapy\n12. Furosemide (in infants)\n13. Prolonged ACTH therapy\n14. Vitamin E (orally)\n15. Vitamin D excess\n16. Calcium (orally)\n17. Nephrotoxic drugs: outdated tetracycline, amphotericin B\n(f) miscellaneous\n18. Sarcoidosis\n19. Idiopathic hypercalciuria\n20. Idiopathic hypercalcemia\n21. Sjögren syndrome (distal RTA)\n(g) genetic\n22. Williams syndrome\n23. Kenny-Caffey syndrome\nB. HYPEROXALURIA $=$ OXALOSIS\nC. HYPERURICOSURIA = urate crystal deposition\n24. Gouty kidney (adult)\n25. Lesch-Nyhan syndrome (child)\nD. URINARY STASIS\n26. Milk-of-calcium in pyelocaliceal diverticulum\n27. Medullary sponge kidney\nE. DYSTROPHIC CALCIFICATION\n28. Renal papillary necrosis $\\leftarrow$ especially analgesic nephropathy\n29. Chronic pyelonephritis\n30. Sickle cell disease\n31. Renal tuberculosis\n\n# mnemonic: HAM HOP \n\nHyperparathyroidism\nAcidosis (renal tubular)\nMedullary sponge kidney",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 989,
            "markdown": "Hypercalcemia / hypercalciuria (sarcoidosis, milk-alkali syndrome, hypervitaminosis D)\n\nOxalosis\nPapillary necrosis\n$\\sqrt{ }$ normal-sized / occasionally enlarged kidneys (medullary sponge kidney)\n$\\sqrt{ }$ small poorly defined / large coarse granular calcifications in renal pyramids:\n$\\checkmark$ uniform deposition: hyperparathyroidism / distal renal tubular acidosis (type 1)\n$\\checkmark$ asymmetric deposition in dilated collecting ducts within papillary tips: medullary sponge kidney\nUS:\n$\\checkmark$ absence of hypoechoic papillary structures (earliest sign)\n$\\checkmark$ hyperechoic rim at corticomedullary junction + around tip and sides of pyramids\n$\\checkmark$ solitary focus of hyperechogenicity at tip of pyramid near fornix\n$\\checkmark$ increased echogenicity of renal pyramids $\\pm$ shadowing (no acoustic shadowing with small + light calcifications)\nDDx of hyperechoic medulla in newborns:\noliguria with transient tubular blockage by Tamm-Horsfall proteinuria\n$C x$ : often followed by urolithiasis\n\n# Medullary Nephrocalcinosis in Children \n\n- Normocalcemia + Hypercalciuria\n(a) iatrogenic\n\n1. Furosemide\n2. Corticotropin therapy\n(b) noniatrogenic\n3. Distal renal tubular acidosis\n4. Idiopathic hypercalciuria\n5. Bartter syndrome\n6. Hyperprostaglandin E syndrome\n7. Hypomagnesemia\n8. Cushing syndrome\n9. Cystinosis\n10. Glycogen storage disease Type 1\n11. Tyrosinemia\n12. Beckwith-Wiedemann syndrome\n13. Hypothyroidism\n\n- Hypercalcemia + Hypercalciuria\n\n1. X-linked hypophospatemic rickets\n2. Hyperparathyroidism\n3. Hypophosphatasia\n4. Sarcoidosis\n5. Vitamin D intoxication\n6. Williams syndrome\n7. Subcutaneous fat necrosis\n8. Idiopathic infantile hypercalcemia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 990,
            "markdown": "- Normocalcemia + Normocalciuria\n\n1. Acetazolamide\n2. Hyperoxaluria\n\n# Cortical Nephrocalcinosis (5\\%) \n\n= calcium deposition in renal cortex\nFrequency: $5 \\%$ of all nephrocalcinoses\nCause:\n\n1. Acute cortical necrosis\n2. Chronic glomerulonephritis\n3. Alport syndrome\n4. Congenital oxalosis, primary hyperoxaluria\n5. Chronic paraneoplastic hypercalcemia\n6. Toxic: ethylene glycol, methoxyflurane\n7. Sickle cell disease\n8. Rejected renal transplant\nmnemonic: COAG\nCortical necrosis (acute)\nOxalosis\nAlport syndrome\nGlomerulonephritis (chronic)\n$\\sqrt{ }$ thin rim of calcification with a \"tramline\" appearance\n$\\sqrt{ }$ spotty appearance (= preferential deposition in necrotic glomeruli)\nUS:\n$\\checkmark$ homogeneously increased echogenicity of renal parenchyma $>$ liver echogenicity\n\n## Calcification of Pyelocaliceal System\n\n1. Staghorn calculus\n2. Nephrolithiasis\n3. Papillary necrosis\n4. Renal tuberculosis\n5. Leukoplakia\n6. Alkaline-encrusted pyelitis\n7. Primary carcinoma of renal pelvis\n8. Renal pelvic argyrosis $\\leftarrow$ contact with silver nitrate\n9. Amyloidosis\n\n## Spontaneous Retroperitoneal Hemorrhage\n\nA. RENAL TUMOR (57-63\\%)\n(a) malignant tumor (30-33\\%)\n\n1. $\\operatorname{RCC}(33 \\%)$\n2. TCC of renal pelvis\n3. Wilms tumor\n4. Lipo-, fibro-, angiosarcoma\n(b) benign tumor ( $24-33 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 991,
            "markdown": "1. Angiomyolipoma (16-24\\%)\n2. Lipoma\n3. Adenoma\n4. Fibromyoma\n5. Ruptured hemorrhagic cyst\nB. VASCULAR DISEASE (18-26\\%)\n6. Ruptured renal artery aneurysm\n7. Vasculitis: eg, polyarteritis nodosa in $13 \\%$\n8. Arteriovenous malformation\n9. Segmental renal infarction\nC. INFLAMMATION / INFECTION (7-10\\%)\n10. Abscess (in $50 \\%$ of infections)\n11. Acute / chronic nephritis\nD. COAGULOPATHY\n12. Anticoagulant therapy (in 4.3-6.6\\% of IV heparin, in $01 .-0.6 \\%$ of oral anticoagulants)\n\nSource: idiopathic ( $42 \\%$ ), tumor ( $21 \\%$ ), stone disease ( $17 \\%$ ), hemorrhagic cystitis\n2. Bleeding diathesis\n3. Long-term hemodialysis\nE. PRIMARY ADRENAL CYST / TUMOR\n\n1. Pheochromocytoma\n$\\diamond$ Massive bleed $\\leftarrow$ an undiagnosed pheochromocytoma has been lethal in $50 \\%$ !\n2. Pseudocyst\n3. Myelolipoma\n4. Hemangioma\n5. Adrenocortical adenoma / carcinoma\n6. Metastasis\n\n- flank pain of sudden onset\n$\\diamond$ Follow-up CT may be indicated at 3 and 6 months if the source of blood remains indeterminate!\n$\\diamond$ Surgical exploration must be considered to uncover a small renal tumor if the cause of hemorrhage is not determined radiologically!\n\n\n# Subcapsular Hematoma \n\n$\\checkmark$ subcapsular mass with flattening of renal parenchyma\n$\\checkmark$ total resorption / formation of pseudocapsule with calcification\nAngio:\n$\\checkmark$ avascular mass\nCx: Page kidney (ischemia, release of renin, HTN)\n\n## URETER\n\n## Congenital Ureteral Abnormalities\n\nA. URETERAL DUPLICATION (most common)\n\n1. Complete ureteral duplication\n2. Partial ureteral duplication",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 992,
            "markdown": "# B. SMOOTH MUSCLE DYSFUNCTION \n\n1. UPJ obstruction\n2. Primary megaureter\nC. ABNORMAL TERMINATION OF SINGLE URETER\n3. Ectopic ureter\n4. Ureterocele\n5. Vesicoureteral reflux\n\n## Ureteral Deviation in Course\n\nA. LUMBAR URETER\n(a) lateral deviation (common)\n\n1. Hypertrophy of psoas muscle\n2. Enlargement of paracaval / para-aortic lymph nodes\n3. Aneurysmal dilatation of aorta\n4. Neurogenic tumors\n5. Fluid collections: abscess, urinoma, lymphocele, hematoma\n(b) medial deviation\n6. Retrocaval ureter (on right side only)\n7. Circumcaval ureter\n8. Retroperitoneal fibrosis\n9. Inflammatory aortic aneurysm\nB. PELVIC URETER\n(a) medial deviation\n10. Hypertrophy of iliopsoas muscle\n11. Enlargement of iliac lymph nodes\n12. Aneurysmal dilatation of iliac vessels\n13. Bladder diverticulum at UVJ (= Hutch diverticulum)\n14. Following abdominoperineal surgery + retroperitoneal lymph node dissection\n15. Pelvic lipomatosis\n(b) lateral deviation with extrinsic compression\n16. Pelvic mass: eg, fibroids, ovarian tumor\n17. Herniated ureter through inguinal canal\nC. INTENTIONAL SURGICAL DIVERSION\nileal conduit, continent cutaneous diversion, orthotopic neobladder\n\n## Ureteral Dilatation / Hydroureter\n\nA dilated ureter is not necessarily obstructed; an obstructed ureter is not always dilated.\nSize of ureter: $>3 \\mathrm{~mm}$\nA. OBSTRUCTION\n\n1. Ureterolithiasis\nB. CONGENITAL\n2. Chronic vesicoureteral reflux\n3. Posterior urethral valves\n4. Megaloureter",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 993,
            "markdown": "4. Prune-belly syndrome\n5. Ectopic ureter\n6. Ureterocele\nC. INFECTION / INFLAMMATION impairing ureteral peristalsis\n7. UTI: eg, E. coli, Pseudomonas, Citrobacter\n8. Appendicitis\n9. Diverticulitis\nD. COMPRESSION\n10. Pelvic / abdominal mass\n11. Vessel:\n> retroiliac / retrocaval course of ureter\n> ovarian vein syndrome\n\n# Unilateral Hydroureter \n\n(a) obstruction: calculus, tumor, clot, sloughed papilla, stricture, extrinsic compression, mass effect\n(b) resolved obstruction (if distension was severe)\n\n## Bilateral Hydroureter\n\n1. Polyuria / diuresis\n2. Bladder outlet obstruction\n3. Neurogenic bladder\n4. Pregnancy: $\\mathrm{R}>\\mathrm{L}$\n\n## Megaureter\n\nA. VESICOURETERAL REFLUX\n(a) primary vesicoureteral reflux\n\n1. Primary reflux megaureter\n\nCause: abnormal ureteral tunnel at UVJ\n2. Prune belly syndrome\n(b) secondary vesicoureteral reflux\n\n1. Hypertonic neurogenic bladder\n2. Bladder outlet obstruction\n3. Posterior urethral valves\nB. OBSTRUCTION\n(a) primary obstruction\n4. Intrinsic ureteral obstruction: stone, stricture, tumor\n5. Ectopic ureter\n6. Ureterocele\n7. Ureteral duplication\n$\\sqrt{ }$ tortuous dilated ureter of upper moiety\n(b) secondary obstruction\n8. Retroperitoneal obstruction: tumor, fibrosis, aortic aneurysm\n9. Bladder wall mass\n10. Bladder outlet obstruction: eg, prostatic enlargement",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 994,
            "markdown": "C. nonreflux-nonobstructed MEGAURETER\n\n1. Congenital primary megaureter $=$ megaloureter\n2. Polyuria: eg, diabetes insipidus, acute diuresis\n3. Infection\n4. Ureter remaining wide after relief of obstruction\nmnemonic: DiaPOUR\nDiabetes insipidus\nPrimary megaureter\nObstruction (recent / old)\nUVJ obstruction\nReflux\n\n# Ureteral Stricture \n\nA stricture is a fixed narrowing with proximal dilatation.\nA. INTRINSIC CAUSE\n(a) mucosal\n\n1. Primary ureteral tumors\n2. Inflammation $\\leftarrow$ stone passage\n(b) mural\n3. Endometriosis\ncommon disorder in menstruating women ( $15 \\%$ ); ureteral involvement is rare and indicates widespread pelvic disease\n$\\checkmark$ abrupt smooth stricture of $0.5-2.5 \\mathrm{~cm}$ length\n$\\checkmark$ rectosigmoid involvement on BE\n4. Infection: tuberculosis, schistosomiasis\n5. Traumatic / iatrogenic\nureterolithotomy, endoscopic stone extraction, gynecologic procedures (esp. hysterectomy), ureteral anastomosis (urinary diversion)\n6. Amyloidosis\n$\\checkmark$ distal stricture with submucosal calcification\n7. Nonspecific (rare)\nB. EXTRINSIC CAUSE\n8. Endometriosis: extrinsic form $\\div$ intrinsic form $=4 \\div 1$\n9. Abscess: tuboovarian, appendiceal, perisigmoidal\n10. Inflammatory bowel disease: eg, Crohn disease, diverticulitis\n11. Radiation fibrosis\n12. Tumor encasement / metastasis: cervix, endometrium, ovary, rectum, prostate, breast, lymphoma\n13. Iliac artery aneurysm $\\rightarrow$ perianeurysmal fibrosis\nmnemonic: MISTER\nMetastasis (extrinsic / intrinsic)\nInflammation from calculus\nSchistosomiasis\nTuberculosis, Transitional cell carcinoma, Trauma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 995,
            "markdown": "Endometriosis + other periureteral inflammatory process\nRadiation therapy, Retroperitoneal fibrosis\nPhysiologic narrowing is common and characterized by absence of proximal dilatation and rapid changeability.\n$D D x$ : Physiologic narrowing\n\n1. Ongoing peristalsis $\\rightarrow$ incomplete opacification resolved on delayed images\n2. Anatomic: UPJ, pelvic brim, UVJ, abrupt turn / kink\n\n# Ureteral Filling Defect \n\nA. FIXED\n(a) neoplasm\n\n1. Urothelial neoplasm\n2. Metastasis\n3. Fibroepithelial polyp\n(b) inflammation / infection\n4. Polyureteritis cystica\n5. Tuberculosis\n6. Fungus: Candida, Aspergillus\n7. Schistosomiasis\n8. Endometriosis\nB. MOBILE\n9. Stone $=$ urolithiasis\n10. Sloughed papilla\n11. Blood clot\n\nCause: trauma, stone, malignancy, anticoagulation\n$\\sqrt{ }$ NO enhancement\n$\\sqrt{ }$ density of $>50 \\mathrm{HU}$ relative to urine and surrounding soft tissues on NECT\n$\\sqrt{ }$ clot resolution at follow-up imaging studies\nC. MULTIPLE\n\n1. Polyureteritis cystica\n2. Malakoplakia\n3. Multifocal urothelial cell cancer\n\nAny ureteral filling defect of soft-tissue attenuation must be considered malignant and requires ureteroscopic assessment, biopsy, and cytologic analysis.\n\n## Ureteral Calcification\n\nA. URETERAL LUMEN\n\n1. Stone: migrated from kidney\n2. Stone: in ureteral diverticulum / ureterocele\n3. Stone street = \"Steinstrasse\" = collection of stone fragments in distal ureter following lithotripsy\nB. URETERAL WALL\n4. Schistosomiasis\n5. Tuberculosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 996,
            "markdown": "3. Amyloid infiltration\n4. Ureteral tumor\n\nDDx: (1) Phlebolith in gonadal vein (multiple, not along course of ureter, centrally radiolucent)\n(2) Orally administered contrast material trapped in appendix / diverticulum\n(3) Dermoid cyst with calcification\n(4) Silastic fallopian tube band\n(5) Radiation seeds used for prostate cancer\n\n# URINARY BLADDER \n\n## Bilateral Narrowing of Urinary Bladder\n\nA. WITH ELEVATION OF BLADDER FLOOR\n\n1. Pelvic lipomatosis\n2. Pelvic hematoma\n\nCause: trauma, anticoagulant therapy, spontaneous rupture of blood vessels, blood dyscrasia (rare), bleeding neoplasm (rare)\n3. Chronic cystitis\nB. WITH SUPERIOR COMPRESSION OF BLADDER\n\n1. Thrombosis of IVC\n\nCause: trauma, hypercoagulability state (oral contra-ceptives), extension of thrombi from lower extremity, abdominal sepsis, Budd-Chiari syndrome, compression of IVC by neoplasm\n$\\sqrt{ }$ collaterals: $\\leftarrow$ gonadal veins, ascending lumbar veins, vertebral plexus, retroperitoneal veins, portal vein (via hemorrhoidal veins)\n$\\sqrt{ }$ notching of distal ureter by ureteral veins\n2. Pelvic lymphadenopathy\n\nCause: lymphoma (most often), prostatic carcinoma\n$\\checkmark$ polycyclic asymmetric compression of bladder\n$\\checkmark$ medial displacement of pelvic segment of ureters\n$\\checkmark$ lateral displacement of upper ureters\n3. Hypertrophy of iliopsoas muscles\n4. Bilateral pelvic masses\n(a) bilateral lymphocysts (after radical pelvic surgery)\n(b) bilateral urinomas\n(c) bilateral pelvic abscesses\n5. Retroperitoneal fibrosis\n6. Large iliac artery aneurysms\n\n## Inverted Pear / Teardrop-shaped Urinary Bladder\n\nmnemonic: PHALL\nPsoas hypertrophy\nHematoma (pelvic)\nAneurysm (bilateral common / external iliac artery)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 997,
            "markdown": "Lipomatosis, pelvic\nLymphadenopathy (pelvic)\n\n# Small Bladder Capacity \n\n## Cause:\n\nA. THICKENED / FIBROTIC BLADDER WALL\n\n1. Interstitial cystitis\n2. Tuberculous cystitis\n3. Cystitis cystica\n4. Schistosomiasis\n5. Trauma: surgical resection, radiation therapy\nB. DISUSE OF BLADDER\n\n- urinary frequency\n- progressive rise in bladder pressure during filling\n$\\checkmark$ reduced bladder compliance\n$\\checkmark$ thickened bladder wall + decreased bladder volume\n$\\checkmark$ vesicoureteral reflux\n\n\n## Bladder Wall Thickening\n\nNormal bladder wall thickness (regardless of age + gender):\n$<5 \\mathrm{~mm}$ in nondistended bladders\n$<3 \\mathrm{~mm}$ in well-distended bladders\nA. TUMOR\n\n1. Neurofibromatosis\nB. INFECTION / INFLAMMATION\n2. Cystitis\nC. MUSCULAR HYPERTROPHY\n3. Neurogenic bladder\n4. Bladder outlet obstruction (eg, posterior urethral valves)\nD. UNDERDISTENDED BLADDER\n\n## Urinary Bladder Wall Masses\n\nA. CONGENITAL\n\n1. Congenital septum\n2. Simple ureterocele\n3. Ectopic ureterocele\nB. BLADDER TUMOR\nC. INFLAMMATION / INFECTION\n4. Cystitis: hemorrhagic cystitis, abacterial cystitis, bullous cystitis, edematous cystitis, interstitial cystitis, cystitis cystica, eosinophilic cystitis, granulomatous cystitis, emphysematous cystitis, cyclophosphamide cystitis, cystitis glandularis (premalignant lesion with villous lesions in bladder dome from proliferation of \"intestinelike\" glands in submucosa)\n5. Tuberculosis\n6. Schistosomiasis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 998,
            "markdown": "4. Malakoplakia\n5. Extravesical inflammation:\n(a) Diverticulitis\n(b) Crohn disease\n(c) endometriosis\nD. HEMATOMA\nafter instrumentation, surgery, trauma\n\n# Bladder Tumor \n\nFrequency: $2-6 \\%$ of all tumors\nA. EPITHELIAL TUMORS ( $95 \\%$ )\n\n1. Urothelial carcinoma $=$ transitional cell carcinoma $(90 \\%)$\n2. Squamous cell carcinoma ( $4 \\%$ in USA) worst prognosis; $\\leftarrow$ chronic disorders (chronic irritation from indwelling catheters, infection, stricture, calculi), cyclophosphamide, smoking, intravesical bacillus Calmette-Guérin, bladder diverticula, schistosomiasis (> $50 \\%$ of bladder tumors in countries with endemic bilharziasis)\n3. Adenocarcinoma ( $1 \\%$ ) most common in bladder exstrophy, less common in cystitis glandularis + urachal carcinoma\n$\\diamond$ Metastatic adenocarcinoma ( $\\leftarrow$ colon, prostate, rectum) more common than primary\n4. Small cell / neuroendocrine carcinoma $(<0.5 \\%)$\n$=$ highly aggressive tumor with invasive disease in $94 \\%$ at presentation\nAge: $20-91$ years; $\\mathrm{M}+\\mathrm{F}=3 \\div 1$ to $5 \\div 1$\n\n- hematuria ( $88 \\%$ )\n\nSize: $3-8 \\mathrm{~cm}$\n$\\sqrt{ }$ large polypoid / nodular tumor\nPrognosis: $16 \\% 5$-year survival rate\n5. Carcinoid\n\nMean size: 6 mm\n6. Melanoma (extremely rare)\nB. NONEPITHELIAL/ MESENCHYMAL TUMORS\n(a) primary benign bladder tumor originating from\n> muscle\n\n1. Leiomyoma $(0.43 \\%)$\n$\\diamond$ Most common nonepithelial tumor\nAge: $22-78$ years; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\n\n- hematuria $\\leftarrow$ ulceration\n\nLocation: arise in submucosa\nSite: submucosal (7\\%) / intravesical (63\\%) / extravesical (30\\%)\n$\\checkmark$ solid homogeneous mass\n$\\checkmark$ smooth indentation of bladder wall\n$\\checkmark$ intraluminal mass $\\pm$ degeneration\n2. Rhabdomyoma (rare)\n> nerve\n\n1. Neurofibroma / NF1 in $60 \\%$\n$\\checkmark$ typically of low attenuation on CT",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 999,
            "markdown": "$\\sqrt{ }$ hypointense mass on T1WI\n$\\sqrt{ }$ \"target\" sign on T2WI in plexiform neurofibroma= central hypointense fibrosis surrounded by hyperintense myxoid stroma\n2. Paraganglioma $=$ pheochromocytoma $(0.1 \\%)$\n$\\diamond 1 \\%$ of all pheochromocytomas\nAge: $10-78$ years; $\\mathrm{M}<\\mathrm{F}$\nOrigin: paraganglia of bladder wall\n\n- adrenergic attack in $50 \\%$ during micturition (\"micturition attack\") or bladder filling (headaches, weakness)\n- intermittent hypertension\n- elevated catecholamine levels\n$\\sqrt{ }$ submucosal mass\n$\\sqrt{ }$ ring calcification around circumference\n$\\sqrt{ }$ marked enhancement (KEY FEATURE)\nN.B.: biopsy may incite hypertensive crisis!\n\nPrognosis: $7 \\%$ are malignant\n> fat\n\n1. Lipoma\nfibrous tissue\n2. Fibroma\n3. Solitary fibrous tumor\nblood vessels\n4. Hemangioma\n\nAge: 58 (range, 19-76) years during adulthood; $50 \\%$ during childhood\nMedian size: 7 (range, 2-30) mm\n2. Plasmacytoma\n3. Nephrogenic adenoma\n\nAssociated with: cystitis cystica / cystitis glandularis\n(b) primary malignant bladder tumor\n\n1. Primary lymphoma\n$\\diamond 2^{\\text {nd }}$ most common nonepithelial tumor of bladder\nAge: 40 years; $\\mathrm{M}+\\mathrm{F}=1 \\div 3$\nHisto: low-grade B-cell mucosa-associated lymphoid tissue (MALT) / diffuse large B-cell type\nLocation: submucosa; at base + trigone of bladder\n2. Rhabdomyosarcoma\n\nAge: $1^{\\text {st }}$ and $2^{\\text {nd }}$ decades of life\n$\\diamond$ Most common bladder tumor in patients $<10$ years\n3. Leiomyosarcoma\n$\\diamond$ Most common nonepithelial malignant bladder tumor\nAge: mainly $>40$ (range, $25-88$ ) years; $\\mathrm{M}+\\mathrm{F}=3 \\div 1$\nLocation: rarely at trigone\nMean size: 7 cm\n$\\checkmark$ poorly circumscribed invasive mass",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        }
    ],
    "model": "mistral-ocr-2503-completion",
    "usage_info": {
        "pages_processed": 1000,
        "doc_size_bytes": 9174657
    }
}